Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
CHL1	"CALL, FLJ44930, L1CAM2, MGC132578"	ENSG00000134121	"Cell adhesion molecule L1 like"	O00533	3	196596-409417	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.9"	"Cell type enhanced"	"Detected in many"	16	"Basal keratinocytes: 20.4;Ciliated cells: 18.7;Muller glia cells: 74.3"	"Cancer enhanced"	"Detected in many"		"glioma: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	56	"memory B-cell: 4.5;naive B-cell: 6.7"	"Lineage enriched"	"Detected in single"	67	"B-cells: 6.7"	"Group enriched"	"Detected in some"	5	"SK-MEL-30: 45.2;WM-115: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003345, CAB026120"	Enhanced				"Intracellular and membrane"	NA	NA		6900000000			"CAB026120: , HPA003345: AB_1078516"	"unprognostic (5.54e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	12.8	4.7	17.8	7.9	32.1	1.1	8.4	7.3	62.9	2.9	10.8	5.0	0.9	4.6	3.9	2.4	8.8	2.8	5.1	10.0	21.2	19.0	17.2	1.5	5.3	5.8	11.1	28.7	16.5	2.4	2.0	3.7	0.8	17.8	3.1	8.1	2.3	7.1	6.9	0.9	12.1	6.1	5.5	9.9	3.3	3.9	2.2	7.5	0.0	1.7	0.0	3.3	2.4	5.3	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	32.1	7.3	36.1	21.2	19.0	11.1	28.7	17.8	7.5	0.0	0.0	0.0	0.6	20.4	1.0	16.1	2.5	18.7	18.2	10.4	0.0	0.0	10.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	6.5	9.0	1.1	1.0	0.0	1.6	0.0	2.5	0.3	1.1	2.6	0.0	3.3	0.0	0.0	74.3	0.1	0.0	0.0	17.0	1.8	0.0	1.0	3.2	0.1	10.7	0.0	0.0	0.0	0.6
CNTN6	NB-3	ENSG00000134115	"Contactin 6"	Q9UQ52	3	1092576-1404217	"Predicted membrane proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 41.4;thyroid gland: 18.9"	"Cell type enriched"	"Detected in some"	6	"Alveolar cells type 1: 32.8"	"Group enriched"	"Detected in some"	15	"renal cancer: 2.7;thyroid cancer: 3.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 41.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"AF22: 5.1;GAMG: 2.4;SH-SY5Y: 5.9;SuSa: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016645	Uncertain					NA	NA		2100000			"HPA016645: AB_1847149"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"		"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.05e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-2)"	0.2	4.7	1.6	0.2	2.2	0.2	0.4	41.4	6.3	0.3	0.3	0.1	0.0	0.2	0.3	0.8	0.3	0.4	0.2	0.4	1.5	3.0	0.5	0.2	5.6	0.2	2.4	2.6	0.2	0.3	0.2	0.5	3.4	7.8	0.2	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.3	1.7	0.2	0.2	0.4	0.3	0.0	18.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	41.4	6.3	1.5	3.0	2.4	2.6	7.8	0.3	32.8	2.2	0.0	0.0	0.0	2.6	0.4	0.0	1.4	5.7	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
CNTN4	BIG-2	ENSG00000144619	"Contactin 4"	Q8IWV2	3	2098813-3057956	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 29.2"	"Cell type enhanced"	"Detected in many"	22	"Bipolar cells: 65.3;Early spermatids: 291.2;Horizontal cells: 95.3;Late spermatids: 104.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"BEWO: 8.7;CACO-2: 9.2;HEK 293: 5.7;SH-SY5Y: 17.6;WM-115: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		89000000				"unprognostic (1.64e-1)"	"unprognostic (7.17e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.00e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	3.7	1.2	5.8	1.5	8.6	0.1	2.9	20.6	14.6	9.2	4.3	0.7	2.0	1.7	7.9	3.1	3.0	4.1	4.8	3.1	2.4	3.2	4.2	2.6	3.4	3.1	3.4	6.8	1.9	1.9	29.2	16.6	7.4	3.1	4.4	3.2	7.6	2.1	5.7	1.4	1.6	3.9	4.4	2.1	0.9	3.2	15.7	0.4	0.4	21.6	1.3	2.4	3.7	4.1	1.0	0.6	1.8	0.5	0.4	0.6	0.1	0.0	0.0	1.2	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	17.6	0.0	0.0	0.1	1.5	0.1	0.2	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.7	1.8	0.5	0.6	0.5	0.2	0.4	0.7	0.5	0.5	0.0	1.0	0.6	0.6	1.0	0.4	0.3	0.6	0.3	0.1	5.8	8.6	20.6	14.6	2.4	3.2	3.4	6.8	3.1	0.4	8.9	2.2	0.0	1.1	0.7	65.3	1.1	2.5	0.0	10.3	0.0	0.0	0.0	0.0	2.5	291.2	0.6	2.6	0.0	0.0	0.1	4.1	0.3	0.0	0.0	0.2	95.3	7.5	0.0	0.3	104.8	4.6	0.6	1.7	0.0	1.9	29.1	0.0	1.4	4.9	3.9	4.9	6.5	8.2	3.9	4.0	0.0	0.2	0.0	2.2	0.1
IL5RA	"CD125, CDw125, IL5R"	ENSG00000091181	"Interleukin 5 receptor subunit alpha"	Q01344	3	3066326-3126613	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 70.1;fallopian tube: 18.6"	"Cell type enhanced"	"Detected in some"	18	"Ciliated cells: 21.4;granulocytes: 18.5;Melanocytes: 5.0"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	196	"basophil: 31.4;eosinophil: 70.1"	"Lineage enriched"	"Detected in single"	308	"granulocytes: 70.1"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 42.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		92000				"unprognostic (1.38e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-4)"	"unprognostic (4.32e-3)"	"unprognostic (3.08e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.93e-2)"	0.5	0.2	6.7	0.6	6.2	0.7	1.3	0.2	0.3	1.8	0.9	1.8	0.0	2.2	0.6	8.2	0.6	18.6	2.0	2.4	2.3	2.1	0.6	1.3	7.9	1.2	0.1	0.0	3.8	0.5	0.1	7.5	0.1	11.8	2.6	1.4	0.5	2.2	0.1	0.3	0.4	2.1	0.6	0.6	4.6	1.3	1.6	0.7	1.1	0.4	1.1	1.9	4.2	0.4	0.1	0.0	70.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.4	0.0	70.1	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	6.7	6.2	0.2	0.3	2.3	2.1	0.1	0.0	11.8	0.7	0.0	4.5	0.0	0.0	0.1	0.0	2.4	0.0	21.4	2.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	18.5	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126916-3150879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	15.2	16.9	17.5	17.8	20.7	8.7	18.2	14.5	22.7	12.9	13.2	13.2	17.4	11.1	18.4	14.7	15.9	12.2	15.6	13.9	17.1	16.0	21.1	16.1	13.7	19.0	17.5	15.6	14.6	13.9	14.3	31.0	19.0	21.3	23.9	16.4	10.1	13.2	13.1	14.8	15.3	12.5	15.3	19.3	20.5	15.5	13.5	15.1	22.1	20.9	10.6	19.8	17.8	13.0	15.1	10.5	29.0	12.0	15.1	16.6	7.4	12.0	17.4	13.5	7.7	16.1	13.8	14.4	13.8	11.5	13.8	14.3	16.1	14.8	22.0	9.2	13.3	22.0	8.7	17.8	12.4	17.6	16.3	8.6	20.4	18.6	16.1	21.5	21.6	16.6	12.9	17.6	14.2	4.8	11.6	13.6	17.0	15.9	9.2	23.7	22.5	13.9	19.5	10.6	18.0	12.7	13.3	18.2	21.4	18.4	18.0	7.7	11.1	20.0	14.5	11.5	19.0	13.4	12.3	11.1	15.6	13.6	16.1	17.7	9.5	18.9	27.7	11.7	19.4	17.4	29.0	8.8	22.5	12.1	11.8	11.9	15.1	15.0	12.7	10.5	9.5	16.6	14.3	11.7	15.1	12.0	9.6	11.1	7.4	17.5	20.7	14.5	22.7	17.1	16.0	17.5	15.6	21.3	15.1	14.9	8.3	13.9	18.6	13.2	12.9	12.1	2.5	10.7	13.6	17.4	13.7	21.8	38.1	16.1	1.5	22.5	9.6	0.0	8.7	14.3	13.9	19.8	22.0	7.8	11.6	9.5	8.1	10.4	12.9	1.9	10.0	11.3	6.8	18.0	9.7	15.8	10.1	8.6	8.1	25.6	16.8	0.0	17.7	20.0	16.9	11.4	23.7	13.8	11.5	18.2
CRBN	"MRT2, MRT2A"	ENSG00000113851	Cereblon	Q96SW2	3	3144628-3179727	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045910	Approved					NA	NA					"HPA045910: AB_10960409"	"unprognostic (1.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.47e-2)"	22.9	17.3	30.9	12.4	29.0	28.1	26.2	41.8	36.6	19.1	19.1	15.3	15.8	15.9	19.7	18.5	15.4	16.8	15.5	22.0	27.6	27.1	23.1	25.6	18.3	18.8	31.4	25.2	25.0	17.3	20.4	23.4	21.4	38.6	20.7	17.7	9.5	27.4	18.9	31.8	17.9	20.3	24.7	37.1	21.2	16.6	33.5	33.1	18.3	24.0	12.9	15.3	20.2	17.9	13.0	10.9	65.3	14.3	26.2	25.5	26.1	7.2	6.1	19.2	8.3	23.2	23.1	8.0	8.2	14.0	10.9	14.8	8.9	10.8	7.9	12.2	10.2	13.3	7.1	11.6	13.7	12.0	13.9	18.5	20.3	12.1	11.1	15.8	18.2	13.3	17.6	18.4	11.8	9.0	21.5	14.6	17.3	11.8	17.2	9.5	10.6	15.9	18.2	15.9	10.0	15.1	14.6	11.5	18.7	12.8	11.5	8.4	14.1	9.1	12.6	19.7	15.0	16.8	13.6	9.3	11.1	5.9	15.9	10.6	19.7	31.9	19.9	17.4	16.8	13.5	65.3	12.6	25.9	18.1	14.2	19.2	13.0	24.4	19.3	10.9	10.1	25.5	21.0	7.2	26.2	14.3	5.7	16.7	26.1	30.9	29.0	41.8	36.6	27.6	27.1	31.4	25.2	38.6	33.1	41.7	33.7	28.3	31.7	32.1	54.5	62.4	35.7	33.5	34.2	36.6	25.5	45.4	61.3	28.7	136.1	69.7	24.8	23.3	18.7	30.4	35.8	22.7	134.3	31.0	31.4	41.3	15.0	47.9	45.5	37.6	58.1	40.7	32.1	46.9	26.5	64.8	20.5	28.5	62.6	57.5	63.0	58.2	39.2	114.7	88.4	33.6	42.0	72.2	28.7	17.6
SUMF1	"FGE, UNQ3037"	ENSG00000144455	"Sulfatase modifying factor 1"	Q8NBK3	3	3700814-4467281	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 39.5;hTERT-RPE1: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038025	Uncertain				"Intracellular and membrane"	NA	NA		350000			"HPA038025: AB_10675624"	"unprognostic (5.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.99e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.79e-7)"	"unprognostic (5.12e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.86e-2)"	19.1	19.6	9.0	15.7	10.9	6.1	21.1	7.7	13.4	16.7	16.6	15.7	19.0	9.2	17.4	23.3	25.3	18.6	19.8	11.7	7.7	8.9	27.9	20.6	17.8	21.9	11.5	8.0	15.2	22.4	33.8	14.4	22.7	10.5	16.3	21.3	17.3	20.8	14.9	4.6	17.4	13.5	15.2	10.1	18.3	17.0	7.5	10.3	11.3	20.4	10.7	13.5	17.9	16.6	10.9	32.3	17.6	38.3	14.7	16.1	28.3	7.9	6.7	3.7	2.0	39.5	21.0	7.2	11.2	17.7	5.4	6.1	3.0	25.8	1.1	6.8	20.3	8.1	4.3	1.6	12.7	8.4	3.8	3.3	1.7	6.6	8.3	10.2	1.9	4.7	19.2	14.3	6.0	1.8	39.4	14.7	2.8	2.8	2.7	15.0	12.7	1.0	2.9	3.9	7.3	7.7	2.0	5.6	5.0	28.6	9.0	0.7	4.2	8.0	18.7	6.3	6.7	24.9	5.0	13.4	10.9	1.4	8.3	6.7	3.4	6.9	0.5	21.2	4.3	8.1	17.6	38.3	12.6	15.2	29.9	13.8	10.3	12.5	12.9	32.3	10.9	16.1	13.1	13.7	14.7	26.9	17.1	6.2	28.3	9.0	10.9	7.7	13.4	7.7	8.9	11.5	8.0	10.5	10.3	17.9	16.1	7.3	17.3	11.3	6.0	4.5	17.8	17.4	9.1	36.6	5.9	27.4	10.0	36.6	10.8	12.8	10.7	0.0	16.8	18.4	19.9	20.1	16.2	16.3	26.5	3.2	8.1	16.5	33.9	7.3	15.3	24.3	18.6	49.5	21.4	9.8	14.1	11.5	16.3	21.1	6.6	6.5	15.5	3.1	3.6	10.3	20.4	8.5	25.0	16.6
LRRN1	FIGLER3	ENSG00000175928	"Leucine rich repeat neuronal 1"	Q6UXK5	3	3799437-3847703	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.5"	"Cell type enhanced"	"Detected in some"	10	"Cholangiocytes: 10.2;Muller glia cells: 4.3;Pancreatic endocrine cells: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.1;memory B-cell: 1.0;neutrophil: 2.6"	"Group enriched"	"Detected in many"	8	"B-cells: 1.0;granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"AF22: 48.6;CAPAN-2: 17.2;HAP1: 14.5;NTERA-2: 28.8;SuSa: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011071	Enhanced					NA	NA		1400000			"HPA011071: AB_1853355"	"unprognostic (1.27e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.25e-2)"	1.4	0.8	12.5	1.1	19.0	2.4	7.6	13.8	32.5	7.1	0.9	5.0	0.3	1.9	4.7	2.5	1.9	2.9	4.6	0.7	11.1	9.4	1.3	0.7	2.1	0.9	8.5	6.1	10.0	3.8	14.2	2.7	0.9	22.2	7.7	1.0	11.5	8.9	8.2	9.2	2.2	2.6	3.2	8.3	1.8	1.8	10.3	10.7	8.7	4.8	0.7	1.7	10.6	1.5	1.0	0.0	2.6	0.0	0.1	0.2	0.0	0.0	0.0	48.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.2	0.0	2.1	0.0	3.6	0.0	0.0	0.4	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	50.0	1.8	0.0	0.0	0.0	5.9	0.0	0.5	5.0	10.1	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.0	0.0	0.2	0.0	0.3	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.0	12.5	19.0	13.8	10.3	11.1	9.4	8.5	6.1	22.2	10.7	3.0	0.0	0.8	1.2	1.9	2.7	0.3	10.2	0.0	1.2	0.0	0.0	0.2	0.0	0.7	2.1	0.2	0.0	0.0	2.0	0.1	0.8	2.2	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.8	2.3	0.0	1.7	0.0	0.3	4.3	6.7	0.0	0.7	0.3	0.5	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.7
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA057999			Supported	Nucleoli		NA	NA			Nucleoli		"HPA057999: AB_2683574"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	14.1	6.2	7.3	7.2	9.2	3.7	14.2	6.9	8.5	12.5	6.5	6.2	5.2	4.3	19.4	7.6	7.2	12.5	8.2	6.3	6.6	4.3	10.1	5.3	5.1	6.5	9.1	8.7	19.4	9.8	5.7	7.4	5.6	6.5	13.9	6.9	5.7	11.9	10.0	7.7	7.3	5.7	16.8	7.2	5.0	6.0	7.3	10.8	13.1	11.5	8.3	4.4	11.3	13.3	3.8	1.6	1.9	3.3	0.5	5.3	1.5	3.0	2.7	8.2	1.7	19.7	6.5	8.3	3.3	1.0	3.3	3.1	2.8	2.3	8.0	3.5	1.8	6.0	2.6	7.2	5.0	3.6	5.4	6.2	10.0	4.9	4.5	2.3	4.7	4.2	7.7	3.9	2.4	0.8	3.0	4.8	9.1	6.6	3.0	5.1	4.1	7.0	3.0	8.0	1.9	4.7	8.3	8.1	3.3	3.1	4.2	6.5	9.6	4.0	5.0	4.3	5.4	4.8	2.7	3.1	4.9	6.9	4.1	4.3	4.0	9.5	19.8	1.8	5.4	4.1	1.9	1.1	1.3	2.3	3.3	2.0	2.9	2.7	2.9	1.0	3.8	4.5	5.3	0.2	0.5	1.9	1.6	1.7	1.5	7.3	9.2	6.9	8.5	6.6	4.3	9.1	8.7	6.5	10.8	0.0	5.3	2.7	7.6	2.2	5.2	5.9	5.1	9.4	13.6	0.0	0.0	20.4	11.6	10.1	0.6	6.8	2.3	0.0	11.6	12.2	7.4	3.2	1.1	2.5	5.2	0.0	3.5	3.7	1.0	0.9	8.9	1.8	0.0	4.6	2.6	4.1	6.6	5.1	12.4	4.3	2.8	6.5	5.7	4.6	5.1	0.5	13.6	1.3	5.6	3.1
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493348-4847840	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 46.6"	"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 49.5;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.0;HeLa: 25.5;HMC-1: 16.9;U-87 MG: 20.8"	"Region enhanced"	"Detected in all"		"cerebellum: 782.1"	"Low region specificity"	"Detected in all"			"HPA014765, HPA016487"	Approved		Approved	Vesicles		NA	NA		37000	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.40e-1)"	4.8	8.2	6.1	7.4	18.6	3.2	11.9	39.5	30.2	10.2	7.4	1.7	21.5	2.4	18.4	13.2	7.8	10.1	11.8	5.3	8.7	5.1	8.7	2.5	6.4	7.1	4.8	10.4	14.2	2.7	46.6	7.3	4.6	3.8	15.0	3.7	12.5	9.6	27.4	3.2	3.2	5.0	17.4	3.7	6.0	5.5	3.0	4.3	7.0	19.3	0.6	8.6	14.1	10.6	8.9	3.6	5.4	1.6	1.2	2.2	1.2	0.0	1.3	0.2	0.6	10.0	0.4	3.2	0.2	0.2	0.3	0.3	0.3	0.3	4.4	0.4	0.4	1.8	0.0	0.9	1.1	0.5	35.0	1.4	12.7	25.5	1.6	13.8	5.4	16.9	2.6	0.7	1.7	0.5	3.6	1.4	3.4	1.4	5.1	1.3	0.5	2.4	1.8	0.9	0.2	3.9	1.4	0.2	0.3	1.1	1.1	0.1	8.5	2.3	1.4	2.3	0.3	0.9	7.7	1.7	0.8	1.4	1.1	1.0	7.8	3.7	2.9	20.8	5.8	1.8	5.4	1.6	1.9	1.5	1.0	1.9	6.6	1.7	1.5	2.1	8.9	2.2	1.9	0.8	1.2	0.7	3.6	1.3	1.2	6.1	18.6	39.5	30.2	8.7	5.1	4.8	10.4	3.8	4.3	0.0	31.8	25.3	4.8	3.4	1.6	4.8	5.1	21.4	14.8	8.7	0.0	0.5	3.3	1.5	4.4	22.4	0.0	0.0	4.5	0.4	13.0	6.1	24.4	1.8	4.7	1.6	3.4	22.1	13.3	5.7	27.9	15.3	6.8	6.4	0.8	3.9	1.5	0.3	49.5	3.5	1.0	38.8	26.4	1.4	2.6	2.8	0.8	19.5	0.6	3.1
BHLHE40	"BHLHB2, bHLHe40, Clast5, DEC1, SHARP2, STRA13"	ENSG00000134107	"Basic helix-loop-helix family member e40"	O14503	3	4979116-4985323	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 415.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 32.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 87.7;Karpas-707: 42.3;U-87 MG: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028922	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA028922: AB_2672828"	"unprognostic (8.64e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (5.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.03e-3)"	41.2	32.0	15.7	19.1	17.0	55.5	52.7	6.5	28.7	33.3	22.4	13.7	10.5	10.8	23.7	34.3	84.2	14.8	35.3	40.4	11.9	9.0	34.6	63.1	30.2	17.1	11.2	16.1	45.1	27.5	26.9	25.6	24.2	17.4	33.7	17.4	50.9	28.8	26.7	79.5	49.6	12.6	22.8	21.8	12.4	13.9	13.5	12.9	5.1	21.2	47.3	39.5	57.1	62.4	3.0	7.2	32.1	3.4	18.9	9.7	3.6	7.2	9.8	0.0	2.7	5.9	4.6	14.7	1.3	3.6	1.4	5.7	0.6	7.3	0.0	3.7	2.6	22.4	5.7	1.2	19.9	2.5	87.7	0.8	1.7	7.1	2.1	5.7	4.5	36.4	10.6	11.9	16.7	4.8	10.1	5.5	0.3	9.5	42.3	3.8	5.1	0.7	1.9	0.5	8.3	16.1	0.1	3.3	4.0	13.9	1.4	0.1	0.3	24.4	6.4	7.1	9.1	14.6	7.1	7.3	5.8	5.6	5.3	9.0	33.0	14.4	0.2	41.5	3.6	2.8	32.1	3.4	18.7	9.4	1.7	9.7	3.0	5.2	6.3	5.5	1.5	1.2	4.0	5.1	18.9	0.2	7.2	0.3	3.6	15.7	17.0	6.5	28.7	11.9	9.0	11.2	16.1	17.4	12.9	62.5	197.6	15.4	70.4	147.0	13.4	39.2	38.2	78.9	143.3	43.6	0.0	21.4	10.0	66.6	0.3	112.9	24.4	0.0	63.5	35.2	80.1	49.5	415.0	56.3	37.4	9.5	10.3	71.2	50.9	1.3	6.6	141.0	102.9	57.7	26.0	55.8	101.6	34.0	3.5	20.3	7.7	6.5	95.9	0.2	0.0	229.0	132.5	56.7	16.8	83.6
ARL8B	"ARL10C, FLJ10702, Gie1"	ENSG00000134108	"ADP ribosylation factor like GTPase 8B"	Q9NVJ2	3	5122220-5180912	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038759, HPA040515, HPA045924"	Approved					NA	NA		2800000			"HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.84e-6)"	"unprognostic (5.90e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-2)"	26.7	32.6	38.0	20.6	37.7	31.4	34.1	35.0	50.7	26.3	20.3	27.4	17.9	18.3	28.5	25.6	41.5	19.8	23.9	32.5	37.7	38.2	33.2	26.3	26.3	22.6	36.3	33.3	25.2	17.2	23.4	21.3	47.9	48.5	28.8	21.8	15.1	23.4	27.6	57.3	37.1	20.4	29.1	37.9	19.4	20.2	18.8	24.4	22.6	38.7	30.1	27.6	28.0	30.4	14.7	23.3	25.0	27.4	15.4	16.9	18.7	12.9	11.9	10.6	5.6	33.5	29.7	20.2	18.5	20.3	17.6	20.9	9.0	12.1	13.8	8.3	17.7	39.4	8.3	16.9	16.3	20.5	15.5	9.9	23.3	9.8	12.9	46.2	19.3	26.9	27.4	49.9	22.4	15.7	18.8	19.6	12.8	19.8	15.1	26.3	11.7	16.5	14.8	9.9	11.9	18.2	11.5	14.5	12.2	17.7	19.5	6.1	11.7	15.8	31.0	25.0	12.4	17.9	58.8	16.7	18.4	15.8	25.2	16.5	14.1	22.9	39.2	26.3	27.6	14.8	25.0	27.4	16.6	14.7	23.6	16.9	14.7	15.1	14.5	23.3	11.8	15.7	15.6	12.2	15.4	18.6	10.2	14.2	18.7	38.0	37.7	35.0	50.7	37.7	38.2	36.3	33.3	48.5	24.4	74.5	48.2	25.9	53.0	113.8	24.0	50.6	28.1	42.8	40.9	33.2	9.8	35.4	16.6	32.4	25.1	35.8	20.3	0.0	32.4	65.2	36.0	54.5	55.4	34.4	87.5	7.9	12.6	19.6	66.1	29.3	21.3	67.5	52.3	120.8	16.2	35.7	48.9	21.0	31.8	36.5	21.0	71.1	43.8	23.8	22.1	143.9	144.7	20.8	14.5	101.3
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219957	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.5;lymphoid tissue: 89.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 96.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"		NA	NA			"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	6.5	7.6	5.3	13.1	6.7	26.3	7.0	4.8	6.3	6.7	7.6	4.5	5.1	5.9	8.4	6.4	10.5	7.0	6.2	4.8	4.3	3.1	6.6	57.5	14.2	16.9	3.9	5.0	8.6	20.3	10.2	6.5	14.2	4.2	6.6	7.6	5.5	9.7	5.7	3.7	10.1	11.8	5.4	3.7	15.4	7.8	7.8	4.0	89.4	7.8	5.5	23.5	8.8	8.1	9.9	10.3	4.3	5.8	2.9	8.9	2.8	4.7	4.8	3.0	3.0	4.0	9.0	9.7	7.8	10.6	5.4	7.1	2.2	6.3	25.5	4.2	7.7	11.8	3.7	3.3	10.7	8.3	48.9	1.9	8.7	4.5	4.9	18.8	10.2	25.5	8.1	13.1	11.5	12.7	7.3	10.7	33.3	2.2	35.3	6.6	2.8	20.5	3.9	1.5	2.2	3.6	29.9	5.4	23.4	6.2	10.0	0.4	4.0	5.6	8.1	11.5	2.8	4.1	32.9	10.4	10.4	7.3	8.8	8.9	20.8	12.6	43.9	17.3	9.9	8.6	3.5	3.8	4.0	5.8	5.0	8.4	9.9	8.8	6.5	4.6	6.8	7.9	6.2	4.3	2.9	5.8	10.3	8.9	2.8	5.3	6.7	4.8	6.3	4.3	3.1	3.9	5.0	4.2	4.0	56.6	96.8	35.0	6.3	18.3	4.1	2.8	17.8	6.7	20.5	15.7	9.8	8.0	0.0	6.0	9.1	11.3	14.8	0.0	10.5	26.0	8.7	10.9	23.1	65.7	15.8	1.6	8.1	14.7	33.3	37.6	7.8	35.8	15.1	47.7	22.7	3.5	14.0	0.0	8.5	7.0	3.5	0.0	12.2	6.7	2.0	23.8	34.2	21.4	10.1	16.1
GRM7	"GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87"	ENSG00000196277	"Glutamate metabotropic receptor 7"	Q14831	3	6770001-7741533	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.8;parathyroid gland: 11.3"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 22.5;Early spermatids: 24.2;Late spermatids: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015964			Uncertain	Cytosol		NA	NA			Cytosol		"HPA015964: "	"unprognostic (2.04e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.37e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.84e-6)"	"unprognostic (1.45e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.59e-2)"	0.9	5.3	8.1	0.6	10.5	0.6	0.9	1.6	15.8	2.9	0.8	2.1	0.0	0.9	3.1	0.5	0.6	1.0	0.7	0.6	11.1	9.3	0.5	0.7	0.8	0.5	2.3	10.1	0.8	0.7	11.3	0.6	0.9	4.3	1.2	0.8	0.8	2.1	1.4	0.5	0.6	0.6	5.9	2.8	0.8	0.6	2.8	4.1	0.0	0.7	0.0	0.7	1.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	10.5	1.6	15.8	11.1	9.3	2.3	10.1	4.3	4.1	0.0	0.0	0.0	0.9	0.1	22.5	1.1	7.6	6.7	1.2	0.0	7.9	0.0	1.7	0.0	24.2	0.1	0.0	0.0	0.0	0.1	0.7	1.1	1.1	0.0	0.1	1.6	0.0	0.0	0.0	29.9	0.3	0.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.2	6.5	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.6
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501707-8574673	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 189.9"	"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 99.6;Horizontal cells: 92.2;Smooth muscle cells: 171.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 30.4;HSkMC: 42.6;hTEC/SVTERT24-B: 31.3;U-2197: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No			"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	38.6	3.3	1.6	10.1	1.8	0.0	36.4	3.9	1.9	11.7	4.4	3.8	5.2	1.9	22.3	20.8	8.3	11.9	15.4	15.9	2.3	1.7	5.5	2.2	25.9	3.8	2.4	1.7	17.9	8.5	5.8	2.0	14.1	4.5	16.1	1.6	4.6	19.2	7.0	189.9	5.7	3.3	72.9	3.7	14.3	10.6	9.3	1.3	0.8	4.6	34.3	7.1	29.4	15.7	1.8	2.7	0.0	0.3	0.0	17.0	0.2	2.9	16.9	2.8	2.1	21.1	11.9	2.9	12.4	6.4	6.8	16.9	12.5	3.8	0.0	1.4	14.3	2.9	0.2	1.6	3.2	2.8	5.1	1.1	3.7	1.1	2.4	30.4	0.0	0.3	42.6	0.0	31.3	0.2	4.0	3.3	0.0	0.0	0.0	8.8	2.1	0.0	0.0	5.5	3.8	0.7	0.0	9.4	0.0	6.3	1.1	0.1	7.1	2.0	10.3	6.4	8.4	13.4	0.0	1.6	6.9	13.8	27.6	8.3	1.7	1.9	0.8	1.4	0.9	8.8	0.0	0.0	0.0	0.0	0.3	0.1	1.8	2.6	0.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.9	17.0	0.2	1.6	1.8	3.9	1.9	2.3	1.7	2.4	1.7	4.5	1.3	8.9	15.4	0.0	47.6	28.0	13.3	13.7	20.4	20.1	15.9	5.2	9.8	2.6	3.3	99.6	0.9	70.2	0.5	0.0	42.3	3.5	58.2	6.1	10.3	11.3	3.1	92.2	11.6	36.2	0.6	1.5	10.6	4.0	50.6	15.4	2.2	34.8	83.3	0.0	30.4	29.2	7.9	0.0	171.0	5.0	7.0	23.7	3.7	2.2	3.3	5.2
SSUH2	"C3orf32, fls485, ssu-2"	ENSG00000125046	"Ssu-2 homolog (C. elegans)"	Q9Y2M2	3	8619400-8745040	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 45.1"	"Group enriched"	"Detected in some"	8	"Early spermatids: 51.3;Late spermatids: 35.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"Hep G2: 24.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049777	Approved					NA	NA					"HPA049777: AB_2680876"	"unprognostic (2.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.65e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.50e-2)"	0.7	0.3	0.3	0.4	0.6	0.0	0.6	0.3	0.4	0.7	37.3	0.3	0.2	8.5	1.0	0.2	0.3	0.7	1.4	2.8	0.3	0.3	1.1	0.5	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.5	0.5	0.4	0.3	0.3	1.7	0.2	0.3	0.2	45.1	0.8	0.2	2.0	0.4	5.6	0.2	0.2	1.1	1.5	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	24.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.4	0.3	0.3	0.2	0.3	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	51.3	0.6	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	1.1	0.0	1.7	0.0	0.9	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.9	0.6	0.9	0.1	0.0	0.0	0.4	0.0
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733800-8841808	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 65.8;tongue: 44.6"	"Cell type enhanced"	"Detected in some"	28	"Cardiomyocytes: 18.9;Early spermatids: 4.4;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 46.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	6.3	2.3	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.7	1.3	0.1	65.8	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	44.6	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0
OXTR		ENSG00000180914	"Oxytocin receptor"	P30559	3	8750408-8769628	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 42.5"	"Cell type enriched"	"Detected in some"	8	"Ciliated cells: 93.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"BJ: 81.2;BJ hTERT+: 24.9;BJ hTERT+ SV40 Large T+: 23.6;fHDF/TERT166: 81.3;HBF TERT88: 18.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.18e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.24e-4)"	"unprognostic (8.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-1)"	0.5	0.4	1.8	0.3	6.5	0.6	42.5	0.9	2.2	0.5	0.3	0.1	0.0	0.3	2.8	0.5	1.1	2.7	1.0	0.6	1.8	4.0	0.6	0.4	1.0	0.4	8.6	0.8	2.8	0.3	0.3	0.3	1.3	3.7	0.9	0.3	1.6	0.4	0.9	0.3	0.4	0.4	0.6	2.5	0.5	0.3	0.5	1.2	0.1	0.4	0.0	0.4	0.4	0.0	0.0	0.2	1.6	0.1	0.1	0.3	1.0	0.2	0.8	0.4	0.1	0.1	0.2	0.1	81.2	24.9	23.6	12.6	0.1	2.1	0.0	0.1	81.3	0.3	0.1	0.3	0.1	18.4	0.7	0.4	0.2	0.3	0.1	0.4	0.1	0.2	0.1	0.1	0.3	0.1	7.1	0.0	0.2	0.0	0.1	13.1	0.0	0.1	0.6	0.5	0.2	3.6	0.1	0.3	4.8	0.9	0.0	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.1	0.1	1.1	0.3	0.2	0.2	0.1	0.2	0.0	0.1	0.2	0.2	0.5	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.3	1.6	0.1	0.0	0.1	0.1	1.0	1.8	6.5	0.9	2.2	1.8	4.0	8.6	0.8	3.7	1.2	8.9	1.4	0.0	0.4	0.3	0.2	1.2	0.0	93.7	11.4	0.0	0.0	0.0	0.0	2.6	0.9	0.0	0.0	0.0	0.0	0.1	0.5	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	5.8	1.0	0.0	0.4	0.0	0.0	0.0	0.5	0.7	1.3	0.1	0.0	0.0	0.0	0.1
RAD18	RNF73	ENSG00000070950	"RAD18, E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	6.2	5.7	7.4	5.6	12.7	7.9	9.5	16.4	11.4	5.5	6.6	3.9	5.4	17.7	6.5	3.7	7.6	4.9	5.6	4.4	4.7	3.3	4.3	5.7	5.9	7.6	8.4	6.9	7.1	4.2	3.4	6.9	6.9	5.7	7.4	9.0	3.5	7.5	3.5	3.7	8.5	10.5	6.0	7.8	8.5	5.1	9.5	9.8	16.6	6.7	4.7	7.5	6.1	6.8	3.7	6.3	8.7	3.0	4.3	5.5	1.5	9.9	9.4	7.9	4.7	2.0	4.2	9.7	15.8	5.4	15.2	10.5	8.6	6.4	12.3	3.0	8.9	8.9	3.5	8.3	8.2	15.6	7.6	10.5	10.4	9.5	5.1	1.2	13.7	9.0	1.6	3.0	15.0	10.2	4.1	4.9	10.5	11.1	12.2	13.3	11.5	13.9	9.8	11.0	7.9	17.4	11.1	8.8	9.7	4.4	7.7	3.3	7.5	7.0	6.8	5.1	6.5	7.0	6.1	4.0	12.7	6.9	10.7	13.5	6.2	9.4	26.7	9.3	15.3	9.3	7.4	2.7	8.7	3.0	3.0	5.5	3.7	4.0	5.2	3.4	3.7	4.3	3.2	1.2	4.3	1.8	6.3	5.0	1.5	7.4	12.7	16.4	11.4	4.7	3.3	8.4	6.9	5.7	9.8	14.9	9.8	8.2	5.8	9.8	5.1	2.0	5.1	4.0	9.1	3.5	2.0	6.6	1.7	6.5	3.3	4.2	3.8	0.0	7.1	10.7	4.3	7.0	12.8	2.9	5.9	3.2	1.7	4.9	3.7	2.1	3.7	4.6	3.3	7.2	5.0	2.8	7.9	5.8	2.5	2.4	2.2	6.5	4.7	15.5	13.6	10.3	5.6	4.6	5.2	2.7
SRGAP3	"ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP"	ENSG00000196220	"SLIT-ROBO Rho GTPase activating protein 3"	O43295	3	8980591-9363053	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.9"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 228.5;Cone photoreceptor cells: 257.2;Horizontal cells: 216.1;Muller glia cells: 117.0;Rod photoreceptor cells: 104.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HBEC3-KT: 8.4;hTCEpi: 8.3;RT4: 11.2;T-47d: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036959, HPA044074, HPA078079"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: "	"unprognostic (3.63e-3)"	"unprognostic (1.12e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.66e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.39e-3)"	1.8	6.1	10.6	1.7	20.4	1.2	3.2	32.4	34.9	9.7	2.1	10.5	0.0	1.9	4.4	3.4	2.6	18.5	2.3	2.7	10.0	11.2	4.9	1.4	2.2	2.3	7.5	9.8	7.2	2.4	2.7	5.7	1.9	15.5	4.7	2.5	4.8	5.7	3.2	2.5	4.0	1.7	2.0	6.1	1.7	2.9	4.4	4.8	0.4	3.3	0.6	2.1	6.7	1.4	0.0	1.9	1.9	0.4	1.0	1.3	0.1	0.5	0.5	9.7	0.4	0.7	1.3	1.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.5	0.0	0.2	4.9	0.2	8.4	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	5.2	0.8	8.3	0.7	0.8	0.3	0.0	2.2	0.0	0.0	0.0	0.1	0.2	2.1	0.9	1.7	0.7	1.1	0.0	0.0	4.2	11.2	1.1	1.3	0.2	3.0	0.1	2.5	10.8	0.0	0.0	0.0	0.4	0.1	0.1	2.9	0.1	0.0	0.8	1.7	0.3	1.2	0.4	1.9	0.0	0.1	0.0	0.0	0.2	0.0	1.9	0.0	0.2	0.0	0.0	1.0	0.1	0.5	1.3	0.1	10.6	20.4	32.4	34.9	10.0	11.2	7.5	9.8	15.5	4.8	3.0	6.4	0.0	23.8	3.7	228.5	8.1	0.0	52.2	27.3	73.3	257.2	1.8	5.0	1.8	18.5	1.8	0.4	0.0	0.4	0.7	4.0	9.9	1.1	1.6	10.6	216.1	2.9	0.6	9.9	15.3	2.3	3.8	1.7	1.0	3.7	117.0	0.5	0.0	1.1	1.0	104.8	0.0	1.4	5.4	4.9	5.1	1.1	2.9	2.2	27.1
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362842-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 224.3;Spermatocytes: 126.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: AB_2674985"	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	17.4	17.2	13.3	12.9	14.8	22.2	14.2	13.4	19.6	15.2	14.4	13.8	12.5	12.8	14.0	15.8	16.5	12.3	10.9	19.3	12.3	13.9	20.7	23.9	11.1	13.5	18.3	11.0	14.3	14.8	22.2	27.8	14.4	23.2	15.9	15.1	14.0	16.1	14.9	29.4	13.4	14.9	12.3	15.8	14.5	12.5	42.8	14.8	22.3	18.2	17.5	13.2	16.2	11.7	13.9	15.4	12.5	19.3	11.7	22.3	10.1	12.8	17.5	12.2	6.4	16.1	15.6	49.2	15.7	12.9	16.0	12.2	13.1	13.6	13.2	12.3	14.2	25.6	8.5	22.3	16.0	16.3	14.7	13.0	16.5	17.7	11.4	15.8	21.0	12.0	12.5	18.2	18.9	19.7	13.0	10.5	21.5	25.9	19.2	21.1	18.2	24.8	9.0	23.5	14.4	17.0	15.8	21.0	18.8	10.5	19.5	5.1	16.5	13.0	9.4	13.9	13.2	15.1	13.6	7.4	15.4	13.3	18.5	17.2	24.6	57.2	42.5	18.7	19.7	22.0	10.6	13.2	12.5	16.2	17.4	21.1	12.3	14.1	16.8	15.0	13.9	22.3	16.8	2.7	11.7	19.3	15.4	13.2	10.1	13.3	14.8	13.4	19.6	12.3	13.9	18.3	11.0	23.2	14.8	23.8	17.9	6.7	21.7	9.5	20.8	43.1	20.4	16.0	29.6	21.0	15.7	29.0	44.7	33.1	224.3	13.1	8.7	0.0	25.5	25.1	18.7	25.5	26.7	23.1	24.1	36.5	2.9	11.6	15.1	105.0	19.0	17.7	11.8	17.2	15.2	28.6	27.1	3.5	24.4	25.2	34.6	6.5	13.4	126.9	51.4	11.3	23.0	15.2	18.8	18.0
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB017093: , HPA035574: AB_2674681"	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	18.9	21.9	33.1	18.2	29.1	13.2	40.9	58.0	38.9	21.7	20.7	15.4	22.1	14.0	24.0	27.0	20.7	22.0	18.4	18.3	29.6	13.8	15.4	22.1	26.5	29.8	23.0	30.1	29.7	22.7	25.6	31.4	23.0	25.1	20.6	20.4	16.7	22.3	22.7	16.6	29.0	19.8	24.1	22.8	22.5	18.7	21.3	26.6	21.0	25.9	14.8	24.2	20.4	37.5	3.7	4.0	4.7	2.0	4.3	4.1	1.0	9.9	12.0	24.7	11.2	14.6	15.2	59.0	9.8	13.3	14.3	16.5	11.9	12.4	21.7	5.9	14.3	12.6	8.3	23.0	13.0	15.8	15.3	11.4	21.2	20.2	11.0	14.9	16.2	14.1	14.7	21.2	21.6	25.7	14.8	15.1	15.4	20.8	14.3	12.2	14.6	14.3	13.5	18.7	7.6	9.7	16.6	19.5	9.6	11.2	16.1	9.9	15.4	14.3	11.8	8.9	23.0	15.8	11.9	17.9	15.1	17.3	8.1	11.7	10.4	13.0	36.2	10.8	11.7	14.1	2.3	2.0	1.7	3.8	1.2	2.5	3.4	2.5	4.1	1.3	3.7	2.4	2.2	4.7	4.3	1.4	4.0	1.0	1.0	33.1	29.1	58.0	38.9	29.6	13.8	23.0	30.1	25.1	26.6	38.7	45.3	34.4	46.5	83.5	109.6	20.7	48.4	56.2	59.1	40.1	108.0	31.2	3.3	31.7	6.2	57.1	35.1	0.0	29.5	33.8	55.5	67.5	46.2	41.4	21.1	52.4	60.0	57.1	28.8	7.5	61.9	31.1	42.2	30.7	47.0	38.4	36.6	45.6	50.5	9.8	62.8	12.9	58.0	37.5	39.3	79.9	47.9	50.7	42.2	63.9
LHFPL4		ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553802	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 29.1;pituitary gland: 9.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 39.8;Cone photoreceptor cells: 17.7;Horizontal cells: 14.3;Rod photoreceptor cells: 16.4"	"Group enriched"	"Detected in some"	13	"glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.3;SCLC-21H: 10.1;SH-SY5Y: 12.5;U-266/84: 10.5;WM-115: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.9	4.9	8.0	1.0	11.4	0.9	0.9	16.0	29.1	0.9	1.4	1.5	0.0	1.2	0.9	0.8	0.9	0.9	0.9	0.8	8.4	8.5	0.9	0.8	1.0	0.8	4.2	8.6	0.8	1.8	1.2	9.0	0.8	9.2	0.9	1.4	1.7	0.9	0.9	0.8	0.9	1.3	0.9	4.2	0.8	1.3	1.6	1.8	0.0	0.9	0.0	0.8	0.8	0.1	0.0	1.2	0.6	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	10.1	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.8	0.0	10.5	0.0	0.5	0.0	3.8	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.0	0.0	8.0	11.4	16.0	15.6	8.4	8.5	4.2	8.6	9.2	1.8	0.0	0.0	0.0	2.6	0.0	39.8	0.6	0.0	0.0	0.0	0.0	17.7	0.5	0.0	0.3	0.4	0.0	0.5	0.0	0.2	0.8	0.3	1.5	1.1	0.0	0.2	14.3	1.2	4.9	0.3	0.4	0.0	0.0	0.0	0.0	0.6	1.3	0.3	1.4	0.0	0.1	16.4	0.0	0.1	1.7	1.0	0.0	1.1	0.0	1.0	2.5
MTMR14	"C3orf29, FLJ22405, FLJ90311, hEDTP, hJumpy"	ENSG00000163719	"Myotubularin related protein 14"	Q8NCE2	3	9649433-9702393	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054063	Approved				"Intracellular and membrane"	NA	NA					"HPA054063: AB_2682365"	"unprognostic (9.50e-2)"	"unprognostic (5.60e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.81e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (2.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.51e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-3)"	16.7	16.9	9.7	15.6	12.2	36.6	13.8	16.3	16.3	12.3	13.8	17.4	16.1	13.3	19.3	13.1	14.1	10.9	14.3	25.7	11.1	9.5	15.4	19.9	16.1	25.2	12.1	9.6	11.6	10.0	11.5	11.6	20.8	13.6	11.0	14.3	21.5	13.2	8.7	37.1	17.1	18.0	10.4	11.5	26.0	12.2	15.9	12.0	24.5	14.1	13.4	30.3	13.3	11.2	22.9	50.1	28.7	41.1	14.9	15.2	27.3	7.8	12.4	8.3	4.7	11.3	7.7	46.4	6.4	12.3	12.8	14.7	9.3	11.8	16.0	7.0	10.2	16.5	4.8	10.1	14.5	11.0	14.4	14.0	16.7	10.4	13.0	20.3	14.6	30.8	14.3	9.9	16.0	16.9	8.7	14.3	12.2	10.2	14.6	8.7	25.0	10.7	11.7	13.6	11.8	10.2	11.2	10.1	17.0	11.3	13.6	4.4	12.6	7.1	9.3	12.1	11.8	12.4	24.0	11.1	6.0	9.6	10.8	9.0	16.2	25.5	20.9	13.6	18.5	7.8	27.9	39.3	28.7	13.5	41.1	13.2	22.9	13.1	13.5	50.1	18.2	12.2	12.3	24.8	14.9	37.3	27.4	15.2	27.3	9.7	12.2	16.3	16.3	11.1	9.5	12.1	9.6	13.6	12.0	14.9	5.4	45.4	10.3	9.6	0.0	19.9	15.3	5.3	3.4	8.7	0.0	40.5	24.9	31.8	9.4	15.0	23.1	0.0	24.8	31.0	11.3	12.1	19.6	12.7	61.2	0.0	12.0	20.3	48.5	8.5	12.0	37.4	11.8	77.5	13.5	0.0	30.9	23.2	12.4	27.9	0.0	6.5	8.2	14.4	34.1	15.7	54.1	27.7	16.1	10.7
CPNE9	KIAA4217	ENSG00000144550	"Copine family member 9"	Q8IYJ1	3	9703807-9729908	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 46.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 13.5;Late spermatids: 33.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.6"	"Group enriched"	"Detected in all"	4	"cerebellum: 26.6;cerebral cortex: 17.0;pons and medulla: 46.9"	"Group enriched"	"Detected in some"	7	"classical monocyte: 1.2;intermediate monocyte: 3.5;non-classical monocyte: 2.4;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	25	"dendritic cells: 1.4;monocytes: 3.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.9;U-937: 5.3"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (2.96e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-4)"	"unprognostic (1.47e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.48e-2)"	0.7	1.4	1.7	0.8	3.1	2.8	0.6	26.6	18.2	0.7	0.8	2.3	0.0	1.1	0.7	0.5	0.6	0.6	0.8	0.4	1.9	7.2	0.8	0.6	1.1	1.0	7.0	5.1	0.6	0.5	0.4	3.4	0.7	46.9	0.5	0.8	0.3	0.8	1.0	0.4	4.2	1.1	0.8	2.3	0.9	0.7	3.0	1.4	0.0	0.4	0.0	0.7	0.8	0.1	0.0	1.4	0.0	3.5	0.0	0.0	0.4	0.1	0.9	0.2	0.0	0.9	0.2	1.0	0.3	0.3	0.1	0.0	0.1	0.3	5.9	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.5	1.8	0.6	0.1	0.0	0.7	0.8	0.9	0.0	0.7	0.3	0.0	0.3	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.7	0.1	0.1	0.0	0.5	0.0	0.7	1.6	1.3	0.1	0.0	0.6	1.2	2.0	2.4	0.0	0.0	0.2	0.8	0.1	0.3	1.8	1.2	0.8	5.3	0.4	0.0	1.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.4	1.4	0.0	0.4	1.7	3.1	26.6	17.0	1.9	7.2	7.0	5.1	46.9	1.4	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.3	33.6	0.0	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.9	0.4	0.0	0.0	0.0	0.0
BRPF1	BR140	ENSG00000156983	"Bromodomain and PHD finger containing 1"	P55201	3	9731729-9748018	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003359	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003359: AB_1078217"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (1.51e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.67e-3)"	10.5	7.7	6.2	10.4	8.1	29.2	10.7	16.5	13.1	10.7	9.5	10.4	5.0	6.8	14.4	8.9	10.7	12.9	10.7	7.0	5.4	4.2	8.2	5.3	10.7	12.3	8.3	7.0	12.5	9.2	11.3	9.5	9.9	7.5	9.0	6.3	9.6	12.1	8.5	11.1	14.2	10.5	8.3	5.1	12.2	9.2	23.7	11.4	24.3	12.0	7.8	11.4	11.5	9.4	1.2	3.5	2.3	1.8	9.3	4.2	1.3	5.4	8.5	8.4	4.1	5.3	4.5	43.2	6.7	4.5	7.9	5.9	7.5	4.6	9.4	3.1	6.7	7.8	4.6	8.5	6.8	5.7	9.9	9.1	12.1	16.9	5.0	6.2	17.1	11.3	5.7	5.7	11.7	7.0	4.4	6.1	9.8	12.8	9.5	4.9	13.1	10.7	14.1	10.7	4.0	8.0	14.4	5.9	6.5	4.2	8.6	5.0	7.8	7.3	5.2	6.2	5.5	5.3	16.7	7.7	9.4	8.0	8.0	12.4	7.7	8.6	17.4	7.3	14.1	8.0	2.2	1.8	2.3	2.7	1.6	4.2	1.1	2.1	2.5	1.5	1.2	2.5	2.9	1.3	9.3	1.5	3.5	1.3	1.3	6.2	8.1	16.5	13.1	5.4	4.2	8.3	7.0	7.5	11.4	14.9	10.6	4.5	4.7	12.6	4.4	3.5	0.0	4.0	7.9	7.0	5.9	3.6	0.0	3.6	1.6	7.5	4.4	0.0	4.7	4.6	4.1	4.4	8.1	2.4	5.5	7.9	9.8	8.6	4.8	0.4	6.1	5.2	1.7	1.0	5.0	4.5	4.3	2.9	5.6	1.8	3.8	6.5	4.7	15.8	11.7	16.2	3.1	7.5	5.8	5.5
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	10.4	12.9	15.4	28.5	16.2	12.7	11.5	22.0	17.7	16.7	18.8	16.2	10.5	22.0	16.2	13.1	10.0	14.7	12.1	10.7	14.7	10.8	30.1	17.8	9.9	28.5	12.3	14.1	22.5	12.0	5.8	10.2	10.3	15.3	14.4	10.2	14.6	14.3	13.2	7.4	11.5	28.2	12.1	13.6	14.1	10.8	7.3	15.6	19.8	12.2	6.3	25.5	12.2	13.3	12.2	11.9	15.4	8.5	19.4	15.4	8.3	5.7	10.8	10.9	6.8	10.7	12.3	20.2	7.5	7.8	11.6	13.9	10.3	5.7	35.2	5.0	9.5	18.5	5.6	6.4	8.2	4.9	12.5	9.2	17.5	17.4	14.8	11.3	6.8	11.2	12.2	10.6	20.0	8.5	9.4	14.3	5.0	5.5	5.7	11.0	10.8	5.4	6.7	5.8	5.2	15.5	4.0	7.4	11.4	6.5	2.9	4.9	8.6	9.7	7.9	5.8	5.9	12.4	11.6	9.2	11.8	12.4	9.2	12.3	5.7	8.2	18.1	9.5	19.6	7.2	11.3	8.5	15.4	15.1	6.6	14.6	10.4	13.0	12.3	7.6	12.2	10.2	9.6	2.1	19.4	5.3	11.9	15.4	8.3	15.4	16.2	22.0	17.7	14.7	10.8	12.3	14.1	15.3	15.6	0.0	4.3	24.5	8.6	4.8	19.3	2.0	7.6	4.0	2.3	8.7	33.4	5.4	10.0	7.2	0.6	8.3	10.4	23.3	5.9	8.2	9.7	5.0	2.3	8.5	15.7	7.9	17.2	6.7	6.7	0.9	13.3	8.2	6.8	12.6	7.6	10.3	7.1	10.1	12.7	65.4	29.4	25.8	9.0	8.3	15.3	4.0	3.3	13.8	12.2	4.3
CAMK1	CaMKI	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757342-9769992	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.5;blood: 59.4"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 76.7;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 59.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 59.4"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 94.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol		NA	NA		550000	Cytosol		"CAB031904: AB_630964, HPA051409: AB_2681473"	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	27.1	60.5	28.0	11.7	26.0	3.5	34.1	12.4	31.2	9.5	10.7	4.4	5.8	6.8	12.6	10.5	7.1	12.6	8.9	10.2	21.4	14.0	13.1	20.7	9.2	10.4	10.3	19.9	21.5	4.5	7.4	7.9	5.1	10.1	18.6	8.1	6.8	5.1	15.1	4.7	3.3	8.3	18.4	7.2	7.1	8.1	13.4	5.6	0.6	7.0	3.7	10.4	9.5	10.3	0.0	3.2	59.4	9.2	0.7	0.4	0.9	0.1	3.7	3.0	0.0	15.4	5.7	7.5	8.8	4.9	10.1	9.6	5.4	0.6	0.2	2.0	5.9	1.5	0.6	0.0	1.1	6.3	0.1	21.6	11.9	7.0	7.5	8.6	1.0	94.0	6.0	0.9	14.2	1.5	8.3	8.4	0.2	1.5	0.2	3.7	2.2	0.0	8.7	2.1	0.1	5.8	0.0	0.1	0.2	6.0	0.6	1.0	3.8	1.5	0.1	0.8	1.3	0.9	15.2	4.4	4.6	5.7	6.5	11.0	0.1	0.0	0.2	9.8	3.3	0.6	3.3	4.8	59.4	0.0	9.2	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.2	0.7	9.2	0.1	0.4	0.9	28.0	26.0	12.4	31.2	21.4	14.0	10.3	19.9	10.1	5.6	0.0	1.9	6.4	17.8	4.4	8.1	0.0	10.2	1.4	2.3	10.4	2.0	0.4	8.3	13.1	1.5	22.7	2.0	0.0	3.6	1.0	11.6	14.9	31.0	21.2	76.7	0.0	5.8	17.8	40.5	3.9	33.4	50.8	5.0	19.0	1.3	30.9	6.0	3.5	42.5	35.3	8.0	58.2	35.0	1.1	1.1	3.3	0.7	7.5	5.5	10.8
TADA3	"ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L"	ENSG00000171148	"Transcriptional adaptor 3"	O75528	3	9779860-9793011	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042250	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042250: AB_10794043"	"unprognostic (5.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.83e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (5.47e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-3)"	21.9	39.3	37.3	28.1	35.2	22.0	44.2	16.8	43.4	29.7	25.8	23.4	30.6	23.1	29.6	25.5	25.1	35.8	34.2	34.1	33.6	30.3	26.1	34.2	32.1	40.8	29.7	26.2	46.8	21.0	25.8	30.3	18.9	27.5	34.2	21.5	23.0	25.9	34.6	39.0	20.0	24.7	26.1	25.3	25.6	24.9	48.0	21.6	32.7	33.9	22.5	28.5	29.6	27.1	13.3	18.3	46.4	31.2	18.7	23.8	18.1	13.8	14.3	23.3	13.2	21.3	19.6	50.0	13.7	25.7	20.0	25.2	14.8	16.5	15.0	17.3	32.5	25.4	8.3	13.5	19.8	9.2	18.1	14.9	32.8	18.1	15.9	30.4	11.6	55.7	19.9	25.9	28.4	20.7	25.5	13.3	22.3	21.8	18.9	24.5	39.5	11.7	11.3	21.5	18.3	13.8	5.7	11.6	19.2	20.4	13.5	8.8	26.2	12.1	6.6	23.7	13.6	24.5	30.3	18.2	26.7	21.9	13.9	19.7	15.2	16.9	25.6	38.7	21.7	21.1	20.6	15.8	46.4	23.8	24.9	12.1	13.3	17.0	19.4	18.3	12.5	15.2	16.4	20.3	18.7	31.2	11.3	20.7	18.1	37.3	35.2	16.8	43.4	33.6	30.3	29.7	26.2	27.5	21.6	11.9	13.8	35.0	74.0	14.9	28.0	7.5	28.1	6.7	9.1	31.4	13.7	41.7	56.3	55.8	69.5	16.1	57.7	23.3	56.6	44.6	38.5	44.3	47.2	35.9	58.1	23.8	34.1	29.4	41.1	62.8	33.9	37.5	30.4	121.8	57.0	61.9	53.4	59.6	40.3	52.5	22.3	71.1	30.9	64.0	73.4	14.4	30.8	64.3	47.2	48.8
ARPC4	"ARC20, p20-Arc"	ENSG00000241553	"Actin related protein 2/3 complex subunit 4"	P59998	3	9792495-9807726	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 524.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		22000000				"unprognostic (2.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.79e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.89e-2)"	"prognostic favorable (2.34e-4)"	49.1	37.1	38.3	48.8	35.9	49.2	46.0	20.1	48.4	27.5	45.2	31.6	33.8	36.0	40.6	35.5	48.3	29.5	39.3	25.7	42.5	32.3	39.6	38.8	34.3	72.2	31.9	34.3	28.4	33.8	20.5	23.6	36.5	24.1	31.1	44.7	24.5	35.3	28.6	28.5	36.4	39.1	40.8	27.3	59.8	30.8	28.2	20.3	55.4	35.0	45.0	72.1	34.1	38.6	27.6	53.3	79.4	56.3	26.3	37.9	52.1	24.2	31.5	26.8	17.8	33.3	27.7	66.3	37.6	32.6	28.7	25.7	19.6	36.3	16.4	21.4	50.7	34.8	15.9	16.9	30.0	34.5	32.1	10.5	52.4	32.5	21.9	34.9	50.4	74.3	29.9	27.6	38.5	24.0	31.2	40.6	9.4	24.8	15.7	54.1	51.2	43.5	30.1	51.6	34.9	29.3	36.1	18.2	28.9	40.7	37.3	11.0	37.5	21.9	29.4	27.6	24.7	34.7	75.4	41.2	35.1	14.7	34.7	53.0	10.6	30.8	48.1	51.9	38.3	54.4	30.4	48.9	51.7	37.9	56.3	31.4	27.6	31.7	31.2	41.2	26.2	22.7	29.8	79.4	26.3	55.1	53.3	33.5	52.1	38.3	35.9	20.1	48.4	42.5	32.3	31.9	34.3	24.1	20.3	14.9	47.3	154.6	66.9	60.7	12.1	22.2	50.9	30.8	27.3	55.8	7.9	102.2	61.3	118.2	7.8	63.0	134.1	0.0	110.8	202.4	71.3	64.0	103.7	46.5	306.2	22.3	108.3	79.2	219.2	4.1	45.8	171.9	74.2	524.8	113.0	34.2	134.7	138.7	62.2	88.5	10.3	38.8	68.4	10.7	31.7	57.5	141.4	172.0	104.8	75.5
ARPC4-TTLL3		ENSG00000250151	"ARPC4-TTLL3 readthrough"		3	9793082-9835401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"Alveolar cells type 2: 3.7;Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (9.59e-3)"	"unprognostic (7.61e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.31e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.42e-4)"	"unprognostic (5.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.37e-4)"	13.0	7.5	10.3	14.9	11.0	29.0	12.4	7.9	12.4	7.2	8.8	7.7	8.6	12.5	10.4	9.3	10.6	8.9	10.2	6.9	9.6	12.5	9.9	9.4	8.8	19.7	9.3	8.5	8.1	8.5	7.5	8.3	9.3	5.5	6.3	6.9	5.6	8.8	5.7	6.8	8.7	11.0	9.5	8.2	14.6	6.7	8.2	4.4	14.7	8.7	12.0	16.9	8.1	9.5	3.5	7.2	7.5	7.4	3.0	6.7	7.1	2.8	0.5	3.2	1.3	3.2	5.2	9.2	3.2	3.5	2.3	2.5	1.5	1.1	3.9	1.5	10.0	4.5	1.6	3.4	2.6	2.8	6.8	1.3	6.2	1.6	0.9	4.7	6.2	10.4	6.2	3.9	5.9	2.6	3.1	3.2	6.2	4.8	4.8	3.4	0.0	3.8	6.0	3.5	1.8	2.2	5.8	2.7	0.2	4.3	3.3	1.8	2.9	2.1	4.6	3.2	1.9	0.9	14.2	4.0	2.0	2.3	3.9	4.5	5.0	6.5	9.9	4.4	5.9	4.2	1.3	5.9	6.8	6.7	6.8	4.4	3.5	4.6	3.5	7.2	3.5	3.8	3.9	7.5	3.0	7.4	6.2	3.6	7.1	10.3	11.0	7.9	12.4	9.6	12.5	9.3	8.5	5.5	4.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TTLL3	"DKFZP434B103, HOTTL"	ENSG00000214021	"Tubulin tyrosine ligase like 3"	Q9Y4R7	3	9808086-9855138	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.6"									HPA051413	Approved					NA	NA					"HPA051413: AB_2681476"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.96e-1)"	"unprognostic (4.04e-4)"	"unprognostic (3.14e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.71e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (6.45e-6)"	"unprognostic (1.77e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (9.51e-6)"	14.3	10.8	18.5	14.5	20.7	19.5	12.9	11.6	15.2	22.7	12.5	23.6	30.6	8.1	21.4	23.7	7.9	18.7	19.9	11.1	18.6	10.5	11.8	4.1	12.2	14.6	11.9	17.8	31.6	7.6	10.6	22.3	9.2	15.6	18.0	9.8	22.2	10.3	26.8	8.1	28.8	10.0	20.5	14.8	13.8	11.7	28.4	17.7	4.0	12.9	4.3	10.6	13.7	19.6	3.3	3.8	10.5	7.6	2.6	3.3	1.1	0.9	2.7	5.8	1.1	10.4	20.1	33.6	3.4	3.5	1.9	2.6	4.3	3.9	5.9	3.0	6.7	1.8	1.5	3.6	0.7	1.2	6.9	10.3	7.2	8.2	4.5	3.5	6.7	12.8	13.0	4.9	3.7	1.4	11.3	3.3	9.0	6.9	14.9	4.2	3.6	1.1	10.1	0.7	0.6	1.4	3.4	2.3	2.6	2.9	7.7	2.6	2.3	1.7	1.0	3.0	3.0	2.6	4.3	10.6	5.1	6.6	4.8	1.6	9.3	4.0	8.3	4.2	9.6	1.7	6.7	2.7	7.2	2.9	7.6	1.2	3.3	2.0	1.4	3.0	3.1	2.4	1.9	10.5	2.6	3.9	3.8	3.3	1.1	18.5	20.7	11.6	15.2	18.6	10.5	11.9	17.8	15.6	17.7	11.9	7.8	3.2	4.6	4.6	9.2	2.8	2.5	28.1	6.8	8.7	23.6	4.2	0.0	3.5	19.8	8.2	4.6	0.0	5.8	4.8	7.8	4.6	8.1	0.9	4.6	6.4	11.5	7.4	13.5	12.7	21.0	6.4	10.1	3.6	9.8	10.8	5.3	6.8	11.7	1.3	15.4	12.9	5.1	14.2	6.1	4.1	4.2	7.7	6.3	6.4
RPUSD3	MGC29784	ENSG00000156990	"RNA pseudouridylate synthase domain containing 3"	Q6P087	3	9837849-9844602	"Predicted intracellular proteins"	"mRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037551, HPA037552"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037551: AB_2675538, HPA037552: AB_10672600"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.83e-2)"	10.8	18.9	19.5	11.8	25.9	17.0	13.2	21.1	26.5	11.1	14.9	12.9	9.8	16.0	14.0	14.4	19.3	13.9	14.0	20.7	17.2	17.0	16.9	19.5	11.8	14.3	14.4	16.5	14.7	17.5	24.1	17.0	15.2	17.4	13.3	15.6	14.6	12.5	17.5	43.3	18.6	11.9	15.6	10.6	13.2	13.6	36.3	16.4	16.5	15.3	13.9	18.7	15.0	12.2	23.7	22.2	12.4	24.7	37.0	29.7	19.0	9.0	13.5	10.3	6.6	17.4	12.9	77.2	7.8	11.2	13.0	13.8	11.8	9.3	15.6	9.8	8.6	19.2	7.7	22.9	14.0	10.4	12.0	24.0	20.8	12.1	12.6	13.6	12.7	13.2	15.8	19.5	15.1	17.6	10.7	17.1	21.1	15.3	10.9	12.8	21.3	17.3	23.3	11.2	13.2	20.3	12.3	8.5	26.1	14.3	6.8	8.0	6.7	9.8	12.6	21.5	15.5	21.5	13.8	10.1	5.2	9.4	9.1	11.4	16.2	19.3	20.5	11.0	24.2	12.0	12.4	24.7	11.9	22.6	17.6	22.9	23.7	21.2	21.1	22.2	20.0	24.2	21.5	6.0	37.0	12.0	21.3	29.7	19.0	19.5	25.9	21.1	26.5	17.2	17.0	14.4	16.5	17.4	16.4	17.9	8.1	21.6	19.2	7.1	24.2	21.4	12.7	13.4	14.8	14.0	19.6	38.5	39.7	26.0	63.8	13.4	18.8	0.0	27.6	39.4	12.4	15.6	20.7	24.1	33.7	11.1	12.7	23.4	14.3	42.6	19.8	16.7	15.1	26.2	14.4	16.9	22.0	14.4	20.1	35.2	21.2	6.5	18.6	105.6	21.0	11.2	14.4	25.9	26.2	10.1
CIDEC	"CIDE-3, FLJ20871, Fsp27"	ENSG00000187288	"Cell death inducing DFFA like effector c"	Q96AQ7	3	9866711-9880254	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	16	"adipose tissue: 129.9;breast: 63.7;intestine: 60.5"	"Cell type enriched"	"Detected in some"	6	"Enterocytes: 107.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.2;plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 197.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018837, HPA020553"	Approved					NA	NA					"HPA018837: AB_1846767, HPA020553: AB_1846769"	"unprognostic (1.83e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-5)"	"unprognostic (9.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.48e-3)"	"unprognostic (8.14e-2)"	"unprognostic (5.37e-5)"	"unprognostic (9.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (2.94e-2)"	129.9	1.1	0.1	5.3	0.1	0.0	63.7	0.1	0.1	0.4	44.3	0.1	0.9	13.5	0.5	0.6	0.1	0.2	5.3	2.3	0.1	0.0	0.6	2.6	0.1	2.7	0.1	0.1	0.1	1.4	0.0	0.1	0.1	0.1	0.4	0.8	0.1	2.9	0.8	1.7	2.4	60.5	0.8	0.1	0.1	0.8	0.4	0.1	0.1	0.4	1.9	0.2	2.4	1.1	2.2	1.8	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	197.1	44.5	0.1	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.5	0.0	2.2	0.1	0.0	0.5	0.6	0.0	0.2	0.0	0.2	0.4	1.8	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	107.8	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	3.4	0.0	0.0	0.8	2.3	0.0	1.7	0.0	1.7	0.0	0.6	17.3	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.1
JAGN1	"FLJ14602, GL009"	ENSG00000171135	"Jagunal homolog 1"	Q8N5M9	3	9890554-9894349	"Disease related genes, Predicted membrane proteins"	"Immunity, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067610			Approved	Vesicles		NA	NA			Vesicles		"HPA067610: "	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.49e-1)"	19.7	31.6	9.8	12.7	11.5	6.8	18.4	10.5	15.4	15.8	27.1	14.1	15.7	16.8	16.9	25.7	13.2	16.8	16.6	13.7	9.7	11.6	21.4	39.6	12.1	18.2	10.8	10.7	18.1	42.3	17.0	12.5	19.6	12.6	17.3	19.1	14.3	21.3	14.2	23.2	17.7	29.4	13.3	11.0	12.8	19.3	12.8	9.7	24.1	27.3	13.7	15.0	16.6	21.7	24.8	26.0	39.0	27.9	21.4	25.1	28.4	9.7	17.2	12.0	7.0	36.8	38.7	40.1	13.6	20.2	15.3	15.6	12.3	12.9	15.6	6.1	13.5	16.6	8.5	19.0	18.2	15.0	11.4	20.6	19.0	17.7	21.3	31.5	13.7	11.9	36.9	27.4	19.9	22.9	15.3	14.5	13.9	20.5	10.5	17.4	28.8	11.2	23.6	15.9	19.0	22.3	9.5	10.0	19.0	21.7	14.0	7.6	14.7	8.9	9.3	16.8	11.3	15.4	17.1	12.3	8.2	8.9	8.9	10.8	19.4	27.2	18.1	10.8	16.3	13.6	39.0	27.9	13.5	22.9	21.2	24.3	24.1	22.7	22.0	25.6	24.8	25.1	23.1	11.2	21.4	15.8	26.0	23.9	28.4	9.8	11.5	10.5	15.4	9.7	11.6	10.8	10.7	12.6	9.7	29.8	13.7	44.5	40.0	24.5	28.0	12.1	38.2	28.1	22.7	36.6	9.8	65.9	18.3	67.2	2.3	32.2	60.0	0.0	85.4	70.3	33.6	53.3	8.1	50.5	49.2	22.3	24.8	27.6	35.9	5.3	36.5	26.2	35.4	82.0	47.9	47.2	66.6	49.1	36.4	48.8	15.8	45.3	21.7	60.6	36.4	32.1	44.3	31.0	53.6	30.1
IL17RE	FLJ23658	ENSG00000163701	"Interleukin 17 receptor E"	Q8NFR9	3	9902612-9916402	"Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 55.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 71.8;Mucus-secreting cells: 43.2;Paneth cells: 38.6;Undifferentiated cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebellum: 19.0"	"Group enriched"	"Detected in some"	8	"basophil: 3.1;MAIT T-cell: 1.9;memory CD8 T-cell: 2.0"	"Group enriched"	"Detected in many"	19	"granulocytes: 3.1;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.0;ASC TERT1: 27.1;BEWO: 10.1;hTCEpi: 11.1;T-47d: 12.9"	"Region enhanced"	"Detected in single"		"cerebellum: 1.7"					HPA019011	Uncertain				"Intracellular and membrane"	NA	NA					"HPA019011: AB_1851667"	"unprognostic (1.08e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.43e-2)"	"unprognostic (6.69e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.85e-2)"	7.6	0.9	0.6	6.9	4.3	0.0	7.8	19.0	0.7	4.5	39.3	0.0	1.9	15.5	2.4	4.0	10.4	1.9	18.3	1.4	0.7	0.8	3.4	1.0	13.5	0.5	0.7	0.1	0.9	12.7	3.6	1.7	4.6	2.5	4.7	10.5	2.6	17.7	3.9	1.0	16.8	55.7	1.2	0.7	1.3	12.4	0.6	0.4	5.1	4.8	6.8	5.3	2.1	4.4	0.0	0.0	3.1	0.0	0.1	2.0	0.0	1.9	0.2	0.0	0.0	11.0	27.1	10.1	1.5	0.9	0.2	0.6	2.0	1.5	0.0	0.5	1.9	0.0	4.5	0.0	4.1	0.0	0.0	0.1	0.5	0.3	4.6	0.3	0.0	2.0	1.9	11.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.5	2.2	0.3	8.1	0.4	5.3	0.4	0.0	0.0	0.0	2.0	2.3	0.5	0.1	0.0	4.3	0.0	0.2	12.9	0.5	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	4.9	0.1	3.1	0.0	0.0	0.0	0.0	1.9	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	4.3	19.0	0.7	0.7	0.8	0.7	0.1	2.5	0.4	6.0	0.6	3.0	10.3	12.9	3.0	0.8	15.3	0.0	1.2	15.7	0.0	3.9	6.6	2.7	0.1	1.0	71.8	0.0	4.1	1.1	3.8	9.2	0.0	13.6	2.2	1.6	32.2	1.8	0.0	0.0	2.0	1.4	5.0	0.0	43.2	2.7	2.3	38.6	3.2	5.6	1.0	19.4	6.4	1.0	1.9	12.9	0.7	1.3	36.3	2.7
IL17RC	IL17-RL	ENSG00000163702	"Interleukin 17 receptor C"	Q8NAC3	3	9917074-9933630	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.6;myeloid DC: 4.8"	"Group enriched"	"Detected in many"	18	"dendritic cells: 4.8;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.1;ASC TERT1: 19.9;HSkMC: 18.1;T-47d: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019885, CAB026255"	Approved				"Intracellular and membrane"	NA	NA					"CAB026255: , HPA019885: AB_1851664"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.58e-2)"	"unprognostic (1.45e-3)"	"unprognostic (8.60e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.27e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.35e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-1)"	11.8	19.9	7.9	6.4	8.7	3.9	11.3	8.0	8.7	16.0	15.0	5.7	14.2	15.7	10.1	12.2	17.1	10.5	16.1	12.3	8.2	3.6	10.5	32.1	6.3	3.8	5.6	7.0	9.9	11.3	9.5	21.0	6.3	7.8	18.6	5.2	11.2	25.0	13.3	8.8	17.3	19.8	13.1	4.2	4.0	10.5	3.8	5.9	1.5	13.1	13.7	8.3	12.7	11.3	0.2	4.8	0.0	3.6	0.0	0.0	0.6	3.5	2.1	0.5	2.0	28.1	19.9	5.6	4.3	10.3	5.1	8.6	0.8	9.7	0.0	6.0	6.0	3.1	2.5	0.6	4.3	1.6	2.4	3.1	1.0	5.4	3.2	10.3	0.0	0.0	18.1	3.3	5.8	1.0	2.3	4.5	0.0	0.3	3.0	4.0	5.5	0.0	0.2	0.4	0.8	15.7	2.2	2.7	1.3	3.4	1.6	1.9	3.1	2.8	6.1	4.8	0.1	19.0	0.4	2.9	6.4	3.2	3.1	2.6	0.0	0.1	0.0	10.1	0.3	4.8	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.8	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.6	7.9	8.7	8.0	8.7	8.2	3.6	5.6	7.0	7.8	5.9	0.0	0.3	3.0	16.2	9.6	1.9	2.4	5.1	2.7	2.3	1.8	0.0	5.2	3.3	11.6	0.4	7.5	29.6	0.0	18.5	3.8	12.9	34.4	0.0	39.0	9.8	1.6	13.8	10.4	7.8	1.1	17.5	5.5	13.5	2.8	16.4	22.0	10.8	28.1	15.9	14.6	0.9	19.4	10.0	0.2	0.4	17.3	2.4	3.2	18.0	14.5
CRELD1	AVSD2	ENSG00000163703	"Cysteine rich with EGF like domains 1"	Q96HD1	3	9933822-9945413	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026964	Uncertain		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA		16000000	Cytosol	Nucleoli	"HPA026964: AB_10602210"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.78e-2)"	21.8	22.9	31.6	15.3	32.4	7.3	27.3	52.2	45.1	9.9	22.4	12.0	17.1	12.5	15.1	17.8	13.1	20.1	15.8	50.2	25.6	24.9	16.6	23.5	15.8	11.0	17.2	30.7	19.7	15.2	21.9	32.4	15.1	27.2	25.4	11.4	10.0	19.4	32.2	24.4	11.6	13.1	19.5	19.4	11.9	14.8	11.1	22.3	5.9	45.7	7.4	8.2	17.8	15.6	10.5	13.7	11.5	12.5	13.4	14.3	10.4	2.8	5.2	8.5	4.4	14.4	9.4	47.1	10.4	3.1	2.6	4.9	5.0	8.5	3.4	22.9	7.2	12.1	1.8	4.1	7.5	1.8	6.7	3.9	3.1	6.7	11.8	28.8	1.1	12.0	9.6	13.9	6.4	5.9	31.4	11.8	5.2	3.7	4.1	2.5	6.8	2.0	8.4	2.3	11.6	3.5	2.1	1.2	8.1	11.0	4.9	3.4	11.0	4.8	4.5	9.3	11.7	11.5	6.8	8.2	5.0	8.1	6.6	2.5	4.7	6.0	6.3	11.1	3.5	5.3	11.5	11.4	9.4	14.2	11.6	14.3	8.9	10.5	13.7	8.2	10.5	14.2	12.7	1.8	13.4	12.5	13.7	8.0	10.4	31.6	32.4	52.2	45.1	25.6	24.9	17.2	30.7	27.2	22.3	17.9	13.7	10.7	19.5	8.7	20.8	34.7	33.1	8.1	7.9	15.7	15.7	20.0	6.6	17.7	5.8	15.0	14.7	0.0	3.9	9.2	21.7	31.7	20.7	11.5	18.5	30.2	25.9	16.0	7.8	7.9	29.7	10.2	11.8	19.0	14.9	21.0	8.8	15.0	24.8	8.2	15.0	25.8	14.1	49.7	11.9	10.8	18.5	12.1	14.1	16.3
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952394	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 23.6;Rod photoreceptor cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;MCF7: 16.1;SK-BR-3: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		18000	"Plasma membrane"	Nucleoplasm	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	1.4	2.9	8.4	1.8	11.9	2.1	2.0	13.4	26.0	2.4	1.4	4.2	0.0	1.0	2.0	2.2	1.7	10.8	1.9	1.6	5.9	3.2	1.5	0.9	1.4	1.8	2.7	8.3	2.9	2.9	24.7	6.9	0.8	11.4	4.0	0.8	1.8	2.0	2.9	1.5	2.5	1.2	1.7	2.3	1.5	1.5	3.9	3.2	1.2	3.4	0.0	2.0	2.1	1.8	1.8	1.5	0.9	0.6	1.7	3.8	1.0	0.2	0.7	2.6	3.4	12.7	1.7	0.8	1.2	2.4	1.5	3.3	0.2	2.4	1.3	0.3	3.0	1.5	0.2	0.9	3.2	0.6	6.8	1.4	0.5	1.3	0.0	1.3	0.3	1.2	3.2	0.2	1.2	0.5	7.1	0.6	4.3	0.7	3.4	1.8	16.1	3.0	0.2	6.2	0.1	1.5	1.8	0.3	1.3	0.7	0.2	4.9	3.2	1.2	24.2	0.4	1.0	6.5	0.3	0.6	0.3	3.5	0.6	0.9	4.4	4.5	0.4	8.0	0.2	0.9	0.9	0.6	0.5	3.3	0.3	3.7	1.6	3.4	3.3	0.2	1.8	3.8	3.5	0.8	1.7	0.4	1.5	0.6	1.0	8.4	11.9	13.4	26.0	5.9	3.2	2.7	8.3	11.4	3.2	0.0	1.3	3.0	3.6	2.4	23.6	2.5	7.6	8.1	1.2	10.4	13.7	0.6	3.3	2.6	3.1	2.8	4.2	0.0	4.4	0.4	4.8	3.6	1.1	2.4	3.1	14.3	10.9	1.8	1.3	2.7	5.2	2.1	1.7	17.2	4.7	9.8	3.2	0.0	2.5	6.2	22.5	0.0	4.7	9.7	5.7	1.9	0.3	4.6	3.6	2.0
EMC3	TMEM111	ENSG00000125037	"ER membrane protein complex subunit 3"	Q9P0I2	3	9962537-10011116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 287.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042372	Approved		Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA042372: AB_10795609"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.81e-6)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.58e-2)"	41.8	31.5	19.8	17.2	27.1	35.4	24.7	17.2	28.0	17.6	25.0	18.6	23.5	23.2	19.4	19.6	31.3	18.8	17.7	28.3	18.6	21.5	33.0	47.2	22.3	12.7	23.6	20.6	16.3	27.2	25.5	15.9	19.6	27.9	20.8	23.2	16.3	26.0	21.9	54.7	25.4	24.8	20.2	21.9	17.1	23.1	52.6	19.2	15.0	37.7	22.4	20.3	27.3	25.4	25.0	35.1	41.6	46.1	28.1	40.2	51.4	13.5	28.8	10.8	6.5	69.2	27.2	36.4	27.9	24.2	17.5	19.0	19.7	21.7	10.8	20.4	31.6	33.7	19.1	18.4	16.5	18.1	29.3	18.5	17.7	21.9	12.8	29.9	19.9	20.0	31.9	29.8	30.5	17.6	22.4	21.7	11.9	22.5	31.7	25.8	33.4	10.5	9.9	12.0	28.9	19.7	13.7	15.2	32.1	21.2	24.6	7.7	15.5	19.9	29.9	17.9	11.9	25.3	16.3	24.8	17.5	14.7	18.9	28.3	17.1	44.3	21.9	37.0	14.7	21.9	38.4	46.1	41.3	27.4	36.2	28.3	24.9	27.2	31.2	35.1	25.0	19.9	26.8	41.6	28.1	34.7	31.5	40.2	51.4	19.8	27.1	17.2	27.9	18.6	21.5	23.6	20.6	27.9	19.2	50.6	63.5	44.0	48.5	45.0	39.0	97.2	56.0	62.9	61.4	43.6	37.3	43.1	39.7	83.4	287.9	55.4	60.4	256.9	103.9	42.9	46.8	56.5	32.4	82.2	88.7	22.3	20.3	42.4	51.0	67.2	46.6	55.9	55.6	120.8	32.8	60.4	90.0	70.2	35.3	57.8	53.0	58.2	48.9	135.1	54.3	53.1	71.7	50.4	50.0	70.1
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 46.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		No	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: AB_2685110"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.7	9.3	17.8	5.0	0.9	1.4	46.0	8.0	3.6	11.5	9.4	6.9	8.7	17.1	3.8	2.6	9.5	7.6	18.3	6.2	11.5	8.1	12.4	23.3	14.3	6.6	0.1	17.3	14.6	0.4	1.0	13.0	7.2	1.6	6.9	14.7	14.2	19.6	8.7	10.0	14.4	6.7	21.4	6.7	6.5	15.8	14.5	12.1	4.0	9.8	4.9	9.8	9.8	7.7	3.1	13.5	11.8	11.0	4.0	9.6	11.0	5.8	11.6	8.3	16.3	28.9	5.5	17.8	16.3	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6	0.0	0.3	9.7	2.8	4.0	2.8	1.6	0.0	1.4	1.2	1.8	9.8	6.6	0.0	1.6	4.4	1.5	0.7	46.7	2.9	12.7	1.3	2.2	1.1	1.0	5.0	0.0	1.2	3.7	3.4	5.6	2.0	5.2	3.3	7.2	2.0	0.8	1.4	2.8	1.4	0.5	5.8	19.4	0.8	55.1	32.4	2.4	5.8	3.8	5.0	2.3
FANCD2OS	"C3orf24, MGC40179"	ENSG00000163705	"FANCD2 opposite strand"	Q96PS1	3	10081317-10108231	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 53.0"	"Group enriched"	"Detected in some"	88	"Early spermatids: 499.8;Late spermatids: 668.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.8;Daudi: 1.5;HEL: 2.5;MCF7: 2.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA076166			Approved	Vesicles		NA	NA			Vesicles		"HPA076166: "	"unprognostic (5.99e-2)"	"unprognostic (4.33e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.63e-2)"		"unprognostic (4.78e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.11e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	8.4	1.6	0.4	0.4	0.1	0.3	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	0.6	1.5	0.7	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	2.3	1.3	0.0	0.1	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.8	0.2	0.1	0.0	1.2	0.6	0.3	0.9	0.6	0.4	0.5	0.3	0.3	0.4	0.2	0.4	0.2	0.1	0.8	0.3	0.3	8.4	0.4	1.6	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	499.8	0.0	0.0	0.0	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	668.2	6.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.0	5.1	2.4	0.0	0.0	0.0	0.0	0.0
BRK1	"C3orf10, HSPC300, MDS027"	ENSG00000254999	"BRICK1, SCAR/WAVE actin nucleating complex subunit"	Q8WUW1	3	10115592-10127190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 1965.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060391			Approved	"Nuclear speckles,Cell Junctions"		NA	NA		130000	"Nuclear speckles"	"Cell Junctions"	"HPA060391: AB_2684272"	"unprognostic (4.99e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.60e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.75e-3)"	67.1	47.6	53.4	40.4	57.1	52.4	62.9	33.4	69.5	52.8	58.6	36.1	47.3	37.9	63.2	68.3	73.0	59.4	70.8	54.4	42.6	45.3	66.8	57.3	49.3	53.2	43.3	53.6	62.7	57.8	38.8	39.2	44.4	40.7	60.8	51.8	41.5	84.2	53.1	62.7	57.0	46.5	74.3	37.2	47.0	57.2	65.2	34.2	50.2	83.3	62.4	64.8	63.0	61.0	67.4	89.7	76.1	75.4	47.2	61.0	89.1	30.6	36.8	39.2	20.4	65.7	71.8	93.0	45.7	45.6	42.9	42.7	25.2	36.1	35.4	21.8	52.5	37.7	16.1	28.2	46.3	47.1	39.0	39.0	48.8	42.5	37.6	37.4	46.4	37.0	47.1	44.8	48.0	35.0	56.6	59.9	29.9	31.6	41.5	64.7	67.4	30.0	37.2	45.2	43.7	46.7	29.1	40.4	38.4	56.4	50.9	15.2	26.5	36.7	32.1	36.9	40.8	52.1	40.7	54.0	43.3	33.1	50.5	40.6	23.9	64.1	79.8	62.6	63.8	35.5	54.1	75.4	75.9	56.5	72.4	50.3	67.4	55.0	53.1	84.3	67.4	50.1	54.4	76.1	47.2	70.9	89.7	61.0	89.1	53.4	57.1	33.4	69.5	42.6	45.3	43.3	53.6	40.7	34.2	59.6	65.2	192.9	249.1	234.3	35.8	112.3	242.0	80.3	80.8	193.7	19.6	217.7	417.8	328.3	849.5	294.2	166.8	93.5	317.6	231.0	237.3	296.5	172.8	204.5	385.0	44.5	286.9	207.5	335.1	1965.9	229.0	331.9	335.8	527.6	186.8	106.0	371.4	168.4	238.6	736.5	29.7	232.8	294.2	162.6	168.0	275.8	178.3	223.7	210.0	344.6
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141008-10152220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 54.7"									"CAB005430, HPA031631, HPA031632"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005430: AB_2241850, HPA031631: AB_2673968, HPA031632: AB_2673969"	"prognostic unfavorable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	13.8	17.4	18.1	29.2	18.4	24.3	15.4	25.8	21.4	13.3	19.8	19.3	14.5	15.9	15.1	13.6	16.4	14.3	18.9	10.5	17.1	18.5	13.7	16.3	14.6	27.9	13.5	12.3	15.2	22.5	13.8	14.6	18.8	12.8	15.1	16.6	12.5	21.8	13.7	14.8	14.0	22.3	13.4	17.0	22.6	16.2	17.9	11.2	39.2	16.9	11.5	29.3	15.4	19.1	5.4	3.9	8.0	4.1	4.4	4.3	1.7	6.8	6.6	14.6	8.9	13.6	10.5	54.7	6.1	8.7	7.8	9.2	7.8	8.6	24.3	8.3	8.2	11.0	5.9	13.5	8.5	9.6	11.6	12.2	18.9	10.8	10.7	12.9	16.6	15.2	10.6	9.7	10.3	13.0	10.4	8.9	15.3	16.8	18.5	7.6	12.4	15.8	12.2	9.8	7.4	8.5	20.1	12.9	12.2	9.5	17.8	5.5	18.3	12.8	6.8	7.3	9.2	13.4	21.1	7.7	7.7	10.4	7.2	9.5	13.2	26.9	38.8	8.6	20.0	7.0	2.6	4.1	3.3	3.8	2.5	3.6	4.1	2.9	4.3	3.9	5.4	2.5	2.7	8.0	4.4	3.2	2.4	3.1	1.7	18.1	18.4	25.8	21.4	17.1	18.5	13.5	12.3	12.8	11.2	11.9	12.2	25.5	15.5	13.1	15.6	5.0	20.4	5.3	5.7	15.7	17.7	13.9	6.6	9.9	7.6	12.1	10.5	0.0	4.5	15.8	9.5	19.0	4.7	12.3	12.9	17.5	13.8	17.2	20.2	6.1	13.0	18.5	11.8	15.4	9.3	10.4	8.5	9.3	10.6	7.3	13.9	6.5	6.2	14.4	25.6	17.9	14.4	17.5	10.7	19.5
IRAK2		ENSG00000134070	"Interleukin 1 receptor associated kinase 2"	O43187	3	10164865-10243743	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 18.1;Glandular cells: 20.2;Urothelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.2;BJ hTERT+: 16.9;CAPAN-2: 17.1;GAMG: 30.8;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"CAB013483: , HPA050520: AB_2681154"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.60e-5)"	12.1	5.8	3.6	8.6	5.9	28.7	5.4	4.5	7.0	3.3	4.0	12.2	2.3	3.3	3.5	2.6	8.4	2.4	6.8	2.7	3.6	5.2	4.3	15.4	12.7	5.3	10.4	3.7	1.9	3.2	2.4	1.8	3.5	7.8	6.4	3.1	2.1	4.8	3.4	19.6	6.2	6.7	3.4	6.1	5.9	5.2	1.7	8.6	3.9	4.1	2.7	16.7	14.3	7.2	5.0	1.3	2.5	1.2	8.4	7.9	2.5	1.2	3.7	0.1	0.5	4.0	3.4	16.2	1.3	16.9	2.3	2.2	1.7	17.1	0.0	0.4	2.0	30.8	0.4	0.4	4.3	3.1	1.0	1.2	0.3	0.8	4.7	2.0	0.0	0.5	2.1	0.7	8.5	11.0	6.1	4.7	0.1	0.8	5.2	2.7	0.0	0.0	0.8	0.1	2.0	3.6	0.8	0.0	0.2	5.1	23.4	0.2	0.1	1.6	0.0	0.1	0.4	0.4	0.8	4.8	5.3	0.4	3.2	3.3	1.7	5.1	1.0	11.3	2.2	0.9	0.2	1.2	0.1	7.5	0.7	7.9	5.0	2.2	4.1	1.3	4.5	1.6	3.9	2.5	8.4	0.2	0.1	0.9	2.5	3.6	5.9	4.5	7.0	3.6	5.2	10.4	3.7	7.8	8.6	0.0	5.5	0.9	18.1	7.1	0.6	1.6	0.0	0.0	2.3	0.0	0.0	0.1	0.0	8.5	3.3	2.1	1.1	0.0	3.5	0.4	1.0	20.2	0.0	4.7	2.9	0.0	0.0	1.3	2.5	1.1	0.9	4.3	5.0	2.8	0.1	1.7	10.4	0.0	0.0	1.0	0.0	0.0	3.1	0.4	0.4	6.5	0.8	1.5	0.4	22.1
TATDN2	KIAA0218	ENSG00000157014	"TatD DNase domain containing 2"	Q93075	3	10248023-10281218	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036822	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036822: AB_10671972"	"unprognostic (4.51e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.48e-2)"	12.0	13.1	20.4	16.2	22.8	32.8	14.3	17.5	31.6	15.5	13.8	15.8	17.5	14.2	17.2	17.9	16.4	12.6	14.5	13.8	18.3	14.0	14.3	12.2	14.3	21.6	13.7	19.2	22.4	20.8	25.8	16.9	11.1	13.8	17.6	17.2	16.2	20.4	15.3	12.0	19.5	15.2	15.8	13.0	20.6	13.7	10.1	13.5	37.5	18.8	8.6	25.2	12.5	15.2	3.3	3.5	2.5	2.5	2.2	6.0	2.3	9.5	16.1	9.0	7.6	11.6	12.8	38.2	11.5	12.1	15.4	10.1	11.7	8.6	23.3	8.8	17.1	16.2	7.0	15.6	11.0	12.4	14.7	17.8	12.3	15.7	12.4	7.7	17.1	12.9	9.7	12.4	21.7	7.2	10.1	12.5	14.4	13.6	21.2	14.1	18.4	22.6	14.3	12.3	12.8	16.1	12.3	9.6	13.3	9.7	13.9	9.9	11.7	9.8	11.7	5.3	8.9	11.4	16.1	10.1	18.0	11.5	14.6	20.7	13.0	21.2	41.5	15.7	17.5	12.1	2.5	1.6	1.2	4.6	2.5	4.5	2.5	3.9	3.7	1.5	3.3	4.0	6.0	1.3	2.2	1.3	3.5	4.4	2.3	20.4	22.8	17.5	31.6	18.3	14.0	13.7	19.2	13.8	13.5	6.0	14.1	6.5	3.7	11.2	4.4	5.0	12.7	1.4	4.5	10.4	5.9	3.0	1.7	4.8	1.3	7.1	6.2	0.0	7.8	3.4	7.2	8.4	4.7	10.2	8.7	4.8	16.1	9.2	12.3	1.5	6.6	7.7	13.5	1.8	8.9	4.1	6.7	0.0	7.1	4.4	2.7	6.5	4.1	1.7	5.1	10.8	2.1	14.9	9.3	6.4
GHRL	"ghrelin, MTLRP, obestatin"	ENSG00000157017	"Ghrelin and obestatin prepropeptide"	Q9UBU3	3	10285675-10292947	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8;stomach 1: 64.9"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 8.2;Bipolar cells: 7.7;Cone photoreceptor cells: 9.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 6.2;classical monocyte: 6.0;eosinophil: 6.0;myeloid DC: 21.8;neutrophil: 13.5;plasmacytoid DC: 15.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 21.8;granulocytes: 13.5;monocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA014246, CAB022731"	Enhanced				"Secreted to blood"	NA	NA	2580000	69000			"CAB022731: , HPA014246: AB_1849659"	"unprognostic (1.74e-2)"	"unprognostic (3.01e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.52e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.79e-4)"	1.2	0.6	1.8	4.2	1.7	1.5	0.6	0.7	1.5	0.6	1.2	1.8	2.2	7.4	0.9	2.3	1.1	1.0	1.7	1.3	1.6	0.7	0.8	0.8	1.8	14.5	0.9	0.4	1.0	1.7	0.2	0.8	0.2	1.1	1.2	0.2	0.7	3.2	0.1	0.7	0.8	1.4	0.3	0.9	4.9	64.9	0.7	1.3	1.7	1.2	0.0	4.3	0.7	0.5	0.8	21.8	13.5	6.0	2.1	0.1	2.0	0.7	0.3	3.0	2.3	2.2	0.0	5.5	2.8	0.0	0.8	0.2	3.2	0.6	1.6	1.0	0.1	2.4	0.4	0.0	0.7	0.0	0.5	3.3	3.4	1.8	6.8	0.0	3.5	6.1	0.4	0.0	0.1	0.1	0.2	0.6	2.1	1.4	16.6	0.0	0.7	1.3	4.8	1.5	0.5	6.0	0.9	0.3	0.9	0.0	3.6	2.1	0.3	1.8	1.2	0.1	2.1	1.7	4.2	2.9	1.4	0.9	1.3	1.8	2.0	2.8	3.5	0.5	3.9	0.6	6.2	6.0	6.0	0.1	2.8	0.0	0.8	0.1	0.0	21.8	0.5	0.1	0.0	13.5	2.1	0.2	15.0	0.1	2.0	1.8	1.7	0.7	1.5	1.6	0.7	0.9	0.4	1.1	1.3	0.0	1.4	8.2	3.3	1.1	7.7	0.0	0.0	0.0	0.0	1.8	9.8	1.3	0.0	1.0	0.2	1.1	0.0	0.0	1.2	1.0	1.0	2.1	0.0	0.0	1.5	3.2	0.0	0.6	2.8	0.4	0.3	7.1	1.7	4.6	0.0	2.9	0.6	0.0	0.4	0.0	5.4	6.5	1.2	1.2	0.8	0.5	0.2	5.2	0.6	1.7
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321178	"Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		15000	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: AB_2683560"	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	25.2	30.7	19.0	24.2	24.7	20.6	25.5	16.2	24.9	37.9	47.0	22.6	38.1	47.7	29.6	30.8	30.1	24.7	41.6	30.6	19.5	20.7	33.2	58.3	27.0	19.9	24.7	17.5	24.7	66.8	22.3	48.1	44.1	20.2	23.2	27.9	22.3	63.5	33.4	42.6	25.5	57.1	32.0	21.9	25.9	27.2	26.4	20.5	29.0	38.2	32.8	28.6	25.8	24.2	26.9	60.8	29.1	44.6	23.2	27.7	41.2	21.2	32.3	26.0	10.0	42.3	47.0	86.4	43.6	53.3	51.0	58.9	26.7	17.5	19.5	20.0	69.0	28.7	8.7	33.4	38.8	26.2	16.9	34.7	23.8	26.2	64.4	58.1	27.1	21.1	41.6	31.4	53.3	33.2	37.6	60.4	26.2	25.4	28.9	39.3	43.9	26.4	29.8	29.5	27.7	39.2	25.7	18.6	34.6	31.0	16.0	14.6	18.2	19.1	17.8	17.0	22.8	22.9	26.4	45.1	21.0	24.0	31.3	37.3	24.0	33.3	45.1	39.7	38.1	34.6	28.0	44.6	28.1	24.5	38.4	27.2	26.9	24.6	23.7	60.8	22.2	20.3	21.2	29.1	23.2	29.5	54.2	27.7	41.2	19.0	24.7	16.2	24.9	19.5	20.7	24.7	17.5	20.2	20.5	44.7	52.3	27.4	45.1	34.9	14.7	37.0	17.8	72.3	47.8	26.2	9.8	98.1	56.3	69.8	20.2	33.5	63.9	0.0	95.6	135.9	66.7	49.4	41.6	54.2	93.9	11.1	39.7	36.8	34.0	6.8	49.5	49.1	25.3	67.7	75.6	30.7	74.0	53.4	49.5	72.3	20.1	12.9	43.2	42.4	36.5	35.1	141.0	40.1	67.8	50.4
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 85.3;Hepatocytes: 27.0;Horizontal cells: 98.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 5.4;RPMI-8226: 15.3;SCLC-21H: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced					NA	NA					"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	1.0	1.5	7.6	1.0	23.0	0.9	1.0	39.9	55.1	3.0	1.0	2.4	0.0	1.0	3.2	1.1	1.1	4.3	1.0	1.0	10.0	6.2	1.1	15.2	1.0	1.0	7.9	14.7	1.0	1.1	0.9	1.7	0.9	15.5	1.0	1.0	0.7	28.6	0.9	30.3	1.3	1.0	2.3	2.5	1.0	1.0	1.5	4.2	0.0	0.9	0.0	1.0	0.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	15.3	0.0	0.0	5.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	7.6	23.0	39.9	55.1	10.0	6.2	7.9	14.7	15.5	4.2	0.0	0.0	0.0	0.0	0.5	85.3	7.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	27.0	0.0	98.5	0.0	0.6	1.0	5.7	0.0	0.0	3.3	0.0	0.0	14.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816200-10940733	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;esophagus: 10.5;skin 1: 11.5"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.8	0.8	11.5	0.7	14.1	0.8	2.9	3.1	23.0	0.9	0.8	5.0	0.0	0.7	1.7	1.1	10.5	1.8	0.7	0.8	8.4	24.5	0.7	0.9	0.8	0.7	37.0	5.9	0.8	1.0	0.7	0.2	1.6	35.4	2.3	0.8	0.4	1.1	0.7	1.0	11.5	0.8	1.0	10.4	1.5	0.7	3.4	9.2	0.0	0.8	0.2	1.1	1.3	0.7	0.5	0.3	1.2	0.4	0.2	0.3	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	12.7	0.0	2.1	0.0	0.0	0.2	0.2	0.0	14.6	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.8	4.4	3.7	0.1	0.0	0.1	4.8	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.5	0.2	0.2	1.2	0.2	0.4	0.3	0.3	0.0	11.5	14.1	3.1	14.7	8.4	24.5	37.0	5.9	35.4	9.2	0.0	0.0	0.0	0.2	1.1	7.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	21.8	0.3	0.0	6.3	0.0	1.3	0.0	0.0	0.2	1.5	3.1	0.8	0.0	0.0	1.5
SLC6A1	"GABATHG, GABATR, GAT1"	ENSG00000157103	"Solute carrier family 6 member 1"	P30531	3	10992186-11039249	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 56.2;liver: 75.6"	"Cell type enhanced"	"Detected in some"	16	"Cholangiocytes: 17.8;Hepatocytes: 24.5;Muller glia cells: 41.9;Sertoli cells: 12.9"	"Group enriched"	"Detected in some"	16	"glioma: 16.1;liver cancer: 24.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013341, CAB022293"	Enhanced		Uncertain	Mitochondria		No	NA			Mitochondria		"CAB022293: , HPA013341: AB_1849509"	"unprognostic (1.66e-3)"	"unprognostic (1.30e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (7.32e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.34e-2)"	1.8	2.1	32.2	1.6	31.0	3.0	1.8	15.1	56.2	2.0	1.7	25.4	0.0	1.7	1.9	3.9	4.3	2.4	2.3	3.3	22.2	16.6	2.1	75.6	2.5	1.7	22.7	25.3	2.4	1.4	9.3	1.0	2.0	17.0	2.1	1.8	1.7	1.6	5.0	3.3	1.7	1.7	1.8	13.7	1.9	1.7	4.4	14.3	0.5	1.9	0.0	1.7	1.9	0.9	1.0	0.8	1.2	0.3	0.2	0.8	0.2	0.8	0.6	1.9	1.3	1.5	0.4	1.1	0.7	0.2	0.8	1.1	1.5	1.0	1.6	0.3	0.4	1.8	1.3	2.3	0.9	0.7	0.2	1.8	1.3	4.6	2.8	0.7	2.2	2.3	1.1	0.2	0.2	1.3	0.5	0.3	1.7	1.1	3.7	0.2	1.1	0.7	1.8	0.8	1.2	1.4	1.2	0.2	0.1	0.6	1.8	0.8	0.3	1.0	0.7	0.2	1.1	1.0	1.0	0.3	0.8	0.5	0.7	0.7	1.1	0.3	1.2	0.9	1.7	0.4	0.3	0.3	1.1	0.5	0.1	0.8	0.9	0.6	0.5	0.3	1.0	0.3	0.5	1.2	0.2	0.3	0.8	0.3	0.2	32.2	31.0	15.1	41.5	22.2	16.6	22.7	25.3	17.0	14.3	0.0	0.3	0.0	0.0	0.2	1.8	1.4	17.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	24.5	0.0	0.0	0.0	0.0	1.0	0.2	5.2	0.0	0.0	0.0	0.0	41.9	0.0	0.0	9.6	0.1	3.3	12.9	2.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 41.0;Club cells: 30.7;Enterocytes: 29.3;Suprabasal keratinocytes: 36.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.5;hTEC/SVTERT24-B: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	9.1	4.4	7.3	4.6	4.4	0.2	9.6	0.5	10.6	8.0	13.5	1.3	2.4	3.8	6.2	7.2	5.7	10.6	9.9	7.0	5.1	4.0	3.3	1.1	8.2	1.8	2.2	2.1	8.7	2.1	1.7	1.2	5.5	3.2	7.2	7.2	2.0	3.4	6.1	3.0	8.0	10.5	9.2	8.6	1.4	3.3	2.4	2.0	0.1	2.5	7.2	3.1	11.2	16.2	0.1	0.3	1.2	0.2	0.1	3.5	0.1	1.5	3.5	0.0	0.0	1.6	17.5	2.4	2.6	8.8	7.8	5.3	0.6	12.6	0.0	7.8	6.1	8.0	9.9	0.0	3.6	10.7	5.5	0.0	0.8	5.7	0.0	5.3	2.4	1.4	6.1	2.2	17.7	6.2	10.9	10.9	0.1	0.0	0.0	3.5	0.0	0.0	1.1	0.0	1.5	3.2	0.2	0.9	0.3	14.0	2.0	0.1	0.0	3.7	2.7	0.0	0.1	0.0	2.0	16.2	8.8	5.5	9.0	13.1	0.0	0.9	0.0	13.5	2.2	7.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	1.3	0.5	0.3	0.1	0.1	0.1	1.2	0.1	0.0	0.1	3.5	0.1	7.3	4.4	0.5	8.4	5.1	4.0	2.2	2.1	3.2	2.0	6.0	1.4	0.0	7.7	41.0	0.0	0.4	0.0	2.7	30.7	1.8	0.0	0.2	0.0	0.4	0.3	9.3	29.3	0.0	0.6	1.0	6.7	3.9	2.3	0.0	21.0	0.0	3.4	0.6	6.9	0.0	3.4	5.7	0.0	0.0	8.0	0.0	8.3	11.4	0.0	0.3	0.1	0.0	2.3	2.3	2.8	36.3	0.5	0.0	8.8	18.2
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		13000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	27.0	18.6	14.8	21.1	21.9	37.5	16.6	14.1	29.2	16.4	15.2	26.2	13.4	11.6	28.9	15.9	18.9	17.4	15.1	12.3	14.0	13.1	13.1	11.8	18.4	18.8	14.8	17.1	15.5	13.1	18.7	23.0	18.7	21.6	12.9	17.8	19.3	16.6	11.6	15.8	22.2	16.9	18.3	16.6	19.7	13.1	19.7	13.9	17.7	12.7	12.2	21.6	16.5	15.2	4.0	23.8	31.3	39.7	5.9	4.8	14.2	18.4	14.6	6.5	3.4	11.5	15.2	32.4	17.4	22.7	17.4	20.3	6.2	16.8	8.5	10.6	15.4	18.1	5.7	7.2	24.4	30.0	7.5	9.1	6.1	14.1	7.4	15.2	17.6	20.3	15.6	11.3	33.7	21.2	18.0	24.0	5.4	9.0	7.0	24.1	12.0	5.0	8.2	5.1	8.5	18.9	6.3	7.8	7.5	13.1	13.3	5.8	5.7	12.4	10.5	6.7	8.4	11.4	17.2	16.3	14.3	10.4	9.4	24.3	4.5	11.7	14.3	23.2	16.6	19.3	13.1	39.7	24.5	4.8	22.9	3.7	4.0	4.0	4.5	23.8	3.7	3.5	4.2	31.3	5.9	16.3	4.2	3.4	14.2	14.8	21.9	14.1	29.2	14.0	13.1	14.8	17.1	21.6	13.9	0.0	9.8	6.1	6.1	9.8	11.1	3.9	0.0	12.0	5.7	7.0	17.7	13.7	6.6	10.0	41.0	10.5	6.9	23.3	11.3	14.0	8.9	5.5	14.9	7.8	50.1	19.1	10.9	20.9	20.3	78.6	9.5	19.9	3.3	9.0	7.0	9.3	12.7	7.0	9.2	5.4	12.5	6.5	5.1	19.5	11.5	6.8	16.0	10.0	7.3	7.3
VGLL4	KIAA0121	ENSG00000144560	"Vestigial like family member 4"	Q14135	3	11556070-11771350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038225, HPA038614"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Nucleoli fibrillar center"	Nucleoplasm	"HPA038225: AB_10674549, HPA038614: AB_2676115"	"unprognostic (1.21e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.26e-1)"	22.3	29.3	26.6	20.7	25.1	10.5	28.2	18.0	23.8	32.3	18.6	22.8	17.8	18.9	35.6	23.3	23.6	36.0	28.9	20.7	23.3	13.2	22.5	10.6	20.4	15.2	22.4	14.9	65.4	18.4	27.2	19.6	19.9	19.7	21.8	14.7	28.8	28.7	23.5	13.8	24.2	18.6	24.7	28.2	15.8	18.6	25.4	23.3	30.0	37.5	21.3	19.9	23.4	30.3	5.6	5.3	16.2	5.8	6.3	11.3	5.8	10.3	7.0	20.1	6.1	25.5	13.8	37.7	6.9	14.3	6.1	6.0	5.9	10.3	14.1	16.0	10.9	10.7	7.0	9.2	11.5	4.3	8.5	14.0	15.1	7.0	9.8	19.9	11.8	10.0	17.2	24.0	8.3	10.7	36.0	22.8	15.0	5.4	2.4	9.4	8.9	14.0	13.6	12.4	15.3	12.4	18.1	13.6	18.4	14.0	15.0	8.8	25.4	7.9	8.5	17.7	13.8	8.3	11.7	12.0	16.6	8.1	10.8	17.4	3.8	10.9	30.9	18.3	20.2	32.1	16.2	4.4	1.0	11.3	2.5	7.3	5.6	6.2	9.2	5.3	4.0	8.5	8.9	2.6	6.3	5.8	4.5	3.1	5.8	26.6	25.1	18.0	23.8	23.3	13.2	22.4	14.9	19.7	23.3	29.8	14.4	15.2	51.3	57.4	41.2	2.8	43.3	53.5	31.8	41.8	139.4	60.4	53.0	61.8	12.4	50.4	28.1	23.3	31.6	68.9	55.2	68.7	13.9	13.0	28.2	69.9	33.3	55.9	17.0	12.4	67.9	13.8	42.2	25.2	29.4	89.9	45.9	42.1	85.2	21.3	50.6	32.3	46.2	10.2	27.7	66.6	37.4	18.8	36.0	58.0
TAMM41	"C3orf31, DKFZp434E0519, MGC16471"	ENSG00000144559	"TAM41 mitochondrial translocator assembly and maintenance homolog"	Q96BW9	3	11790442-11846919	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036834, HPA044861"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036834: AB_10672270, HPA044861: AB_2679116"	"unprognostic (2.40e-2)"	"unprognostic (4.41e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.59e-3)"	13.9	12.9	21.8	15.9	27.5	9.1	15.7	25.6	19.8	12.5	12.2	14.2	12.5	11.5	17.7	23.7	15.2	12.4	10.0	13.8	13.9	11.5	12.4	12.0	18.7	25.0	11.3	15.3	21.7	12.9	12.5	15.4	9.9	11.4	10.7	12.0	11.2	11.7	14.2	15.2	17.3	10.4	15.0	13.7	12.3	10.1	14.1	14.8	12.7	10.8	8.4	17.4	13.8	13.8	8.7	8.9	7.7	7.1	7.1	11.3	5.0	4.2	7.9	9.7	6.7	10.5	13.3	17.9	6.5	4.7	10.0	10.0	9.5	7.0	16.2	9.6	6.8	4.4	5.2	16.2	9.8	13.0	6.0	15.3	9.6	7.6	11.0	12.3	17.6	5.1	7.6	14.6	9.4	10.6	6.6	15.4	12.9	14.1	5.0	12.8	12.2	9.9	13.2	7.7	6.6	16.9	9.9	5.5	14.2	15.3	10.4	4.5	3.9	5.7	7.4	10.8	11.4	9.6	8.0	4.0	5.2	6.0	15.6	9.2	3.9	9.5	8.3	6.3	15.0	4.8	2.2	5.3	7.7	7.2	3.6	9.2	8.7	11.3	7.0	8.9	8.0	10.4	10.6	0.2	7.1	7.1	6.6	8.7	5.0	21.8	27.5	25.6	19.8	13.9	11.5	11.3	15.3	11.4	14.8	6.0	6.5	7.3	7.8	3.8	10.6	8.1	0.0	10.7	5.7	3.5	11.8	10.3	8.3	9.7	1.6	5.8	2.8	0.0	8.0	9.1	4.6	5.4	2.3	5.7	8.1	9.5	2.9	4.9	6.5	1.1	7.2	7.2	3.3	4.6	7.3	10.8	6.6	3.5	6.0	7.9	14.0	0.0	6.2	8.4	11.9	3.6	5.8	9.5	7.6	4.6
SYN2	"SYNII, SYNIIa, SYNIIb"	ENSG00000157152	"Synapsin II"		3	12004402-12191400	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	20	"brain: 72.5"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 14.6;Cone photoreceptor cells: 5.9;Horizontal cells: 12.7;Spermatocytes: 4.9;Spermatogonia: 6.6"	"Cancer enhanced"	"Detected in many"		"glioma: 4.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.3;HMC-1: 6.1;NTERA-2: 5.2;SCLC-21H: 4.2;SH-SY5Y: 16.5;SuSa: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037012, CAB079005"		Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB079005: , HPA037012: AB_2675431"	"unprognostic (1.62e-3)"	"unprognostic (1.60e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-4)"	"unprognostic (9.94e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.78e-2)"	3.7	2.7	28.2	0.7	23.3	0.5	1.4	9.2	72.5	1.0	0.8	0.2	0.0	0.8	1.2	1.2	0.5	0.8	0.7	0.7	15.4		1.4	0.4	0.8	0.5	0.0	33.4	1.5	0.5	1.8	0.0	2.3	15.3	0.7	0.9	0.0	0.9	0.6	0.9	0.9	1.2	1.9	2.2	0.8	1.2	2.4	1.6	0.0	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.7	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.1	0.4	0.0	0.5	1.5	0.0	0.4	0.0	0.0	0.0	0.0	5.2	0.1	0.4	0.0	0.0	0.0	0.0	0.2	4.2	16.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	14.6	1.0	0.0	0.0	0.0	0.0	5.9	1.4	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.5	12.7	0.0	0.0	1.6	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	2.3	2.6	0.0	0.0	4.9	6.6	0.0	0.7	0.0	0.0	0.1
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153051-12159351	"Plasma proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 72.2;breast: 97.5"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 23.3;Ito cells: 14.7;Sertoli cells: 32.3"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 54.7;ASC TERT1: 13.7;HSkMC: 23.7;NTERA-2: 13.6;U-87 MG: 13.9"	"Region enhanced"	"Detected in all"		"cerebellum: 118.9"	"Region enriched"	"Detected in all"	5	"cerebellum: 100.1"						"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	72.2	4.3	1.9	2.2	1.6	0.7	97.5	17.8	11.2	2.6	11.7	2.4	0.7	1.1	1.9	0.9	3.2	1.6	2.9	10.9	1.7	1.5	1.9	0.8	2.6	6.0	3.1	1.5	1.2	1.5	1.2	3.2	4.6	3.8	2.9	2.4	2.4	3.1	1.6	7.7	1.7	2.4	2.4	2.9	0.8	2.3	1.8	1.2	0.1	6.1	3.8	0.6	3.7	9.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	6.0	0.2	0.0	54.7	13.7	6.7	0.2	2.2	0.2	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	3.5	0.2	8.5	0.0	0.0	23.7	0.5	1.4	0.0	0.4	0.0	0.0	0.1	4.4	0.0	0.1	0.0	0.0	13.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	13.9	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	17.8	1.3	1.7	1.5	3.1	1.5	3.8	1.2	0.0	0.0	0.0	1.2	0.1	0.3	4.8	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.7	1.1	2.9	0.7	23.3	2.4	1.9	1.4	5.6	0.0	0.0	2.9	0.0	6.3	14.7	0.6	4.8	11.2	0.1	3.3	0.0	2.6	0.7	2.7	2.8	2.5	0.3	0.0	32.3	3.4	0.0	0.0	0.1	0.1	0.0	2.3	2.0
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 97.6;breast: 102.1"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 90.9;Extravillous trophoblasts: 187.1;Urothelial cells: 210.8"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 47.9;ASC TERT1: 27.3;BEWO: 56.5;CAPAN-2: 25.2;HSkMC: 28.1;RT4: 34.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081"	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favorable (5.52e-5)"	97.6	1.6	1.9	17.1	1.2	0.7	102.1	1.5	1.3	3.1	24.9	0.8	2.1	7.5	3.5	2.2	2.8	2.4	8.7	12.5	1.4	0.9	6.7	5.9	24.8	11.4	1.1	0.9	6.7	1.2	2.8	0.3	26.8	0.9	10.4	13.9	1.1	5.8	1.5	5.0	2.7	9.6	7.4	1.2	7.0	11.9	3.5	0.6	0.9	6.2	4.3	2.1	30.2	14.1	0.0	0.4	0.0	2.3	0.0	0.7	0.3	9.7	8.7	0.0	0.0	47.9	27.3	56.5	0.9	10.5	1.3	0.5	1.8	25.2	0.0	0.0	0.9	17.1	4.0	3.5	0.1	0.2	23.5	4.9	0.0	1.9	2.3	12.8	0.0	0.0	28.1	2.3	2.4	9.1	5.0	0.1	0.2	0.0	0.0	2.0	2.5	0.0	0.1	0.1	22.7	25.2	0.0	0.0	0.0	7.2	34.5	0.0	0.2	4.1	1.5	0.5	1.7	0.0	7.8	7.9	1.8	2.6	1.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	1.9	1.2	1.5	1.3	1.4	0.9	1.1	0.9	0.9	0.6	3.0	7.4	0.0	33.7	0.9	0.5	5.2	2.5	2.7	3.4	5.2	0.0	90.9	1.7	0.1	2.6	17.7	47.1	0.0	0.6	187.1	4.3	35.2	9.2	3.8	46.3	0.0	8.1	19.6	14.5	0.8	3.7	8.6	3.3	2.8	20.5	0.5	10.2	42.1	0.0	11.3	0.0	12.9	5.7	7.9	21.8	1.0	74.4	1.3	16.6	210.8
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484432-12539623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.8	10.6	9.7	8.8	19.1	6.7	10.9	16.5	14.0	10.4	9.8	12.7	8.4	5.8	14.0	9.9	7.9	12.8	10.3	14.3	10.5	12.3	9.8	7.3	7.3	10.9	11.5	7.6	18.0	11.9	14.3	15.3	4.9	10.2	10.5	10.9	13.5	7.2	13.1	16.7	15.3	6.1	12.3	12.3	6.1	8.5	11.3	9.1	9.9	12.5	9.6	8.1	8.6	8.3	8.5	7.1	2.6	4.2	5.0	13.7	5.6	7.8	13.7	7.4	9.6	12.5	13.3	17.0	7.4	6.6	8.0	5.8	7.7	8.4	9.4	5.2	6.0	9.5	7.3	12.3	12.7	9.1	7.4	15.2	10.3	18.3	7.9	9.6	16.2	4.0	11.5	14.8	14.5	17.8	5.9	6.4	13.8	15.3	5.2	9.2	14.8	12.4	7.4	10.4	22.2	16.5	9.4	5.1	18.9	11.9	8.1	4.8	8.4	6.9	6.2	5.8	5.3	11.2	11.3	5.7	5.1	5.0	6.9	11.5	4.9	12.5	11.8	6.8	16.4	6.3	2.4	4.2	0.3	6.4	4.2	10.9	8.5	9.8	7.4	5.9	8.3	13.7	11.7	2.6	5.0	3.6	7.1	3.5	5.6	9.7	19.1	16.5	14.0	10.5	12.3	11.5	7.6	10.2	9.1	3.0	3.5	10.9	9.7	2.6	27.2	6.2	15.3	9.4	2.3	10.4	41.2	7.4	1.7	4.9	1.3	5.6	2.6	0.0	3.7	3.2	3.8	5.0	4.7	5.5	4.1	9.5	4.1	3.1	4.0	2.1	8.3	3.2	3.3	1.0	4.7	8.7	3.5	3.5	9.6	5.0	33.9	6.5	5.1	10.3	19.3	4.3	1.6	5.7	8.2	8.0
MKRN2OS	"C3orf83, MKRN2-AS1"	ENSG00000225526	"MKRN2 opposite strand"	H3BPM6	3	12514934-12561059	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.1;epididymis: 8.8"	"Cell type enhanced"	"Detected in some"	10	"Cholangiocytes: 5.1;Ciliated cells: 8.1;Collecting duct cells: 3.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.4;CAPAN-2: 16.7;HBEC3-KT: 4.3;MCF7: 3.8;RT4: 7.0;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA065586, HPA065753"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA065586: AB_2685514, HPA065753: AB_2685553"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.03e-3)"	"unprognostic (3.81e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.53e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.17e-3)"	0.0	0.0	0.0	0.0	0.6	0.0	0.9	10.1	0.5	1.4	3.7			7.0	0.2	8.8	5.5	1.5	1.7	1.4	0.0	0.3	0.5	0.0	0.1	0.0	0.0		0.1	5.1	1.1	1.9	0.0		0.6	4.3		5.8	1.5	0.3	2.0	6.6	0.0	0.0	0.0	4.5	0.0			0.1		0.3	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	16.7	0.0	0.4	0.0	0.0	0.7	0.0	4.3	0.0	0.0	1.1	0.0	0.3	0.4	0.0	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.1	0.1	0.1	0.9	0.0	0.0	0.0	0.2	2.7	7.0	0.3	0.0	0.0	1.1	0.0	0.1	3.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.7	0.0	0.7	0.6	5.1	8.1	1.2	3.5	0.0	2.1	0.0	1.1	1.3	0.0	2.1	0.0	2.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	2.6	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.9
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557014-12583713	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 562.3;Late spermatids: 587.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favorable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	13.7	10.4	15.1	11.1	18.3	16.4	11.6	29.3	19.5	13.7	12.7	12.4	16.1	12.5	15.2	12.3	16.2	13.1	10.9	26.3	14.0	15.1	13.7	12.5	12.1	12.6	15.2	14.8	20.8	26.6	17.3	11.9	14.4	16.0	11.3	11.5	13.2	12.8	13.1	24.5	12.8	10.9	15.9	16.2	10.1	11.7	46.1	14.7	15.4	18.2	17.0	13.7	13.0	12.6	21.3	19.0	30.0	20.3	25.3	26.2	18.7	10.7	12.5	14.9	11.2	23.3	22.7	28.8	16.7	17.9	21.3	17.9	12.0	10.7	15.3	9.6	18.4	9.8	6.6	19.3	16.4	19.0	17.3	16.3	21.8	14.3	16.1	26.9	21.4	9.9	25.2	15.3	24.8	15.6	19.1	17.4	21.3	20.3	21.7	18.3	15.2	26.2	11.1	9.9	10.5	22.0	25.3	14.4	17.2	14.9	14.3	8.7	14.8	14.5	7.4	14.8	11.0	16.8	19.0	17.6	14.6	14.3	17.3	22.6	16.5	33.7	32.8	15.8	25.7	21.9	18.9	17.2	30.0	21.5	15.6	26.2	21.3	22.1	22.0	19.0	16.4	23.9	22.3	15.0	25.3	20.3	15.1	23.4	18.7	15.1	18.3	29.3	19.2	14.0	15.1	15.2	14.8	16.0	14.7	17.9	8.1	9.3	8.8	8.5	14.5	12.1	2.5	17.4	11.4	5.2	3.9	16.1	16.6	13.6	562.3	11.6	7.3	0.0	14.7	16.7	10.4	6.8	18.5	5.4	13.3	11.1	2.4	6.7	9.8	587.8	19.0	7.9	15.1	24.4	11.9	18.1	12.7	12.9	19.4	8.1	12.4	12.9	14.7	60.0	42.8	8.2	13.5	9.6	11.4	7.9
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12583601-12664226	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 53.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 53.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002640, CAB019291"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB019291: , HPA002640: AB_1856047"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.17e-3)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-2)"	19.5	15.6	15.1	14.7	17.1	32.2	17.5	35.2	18.9	19.9	20.3	21.1	19.6	18.4	24.9	15.7	24.6	18.6	20.2	39.3	15.3	11.0	21.7	36.2	19.7	15.7	16.0	13.4	24.9	31.3	30.7	16.9	24.8	14.3	18.8	19.2	25.0	18.3	18.4	79.7	23.9	29.6	23.7	13.8	22.1	23.7	16.7	17.8	27.7	26.9	27.9	26.1	20.5	20.4	6.6	9.3	53.9	9.9	8.5	8.6	7.7	15.4	17.8	27.1	21.0	23.6	19.1	54.6	23.6	40.0	31.3	35.5	13.9	12.8	16.2	11.3	36.5	16.9	9.9	28.5	20.9	32.6	28.3	22.4	21.8	21.4	12.9	23.9	21.2	20.7	17.6	21.2	32.2	26.1	21.6	22.4	24.9	15.8	42.6	30.1	26.4	27.2	15.7	27.6	19.3	24.2	22.0	23.8	20.4	18.7	23.4	8.5	17.8	19.3	18.7	12.5	22.0	31.0	28.1	16.0	21.5	20.5	18.0	26.2	33.2	52.9	34.9	18.5	24.8	22.8	11.3	9.7	18.4	7.4	9.9	7.5	6.6	7.3	7.2	9.3	6.3	7.5	7.6	53.9	8.5	9.6	4.2	8.6	7.7	15.1	17.1	35.2	18.9	15.3	11.0	16.0	13.4	14.3	17.8	20.8	36.5	39.7	31.1	30.6	51.6	25.8	28.1	25.4	21.6	26.2	62.8	34.3	11.6	22.9	7.1	29.1	32.5	0.0	32.0	39.8	32.9	38.2	33.5	36.5	25.2	41.3	28.2	31.3	36.8	3.4	36.2	34.2	25.3	29.7	29.6	32.1	28.8	34.8	38.9	15.7	84.2	32.3	33.0	17.7	27.4	38.0	52.1	38.3	29.5	36.9
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733525-12769457	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5"	"Cell type enhanced"	"Detected in many"	24	"Cytotrophoblasts: 120.6;Suprabasal keratinocytes: 176.4;Syncytiotrophoblasts: 549.0;Urothelial cells: 120.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 73.7;hTCEpi: 16.6;hTERT-HME1: 21.0;RT4: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044165, HPA073122"	Enhanced		Approved	Cytosol		NA	NA		7000000	Cytosol		"HPA044165: AB_10961279, HPA073122: "	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.0	0.0	0.0	0.0	0.2	1.4	1.8	0.0	0.0	11.7	0.0	0.0	0.4	0.0	0.9	0.6	62.9	1.6	0.1	1.6	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	53.6	0.1	2.3	0.0	0.0	6.6	1.4	0.4	24.0	0.0	0.7	0.0	1.1	0.0	0.4	0.0	0.4	0.0	40.5	41.8	10.6	18.6	0.0	0.5	4.5	0.6	0.0	0.3	21.1	7.4	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.3	0.3	0.4	0.2	1.1	0.0	0.0	0.0	0.2	2.1	0.0	73.7	1.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	16.6	0.0	21.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.4	10.3	0.0	0.0	0.0	9.2	0.0	1.4	0.8	0.2	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.0	0.0	0.5	0.0	21.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	71.9	57.1	0.0	3.3	0.0	22.7	6.8	1.8	0.0	120.6	0.0	0.5	0.6	0.4	0.0	0.0	0.0	12.6	4.3	9.6	0.0	0.6	9.6	0.0	0.0	0.0	0.3	1.6	0.3	0.2	10.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.3	0.2	1.9	176.4	549.0	0.0	0.0	120.1
CAND2	"KIAA0667, TIP120B, Tp120b"	ENSG00000144712	"Cullin associated and neddylation dissociated 2 (putative)"	O75155	3	12796472-12871916	"Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 76.2"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 98.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 18.4;REH: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005777	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	Cytosol	"HPA005777: AB_2667431"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.78e-5)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-3)"	2.9	2.8	6.4	1.4	7.6	1.4	1.4	7.2	11.8	2.3	3.2	3.7	0.5	1.5	3.7	2.6	2.6	3.6	2.1	17.8	4.7	4.3	1.7	1.7	1.9	1.4	2.7	5.5	3.3	2.5	6.4	4.9	1.4	3.1	3.0	1.4	4.2	2.2	3.4	76.2	1.6	1.7	5.2	2.2	2.2	2.1	11.4	2.6	0.1	2.4	11.1	1.2	3.0	5.0	1.2	0.2	0.7	0.5	0.0	2.2	0.6	0.7	1.5	5.8	0.2	0.2	0.1	0.3	1.7	0.6	3.1	4.3	0.8	0.3	0.9	1.7	0.8	0.8	0.2	6.4	0.1	2.8	1.6	18.4	1.3	2.2	1.2	4.9	0.1	0.1	1.3	0.3	3.1	0.1	3.3	0.7	6.8	4.7	0.9	0.9	3.0	2.3	0.7	4.1	0.4	1.8	11.4	1.1	0.9	0.2	1.3	3.9	5.2	0.1	0.8	1.0	1.1	1.7	5.6	0.4	0.9	1.0	0.9	1.2	1.5	9.0	8.7	0.5	1.1	1.9	0.0	0.5	0.0	1.2	0.2	0.6	1.2	0.6	2.2	0.1	0.5	1.3	0.9	0.7	0.0	0.1	0.2	1.6	0.6	6.4	7.6	7.2	11.8	4.7	4.3	2.7	5.5	3.1	2.6	3.0	0.6	0.0	0.7	0.3	13.3	3.6	0.0	0.0	1.2	1.8	9.8	0.1	0.0	0.6	98.3	1.0	0.0	0.0	0.0	0.1	1.3	0.4	0.0	2.1	3.2	12.7	0.0	1.8	0.0	17.8	4.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	9.6	0.5	2.5	0.0	1.7	1.4	3.8	0.1	0.1	0.7	0.0	0.3
RPL32	L32	ENSG00000144713	"Ribosomal protein L32"	P62910	3	12834485-12841588	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 406.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047501, HPA051994"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		140000	"Endoplasmic reticulum, Cytosol"		"HPA047501: AB_2680070, HPA051994: AB_2681686"	"unprognostic (6.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.44e-2)"	80.5	42.2	62.9	55.4	44.5	106.7	109.0	33.2	50.8	101.5	58.9	34.9	38.3	37.3	63.1	91.5	94.8	82.3	49.5	53.5	46.5	36.5	68.4	132.9	63.7	117.4	50.1	41.1	167.0	406.2	20.4	38.6	48.6	32.8	62.6	68.4	41.8	67.9	43.3	121.4	90.5	48.6	78.0	48.4	77.7	52.0	55.9	30.7	103.9	66.9	87.7	121.5	91.2	68.9	230.3	119.2	38.8	86.1	104.4	281.7	293.2	74.3	89.4	78.1	99.5	122.9	220.1	258.1	61.4	114.5	129.9	89.1	118.1	76.3	129.7	56.2	88.2	42.7	46.7	88.5	127.7	106.9	59.8	148.2	75.4	113.4	127.6	183.7	121.4	76.5	197.5	278.9	99.1	191.7	128.7	113.3	95.8	92.5	120.7	106.1	224.3	136.5	209.9	131.5	107.3	169.8	109.0	70.2	168.9	131.2	123.8	49.6	99.3	41.4	111.2	132.1	73.0	162.7	234.2	65.3	56.4	72.1	74.0	112.7	81.6	128.1	226.8	71.8	174.4	83.9	38.8	86.1	22.9	99.1	66.7	178.3	230.3	197.2	143.1	119.2	214.7	281.7	213.1	12.7	104.4	53.6	118.2	147.0	293.2	62.9	44.5	33.2	50.8	46.5	36.5	50.1	41.1	32.8	30.7	994.6	1705.3	6619.8	6646.5	8194.1	323.1	436.2	2817.8	1037.3	2033.7	1385.3	157.1	4359.8	3864.6	2400.6	1607.7	4582.5	1755.3	1822.2	5640.8	6521.8	3945.6	4507.1	2255.6	2952.6	3734.4	170.0	2220.9	3848.6	5359.1	5126.5	6169.0	6114.9	4595.6	3626.7	4532.6	595.4	4264.1	3517.5	2818.3	4510.9	491.8	1933.8	4140.6	977.2	891.7	9583.4	4079.8	4680.5	6188.5	6735.9
IQSEC1	"ARF-GEP100, BRAG2, GEP100, KIAA0763"	ENSG00000144711	"IQ motif and Sec7 domain 1"	Q6DN90	3	12897220-13073117	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 163.4;Cone photoreceptor cells: 182.6;Horizontal cells: 222.5;Rod photoreceptor cells: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.9;U-266/84: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038143, HPA038144"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Vesicles"		NA	NA			"Nucleoli, Nucleoli rim, Vesicles"		"HPA038143: AB_10697241, HPA038144: AB_2675860"	"prognostic unfavorable (3.03e-5)"	"unprognostic (1.80e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (4.42e-1)"	"prognostic favorable (3.58e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.65e-2)"	17.8	14.1	27.8	12.3	27.0	32.5	7.1	31.9	41.5	9.5	6.7	18.5	3.5	4.8	8.0	4.7	6.1	8.5	7.4	16.0	25.0	17.8	7.0	11.5	12.4	14.8	16.4	24.8	12.3	13.0	25.7	7.8	13.4	36.7	11.6	4.8	17.0	9.3	10.0	21.0	6.2	7.7	8.4	10.6	20.6	6.9	5.6	15.5	2.6	6.3	4.3	14.0	7.8	5.9	6.2	6.8	12.9	4.0	1.8	3.6	2.3	5.0	6.9	6.2	7.0	5.2	7.2	34.9	5.7	4.7	3.8	2.9	4.7	4.5	10.7	6.6	10.7	4.2	2.8	4.7	3.0	2.8	7.2	9.9	6.3	4.1	20.0	5.7	0.1	2.7	7.1	5.5	7.8	4.4	5.2	3.5	4.4	17.9	11.4	2.6	16.2	4.0	6.8	6.5	4.0	14.1	5.4	2.0	15.4	2.2	6.6	5.4	9.9	4.1	14.4	3.3	5.6	6.1	4.4	9.4	4.2	10.6	3.5	0.7	22.8	31.2	4.2	7.9	3.2	3.3	5.0	3.8	4.8	3.6	4.0	2.7	6.2	2.4	2.7	1.9	6.1	2.4	3.0	12.9	1.8	3.9	6.8	1.7	2.3	27.8	27.0	31.9	41.5	25.0	17.8	16.4	24.8	36.7	15.5	3.0	22.7	41.9	6.8	10.2	106.3	163.4	28.1	12.0	7.9	3.5	182.6	7.8	6.6	5.7	2.1	20.1	2.0	23.3	11.1	36.0	17.8	15.7	14.0	38.5	19.4	222.5	9.8	28.3	52.6	3.4	15.5	24.7	6.8	3.6	13.6	16.7	7.9	0.0	21.2	4.7	119.9	25.8	33.0	1.8	1.5	6.8	18.2	16.2	7.6	10.7
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420309	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.0;lymphoid tissue: 44.2"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 33.4;T-cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 47.0;U-266/84: 52.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					NA	NA		28000			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	1.6	4.1	4.0	25.6	5.2	31.0	3.7	12.6	6.7	1.7	4.2	8.0	3.3	4.9	1.8	7.0	5.6	2.9	4.0	2.0	4.1	5.3	6.8	13.8	5.3	25.6	4.9	3.5	1.4	11.4	7.2	10.9	4.3	4.5	4.2	3.9	6.3	6.8	4.4	7.2	3.8	16.4	1.6	3.6	25.3	5.6	6.6	6.1	44.2	6.5	3.1	23.1	5.6	1.8	6.7	6.8	1.0	3.9	6.2	9.3	3.6	8.4	14.9	7.4	19.1	0.0	0.0	29.4	0.1	0.0	1.8	0.0	7.6	13.8	34.4	11.9	0.0	0.8	4.9	16.3	0.0	0.7	27.6	12.1	13.3	16.9	8.0	0.0	42.5	4.8	0.0	0.0	0.0	0.0	1.3	0.0	26.0	20.5	37.0	0.0	21.1	22.5	16.9	8.5	2.6	3.1	0.0	0.0	47.0	3.6	7.9	8.5	8.5	10.7	14.3	4.5	3.4	13.6	35.4	0.1	0.0	2.5	0.0	6.5	37.6	52.0	30.0	0.0	23.8	0.0	0.0	2.9	1.0	9.3	3.9	7.4	6.7	6.7	9.0	6.4	4.5	5.6	7.3	0.1	6.2	2.4	6.8	5.6	3.6	4.0	5.2	12.6	6.7	4.1	5.3	4.9	3.5	4.5	6.1	14.9	4.8	32.0	1.2	1.4	16.7	9.6	10.2	2.7	6.8	5.2	13.7	13.4	3.3	5.0	18.8	0.7	1.1	23.3	3.8	3.8	0.5	3.1	4.7	11.6	14.7	33.4	7.9	4.3	12.8	16.6	0.6	8.0	1.7	2.8	4.6	3.2	3.5	0.0	0.4	3.4	20.9	0.0	0.3	3.8	10.0	2.0	4.1	37.3	3.8	1.6
HDAC11		ENSG00000163517	"Histone deacetylase 11"	Q96DB2	3	13479724-13506424	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Early spermatids: 300.6;Late spermatids: 525.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 27.9;T-47d: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.22e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.78e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.94e-1)"	"prognostic favorable (7.88e-10)"	"unprognostic (3.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-3)"	4.8	7.6	24.6	3.2	31.7	0.7	5.8	7.6	30.6	8.8	7.1	29.2	3.8	8.9	6.5	5.1	9.5	10.1	6.5	19.6	24.4	19.0	9.9	2.1	6.4	3.0	25.4	20.7	12.5	18.8	10.4	7.7	3.4	16.5	8.2	5.1	6.6	12.8	9.7	35.1	13.2	9.6	5.4	19.9	3.0	4.9	24.0	20.3	1.5	9.9	4.9	3.7	4.4	6.6	1.4	2.3	7.5	3.3	11.4	4.5	2.3	6.9	4.5	4.8	3.9	7.1	6.2	3.6	4.6	3.2	4.6	3.1	2.2	5.8	0.5	5.5	6.4	7.3	5.3	2.8	8.3	3.0	3.0	2.6	1.3	1.9	6.3	8.0	0.1	2.5	5.2	15.6	5.1	3.9	8.6	3.3	4.3	2.7	1.3	4.3	7.0	0.8	0.9	1.3	4.5	12.0	0.9	6.9	2.0	9.6	5.1	0.8	3.6	6.6	27.9	13.2	4.1	24.6	1.6	3.1	3.9	7.9	7.7	2.7	0.9	2.5	0.1	1.2	1.0	2.2	0.2	3.3	7.5	4.5	1.8	3.1	1.4	4.1	3.5	2.3	0.6	4.1	2.7	1.4	11.4	0.7	2.3	3.3	2.3	24.6	31.7	7.6	23.0	24.4	19.0	25.4	20.7	16.5	20.3	8.9	5.3	0.0	7.4	10.2	8.7	71.4	10.2	9.4	3.4	10.4	0.0	15.7	16.6	11.3	300.6	4.5	28.8	0.0	10.0	2.1	7.6	4.5	1.1	2.6	5.2	9.5	8.5	7.4	4.3	525.1	15.0	3.1	8.5	6.4	14.8	17.7	10.6	16.9	14.5	14.2	5.8	0.0	6.9	10.2	6.0	9.3	4.8	4.3	18.5	5.0
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549131-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.5"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 266.2;Leydig cells: 158.2;Peritubular cells: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.2;naive CD8 T-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 75.4;fHDF/TERT166: 49.5;HMC-1: 60.2;HSkMC: 43.7;U-2197: 26.7"	"Region enriched"	"Detected in some"	7	"olfactory region: 15.4"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		28000000	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	58.5	2.7	1.8	8.0	2.2	0.1	34.3	0.8	3.2	21.4	11.5	1.3	9.5	2.1	11.6	23.6	32.7	7.2	21.9	80.5	1.6	1.7	2.1	1.2	7.8	5.1	2.4	1.4	6.3	3.2	1.1	0.9	31.8	2.3	22.1	4.2	7.9	10.8	3.3	20.1	20.8	6.1	42.9	1.5	2.3	6.9	41.8	0.5	4.8	20.7	23.8	8.5	34.2	36.3	2.2	9.2	0.0	0.0	0.4	5.4	1.1	0.0	0.2	9.8	0.0	75.4	10.2	4.5	23.5	18.8	23.6	15.6	1.5	0.0	0.0	1.1	49.5	0.0	0.0	0.0	0.1	4.4	0.0	0.0	18.6	0.4	0.0	5.1	0.0	60.2	43.7	0.3	3.7	0.0	0.0	0.0	1.6	0.1	0.1	0.1	0.0	0.9	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.0	17.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.3	9.2	2.2	0.0	5.4	0.0	0.4	0.0	0.7	0.0	1.1	1.8	2.2	0.8	3.2	1.6	1.7	2.4	1.4	2.3	0.5	0.0	1.0	0.0	0.7	27.4	0.0	7.3	0.0	0.0	3.4	7.0	2.0	6.6	0.0	0.0	3.4	29.2	0.0	0.0	0.2	4.5	266.2	1.0	24.1	0.2	3.2	0.0	0.0	25.8	0.3	6.5	158.2	2.1	37.1	0.0	0.0	1.3	0.2	0.0	213.6	0.0	0.2	12.9	19.6	2.6	8.8	25.2	5.1	0.0	0.0	0.9
WNT7A		ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880121	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;gallbladder: 8.7;placenta: 19.4"	"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 48.0;Extravillous trophoblasts: 129.2;Pancreatic endocrine cells: 57.6;Syncytiotrophoblasts: 155.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 25.3;EFO-21: 23.8;PC-3: 8.3;RPTEC TERT1: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"	NA	NA					"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.4	0.4	7.8	0.6	6.1	0.7	0.4	1.2	11.5	1.1	0.4	2.1	0.0	0.4	3.4	1.0	1.6	0.7	8.7	0.4	3.3	2.8	0.7	0.5	5.7	1.4	3.1	3.2	0.4	0.8	0.4	0.2	19.4	3.9	0.5	0.4	0.0	0.5	1.4	0.4	2.8	0.4	0.5	4.4	3.1	0.4	2.3	2.3	0.0	0.4	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.5	3.4	0.0	0.3	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	3.1	0.0	23.8	0.0	0.0	4.6	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.6	42.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.6	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.5	7.8	6.1	1.2	7.2	3.3	2.8	3.1	3.2	3.9	2.3	11.9	0.0	0.0	2.3	5.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	48.0	0.0	13.3	14.3	0.0	0.0	0.0	8.2	129.2	0.5	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	1.1	155.3	0.5	0.0	4.7
CHCHD4	"FLJ31709, MIA40, TIMM40"	ENSG00000163528	"Coiled-coil-helix-coiled-coil-helix domain containing 4"	Q8N4Q1	3	14112077-14124870	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034688, HPA063727"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA034688: AB_10696361, HPA063727: AB_2685103"	"unprognostic (3.89e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.63e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.65e-2)"	"unprognostic (7.85e-3)"	11.4	13.3	15.0	8.8	16.4	3.3	12.8	11.6	17.7	9.2	15.8	12.6	9.5	15.7	8.7	11.7	12.1	10.9	9.8	27.3	13.7	13.5	22.3	20.1	7.8	8.9	17.0	10.7	11.5	18.8	21.7	9.3	9.2	13.5	12.7	17.2	9.6	10.7	13.8	32.2	8.9	12.7	15.3	11.1	9.6	11.9	9.4	14.3	7.2	13.4	12.4	13.2	14.0	16.4	14.1	19.8	7.9	18.1	16.6	14.3	8.6	8.0	16.8	8.8	8.6	7.6	8.6	25.5	8.7	8.2	10.8	9.6	9.9	6.6	17.5	8.6	6.6	11.0	6.6	18.1	18.1	13.4	10.9	18.1	20.4	12.5	13.0	12.8	13.7	8.8	7.5	19.3	17.7	28.4	7.7	12.1	14.1	21.1	15.7	11.5	17.1	17.1	8.3	13.5	25.3	22.7	12.4	8.8	37.2	12.2	8.9	7.3	8.9	9.8	31.7	12.7	7.9	15.2	14.0	4.3	9.9	7.2	12.3	15.9	8.8	23.1	17.4	9.8	21.2	7.2	5.7	12.5	7.9	6.6	18.1	11.4	11.2	11.0	9.9	19.8	14.1	14.3	9.7	5.4	16.6	17.5	8.1	12.2	8.6	15.0	16.4	11.6	17.7	13.7	13.5	17.0	10.7	13.5	14.3	14.9	7.5	18.2	10.7	8.4	7.6	21.8	12.7	5.3	6.8	8.7	0.0	20.2	71.3	16.6	1.9	8.1	15.9	0.0	11.7	16.8	9.9	11.4	10.4	16.3	18.5	4.8	4.7	3.7	6.9	4.0	10.6	8.2	8.5	7.2	12.1	7.4	10.7	13.5	9.6	37.8	5.6	6.5	7.8	16.6	36.8	10.3	10.9	7.5	17.9	10.9
TMEM43	"ARVD5, DKFZp586G1919, LUMA, MGC3222"	ENSG00000170876	"Transmembrane protein 43"	Q9BTV4	3	14124940-14143679	"Disease related genes, Predicted membrane proteins"			"Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 128.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019198	Approved					NA	NA		94000			"HPA019198: AB_1858118"	"unprognostic (3.65e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.66e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	32.3	15.3	14.7	15.0	15.1	7.7	41.5	16.6	15.6	32.3	22.4	13.3	14.9	9.9	45.8	22.2	32.0	27.7	21.4	28.7	12.1	8.6	17.4	13.9	24.8	20.1	14.0	11.2	37.7	20.2	11.1	14.4	50.6	10.9	21.9	13.0	17.2	17.2	29.8	32.7	45.8	16.4	38.4	10.8	14.2	16.6	13.7	12.1	8.8	31.7	27.6	14.9	29.4	28.8	13.3	23.3	54.1	18.0	25.9	25.3	21.3	10.1	11.6	11.3	14.7	45.2	47.5	26.9	20.2	41.4	33.3	24.1	9.5	13.5	4.8	14.5	49.9	16.6	22.1	11.8	17.8	23.9	12.1	9.6	8.6	11.5	13.2	28.6	12.5	10.4	35.5	44.4	27.6	34.2	26.7	23.9	9.2	13.6	12.1	19.3	13.2	5.6	10.5	12.3	15.4	19.1	7.8	11.9	18.9	15.1	17.7	3.3	9.1	25.2	15.0	16.2	10.0	9.4	18.2	21.6	30.5	16.6	30.6	18.6	8.3	13.1	6.2	22.9	16.9	27.3	21.1	18.0	33.4	25.3	15.7	23.3	13.3	24.9	22.9	23.3	10.8	16.9	18.5	54.1	25.9	15.6	14.8	21.8	21.3	14.7	15.1	16.6	15.6	12.1	8.6	14.0	11.2	10.9	12.1	128.1	41.4	8.3	28.0	38.8	5.2	11.8	10.2	18.7	80.8	17.4	13.7	22.4	0.0	27.3	0.7	36.0	8.1	0.0	8.7	56.4	65.8	20.5	26.7	7.8	16.6	6.4	4.7	20.3	15.2	2.8	40.0	27.3	28.7	19.8	6.7	8.9	20.1	11.0	66.4	9.6	8.0	32.3	34.4	4.9	10.9	39.6	31.4	23.5	11.1	25.3
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178783	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167"	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favorable (2.46e-4)"	20.2	17.1	14.2	24.0	30.2	8.4	21.4	16.1	19.3	22.3	18.9	20.8	27.5	18.0	24.6	18.3	16.9	24.9	25.1	12.4	16.2	14.4	24.6	23.4	19.9	21.1	33.4	15.2	35.0	20.9	35.4	26.7	28.0	22.1	20.9	15.9	16.7	17.6	30.3	22.4	30.5	23.6	17.7	22.6	23.3	15.9	12.9	30.6	18.5	25.7	12.4	20.8	22.4	22.3	10.9	7.0	34.6	8.8	8.8	12.2	6.1	4.5	11.6	13.1	8.4	19.7	13.6	44.5	11.3	32.3	10.9	8.5	4.2	5.4	15.1	5.0	13.7	5.1	5.7	8.6	18.0	9.0	6.1	7.4	8.0	12.3	7.8	17.5	6.0	15.3	19.3	21.4	14.5	29.1	12.8	12.9	6.9	11.0	8.2	12.1	9.5	4.9	5.7	7.8	7.4	7.9	6.3	5.9	12.1	13.8	13.5	2.8	10.2	12.3	10.2	8.1	21.5	10.7	4.9	20.2	4.2	11.5	6.4	5.2	18.9	13.7	8.9	10.1	7.0	15.2	12.0	8.2	9.4	9.8	6.3	9.6	10.7	11.2	9.6	7.0	10.9	12.2	8.7	34.6	8.8	8.8	6.7	9.2	6.1	14.2	30.2	16.1	19.3	16.2	14.4	33.4	15.2	22.1	30.6	56.6	54.6	22.2	18.7	12.2	33.8	11.2	33.1	84.3	73.9	15.7	37.3	34.0	29.9	16.3	1.9	24.9	12.3	46.7	16.9	17.1	16.4	15.5	44.1	30.4	16.2	25.4	15.6	22.1	24.3	1.8	28.4	28.4	8.5	38.7	12.2	29.9	15.2	14.8	26.5	34.1	50.6	25.8	18.0	22.7	57.3	9.7	26.8	34.6	13.3	8.7
LSM3	"SMX4, USS2, YLR438C"	ENSG00000170860	"LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62310	3	14178358-14201119	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044966	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA044966: AB_2679159"	"unprognostic (3.84e-3)"	"unprognostic (7.00e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.07e-3)"	"unprognostic (4.93e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-3)"	14.1	13.6	18.2	12.5	17.1	18.9	15.5	13.2	17.3	11.5	15.6	11.8	7.6	15.0	11.6	13.4	19.1	10.3	11.3	20.1	15.1	12.5	27.6	26.7	10.1	14.2	14.2	13.5	12.4	15.6	7.3	12.4	16.5	14.4	14.2	13.9	12.3	13.3	11.0	31.9	12.1	17.6	15.8	15.0	16.3	12.5	21.5	13.9	24.4	19.7	21.4	13.9	12.9	11.1	21.3	23.1	27.2	18.3	17.1	17.7	18.7	14.6	11.9	12.8	13.2	6.0	7.0	32.7	12.2	8.1	15.6	15.0	13.4	11.6	16.2	10.1	8.4	11.0	6.9	14.4	11.8	15.4	15.3	17.9	17.1	17.2	12.8	3.1	19.1	12.5	5.2	8.6	15.6	6.7	7.0	8.0	14.2	18.4	13.0	11.5	16.8	20.2	26.1	22.2	16.5	16.2	11.2	15.9	17.8	14.5	15.2	7.2	11.7	13.9	19.5	11.3	15.4	22.5	24.4	7.2	10.0	16.0	12.1	20.7	9.2	26.9	30.5	12.7	18.8	14.2	27.2	15.9	23.3	12.8	18.3	15.0	21.3	15.0	14.9	14.6	17.1	16.5	17.3	15.2	17.1	15.3	23.1	17.7	18.7	18.2	17.1	13.2	17.3	15.1	12.5	14.2	13.5	14.4	13.9	62.5	87.7	130.3	102.5	86.8	44.5	230.9	170.7	87.0	91.0	120.4	17.7	322.3	411.1	178.6	266.0	108.5	137.9	70.0	230.7	336.7	102.8	94.5	135.1	199.8	207.0	52.4	100.7	114.8	112.2	107.8	129.8	142.9	92.8	201.0	161.2	94.1	180.4	182.4	131.5	513.1	53.0	103.5	91.2	226.0	285.5	88.3	266.3	100.1	174.8	132.7
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 76.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 33.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.2"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.2	25.9	5.7	18.0	16.5	46.4	8.1	11.1	12.2	11.3	9.5	8.7	3.6	8.5	14.5	4.4	7.0	7.0	14.5	23.2	5.6	4.6	16.6	2.3	18.6	12.9	18.0	7.6	31.3	2.8	3.8	9.6	18.0	13.3	5.0	4.1	76.4	15.7	7.7	26.6	16.8	22.2	8.2	11.1	20.3	14.0	4.0	12.6	6.2	10.4	11.3	11.2	8.8	6.1	1.6	1.9	33.2	6.9	0.7	3.9	2.3	4.6	17.3	6.2	4.7	8.1	2.5	12.8	7.0	27.8	8.3	6.1	6.3	8.0	13.5	6.4	11.0	12.0	3.7	4.2	5.7	7.4	1.5	5.2	12.8	22.7	9.4	0.2	3.5	27.8	1.3	1.7	7.6	2.0	7.2	9.0	6.3	7.1	2.7	7.3	4.9	9.8	6.8	9.6	6.5	5.0	7.0	7.4	21.1	45.5	9.7	11.5	4.1	5.2	2.8	1.5	24.4	10.7	1.9	22.7	10.6	5.7	2.6	5.0	3.0	3.4	5.0	24.7	6.9	32.4	2.5	5.1	5.0	1.3	4.2	0.7	1.6	1.4	1.7	1.9	0.9	0.2	0.3	33.2	0.7	6.9	0.7	3.9	2.3	5.7	16.5	11.1	12.2	5.6	4.6	18.0	7.6	13.3	12.6	6.0	22.1	4.7	11.2	43.8	102.1	3.6	2.5	12.0	12.5	19.2	538.0	2.2	0.0	9.6	17.0	16.1	0.7	0.0	7.1	12.8	16.4	5.5	12.7	0.4	26.7	9.5	13.8	11.6	62.5	13.3	16.1	47.4	16.9	129.0	2.9	28.2	21.5	2.9	16.3	26.3	502.9	0.0	8.2	0.5	1.5	20.8	4.2	22.4	1.2	10.6
GRIP2	KIAA1719	ENSG00000144596	"Glutamate receptor interacting protein 2"		3	14489111-14556075	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 10.3;skeletal muscle: 25.7"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 9.4;Cardiomyocytes: 7.3;Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 21.1;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.2;BJ hTERT+ SV40 Large T+ RasG12V: 3.3;NTERA-2: 3.6;PC-3: 10.2;SCLC-21H: 5.7;U-2 OS: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035673			Approved	Cytosol		NA	NA			Cytosol		"HPA035673: AB_10669776"	"unprognostic (1.48e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.82e-1)"	"unprognostic (4.01e-1)"	0.5	0.8	3.2	0.4	2.6	0.0	0.5	0.7	6.0	0.4	0.4	1.2	1.9	0.1	1.3	0.5	1.7	0.3	1.0	10.3	3.2		1.5	0.1	0.2	0.1	0.0	3.3	2.0	0.2	0.1	0.1	3.0	1.1	0.4	0.7	0.6	0.4	0.2	25.7	1.4	0.4	0.6	0.0	1.0	2.7	0.4	1.0	0.0	0.0	4.6	0.4	0.5	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.5	0.3	0.0	0.5	5.2	0.6	3.3	2.0	0.0	0.0	1.3	0.3	0.9	0.3	1.2	0.0	0.0	0.0	0.4	0.0	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	2.4	10.2	0.0	0.1	0.0	0.0	0.0	5.7	1.1	0.5	0.0	1.8	1.9	0.0	0.0	0.0	0.3	3.9	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.1	0.0	9.4	7.3	0.0	0.0	1.2	0.0	13.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.1	0.0	4.1	0.6	0.0	3.4	3.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.1	0.1	21.1	19.4	0.5	0.0	0.8	0.0	0.1	0.0	0.0	0.0
CCDC174	"C3orf19, FLJ33839"	ENSG00000154781	"Coiled-coil domain containing 174"	Q6PII3	3	14651746-14672659	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043468, HPA060129"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043468: AB_2678493, HPA060129: AB_2684208"	"unprognostic (6.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.81e-5)"	16.8	12.9	15.7	13.4	17.5	27.1	17.1	22.3	18.2	19.2	18.5	17.8	15.2	16.8	24.0	14.5	16.1	15.5	12.9	14.4	13.1	10.9	17.9	15.3	13.0	15.7	17.9	14.8	28.0	18.6	15.7	29.9	15.6	16.9	17.7	13.7	12.6	16.1	15.7	26.9	17.4	20.6	14.9	18.7	20.2	18.2	15.3	19.2	23.1	17.5	9.8	18.4	19.0	17.6	14.7	9.5	21.0	9.9	15.4	16.7	8.4	5.1	5.7	8.8	9.3	12.2	10.1	22.3	7.0	10.0	8.8	6.9	6.4	6.1	10.8	5.1	6.1	6.0	4.6	6.3	5.8	6.9	8.1	7.7	11.0	6.8	6.8	17.7	10.7	12.8	11.6	15.0	11.8	14.6	12.4	7.5	11.6	10.9	9.9	6.5	9.1	11.2	9.5	11.8	8.6	9.4	8.4	8.2	8.8	9.0	9.2	4.3	11.6	8.1	6.4	11.2	10.7	9.7	15.3	6.9	7.1	6.9	6.5	8.0	13.2	11.7	12.6	7.1	8.3	9.6	21.0	9.5	18.4	12.1	9.7	14.1	14.7	15.1	13.9	8.4	13.3	16.7	13.3	18.4	15.4	9.9	9.5	10.3	8.4	15.7	17.5	22.3	18.2	13.1	10.9	17.9	14.8	16.9	19.2	8.9	34.6	52.9	25.1	14.3	31.2	32.7	28.1	36.1	34.2	12.2	19.6	26.1	48.0	29.4	124.0	26.9	26.2	70.0	30.5	21.0	25.8	23.3	50.8	26.6	23.1	14.3	17.7	27.6	22.9	39.8	31.1	28.8	13.5	55.1	21.6	23.3	32.0	31.7	37.8	29.8	23.3	32.3	21.7	47.7	31.1	11.8	54.9	42.1	21.1	27.8
C3orf20	DKFZP434N1817	ENSG00000131379	"Chromosome 3 open reading frame 20"	Q8ND61	3	14675099-14773034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 30.9"	"Group enriched"	"Detected in some"	27	"Early spermatids: 16.4;Late spermatids: 27.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"Daudi: 5.7;HEL: 12.2;U-698: 9.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA039584	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039584: AB_10795152"	"unprognostic (1.23e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-4)"	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	30.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	12.2	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.5	0.8	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
FGD5	"FLJ00274, FLJ39957, ZFYVE23"	ENSG00000154783	"FYVE, RhoGEF and PH domain containing 5"	Q6ZNL6	3	14810853-14934565	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Endothelial cells: 35.2;Ito cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 41.3;TIME: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014436, HPA014536, HPA019191"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519"	"unprognostic (2.57e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.50e-4)"	18.9	3.7	2.2	10.7	2.7	0.0	18.9	1.2	4.0	11.0	9.2	1.9	8.3	7.3	17.7	9.5	5.7	8.1	14.3	12.3	2.3	2.2	10.3	2.5	27.3	8.1	2.7	1.9	7.2	6.5	2.8	3.9	14.3	3.1	8.3	3.8	8.4	4.5	4.0	7.9	6.0	8.6	9.6	2.4	29.3	5.2	7.1	1.6	1.0	8.6	8.4	3.6	7.2	20.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	33.8	0.0	2.9	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.7	1.2	4.0	2.3	2.2	2.7	1.9	3.1	1.6	0.0	5.8	1.3	0.2	2.7	0.0	2.2	2.5	0.0	1.2	0.0	0.0	0.2	1.7	0.0	6.7	35.2	0.0	0.0	0.2	0.1	8.3	0.2	0.0	0.8	8.9	0.0	0.0	52.8	2.8	5.2	10.6	3.4	1.7	0.0	0.0	0.0	2.8	0.0	4.2	6.3	0.0	0.0	2.1	0.2	4.7	1.6	0.5	0.7	0.0	0.3
NR2C2	"hTAK1, TAK1, TR2R1, TR4"	ENSG00000177463	"Nuclear receptor subfamily 2 group C member 2"	P49116	3	14947584-15053600	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006313	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006313: AB_1079503"	"unprognostic (1.32e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.51e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.82e-3)"	13.2	13.1	22.5	17.0	17.5	17.1	16.1	30.5	26.4	11.9	14.0	12.8	14.1	18.5	17.8	11.0	13.6	12.6	12.3	14.5	18.3	12.0	12.4	12.6	18.7	16.9	12.6	20.4	18.8	14.2	18.0	23.2	11.9	13.1	12.3	12.2	13.7	13.0	21.5	31.5	19.6	18.1	15.7	13.5	18.8	14.7	29.2	13.3	26.0	19.4	9.0	15.5	15.5	17.8	5.1	4.2	6.2	3.4	2.7	4.9	1.5	10.1	11.5	13.2	10.2	9.4	11.3	30.3	14.7	11.9	11.9	12.4	7.4	10.0	15.7	7.7	13.1	10.5	10.2	12.1	7.5	12.4	20.6	17.2	20.5	24.6	6.6	7.9	15.0	15.9	8.9	10.0	15.0	7.9	10.0	13.4	15.5	14.5	10.8	10.5	9.0	23.0	11.8	8.7	4.8	11.9	18.5	15.7	10.4	5.7	15.4	8.4	21.1	13.3	11.2	13.5	10.9	11.2	15.0	17.3	18.5	22.1	16.8	20.0	16.5	21.3	17.0	13.3	14.4	16.2	6.2	2.5	1.9	4.9	3.4	4.4	2.3	2.7	2.9	2.6	5.1	3.9	3.5	3.5	2.7	3.0	4.2	2.5	1.5	22.5	17.5	30.5	26.4	18.3	12.0	12.6	20.4	13.1	13.3	20.8	9.8	10.9	9.5	3.3	15.5	5.1	12.7	24.1	7.9	7.0	13.7	6.7	5.0	6.1	46.1	6.4	10.7	0.0	6.3	6.3	5.8	13.8	9.2	7.8	6.7	12.7	24.1	20.3	20.9	49.4	17.8	7.7	5.0	7.2	10.7	13.3	9.4	11.8	19.4	5.7	16.3	0.0	4.8	30.9	16.3	2.8	12.5	13.6	10.6	10.7
MRPS25	"DKFZp313H0817, FLJ00023, MRP-S25, RPMS25"	ENSG00000131368	"Mitochondrial ribosomal protein S25"	P82663	3	15042460-15065335	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Late spermatids: 1039.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043490	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA043490: AB_10794888"	"unprognostic (3.98e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (3.60e-7)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.91e-3)"	14.8	18.5	18.7	18.4	28.3	12.0	14.3	24.9	21.9	11.7	20.9	13.1	15.2	31.6	16.8	15.8	15.6	15.4	15.0	41.7	15.2	16.5	18.4	27.5	14.4	17.7	16.3	24.0	18.1	24.1	18.1	21.4	11.4	16.8	14.9	23.3	20.3	14.9	17.4	47.6	18.8	26.4	24.5	13.2	17.4	17.3	33.3	15.0	10.2	28.5	15.7	18.6	14.8	13.5	21.1	16.1	3.6	18.6	6.8	15.3	9.4	8.4	12.6	10.3	14.3	10.9	9.4	32.9	11.6	4.5	9.4	8.1	14.3	9.2	22.3	6.2	5.1	6.3	11.0	14.9	11.0	8.1	8.9	20.9	18.4	25.9	17.8	7.7	16.3	14.1	11.3	10.5	14.8	4.5	6.4	8.7	15.1	19.5	13.4	7.0	27.0	12.6	15.8	10.7	19.8	19.8	17.2	8.9	23.0	11.7	14.7	8.2	12.3	8.5	16.2	16.7	6.6	21.9	14.2	10.7	8.5	12.5	11.6	14.5	13.0	13.9	16.0	8.6	21.0	7.9	1.1	15.4	3.6	10.1	18.4	11.8	21.1	9.6	10.4	16.1	18.2	15.3	12.5	1.0	6.8	18.6	13.3	7.4	9.4	18.7	28.3	24.9	21.9	15.2	16.5	16.3	24.0	16.8	15.0	47.6	31.7	62.5	44.0	34.2	56.6	264.1	53.5	44.2	52.4	34.9	155.1	83.6	189.0	44.3	290.5	31.6	105.8	0.0	29.4	55.3	41.2	30.5	25.4	89.4	82.4	63.5	51.9	19.6	22.7	1039.4	42.6	38.5	35.4	39.7	65.2	21.4	40.9	52.6	28.3	157.3	98.1	71.1	42.0	60.3	28.0	42.4	60.8	27.3	108.1	58.0
RBSN	ZFYVE20	ENSG00000131381	"Rabenosyn, RAB effector"	Q9H1K0	3	15070073-15099163	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044878	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA044878: AB_10967610"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.78e-1)"	11.6	8.7	18.0	8.7	19.8	21.4	10.7	19.6	26.1	9.9	10.6	21.9	9.4	6.4	12.9	10.2	12.3	11.2	7.7	12.9	16.6	13.7	7.4	9.3	11.3	8.2	16.6	15.3	18.2	7.1	13.3	7.1	10.6	17.0	10.6	7.5	10.9	7.6	13.1	15.7	13.7	7.7	14.5	16.2	9.2	8.6	11.6	16.7	3.6	15.5	7.6	8.1	9.9	9.6	7.9	4.3	13.6	7.3	3.2	9.5	2.9	8.3	12.3	10.0	13.0	11.1	8.3	26.7	9.3	9.0	11.1	10.1	7.4	5.0	5.9	5.4	12.2	6.5	5.4	12.8	11.2	9.9	7.4	11.4	6.7	14.6	6.0	7.6	6.7	7.5	8.9	12.6	14.2	9.5	6.6	9.0	6.7	10.0	6.9	8.4	11.1	3.6	3.4	8.6	5.4	9.9	4.8	11.5	6.5	5.8	9.6	2.7	9.4	11.3	6.9	8.2	7.7	17.7	5.0	10.9	10.1	10.6	9.8	13.0	6.2	9.2	7.0	9.7	7.6	9.4	9.0	5.4	12.3	5.3	7.3	4.7	5.2	7.2	6.5	4.3	7.9	9.5	6.4	13.6	3.2	6.2	4.1	4.7	2.9	18.0	19.8	19.6	25.3	16.6	13.7	16.6	15.3	17.0	16.7	14.9	14.7	4.5	5.1	0.0	18.9	17.3	5.1	14.7	18.2	3.5	21.6	8.9	5.0	6.8	10.2	10.5	3.3	0.0	8.2	8.4	8.1	9.9	9.3	13.0	9.1	20.6	1.2	9.2	12.9	12.2	17.5	7.5	0.0	5.4	8.9	14.1	8.2	7.0	13.8	5.4	21.0	6.5	6.3	8.9	13.8	0.0	10.8	6.9	6.4	6.7
CAPN7	PalBH	ENSG00000131375	"Calpain 7"	Q9Y6W3	3	15206152-15252918	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Rod photoreceptor cells: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004745, HPA046617"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA004745: , HPA046617: AB_2679721"	"unprognostic (2.70e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.85e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.05e-2)"	16.3	15.0	9.7	12.8	13.4	10.5	18.9	21.7	13.7	18.6	15.5	11.1	14.3	11.8	17.6	15.9	13.4	16.7	10.4	13.8	9.2	8.9	14.8	17.6	17.9	20.0	11.4	8.4	20.6	15.9	20.4	29.0	14.7	11.7	14.7	11.7	15.9	15.9	12.7	33.7	14.9	14.5	19.5	14.1	12.1	15.2	12.1	12.3	19.3	22.6	11.1	14.5	17.7	14.5	6.6	5.1	8.7	7.0	5.8	10.0	5.0	8.7	11.5	9.6	6.0	16.9	13.2	32.8	11.3	13.0	14.1	10.8	8.2	6.3	15.1	7.9	12.8	8.7	6.1	14.1	14.5	12.3	14.4	11.1	18.9	16.2	10.8	12.6	15.1	9.6	9.0	21.2	18.3	9.1	13.4	10.0	14.6	18.2	15.9	13.6	12.7	10.7	6.3	9.2	12.7	11.3	6.2	16.0	10.4	10.5	16.0	7.8	10.1	18.4	10.0	12.5	12.8	17.6	15.9	8.9	12.8	9.7	16.5	13.1	11.1	22.0	7.7	11.6	11.1	11.0	6.3	5.4	8.7	6.4	4.4	10.0	6.6	7.0	5.2	5.1	5.9	9.6	8.8	3.2	5.8	7.0	4.3	5.1	5.0	9.7	13.4	21.7	13.7	9.2	8.9	11.4	8.4	11.7	12.3	11.9	17.6	15.2	14.2	19.1	41.7	27.4	7.6	45.5	27.3	1.8	53.0	17.3	8.3	10.3	11.3	16.8	10.2	23.3	14.8	10.3	16.0	16.9	15.1	14.3	10.6	52.4	20.1	15.4	12.4	11.7	23.0	15.2	20.3	12.6	9.8	37.3	10.8	7.0	24.8	12.2	99.8	38.8	22.8	22.4	14.7	20.3	21.9	17.0	10.3	7.3
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254853-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 199.4;Extravillous trophoblasts: 335.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: AB_2683572"	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	38.6	72.5	12.7	20.0	13.4	29.9	35.7	34.8	22.3	30.5	12.7	20.7	42.0	7.5	33.9	20.4	11.9	32.2	29.0	9.6	17.2	11.2	19.6	9.9	38.8	25.1	13.0	18.9	49.6	7.1	30.0	14.7	19.5	15.1	13.5	4.9	12.4	22.4	45.1	61.7	10.1	10.3	21.0	19.0	14.8	7.2	17.0	10.8	9.3	20.8	7.7	18.9	25.3	44.3	13.3	4.8	8.0	3.9	13.0	28.9	9.5	7.4	3.7	1.7	3.5	16.1	13.6	94.1	4.1	2.7	2.2	2.8	2.4	3.4	6.2	1.7	10.8	4.7	0.9	0.8	3.5	1.9	4.8	3.4	4.2	16.9	0.4	6.1	1.1	2.1	10.9	2.6	10.2	2.2	10.6	31.4	8.1	4.6	2.1	3.0	26.6	14.8	6.9	3.7	0.9	5.6	0.2	8.4	28.1	2.7	12.4	4.2	2.2	5.6	5.1	5.9	7.2	4.6	3.1	24.1	6.0	8.4	5.7	3.1	0.8	1.7	4.3	11.5	4.1	8.1	3.5	3.9	4.5	28.9	1.3	9.1	10.9	13.7	19.9	4.8	13.3	7.5	9.8	8.0	13.0	2.1	2.2	5.7	9.5	12.7	13.4	34.8	19.2	17.2	11.2	13.0	18.9	15.1	10.8	0.0	18.9	87.1	5.5	15.0	40.9	0.5	7.6	6.7	17.0	64.6	13.7	9.5	3.3	2.9	199.4	71.8	1.4	0.0	7.7	335.6	62.1	6.6	2.3	5.1	28.9	62.0	2.4	138.1	68.8	76.3	45.5	65.1	32.1	17.2	1.8	4.7	3.6	0.0	111.4	22.1	45.9	6.5	7.7	2.1	3.0	10.7	144.9	40.5	0.9	8.1
METTL6	MGC24132	ENSG00000206562	"Methyltransferase like 6"	Q8TCB7	3	15381275-15440566	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 171.3;Late spermatids: 95.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035166	Uncertain		Approved	Vesicles		No	No			Vesicles		"HPA035166: AB_10602709"	"unprognostic (2.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (3.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	8.6	9.6	19.4	8.6	19.3	5.0	11.7	18.4	18.9	11.7	7.1	16.8	6.2	7.1	10.7	10.6	10.0	11.5	7.7	9.3	13.1	14.3	8.4	7.9	7.8	10.3	13.3	9.6	14.8	10.7	12.5	17.9	11.0	13.7	10.6	8.7	12.0	7.5	11.3	7.8	8.8	6.4	12.4	14.2	8.7	7.8	20.2	11.3	11.8	11.8	3.8	12.0	9.0	8.3	14.1	16.5	15.7	14.0	14.2	14.5	9.4	8.0	13.4	14.6	12.6	13.1	15.4	39.1	14.8	16.2	19.8	19.8	8.5	10.9	13.7	9.6	14.4	15.1	6.8	15.1	12.9	20.3	9.6	16.9	13.3	13.2	12.0	26.4	12.6	11.5	13.5	16.6	23.3	10.7	14.7	16.9	13.9	13.7	14.0	19.3	18.1	13.2	9.9	16.2	8.9	17.0	10.2	18.8	13.5	11.3	11.6	6.5	11.7	12.6	12.5	12.0	11.1	18.1	11.0	10.9	14.2	9.1	13.8	13.3	15.0	25.3	16.7	14.9	12.3	13.3	9.0	11.1	15.7	13.8	14.0	13.4	10.6	13.1	13.5	12.3	14.1	13.4	14.5	6.7	14.2	13.0	16.5	11.9	9.4	19.4	19.3	18.4	18.9	13.1	14.3	13.3	9.6	13.7	11.3	3.0	5.6	0.8	6.7	3.5	16.3	5.2	2.5	10.7	4.5	8.7	5.9	7.9	5.0	9.2	171.3	6.8	1.7	0.0	11.8	16.3	5.4	4.1	4.7	1.9	8.0	19.1	1.7	4.9	5.4	95.3	8.3	6.6	5.0	7.2	2.2	11.0	7.0	3.5	8.5	5.0	14.0	6.5	5.3	30.2	13.8	2.5	9.7	8.5	3.9	5.3
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427355-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 229.6;Late spermatids: 321.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 56.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	15.6	11.5	13.9	12.2	20.0	55.7	11.4	18.1	19.1	9.8	11.7	13.3	11.5	12.7	10.1	9.9	13.1	9.4	12.9	7.6	14.3	18.1	13.7	22.2	12.0	12.4	14.7	13.0	8.0	11.8	13.0	17.6	18.9	18.6	12.7	12.4	9.6	9.5	15.4	8.6	15.9	12.5	10.4	13.7	15.1	13.7	9.7	10.1	14.0	13.0	9.1	12.9	11.9	9.0	5.1	9.9	7.1	7.4	8.1	15.4	4.3	4.0	6.6	7.0	7.1	4.1	3.5	56.2	5.9	4.2	6.8	6.7	9.0	4.5	11.3	3.8	4.3	4.5	3.4	9.0	5.2	7.9	9.2	6.5	9.7	6.0	8.1	9.2	9.1	7.9	4.6	9.3	9.9	6.7	5.2	6.8	9.3	10.3	8.3	5.6	8.3	9.0	5.1	12.4	7.6	6.8	8.3	5.8	6.2	5.9	7.1	7.2	12.6	7.2	6.8	6.9	9.4	10.1	7.3	6.6	7.2	5.3	6.3	8.5	11.0	22.1	11.9	7.0	10.9	8.5	7.1	7.4	4.5	12.0	5.4	15.4	5.1	10.1	9.3	4.3	3.8	6.0	9.8	6.7	8.1	6.5	9.9	10.5	4.3	13.9	20.0	18.1	19.1	14.3	18.1	14.7	13.0	18.6	10.1	8.9	12.9	2.9	7.7	41.7	6.8	4.5	7.6	6.7	10.3	12.2	5.9	7.2	8.3	7.8	229.6	11.7	13.6	0.0	7.0	11.7	16.0	15.1	10.3	27.0	14.1	20.6	33.0	11.6	21.8	321.2	10.6	14.6	21.9	5.4	11.2	4.8	11.8	10.5	11.3	18.9	6.0	25.8	11.3	18.6	11.5	47.4	30.0	20.4	10.9	14.5
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Neurotransmitter degradation"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 31.8;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 6.7;Early spermatids: 4.2;Horizontal cells: 6.4;Late spermatids: 11.3;Peritubular cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 31.8"	"Lineage enriched"	"Detected in single"	35	"T-cells: 31.8"	"Group enriched"	"Detected in some"	5	"BEWO: 17.3;HDLM-2: 5.6;U-937: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA045876: AB_2679479"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.7	0.7	0.9	0.7	1.1	1.3	0.9	11.4	2.1	2.4	2.3	0.4	0.2	0.8	3.2	2.7	1.3	8.8	1.8	15.9	1.5	1.2	0.5	0.9	2.1	19.6	0.9	1.1	2.3	0.6	10.0	1.1	0.5	2.1	2.0	0.5	2.0	1.1	1.4	14.3	0.9	1.4	1.1	1.5	3.8	1.5	2.0	0.4	3.8	1.0	0.6	3.3	1.3	1.4	0.0	0.2	0.0	0.4	0.9	31.8	1.7	0.1	0.5	2.0	1.2	1.5	1.0	17.3	0.3	0.5	0.4	0.6	0.0	0.3	0.1	0.7	0.3	0.1	0.2	0.3	0.4	0.5	5.6	1.2	0.6	0.7	0.2	0.2	0.4	1.2	0.8	0.4	0.8	0.3	0.8	0.3	1.5	0.0	0.6	0.8	0.3	0.6	1.8	0.2	0.0	0.6	0.8	0.2	0.4	0.4	0.4	0.6	1.8	0.2	0.1	0.4	1.9	1.2	0.8	0.1	0.2	1.1	1.9	0.6	1.7	1.5	0.1	0.1	8.7	0.1	0.0	0.4	0.0	5.5	0.0	31.8	0.0	2.7	3.9	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.2	0.1	1.7	0.9	1.1	11.4	2.1	1.5	1.2	0.9	1.1	2.1	0.4	0.0	1.1	0.0	0.1	0.2	0.3	0.7	0.0	6.7	2.3	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.8	0.2	6.4	1.2	2.5	0.0	11.3	1.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	4.2	0.0	0.6	0.0	0.2	0.7	0.2	0.1	1.9	1.3	0.0	0.0
HACL1	"2-HPCL, HPCL, PHYH2"	ENSG00000131373	"2-hydroxyacyl-CoA lyase 1"	Q9UJ83	3	15560704-15601852	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 34.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035496, HPA035497, HPA073760"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633"	"unprognostic (6.64e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (5.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.62e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.07e-2)"	12.9	12.1	9.1	7.3	12.5	7.6	11.6	20.7	14.1	9.0	22.4	13.5	5.8	39.6	13.1	13.2	6.7	7.9	6.6	7.9	6.7	6.0	18.8	38.1	7.5	9.0	9.1	8.3	7.9	14.3	12.9	16.8	6.4	10.1	8.2	9.0	10.9	8.5	6.9	15.7	9.9	31.6	7.2	8.2	11.0	11.5	18.4	10.3	16.6	15.1	6.1	10.7	8.2	6.5	8.5	6.5	34.1	9.1	9.1	9.3	5.0	6.0	12.5	4.0	13.9	7.0	5.6	39.4	5.9	9.6	12.7	12.5	12.9	6.0	6.2	4.3	8.0	5.0	4.5	9.2	11.4	11.3	5.2	17.5	12.2	9.5	12.5	10.5	13.3	10.7	6.4	8.4	18.0	7.5	3.8	15.9	8.3	10.0	10.4	10.8	13.3	6.4	6.3	9.1	9.6	14.6	6.0	9.8	8.2	13.6	9.5	4.2	5.5	8.8	9.7	11.6	6.6	3.1	12.5	9.7	6.9	6.8	8.5	10.8	12.8	21.6	12.2	12.9	12.1	7.8	34.1	6.5	7.0	6.0	8.2	9.3	6.4	6.5	7.5	6.5	8.5	6.4	7.1	1.4	9.1	9.1	4.0	7.8	5.0	9.1	12.5	20.7	14.1	6.7	6.0	9.1	8.3	10.1	10.3	8.9	15.9	11.9	9.6	9.2	18.3	4.9	12.7	37.5	15.9	10.4	27.5	24.4	11.6	10.9	53.9	11.1	8.8	0.0	22.1	15.1	8.6	8.1	12.7	26.4	11.8	12.7	8.7	8.6	9.1	43.3	21.6	8.7	11.8	24.4	5.8	22.5	12.7	10.5	14.5	27.1	32.9	6.5	9.0	49.7	22.6	6.1	15.8	18.7	8.6	5.8
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15647640	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"	NA	NA		2900000000			"HPA052275: AB_2681782"	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	18.5	17.9	7.5	3.9	10.2	4.4	13.5	17.0	11.8	11.2	28.1	19.6	12.2	25.3	12.3	34.1	7.1	10.3	10.4	6.9	8.0	6.8	20.0	50.7	8.2	5.2	12.3	9.5	17.2	26.6	19.6	11.1	10.7	9.3	10.7	9.4	20.0	11.6	12.1	6.9	6.5	40.5	7.9	8.8	7.6	12.9	15.0	12.6	5.9	14.8	3.8	6.2	11.7	9.1	8.4	13.7	31.0	11.9	7.5	15.6	8.7	3.8	10.8	3.3	3.2	28.3	7.8	19.6	7.0	9.4	8.3	15.0	3.8	10.3	1.0	8.4	16.2	3.4	4.3	2.6	8.3	9.7	3.3	5.5	5.9	14.5	11.6	6.8	2.9	6.9	9.5	8.6	21.9	2.2	19.6	15.9	2.4	3.8	13.8	23.3	4.6	1.6	3.4	3.6	8.2	6.0	2.1	8.3	13.0	8.0	7.8	2.3	5.7	8.3	2.0	11.0	7.7	10.2	5.6	10.8	9.0	6.9	8.4	4.4	3.2	4.9	1.2	10.5	3.5	6.5	31.0	11.9	25.2	13.2	11.1	12.3	8.4	14.1	11.3	12.1	7.8	12.2	9.2	10.8	7.5	8.4	13.7	15.6	8.7	7.5	10.2	17.0	11.8	8.0	6.8	12.3	9.5	9.3	12.6	6.0	8.3	10.4	10.9	5.3	12.4	5.3	45.9	17.4	3.4	17.4	17.7	22.1	5.0	15.4	24.9	7.1	10.6	23.3	24.6	16.7	10.3	6.2	4.7	58.9	13.6	4.8	6.9	23.4	8.9	12.5	30.0	8.2	10.1	10.8	7.5	18.0	12.6	17.3	17.0	23.2	43.4	12.9	5.2	20.4	6.8	4.8	19.3	13.8	7.6	9.1
ANKRD28	"KIAA0379, PITK, PP6-ARS-A, PPP1R65"	ENSG00000206560	"Ankyrin repeat domain 28"	O15084	3	15667236-15859771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"granulocytes: 194.8;Melanocytes: 268.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"basophil: 14.1"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 14.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.72e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.48e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (7.71e-2)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.06e-1)"	20.5	4.9	10.9	5.2	9.4	7.3	10.4	23.8	9.6	10.8	7.6	7.0	7.7	7.0	7.1	22.6	9.3	7.0	7.5	5.6	7.6	4.6	7.9	9.9	7.5	3.6	7.1	7.5	12.2	10.3	12.2	5.2	4.5	7.4	6.1	7.4	6.1	8.5	6.9	22.9	8.1	6.4	7.1	8.2	4.9	7.6	8.3	9.4	8.8	10.3	7.6	6.3	7.7	7.3	0.2	0.3	14.1	0.0	0.3	0.7	0.2	7.2	4.8	5.4	3.6	18.2	15.2	17.6	9.3	13.2	12.1	14.0	2.9	7.4	14.1	3.2	9.4	9.5	2.9	4.4	7.7	12.4	3.0	6.2	6.7	6.6	4.8	29.9	10.3	4.6	22.1	5.4	11.4	12.0	15.2	12.6	7.9	5.0	19.1	31.1	4.8	8.6	6.7	11.0	4.8	4.0	7.6	10.1	11.9	11.6	7.3	2.7	4.9	6.9	7.1	28.2	5.0	4.2	8.2	9.9	15.5	9.5	11.6	9.1	11.7	13.6	8.5	11.5	7.5	11.7	14.1	0.0	0.0	0.3	0.0	0.5	0.2	0.7	0.4	0.1	0.2	0.2	0.4	0.1	0.3	0.0	0.3	0.2	0.2	10.9	9.4	23.8	9.6	7.6	4.6	7.1	7.5	7.4	9.4	29.8	49.3	33.4	17.8	37.8	28.1	14.9	10.2	32.1	52.4	7.0	131.6	6.9	8.3	11.4	82.9	24.3	12.0	0.0	17.8	7.0	42.1	21.7	194.8	38.5	37.6	49.3	19.0	15.4	25.2	60.6	32.2	32.9	268.2	24.4	17.7	45.3	12.7	14.0	10.3	8.6	43.7	0.0	24.5	23.0	11.5	29.4	2.9	69.2	17.0	15.8
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174649-16231992	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 66.7;brain: 52.3"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 19.5;Endothelial cells: 15.2;Ito cells: 39.9;Muller glia cells: 48.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 44.9;ASC TERT1: 44.3;HSkMC: 33.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 10.7;pons and medulla: 6.7"	"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		25000	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	66.7	5.3	7.6	2.6	17.4	1.1	22.8	2.3	31.5	3.9	8.6	28.1	1.1	2.8	3.5	3.3	11.4	5.3	5.2	7.3	14.8	6.6	8.3	2.8	3.1	3.4	38.9	8.4	8.4	3.2	1.6	1.0	35.5	24.8	4.9	3.8	1.3	8.0	4.1	17.3	11.6	5.3	10.5	52.3	12.8	4.6	8.1	19.9	0.0	6.3	1.6	1.5	16.6	23.5	0.6	0.9	0.9	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.0	44.9	44.3	0.0	1.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	33.7	0.0	0.4	0.5	0.3	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.2	7.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.0	0.6	0.4	0.2	0.9	0.3	0.3	0.9	0.3	0.3	7.6	17.4	2.3	13.6	14.8	6.6	38.9	8.4	24.8	19.9	0.0	1.7	0.0	0.5	0.5	0.8	1.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	19.5	15.2	0.0	0.0	0.0	0.0	2.9	1.2	1.1	0.2	0.1	0.0	0.0	39.9	0.6	10.6	1.7	0.2	0.0	0.0	0.0	48.3	0.2	0.0	0.7	0.0	3.1	0.0	1.2	10.2	0.5	0.6	0.0	0.0	0.0	0.1
DPH3	"DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2"	ENSG00000154813	"Diphthamide biosynthesis 3"	Q96FX2	3	16257978-16264972	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035287	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035287: AB_10604113"	"unprognostic (2.49e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.44e-2)"	17.6	13.9	15.7	10.6	14.8	8.0	21.3	10.7	15.0	12.6	15.3	8.9	8.2	12.4	13.2	13.0	12.6	11.5	12.1	15.4	14.2	17.3	17.9	27.4	12.5	10.0	19.3	6.9	15.8	9.1	7.6	19.3	17.3	18.6	11.0	10.4	5.6	7.2	13.6	33.2	5.4	32.8	17.3	17.4	15.3	12.0	13.2	12.6	12.8	14.4	10.1	9.0	15.3	12.8	7.3	11.3	25.6	15.6	7.2	10.6	8.7	5.3	7.9	16.9	10.4	31.3	22.9	13.5	15.6	12.5	14.7	17.2	9.7	3.3	5.1	5.2	19.1	12.8	3.3	15.5	9.9	17.7	25.7	10.6	8.5	6.3	10.8	19.7	12.6	8.5	15.8	13.2	20.0	8.7	9.4	13.4	9.3	14.6	8.8	20.8	7.0	9.4	8.2	13.6	8.4	8.2	6.7	11.1	7.9	13.1	4.3	3.7	10.8	7.2	3.6	17.7	14.6	6.9	12.4	15.6	12.7	7.9	22.3	12.9	6.9	22.8	6.8	18.2	14.2	10.9	15.3	12.0	17.8	8.6	15.6	10.6	7.3	9.2	10.4	11.3	6.6	7.8	9.1	25.6	7.2	14.4	4.5	8.1	8.7	15.7	14.8	10.7	15.0	14.2	17.3	19.3	6.9	18.6	12.6	17.9	19.0	32.8	34.6	45.8	11.4	33.0	25.5	25.4	27.3	15.7	11.8	40.7	34.9	45.9	86.0	30.1	55.8	23.3	49.9	63.0	35.9	36.4	50.8	35.8	86.6	6.4	17.1	26.4	41.7	53.8	19.0	47.4	27.0	82.0	20.7	14.9	53.2	34.5	14.9	37.6	13.9	12.9	28.0	54.9	41.1	45.8	67.6	32.4	15.6	45.1
OXNAD1	MGC15763	ENSG00000154814	"Oxidoreductase NAD binding domain containing 1"	Q96HP4	3	16265160-16350299	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"T-cells: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 33.0"	"Lineage enriched"	"Detected in all"	5	"T-cells: 33.0"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA036830, HPA059160"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA036830: AB_2675338, HPA059160: AB_2683936"	"unprognostic (4.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.38e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (1.00e-7)"	"unprognostic (2.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-3)"	"prognostic favorable (7.63e-4)"	8.1	8.8	7.5	14.1	11.1	10.9	8.1	9.1	13.6	5.4	11.4	9.1	7.3	16.3	7.7	4.3	10.8	6.2	7.1	12.0	7.1	5.9	15.5	22.4	6.6	20.7	10.9	7.9	6.9	7.4	6.5	12.4	5.2	9.5	5.4	10.2	6.8	9.4	9.3	18.1	8.2	18.4	4.2	8.9	9.2	9.4	9.3	12.1	8.2	8.0	7.0	16.0	7.8	6.6	1.9	2.2	1.3	2.0	6.4	33.0	7.5	5.6	8.2	5.4	8.5	6.4	5.7	21.1	6.1	4.5	8.4	6.8	11.8	5.7	8.0	3.8	3.8	4.6	4.1	11.1	9.9	8.0	14.6	7.3	11.8	7.0	6.3	6.6	19.0	7.2	4.2	7.4	13.6	6.6	2.6	6.5	8.3	16.1	19.3	3.6	10.0	11.0	10.0	11.5	8.4	9.7	9.9	6.6	14.1	5.7	6.8	3.8	5.4	6.8	11.5	9.4	6.1	7.3	11.0	2.9	5.5	7.0	6.0	9.8	7.0	12.6	13.0	6.5	16.6	7.3	0.0	1.4	1.1	9.0	2.0	11.9	1.9	13.8	9.7	2.2	1.5	33.0	24.4	1.3	6.4	1.8	1.7	7.3	7.5	7.5	11.1	9.1	13.6	7.1	5.9	10.9	7.9	9.5	12.1	0.0	10.4	12.0	4.7	2.2	5.7	12.3	5.1	9.4	3.4	7.0	5.9	9.1	26.6	7.6	32.8	3.5	9.2	0.0	5.5	6.7	4.7	4.5	19.7	18.3	7.5	3.2	2.9	3.7	3.3	24.8	2.8	3.8	5.0	10.8	6.9	5.0	6.3	2.9	1.8	12.6	11.0	6.5	3.4	6.6	10.0	3.0	4.2	39.9	10.3	4.8
RFTN1	"FLJ23866, KIAA0084, MIG2, Raftlin"	ENSG00000131378	"Raftlin, lipid raft linker 1"	Q14699	3	16313574-16514026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"monocytes: 231.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.7;HDLM-2: 45.8;SH-SY5Y: 36.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048725	Approved					NA	NA		9400			"HPA048725: AB_2680502"	"unprognostic (1.98e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.55e-3)"	"unprognostic (9.99e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.81e-1)"	25.7	5.3	5.1	43.5	6.3	5.2	17.0	5.1	13.3	13.1	6.4	3.5	4.4	4.2	21.2	9.0	8.4	13.1	7.5	17.5	7.0	6.8	10.4	11.6	24.2	47.2	4.6	9.1	17.5	2.7	3.9	4.4	22.7	4.9	8.9	6.6	15.3	7.9	5.0	10.3	9.3	11.4	14.1	4.6	23.6	6.4	4.6	2.8	50.1	30.2	9.5	50.2	10.4	15.5	14.3	13.8	19.0	30.1	31.5	23.5	14.3	0.0	0.7	1.4	0.0	41.7	21.0	2.0	10.4	17.4	5.2	4.2	6.0	0.2	32.1	5.0	18.6	1.1	0.1	0.0	13.5	6.9	45.8	2.6	5.1	1.3	0.1	21.7	3.7	2.9	30.7	0.9	16.3	5.1	18.3	10.8	5.3	0.1	0.1	12.5	1.7	7.9	1.3	0.9	0.0	0.4	7.6	16.6	3.9	2.1	0.0	0.0	36.2	0.3	0.3	1.8	2.0	0.0	3.1	16.0	13.0	6.2	12.9	4.3	0.1	0.1	21.5	6.0	10.1	5.1	19.0	8.4	5.3	15.6	18.3	7.9	6.8	12.2	16.3	13.8	14.3	8.4	12.6	0.5	31.5	30.1	10.7	23.5	14.3	5.1	6.3	5.1	13.3	7.0	6.8	4.6	9.1	4.9	2.8	20.8	33.6	20.9	0.2	5.8	1.9	10.2	7.6	4.0	10.3	0.0	0.0	4.3	0.0	6.7	22.4	23.9	0.0	0.0	0.8	1.3	22.9	0.3	24.3	6.4	9.6	0.0	1.2	41.7	11.4	9.0	17.3	21.7	10.1	231.8	0.0	35.4	0.9	0.0	8.1	0.0	3.1	0.0	27.7	0.2	1.7	4.4	2.1	30.2	0.0	0.3
DAZL	"DAZH, DAZL1, DAZLA, MGC26406, SPGYLA"	ENSG00000092345	"Deleted in azoospermia like"	Q92904	3	16586792-16670306	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 68.6"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 242.1;Spermatogonia: 122.2"	"Cancer enriched"	"Detected in single"	51	"testis cancer: 13.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	27	"B-cells: 2.7"	"Cell line enriched"	"Detected in some"	8	"HAP1: 20.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.7"	"Not detected"	"Not detected"			"HPA019777, HPA047113"	Enhanced					NA	NA					"HPA019777: AB_1847495, HPA047113: AB_2679936"	"unprognostic (5.61e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.80e-1)"			"unprognostic (5.85e-2)"		"unprognostic (2.32e-3)"	"unprognostic (2.60e-2)"	"unprognostic (6.34e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.69e-2)"		"unprognostic (7.79e-2)"	"unprognostic (2.04e-1)"		"unprognostic (3.47e-1)"	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	68.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	6.5	0.0	242.1	122.2	0.0	0.1	0.0	0.0	0.0
PLCL2	"KIAA1092, PLCE2"	ENSG00000154822	"Phospholipase C like 2"	Q9UPR0	3	16802651-17090594	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 32.7;Extravillous trophoblasts: 52.0;Syncytiotrophoblasts: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 15.7;Daudi: 17.1;HAP1: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047616, HPA061728"	Enhanced					NA	NA					"HPA047616: AB_2680105, HPA061728: "	"unprognostic (2.95e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (2.98e-10)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.97e-2)"	6.7	9.2	5.6	9.0	7.9	9.6	5.3	32.0	9.2	5.1	5.1	2.0	1.7	7.0	7.3	6.9	1.5	4.8	5.2	11.3	4.9	3.4	8.1	5.8	4.3	12.3	3.0	7.4	14.1	4.7	0.5	7.8	5.5	8.0	2.7	6.2	3.1	3.6	1.5	22.7	2.1	7.6	4.5	3.8	13.0	5.6	3.2	3.4	7.3	4.0	1.0	8.0	3.4	3.1	2.4	1.6	3.0	1.8	10.0	4.9	1.7	0.0	1.3	1.8	0.0	6.8	15.7	1.4	1.3	3.6	0.6	1.5	0.0	1.3	17.1	0.0	1.1	0.7	0.0	17.6	0.7	1.3	8.1	3.7	0.0	1.9	0.0	0.2	2.6	2.0	2.5	0.1	5.0	0.0	1.1	3.1	5.7	3.9	6.7	0.0	0.0	2.9	0.3	3.6	0.0	1.8	6.5	0.0	9.2	0.0	0.2	5.8	2.6	0.7	2.2	0.5	1.3	0.0	2.8	3.1	0.9	1.2	0.8	2.9	6.4	0.0	11.1	0.9	3.6	0.6	1.2	1.4	2.8	3.6	1.5	4.5	2.2	3.4	4.9	1.6	2.4	3.3	3.7	3.0	10.0	1.8	0.9	2.4	1.7	5.6	7.9	32.0	9.2	4.9	3.4	3.0	7.4	8.0	3.4	0.0	2.1	7.1	1.0	0.9	11.0	32.7	17.8	1.4	1.2	3.5	3.9	1.6	6.6	1.7	0.6	3.3	9.0	23.3	8.3	52.0	4.5	0.4	2.3	4.2	6.5	15.9	3.5	4.9	8.8	1.1	18.1	7.8	0.0	0.0	7.6	0.8	2.1	25.9	18.0	5.0	1.8	6.5	3.8	1.4	5.8	0.5	41.6	16.6	4.7	0.4
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	22.2	20.9	24.8	21.3	24.7	21.1	17.7	25.5	25.1	21.0	13.3	25.7	14.5	10.3	17.4	15.9	16.4	22.4	18.5	16.2	24.4	20.0	19.9	13.9	16.9	20.4	25.9	14.9	28.3	17.2	35.3	27.8	16.5	21.4	14.2	13.7	16.6	13.9	17.0	10.3	15.2	13.8	17.7	31.3	24.3	12.9	17.3	24.7	10.0	29.1	9.7	21.2	17.8	20.7	13.5	9.7	12.3	8.6	4.2	8.7	4.6	11.7	13.2	10.9	10.2	21.5	31.7	11.9	12.7	18.6	8.3	7.2	6.4	10.7	21.9	13.8	25.7	12.8	3.7	9.5	15.4	17.4	19.2	3.7	21.0	5.3	7.4	13.8	20.3	18.3	20.4	18.5	18.0	11.0	18.8	18.9	13.0	13.1	20.3	20.2	7.9	9.9	4.6	8.9	7.6	13.9	21.9	14.0	15.6	12.5	9.2	4.1	19.3	24.3	5.7	8.6	10.7	16.1	17.0	20.4	23.1	10.4	11.9	13.8	11.8	15.9	21.3	17.8	19.4	21.6	10.2	8.6	12.3	6.7	7.1	8.7	11.7	5.1	4.8	9.7	13.5	3.9	4.4	11.5	4.2	6.4	6.3	5.5	4.6	24.8	24.7	25.5	24.6	24.4	20.0	25.9	14.9	21.4	24.7	14.9	31.2	20.1	17.0	16.4	19.3	16.2	25.5	17.4	39.8	14.0	9.8	12.9	5.0	14.3	52.3	25.4	9.5	23.3	8.7	14.6	17.4	9.9	17.4	16.4	18.6	33.4	12.6	39.3	34.9	30.1	28.4	26.6	13.5	10.0	12.3	23.0	10.9	11.2	28.7	13.5	21.3	6.5	10.5	17.0	26.2	14.9	6.9	14.9	11.7	18.7
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345387-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"lymphoid tissue: 331.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 37.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 18.6;T-cells: 37.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 91.1;JURKAT: 44.0;REH: 25.4;THP-1: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144, HPA070534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favorable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	6.7	5.3	11.8	11.7	11.0	16.4	5.9	10.1	22.7	5.6	15.1	3.6	16.1	6.8	5.9	11.1	5.3	8.0	7.7	10.9	10.8	8.1	5.4	7.2	7.6	25.9	10.0	15.6	6.2	14.8	22.4	12.9	1.8	6.6	10.1	8.2	5.9	17.9	26.2	35.7	9.2	11.3	12.1	8.1	11.5	10.4	2.9	4.5	331.6	11.3	4.6	11.8	18.7	11.0	4.7	1.2	4.7	0.6	18.6	37.9	7.9	0.4	0.0	2.6	0.0	3.6	3.6	0.2	0.7	2.5	0.6	2.0	0.1	4.7	0.9	0.0	0.8	0.2	0.0	9.5	1.1	1.2	91.1	5.8	0.0	0.2	0.0	0.5	5.3	0.8	1.5	0.8	0.0	0.1	7.4	0.6	44.0	0.1	5.0	0.4	0.0	21.2	6.8	3.8	0.3	0.3	25.4	1.3	0.9	1.0	3.1	1.2	7.2	0.0	0.8	0.0	2.2	20.4	38.9	0.3	2.6	1.7	1.2	0.7	0.2	0.0	2.0	2.1	20.5	1.1	4.7	0.5	1.3	14.3	0.6	25.8	0.5	9.7	7.4	1.0	4.7	37.9	22.6	1.2	18.6	0.3	1.2	1.7	7.9	11.8	11.0	10.1	22.7	10.8	8.1	10.0	15.6	6.6	4.5	23.8	26.4	13.7	11.8	12.7	10.1	57.9	22.9	46.8	14.8	29.6	82.5	0.4	1.7	10.0	4.8	11.7	11.0	23.3	10.8	0.1	8.7	29.4	22.0	18.8	9.1	0.0	31.2	31.3	44.9	3.5	7.8	19.2	10.1	1.0	32.6	14.2	11.1	28.1	7.8	7.3	62.2	6.5	9.5	0.7	2.5	19.3	0.2	62.3	25.2	14.4
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148454-19535646	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.3;pituitary gland: 16.1"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 4.7;Early spermatids: 2.7;Intestinal endocrine cells: 3.5;Melanocytes: 3.3;Muller glia cells: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;OE19: 4.0;SH-SY5Y: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.6	7.0	8.4	1.6	22.0	1.4	2.4	1.3	11.4	1.3	1.9	31.3	0.0	2.2	1.2	1.2	0.7	1.4	2.2	1.0	11.8	5.7	0.7	0.7	0.8	3.2	16.4	10.2	0.7	2.7	0.8	16.1	0.6	15.0	2.2	2.5	0.1	3.3	1.4	0.6	1.9	1.8	1.1	9.9	2.6	5.9	4.0	18.1	0.0	1.1	0.0	3.2	0.9	0.5	4.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.8	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.4	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	8.4	22.0	1.3	11.4	11.8	5.7	16.4	10.2	15.0	18.1	0.0	0.0	0.0	1.6	0.5	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.7	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.1	0.0	3.5	0.0	0.0	1.1	0.0	0.0	3.3	0.0	1.7	3.7	0.6	0.0	0.0	0.0	0.9	0.0	0.2	0.7	1.9	0.0	0.1	0.0	0.2	0.2
EFHB	"CFAP21, FLJ25200"	ENSG00000163576	"EF-hand domain family member B"	Q8N7U6	3	19879472-19947025	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.3;testis: 19.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 129.8;Early spermatids: 43.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	33	"RPTEC TERT1: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078067			Approved	Nucleoli		NA	NA			Nucleoli		"HPA078067: AB_2732370"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.51e-5)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	1.1	1.5	3.9	0.7	6.0	0.7	1.8	0.7	4.3	2.0	0.7	6.5	0.0	0.6	2.0	7.8	1.0	23.3	1.3	0.8	6.3	4.7	1.8	0.7	3.9	0.7	4.4	2.2	5.5	0.5	0.5	1.6	1.0	9.5	1.0	1.0	2.3	0.6	1.3	0.7	1.1	0.6	1.6	3.1	1.2	0.6	19.2	6.0	0.0	1.2	0.0	0.8	0.7	0.6	1.3	0.6	1.1	0.8	0.4	2.2	0.4	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	21.5	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	2.2	0.1	0.1	0.8	0.3	0.4	0.0	1.3	0.5	0.3	1.1	0.4	0.3	0.6	0.0	0.4	3.9	6.0	0.7	3.8	6.3	4.7	4.4	2.2	9.5	6.0	0.0	0.6	0.0	0.4	0.1	0.5	0.3	7.6	129.8	20.5	3.5	2.0	0.8	5.0	0.3	43.0	0.2	0.5	0.0	0.2	0.4	1.1	0.3	3.5	0.4	0.4	1.6	1.2	0.6	1.3	16.0	2.3	0.7	0.0	0.0	0.0	3.6	0.4	0.0	2.1	4.5	0.7	0.0	0.3	18.4	3.3	0.1	0.7	0.0	0.3	0.1
RAB5A	RAB5	ENSG00000144566	"RAB5A, member RAS oncogene family"	P20339	3	19947079-19985175	"Predicted intracellular proteins, RAS pathway related proteins"	"Endocytosis, Phagocytosis, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004567, HPA049354"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		920000	"Nucleoplasm, Vesicles"		"CAB004567: AB_628191, HPA049354: AB_2680725"	"unprognostic (2.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	25.8	21.2	42.5	19.3	34.7	26.5	25.5	25.2	36.6	24.8	21.9	26.0	18.1	21.6	17.5	33.4	32.4	16.3	24.7	28.3	38.4	38.0	25.5	31.3	22.5	16.3	43.5	33.8	16.2	21.9	39.2	23.8	36.1	35.1	24.0	23.4	16.2	25.4	23.3	35.8	27.2	21.6	21.2	49.1	17.0	23.6	15.7	30.3	22.7	31.4	22.2	20.8	23.7	23.7	5.0	11.2	22.7	14.8	12.5	7.0	6.8	11.6	10.7	15.7	10.8	27.6	24.6	16.0	20.6	24.2	19.7	22.8	12.6	18.6	8.6	12.5	22.6	11.5	7.4	11.7	15.3	23.1	14.8	9.7	12.5	10.4	12.2	34.6	17.4	15.8	22.5	29.1	23.0	33.9	24.8	24.8	11.5	14.3	13.9	23.5	18.0	13.5	12.5	19.7	16.2	17.3	10.1	11.1	12.5	40.2	15.5	4.9	16.3	14.7	18.5	23.7	24.5	14.4	14.2	24.6	14.4	12.5	18.2	17.4	17.2	28.2	11.4	22.9	16.0	23.3	15.1	11.4	18.7	5.3	12.1	7.0	5.0	6.3	6.4	11.2	3.5	5.9	5.4	22.7	12.5	14.8	7.4	6.6	6.8	42.5	34.7	25.2	36.6	38.4	38.0	43.5	33.8	35.1	30.3	56.6	39.7	36.6	109.3	151.1	33.1	53.1	22.9	46.8	40.9	40.1	29.5	67.4	87.9	48.7	14.5	60.9	53.0	23.3	40.0	57.3	76.1	98.0	84.2	36.4	48.3	14.3	59.4	39.3	42.9	12.4	33.9	55.8	79.2	41.5	43.4	64.7	48.5	38.6	33.2	49.4	31.1	51.8	76.2	19.5	25.5	164.4	137.4	44.9	37.0	131.9
PP2D1	"C3orf48, FLJ25449"	ENSG00000183977	"Protein phosphatase 2C like domain containing 1"	A8MPX8	3	19979961-20012330	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"testis: 28.8"	"Group enriched"	"Detected in some"	83	"Early spermatids: 319.7;Late spermatids: 185.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-266/84: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036870, HPA066083"	Enhanced		Uncertain	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA036870: AB_10671246, HPA066083: AB_2685611"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.76e-1)"	"unprognostic (6.27e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.04e-1)"	0.2	0.1	0.1	0.2	0.1	3.0	0.1	0.7	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.2	0.1	0.1	0.3	0.2	28.8	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.7	0.5	1.2	0.6	0.0	0.9	0.0	0.3	0.6	0.7	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.5	0.8	1.5	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.2	0.6	0.6	0.9	0.2	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.5	0.7	0.0	0.2	1.0	0.8	1.0	0.4	0.3	0.9	0.9	1.6	0.0	0.3	0.4	1.9	0.1	2.3	1.4	1.1	0.7	0.8	0.3	0.0	0.3	0.3	0.5	0.6	4.1	1.6	1.8	0.8	0.3	0.0	0.5	0.9	0.8	0.6	0.3	0.2	0.5	0.4	0.1	0.7	0.9	0.8	1.2	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	319.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	3.1	1.3	0.0	0.0	0.0	0.0	0.0
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	4.0	2.2	3.6	9.1	8.6	5.2	5.1	7.6	5.4	7.9	1.2	2.6	13.7	2.1	9.6	6.8	1.1	5.5	1.6	4.5	12.4	5.2	12.0	6.3	0.4	4.3	1.8	15.6	3.7	3.0	4.7	3.0	9.5	5.1	3.4	7.7	19.4	7.6	1.9	3.9	3.6	0.9	3.8	3.9	5.1	4.2	2.9	7.3	8.1	1.1	2.4	2.8	4.6	17.3	3.6	4.8	8.1	4.9	9.1	3.7	3.4	5.8	7.4	15.4	3.3	8.3	7.9	19.2	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1	29.8	17.3	4.7	10.0	7.6	11.9	56.5	2.5	17.4	14.8	5.2	3.9	5.4	10.0	2.8	2.3	10.5	13.6	23.3	3.8	1.1	9.3	10.0	10.4	26.1	6.5	14.3	11.1	18.4	21.9	1.3	6.1	15.7	16.9	5.4	5.7	12.6	3.7	0.0	4.9	5.3	11.2	6.5	9.9	0.9	0.9	11.3	8.2	13.8	3.1	7.1
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186292	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 40.1"	"Cell type enhanced"	"Detected in some"	27	"Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.6	0.6	0.4	9.1	0.4	8.9	1.0	0.4	1.5	0.9	3.4	0.3	0.6	2.7	0.8	0.5	4.0	0.3	1.7	0.4	0.3	0.4	0.8	1.0	0.9	6.9	0.4	0.1	0.5	0.5	0.0	0.4	3.7	0.2	0.6	3.5	0.1	1.0	0.1	0.3	1.1	3.4	0.8	0.4	4.9	1.5	8.6	0.2	40.1	0.5	2.4	7.4	1.2	1.5	9.0	4.5	8.3	0.2	0.3	2.7	0.6	9.5	10.9	14.9	9.1	0.7	1.3	10.1	10.3	5.3	15.0	16.5	7.7	11.8	14.6	5.2	4.2	10.6	5.6	14.0	5.7	19.0	18.6	9.3	16.6	7.5	6.1	0.1	15.1	14.3	0.1	0.4	16.5	7.0	2.1	8.9	17.4	14.2	26.2	12.4	9.4	23.7	8.5	15.8	10.2	8.3	15.2	19.1	8.5	3.8	7.0	7.4	7.8	11.4	14.1	6.8	11.6	9.1	10.6	2.4	11.4	13.7	10.2	20.5	11.3	26.2	17.0	6.2	15.3	17.1	8.3	0.1	1.5	0.3	0.2	0.1	8.6	0.7	0.8	0.4	9.0	0.2	0.4	1.6	0.3	0.2	4.5	2.7	0.6	0.4	0.4	0.4	1.5	0.3	0.4	0.4	0.1	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	5.4	0.0	1.1	0.0	0.0	0.0	0.0	1.6	33.5	0.0	0.0	1.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
ZNF385D	"FLJ22419, ZNF659"	ENSG00000151789	"Zinc finger protein 385D"	Q9H6B1	3	21412222-22373321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 17.7;brain: 59.5;testis: 18.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 137.4;Horizontal cells: 305.1;Late spermatids: 198.0;Muller glia cells: 119.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 59.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;hTERT-RPE1: 4.2;RPTEC TERT1: 6.7;U-87 MG: 12.6"					"Low region specificity"	"Detected in all"			HPA036190	Uncertain					NA	NA					"HPA036190: AB_10602355"	"unprognostic (4.07e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-7)"	"unprognostic (8.70e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.15e-5)"	17.7	1.1	4.0	2.2	5.9	1.1	5.3	59.5	9.1	4.3	2.2	0.1	1.2	1.2	2.3	3.9	4.0	2.3	4.7	3.9	3.9	3.6	3.2	0.9	1.9	2.0	7.4	4.0	1.7	2.5	1.3	0.5	0.7	4.1	3.0	1.8	4.1	1.9	3.2	2.8	2.4	1.3	3.5	1.9	1.3	1.3	18.5	1.7	0.1	1.5	5.2	2.0	4.0	5.7	0.7	0.3	2.0	0.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.5	4.9	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	4.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.3	0.0	1.4	0.0	0.0	0.0	6.7	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.7	0.0	0.1	2.0	0.1	0.0	0.3	0.0	0.2	4.0	5.9	59.5	9.1	3.9	3.6	7.4	4.0	4.1	1.7	11.9	14.9	0.5	0.6	8.7	41.0	2.8	0.0	8.1	35.2	1.8	7.9	0.2	23.2	0.4	137.4	35.0	1.1	0.0	0.6	0.1	13.6	1.3	4.7	5.9	0.4	305.1	0.0	3.7	0.0	198.0	15.5	5.6	11.8	0.0	0.5	119.7	1.1	0.0	12.7	6.2	28.4	12.9	14.4	9.1	1.3	6.8	0.1	0.0	0.4	0.1
UBE2E2	"FLJ25157, UbcH8"	ENSG00000182247	"Ubiquitin conjugating enzyme E2 E2"	Q96LR5	3	23203020-23591793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.2;intermediate monocyte: 17.8;memory B-cell: 12.3;myeloid DC: 20.9;naive B-cell: 14.8;non-classical monocyte: 18.3;plasmacytoid DC: 27.1"	"Group enriched"	"Detected in many"	6	"B-cells: 14.8;dendritic cells: 27.1;monocytes: 18.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003303, HPA028872, HPA030445, CAB073417"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.68e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.19e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.11e-3)"	22.7	11.4	19.2	12.0	23.3	7.6	15.9	18.8	32.7	22.4	14.5	20.8	7.5	5.9	17.7	31.9	19.7	12.0	18.5	23.4	21.3	21.8	19.1	15.8	16.7	17.7	14.1	19.7	19.0	9.8	15.5	14.4	9.0	20.9	18.2	6.4	8.4	11.2	17.0	32.0	14.8	7.2	22.4	17.6	15.9	11.1	17.8	13.3	14.8	16.8	11.1	14.5	17.0	16.2	14.8	27.1	0.4	18.3	0.8	3.6	5.2	17.1	6.2	16.3	0.3	14.5	16.2	14.8	10.8	18.5	10.2	14.4	1.7	14.1	14.9	7.5	9.5	14.1	1.7	11.8	16.9	13.2	0.1	11.9	0.0	7.3	2.0	10.4	0.0	12.0	12.8	17.8	14.7	24.8	10.5	9.8	11.8	0.8	15.9	9.2	2.7	7.8	3.3	11.6	9.8	9.0	16.4	6.3	17.1	10.0	0.4	4.2	8.7	11.9	7.0	0.2	12.3	15.0	9.9	8.5	10.1	14.3	6.7	12.2	15.3	5.0	22.0	9.5	6.7	2.8	0.0	15.2	0.0	0.2	17.8	0.3	12.3	0.5	0.2	20.9	14.8	3.6	1.3	0.4	0.8	18.3	27.1	0.2	5.2	19.2	23.3	18.8	32.7	21.3	21.8	14.1	19.7	20.9	13.3	20.8	9.8	36.3	10.5	22.8	22.7	32.7	20.4	5.3	4.5	29.6	15.7	28.0	58.0	12.3	17.6	20.4	0.0	0.0	25.6	33.5	29.3	47.2	0.0	38.4	44.7	30.2	1.7	14.7	43.5	12.0	36.5	55.4	74.2	35.1	0.7	10.9	13.5	0.3	49.8	98.2	2.9	32.3	50.9	33.5	99.2	36.9	32.3	2.5	0.5	5.1
UBE2E1	UbcH6	ENSG00000170142	"Ubiquitin conjugating enzyme E2 E1"	P51965	3	23805903-23891316	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030445, CAB073413"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB073413: , HPA030445: AB_10669599"	"unprognostic (7.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.91e-3)"	"unprognostic (7.13e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (9.97e-7)"	"unprognostic (3.69e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	32.0	28.1	50.8	34.7	44.4	56.1	52.6	38.7	43.4	41.9	40.6	32.4	27.5	23.9	35.3	35.6	57.9	29.5	29.9	58.5	47.3	43.2	33.6	34.0	34.9	44.9	52.0	36.9	36.5	32.0	41.6	22.5	44.5	38.1	38.5	37.8	23.2	30.3	36.4	52.2	33.3	25.8	44.1	55.6	36.3	29.9	24.3	43.3	33.8	41.4	38.0	47.3	52.2	46.3	6.7	7.6	6.8	9.1	7.0	7.2	4.1	33.9	21.4	33.7	16.8	20.6	30.1	29.5	25.7	40.0	28.9	38.8	16.1	37.6	30.1	21.8	24.8	24.6	11.0	39.8	31.8	37.9	36.3	44.5	41.5	16.1	19.6	29.7	40.9	22.1	28.4	30.0	36.8	49.5	34.0	45.9	21.1	29.0	33.5	23.1	17.5	28.7	44.5	49.5	18.7	54.9	32.0	14.8	86.5	45.0	24.3	9.8	35.1	23.0	21.4	37.0	35.2	24.0	54.1	29.8	21.2	26.3	15.7	19.1	28.0	16.5	59.5	22.9	39.3	16.4	2.4	8.4	6.8	4.5	9.1	6.5	6.5	5.4	3.8	7.3	6.7	7.2	4.3	3.3	7.0	5.8	7.6	3.9	4.1	50.8	44.4	38.7	43.4	47.3	43.2	52.0	36.9	38.1	43.3	41.7	28.2	30.6	52.3	64.2	26.4	54.9	28.1	46.8	28.4	17.4	3.9	83.0	48.0	80.0	20.6	53.7	35.4	0.0	68.5	82.1	57.3	58.6	40.3	19.1	88.2	19.1	44.5	42.4	63.6	39.3	37.7	75.5	92.8	111.0	36.1	49.9	62.2	59.6	45.6	32.6	20.9	51.8	80.2	36.3	62.2	78.9	60.3	35.4	44.6	59.6
NKIRAS1	"kappaB-Ras1, KBRAS1"	ENSG00000197885	"NFKB inhibitor interacting Ras like 1"	Q9NYS0	3	23891660-23946591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 60.9;Rod photoreceptor cells: 54.6;Spermatocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077387	Approved		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA077387: "	"unprognostic (1.36e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (1.08e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.30e-2)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.69e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.71e-13)"	"unprognostic (1.98e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-3)"	8.1	12.2	20.2	4.2	20.8	2.3	8.1	21.8	30.3	8.7	5.8	7.4	6.3	3.3	7.8	8.5	7.6	7.2	5.7	13.3	18.3	25.0	14.2	21.6	5.7	4.0	18.1	15.5	10.8	5.1	19.2	16.2	5.7	23.7	8.8	3.9	8.5	5.9	12.3	24.0	4.4	3.5	8.0	11.2	5.3	4.4	18.4	8.2	0.5	9.0	2.5	4.0	7.1	9.2	8.8	5.1	9.4	5.3	4.0	10.7	4.7	6.5	5.5	6.0	6.1	16.6	8.1	5.2	15.6	9.5	11.3	9.7	5.6	1.9	3.4	6.8	8.8	6.8	3.2	10.0	6.8	10.2	12.6	6.9	1.9	5.4	5.4	8.5	3.4	1.8	6.3	9.7	13.9	7.1	11.7	3.2	3.3	3.2	12.9	12.5	3.4	2.3	3.0	7.5	4.1	7.3	3.5	8.7	3.3	8.4	2.8	2.2	10.8	4.8	7.8	10.8	6.6	5.6	4.9	5.9	5.5	6.0	13.6	12.6	28.6	28.0	2.2	7.1	5.1	4.9	9.4	5.3	6.8	9.5	3.8	10.6	6.5	6.9	9.1	5.1	8.8	10.7	8.9	2.7	4.0	4.1	3.6	5.2	4.7	20.2	20.8	21.8	30.3	18.3	25.0	18.1	15.5	23.7	8.2	6.0	8.0	2.2	9.5	10.0	31.6	17.4	0.0	16.0	10.3	5.2	60.9	10.1	13.3	6.4	10.5	5.8	3.6	0.0	4.0	8.6	9.7	6.7	6.9	13.9	6.4	12.7	1.2	6.7	3.1	4.5	6.9	8.8	10.1	6.4	2.0	42.9	4.5	3.1	8.5	19.1	54.6	12.9	12.3	67.0	40.9	8.7	8.7	5.0	2.2	6.7
RPL15	"EC45, L15, RPL10, RPLY10, RPYL10"	ENSG00000174748	"Ribosomal protein L15"	P61313	3	23916545-23924374	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA		56000				"unprognostic (8.73e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.17e-2)"	74.1	64.1	63.1	56.1	82.7	146.4	119.6	65.7	102.7	92.0	73.2	63.8	50.1	50.5	89.7	84.5	92.3	100.9	61.8	58.1	49.7	48.4	75.2	120.6	58.1	105.8	55.4	67.2	209.8	139.7	33.5	67.2	81.5	80.5	78.2	64.4	68.5	139.4	62.1	100.9	97.8	61.6	84.0	58.9	79.9	77.1	161.7	35.1	102.1	108.5	84.1	108.9	92.6	87.8	187.3	155.1	36.8	109.3	115.7	184.8	271.3	91.7	84.3	98.6	112.9	168.5	278.3	116.4	89.2	169.8	137.3	120.0	95.7	107.2	192.0	83.8	136.7	71.1	62.8	117.2	199.0	101.9	87.3	165.6	76.5	91.7	112.4	215.8	130.9	97.8	272.5	286.1	147.9	261.4	214.2	178.7	135.1	92.3	154.0	147.8	127.1	166.9	166.4	167.0	118.0	138.5	146.3	86.7	195.1	144.3	109.7	51.7	125.7	52.3	226.1	182.5	93.6	150.6	259.4	97.0	80.7	105.2	85.3	158.4	134.7	177.2	163.7	83.8	177.0	92.8	36.8	109.3	22.6	95.9	96.7	168.2	186.5	147.5	132.2	155.1	187.3	184.8	157.9	14.1	115.7	79.4	124.6	127.4	271.3	63.1	82.7	65.7	102.7	49.7	48.4	55.4	67.2	80.5	35.1	693.8	945.5	4306.0	5855.7	6284.3	511.5	337.1	2117.2	847.2	1484.3	977.0	170.8	4379.2	3547.9	2741.5	2581.4	2654.4	1136.7	1261.4	3907.0	5939.4	3473.8	5026.8	1411.3	1366.5	3153.5	262.2	1654.5	2097.4	2993.9	4059.1	3391.2	3841.4	3762.2	4795.4	2422.4	618.7	3528.1	2076.1	2197.1	2892.3	420.1	1338.8	3898.5	1663.2	1013.0	7586.4	4233.0	3830.7	3722.1	5929.6
NR1D2	"BD73, EAR-1r, Hs.37288, HZF2, RVR"	ENSG00000174738	"Nuclear receptor subfamily 1 group D member 2"	Q14995	3	23945260-23980618	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053868, HPA054798"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053868: AB_2682284, HPA054798: AB_2616453"	"unprognostic (8.64e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.47e-7)"	"unprognostic (2.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	15.2	12.5	15.2	7.9	17.1	9.5	15.9	40.9	31.9	21.1	13.3	14.0	20.9	10.0	19.0	11.0	12.2	13.3	11.0	22.5	15.0	13.4	16.8	22.1	10.6	9.6	14.4	16.1	24.3	12.7	41.6	15.8	10.0	16.1	15.1	9.0	16.3	22.2	23.1	35.4	14.2	10.4	15.6	14.6	13.1	10.9	5.6	15.1	5.5	40.7	23.2	10.5	13.0	14.3	2.4	0.9	0.2	2.5	1.1	6.1	1.0	9.9	2.2	5.3	5.0	5.6	6.0	3.3	14.8	19.5	8.2	9.2	1.7	9.8	7.1	5.0	20.7	12.9	6.7	6.6	9.7	17.3	2.5	7.7	1.1	5.3	2.0	11.7	3.7	1.1	8.0	10.3	10.0	25.9	15.4	5.6	4.2	2.5	25.9	6.5	5.7	2.0	1.2	5.7	8.1	11.3	1.8	8.6	4.8	4.6	13.8	5.5	12.2	10.8	6.2	12.8	9.0	5.5	3.3	11.1	21.6	22.0	14.0	16.8	12.7	17.1	3.3	12.3	5.7	12.5	0.0	0.8	0.1	3.3	2.5	6.1	2.4	3.7	3.1	0.9	1.9	2.6	2.6	0.2	1.1	1.4	0.9	2.2	1.0	15.2	17.1	40.9	31.9	15.0	13.4	14.4	16.1	16.1	15.1	11.9	6.9	16.2	30.6	29.7	80.4	32.7	15.3	6.7	17.0	19.2	37.3	8.9	6.6	10.1	8.3	26.1	10.7	0.0	12.9	2.0	40.4	34.0	8.1	27.7	8.5	90.6	27.3	8.6	9.9	9.0	31.7	16.9	27.0	5.4	16.8	58.7	15.8	8.6	40.0	8.8	48.7	32.3	40.9	7.7	10.4	29.4	5.7	18.5	12.4	26.4
THRB	"ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2"	ENSG00000151090	"Thyroid hormone receptor beta"	P10828	3	24117153-24495756	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 155.1;Urothelial cells: 57.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.2;naive B-cell: 4.3"	"Group enriched"	"Detected in many"	11	"B-cells: 4.3;granulocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"K-562: 26.5;RT4: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002008, CAB002009, HPA061035"	Approved		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB002008: , CAB002009: , HPA061035: AB_2684422"	"unprognostic (1.82e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-6)"	"unprognostic (3.37e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.46e-8)"	"unprognostic (1.32e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.34e-2)"	10.7	5.5	12.5	3.2	14.8	1.1	12.0	2.6	27.0	3.6	11.2	1.9	5.5	2.7	7.5	2.2	7.0	4.3	2.5	7.9	9.2	5.7	12.9	20.8	5.4	1.6	4.3	20.1	2.9	9.6	6.8	20.3	4.7	3.5	8.2	9.0	3.2	6.1	10.4	21.9	7.1	4.0	11.1	3.0	5.7	8.1	1.0	4.0	0.0	4.9	4.7	1.6	9.8	14.6	4.3	0.5	7.2	0.1	0.0	0.0	3.5	6.0	1.8	0.4	0.0	11.0	5.7	4.1	0.3	1.3	1.0	2.0	4.0	6.0	0.0	1.5	4.3	0.7	9.2	6.6	2.5	0.7	0.0	4.0	0.0	1.6	5.2	0.3	0.0	0.0	10.1	4.5	0.1	0.8	2.4	0.0	0.0	26.5	0.0	0.9	0.3	0.0	0.0	4.0	0.4	2.2	0.0	0.0	0.0	6.3	19.7	1.1	0.4	10.0	5.4	0.1	3.0	6.0	0.0	0.5	2.5	1.9	0.0	1.1	0.1	0.3	0.0	1.8	0.0	0.2	7.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	4.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.5	12.5	14.8	2.6	27.0	9.2	5.7	4.3	20.1	3.5	4.0	3.0	10.7	3.0	21.7	8.9	18.7	11.5	2.5	9.4	9.1	22.7	155.1	9.6	1.7	1.8	2.0	7.3	9.2	0.0	10.7	19.3	7.7	26.4	0.0	31.6	1.5	0.0	24.2	2.5	8.8	2.0	0.6	3.2	1.7	0.0	8.2	15.3	9.1	17.5	2.1	7.5	22.1	6.5	10.0	0.2	0.2	20.8	4.6	0.0	7.8	57.2
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 39.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 22.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1"	"Region enriched"	"Detected in many"	9	"basal ganglia: 97.9"	"Low region specificity"	"Detected in all"			"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	3.9	7.1	2.4	2.3	22.6	0.0	6.8	1.5	9.1	13.4	6.0	2.2	6.8	1.7	14.4	7.5	8.1	6.2	5.3	13.6	2.6	2.2	17.5	6.2	5.6	5.6	2.0	3.7	12.2	1.5	12.8	18.9	13.9	3.2	13.0	2.3	39.1	13.7	11.8	2.5	1.4	2.4	14.7	4.6	7.7	4.8	1.7	4.8	0.0	10.0	2.9	4.6	12.1	10.2	1.0	0.4	0.1	0.6	0.1	0.8	0.0	0.0	0.9	0.6	3.1	7.0	1.8	0.0	0.8	0.4	0.0	0.3	0.1	0.0	0.0	0.1	1.2	0.1	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.5	0.1	0.1	0.0	3.7	0.0	0.0	0.0	41.7	6.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	4.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.5	0.0	1.1	3.4	0.1	0.0	0.0	2.8	0.1	18.1	0.0	0.6	0.0	0.8	0.1	0.3	0.3	0.5	0.5	0.4	1.0	0.6	0.8	0.1	0.1	0.1	0.4	0.0	0.0	2.4	22.6	1.5	9.1	2.6	2.2	2.0	3.7	3.2	4.8	0.0	0.3	0.0	17.9	0.1	4.2	9.3	7.6	6.7	12.5	10.4	23.6	0.1	0.0	1.4	1.3	3.8	0.0	0.0	0.8	0.1	3.1	5.5	0.0	2.0	0.3	4.8	0.0	20.3	4.1	0.4	0.0	0.0	0.0	0.0	0.0	27.5	1.1	0.0	0.0	0.5	6.1	0.0	9.2	0.2	1.1	0.1	0.2	0.0	0.0	7.1
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	19.3	18.8	23.4	23.1	29.7	26.5	21.1	48.4	33.5	24.1	22.4	21.1	18.9	17.1	29.6	25.6	21.1	20.6	20.7	22.7	22.0	19.9	20.3	18.4	17.7	28.2	21.0	28.5	26.8	17.2	43.0	21.6	22.3	26.4	24.7	20.8	17.6	21.3	22.3	31.3	20.9	19.3	24.4	23.4	24.6	20.1	11.3	22.7	60.2	28.3	20.7	27.3	34.8	21.5	5.5	5.6	5.3	4.6	7.8	7.2	2.2	10.7	11.1	24.6	30.1	8.2	10.4	9.8	10.4	13.4	9.7	10.6	5.7	8.5	33.3	7.3	15.0	6.0	9.1	20.3	11.6	16.3	15.9	10.9	50.4	13.8	9.5	5.8	39.4	27.0	7.4	5.8	10.8	9.5	9.8	15.7	22.8	16.9	16.4	12.4	11.9	25.5	9.7	18.6	7.2	8.5	106.6	13.8	15.4	8.7	37.9	12.4	21.5	15.5	11.1	9.5	14.8	11.5	35.3	15.0	13.5	10.5	10.7	11.1	25.4	14.4	35.3	8.8	29.5	8.9	4.2	2.9	5.3	6.3	3.3	6.9	4.3	6.1	6.4	4.3	5.5	7.2	6.4	2.0	7.8	4.6	5.6	4.4	2.2	23.4	29.7	48.4	33.5	22.0	19.9	21.0	28.5	26.4	22.7	59.6	57.9	25.1	36.1	34.8	53.5	109.0	43.3	34.8	40.9	24.4	53.0	41.2	11.6	29.3	2.9	32.2	17.7	23.3	28.8	20.8	35.0	47.5	31.4	33.5	23.1	57.2	57.0	21.5	40.9	4.8	36.2	38.8	21.9	21.6	32.6	46.4	32.0	17.5	31.5	21.9	89.3	32.3	36.7	66.2	27.0	33.0	39.0	45.0	37.9	57.7
NGLY1	"FLJ11005, PNG1"	ENSG00000151092	"N-glycanase 1"	Q96IV0	3	25718944-25790039	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 518.0;Late spermatids: 684.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036825	Approved				"Intracellular and membrane"	NA	NA					"HPA036825: AB_10672231"	"unprognostic (3.65e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (1.96e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-2)"	10.7	14.4	11.4	19.6	11.4	12.9	15.0	17.1	15.0	9.5	12.4	6.9	11.7	10.5	10.2	13.8	13.2	8.4	10.5	14.3	12.0	9.0	12.8	18.1	13.9	17.4	9.5	12.5	10.6	20.7	9.0	11.3	8.7	11.0	10.9	15.2	7.8	12.4	18.0	46.6	9.0	11.2	8.7	10.1	14.6	11.9	42.0	9.0	18.0	10.3	10.9	18.1	11.5	10.6	26.1	39.7	19.9	10.8	22.6	14.7	10.3	12.5	10.7	6.0	12.7	11.6	10.7	8.6	10.8	9.1	13.6	12.3	6.6	9.6	31.9	12.3	9.1	14.1	5.7	20.2	5.7	18.5	15.0	8.6	23.7	8.2	10.7	13.0	21.8	13.0	9.5	7.6	14.9	14.0	14.8	14.5	15.7	22.4	23.0	13.8	5.5	25.9	12.9	8.1	14.7	19.5	26.5	7.9	22.7	12.5	15.4	3.7	4.5	15.6	15.1	10.0	12.0	14.3	18.3	9.8	10.7	11.1	12.9	13.9	28.3	24.4	22.2	12.9	23.7	8.4	19.9	10.8	18.9	13.7	10.1	14.7	26.1	13.8	12.6	16.3	21.7	14.0	13.6	12.8	22.6	8.4	39.7	10.4	10.3	11.4	11.4	17.1	15.0	12.0	9.0	9.5	12.5	11.0	9.0	17.9	12.9	39.7	20.7	11.2	21.6	22.4	22.9	28.1	15.9	5.2	11.8	36.2	29.9	26.6	518.0	20.1	20.2	0.0	38.1	28.0	19.8	22.0	19.7	22.7	21.1	11.1	6.9	15.4	16.4	684.0	13.8	24.8	23.6	20.8	27.3	19.8	25.0	24.6	14.9	29.8	20.4	0.0	14.6	73.4	43.7	12.0	47.4	33.3	28.9	19.0
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.2	13.7	6.7	9.8	10.5	3.7	10.3	8.3	11.9	6.0	11.8	6.2	13.7	10.1	6.4	16.2	10.3	7.7	7.9	13.5	6.6	6.4	14.9	26.1	10.0	7.7	6.6	6.5	6.4	18.7	8.3	13.0	7.3	7.0	8.0	13.8	10.4	15.5	15.6	19.4	8.3	8.9	5.8	6.7	9.6	8.9	19.9	8.0	8.1	11.7	12.3	11.3	7.9	6.4	8.4	9.0	3.7	6.5	10.3	11.8	6.6	7.7	12.9	2.7	7.6	8.0	8.8	8.0	6.2	9.0	11.7	8.3	9.8	9.3	14.3	8.4	5.7	6.8	8.2	11.4	11.9	11.0	8.6	11.5	15.8	10.9	11.8	9.8	12.7	10.1	8.2	14.8	9.3	9.8	7.6	10.0	13.6	16.2	11.6	9.9	11.5	9.3	9.8	0.5	6.2	14.9	12.4	7.2	23.4	17.1	4.8	3.9	7.2	9.9	17.0	12.6	4.6	18.6	11.9	6.1	7.3	8.8	9.6	8.9	11.1	12.8	4.5	10.3	11.2	7.5	2.1	5.4	3.7	9.4	6.0	10.8	8.4	9.7	11.6	8.6	8.2	11.4	11.8	0.9	10.3	6.5	9.0	6.0	6.6	6.7	10.5	8.3	11.9	6.6	6.4	6.6	6.5	7.0	8.0	0.0	10.3	2.9	5.0	2.7	6.2	9.8	7.6	5.3	4.5	10.4	3.9	17.5	10.0	11.3	38.3	4.9	6.3	0.0	5.9	13.9	6.5	5.4	9.3	13.9	7.7	4.8	2.4	6.7	2.7	11.5	6.6	3.7	5.0	6.4	9.8	8.3	7.4	7.6	3.9	16.1	6.5	0.0	3.1	26.1	12.0	3.9	11.8	5.0	9.6	2.4
LRRC3B	LRP15	ENSG00000179796	"Leucine rich repeat containing 3B"	Q96PB8	3	26622806-26710776	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 21.3;skeletal muscle: 17.4;testis: 12.0"	"Cell type enriched"	"Detected in some"	28	"Early spermatids: 56.9"	"Group enriched"	"Detected in some"	9	"endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.8;REH: 1.8;SuSa: 9.0;THP-1: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015568	Approved					NA	NA					"HPA015568: AB_1853282"	"unprognostic (1.22e-2)"			"unprognostic (2.94e-1)"	"unprognostic (1.87e-1)"		"unprognostic (7.42e-2)"	"unprognostic (8.82e-4)"		"unprognostic (2.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.91e-4)"	"unprognostic (3.31e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-1)"	0.8	0.9	15.5	0.7	13.6	0.6	1.6	18.5	21.3	0.8	1.2	2.2	0.0	0.8	2.3	0.7	1.5	1.6	0.7	1.4	9.5	7.3	0.8	0.8	0.8	0.6	8.7	5.6	2.9	0.6	0.7	0.8	0.7	5.7	0.8	1.9	3.0	1.9	1.1	17.4	0.7	1.2	2.0	4.9	0.8	1.5	12.0	1.7	0.0	0.7	0.1	0.7	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	3.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	15.5	13.6	18.5	10.1	9.5	7.3	8.7	5.6	5.7	1.7	0.0	0.0	0.0	0.0	0.1	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.7	0.5	0.1	0.0	0.0	0.0	0.0
NEK10	FLJ32685	ENSG00000163491	"NIMA related kinase 10"	Q6ZWH5	3	27110085-27369460	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 97.7;Cone photoreceptor cells: 82.5;Early spermatids: 98.7;Late spermatids: 45.8"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 1.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 7.7;LHCN-M2: 10.6;U-2 OS: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038941	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA038941: AB_10673600"	"prognostic favorable (4.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.14e-1)"	0.4	0.5	4.5	0.5	14.6	0.4	14.2	0.6	6.8	1.6	2.0	1.1	2.0	2.5	0.9	8.3	2.0	10.5	2.1	3.1	8.4	3.8	1.4	2.5	4.5	0.6	0.8	6.7	2.7	0.8	0.5	9.0	0.3	3.4	1.9	0.7	1.3	0.5	1.4	10.5	0.4	1.0	1.2	0.8	0.6	1.1	31.4	1.3	0.3	0.8	0.3	0.7	1.4	0.4	0.4	0.2	1.9	0.1	0.1	0.6	0.1	1.0	2.1	1.1	1.2	0.9	2.1	0.4	7.7	1.2	2.1	1.9	0.0	0.5	0.7	1.9	3.2	1.5	0.1	0.5	0.5	2.3	1.4	0.8	0.2	4.1	3.7	0.2	0.4	1.0	2.5	0.5	3.3	0.1	2.7	1.5	4.4	0.1	0.7	10.6	0.1	0.8	0.5	0.7	0.2	0.3	1.0	0.4	0.3	4.1	0.6	0.2	0.2	1.2	0.5	0.6	0.8	6.2	0.4	0.9	5.7	9.0	0.3	0.8	0.3	0.2	0.5	4.8	0.9	2.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.5	0.4	0.0	0.4	0.1	0.5	1.9	0.1	0.0	0.2	0.0	0.1	4.5	14.6	0.6	6.8	8.4	3.8	0.8	6.7	3.4	1.3	6.0	0.0	0.0	0.2	0.2	4.0	10.2	2.5	97.7	13.6	1.8	82.5	0.0	0.0	0.3	98.7	0.7	0.7	0.0	0.0	0.2	2.9	1.5	0.0	0.5	0.2	0.0	0.0	0.6	1.3	45.8	1.7	0.4	0.0	0.0	0.1	1.4	0.2	0.6	1.1	0.0	19.6	0.0	1.1	25.4	1.7	0.4	0.0	0.0	0.1	0.1
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 48.5"	"Group enriched"	"Detected in many"	10	"Cone photoreceptor cells: 691.1;Rod photoreceptor cells: 667.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	14.5	5.0	3.2	10.5	4.6	3.3	17.0	4.0	4.8	10.8	38.2	5.0	8.8	48.5	8.1	12.6	8.4	6.5	12.5	9.3	5.0	3.8	15.3	3.7	9.3	10.3	4.8	1.9	9.0	3.3	2.4	4.4	5.6	4.5	10.3	6.9	20.0	8.3	8.4	5.6	5.6	43.4	18.2	5.8	9.7	7.8	6.1	5.5	6.8	6.3	14.7	15.5	15.0	14.9	1.8	2.0	0.1	0.9	2.4	3.9	0.7	5.9	11.1	10.0	4.6	4.7	8.4	7.1	20.2	9.4	7.8	6.1	3.0	3.1	13.5	1.7	7.8	7.5	2.6	9.5	9.8	12.4	11.4	3.1	6.2	7.6	3.2	8.1	14.0	5.4	6.7	4.3	11.8	38.2	16.5	12.8	8.9	4.1	4.8	16.0	2.1	13.9	3.2	6.6	0.7	11.0	9.5	7.9	2.7	18.3	4.2	2.5	6.3	9.2	6.8	3.1	8.9	15.5	5.4	8.9	18.4	5.1	12.7	15.6	1.8	1.9	7.7	16.1	9.9	8.4	0.0	0.5	0.0	3.0	0.6	2.0	1.2	3.8	3.9	1.4	1.8	1.5	2.7	0.1	2.4	0.9	2.0	3.2	0.7	3.2	4.6	4.0	4.8	5.0	3.8	4.8	1.9	4.5	5.5	0.0	12.8	13.2	28.2	26.1	65.7	18.7	15.3	5.3	25.0	59.3	691.1	4.5	8.3	13.6	6.7	25.3	5.8	0.0	6.2	23.0	30.2	41.3	23.1	5.9	16.9	6.4	36.7	14.7	33.1	5.9	8.3	36.7	33.7	20.8	50.6	45.2	13.6	12.7	9.2	10.5	667.4	38.8	32.8	32.4	21.7	26.8	6.8	33.0	12.2	33.6
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.9;brain: 22.6;lymphoid tissue: 21.4"	"Group enriched"	"Detected in some"	8	"Erythroid cells: 23.3;T-cells: 32.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in some"	20	"cerebellum: 22.6"	"Group enriched"	"Detected in many"	7	"gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9"	"Group enriched"	"Detected in many"	102	"NK-cells: 17.9;T-cells: 16.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.2;JURKAT: 12.3;SCLC-21H: 5.7"	"Region enriched"	"Detected in some"	8	"olfactory region: 95.2"	"Group enriched"	"Detected in many"	13	"cerebellum: 44.2;olfactory region: 21.9"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.4	0.7	0.5	6.8	0.4	1.6	1.6	22.6	0.4	1.8	0.8	0.0	0.0	0.3	3.2	0.9	1.4	0.6	5.0	0.7	0.4	0.7	1.0	4.9	10.1	15.6	0.5	0.3	1.3	0.9	0.0	0.6	1.6	1.1	2.1	0.9	3.3	2.2	0.1	0.4	0.4	1.8	0.7	0.9	21.4	1.4	0.5	0.0	1.8	1.1	0.9	11.2	3.3	0.8	0.0	0.0	0.1	0.0	17.9	16.5	1.4	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	2.6	2.0	0.0	10.2	1.5	0.0	0.1	0.8	0.0	1.2	0.0	0.1	1.2	0.0	1.4	0.5	0.0	12.3	0.3	0.0	0.0	3.0	2.7	0.0	0.3	0.2	1.2	1.9	0.0	0.0	1.0	0.0	5.7	0.0	0.0	0.0	1.2	0.5	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	10.0	0.0	16.5	0.0	1.9	12.0	0.0	0.0	0.1	7.5	0.1	17.9	0.0	0.0	0.0	1.4	0.5	0.4	22.6	0.4	0.4	0.7	0.5	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	3.7	3.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.6	0.1	0.0	32.6	0.0	0.0
CMC1	"C3orf68, MGC61571"	ENSG00000187118	"C-X9-C motif containing 1"	Q7Z7K0	3	28241584-28325142	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 197.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cell: 48.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043333	Approved					NA	NA					"HPA043333: AB_10797139"	"unprognostic (1.16e-1)"	"unprognostic (8.01e-3)"	"unprognostic (6.90e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.30e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (3.54e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.55e-1)"	"prognostic favorable (5.52e-4)"	13.2	19.1	12.8	8.7	11.2	7.8	18.5	8.0	16.3	7.2	13.6	6.2	11.4	13.9	9.1	11.7	8.9	6.9	12.5	37.6	10.5	11.7	15.2	18.2	15.7	18.7	12.4	8.1	10.2	24.0	2.7	14.3	12.1	11.2	11.3	8.1	8.1	15.1	9.6	38.2	6.1	12.1	10.6	11.1	11.4	10.3	7.9	8.9	8.0	7.2	12.3	7.0	7.2	9.2	5.9	9.8	6.9	9.8	48.4	23.7	9.1	9.0	15.2	4.2	4.4	11.6	11.8	10.8	12.1	3.7	5.2	5.3	4.5	12.7	8.0	15.6	2.0	8.9	4.3	5.3	11.3	3.1	18.1	13.3	8.5	15.8	9.4	12.1	5.4	6.6	6.2	8.5	5.3	6.7	12.0	6.6	20.7	8.3	11.8	4.2	8.3	8.0	14.8	4.9	9.1	16.6	7.5	4.9	6.6	6.6	4.1	4.2	7.7	9.0	5.6	25.8	6.1	11.6	16.4	7.8	5.7	7.0	8.6	7.8	5.6	12.5	11.2	15.2	12.4	11.7	6.9	7.6	5.3	13.7	9.0	19.5	5.9	8.9	23.7	9.6	5.4	6.7	15.0	2.2	48.4	9.8	9.8	8.5	9.1	12.8	11.2	8.0	16.3	10.5	11.7	12.4	8.1	11.2	8.9	35.7	27.0	26.0	33.9	18.8	13.5	197.3	30.6	50.9	25.0	29.6	9.8	57.3	187.3	53.8	117.2	37.3	52.3	23.3	51.0	39.7	29.4	34.6	34.8	78.0	57.9	3.2	27.1	47.3	60.2	12.4	45.8	39.6	28.7	49.5	66.4	19.5	59.8	63.1	36.7	98.2	24.4	38.8	25.0	24.4	43.4	28.7	26.3	172.8	66.3	36.3
AZI2	"AZ2, FLJ21939, NAP1"	ENSG00000163512	"5-azacytidine induced 2"	Q9H6S1	3	28315003-28349127	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035258	Approved					NA	NA					"HPA035258: AB_10602329"	"unprognostic (1.86e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.77e-4)"	31.9	15.6	21.3	12.8	23.4	24.4	38.1	16.6	23.0	16.6	15.7	7.5	16.5	15.0	15.4	21.4	15.8	13.6	16.7	17.9	20.0	23.4	16.6	18.5	15.3	14.8	20.6	13.8	17.7	14.1	15.8	38.1	15.5	18.1	16.8	12.6	9.6	29.6	19.9	18.1	11.5	14.1	14.7	14.7	15.9	13.5	20.6	14.5	18.5	19.6	13.1	10.4	20.3	30.1	4.1	8.7	30.8	19.5	5.2	9.3	8.9	8.8	9.1	11.9	7.0	18.7	30.7	18.3	11.1	22.8	19.8	23.6	7.9	8.9	5.4	7.1	15.4	13.3	3.7	9.2	18.4	16.0	14.9	10.4	10.3	9.2	10.8	28.9	10.3	6.7	30.7	24.9	15.8	27.4	12.0	10.6	11.6	15.3	10.2	17.7	8.4	13.0	8.1	8.4	5.6	13.4	6.3	13.1	5.6	8.4	5.0	6.4	16.0	9.9	11.1	21.7	11.4	7.8	10.8	7.1	13.3	11.0	11.2	13.4	11.8	11.6	8.1	13.6	21.9	11.9	30.8	19.5	12.7	7.4	15.5	8.9	3.5	7.0	8.5	8.7	4.1	6.9	6.2	5.6	5.2	13.3	7.2	9.3	8.9	21.3	23.4	16.6	23.0	20.0	23.4	20.6	13.8	18.1	14.5	59.6	43.8	14.8	33.3	22.0	27.2	22.0	20.4	57.6	50.0	22.7	35.3	27.5	38.1	22.3	14.2	25.0	30.6	23.3	24.5	45.8	39.0	32.8	18.5	34.4	31.2	14.3	25.8	29.4	67.3	20.7	43.4	49.9	8.5	13.6	25.6	24.1	25.0	23.7	38.5	37.7	28.6	45.3	28.8	70.1	58.8	30.4	52.4	25.5	21.2	22.9
ZCWPW2	ZCW2	ENSG00000206559	"Zinc finger CW-type and PWWP domain containing 2"	Q504Y3	3	28349146-28538122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 46.6;Spermatocytes: 62.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035035, HPA039839"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA035035: AB_10602256, HPA039839: AB_2676708"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.53e-2)"	"unprognostic (6.09e-4)"	"unprognostic (3.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-4)"	"unprognostic (1.06e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.38e-2)"	2.6	3.1	3.9	2.8	5.3	1.3	3.4	4.8	4.2	3.3	2.9	3.1	5.2	2.1	6.2	4.1	2.8	2.6	4.1	5.1	3.5	2.7	3.2	2.7	4.4	1.9	3.9	2.3	5.0	3.5	3.7	10.5	2.5	3.9	4.2	2.0	2.9	4.8	2.6	9.6	3.6	2.4	5.7	5.4	2.4	2.8	16.1	5.1	2.8	5.2	0.4	2.6	2.7	2.6	0.9	1.4	3.6	2.4	0.6	2.4	0.7	0.7	0.4	1.8	0.8	2.5	5.9	3.0	2.4	2.0	0.9	0.8	0.6	1.9	1.8	1.2	1.4	1.7	1.1	0.5	0.6	1.1	0.9	0.8	0.6	2.2	0.6	1.8	0.7	1.2	3.5	1.6	0.7	1.1	3.2	2.0	3.7	0.8	2.2	3.8	1.0	0.5	1.4	0.8	0.3	2.5	0.6	0.7	1.3	2.8	0.3	0.9	2.8	0.2	1.2	1.6	2.1	1.0	5.6	1.9	2.3	1.1	1.6	1.4	0.9	0.6	0.5	6.6	1.1	2.4	2.7	2.4	3.1	0.8	2.1	0.5	0.4	0.8	0.6	1.0	0.9	1.8	2.4	3.6	0.6	0.5	1.4	0.8	0.7	3.9	5.3	4.8	4.2	3.5	2.7	3.9	2.3	3.9	5.1	0.0	1.3	0.0	2.7	0.6	2.3	10.1	0.0	1.4	4.5	0.0	0.0	1.8	5.0	0.5	46.6	0.1	0.1	0.0	0.7	1.2	1.9	1.5	2.3	0.4	1.2	3.2	1.2	1.3	1.2	9.4	4.4	0.8	0.0	1.0	1.6	3.1	0.8	0.0	4.6	2.1	1.7	0.0	2.0	62.1	5.7	1.4	1.0	0.5	0.5	1.3
RBMS3		ENSG00000144642	"RNA binding motif single stranded interacting protein 3"	Q6XE24	3	28574791-30010391	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 110.2;Ito cells: 119.7;Leydig cells: 147.9;Peritubular cells: 104.0;Sertoli cells: 109.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 7.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 14.5;HHSteC: 14.2;WM-115: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034719	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA034719: AB_10670172"	"unprognostic (8.39e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.25e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.48e-2)"	"unprognostic (3.24e-4)"	16.5	10.3	4.8	3.2	5.6	0.1	9.9	1.6	4.2	10.6	6.6	2.6	7.9	1.7	5.6	9.3	6.0	6.7	8.5	16.5	5.1	2.4	6.2	4.4	12.3	5.6	5.1	3.4	13.3	2.5	10.8	4.8	12.3	8.5	8.4	3.3	10.0	4.6	13.5	9.7	3.3	3.6	13.7	8.6	7.4	4.6	4.9	4.7	3.7	18.6	5.5	2.0	9.3	8.9	0.2	7.3	0.0	0.0	0.0	0.8	0.1	1.4	0.1	7.0	0.1	13.4	8.8	0.0	3.7	2.4	4.0	4.9	0.0	0.2	0.0	4.0	14.5	1.1	0.1	0.4	2.8	7.9	0.0	0.5	3.9	5.4	0.0	14.2	0.0	0.0	8.4	1.7	7.1	8.4	5.8	5.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.2	0.0	0.3	0.2	5.2	0.0	1.5	0.0	0.0	13.4	9.0	0.0	0.4	3.3	0.0	0.0	11.7	7.9	7.3	9.2	7.6	0.0	0.0	0.5	1.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	7.3	0.6	0.1	4.8	5.6	1.6	4.2	5.1	2.4	5.1	3.4	8.5	4.7	110.2	19.7	0.0	23.2	7.3	0.4	14.5	25.5	12.0	29.6	8.7	0.0	14.0	0.0	4.0	20.0	46.7	0.0	0.0	1.1	3.7	69.8	5.7	4.7	0.9	2.5	0.0	0.0	119.7	23.9	14.8	147.9	3.8	6.8	1.0	0.0	0.0	0.6	0.0	104.0	2.6	0.0	109.9	52.6	0.9	1.1	6.4	8.0	1.9	0.0	3.3
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606502-30694142	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 188.8;Ito cells: 564.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 54.5;ASC TERT1: 82.2;HSkMC: 70.9;LHCN-M2: 67.2;TIME: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		560000	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	91.8	24.6	6.7	24.6	10.3	7.3	88.3	3.6	7.3	36.5	42.6	9.8	18.6	13.2	42.6	23.3	36.2	28.4	42.6	73.5	6.9	5.2	32.6	21.9	52.6	75.7	12.6	3.7	22.2	26.0	17.4	10.3	24.2	9.9	35.2	17.5	27.9	22.5	19.5	34.9	17.0	31.3	37.2	12.0	68.7	26.8	15.4	8.2	19.3	40.9	16.8	26.9	48.0	82.0	5.3	6.8	20.0	6.6	1.4	19.7	3.9	2.5	14.7	0.9	0.0	54.5	82.2	2.5	12.8	18.0	4.4	4.4	3.3	13.6	0.3	46.2	17.1	5.2	5.1	0.6	18.7	7.3	1.0	1.3	1.4	1.7	16.5	23.3	2.3	12.1	70.9	16.6	19.0	18.4	20.2	47.6	1.7	0.3	0.0	67.2	0.2	2.3	1.7	0.4	12.8	5.9	2.1	5.9	0.3	23.6	6.0	0.0	0.9	3.8	1.0	3.6	1.2	0.0	2.5	61.6	21.7	5.4	9.8	4.8	0.5	0.0	2.0	13.0	2.5	8.7	6.9	2.9	20.0	3.5	3.0	3.2	4.0	5.4	4.2	2.6	5.3	19.7	9.1	12.6	1.4	6.6	6.8	1.2	3.9	6.7	10.3	3.6	7.3	6.9	5.2	12.6	3.7	9.9	8.2	134.0	83.8	41.5	14.2	33.2	1.9	64.1	48.4	12.0	53.4	26.2	0.0	5.3	3.3	11.4	2.0	188.8	9.7	0.0	13.8	4.3	48.1	7.3	28.9	45.3	27.1	0.0	8.1	564.1	139.2	2.0	30.5	46.1	28.7	1.8	11.9	0.2	25.3	10.8	44.6	5.6	0.9	32.3	36.0	0.3	1.1	26.7	3.1	39.4	13.0	9.0
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 21.6"	"Cell type enhanced"	"Detected in some"	18	"Club cells: 2.3;Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 9.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.5	0.3	0.2	0.2	0.3	1.0	0.4	0.5	0.7	0.4	0.2	0.0	0.0	0.1	0.2	1.6	1.4	0.2	2.0	2.3	0.2	0.3	0.7	0.2	1.6	0.3	0.3	0.8	0.5	0.3	0.1	0.6	0.5	2.1	0.5	0.1	0.3	0.3	0.0	21.6	0.8	0.2	2.5	0.7	0.5	0.2	1.1	0.0	0.0	1.2	3.3	0.7	0.5	0.3	1.7	0.5	1.9	0.8	0.5	1.3	0.3	1.3	0.3	0.8	1.1	0.9	0.5	1.6	0.6	0.3	0.3	0.2	1.3	1.2	1.1	0.5	0.2	0.7	0.9	9.9	0.3	0.4	1.7	0.5	1.6	1.6	0.5	0.4	0.9	3.4	0.4	0.6	0.7	0.3	1.0	0.6	1.0	1.2	4.1	0.9	1.1	0.7	1.3	1.9	0.7	0.5	1.9	2.1	1.0	1.0	1.5	1.2	1.0	1.2	0.7	2.9	1.2	1.2	0.8	5.1	1.5	1.4	1.9	0.7	1.6	0.8	0.7	0.6	0.9	1.9	1.9	0.7	0.8	1.0	0.6	0.8	1.2	0.9	0.6	0.4	1.7	1.1	1.0	1.7	0.5	0.8	0.5	1.3	0.3	0.2	0.3	0.5	0.7	0.2	0.3	0.3	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3B, catalytic subunit of the oligosaccharyltransferase complex"	Q8TCJ2	3	31532638-31637622	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		9300	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	23.0	30.3	16.0	27.5	16.7	21.7	27.4	15.4	19.4	28.4	25.0	16.9	37.0	18.6	28.4	37.9	28.8	22.4	29.0	27.5	15.1	15.6	28.2	64.1	30.1	36.9	16.5	15.5	62.3	39.4	36.2	20.3	85.9	16.5	26.3	25.1	22.3	25.2	26.3	31.2	19.2	29.2	23.2	19.7	29.4	22.9	36.7	13.6	60.2	44.3	23.4	30.3	27.5	27.7	3.6	7.7	8.4	5.3	8.4	8.5	3.0	16.6	28.0	25.8	27.0	32.5	32.8	56.4	31.3	27.5	23.4	27.2	25.5	36.2	29.0	15.4	28.3	19.3	14.1	23.8	27.1	30.8	81.6	15.7	24.8	28.5	27.1	25.1	53.5	29.7	25.1	29.1	33.3	42.2	36.2	23.6	37.2	13.3	46.5	31.8	9.4	52.3	33.1	20.8	27.9	15.8	54.7	14.0	42.0	27.2	24.1	11.0	13.4	31.0	46.1	18.1	23.0	20.7	28.6	45.9	31.7	20.3	31.3	27.5	29.3	35.1	24.3	28.7	36.8	26.0	2.3	4.6	8.4	4.7	5.3	7.5	3.4	8.5	6.5	4.0	3.6	8.2	6.5	1.7	8.4	3.7	7.7	4.1	3.0	16.0	16.7	15.4	19.4	15.1	15.6	16.5	15.5	16.5	13.6	80.4	51.9	42.7	51.5	60.6	48.3	64.1	56.0	40.2	88.7	41.8	64.8	58.7	11.6	32.8	125.1	35.0	40.6	0.0	38.9	84.1	47.2	61.2	31.1	58.2	50.2	42.9	43.4	38.6	46.8	186.1	33.6	58.1	49.0	9.0	50.8	36.3	38.5	49.1	30.8	26.4	33.6	25.8	38.9	61.2	52.7	54.1	79.8	62.1	51.2	55.9
OSBPL10		ENSG00000144645	"Oxysterol binding protein like 10"	Q9BXB5	3	31657890-32077580	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 39.6"	"Group enriched"	"Detected in many"	13	"Early spermatids: 436.6;Late spermatids: 951.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"memory B-cell: 11.5;naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	22	"B-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 31.5;RPTEC TERT1: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003636			Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA003636: AB_1079529"	"unprognostic (5.28e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (5.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.85e-4)"	11.7	3.5	3.8	8.7	4.3	1.0	6.7	1.4	7.6	8.6	5.6	0.4	5.9	2.5	11.8	6.7	10.0	5.5	16.7	2.9	2.6	2.6	14.5	1.6	4.6	8.2	3.1	3.6	4.1	2.5	1.3	12.0	16.5	2.5	12.8	6.0	8.5	7.3	16.6	2.0	5.5	7.3	39.6	1.2	9.5	4.4	24.0	1.2	0.4	4.3	4.3	15.1	25.2	11.8	11.5	0.1	0.5	0.0	0.0	0.0	0.2	6.2	3.5	0.6	12.5	1.1	2.3	20.9	1.7	1.9	1.6	2.3	8.7	4.5	14.7	16.8	0.4	5.7	3.7	2.7	14.7	1.9	0.1	2.7	0.0	8.7	5.5	0.9	0.0	0.1	2.4	12.4	2.5	31.5	6.1	7.2	0.0	0.0	0.0	6.8	5.1	0.0	0.0	7.9	20.0	9.0	0.1	0.2	0.2	33.2	2.5	0.9	0.1	3.1	5.4	1.7	12.3	3.6	0.0	5.1	2.0	21.5	0.2	8.2	1.4	1.0	14.0	2.9	0.0	12.7	0.2	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	6.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3.8	4.3	1.4	7.6	2.6	2.6	3.1	3.6	2.5	1.2	8.9	3.8	36.5	6.8	9.6	4.8	2.0	5.1	6.7	4.5	7.0	0.0	12.6	8.3	1.9	436.6	17.1	5.7	0.0	4.4	21.8	5.4	16.4	0.0	0.0	2.2	0.0	14.5	20.9	1.2	951.1	10.3	0.9	8.5	1.8	3.5	52.0	10.6	4.5	3.9	20.7	1.7	19.4	9.4	6.5	4.1	10.8	25.3	2.9	7.4	8.6
ZNF860		ENSG00000197385	"Zinc finger protein 860"	A6NHJ4	3	31981771-31991628	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.2"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 3.4;Ciliated cells: 6.7;Club cells: 4.5;Intestinal endocrine cells: 3.4;Syncytiotrophoblasts: 3.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	61	"memory B-cell: 9.1;naive B-cell: 6.4"	"Lineage enriched"	"Detected in single"	71	"B-cells: 9.1"	"Cell line enriched"	"Detected in many"	4	"BEWO: 31.9"									HPA063386	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063386: AB_2684999"	"unprognostic (1.19e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.75e-3)"	2.0	1.0	0.7	11.2	1.0	0.1	2.8	0.8	1.5	4.3	1.1	0.0	1.7	0.3	4.1	4.9	6.2	1.9	3.6	1.3	0.6	1.6	7.2	0.4	3.7	8.3	1.6	0.6	1.8	0.6	0.1	5.5	8.1	1.1	6.0	1.6	1.6	5.6	2.6	0.4	2.3	3.7	6.7	0.5	9.6	1.1	2.2	0.0	0.5	1.8	4.2	20.2	6.4	3.6	9.1	0.0	0.1	0.0	0.0	0.0	0.2	2.1	0.7	0.0	1.6	0.0	0.0	31.9	0.2	0.1	0.2	0.2	2.1	2.5	2.3	2.3	0.0	1.0	1.9	0.7	3.1	0.2	0.0	0.3	0.0	3.2	1.0	0.0	0.0	0.0	0.1	1.4	0.2	6.1	0.2	0.6	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	5.6	3.4	0.0	0.0	0.1	7.2	0.9	0.2	0.0	0.5	3.8	0.0	1.6	2.9	0.0	1.2	0.2	2.6	0.0	0.2	0.0	0.0	3.6	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	1.0	0.8	1.5	0.6	1.6	1.6	0.6	1.1	0.0	0.0	0.0	3.4	0.4	0.8	0.2	0.6	0.0	6.7	4.5	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.0	0.0	0.5	3.0	0.5	0.9	0.0	0.0	0.3	0.0	3.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.4	1.1	0.0	0.0	0.3	0.1	0.1	0.3	3.5	0.0	0.3	0.6
GPD1L	KIAA0089	ENSG00000152642	"Glycerol-3-phosphate dehydrogenase 1 like"	Q8N335	3	32105689-32168713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Brugada syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 142.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.23e-1)"	"unprognostic (3.12e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (2.63e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (5.71e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.33e-15)"	"unprognostic (1.50e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-3)"	"unprognostic (5.51e-3)"	14.6	18.8	7.4	4.5	12.2	2.9	13.3	8.3	15.7	10.0	16.1	7.2	5.3	10.6	7.1	6.7	17.0	11.0	6.7	49.5	8.3	8.4	14.2	1.4	12.7	6.1	8.2	11.7	7.5	9.0	7.9	5.7	8.3	10.8	25.1	15.2	8.5	15.2	18.0	65.5	5.4	15.5	14.5	11.6	4.9	11.9	3.2	6.3	0.8	16.9	22.5	9.6	22.4	9.0	1.9	6.6	6.5	4.1	8.3	10.1	3.2	4.0	3.6	1.3	5.8	18.8	4.5	51.2	3.2	1.1	3.7	2.6	3.9	2.0	7.1	5.0	2.2	4.5	4.7	8.6	3.3	4.4	3.0	7.9	4.0	5.7	6.0	4.7	10.4	14.8	13.6	4.5	3.5	4.6	3.6	6.0	5.9	2.8	2.3	2.7	5.3	4.5	3.4	0.8	9.9	16.8	8.4	5.9	14.4	5.6	24.4	5.7	5.7	2.6	22.6	9.0	1.9	14.7	5.1	3.1	4.0	2.0	6.3	8.7	1.8	0.7	7.0	9.2	8.1	2.2	0.4	3.2	6.5	4.3	4.1	10.1	1.9	5.5	5.1	6.6	1.7	3.2	4.7	1.9	8.3	2.5	5.3	10.0	3.2	7.4	12.2	8.3	15.7	8.3	8.4	8.2	11.7	10.8	6.3	26.8	33.2	2.2	3.8	4.0	3.6	142.4	5.1	10.7	14.8	8.7	2.0	30.5	33.2	1.8	7.4	8.7	36.9	0.0	3.2	5.6	6.4	16.3	39.2	0.4	8.3	1.6	7.5	7.4	5.9	13.3	5.5	4.7	8.5	0.0	21.4	29.9	3.8	14.0	12.0	15.3	3.6	0.0	7.3	0.5	1.9	6.0	22.7	10.2	20.6	5.2
CMTM8	CKLFSF8	ENSG00000170293	"CKLF like MARVEL transmembrane domain containing 8"	Q8IZV2	3	32238679-32370325	"Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 81.9;Syncytiotrophoblasts: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.2;memory CD4 T-cell: 2.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.2;T-cells: 2.8"	"Group enriched"	"Detected in many"	4	"BEWO: 68.3;SK-BR-3: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055077, HPA073258"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055077: AB_2682691, HPA073258: AB_2686591"	"unprognostic (9.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	9.7	9.9	4.3	4.1	3.5	0.9	27.0	1.5	3.4	4.7	6.8	1.3	10.8	5.2	3.4	13.4	4.2	6.3	5.7	8.2	3.6	3.2	8.8	40.0	19.9	12.6	3.9	3.3	2.1	79.8	2.8	3.1	12.4	2.5	8.8	5.5	4.4	13.5	19.2	4.3	6.2	8.1	2.0	3.1	1.5	10.0	1.1	1.6	5.5	20.7	6.0	11.2	4.7	5.6	0.1	0.0	4.2	0.1	0.4	2.8	0.3	3.3	3.5	0.6	4.3	3.1	4.9	68.3	0.0	0.1	0.3	0.4	4.7	4.8	0.0	7.1	0.0	0.0	1.8	5.5	1.1	0.3	0.0	10.1	2.1	0.7	7.9	0.2	0.8	1.7	9.6	3.5	0.4	3.4	1.7	2.7	3.6	0.0	0.0	3.4	2.4	2.7	0.3	1.4	5.1	3.2	3.9	0.8	0.6	4.2	3.8	1.2	1.0	0.5	19.3	1.7	0.8	5.5	0.4	2.4	0.0	5.2	0.0	1.0	0.1	0.1	0.0	0.0	1.5	1.1	0.0	0.1	4.2	0.3	0.0	0.4	0.0	2.8	0.8	0.0	0.1	1.8	0.3	0.0	0.4	0.0	0.0	0.0	0.3	4.3	3.5	1.5	3.4	3.6	3.2	3.9	3.3	2.5	1.6	35.7	27.6	0.8	29.9	10.3	0.0	1.7	12.7	6.7	19.4	0.0	0.0	81.9	10.0	16.6	7.5	35.8	13.1	23.3	32.2	59.6	6.9	51.8	0.0	67.6	8.5	0.0	21.4	46.1	6.0	1.8	2.3	4.1	5.0	1.0	41.2	30.7	28.4	10.5	1.1	21.6	1.7	0.0	4.7	3.4	2.1	5.6	97.1	15.0	21.1	38.8
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391671-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 104.7;Kupffer cells: 102.2;Macrophages: 86.9;monocytes: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 39.8;hTERT-RPE1: 41.0"	"Low region specificity"	"Detected in all"							HPA077409			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077409: AB_2686838"	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	14.5	6.5	3.3	18.9	5.7	23.8	43.1	4.5	2.2	10.0	6.2	4.3	11.0	3.1	7.7	12.3	4.8	24.5	14.6	8.3	2.8	2.8	14.8	5.9	25.1	47.5	5.9	1.0	9.3	27.6	0.9	2.8	11.4	4.7	12.8	5.9	6.1	8.7	17.6	4.0	6.4	10.9	7.0	10.3	32.4	8.2	5.8	4.6	45.9	24.5	3.3	23.1	16.5	12.4	10.0	24.8	24.4	47.0	4.9	36.2	22.1	0.1	4.5	9.8	11.9	9.2	9.1	27.9	4.4	5.3	8.0	7.4	5.0	39.8	0.0	13.8	5.3	9.9	5.0	12.1	20.5	7.1	0.0	9.6	5.3	0.0	11.6	37.6	1.3	8.5	9.6	2.7	8.2	13.1	41.0	18.0	0.0	4.4	12.0	5.9	0.1	0.0	12.3	11.8	2.0	20.9	25.6	3.7	24.4	11.3	8.8	0.5	10.2	0.6	0.7	22.8	4.4	6.2	13.8	10.3	7.6	7.6	8.3	15.4	3.4	1.2	0.0	2.7	16.7	15.9	5.5	47.0	24.4	5.3	44.1	3.2	10.0	17.9	10.9	24.8	7.0	19.5	13.5	18.0	4.9	37.2	10.5	36.2	22.1	3.3	5.7	4.5	2.2	2.8	2.8	5.9	1.0	4.7	4.6	23.8	14.7	40.7	17.6	8.8	0.2	1.5	15.3	14.7	23.9	17.4	0.0	19.8	0.0	83.6	0.1	15.7	1.3	23.3	13.6	6.7	16.0	11.2	28.9	1.0	104.7	1.6	16.6	18.4	102.2	1.0	1.4	86.9	23.6	120.0	3.4	1.3	59.3	8.6	1.1	24.0	0.2	6.5	14.5	1.2	7.2	4.8	5.7	43.6	3.0	10.2
CMTM6	"CKLFSF6, FLJ20396"	ENSG00000091317	"CKLF like MARVEL transmembrane domain containing 6"	Q9NX76	3	32481312-32503408	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.5"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 520.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026980, HPA063491"	Enhanced		Supported	Vesicles		NA	NA		390000	Vesicles		"HPA026980: AB_10602801, HPA063491: "	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.55e-3)"	5.5	6.4	2.8	8.2	2.6	10.4	6.7	1.4	1.4	6.6	5.5			2.5	6.7	4.9	9.8	24.4	6.1	4.2	2.4	2.4	5.1	21.6	9.0	5.6	2.8		4.1	6.0	4.0	3.0	8.6		6.0	7.3		9.0	5.0	0.7	12.6	5.9	4.7	3.9	10.5	6.3	5.7			7.7		9.5	9.3	6.1	10.0	12.8	55.5	35.4	11.2	8.1	16.3	22.9	7.4	14.8	11.1	25.7	25.6	65.6	17.0	24.4	17.9	20.7	7.9	38.4	13.7	19.4	22.7	12.1	14.9	10.3	28.2	24.5	61.1	12.6	17.3	5.4	11.7	18.3	28.8	34.5	25.3	18.2	20.6	15.5	28.9	28.7	13.4	8.4	25.8	22.8	7.1	17.3	15.0	13.2	19.2	11.0	14.7	11.6	10.6	24.8	32.2	3.4	10.0	15.5	8.8	16.3	15.7	12.9	28.9	25.7	19.9	13.2	19.4	20.3	13.4	13.3	12.8	13.9	25.3	24.8	24.6	15.1	35.2	5.6	23.3	6.2	10.0	7.5	5.3	12.8	7.1	4.4	4.9	55.5	11.2	35.4	6.9	8.1	16.3											32.8	47.1	95.1	72.5	85.3	9.9	5.1	81.5	112.4	53.4	90.7	11.8	219.6	28.2	87.5	4.6	59.7	40.2	0.0	72.9	81.3	109.6	119.8	124.6	218.5	140.7	47.7	126.8	122.2	288.9	5.4	36.5	262.8	77.6	520.2	93.6	137.9	99.4	49.1	40.3	54.3	17.2	38.8	75.2	34.5	20.2	110.7	218.9	111.7	53.2	91.4
DYNC1LI1	DNCLI1	ENSG00000144635	"Dynein cytoplasmic 1 light intermediate chain 1"	Q9Y6G9	3	32525971-32570874	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 165.8;Spermatogonia: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035013	Approved		Supported	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA035013: AB_10600807"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (9.19e-9)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-2)"	16.1	11.6	15.8	14.8	18.6	27.5	18.9	24.5	28.0	13.4	13.8	12.7	9.2	11.6	17.0	11.6	13.9	14.7	14.1	40.1	16.3	23.4	18.4	15.9	16.3	15.8	18.3	16.4	15.2	18.6	16.8	18.9	14.9	26.5	18.6	14.2	14.1	12.0	12.9	41.1	32.1	13.0	19.7	16.6	18.1	13.8	34.0	11.7	19.3	12.8	16.6	17.2	15.5	13.5	6.2	15.3	29.8	25.1	7.5	6.1	10.7	13.3	14.5	22.5	14.1	13.0	15.3	62.3	20.7	28.6	37.5	30.8	15.3	11.6	16.8	14.1	21.0	17.8	6.9	22.6	16.2	35.8	15.8	15.6	22.2	10.6	13.6	16.0	25.1	13.0	12.3	13.0	26.4	20.7	13.7	24.1	19.2	25.7	15.5	20.0	10.7	19.2	11.1	23.3	12.9	19.5	17.0	12.0	17.5	15.3	12.3	9.7	14.3	14.6	18.0	15.6	18.9	15.0	14.7	17.9	20.7	17.4	17.9	20.8	11.2	28.2	27.2	11.5	21.8	16.0	11.3	13.3	11.7	5.2	16.8	5.4	6.1	5.6	5.7	15.3	6.2	3.9	5.0	29.8	7.5	25.1	8.4	6.1	10.7	15.8	18.6	24.5	28.0	16.3	23.4	18.3	16.4	26.5	11.7	23.8	24.1	30.7	27.6	38.1	44.2	87.1	12.7	57.6	42.1	14.0	17.7	31.9	39.7	46.8	67.1	34.6	15.3	46.7	40.4	30.5	29.2	19.6	16.2	24.9	36.1	62.0	29.6	23.4	32.9	26.8	24.2	50.1	27.0	83.0	18.0	30.8	44.9	17.3	26.9	37.2	71.7	45.3	37.1	165.8	163.3	43.8	9.3	28.0	13.6	14.0
CNOT10	"FLJ12890, FLJ13165"	ENSG00000182973	"CCR4-NOT transcription complex subunit 10"	Q9H9A5	3	32685145-32773875	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 66.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035614, HPA041450"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Centrosome"	Cytosol	"HPA035614: AB_10669975, HPA041450: AB_2677487"	"unprognostic (3.75e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.43e-1)"	12.3	12.6	11.3	15.2	12.4	16.6	14.0	14.2	13.4	13.4	14.0	12.5	12.8	10.8	19.8	13.5	14.8	16.1	9.8	13.0	10.5	9.4	13.1	13.5	11.4	14.7	9.7	11.9	14.7	14.0	16.0	23.0	11.3	13.3	13.1	15.7	12.2	12.0	10.9	13.5	14.9	14.7	12.8	10.5	15.1	12.2	40.5	10.9	30.2	13.8	11.9	17.4	13.0	12.6	15.0	14.1	16.0	21.0	9.0	18.5	11.2	8.4	9.5	9.9	9.3	4.8	5.5	66.1	7.1	7.2	10.2	11.5	7.2	7.3	13.9	4.8	5.1	6.6	7.4	11.7	9.4	10.2	12.0	12.0	17.8	8.6	6.9	14.0	14.6	6.9	4.0	8.5	11.2	14.9	6.8	8.3	13.0	18.5	10.8	5.9	6.9	13.0	7.1	14.9	9.8	9.1	13.2	6.7	13.8	6.5	9.9	5.6	10.9	10.5	14.8	8.6	7.3	14.4	16.6	5.1	6.3	9.0	8.3	11.8	11.2	22.9	13.9	6.5	11.1	7.6	12.8	11.2	16.0	11.4	15.7	12.3	14.8	18.5	13.6	14.1	15.0	18.5	16.2	8.8	9.0	21.0	7.8	14.4	11.2	11.3	12.4	14.2	13.4	10.5	9.4	9.7	11.9	13.3	10.9	14.9	21.4	14.3	5.8	9.3	15.9	10.8	7.6	32.1	15.9	14.0	31.4	11.6	5.0	11.2	42.3	11.4	11.8	0.0	11.7	14.6	9.8	6.0	10.4	8.5	10.3	14.3	15.0	11.1	14.8	29.1	8.9	12.9	11.8	47.7	8.3	8.0	9.9	14.4	9.9	5.6	18.7	6.5	10.6	35.7	32.4	12.7	6.9	18.3	13.6	6.7
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32818018-32897826	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 6.5;testis: 11.1"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 8.9;Extravillous trophoblasts: 13.2;Spermatogonia: 12.6"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.9;BEWO: 36.1;Hep G2: 23.3;NTERA-2: 31.9;SuSa: 30.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.1	0.0	0.7	0.1	1.9	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.7	2.2	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.5	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.6	0.0	23.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.2	2.5	31.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.0	0.5	2.7	0.7	0.2	0.0	1.9	0.0	8.9	2.6	0.0	0.0	0.0	0.4	2.8	0.0	1.4	3.4	0.0	0.0	3.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.9	0.4	0.0	0.0	0.3	12.6	0.0	3.3	0.0	0.0	0.0
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951574-32956349	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 28.9;lymphoid tissue: 57.1"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 1.4;granulocytes: 2.3;Horizontal cells: 4.8;T-cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 28.9"	"Lineage enriched"	"Detected in single"	48	"T-cells: 28.9"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 67.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031613	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.63e-3)"	"unprognostic (8.70e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.59e-7)"	"unprognostic (3.02e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.40e-1)"	1.5	0.6	0.3	12.6	0.4	1.5	1.1	0.3	0.3	1.1	1.1	0.1	0.7	0.4	1.0	0.6	1.6	0.8	3.8	0.8	0.3	0.3	1.8	0.9	6.0	24.1	0.3	0.0	0.5	0.5	0.5	0.5	0.1	0.1	1.5	1.2	0.8	4.3	0.2	1.8	2.2	5.0	0.4	0.4	10.2	1.3	2.7	0.0	57.1	1.3	2.8	29.7	8.6	1.1	0.2	0.2	0.5	0.1	0.1	28.9	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	67.1	0.0	4.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.9	1.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.2	0.1	0.2	0.1	6.0	1.8	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.2	28.9	0.8	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	0.1	0.0	0.0	1.1	0.0	0.5	0.3	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	1.0	0.1	0.0	2.2	0.0	0.4
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.8	10.0	6.5	7.7	39.9	20.7	139.7	9.3	25.2	12.0	15.4	14.2	13.8	2.8	8.3	19.0	8.9	5.6	6.1	11.9	8.9	16.3	5.1	11.2	6.0	7.3	20.5	7.7	11.4	23.9	11.4	10.8	6.4	23.6	18.4	3.9	10.1	10.9	13.1	6.8	4.6	5.1	4.4	12.2	4.4	4.0	4.3	13.2	12.9	8.5	2.0	6.8	12.0	19.4	11.7	12.0	12.9	20.4	10.7	7.7	5.4	10.5	7.9	8.6	13.7	0.9	16.2	11.2	5.8	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0	17.9	22.3	15.9	10.2	5.4	11.3	7.1	35.7	14.7	17.0	26.2	5.9	80.5	23.2	42.1	22.3	10.5	31.5	0.0	31.3	47.6	24.4	11.4	26.5	36.5	70.6	4.8	16.3	18.4	38.2	3.1	14.1	38.3	13.5	81.2	22.4	20.0	27.0	39.5	19.8	24.2	15.0	12.9	10.8	1.1	7.2	3.0	41.1	20.0	28.4	8.4
TMPPE	FLJ45032	ENSG00000188167	"Transmembrane protein with metallophosphoesterase domain"	Q6ZT21	3	33090421-33096801	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	5	"Alveolar cells type 2: 2.2;Rod photoreceptor cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"BEWO: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027019	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Nucleoplasm, Mitochondria"		"HPA027019: AB_1848942"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.34e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-7)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.33e-2)"	6.3	5.4	3.7	6.8	5.2	20.3	6.8	5.3	7.4	4.5	6.9	4.1	7.4	6.4	6.5	12.0	7.0	5.4	9.9	4.4	3.6	3.7	13.9	13.1	9.3	9.6	3.5	3.0	5.7	9.7	12.1	5.2	8.4	4.9	4.6	6.5	9.0	7.7	6.5	3.8	10.3	11.0	4.6	3.8	7.2	6.8	3.2	2.3	2.4	9.5	2.2	7.2	5.3	5.0	0.8	2.2	4.2	5.5	0.1	1.4	0.9	1.3	1.7	1.0	1.6	1.2	1.0	25.5	0.6	0.9	1.5	0.9	2.5	3.5	0.7	1.1	1.6	0.8	1.4	1.6	1.4	2.5	3.8	0.6	3.1	1.7	1.9	0.8	2.6	4.5	1.1	1.2	1.9	1.3	0.7	1.8	1.6	2.3	2.7	1.1	1.2	1.1	1.2	1.0	0.3	1.0	1.3	0.5	1.7	1.4	1.7	0.2	0.6	0.8	2.4	0.6	1.3	1.3	3.8	2.5	2.3	2.9	1.2	2.4	2.2	1.4	0.4	2.9	2.0	1.5	0.0	2.3	0.7	0.4	5.5	1.4	0.8	0.5	0.1	2.2	0.3	0.0	0.0	4.2	0.1	2.3	0.4	0.5	0.9	3.7	5.2	5.3	7.4	3.6	3.7	3.5	3.0	4.9	2.3	0.0	2.2	0.0	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	1.3	0.0	0.7	1.2	0.3	0.2	0.0	0.2	0.8	1.6	0.0	0.6	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.4	0.9	0.4	0.3	2.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.6	0.1
CRTAP	"CASP, LEPREL3, P3H5"	ENSG00000170275	"Cartilage associated protein"	O75718	3	33113979-33147773	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 172.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 67.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 55.8;monocytes: 67.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 122.6;ASC TERT1: 80.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043598, HPA044150"	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"	"Secreted to blood"	NA	NA			"Intermediate filaments, Actin filaments, Cytosol"		"HPA043598: AB_10960991, HPA044150: AB_10959594"	"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.85e-3)"	"unprognostic (7.36e-2)"	"unprognostic (4.73e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.28e-3)"	59.2	33.4	16.3	13.4	22.2	13.6	63.2	5.4	14.1	57.5	39.4	23.3	32.7	12.8	54.2	41.1	42.8	35.1	43.5	37.0	16.8	13.1	25.7	16.8	35.9	37.8	24.2	13.0	48.5	13.3	14.6	7.6	25.4	13.8	54.5	19.7	35.4	16.4	42.2	23.9	24.6	18.8	66.1	22.8	17.6	25.2	26.1	19.0	5.1	34.1	25.8	18.3	62.4	59.7	7.6	55.8	5.5	67.8	6.9	12.9	30.8	9.1	18.1	5.7	17.8	122.6	80.3	33.0	20.0	43.7	24.3	23.2	6.1	5.2	6.4	22.4	38.0	19.6	11.8	10.1	15.3	17.6	15.8	15.7	10.0	14.2	6.3	36.7	6.4	8.2	64.0	31.4	21.9	27.9	47.3	25.5	4.0	8.5	12.3	24.5	7.8	2.3	6.6	6.8	9.8	24.7	8.5	16.7	12.3	19.0	6.1	1.2	9.2	13.5	11.9	28.8	13.8	12.8	15.9	16.6	31.9	13.6	17.3	21.1	8.9	30.1	0.9	25.0	13.0	17.4	2.1	67.8	4.9	6.9	26.3	10.0	7.6	10.1	7.7	55.8	6.8	5.8	5.4	5.5	6.9	7.8	15.0	12.9	30.8	16.3	22.2	5.4	14.1	16.8	13.1	24.2	13.0	13.8	19.0	8.9	42.6	18.6	27.6	53.7	18.7	29.5	25.5	4.0	19.4	36.6	7.9	42.5	10.0	19.9	1.0	55.3	18.1	0.0	27.7	59.7	94.1	20.8	46.2	44.4	93.2	33.4	5.8	103.2	172.9	2.2	132.3	73.7	75.9	27.9	22.6	17.7	20.2	10.5	136.2	43.7	10.5	109.9	117.1	1.4	7.9	40.8	23.5	20.8	33.1	22.1
SUSD5	KIAA0527	ENSG00000173705	"Sushi domain containing 5"	O60279	3	33150042-33219215	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Sertoli cells: 32.3;Smooth muscle cells: 13.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.9;neutrophil: 1.5"	"Group enriched"	"Detected in many"	9	"B-cells: 1.9;granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 14.8;HUVEC TERT2: 36.7;LHCN-M2: 14.2;TIME: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052788	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA		4300000	"Golgi apparatus, Vesicles"		"HPA052788: AB_2681948"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.45e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.89e-2)"	7.6	2.5	7.0	1.5	6.1	0.4	2.5	2.0	13.2	11.0	2.6	4.6	2.3	1.5	7.0	6.5	2.3	7.9	13.1	5.7	6.4	8.1	2.6	1.1	3.0	4.4	6.9	6.9	6.4	1.2	1.0	1.3	0.5	6.3	1.9	2.2	3.7	1.3	10.7	2.2	2.8	2.7	7.7	4.6	3.9	3.3	4.7	3.3	0.0	5.3	2.9	8.1	3.0	3.5	1.9	0.1	1.5	0.1	0.1	0.1	0.1	0.0	0.5	0.6	0.3	0.8	0.1	0.0	4.5	1.6	14.8	5.0	0.0	0.0	0.0	4.2	1.1	4.6	0.0	6.4	2.1	6.1	0.1	7.1	0.0	1.0	0.0	0.1	0.0	0.0	0.6	1.1	9.5	1.8	7.2	36.7	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	1.1	0.3	0.8	0.9	14.4	0.0	7.0	0.6	2.1	0.0	0.3	0.0	0.1	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.1	0.1	1.5	0.1	0.0	0.1	0.0	0.1	7.0	6.1	2.0	13.2	6.4	8.1	6.9	6.9	6.3	3.3	0.0	0.0	0.0	0.0	0.9	1.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	3.2	0.0	0.6	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	32.3	13.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0
FBXL2	"FBL2, FBL3"	ENSG00000153558	"F-box and leucine rich repeat protein 2"	Q9UKC9	3	33277025-33403662	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 23.6;Early spermatids: 41.5;Late spermatids: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 8.9;LHCN-M2: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061783			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA061783: AB_2684605"	"unprognostic (5.73e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.72e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.90e-2)"	3.2	5.2	8.0	2.2	15.0	1.9	4.1	7.2	18.1	3.7	2.9	4.1	1.8	3.2	5.2	8.2	2.3	6.0	3.0	2.7	8.7	11.3	5.5	1.4	4.6	1.8	6.6	13.4	4.5	3.5	7.7	16.1	5.5	13.1	4.3	1.5	6.4	3.1	6.5	1.5	2.9	2.0	3.5	4.5	2.3	2.5	4.3	2.8	0.0	8.6	0.6	1.5	2.6	2.5	1.3	0.9	2.8	1.0	0.9	1.1	0.1	3.9	1.1	1.6	1.8	2.3	3.8	0.6	3.1	2.5	2.8	4.1	0.8	4.7	0.2	0.9	2.0	1.3	1.0	1.4	3.4	1.9	0.4	1.9	0.7	3.2	0.8	2.8	0.3	0.7	1.5	2.5	1.8	1.3	8.9	5.0	2.8	0.9	0.3	9.4	0.4	0.8	0.7	1.2	0.5	0.9	0.1	1.0	0.1	7.1	1.1	2.0	2.0	1.3	0.8	2.3	2.7	2.2	1.2	3.9	1.4	1.3	1.1	1.7	0.4	0.2	0.2	1.3	0.3	0.9	1.5	1.0	0.7	0.9	0.5	0.7	0.5	0.7	0.9	0.3	1.3	1.1	1.1	2.8	0.9	0.7	0.9	0.4	0.1	8.0	15.0	7.2	18.1	8.7	11.3	6.6	13.4	13.1	2.8	3.0	8.2	0.0	5.1	1.0	16.5	2.0	2.5	13.4	4.5	5.2	23.6	0.4	3.3	3.5	41.5	2.2	0.0	0.0	0.3	1.0	3.6	2.9	0.0	0.0	0.4	17.5	0.0	3.1	0.3	37.9	1.4	1.2	1.7	0.0	0.1	6.7	3.4	0.0	3.9	2.1	14.2	6.5	2.9	11.7	7.9	1.0	0.6	1.3	0.0	3.3
UBP1	LBP-1a	ENSG00000153560	"Upstream binding protein 1"	Q9NZI7	3	33388336-33441371	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003967			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003967: AB_10601829"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (4.64e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.88e-2)"	19.3	18.7	22.6	25.0	30.7	14.8	19.9	39.1	28.8	21.0	26.4	14.8	20.0	21.1	26.1	20.3	24.6	19.7	22.5	21.9	16.5	17.0	15.9	23.1	21.7	29.2	13.6	22.1	22.2	23.6	20.1	26.0	15.7	15.4	21.5	25.5	20.4	18.1	30.3	14.6	18.7	23.4	36.3	15.0	25.1	22.6	13.8	17.8	36.0	20.9	16.6	30.3	28.0	30.9	2.8	5.7	6.5	5.2	4.9	6.3	3.6	17.7	21.7	16.7	27.6	25.5	18.8	8.2	21.5	23.9	25.7	26.3	20.9	15.8	33.4	12.7	31.2	18.5	12.4	49.9	25.0	31.8	18.2	15.3	35.8	21.1	25.0	17.9	26.0	15.5	15.4	20.7	24.9	25.3	21.1	30.7	18.5	32.6	18.4	24.7	16.7	20.5	15.4	39.8	14.2	22.5	21.7	12.3	30.9	18.2	26.8	11.6	13.8	17.0	29.5	18.6	23.2	22.4	31.8	25.5	22.8	17.6	25.6	29.7	14.8	26.5	34.3	19.6	30.2	16.8	6.5	3.9	3.7	5.3	4.0	5.0	2.8	5.3	5.2	5.7	2.1	6.3	5.1	1.0	4.9	5.2	4.8	3.3	3.6	22.6	30.7	39.1	28.8	16.5	17.0	13.6	22.1	15.4	17.8	6.0	18.1	9.1	7.5	22.7	22.6	26.4	22.9	5.3	6.8	10.4	13.7	6.5	3.3	10.8	1.3	21.5	18.7	23.3	12.5	8.2	13.8	14.7	2.3	34.5	13.3	22.3	11.6	18.4	30.1	1.6	9.2	20.9	25.3	17.2	27.8	7.5	12.2	14.0	16.6	9.1	17.0	12.9	17.6	12.2	12.6	27.1	4.6	14.6	24.3	11.5
CLASP2	KIAA0627	ENSG00000163539	"Cytoplasmic linker associated protein 2"	O75122	3	33496245-33718356	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.1"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 95.1;Cone photoreceptor cells: 147.3;Horizontal cells: 87.4;Rod photoreceptor cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067071			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA067071: AB_2685775"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.48e-6)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.72e-2)"	7.9	14.5	20.6	6.5	31.6	6.0	9.0	45.4	67.1	13.0	8.9	50.7	3.4	5.6	11.7	6.7	10.2	9.4	10.0	22.0	19.1	16.8	10.4	6.1	8.6	7.9	33.4	22.1	16.1	6.5	11.6	16.1	8.7	44.7	9.8	7.7	13.4	6.5	12.4	31.7	7.3	6.7	11.2	29.7	7.7	6.8	6.5	37.3	4.1	8.1	4.9	8.6	8.0	7.5	8.4	8.7	4.7	8.4	12.3	7.2	5.6	7.2	16.2	18.5	15.6	12.1	11.9	13.4	13.7	13.0	16.2	17.5	9.4	7.6	24.1	8.0	10.7	10.4	6.4	24.0	10.9	19.7	19.4	17.0	23.7	14.3	8.3	5.8	23.3	20.3	7.3	10.9	17.4	16.7	9.4	15.6	15.0	23.1	13.8	17.4	4.0	17.2	10.0	13.8	7.3	10.3	18.6	17.5	13.1	10.3	8.3	15.6	26.4	15.9	12.4	13.7	15.7	11.7	20.8	14.9	12.7	11.1	9.5	15.1	9.8	18.3	20.0	11.5	16.2	16.1	4.7	5.9	3.3	4.8	6.3	7.2	8.4	4.2	4.5	8.7	5.6	5.7	5.2	1.2	12.3	8.4	8.3	4.5	5.6	20.6	31.6	45.4	38.7	19.1	16.8	33.4	22.1	44.7	37.3	6.0	9.4	14.3	7.0	18.7	95.1	34.3	17.8	9.4	12.5	14.0	147.3	10.5	1.7	5.7	2.3	12.1	7.3	0.0	5.9	6.5	12.4	12.6	11.5	12.2	13.1	87.4	13.8	14.7	32.0	2.6	13.3	16.7	15.1	9.0	10.0	36.3	7.3	7.0	12.7	9.9	124.9	6.5	18.9	10.8	13.8	26.8	10.8	17.0	10.1	7.8
PDCD6IP	"AIP1, Alix, Hp95"	ENSG00000170248	"Programmed cell death 6 interacting protein"	Q8WUM4	3	33798352-33869707	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011905, CAB016212, HPA051604"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		6200000	Vesicles		"CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: "	"unprognostic (1.53e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.88e-3)"	"unprognostic (4.49e-2)"	"prognostic favorable (3.90e-9)"	"unprognostic (9.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.11e-1)"	39.1	26.8	18.6	26.2	27.2	16.0	27.0	24.0	31.5	33.8	36.8	26.3	16.5	28.6	33.7	22.7	45.2	27.1	26.2	29.6	20.7	19.7	42.8	41.5	29.9	24.8	22.7	18.1	33.0	21.2	34.9	26.3	43.2	48.9	26.6	34.0	23.0	27.4	20.4	29.5	31.7	57.9	25.9	24.8	32.2	29.1	24.2	16.8	35.9	35.1	25.6	37.3	28.6	31.6	11.8	12.3	10.8	18.2	12.0	9.7	8.9	17.9	18.8	12.2	10.2	31.9	32.9	13.4	23.1	22.1	20.6	21.5	13.0	17.7	25.8	14.4	30.3	13.4	16.0	18.8	24.2	23.5	10.8	15.7	22.1	15.5	10.7	21.3	22.0	22.9	25.6	28.1	23.2	27.8	24.7	30.5	12.0	19.8	10.7	29.8	9.4	13.5	13.2	11.7	16.5	23.4	12.9	15.0	16.7	25.7	15.4	6.0	10.8	22.6	27.1	12.2	20.6	26.2	21.2	37.7	24.4	12.3	20.2	19.1	10.9	14.5	21.6	23.0	24.2	12.0	6.3	13.4	10.8	8.7	18.2	9.3	11.8	9.6	8.6	12.3	10.1	8.5	8.2	8.1	12.0	17.2	5.7	9.7	8.9	18.6	27.2	24.0	31.5	20.7	19.7	22.7	18.1	48.9	16.8	80.4	77.5	41.0	48.9	37.1	29.4	46.6	76.5	112.4	72.8	61.1	49.1	43.5	31.5	60.9	71.2	58.2	165.2	0.0	68.3	44.1	40.1	52.8	51.0	50.4	54.7	23.8	34.7	52.8	89.1	35.9	68.4	71.9	27.0	31.5	82.0	25.1	88.6	90.8	75.7	55.1	45.5	45.3	38.7	87.4	42.1	37.8	80.8	39.2	56.8	62.1
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 2.8;Cardiomyocytes: 3.4;Early spermatids: 1.6;Late spermatids: 2.2"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 146.9"	"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 12.1"	"Cell line enhanced"	"Detected in some"		"JURKAT: 46.2;MOLT-4: 27.1;REH: 15.0;RH-30: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017303	Enhanced	Supported	Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		1.2	1.3	12.3	1.5	146.9	4.6	1.1	27.8	67.9	1.1	1.4	0.3	0.0	1.3	1.1	1.1	3.2	1.1	1.1	1.1	6.8	2.8	2.0	2.9	1.2	1.2	3.9	11.5	1.1	1.1	1.1	1.9	1.1	6.7	2.0	1.5	0.0	1.1	1.3	43.6	1.1	1.4	1.1	0.8	1.2	1.1	1.1	14.8	41.2	1.5	3.5	1.5	1.1	0.1	0.1	12.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.2	0.0	46.2	0.0	0.1	1.1	0.0	27.1	0.0	0.0	0.0	1.1	15.0	8.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	12.3	146.9	27.8	14.7	6.8	2.8	3.9	11.5	6.7	14.8	0.0	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380344-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	22	"Distal tubular cells: 5.0;Early spermatids: 4.5;granulocytes: 5.8;Muller glia cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 21.3"	"Group enriched"	"Detected in some"	5	"eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.0;HaCaT: 16.2;hTERT-RPE1: 13.5;SH-SY5Y: 23.2;U-251 MG: 14.1;U-87 MG: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	3.7	6.4	1.4	1.1	5.4	0.6	5.7	21.3	0.8	9.2	4.6	1.2	4.7	0.3	9.0	2.2	3.3	4.0	5.1	0.7	0.9	3.9	3.3	1.8	15.0	0.7	1.6	0.2	3.2	0.6	18.8	1.8	0.6	5.2	17.2	1.1	1.9	1.8	5.7	4.0	1.6	0.6	12.5	1.2	0.9	1.5	2.4	0.2	0.7	1.0	4.4	0.5	8.4	15.5	0.0	0.6	3.2	0.4	2.8	3.8	0.2	3.5	1.5	0.8	0.0	3.2	1.0	0.0	9.0	0.2	1.9	2.3	0.0	0.0	0.0	3.7	22.0	6.3	16.2	1.1	3.9	2.0	0.0	2.8	0.5	4.9	0.1	0.0	9.0	0.1	1.2	0.1	0.0	0.3	13.5	0.0	0.9	0.0	0.2	0.2	0.0	1.8	0.1	6.7	0.0	1.4	0.0	0.0	0.0	5.1	0.0	3.0	23.2	3.6	2.5	0.0	7.0	0.0	0.9	4.0	0.2	9.4	0.3	14.1	0.0	0.0	0.0	23.9	3.6	4.0	0.0	0.1	3.2	0.0	0.4	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.1	0.0	3.8	0.2	1.4	5.4	21.3	0.8	0.9	3.9	1.6	0.2	5.2	0.2	0.0	0.3	0.0	0.0	0.0	0.7	1.1	0.0	0.0	2.3	0.0	0.0	0.0	5.0	0.1	4.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.6	0.0	2.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	"Doublecortin like kinase 3"	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.0;testis: 8.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 24.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;SCLC-21H: 3.3;SH-SY5Y: 2.7;U-2 OS: 1.9;U-2197: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040685	Approved					NA	NA					"HPA040685: AB_2732487"	"unprognostic (9.09e-3)"	"unprognostic (1.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.11e-5)"	"unprognostic (7.94e-3)"	"unprognostic (5.80e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.36e-2)"	1.1	0.4	2.6	1.4	10.0	0.3	0.1	0.1	2.3	0.5	0.2	0.3	0.0	0.5	0.3	0.1	0.1	0.2	0.6	0.9	1.4	0.9	0.0	0.1	0.3	0.2	0.6	0.0	0.0	0.2	0.4	1.8	1.1	0.4	0.3	0.3	1.3	1.7	0.2	2.7	0.4	0.4	0.9	0.7	0.1	0.0	8.0	3.2	0.0	0.9	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	2.7	0.1	0.3	0.0	0.2	0.0	0.4	0.3	0.0	1.9	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	10.0	0.1	2.3	1.4	0.9	0.6	0.0	0.4	3.2	0.0	0.0	0.0	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0
TRANK1	"KIAA0342, LBA1"	ENSG00000168016	"Tetratricopeptide repeat and ankyrin repeat containing 1"	O15050	3	36826820-36945098	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.3"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 14.9;Enterocytes: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 42.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 42.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.8;HMC-1: 15.6"	"Low region specificity"	"Detected in all"							HPA035508	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035508: AB_10671105"	"unprognostic (7.11e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.04e-3)"	"unprognostic (9.13e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.07e-3)"	4.1	3.6	4.5	10.4	11.2	6.9	4.7	21.5	12.0	8.5	14.2	1.7	3.1	8.6	12.3	4.5	3.1	19.3	7.3	4.1	3.3	3.9	3.2	7.9	6.2	13.9	2.9	6.6	9.0	2.8	5.0	3.8	3.7	6.0	7.9	10.9	4.4	4.9	5.0	2.6	2.9	23.1	10.5	3.2	9.9	6.0	2.9	1.7	15.1	5.8	1.1	16.2	9.8	6.0	5.2	0.5	42.3	1.3	2.8	5.7	0.9	0.7	0.9	0.2	0.0	2.4	9.7	0.0	0.7	5.1	2.3	4.5	0.0	3.9	38.8	1.6	2.9	7.7	0.2	0.1	0.5	0.4	1.9	0.0	6.3	2.6	0.0	3.1	1.7	15.6	3.2	2.0	1.7	0.1	0.5	2.8	4.2	5.0	5.6	1.7	0.0	4.9	0.7	0.2	0.0	1.0	1.4	0.1	0.7	0.8	1.7	0.3	0.0	3.9	1.0	0.3	0.4	0.6	2.2	1.9	1.8	0.7	0.1	0.6	5.5	1.1	8.6	0.3	1.4	0.2	2.5	0.6	3.9	5.6	0.9	4.2	4.0	4.8	5.7	0.5	5.2	4.4	4.2	42.3	2.8	1.3	0.0	4.0	0.9	4.5	11.2	21.5	12.0	3.3	3.9	2.9	6.6	6.0	1.7	14.9	5.6	3.9	1.2	0.7	1.1	2.4	2.5	5.3	4.5	3.5	2.0	1.0	0.0	2.2	0.2	3.3	15.2	0.0	1.6	1.1	3.0	1.9	5.8	13.9	4.2	0.0	5.2	6.2	6.3	0.0	4.0	3.6	5.0	1.0	8.8	1.4	3.0	12.2	5.6	0.6	0.7	0.0	1.7	0.2	0.2	0.6	0.6	13.8	3.8	1.4
EPM2AIP1	"FLJ11207, KIAA0766"	ENSG00000178567	"EPM2A interacting protein 1"	Q7L775	3	36985043-36993168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (7.24e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (6.24e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.25e-3)"	9.7	14.4	13.0	12.9	20.1	14.4	15.2	31.9	25.9	15.4	10.2	14.2	11.1	9.6	17.6	21.2	9.4	14.3	10.7	16.0	13.5	22.4	12.3	12.4	12.3	14.3	18.5	19.3	23.2	9.9	22.2	30.1	10.0	25.2	19.4	11.4	11.7	12.3	14.0	14.0	10.7	12.0	13.3	13.3	16.7	10.6	9.9	18.4	22.3	26.7	10.8	14.3	11.4	12.8	7.9	7.0	8.7	11.8	7.4	7.5	2.1	3.7	3.6	18.0	0.0	8.1	11.6	4.2	8.4	5.6	6.1	7.3	3.1	6.7	11.2	3.6	6.2	7.0	8.2	5.2	5.2	7.3	5.6	5.0	8.8	17.6	6.7	5.1	10.3	5.4	13.1	4.9	7.2	4.3	9.8	6.0	12.6	8.6	23.2	8.5	3.7	6.3	7.4	2.6	3.0	4.4	5.0	12.7	5.8	5.7	9.4	7.5	9.6	9.9	12.5	2.6	6.3	21.3	6.4	7.1	9.3	7.7	6.9	6.2	12.7	7.6	7.1	6.3	8.0	5.2	8.7	4.4	8.1	5.0	5.9	5.8	7.0	7.5	4.4	4.7	7.9	7.5	6.2	4.3	7.4	11.8	7.0	4.4	2.1	13.0	20.1	31.9	25.9	13.5	22.4	18.5	19.3	25.2	18.4	38.7	29.3	41.9	31.6	18.0	67.8	38.6	30.6	10.7	26.1	33.2	39.3	16.9	10.0	8.9	4.1	23.3	13.3	0.0	8.6	6.1	22.7	25.3	25.4	26.9	10.8	65.2	33.0	27.0	32.7	1.8	38.0	31.1	23.6	10.8	18.5	58.2	7.7	14.1	35.0	11.5	61.0	12.9	26.9	17.9	14.5	23.5	7.4	39.8	16.8	13.6
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993332-37050918	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348"	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	16.3	20.7	18.2	19.4	21.4	24.4	18.7	19.7	19.6	15.3	17.3	28.8	19.6	12.4	18.7	23.6	15.1	16.2	14.4	32.0	17.3	17.7	18.8	20.5	17.8	22.8	19.9	16.0	17.6	18.1	26.0	29.4	17.3	19.2	18.5	17.7	16.7	15.6	18.1	46.4	14.2	14.1	21.1	21.6	20.7	16.5	27.6	21.5	29.0	22.2	19.5	24.5	16.9	21.4	12.0	12.9	13.2	23.2	6.7	13.4	9.0	14.2	22.5	28.1	0.0	12.5	15.7	12.6	21.3	17.0	24.8	26.4	17.0	15.9	35.3	10.6	17.3	14.0	9.8	24.2	18.0	26.6	16.0	12.5	24.7	20.8	23.8	13.9	30.3	17.2	11.7	12.7	23.1	28.8	9.8	15.3	23.9	31.6	16.9	25.1	11.5	31.6	12.4	20.6	14.5	12.4	3.1	34.4	14.9	15.7	15.5	6.0	14.2	21.6	23.0	14.2	16.4	33.2	21.6	12.1	19.5	21.0	19.1	25.0	13.4	36.6	33.1	15.1	28.7	17.5	10.9	11.7	13.2	13.4	19.5	9.7	12.0	8.4	10.7	12.9	10.3	9.6	9.7	3.4	6.7	23.2	6.1	12.5	9.0	18.2	21.4	19.7	19.6	17.3	17.7	19.9	16.0	19.2	21.5	23.8	12.0	16.0	10.7	6.4	19.2	37.1	15.3	16.0	13.6	10.4	9.8	27.1	16.6	12.5	20.3	11.2	5.3	0.0	13.0	23.0	13.4	8.0	7.0	14.5	17.5	3.2	5.2	12.3	14.3	9.5	10.3	11.4	8.5	19.8	7.2	14.3	8.6	7.0	13.1	9.2	17.9	12.9	9.5	37.0	25.4	4.8	16.7	13.1	7.6	3.4
LRRFIP2	HUFI-2	ENSG00000093167	"LRR binding FLII interacting protein 2"	Q9Y608	3	37052656-37183689	"Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 388.9;Urothelial cells: 309.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035956, HPA042023"	Uncertain		Approved	"Plasma membrane,Actin filaments"		NA	NA		1000000	"Plasma membrane, Actin filaments"		"HPA035956: AB_10671238, HPA042023: AB_2677802"	"unprognostic (2.03e-3)"	"prognostic favorable (6.31e-4)"	"unprognostic (1.16e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.84e-3)"	"unprognostic (3.76e-2)"	15.4	17.3	23.0	17.5	22.0	27.5	21.9	30.0	22.8	35.7	35.8	26.5	17.7	24.7	28.2	20.0	33.0	15.7	22.8	47.4	23.8	25.3	19.8	33.9	18.7	19.3	24.2	19.4	20.6	16.9	33.9	18.3	16.9	24.4	30.3	24.8	19.6	19.3	19.5	58.5	23.2	37.1	27.3	31.2	29.7	17.0	47.2	24.8	11.6	20.6	33.6	21.6	23.7	25.1	7.1	9.8	22.7	17.2	11.9	8.8	7.5	15.6	8.7	10.1	7.9	13.5	20.8	8.8	42.7	42.6	24.1	27.8	8.1	7.2	6.2	7.0	41.1	11.9	8.2	7.4	21.1	39.5	13.8	5.8	11.1	12.5	7.9	19.3	8.7	6.8	9.2	15.2	31.3	32.5	13.4	16.7	9.7	8.8	10.9	20.0	4.0	7.4	4.7	6.6	6.4	11.2	3.6	28.9	6.3	16.9	6.1	3.6	5.8	16.5	15.3	13.8	8.5	8.8	9.1	16.0	18.5	12.5	27.1	20.0	8.5	15.2	9.5	10.9	7.9	26.2	12.2	15.0	22.7	6.6	10.4	8.5	7.1	7.0	7.0	9.8	5.4	5.2	6.2	14.0	11.9	17.2	5.5	8.8	7.5	23.0	22.0	30.0	22.8	23.8	25.3	24.2	19.4	24.4	24.8	26.8	32.2	18.0	127.0	120.9	34.6	89.3	25.5	36.1	66.0	22.7	27.5	25.5	54.7	70.3	388.9	46.3	105.3	23.3	82.3	35.6	59.0	267.5	50.8	52.9	22.7	116.0	51.9	60.8	39.4	269.5	39.1	42.2	70.9	77.5	39.2	48.7	85.8	59.6	54.1	33.1	51.1	38.8	54.0	116.1	61.4	149.1	32.8	24.5	60.8	309.6
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 608.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	22.3	20.6	16.7	14.0	29.0	11.4	30.6	26.9	27.1	19.1	25.1	14.5	29.1	23.9	12.8	18.4	22.0	11.3	16.7	34.3	18.1	12.3	22.1	32.7	15.2	12.2	30.5	12.8	14.8	27.7	27.1	42.8	34.5	18.9	21.1	18.1	20.2	24.8	24.4	64.6	29.8	29.1	19.0	23.9	14.8	21.2	26.0	24.9	10.3	29.9	22.6	11.8	20.5	24.8	10.0	9.9	19.8	11.0	13.0	14.9	3.2	23.7	16.5	8.5	10.7	22.5	19.4	21.7	30.6	25.7	12.1	14.6	14.1	13.3	8.2	8.0	26.0	13.9	14.0	13.5	21.7	25.2	10.4	9.9	11.1	14.6	22.4	22.6	11.7	8.1	10.4	20.8	19.0	37.2	19.6	17.5	6.2	13.5	12.9	19.4	10.2	8.9	5.1	9.3	12.2	15.7	2.0	25.8	8.6	15.0	25.0	5.5	7.3	18.9	20.5	23.4	17.1	30.2	8.6	21.0	12.4	14.4	23.9	21.8	15.9	11.2	7.2	22.0	10.3	14.5	19.8	5.5	12.0	14.9	6.4	12.5	8.1	9.2	10.3	4.5	10.0	9.6	7.2	7.7	13.0	11.0	9.9	6.0	3.2	16.7	29.0	26.9	27.1	18.1	12.3	30.5	12.8	18.9	24.9	220.3	277.4	69.8	105.1	140.7	166.1	608.0	73.9	104.4	195.7	43.6	337.7	86.2	24.9	103.7	122.0	85.9	153.6	23.3	105.1	100.5	87.0	136.9	59.1	125.8	75.0	178.0	85.9	71.8	62.7	17.5	111.0	62.5	65.8	83.8	108.9	122.0	118.5	95.4	106.8	55.9	360.2	84.1	88.0	351.1	212.3	153.6	208.7	59.7	96.2	157.6
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823514	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Ito cells: 62.0;Kupffer cells: 24.9;Leydig cells: 38.3;Peritubular cells: 70.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HEL: 7.5;SH-SY5Y: 11.2;SuSa: 17.0;WM-115: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		250000	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.5	15.5	3.1	5.3	3.7	5.8	9.6	1.6	5.7	17.9	11.1	2.9	5.8	4.6	17.3	7.5	12.3	6.9	17.8	25.0	4.5	2.0	4.6	13.6	8.3	16.8	3.4	2.7	7.5	2.1	2.4	3.0	7.3	2.6	10.0	5.3	8.4	4.7	8.7	3.7	3.5	8.7	16.2	4.0	30.5	10.9	10.2	2.7	1.0	35.4	7.2	3.6	7.4	8.4	0.0	0.7	2.1	0.2	0.0	0.0	0.4	0.2	0.0	4.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	9.4	0.0	3.0	1.3	0.0	0.1	0.2	3.6	0.0	0.0	0.0	0.6	7.5	0.1	0.2	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.5	11.2	0.1	0.5	0.6	17.0	0.0	2.9	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	5.8	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	3.1	3.7	1.6	5.7	4.5	2.0	3.4	2.7	2.6	2.7	0.0	14.3	0.0	1.0	2.3	0.8	13.2	2.5	0.0	5.7	1.8	0.0	0.2	0.0	0.1	0.9	18.0	0.0	0.0	0.0	0.2	3.2	0.2	5.8	0.2	2.2	0.0	0.0	62.0	24.9	3.1	38.3	1.3	3.3	0.0	0.0	0.5	0.0	0.0	70.4	0.0	0.0	0.0	3.3	0.5	0.9	1.5	0.2	0.0	0.0	0.3
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861960-37984469	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		10000	Vesicles	Nucleoplasm	"HPA048325: AB_2680359"	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	12.8	6.3	11.1	7.8	12.4	5.6	22.0	30.2	14.1	15.5	19.9	8.0	25.7	9.3	14.5	18.3	16.8	12.2	37.2	18.9	13.1	5.9	26.7	13.3	19.0	4.9	7.8	9.9	13.7	10.2	8.3	9.4	20.6	6.9	17.5	20.3	15.6	45.5	22.4	12.5	34.8	11.2	21.3	8.1	11.3	19.7	8.1	8.3	2.9	10.0	13.9	6.9	19.6	21.7	0.0	0.2	1.1	0.5	0.0	0.5	5.6	15.8	6.9	2.9	9.0	11.3	16.2	21.4	10.9	13.8	7.6	8.9	10.0	13.0	0.0	6.7	13.5	3.1	13.3	7.0	20.7	6.1	0.0	5.5	9.7	7.4	22.6	10.3	0.0	2.4	8.3	50.9	8.0	9.6	8.6	10.6	4.4	3.1	0.0	12.5	5.0	3.9	0.0	11.8	6.5	1.0	4.4	5.5	0.1	24.3	10.6	2.4	7.5	6.0	10.8	12.2	12.1	10.4	2.6	8.4	5.5	7.7	10.2	6.8	0.2	0.0	0.0	6.1	5.4	10.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.0	0.0	0.0	5.6	11.1	12.4	30.2	14.1	13.1	5.9	7.8	9.9	6.9	8.3	62.5	19.3	0.0	13.3	26.8	9.6	33.8	71.4	14.7	31.8	22.7	0.0	27.6	19.9	10.8	21.9	17.5	10.3	0.0	4.2	7.7	21.7	12.0	1.1	13.9	6.3	9.5	43.5	19.0	9.5	32.3	66.4	5.5	8.5	0.0	17.7	7.1	10.0	5.8	92.3	14.9	1.6	25.8	22.7	2.8	15.8	25.1	7.9	2.2	29.9	14.2
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.3;stomach 1: 52.5"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 130.9;Paneth cells: 94.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.2;OE19: 40.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA035675, HPA035676"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA035675: AB_10671223, HPA035676: "	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (1.35e-4)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	2.7	2.1	7.1	12.3	7.2	6.3	3.4	4.7	5.3	5.3	28.0	1.7	3.9	33.2	6.2	3.2	3.8	4.1	21.8	3.3	5.3	4.1	2.8	0.6	7.0	7.3	2.9	4.6	3.9	2.2	0.6	3.4	3.6	2.9	8.5	14.8	4.5	3.8	4.8	1.0	5.1	46.3	3.8	3.4	6.3	52.5	3.5	3.5	12.1	4.5	3.1	9.6	15.0	3.8	5.4	4.6	0.1	3.9	4.0	9.2	4.8	4.2	0.0	0.1	0.2	1.5	1.2	0.4	1.2	1.0	1.2	1.2	3.2	13.2	2.0	1.9	0.8	0.0	1.0	0.9	0.1	0.2	0.4	0.0	3.7	0.0	0.3	1.9	3.9	5.1	1.8	1.2	1.2	0.0	0.0	2.4	8.5	3.7	1.2	1.4	0.0	6.2	4.4	0.1	40.5	0.0	2.4	0.0	1.0	0.4	5.1	0.0	0.1	0.0	0.3	0.9	0.0	0.3	6.4	1.4	0.5	0.2	1.6	0.0	0.7	1.5	0.6	0.3	5.6	2.6	0.0	3.9	0.0	8.7	2.4	9.2	4.4	5.8	4.9	2.6	5.4	7.4	5.4	0.1	4.0	1.6	4.6	6.8	4.8	7.1	7.2	4.7	5.3	5.3	4.1	2.9	4.6	2.9	3.5	8.9	9.0	0.5	5.1	2.1	0.8	1.5	10.2	12.0	14.8	0.0	0.0	2.4	0.0	2.1	4.9	3.7	130.9	0.0	15.4	2.8	3.7	5.4	8.1	0.0	2.0	1.6	9.2	3.1	1.0	14.5	3.4	2.7	1.7	1.8	40.6	26.2	22.9	94.7	2.5	1.4	0.4	0.0	3.8	4.5	2.4	1.3	0.8	10.0	38.0	23.8
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029762	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;ASC TERT1: 14.3;fHDF/TERT166: 15.8;hTCEpi: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules		NA	NA			Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	10.9	11.3	11.2	5.6	12.1	5.1	8.0	6.0	11.2	11.6	19.3	15.2	7.3	6.6	9.1	7.6	21.9	8.6	8.5	8.0	13.0	6.9	7.8	5.8	9.4	9.3	10.5	11.4	12.8	6.2	4.7	7.3	6.9	15.9	10.6	12.7	8.3	10.9	12.6	4.5	17.0	6.5	12.3	15.5	6.3	6.5	37.3	8.7	7.7	6.6	21.2	12.2	14.6	23.1	1.0	2.6	8.6	2.4	3.7	13.2	5.4	0.6	1.7	5.7	1.6	16.0	14.3	1.8	1.7	6.9	2.7	4.1	0.6	1.4	0.4	0.9	15.8	1.7	9.1	3.0	1.8	0.8	2.5	0.7	0.2	0.9	2.9	9.4	0.0	1.0	11.6	19.6	7.9	1.1	5.9	5.0	1.4	9.6	0.8	5.9	0.7	1.3	0.6	1.5	3.3	1.7	0.5	0.8	2.2	3.1	3.1	0.0	1.6	0.5	7.7	1.9	1.9	1.6	0.7	2.9	1.6	4.1	4.2	0.0	3.5	1.4	0.3	4.1	0.0	0.9	8.6	1.9	0.1	10.2	2.4	11.6	1.0	13.2	9.8	2.6	0.5	7.8	6.1	6.9	3.7	1.4	1.5	11.8	5.4	11.2	12.1	6.0	10.7	13.0	6.9	10.5	11.4	15.9	8.7	3.0	6.9	1.4	11.2	2.5	1.0	3.8	10.2	0.0	4.5	8.7	2.0	1.5	3.3	9.2	1.4	7.4	48.4	0.0	2.6	3.8	6.6	12.4	4.6	3.8	3.5	3.2	4.7	19.6	3.5	2.5	11.8	5.1	1.7	3.6	23.8	14.2	3.3	15.9	13.4	5.0	1.4	6.5	9.1	2.6	3.2	5.1	0.7	8.2	9.4	15.0
DLEC1	"CFAP81, DLC1"	ENSG00000008226	"Deleted in lung and esophageal cancer 1"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 23.2;testis: 28.9"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 68.3;Club cells: 21.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.7;NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019077	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	0.8	0.3	1.3	0.7	8.3	1.1	0.5	0.0	0.6	3.3	0.6	6.1	3.5	0.7	1.1	21.1	0.3	23.2	1.3	0.3	1.7	2.5	0.3	0.3	10.0	1.7	0.5	0.2	6.3	0.2	0.6	14.2	0.3	9.8	0.8	0.6	0.8	0.6	1.8	0.2	0.7	0.7	0.3	0.6	0.7	0.6	28.9	1.7	0.0	0.8	0.0	0.6	0.4	0.1	0.2	0.1	0.9	0.4	0.1	1.1	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.3	0.0	0.4	0.2	0.1	3.4	0.5	0.0	0.0	0.0	0.2	0.1	2.8	0.5	0.2	0.3	1.7	0.5	0.2	0.1	0.3	0.0	0.0	0.5	0.3	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.8	0.2	0.4	0.2	1.1	0.0	0.1	0.1	0.2	0.0	0.9	0.1	0.1	0.1	0.2	0.1	1.3	8.3	0.0	0.6	1.7	2.5	0.5	0.2	9.8	1.7	3.0	4.8	0.0	0.6	0.5	1.1	0.6	0.0	68.3	21.6	0.0	0.0	0.1	0.0	0.1	2.7	0.3	0.7	0.0	0.2	0.1	0.6	0.5	2.3	0.2	0.4	0.0	1.2	0.0	0.0	4.3	0.9	0.9	0.0	1.0	0.4	0.1	0.1	0.8	0.0	0.0	0.5	0.0	0.2	8.4	1.0	0.3	0.1	0.5	0.0	0.4
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 651.0;Proximal tubular cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 51.9;SK-BR-3: 82.5"					"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Supported	Peroxisomes		NA	NA		4300000	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favorable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	9.5	12.7	11.0	5.6	11.9	9.6	10.2	8.1	14.3	6.7	16.1	12.5	10.6	23.4	4.9	13.3	12.1	4.6	16.0	17.7	10.2	8.9	48.7	152.1	8.2	5.9	14.0	9.4	5.0	19.2	7.4	5.9	6.8	11.0	13.4	12.4	7.3	11.5	9.4	9.8	6.2	23.8	4.8	12.7	10.0	8.5	4.4	10.9	5.7	9.3	10.1	10.2	9.4	7.0	9.2	47.0	32.8	45.2	17.8	19.3	18.8	8.1	8.9	3.0	9.5	13.1	7.7	10.6	7.5	10.9	8.6	8.2	11.9	9.2	4.8	5.4	12.0	4.2	5.4	8.2	12.7	4.7	7.0	8.5	6.2	7.9	33.7	8.5	14.3	14.0	14.2	9.1	7.4	5.3	5.4	11.6	11.8	5.8	5.7	9.5	10.6	13.8	10.2	3.2	51.9	10.8	3.1	5.8	8.1	24.2	24.2	2.6	4.1	7.3	82.5	5.2	4.4	8.5	11.5	8.4	5.2	5.0	10.4	10.3	7.6	4.8	3.8	8.5	12.5	8.3	15.3	29.9	32.8	13.6	40.7	11.4	9.2	13.1	13.3	47.0	8.7	13.0	12.1	20.4	17.8	45.2	27.7	19.3	18.8	11.0	11.9	8.1	14.3	10.2	8.9	14.0	9.4	11.0	10.9	38.7	31.4	45.5	55.9	29.7	37.5	2.4	109.5	17.4	19.4	62.8	13.7	77.1	140.9	89.4	3.0	25.4	292.3	23.3	69.3	52.5	32.7	64.1	18.5	651.0	74.1	7.9	52.9	34.4	86.5	6.4	33.1	68.8	55.6	86.6	63.2	33.0	78.8	122.8	31.1	601.4	14.2	32.3	25.8	17.5	11.7	31.0	83.1	42.0	60.0	69.8
MYD88		ENSG00000172936	"Myeloid differentiation primary response 88"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 68.0"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favorable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	25.0	11.3	5.9	19.5	6.9	18.1	14.7	5.2	4.6	10.0	13.4	5.8	5.0	15.1	9.5	12.3	25.5	9.8	12.4	10.4	5.3	3.2	15.1	47.9	25.6	40.1	6.2	3.5	13.3	10.3	5.4	10.4	17.8	6.7	11.3	14.3	8.8	13.9	5.4	3.9	12.5	30.4	10.7	7.0	39.0	12.5	5.8	5.1	28.5	10.4	17.5	30.8	13.9	13.7	7.8	34.7	49.0	68.0	8.3	14.3	34.6	8.1	12.2	1.8	10.8	8.6	11.2	3.8	8.1	13.2	22.8	24.3	7.6	10.0	17.6	4.8	14.5	5.2	10.3	14.4	8.1	7.6	13.6	3.0	9.5	6.2	11.5	7.1	12.1	24.8	12.9	8.6	12.9	4.8	4.3	13.0	13.5	4.1	7.2	12.0	8.3	19.8	3.9	7.7	17.2	12.1	8.5	2.3	7.5	11.7	19.3	0.8	4.0	11.5	55.1	7.1	1.5	8.6	13.7	12.0	4.5	2.7	20.7	7.7	10.7	11.8	13.1	8.7	21.1	9.7	38.3	37.6	48.1	12.2	56.5	10.4	7.8	11.0	12.2	34.7	6.7	7.7	10.9	49.0	8.3	68.0	16.6	14.3	34.6	5.9	6.9	5.2	4.6	5.3	3.2	6.2	3.5	6.7	5.1	6.0	14.6	17.4	10.4	12.8	0.9	1.5	7.6	10.7	11.4	5.2	0.0	12.2	6.6	22.7	0.7	10.5	25.9	0.0	24.0	20.1	9.1	11.9	24.2	27.6	30.3	0.0	9.2	9.8	75.0	0.6	12.7	48.3	3.3	18.0	16.3	3.5	43.6	34.5	9.9	9.2	0.0	12.9	7.0	2.1	0.4	15.1	10.1	20.3	13.1	37.7
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	"Oxidative stress responsive 1"	O95747	3	38165089-38255488	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol		NA	NA		21000000	Cytosol		"CAB017181: , HPA008237: AB_1079540"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.99e-3)"	17.6	16.8	9.4	18.3	13.4	24.2	15.9	17.4	14.9	16.8	15.4	9.2	35.7	12.4	14.9	14.7	31.6	11.6	18.9	15.5	11.9	9.0	18.3	17.6	14.6	13.9	13.6	9.3	16.7	12.3	23.7	15.3	21.4	12.3	16.5	16.8	13.0	15.1	23.9	32.6	17.4	21.4	17.0	12.9	15.8	14.0	11.2	13.2	26.2	14.2	24.1	19.6	23.5	19.2	2.3	4.4	10.1	4.8	5.0	4.7	1.6	17.7	8.1	16.3	11.3	11.4	13.2	18.5	15.7	21.6	22.8	24.8	10.5	11.6	19.7	8.0	18.8	9.8	11.1	21.8	16.2	30.1	20.8	8.9	21.5	17.3	11.4	13.6	13.3	13.2	10.4	19.1	21.0	34.1	21.5	14.2	25.5	16.3	11.4	39.0	5.0	25.6	9.6	17.1	11.5	9.7	8.9	13.6	15.2	14.0	13.5	8.5	13.1	17.2	43.6	10.7	18.7	14.3	8.7	12.9	14.3	14.2	21.7	23.2	8.7	10.3	14.5	19.7	16.6	28.5	10.1	2.8	6.1	3.3	4.8	3.5	1.9	4.0	3.1	4.4	2.3	3.0	3.7	5.5	5.0	4.1	2.5	4.7	1.6	9.4	13.4	17.4	14.9	11.9	9.0	13.6	9.3	12.3	13.2	11.9	26.3	13.3	24.0	39.2	11.8	26.6	2.5	12.0	27.3	26.2	19.6	9.4	16.6	25.2	3.1	17.1	28.7	0.0	12.5	15.6	14.9	44.7	15.1	17.8	13.4	20.6	23.2	12.3	32.9	1.4	8.9	28.2	6.8	33.3	18.0	7.6	33.8	24.6	12.0	19.4	5.5	12.9	26.7	12.7	15.0	45.4	27.6	17.5	15.3	110.3
SLC22A13	"OAT10, OCTL1, OCTL3, ORCTL3"	ENSG00000172940	"Solute carrier family 22 member 13"	Q9Y226	3	38265812-38278315	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 16.4"	"Cell type enriched"	"Detected in single"	23	"Proximal tubular cells: 6.5"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 0.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.2"					"Low region specificity"	"Detected in all"			"HPA035603, HPA035962"	Enhanced					NA	NA					"HPA035603: AB_10672869, HPA035962: AB_2674890"	"unprognostic (2.73e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.50e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.74e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	16.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.1	0.3	0.0	2.3	0.0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.3	0.0	0.2	0.3	0.0	0.5	0.9	0.2	0.1	0.6	0.8	0.5	0.7	0.1	0.4	0.1	0.0	2.2	0.0	0.1	0.0	0.8	0.0	0.5	0.1	1.5	0.8	0.0	0.9	0.0	0.1	1.1	0.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.0	0.5	0.0	0.4	0.1	0.1	0.0	0.3	0.7	1.2	0.3	0.3	0.4	0.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.4	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A14	"OCTL2, ORCTL4"	ENSG00000144671	"Solute carrier family 22 member 14"	Q9Y267	3	38282294-38318575	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"testis: 13.2"	"Group enriched"	"Detected in some"	44	"Early spermatids: 57.6;Late spermatids: 81.6"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	13	"neutrophil: 1.4;plasmacytoid DC: 1.2"	"Group enriched"	"Detected in many"	13	"dendritic cells: 1.2;granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (6.26e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-4)"	"unprognostic (2.19e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.35e-1)"	0.1	0.0	0.2	0.0	0.3	0.5	0.0	1.6	0.9	0.0	0.0			0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.3	1.1	0.0	0.0	0.1	0.2		0.0	0.1	0.0	0.2	0.0		0.1	0.1		0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.2	13.2			0.0		0.0	0.0	0.0	0.0	1.2	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.7	0.7	1.3	0.2	0.1	0.6	0.4	1.0	1.6	0.1	0.0	0.4	0.9	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.9	2.9	0.0	0.8	1.1	0.1	1.1	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.4	0.7	0.1	1.4	0.0	0.0	1.9	0.0	1.1	0.6	0.3	0.3	0.3	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	81.6	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.1
XYLB	"FLJ10343, FLJ12539"	ENSG00000093217	Xylulokinase	O75191	3	38346760-38421348	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Xylose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.0"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 42.9;Proximal tubular cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 6.4;monocytes: 3.6;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037863, HPA038415"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA037863: AB_10672729, HPA038415: AB_10672592"	"unprognostic (2.48e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.37e-2)"	2.3	3.2	2.7	1.9	3.4	2.5	3.0	10.3	4.7	2.7	5.9	2.3	1.6	5.8	3.7	3.6	3.1	1.9	2.5	1.5	1.8	1.8	11.3	34.0	1.8	1.3	1.9	3.3	2.8	6.1	1.2	3.1	1.4	4.1	2.1	5.1	3.0	7.1	1.8	1.3	1.9	9.8	3.6	2.0	1.6	3.7	2.1	1.6	2.3	1.5	1.8	1.3	2.7	2.9	0.4	6.4	1.1	3.6	0.9	3.9	1.1	3.0	5.8	2.1	4.7	2.9	3.3	5.2	4.3	1.6	3.9	3.8	7.8	3.3	2.7	1.1	5.5	5.0	2.1	6.3	2.6	4.3	3.8	4.9	5.3	4.5	21.3	1.8	7.6	5.8	2.1	4.4	5.3	2.1	1.2	3.5	7.2	14.6	5.3	3.7	1.6	6.5	1.0	3.1	6.4	7.0	3.2	4.2	3.9	0.4	4.8	2.6	2.5	2.5	11.6	9.4	1.9	5.6	4.4	1.4	7.4	5.8	11.2	1.9	2.8	4.6	7.4	4.0	6.3	5.4	0.5	2.2	0.7	1.5	3.6	1.0	0.3	1.2	0.8	6.4	0.4	1.5	1.5	1.1	0.9	2.9	1.3	3.9	1.1	2.7	3.4	10.3	4.7	1.8	1.8	1.9	3.3	4.1	1.6	0.0	2.2	0.0	1.6	0.8	3.1	0.8	0.0	1.4	2.3	0.0	0.0	3.2	1.7	0.9	0.2	1.0	4.9	0.0	2.6	3.0	1.3	0.9	0.0	42.9	3.4	0.0	0.0	1.8	1.2	0.0	1.4	2.3	0.0	1.0	4.7	0.4	1.3	6.6	1.8	19.9	5.0	0.0	0.9	0.3	2.7	0.6	1.1	0.5	4.5	1.8
ACVR2B	ActR-IIB	ENSG00000114739	"Activin A receptor type 2B"	Q13705	3	38453851-38493142	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 16.4;NTERA-2: 20.3;SuSa: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007398, CAB025115, HPA040384"	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			Cytosol	"Nucleoplasm, Nuclear bodies"	"CAB025115: , HPA007398: AB_2667822, HPA040384: AB_2732484"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.75e-1)"	2.8	7.4	5.5	4.6	7.9	1.1	5.5	13.2	7.5	5.2	3.4	7.2	4.5	2.8	4.7	5.1	2.5	5.6	3.3	3.9	5.9	5.4	5.3	5.4	6.9	2.2	5.9	5.4	8.3	6.1	11.3	5.1	16.0	6.5	3.9	3.6	5.0	4.6	4.2	15.9	2.4	2.8	4.6	4.7	3.1	4.0	9.1	9.1	12.8	4.8	1.7	2.2	4.2	10.3	0.3	0.3	0.5	0.2	0.5	1.6	0.3	0.8	1.4	16.4	1.4	0.6	0.4	8.8	0.3	0.5	0.3	0.7	2.3	1.1	0.1	1.2	0.3	0.5	1.0	6.3	1.0	0.9	2.4	4.1	4.2	2.5	3.5	0.8	2.9	1.6	0.7	0.9	0.5	1.8	1.0	1.1	6.2	6.9	1.4	0.3	1.3	5.1	1.9	20.3	0.8	0.7	1.7	5.5	1.0	1.0	1.9	3.8	6.7	0.4	2.5	2.2	12.2	1.3	3.9	0.9	0.5	2.7	0.4	1.4	3.9	5.4	0.9	0.6	2.5	1.1	0.5	0.1	0.1	0.4	0.2	0.6	0.2	1.0	0.5	0.0	0.3	1.6	1.5	0.3	0.5	0.2	0.3	0.7	0.3	5.5	7.9	13.2	7.0	5.9	5.4	5.9	5.4	6.5	9.1	6.0	6.7	0.5	3.6	3.5	20.7	11.6	5.1	6.7	4.5	0.0	21.6	6.7	0.0	3.2	9.1	6.1	2.9	0.0	3.3	5.8	3.1	3.2	1.1	7.5	2.2	20.6	6.9	4.9	2.1	12.6	10.9	3.2	6.8	0.0	3.2	9.6	3.8	2.5	7.4	2.8	25.5	0.0	5.6	8.1	19.0	3.4	5.1	2.5	4.7	3.3
EXOG	"ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b"	ENSG00000157036	"Exo/endonuclease G"	Q9Y2C4	3	38496127-38542161	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 52.2;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012531, HPA071050"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA012531: AB_2732403, HPA071050: "	"unprognostic (2.88e-1)"	"unprognostic (5.81e-3)"	"unprognostic (3.55e-3)"	"unprognostic (2.77e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (1.92e-5)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (6.51e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	7.4	9.9	14.1	12.8	14.2	8.1	6.6	18.5	14.1	8.2	8.0	10.5	6.6	5.4	9.7	8.9	5.2	7.4	9.0	22.8	11.7	9.1	7.2	5.8	7.2	12.9	11.1	11.0	8.0	7.4	7.6	16.8	7.3	8.7	9.4	8.2	6.8	5.9	9.3	9.5	4.8	8.1	11.2	8.0	10.8	6.6	9.7	11.2	11.5	8.7	4.0	11.0	9.0	6.4	24.5	6.8	2.1	5.2	12.0	13.6	2.6	3.7	6.7	7.7	6.7	5.2	7.7	3.1	12.0	7.7	10.5	11.8	6.1	3.7	13.0	3.2	4.9	2.9	3.8	9.7	4.2	8.9	14.5	8.7	9.8	10.1	6.3	6.3	10.6	8.2	5.9	4.6	9.3	4.9	4.9	14.1	7.3	4.5	8.6	16.6	2.5	7.4	3.5	7.4	3.2	8.5	4.8	4.3	5.8	5.5	5.1	3.5	1.8	7.4	1.8	3.2	3.6	2.6	5.0	11.7	8.7	6.2	9.3	9.7	4.8	8.2	11.9	6.6	9.1	6.3	0.4	5.0	2.1	13.6	4.4	11.9	24.5	13.0	13.0	3.4	22.4	13.1	13.0	0.2	12.0	5.2	6.8	5.8	2.6	14.1	14.2	18.5	14.1	11.7	9.1	11.1	11.0	8.7	11.2	6.0	5.0	24.1	5.1	2.6	52.2	29.9	12.7	8.1	1.2	10.4	53.0	9.3	0.0	7.6	3.0	9.0	3.9	0.0	4.6	1.1	10.8	4.4	1.1	5.4	5.9	38.1	16.3	8.6	7.0	2.9	25.0	5.6	11.8	8.2	6.9	18.4	5.5	10.1	16.6	2.8	77.1	12.9	11.2	37.0	22.8	0.9	1.6	25.4	9.0	5.0
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 66.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 22.0;RH-30: 18.3"	"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.9	0.9	2.7	0.0	0.4	0.0	1.2	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	1.7	3.6	0.4	0.0	0.0	22.0	1.1	0.0	0.0	2.0	0.0	0.0	0.0	18.3	0.0	0.0	2.4	0.3	2.4	0.0	0.0	0.0	0.7	0.0	0.0	4.4	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	3.1	66.1	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.3	0.9	0.0	0.0	0.0	0.0	1.0
SCN10A	"hPN3, Nav1.8, PN3, SNS"	ENSG00000185313	"Sodium voltage-gated channel alpha subunit 10"	Q9Y5Y9	3	38696807-38816217	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"heart muscle: 1.5;testis: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HUVEC TERT2: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.57e-2)"										"unprognostic (7.85e-2)"		"unprognostic (2.09e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845769-38950561	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.5;placenta: 5.2"	"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 4.0;Early spermatids: 5.4;Sertoli cells: 6.5;Spermatocytes: 3.9;Spermatogonia: 6.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;HDLM-2: 5.0;SCLC-21H: 1.1;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036746, HPA036747"	Uncertain					NA	NA					"HPA036746: AB_10696785, HPA036747: AB_2675287"	"unprognostic (6.11e-2)"	"unprognostic (5.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.79e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.30e-4)"	0.9	0.2	0.8	0.5	0.8	0.0	0.6	0.1	0.3	0.0	1.1			0.4	0.0	1.4	0.0	0.1	0.1	0.0	0.4	0.5	0.4	0.3	0.0	0.2	0.4		0.0	0.1	0.0	0.4	5.2		0.1	1.3		0.0	0.0	0.1	0.8	1.0	0.5	0.6	7.5	0.0	2.6			0.1		0.1	3.4	0.1	0.2	0.4	0.9	0.1	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.1	5.0	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.1	0.6	0.0	0.0	0.0	1.3	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.9	0.1	0.1	0.4	0.0	0.0											0.0	0.0	0.0	0.8	0.7	0.1	0.8	0.0	4.0	1.2	0.0	0.0	0.2	0.0	0.0	5.4	0.6	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.2	0.3	0.0	0.0	2.5	0.0	1.0	0.0	0.0	1.7	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.4	6.5	0.9	3.9	6.0	0.6	0.2	0.0	0.0	0.9
WDR48	"KIAA1449, P80, SPG60"	ENSG00000114742	"WD repeat domain 48"	Q8TAF3	3	39051998-39096671	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038421, HPA058015"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA038421: AB_10670780, HPA058015: AB_2683580"	"unprognostic (1.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.14e-3)"	"unprognostic (9.87e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.63e-7)"	"unprognostic (2.41e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.69e-2)"	16.0	15.0	16.3	9.2	22.0	22.3	13.9	22.3	24.2	15.4	14.0	15.4	19.0	10.1	19.9	9.1	11.9	14.1	10.5	11.8	16.4	14.0	16.5	11.9	10.5	12.1	17.3	16.3	17.0	12.1	21.1	20.2	16.0	20.4	14.5	12.4	9.4	14.0	17.4	14.7	11.3	12.0	14.4	17.4	10.9	11.9	36.8	18.0	21.9	20.4	7.0	15.2	22.6	11.9	12.2	10.1	16.7	12.8	14.9	13.2	9.7	4.9	8.0	17.1	9.9	11.4	13.4	6.5	7.6	10.6	10.0	12.4	5.6	5.4	14.7	4.6	10.2	7.5	5.9	15.4	9.7	10.5	35.6	17.6	13.2	12.1	7.4	4.5	9.8	5.9	8.8	8.9	11.1	11.8	14.6	10.7	9.1	14.9	12.7	7.1	4.5	10.1	3.7	15.8	6.3	9.9	4.1	8.7	10.1	8.5	11.4	11.9	13.4	6.5	12.1	9.3	14.4	6.9	9.8	9.1	7.6	5.3	7.3	7.2	12.9	22.2	10.6	8.1	7.3	6.6	16.7	6.6	7.2	11.2	9.6	10.5	10.9	11.5	12.4	10.1	12.2	12.4	10.7	9.3	14.9	12.8	6.7	13.2	9.7	16.3	22.0	22.3	24.2	16.4	14.0	17.3	16.3	20.4	18.0	14.9	22.4	9.9	11.9	15.7	19.1	21.5	5.1	22.7	18.2	10.4	15.7	13.4	14.9	13.6	57.2	18.3	15.5	0.0	10.5	10.2	15.3	15.7	23.1	9.0	7.4	20.6	21.2	11.1	9.2	48.4	17.3	14.3	13.5	19.0	13.7	21.8	11.2	12.4	15.6	11.6	16.9	25.8	17.3	76.5	57.7	18.4	18.0	13.8	11.2	13.1
GORASP1	"FLJ23443, GOLPH5, GRASP65, P65"	ENSG00000114745	"Golgi reassembly stacking protein 1"	Q9BQQ3	3	39096659-39108363	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 80.8;Late spermatids: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056283	Supported		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA056283: AB_2683085"	"unprognostic (1.06e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.92e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (2.13e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.73e-3)"	"prognostic favorable (1.91e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.24e-3)"	13.8	12.5	14.7	12.2	18.1	10.2	19.5	19.6	26.7	29.6	21.6	26.5	25.7	10.4	18.3	18.4	20.3	20.3	17.9	14.7	16.3	15.1	18.0	24.0	18.5	11.5	18.5	20.9	13.9	22.0	26.7	15.6	21.6	19.9	21.6	27.7	18.0	21.0	31.5	11.8	16.9	17.5	24.7	16.3	21.2	18.0	19.6	18.2	8.2	22.8	12.4	17.2	17.6	14.0	8.5	7.8	4.8	9.3	1.4	3.5	3.9	4.2	1.6	8.2	5.8	23.2	16.0	3.4	5.4	15.7	12.1	11.4	2.3	6.6	4.5	3.0	20.1	5.4	8.4	9.4	12.3	10.1	5.2	4.9	6.6	5.1	5.3	7.1	4.4	6.8	10.8	22.3	12.6	15.2	15.9	16.8	1.9	4.1	6.7	13.4	6.8	1.6	7.4	2.4	13.5	5.2	2.0	1.1	8.4	12.8	8.2	1.1	2.1	5.2	14.9	3.9	10.5	11.9	8.7	6.3	5.2	2.9	7.9	3.7	3.1	3.0	1.4	4.6	5.2	5.6	1.3	6.4	3.7	1.6	6.7	2.8	8.5	2.5	1.8	7.8	7.5	2.7	2.4	4.8	1.4	9.3	5.3	3.5	3.9	14.7	18.1	19.6	26.7	16.3	15.1	18.5	20.9	19.9	18.2	3.0	6.0	6.0	10.0	3.7	8.8	7.0	12.7	5.3	4.5	12.2	0.0	9.7	10.0	9.7	80.8	11.1	15.6	0.0	7.6	8.5	8.4	15.0	1.1	8.9	8.3	7.9	10.9	12.9	6.5	48.5	6.6	8.8	11.8	3.6	13.0	7.1	8.8	7.0	6.0	5.0	10.2	0.0	8.0	7.1	6.6	5.1	16.6	2.5	12.6	11.4
TTC21A	"IFT139A, STI2"	ENSG00000168026	"Tetratricopeptide repeat domain 21A"	Q8NDW8	3	39107704-39138903	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 51.9"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 41.5;Early spermatids: 60.9;Late spermatids: 68.3;Spermatocytes: 73.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;naive B-cell: 2.7"	"Group enriched"	"Detected in many"	6	"B-cells: 2.7;monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035510, HPA035511"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035510: AB_2674659, HPA035511: AB_10671514"	"unprognostic (1.85e-3)"	"unprognostic (6.95e-3)"	"unprognostic (7.74e-3)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.58e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.91e-4)"	0.9	0.8	2.5	2.2	4.1	0.7	0.8	1.0	2.9	0.9	0.9	2.2	1.9	0.9	1.8	3.0	0.9	2.0	0.7	0.9	2.4	0.8	0.9	0.9	1.0	1.0	0.9	3.6	1.0	2.1	0.9	7.0	0.7	2.9	0.9	0.7	1.4	1.0	0.8	1.0	0.9	0.8	0.6	0.9	0.8	0.9	51.9	1.9	0.0	0.9	0.0	1.6	0.8	0.9	2.7	0.3	0.3	1.7	0.0	0.0	0.1	0.6	1.1	0.3	0.7	0.0	0.7	0.9	1.2	0.9	0.9	0.5	0.0	0.6	2.6	0.0	0.4	0.2	0.5	0.4	1.7	0.2	1.1	0.5	0.1	1.1	0.0	1.3	1.0	0.8	0.9	0.9	0.0	1.3	1.1	0.0	0.7	0.0	3.8	0.0	1.2	0.1	0.4	0.1	0.0	0.0	0.2	0.2	0.4	0.0	1.1	1.3	0.5	1.2	3.0	1.3	0.3	2.9	0.1	0.6	0.3	0.5	2.5	0.5	2.7	0.3	0.2	1.0	0.0	0.6	0.0	0.5	0.0	0.0	1.7	0.0	2.0	0.0	0.0	0.3	2.7	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	2.5	4.1	1.0	2.9	2.4	0.8	0.9	3.6	2.9	1.9	0.0	4.0	3.2	3.9	0.6	3.8	5.6	2.5	41.5	5.7	1.8	7.9	1.2	0.0	1.3	60.9	1.8	2.0	0.0	1.6	1.5	1.7	1.9	1.1	1.0	1.3	4.8	4.1	3.7	1.8	68.3	6.6	2.1	3.3	1.0	2.2	3.1	1.4	2.5	5.6	0.8	13.9	6.5	2.3	73.9	3.4	0.5	3.1	1.3	1.9	2.1
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: AB_2683726"	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.07e-4)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	33.5	24.9	5.9	16.4	11.5	70.1	20.4	4.9	8.6	16.2	14.4	11.4	13.9	5.1	12.9	9.6	25.9	35.8	28.7	19.7	5.4	5.3	9.6	33.3	35.7	7.9	8.8	3.3	24.9	16.3	11.7	17.6	30.9	15.3	15.8	6.8	9.7	10.9	50.1	22.4	19.9	21.0	26.9	11.9	9.2	20.3	11.4	7.5	8.9	14.5	14.6	7.8	21.4	16.9	3.6	3.9	15.9	9.2	2.2	2.5	1.9	2.3	5.3	1.4	2.7	2.7	2.8	4.4	8.7	12.3	7.3	6.0	7.5	2.2	7.8	1.9	6.6	5.3	2.7	1.6	11.6	3.6	11.6	2.2	8.9	4.3	5.6	3.3	2.2	8.9	1.3	6.3	11.5	1.8	6.6	9.9	2.1	6.7	13.9	6.0	7.5	0.4	3.6	6.4	4.0	4.5	3.6	5.8	12.7	5.8	8.7	3.9	0.6	4.8	36.2	2.9	8.6	4.0	4.1	4.9	3.7	16.0	3.1	6.4	3.6	3.0	3.6	8.2	2.8	4.6	0.1	2.7	3.2	1.7	5.6	2.1	3.6	1.6	1.9	3.0	3.6	2.0	1.3	15.9	2.2	9.2	3.9	2.5	1.9	5.9	11.5	4.9	8.6	5.4	5.3	8.8	3.3	15.3	7.5	44.7	66.0	21.2	65.0	91.8	1.4	12.9	17.8	9.4	17.0	10.4	0.0	13.0	8.3	30.2	47.7	63.8	51.3	23.3	34.0	40.3	70.9	58.0	96.7	34.8	35.2	0.0	56.9	49.7	35.1	34.1	1.4	49.4	65.8	20.8	34.8	4.3	37.1	28.1	3.9	4.8	1.6	12.9	150.2	0.2	3.2	69.5	75.9	27.7	25.5	32.3
XIRP1	"CMYA1, DKFZp451D042, Xin"	ENSG00000168334	"Xin actin binding repeat containing 1"	Q702N8	3	39183210-39192596	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"heart muscle: 95.0;skeletal muscle: 219.0"	"Cell type enriched"	"Detected in single"	1478	"Cardiomyocytes: 827.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 9.3;LHCN-M2: 2.3;RH-30: 6.2;SuSa: 1.9"									"HPA016750, HPA018458, CAB026391"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885"	"unprognostic (2.19e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.02e-5)"	"unprognostic (2.08e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.86e-4)"	"unprognostic (4.12e-2)"	1.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.7	1.9	0.0	0.4	95.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.2	0.3	1.1	0.0	0.0	1.3	0.0	219.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	4.9	18.2	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	827.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CX3CR1	"CCRL1, CMKBRL1, CMKDR1, GPR13, V28"	ENSG00000168329	"C-X3-C motif chemokine receptor 1"	P49238	3	39263494-39281735	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"	"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 69.2;brain: 51.6"	"Cell type enhanced"	"Detected in some"	17	"Kupffer cells: 14.4;Macrophages: 26.4;Sertoli cells: 6.5;T-cells: 15.2"	"Cancer enhanced"	"Detected in many"		"glioma: 21.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 69.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	20	"RPMI-8226: 114.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032478, HPA046587"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB032478: AB_638830, HPA046587: AB_2679708"	"unprognostic (2.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.12e-1)"	2.3	3.8	14.9	6.0	17.3	0.9	4.8	2.5	34.1	2.7	1.2	51.6	0.0	1.2	2.7	4.2	1.4	5.9	2.5	2.2	12.4	11.9	2.5	1.9	9.0	1.8	21.8	7.4	1.8	1.8	5.2	2.5	4.3	21.8	3.7	1.2	3.5	6.4	7.0	5.2	2.4	1.2	3.3	33.5	10.3	1.5	1.8	16.3	0.8	2.4	0.7	4.7	2.8	1.3	0.1	15.7	3.5	69.2	6.5	46.5	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	114.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	1.2	15.9	0.2	46.5	43.3	0.5	0.1	10.4	25.2	15.7	0.1	3.7	22.7	3.5	6.5	69.2	1.1	0.2	29.8	14.9	17.3	2.5	19.9	12.4	11.9	21.8	7.4	21.8	16.3	0.0	0.3	0.0	0.0	0.5	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.7	0.0	3.5	0.0	0.0	0.6	14.4	0.0	0.3	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.5	0.0	0.7	0.2	0.5	0.0	15.2	0.0	0.0
CCR8	"CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1"	ENSG00000179934	"C-C motif chemokine receptor 8"	P51685	3	39329706-39333511	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"blood: 19.8;lymphoid tissue: 19.3;urinary bladder: 5.3"	"Cell type enriched"	"Detected in single"	11	"Alveolar cells type 2: 1.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 19.8"	"Lineage enriched"	"Detected in single"	30	"T-cells: 19.8"	"Cell line enriched"	"Detected in some"	22	"HDLM-2: 50.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042383	Enhanced					NA	NA					"HPA042383: AB_2732497"	"unprognostic (2.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.63e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.37e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.65e-8)"	"unprognostic (7.96e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.14e-1)"	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	0.2	0.3	0.5	0.1	0.1	0.0	0.3	0.1	0.8	0.1	2.1	0.2	0.2	0.2	0.5	0.3	1.4	2.8	0.1	0.1	0.2	0.3	0.0	0.2	0.1	0.1	0.4	1.3	0.1	0.5	0.1	0.2	1.0	1.2	0.1	0.4	1.7	0.8	0.3	0.1	19.3	0.4	1.2	3.5	5.3	0.3	0.0	0.0	0.0	0.0	0.6	19.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	19.8	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A38	FLJ20551	ENSG00000144659	"Solute carrier family 25 member 38"	Q96DW6	3	39383324-39397351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041027	Approved					NA	NA					"HPA041027: AB_10794403"	"unprognostic (3.82e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (7.29e-4)"	14.0	24.6	12.2	18.2	17.1	38.1	20.9	16.7	21.9	17.2	17.8	11.9	22.2	16.0	21.3	18.2	13.3	17.8	18.2	12.9	12.0	15.3	18.0	35.9	14.7	22.5	12.8	16.2	29.1	41.3	27.2	21.7	12.8	13.4	21.3	24.1	15.1	15.5	18.4	30.0	10.6	16.4	17.0	11.3	18.9	21.3	17.7	13.0	24.7	39.8	12.5	21.5	20.5	22.7	21.6	8.1	12.4	4.2	23.2	22.7	11.9	9.7	15.6	10.3	17.3	24.2	20.1	12.9	14.0	19.1	20.3	18.5	10.7	2.3	27.4	8.3	12.9	17.3	7.6	22.9	16.4	15.3	17.5	18.4	21.2	13.8	15.7	32.5	14.9	14.5	25.2	19.4	19.5	39.6	19.0	13.1	21.9	18.9	17.3	15.1	14.0	17.8	26.5	27.6	14.6	18.1	6.5	11.0	18.9	15.9	18.6	10.3	13.1	4.8	27.6	13.5	19.8	14.0	14.1	11.2	16.3	11.1	23.5	19.8	23.2	36.5	16.7	12.4	19.6	10.3	12.4	4.2	7.7	17.7	2.5	20.4	21.6	18.3	19.4	6.4	19.0	19.6	19.0	0.6	23.2	3.4	8.1	22.7	11.9	12.2	17.1	16.7	21.9	12.0	15.3	12.8	16.2	13.4	13.0	20.8	27.2	29.7	11.4	10.2	13.9	15.3	17.8	13.4	6.8	26.2	5.9	28.2	18.3	13.7	5.2	9.0	18.2	0.0	14.6	27.5	14.4	13.3	21.9	24.1	13.2	4.8	12.1	10.4	9.8	6.3	14.4	8.3	11.8	13.6	25.4	16.3	12.3	21.0	12.7	15.4	10.3	6.5	15.6	10.4	4.7	8.9	16.2	36.2	26.0	7.2
RPSA	"37LRP, LAMR1, LRP, p40, SA"	ENSG00000168028	"Ribosomal protein SA"	P08865	3	39406689-39412542	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB009561	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		710000	"Plasma membrane, Cytosol"		"CAB009561: AB_2182543"	"unprognostic (3.67e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-1)"	47.5	42.9	48.8	88.4	56.9	107.0	76.7	26.3	56.2	50.9	63.6	29.1	65.6	48.4	73.5	50.1	93.4	82.4	52.2	67.3	43.2	33.7	44.1	63.8	67.5	300.2	41.7	37.7	145.1	264.7	35.7	42.2	45.0	43.5	58.9	71.5	31.4	148.1	50.2	60.4	70.5	53.0	73.9	48.1	76.8	58.4	60.2	26.8	83.5	72.8	105.2	112.4	53.8	80.4	92.4	64.0	6.9	24.8	61.5	101.2	114.8	94.0	86.2	75.0	123.6	66.0	150.6	117.9	67.2	109.0	153.3	89.8	94.2	82.0	213.0	41.3	132.2	40.9	37.6	162.1	155.2	132.2	76.8	84.8	96.4	81.9	91.4	127.9	135.4	90.9	167.2	258.7	117.8	189.1	111.8	157.7	127.2	100.1	103.3	110.7	65.8	157.2	101.3	250.8	146.3	148.3	74.3	107.5	156.3	107.1	43.5	54.3	110.8	36.6	283.1	116.5	106.9	82.6	188.5	62.1	47.1	86.9	78.3	163.4	79.9	121.4	127.0	75.6	131.9	62.2	6.9	20.6	4.8	53.8	24.8	93.5	92.4	89.8	71.4	58.1	89.5	101.2	88.4	3.0	61.5	20.4	64.0	66.1	114.8	48.8	56.9	26.3	56.2	43.2	33.7	41.7	37.7	43.5	26.8	482.4	691.4	2495.2	2051.4	1601.1	264.3	56.9	960.5	540.7	781.4	308.8	90.3	2456.3	840.6	1172.8	115.3	934.8	552.2	584.0	2956.9	3841.9	1034.7	1574.0	748.4	620.0	1468.8	163.7	993.6	761.1	1046.6	195.0	1148.6	961.8	700.1	1430.1	1771.7	254.3	1913.9	673.4	702.5	847.9	249.3	465.7	1029.7	293.8	1026.5	1675.1	2024.4	2012.8	2593.9	2441.2
MOBP		ENSG00000168314	"Myelin-associated oligodendrocyte basic protein"	Q13875	3	39467198-39529479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"brain: 194.3"	"Group enriched"	"Detected in some"	8	"Early spermatids: 82.2;Late spermatids: 87.8"	"Cancer enriched"	"Detected in single"	63	"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	52	"HAP1: 20.7"	"Low region specificity"	"Detected in all"							HPA035152	Enhanced		Supported	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA035152: AB_10603020"	"unprognostic (1.76e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.35e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.04e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	1.7	1.8	35.0	1.7	58.5	1.7	1.7	3.8	101.8	1.7	2.3	102.1	0.0	1.6	1.8	1.7	1.7	2.7	1.7	1.7	51.4	33.4	1.7	1.6	2.3	1.6	84.8	14.7	2.1	1.6	6.0	0.0	1.6	68.2	1.6	1.8	0.0	1.6	1.7	1.8	1.7	1.7	1.8	194.3	1.6	1.7	5.0	64.2	0.0	1.7	0.0	1.6	1.7	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	35.0	58.5	3.8	29.1	51.4	33.4	84.8	14.7	68.2	64.2	0.0	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	87.8	1.4	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.3	0.0	0.4	8.6	4.9	0.4	0.0	0.0	0.0	0.0
MYRIP	"DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C"	ENSG00000170011	"Myosin VIIA and Rab interacting protein"	Q8NFW9	3	39808914-40260321	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;retina: 36.3"	"Cell type enhanced"	"Detected in many"	17	"Hepatocytes: 14.7;Ito cells: 44.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.5;HUVEC TERT2: 17.0;REH: 3.9;SCLC-21H: 3.6;SH-SY5Y: 10.5;T-47d: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006433			Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"		"HPA006433: AB_10603023"	"unprognostic (1.87e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.96e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.16e-2)"	4.8	2.0	31.0	2.2	7.8	0.5	3.4	23.7	19.4	9.0	4.2	3.9	1.3	2.9	6.0	3.8	2.4	3.3	4.3	2.8	13.9	9.6	2.7	16.7	1.7	2.6	8.5	11.0	5.3	13.1	2.1	8.4	0.6	10.8	3.4	4.4	36.3	16.0	1.8	2.7	1.8	2.8	3.9	5.5	10.2	7.7	1.7	4.2	0.0	2.1	1.6	2.9	2.8	2.7	0.8	0.1	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	1.1	0.0	0.1	3.9	0.0	0.0	0.4	2.2	3.6	10.5	0.0	0.0	0.0	0.0	4.2	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	31.0	7.8	23.7	18.4	13.9	9.6	8.5	11.0	10.8	4.2	0.0	5.6	0.0	0.1	0.7	2.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	9.9	0.0	0.0	2.3	0.0	0.2	1.7	2.3	14.7	0.0	4.8	0.0	44.8	4.3	3.6	0.9	0.0	0.0	0.0	9.6	6.3	1.0	0.0	0.0	0.8	4.3	0.0	0.5	2.7	0.2	0.5	0.0	0.0	0.6	0.0
EIF1B	GC20	ENSG00000114784	"Eukaryotic translation initiation factor 1B"	O60739	3	40309684-40312424	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 156.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.54e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.64e-2)"	"unprognostic (7.91e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (3.16e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.33e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.87e-2)"	21.9	35.7	36.1	17.3	39.2	70.4	36.2	42.4	57.5	20.5	21.8	20.1	11.9	15.6	24.9	23.8	16.3	24.4	23.3	156.7	39.4	40.5	36.5	34.3	21.6	22.7	35.1	43.0	38.0	22.7	28.9	43.7	19.8	58.6	19.9	16.6	17.0	17.5	22.9	52.1	14.3	17.9	23.9	53.7	20.0	21.1	31.7	24.7	12.7	22.7	16.0	21.6	23.4	21.0	31.3	24.3	44.7	18.7	12.9	19.0	12.9	10.3	8.5	29.1	16.5	35.2	34.6	17.4	21.3	28.1	21.1	27.6	13.3	14.1	21.4	11.9	14.5	12.7	7.1	19.8	10.4	21.6	32.3	20.1	34.4	9.1	30.4	56.0	20.7	17.8	25.1	32.2	18.6	31.9	30.0	22.2	14.5	28.7	26.5	24.4	6.6	16.6	22.5	39.4	9.2	22.7	11.5	16.2	17.2	20.6	13.3	12.4	20.4	15.4	9.0	57.1	28.8	11.4	21.1	17.0	12.2	12.7	24.7	14.8	24.6	43.4	31.0	15.3	22.8	17.4	24.3	16.4	43.7	13.0	18.7	15.5	31.3	16.0	16.5	15.0	29.2	19.0	16.4	44.7	12.9	17.2	24.3	18.8	12.9	36.1	39.2	42.4	57.5	39.4	40.5	35.1	43.0	58.6	24.7	86.4	63.3	142.5	178.7	168.9	98.3	402.0	73.9	78.9	54.6	83.7	51.1	96.0	248.7	84.2	121.0	94.4	91.5	210.2	99.3	99.2	140.4	90.8	128.0	63.6	111.8	141.4	112.7	92.1	138.5	56.3	100.9	134.4	141.7	129.0	77.2	134.9	73.1	164.9	86.3	216.1	189.9	90.5	167.9	467.4	251.4	129.2	96.7	111.5	78.2	186.4
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387156-40428619	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.2;pancreas: 37.3"	"Group enriched"	"Detected in many"	4	"Exocrine glandular cells: 19.8;Pancreatic endocrine cells: 5.7;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 7.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;HBEC3-KT: 12.7;hTCEpi: 8.6;RT4: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.6	2.2	5.7	1.7	25.9	0.5	2.1	5.4	15.8	26.2	3.3	0.6	1.9	1.7	4.0	4.4	7.5	1.3	3.6	1.4	4.9	6.3	3.6	0.5	4.8	0.9	4.0	6.3	2.6	37.3	1.7	4.2	2.9	14.5	5.3	3.6	2.8	21.2	5.1	1.7	3.2	1.6	2.5	1.7	5.1	8.8	1.3	4.8	0.0	7.0	5.6	4.8	13.7	2.9	0.5	7.4	1.4	0.3	0.9	0.8	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.1	3.8	0.0	12.7	0.3	0.7	0.4	0.7	0.5	0.2	0.0	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.5	0.0	0.1	0.1	0.3	1.1	0.1	0.0	0.3	1.6	18.3	1.9	0.4	0.8	1.4	0.3	0.4	0.7	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.4	0.0	1.1	0.1	0.1	1.4	0.2	0.0	0.2	0.3	0.8	0.3	0.2	0.3	0.0	0.5	0.6	0.6	0.0	0.9	0.2	7.4	0.6	0.1	5.7	25.9	5.4	15.8	4.9	6.3	4.0	6.3	14.5	4.8	3.0	3.4	0.0	1.0	2.1	0.0	0.4	0.0	1.4	2.3	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	19.8	0.0	0.2	2.3	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	5.7	0.0	0.7	0.0	0.6	19.4	3.1	0.3	0.1	1.9	0.0	0.0	0.0	3.7
RPL14	"CTG-B33, hRL14, L14, RL14"	ENSG00000188846	"Ribosomal protein L14"	P50914	3	40457292-40468587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 95.3"	"Low region specificity"	"Detected in all"							HPA004136	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		210000	"Endoplasmic reticulum, Cytosol"		"HPA004136: AB_1079839"	"unprognostic (1.36e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.15e-1)"	49.9	33.5	28.3	57.4	43.8	47.2	134.4	28.7	57.6	85.4	68.2	21.4	48.0	29.8	87.0	30.9	66.0	61.0	56.7	46.7	40.8	22.8	42.5	69.8	44.6	61.7	24.7	22.2	151.9	117.3	48.4	34.4	60.8	40.6	81.8	42.0	36.2	162.9	73.6	72.3	66.7	39.0	59.1	24.7	69.6	52.4	23.8	11.7	42.9	63.3	100.2	58.5	48.7	77.0	26.6	16.0	4.6	11.6	14.3	38.3	47.9	9.4	5.2	32.0	11.4	25.9	91.2	18.6	14.5	48.6	54.7	41.5	11.0	3.7	41.3	12.3	14.3	20.9	2.9	16.2	25.4	32.3	14.0	17.9	19.8	9.1	10.5	39.7	28.1	10.7	44.1	95.3	15.5	33.0	66.1	50.1	49.6	23.2	5.8	37.8	9.1	9.2	25.6	9.1	46.3	17.1	4.3	12.1	20.0	40.5	7.0	10.0	16.0	7.6	7.4	22.0	38.0	11.5	15.5	16.6	11.1	8.1	14.0	18.3	18.1	21.7	22.5	5.0	21.2	10.2	3.7	11.6	4.6	21.1	11.6	35.5	26.6	31.7	27.7	16.0	24.1	38.3	34.9	1.8	14.3	9.9	14.6	24.9	47.9	28.3	43.8	28.7	57.6	40.8	22.8	24.7	22.2	40.6	11.7	771.2	883.3	2536.9	4403.4	2765.6	207.8	306.9	1449.7	777.6	1508.2	642.0	96.2	2943.8	2143.7	1521.6	222.8	1840.1	1118.8	887.7	3599.1	4111.4	1918.7	2744.5	1484.2	1016.8	1943.1	95.3	1181.4	1316.6	1781.7	387.3	2000.3	2174.5	1690.4	2539.2	2184.9	232.3	2849.1	1855.2	1019.7	2575.0	247.3	950.7	1701.5	263.4	350.5	2988.0	2771.9	1999.5	2848.8	3958.2
ZNF619	FLJ90764	ENSG00000177873	"Zinc finger protein 619"	Q8N2I2	3	40477113-40490236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 3.8;Collecting duct cells: 3.5;Rod photoreceptor cells: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045094	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA045094: AB_10959900"	"unprognostic (7.16e-2)"	"unprognostic (5.94e-1)"	"unprognostic (8.38e-3)"	"unprognostic (5.42e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-3)"	"unprognostic (8.28e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.38e-2)"	8.8	7.6	6.3	9.2	9.5	9.0	9.2	7.9	8.7	7.0	6.7	13.3	8.4	7.3	9.3	6.6	6.4	8.4	8.9	6.9	7.8	5.8	7.1	8.1	9.6	18.0	12.7	9.2	9.4	12.3	14.0	6.6	6.3	7.3	7.0	8.2	9.7	8.6	10.4	8.5	7.3	7.5	7.6	9.6	9.0	7.3	3.8	9.3	6.0	10.2	5.0	9.4	8.0	6.8	4.1	4.5	5.1	4.5	5.2	5.1	2.7	2.7	4.0	4.7	4.1	6.9	7.2	1.7	3.6	4.5	7.0	7.0	1.2	3.9	0.3	2.3	3.4	3.2	3.0	4.3	7.5	7.6	4.8	1.6	8.3	3.2	1.9	7.2	5.8	7.5	5.8	5.6	7.1	10.5	6.2	6.5	0.3	5.5	3.9	4.3	3.4	0.1	2.6	2.5	3.4	3.6	1.6	4.8	4.5	2.9	6.3	3.0	3.1	4.1	6.0	3.2	4.4	4.8	3.9	4.9	5.1	4.0	2.8	4.1	2.2	2.8	0.3	3.1	3.6	5.4	2.8	3.2	5.1	3.0	4.5	3.3	3.3	3.0	3.8	4.5	4.1	3.1	3.9	3.8	5.2	4.3	2.8	5.1	2.7	6.3	9.5	7.9	8.7	7.8	5.8	12.7	9.2	7.3	9.3	0.0	0.6	0.0	0.7	0.2	3.8	0.8	0.0	1.4	0.0	3.5	2.0	1.2	0.0	1.1	0.0	1.1	1.0	0.0	1.3	0.8	0.6	0.5	0.0	0.5	1.0	0.0	0.0	1.8	1.0	0.0	1.1	0.2	0.0	1.0	0.7	2.9	0.6	0.0	0.4	1.3	3.7	0.0	0.5	1.0	1.3	0.1	0.3	0.0	1.0	0.6
ZNF620	MGC50836	ENSG00000177842	"Zinc finger protein 620"	Q6ZNG0	3	40505992-40518736	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;monocytes: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 14.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA031452, HPA059383"	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA031452: AB_10603939, HPA059383: AB_2732636"	"unprognostic (1.42e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.15e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.21e-5)"	"unprognostic (1.28e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.19e-4)"	5.8	5.7	5.2	3.0	8.2	8.0	6.1	15.6	8.5	3.7	5.0	8.9	4.8	4.4	4.0	6.3	3.1	5.3	3.2	4.4	5.6	5.7	6.2	4.5	6.2	3.4	10.3	5.8	4.5	8.1	8.7	15.2	6.3	6.4	5.2	5.9	6.1	3.5	5.7	6.3	2.4	4.7	4.3	5.3	5.2	7.3	3.0	7.4	3.7	9.5	3.7	3.1	4.8	4.5	2.0	1.3	14.2	1.0	3.1	3.9	1.2	2.4	3.5	8.4	3.1	0.9	0.9	4.4	0.6	0.9	4.0	5.8	8.2	5.2	0.0	2.6	0.4	3.5	0.6	12.5	1.1	2.9	7.1	9.7	6.0	8.8	4.6	1.5	2.1	1.2	0.5	0.8	2.5	1.1	1.0	2.7	0.1	3.1	1.0	0.5	4.0	0.4	1.8	9.8	4.6	1.9	3.2	3.6	1.1	3.7	8.5	9.9	7.5	0.6	5.9	3.8	8.7	7.7	2.3	1.8	0.4	5.7	0.8	2.6	1.3	2.1	0.1	1.3	1.2	1.5	14.2	0.6	1.2	2.6	1.0	3.2	0.8	1.0	2.7	0.6	2.0	2.1	2.7	0.9	3.1	0.3	1.3	3.9	1.2	5.2	8.2	15.6	8.5	5.6	5.7	10.3	5.8	6.4	7.4	6.0	2.6	0.8	3.1	0.5	8.8	1.4	5.1	2.7	4.5	0.0	3.9	6.2	5.0	4.5	0.1	4.5	1.9	23.3	2.6	1.3	1.1	2.7	6.9	1.7	1.2	3.2	8.6	4.3	1.8	0.0	0.3	1.6	0.0	18.0	3.3	8.3	2.6	2.8	0.4	3.4	10.6	0.0	3.6	3.1	6.5	0.1	1.6	2.5	3.8	1.3
ZNF621	FLJ45246	ENSG00000172888	"Zinc finger protein 621"	Q6ZSS3	3	40524878-40574685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA065518, HPA071440"			Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA065518: AB_2685501, HPA071440: AB_2686395"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.33e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.01e-3)"	12.3	11.3	14.6	10.6	27.1	11.6	16.6	20.4	17.3	14.2	11.1	26.2	15.5	9.6	16.4	18.3	9.1	10.9	11.3	9.3	17.3	14.1	11.8	10.0	12.5	11.1	26.7	12.1	14.1	15.0	18.4	15.6	10.6	17.6	13.3	11.4	12.1	12.6	14.8	10.5	16.2	10.4	15.9	22.7	11.6	11.2	8.6	24.7	4.8	13.9	8.1	11.5	10.4	10.6	7.4	4.3	5.5	3.4	4.9	4.8	1.8	9.2	4.9	13.0	12.8	9.5	14.1	7.0	9.6	11.8	12.7	12.2	10.4	5.0	3.7	7.2	12.9	8.6	3.1	12.4	7.1	14.9	13.0	13.7	12.4	18.4	9.6	15.1	11.7	12.1	11.2	16.3	12.8	20.7	14.1	9.9	4.5	12.7	10.9	10.5	5.0	2.9	13.7	7.6	3.3	10.1	1.3	8.4	3.9	6.7	11.2	4.3	11.4	9.0	7.2	11.4	13.5	10.9	9.7	12.2	21.4	10.6	10.1	13.8	16.5	15.4	7.9	10.1	8.7	13.2	5.5	3.0	2.5	3.9	3.4	2.7	6.1	3.8	4.8	2.4	7.4	4.4	3.9	4.4	4.9	1.9	4.3	3.1	1.8	14.6	27.1	20.4	17.3	17.3	14.1	26.7	12.1	17.6	24.7	8.9	10.5	7.5	4.2	1.3	12.5	10.1	10.2	4.0	11.4	10.4	11.8	4.5	5.0	6.0	6.0	8.7	5.0	0.0	4.9	2.9	5.1	4.9	3.5	4.0	3.3	14.3	9.8	5.5	6.7	5.7	6.9	4.4	3.3	10.0	5.6	9.4	5.5	3.5	11.3	2.9	15.0	0.0	4.9	9.4	7.0	1.6	4.6	5.7	5.8	4.2
CTNNB1	"armadillo, beta-catenin, CTNNB"	ENSG00000168036	"Catenin beta 1"	P35222	3	41194741-41260096	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway"	Activator	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 451.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000108, CAB001950, HPA029159, HPA029160"	Supported		Enhanced	"Plasma membrane"		NA	NA		1000000	"Plasma membrane"		"CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996"	"unprognostic (2.47e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.79e-2)"	52.9	54.5	38.8	33.5	45.9	46.3	70.5	78.8	59.3	71.7	49.6	57.3	34.2	48.7	79.2	42.5	46.3	49.8	45.0	42.1	38.6	41.5	46.9	53.2	53.6	31.6	37.0	47.0	84.2	38.6	59.2	44.0	82.6	41.5	50.8	50.1	75.9	53.9	49.7	31.2	44.7	70.4	66.5	39.4	41.0	37.3	29.0	39.3	40.1	62.3	44.5	36.6	46.9	54.2	10.1	13.5	7.5	14.5	11.1	13.5	4.8	22.5	30.0	63.3	35.4	34.1	28.0	48.6	25.4	36.1	42.5	42.3	20.7	32.2	18.5	23.2	44.9	19.1	16.9	45.8	73.4	45.6	17.1	31.2	29.8	39.9	73.8	25.5	16.9	14.4	40.8	33.3	50.8	30.9	34.8	37.3	8.9	21.1	11.5	47.1	22.8	11.8	9.1	57.6	30.1	23.3	8.9	41.2	12.3	26.3	70.4	15.1	25.6	42.1	21.5	113.0	78.5	35.2	35.2	48.1	32.0	24.5	20.5	37.2	7.2	11.1	19.7	32.8	21.3	53.4	4.3	8.1	6.9	11.2	14.5	13.5	9.6	10.5	12.1	13.5	10.1	10.7	10.8	7.5	11.1	13.7	11.7	12.6	4.8	38.8	45.9	78.8	59.3	38.6	41.5	37.0	47.0	41.5	39.3	128.1	177.9	34.4	112.8	189.7	38.8	66.6	99.3	119.1	161.5	59.3	31.4	274.7	29.9	114.0	5.5	164.1	147.7	46.7	68.4	90.6	121.0	101.1	113.2	146.9	108.7	12.7	90.0	114.2	130.0	5.0	55.3	139.8	192.3	115.4	132.0	103.7	102.3	182.4	81.7	57.4	56.6	45.3	106.2	71.5	40.7	152.9	451.2	62.8	118.4	109.3
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 279.5;Late spermatids: 329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	4.3	4.8	5.1	4.7	8.3	10.3	4.2	4.3	5.4	11.9	2.8	5.9	6.0	2.1	10.7	10.9	2.8	12.3	3.1	13.1	5.2	3.0	5.4	3.4	5.5	4.2	3.1	4.2	4.5	3.6	13.5	19.7	9.0	5.8	4.4	2.8	6.7	4.2	4.5	1.4	3.5	3.3	5.1	5.7	4.4	3.4	27.5	3.4	6.3	7.1	1.7	8.4	4.0	6.0	6.4	5.1	10.7	6.3	2.6	10.3	5.2	7.3	1.7	2.7	3.0	1.1	1.7	4.6	2.5	2.6	3.1	2.6	0.9	2.2	8.6	1.4	5.8	3.0	3.7	3.2	1.9	2.8	1.1	0.9	1.6	5.4	2.9	3.9	5.6	1.7	1.6	2.2	15.0	3.1	3.9	2.1	5.9	1.9	7.2	2.2	5.9	7.0	4.5	3.3	1.8	3.1	1.6	8.5	3.7	6.5	7.1	1.4	9.9	2.6	1.2	2.1	1.8	3.0	1.8	6.2	2.0	2.2	13.2	2.1	4.3	8.0	3.6	11.0	5.9	2.4	5.7	5.8	5.8	8.0	6.3	6.5	5.6	8.6	7.2	5.1	6.4	6.5	9.2	10.7	2.6	3.2	4.6	10.3	5.2	5.1	8.3	4.3	5.4	5.2	3.0	3.1	4.2	5.8	3.4	8.9	5.8	1.9	2.8	1.8	5.4	12.8	5.1	53.5	4.5	3.5	51.1	2.8	0.0	2.3	279.5	4.4	1.1	0.0	2.1	3.9	3.3	1.2	1.1	5.9	6.5	11.1	1.7	1.8	4.1	329.6	6.1	5.6	0.0	6.4	1.1	11.2	2.8	0.0	3.9	5.0	25.1	6.5	3.3	29.9	8.7	3.1	3.5	4.4	1.7	0.8
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225889	"Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.9;skeletal muscle: 101.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 240.0;Rod photoreceptor cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 57.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoplasm	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favorable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	11.3	5.9	14.7	8.3	15.7	7.6	8.6	20.5	20.1	7.1	23.5	15.4	4.2	15.5	6.1	8.0	14.9	9.6	21.9	71.9	15.1	12.4	9.5	7.7	11.0	9.8	14.3	15.6	4.1	6.5	16.8	11.0	9.7	16.2	7.8	11.9	23.8	22.9	7.7	101.1	21.6	23.7	7.9	11.7	12.2	26.9	7.0	10.6	4.9	14.4	31.9	14.2	19.1	10.5	7.1	4.8	1.6	4.3	1.7	1.8	1.1	7.5	6.6	13.1	5.6	9.2	9.0	17.2	10.2	11.5	6.7	7.3	4.3	10.7	14.8	5.4	25.3	7.3	3.6	9.1	23.5	7.3	13.4	6.5	10.2	6.7	12.1	4.6	11.6	8.1	7.7	10.1	14.8	13.6	9.7	13.4	4.0	5.2	11.9	8.5	3.1	1.2	6.1	5.7	20.6	5.1	5.4	4.9	12.4	9.2	57.0	8.5	9.9	3.9	5.7	5.4	11.4	5.1	9.8	13.7	5.8	6.9	34.8	5.9	8.9	7.5	13.4	6.4	10.2	5.6	1.6	2.5	1.0	1.2	4.3	1.1	5.0	1.8	1.5	2.8	7.1	0.8	1.8	1.1	1.7	2.4	4.8	0.8	1.1	14.7	15.7	20.5	20.1	15.1	12.4	14.3	15.6	16.2	10.6	29.8	26.7	25.6	13.5	33.8	21.5	240.0	28.1	84.3	35.2	14.0	94.2	20.3	1.7	9.5	1.0	20.2	61.3	0.0	10.9	15.7	10.1	17.2	10.4	8.5	13.4	31.8	21.9	4.3	13.9	2.7	1.7	23.7	23.6	4.6	35.6	32.5	17.2	36.5	2.5	7.9	131.7	32.3	18.4	0.7	3.6	37.8	13.2	5.3	28.1	23.2
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266207	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 95.1;intestine: 71.6"	"Group enriched"	"Detected in some"	5	"Glandular cells: 57.6;Melanocytes: 38.8;Muller glia cells: 33.0"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 59.0;basal ganglia: 29.8;cerebral cortex: 95.1;hippocampal formation: 35.8;olfactory region: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"OE19: 72.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 565.3"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"	NA	NA					"HPA045039: , HPA069515: AB_2732135"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.9	1.1	59.0	1.1	29.8	0.8	0.9	0.2	95.1	0.8	11.3	1.4	0.0	71.6	0.8	0.8	0.9	0.9	0.9	0.9	35.8	10.8	0.8	0.9	1.1	0.8	8.0	26.9	0.8	1.1	0.8	4.1	9.4	1.3	13.5	0.9	0.0	0.8	1.0	0.8	0.9	10.5	1.0	1.3	0.8	1.7	1.7	0.5	0.0	0.8	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0	0.0	0.0	0.3	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.0	29.8	0.2	95.1	35.8	10.8	8.0	26.9	1.3	0.5	0.0	0.0	0.0	1.0	5.0	1.1	0.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	57.6	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	38.8	0.0	0.0	33.0	0.5	0.0	0.0	0.0	3.2	0.0	2.1	0.0	0.4	1.1	8.8	0.0	0.0	3.3
LYZL4	"LYC4, MGC26768"	ENSG00000157093	"Lysozyme like 4"	Q96KX0	3	42397078-42410600	"Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 29.0"	"Group enriched"	"Detected in some"	72	"Early spermatids: 297.8;Late spermatids: 112.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"OE19: 9.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA038806	Approved				"Secreted in male reproductive system"	NA	NA					"HPA038806: AB_10674841"					"unprognostic (4.03e-1)"							"unprognostic (5.68e-1)"		"unprognostic (1.06e-1)"				0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	297.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.4	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.3	0.0	0.0	1.9	2.1	0.0	0.0	0.0	0.0	0.0
VIPR1	"HVR1, RDC1, VPAC1, VPAC1R"	ENSG00000114812	"Vasoactive intestinal peptide receptor 1"	P32241	3	42489299-42537573	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 83.1"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 40.7;Mucus-secreting cells: 38.5;Paneth cells: 92.0;Sertoli cells: 32.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.2;intermediate monocyte: 2.6;MAIT T-cell: 1.9;memory CD4 T-cell: 4.8;memory CD8 T-cell: 1.9;myeloid DC: 3.9;naive CD4 T-cell: 5.5;naive CD8 T-cell: 1.7;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	32	"dendritic cells: 3.9;monocytes: 3.2;T-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 27.3;OE19: 15.9;RT4: 19.5;SK-BR-3: 11.1;WM-115: 35.4"	"Group enriched"	"Detected in many"	5	"amygdala: 6.5;basal ganglia: 4.1;cerebral cortex: 9.2;hippocampal formation: 8.5"	"Low region specificity"	"Detected in all"			HPA026777	Approved					NA	NA					"HPA026777: AB_10604003"	"unprognostic (9.02e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.89e-4)"	"unprognostic (4.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.05e-2)"	8.1	1.8	5.6	6.4	11.8	1.3	7.4	10.2	13.8	2.0	17.7	0.6	27.8	22.0	0.9	4.6	2.7	1.0	10.6	3.1	2.9	1.2	1.4	15.4	83.1	5.1	1.3	8.4	0.5	1.4	2.9	1.2	1.9	1.9	13.0	18.1	2.2	9.7	29.0	0.8	12.2	25.9	1.3	0.9	2.7	3.7	0.9	1.3	0.0	7.2	3.2	3.1	6.0	2.4	0.1	3.9	0.1	3.2	0.0	5.5	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.9	27.3	0.1	1.3	0.0	0.0	1.1	0.0	0.7	0.0	0.0	2.1	1.6	0.8	0.0	0.1	0.0	0.2	0.0	1.7	0.1	0.5	0.0	0.3	0.2	0.0	0.0	0.0	2.2	0.0	0.1	1.7	15.9	0.1	0.2	0.0	1.2	0.0	19.5	0.6	0.0	0.0	11.1	0.0	3.3	6.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.4	0.0	3.2	0.0	0.4	2.6	1.9	0.1	4.8	1.9	3.9	0.0	5.5	1.7	0.1	0.0	2.3	0.0	0.7	1.3	5.6	11.8	10.2	13.8	2.9	1.2	1.3	8.4	1.9	1.3	3.0	5.9	2.0	4.2	6.8	0.1	1.2	5.1	1.4	2.3	1.8	7.9	0.0	0.0	0.4	0.7	1.4	40.7	0.0	0.8	0.3	0.4	9.6	0.0	0.0	0.6	0.0	4.6	14.7	8.9	0.4	0.0	2.4	0.0	0.0	38.5	1.2	0.8	92.0	0.0	0.0	5.1	32.3	2.2	0.0	0.0	6.8	0.2	1.3	22.9	3.2
SEC22C	"MGC13261, MGC5373, SEC22L3"	ENSG00000093183	"SEC22 homolog C, vesicle trafficking protein"	Q9BRL7	3	42547969-42601080	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031242			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA031242: "	"unprognostic (1.68e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.15e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.35e-7)"	"unprognostic (2.59e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-3)"	25.3	20.9	27.6	13.4	30.5	28.0	28.8	19.0	30.5	24.1	21.1	32.8	17.4	28.4	26.2	25.8	16.4	22.2	17.4	22.6	27.5	25.4	22.5	14.1	24.6	18.9	34.7	24.6	29.0	26.6	23.8	23.7	17.7	27.6	36.4	14.5	25.7	23.3	25.1	15.4	14.5	31.6	24.9	49.2	15.8	20.7	32.0	25.6	14.5	23.5	11.8	15.2	18.4	17.6	11.5	10.3	18.8	10.7	9.9	19.4	9.2	12.3	11.6	16.2	14.5	32.5	30.7	4.5	22.4	20.7	21.5	22.7	8.2	18.4	12.0	9.2	23.2	15.5	6.6	12.5	18.9	19.4	16.7	14.2	18.7	19.6	9.3	25.7	10.3	19.2	18.2	23.2	26.9	28.7	20.6	24.5	19.3	18.5	21.1	21.1	8.0	12.3	9.5	10.2	6.8	17.3	6.3	11.5	10.5	17.7	10.1	9.5	13.7	17.1	12.6	15.7	12.4	24.5	9.6	22.3	19.6	15.6	29.7	21.7	17.8	26.9	11.3	21.3	13.2	18.2	8.7	10.7	18.8	13.7	7.7	19.4	11.5	17.7	16.1	9.9	9.8	15.2	13.4	6.0	9.9	8.0	10.3	14.2	9.2	27.6	30.5	19.0	30.5	27.5	25.4	34.7	24.6	27.6	25.6	23.8	25.9	19.9	14.3	13.4	15.4	16.9	25.5	18.7	18.2	10.4	27.5	18.6	34.9	26.6	32.1	31.2	4.2	70.0	28.5	17.2	32.7	23.5	48.5	10.6	28.2	25.4	8.6	27.6	18.3	9.9	30.2	19.3	38.8	45.1	4.4	31.0	23.7	0.0	40.3	22.3	31.8	38.8	31.4	75.8	54.1	8.9	8.8	28.7	6.7	5.4
SS18L2	KIAA-iso	ENSG00000008324	"SS18 like 2"	Q9UHA2	3	42581840-42595114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047377	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		Yes	No			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA047377: AB_2680020"	"unprognostic (4.09e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.64e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (6.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.24e-3)"	12.7	11.6	24.5	17.8	26.4	29.9	20.8	25.2	23.8	14.0	14.8	14.4	9.1	19.4	9.1	20.6	16.6	10.6	11.8	10.8	23.5	20.6	15.8	26.2	11.9	34.8	20.5	15.9	13.5	29.0	10.9	16.1	10.7	17.4	22.2	15.5	11.3	18.6	10.8	10.1	14.9	19.3	8.4	24.0	19.7	15.6	6.4	14.9	20.4	18.7	14.7	32.0	16.0	11.1	48.0	30.0	32.8	25.9	31.0	53.5	32.9	16.1	7.4	14.9	13.5	19.2	15.6	9.3	10.5	12.0	15.7	17.8	14.2	14.8	22.1	9.6	7.2	16.5	9.1	17.8	14.7	17.3	11.0	20.8	24.0	14.5	23.8	13.8	31.3	18.9	12.2	9.5	12.6	11.9	10.9	17.1	19.7	21.7	33.4	12.6	15.3	22.0	38.9	23.6	21.8	18.2	11.7	10.9	30.7	17.4	20.4	8.4	12.0	8.9	14.0	14.1	16.8	18.3	29.3	10.0	9.2	15.1	22.1	19.1	24.3	38.4	37.5	13.6	34.4	8.8	19.0	23.5	32.8	38.4	25.9	51.6	48.0	50.5	45.3	24.9	40.8	43.9	44.1	31.1	31.0	19.2	30.0	53.5	32.9	24.5	26.4	25.2	23.8	23.5	20.6	20.5	15.9	17.4	14.9	11.9	11.8	77.1	64.6	95.1	14.4	16.1	38.2	14.7	15.9	26.2	7.9	47.4	48.0	38.3	2.3	39.4	43.1	23.3	43.1	65.4	37.6	63.9	45.0	58.7	58.5	22.3	52.9	28.3	37.6	2.5	31.9	41.0	49.0	61.3	42.2	24.6	41.3	53.7	14.9	68.9	23.5	12.9	39.1	13.2	24.0	120.8	31.2	95.9	48.0	96.2
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600614-42648741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: AB_2681540"	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.01e-4)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.05e-5)"	12.9	14.4	9.8	18.8	22.2	16.3	15.9	42.0	12.3	18.8	10.4	18.5	15.4	11.8	27.2	17.4	11.0	12.0	13.1	11.2	10.9	10.5	9.5	9.7	14.6	15.5	14.5	11.3	22.7	18.4	19.2	26.9	11.1	14.1	12.9	11.1	20.4	13.2	19.5	12.0	20.0	13.3	19.4	15.0	18.5	10.1	17.8	13.8	20.6	14.9	10.9	19.4	12.9	13.9	9.3	8.5	11.7	10.0	11.1	10.2	3.6	8.9	5.2	17.2	7.0	10.3	12.6	9.7	14.6	3.7	6.1	8.3	9.0	7.2	14.2	7.0	4.4	6.0	7.9	10.1	3.7	12.5	7.1	8.5	18.2	16.3	14.6	4.4	14.0	12.0	5.1	7.2	12.0	4.6	11.1	10.7	3.4	18.3	11.0	11.5	3.7	9.5	13.7	14.8	4.8	7.6	10.1	7.7	5.8	8.5	6.9	6.1	3.6	15.7	6.5	2.4	8.0	9.6	10.2	17.1	10.9	8.0	11.9	14.0	9.5	13.3	9.9	5.8	17.2	6.7	9.2	6.2	11.7	10.2	7.7	9.4	8.9	9.8	8.5	4.7	9.3	10.0	8.7	9.1	11.1	10.0	8.5	8.3	3.6	9.8	22.2	42.0	12.3	10.9	10.5	14.5	11.3	14.1	13.8	101.3	122.0	67.1	53.1	52.4	190.3	63.1	50.9	45.5	75.1	83.7	231.7	56.8	14.9	39.7	13.6	120.9	75.7	23.3	34.0	42.2	62.5	58.7	92.6	44.7	39.4	125.5	69.0	103.2	49.9	13.7	155.3	72.2	49.0	62.3	51.5	160.2	38.7	44.6	126.2	9.7	283.7	90.5	58.5	210.1	183.7	50.1	26.2	126.8	54.0	42.1
ZBTB47	"DKFZp434N0615, KIAA1190, ZNF651"	ENSG00000114853	"Zinc finger and BTB domain containing 47"	Q9UFB7	3	42653684-42665854	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 28.1;skeletal muscle: 33.1"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 7.9;Early spermatids: 9.9;Melanocytes: 8.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 33.9;fHDF/TERT166: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074057	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074057: AB_2686657"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.86e-2)"	"unprognostic (8.99e-2)"	"prognostic favorable (7.96e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.10e-2)"	5.8	3.3	11.4	3.1	18.0	0.5	2.8	3.3	11.3	4.8	4.4	15.7	0.7	1.1	5.4	1.5	4.4	3.1	4.4	28.1	16.1	4.7	1.2	2.0	2.6	2.1	8.6	9.1	5.0	4.5	2.7	3.0	2.1	6.3	4.8	1.0	2.9	7.6	6.2	33.1	2.8	1.4	5.8	12.8	1.7	3.0	3.1	16.7	0.7	5.2	4.2	1.6	3.7	3.3	0.0	0.9	2.8	1.6	0.3	0.3	0.4	3.6	3.3	2.0	1.3	33.9	13.2	0.7	8.8	7.6	3.9	2.8	0.7	1.5	0.0	3.6	18.0	1.4	0.9	0.5	3.4	0.8	0.0	4.4	2.2	9.5	0.8	10.4	0.0	3.0	14.1	6.2	4.9	4.3	10.0	4.2	0.0	2.0	2.6	7.7	0.9	0.1	0.3	1.1	0.1	2.2	2.7	3.9	1.0	2.1	0.8	2.3	3.8	4.1	0.7	3.3	0.9	4.6	4.8	9.5	8.1	4.7	7.8	3.5	0.1	0.0	0.0	7.4	2.6	2.4	0.0	1.6	0.1	0.3	1.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	2.8	0.3	0.9	0.0	0.0	0.4	11.4	18.0	3.3	9.3	16.1	4.7	8.6	9.1	6.3	16.7	0.0	0.6	0.0	1.2	3.5	4.8	7.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.6	9.9	1.5	0.0	0.0	1.1	0.1	3.0	1.1	4.6	0.5	1.2	0.0	0.0	1.8	1.8	1.4	3.1	1.3	8.5	1.0	0.0	6.6	0.7	0.2	2.8	0.6	1.7	0.0	5.6	0.0	0.2	2.8	0.1	0.0	0.0	1.0
KLHL40	"KBTBD5, NEM8, SRYP"	ENSG00000157119	"Kelch like family member 40"	Q2TBA0	3	42685519-42692544	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"	"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 132.0"	"Group enriched"	"Detected in some"	13	"Early spermatids: 3.9;Late spermatids: 6.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HSkMC: 3.2;RH-30: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024463, HPA052201"	Enhanced					NA	NA					"HPA024463: AB_1852095, HPA052201: AB_2681759"					"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"			"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"		"unprognostic (7.85e-2)"			"unprognostic (2.50e-1)"	"unprognostic (4.04e-1)"		2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	0.0	132.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.7	19.6	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
HHATL	"C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3"	ENSG00000010282	"Hedgehog acyltransferase like"	Q9HCP6	3	42692663-42702827	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 57.1;heart muscle: 184.7;skeletal muscle: 93.6"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 96.4;Cardiomyocytes: 54.3;Muller glia cells: 48.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.2;HSkMC: 1.3;Karpas-707: 1.2;NTERA-2: 1.4;RPMI-8226: 4.2;THP-1: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA018174	Enhanced					NA	NA					"HPA018174: AB_2116671"	"unprognostic (1.72e-2)"	"unprognostic (1.56e-1)"		"unprognostic (5.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.94e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.14e-1)"	1.5	1.6	12.9	1.3	29.0	1.3	1.9	2.3	15.2	1.5	1.4	36.5	0.0	1.3	1.7	1.5	2.7	2.0	1.5	184.7	14.5	8.9	1.4	1.3	1.5	1.4	51.6	10.5	1.4	1.8	1.4	0.9	1.4	25.9	1.9	1.4	5.4	4.7	1.4	93.6	1.6	1.4	1.4	57.1	1.4	1.3	1.7	39.9	0.0	9.3	7.2	1.4	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.5	0.0	4.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.3	0.5	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	29.0	2.3	15.2	14.5	8.9	51.6	10.5	25.9	39.9	0.0	0.0	0.0	0.0	0.3	96.4	54.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	48.8	0.3	0.0	0.0	0.0	9.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
CCDC13	FLJ25467	ENSG00000244607	"Coiled-coil domain containing 13"	Q8IYE1	3	42692663-42773253	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.2;fallopian tube: 13.6;testis: 15.0"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 24.5;Ciliated cells: 50.9;Distal tubular cells: 14.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.1;ASC diff: 2.4;Daudi: 1.3;HDLM-2: 3.0;NTERA-2: 1.5"	"Low region specificity"	"Detected in all"							HPA047429	Approved		Supported	Centrosome		NA	NA			Centrosome		"HPA047429: AB_2680043"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.83e-7)"	"unprognostic (6.21e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (2.04e-2)"	0.7	1.0	3.0	0.7	12.2	0.6	0.7	0.8	4.0	1.3	0.9	6.3	2.3	1.1	2.1	7.0	0.7	13.6	1.5	1.7	3.7	2.7	1.1	1.7	2.5	0.7	1.9	4.6	1.5	2.0	1.0	3.7	0.7	8.1	0.7	1.4	1.5	1.6	1.1	2.0	0.6	1.1	0.9	3.4	0.8	0.8	15.0	2.5	0.0	1.9	0.3	0.6	0.7	0.5	0.0	0.0	0.1	0.2	0.5	1.2	0.2	0.0	0.0	0.0	1.1	2.4	0.9	0.8	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.1	0.0	0.1	3.0	0.9	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	3.0	12.2	0.8	4.0	3.7	2.7	1.9	4.6	8.1	2.5	0.0	1.1	0.0	0.2	0.9	24.5	1.1	2.5	50.9	7.9	3.5	3.9	0.1	14.9	0.8	11.5	0.5	0.2	0.0	0.2	0.4	1.0	0.9	1.1	0.0	2.4	0.0	0.0	0.6	0.8	12.4	1.4	1.8	1.7	2.8	0.1	1.5	0.2	0.6	0.7	2.5	5.4	0.0	0.7	8.8	5.1	1.0	0.0	0.0	0.0	0.6
HIGD1A	"DKFZP564K247, HIG1, RCF1A"	ENSG00000181061	"HIG1 hypoxia inducible domain family member 1A"	Q9Y241	3	42784298-42804531	"Predicted membrane proteins"	"Electron transport, Respiratory chain, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 535.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 89.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043336	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA043336: AB_10795039"	"unprognostic (6.46e-2)"	"unprognostic (3.72e-3)"	"prognostic favorable (2.12e-4)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.45e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (3.99e-8)"	"unprognostic (7.37e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	27.7	30.4	50.1	15.5	43.4	9.6	20.4	20.3	56.4	18.3	63.8	25.2	10.8	35.2	15.7	24.8	36.7	13.5	18.8	68.6	43.2	43.3	45.9	78.4	15.3	16.0	54.4	35.9	12.8	12.8	14.7	29.2	17.2	50.9	24.4	67.3	21.8	16.6	26.8	34.9	15.0	28.4	22.8	58.8	13.0	31.6	14.7	20.7	8.9	28.1	30.6	16.9	20.1	25.0	11.9	89.9	25.9	26.6	12.3	18.8	30.1	27.4	15.4	34.3	28.1	87.8	52.5	33.4	37.1	30.5	36.4	33.4	27.2	28.0	16.8	22.3	32.4	22.6	16.6	27.5	40.9	45.5	24.1	30.4	51.9	27.7	50.3	40.1	29.8	24.5	54.4	45.0	27.8	38.8	18.1	31.9	25.6	51.2	18.0	50.7	11.2	16.4	10.9	28.8	23.3	37.6	13.4	24.3	11.9	89.7	68.2	14.5	18.9	32.5	24.7	35.0	35.7	24.7	22.5	27.9	21.5	19.5	60.1	38.3	16.8	34.7	34.7	28.3	31.7	16.6	16.9	14.7	25.9	15.4	22.7	13.7	11.9	15.1	15.1	16.3	8.5	12.9	15.3	14.9	12.3	26.6	89.9	18.8	30.1	50.1	43.4	20.3	56.4	43.2	43.3	54.4	35.9	50.9	20.7	50.6	73.8	43.3	134.0	116.5	33.4	319.5	79.0	48.2	60.3	130.9	9.8	99.0	535.5	105.9	6.7	57.3	183.7	93.5	127.6	162.8	82.5	160.2	92.2	169.5	69.4	27.0	78.7	55.3	46.3	9.1	28.4	70.1	167.0	114.6	120.5	121.0	198.7	300.1	49.1	213.1	25.1	77.6	125.8	135.9	72.8	178.8	250.8	45.7	135.9	173.3
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 96.2;salivary gland: 74.8"	"Group enriched"	"Detected in many"	10	"Cytotrophoblasts: 26.5;Extravillous trophoblasts: 87.8;Syncytiotrophoblasts: 61.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 7.3;NK-cell: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.3;NK-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 32.2;HEL: 10.3;SK-BR-3: 17.2;U-937: 6.5"	"Group enriched"	"Detected in many"	9	"amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6"	"Not detected"	"Not detected"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"HPA013819: AB_1846126, HPA073493: AB_2686610"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	10.4	0.9	0.4	0.7	0.5	0.4	5.3	0.2	0.4	2.9	1.8	0.1	0.6	0.7	2.0	5.2	2.5	2.4	1.2	1.0	0.5	0.4	1.1	14.5	1.5	1.0	0.5	0.2	0.9	0.7	0.3	0.6	96.2	0.2	1.1	2.0	0.3	74.8	0.4	2.1	2.5	1.0	3.2	0.7	1.1	0.9	1.5	0.1	0.4	3.8	2.3	2.0	3.2	4.1	0.8	0.4	7.3	0.6	2.2	0.4	0.3	0.1	0.0	0.1	0.2	1.5	0.1	32.2	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	10.3	0.2	1.8	0.0	0.1	1.2	0.3	0.3	0.0	0.0	0.0	0.0	0.3	1.3	0.2	0.2	0.2	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.4	4.5	0.1	0.1	0.8	17.2	0.0	1.9	1.7	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	6.5	0.1	0.7	0.2	7.3	0.4	0.5	0.1	0.2	0.1	0.2	0.4	0.8	0.3	0.3	1.0	2.2	0.6	0.3	0.1	0.3	0.4	0.5	0.2	0.4	0.5	0.4	0.5	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.6	2.5	1.4	0.0	0.0	2.0	26.5	1.7	0.0	1.9	1.4	2.0	0.0	0.0	87.8	1.8	0.4	2.3	5.8	4.6	1.6	1.7	3.7	0.3	1.1	0.3	0.2	0.0	0.0	0.1	2.5	0.6	0.0	1.1	0.3	0.9	0.0	0.0	4.5	3.3	0.0	61.6	0.5	0.4	0.1
AC092042.3		ENSG00000273291			3	42809446-43055871	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	29	"testis: 57.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;U-2197: 1.7"															NA	NA						"unprognostic (2.83e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.81e-1)"	0.5	0.5	0.4	0.4	1.5	0.4	0.5	1.5	1.7	0.7	0.5	1.1	0.4	0.4	1.0	1.9	0.5	0.4	0.6	1.6	0.6	0.5	0.5	0.4	0.5	0.4	0.4	0.6	0.7	1.4	0.4	1.1	0.6	1.0	1.0	1.3	1.6	0.5	0.4	0.5	0.5	0.5	1.3	0.9	0.5	0.5	57.2	0.0	0.0	1.2	0.0	0.4	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	1.5	1.5	1.7	0.6	0.5	0.4	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRBOX1		ENSG00000240747	"KRAB box domain containing 1"	C9JBD0	3	42809483-42942792	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	8	"placenta: 78.4;testis: 68.5"	"Cell type enriched"	"Detected in many"	7	"Spermatocytes: 1048.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 9.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 9.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.6;CAPAN-2: 22.9;EFO-21: 11.2;GAMG: 17.6;hTEC/SVTERT24-B: 16.1;hTERT-HME1: 10.8;U-2197: 31.8"									HPA046901			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA046901: AB_2797232"	"unprognostic (2.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-3)"	"unprognostic (7.63e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.95e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	1.1	1.8	1.6	0.3	2.1	0.3	1.4	2.1	2.3	1.9	1.6	1.8	1.2	0.8	2.6	5.4	2.1	1.9	1.2	2.3	1.4	1.2	1.4	0.3	0.7	0.7	1.4	1.2	3.2	2.3	0.3	1.9	78.4	1.6	1.6	1.0	2.3	2.1	2.7	0.5	2.5	1.0	2.3	1.8	0.7	1.1	68.5	0.6	0.2	2.5	1.1	0.8	1.2	1.1	0.8	1.7	1.2	1.2	9.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	10.6	0.0	0.0	0.0	22.9	0.0	11.2	0.8	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.5	0.0	16.1	10.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	8.2	0.0	31.8	0.0	3.4	1.1	0.0	1.7	0.0	0.6	0.0	0.6	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.9	0.0	9.0	1.2	1.7	0.5	0.2	1.6	2.1	2.1	2.3	1.4	1.2	1.4	1.2	1.6	0.6	0.0	1.6	0.0	2.5	0.0	6.5	4.8	5.1	1.4	3.4	5.2	2.0	9.4	16.6	4.1	134.8	0.4	0.7	0.0	10.5	8.6	1.6	1.5	0.0	0.5	2.0	1.6	0.0	1.3	0.0	72.9	18.7	0.0	0.0	0.0	0.8	12.4	6.2	1.9	12.7	1.7	7.4	12.9	3.3	1048.9	159.2	0.0	7.6	0.0	1.7	0.8
CYP8B1	CYP12	ENSG00000180432	"Cytochrome P450 family 8 subfamily B member 1"	Q9UNU6	3	42856005-42876165	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 132.7"	"Cell type enriched"	"Detected in some"	57	"Hepatocytes: 737.2"	"Cancer enriched"	"Detected in some"	46	"liver cancer: 69.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Group enriched"	"Detected in some"	5	"BEWO: 6.8;HEL: 1.7;Hep G2: 2.6;SK-BR-3: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (5.86e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	6.7	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.4	0.2	0.1	0.2	0.1	0.4	0.7	0.3	0.2	0.0	0.0	6.8	0.1	0.0	0.0	0.0	0.5	0.3	0.2	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	1.7	0.2	2.6	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.2	0.0	0.4	0.2	0.0	0.3	0.1	0.4	0.5	0.6	0.3	0.3	0.5	0.1	0.0	0.6	3.1	0.3	0.4	0.3	0.1	0.3	0.3	0.6	0.3	0.2	0.4	0.1	0.3	0.3	0.4	0.1	1.4	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	737.2	0.1	0.0	0.0	10.4	10.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ZNF662	FLJ45880	ENSG00000182983	"Zinc finger protein 662"	Q6ZS27	3	42905731-42917641	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;HSkMC: 4.5;SH-SY5Y: 5.7;THP-1: 5.6;U-2 OS: 8.1"					"Low region specificity"	"Detected in all"			"HPA039116, HPA040377"	Uncertain					NA	NA					"HPA039116: AB_2676355, HPA040377: AB_2676949"	"unprognostic (2.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.55e-4)"	"unprognostic (1.80e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.39e-3)"	"unprognostic (7.18e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-2)"	4.6	3.7	4.1	3.1	5.9	0.9	9.6	17.5	8.1	7.8	5.8	12.3	4.7	2.8	15.2	7.4	5.3	7.1	4.0	3.6	4.4	2.3	4.0	4.2	5.2	2.1	7.2	5.2	13.3	9.1	4.6	11.5	3.0	6.7	10.3	5.4	10.7	9.6	6.7	4.4	15.7	4.2	6.7	6.0	4.7	7.0	8.2	6.3	0.7	8.9	4.4	2.3	6.5	7.5	0.8	1.3	1.0	0.7	1.6	4.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	4.4	1.8	0.0	1.2	1.0	3.9	2.3	0.0	3.0	2.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.4	0.0	1.8	0.2	0.0	4.5	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.1	3.7	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.3	0.0	3.1	5.7	0.0	2.0	0.0	1.1	0.0	5.6	0.0	1.5	8.1	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.3	0.7	0.2	0.3	0.7	0.6	0.4	1.1	0.8	4.2	4.1	1.0	1.6	0.3	1.3	0.7	0.6	4.1	5.9	17.5	8.1	4.4	2.3	7.2	5.2	6.7	6.3	11.9	2.9	0.0	2.5	2.2	6.2	2.4	0.0	1.4	6.8	1.8	5.9	1.5	1.7	1.5	1.7	3.8	0.4	0.0	2.9	2.1	4.1	2.1	0.0	2.6	0.1	6.4	5.2	1.3	0.6	3.1	10.6	1.6	5.0	0.0	3.4	3.4	2.5	0.0	4.2	1.3	10.1	12.9	2.1	16.7	10.7	1.6	2.4	0.0	4.0	2.0
FAM198A	"C3orf41, DKFZP434B172"	ENSG00000144649	"Family with sequence similarity 198 member A"	Q9UFP1	3	42979267-43060211	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 11.9;Leydig cells: 9.2;Muller glia cells: 17.2;Peritubular cells: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.9;RPMI-8226: 6.2;SK-BR-3: 4.2;T-47d: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047726	Approved		Supported	Vesicles	"Secreted - unknown location"	NA	NA		440000	Vesicles		"HPA047726: AB_10960554"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.81e-1)"	8.9	3.5	6.2	3.7	8.3	0.1	5.4	4.1	6.8	10.8	3.5	6.1	2.4	1.3	11.7	9.4	4.0	13.8	13.0	2.0	7.2	2.6	1.3	12.1	3.8	1.1	5.1	5.5	9.4	3.0	0.3	2.6	3.2	11.2	2.7	1.8	4.0	4.1	3.8	1.4	1.8	2.5	9.2	5.2	1.2	4.3	3.1	6.8	0.0	2.0	1.1	0.6	3.8	4.2	0.0	1.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	5.9	0.2	0.0	1.7	0.3	0.6	0.0	0.0	0.2	1.8	0.0	1.8	0.0	2.8	0.0	0.7	0.0	0.0	0.0	2.5	0.9	0.0	0.0	1.3	0.5	2.1	1.2	0.0	0.6	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	3.4	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.1	0.4	0.0	4.2	0.0	0.3	11.9	1.4	0.0	0.8	1.2	2.4	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	0.0	6.2	8.3	4.1	6.8	7.2	2.6	5.1	5.5	11.2	6.8	0.0	0.0	0.0	0.1	0.1	1.2	0.6	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.1	0.6	0.3	0.0	0.0	0.2	1.9	3.1	0.2	0.0	11.9	3.1	3.2	0.0	1.8	0.3	0.0	9.2	0.0	0.0	1.0	0.0	17.2	0.3	0.0	18.7	0.3	1.6	6.5	1.4	0.9	0.9	0.5	2.3	0.0	0.0	0.0
POMGNT2	"AGO61, C3orf39, FLJ14566, GTDC2"	ENSG00000144647	"Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)"	Q8NAT1	3	43079232-43106076	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034870, HPA040989"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA034870: AB_10602701, HPA040989: AB_2677238"	"unprognostic (2.37e-3)"	"unprognostic (8.22e-2)"	"prognostic favorable (8.13e-5)"	"unprognostic (2.57e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (8.71e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (4.00e-7)"	"unprognostic (4.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	8.4	12.7	13.9	4.1	20.2	16.6	6.8	28.4	32.7	14.2	7.1	13.1	6.2	3.8	28.2	12.0	7.9	21.7	10.3	15.6	12.5	13.2	7.8	6.8	7.3	2.9	10.6	12.3	21.1	14.7	14.0	10.6	5.6	13.5	10.6	3.2	11.1	13.5	15.8	15.0	7.2	4.1	20.1	7.3	4.4	7.4	9.1	8.8	4.4	10.6	3.4	3.4	7.6	7.6	2.9	1.2	1.0	0.9	1.6	5.7	1.8	11.4	8.7	5.1	15.5	19.6	5.1	8.1	3.3	5.9	11.8	13.8	10.6	8.1	0.0	12.5	5.9	14.2	0.2	8.3	9.6	5.1	0.0	23.2	8.0	6.9	10.0	7.5	5.6	9.6	5.8	7.1	7.9	4.6	4.6	4.5	17.5	6.6	0.0	4.5	6.7	10.2	1.4	11.2	7.2	16.5	4.0	3.6	7.1	6.9	8.4	8.0	7.3	6.9	5.6	6.2	3.6	10.6	4.9	2.1	9.5	13.4	14.0	13.4	8.7	12.9	0.1	12.2	11.4	10.0	0.0	0.9	1.0	5.7	0.8	5.1	2.9	3.8	3.8	1.1	1.9	4.9	3.8	0.0	1.6	0.8	1.2	2.9	1.8	13.9	20.2	28.4	32.7	12.5	13.2	10.6	12.3	13.5	8.8	3.0	1.3	0.8	2.6	7.1	14.0	13.2	12.7	6.7	2.3	14.0	7.9	2.9	5.0	8.7	8.2	2.8	1.6	0.0	9.5	4.8	10.3	3.4	0.0	5.6	5.3	9.5	5.8	6.2	3.1	19.8	18.4	2.2	5.0	0.0	1.8	8.7	5.0	2.0	27.6	5.3	4.3	12.9	7.5	7.1	18.3	10.2	1.5	2.5	2.3	1.8
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 86.5;Sertoli cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 51.9;TIME: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	31.5	8.8	9.8	13.1	14.4	41.0	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11.0	11.0	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18.0	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17.0	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3.0	20.9	5.5	8.1	10.7	6.5	3.3	2.0	3.8	3.6	11.3	4.0	3.6	3.6	6.1	3.9	3.8	2.8	4.8	5.3	2.8	4.5	2.6	2.1	4.4	7.7	4.1	6.0	3.6	6.0	3.8	3.2	5.9	6.7	6.7	4.5	5.3	4.4	7.5	4.0	51.9	6.1	2.6	6.1	3.5	1.7	6.8	5.9	4.2	1.8	9.3	4.7	2.8	5.5	10.1	5.7	2.7	5.6	3.1	3.3	4.3	3.4	2.3	8.6	30.2	3.4	3.5	3.9	4.1	9.9	7.1	4.5	2.4	8.1	4.9	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3.0	3.2	10.1	10.1	20.9	8.1	5.0	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11.0	11.0	11.4	10.6	22.5	7.2	29.8	30.3	12.9	9.7	46.9	49.8	14.5	22.9	16.0	18.2	15.7	15.7	6.3	10.0	9.2	40.0	52.3	28.4	0.0	7.8	2.7	11.8	9.9	13.9	21.3	11.3	28.6	10.4	86.5	27.6	4.9	11.5	16.6	21.9	4.6	8.9	15.6	8.4	8.2	11.0	10.4	17.2	122.9	26.4	10.7	15.7	44.8	6.9	41.7	8.5	15.4
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: AB_2681537"	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.70e-4)"	"prognostic favorable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	21.6	12.7	11.8	12.6	13.2	20.6	22.0	18.2	14.1	17.5	27.4	14.3	13.2	42.0	17.9	12.4	19.8	10.4	16.7	10.5	12.3	15.2	22.2	10.5	13.6	10.7	17.3	12.3	12.7	14.4	18.6	14.4	17.5	19.4	10.7	24.4	18.6	23.1	19.5	11.3	24.6	52.9	19.9	23.6	9.4	11.1	9.1	8.8	5.5	17.7	15.8	13.9	13.7	17.0	2.0	8.5	22.4	12.5	6.3	4.6	4.3	9.0	7.2	8.0	8.4	32.6	17.6	9.8	26.5	44.2	13.6	17.3	4.8	8.4	1.0	8.5	34.9	13.4	4.9	6.3	14.5	16.5	10.0	4.5	11.8	9.7	5.2	14.3	2.1	9.6	16.3	11.6	16.7	22.8	24.9	31.7	5.7	8.8	7.7	30.0	6.4	2.3	1.5	9.6	7.0	8.4	1.8	5.7	3.1	26.7	9.5	2.0	5.9	10.5	8.6	6.1	14.8	18.4	4.3	25.8	20.7	7.7	21.7	12.1	5.0	6.5	0.3	18.9	4.5	13.6	4.4	12.5	0.9	4.6	7.1	2.7	1.9	3.2	3.1	8.5	2.0	2.8	4.3	22.4	6.3	7.7	1.5	3.5	4.3	11.8	13.2	18.2	14.1	12.3	15.2	17.3	12.3	19.4	8.8	6.0	2.7	2.2	5.2	4.9	7.1	4.5	10.2	4.0	7.9	14.0	0.0	12.0	104.5	19.0	2.7	14.0	47.9	23.3	15.4	15.5	7.8	5.5	2.3	6.8	10.4	9.5	9.2	19.0	9.2	3.1	5.2	8.2	13.5	1.8	19.1	20.3	11.8	16.5	9.6	14.9	3.6	6.5	12.3	14.7	22.6	5.4	14.3	3.9	24.3	4.6
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 70.3"	"Cell type enhanced"	"Detected in many"	7	"Syncytiotrophoblasts: 171.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 26.1;monocytes: 7.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	26.5	10.5	5.2	7.4	12.2	32.2	70.3	8.5	10.3	7.6	10.2	10.5	5.9	7.4	4.6	4.0	22.7	3.7	10.4	9.8	7.4	4.5	10.1	18.4	14.1	8.7	18.5	4.6	4.2	12.8	9.1	8.6	20.2	14.9	5.8	6.7	4.4	21.1	7.4	10.4	24.8	15.1	8.1	19.0	7.0	8.9	8.1	12.5	3.3	13.2	9.9	6.7	11.2	16.0	1.7	3.6	26.1	7.6	0.9	2.4	2.5	8.5	3.0	3.6	3.8	15.2	5.8	7.5	34.9	13.9	9.6	7.2	4.7	3.0	7.1	4.8	10.9	8.5	2.8	5.7	8.5	9.8	25.8	5.5	18.2	11.6	3.2	7.6	4.1	5.9	6.4	29.5	16.1	13.8	8.4	16.0	4.8	10.8	5.4	21.3	4.6	2.9	2.9	9.7	6.8	9.8	1.3	10.4	4.1	12.4	17.0	4.4	6.0	15.3	8.3	3.6	4.0	8.9	3.5	8.8	8.5	6.7	15.7	15.1	4.9	13.6	3.4	9.0	7.5	6.6	26.1	7.6	4.4	1.2	3.7	1.0	1.7	0.9	1.4	3.6	1.2	0.8	1.3	21.0	0.9	2.7	0.9	2.4	2.5	5.2	12.2	8.5	10.3	7.4	4.5	18.5	4.6	14.9	12.5	23.8	43.8	8.5	23.5	35.4	11.3	9.7	15.3	17.4	25.0	26.2	25.5	13.3	28.2	49.4	13.5	16.9	64.4	23.3	53.5	21.2	16.2	21.6	16.1	11.3	16.6	3.2	34.9	14.7	26.6	12.9	4.9	30.4	6.8	16.2	17.1	12.4	61.4	24.6	5.3	31.4	14.7	0.0	26.8	35.6	43.9	35.8	171.7	15.8	18.2	41.1
TOPAZ1	"C3orf77, FLJ36157"	ENSG00000173769	"Testis and ovary specific PAZ domain containing 1"	Q8N9V7	3	44241886-44332098	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	49	"testis: 9.2"	"Group enriched"	"Detected in some"	17	"Sertoli cells: 19.4;Spermatocytes: 62.3;Spermatogonia: 44.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047431, HPA051034"	Uncertain					NA	NA					"HPA047431: AB_2680045, HPA051034: AB_2681318"														"unprognostic (1.68e-1)"	"unprognostic (8.88e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2			0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	19.4	0.0	62.3	44.4	0.0	0.0	0.0	0.0	0.0
TCAIM	"C3orf23, DKFZp313N0621, TOAG-1"	ENSG00000179152	"T cell activation inhibitor, mitochondrial"	Q8N3R3	3	44338119-44409451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.93e-3)"	"unprognostic (5.07e-3)"	"unprognostic (5.60e-2)"	"prognostic favorable (2.19e-7)"	"unprognostic (4.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.81e-4)"	10.1	10.0	10.4	7.4	11.7	5.1	9.7	17.4	12.2	6.5	9.9	9.9	5.9	9.7	9.4	8.7	12.0	6.4	9.3	15.4	9.8	10.4	21.8	38.4	9.4	7.4	12.9	6.4	8.2	8.4	17.9	11.6	8.6	12.0	10.2	10.3	7.6	7.2	8.0	17.0	7.5	10.1	8.4	19.6	9.8	9.9	5.5	11.1	12.0	7.5	8.5	7.7	11.3	6.8	3.5	10.7	11.5	10.1	3.2	8.6	4.1	9.4	4.9	4.7	6.5	7.3	5.3	10.5	7.6	9.8	10.1	9.9	4.6	23.8	13.7	6.3	5.5	7.6	4.2	4.6	11.2	10.4	5.6	6.2	9.8	6.8	10.3	14.4	14.2	8.9	7.8	20.3	9.8	11.8	7.6	12.6	14.2	12.3	8.4	8.4	6.4	15.1	7.5	4.3	11.0	11.2	3.2	5.6	10.3	19.2	13.8	5.2	9.7	10.8	14.7	14.9	8.5	10.7	9.8	10.5	5.3	7.1	13.7	13.0	4.4	8.3	10.0	13.2	13.0	7.5	11.5	8.2	10.0	3.8	10.1	4.0	2.4	4.6	3.9	10.7	3.5	3.9	5.6	3.9	3.2	9.8	5.7	8.6	4.1	10.4	11.7	17.4	12.2	9.8	10.4	12.9	6.4	12.0	11.1	8.9	17.3	6.0	8.3	9.2	16.5	28.1	25.5	10.7	6.8	14.0	11.8	11.3	51.4	21.1	1.8	9.5	10.4	0.0	18.1	16.8	10.8	9.1	20.7	41.9	17.5	23.8	5.8	14.7	16.7	1.4	8.1	12.5	6.8	12.6	15.4	12.8	20.4	16.9	4.6	33.8	12.7	12.9	8.2	5.4	9.5	8.3	11.2	7.5	15.1	9.5
ZNF445	"ZKSCAN15, ZNF168, ZSCAN47"	ENSG00000185219	"Zinc finger protein 445"	P59923	3	44431720-44477670	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 34.4;Cone photoreceptor cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006678	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA006678: AB_10603329"	"unprognostic (7.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.05e-1)"	6.8	6.4	8.3	6.4	10.9	4.5	7.5	16.5	10.9	8.6	7.1	11.7	8.0	5.1	13.6	7.7	5.2	8.3	6.1	6.3	7.7	7.0	6.3	7.5	6.7	6.6	11.3	10.5	13.0	7.6	16.1	13.9	7.1	7.9	8.6	6.6	9.9	8.1	8.2	11.2	8.2	5.7	12.3	6.6	7.0	7.3	6.5	8.9	14.2	6.9	4.8	8.1	6.7	8.2	1.1	1.1	4.1	2.5	1.9	1.5	0.5	2.5	2.9	9.1	7.1	5.1	5.2	4.1	3.5	2.9	5.3	5.3	4.4	2.3	4.5	2.2	3.6	3.4	2.1	6.1	2.4	6.4	4.9	2.3	8.3	5.9	4.3	3.2	10.5	7.0	3.6	3.0	5.9	3.8	4.5	3.7	6.4	6.4	3.4	4.2	1.7	10.0	7.1	6.2	1.6	2.7	4.5	5.7	2.2	2.9	5.3	4.5	5.6	5.4	2.8	1.4	7.1	5.2	4.6	4.4	7.5	6.7	4.6	4.4	2.7	2.0	3.8	2.8	5.3	4.5	2.7	1.3	2.3	1.2	0.8	1.1	0.7	0.9	0.9	0.9	1.1	1.5	1.1	4.1	1.9	2.5	1.1	0.4	0.5	8.3	10.9	16.5	10.9	7.7	7.0	11.3	10.5	7.9	8.9	11.9	16.7	7.3	4.1	3.7	34.4	7.8	2.5	12.0	10.3	10.4	35.3	3.3	1.7	4.4	1.9	6.8	2.6	0.0	7.3	1.5	6.1	5.2	10.5	8.5	4.7	27.0	6.9	10.4	14.0	1.6	8.6	7.7	0.0	1.0	6.5	13.4	4.4	3.5	9.2	2.3	30.0	12.9	6.1	5.7	6.1	2.3	1.1	5.7	6.9	3.4
ZNF852		ENSG00000178917	"Zinc finger protein 852"	Q6ZMS4	3	44498970-44510636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 4.8;Ciliated cells: 6.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA048312, HPA049885, HPA071850"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA048312: AB_2680352, HPA049885: AB_2680933, HPA071850: AB_2686458"	"unprognostic (2.64e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.62e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.11e-2)"	3.8	4.0	5.0	4.7	5.4	3.1	4.7	12.9	6.9	4.6	4.0	3.2	4.6	3.6	5.2	3.7	3.6	4.2	3.1	3.3	4.8	2.1	4.0	3.7	4.8	4.8	5.5	3.9	6.4	10.3	9.0	13.5	4.7	5.4	5.6	5.8	4.2	8.8	4.6	2.9	4.6	5.4	7.0	4.7	5.1	6.0	2.9	4.6	7.1	4.4	2.5	6.3	5.0	6.1	2.4	2.7	1.4	1.3	0.7	1.8	0.4	0.8	1.4	3.4	5.9	0.8	2.0	2.4	0.9	1.2	1.6	2.7	1.8	1.0	2.9	0.7	1.0	0.9	0.9	3.7	0.9	2.3	2.3	1.7	2.6	5.8	1.5	1.5	2.9	5.3	0.8	1.9	2.4	0.8	2.1	1.4	2.9	3.2	1.6	1.7	0.2	2.5	2.4	1.9	0.9	0.7	1.3	3.5	1.3	1.1	2.9	2.9	2.1	1.8	0.8	0.8	6.0	1.9	2.7	1.8	2.2	2.4	1.3	0.9	2.4	1.5	1.5	0.7	2.2	1.4	0.0	0.6	1.4	0.6	1.3	1.0	2.4	1.1	0.7	0.5	1.6	1.0	1.8	0.9	0.7	0.3	2.7	0.1	0.4	5.0	5.4	12.9	6.9	4.8	2.1	5.5	3.9	5.4	4.6	0.0	4.8	0.0	0.7	3.0	1.7	1.6	0.0	6.7	1.2	0.0	2.0	0.7	3.3	1.4	0.0	0.7	0.8	0.0	1.2	0.9	0.6	0.6	1.1	1.0	0.6	1.6	0.0	2.5	0.0	0.0	0.6	1.4	1.7	1.8	0.3	2.5	1.4	0.0	1.1	0.6	1.4	0.0	0.8	2.6	1.5	1.6	0.2	0.0	0.6	0.7
ZKSCAN7	"FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39"	ENSG00000196345	"Zinc finger with KRAB and SCAN domains 7"	Q9P0L1	3	44555193-44594173	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Early spermatids: 13.1;Late spermatids: 11.0;Spermatocytes: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;NTERA-2: 5.1;SH-SY5Y: 8.0;SuSa: 5.0"	"Low region specificity"	"Detected in all"							"HPA048312, HPA049906, HPA071850"	Uncertain		Supported	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458"	"unprognostic (3.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.78e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.22e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.17e-3)"	3.4	6.0	5.7	6.3	3.9	1.9	5.3	9.9	6.1	6.1	3.9	6.0	6.1	2.0	6.9	9.5	2.9	6.4	5.3	4.8	5.6	3.9	4.5	4.6	5.1	5.1	4.4	3.4	13.0	6.7	6.8	18.2	3.4	4.1	6.6	3.5	7.2	3.7	5.8	4.3	2.2	3.8	7.2	3.9	4.8	3.7	18.6	4.4	12.1	6.0	1.9	4.8	5.5	5.9	3.7	2.5	2.0	1.2	2.4	3.4	1.2	0.0	0.0	4.6	6.6	1.3	0.7	0.0	2.2	1.9	2.3	2.7	0.0	0.1	0.1	0.8	1.5	0.8	0.0	0.0	1.4	2.9	0.0	0.0	0.2	1.4	1.7	4.1	0.0	0.0	3.2	1.5	1.3	0.0	0.0	0.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	5.1	0.0	0.0	0.0	2.1	0.0	1.3	0.6	3.1	8.0	0.1	0.2	0.0	5.0	0.0	3.1	0.7	1.4	0.5	1.8	0.0	0.2	0.1	0.0	0.3	0.0	1.1	2.0	1.2	1.6	3.4	0.5	1.0	1.3	2.1	2.6	1.0	3.7	1.6	3.2	1.6	2.4	1.1	2.5	2.1	1.2	5.7	3.9	9.9	6.1	5.6	3.9	4.4	3.4	4.1	4.4	0.0	0.3	0.0	0.6	0.1	5.0	3.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.6	13.1	0.6	0.0	0.0	0.4	0.0	0.9	0.3	0.0	1.0	0.9	3.2	2.9	0.0	0.0	11.0	0.9	0.2	0.0	1.0	0.0	4.1	0.9	0.0	2.5	0.6	4.0	0.0	0.3	9.4	3.4	0.4	0.1	0.7	0.4	0.1
ZNF660	FLJ36870	ENSG00000144792	"Zinc finger protein 660"	Q6AZW8	3	44578223-44599694	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 23.8;Muller glia cells: 30.4;Rod photoreceptor cells: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"myeloid DC: 1.1;naive B-cell: 1.3;NK-cell: 1.6;plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"B-cells: 1.3;dendritic cells: 3.7;NK-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"AF22: 5.6;HEL: 5.5;NTERA-2: 8.6;RH-30: 5.7;SuSa: 4.9"					"Low region specificity"	"Detected in all"			HPA029705	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"		"HPA029705: AB_10602592"	"unprognostic (5.43e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.87e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.94e-2)"	3.1	3.1	3.5	3.0	5.9	3.5	3.0	10.3	7.2	7.6	3.8	3.8	4.4	1.3	7.9	5.2	2.2	5.2	3.6	2.9	4.4	3.8	2.5	1.3	2.9	4.2	5.7	6.2	11.3	2.6	6.3	11.5	3.7	6.0	5.7	2.2	5.5	2.1	4.7	2.3	2.1	2.7	5.9	6.4	3.4	2.7	4.4	4.7	1.8	4.7	0.8	3.1	4.1	4.1	1.3	3.7	0.4	0.4	1.6	0.3	0.2	0.0	0.0	5.6	1.3	0.1	0.0	0.8	0.6	1.4	0.8	0.8	0.0	0.0	0.1	1.2	0.5	0.0	0.0	1.8	0.0	1.0	0.0	0.0	5.5	0.4	0.8	1.3	0.1	0.0	2.3	0.1	2.0	0.0	0.1	1.3	0.0	0.0	0.3	2.9	0.0	0.0	3.2	8.6	0.0	0.0	0.1	5.7	0.0	0.1	0.3	1.4	3.8	0.0	0.0	0.1	4.9	0.1	2.1	0.4	1.6	1.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.2	0.1	0.1	0.2	0.2	0.3	1.1	1.3	0.2	0.2	0.2	1.6	0.0	3.7	0.0	0.2	3.5	5.9	10.3	7.2	4.4	3.8	5.7	6.2	6.0	4.7	0.0	5.9	0.0	0.8	0.1	23.8	1.9	5.1	1.4	5.7	0.0	5.9	0.0	0.0	0.9	8.0	3.6	0.0	0.0	0.5	0.0	2.4	0.6	5.8	0.0	1.6	11.1	4.1	1.8	0.6	1.3	4.6	1.1	0.0	3.6	0.1	30.4	0.8	0.0	3.2	0.1	22.7	0.0	2.5	3.9	3.1	0.0	0.0	0.8	0.2	0.3
ZNF197	"D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41"	ENSG00000186448	"Zinc finger protein 197"	O14709	3	44584888-44648471	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA054567	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054567: AB_2682527"	"unprognostic (1.06e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.85e-2)"	9.9	9.9	14.0	12.4	16.1	4.2	12.7	23.7	15.4	13.5	10.9	8.6	18.3	8.9	13.6	13.4	8.3	11.0	9.2	9.8	13.2	12.4	10.2	12.8	9.4	9.7	15.0	14.0	18.4	10.2	17.8	23.5	11.1	16.0	13.7	11.1	9.2	9.0	19.8	18.2	10.8	8.8	17.6	18.3	10.1	9.2	10.1	16.2	11.8	15.9	8.9	9.6	12.0	15.7	2.7	3.2	0.9	8.4	2.5	1.7	0.7	3.0	1.4	14.0	4.5	7.9	8.6	0.4	6.2	7.9	5.4	5.8	3.0	2.6	3.0	3.7	5.2	3.1	2.1	7.1	5.4	6.1	0.7	1.7	12.7	5.3	2.1	7.6	10.2	3.3	9.1	8.1	5.8	9.8	7.9	3.8	4.4	7.9	5.0	8.7	0.7	5.8	6.7	9.2	3.3	4.4	1.9	10.1	3.7	5.7	3.7	6.0	10.1	5.8	2.7	8.4	7.9	7.8	8.8	4.4	6.0	4.3	8.4	5.1	6.5	7.5	2.0	4.7	3.1	5.9	0.6	1.4	0.9	1.5	0.6	1.5	1.1	1.4	1.4	1.9	2.7	1.7	1.0	0.9	2.5	8.4	3.2	1.5	0.7	14.0	16.1	23.7	14.7	13.2	12.4	15.0	14.0	16.0	16.2	14.9	5.4	3.7	4.2	2.3	11.8	10.1	2.5	5.3	14.8	0.0	7.9	1.0	1.7	6.4	11.8	4.5	4.5	0.0	7.7	0.5	4.3	4.0	3.5	6.7	4.0	15.9	5.8	5.5	3.5	2.2	5.2	3.6	5.0	7.2	6.5	12.2	5.8	7.0	4.9	3.7	8.9	6.5	4.2	10.8	5.3	3.0	0.3	5.2	5.0	2.6
ZNF35	"HF.10, HF10, Zfp105"	ENSG00000169981	"Zinc finger protein 35"	P13682	3	44648727-44660791	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 15.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051859, HPA054738"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051859: AB_2681642, HPA054738: AB_2682588"	"unprognostic (1.54e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.91e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.30e-1)"	8.8	5.9	8.3	6.2	10.4	6.2	8.2	8.7	11.5	8.1	8.3	8.4	7.2	5.2	10.8	11.0	8.8	6.4	6.8	7.9	7.3	6.3	10.2	4.5	7.1	5.3	8.2	7.0	6.4	6.3	8.4	15.3	5.9	10.8	8.7	6.6	7.7	7.2	8.8	8.1	7.9	7.6	12.0	8.5	11.9	7.4	17.7	7.5	3.9	7.9	8.4	8.8	8.3	7.0	4.0	3.9	1.5	4.0	4.6	2.4	1.9	3.1	2.4	6.3	8.0	4.1	3.3	1.2	3.8	5.4	6.8	6.5	4.2	1.4	2.7	1.7	5.3	3.0	2.3	0.3	5.5	7.1	0.0	2.2	9.0	4.4	0.2	3.8	8.9	6.9	3.4	4.3	6.1	5.5	3.3	5.4	0.1	6.0	2.6	7.4	2.0	0.2	2.9	13.9	2.3	6.7	0.1	6.7	4.7	3.6	8.9	3.5	9.0	4.9	3.0	0.8	5.4	8.0	5.6	5.5	7.3	5.3	3.9	7.6	7.2	11.0	1.5	6.2	4.4	5.6	0.0	3.8	1.5	2.2	4.0	1.4	3.6	0.6	2.4	3.9	4.0	1.1	1.2	0.2	4.6	3.7	1.6	0.2	1.9	8.3	10.4	8.7	11.5	7.3	6.3	8.2	7.0	10.8	7.5	6.0	8.3	6.1	3.3	2.5	4.5	2.8	5.1	5.3	3.4	1.8	0.0	0.2	1.7	6.5	8.0	4.9	1.6	0.0	7.6	0.1	2.6	2.8	0.0	0.4	3.3	6.4	2.4	4.3	4.0	4.9	1.1	3.8	1.7	3.6	1.5	4.3	7.5	2.0	4.2	2.4	6.2	0.0	3.1	15.4	9.6	2.5	0.3	2.2	2.3	3.0
ZNF502	"FLJ12515, FLJ14855"	ENSG00000196653	"Zinc finger protein 502"	Q8TBZ5	3	44712643-44723831	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 14.9;Spermatogonia: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA024761, HPA029557"	Uncertain					NA	NA					"HPA024761: AB_10599830, HPA029557: AB_10601448"	"unprognostic (1.80e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.35e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.49e-2)"	"prognostic favorable (4.51e-5)"	"unprognostic (1.88e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.06e-4)"	8.2	5.1	6.4	3.9	11.7	2.5	9.5	12.9	7.3	8.7	6.0	4.3	5.7	3.0	8.4	8.6	5.6	7.3	3.6	4.9	6.0	3.9	5.3	3.3	4.3	3.7	3.1	8.3	10.6	6.7	5.1	14.5	6.0	5.8	10.0	5.5	8.3	6.1	7.9	6.6	8.2	4.2	10.5	4.7	5.8	5.1	8.3	4.7	2.7	9.9	4.8	3.9	6.7	5.8	4.1	1.5	1.3	1.0	3.4	4.9	1.1	0.0	1.2	3.3	0.0	3.8	5.6	0.0	2.9	0.7	3.6	2.0	0.2	1.6	0.0	0.8	2.7	3.3	1.7	0.0	4.1	3.0	0.0	1.6	0.0	0.1	0.0	4.2	0.0	1.6	4.2	1.8	3.7	0.0	0.9	2.2	0.0	0.0	0.0	3.3	0.0	0.0	0.9	5.2	0.9	0.0	0.0	2.0	0.0	3.8	3.9	3.0	4.5	1.6	2.8	0.0	4.0	0.0	0.0	2.8	0.0	2.7	5.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.6	1.3	1.8	1.0	3.3	2.6	3.2	2.5	1.5	4.1	4.9	3.5	0.0	3.4	1.0	0.8	0.6	1.1	6.4	11.7	12.9	7.3	6.0	3.9	3.1	8.3	5.8	4.7	6.0	3.2	1.5	3.4	1.4	11.2	4.0	2.5	4.0	5.7	3.5	13.7	2.0	0.0	2.4	2.1	5.8	1.3	0.0	2.6	1.0	1.7	2.8	2.3	0.8	0.9	9.5	4.7	3.1	1.2	1.9	4.4	0.7	0.0	1.0	1.3	10.3	2.3	0.0	6.3	1.3	14.9	0.0	1.2	14.0	17.9	2.3	1.3	0.0	2.8	1.0
ZNF501	"MGC21738, ZNF52"	ENSG00000186446	"Zinc finger protein 501"	Q96CX3	3	44729596-44737083	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 9.5;Spermatogonia: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 6.7"					"Low region specificity"	"Detected in all"			HPA044161	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044161: AB_2678841"	"unprognostic (8.89e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.02e-2)"	5.6	2.8	6.8	3.6	8.3	1.3	8.5	11.7	8.0	7.0	6.2	7.5	4.7	2.6	7.5	4.0	4.7	7.3	4.5	5.6	7.3	4.8	5.0	2.3	4.7	6.8	5.9	6.7	10.0	5.3	2.7	5.7	5.9	4.9	8.1	4.1	3.6	4.9	7.3	5.3	4.4	3.6	8.0	6.3	4.9	4.4	6.7	9.8	4.2	6.6	3.4	4.3	7.2	7.2	3.4	1.1	2.9	1.1	2.7	3.5	1.2	0.0	0.0	2.1	0.0	3.9	6.7	0.8	2.4	2.2	2.6	3.0	0.9	0.9	1.8	0.0	1.1	1.9	0.7	0.0	0.9	2.5	0.0	1.2	0.0	0.2	1.7	5.4	0.0	0.0	3.9	2.5	2.9	0.2	0.8	1.6	0.0	0.0	0.0	0.8	0.0	0.8	0.1	4.9	1.1	0.0	1.3	0.0	1.0	2.2	1.4	2.6	1.7	1.4	1.5	1.0	4.1	0.1	0.1	1.0	0.1	2.3	2.4	1.9	4.2	2.6	0.0	0.1	0.0	3.1	2.0	0.7	2.9	2.4	0.9	3.3	2.9	2.3	2.6	1.1	3.4	3.5	2.4	1.1	2.7	1.1	1.0	2.3	1.2	6.8	8.3	11.7	8.0	7.3	4.8	5.9	6.7	4.9	9.8	0.0	0.3	0.0	1.7	0.8	2.9	2.0	0.0	1.4	2.3	3.5	2.0	1.5	0.0	2.1	0.6	2.1	0.5	0.0	1.7	1.5	2.5	0.9	0.0	0.8	1.4	9.5	1.2	1.8	1.8	1.3	1.4	0.8	0.0	1.0	0.7	7.0	1.7	0.0	1.4	1.0	3.2	6.5	1.9	4.8	10.2	1.4	0.2	1.7	0.9	0.7
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761662	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	21.7	14.6	19.8	13.2	16.9	9.0	18.8	17.2	21.7	18.9	15.7	13.6	11.9	10.4	19.9	13.3	17.9	16.5	12.8	22.0	19.9	17.9	16.2	11.4	13.6	13.8	21.4	12.7	26.0	16.2	22.2	15.2	14.5	18.8	20.9	12.2	9.1	13.3	15.3	28.9	16.0	14.2	17.9	21.7	16.7	12.7	9.4	16.7	25.0	19.4	16.5	15.8	23.3	17.8	6.6	5.5	9.5	8.7	7.6	7.4	4.5	6.6	4.3	12.4	8.6	8.4	13.2	6.2	7.7	10.8	9.9	10.1	4.4	5.9	16.4	5.9	8.0	4.7	4.7	14.5	8.1	13.1	9.0	4.9	11.9	8.1	5.3	5.8	14.9	8.4	9.4	9.9	10.1	9.6	11.0	8.2	10.2	16.8	9.0	9.6	3.8	16.5	10.5	11.6	7.1	5.6	6.8	11.8	9.2	6.3	5.7	6.2	10.6	8.9	7.0	6.1	8.6	11.6	12.8	9.4	5.5	5.0	14.4	8.7	5.8	16.5	10.0	10.2	14.5	8.0	5.3	5.7	9.5	7.4	6.3	6.5	6.6	6.4	5.9	5.5	6.3	6.8	6.2	5.7	7.6	8.7	3.7	5.3	4.5	19.8	16.9	17.2	21.7	19.9	17.9	21.4	12.7	18.8	16.7	35.7	29.6	39.6	25.1	30.7	17.4	23.8	30.6	32.1	45.5	22.7	7.9	37.2	58.0	37.7	149.2	31.5	17.6	0.0	53.7	48.7	27.7	35.1	37.0	22.9	30.8	14.3	15.0	30.7	39.1	61.4	34.8	35.6	13.5	26.2	22.9	41.7	40.6	23.5	46.3	29.3	12.2	0.0	25.5	46.8	40.9	24.3	47.8	34.8	24.1	36.6
KIF15	"HKLP2, KNSL7, NY-BR-62"	ENSG00000163808	"Kinesin family member 15"	Q9NS87	3	44761717-44873376	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 33.5;testis: 13.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 128.6;Erythroid cells: 46.7;Late spermatids: 55.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035516, HPA035517, HPA061469"	Approved					NA	NA					"HPA035516: AB_2674664, HPA035517: AB_10671935, HPA061469: "	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.17e-3)"	"unprognostic (6.68e-7)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.14e-4)"	"unprognostic (2.72e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.58e-1)"	0.4	0.3	0.4	4.4	0.4	6.5	0.4	0.4	0.9	0.8	2.0	0.1	0.5	1.9	0.4	0.7	2.6	0.3	0.3	0.6	0.4	0.3	0.3	0.3	0.5	3.2	0.4	0.0	0.3	0.2	0.0	0.3	0.9	0.2	0.3	2.4	0.3	0.6	0.0	0.3	1.1	1.9	0.3	0.3	1.9	0.8	13.0	0.0	33.5	0.3	2.4	3.2	0.6	0.9	0.9	0.0	0.0	0.4	0.0	2.0	0.4	5.4	2.9	12.7	9.4	0.9	1.0	2.9	6.3	3.8	7.6	6.6	4.7	5.4	9.4	2.1	2.1	2.9	4.7	7.2	3.3	9.3	8.4	2.1	10.4	6.0	5.9	0.1	10.5	4.8	0.2	0.1	5.2	5.2	1.1	6.1	12.9	6.6	12.2	6.1	3.0	20.6	4.1	13.5	6.6	5.0	8.1	14.0	5.7	1.7	3.6	6.2	5.6	10.1	3.3	2.1	3.4	5.4	8.2	3.4	8.0	6.5	6.2	8.5	5.4	8.8	12.4	4.2	12.2	7.5	0.0	0.0	0.0	0.5	0.4	0.0	0.9	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.4	0.4	0.4	0.4	0.9	0.4	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.6	1.6	0.0	1.1	0.0	0.0	1.2	0.0	2.0	0.5	0.0	0.6	128.6	0.0	0.5	46.7	0.0	5.6	0.3	0.3	0.0	0.0	2.8	0.0	0.0	0.0	1.0	55.6	0.0	1.4	0.0	0.0	0.5	0.4	0.4	0.0	0.4	0.0	0.0	0.0	0.7	19.1	10.7	0.9	0.6	0.5	0.6	0.4
TMEM42	MGC29956	ENSG00000169964	"Transmembrane protein 42"	Q69YG0	3	44861869-44865670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052569	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA052569: AB_2681871"	"prognostic favorable (5.23e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.16e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	11.1	14.6	18.6	5.7	26.1	4.6	13.4	7.8	17.3	12.7	8.5	17.7	8.5	6.1	10.4	25.9	7.2	16.8	8.9	10.2	18.4	19.7	12.9	19.1	9.7	9.3	19.1	14.1	17.1	17.5	12.7	16.5	8.9	16.4	12.7	8.5	8.5	10.9	12.7	16.6	8.6	6.2	9.2	19.8	8.7	9.9	20.0	15.5	11.6	17.1	6.5	9.1	7.5	8.7	13.9	11.8	4.2	10.2	9.1	15.9	9.2	4.1	4.2	1.2	2.4	16.1	12.7	0.1	3.4	4.8	4.2	4.2	0.9	8.2	2.8	6.7	6.6	1.9	2.8	0.3	5.2	4.2	4.4	0.0	1.7	5.4	4.4	17.1	2.0	0.1	13.1	13.4	4.3	9.7	9.0	7.1	7.2	0.1	5.8	6.3	3.2	1.7	3.4	2.3	5.0	1.9	1.5	0.7	0.6	9.1	1.6	1.3	1.7	4.1	1.4	1.6	4.2	3.0	3.5	4.6	3.7	0.4	5.4	3.7	2.0	1.5	0.8	7.4	2.4	1.6	3.7	8.6	4.2	7.8	7.7	8.2	13.9	11.6	7.2	10.6	11.9	15.9	12.6	1.6	9.1	10.2	11.8	9.2	9.2	18.6	26.1	7.8	17.3	18.4	19.7	19.1	14.1	16.4	15.5	20.8	4.8	10.7	14.4	5.5	8.0	10.1	15.3	16.0	4.5	31.4	2.0	17.6	11.6	15.3	56.7	9.3	5.2	0.0	8.9	11.3	14.2	14.8	3.5	15.3	19.8	17.5	11.5	11.6	13.3	73.6	25.3	10.3	6.8	9.0	9.1	20.9	11.7	8.4	18.4	17.0	15.9	6.5	6.9	36.1	19.3	7.9	8.1	13.1	11.8	6.2
TGM4	TGP	ENSG00000163810	"Transglutaminase 4"	P49221	3	44874608-44914990	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"prostate: 107.8"	"Cell type enriched"	"Detected in some"	37	"Glandular cells: 201.3"	"Cancer enriched"	"Detected in single"	312	"prostate cancer: 75.4"	"Region enriched"	"Detected in single"	254	"cerebral cortex: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;hTERT-HME1: 2.6;NB-4: 5.2;RPMI-8226: 3.7;SH-SY5Y: 2.9"	"Not detected"	"Not detected"							"CAB033571, HPA073290"	Enhanced					NA	NA					"CAB033571: AB_2287329, HPA073290: "	"unprognostic (4.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.56e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.41e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	25.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	2.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.0	0.7	0.7	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.5	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.2	201.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.8	0.0	0.0	2.6
ZDHHC3	"DHHC3, GODZ, ZNF373"	ENSG00000163812	"Zinc finger DHHC-type containing 3"	Q9NYG2	3	44915257-44976185	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 493.4;Late spermatids: 1185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012465, HPA016616"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB012465: , HPA016616: AB_1859004"	"unprognostic (2.80e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.81e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-2)"	23.1	25.8	11.7	17.5	14.0	29.5	39.8	12.5	20.8	17.2	27.9	13.7	17.8	18.4	19.2	17.9	29.1	13.0	22.7	34.6	11.2	9.1	21.7	19.0	20.2	16.1	12.1	7.7	16.5	15.0	16.9	8.8	19.5	19.4	16.1	28.9	14.7	17.4	22.5	20.0	43.0	33.2	15.4	13.6	15.4	20.9	48.0	10.1	14.1	20.4	22.1	20.6	21.4	20.7	5.4	11.4	17.1	10.0	6.0	7.1	5.2	12.0	9.7	8.8	12.1	37.5	19.0	9.8	10.6	13.3	13.6	12.3	11.6	15.9	11.0	5.8	18.8	8.2	15.5	13.5	18.8	14.5	10.8	5.7	9.7	13.4	8.5	8.5	25.1	7.9	16.3	23.3	13.0	12.9	10.7	14.3	11.0	14.2	9.8	12.5	7.8	7.6	18.3	11.7	27.2	19.4	5.7	7.4	8.3	13.5	37.8	2.7	10.6	12.8	13.2	5.8	13.9	10.0	17.4	15.2	11.8	10.9	13.8	13.9	6.7	12.5	10.8	10.8	38.5	8.8	17.1	10.0	13.8	6.5	5.5	6.1	4.7	4.7	7.1	11.4	5.4	4.9	6.3	11.4	6.0	7.2	6.7	6.9	5.2	11.7	14.0	12.5	20.8	11.2	9.1	12.1	7.7	19.4	10.1	38.7	75.1	15.7	29.8	42.7	9.4	24.0	25.5	16.0	18.2	50.6	5.9	40.9	61.3	37.0	493.4	30.7	99.2	23.3	69.9	48.5	26.6	52.0	18.5	25.9	43.7	14.3	34.4	38.1	31.1	1185.8	48.1	27.2	23.6	30.7	65.3	25.6	78.0	59.6	42.1	23.7	8.6	19.4	23.7	52.6	40.9	52.7	85.0	20.8	60.2	82.9
EXOSC7	"EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p"	ENSG00000075914	"Exosome component 7"	Q15024	3	44975241-45036066	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036182, HPA057980"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036182: AB_10673346, HPA057980: AB_2683571"	"unprognostic (1.69e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.67e-3)"	"prognostic favorable (2.69e-4)"	"unprognostic (4.33e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.20e-1)"	13.2	37.1	11.2	14.2	18.8	13.0	17.2	16.5	17.6	17.7	11.9	15.8	14.2	10.5	17.7	17.8	21.1	14.8	12.5	23.4	17.4	12.9	17.0	18.8	12.1	15.6	13.3	15.5	16.1	18.6	11.3	17.6	13.9	15.8	14.7	10.0	16.2	14.4	17.8	30.3	33.2	10.8	15.7	9.3	12.9	15.6	26.0	11.9	14.8	18.2	19.6	18.3	16.5	17.1	27.4	27.6	3.0	17.7	22.7	23.6	17.8	18.8	17.6	14.3	11.6	15.0	16.6	13.0	8.1	13.4	18.1	18.8	29.2	15.1	24.0	13.0	14.2	13.8	10.7	17.6	22.8	14.8	16.0	15.6	20.7	20.1	28.1	29.4	28.9	8.5	14.5	14.6	19.7	40.4	11.8	17.3	26.9	32.4	11.8	12.7	19.5	20.6	51.7	17.2	17.1	25.0	10.4	13.4	36.3	16.1	26.8	6.6	10.1	11.6	10.0	12.1	12.8	14.8	24.0	12.3	9.3	13.9	15.2	22.2	15.2	14.1	28.4	13.7	40.9	8.1	2.0	17.7	3.0	17.2	17.1	19.1	27.4	20.0	17.8	27.6	20.9	23.6	18.9	0.9	22.7	12.0	16.7	18.9	17.8	11.2	18.8	16.5	17.6	17.4	12.9	13.3	15.5	15.8	11.9	32.8	29.6	22.6	61.8	55.0	26.2	29.3	17.8	25.4	25.0	33.2	17.7	56.9	114.4	37.6	3.1	21.2	9.6	0.0	40.6	51.6	36.1	28.6	14.0	23.2	40.7	19.1	12.6	16.0	12.4	5.8	44.3	19.1	25.3	19.8	17.3	35.5	33.7	10.5	38.5	38.2	20.0	12.9	28.8	53.5	60.5	64.7	52.7	25.5	23.7	47.4
CLEC3B	"TN, TNA"	ENSG00000163815	"C-type lectin domain family 3 member B"	P05452	3	45001548-45036071	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 185.2;lung: 216.5"	"Cell type enhanced"	"Detected in some"	15	"Fibroblasts: 14.4;Ito cells: 43.0;Late spermatids: 15.2;Leydig cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 51.1;ASC TERT1: 101.9;U-2197: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002582, HPA034794"	Approved				"Secreted to blood"	NA	NA	6540000000	46000000000			"CAB002582: AB_564027, HPA034794: AB_2674332"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.53e-4)"	"prognostic favorable (9.99e-9)"	"unprognostic (1.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.21e-2)"	70.8	11.5	6.6	16.9	8.9	0.5	185.2	5.9	10.2	17.4	20.3	4.8	39.0	8.4	15.7	54.2	17.2	6.9	38.8	72.8	8.1	6.8	20.6	7.0	216.5	8.3	8.8	7.4	5.1	6.1	2.1	5.0	37.7	13.2	7.4	10.1	17.7	9.7	19.2	26.5	27.6	16.3	90.3	10.0	65.5	8.3	24.9	1.5	2.3	15.8	40.8	5.4	28.0	24.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	51.1	101.9	0.0	6.7	10.5	0.2	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	20.5	0.0	0.2	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	8.9	5.9	10.2	8.1	6.8	8.8	7.4	13.2	1.5	0.0	0.0	0.0	0.0	3.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	3.3	0.0	2.8	10.5	0.0	0.0	0.2	0.0	14.4	0.0	0.0	0.0	0.8	0.0	0.0	43.0	1.2	15.2	27.9	0.8	3.3	1.0	0.0	0.0	0.1	0.0	6.0	0.0	0.1	0.0	4.2	0.0	0.0	3.3	0.1	0.0	0.0	0.0
CDCP1	"CD318, SIMA135"	ENSG00000163814	"CUB domain containing protein 1"	Q9H5V8	3	45082278-45146422	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 107.6;Ductal cells: 84.9;Pancreatic endocrine cells: 100.0;Urothelial cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	5	"pons and medulla: 5.5"	"Group enriched"	"Detected in some"	5	"myeloid DC: 4.0;neutrophil: 1.8;NK-cell: 7.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.0;granulocytes: 1.8;NK-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.8;HBEC3-KT: 27.2;hTEC/SVTERT24-B: 67.5;hTERT-HME1: 45.8;PC-3: 21.1;RPTEC TERT1: 20.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010978, HPA010979, CAB025637"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401"	"unprognostic (9.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (9.98e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.34e-1)"	2.3	0.7	0.5	5.6	1.0	0.2	4.4	0.3	0.7	6.9	17.4	1.1	10.1	11.4	3.2	11.1	28.6	2.4	9.8	0.8	1.0	0.5	4.4	0.8	7.1	1.4	0.6	0.3	1.6	13.9	0.0	2.3	4.0	5.5	5.2	11.3	0.5	11.4	13.0	0.6	15.2	29.8	1.8	1.3	0.8	10.8	1.3	0.5	1.0	21.8	19.2	19.1	7.3	11.7	0.2	4.0	1.8	0.9	7.1	0.3	0.3	12.3	3.7	0.0	0.0	0.0	0.6	3.0	2.2	0.4	1.1	1.0	5.2	23.8	0.0	2.8	0.7	0.6	10.0	0.0	27.2	2.3	0.0	0.0	0.0	4.2	0.0	2.0	0.0	0.9	0.9	14.3	67.5	45.8	4.1	0.2	0.0	7.2	0.0	3.4	0.0	0.0	0.2	1.8	6.0	21.1	0.0	0.0	2.1	20.8	10.0	0.8	0.0	4.6	1.2	0.0	1.2	5.8	0.1	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.9	0.1	0.1	0.1	0.0	0.1	0.3	0.1	4.0	0.2	0.2	0.1	1.8	7.1	0.0	0.1	0.0	0.3	0.5	1.0	0.3	0.7	1.0	0.5	0.6	0.3	5.5	0.5	3.0	13.3	0.0	52.1	107.6	0.0	0.4	12.7	26.8	18.2	8.7	0.0	4.5	0.0	84.9	0.0	0.6	30.4	0.0	61.1	6.7	5.8	52.2	8.1	0.0	10.2	0.0	36.0	0.0	4.8	0.0	2.8	26.8	3.3	18.0	34.1	0.0	100.0	28.8	0.0	0.0	0.0	0.0	3.3	0.0	0.4	65.6	2.7	0.0	22.5	90.5
TMEM158	"p40BBp, RIS1"	ENSG00000249992	"Transmembrane protein 158 (gene/pseudogene)"	Q8WZ71	3	45224466-45226278	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.8;endometrium 1: 31.1"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 21.8;Muller glia cells: 57.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 66.1;GAMG: 22.4;U-138 MG: 28.0;U-87 MG: 91.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 85.5"	"Low region specificity"	"Detected in all"			HPA074974	Approved					NA	NA					"HPA074974: AB_2732274"	"unprognostic (3.84e-1)"	"unprognostic (9.83e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.31e-2)"	"unprognostic (4.67e-3)"	"unprognostic (6.23e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.84e-3)"	"prognostic favorable (6.43e-5)"	"prognostic unfavorable (5.42e-9)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.49e-3)"	1.8	6.4	16.4	4.5	46.8	2.2	2.3	2.1	10.9	13.1	3.4	2.3	18.5	1.4	31.1	7.3	21.3	2.0	11.0	0.8	9.0	11.2	1.9	1.2	1.0	1.1	2.5	5.0	1.7	2.4	0.7	5.7	1.4	2.6	15.6	2.7	0.5	1.3	27.0	2.4	2.7	1.2	19.6	1.8	0.8	2.2	3.0	4.3	0.0	0.7	0.8	1.7	6.7	1.6	0.0	0.0	0.9	0.1	0.0	0.0	1.1	2.4	0.4	0.8	0.1	1.5	3.7	0.7	6.1	66.1	3.4	5.5	0.1	0.1	0.0	0.3	2.0	22.4	3.3	1.0	0.2	10.1	0.1	0.3	0.0	1.2	0.0	2.2	0.4	1.2	5.0	0.1	6.7	0.5	7.9	0.3	0.0	15.0	0.1	6.0	0.1	0.0	4.2	7.5	0.0	9.1	0.0	0.2	0.9	1.3	2.3	1.2	0.2	2.3	0.0	0.3	0.7	0.0	0.8	1.0	28.0	2.1	17.6	21.2	0.0	0.0	0.0	91.7	2.4	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	16.4	46.8	2.1	10.9	9.0	11.2	2.5	5.0	2.6	4.3	0.0	0.3	0.0	1.8	21.8	3.8	0.8	2.5	0.0	1.2	8.7	0.0	0.1	0.0	3.3	0.1	0.1	0.0	0.0	0.3	0.1	2.9	1.6	0.0	2.6	4.0	1.6	7.5	1.3	0.3	0.2	7.8	4.5	0.0	1.8	0.2	57.5	0.7	0.0	0.0	0.0	2.7	0.0	2.3	0.1	0.4	9.3	0.2	0.0	0.0	2.0
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388506-45549421	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	9.6	14.3	18.8	9.6	21.8	6.7	8.1	11.9	17.9	9.2	14.8	13.1	8.3	9.6	9.8	8.9	10.4	11.2	8.4	14.2	14.6	13.6	18.9	17.2	7.0	10.3	15.7	9.5	10.2	8.2	20.0	14.0	10.6	12.3	10.8	15.3	10.0	8.7	9.8	14.1	7.8	8.8	11.0	8.8	10.0	8.9	7.3	11.8	16.1	10.5	8.3	12.8	11.3	7.8	5.1	5.9	2.4	3.3	8.4	6.0	3.7	6.4	8.0	9.4	8.9	8.6	9.7	10.1	10.0	10.3	18.7	13.9	14.2	8.9	13.3	8.6	11.6	13.7	7.0	34.9	20.9	14.2	11.6	8.8	14.4	13.0	13.8	9.0	20.8	5.3	12.5	12.9	17.8	9.4	9.7	11.6	16.1	22.3	7.5	11.6	7.0	14.9	7.6	23.5	10.8	14.9	8.5	9.3	14.8	16.6	15.5	7.4	9.3	15.9	9.0	8.3	11.2	14.3	12.2	10.2	11.4	8.5	9.5	12.0	6.0	10.8	14.2	13.5	14.1	10.1	0.6	2.8	2.4	6.0	3.3	5.8	5.1	4.4	5.4	5.9	4.0	4.8	5.4	1.2	8.4	3.0	4.5	3.9	3.7	18.8	21.8	11.9	17.9	14.6	13.6	15.7	9.5	12.3	11.8	0.0	1.3	2.7	1.1	1.0	5.0	7.8	2.5	2.7	1.2	5.2	3.9	4.1	5.0	2.5	0.6	3.8	2.3	0.0	2.4	4.2	1.6	2.2	1.1	6.7	4.4	1.6	4.6	2.5	3.7	1.1	1.1	1.6	1.7	2.8	4.3	3.6	2.8	6.6	2.1	2.1	4.4	0.0	1.2	0.7	2.4	1.1	2.4	1.8	6.3	1.6
LIMD1		ENSG00000144791	"LIM domains containing 1"	Q9UGP4	3	45555394-45686338	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 35.7;B-cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064220, HPA071736"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Nucleoplasm, Focal adhesion sites"		"HPA064220: AB_2685216, HPA071736: "	"unprognostic (2.77e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.73e-5)"	"unprognostic (8.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.61e-3)"	12.6	7.0	4.8	14.9	5.5	6.2	13.9	2.5	6.0	10.2	9.7	8.1	13.0	8.4	14.4	12.0	10.4	9.6	10.9	11.5	5.1	4.1	8.3	16.6	24.8	17.1	9.2	2.2	7.6	24.5	11.3	5.5	11.7	9.4	12.1	9.2	20.2	19.1	8.2	25.2	8.3	12.2	12.5	6.8	16.4	11.4	6.2	6.4	20.3	17.9	10.7	24.9	12.9	18.9	6.7	8.8	4.1	5.5	1.1	1.6	1.0	7.4	14.2	5.2	7.0	4.6	9.0	10.4	7.2	10.1	7.7	6.7	6.7	3.9	0.9	4.8	6.6	15.7	5.1	11.0	5.9	6.4	15.7	6.7	8.3	11.2	5.5	4.7	7.4	10.7	3.7	4.9	11.4	6.0	5.6	6.7	8.6	6.9	23.5	7.6	4.9	9.0	4.7	8.4	6.0	13.7	4.5	6.0	11.3	4.0	13.3	2.4	4.7	6.1	11.1	7.2	5.6	6.7	6.7	11.9	8.5	7.7	8.5	7.6	22.5	28.9	3.7	18.5	6.8	9.2	4.1	1.4	1.4	1.6	3.1	1.0	3.9	1.3	1.4	1.4	6.7	1.4	1.4	1.6	1.1	5.5	8.8	1.3	1.0	4.8	5.5	2.5	6.0	5.1	4.1	9.2	2.2	9.4	6.4	35.7	20.6	31.3	5.1	2.6	1.5	14.2	12.7	10.7	13.6	7.0	2.0	5.1	1.7	6.0	1.0	4.3	5.9	0.0	4.6	10.3	4.8	9.5	3.5	16.3	14.1	6.4	6.4	9.8	15.3	0.2	10.9	9.0	5.0	1.0	16.0	7.0	5.6	3.5	3.2	3.0	1.0	6.5	8.0	0.7	4.1	1.9	4.5	7.4	8.8	3.6
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745424	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		8400000	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	18.4	24.9	22.0	18.9	23.3	14.9	18.2	23.3	26.3	19.0	19.4	16.4	21.2	18.9	22.6	19.3	17.0	18.1	16.6	15.6	21.8	22.8	31.9	22.7	23.2	19.9	20.5	24.9	15.7	18.3	25.1	31.9	21.2	28.7	21.1	20.1	17.7	20.0	18.2	12.7	14.7	20.4	17.0	22.2	20.9	20.5	11.0	19.6	26.8	35.8	8.5	19.7	20.9	20.9	5.8	13.7	13.4	8.7	30.1	14.9	13.4	11.0	8.3	15.5	8.6	26.4	18.1	11.9	17.0	18.1	16.0	13.8	11.0	9.0	18.1	9.8	16.3	20.3	8.7	19.1	11.5	20.6	11.4	11.6	18.6	13.6	10.6	14.2	27.9	22.8	11.9	18.2	16.2	12.5	13.1	10.9	17.6	20.4	18.7	26.2	5.4	23.7	15.3	16.6	12.2	17.0	6.2	8.1	17.0	17.5	16.2	6.1	14.7	11.7	15.5	17.9	16.4	11.6	27.0	12.3	14.6	8.1	14.7	17.5	10.7	26.1	12.9	17.0	43.1	14.5	4.3	8.7	13.4	13.6	7.0	14.9	5.8	9.8	13.6	13.7	5.3	10.1	13.1	7.1	30.1	6.0	5.7	8.2	13.4	22.0	23.3	23.3	26.3	21.8	22.8	20.5	24.9	28.7	19.6	26.8	31.2	19.3	7.8	17.4	22.6	14.0	17.8	10.7	13.6	7.0	29.5	17.8	16.6	9.1	1.3	13.5	15.8	0.0	8.7	9.5	15.3	14.3	16.2	13.1	21.0	31.8	11.5	14.7	19.1	2.4	15.5	17.3	16.9	18.0	8.8	14.1	10.7	17.3	21.5	16.5	21.4	6.5	12.0	10.1	10.9	15.2	15.3	41.7	10.3	8.9
SLC6A20	"XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755450-45796535	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 14.3;intestine: 25.5;retina: 51.3"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 5.3;Cholangiocytes: 12.7;Ductal cells: 10.1;Pancreatic endocrine cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HaCaT: 3.1;OE19: 7.1;SuSa: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029873	Uncertain					NA	NA					"HPA029873: AB_10602403"	"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.3	0.1	0.3	0.6	0.8	0.5	0.7	1.5	2.2	2.4	11.2	3.0	0.4	22.3	1.3	1.7	0.1	0.4	14.3	0.1	0.5	0.4	3.3	0.2	1.9	0.2	1.0	1.7	0.1	5.1	0.0	2.0	0.1	6.1	1.0	0.2	51.3	1.3	0.1	0.9	0.6	25.5	0.3	1.5	0.1	4.7	0.4	0.3	0.0	0.1	0.4	0.1	0.2	0.3	0.8	0.7	2.6	0.2	0.5	0.4	0.1	0.2	0.4	0.4	0.4	0.1	0.0	0.5	0.1	0.0	0.0	0.0	1.6	1.4	0.2	1.1	0.0	0.3	3.1	0.1	0.0	0.2	0.1	0.2	1.3	1.2	0.2	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.2	0.0	0.5	0.2	0.5	0.0	0.3	0.5	0.3	1.4	7.1	0.3	0.5	0.1	0.4	0.2	0.3	0.4	0.4	1.5	0.2	0.0	10.3	0.3	0.1	0.1	0.5	0.4	0.4	0.3	0.8	0.3	0.1	0.2	0.3	0.1	1.0	0.2	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.8	0.4	0.3	2.6	0.5	0.1	0.7	0.1	0.1	0.3	0.8	1.5	2.2	0.5	0.4	1.0	1.7	6.1	0.3	0.0	5.3	0.0	0.4	0.5	0.0	0.8	12.7	0.0	2.3	0.0	0.0	0.0	0.0	10.1	0.5	0.0	2.6	0.0	0.2	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	6.2	0.0	1.1	1.4	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.4	0.4
LZTFL1	BBS17	ENSG00000163818	"Leucine zipper transcription factor like 1"	Q9NQ48	3	45823316-45916042	"Disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.7"	"Cell type enhanced"	"Detected in all"	11	"Ciliated cells: 188.7;Spermatocytes: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043466, HPA048447"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA043466: AB_2678491, HPA048447: AB_2680398"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.27e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.19e-1)"	5.8	7.2	12.3	5.0	14.9	4.8	13.6	9.3	21.6	14.5	6.9	4.4	10.4	6.0	14.4	16.6	6.1	20.8	7.3	5.3	10.2	11.6	12.9	10.1	9.7	4.4	6.9	13.4	12.8	8.6	14.6	30.7	6.2	10.1	9.0	6.8	5.6	7.5	10.4	3.6	6.4	6.8	8.7	6.1	5.8	6.3	27.7	5.6	55.7	20.4	4.3	5.7	7.3	6.4	7.2	4.6	1.9	2.5	2.3	4.0	2.7	6.8	3.5	5.5	3.6	5.2	12.7	2.6	3.7	6.1	7.6	9.9	1.0	5.2	2.1	2.2	4.6	9.8	3.2	6.0	6.1	10.6	0.0	4.2	1.3	4.9	2.9	6.9	6.7	2.0	6.8	21.1	9.5	6.2	5.6	4.3	10.8	6.3	4.4	4.1	1.1	18.3	6.4	5.8	4.5	3.0	2.5	0.5	7.2	10.5	2.6	3.8	7.8	4.5	4.1	8.9	6.3	5.0	11.7	6.9	3.2	2.2	8.6	4.7	12.4	6.5	0.0	10.2	7.9	2.6	0.0	1.9	0.7	2.8	2.5	3.9	7.2	2.5	2.4	4.6	3.7	4.0	3.3	1.9	2.3	1.6	4.5	3.5	2.7	12.3	14.9	9.3	21.6	10.2	11.6	6.9	13.4	10.1	5.6	26.8	18.5	8.8	8.3	11.9	7.7	6.9	10.2	188.7	33.0	14.0	13.7	2.5	13.3	10.7	53.9	7.3	2.6	23.3	6.1	4.3	11.0	7.6	8.1	11.6	5.9	22.3	10.9	8.6	3.7	8.6	9.2	5.8	8.5	13.6	11.3	15.2	5.6	3.5	12.7	16.7	14.1	12.9	6.1	140.9	20.0	8.7	1.7	15.3	8.8	4.1
CCR9	"CDw199, GPR-9-6, GPR28"	ENSG00000173585	"C-C motif chemokine receptor 9"	P51686	3	45886504-45903177	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 130.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 17.5;naive B-cell: 9.2;T-reg: 5.7"	"Group enriched"	"Detected in many"	42	"B-cells: 17.5;T-cells: 5.7"	"Cell line enriched"	"Detected in single"	50	"MOLT-4: 49.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB006839	Uncertain					NA	NA					"CAB006839: "	"unprognostic (3.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.65e-3)"	"unprognostic (7.88e-3)"	"unprognostic (4.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-3)"	0.1	0.1	0.1	1.8	0.1	0.7	0.1	0.1	0.3	0.1	2.2	0.1	0.1	7.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.2	0.1	10.7	0.1	0.2	2.2	0.3	0.1	0.1	130.2	0.1	0.1	0.7	0.1	0.1	17.5	0.2	0.0	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	17.5	2.2	1.8	0.2	9.2	0.3	0.1	0.0	0.0	0.0	0.2	5.7	1.8	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FYCO1	"FLJ13335, ZFYVE7"	ENSG00000163820	"FYVE and coiled-coil domain containing 1"	Q9BQS8	3	45917899-45995824	"Disease related genes, Predicted intracellular proteins"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 105.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 78.1;Rod photoreceptor cells: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035526, HPA057966"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA035526: AB_10672867, HPA057966: AB_2683567"	"unprognostic (2.45e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.85e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.33e-11)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.99e-2)"	11.6	7.8	4.1	11.4	4.7	3.1	11.6	1.4	3.5	13.5	20.2	7.3	11.4	4.2	19.8	11.1	12.6	7.9	22.0	29.1	4.2	2.7	5.7	6.2	7.9	5.0	4.7	3.5	14.8	15.9	11.4	4.9	4.3	6.1	14.5	5.6	16.2	9.5	11.6	105.8	9.9	7.7	39.9	6.4	6.4	11.6	5.0	5.3	8.5	10.4	25.5	9.5	23.3	27.0	0.6	2.8	1.1	1.1	3.0	6.0	1.3	6.4	6.3	1.8	8.1	17.9	14.1	3.1	6.2	14.7	8.4	9.3	3.4	5.7	4.8	3.6	8.8	8.0	4.9	5.3	10.5	9.9	2.0	5.6	6.8	5.2	3.8	12.2	5.2	5.0	15.6	10.5	13.2	13.1	12.8	16.5	8.3	4.4	7.0	5.9	4.0	5.3	3.2	2.8	5.3	6.0	1.8	5.2	2.6	10.0	22.8	1.4	2.1	3.9	12.4	10.9	2.9	6.0	3.5	12.7	3.1	3.7	10.7	3.4	4.0	2.5	1.6	10.9	6.7	5.9	1.1	1.0	0.6	4.4	1.1	6.0	0.6	2.6	4.6	0.4	0.6	1.1	1.8	0.9	3.0	0.7	2.8	2.6	1.3	4.1	4.7	1.4	3.5	4.2	2.7	4.7	3.5	6.1	5.3	26.8	10.7	3.0	4.1	3.7	10.8	78.1	7.6	14.7	11.4	15.7	33.4	3.6	3.3	6.9	0.0	7.5	6.3	0.0	7.1	2.0	6.1	11.8	2.3	9.5	3.6	0.0	9.2	12.3	5.9	0.4	11.8	3.2	10.1	0.0	7.9	16.2	9.8	0.0	16.6	4.4	38.5	6.5	9.8	2.6	0.7	3.6	2.4	6.9	5.7	5.2
CXCR6	"BONZO, CD186, STRL33, TYMSTR"	ENSG00000172215	"C-X-C motif chemokine receptor 6"	O00574	3	45940933-45948353	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.3"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 66.4;T-cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	4	"MAIT T-cell: 81.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 81.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;CAPAN-2: 15.7;JURKAT: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.05e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.77e-3)"	"prognostic favorable (6.74e-6)"	"unprognostic (6.67e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.57e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.57e-2)"	2.5	1.1	0.5	7.6	0.5	0.5	2.1	0.4	0.5	2.3	9.9	1.1	1.5	3.0	2.7	3.2	3.0	2.4	5.2	1.7	0.6	0.6	2.5	2.5	9.2	10.4	0.6	0.2	3.7	1.6	0.0	0.9	18.9	1.0	2.6	2.6	3.0	3.3	0.2	7.7	1.1	10.8	1.0	1.3	22.3	6.0	2.3	0.2	5.2	4.1	5.3	14.6	5.2	2.6	0.0	0.1	0.1	0.0	13.4	81.3	3.8	0.3	0.1	0.0	0.3	0.0	0.0	4.1	0.2	0.0	0.0	0.0	1.1	15.7	0.3	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.2	0.5	0.0	0.2	0.8	0.2	0.3	0.0	0.6	0.1	0.0	0.0	0.0	1.7	0.0	0.1	0.3	0.9	0.0	2.1	0.2	0.8	0.4	1.5	0.7	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	17.3	0.0	81.3	0.0	4.9	20.3	0.0	0.0	0.2	3.1	0.1	13.4	0.0	0.1	14.5	3.8	0.5	0.5	0.4	0.5	0.6	0.6	0.6	0.2	1.0	0.2	0.0	0.0	0.0	0.0	0.9	0.7	0.7	0.0	0.0	0.0	0.0	2.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.4	0.5	0.1	1.1	0.8	0.7	0.0	0.0	1.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.0	0.0	1.0	8.6	54.5	0.0	0.0
XCR1	"CCXCR1, GPR5"	ENSG00000173578	"X-C motif chemokine receptor 1"	P46094	3	46017024-46027742	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.5"	"Cell type enhanced"	"Detected in some"	16	"Late spermatids: 1.3;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 7.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 7.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.6;RT4: 4.4;U-266/84: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013169	Uncertain					NA	NA					"HPA013169: AB_1846211"	"unprognostic (3.49e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.53e-6)"	"unprognostic (3.89e-6)"	"unprognostic (9.27e-3)"	"unprognostic (4.41e-3)"	"unprognostic (3.40e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-1)"	0.7	0.5	0.4	4.0	0.5	2.5	0.7	0.4	0.5	1.1	2.5	0.1	0.1	1.1	0.6	4.9	2.5	0.7	3.3	0.9	0.4	0.4	0.8	0.7	1.8	9.8	0.4	0.1	0.9	0.6	0.0	0.5	9.4	0.2	0.5	0.8	1.7	2.1	0.2	0.6	7.6	3.3	1.1	0.5	6.8	0.8	0.7	0.1	27.5	0.8	6.3	5.1	1.0	1.2	0.1	7.2	0.9	0.3	0.3	0.7	0.6	0.1	1.9	0.9	0.0	0.0	0.0	1.6	0.8	1.9	0.0	0.0	1.6	0.0	1.6	0.1	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.4	3.1	0.0	0.9	0.0	0.0	1.0	0.6	1.1	5.6	0.0	1.8	0.9	0.0	0.0	1.0	0.0	1.1	0.0	0.6	0.8	4.4	0.4	0.0	0.0	0.5	0.1	1.7	0.5	0.1	0.0	1.0	2.2	0.4	0.2	2.7	4.6	1.5	3.2	0.0	0.4	0.9	0.1	0.3	0.7	0.1	0.1	0.0	0.1	0.6	7.2	0.1	0.1	0.4	0.7	0.3	0.3	0.2	0.1	0.6	0.4	0.5	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0
CCR3	"CC-CKR-3, CD193, CKR3, CMKBR3"	ENSG00000183625	"C-C motif chemokine receptor 3"	P51677	3	46163604-46266706	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"blood: 175.9"	"Cell type enhanced"	"Detected in some"	17	"granulocytes: 1.1;Melanocytes: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	22	"basophil: 175.9;eosinophil: 152.0"	"Lineage enriched"	"Detected in many"	92	"granulocytes: 175.9"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003795, HPA069514"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB003795: AB_562259, HPA069514: "	"unprognostic (1.56e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.11e-7)"	"unprognostic (4.36e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.17e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.81e-2)"	0.6	0.2	0.3	2.9	1.1	0.4	0.3	0.2	0.8	0.3	1.3	0.2	0.2	2.9	0.8	0.2	0.4	0.5	1.3	0.3	0.2	0.2	0.5	1.2	5.8	0.6	0.3	0.2	0.2	0.3	0.0	0.3	7.0	0.7	1.0	1.4	0.9	2.4	0.2	3.2	3.6	5.1	1.6	0.5	2.7	2.2	0.4	0.2	0.6	1.8	2.8	0.6	4.0	0.3	0.0	0.2	175.9	0.0	0.0	1.9	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	2.3	0.0	0.7	0.0	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.2	0.0	25.5	0.0	2.1	0.1	0.0	0.0	0.7	0.0	0.8	0.0	0.6	0.0	0.1	0.2	0.0	0.1	2.8	2.2	0.0	0.0	0.5	0.0	175.9	0.0	152.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.2	1.9	0.3	0.3	1.1	0.2	0.8	0.2	0.2	0.3	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
CCR1	"CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1"	ENSG00000163823	"C-C motif chemokine receptor 1"	P32246	3	46201709-46208396	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.0;lymphoid tissue: 40.2"	"Group enriched"	"Detected in many"	17	"Extravillous trophoblasts: 72.1;Hofbauer cells: 97.6;Kupffer cells: 150.1;Macrophages: 66.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 78.3;RPMI-8226: 36.0;U-266/70: 13.8;U-266/84: 40.5"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.95e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	21.2	6.0	5.1	23.8	8.4	11.2	4.9	1.0	3.7	1.9	2.9	7.2	0.5	3.9	2.0	5.1	2.0	4.5	6.7	4.1	5.4	3.2	4.4	9.6	11.6	26.3	9.0	1.6	2.8	2.3	1.0	2.6	14.9	6.9	2.3	4.1	2.9	3.3	1.3	1.4	1.4	4.5	8.5	11.6	40.2	2.9	1.2	8.7	2.2	1.8	1.0	5.5	6.9	1.5	0.9	15.3	32.5	34.0	22.1	15.3	11.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	36.0	0.0	1.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	8.2	0.0	0.2	0.0	0.0	0.0	13.8	40.5	0.0	7.0	6.1	0.1	21.5	34.0	6.8	3.1	21.4	15.3	0.9	0.0	2.5	15.3	0.0	0.0	0.4	32.5	22.1	13.1	5.5	0.0	11.8	5.1	8.4	1.0	3.3	5.4	3.2	9.0	1.6	6.9	8.7	3.0	4.0	5.4	0.0	0.8	0.0	0.4	0.0	2.7	2.3	0.0	0.0	0.6	1.7	0.0	0.2	0.5	0.0	0.0	0.0	72.1	1.5	0.0	3.5	0.8	97.6	0.0	0.0	2.5	150.1	0.0	0.0	66.6	5.0	0.0	0.0	0.4	0.1	0.0	0.0	2.4	0.0	0.0	0.3	0.0	0.0	1.5	2.4	5.7	0.0	0.0
CCR2	"CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R"	ENSG00000121807	"C-C motif chemokine receptor 2"	P41597	3	46353734-46360928	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Host-virus interaction, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 96.3;lymphoid tissue: 36.1"	"Cell type enriched"	"Detected in some"	6	"Kupffer cells: 61.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 96.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 48.6;THP-1: 23.0;U-266/70: 111.8;U-266/84: 44.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			CAB003793	Approved					NA	NA					"CAB003793: AB_344889"	"unprognostic (1.09e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.49e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.16e-4)"	"unprognostic (8.06e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.19e-1)"	2.5	1.3	0.6	20.7	0.8	0.9	1.9	0.5	0.8	4.3	5.8	0.5	1.5	5.6	2.6	2.4	6.1	2.2	2.5	1.8	0.6	0.6	3.7	1.8	8.6	30.1	1.6	0.1	1.7	1.7	0.0	0.8	2.1	1.8	3.7	4.0	2.6	10.2	3.5	0.8	1.3	7.3	5.6	1.5	36.1	3.7	1.5	0.5	3.6	2.0	3.5	5.9	5.8	1.7	1.6	29.0	96.3	28.4	2.5	19.3	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	48.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	111.8	44.5	0.0	0.0	0.8	0.0	96.3	28.4	0.4	2.5	2.6	19.3	1.6	5.2	4.2	29.0	0.3	0.1	0.1	0.7	2.5	0.0	23.0	2.3	13.5	0.6	0.8	0.5	0.8	0.6	0.6	1.6	0.1	1.8	0.5	0.0	2.2	7.8	0.0	0.2	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	3.1	61.3	0.4	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0
CCR5	"CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22"	ENSG00000160791	"C-C motif chemokine receptor 5 (gene/pseudogene)"	P51681	3	46370854-46376206	"CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5"	"Cell type enhanced"	"Detected in some"	17	"Hofbauer cells: 4.9;Kupffer cells: 4.1;Macrophages: 16.2;T-cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 24.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 24.5"	"Cell line enhanced"	"Detected in some"		"JURKAT: 2.5;Karpas-707: 12.0;U-266/84: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.32e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.89e-3)"	"prognostic favorable (7.42e-5)"	"unprognostic (1.80e-2)"	"prognostic favorable (9.33e-5)"	"unprognostic (3.38e-3)"	"unprognostic (9.90e-3)"	"unprognostic (7.65e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.14e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.42e-2)"	7.1	2.3	3.4	13.8	6.1	0.8	2.1	0.8	2.5	2.3	3.0	3.0	0.8	3.8	3.7	4.0	2.6	2.6	5.0	3.6	1.6	2.0	2.7	3.0	9.3	11.9	8.1	0.5	3.0	2.1	0.4	1.9	1.2	4.0	2.8	3.8	3.5	4.4	2.5	0.8	1.1	7.2	2.9	6.1	14.6	6.0	0.9	5.9	2.0	2.6	1.5	13.9	5.7	2.0	0.3	5.5	5.6	2.1	3.2	24.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	12.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.4	5.1	0.0	0.0	0.3	0.0	5.6	1.1	0.0	6.7	2.1	24.5	0.3	2.9	9.7	5.5	0.0	0.3	2.6	0.3	3.2	0.0	5.2	4.5	1.5	3.4	6.1	0.8	2.5	1.6	2.0	8.1	0.5	4.0	5.9	0.0	1.7	0.9	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.2	4.9	0.0	0.0	1.3	4.1	0.0	0.0	16.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13.1	0.0	0.0
CCRL2	"ACKR5, CKRX, CRAM-A, CRAM-B, HCR"	ENSG00000121797	"C-C motif chemokine receptor like 2"	O00421	3	46407163-46412997	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.4"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 16.9;Hofbauer cells: 40.0;Macrophages: 28.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 16.5;OE19: 6.6;PC-3: 12.8;TIME: 12.5;U-266/84: 6.7"					"Low region specificity"	"Detected in many"			HPA043238	Approved					NA	NA					"HPA043238: AB_10794924"	"unprognostic (3.94e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (9.67e-5)"	31.4	1.4	1.3	9.2	1.5	6.0	9.0	0.6	1.2	1.8	9.5	0.9	2.8	9.5	3.5	1.4	1.8	1.3	4.5	2.3	1.5	1.3	2.0	3.4	13.7	4.3	1.9	0.9	2.3	4.8	0.3	1.3	3.9	1.8	2.4	8.8	1.7	1.4	0.7	2.6	1.1	16.9	1.9	2.9	11.2	4.5	2.3	1.2	9.4	1.9	1.3	3.0	3.6	3.5	2.5	7.7	5.6	16.7	5.4	3.9	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.2	0.5	3.8	0.0	16.5	0.0	0.0	0.0	1.0	0.2	0.0	0.0	4.2	0.2	0.0	5.9	3.5	2.2	0.1	4.2	0.0	1.3	2.1	0.0	6.6	12.8	0.3	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.5	0.5	0.2	0.6	0.2	0.0	6.7	0.2	6.5	5.1	0.0	5.6	12.1	3.2	2.4	16.7	2.9	1.4	1.4	3.9	7.7	2.5	0.9	2.2	2.0	5.4	7.8	2.4	3.7	3.6	1.3	1.5	0.6	1.2	1.5	1.3	1.9	0.9	1.8	1.2	0.0	6.6	5.1	0.1	1.8	0.0	0.8	2.5	0.0	1.2	0.0	0.0	0.2	0.0	0.5	0.0	9.0	16.9	0.0	7.4	0.9	0.9	0.2	9.2	0.4	40.0	0.0	0.0	5.5	16.4	0.0	0.0	28.2	1.7	7.2	14.9	0.0	7.8	6.8	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	2.1	6.9	7.2	0.9
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport"	"Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 277.8;salivary gland: 181.9;seminal vesicle: 177.1"	"Group enriched"	"Detected in many"	4	"Club cells: 55.7;Collecting duct cells: 68.0;Glandular cells: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	27	"neutrophil: 4.0;non-classical monocyte: 13.5"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 13.5"	"Group enriched"	"Detected in some"	10	"RPMI-8226: 29.8;TIME: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted in other tissues"	NA	NA		600000000			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	1.0	0.3	0.4	8.8	0.5	277.8	23.0	0.3	0.3	53.1	0.3	3.2	108.0	0.0	0.7	39.3	3.8	0.9	2.2	2.5	0.6	0.6	20.8	0.6	10.8	1.3	0.6	0.0	0.3	2.7	0.0	1.2	0.8	1.5	13.0	0.0	0.2	181.9	177.1	0.4	1.2	0.9	0.1	0.7	9.1	22.6	2.8	0.1	4.0	1.6	13.4	30.7	2.3	1.0	0.0	0.3	4.0	13.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.5	29.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.2	0.9	0.1	0.5	0.0	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	13.5	0.3	0.0	14.7	0.4	0.5	0.3	0.3	0.6	0.6	0.6	0.0	1.5	0.1	0.0	3.2	0.0	7.7	1.0	0.0	1.2	5.1	12.0	55.7	68.0	0.0	0.0	0.0	0.3	0.7	2.3	0.0	0.0	0.8	0.1	0.5	88.7	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.7	4.6	0.9	0.0	0.0	0.0	0.0	5.0	0.0	0.0	10.8	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	16.6
RTP3	"LTM1, TMEM7, Z3CXXC3"	ENSG00000163825	"Receptor transporter protein 3"	Q9BQQ7	3	46497491-46500949	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	91	"liver: 43.3"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 59.6"	"Group enriched"	"Detected in some"	17	"liver cancer: 22.9;testis cancer: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SiHa: 15.1"									HPA075932			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA075932: "		"unprognostic (2.09e-1)"				"unprognostic (1.64e-1)"	"prognostic favorable (3.11e-6)"								"unprognostic (1.08e-1)"	"unprognostic (1.58e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	15.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	59.6	0.0	0.0	0.0	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515423-46580099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0"	"Cell type enriched"	"Detected in many"	17	"Cardiomyocytes: 175.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.8;HEL: 6.2;LHCN-M2: 6.2;TIME: 4.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039138, HPA064844"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA039138: AB_10795461, HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	1.8	0.5	1.9	0.4	1.4	0.4	1.0	1.4	3.0	2.6	1.1	0.2	0.0	0.4	3.9	1.4	1.1	1.1	1.4	53.9	1.3	0.4	2.2	2.5	0.6	0.3	0.5	2.3	2.8	0.7	0.1	2.2	0.5	1.0	1.2	0.8	0.4	1.4	0.2	70.3	1.2	0.6	2.3	0.4	1.3	1.0	0.4	0.0	1.4	10.1	20.0	1.2	1.7	1.8	1.2	0.8	2.6	0.7	1.1	2.5	0.3	0.2	0.1	0.2	0.3	1.0	2.3	0.1	0.8	1.5	0.6	0.8	0.0	0.2	0.3	0.2	10.8	0.1	0.2	3.8	0.0	1.4	0.5	0.1	6.2	0.4	0.2	0.3	0.2	0.1	0.2	0.1	4.3	0.0	3.6	0.2	0.8	0.1	0.4	6.2	0.1	0.8	0.1	1.5	0.5	0.2	0.1	0.1	0.3	0.1	0.3	0.5	1.2	0.8	0.2	1.6	1.3	0.2	0.8	4.9	0.3	0.6	2.5	1.6	0.4	0.3	2.9	0.2	0.1	1.4	2.2	0.7	0.6	0.6	0.4	0.4	0.7	1.6	0.3	0.2	1.2	0.8	0.6	2.6	1.1	0.5	0.8	2.5	0.3	1.9	1.4	1.4	3.0	1.3	0.4	0.5	2.3	1.0	0.0	8.9	0.6	0.0	0.8	1.6	0.0	175.7	2.5	1.4	0.0	1.8	0.0	0.1	8.3	0.2	2.0	1.5	0.0	0.0	0.8	0.0	4.3	0.4	10.3	8.9	1.5	0.0	2.9	5.5	0.0	1.7	0.6	1.1	10.1	0.0	1.5	0.3	1.5	0.0	0.0	0.5	0.1	0.0	3.9	0.6	0.2	2.0	0.1	0.7	1.7	0.4
TDGF1	"CR, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582463	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7"	"Cell type enriched"	"Detected in some"	18	"Distal tubular cells: 102.8"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 6.4;testis cancer: 27.1"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 9.5;NTERA-2: 43.2;SuSa: 27.0"	"Group enriched"	"Detected in many"	5	"cerebellum: 12.5;pons and medulla: 9.1"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA			Vesicles	Cytosol	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.6	3.9	0.6	0.6	0.8	0.0	0.6	0.6	0.6	0.6	2.1	0.6	0.6	0.2	0.7	1.3	0.6	0.0	0.6	0.6	1.0	0.6	9.9	0.8	0.6	0.6	0.9	0.6	9.7	0.6	0.0	0.6	0.6	0.6	0.6	4.3	1.1	0.6	0.6	1.0	0.0	0.6	0.8	1.0	16.7	2.4	0.6	0.6	5.2	2.1	0.6	0.6	0.6	0.6	1.0	0.7	3.7	0.6	1.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	9.5	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.2	1.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.6	0.5	0.5	0.3	0.3	0.6	0.4	0.3	0.1	1.0	0.6	0.4	3.7	1.5	0.4	0.7	0.2	0.1	0.6	0.8	0.6	0.6	1.0	0.6	0.9	0.6	0.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	5.2	0.0	0.0	102.8	0.1	4.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	2.4	0.0	0.0	0.7	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.0
FAM240A		ENSG00000283473	"Family with sequence similarity 240 member A"	A0A1B0GVK7	3	46612435-46626543	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	4	"breast: 1.9;salivary gland: 3.3"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.0"	"Region enhanced"	"Detected in single"		"hippocampal formation: 0.7"	"Low region specificity"	"Detected in single"									NA	NA																							0.6	0.0		0.0		0.0	1.9		0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.3	0.2	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		3.3	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.1			0.3		0.0	0.0		0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.0	0.5	0.4	0.8	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALS2CL	"DKFZp686I0110, FLJ36525, RN49018"	ENSG00000178038	"ALS2 C-terminal like"	Q60I27	3	46668997-46693704	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 31.8"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.8;HaCaT: 11.5;HBEC3-KT: 21.7;hTCEpi: 15.4;RT4: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB046465, HPA048301"	Uncertain					NA	NA					"CAB046465: AB_10638285, HPA048301: AB_2680346"	"unprognostic (6.38e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-3)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.60e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.45e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.14e-3)"	3.8	1.8	0.7	2.9	1.3	0.6	3.0	5.2	3.3	5.4	5.1	0.9	3.0	4.3	4.2	3.4	22.2	2.6	11.7	5.5	1.7	0.9	15.2	4.2	9.3	2.0	0.7	3.2	1.9	3.5	0.5	4.5	4.3	1.7	2.7	1.5	4.9	7.0	4.3	6.1	31.8	3.3	4.9	1.1	5.9	3.6	0.5	0.2	0.7	9.8	17.9	12.1	5.6	10.7	0.0	0.7	0.0	0.3	0.0	3.1	0.6	6.2	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.1	20.8	0.0	6.2	0.5	0.3	11.5	0.0	21.7	0.0	0.0	0.0	0.5	2.9	0.0	0.2	0.0	0.0	0.0	15.4	0.0	2.5	0.2	0.6	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	3.0	1.5	0.0	0.0	7.4	5.3	11.4	0.2	0.1	8.3	6.3	0.0	0.4	1.5	0.1	4.4	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	2.0	0.4	0.7	0.0	3.1	0.3	0.0	0.0	0.0	0.0	1.7	0.6	0.7	1.3	5.2	3.3	1.7	0.9	0.7	3.2	1.7	0.2	68.5	11.7	0.8	7.5	13.5	0.0	9.3	20.4	6.7	17.0	10.4	0.0	0.7	0.0	9.4	0.4	7.7	20.0	0.0	11.9	5.7	4.3	11.5	1.1	7.8	2.1	0.0	0.0	7.4	0.0	0.0	0.3	2.2	1.7	1.0	6.0	0.0	17.9	11.6	0.0	0.3	0.0	19.4	4.7	0.9	0.8	14.3	1.7	0.7	9.6	18.7
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.7;brain: 11.4"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 3.5;Distal tubular cells: 1.7;Spermatogonia: 3.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.3;EFO-21: 3.8;JURKAT: 15.0;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	1.2	11.7	6.7	0.7	2.9	0.0	0.5	2.7	7.0	0.8	0.9	2.3	0.4	0.6	0.8	1.2	2.2	1.0	0.4	1.0	5.9	11.4	1.4	0.9	1.8	1.2	5.8	4.8	2.8	0.4	0.0	8.1	0.7	3.8	0.9	0.6	1.1	0.8	1.8	5.8	1.3	0.6	0.7	5.2	1.2	0.3	1.6	1.0	0.4	0.8	1.7	1.3	0.8	0.4	0.0	0.3	0.0	0.1	0.0	6.1	1.2	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.3	0.0	3.8	0.0	0.7	0.2	0.2	0.3	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	2.6	0.0	1.7	0.0	0.7	15.0	0.0	0.4	0.0	0.2	0.1	0.0	0.3	1.0	0.2	1.6	0.0	0.3	0.1	0.1	0.4	3.3	0.4	0.5	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.0	1.8	1.0	0.3	0.0	6.1	0.9	0.0	0.0	0.0	0.0	1.0	1.2	6.7	2.9	2.7	7.0	5.9	11.4	5.8	4.8	3.8	1.0	0.0	0.0	0.0	0.1	0.7	3.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.2	0.2	0.0	0.0	0.4	0.1	0.5	0.2	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.6	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.4	0.0	0.4	0.0	1.4	1.4	3.1	0.6	0.1	0.0	0.0	0.1
PRSS50	"CT20, TSP50"	ENSG00000206549	"Serine protease 50"	Q9UI38	3	46712115-46812574	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.4;SuSa: 1.8"									HPA040768	Supported					NA	NA					"HPA040768: AB_2677126"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.32e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.91e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.66e-3)"	0.1	0.7	0.0	0.0	0.0	0.0	0.6	0.4	0.3	1.3	0.2			0.1	0.7	6.2	0.1	0.5	0.0	0.9	0.0	0.6	1.8	0.7	0.2	0.0	0.0		0.7	1.7	4.7	8.2	0.0		1.6	0.0		1.7	1.7	7.7	0.0	0.0	0.2	0.0	0.0	0.2	22.3			7.9		0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS50	"CT20, TSP50"	ENSG00000283706	"Serine protease 50"	Q9UI38	3	46712115-46717907	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 33.4"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 155.2;Spermatogonia: 236.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HMC-1: 5.4;NTERA-2: 2.1"									HPA040768	Supported				"Intracellular and membrane"	NA	NA					"HPA040768: AB_2677126"																		0.1	0.8	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.9	0.1	0.2	0.1	0.1	0.1		0.2	0.1	0.1	0.1	0.3	0.1	0.3	0.9	1.7	1.1	0.1	0.1	0.2	0.0	0.1	1.6	1.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	33.4	0.1	0.4	1.6	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.3	0.9	0.4	0.0	0.0	0.0	0.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.5	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	38.8	0.0	155.2	236.5	0.0	0.0	0.0	0.0	0.3
PRSS45	TESSP5	ENSG00000188086	"Serine protease 45"	Q7RTY3	3	46742092-46744755	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 7.6;skeletal muscle: 6.7"	"Cell type enhanced"	"Detected in some"	14	"Late spermatids: 1.1;Melanocytes: 1.7;Spermatocytes: 1.9;Spermatogonia: 1.2"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	19	"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;HHSteC: 2.4;OE19: 1.7;SuSa: 1.1"									HPA060284	Uncertain					NA	NA					"HPA060284: AB_2684242"	"unprognostic (4.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-4)"	"unprognostic (2.33e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.97e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.5	0.2			0.1	0.2	7.6	0.1	0.8	0.0	0.2	0.0	0.0	0.9	0.7	0.2	0.1	0.0		0.3	1.3	2.0	0.5	0.1		0.5	0.0		0.5	0.3	6.7	0.3	0.0	0.0	0.0	0.0	0.2	1.6			3.2		0.0	0.4	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0
PRSS42	TESSP2	ENSG00000178055	"Serine protease 42"	Q7Z5A4	3	46829542-46834095	"Enzymes, Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"heart muscle: 12.9;skeletal muscle: 19.2"	"Cell type enriched"	"Detected in single"	4	"Cardiomyocytes: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.7"									HPA046925	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046925: AB_10961401"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.26e-1)"		"unprognostic (2.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.54e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.98e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2			0.0	0.2	3.4	0.0	0.2	0.0	12.9	0.0	0.0	1.3	0.5	0.2	0.0	0.0		0.2	0.2	1.6	0.0	0.1		0.4	0.0		0.3	0.2	19.2	0.0	0.0	0.0	0.0	0.4	0.0	0.7			0.8		0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.8	0.2	1.6	0.0	0.0	0.0	0.7	0.2	2.3	4.0	0.4	0.0	0.1	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.4	3.7	0.5	0.0	1.3	0.0	0.0	0.1	0.0	0.6	0.5	0.5	0.0	0.3	1.2	0.0	0.5	0.0	1.0	0.7	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46857872-46882169	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 398.1;skeletal muscle: 319.8"	"Cell type enriched"	"Detected in some"	65	"Cardiomyocytes: 3031.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA		15000000	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	0.9	0.2	0.5	0.2	0.4	0.0	0.6	0.2	0.4	0.5	0.1	0.3	0.0	0.0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0.0	0.0	0.3	0.3	1.6	0.0	0.3	5.5	0.0	319.8	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.4	0.0	1.1	30.1	3.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	1.6	0.3	0.1	0.0	0.1	5.9	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4	0.0	0.0	0.0	0.1	0.7	0.1	3031.1	0.0	0.0	0.0	1.8	0.0	0.4	46.4	0.0	2.0	0.3	0.0	0.0	0.0	5.0	7.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.5	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.7	46.2	0.4	6.5	1.3	0.0	0.4	0.4	0.7	0.0	0.0	0.0
PTH1R	"PTHR, PTHR1"	ENSG00000160801	"Parathyroid hormone 1 receptor"	Q03431	3	46877746-46903799	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 90.4"	"Cell type enhanced"	"Detected in many"	20	"Distal tubular cells: 81.2;Proximal tubular cells: 259.5;Sertoli cells: 135.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075879	Enhanced					NA	NA					"HPA075879: "	"unprognostic (1.26e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.24e-5)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (6.79e-6)"	"unprognostic (4.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-4)"	"unprognostic (6.62e-3)"	8.5	17.9	4.2	1.4	5.9	0.8	5.0	3.7	5.0	6.2	2.3	5.2	1.1	1.5	4.5	2.5	2.3	3.8	2.8	4.3	5.5	3.9	90.4	13.4	4.1	6.9	6.0	5.0	5.4	1.6	1.0	0.9	10.1	4.7	3.2	1.2	3.4	1.5	3.0	4.0	2.6	1.8	4.6	4.1	9.6	1.5	2.2	5.7	0.0	1.2	0.6	1.0	2.8	5.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	7.2	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	2.3	0.0	51.7	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	5.9	3.7	5.0	5.5	3.9	6.0	5.0	4.7	5.7	0.0	0.0	0.5	0.0	1.1	0.7	2.2	0.0	0.0	0.0	31.4	0.0	0.5	81.2	0.0	8.7	1.5	0.0	0.0	0.5	48.7	10.8	0.0	0.0	0.4	1.8	1.6	0.0	22.1	1.5	22.5	5.5	0.0	0.0	0.0	0.0	3.0	0.2	0.0	2.1	259.5	0.6	135.8	3.1	0.7	1.3	0.6	0.7	0.0	0.0	0.1
CCDC12	MGC23918	ENSG00000160799	"Coiled-coil domain containing 12"	Q8WUD4	3	46921726-46982010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA056814, HPA060530"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056814: AB_2683241, HPA060530: AB_2684309"	"unprognostic (1.47e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.15e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.08e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.65e-2)"	11.1	14.0	7.8	10.5	9.2	15.1	8.9	13.0	10.3	17.4	13.0	6.1	35.7	11.8	12.5	14.9	50.9	8.4	23.7	11.3	8.3	7.8	10.0	9.5	15.6	13.8	8.2	6.2	9.9	11.2	5.5	8.2	9.0	7.6	14.4	6.1	7.3	52.0	56.7	48.9	16.5	10.4	10.1	7.9	11.5	13.5	6.6	5.2	6.7	9.8	19.6	27.6	11.6	13.5	54.3	55.7	31.9	39.5	31.3	40.9	29.6	17.4	14.7	17.3	9.0	9.8	8.1	13.3	17.7	9.1	13.4	9.8	19.0	15.1	34.2	16.2	10.6	19.1	9.8	14.7	16.5	5.7	33.5	11.1	37.5	21.6	28.6	13.4	40.2	26.8	10.9	15.7	17.0	15.1	10.7	13.0	22.0	40.0	17.0	6.5	21.1	31.1	38.1	22.6	17.3	12.2	13.2	13.4	21.9	13.8	18.4	9.2	17.9	21.7	18.0	16.8	8.0	13.7	40.1	26.5	9.0	17.7	18.3	28.1	22.3	48.7	42.5	12.6	28.6	12.9	11.1	37.4	31.9	40.9	38.3	32.1	54.3	31.6	35.7	35.0	53.5	27.3	32.2	11.3	31.3	39.5	55.7	38.5	29.6	7.8	9.2	13.0	9.4	8.3	7.8	8.2	6.2	7.6	5.2	74.5	47.8	116.2	114.6	70.3	51.3	44.4	56.0	52.2	50.0	76.8	51.1	113.1	94.5	89.3	3.4	66.6	110.9	23.3	109.2	94.8	57.8	77.8	80.8	48.7	87.8	55.6	76.0	52.8	65.3	6.2	54.1	66.7	43.9	106.4	65.7	64.2	89.4	132.5	45.3	73.9	75.0	38.8	61.4	17.9	50.9	95.1	139.6	102.3	79.7	187.7
NBEAL2	KIAA0540	ENSG00000160796	"Neurobeachin like 2"	Q6ZNJ1	3	46979683-47009703	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.4"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"HEL: 31.3;SK-BR-3: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051969	Approved					NA	NA		490000			"HPA051969: "	"unprognostic (3.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.99e-3)"	"prognostic favorable (4.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.34e-2)"	7.6	5.5	3.5	14.8	4.2	53.4	7.0	5.5	3.9	11.6	10.5	2.8	17.0	7.5	7.1	5.7	36.2	5.6	20.9	3.8	3.7	1.8	11.4	3.9	19.4	10.7	5.6	2.4	3.0	15.0	4.2	4.8	3.3	4.2	7.6	6.6	5.2	14.2	10.3	2.7	26.5	14.2	6.9	3.8	26.3	16.2	2.7	3.8	11.5	5.4	22.1	39.0	6.7	18.7	0.1	0.2	8.1	1.2	0.7	1.1	0.4	8.5	9.4	2.1	5.1	1.3	0.4	5.6	1.1	0.7	1.7	1.2	8.5	6.2	7.4	3.4	1.2	1.8	5.9	3.8	4.2	1.0	6.7	5.7	31.3	11.4	5.1	0.9	5.3	22.6	0.8	7.1	1.8	3.4	2.3	15.7	16.3	6.3	13.0	0.7	13.4	8.6	14.2	4.8	13.9	4.5	9.5	0.2	9.5	4.5	18.3	2.8	4.4	1.1	28.6	2.4	3.3	13.9	8.5	11.5	0.1	5.3	2.3	3.9	9.1	8.5	7.2	2.2	24.9	1.2	0.4	1.2	0.6	1.1	1.1	0.3	0.1	0.4	1.1	0.2	0.1	0.2	0.2	8.1	0.7	0.8	0.2	0.5	0.4	3.5	4.2	5.5	3.9	3.7	1.8	5.6	2.4	4.2	3.8	11.9	10.3	5.6	4.6	3.0	1.3	4.2	5.1	0.0	7.9	31.4	17.7	1.8	1.7	19.4	1.3	6.3	4.0	0.0	20.2	1.0	1.6	6.3	5.8	1.0	9.7	0.0	6.9	11.6	14.0	0.9	1.1	8.8	0.0	5.4	10.6	1.5	22.3	3.5	0.0	1.0	1.7	12.9	1.6	0.2	2.3	6.9	1.6	10.2	9.3	12.2
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2"	Q9BYW2	3	47016429-47163967	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favorable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	13.2	10.5	12.2	15.2	15.4	20.0	11.7	22.4	16.4	13.4	14.0	9.1	12.9	9.5	15.8	7.5	10.8	11.4	8.7	8.8	10.6	6.8	11.4	10.3	10.4	11.8	11.7	9.5	16.0	13.4	21.4	16.3	10.7	11.3	12.4	10.9	7.7	12.7	14.8	27.6	12.5	11.5	11.9	9.8	13.8	10.4	12.8	12.8	23.2	15.8	5.5	12.8	16.1	15.5	4.8	2.6	6.0	2.3	7.1	3.9	1.0	11.6	9.2	15.4	7.9	9.3	10.7	6.5	10.7	10.4	12.6	11.5	9.7	7.6	25.7	6.7	14.8	12.3	7.1	16.7	10.2	17.1	14.7	6.6	26.4	15.3	7.5	7.0	19.7	15.3	9.2	9.9	12.4	15.4	10.2	11.6	13.3	16.9	9.7	10.3	6.1	14.5	2.6	11.7	5.6	7.7	9.6	15.0	13.3	6.4	15.3	6.7	10.6	18.1	7.1	6.7	11.5	7.5	14.7	14.8	13.9	10.4	11.8	17.1	12.5	13.9	26.0	8.0	11.3	8.1	2.4	2.2	5.2	3.9	2.3	2.4	3.7	2.4	3.0	2.5	4.8	3.5	3.0	6.0	7.1	1.9	2.6	1.0	1.0	12.2	15.4	22.4	16.4	10.6	6.8	11.7	9.5	11.3	12.8	44.7	53.3	20.6	20.5	29.7	33.4	58.5	22.9	66.9	80.8	10.4	39.3	16.3	10.0	17.4	24.0	29.3	26.5	0.0	19.3	10.1	20.8	25.9	55.6	26.7	14.3	25.4	21.2	23.4	27.2	20.8	28.1	21.6	16.9	20.8	27.8	21.7	20.0	17.5	31.1	9.3	37.0	12.9	21.7	78.1	18.9	31.1	15.4	27.7	24.8	34.2
KIF9	MGC104186	ENSG00000088727	"Kinesin family member 9"	Q9HAQ2	3	47228026-47283451	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.0"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 279.7;Early spermatids: 510.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022031, HPA022033, HPA030429"	Approved					NA	NA					"HPA022031: AB_1852502, HPA022033: AB_1852504, HPA030429: AB_10601921"	"unprognostic (1.93e-2)"	"unprognostic (6.37e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (1.17e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.59e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (5.95e-6)"	"unprognostic (4.21e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.23e-1)"	3.3	5.1	8.4	3.6	9.9	7.7	8.7	3.7	10.1	6.4	7.0	6.5	5.3	4.8	5.6	17.0	3.3	21.0	8.2	8.2	7.5	12.1	12.3	4.7	6.9	5.3	10.5	7.2	3.1	9.9	4.6	10.0	3.1	24.5	5.0	6.7	4.5	6.1	5.0	5.9	4.5	4.2	5.6	5.2	3.4	6.5	47.0	5.5	1.8	16.8	4.8	3.0	3.5	3.0	4.3	8.4	9.9	5.4	5.0	4.9	1.9	10.7	12.3	4.4	10.9	2.1	5.2	3.6	3.3	3.5	5.2	4.6	4.7	13.1	7.1	4.2	4.3	6.9	6.7	12.9	8.7	5.1	3.6	8.4	6.6	8.9	14.9	2.0	13.9	2.2	2.6	8.9	7.4	5.6	4.3	10.9	7.7	14.5	2.9	3.8	8.6	7.5	20.8	12.5	24.8	17.5	4.8	3.1	10.2	21.2	6.1	6.3	11.6	3.8	7.5	11.8	2.4	4.8	9.8	5.1	3.0	6.4	4.8	7.5	2.6	10.6	8.9	11.1	14.0	6.5	3.0	5.4	3.0	2.4	4.0	4.9	4.3	2.3	3.6	8.4	1.0	2.8	3.0	9.9	5.0	3.2	4.7	1.4	1.9	8.4	9.9	3.7	10.1	7.5	12.1	10.5	7.2	24.5	5.5	17.9	17.3	4.7	41.7	17.9	6.5	27.1	38.2	279.7	54.6	61.1	33.4	9.5	92.9	28.8	510.7	27.0	12.4	0.0	28.4	10.1	11.4	32.9	27.8	16.4	8.2	4.8	56.6	14.7	6.3	92.6	13.0	9.9	15.1	1.0	37.0	8.2	21.8	7.0	12.4	112.8	32.5	12.9	10.3	135.4	39.1	17.7	6.9	6.9	37.0	36.6
KLHL18	"FLJ13703, KIAA0795"	ENSG00000114648	"Kelch like family member 18"	O94889	3	47282917-47346816	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035027, HPA035028"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA035027: AB_10602340, HPA035028: AB_10669899"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.67e-1)"	9.1	9.0	11.5	9.7	12.2	21.1	7.1	16.7	15.7	7.8	8.2	10.4	11.7	6.8	9.1	8.4	13.8	7.7	8.5	9.3	8.8	9.4	7.2	5.8	9.6	9.7	7.7	13.5	6.6	8.5	13.9	9.8	8.6	10.6	8.2	7.4	16.0	7.2	10.7	23.7	20.0	8.4	10.3	6.3	13.9	7.6	9.6	9.9	7.0	11.3	9.3	11.2	9.5	10.1	3.5	6.7	4.6	14.0	1.1	3.7	4.5	7.4	9.6	7.4	10.9	8.2	5.9	5.3	10.2	5.3	10.4	8.5	10.1	4.6	14.5	5.8	8.5	9.5	4.6	22.2	10.8	10.8	11.4	7.4	21.3	13.8	9.2	8.4	11.3	9.8	6.8	8.4	14.9	14.0	5.8	11.5	8.0	25.7	6.1	8.3	6.1	8.6	6.6	13.5	6.0	19.3	6.0	4.9	8.5	9.8	14.1	5.1	6.8	7.1	8.8	5.1	7.9	5.1	6.3	12.0	9.7	9.9	11.0	12.8	6.9	13.2	12.7	6.2	13.2	10.1	4.6	10.2	3.2	1.9	9.2	2.9	3.5	1.5	3.7	6.7	2.1	1.3	1.8	4.5	1.1	14.0	1.8	1.5	4.5	11.5	12.2	16.7	15.7	8.8	9.4	7.7	13.5	10.6	9.9	11.9	10.7	16.7	8.4	10.1	66.8	53.4	2.5	5.3	5.7	3.5	19.6	9.3	18.3	13.9	2.4	13.5	11.0	23.3	12.8	10.4	6.6	8.2	34.7	16.3	25.5	12.7	9.1	16.5	25.7	2.1	5.5	16.7	0.0	10.8	8.2	12.5	14.5	10.5	7.8	19.2	47.9	6.5	11.7	10.1	15.0	18.3	11.8	10.0	8.9	9.5
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase, non-receptor type 23"	Q9H3S7	3	47381011-47413441	"Enzymes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	15.9	18.5	23.1	17.4	22.3	19.2	21.6	22.8	25.0	18.1	12.5	21.4	14.6	20.7	20.0	15.1	17.2	17.2	12.8	13.2	17.9	11.7	16.4	13.0	16.8	17.8	24.6	23.7	23.4	19.4	53.4	29.9	17.1	20.5	16.9	10.4	15.2	20.8	19.0	25.7	25.9	16.0	16.0	20.3	19.2	17.9	17.8	22.7	9.7	24.8	9.7	11.1	17.7	18.1	1.4	1.1	3.7	1.2	0.9	1.5	0.8	13.0	18.6	10.4	13.4	13.6	10.5	10.0	11.9	11.9	11.2	9.5	15.7	12.9	9.3	11.0	13.5	19.9	11.7	8.9	12.9	5.4	8.6	9.6	12.8	13.6	14.6	15.0	7.5	17.4	13.9	13.3	14.5	14.9	7.9	13.7	7.9	9.5	12.8	11.9	18.3	7.1	6.3	11.1	9.1	13.1	4.4	5.0	11.2	8.4	25.3	5.5	13.0	10.5	22.4	8.7	6.6	12.8	7.2	13.7	17.1	14.5	23.7	16.8	18.4	12.0	5.4	18.6	7.1	12.1	3.7	1.2	0.0	0.8	0.5	0.6	1.4	0.6	1.3	0.4	0.7	0.6	0.8	1.4	0.9	0.5	1.1	1.5	0.8	23.1	22.3	22.8	25.0	17.9	11.7	24.6	23.7	20.5	22.7	8.9	6.5	1.5	4.4	7.1	11.3	6.2	10.2	10.7	7.9	5.2	13.7	8.5	1.7	9.1	1.4	11.1	14.2	0.0	7.6	6.5	6.1	7.9	2.3	9.6	11.6	15.9	7.0	12.3	11.1	2.1	17.8	7.8	11.8	9.0	15.6	9.2	11.8	8.6	12.7	8.2	13.8	6.5	6.2	7.4	10.9	9.5	7.8	4.3	11.5	6.3
SCAP	KIAA0199	ENSG00000114650	"SREBF chaperone"	Q12770	3	47413694-47477126	"Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004713	Approved					NA	NA					"HPA004713: AB_1079868"	"unprognostic (4.02e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.33e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-3)"	11.1	47.4	15.9	10.7	21.4	11.3	15.0	23.7	28.7	13.8	18.2	22.6	13.9	17.8	17.7	14.8	17.8	16.0	14.5	10.9	16.9	11.5	13.5	34.1	11.3	17.1	15.6	12.2	18.8	22.1	26.3	15.2	16.9	17.3	13.1	16.0	19.3	16.0	14.2	15.6	26.2	17.1	14.9	11.6	15.0	15.5	19.5	18.5	18.8	15.4	9.4	12.0	18.5	13.6	6.7	7.7	18.3	6.4	7.5	10.5	4.7	10.6	15.1	16.4	25.3	29.8	15.8	29.2	10.5	15.5	17.6	16.7	20.1	17.6	17.8	15.3	17.8	18.0	11.6	23.0	22.1	18.3	12.2	16.6	30.7	21.2	21.7	29.0	18.3	18.4	19.7	23.8	22.3	24.6	14.2	15.0	17.8	20.8	12.4	14.1	15.1	20.0	27.1	17.1	22.2	22.6	11.8	15.0	21.3	13.9	21.1	11.3	21.2	15.4	19.6	10.2	22.6	17.0	20.2	12.8	16.2	19.4	22.2	14.6	12.3	13.4	10.3	15.3	17.0	11.9	5.8	6.4	6.7	7.8	5.7	10.5	6.6	6.6	7.0	7.7	6.7	7.5	7.3	18.3	7.5	4.5	6.2	8.0	4.7	15.9	21.4	23.7	28.7	16.9	11.5	15.6	12.2	17.3	18.5	0.0	13.6	7.5	8.1	10.3	20.9	12.4	10.2	12.0	12.5	19.2	27.5	18.7	0.0	12.3	11.1	8.8	38.3	0.0	13.0	12.3	12.7	8.4	6.9	39.9	14.1	50.9	11.5	6.7	7.9	21.9	18.1	10.1	23.6	2.8	17.8	17.8	9.6	28.6	20.1	10.5	30.9	32.3	9.2	15.3	23.5	10.2	66.1	10.0	24.1	6.3
ELP6	"C3orf75, FLJ20211, TMEM103"	ENSG00000163832	"Elongator acetyltransferase complex subunit 6"	Q0PNE2	3	47495640-47513761	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046358, HPA064545"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA046358: AB_10961011, HPA064545: AB_2685282"	"unprognostic (2.00e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.07e-2)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.42e-6)"	"unprognostic (1.54e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.29e-2)"	10.8	25.9	15.6	16.3	18.5	8.8	15.3	23.2	24.6	12.8	13.3	22.7	19.0	13.3	17.5	22.1	14.2	16.0	13.3	17.0	16.3	15.7	16.4	18.7	11.6	17.5	16.7	21.8	20.8	18.8	16.6	18.8	12.9	19.9	18.1	13.0	18.5	14.8	17.5	23.6	14.7	11.7	16.4	18.6	14.9	13.9	24.9	13.6	23.7	17.8	13.7	17.8	15.5	11.9	20.4	19.5	10.4	12.0	18.4	21.3	14.2	16.9	16.0	21.5	21.7	17.3	16.0	12.2	20.5	14.2	26.2	23.8	15.6	18.0	32.0	12.8	17.7	24.8	10.5	20.8	29.9	16.1	17.8	16.1	28.9	24.8	17.4	19.0	21.8	18.0	17.2	16.2	29.9	19.1	15.3	22.6	27.6	30.2	10.0	26.1	18.7	26.0	24.8	25.7	16.4	27.5	13.1	10.4	19.5	18.4	15.0	19.2	18.7	17.5	14.1	10.6	18.2	19.2	17.6	14.7	26.9	19.2	13.9	25.6	21.1	27.7	29.3	13.9	26.7	27.4	10.4	12.0	8.4	19.5	11.0	15.1	18.7	18.3	19.5	15.0	20.4	17.3	17.4	1.7	18.4	7.6	19.5	21.3	14.2	15.6	18.5	23.2	24.6	16.3	15.7	16.7	21.8	19.9	13.6	6.0	10.5	27.4	16.0	7.4	23.6	21.6	25.5	14.7	13.6	31.4	13.7	38.8	51.4	24.8	6.1	18.9	16.3	0.0	20.7	32.8	14.8	8.1	21.9	25.2	24.9	36.5	16.7	25.8	14.9	10.7	21.3	12.1	15.1	23.4	12.0	39.0	16.7	14.7	28.7	36.1	25.6	6.5	19.3	55.3	23.8	7.3	22.4	26.2	20.4	7.3
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562239-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 81.1"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 28.1;Muller glia cells: 86.9;Rod photoreceptor cells: 19.5;Spermatocytes: 17.2"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.8;HEK 293: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446"	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	1.8	1.8	30.6	1.3	25.8	1.1	1.6	7.2	81.1	1.3	1.4	6.7	0.0	1.1	1.3	1.2	1.3	1.4	1.2	1.3	20.2	17.1	1.2	1.2	1.7	1.3	12.9	12.6	1.1	1.4	1.1	0.2	1.8	5.6	1.5	1.3	8.0	1.1	1.1	1.5	1.6	1.3	1.4	6.2	1.1	1.2	2.2	4.1	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	26.8	4.7	0.5	0.0	0.7	0.5	0.1	1.0	0.3	0.2	1.6	0.1	2.1	0.0	2.0	0.4	2.2	0.2	0.2	0.0	7.4	0.4	1.1	0.0	0.0	0.3	1.2	0.0	0.9	0.1	0.0	0.7	0.0	0.9	5.2	0.2	0.1	1.2	0.2	0.3	2.6	1.9	2.7	0.4	0.2	0.6	1.1	0.9	2.8	1.3	1.7	3.4	0.1	0.7	1.3	2.4	0.2	0.0	5.6	0.1	1.5	0.6	0.6	0.0	0.4	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	25.8	7.2	22.4	20.2	17.1	12.9	12.6	5.6	4.1	3.0	1.3	0.0	0.1	0.7	28.1	1.2	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.5	0.2	6.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	86.9	0.2	0.0	0.0	0.0	19.5	0.0	0.2	17.2	1.0	0.5	0.1	0.0	0.2	0.1
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585272-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	16.5	9.3	14.5	22.6	18.9	16.7	21.8	16.5	17.2	19.3	22.4	19.6	13.1	13.3	20.0	15.2	21.8	12.5	16.4	10.3	13.9	11.3	18.7	15.6	13.6	18.6	18.1	11.3	18.7	25.6	16.4	15.1	28.0	11.7	22.1	20.8	14.5	18.9	16.9	19.8	24.3	17.8	32.6	16.1	18.7	16.6	18.7	18.3	45.0	21.1	12.8	27.7	24.9	27.0	8.2	4.7	4.3	5.4	4.0	8.1	3.9	14.5	7.7	32.4	25.1	7.2	12.5	21.8	11.6	10.9	15.1	15.4	13.8	15.5	34.0	9.4	14.6	8.8	12.5	30.4	18.0	22.2	16.2	18.1	33.3	13.3	18.7	10.9	30.4	15.4	10.4	16.0	17.0	18.9	11.3	17.6	22.9	27.9	11.6	16.2	10.8	39.6	15.9	42.7	14.1	11.9	17.8	18.8	29.9	16.2	19.1	14.5	29.1	18.1	17.7	12.9	23.7	15.4	28.5	14.1	10.1	14.4	11.4	18.9	14.2	18.1	40.6	7.4	28.9	14.2	4.0	3.5	3.4	6.2	5.4	5.6	8.2	6.7	8.1	4.4	6.3	6.4	7.5	4.3	4.0	3.8	4.7	6.3	3.9	14.5	18.9	16.5	17.2	13.9	11.3	18.1	11.3	11.7	18.3	38.7	41.6	33.7	45.3	47.2	27.1	26.6	35.7	33.5	69.4	54.1	35.3	65.8	11.6	61.0	86.4	27.0	20.0	23.3	40.5	94.1	27.3	55.4	23.2	35.0	26.8	19.1	87.9	19.6	24.2	81.6	23.6	30.7	21.9	56.9	60.1	17.9	53.5	20.1	26.9	30.5	30.1	38.8	29.3	55.9	92.0	58.3	60.6	30.5	59.9	48.2
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	18.4	18.7	22.1	18.5	31.1	23.6	18.3	31.2	43.5	22.3	17.8	26.9	15.5	17.3	23.3	14.8	21.0	24.8	17.9	21.3	19.1	19.8	18.6	19.3	16.7	22.0	20.4	28.0	27.1	21.2	37.3	24.8	20.6	23.6	20.4	13.0	22.0	20.4	23.6	27.1	26.2	16.1	18.8	15.3	21.2	18.7	54.4	18.4	23.8	20.1	15.2	16.9	18.6	17.6	9.9	13.0	9.8	10.5	8.2	16.1	11.6	8.1	20.7	20.5	21.1	9.5	7.9	14.0	15.4	13.2	26.6	19.2	23.8	17.4	26.5	12.1	15.0	18.5	12.5	30.3	21.5	9.5	18.0	36.3	23.1	30.5	23.2	16.5	21.5	24.0	13.8	13.7	28.1	19.8	10.5	17.3	24.5	32.5	17.1	12.4	22.0	27.3	23.6	22.8	10.8	35.4	18.2	11.0	23.5	13.3	20.7	16.9	22.5	15.0	21.4	11.1	10.3	15.0	22.6	12.0	16.1	20.9	18.1	28.2	20.7	25.8	24.0	16.7	18.8	19.9	9.8	10.1	7.2	15.0	10.3	13.0	9.9	12.7	16.1	13.0	9.3	12.1	13.0	1.5	8.2	10.5	7.8	14.3	11.6	22.1	31.1	31.2	43.5	19.1	19.8	20.4	28.0	23.6	18.4	35.7	44.3	33.3	22.5	16.1	46.6	31.3	35.7	42.8	28.4	48.8	41.2	35.6	56.3	33.4	93.4	33.1	32.4	23.3	31.3	18.8	20.4	23.6	23.1	43.3	30.5	55.6	38.5	23.4	27.7	89.2	23.0	28.0	18.6	25.2	23.6	39.2	38.5	29.6	28.3	56.9	46.8	32.3	19.4	136.8	41.1	17.3	24.7	23.5	30.9	22.7
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.5;skeletal muscle: 197.9"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 398.9;Cardiomyocytes: 855.4;Cone photoreceptor cells: 589.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038149, HPA038150"	Enhanced		Enhanced	"Plasma membrane,Microtubules,Cytosol"		NA	NA		120000	"Plasma membrane, Microtubules, Cytosol"		"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	39.3	14.8	60.5	18.2	50.9	6.3	16.4	29.3	56.0	26.9	26.4	80.8	15.8	13.6	25.8	27.4	27.0	24.6	20.1	110.2	63.7	57.5	20.8	13.8	22.7	12.4	86.8	26.1	26.8	18.9	14.6	9.3	24.0	59.5	21.8	18.8	25.2	14.0	34.9	197.9	25.1	15.2	35.0	131.5	18.3	16.2	21.2	41.8	7.3	15.4	31.3	14.2	24.3	18.1	9.9	8.9	6.3	19.7	10.7	13.4	6.7	22.2	17.9	22.4	17.0	33.1	59.1	9.5	41.8	45.7	35.4	39.8	15.0	14.0	18.9	9.8	63.0	33.3	14.9	28.6	37.9	39.8	27.2	12.1	12.7	20.0	19.4	45.0	8.8	10.4	49.4	47.4	43.0	52.7	32.3	46.4	13.3	16.4	22.0	27.8	12.6	12.5	10.8	13.5	11.0	37.0	6.7	21.1	23.4	22.7	18.7	8.9	13.9	32.1	13.0	22.1	32.8	9.5	8.2	62.6	33.5	25.9	35.0	26.7	15.4	11.9	8.9	43.1	10.9	31.6	6.3	5.3	2.8	13.4	9.0	6.5	9.9	9.0	10.9	5.7	9.4	4.3	6.7	2.2	10.7	19.7	8.9	10.2	6.7	60.5	50.9	29.3	51.8	63.7	57.5	86.8	26.1	59.5	41.8	65.5	44.5	28.6	38.3	66.4	398.9	855.4	48.4	45.5	70.5	76.8	589.0	27.7	23.2	85.7	90.1	78.7	34.2	0.0	56.1	64.5	84.5	58.1	26.6	49.9	34.2	44.5	27.6	41.1	23.5	28.8	71.4	40.8	74.2	101.8	29.5	77.6	76.7	23.0	96.9	27.0	86.7	71.1	108.8	53.1	49.0	60.9	18.8	48.4	33.0	40.0
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188402	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 106.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.8	1.2	1.1	5.5	1.1	13.0	0.8	0.7	1.2	1.1	3.3	0.6	1.0	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1.0	4.0	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23.0	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0.0	1.0	0.1	7.6	3.8	18.1	9.7	0.6	1.2	12.5	10.6	4.0	13.4	10.9	16.4	4.0	22.8	4.2	2.8	8.5	5.8	30.9	7.3	14.2	7.4	16.3	29.1	6.9	8.1	0.6	20.5	8.5	0.6	1.1	16.6	7.2	1.6	5.0	17.0	23.1	12.1	7.2	4.1	25.6	16.0	26.4	7.0	8.7	11.5	11.9	12.4	3.4	7.2	8.5	10.6	6.6	7.7	3.4	12.0	4.0	14.6	2.5	6.6	10.2	7.3	14.5	6.1	18.2	35.8	4.9	22.9	5.5	0.0	0.0	0.5	0.4	0.0	0.0	1.7	0.6	0.2	0.9	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2	0.0	0.0	0.0	0.4	0.3	0.0	106.0	0.0	0.0	0.0	0.0	2.0	1.9	0.0	0.5	14.7	0.1	0.3	0.0	0.8	5.7	0.5	0.4	0.0	0.2	2.5	0.0	1.2	1.3	0.3	22.9	1.4	0.0	0.0	0.0	1.5	0.5	0.9	0.0	1.8	0.2	0.4	0.0	0.4	15.8	13.7	0.0	0.2	0.0	3.2	0.3
CAMP	"CAP18, FALL-39, FALL39, LL37"	ENSG00000164047	"Cathelicidin antimicrobial peptide"		3	48223347-48225491	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 63.7;bone marrow: 201.8;epididymis: 275.0"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 14.1;Glandular cells: 10.4;Late spermatids: 6.8;Spermatogonia: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 63.7"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 63.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.6;hTCEpi: 9.5;U-698: 39.4"	"Low region specificity"	"Detected in single"							"CAB015949, CAB016522, HPA029874"	Enhanced				"Secreted to blood"	NA	NA	617000000				"CAB015949: , CAB016522: , HPA029874: AB_10600859"	"unprognostic (2.14e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (4.59e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.57e-5)"	"unprognostic (3.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.08e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-2)"	0.2	0.1	0.1	0.1	0.2	201.8	0.2	0.1	0.1	0.1	0.1	0.0	14.7	0.0	0.0	275.0	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.2	1.5	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.0	0.1	1.1	0.1	0.1	0.1	2.6	0.0	0.1	10.1	0.1	4.0	0.0	0.4	0.4	0.1	0.2	0.4	0.1	0.5	1.5	63.7	5.2	0.5	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	39.4	0.0	1.5	0.0	5.5	1.1	15.8	0.0	1.7	0.0	0.5	0.0	0.0	1.5	0.3	0.0	0.0	63.7	0.5	5.2	0.8	0.0	10.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.2	0.0	0.2	10.4	0.0	0.0	3.3	0.0	0.0	0.6	0.6	6.8	0.9	0.8	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.9	0.0	0.0	0.0	0.0	0.4
ZNF589	SZF1	ENSG00000164048	"Zinc finger protein 589"	Q86UQ0	3	48241100-48299253	"Predicted intracellular proteins, Transcription factors"		"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 15.2;Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HAP1: 23.4;NTERA-2: 37.1"									HPA003145	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003145: AB_1080738"	"unprognostic (2.49e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.01e-5)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.64e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.19e-2)"	6.6	9.8	15.5	10.2	17.0	5.2	7.4	42.8	16.2	7.7	7.2	10.4	7.6	4.5	8.4	22.6	9.4	8.3	5.4	6.0	13.5	6.6	6.3	3.5	9.0	12.9	18.2	7.9	16.1	6.4	9.9	16.3	3.5	14.0	20.8	7.5	10.7	9.6	18.1	6.4	11.0	14.4	9.2	13.9	22.8	7.0	5.8	14.9	5.7	18.8	3.3	13.0	7.2	9.6	4.0	13.3	1.8	3.1	1.3	5.1	2.2	2.3	1.6	6.8	5.6	8.8	4.7	8.6	2.1	1.8	2.8	3.6	3.5	3.2	9.2	1.8	2.5	2.1	2.0	23.4	5.8	2.1	5.8	5.4	10.9	6.6	2.7	1.6	2.4	3.0	1.5	3.9	3.2	2.3	2.9	4.8	7.2	7.7	2.1	1.5	2.2	3.4	2.0	37.1	2.0	3.6	1.6	2.5	3.4	2.0	2.3	2.3	4.9	1.7	2.0	6.9	10.6	2.9	3.9	7.6	1.6	3.2	3.6	1.4	4.8	5.9	7.5	1.7	6.7	4.8	1.1	2.8	1.8	3.8	2.4	4.4	4.0	4.4	4.9	2.8	2.7	5.1	4.9	1.5	1.3	3.1	13.3	3.8	2.2	15.5	17.0	42.8	16.2	13.5	6.6	18.2	7.9	14.0	14.9	0.0	4.8	0.8	1.0	1.0	15.2	3.0	0.0	2.7	3.4	8.7	19.6	1.9	3.3	1.2	1.3	2.1	1.3	0.0	0.9	0.9	1.8	0.8	0.0	1.0	3.1	1.6	1.7	1.8	3.7	1.5	2.0	4.6	1.7	0.0	2.3	4.8	0.7	1.4	4.2	1.4	11.0	6.5	1.9	0.6	2.7	1.1	0.0	2.5	2.3	0.7
NME6	"IPIA-ALPHA, NM23-H6"	ENSG00000172113	"NME/NM23 nucleoside diphosphate kinase 6"	O75414	3	48290722-48301685	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017909	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA017909: AB_1854530"	"unprognostic (7.31e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (1.98e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.50e-2)"	11.7	12.2	7.0	14.4	11.0	7.7	13.5	9.2	10.9	12.2	12.0	11.9	14.6	13.5	16.1	13.2	16.1	16.3	8.8	13.7	9.9	6.8	18.0	17.5	11.1	12.9	9.2	10.3	14.5	20.6	12.1	13.3	22.1	8.8	13.2	12.7	13.5	20.8	17.6	20.1	10.3	13.4	13.3	7.1	14.2	13.4	9.0	8.2	12.6	17.5	14.3	15.1	13.9	15.7	26.4	23.5	43.3	22.7	23.0	25.8	14.3	17.9	11.2	15.3	11.1	12.5	16.8	13.7	17.6	13.6	25.9	19.7	18.7	15.8	18.1	9.2	13.7	24.3	6.3	13.7	19.4	15.4	21.6	13.3	11.8	15.0	15.2	16.7	14.9	12.7	13.7	21.3	23.0	27.4	12.4	13.9	13.7	19.7	14.0	9.7	8.5	12.5	6.4	12.9	12.7	14.7	7.4	13.4	15.2	13.0	15.5	4.7	8.1	12.0	13.2	15.7	12.4	14.8	13.9	12.4	5.1	20.4	12.7	25.0	16.6	22.4	16.3	9.7	19.8	11.3	22.0	20.1	43.3	25.8	20.7	23.6	26.4	24.2	21.9	23.5	24.4	18.7	17.7	22.5	23.0	22.7	21.1	19.4	14.3	7.0	11.0	9.2	10.9	9.9	6.8	9.2	10.3	8.8	8.2	26.8	20.2	17.6	7.9	4.4	12.2	9.2	20.4	44.2	21.6	8.7	13.7	42.3	33.2	22.4	1.9	8.3	11.2	0.0	26.1	34.3	7.8	7.3	9.3	8.3	29.6	9.5	4.1	6.7	6.7	1.5	10.9	12.4	15.1	29.7	8.8	14.6	25.4	7.0	6.7	12.8	12.2	12.9	7.4	9.1	13.2	3.6	16.5	13.8	12.8	5.9
SPINK8		ENSG00000229453	"Serine peptidase inhibitor, Kazal type 8 (putative)"	P0C7L1	3	48306842-48328341	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"breast: 33.5"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 1.1;Exocrine glandular cells: 1.2;Glandular cells: 2.2"	"Group enriched"	"Detected in some"	10	"breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4"					"Group enriched"	"Detected in some"	10	"eosinophil: 3.3;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 4.5"	"Cell line enriched"	"Detected in single"	62	"SK-BR-3: 41.2"	"Region enriched"	"Detected in some"	9	"hippocampal formation: 80.7"					HPA053151	Uncertain				"Secreted to blood"	NA	NA					"HPA053151: AB_2682059"	"prognostic unfavorable (8.47e-4)"			"unprognostic (1.98e-1)"	"unprognostic (1.75e-2)"					"unprognostic (1.99e-1)"		"unprognostic (1.15e-1)"					"unprognostic (1.20e-1)"	0.0	0.0	1.4	0.0	1.0	7.3	33.5	0.3	0.6	0.0	0.0			0.0	0.0	1.8	4.1	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	1.5		0.0	0.2	0.0	0.2	0.0		0.4	0.0		1.8	0.1	0.0	0.2	0.0	0.0	2.3	1.2	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	41.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4
FBXW12	"Fbw12, FBXO35"	ENSG00000164049	"F-box and WD repeat domain containing 12"	Q6X9E4	3	48372219-48401259	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"pancreas: 12.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 8.6;Late spermatids: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;HEK 293: 1.7;SH-SY5Y: 1.0;THP-1: 1.5"									"HPA037491, HPA037492"	Uncertain					NA	NA					"HPA037491: AB_2675504, HPA037492: AB_2675505"	"unprognostic (5.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.36e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.81e-3)"	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.9	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1		0.1	12.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	1.0	0.0	0.2	0.0	0.2	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0
PLXNB1	"KIAA0407, PLXN5, SEP"	ENSG00000164050	"Plexin B1"	O43157	3	48403854-48430051	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.7"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 51.3;Intestinal endocrine cells: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040586	Enhanced				"Intracellular and membrane"	NA	NA		55000000			"HPA040586: AB_10794034"	"unprognostic (1.31e-3)"	"unprognostic (7.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-2)"	"prognostic favorable (2.77e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.98e-2)"	"prognostic favorable (7.60e-4)"	5.8	3.6	23.1	3.7	34.0	1.4	7.5	11.5	25.6	8.4	9.0	47.4	7.2	10.6	10.8	6.7	14.3	25.0	11.3	7.8	26.3	7.4	17.1	14.8	10.8	2.0	48.7	19.3	11.1	24.9	9.1	9.9	7.6	28.9	12.5	6.2	8.8	11.5	18.7	1.0	21.0	9.9	8.5	22.6	6.3	10.1	3.2	34.7	1.4	19.9	3.6	3.0	11.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	9.3	5.5	3.4	2.8	19.1	2.5	1.4	1.5	0.9	6.1	11.4	0.0	9.3	1.7	0.9	9.0	2.0	20.2	0.3	5.1	0.4	0.0	9.7	11.5	5.1	3.9	1.7	5.0	17.7	0.3	4.2	5.7	2.4	2.0	0.7	0.4	1.4	5.1	0.7	3.5	16.5	6.4	1.1	4.5	2.0	0.6	8.8	13.4	4.8	10.3	3.2	19.3	2.9	2.6	10.3	3.3	4.6	1.5	4.5	2.1	2.8	0.1	0.0	0.1	0.3	1.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	34.0	11.5	25.6	26.3	7.4	48.7	19.3	28.9	34.7	32.8	22.4	0.0	14.1	10.2	1.9	16.5	33.1	28.1	23.9	43.6	2.0	17.8	5.0	17.9	4.3	3.1	27.1	0.0	13.6	2.1	4.8	11.8	0.0	51.3	2.5	3.2	50.6	6.7	2.4	2.9	14.1	1.1	1.7	1.0	18.0	19.3	17.6	22.0	14.5	10.9	4.9	0.0	5.9	0.5	2.6	8.4	8.2	1.5	21.5	9.5
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.24e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.47e-3)"	"unprognostic (6.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	9.9	14.9	10.1	7.1	12.7	4.5	9.6	10.4	15.9	8.9	12.8	7.5	12.4	11.6	8.2	11.4	15.9	9.7	8.4	12.3	9.2	8.2	15.2	17.8	7.1	9.0	9.9	15.4	8.7	8.5	9.4	7.4	8.5	10.6	7.7	15.1	9.9	11.0	11.2	16.3	10.9	8.8	11.6	8.8	14.7	7.9	10.7	8.9	10.4	11.3	16.1	12.0	8.8	9.7	19.2	18.2	4.8	10.4	10.6	14.8	9.7	9.7	11.9	7.2	8.4	10.6	11.3	19.7	6.5	6.0	13.1	10.7	18.8	16.4	21.2	9.3	5.1	9.8	14.3	17.6	21.2	8.0	9.9	11.6	18.1	18.9	14.1	16.4	8.8	8.3	8.5	48.2	16.1	17.7	7.1	7.4	12.5	10.0	6.2	12.3	9.3	10.2	11.4	15.7	21.0	19.3	7.1	8.4	16.3	17.7	12.2	5.9	12.5	10.7	11.7	17.4	7.0	12.6	13.7	5.6	7.6	10.3	18.8	12.4	10.0	14.6	11.1	10.1	19.1	7.1	2.0	10.4	4.8	12.0	10.2	12.1	19.2	11.2	14.8	18.2	15.4	11.7	13.4	4.5	10.6	6.1	15.2	13.4	9.7	10.1	12.7	10.4	15.9	9.2	8.2	9.9	15.4	10.6	8.9	11.9	1.6	8.9	3.0	4.1	6.8	7.3	22.9	5.3	5.7	8.7	0.0	35.3	19.9	13.2	2.5	5.3	12.6	0.0	10.8	15.3	10.7	3.7	3.5	11.9	14.1	7.9	5.2	3.1	3.8	2.2	11.2	4.1	13.5	13.6	6.3	10.1	12.4	5.8	12.4	27.0	9.5	6.5	3.1	4.8	17.3	4.1	5.6	4.3	12.4	3.1
TMA7	"CCDC72, HSPC016"	ENSG00000232112	"Translation machinery associated 7 homolog"	Q9Y2S6	3	48440257-48444208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047397			Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Nuclear bodies"	"HPA047397: AB_2680029"	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.55e-2)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.14e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.31e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.64e-3)"	38.7	54.0	76.1	41.7	82.7	72.5	49.8	41.7	55.8	35.3	49.0	22.6	44.7	37.8	28.4	72.6	43.0	30.5	40.3	49.8	61.4	61.6	50.3	50.3	36.6	50.3	63.6	46.0	41.7	59.5	21.6	45.4	28.7	53.3	36.9	47.0	39.2	39.6	37.4	107.4	28.4	41.1	36.5	57.4	41.5	39.0	35.0	41.0	37.9	38.3	67.6	56.6	29.9	37.7	125.7	139.0	192.1	98.7	79.4	146.7	204.3	65.2	47.4	76.9	55.0	63.8	62.3	53.0	54.0	42.6	51.8	51.5	38.5	47.3	42.7	38.6	46.9	67.6	25.6	67.0	60.9	57.9	52.5	57.1	80.5	102.1	98.1	49.7	91.3	54.0	57.0	65.5	48.9	47.7	50.8	65.3	76.4	43.0	45.7	73.8	67.6	106.2	124.3	102.5	71.0	76.5	30.4	48.2	72.3	89.0	88.5	25.3	64.3	60.8	44.5	81.2	74.5	42.9	135.7	48.8	44.0	79.1	67.9	105.3	76.3	112.4	102.9	56.4	88.3	45.5	141.0	98.7	192.1	110.7	89.8	119.5	125.7	146.7	132.9	104.9	100.5	146.3	140.0	188.5	79.4	87.7	139.0	143.8	204.3	76.1	82.7	41.7	55.8	61.4	61.6	63.6	46.0	53.3	41.0	223.4	369.4	511.1	446.0	636.3	196.3	594.9	570.7	348.0	349.2	854.9	100.1	706.5	1455.6	502.0	547.1	428.3	899.7	443.9	893.2	693.8	535.7	516.2	437.2	865.9	741.4	112.8	610.5	535.9	636.7	794.0	598.9	617.4	737.2	776.3	895.2	244.7	727.5	821.9	436.7	886.4	223.1	349.3	415.1	507.5	743.5	785.4	368.1	657.2	795.4	485.3
ATRIP	"FLJ12343, MGC20625, MGC21482, MGC26740"	ENSG00000164053	"ATR interacting protein"	Q8WXE1	3	48446710-48467645	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.3"	"Cell type enhanced"	"Detected in some"	7	"Ciliated cells: 5.3;Exocrine glandular cells: 3.3;Pancreatic endocrine cells: 3.5;Suprabasal keratinocytes: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033109, HPA047590"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB033109: AB_634993, HPA047590: AB_2680094"	"unprognostic (5.43e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"unprognostic (4.72e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.40e-2)"	"unprognostic (8.52e-2)"	6.1	5.3	4.9	6.2	5.5	7.1	6.5	9.4	6.4	7.0	5.2	7.2	5.1	3.8	8.2	5.1	7.0	5.7	5.0	5.4	3.5	2.8	5.4	5.4	6.0	5.5	4.8	3.6	6.8	5.3	5.3	5.5	9.2	3.8	6.2	6.0	6.5	5.1	7.2	7.3	8.0	4.6	5.4	3.4	6.3	5.2	38.3	4.6	13.4	9.3	6.6	9.0	5.5	6.2	0.9	2.9	1.0	1.4	1.4	3.4	1.5	7.0	2.9	8.2	6.2	5.0	8.5	8.7	10.7	5.0	13.3	11.1	4.3	5.0	15.7	5.1	4.5	6.2	7.3	9.2	8.4	13.0	9.3	4.7	12.2	13.1	2.9	2.7	11.8	7.8	3.6	2.7	7.1	3.4	2.9	5.8	5.9	9.7	8.1	12.4	3.9	9.9	4.2	6.4	3.6	8.8	6.7	7.5	11.5	4.5	3.5	4.0	5.8	8.6	8.7	3.4	7.7	7.4	4.5	6.5	8.9	5.8	10.7	12.4	9.6	15.3	10.8	4.7	8.9	4.9	0.7	1.4	0.0	3.3	0.8	0.5	0.9	3.0	1.7	0.9	0.5	2.1	3.3	1.0	1.4	1.0	2.9	3.4	1.5	4.9	5.5	9.4	6.4	3.5	2.8	4.8	3.6	3.8	4.6	0.0	1.0	0.0	0.0	2.6	0.8	1.3	0.0	5.3	2.3	0.0	2.0	0.1	0.0	3.0	0.0	0.7	0.0	0.0	3.3	0.1	0.2	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	2.8	0.0	0.6	3.5	0.0	0.0	1.5	2.0	0.0	0.9	0.0	0.0	3.3	0.1	0.0	0.0	0.0
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 8.0;Cardiomyocytes: 5.0;Melanocytes: 23.6;Smooth muscle cells: 7.6;Suprabasal keratinocytes: 12.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.9"					"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA035437: AB_10672092, HPA046721: AB_2732531"																		14.2	14.3	16.7	14.6	10.6	20.7	17.2	13.0	16.9	13.4	11.0	12.8	17.5	10.3	8.1	14.9	16.6	14.5	12.3	9.8	14.4	14.2	11.6	12.7	12.5	26.2	14.6	17.4	7.3	13.0	6.8	31.2	11.6	11.2	15.4	9.3	10.8	32.2	19.3	10.8	22.9	10.9	8.2	12.6	25.5	12.4	4.6	10.1	18.5	7.4	18.3	21.7	13.3	10.6	24.9	35.5	23.3	41.8	8.6	13.1	20.1	8.0	7.4	6.2	4.4	7.7	7.9	0.0	2.6	13.1	22.0	30.9	0.1	9.6	9.5	5.4	11.1	20.8	9.4	0.4	11.8	3.1	8.0	0.7	5.5	26.5	0.4	9.7	5.0	3.9	6.9	1.1	11.1	4.4	4.5	9.3	6.6	0.0	14.6	9.3	0.1	7.0	3.6	0.0	4.7	4.6	5.8	1.6	18.5	5.8	1.6	0.0	3.7	9.6	13.0	6.3	0.4	0.4	8.4	9.8	4.1	3.9	8.7	6.1	11.8	6.8	4.0	9.1	10.7	3.3	2.1	41.8	3.0	9.8	32.5	5.6	24.6	13.1	9.4	35.5	24.9	12.4	10.3	23.3	8.6	24.3	28.0	11.6	20.1	16.7	10.6	13.0	16.9	14.4	14.2	14.6	17.4	11.2	10.1	0.0	0.3	0.0	0.0	8.0	0.0	5.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	12.2	0.0	0.0	0.0	0.0
SHISA5	"hShisa5, SCOTIN"	ENSG00000164054	"Shisa family member 5"	Q8N114	3	48467798-48504826	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042295	Approved					NA	NA					"HPA042295: AB_10794794"	"unprognostic (3.52e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.72e-6)"	"unprognostic (3.82e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.64e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.08e-3)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-2)"	35.7	27.1	31.9	32.0	30.9	28.2	32.1	16.4	39.2	32.5	27.3	23.5	18.8	29.6	35.8	33.8	54.3	43.2	35.0	27.5	26.7	31.5	40.7	57.9	36.4	34.7	22.9	19.8	41.7	23.0	20.5	27.2	84.2	24.7	38.8	20.1	49.1	26.5	37.7	12.9	21.6	35.8	33.3	18.4	43.1	28.0	19.6	18.0	35.5	37.2	28.3	35.2	45.0	34.5	33.2	23.1	127.1	41.6	17.9	47.1	56.0	13.2	27.1	16.0	25.5	30.6	39.2	81.8	22.0	40.4	49.9	37.2	29.7	33.8	18.4	24.2	38.2	47.3	17.6	17.7	28.4	14.0	21.7	12.2	16.7	18.4	23.9	51.5	11.5	32.1	40.1	33.0	40.2	28.0	27.9	37.3	24.8	10.4	22.4	26.6	28.8	12.9	20.7	29.2	19.0	21.8	9.0	7.1	24.9	25.4	85.0	4.8	2.7	14.3	15.4	28.8	28.1	17.7	17.2	29.3	17.9	20.0	30.2	21.0	17.0	13.7	16.0	25.3	22.3	17.3	23.4	41.6	32.8	47.1	36.1	41.7	24.1	39.4	42.9	23.1	33.2	32.2	33.2	127.1	17.9	39.5	17.5	45.8	56.0	31.9	30.9	16.4	39.2	26.7	31.5	22.9	19.8	24.7	18.0	38.7	39.1	53.3	58.0	24.6	20.9	14.5	50.9	37.5	38.7	61.1	15.7	220.5	10.0	70.1	3.7	62.1	47.7	0.0	90.6	183.8	55.4	43.7	33.5	74.4	90.8	6.4	36.4	58.9	49.8	4.4	45.5	49.0	43.9	17.2	44.0	24.4	73.3	24.6	36.7	37.9	4.6	32.3	47.4	4.7	5.9	28.1	100.8	68.2	36.3	39.9
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.0"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 36.2;Mucus-secreting cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 21.6;monocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 22.9;U-87 MG: 36.5;WM-115: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA047719: AB_2680129, HPA066058: AB_2685606"	"unprognostic (7.60e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	2.0	2.2	4.0	3.9	4.9	12.7	2.1	6.3	6.3	2.6	17.1	8.6	3.0	17.8	2.1	18.5	6.4	1.5	1.8	1.4	4.2	5.2	3.6	1.7	3.8	6.3	7.4	2.7	3.5	18.9	4.1	5.1	9.5	6.9	3.3	3.5	3.3	2.5	2.0	4.8	3.3	24.0	2.5	5.3	10.0	1.2	26.0	5.2	0.4	1.6	3.6	2.6	4.9	4.2	0.2	2.7	21.6	12.2	0.2	0.5	2.1	5.0	1.5	3.6	3.3	1.2	1.8	7.1	2.5	4.3	5.2	12.6	2.5	1.8	2.2	2.4	1.9	12.4	1.4	1.5	4.4	4.6	1.5	1.2	5.1	3.3	2.7	1.0	0.9	2.3	1.8	6.6	8.3	0.8	22.9	1.2	2.9	1.7	1.9	4.1	1.1	0.3	7.1	2.2	1.0	3.4	0.4	1.7	2.3	2.0	4.7	1.0	2.2	2.7	1.2	9.9	3.7	2.8	2.2	0.3	5.3	2.1	0.6	15.3	8.8	1.9	1.3	36.5	1.8	31.7	0.0	6.5	11.4	0.2	7.3	0.1	0.2	0.3	0.0	2.7	0.1	0.5	0.1	21.6	0.2	12.2	0.3	0.0	2.1	4.0	4.9	6.3	6.3	4.2	5.2	7.4	2.7	6.9	5.2	0.0	2.2	0.0	0.3	2.9	5.0	0.6	0.0	1.4	1.2	0.0	2.0	11.1	0.0	2.0	2.6	0.4	1.7	0.0	1.3	36.2	1.5	0.4	1.1	0.0	5.3	6.4	4.1	1.8	11.0	2.0	0.9	4.4	1.7	0.0	11.8	3.6	2.9	0.3	0.7	0.0	4.3	0.0	0.8	0.5	0.5	1.5	4.6	0.0	1.5	0.0
UCN2	"SRP, UCN-II, UCNI, URP"	ENSG00000145040	"Urocortin 2"	Q96RP3	3	48561727-48563773	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 18.6;vagina: 6.3"	"Cell type enriched"	"Detected in single"	5	"Basal keratinocytes: 2.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 18.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.7;hTEC/SVTERT24-B: 12.4;SiHa: 10.8;U-251 MG: 11.4;WM-115: 31.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066841	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	98600		Vesicles		"HPA066841: AB_2685735"	"unprognostic (7.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-14)"	"unprognostic (4.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-2)"	1.7	0.0	0.3	0.5	0.9	0.1	0.6	0.3	0.3	2.0	0.3	0.3	0.3	0.1	1.8	1.1	3.7	0.1	0.6	0.3	0.3	0.5	0.9	0.3	0.3	0.3	1.6	0.3	0.3	0.3	0.0	0.3	0.3	0.9	3.3	0.1	0.3	1.6	0.7	0.3	18.6	0.3	0.4	0.3	0.5	0.1	1.1	0.3	0.3	0.3	0.3	0.3	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	1.0	0.6	1.5	5.4	6.8	3.4	2.5	0.0	0.0	0.0	0.2	1.3	4.1	1.0	0.0	6.5	1.8	5.0	0.1	0.1	8.9	0.8	1.1	0.0	0.3	0.7	15.7	12.4	2.5	2.4	0.0	0.1	0.0	0.1	0.5	0.0	0.0	1.0	0.4	0.0	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.0	10.8	0.0	8.1	1.0	0.1	0.2	0.0	1.5	1.0	0.1	11.4	0.0	0.1	0.0	5.1	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.5	1.6	0.3	0.9	0.3	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COL7A1	"EBD1, EBDCT, EBR1"	ENSG00000114270	"Collagen type VII alpha 1 chain"	Q02388	3	48564073-48595267	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 59.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 22.7;Basal keratinocytes: 64.5;Suprabasal keratinocytes: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.8;HaCaT: 20.0;HBEC3-KT: 31.9;HDLM-2: 30.1;HeLa: 39.2;SiHa: 26.2"	"Region enhanced"	"Detected in single"		"cerebellum: 0.7"	"Not detected"	"Not detected"			"CAB016357, HPA018877, HPA042420"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum"	Vesicles	"CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990"	"unprognostic (2.69e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (6.31e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.86e-2)"	1.3	1.0	0.6	2.6	3.3	0.4	2.5	8.2	3.6	11.7	1.3	0.8	5.2	1.4	8.0	11.9	11.3	2.5	4.5	1.6	2.3	4.4	3.4	1.2	0.9	1.0	1.5	1.0	1.8	0.5	0.4	1.1	2.2	4.8	17.1	0.9	2.6	7.3	10.8	2.3	59.2	1.8	2.9	3.2	4.3	1.2	1.6	0.7	0.5	0.4	13.5	4.8	3.3	14.2	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	8.0	0.3	0.1	3.0	4.1	10.0	20.8	13.1	5.5	3.3	0.1	0.1	0.0	0.6	4.7	5.0	20.0	0.0	31.9	1.0	30.1	0.1	0.0	39.2	1.3	8.4	0.0	0.1	6.6	19.1	11.1	8.7	7.5	0.0	0.2	0.1	0.2	0.6	0.1	0.0	0.2	1.0	0.4	0.4	0.1	0.7	0.0	3.0	0.0	0.0	0.0	26.2	0.0	0.2	1.2	0.4	0.1	0.0	1.8	1.0	1.0	15.5	0.6	0.5	0.0	16.0	0.1	0.9	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	8.2	3.6	2.3	4.4	1.5	1.0	4.8	0.7	0.0	0.0	0.5	22.7	64.5	15.5	5.3	0.0	0.0	13.6	10.4	9.8	1.0	0.0	0.6	11.6	0.8	0.2	0.0	0.6	0.8	2.6	2.0	0.0	0.4	1.5	7.9	1.7	0.0	0.3	3.8	4.6	0.7	8.5	0.0	0.2	2.3	9.3	0.0	5.3	0.0	11.7	0.0	8.5	2.8	0.9	21.1	1.0	0.0	0.0	4.6
UQCRC1	"D3S3191, QCR1, UQCR1"	ENSG00000010256	"Ubiquinol-cytochrome c reductase core protein 1"	P31930	3	48599002-48610976	"Enzymes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.7"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 576.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002815, HPA003525, CAB033782"	Enhanced		Supported	Mitochondria		NA	NA		1300000	Mitochondria		"CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484"	"unprognostic (1.29e-1)"	"unprognostic (3.15e-3)"	"unprognostic (6.91e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (2.35e-10)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.72e-2)"	18.1	13.7	11.1	9.8	12.5	9.4	11.8	12.5	20.5	11.0	33.7	6.9	10.4	20.0	9.1	9.7	15.8	12.4	10.8	66.7	10.8	11.2	23.0	30.5	7.7	9.3	13.3	13.5	6.3	14.4	20.4	7.8	11.5	13.3	12.5	12.3	7.8	19.5	21.9	172.7	14.0	20.9	12.0	8.7	8.4	23.0	18.4	7.4	9.4	9.1	39.9	9.8	10.3	9.1	23.3	52.7	28.1	57.8	15.1	22.0	74.3	10.1	16.5	6.0	3.6	8.8	8.1	27.1	18.8	15.2	15.6	14.2	25.6	3.0	26.3	11.9	8.4	18.3	9.8	7.5	21.8	2.9	15.6	35.9	27.0	14.3	27.7	17.5	16.9	11.7	11.1	24.8	10.6	17.5	7.4	15.5	17.4	14.5	1.8	9.4	17.7	12.2	19.3	15.0	15.0	65.5	8.3	16.0	21.5	16.1	11.1	6.4	11.4	25.4	3.1	15.0	1.7	6.5	2.7	15.5	4.3	16.5	13.6	19.3	16.0	14.1	15.2	9.6	19.5	13.9	17.6	57.8	28.1	18.9	56.9	17.9	23.3	18.9	19.0	52.7	18.6	17.1	16.4	14.1	15.1	48.5	21.0	22.0	74.3	11.1	12.5	12.5	20.5	10.8	11.2	13.3	13.5	13.3	7.4	53.6	50.3	63.6	133.4	104.5	38.0	576.9	142.7	78.9	46.6	115.1	27.5	292.1	310.0	150.4	116.4	44.8	496.0	46.7	145.4	266.4	68.1	72.4	80.8	173.2	214.8	38.1	138.8	44.2	110.4	218.8	54.1	87.6	113.1	113.6	228.6	55.4	138.8	252.6	66.4	309.3	39.8	58.2	92.9	102.7	76.4	92.1	281.6	56.5	307.7	117.4
TMEM89		ENSG00000183396	"Transmembrane protein 89"	A2RUT3	3	48620759-48621855	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 28.3"	"Group enriched"	"Detected in some"	79	"Early spermatids: 252.0;Late spermatids: 154.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.8;U-2197: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA053577	Uncertain					NA	NA					"HPA053577: AB_2682196"	"unprognostic (1.61e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.31e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.86e-2)"	0.1	0.0	0.1	0.1	0.1	2.8	0.1	0.1	0.5	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.5	0.5	0.1	0.1	0.1	0.7	28.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.7	0.4	1.1	0.3	1.1	0.7	0.0	0.2	0.0	1.1	1.8	0.2	0.4	0.0	0.0	0.3	0.0	0.5	0.8	0.6	0.5	0.0	1.5	0.0	1.4	1.9	0.6	0.2	0.0	0.8	0.0	0.0	0.0	0.8	0.0	2.8	0.6	0.4	0.0	0.7	0.5	0.0	0.7	1.2	0.1	0.9	0.0	0.7	0.4	0.5	0.8	0.0	0.0	1.4	1.5	3.1	1.6	0.5	0.8	0.5	1.8	0.7	2.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	154.1	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0
SLC26A6	DKFZp586E1422	ENSG00000225697	"Solute carrier family 26 member 6"	Q9BXS9	3	48625723-48635493	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 43.3;Mucus-secreting cells: 32.0;Paneth cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048363	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA048363: AB_2680371"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.66e-3)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.58e-2)"	5.3	5.7	6.4	12.3	9.8	18.8	5.7	6.8	6.9	6.3	24.8	6.0	7.3	9.7	6.8	7.4	6.5	4.7	6.3	6.7	4.9	3.1	13.6	6.2	7.8	7.4	9.4	3.1	6.7	14.9	6.8	5.8	6.5	9.3	10.2	25.4	7.7	9.6	7.4	8.8	6.7	19.5	6.8	4.8	10.6	19.7	7.7	9.9	7.7	5.5	5.4	6.3	5.1	6.6	0.9	8.8	5.2	10.7	0.5	3.3	4.5	4.5	5.1	7.3	8.2	23.1	11.6	6.2	7.5	9.9	14.6	15.7	9.7	4.2	6.5	2.6	6.4	16.2	6.1	6.8	6.9	4.2	4.8	6.8	5.9	14.5	18.7	16.8	2.8	9.2	15.8	24.8	9.9	7.2	12.6	4.5	6.7	4.5	7.4	3.5	5.4	5.4	14.8	10.4	12.5	9.9	2.8	2.7	7.9	10.7	4.5	1.8	3.5	9.8	12.1	14.1	10.6	6.3	10.5	3.6	6.3	5.3	8.5	17.1	8.8	9.2	2.9	5.3	11.1	15.9	5.2	10.7	2.1	3.1	10.0	2.8	0.9	1.9	2.0	8.8	0.2	1.1	1.6	1.5	0.5	8.9	5.0	3.3	4.5	6.4	9.8	6.8	6.9	4.9	3.1	9.4	3.1	9.3	9.9	3.0	5.1	0.8	2.4	2.9	1.5	6.4	2.5	2.7	1.2	1.8	13.7	7.5	0.0	2.5	1.2	2.9	43.3	0.0	5.6	13.1	4.3	1.9	0.0	4.2	6.2	4.8	19.5	5.5	5.2	0.7	3.4	7.0	5.0	4.6	32.0	2.0	5.2	36.6	8.9	5.1	6.4	0.0	5.7	2.5	5.7	3.0	8.8	3.8	23.5	0.8
CELSR3	"ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2"	ENSG00000008300	"Cadherin EGF LAG seven-pass G-type receptor 3"	Q9NYQ7	3	48636469-48662915	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;pituitary gland: 11.2"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 16.2;Cone photoreceptor cells: 15.7;Horizontal cells: 28.6;Intestinal endocrine cells: 8.6;Rod photoreceptor cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.1;SH-SY5Y: 15.0;SiHa: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062866	Approved					NA	NA					"HPA062866: AB_2684886"	"unprognostic (7.80e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (9.12e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-6)"	"unprognostic (3.61e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.87e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.73e-1)"	0.7	4.0	10.9	1.2	8.3	1.7	0.8	19.7	11.1	0.6	1.3	0.0	0.0	1.2	0.8	1.2	0.6	0.7	0.7	0.5	7.1	1.4	0.6	0.6	0.8	1.4	2.0	10.4	0.9	2.6	1.4	11.2	1.0	3.6	0.7	1.2	1.4	0.6	0.8	0.5	1.2	1.3	0.8	3.3	1.0	2.1	5.4	1.4	0.0	0.9	0.0	1.0	0.7	0.7	0.3	0.1	0.0	0.1	0.2	1.5	0.4	3.9	2.9	4.9	2.9	0.6	0.9	1.3	0.3	0.5	0.6	0.9	5.5	3.0	0.8	0.8	0.2	2.5	0.5	1.5	0.2	0.3	13.1	0.8	1.3	11.3	2.0	0.9	1.3	2.1	0.4	3.9	0.3	7.0	0.2	0.0	2.8	0.5	4.0	1.0	4.2	0.1	0.0	2.7	1.4	1.3	0.3	0.7	4.1	0.0	2.7	11.0	15.0	13.2	0.3	0.5	0.7	6.5	2.5	0.1	4.8	4.7	6.4	2.3	0.3	7.2	3.5	3.4	0.9	7.6	0.0	0.1	0.0	1.0	0.0	0.2	0.3	0.2	0.2	0.1	0.0	0.3	1.5	0.0	0.2	0.0	0.0	1.1	0.4	10.9	8.3	19.7	11.1	7.1	1.4	2.0	10.4	3.6	1.4	0.0	0.3	0.5	0.1	0.3	16.2	2.5	0.0	0.0	0.0	0.0	15.7	0.2	0.0	0.1	2.8	0.0	0.4	0.0	0.0	0.2	0.2	0.1	1.1	0.4	0.2	28.6	8.6	0.6	0.0	1.6	0.3	0.0	0.0	0.0	1.8	0.8	0.2	0.0	0.0	0.0	11.2	0.0	0.0	5.9	3.4	0.4	0.1	0.0	0.2	0.0
NCKIPSD	"AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH"	ENSG00000213672	"NCK interacting protein with SH3 domain"	Q9NZQ3	3	48673844-48686364	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 39.6;parathyroid gland: 123.9"	"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019267, HPA050005"			Enhanced	"Plasma membrane"		NA	NA		42000	"Plasma membrane"		"CAB019267: , HPA050005: AB_2680988"	"unprognostic (1.55e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.50e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"	11.7	11.9	14.4	4.9	18.5	4.4	7.8	17.9	39.6	7.0	7.9	10.3	3.5	7.3	7.8	8.6	7.8	9.6	9.3	17.8	12.9	16.0	8.7	6.8	7.4	5.9	11.1	17.8	17.7	8.5	123.9	10.0	8.0	16.9	8.1	7.4	9.6	8.9	11.7	6.4	9.8	7.3	8.7	9.2	5.7	6.2	8.4	10.9	2.9	7.7	1.9	5.4	7.7	6.5	4.9	8.5	1.0	5.3	4.8	6.4	4.7	11.8	10.5	10.7	11.0	14.6	8.9	14.9	11.9	13.4	13.3	17.0	15.4	7.3	8.8	6.5	7.0	15.2	8.0	13.6	15.8	7.7	9.8	16.6	15.7	38.9	12.2	12.8	10.6	17.7	8.5	13.8	18.4	11.6	15.1	7.5	11.2	5.3	11.8	10.6	8.7	9.6	9.0	12.4	11.8	18.6	4.9	4.9	14.6	7.2	12.3	11.2	9.1	12.5	11.8	10.0	10.2	10.5	13.0	4.1	11.5	12.9	13.6	15.7	10.6	7.7	9.8	13.1	14.2	17.5	1.0	4.6	0.2	3.5	5.3	2.6	4.9	4.2	4.1	5.8	2.6	6.4	4.1	0.3	4.8	2.8	8.5	4.6	4.7	14.4	18.5	17.9	39.6	12.9	16.0	11.1	17.8	16.9	10.9	0.0	8.6	0.0	3.2	2.3	8.9	7.5	7.6	1.4	1.2	1.8	11.8	8.9	5.0	5.5	1.9	4.0	10.6	0.0	4.0	8.8	5.1	2.4	5.7	5.5	7.7	11.1	8.1	24.5	6.3	1.7	17.0	6.9	1.7	4.6	6.4	3.6	7.3	8.0	44.6	5.7	5.9	12.9	5.6	4.1	17.4	1.5	6.9	2.2	9.0	1.8
IP6K2	IHPK2	ENSG00000068745	"Inositol hexakisphosphate kinase 2"	Q9UHH9	3	48688003-48740353	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007532, HPA070811"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA007532: AB_1851542, HPA070811: AB_2732165"	"prognostic favorable (1.25e-4)"	"unprognostic (2.55e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (6.57e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.83e-4)"	18.3	31.1	40.4	20.0	55.9	51.7	28.2	74.1	37.3	29.5	32.5	23.7	34.0	36.9	34.6	56.1	30.0	28.1	24.0	19.0	30.7	19.2	32.4	24.3	18.4	22.5	35.4	27.6	33.9	28.1	23.5	42.3	20.7	29.4	34.9	41.9	22.2	28.3	32.1	19.1	50.0	31.6	21.1	28.3	25.5	27.6	26.0	37.4	31.7	35.7	21.6	19.5	24.1	34.0	27.3	22.8	50.7	25.7	27.9	35.1	19.0	8.5	16.7	34.7	24.4	19.6	24.5	25.1	16.3	18.3	18.7	21.7	13.8	22.9	15.1	13.4	15.2	23.5	22.3	17.3	24.4	17.5	17.8	15.2	17.3	51.7	29.6	15.9	16.4	16.9	23.2	35.6	25.4	21.0	24.9	25.9	49.1	12.9	19.0	21.7	19.0	35.0	22.5	26.6	16.7	31.0	14.7	11.5	16.5	25.4	41.0	21.7	32.8	35.3	24.0	17.3	28.8	23.2	27.7	18.4	20.4	20.3	12.8	16.1	17.6	20.8	21.3	18.5	19.2	17.8	50.7	22.5	38.5	29.7	21.6	26.5	27.3	25.8	27.7	21.7	25.7	24.2	24.9	35.3	27.9	25.7	22.8	35.1	19.0	40.4	55.9	74.1	37.3	30.7	19.2	35.4	27.6	29.4	37.4	65.5	38.7	24.2	78.6	73.7	63.9	10.1	33.1	69.6	69.4	94.2	37.3	101.3	64.6	51.7	30.9	42.0	85.6	0.0	41.6	64.1	64.4	60.2	53.1	20.7	35.7	19.1	105.7	35.0	15.3	14.2	75.1	31.2	25.3	34.3	96.2	28.0	50.1	90.2	64.3	55.6	50.0	51.8	35.7	56.7	54.0	72.5	103.7	47.2	78.7	75.6
PRKAR2A	PRKAR2	ENSG00000114302	"Protein kinase cAMP-dependent type II regulatory subunit alpha"	P13861	3	48744597-48847846	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 709.6;Late spermatids: 1080.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005023, HPA038268"	Uncertain					NA	NA		350000			"CAB005023: AB_562330, HPA038268: AB_2675921"	"unprognostic (2.81e-2)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.17e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (4.77e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-2)"	14.4	14.0	7.7	8.2	7.9	10.0	8.7	8.3	9.1	11.0	13.9	9.7	12.7	7.9	10.5	9.6	13.7	11.2	10.6	16.8	6.5	8.4	13.2	20.1	8.1	7.2	7.7	7.9	13.2	9.2	11.6	6.9	7.0	7.9	10.6	12.4	11.3	14.3	13.5	47.7	9.5	12.6	10.6	6.9	8.3	9.7	58.4	6.1	3.2	11.0	14.2	10.6	13.3	13.9	8.1	8.7	13.3	14.6	9.7	10.1	6.7	17.2	11.6	9.7	7.5	14.7	14.9	11.0	19.8	9.9	17.4	11.1	15.3	7.8	15.2	13.9	20.5	11.3	7.9	27.7	17.4	23.6	12.4	10.3	20.2	21.2	11.3	10.8	21.1	13.1	12.4	13.7	22.4	16.5	6.5	18.3	5.2	22.7	9.8	16.4	6.7	0.1	6.9	6.9	12.7	13.0	6.4	12.4	19.2	11.2	19.0	9.7	10.0	19.5	23.4	13.1	11.0	15.7	16.5	23.1	15.4	12.3	24.9	27.2	16.7	32.0	14.7	20.7	23.5	11.6	10.9	9.1	10.5	10.1	8.1	9.7	8.1	8.5	8.6	8.7	7.6	6.1	6.0	13.3	9.7	14.6	5.4	7.4	6.7	7.7	7.9	8.3	9.1	6.5	8.4	7.7	7.9	7.9	6.1	17.9	57.6	32.6	21.1	37.3	43.0	58.5	48.4	37.5	29.6	43.6	64.8	20.5	18.3	35.9	709.6	35.8	55.1	0.0	52.6	28.9	32.5	32.7	12.7	106.1	42.1	58.8	40.4	56.4	50.0	1080.4	50.9	37.1	28.7	25.2	39.0	26.1	51.6	31.6	52.3	35.6	43.2	51.8	53.8	64.4	59.7	54.8	19.7	27.4	66.4	22.6
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856931-48898993	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.8;liver: 58.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 35.4;RPMI-8226: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA		13000	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	11.9	13.7	6.7	5.6	7.3	3.4	10.2	3.0	5.6	3.3	19.7	4.7	5.2	25.0	4.7	3.1	3.3	5.0	9.9	37.1	7.3	4.6	16.8	58.3	6.6	4.9	8.5	5.1	2.7	16.8	5.9	5.1	3.3	5.8	5.0	9.1	5.4	7.4	3.7	27.4	4.0	32.2	5.7	5.5	8.8	7.5	4.4	6.6	9.1	5.5	5.5	5.9	4.5	9.8	9.4	33.3	57.8	29.0	17.3	28.4	24.7	1.4	4.5	3.6	5.0	11.5	4.4	0.7	8.0	4.3	5.6	5.8	5.6	6.9	6.6	5.7	12.6	6.8	1.4	8.8	3.5	4.2	16.8	4.2	9.2	7.0	7.1	5.2	9.6	17.8	5.6	4.0	7.5	1.2	2.2	7.2	10.1	8.2	35.4	7.3	3.7	10.5	4.8	1.8	8.1	10.2	3.8	2.1	48.7	6.0	3.5	1.4	5.1	7.4	0.0	4.0	5.2	11.3	4.5	5.8	6.4	1.1	9.3	5.8	13.1	9.1	7.7	9.1	6.8	8.4	13.8	29.0	57.8	28.4	21.0	18.1	9.4	16.1	20.8	27.0	7.8	12.7	21.3	13.5	17.3	21.4	33.3	16.1	24.7	6.7	7.3	3.0	5.6	7.3	4.6	8.5	5.1	5.8	6.6	6.0	2.4	7.5	2.3	1.5	1.1	31.1	7.6	5.3	2.3	0.0	5.9	1.7	3.3	3.2	1.1	3.1	38.0	0.0	3.7	1.9	4.1	2.4	1.1	55.2	15.8	0.0	7.0	9.2	13.2	1.0	9.8	7.5	1.7	40.5	10.8	2.8	4.0	13.5	11.7	12.5	1.1	0.0	2.2	7.1	7.0	1.1	1.0	13.8	12.8	2.0
ARIH2OS	C3orf71	ENSG00000221883	"Ariadne RBR E3 ubiquitin protein ligase 2 opposite strand"	Q8N7S6	3	48917788-48919385	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA						"unprognostic (2.40e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.67e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.00e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.72e-5)"	"unprognostic (4.02e-2)"	"unprognostic (4.06e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.46e-1)"	2.1	2.7	3.0	2.1	5.6	5.5	2.2	2.1	2.4	2.1	2.1	2.1	2.1	1.9	2.2	2.9	2.1	3.2	2.1	2.5	3.2	3.0	2.2	2.1	2.1	3.1	3.6	2.1	5.5	2.7	1.3	3.6	2.1	2.1	2.6	1.5	2.1	4.3	2.2	2.1	2.7	2.5	2.1	3.8	2.5	2.0	5.4	2.1	2.1	3.2	2.1	2.1	2.1	2.1	5.0	7.6	9.1	3.2	4.7	7.9	2.2	1.2	0.0	0.9	2.0	5.0	1.6	3.7	1.3	1.5	2.3	1.1	0.4	2.7	1.6	1.0	0.8	1.5	0.6	0.8	0.7	0.9	2.0	1.3	2.2	1.8	1.9	3.4	0.7	1.2	4.7	2.4	2.0	1.6	1.2	1.3	7.2	1.1	7.1	0.6	0.9	3.4	1.5	1.3	1.1	1.1	0.9	0.8	4.9	1.8	1.0	1.2	3.3	3.0	1.6	3.7	1.5	2.3	1.8	0.8	1.0	1.8	1.0	0.8	4.4	5.7	4.0	1.0	1.8	2.6	4.5	3.2	7.4	3.9	2.9	3.4	4.9	3.9	4.8	3.7	5.0	7.9	5.7	9.1	4.7	2.1	7.6	4.8	2.2	3.0	5.6	2.1	2.1	3.2	3.0	3.6	2.1	2.1	2.1	3.0	3.2	3.0	2.1	1.6	16.9	1.6	2.5	2.7	5.7	1.8	43.2	4.2	1.7	2.2	0.7	3.0	8.5	0.0	1.8	1.6	3.3	1.6	5.8	1.7	4.4	4.8	5.8	6.2	5.1	0.4	2.0	6.3	5.0	6.4	4.2	11.2	2.4	2.5	1.1	2.2	40.7	0.0	3.8	6.9	2.5	2.5	2.7	11.5	5.0	0.9
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329"	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	15.0	16.2	14.1	12.8	20.6	16.0	19.2	22.7	22.5	14.1	18.6	25.4	13.9	10.0	18.7	29.2	14.9	16.2	12.8	38.5	15.8	14.9	14.3	17.2	14.5	17.8	24.7	18.3	18.3	20.5	23.1	19.8	15.3	19.7	16.5	15.5	19.2	13.2	19.5	71.3	11.4	14.4	23.0	18.8	17.5	15.7	27.5	21.4	17.7	18.7	15.2	17.2	16.4	14.1	20.6	21.7	27.6	24.5	15.8	32.6	25.3	14.3	14.5	14.0	19.8	20.7	11.4	19.0	16.9	19.8	21.2	23.5	15.2	12.8	29.3	7.9	18.1	30.8	8.6	28.8	17.3	26.0	19.7	17.5	30.2	19.1	12.4	18.8	22.3	14.6	12.2	26.2	26.4	35.9	12.1	15.9	14.1	23.8	20.1	18.7	9.9	22.5	9.2	23.8	15.5	22.0	8.4	16.0	24.4	12.4	19.4	6.1	16.6	16.6	20.9	16.2	17.3	10.6	15.9	15.1	12.9	18.7	19.2	26.5	26.3	50.8	37.1	14.1	18.7	16.1	27.6	24.5	26.2	32.6	21.6	22.1	19.5	20.9	26.7	21.7	20.6	21.6	27.8	17.2	15.8	13.5	18.7	22.9	25.3	14.1	20.6	22.7	22.5	15.8	14.9	24.7	18.3	19.7	21.4	32.8	22.3	31.1	35.9	45.2	56.4	60.0	30.6	37.5	58.0	27.9	82.5	31.2	24.9	23.6	8.2	33.8	20.3	23.3	37.3	30.6	28.0	46.9	42.9	36.5	23.8	54.0	16.0	35.0	26.4	4.7	38.6	33.2	28.7	41.5	22.9	39.7	33.1	22.9	40.7	25.6	73.6	25.8	35.4	140.0	77.3	47.2	44.6	50.1	26.5	58.6
P4HTM	"EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4"	ENSG00000178467	"Prolyl 4-hydroxylase, transmembrane"	Q9NXG6	3	48989886-49007154	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007199	Supported		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA007199: AB_1855272"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (7.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-2)"	"prognostic favorable (3.28e-5)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.65e-3)"	7.4	25.5	22.1	6.4	28.5	4.7	8.9	17.6	32.9	13.5	10.8	15.9	13.8	10.4	9.7	18.9	5.4	34.7	13.0	18.6	23.0	26.5	14.1	5.4	10.6	5.6	18.7	20.3	11.4	29.9	20.8	35.7	9.6	15.7	15.5	6.7	14.1	16.0	16.5	10.0	4.3	7.8	7.0	14.3	6.3	15.7	11.7	16.4	3.4	21.5	3.3	6.7	7.5	6.1	9.8	7.8	6.7	7.6	4.9	14.4	4.8	3.7	10.3	1.9	0.0	5.8	6.9	0.1	6.7	8.9	5.1	5.5	2.3	20.2	3.2	7.1	8.2	4.1	2.0	4.4	2.2	1.5	12.1	7.6	0.0	15.3	0.0	15.3	3.1	0.1	4.0	2.2	5.1	0.4	19.2	5.7	0.0	0.0	14.0	2.4	16.1	0.4	0.4	2.8	18.8	12.1	0.0	0.0	18.8	9.0	5.8	8.0	0.1	7.6	8.1	0.0	0.5	7.1	5.2	4.0	3.0	2.6	7.6	5.3	19.9	11.0	0.0	22.5	0.3	3.1	6.7	7.6	4.8	6.4	2.7	8.7	7.0	11.6	10.3	7.8	9.8	12.0	8.3	0.8	4.9	3.6	1.4	14.4	4.8	22.1	28.5	17.6	32.9	23.0	26.5	18.7	20.3	15.7	16.4	20.8	12.9	13.4	30.2	8.1	71.6	10.6	22.9	76.3	21.6	43.6	82.5	24.6	16.6	32.6	102.4	11.9	34.1	0.0	34.1	8.5	27.3	29.0	23.0	7.6	14.9	111.2	77.7	12.3	8.1	112.9	28.1	11.2	11.8	12.6	33.5	60.4	23.6	40.3	24.4	25.5	55.3	19.4	27.4	37.5	7.9	9.2	21.9	22.4	42.1	30.2
WDR6		ENSG00000178252	"WD repeat domain 6"	Q9NNW5	3	49007062-49015953	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042622	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA042622: AB_10966784"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.94e-2)"	"prognostic favorable (4.52e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	15.8	36.7	21.5	26.1	23.5	14.9	19.7	29.9	29.9	32.7	31.0	30.8	56.4	27.5	39.0	37.0	18.7	33.1	32.6	20.4	20.1	20.4	26.0	22.0	21.1	28.2	22.8	26.9	60.9	46.0	56.7	55.8	24.3	22.1	39.0	22.1	34.3	33.4	54.4	23.9	26.6	28.3	40.8	17.5	29.1	24.7	23.7	22.1	26.9	50.7	20.3	25.1	31.2	24.6	12.3	14.4	10.3	12.9	11.7	18.9	12.0	17.6	24.3	40.2	34.1	27.0	22.1	27.2	26.3	21.7	29.8	24.2	21.5	25.6	28.3	16.8	41.9	22.9	20.1	32.1	36.8	21.3	22.5	21.3	26.8	59.6	28.4	27.4	27.7	12.1	39.6	26.5	27.5	20.8	41.4	21.7	30.2	15.2	30.4	26.9	35.0	32.1	31.6	35.7	16.1	22.6	18.8	17.2	17.8	35.3	52.4	19.6	36.7	19.7	16.2	11.4	30.7	28.2	22.2	28.9	22.2	35.7	21.5	34.9	53.6	22.9	24.6	30.1	35.5	15.9	3.7	9.1	10.3	16.9	12.9	18.9	12.0	12.5	12.9	11.3	12.3	14.7	10.9	3.4	11.7	6.5	14.4	10.5	12.0	21.5	23.5	29.9	29.9	20.1	20.4	22.8	26.9	22.1	22.1	20.8	44.0	22.5	20.1	15.9	23.5	2.0	28.1	22.7	38.7	45.4	45.2	35.1	8.3	25.4	3.7	17.3	21.2	0.0	22.4	17.9	19.9	24.4	27.8	38.0	22.8	35.0	69.4	23.9	14.5	4.2	35.4	16.4	11.8	20.8	31.0	44.4	24.7	21.0	26.5	25.9	45.7	25.8	16.9	22.3	17.6	9.9	47.3	24.1	30.2	15.3
DALRD3	FLJ10496	ENSG00000178149	"DALR anticodon binding domain containing 3"	Q5D0E6	3	49015488-49022293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 129.7;Late spermatids: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036862	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA036862: AB_10673507"	"unprognostic (2.76e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.56e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.33e-2)"	"unprognostic (9.52e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	9.4	14.1	9.3	13.9	9.0	4.4	21.6	10.2	11.9	11.3	9.5	7.7	14.9	7.2	7.7	14.7	13.1	34.3	14.2	8.6	8.6	7.3	16.0	9.3	10.8	9.1	7.2	9.4	13.5	29.3	12.6	11.1	8.7	6.3	8.4	7.5	8.4	13.2	18.5	7.5	13.0	10.2	6.5	5.1	8.5	9.9	32.0	6.8	21.1	21.1	13.5	12.7	9.5	14.1	17.7	8.2	7.3	9.3	14.5	19.2	9.3	6.2	8.5	5.3	10.5	15.4	20.5	6.6	5.3	14.3	8.8	8.4	6.0	7.8	2.5	7.5	14.0	7.6	4.1	7.0	13.5	6.1	3.8	4.7	2.7	7.9	11.2	10.0	7.5	5.4	13.8	14.0	11.0	24.6	22.3	13.5	5.8	2.1	6.2	8.5	10.6	3.4	5.1	8.9	12.9	8.1	1.7	0.7	17.9	23.3	9.8	3.4	11.4	5.7	15.8	11.9	9.3	11.2	8.3	8.4	3.4	5.4	12.1	4.7	19.9	10.9	1.3	13.0	3.5	6.7	7.1	7.7	3.7	10.2	9.3	18.8	17.7	17.0	12.7	8.2	15.5	14.4	9.3	7.3	14.5	8.6	5.6	19.2	9.3	9.3	9.0	10.2	11.9	8.6	7.3	7.2	9.4	6.3	6.8	14.9	9.8	15.9	21.0	22.8	29.2	1.2	15.3	65.6	19.4	26.2	17.7	23.7	31.5	33.6	129.7	14.3	30.3	0.0	34.6	30.0	20.5	9.2	24.3	5.8	17.2	38.1	18.3	15.4	10.8	227.2	22.5	15.9	20.3	29.7	19.2	23.2	22.0	17.5	17.3	36.2	53.2	45.3	15.5	91.9	33.3	29.7	15.3	17.5	25.0	13.2
NDUFAF3	"2P1, C3orf60, DKFZP564J0123, E3-3, MGC10527"	ENSG00000178057	"NADH:ubiquinone oxidoreductase complex assembly factor 3"	Q9BU61	3	49020459-49023495	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 929.9;Late spermatids: 1018.8;Spermatocytes: 737.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035376, HPA035377"	Enhanced					NA	NA					"HPA035376: AB_2674597, HPA035377: AB_10673219"	"unprognostic (2.90e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.60e-1)"	24.4	39.6	32.5	15.8	32.9	21.0	20.1	14.5	37.3	23.7	16.8	31.9	32.7	15.6	19.7	25.4	17.6	32.1	23.7	68.6	31.7	30.4	32.6	31.4	21.1	28.0	34.3	24.2	28.9	28.5	32.6	33.1	15.4	26.6	23.3	14.1	30.7	34.6	37.1	51.7	13.7	17.1	16.1	37.2	23.1	15.7	89.9	19.0	29.2	34.2	34.3	18.7	18.1	14.7	51.6	67.4	32.0	42.8	32.2	54.3	51.4	12.0	18.8	17.2	16.9	22.8	19.3	8.4	12.5	16.2	23.6	18.5	25.6	20.9	12.4	18.9	25.6	32.4	8.3	12.2	26.7	8.5	17.9	12.1	27.1	34.7	31.7	32.1	23.3	13.5	19.9	20.5	33.2	24.8	28.4	20.6	47.3	6.1	38.6	25.4	18.4	29.6	10.9	5.3	21.4	36.3	10.8	3.8	43.9	38.0	26.1	14.1	16.0	12.6	32.5	15.5	8.1	18.5	45.9	15.2	22.2	14.0	29.6	25.8	27.3	19.0	20.2	26.8	12.2	33.4	23.9	36.9	32.0	37.9	35.9	40.2	51.6	41.6	38.9	32.5	48.8	54.3	40.0	11.8	32.2	42.8	67.4	37.7	51.4	32.5	32.9	14.5	37.3	31.7	30.4	34.3	24.2	26.6	19.0	86.4	75.1	107.9	127.8	47.4	62.5	162.6	122.3	165.9	78.5	143.1	2.0	111.2	402.9	146.0	929.9	101.9	128.9	70.0	136.4	103.4	125.6	160.9	115.4	134.3	187.8	65.2	126.8	103.7	112.2	1018.8	157.6	88.9	129.9	184.9	80.4	128.3	122.0	119.3	113.5	435.4	40.1	71.1	105.7	737.1	90.7	47.9	89.4	89.7	95.0	123.9
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029408	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001400, CAB020717"	Approved		Supported	"Cytosol,Rods & Rings"		NA	NA		19000	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.47e-2)"	25.0	21.5	16.1	25.7	15.4	23.9	47.0	9.7	21.1	34.7	24.9	15.1	19.1	18.9	29.5	19.8	40.1	51.9	33.3	29.3	13.0	11.2	21.4	29.4	19.9	52.5	18.1	13.0	89.0	88.8	19.1	16.6	23.2	15.6	33.2	31.7	10.8	22.1	22.2	61.4	40.7	17.8	34.1	15.2	23.7	22.2	15.3	15.4	31.2	29.8	51.3	33.4	30.3	32.1	31.6	18.8	6.2	16.8	21.6	34.8	16.0	40.1	23.2	32.2	33.3	48.2	88.1	31.3	27.9	45.2	67.3	57.4	40.3	36.3	73.4	20.0	33.6	19.1	28.0	66.5	56.6	59.0	19.2	22.2	54.4	34.3	36.9	41.4	57.5	22.4	78.2	62.4	64.3	116.9	51.6	47.2	52.0	32.5	41.6	54.1	32.7	48.7	40.1	41.8	38.4	46.9	21.2	33.9	72.0	38.3	26.0	20.9	20.6	30.3	34.3	50.4	27.9	42.4	25.7	23.7	29.5	54.8	71.6	71.5	40.3	29.1	35.2	34.1	64.3	28.8	6.2	10.1	4.0	17.0	16.8	31.7	31.6	23.3	19.6	18.8	31.1	34.8	28.6	4.4	21.6	13.9	14.5	15.5	16.0	16.1	15.4	9.7	21.1	13.0	11.2	18.1	13.0	15.6	15.4	59.6	51.7	94.7	205.9	180.0	15.2	31.5	58.6	44.2	79.6	34.9	13.7	273.1	68.0	75.3	1.3	60.9	35.9	0.0	160.1	214.5	119.3	96.3	66.7	22.1	86.0	14.3	58.3	51.0	42.7	4.7	114.2	60.0	84.4	76.7	112.2	22.9	107.0	31.6	66.8	71.0	14.2	38.8	124.9	26.3	53.7	171.0	262.6	46.8	265.0	109.1
QRICH1	FLJ20259	ENSG00000198218	"Glutamine rich 1"	Q2TAL8	3	49029707-49094363	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037677, HPA037678"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037677: AB_10671883, HPA037678: AB_2675603"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.82e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-1)"	28.9	27.6	20.4	23.6	26.8	43.1	27.8	38.9	35.0	26.2	23.3	27.0	21.2	21.0	30.7	22.0	28.4	26.7	23.7	21.5	20.9	16.7	20.3	22.1	26.0	30.3	17.8	22.1	30.5	23.3	30.7	27.3	32.1	23.6	22.6	21.4	28.4	26.4	26.0	32.3	34.1	30.0	24.6	15.9	35.2	25.8	53.9	21.8	40.3	25.9	20.2	37.1	28.1	23.6	15.5	16.0	15.9	26.0	15.8	20.1	11.1	18.6	17.9	35.6	16.4	23.4	22.5	22.2	21.1	27.7	35.4	32.3	19.5	23.7	29.9	13.6	27.5	28.6	14.9	32.6	29.5	30.8	25.6	19.6	29.3	24.8	16.1	21.1	25.5	33.8	25.5	22.5	35.4	22.7	21.6	27.4	27.6	19.8	27.4	24.0	13.8	37.1	17.5	29.1	19.6	22.5	18.6	18.6	24.7	22.1	29.1	13.6	27.4	24.0	22.4	17.4	29.4	20.0	28.9	23.8	23.2	26.4	20.5	30.1	24.7	28.7	36.2	21.2	24.6	26.5	14.0	13.2	15.9	16.8	16.5	19.9	15.4	16.2	18.6	16.0	15.5	17.5	20.1	9.9	15.8	26.0	11.4	16.6	11.1	20.4	26.8	38.9	35.0	20.9	16.7	17.8	22.1	23.6	21.8	8.9	13.9	26.2	11.9	19.7	13.5	17.6	17.8	12.0	17.0	19.2	21.6	22.0	1.7	13.7	8.6	15.8	13.1	0.0	11.9	22.9	14.2	14.3	16.1	18.7	17.0	11.1	24.9	18.4	24.3	7.9	20.8	21.5	11.8	17.2	21.2	10.6	16.0	7.0	29.0	9.7	17.1	6.5	17.0	40.7	25.1	19.7	30.8	18.4	16.9	13.5
QARS		ENSG00000172053	"Glutaminyl-tRNA synthetase"	P47897	3	49095932-49105135	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 438.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		No	No		21000	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favorable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	20.9	16.3	9.7	19.3	10.2	18.4	22.7	15.8	13.2	17.6	27.3	13.1	27.7	17.2	12.3	19.8	35.1	16.4	20.0	22.0	9.8	9.6	27.1	26.0	15.0	33.9	12.4	7.2	21.6	33.8	20.3	13.7	25.7	9.6	16.2	29.9	15.2	31.7	28.7	33.3	26.7	31.8	16.7	11.2	21.1	16.9	30.1	11.3	36.8	16.5	34.8	33.3	19.4	18.5	20.4	40.0	8.9	32.3	21.8	24.0	19.6	18.8	19.2	32.1	45.9	41.3	44.9	33.1	21.0	48.1	41.7	41.0	24.3	24.5	58.4	13.5	34.8	23.4	24.0	45.5	34.6	30.0	16.6	36.3	46.0	30.8	42.3	21.8	37.4	28.4	47.3	30.3	32.1	27.3	44.8	45.5	34.2	20.5	26.0	30.5	10.1	26.9	33.6	27.5	38.6	30.0	17.8	27.0	43.0	28.0	28.1	11.8	32.8	18.6	47.3	28.9	33.0	39.2	43.7	26.2	19.0	27.0	31.3	23.4	22.4	38.1	32.8	19.5	33.7	12.0	8.9	23.1	8.7	13.5	32.3	18.1	20.4	16.8	14.9	40.0	15.2	15.5	15.4	2.6	21.8	26.1	16.9	24.0	19.6	9.7	10.2	15.8	13.2	9.8	9.6	12.4	7.2	9.6	11.3	20.8	57.3	55.9	52.1	59.8	10.1	50.4	40.8	22.7	35.2	38.4	9.8	160.6	58.0	67.5	150.2	50.3	110.2	23.3	94.9	127.6	48.0	47.5	38.1	41.8	85.6	19.1	62.3	50.3	98.5	438.0	54.4	55.2	45.5	120.0	127.2	20.6	67.1	71.9	34.3	63.0	13.0	45.3	43.4	18.4	46.6	75.3	156.4	69.2	176.8	57.2
USP19	"KIAA0891, ZMYND9"	ENSG00000172046	"Ubiquitin specific peptidase 19"	O94966	3	49108046-49120938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.23e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (7.05e-9)"	"unprognostic (2.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.54e-2)"	13.9	19.5	10.3	14.6	12.2	16.2	14.9	19.4	37.1	17.0	16.3	12.5	19.6	14.6	18.7	17.9	14.3	17.2	19.9	17.9	10.3	9.4	14.8	16.5	14.7	13.8	11.9	9.5	17.2	15.2	22.4	13.2	17.6	11.4	14.2	10.9	14.9	24.7	26.0	57.3	18.4	16.1	13.9	8.5	17.5	15.1	14.9	11.7	23.0	17.7	15.2	12.6	17.4	14.1	5.1	6.7	12.3	5.7	4.3	8.4	5.3	8.3	12.0	14.4	20.3	17.7	12.2	18.4	9.4	12.6	17.6	13.3	12.0	12.8	18.0	9.6	11.8	17.5	11.1	18.2	13.6	7.3	14.1	14.0	17.5	24.1	11.0	18.4	19.8	18.5	17.3	10.6	16.6	12.1	12.3	11.5	16.1	13.7	13.6	8.8	10.8	18.7	20.5	27.3	12.5	17.6	9.1	10.7	20.8	10.9	15.9	7.9	22.7	13.9	18.2	16.3	12.5	12.3	26.4	9.1	11.7	14.3	17.3	14.2	34.4	33.3	15.9	15.1	15.7	14.5	12.3	4.9	7.5	7.2	5.3	6.8	4.6	5.8	8.4	6.7	5.1	5.7	6.2	8.8	4.3	5.7	3.0	4.1	5.3	10.3	12.2	19.4	37.1	10.3	9.4	11.9	9.5	11.4	11.7	11.9	9.7	2.9	4.0	5.6	11.4	9.6	2.5	10.7	10.3	7.0	17.7	8.5	5.0	6.6	2.7	7.1	13.1	0.0	6.7	4.4	5.8	4.6	2.3	12.1	7.8	12.7	8.7	7.4	6.1	4.1	12.0	8.4	3.3	1.8	11.3	7.7	9.8	11.8	11.7	6.3	11.2	12.9	5.2	10.5	10.0	4.6	11.3	6.4	10.9	2.6
LAMB2	"LAMS, NPHS5"	ENSG00000172037	"Laminin subunit beta 2"	P55268	3	49121114-49133118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 142.0;Leydig cells: 135.4;Peritubular cells: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;myeloid DC: 2.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.0;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000053, HPA001895, HPA050033, CAB078160"	Supported		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		18000000	Vesicles	Cytosol	"CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: "	"unprognostic (1.12e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.24e-2)"	46.1	35.3	7.4	13.0	7.7	0.9	29.0	5.1	8.3	55.0	25.9	10.5	41.3	9.3	43.4	38.6	34.3	27.1	37.7	62.5	9.7	4.1	30.6	29.6	28.2	5.7	8.2	6.1	56.0	12.9	51.7	8.0	41.3	9.9	37.7	7.3	45.1	17.4	39.2	22.7	17.0	23.0	31.5	6.9	16.7	22.7	24.1	8.1	2.1	36.5	21.8	11.4	45.3	38.4	0.0	2.0	0.2	2.4	0.0	0.0	0.4	3.2	8.0	7.4	26.4	43.4	45.0	6.7	28.0	34.7	16.7	16.8	3.8	11.1	0.0	9.7	63.2	8.4	10.5	6.4	10.0	11.5	0.0	2.0	1.4	12.6	6.6	29.3	0.0	0.0	39.1	15.0	13.3	13.6	40.5	16.3	0.0	0.8	0.0	13.5	6.2	0.0	0.0	3.2	4.2	6.7	0.0	3.6	0.1	11.7	4.1	0.0	4.4	16.0	9.3	14.6	13.1	20.2	0.2	27.0	18.1	7.9	6.4	7.3	0.0	0.0	0.0	8.6	0.0	12.2	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	7.4	7.7	5.1	8.3	9.7	4.1	8.2	6.1	9.9	8.1	110.2	52.2	0.0	12.0	27.7	1.3	142.0	43.3	2.7	38.7	52.4	5.9	8.5	5.0	25.4	2.6	76.6	5.9	0.0	8.0	4.8	81.7	11.7	1.1	44.7	9.0	7.9	0.0	93.9	11.6	7.1	135.4	9.2	40.5	3.6	2.2	44.2	14.8	8.6	132.2	36.6	2.1	116.4	74.5	3.5	7.3	21.3	7.9	2.2	4.7	7.1
CCDC71	FLJ12800	ENSG00000177352	"Coiled-coil domain containing 71"	Q8IV32	3	49162535-49166321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047547	Uncertain		Approved	"Nuclear membrane"		No	No			"Nuclear membrane"		"HPA047547: AB_2680083"	"unprognostic (1.06e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.71e-3)"	"unprognostic (7.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (9.65e-9)"	"unprognostic (3.53e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.14e-2)"	15.5	20.2	7.9	11.2	14.4	7.9	18.0	10.8	19.2	17.6	12.3	15.7	14.7	10.1	19.9	17.3	17.4	21.3	17.5	14.8	8.9	8.5	16.2	20.3	13.7	15.2	9.6	9.9	24.1	12.3	12.2	13.1	18.7	10.6	15.3	9.6	16.3	15.8	15.7	17.2	15.8	16.3	12.8	7.3	20.4	13.2	18.1	8.8	33.2	21.5	12.1	19.4	18.3	14.9	3.2	1.9	1.9	3.5	7.8	3.2	1.3	7.9	11.0	12.9	12.3	14.8	10.9	12.4	9.9	14.4	17.4	15.4	11.3	13.0	7.1	8.7	16.9	14.0	8.5	12.7	26.5	6.2	15.8	9.2	14.5	14.3	11.3	17.6	11.6	11.0	18.3	20.9	20.6	15.9	13.0	17.0	17.5	14.5	3.1	13.8	17.1	19.9	7.1	19.9	12.0	11.9	7.3	7.1	6.6	16.4	15.5	6.6	14.2	10.1	10.8	11.8	10.9	14.3	19.4	11.1	12.3	13.1	12.1	12.8	11.7	5.0	9.8	8.9	11.0	13.6	0.0	2.0	0.8	2.0	3.5	3.2	1.2	1.7	2.5	1.9	3.2	2.7	1.7	1.9	7.8	2.6	0.7	1.9	1.3	7.9	14.4	10.8	19.2	8.9	8.5	9.6	9.9	10.6	8.8	6.0	1.0	4.4	10.6	2.4	1.2	1.1	7.6	2.7	0.0	7.0	0.0	19.5	21.6	16.8	6.7	6.3	6.3	0.0	10.3	15.3	6.0	8.9	2.3	8.7	17.4	0.0	8.1	19.0	3.7	8.2	10.9	5.6	5.0	9.0	8.3	4.5	13.7	8.6	12.7	11.9	1.3	12.9	5.2	9.1	15.6	2.4	18.8	2.9	9.7	9.9
KLHDC8B	MGC35097	ENSG00000185909	"Kelch domain containing 8B"	Q8IXV7	3	49171611-49176486	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.4"	"Group enriched"	"Detected in many"	9	"granulocytes: 19.4;monocytes: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008463, HPA014467"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA008463: AB_1852563, HPA014467: AB_1852565"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.66e-1)"	"unprognostic (5.03e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (1.47e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	15.0	44.0	5.6	4.7	5.8	3.2	12.6	4.5	8.8	12.8	19.3	6.2	10.5	4.6	15.9	12.2	22.6	11.6	13.6	30.5	3.7	8.5	5.6	8.8	6.6	6.3	4.9	5.4	29.6	6.2	5.2	4.2	7.9	5.2	15.2	2.5	21.8	8.4	9.5	15.8	9.8	5.4	18.0	2.4	6.7	6.7	10.0	3.0	2.0	17.1	10.7	6.6	20.0	8.8	0.1	0.6	19.4	5.7	0.0	1.4	1.6	1.5	3.4	14.3	7.2	8.8	5.2	4.4	5.2	3.0	5.2	4.2	2.2	4.6	0.0	3.0	8.7	1.5	0.0	3.5	3.2	1.3	2.8	0.9	9.2	9.3	5.8	16.8	0.0	5.4	8.7	15.3	6.8	0.5	11.8	13.4	3.3	14.3	0.1	3.9	0.4	0.9	10.2	4.7	0.8	8.2	1.4	1.4	0.4	3.9	0.8	0.6	16.2	4.2	0.1	10.4	3.1	4.3	4.5	5.8	4.0	11.3	7.1	1.6	1.3	0.4	0.2	2.9	0.0	1.9	0.0	3.8	19.4	0.8	5.7	0.3	0.0	0.4	0.6	0.3	0.1	1.4	0.8	6.7	0.0	5.0	0.6	0.1	1.6	5.6	5.8	4.5	8.8	3.7	8.5	4.9	5.4	5.2	3.0	8.9	10.4	0.5	10.9	6.8	1.2	36.6	7.6	0.0	5.7	7.0	2.0	6.9	14.9	13.0	6.0	17.8	0.7	0.0	5.2	7.0	14.6	6.8	1.1	5.8	37.1	0.0	6.4	33.7	5.4	5.8	14.1	6.3	11.8	0.0	2.0	19.8	8.8	1.4	13.4	11.3	2.6	97.0	26.4	3.7	4.1	8.5	41.6	2.1	1.5	6.2
C3orf84		ENSG00000236980	"Chromosome 3 open reading frame 84"	H3BNL1	3	49177632-49191858	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 10.8"	"Group enriched"	"Detected in some"	89	"Early spermatids: 89.8;Late spermatids: 61.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"NB-4: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8			0.0		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0
CCDC36	"CT74, FLJ25320"	ENSG00000173421	"Coiled-coil domain containing 36"	Q8IYA8	3	49198428-49258104	"Predicted intracellular proteins"	"Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 51.2;Late spermatids: 32.2;Spermatocytes: 85.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 3.9;hTEC/SVTERT24-B: 13.3;LHCN-M2: 5.5;U-2197: 7.2;WM-115: 3.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA045690, HPA069534"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045690: AB_10964634, HPA069534: AB_2686146"	"unprognostic (1.54e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.51e-4)"	"unprognostic (3.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.33e-2)"	6.5	1.7	0.8	1.8	0.8	0.4	3.6	0.8	0.7	3.7	2.2	0.7	2.1	0.4	6.3	1.2	1.1	1.3	1.4	1.9	0.9	0.4	0.5	0.4	1.4	0.5	1.1	0.1	5.0	0.4	0.2	0.4	1.4	2.0	0.6	0.4	2.6	2.0	0.8	1.6	0.8	0.6	3.9	0.4	0.7	0.6	35.4	0.3	0.0	1.3	0.3	0.6	1.2	0.9	0.9	0.6	3.6	0.3	0.8	0.5	0.2	0.0	0.2	0.1	0.2	2.8	3.1	0.1	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	3.5	0.0	0.2	2.4	0.0	13.3	0.0	0.0	1.7	0.1	0.0	0.3	5.5	0.0	0.0	0.2	3.5	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	2.5	7.2	0.1	0.1	0.1	0.1	0.0	0.2	3.6	2.1	0.3	0.6	0.4	0.2	0.3	0.8	0.4	0.3	0.1	0.9	0.4	0.5	3.6	0.8	0.2	0.6	0.3	0.2	0.8	0.8	0.8	0.7	0.9	0.4	1.1	0.1	2.0	0.3	0.0	1.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.8	5.9	0.0	0.0	0.0	51.2	2.4	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.3	0.0	0.0	0.6	0.0	32.2	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.9	0.0	0.0	85.6	6.8	0.4	0.1	0.0	0.0	0.0
C3orf62	FLJ43654	ENSG00000188315	"Chromosome 3 open reading frame 62"	Q6ZUJ4	3	49268602-49277909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"blood: 25.0;testis: 76.9"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 25.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043328			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA043328: AB_10795613"	"prognostic favorable (3.93e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.20e-4)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.40e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (7.23e-2)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.29e-5)"	"unprognostic (2.46e-1)"	"unprognostic (4.79e-1)"	"prognostic favorable (1.62e-5)"	4.2	5.5	3.2	4.4	4.0	7.4	2.7	6.6	4.8	3.8	3.6	2.8	4.4	3.1	3.5	4.9	3.7	4.1	5.0	3.5	3.7	4.3	2.7	2.8	3.9	4.5	3.3	4.0	8.0	4.7	2.4	4.5	2.6	3.6	4.1	2.3	5.7	4.4	2.2	3.7	3.5	2.7	3.6	3.6	7.0	2.6	76.9	3.3	2.2	3.7	2.2	3.3	4.8	7.5	1.2	1.6	25.0	3.2	0.6	1.0	0.7	4.8	2.9	6.9	8.7	5.7	5.2	3.9	2.9	4.9	2.6	3.9	4.1	3.7	9.6	4.6	4.4	5.4	3.8	3.5	3.2	3.0	8.5	4.0	6.3	6.1	4.6	2.0	8.9	11.9	4.0	9.5	3.8	7.1	4.5	3.1	5.6	7.1	7.3	2.2	3.0	6.6	6.4	4.9	3.8	4.2	5.0	3.6	5.0	4.3	11.2	5.3	7.2	8.0	6.1	10.4	5.4	3.1	9.9	3.5	3.6	8.8	6.1	5.3	6.7	10.9	8.3	2.7	8.6	4.9	1.5	3.2	3.4	0.8	1.2	0.9	1.2	0.9	0.8	0.7	0.9	0.9	0.8	25.0	0.6	1.4	1.6	1.0	0.7	3.2	4.0	6.6	4.8	3.7	4.3	3.3	4.0	3.6	3.3	8.9	17.3	3.0	3.1	6.1	11.5	7.8	7.6	9.4	11.4	10.4	21.6	5.2	0.0	4.1	9.1	5.8	4.3	0.0	3.4	3.6	5.3	5.4	2.3	5.7	9.0	4.8	5.2	8.0	17.3	12.8	8.1	9.2	8.5	9.0	8.6	6.5	4.3	3.5	8.1	4.9	13.5	0.0	3.8	64.4	6.5	7.5	3.4	6.4	6.3	2.0
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277831-49340712	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 100.2;Late spermatids: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	22.1	18.4	21.4	22.4	29.3	41.4	23.1	30.3	32.5	20.7	20.1	26.8	16.9	16.1	23.6	20.9	23.5	19.3	17.5	22.8	22.2	18.0	20.2	18.5	25.7	25.5	20.2	17.5	23.6	17.1	23.6	19.7	22.1	24.3	20.9	21.9	23.6	19.1	21.3	25.7	27.6	19.4	25.9	20.4	30.6	17.7	25.0	19.7	36.8	21.2	14.1	42.4	22.1	22.0	17.0	24.1	59.4	27.3	21.5	18.6	22.2	6.4	7.4	10.2	13.6	19.0	20.4	6.9	17.5	15.6	22.7	20.5	7.8	16.2	12.4	7.0	25.5	13.1	8.7	13.6	24.8	21.2	19.1	4.0	27.5	14.7	8.7	27.9	14.5	15.9	20.9	10.9	24.9	20.5	16.5	26.2	14.1	9.6	19.7	21.0	10.9	17.1	24.6	8.7	8.0	12.9	7.1	6.4	10.8	17.8	13.3	8.5	11.4	12.7	9.0	6.5	10.7	6.2	23.3	23.2	15.3	8.3	19.1	10.2	15.8	7.6	18.1	13.7	23.0	17.5	18.0	27.3	30.0	16.9	22.1	18.6	17.0	17.6	16.9	24.1	14.1	17.1	15.0	59.4	21.5	24.4	9.6	18.6	22.2	21.4	29.3	30.3	32.5	22.2	18.0	20.2	17.5	24.3	19.7	38.7	21.4	18.1	15.0	16.7	16.6	15.3	15.3	33.5	25.0	19.2	19.6	18.9	18.3	14.2	100.2	17.9	11.6	0.0	11.9	12.1	12.3	13.1	32.4	12.1	21.7	11.1	10.3	16.0	38.8	90.2	14.4	25.3	15.1	30.7	11.4	12.0	14.6	5.8	18.0	10.5	21.5	12.9	14.7	18.5	13.6	16.2	20.3	24.9	11.9	11.8
RHOA	"ARH12, ARHA, Rho12, RhoA, RHOH12"	ENSG00000067560	"Ras homolog family member A"	P61586	3	49359145-49412998	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Host-virus interaction"	Hydrolase	"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005052	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		65000000	"Plasma membrane, Cytosol"		"CAB005052: AB_562216"	"unprognostic (1.50e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.44e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (5.14e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.52e-2)"	141.1	89.5	63.0	79.8	60.6	91.4	93.1	34.3	77.3	80.3	79.1	100.4	48.9	63.6	84.4	66.4	116.7	67.8	74.2	72.5	57.6	54.8	104.0	80.7	104.6	102.4	74.0	43.8	102.7	64.9	45.8	48.2	105.3	68.8	76.0	80.3	81.6	66.5	72.0	86.0	73.9	90.8	88.9	97.3	116.0	73.4	57.3	60.3	127.1	108.1	80.1	99.8	103.4	75.7	42.6	78.4	124.2	125.7	38.3	50.5	151.5	55.7	43.0	54.0	57.9	62.0	94.0	42.2	121.4	77.8	84.9	78.3	36.4	58.5	81.8	34.9	145.8	49.3	31.8	59.3	66.2	87.2	63.1	35.3	78.1	57.9	42.7	66.5	77.0	58.6	73.4	47.1	69.4	55.9	85.8	108.6	43.5	41.6	51.5	100.6	26.6	83.8	75.1	51.6	56.0	54.8	38.8	54.3	64.3	73.4	63.7	19.8	45.1	72.9	52.8	54.7	55.8	34.2	86.8	117.2	68.2	61.8	89.9	87.2	51.2	103.7	93.9	66.4	75.8	77.8	52.5	99.7	106.8	49.1	125.7	41.6	42.6	41.4	47.6	78.4	37.5	32.2	40.1	124.2	38.3	120.4	58.7	50.5	151.5	63.0	60.6	34.3	77.3	57.6	54.8	74.0	43.8	68.8	60.3	360.3	233.2	266.1	228.8	240.6	42.2	113.5	155.4	182.0	182.0	171.0	5.9	328.4	288.5	303.4	30.3	372.7	339.7	93.5	302.0	572.5	345.6	260.3	251.7	153.0	691.2	77.9	225.0	312.5	712.8	42.2	310.4	490.6	310.4	582.5	261.8	172.7	313.0	270.7	383.3	255.4	33.0	271.7	354.1	227.5	221.8	244.4	439.3	304.1	267.8	270.4
TCTA		ENSG00000145022	"T cell leukemia translocation altered"	P57738	3	49412206-49416475	"Disease related genes, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007342	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA007342: AB_2202399"	"unprognostic (5.58e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.17e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (3.74e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.00e-15)"	"unprognostic (1.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.41e-3)"	15.4	29.3	21.8	9.2	21.9	7.9	16.3	12.5	26.1	18.3	16.9	23.1	19.5	14.0	13.6	46.9	12.8	20.1	19.3	13.1	20.6	20.8	35.6	27.2	17.2	14.3	23.2	18.5	19.4	18.5	17.9	28.4	19.1	22.2	25.2	21.8	23.3	16.0	20.0	10.5	7.8	19.4	16.5	25.6	15.1	16.3	9.3	12.8	12.6	34.1	10.2	11.4	13.0	8.9	9.5	10.1	14.6	28.0	13.4	13.0	13.4	5.9	7.3	4.8	7.1	21.2	9.3	6.3	12.3	9.2	12.6	10.6	4.3	6.5	7.1	9.1	29.1	14.5	6.9	9.3	12.4	10.3	10.6	6.4	11.8	9.6	5.5	12.8	5.1	15.6	20.0	13.0	13.9	11.2	12.1	12.9	5.7	4.3	16.3	30.6	5.5	6.1	4.5	3.9	11.3	17.1	3.7	5.2	16.7	21.5	7.9	12.8	4.2	14.7	16.3	13.4	10.1	13.9	4.8	11.7	9.5	5.9	19.6	4.6	9.0	11.8	4.8	22.3	9.0	13.0	12.7	11.5	14.6	13.0	21.9	7.6	8.0	8.4	10.0	6.6	9.5	10.4	11.0	13.2	13.4	28.0	10.1	10.7	13.4	21.8	21.9	12.5	26.1	20.6	20.8	23.2	18.5	22.2	12.8	23.8	17.0	11.9	9.0	2.4	10.1	11.0	25.5	29.4	12.5	26.2	11.8	21.6	39.7	13.5	5.9	10.8	32.5	0.0	10.0	10.1	10.8	18.7	5.7	27.2	21.4	9.5	16.8	12.3	20.2	11.1	14.4	13.1	13.5	16.2	16.3	20.7	12.8	21.0	15.2	42.1	10.7	6.5	15.1	7.2	6.1	4.0	16.7	20.1	15.1	7.0
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416775-49422753	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.4;Hep G2: 29.9;NTERA-2: 5.4;SH-SY5Y: 7.9;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005566	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favorable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	10.9	6.6	8.0	8.8	6.0	6.6	16.7	10.4	8.4	10.0	7.4	21.3	10.9	9.2	11.1	3.4	9.7	13.0	16.6	7.4	2.0	21.4	41.2	5.6	2.3	7.6	8.3	14.5	18.5	16.3	10.4	2.5	10.7	9.1	10.1	12.2	9.8	20.0	3.8	5.4	11.0	7.1	5.8	7.9	8.1	2.6	7.4	1.7	8.7	0.4	1.8	6.2	8.1	0.7	5.4	4.7	3.2	8.9	1.6	2.3	0.1	0.5	0.7	0.1	0.4	0.0	10.4	0.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.2	0.0	0.2	0.1	0.4	0.1	0.2	0.2	0.0	0.3	29.9	1.1	0.0	0.1	0.3	0.7	0.0	0.4	1.1	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.2	5.4	0.0	0.1	0.0	0.1	0.2	0.7	0.2	0.0	7.9	0.1	0.0	0.6	7.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	3.2	4.7	0.0	1.9	0.1	0.6	0.0	0.0	5.4	0.7	1.6	1.5	0.3	8.9	0.7	0.5	0.0	2.3	6.6	8.8	16.7	10.4	7.4	2.0	7.6	8.3	10.7	7.4	3.0	11.6	3.7	11.4	2.5	17.2	18.3	17.8	6.7	7.9	0.0	19.6	22.7	0.0	0.7	1.7	2.7	19.7	0.0	0.6	6.5	4.7	10.1	7.0	37.3	4.4	7.9	12.2	3.1	2.7	1.6	9.8	3.5	5.0	0.0	16.2	21.5	0.5	14.0	6.0	0.7	17.7	6.5	4.3	1.4	0.4	2.4	8.6	5.7	31.1	8.6
AC104452.1		ENSG00000283189			3	49416777-49429314	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Collecting duct cells: 1.8;granulocytes: 1.1"									"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.4;NK-cell: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.6;TIME: 3.9;U-266/70: 1.4"															NA	NA																							1.8	1.3	5.2	2.4	6.6	2.8	2.2	2.9	7.6	1.3	1.3	1.5	3.0	4.4	1.8	1.8	1.9	2.8	1.6	1.3	3.0		1.3	2.5	3.4	1.3	1.1	6.0	3.1	2.9	1.3	2.1	1.8	2.9	2.2	1.3	2.2	1.6	2.8	5.5	1.9	1.3	2.0	1.0	1.3	1.3	2.3	2.3	1.0	1.5	1.0	1.6	2.1	0.0	0.6	2.4	0.0	1.1	2.9	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.3	0.0	0.8	0.0	0.0	1.1	0.0	0.6	0.0	0.0	2.4	0.0	0.4	0.0	0.0	2.9	0.5	0.0	0.1	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NICN1	MGC12936	ENSG00000145029	"Nicolin 1"	Q9BSH3	3	49422946-49429326	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 25.0;Erythroid cells: 23.3;Late spermatids: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA058014			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058014: AB_2683579"	"unprognostic (4.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (2.46e-1)"	"prognostic favorable (8.81e-7)"	"unprognostic (3.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.96e-2)"	9.6	12.1	19.3	5.7	23.4	3.6	10.5	21.5	27.9	9.2	9.7	8.4	12.8	7.8	12.0	12.8	5.3	10.7	8.7	16.9	12.7	10.9	16.8	10.9	10.4	8.5	9.6	21.6	13.7	12.6	10.1	10.2	6.1	12.5	10.9	5.8	10.3	13.0	10.2	14.4	8.6	8.3	9.7	8.1	9.7	10.0	13.5	10.6	7.0	13.7	7.0	8.8	9.5	8.9	9.2	8.1	8.1	8.5	6.7	10.9	7.3	2.5	8.5	8.8	6.2	3.7	4.5	3.3	3.0	2.9	2.9	3.5	1.9	7.9	8.2	3.2	6.6	6.3	2.3	5.1	4.0	2.8	14.7	3.2	7.9	8.8	9.5	6.9	3.5	5.3	9.2	4.8	6.4	2.1	14.0	4.0	17.0	4.9	0.2	3.2	2.6	5.7	5.6	3.4	3.3	2.6	4.2	2.8	10.3	5.3	1.4	2.1	3.5	2.3	2.5	6.1	19.1	4.4	2.3	10.5	2.0	2.3	2.1	1.6	9.1	3.7	2.8	7.1	8.6	3.8	8.1	7.3	6.9	8.0	5.4	5.3	9.2	5.0	9.4	5.9	5.6	6.2	7.6	2.1	6.7	8.5	8.1	10.9	7.3	19.3	23.4	21.5	26.2	12.7	10.9	9.6	21.6	12.5	10.6	0.0	0.6	0.5	5.0	3.7	6.1	10.7	5.1	1.4	1.2	0.0	9.8	5.3	0.0	0.0	25.0	3.8	4.0	23.3	0.0	1.7	4.6	2.6	1.1	4.5	4.9	3.2	11.6	1.8	4.7	27.9	8.9	1.5	3.3	0.0	3.4	5.8	0.0	1.4	5.6	0.0	6.3	6.5	3.1	12.2	2.3	2.9	2.7	5.2	2.3	4.2
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 62.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		70000000	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	19.2	17.4	16.5	10.1	21.1	2.8	16.2	17.3	27.1	17.3	23.9	24.1	13.1	14.1	23.4	14.3	19.1	19.6	19.7	40.9	19.9	10.3	22.7	31.7	18.9	6.3	16.7	15.7	22.6	35.0	32.7	15.8	45.6	18.1	18.6	18.9	22.2	19.9	24.3	57.3	18.7	17.5	27.9	14.0	7.3	22.2	29.4	16.3	6.0	15.3	24.0	14.3	20.4	15.0	3.2	3.6	1.8	6.1	1.9	3.7	3.3	19.5	19.5	13.6	33.6	18.2	8.9	62.0	13.8	20.5	23.7	15.3	16.0	20.8	2.7	14.1	22.5	20.1	36.7	11.8	17.9	14.7	2.6	3.9	1.8	19.6	18.2	8.1	2.4	3.9	7.8	16.2	22.5	7.5	21.7	21.2	3.3	2.8	2.1	6.4	15.7	2.0	1.6	14.6	24.1	6.5	1.2	13.2	4.6	18.6	27.5	4.8	9.9	16.6	45.8	22.4	41.3	38.6	4.8	11.1	9.0	14.3	16.7	19.7	2.4	4.9	1.7	10.9	2.6	54.3	1.8	2.8	1.1	3.3	3.5	3.7	3.2	2.8	2.5	1.8	2.6	3.0	2.4	0.6	1.9	6.1	3.6	1.9	3.3	16.5	21.1	17.3	27.1	19.9	10.3	16.7	15.7	18.1	16.3	50.6	13.6	9.0	8.0	12.7	7.8	50.0	30.6	10.7	11.4	33.2	3.9	95.1	1.7	26.2	25.8	16.8	20.6	0.0	69.3	96.3	24.2	13.2	6.9	48.8	18.3	3.2	31.7	17.8	7.2	13.6	19.8	4.0	32.1	5.4	27.5	30.3	50.2	25.1	34.6	6.8	8.7	45.3	23.7	7.0	18.6	14.9	80.2	5.0	26.4	9.0
BSN	ZNF231	ENSG00000164061	"Bassoon presynaptic cytomatrix protein"	Q9UPA5	3	49554489-49671545	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 36.9"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 10.7;Horizontal cells: 23.8;Late spermatids: 9.1;Rod photoreceptor cells: 9.1;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 3.8;SCLC-21H: 9.1;SH-SY5Y: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034757	Enhanced					NA	NA					"HPA034757: AB_10671233"	"unprognostic (8.57e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.50e-4)"	"unprognostic (7.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.21e-5)"	"unprognostic (2.50e-3)"	"unprognostic (5.38e-5)"	"unprognostic (9.33e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.34e-2)"	1.2	3.9	23.0	1.3	22.4	1.1	1.2	25.4	36.9	1.3	1.2	1.8	0.0	1.3	1.5	7.0	1.2	1.4	1.2	1.3	13.1	5.1	1.4	1.3	1.3	1.2	3.9	19.1	1.6	2.1	1.7	4.4	1.3	7.9	1.3	1.2	0.7	1.3	1.4	1.4	1.3	1.3	1.3	1.6	1.3	1.7	5.1	4.0	0.0	1.4	0.0	1.1	1.1	0.3	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.2	0.4	2.1	1.4	0.1	0.0	0.8	0.0	0.0	0.1	0.1	0.5	0.4	2.4	0.5	0.0	0.4	0.3	0.3	0.0	0.1	0.5	1.0	0.3	0.7	1.1	0.0	0.4	1.0	0.1	0.0	0.0	0.4	0.0	0.0	1.5	3.8	0.4	0.1	0.8	0.4	0.2	1.7	0.3	1.0	0.0	0.2	0.4	0.0	0.5	9.1	5.6	0.8	0.1	0.1	0.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.3	1.0	0.2	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	23.0	22.4	25.4	36.9	13.1	5.1	3.9	19.1	7.9	4.0	0.0	0.0	0.0	0.0	0.0	10.7	2.2	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.1	23.8	0.0	0.6	0.0	9.1	1.1	0.0	1.7	0.0	0.0	2.9	0.2	0.0	0.4	0.1	9.1	0.0	0.4	6.6	8.0	0.1	0.1	0.0	0.0	0.1
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674002-49683963	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		1600000	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	12.3	31.4	14.3	16.9	18.4	17.3	13.5	14.2	28.2	13.4	23.5	14.4	25.3	24.2	14.1	19.0	23.8	17.2	19.1	23.1	14.2	14.2	33.6	36.9	15.0	23.9	13.9	20.0	13.9	22.7	33.5	26.6	18.6	16.3	16.1	26.6	19.5	19.8	19.8	55.1	16.9	21.7	14.1	9.8	19.2	21.9	22.3	11.7	22.6	26.6	26.6	20.7	19.9	13.7	20.5	26.2	30.4	27.9	21.8	29.5	28.1	25.8	21.1	23.2	30.0	20.3	13.6	30.7	16.9	21.7	23.8	25.5	34.0	28.1	33.1	19.0	19.2	21.7	24.0	25.9	39.2	18.1	15.7	10.7	35.7	35.3	27.8	20.1	38.2	55.6	15.4	29.6	13.6	28.3	23.8	21.5	23.3	22.1	16.5	23.6	23.9	26.9	19.4	13.7	37.3	19.3	10.2	19.9	43.0	47.1	61.4	11.1	19.3	19.1	46.4	21.0	17.9	30.6	20.4	9.7	14.7	25.8	23.0	22.8	18.9	13.5	19.7	25.4	27.1	21.2	30.2	25.5	30.4	28.5	27.9	22.5	20.5	23.5	26.7	26.2	17.4	24.9	24.2	8.0	21.8	26.7	21.0	29.5	28.1	14.3	18.4	14.2	28.2	14.2	14.2	13.9	20.0	16.3	11.7	38.7	22.3	16.0	19.8	7.7	7.8	42.0	33.1	9.4	20.5	26.2	11.8	72.6	36.5	39.0	4.6	8.3	73.8	23.3	30.4	54.6	12.8	15.2	23.1	65.2	45.5	7.9	25.4	14.1	36.8	8.1	14.1	18.1	20.3	22.6	44.7	21.8	35.8	28.8	12.7	64.9	9.9	12.9	14.2	30.5	28.4	8.2	51.9	25.3	51.1	21.0
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	8	"liver: 117.0"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 361.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;memory B-cell: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 42.3;NB-4: 8.6;U-266/70: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"	NA	NA					"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.7	3.5	4.0	0.3	4.8	1.4	1.0	4.9	5.4	0.9	1.4	2.5	1.9	14.4	1.2	3.3	0.8	1.7	1.9	0.5	6.5	1.1	8.8	117.0	1.6	0.7	2.0	2.9	1.7	1.9	3.8	4.8	1.5	4.8	1.5	0.5	1.6	3.4	3.7	2.8	4.0	8.2	1.3	4.2	1.7	0.8	9.9	2.3	0.9	5.0	0.3	1.1	0.8	0.7	1.2	0.9	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.6	1.0	1.9	4.1	1.9	0.5	0.7	0.3	0.4	2.0	0.6	0.1	1.3	0.6	0.3	0.4	0.3	0.8	0.3	0.6	0.3	0.3	0.9	42.3	3.1	0.0	0.8	5.5	1.3	0.3	1.1	7.5	0.7	1.8	0.3	5.2	1.0	0.3	0.2	8.6	0.1	0.5	0.5	0.2	0.2	1.1	2.3	0.3	0.1	1.5	0.0	0.9	0.2	1.3	0.7	2.8	0.5	1.0	0.3	0.0	0.1	11.5	1.4	0.2	1.1	1.6	0.7	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.2	4.0	4.8	4.9	5.4	6.5	1.1	2.0	2.9	4.8	2.3	6.0	3.8	6.0	4.8	2.6	7.2	1.7	38.2	5.3	4.5	26.2	7.9	3.6	53.0	5.4	4.2	2.1	4.6	46.7	3.3	13.8	3.3	1.1	1.1	361.8	1.2	1.6	7.9	11.6	9.5	0.5	2.8	1.4	3.3	0.0	7.3	7.7	2.3	7.0	1.8	54.1	6.9	0.0	2.0	18.7	4.4	4.1	4.2	2.1	12.1	2.7
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689499-49721529	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA065983: AB_2685592, HPA071879: AB_2686468"	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	5.3	8.0	7.7	8.0	10.4	17.5	5.0	13.8	13.6	5.2	6.8	6.2	7.8	12.7	6.4	8.0	7.5	6.4	7.0	12.9	8.5	6.8	8.4	21.8	5.7	6.1	7.3	6.6	5.1	7.7	8.9	8.4	7.3	6.6	7.3	4.8	7.6	6.9	6.7	81.2	7.7	12.5	6.2	6.7	7.6	6.9	8.8	7.8	8.3	6.2	12.0	9.1	6.6	4.8	11.3	12.7	11.8	10.9	7.7	11.4	5.3	6.7	9.6	11.4	11.8	17.4	10.8	12.3	8.8	11.7	11.3	12.6	10.2	11.7	16.5	8.1	12.6	10.0	8.5	8.6	13.3	7.9	10.9	11.8	13.4	18.9	22.3	17.4	13.0	14.6	13.6	13.1	10.6	12.3	11.2	11.6	16.8	14.1	14.3	9.5	10.1	13.7	21.1	6.3	8.5	15.5	6.5	7.0	17.0	15.4	11.5	7.8	15.7	12.2	10.8	13.4	6.7	11.1	23.4	12.0	9.9	12.1	8.9	10.9	19.5	19.1	6.6	14.1	16.5	14.9	11.8	10.9	7.9	11.4	9.5	6.8	9.8	7.2	6.8	8.6	11.3	8.7	8.2	6.3	7.7	9.7	12.7	5.5	5.3	7.7	10.4	13.8	13.6	8.5	6.8	7.3	6.6	6.6	7.8	8.9	4.0	4.4	2.4	2.1	8.6	1.0	20.4	1.4	4.5	3.5	3.9	5.6	5.0	4.9	10.6	3.6	13.1	0.0	4.8	3.6	4.9	4.4	6.9	23.8	4.8	6.4	6.4	9.8	9.9	12.6	6.9	3.2	3.3	4.6	5.9	3.5	6.0	7.0	5.3	8.5	8.2	0.0	4.9	8.7	9.1	2.6	7.1	2.9	6.3	3.7
AMIGO3		ENSG00000176020	"Adhesion molecule with Ig like domain 3"	Q86WK7	3	49716834-49719695	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	23	"Intestinal endocrine cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 12.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.6;HeLa: 5.6;HMC-1: 3.7;SH-SY5Y: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.33e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.92e-3)"	"unprognostic (3.75e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.56e-2)"	"unprognostic (7.85e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.58e-3)"	2.4	1.3	1.6	1.5	1.7	4.8	1.0	2.8	4.3	1.0	0.9	1.7	5.8	2.0	1.4	4.5	1.8	1.9	1.2	1.6	0.7	2.1	1.0	3.5	1.6	3.6	0.7	0.5	2.0	2.9	0.7	6.6	0.9	1.9	1.9	0.7	1.9	4.1	5.4	11.7	5.3	1.7	0.7	0.9	2.0	1.7	8.7	0.9	8.7	1.7	5.7	3.8	0.8	1.1	0.4	12.6	0.1	0.1	1.1	1.1	0.4	0.2	0.0	0.2	0.0	0.0	0.4	1.2	0.0	0.0	0.1	0.1	4.6	0.5	0.0	0.4	0.0	0.1	2.6	0.0	0.0	0.0	2.5	1.4	0.0	5.6	2.3	0.0	0.8	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.8	0.0	2.6	2.9	1.6	0.0	0.0	0.0	0.1	0.4	0.2	0.0	2.5	1.4	3.7	0.5	0.2	0.0	0.0	0.3	0.7	0.6	0.4	1.3	0.9	0.2	3.1	2.2	0.4	0.0	1.4	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.2	1.1	0.1	0.1	0.4	0.7	0.1	1.1	0.0	12.6	0.4	0.4	1.6	1.7	2.8	4.3	0.7	2.1	0.7	0.5	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GMPPB	KIAA1851	ENSG00000173540	"GDP-mannose pyrophosphorylase B"	Q9Y5P6	3	49716844-49723951	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014657	Uncertain					NA	NA		10000			"HPA014657: AB_1849852"	"unprognostic (3.48e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (6.19e-6)"	"unprognostic (1.01e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	7.5	17.1	7.6	17.5	8.1	7.4	9.7	4.3	9.6	14.4	13.2	7.2	28.7	12.1	11.5	23.2	15.3	12.6	13.3	10.9	5.2	4.7	13.1	41.3	12.9	15.9	8.3	6.8	10.1	32.0	8.9	23.0	15.3	6.9	16.6	11.3	7.9	50.8	37.2	7.2	8.2	12.2	7.9	4.3	16.8	18.1	6.9	5.8	16.5	16.8	8.6	17.5	8.8	9.3	13.4	34.5	10.1	11.1	5.5	11.2	8.1	17.8	17.5	12.7	7.7	10.2	7.7	13.0	20.7	12.3	21.0	19.9	11.3	13.3	10.5	9.2	12.9	13.0	10.3	10.6	22.3	7.1	9.4	8.7	7.5	19.4	13.3	23.5	11.3	12.1	5.4	9.6	29.7	23.7	6.8	18.9	12.1	5.6	17.3	12.1	13.5	15.4	5.8	7.0	13.3	21.1	5.3	6.4	18.0	11.6	16.8	8.4	8.9	9.4	23.0	6.8	6.5	13.1	7.5	13.1	15.2	14.7	20.5	22.1	20.0	5.4	7.4	16.0	8.0	17.4	10.1	8.6	3.7	10.8	11.0	11.0	13.4	9.5	11.2	8.2	10.3	7.3	8.8	2.2	5.5	11.1	34.5	6.3	8.1	7.6	8.1	4.3	9.6	5.2	4.7	8.3	6.8	6.9	5.8	8.9	15.0	22.9	17.2	0.7	3.1	3.8	12.7	24.1	5.7	17.4	2.0	26.1	24.9	33.3	4.8	8.3	35.4	0.0	44.5	49.4	8.2	47.6	0.0	24.1	35.8	6.4	16.0	11.6	8.9	7.2	14.4	10.5	1.7	62.3	28.8	5.2	32.1	25.9	7.1	19.3	5.4	0.0	3.8	17.4	10.6	1.5	66.5	17.8	26.8	29.7
IP6K1	"IHPK1, KIAA0263"	ENSG00000176095	"Inositol hexakisphosphate kinase 1"	Q92551	3	49724294-49786542	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cone photoreceptor cells: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040825	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA040825: AB_10960426"	"unprognostic (6.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.08e-4)"	"unprognostic (9.97e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.75e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.64e-2)"	14.2	17.5	23.5	12.9	26.9	12.1	15.8	38.6	40.4	17.7	16.1	20.7	16.1	13.6	21.4	14.5	19.6	20.0	14.7	13.7	23.8	23.5	16.3	15.9	16.9	16.3	17.9	18.3	30.2	21.9	30.3	16.7	18.3	21.2	14.3	13.2	18.6	18.3	21.1	9.0	18.2	12.7	19.5	16.9	16.9	13.7	27.3	14.8	22.3	17.1	8.4	14.4	16.3	15.6	6.8	4.1	24.0	4.8	6.9	9.7	6.0	12.3	15.0	17.6	20.6	18.4	14.2	14.2	16.5	17.4	27.1	23.8	19.5	12.9	10.8	10.7	18.2	18.4	9.2	24.8	14.9	15.4	21.7	19.8	24.4	23.0	13.1	20.4	14.9	17.1	16.5	18.6	29.2	17.7	15.3	22.6	12.6	16.0	12.7	13.3	11.0	18.1	15.6	18.9	9.8	25.0	11.5	12.5	21.6	17.5	18.9	9.5	19.0	21.0	13.7	18.9	10.6	11.0	22.0	20.2	15.2	15.3	20.8	19.1	15.5	20.8	11.5	13.9	17.3	15.5	2.5	4.8	8.2	8.7	3.9	8.8	4.6	8.0	9.6	4.1	6.8	9.7	9.5	24.0	6.9	4.8	2.9	8.2	6.0	23.5	26.9	38.6	40.4	23.8	23.5	17.9	18.3	21.2	14.8	23.8	10.5	11.8	13.7	13.9	37.4	8.9	15.3	17.4	10.3	12.2	84.4	15.7	5.0	12.1	69.3	16.6	12.9	23.3	11.3	13.2	13.6	16.1	19.6	10.6	10.8	28.6	26.5	17.8	11.8	11.8	19.5	10.7	18.6	14.4	12.2	22.0	16.3	8.6	15.6	10.3	70.3	19.4	11.5	17.9	22.6	16.4	23.0	23.5	11.0	13.3
CDHR4	"CDH29, VLLR9392"	ENSG00000187492	"Cadherin related family member 4"	A6H8M9	3	49790732-49799835	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 37.8;fallopian tube: 42.7"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 132.5"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 6.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 5.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.7;HeLa: 4.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 17.7"	"Low region specificity"	"Detected in single"			HPA076277	Enhanced				"Intracellular and membrane"	NA	NA					"HPA076277: AB_2732306"	"unprognostic (1.50e-4)"	"unprognostic (4.87e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.35e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-11)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.37e-1)"	0.2	0.1	0.4	0.1	1.6	0.3	0.1	0.0	0.0	4.9	0.2	1.9	0.0	0.1	1.3	37.8	0.1	42.7	0.1	0.1	0.7	0.9	0.1	0.1	11.4	0.1	0.0	0.0	8.0	0.0	0.0	0.8	0.6	5.7	0.1	0.1	0.0	0.1	0.2	0.1	0.9	0.1	0.3	0.2	0.0	0.1	3.9	0.0	0.0	0.0	0.5	0.2	0.2	0.1	1.1	1.5	3.0	4.1	1.3	0.4	5.8	0.5	1.8	0.5	0.3	0.5	4.7	0.3	0.4	0.1	1.0	1.0	0.0	2.7	0.0	0.2	1.1	0.6	0.5	0.1	0.0	0.3	0.3	0.3	0.8	4.5	1.0	0.0	0.3	0.5	0.7	1.5	0.8	0.3	1.2	0.0	0.3	0.2	0.7	0.0	0.0	0.0	0.8	0.3	0.6	0.2	0.8	0.2	0.0	0.0	0.3	0.1	0.1	1.6	1.1	0.0	0.1	0.2	0.1	0.0	0.6	0.2	0.7	0.1	0.7	2.4	0.1	2.2	1.3	0.0	3.0	4.1	0.4	0.4	1.6	0.3	0.4	0.3	0.3	1.5	1.1	0.3	0.4	2.5	1.3	0.2	0.5	0.2	5.8	0.4	1.6	0.0	0.0	0.7	0.9	0.0	0.0	5.7	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.4	0.0	132.5	18.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.4	0.5	0.0	0.0	0.0	0.0	0.1
FAM212A	"C3orf54, INKA1"	ENSG00000185614	"Family with sequence similarity 212 member A"	Q96EL1	3	49803254-49805030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 25.8;skin 1: 30.0"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 22.2;granulocytes: 19.8;Hofbauer cells: 41.3;Ito cells: 39.3;Suprabasal keratinocytes: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 19.0;memory B-cell: 25.8;naive B-cell: 23.4"	"Group enriched"	"Detected in many"	6	"B-cells: 25.8;granulocytes: 19.0"	"Cell line enhanced"	"Detected in many"		"HEL: 31.9;HMC-1: 21.9;NB-4: 17.7;THP-1: 19.7;U-937: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041879	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA041879: AB_10797269"	"unprognostic (1.36e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.96e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.40e-2)"	6.0	4.1	5.8	3.2	4.7	5.0	3.5	8.0	6.3	6.8	2.6	4.9	1.4	1.7	5.5	2.8	16.3	2.9	4.8	7.6	4.4	4.3	3.4	1.2	7.3	5.9	6.3	4.8	3.6	2.3	0.8	2.0	5.2	5.6	5.4	1.4	3.2	4.5	3.9	15.3	30.0	3.5	5.3	8.3	6.9	2.2	2.4	4.3	1.8	1.9	10.4	8.4	4.8	8.5	25.8	3.6	19.0	2.9	0.0	1.5	2.8	0.6	0.5	0.7	0.5	0.9	2.0	0.0	1.4	0.9	0.7	0.8	0.0	0.0	6.9	0.2	1.0	0.7	4.1	0.2	4.9	0.0	1.2	0.0	31.9	0.3	0.1	1.3	4.8	21.9	2.7	7.0	1.4	1.3	0.4	2.9	0.5	2.1	0.6	0.6	0.3	0.4	17.7	0.5	0.0	2.8	6.5	0.4	1.5	0.0	7.9	0.3	2.5	1.3	0.2	0.7	0.2	0.1	19.7	1.8	3.6	0.4	1.6	0.6	0.8	0.7	0.5	1.5	16.4	0.8	19.0	0.9	4.3	0.6	2.2	0.1	25.8	0.6	0.7	0.2	23.4	0.9	1.5	0.5	0.0	2.9	3.6	0.6	2.8	5.8	4.7	8.0	6.3	4.4	4.3	6.3	4.8	5.6	4.3	3.0	1.1	0.0	11.6	22.2	1.0	0.0	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.0	1.6	7.5	0.0	0.0	0.0	0.4	7.5	1.1	19.8	0.0	41.3	0.0	0.0	39.3	2.2	7.4	1.7	0.0	11.8	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.4	12.9	0.5	1.7	3.2	24.1	0.9	0.0	0.0	4.7
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805207-49813946	"Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 22.7;HEL: 21.2;HMC-1: 41.2;HSkMC: 19.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1400000	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: AB_2683631"	"prognostic favorable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.48e-4)"	11.3	12.1	6.8	22.0	7.5	16.0	11.5	2.0	6.7	10.8	12.7	14.4	25.4	19.6	17.2	31.6	17.7	12.9	33.1	9.1	6.7	3.9	15.9	11.9	18.8	28.2	6.0	6.2	19.1	9.5	1.4	8.4	8.9	9.4	18.5	12.1	14.2	24.5	34.2	3.3	9.0	25.5	11.3	7.7	35.9	13.2	3.4	5.9	20.4	17.8	18.4	23.5	12.6	13.1	12.4	14.3	24.8	21.7	11.1	11.8	13.0	4.3	0.0	0.3	0.1	12.2	12.9	1.4	2.3	10.6	16.9	22.7	0.0	9.3	0.1	1.9	8.6	7.3	2.4	0.0	4.2	1.5	11.3	0.0	21.2	0.2	1.3	9.0	2.0	41.2	19.8	0.2	6.6	0.4	11.8	8.5	0.7	0.0	1.3	3.9	0.1	4.3	5.1	0.0	0.0	0.4	5.5	0.4	0.7	3.5	8.6	0.0	0.3	2.8	4.2	1.4	0.2	0.4	14.1	3.7	3.3	0.4	1.4	0.9	0.0	0.0	0.1	9.2	7.5	0.7	13.9	14.7	24.8	11.8	21.7	10.3	12.3	10.8	10.5	14.3	12.4	9.9	8.9	4.6	11.1	17.2	5.2	10.6	13.0	6.8	7.5	2.0	6.7	6.7	3.9	6.0	6.2	9.4	5.9	29.8	23.6	22.9	5.9	3.4	0.1	6.9	15.3	2.7	13.6	12.2	0.0	4.5	0.0	7.6	4.5	14.3	35.5	0.0	6.9	2.2	8.9	5.1	80.8	6.7	18.2	0.0	9.1	17.8	21.9	24.1	10.3	10.6	0.0	10.8	19.5	2.9	5.1	12.9	10.6	4.1	1.1	6.5	7.1	0.9	0.4	4.1	2.4	27.4	15.3	5.0
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828599-49856574	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.0"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 11.8;Spermatogonia: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavorable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	4.8	1.6	3.4	6.0	10.7	9.5	3.0	7.4	3.0	3.5	3.7	2.0	3.2	2.3	3.8	2.4	4.5	3.0	2.9	1.5	2.7	2.7	1.6	1.2	1.3	8.1	2.0	2.8	3.4	1.6	1.6	2.0	2.5	3.0	2.9	4.8	2.7	3.1	1.7	2.8	6.7	3.4	3.4	5.1	3.7	1.9	25.0	3.4	11.5	2.2	3.1	6.8	1.9	3.0	5.1	1.6	0.6	3.0	2.7	4.9	1.6	6.4	7.9	11.3	11.4	1.0	1.6	9.4	7.8	3.8	16.6	15.9	9.6	7.5	16.0	5.6	4.5	11.6	8.6	11.9	9.0	12.4	9.2	7.9	12.0	9.6	8.5	0.4	9.8	10.1	1.1	1.3	13.3	7.1	2.0	4.3	14.3	8.6	11.6	7.3	9.4	16.2	12.5	9.1	7.7	13.1	9.0	7.7	9.3	3.0	9.1	5.5	9.4	8.7	7.3	5.5	8.5	6.6	13.9	3.3	10.6	12.7	14.6	15.3	8.5	20.3	17.1	5.3	13.3	9.5	0.0	1.5	0.6	2.3	0.8	2.0	5.1	1.3	4.9	1.3	3.8	1.7	2.6	0.3	2.7	3.0	1.6	0.8	1.6	3.4	10.7	7.4	3.0	2.7	2.7	2.0	2.8	3.0	3.4	3.0	1.1	2.2	0.6	1.0	3.1	2.0	0.0	0.0	0.0	3.5	0.0	2.1	0.0	1.3	3.3	0.7	0.5	0.0	0.8	6.7	1.4	0.5	0.0	0.8	3.0	0.0	0.0	0.6	0.3	4.0	2.3	0.5	1.7	2.8	1.3	1.9	0.9	0.0	1.1	0.3	3.6	0.0	1.0	11.8	9.5	0.3	0.8	2.9	2.3	0.1
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49870222	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"brain: 77.2"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 2.3;Cone photoreceptor cells: 2.0;Early spermatids: 4.6;Horizontal cells: 3.2;Late spermatids: 6.5"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"AF22: 5.3;HAP1: 7.0;NTERA-2: 25.2;RPMI-8226: 4.8;SCLC-21H: 8.6;SH-SY5Y: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"		NA	NA			Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	1.2	2.1	20.7	1.2	77.2	1.2	1.2	0.5	62.8	1.2	1.2	1.7	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	33.4	11.7	1.2	1.2	1.2	1.2	3.3	23.5	1.2	1.2	1.2	1.8	1.2	2.1	1.2	1.2	0.0	1.2	1.2	1.2	1.3	1.2	1.2	1.9	1.2	1.3	2.1	6.0	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	5.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.1	0.7	0.1	25.2	0.0	0.1	0.8	0.0	4.8	0.0	0.0	8.6	5.5	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	20.7	77.2	0.5	34.0	33.4	11.7	3.3	23.5	2.1	6.0	0.0	0.0	0.0	0.0	0.2	2.3	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.2	1.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.7	0.1	0.2	0.0	0.1	0.0
MST1R	"CD136, CDw136, PTK8, RON"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 34.3;skin 1: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 23.8;Enterocytes: 29.1;Mucus-secreting cells: 21.5;Pancreatic endocrine cells: 19.7;Paneth cells: 20.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.9;HaCaT: 19.8;HBEC3-KT: 21.6;hTCEpi: 30.3;RT4: 23.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favorable (2.33e-5)"	1.7	0.1	0.4	7.5	0.6	0.0	2.4	0.5	0.7	1.8	20.5	0.7	2.0	11.2	1.2	1.3	6.1	0.6	27.7	0.9	0.5	0.1	1.4	0.4	5.0	1.1	0.4	0.6	0.5	4.1	0.0	1.3	0.8	0.9	1.7	9.7	2.5	2.1	0.4	0.5	28.7	34.3	0.7	0.4	0.6	19.1	1.9	0.4	7.7	1.3	6.0	4.5	4.3	3.5	0.2	0.0	0.0	0.0	0.6	2.1	0.0	12.9	5.0	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.2	35.9	0.5	3.1	0.2	0.0	19.8	0.0	21.6	0.0	0.3	0.3	0.0	8.5	0.3	0.3	0.0	0.4	0.1	30.3	0.1	4.3	0.1	0.0	0.0	0.2	0.1	0.0	1.8	0.0	0.0	0.1	11.6	10.5	0.9	0.0	0.3	13.3	23.1	0.3	0.0	3.6	8.4	0.0	0.0	6.6	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.4	0.6	0.5	0.7	0.5	0.1	0.4	0.6	0.9	0.4	23.8	10.1	0.0	2.2	7.8	0.0	1.2	0.0	2.7	9.1	0.0	0.0	0.1	0.0	5.2	13.7	0.0	29.1	0.0	8.7	0.4	0.4	1.7	0.0	0.0	0.1	0.0	4.1	0.0	0.0	7.9	0.3	0.0	0.0	1.0	21.5	0.0	19.7	20.4	0.0	0.0	0.0	0.0	0.4	1.6	0.8	4.1	0.0	0.0	12.4	4.6
MON1A	"MGC13272, SAND1"	ENSG00000164077	"MON1 homolog A, secretory trafficking associated"	Q86VX9	3	49907160-49930173	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3;Late spermatids: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053752, HPA058032"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA053752: AB_2682250, HPA058032: AB_2683584"	"unprognostic (1.81e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-1)"	7.1	6.5	11.7	6.1	10.4	4.1	4.6	5.2	17.8	5.9	9.3	7.6	3.8	27.9	5.6	3.2	5.6	5.1	6.3	5.4	10.8	10.3	6.0	11.0	4.9	5.2	10.3	8.8	4.7	10.9	5.8	7.4	4.9	8.9	5.0	4.0	5.6	6.0	6.7	15.2	6.9	17.6	5.9	9.7	4.6	5.8	12.6	6.6	6.6	6.3	4.1	4.5	4.6	4.4	8.8	7.8	3.3	6.4	13.6	13.5	7.8	4.6	3.9	2.4	7.5	7.7	4.6	3.4	6.7	3.3	6.5	7.3	5.8	3.1	14.2	6.1	6.2	5.6	5.9	5.2	8.4	2.7	11.8	13.1	6.2	4.6	7.4	9.7	7.2	9.0	6.3	9.1	12.6	4.4	3.3	9.4	6.1	9.6	5.0	4.9	7.7	8.2	10.6	5.4	10.1	20.1	5.1	2.7	10.9	4.6	3.4	7.0	4.2	2.8	5.6	6.7	1.7	4.3	4.9	7.4	4.3	5.1	11.9	10.6	10.5	10.3	8.8	6.6	11.2	6.4	0.1	6.4	3.3	11.9	4.9	13.5	8.8	10.0	11.9	7.8	4.8	12.4	10.0	1.9	13.6	3.9	3.9	10.1	7.8	11.7	10.4	5.2	17.8	10.8	10.3	10.3	8.8	8.9	6.6	3.0	4.8	4.3	1.7	13.3	2.8	5.3	0.0	4.0	3.4	1.8	3.9	3.7	1.7	4.2	11.9	3.8	9.3	23.3	5.8	2.6	3.5	3.7	4.6	12.9	4.7	0.0	6.4	4.3	3.8	25.2	3.1	2.5	5.0	1.8	4.0	4.6	9.6	5.8	5.3	10.5	2.2	0.0	6.2	14.0	5.7	8.0	3.3	4.9	4.9	1.8
RBM6	"3G2, DEF-3, DEF3, g16, NY-LU-12"	ENSG00000004534	"RNA binding motif protein 6"	P78332	3	49940007-50100045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026272, HPA027164"	Enhanced		Approved	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA026272: AB_1847592, HPA027164: AB_1847593"	"unprognostic (3.81e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (7.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.13e-5)"	24.4	30.2	30.2	51.3	37.1	30.0	25.1	49.4	41.1	31.2	31.0	28.9	38.5	30.3	51.4	34.3	21.8	28.8	32.6	25.3	32.1	19.8	29.2	30.6	26.8	39.8	38.1	26.0	42.6	35.9	41.9	36.9	21.9	30.5	40.1	29.8	25.6	28.1	38.3	25.3	35.9	32.4	36.7	40.9	42.6	28.0	29.7	38.0	24.9	32.6	21.9	35.9	25.1	36.6	12.8	9.9	14.7	8.6	7.3	15.6	5.9	9.7	6.2	25.4	16.9	26.0	14.3	9.0	16.5	14.3	14.6	15.4	10.7	11.1	50.1	9.7	16.4	14.9	8.1	21.7	14.5	18.6	20.1	8.1	23.2	14.2	13.9	14.8	24.4	24.1	13.3	18.0	16.5	18.6	27.0	18.4	13.1	19.0	12.6	13.9	9.3	22.9	36.2	20.3	12.1	11.4	8.8	10.9	12.8	14.4	19.0	10.1	18.2	15.1	10.9	10.3	23.6	8.5	19.3	17.0	14.6	17.4	11.9	16.7	17.4	41.2	30.2	8.4	20.5	14.3	14.7	8.6	5.0	15.6	4.7	12.1	12.8	10.2	8.5	8.8	11.9	10.5	11.5	6.1	7.3	7.7	9.9	6.7	5.9	30.2	37.1	49.4	41.1	32.1	19.8	38.1	26.0	30.5	38.0	53.6	75.9	98.3	36.2	48.0	117.7	27.5	35.7	52.2	50.0	59.3	96.2	29.5	10.0	26.7	26.1	51.5	48.5	23.3	24.1	24.9	50.1	43.0	40.6	28.4	24.2	87.4	45.4	47.3	59.4	17.2	60.7	54.9	57.3	40.5	32.6	52.2	32.6	31.6	57.0	10.3	141.3	45.3	50.9	108.1	28.1	39.5	30.3	54.2	31.0	31.9
RBM5	"H37, LUCA15"	ENSG00000003756	"RNA binding motif protein 5"	P52756	3	50088908-50119021	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017335, HPA018011"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017335: AB_1856134, HPA018011: AB_1856135"	"unprognostic (4.11e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-3)"	"prognostic unfavorable (9.77e-4)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.58e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.89e-3)"	33.8	25.9	34.1	43.7	37.8	37.7	37.0	51.2	38.9	38.5	33.1	47.7	41.3	25.1	53.2	45.9	28.9	40.5	27.6	28.5	31.1	25.0	30.4	26.9	30.3	41.2	38.1	38.4	63.5	36.3	37.7	58.6	40.3	30.3	41.5	33.5	40.4	35.7	37.9	45.9	54.5	34.7	37.9	41.1	47.0	30.9	36.4	39.5	41.4	42.0	28.5	45.5	31.8	36.6	14.3	12.2	29.6	14.4	14.0	20.1	10.3	9.7	12.1	43.8	19.0	18.3	26.7	10.3	29.8	18.0	22.2	15.7	12.1	11.3	23.0	10.3	19.4	21.9	8.6	29.6	14.4	23.9	21.4	10.8	28.9	41.2	10.8	22.7	26.4	23.4	23.7	16.4	24.1	23.8	38.3	23.5	23.7	19.7	15.5	20.8	8.7	26.8	17.9	15.7	16.7	13.8	14.6	19.2	11.8	16.1	49.1	6.3	14.6	24.5	10.7	14.8	31.2	9.9	25.4	26.6	14.8	15.5	20.4	17.2	21.5	31.4	24.4	11.0	16.2	17.0	29.6	14.0	18.5	17.5	14.4	16.6	13.7	15.8	18.1	12.2	14.3	20.1	15.8	26.1	14.0	14.0	9.3	18.4	10.3	34.1	37.8	51.2	38.9	31.1	25.0	38.1	38.4	30.3	39.5	65.5	105.1	31.8	36.7	28.4	88.7	39.5	17.8	100.4	86.4	36.6	172.8	40.3	10.0	22.5	120.2	50.7	39.5	0.0	18.1	21.2	40.9	41.1	64.9	37.6	27.8	89.0	70.6	55.3	39.9	150.2	59.5	45.4	42.2	37.9	45.1	49.6	24.7	36.8	54.5	7.6	131.6	32.3	43.2	48.9	34.1	29.6	68.3	55.8	33.6	34.9
SEMA3F	"Sema4, SEMAK"	ENSG00000001617	"Semaphorin 3F"	Q13275	3	50155045-50189075	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 23.1;Collecting duct cells: 17.4;Ito cells: 28.3;Rod photoreceptor cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 24.3;HUVEC TERT2: 42.3;RT4: 24.6;SK-BR-3: 39.5;TIME: 76.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035008	Approved				"Secreted to blood"	NA	NA	1700000	4000000			"HPA035008: AB_10604091"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.88e-3)"	"unprognostic (6.87e-3)"	17.4	3.7	2.8	5.0	3.6	1.5	26.5	3.5	5.0	12.2	7.5	2.5	45.3	8.1	9.2	10.5	42.6	9.7	8.2	12.3	3.1	3.1	15.1	4.9	20.4	5.8	2.9	0.5	5.5	4.2	2.9	5.7	28.9	6.4	14.8	4.1	19.3	12.5	22.1	7.9	44.4	9.3	5.7	2.6	57.6	10.2	3.1	3.6	2.7	13.8	19.5	21.5	14.7	22.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.0	0.7	0.1	3.2	0.0	0.3	0.6	1.7	5.5	1.5	2.3	1.2	1.4	0.1	17.7	0.2	0.1	10.5	1.5	22.8	0.5	0.0	0.4	0.1	24.3	4.0	1.3	0.3	0.7	1.5	12.7	3.4	10.5	21.1	42.3	0.2	0.6	0.0	0.3	2.6	0.3	1.6	1.9	1.4	2.2	2.5	0.0	0.1	1.6	24.6	0.2	0.6	2.8	39.5	0.0	2.5	15.4	1.6	76.0	0.9	7.5	6.7	1.2	0.0	0.0	0.1	0.0	0.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.6	3.5	5.0	3.1	3.1	2.9	0.5	6.4	3.6	0.0	1.4	0.0	3.0	6.1	23.1	1.4	2.5	1.4	2.3	17.4	9.8	8.2	0.0	0.2	0.0	13.5	5.0	0.0	0.7	0.3	1.5	2.5	0.0	0.5	1.2	6.4	0.0	28.3	0.8	0.0	0.3	0.0	0.0	0.0	9.1	8.1	4.0	3.5	0.0	0.6	18.6	0.0	2.3	0.0	0.4	7.9	5.3	0.0	5.0	6.7
GNAT1	CSNBAD3	ENSG00000114349	"G protein subunit alpha transducin 1"	P11488	3	50191612-50196516	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	Transducer	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"retina: 171.9"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 1622.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;MCF7: 2.4;RT4: 2.6;SCLC-21H: 1.1"	"Not detected"	"Not detected"							HPA045393	Enhanced					NA	NA					"HPA045393: AB_2679310"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"		"unprognostic (8.56e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.82e-3)"		"unprognostic (6.10e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.48e-3)"	0.3	0.5	0.3	0.0	0.3	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.2	0.0	0.3	0.3	0.1	0.7	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	171.9	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	177.2	0.3	0.0	0.0	0.0	0.0	227.8	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.8	0.0	0.0	0.0	26.2	0.6	0.0	0.0	0.0	0.0	228.8	0.1	0.0	0.0	0.0	1622.9	0.0	0.0	1.7	0.4	0.0	0.1	0.0	0.0	0.1
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 107.8"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 86.1;Cone photoreceptor cells: 176.7;Hepatocytes: 93.4;Muller glia cells: 75.9;Rod photoreceptor cells: 112.3"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"					"Cell type enhanced"	"Detected in some"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Hep G2: 32.4;SCLC-21H: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA031871: AB_2674080"	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	0.7	0.3	3.4	0.3	5.2	0.5	0.7	2.4	10.5	0.3	0.3	10.3	0.0	0.7	0.4	0.4	0.6	0.4	0.4	2.0	4.1		1.5	107.8	0.3	0.4	3.4	4.0	2.4	11.6	1.8	0.7	0.6	7.8	0.4	0.3	22.2	0.9	0.3	10.4	0.5	0.4	0.3	4.7	0.3	0.9	0.7	5.2	0.0	0.6	1.9	0.4	0.3	0.0	1.1	1.0	5.6	0.8	1.5	0.8	0.2	0.0	0.0	0.8	4.9	0.0	0.0	1.3	0.0	0.0	0.9	0.4	2.9	0.1	0.1	0.8	0.0	0.2	0.0	1.3	0.0	0.6	0.1	0.4	0.0	0.6	32.4	0.1	0.3	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.5	0.1	0.0	0.4	0.3	0.0	0.1	0.2	10.8	0.9	0.5	0.1	0.0	1.5	1.3	0.2	0.0	0.2	0.9	0.0	0.7	0.3	0.0	0.1	0.1	0.2	0.1	5.6	0.8	0.9	0.6	0.2	0.4	0.7	0.5	0.4	0.2	1.1	0.6	0.8	3.3	1.5	0.2	1.0	0.4	0.2											0.0	0.0	1.9	0.1	0.0	86.1	2.8	15.3	0.0	0.0	0.0	176.7	0.2	0.0	0.7	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	93.4	0.1	7.9	3.4	0.0	3.3	0.0	2.0	0.0	0.0	1.0	0.0	75.9	0.8	0.0	0.4	1.4	112.3	0.0	0.0	1.0	1.8	0.0	1.1	0.0	0.0	0.0
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259355	"Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		53000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favorable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	81.9	37.8	50.8	69.5	47.2	102.5	53.4	17.7	45.3	56.2	47.9	67.2	34.5	22.6	51.4	41.1	44.4	47.1	55.5	57.0	44.6	48.0	34.1	50.9	72.8	78.7	53.3	34.3	54.0	21.4	24.9	42.1	81.3	46.8	44.3	22.5	38.5	25.8	60.0	29.6	29.0	35.7	53.6	81.8	96.7	30.1	28.5	45.9	70.0	37.7	32.4	55.5	60.7	49.8	5.3	14.2	35.8	19.4	6.1	8.4	5.6	15.3	8.3	25.2	25.2	31.0	38.9	4.5	33.5	54.1	48.4	49.8	9.3	21.7	18.3	14.7	75.6	26.2	12.3	17.9	46.8	31.0	39.1	6.3	46.2	22.6	14.5	30.6	42.2	61.6	37.7	20.9	43.7	17.9	40.0	113.3	15.7	3.0	39.9	48.2	19.9	35.6	45.6	13.5	7.5	32.6	22.4	12.1	26.8	31.1	17.4	6.1	10.6	24.5	7.4	15.4	21.6	11.7	43.8	98.5	41.7	24.5	39.3	33.5	25.2	32.2	16.1	47.0	57.6	49.9	2.6	16.5	23.4	8.4	19.4	4.9	5.0	6.3	7.6	14.2	5.3	5.0	5.7	35.8	6.1	15.0	11.7	6.6	5.6	50.8	47.2	17.7	45.3	44.6	48.0	53.3	34.3	46.8	45.9	38.7	40.4	91.6	50.8	50.5	26.8	19.8	53.5	14.7	25.0	41.8	13.7	65.7	5.0	114.9	164.1	226.6	12.0	23.3	53.2	68.9	80.2	40.6	86.7	69.5	291.0	6.4	88.5	179.9	279.9	235.2	84.0	263.9	79.2	299.4	19.5	264.2	106.8	32.8	89.8	22.6	18.1	51.8	75.6	14.0	24.7	55.0	97.4	119.3	13.3	55.9
SEMA3B	"LUCA-1, SemA, sema5, SEMAA, semaV"	ENSG00000012171	"Semaphorin 3B"	Q13214	3	50267558-50277546	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 147.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 151.8;Enterocytes: 193.7;Syncytiotrophoblasts: 93.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	7	"eosinophil: 3.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 23.0;Hep G2: 34.8;SK-BR-3: 18.1;WM-115: 56.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA030651	Uncertain				"Secreted in other tissues"	NA	NA		29000			"HPA030651: AB_10602224"	"prognostic favorable (1.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.69e-2)"	3.3	18.8	2.5	2.0	7.4	0.0	1.0	0.3	9.2	9.2	6.0	18.6	2.3	13.3	4.4	3.5	2.5	3.4	5.6	3.4	3.6		7.7	0.0	8.1	0.0	12.9	4.9	2.6	5.6	3.5	0.0	147.6	8.2	2.8	2.8	8.5	1.2	6.8	1.5	0.5	19.7	3.9	5.9	0.3	11.9	0.5	9.5	0.0	1.6	0.6	0.0	1.9	0.6	0.0	0.4	3.3	0.0	0.0	0.0	0.0	4.0	2.6	0.2	2.6	0.2	0.3	0.6	5.3	7.3	1.5	2.6	2.0	10.1	0.0	4.9	5.1	0.0	0.6	0.1	8.5	0.6	0.0	0.2	0.0	23.0	34.8	5.8	0.0	0.2	1.7	0.1	1.7	1.3	6.8	0.0	0.0	0.0	0.6	0.2	7.2	0.0	0.2	0.3	7.5	1.4	0.1	0.4	0.1	2.5	0.4	0.3	1.2	1.3	18.1	2.7	0.8	1.3	0.0	0.1	0.4	5.3	1.4	1.7	1.4	0.0	0.0	2.7	0.0	56.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0											151.8	18.1	2.7	7.9	0.0	3.7	11.6	43.3	9.4	34.2	61.1	0.0	3.3	1.7	32.0	9.1	3.6	193.7	0.0	20.4	0.9	22.9	9.4	11.5	0.9	1.7	0.0	9.9	8.0	2.6	14.9	3.7	1.3	0.0	1.0	31.6	18.8	31.2	56.1	2.8	45.3	1.6	6.5	2.1	4.9	4.7	0.0	93.4	0.0	25.9	27.1
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279027-50288114	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 197.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.7;WM-115: 3.5"					"Low region specificity"	"Detected in many"			HPA079523			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA079523: "	"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.6	0.3	1.2	0.2	2.1	0.4	0.2	0.7	1.9	1.1	0.3	2.1	0.1	0.4	1.4	0.4	0.7	0.8	0.4	26.6	1.4	0.7	0.3	0.1	0.3	0.1	1.3	0.6	0.9	0.3	0.1	0.1	0.2	1.3	0.4	0.3	1.6	1.4	0.5	16.3	0.1	0.5	0.5	1.6	0.2	0.2	3.0	0.9	0.1	0.2	7.2	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.4	0.4	0.4	0.2	0.3	0.5	0.1	0.1	0.0	0.5	0.1	0.1	1.1	0.1	0.0	0.5	0.2	3.7	0.2	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.5	0.0	1.1	0.0	1.0	0.0	0.2	0.1	0.7	0.5	0.4	0.0	0.0	0.3	0.0	0.3	0.3	0.1	0.5	0.0	0.8	1.0	0.4	0.0	0.0	0.0	0.2	1.3	0.4	0.4	0.9	0.6	0.6	0.1	0.9	3.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	0.7	1.9	1.4	0.7	1.3	0.6	1.3	0.9	0.0	1.1	0.0	0.1	0.9	0.1	3.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	41.7	0.0	0.9	0.0	0.2	0.1	0.3	0.3	4.7	0.0	0.1	0.0	0.0	0.0	0.0	197.4	1.1	0.0	1.7	0.0	0.4	0.5	0.1	0.0	0.7	0.0	0.2	0.0	0.7	1.6	1.0	1.1	0.1	0.0	0.6	0.1
IFRD2	"IFNRP, SKMc15, SM15"	ENSG00000214706	"Interferon related developmental regulator 2"	Q12894	3	50287732-50292918	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA068560	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA068560: AB_2686005"	"prognostic favorable (7.22e-4)"	"unprognostic (5.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.78e-3)"	"prognostic favorable (2.50e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	11.0	10.0	5.2	10.8	7.7	6.9	15.4	9.0	6.6	7.9	13.7	6.4	21.2	10.7	6.9	7.7	11.8	8.0	17.0	23.9	4.9	4.5	11.1	41.1	8.4	6.5	7.8	3.5	9.8	34.7	10.2	7.6	6.7	7.1	15.6	8.3	8.0	23.7	22.3	39.2	7.8	12.0	8.5	4.9	9.4	18.4	9.9	6.9	7.4	15.8	24.3	8.5	7.8	7.5	17.5	17.8	3.9	16.9	18.5	25.2	15.2	22.8	23.6	6.5	20.5	6.7	7.8	15.1	17.6	9.6	21.7	15.4	19.4	23.5	15.7	13.0	12.1	18.6	13.4	13.6	28.2	11.2	14.9	27.3	22.6	31.2	22.8	13.3	22.9	14.3	7.2	24.3	22.6	28.4	7.2	18.3	14.1	14.3	12.9	12.7	21.5	14.9	26.9	16.4	28.5	46.0	9.8	9.5	35.7	12.9	13.8	11.6	11.2	11.1	30.8	11.1	6.6	14.6	22.0	13.2	18.1	22.8	31.2	35.5	9.1	15.5	13.4	14.4	30.1	26.4	3.9	12.5	1.7	17.9	16.9	25.2	17.5	18.9	17.1	17.8	17.3	20.2	18.3	1.1	18.5	9.3	17.5	14.9	15.2	5.2	7.7	9.0	6.6	4.9	4.5	7.8	3.5	7.1	6.9	17.9	27.7	30.0	43.2	59.8	16.6	1.6	33.1	2.7	15.9	19.2	19.6	29.0	24.9	47.3	66.9	24.8	23.6	0.0	77.7	36.7	26.6	71.8	7.0	44.0	28.7	17.5	15.0	9.8	9.4	95.0	12.7	14.5	33.7	19.0	24.8	13.0	62.8	21.0	13.4	43.7	11.7	0.0	48.6	17.2	16.2	60.0	25.4	20.8	46.4	75.9
HYAL3	"LUCA-3, LUCA14, Minna14"	ENSG00000186792	"Hyaluronoglucosaminidase 3"	O43820	3	50292831-50299468	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.9;bone marrow: 48.8;brain: 12.5;testis: 31.1"	"Group enriched"	"Detected in many"	16	"Early spermatids: 73.0;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.1;eosinophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Cell line enhanced"	"Detected in many"		"HEL: 22.4;HMC-1: 40.2;THP-1: 41.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049402	Uncertain				"Secreted to blood"	NA	NA					"HPA049402: AB_2680746"	"unprognostic (1.21e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.45e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.98e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.12e-5)"	3.5	4.2	6.3	3.1	8.8	48.8	3.3	11.4	12.5	4.2	3.6	3.8	6.1	3.8	2.7	5.1	5.6	3.7	5.4	3.4	6.4	5.6	2.9	7.0	3.2	4.2	5.3	5.6	4.3	3.7	2.6	3.1	3.6	11.1	4.9	2.9	3.7	6.7	5.6	3.9	3.0	4.1	4.6	3.4	2.8	6.6	31.1	2.7	3.0	3.3	5.1	3.7	4.8	3.8	1.1	4.2	26.9	2.1	1.0	2.2	1.2	2.2	2.6	1.5	1.7	3.1	1.6	0.9	2.5	2.2	3.2	2.4	3.5	2.4	2.0	1.2	2.9	4.9	2.5	2.7	5.9	1.2	4.6	1.4	22.4	6.8	2.8	2.2	2.4	40.2	3.3	4.5	3.2	2.1	2.3	3.2	2.2	1.7	2.5	1.5	1.3	0.9	14.2	1.1	2.6	6.6	1.0	2.0	3.6	3.8	1.0	1.8	2.1	3.6	2.9	2.0	1.8	1.9	41.3	4.3	2.7	1.9	8.6	1.4	1.2	2.5	1.5	2.4	8.6	2.2	12.1	2.1	26.9	0.7	1.1	1.2	0.9	2.2	1.0	4.2	1.1	0.6	0.8	0.7	1.0	0.7	1.1	1.3	1.2	6.3	8.8	11.4	12.5	6.4	5.6	5.3	5.6	11.1	2.7	3.0	1.4	0.0	2.2	2.7	1.5	0.3	0.0	1.4	4.5	3.5	3.9	2.5	8.3	4.5	73.0	3.4	0.3	0.0	0.6	4.1	1.8	2.3	6.9	1.0	2.0	4.8	4.1	7.4	1.8	206.1	1.7	2.8	3.3	9.0	1.2	1.5	3.1	0.0	2.5	1.9	0.4	6.5	3.1	4.3	3.8	3.1	2.5	1.3	1.6	3.0
NAT6	FUS2	ENSG00000243477	"N-acetyltransferase 6"	Q93015	3	50296402-50299421	"Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.3"	"Group enriched"	"Detected in many"	21	"Early spermatids: 179.7;Late spermatids: 391.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 29.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.0"	"Cell line enhanced"	"Detected in all"		"HMC-1: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039576	Approved					NA	NA					"HPA039576: AB_10794750"	"prognostic favorable (3.62e-4)"	"unprognostic (1.02e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.16e-2)"	"unprognostic (2.55e-1)"	7.9	6.9	9.3	7.7	17.5	30.6	8.6	15.4	24.8	9.6	7.0	8.8	12.9	6.8	10.7	11.1	9.7	10.6	11.6	10.9	11.5	9.9	8.9	8.8	9.8	10.1	8.8	12.1	13.4	8.8	14.5	8.8	6.3	22.3	10.6	8.7	8.5	13.2	12.6	12.0	15.5	7.9	7.6	8.9	9.9	10.0	59.3	6.7	7.2	8.8	11.1	10.4	8.0	9.3	6.1	2.8	29.0	2.3	5.3	6.1	2.8	4.0	3.1	4.8	5.0	5.8	6.8	3.1	3.9	7.8	6.2	5.3	2.7	7.8	12.6	2.9	6.7	5.0	5.2	2.9	12.7	2.6	8.0	5.0	25.2	18.0	6.3	5.2	4.2	32.3	8.1	9.0	10.3	7.2	9.4	7.4	7.0	2.3	12.0	5.5	4.3	4.9	19.3	2.6	1.8	10.6	3.2	1.7	15.1	10.5	2.1	3.4	4.8	4.4	9.2	1.8	3.2	4.0	12.3	6.0	5.0	5.0	6.0	3.7	8.2	4.3	3.1	8.6	7.9	4.6	6.7	1.6	29.0	4.2	2.3	6.1	6.1	5.7	5.0	2.8	4.3	4.6	3.7	0.5	5.3	1.4	1.4	5.1	2.8	9.3	17.5	15.4	24.8	11.5	9.9	8.8	12.1	22.3	6.7	6.0	5.1	2.2	7.5	3.0	5.0	0.0	0.0	5.3	3.4	0.0	3.9	4.7	0.0	0.0	179.7	7.1	3.0	0.0	0.0	4.3	4.1	5.5	12.7	4.7	4.1	0.0	8.7	8.6	4.0	391.0	7.8	2.6	5.0	0.0	2.4	3.7	0.0	3.5	8.5	0.0	2.7	12.9	5.7	13.6	10.2	3.4	4.2	7.2	3.3	8.1
HYAL1	"FUS2, HYAL-1, LUCA1, NAT6"	ENSG00000114378	"Hyaluronoglucosaminidase 1"	Q12794	3	50299889-50312381	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 105.8"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 116.0;Proximal tubular cells: 50.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Group enriched"	"Detected in some"	4	"Hep G2: 45.8;SK-BR-3: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		15000			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	4.9	6.3	1.0	0.9	1.3	0.0	8.4	0.9	1.4	2.9	1.8	1.7	1.3	1.2	3.5	3.5	5.8	1.9	19.3	18.2	1.1	0.5	25.0	105.8	11.3	2.5	1.2	0.9	1.9	3.1	8.0	0.8	1.3	2.9	1.4	1.0	3.1	3.6	1.2	5.2	5.8	1.4	2.7	1.2	28.0	7.2	1.7	0.8	0.2	3.1	4.2	1.0	1.3	4.3	1.2	1.1	7.3	0.9	0.7	1.5	0.2	1.3	0.8	0.1	0.4	0.2	0.3	0.2	0.0	0.1	0.0	0.2	5.2	1.4	0.0	0.4	0.2	0.3	3.1	0.1	0.2	0.0	0.0	0.0	0.1	3.9	45.8	2.1	0.3	0.3	1.9	6.6	0.0	0.2	0.4	1.3	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.3	3.3	0.2	0.0	0.1	0.1	2.7	0.1	0.1	1.0	0.0	13.3	0.1	1.2	1.0	0.1	0.9	0.3	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.3	0.1	2.2	0.9	2.9	0.7	0.3	1.5	0.9	0.7	1.0	0.4	1.2	1.5	0.8	7.3	0.7	0.7	1.1	0.9	0.2	1.0	1.3	0.9	1.4	1.1	0.5	1.2	0.9	2.9	0.8	17.9	14.4	0.0	0.2	2.6	1.1	19.5	17.8	1.4	0.0	10.4	3.9	0.0	19.9	13.8	7.3	16.5	0.7	0.0	13.2	0.0	1.0	0.2	0.0	116.0	0.1	0.0	1.7	30.1	4.0	6.7	2.0	0.9	0.0	0.0	0.8	0.2	7.9	0.0	1.1	50.7	0.5	6.5	2.3	0.0	1.0	2.8	0.6	0.0	0.2	1.6
HYAL2	"LuCa-2, LUCA2"	ENSG00000068001	"Hyaluronoglucosaminidase 2"	Q12891	3	50317790-50322906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.0"	"Group enriched"	"Detected in many"	4	"Endothelial cells: 160.0;Ito cells: 253.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"HUVEC TERT2: 68.6;TIME: 93.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036436	Uncertain					NA	NA					"HPA036436: AB_10670104"	"unprognostic (9.97e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-3)"	"unprognostic (3.44e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.93e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (7.36e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.62e-2)"	46.5	16.4	5.4	11.0	13.9	1.2	52.1	3.5	7.6	16.0	9.5	6.6	9.0	7.3	18.8	11.3	16.0	16.5	19.9	33.6	11.1	6.0	35.7	20.2	61.1	25.6	7.5	4.0	13.6	11.2	7.9	11.9	34.4	16.3	10.3	4.8	20.4	10.9	9.7	11.6	9.7	9.9	15.1	8.0	107.0	10.2	8.6	5.5	1.1	23.2	16.0	8.3	14.8	20.2	0.9	4.4	8.6	11.3	2.0	3.4	2.6	4.9	7.3	12.0	12.2	7.4	6.5	7.8	5.9	7.7	8.0	6.3	8.3	14.6	1.3	20.2	8.0	15.9	5.2	4.5	10.9	2.1	2.7	3.9	1.7	6.8	12.6	6.4	1.4	4.8	10.1	9.2	8.1	2.6	7.3	68.6	3.4	3.2	1.5	6.6	6.7	3.2	3.0	14.0	4.3	11.3	2.9	2.4	4.8	9.9	4.4	3.2	10.5	5.8	6.0	5.9	4.2	6.6	3.7	93.9	9.7	9.9	6.5	8.8	2.8	4.4	4.0	5.7	4.7	14.0	0.0	8.0	8.6	1.3	11.3	2.8	0.9	1.1	3.4	4.4	0.9	0.4	0.6	7.6	2.0	10.4	3.3	1.4	2.6	5.4	13.9	3.5	7.6	11.1	6.0	7.5	4.0	16.3	5.5	17.9	6.9	3.0	22.2	11.6	6.2	6.5	17.8	4.0	2.3	31.4	5.9	25.4	10.0	47.4	4.0	160.0	12.7	0.0	34.5	32.3	14.1	25.0	0.0	9.7	38.3	7.9	7.0	253.5	15.5	4.2	22.7	8.6	16.9	8.2	10.7	19.8	35.0	14.0	20.8	10.5	5.5	38.8	13.3	5.9	45.9	11.0	27.3	5.7	15.0	28.5
TUSC2	"C3orf11, FUS1, PAP, PDAP2"	ENSG00000114383	"Tumor suppressor candidate 2"	O75896	3	50320027-50328251	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 269.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030116			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA030116: AB_10602253"	"unprognostic (1.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (8.70e-7)"	"unprognostic (9.22e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-3)"	13.4	16.3	28.5	12.2	27.2	9.2	15.1	18.9	38.1	11.9	15.9	11.1	13.9	11.1	10.3	26.2	10.8	18.6	15.5	22.0	26.4	25.8	18.9	18.0	13.5	13.2	26.2	17.0	12.0	15.3	21.3	12.3	15.3	27.3	13.2	15.0	12.2	13.5	17.0	29.9	8.8	12.1	12.3	13.2	14.2	13.9	15.2	8.1	12.0	21.1	15.0	17.2	9.9	8.5	19.5	20.4	26.3	17.3	17.1	22.0	22.9	12.2	10.2	14.4	15.6	15.9	8.3	15.8	10.1	13.6	19.1	16.2	18.0	11.3	21.0	11.1	9.3	19.6	7.9	17.5	13.1	16.8	12.3	16.1	10.3	9.6	19.2	14.0	18.2	18.2	9.0	21.2	19.0	9.5	13.4	19.6	16.9	12.5	10.1	10.9	9.3	19.0	23.4	19.5	15.3	14.8	6.6	7.0	17.2	19.1	13.4	7.7	15.9	7.3	13.1	14.5	14.9	12.5	22.3	15.4	5.7	14.0	12.9	20.2	25.0	38.7	14.7	12.7	12.1	8.9	10.2	17.3	26.3	20.4	15.3	20.4	19.4	18.1	21.2	11.3	19.5	20.9	22.0	24.5	17.1	13.9	20.4	19.5	22.9	28.5	27.2	18.9	38.1	26.4	25.8	26.2	17.0	27.3	8.1	11.9	17.1	52.9	27.8	51.1	49.3	31.3	56.0	42.8	12.5	54.1	21.6	54.3	97.8	67.6	91.0	42.5	47.7	0.0	64.8	46.8	29.0	59.9	29.9	66.0	66.6	69.9	48.4	33.2	42.6	269.2	25.0	30.8	52.3	60.5	39.6	40.9	64.1	59.6	23.3	141.5	35.8	12.9	44.8	55.4	54.5	79.7	58.2	40.5	40.0	51.0
RASSF1	"123F2, NORE2A, RDA32, REH3P21"	ENSG00000068028	"Ras association domain family member 1"	Q9NS23	3	50329782-50340980	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 56.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040735	Approved					NA	Yes					"HPA040735: AB_10671692"	"unprognostic (5.02e-2)"	"prognostic favorable (2.64e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-3)"	"prognostic favorable (2.60e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (3.80e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (4.27e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.71e-2)"	21.5	9.9	8.5	21.3	13.0	50.3	23.3	12.4	13.8	17.9	17.1	12.3	15.7	11.2	15.7	13.7	13.6	13.4	25.2	17.7	10.4	7.5	12.2	10.6	25.9	24.5	17.6	8.6	14.7	23.2	5.2	10.3	18.4	12.9	13.5	8.7	15.0	23.7	12.8	18.8	17.8	17.2	16.0	12.5	32.3	13.3	24.6	12.9	9.7	13.6	15.2	21.4	19.7	16.9	12.7	6.9	56.8	15.1	16.7	23.1	10.0	14.2	5.9	4.4	7.3	10.2	14.0	6.5	24.6	16.3	21.2	17.0	13.5	10.8	6.9	3.8	26.3	9.5	7.7	9.3	10.2	11.5	17.1	6.0	23.8	18.4	7.0	11.8	23.3	26.3	10.7	7.3	20.9	7.5	6.2	9.4	8.6	9.9	16.2	9.5	5.0	8.8	31.4	5.9	12.0	17.8	7.3	4.6	15.9	6.2	4.2	5.2	9.6	21.9	14.8	16.4	4.7	8.9	23.0	8.9	14.7	11.0	20.8	12.1	6.6	4.3	15.0	8.2	29.2	26.2	56.8	6.6	21.2	23.1	11.1	14.5	12.7	7.5	16.3	6.9	9.7	4.8	11.4	5.1	16.7	15.1	5.2	7.5	10.0	8.5	13.0	12.4	13.8	10.4	7.5	17.6	8.6	12.9	12.9	14.9	7.2	27.0	30.7	65.6	12.0	9.5	10.2	5.3	13.6	1.8	13.7	23.5	5.0	21.6	1.7	46.0	9.2	0.0	22.9	22.0	28.3	20.6	56.5	4.2	32.7	3.2	16.0	26.4	22.3	7.2	17.5	21.8	86.0	16.2	14.1	7.8	29.1	14.4	13.8	6.3	9.1	25.8	58.7	31.7	9.3	43.8	13.8	61.7	12.0	18.2
ZMYND10	"BLU, CILD22"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50346852	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 55.7;testis: 99.4"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 293.1;Early spermatids: 194.4;Late spermatids: 324.6;Spermatocytes: 352.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 10.6;U-87 MG: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035255			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.1	0.1	1.9	0.2	4.8	0.3	0.6	0.3	0.8	1.6	0.1	5.5	0.2	0.2	0.9	4.6	0.2	55.7	0.3	0.1	2.6	3.1	0.5	0.2	4.7	0.2	0.2	0.3	4.2	0.2	1.4	1.6	0.1	10.2	0.1	0.1	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.5	0.2	0.1	99.4	1.2	0.1	0.8	0.1	0.1	0.1	0.0	0.4	1.1	0.8	0.7	3.8	2.5	0.5	2.7	1.0	0.4	0.8	1.0	1.6	0.8	0.4	1.8	3.0	0.9	0.2	1.4	1.0	1.1	1.7	0.3	0.6	2.4	0.1	0.3	1.1	1.1	2.5	3.6	0.1	0.1	0.7	1.2	0.1	0.3	3.8	0.2	2.7	0.2	2.2	0.6	0.6	0.5	1.4	0.5	3.4	0.0	0.4	1.1	1.1	0.1	0.8	3.7	0.1	2.9	1.2	0.3	0.8	0.2	0.1	10.6	0.9	0.0	0.8	0.8	1.8	0.2	1.4	0.6	0.3	7.4	3.4	0.2	0.3	0.4	0.3	2.5	0.4	1.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.8	3.8	0.7	0.4	0.1	0.5	1.9	4.8	0.3	0.8	2.6	3.1	0.2	0.3	10.2	1.2	3.0	6.1	0.0	0.3	0.5	1.2	0.8	0.0	293.1	29.6	1.8	3.9	0.1	0.0	0.7	194.4	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.0	0.5	0.5	0.0	0.0	1.3	0.0	324.6	8.3	0.2	1.7	0.0	0.4	1.0	0.1	0.0	5.3	0.7	5.7	0.0	0.4	352.7	8.5	0.4	0.1	0.7	0.2	0.1
NPRL2	"NPR2, NPR2L, TUSC4"	ENSG00000114388	"NPR2 like, GATOR1 complex subunit"	Q8WTW4	3	50347330-50351091	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038196, HPA038197"	Approved					NA	NA					"HPA038196: AB_10675631, HPA038197: AB_10671523"	"unprognostic (7.25e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.06e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.06e-2)"	7.4	14.6	14.9	8.7	14.9	7.5	11.5	20.9	18.2	14.7	12.5	8.8	12.8	7.6	9.7	16.3	10.1	14.4	11.3	13.8	12.0	15.2	14.0	18.6	9.0	9.8	15.1	14.4	13.4	30.9	16.6	15.8	8.4	13.5	13.2	12.4	7.4	16.0	13.6	18.3	9.3	8.9	11.7	10.2	11.7	11.1	11.9	16.5	10.5	13.1	9.1	11.6	10.4	8.9	11.1	9.2	20.2	8.9	23.6	29.7	19.6	7.0	6.9	3.6	7.8	13.8	7.8	4.6	2.9	10.0	10.7	10.9	4.5	5.9	7.0	5.6	6.7	5.6	3.4	9.4	11.6	7.4	5.6	7.2	7.1	6.1	9.7	12.7	9.8	11.1	8.1	11.4	12.8	9.5	6.4	10.3	10.9	5.4	7.1	9.1	1.1	10.4	5.5	4.8	21.6	17.9	4.1	3.1	19.6	12.3	6.1	3.1	7.8	3.2	6.4	7.4	4.3	10.3	5.8	3.3	4.3	4.7	7.4	6.4	10.3	12.8	5.7	8.4	11.5	3.9	13.6	7.7	20.2	29.7	7.9	26.4	11.1	16.9	25.6	9.2	9.6	13.7	21.2	9.6	23.6	8.9	6.8	19.4	19.6	14.9	14.9	20.9	18.2	12.0	15.2	15.1	14.4	13.5	16.5	8.9	14.0	12.6	9.5	10.6	17.2	12.7	12.7	8.1	7.9	14.0	19.6	22.7	31.5	14.0	77.7	11.2	16.8	23.3	13.0	18.3	11.8	5.8	18.5	11.5	13.1	23.8	11.3	10.4	12.4	50.6	17.8	8.4	11.8	16.2	17.1	14.3	12.0	11.5	14.2	23.7	24.8	6.5	15.5	11.9	14.0	10.9	7.6	27.4	16.5	5.9
CYB561D2	"101F6, TSP10"	ENSG00000114395	"Cytochrome b561 family member D2"	O14569	3	50350695-50358460	"Predicted membrane proteins"	"Electron transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA071862	Approved					NA	NA					"HPA071862: "	"unprognostic (4.89e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.41e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (3.26e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.57e-2)"	8.7	16.6	9.8	11.9	11.6	14.8	12.0	10.9	12.2	8.5	14.6	11.5	12.8	16.4	6.3	20.5	11.1	7.8	16.0	7.6	8.8	6.9	15.2	42.2	11.2	16.6	12.2	10.0	5.9	27.3	13.6	14.8	12.2	8.0	12.6	13.9	8.9	15.2	18.2	7.1	6.9	19.0	6.2	11.5	19.7	16.4	7.4	12.4	12.3	16.1	6.5	11.2	9.7	6.9	29.9	31.0	58.3	46.9	34.4	53.2	33.8	7.4	16.6	4.2	7.9	8.9	7.7	9.9	13.4	10.0	12.4	14.2	11.6	12.3	11.9	14.2	16.7	15.3	8.1	6.2	12.4	5.4	17.9	15.5	11.0	19.5	10.5	12.8	12.1	25.9	11.6	5.6	14.9	7.1	6.4	10.3	9.4	4.8	15.8	9.8	14.2	7.7	10.9	6.7	11.9	26.2	5.5	2.9	23.7	12.9	12.8	4.2	11.8	6.6	27.3	8.2	4.6	9.7	14.4	11.1	11.2	9.6	18.7	16.5	12.1	11.3	7.6	15.5	15.2	12.0	42.4	41.1	58.3	53.2	46.9	34.8	29.9	36.1	42.0	30.0	27.4	25.6	38.0	39.0	34.4	44.1	31.0	37.1	33.8	9.8	11.6	10.9	12.2	8.8	6.9	12.2	10.0	8.0	12.4	6.0	23.7	4.5	12.5	4.4	5.8	0.0	0.0	9.4	5.7	24.4	5.9	30.2	10.0	36.4	10.5	4.1	40.7	0.0	59.2	35.9	11.9	18.5	20.8	0.0	51.2	7.9	30.5	0.0	0.0	5.2	8.1	24.4	18.6	37.9	39.9	23.0	38.7	49.1	7.4	20.3	5.2	12.9	4.1	5.0	13.0	6.5	46.1	13.1	23.6	13.9
Z84492.2		ENSG00000272104			3	50350892-50367923	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 10.3;Karpas-707: 12.0"															NA	NA										"unprognostic (2.51e-1)"							"unprognostic (9.06e-2)"						3.3	3.3	4.1	4.7	4.2	2.2	4.4	3.9	4.7	2.7	6.0	4.2	4.8	9.0	3.8	8.9	2.6	4.3	6.2	2.7	4.1	3.9	5.2	18.2	3.3	7.2	4.5	3.5	5.1	11.4	4.1	10.3	4.5	2.5	5.4	2.3	3.0	7.4	7.2	2.9	6.7	9.3	1.7	3.9	5.0	7.3	2.3	4.6	4.5	5.6	1.9	4.0	2.6	2.7	8.7	1.9	4.8	1.0	9.9	14.2	3.8	3.2	2.0	0.0	1.4	1.5	0.0	0.6	4.7	1.6	0.4	1.8	0.0	2.2	1.5	6.6	0.0	0.3	1.8	0.0	1.0	1.2	3.5	0.6	3.1	2.5	0.0	0.8	0.0	10.3	0.0	1.1	0.8	0.0	0.3	0.4	3.7	0.4	12.0	0.0	0.7	4.8	0.0	1.0	2.8	0.0	1.1	0.5	5.0	0.3	0.0	2.0	4.9	0.0	6.1	0.4	0.7	2.0	0.0	3.2	0.5	1.1	0.0	5.0	5.0	6.9	3.5	0.0	0.8	0.0	4.8	0.1	4.2	7.5	0.4	9.3	8.7	11.4	9.9	0.1	8.7	14.2	9.7	0.8	9.9	1.0	1.9	13.9	3.8	4.1	4.2	3.9	4.7	4.1	3.9	4.5	3.5	2.5	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM115	PL6	ENSG00000126062	"Transmembrane protein 115"	Q12893	3	50354749-50359610	"Plasma proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006319, HPA015497"	Supported		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB006319: AB_425880, HPA015497: AB_1858076"	"unprognostic (1.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.00e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.04e-7)"	"unprognostic (4.88e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	20.8	23.8	15.1	11.3	15.2	10.1	19.7	19.4	24.3	20.2	23.5	18.7	21.5	23.1	24.5	21.3	20.6	21.3	23.9	19.8	12.5	12.8	22.4	24.1	18.5	15.7	13.6	13.3	24.9	24.0	25.7	14.8	37.3	16.2	22.4	13.0	22.4	26.3	22.5	18.2	28.1	25.5	17.3	10.6	17.6	20.7	18.6	11.8	20.4	42.2	16.9	15.9	19.0	17.3	13.2	17.2	28.4	18.4	17.2	18.3	14.5	11.0	13.6	8.8	14.5	25.3	20.3	11.5	17.2	25.6	21.9	16.8	10.1	13.0	5.4	14.5	22.4	20.2	11.9	10.6	13.9	6.2	9.9	18.4	8.1	12.2	13.6	35.6	8.8	11.9	30.4	18.1	18.0	13.2	19.0	16.6	6.7	8.7	9.4	16.3	10.2	6.1	14.0	15.8	7.3	21.5	3.0	7.1	11.9	16.5	10.4	9.9	21.3	10.4	11.7	14.2	8.1	9.6	9.4	17.2	19.9	10.1	20.9	18.0	14.0	8.0	3.0	18.3	9.8	13.1	28.4	18.4	25.6	18.3	16.5	12.1	12.6	12.3	14.8	15.3	13.2	13.6	13.0	25.3	17.2	14.8	17.2	15.3	14.5	15.1	15.2	19.4	24.3	12.5	12.8	13.6	13.3	16.2	11.8	14.9	11.3	10.2	17.3	26.9	16.9	6.3	17.8	5.3	7.9	10.4	5.9	51.7	3.3	36.7	0.7	18.0	33.8	0.0	23.2	34.3	33.2	28.1	11.5	15.7	31.6	17.5	15.1	19.0	9.2	1.1	27.0	13.8	10.1	25.2	23.7	23.9	28.4	28.6	23.7	21.9	12.0	25.8	19.8	18.6	7.6	30.6	77.6	13.8	23.3	23.0
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362799-50504244	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 86.1"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 71.5;Alveolar cells type 2: 145.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		1000000	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.9	1.6	1.3	11.1	1.1	1.4	14.9	6.5	1.1	1.7	0.9	0.6	1.4	1.7	1.2	0.9	1.1	0.9	7.6	1.7	9.1	1.6	0.5	86.1	1.3	3.9	3.2	2.2	4.0	3.8	6.0	1.9	6.1	3.0	2.0	6.1	1.5	1.4	1.7	2.6	1.7	1.4	1.4	1.5	4.1	5.8	2.5	0.2	2.3	0.1	0.7	0.7	0.7	1.8	0.3	0.7	0.1	2.3	3.6	1.1	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	8.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.4	66.5	0.2	0.1	0.0	2.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.2	0.0	2.7	1.8	2.6	2.0	0.0	1.3	3.6	2.2	0.0	2.3	0.1	0.3	3.2	1.1	1.6	11.1	14.9	6.5	1.7	9.1	3.9	3.2	6.1	2.5	71.5	145.9	0.0	0.3	1.3	7.2	3.0	0.0	4.0	4.5	1.8	19.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.7	19.7	0.0	0.1	0.0	1.2	0.6	0.0	2.3	0.3	0.0	0.0	0.0	3.5	4.0	0.6	0.0	1.8	0.4	10.0	12.9	0.8	1.6	11.1	0.5	0.2	1.0	0.4	0.3
C3orf18	G20	ENSG00000088543	"Chromosome 3 open reading frame 18"	Q9UK00	3	50558025-50571027	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 26.3;Early spermatids: 47.6;Late spermatids: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;NK-cells: 2.1;T-cells: 7.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.8"	"Group enriched"	"Detected in many"	4	"cerebellum: 31.6;olfactory region: 33.8"	"Low region specificity"	"Detected in all"			HPA012105	Approved		Approved	Cytosol		No	No			Cytosol		"HPA012105: AB_1845717"	"unprognostic (9.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (2.80e-9)"	"unprognostic (7.65e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.59e-1)"	5.1	6.7	10.0	3.4	12.3	1.2	6.2	34.5	20.1	6.0	6.1	8.0	2.2	2.2	8.0	5.1	5.0	8.4	6.0	25.3	8.1	9.7	6.0	3.0	4.1	3.9	11.4	9.3	14.0	6.1	19.2	7.4	2.6	10.3	8.5	3.2	11.9	7.3	11.0	32.4	2.8	2.9	10.4	6.9	4.1	5.2	9.8	6.1	1.8	6.9	7.2	4.0	6.8	4.9	2.9	0.9	0.8	0.5	2.1	7.7	3.0	1.1	1.7	1.9	0.4	6.6	5.9	0.6	6.9	10.8	6.3	4.6	0.1	1.7	1.4	1.7	9.4	6.0	0.1	0.0	2.7	3.3	29.8	0.2	2.8	3.9	0.5	3.3	0.0	3.8	5.8	0.4	6.1	0.3	5.1	1.2	4.5	0.6	1.3	3.7	0.2	0.2	0.9	2.4	1.2	7.7	0.6	0.2	1.6	0.3	0.2	2.2	10.3	1.8	0.4	0.1	2.3	2.1	0.8	0.3	6.4	5.0	11.5	0.8	1.8	1.5	0.2	9.1	3.1	0.1	0.0	0.5	0.8	6.3	0.2	7.7	2.9	5.5	6.0	0.5	1.8	6.4	7.7	0.0	2.1	0.1	0.9	2.5	3.0	10.0	12.3	34.5	20.1	8.1	9.7	11.4	9.3	10.3	6.1	0.0	0.6	0.0	1.5	1.0	9.2	26.3	0.0	1.4	2.3	1.8	7.9	0.4	3.3	1.8	47.6	1.6	0.0	0.0	1.6	0.5	4.1	0.6	0.0	1.7	1.4	1.6	1.7	2.5	0.3	47.3	4.4	0.4	0.0	15.4	0.3	8.9	0.7	0.0	3.9	1.8	15.9	12.9	3.0	2.8	1.7	0.4	0.1	2.2	0.1	0.1
HEMK1	MTQ1	ENSG00000114735	"HemK methyltransferase family member 1"	Q9Y5R4	3	50569152-50596168	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 124.5;Late spermatids: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034701, HPA034702"	Uncertain					NA	NA					"HPA034701: AB_10601429, HPA034702: AB_10673101"	"unprognostic (1.27e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.95e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.44e-3)"	8.8	15.1	8.8	10.8	13.3	7.6	12.9	4.9	11.2	13.0	13.6	15.1	33.3	11.7	17.9	12.6	12.4	15.3	12.8	11.9	10.5	8.2	15.9	21.8	11.1	13.5	13.1	13.3	19.7	24.3	20.2	19.2	14.1	12.5	18.7	11.4	14.9	27.1	14.7	7.8	8.9	11.9	19.4	12.8	15.5	13.8	19.5	14.1	18.3	21.1	4.2	14.9	12.6	15.6	16.5	17.4	12.1	10.1	13.0	15.7	10.8	7.1	4.2	6.9	6.2	15.3	11.8	9.9	8.9	6.8	7.9	9.9	3.6	11.7	6.9	6.7	11.8	9.1	8.5	5.2	19.4	3.6	35.5	3.9	8.3	8.3	5.0	12.5	8.3	5.7	9.8	15.0	9.0	11.7	14.2	9.5	13.7	7.3	7.3	7.7	6.3	13.7	8.8	2.8	8.0	12.1	4.9	3.4	13.5	9.5	8.6	2.4	7.8	3.2	9.2	9.6	9.9	7.9	12.3	4.6	9.1	8.1	7.4	10.1	6.5	3.3	3.7	13.2	11.0	5.0	12.1	10.1	9.1	15.7	6.8	13.9	16.5	12.7	13.2	13.6	13.6	14.0	14.7	1.7	13.0	4.3	17.4	8.1	10.8	8.8	13.3	4.9	11.2	10.5	8.2	13.1	13.3	12.5	14.1	11.9	12.0	6.9	11.3	3.9	12.5	12.9	7.6	24.1	14.8	7.0	0.0	21.9	10.0	11.7	124.5	5.6	11.2	0.0	7.1	15.0	8.9	10.0	16.2	13.9	17.1	6.4	0.0	16.5	6.4	104.6	10.6	10.6	8.5	20.8	19.6	12.4	8.8	10.5	7.8	16.6	20.2	19.4	5.3	24.7	5.5	3.0	11.4	9.6	16.4	9.7
CISH	"CIS, CIS-1, G18, SOCS"	ENSG00000114737	"Cytokine inducible SH2 containing protein"	Q9NSE2	3	50606490-50611831	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 49.7;Proximal tubular cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 82.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB034039, HPA040812"	Approved		Approved	"Microtubules,Cytokinetic bridge"		Yes	No			Microtubules	"Cytokinetic bridge"	"CAB034039: AB_2080282, HPA040812: AB_2677148"	"unprognostic (2.36e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.89e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (8.54e-2)"	"unprognostic (9.38e-2)"	"prognostic favorable (6.98e-4)"	"unprognostic (6.97e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (2.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	11.8	2.8	0.8	9.7	1.9	3.7	38.0	0.6	1.1	5.2	7.5	0.7	15.6	5.9	6.8	5.9	7.4	4.5	6.4	20.8	1.3	1.0	26.1	36.2	20.5	6.4	1.2	0.2	10.6	11.3	1.9	8.6	47.6	3.8	5.6	5.3	2.8	18.4	19.6	54.0	7.0	6.3	2.8	3.5	7.6	5.5	2.5	1.4	13.8	31.3	7.1	7.0	5.9	5.4	0.4	2.8	7.3	4.0	0.8	23.3	8.1	0.6	0.2	0.7	1.5	0.1	0.9	0.6	0.1	0.1	0.1	0.1	0.6	0.1	0.0	0.5	0.2	0.3	0.7	1.2	1.0	0.0	82.0	0.2	4.9	0.4	0.6	0.5	0.6	6.0	3.9	0.4	0.1	0.3	0.0	0.1	0.5	19.3	0.1	0.1	3.7	1.0	4.4	0.7	2.2	0.7	0.4	0.3	5.0	1.6	0.7	0.4	1.2	0.2	10.0	0.1	0.2	5.6	4.0	0.1	0.2	0.6	0.7	0.3	0.1	0.1	0.0	0.1	5.9	0.1	7.3	4.0	5.3	14.3	2.4	22.2	0.4	23.3	17.8	2.8	0.1	18.3	17.5	3.5	0.8	1.5	1.8	13.9	8.1	0.8	1.9	0.6	1.1	1.3	1.0	1.2	0.2	3.8	1.4	3.0	29.7	0.0	7.1	7.1	0.5	10.9	0.0	1.4	11.4	17.4	0.0	7.6	49.7	10.0	0.8	3.0	5.8	0.0	14.1	3.8	6.1	2.7	1.1	6.0	11.2	0.0	2.4	2.5	13.2	0.2	7.8	18.8	1.7	23.4	8.4	0.0	10.1	7.0	3.5	40.0	0.1	12.9	5.1	0.5	1.4	7.9	13.3	20.1	12.3	4.2
MAPKAPK3	"3pK, MAPKAP3"	ENSG00000114738	"Mitogen-activated protein kinase-activated protein kinase 3"	Q16644	3	50611520-50649297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 86.7;skeletal muscle: 70.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 193.9;Hofbauer cells: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058275: AB_2683663"	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	8.9	16.1	5.6	9.3	7.2	30.4	6.3	1.9	6.2	5.5	9.5	7.1	7.5	9.9	5.5	8.6	16.8	5.1	8.5	86.7	4.8	3.7	17.9	11.9	11.0	15.1	7.2	4.1	8.7	24.2	11.2	9.0	9.0	6.0	7.6	6.7	10.9	12.4	9.2	70.1	17.6	12.0	5.2	5.9	12.5	9.0	4.0	5.2	25.9	22.6	40.9	14.3	6.1	7.5	3.0	27.1	23.0	61.4	7.3	6.4	19.5	23.4	7.3	3.0	8.6	4.6	11.7	6.9	5.7	8.2	8.8	7.5	11.3	21.9	9.4	5.8	19.1	21.9	8.4	20.9	22.5	7.9	20.8	5.0	49.5	10.3	10.2	9.3	35.6	26.4	9.3	14.0	20.5	28.0	8.8	7.8	16.8	13.9	6.2	18.5	9.5	15.1	35.9	11.4	8.2	30.0	6.7	7.3	14.2	41.0	13.5	5.7	4.0	5.1	14.5	6.5	5.3	9.1	22.1	5.6	7.0	16.0	36.0	14.1	4.2	7.7	7.8	37.0	56.1	2.8	6.4	30.2	23.0	5.5	50.0	5.4	3.0	6.2	6.4	27.1	1.8	4.9	5.5	20.5	7.3	61.4	16.9	5.2	19.5	5.6	7.2	1.9	6.2	4.8	3.7	7.2	4.1	6.0	5.2	8.9	9.4	7.5	19.5	10.1	0.9	193.9	10.2	6.7	6.8	10.4	0.0	5.0	54.7	35.3	28.4	6.7	23.1	0.0	26.4	5.7	11.0	21.5	35.7	10.9	91.5	0.0	5.8	4.9	48.9	60.2	6.6	40.9	6.8	46.9	13.9	10.8	54.8	8.6	3.2	28.5	2.3	25.8	11.7	3.4	4.3	17.7	4.2	18.7	27.9	30.1
DOCK3	"KIAA0299, MOCA, PBP"	ENSG00000088538	"Dedicator of cytokinesis 3"	Q8IZD9	3	50675241-51384198	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 20.8;Early spermatids: 10.4;Horizontal cells: 31.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.6;GAMG: 7.5;HMC-1: 6.1;JURKAT: 7.2;U-87 MG: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037543, HPA037544"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			Cytosol		"HPA037543: AB_10672495, HPA037544: AB_10670383"	"unprognostic (1.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-3)"	"unprognostic (6.35e-8)"	"unprognostic (2.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.83e-5)"	"unprognostic (7.96e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.24e-1)"	1.6	5.5	15.3	1.7	19.8	1.6	1.7	24.2	38.9	1.7	2.3	11.6	1.9	1.7	2.1	2.7	4.2	2.2	1.9	4.6	11.5	9.8	1.9	1.3	1.8	1.8	9.1	17.6	1.7	2.0	15.8	9.2	1.5	13.1	3.8	1.9	1.8	3.2	5.0	4.3	4.0	1.7	3.1	8.5	1.8	1.7	9.0	10.7	0.0	17.4	0.0	1.9	2.0	0.7	0.7	0.7	0.2	2.0	0.6	1.3	0.0	0.1	0.2	0.2	7.6	0.0	0.0	3.3	0.1	0.2	0.4	0.3	0.2	0.5	0.0	0.6	2.4	7.5	0.5	5.1	0.0	0.1	4.3	5.3	0.1	1.3	0.1	0.1	0.2	6.1	0.1	0.1	0.2	0.0	0.4	0.0	7.2	0.0	0.1	0.6	0.2	0.0	0.0	2.5	0.3	2.4	0.0	0.7	0.0	0.4	0.7	4.7	0.0	0.3	4.3	0.1	5.5	0.1	0.0	0.5	0.2	2.1	0.2	2.7	0.3	0.0	0.0	10.1	1.0	0.1	0.0	0.1	0.2	0.5	0.4	0.5	0.4	0.4	0.2	0.1	0.7	1.3	0.5	0.2	0.6	2.0	0.7	0.1	0.0	15.3	19.8	24.2	25.3	11.5	9.8	9.1	17.6	13.1	10.7	0.0	1.1	0.0	0.1	0.0	20.8	6.7	0.0	0.0	1.2	0.0	2.0	0.0	1.7	0.0	10.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	31.8	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	4.9	0.0	1.4	3.5	2.9	0.1	0.0	0.0	0.0	0.0
MANF	"ARMET, ARP"	ENSG00000145050	"Mesencephalic astrocyte derived neurotrophic factor"		3	51385047-51389397	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 383.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011175	Approved		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA			"Endoplasmic reticulum"		"HPA011175: AB_1845039"	"unprognostic (2.90e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (9.58e-6)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.10e-2)"	13.2	14.6	11.6	18.9	16.8	8.3	19.8	6.7	12.4	20.7	16.1	5.2	47.4	11.6	15.1	52.8	19.9	14.0	16.1	23.4	9.7	9.8	22.2	65.6	16.9	15.9	12.9	5.7	11.5	64.2	6.5	23.4	23.3	20.9	16.1	16.8	5.1	64.7	37.9	7.8	13.1	11.9	14.3	8.8	21.7	16.4	14.3	12.5	12.7	64.4	20.7	21.4	14.0	37.2	5.4	32.7	19.2	4.8	7.4	11.2	4.9	18.5	9.3	24.9	30.7	17.2	22.4	26.6	29.9	24.7	30.5	29.3	14.4	43.5	40.7	25.0	18.5	70.4	11.1	30.9	30.8	29.8	18.7	15.6	32.7	14.0	33.1	56.3	15.6	21.0	9.6	26.0	31.6	42.5	29.4	39.3	16.9	7.0	44.6	28.2	11.3	25.9	31.2	21.6	44.2	40.4	11.2	16.0	41.8	25.6	12.4	9.4	30.4	25.1	15.1	18.1	28.6	12.1	21.0	18.4	17.3	17.0	21.0	32.8	36.2	14.7	26.3	30.3	31.2	33.5	19.2	4.8	2.7	8.9	3.8	11.2	5.4	6.5	8.5	4.7	3.5	4.9	5.1	2.4	7.4	2.4	32.7	3.9	4.9	11.6	16.8	6.7	12.4	9.7	9.8	12.9	5.7	20.9	12.5	29.8	19.2	79.0	180.0	144.9	12.1	43.7	68.8	24.1	18.2	52.4	5.9	166.0	36.5	141.5	75.3	67.4	57.1	0.0	109.7	259.3	107.8	169.1	63.3	130.9	163.5	11.1	111.7	81.0	38.0	80.4	55.5	75.0	172.1	98.2	64.3	32.2	172.7	66.6	48.4	54.7	15.7	64.7	82.0	145.8	74.5	140.4	383.9	60.7	57.1	181.4
RBM15B	"HUMAGCGB, OTT3"	ENSG00000259956	"RNA binding motif protein 15B"	Q8NDT2	3	51391268-51397908	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036645, HPA058136"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036645: AB_10671965, HPA058136: AB_2683618"	"unprognostic (2.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.84e-1)"	8.6	3.8	4.9	5.6	6.3	5.2	7.1	4.4	9.0	8.0	7.5	6.1	6.3	5.9	7.4	6.5	8.4	7.2	10.1	5.6	5.2		4.8	9.4	6.7	11.6	4.9	4.1	9.3	9.8	9.2	3.3	7.3	4.1	8.3	7.1	5.1	7.2	7.0	4.9	9.9	9.3	7.4	2.2	7.8	6.4	9.1	4.1	23.0	8.2	5.4	7.3	6.8	9.3	4.5	4.9	1.5	5.7	3.4	5.0	3.1	10.9	9.8	22.9	23.8	20.7	16.2	14.0	10.2	19.1	16.4	13.6	12.1	8.0	15.9	8.5	18.4	18.1	10.2	13.1	18.4	7.9	12.7	10.2	13.7	15.3	10.3	12.1	17.8	7.8	17.6	22.9	15.0	17.9	17.9	16.9	26.2	10.2	10.8	14.0	11.7	31.0	11.3	18.2	10.1	15.4	11.1	10.1	13.5	14.6	26.6	14.9	21.4	13.2	17.6	11.7	15.9	13.9	21.2	15.2	16.8	14.7	14.1	19.2	16.0	14.4	17.7	13.7	14.4	17.8	0.0	4.1	1.5	4.0	5.7	4.4	2.4	5.0	4.2	4.5	4.5	5.0	3.1	0.8	3.4	5.3	4.9	2.3	3.1											3.0	4.8	10.7	31.2	22.6	18.0	15.1	5.1	8.1	7.9	14.0	9.8	13.5	10.0	18.2	18.6	17.5	15.0	23.3	19.7	17.7	12.1	26.3	4.7	18.3	15.9	14.3	12.1	12.3	26.2	8.6	14.7	10.5	6.8	4.6	19.4	12.3	25.8	8.6	14.2	14.3	12.9	25.8	18.7	11.4	6.4	24.6	16.5	11.7	20.8	29.3
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 8.8;Ciliated cells: 9.4;Club cells: 12.5;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	13.3	12.5	11.5	16.3	12.3	12.9	12.2	17.9	12.5	9.6	10.3	11.0	12.5	7.6	13.1	10.1	11.3	9.2	8.4	8.8	9.6	6.8	11.0	11.1	10.9	13.0	11.1	9.1	11.9	11.1	24.8	12.9	15.4	10.3	10.1	10.9	8.6	12.5	11.8	28.1	14.1	11.8	10.4	9.1	11.9	10.7	50.7	10.9	18.5	14.2	7.6	16.7	12.5	16.5	7.3	6.4	3.3	6.0	7.3	10.7	6.2	10.8	13.4	13.0	11.8	11.8	9.4	12.4	12.2	9.2	13.2	13.0	14.6	10.6	26.5	6.8	9.6	20.3	9.6	24.5	10.9	17.2	18.4	12.1	22.7	18.3	12.5	8.6	29.5	16.5	6.2	12.7	17.1	12.5	8.7	10.2	14.7	13.2	17.3	10.3	11.1	22.5	12.0	13.7	13.0	14.7	9.6	14.0	17.5	10.3	17.0	6.8	12.1	13.5	12.5	7.4	10.0	8.5	12.6	12.8	10.9	14.6	17.9	18.7	11.8	15.9	27.3	12.7	20.3	8.9	3.2	4.0	3.3	9.4	4.5	10.7	7.1	8.1	8.0	6.4	7.3	8.9	7.3	1.0	7.3	6.0	5.2	8.7	6.2	11.5	12.3	17.9	12.5	9.6	6.8	11.1	9.1	10.3	10.9	3.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	9.4	12.5	3.5	0.0	6.6	1.7	5.9	0.0	0.0	0.0	0.0	5.8	4.8	0.0	0.0	5.8	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	4.6	0.0	0.0	6.5	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.4	4.1	3.3	3.5	4.3	5.2	4.1	7.8	4.3	3.6	4.4			2.2	5.3	4.6	3.6	3.9	2.5	3.1	3.4	3.5	3.4	8.8	4.2	3.8	3.4		5.6	5.0	5.3	3.9	4.9		3.8	3.5		3.7	4.2	7.3	4.6	4.1	4.3	4.1	4.7	4.4	4.7			4.2		5.2	3.8	3.5	6.9	5.2	6.5	7.1	6.3	8.3	4.0	5.6	4.4	11.4	11.2	6.4	4.6	6.0	4.8	6.8	6.6	6.3	7.8	3.3	14.8	1.4	8.4	6.9	4.4	17.9	6.0	8.2	7.8	4.0	12.7	9.5	5.1	5.8	14.1	7.6	5.2	4.8	10.1	9.8	4.2	7.3	12.9	8.3	8.1	5.2	4.3	12.6	6.4	9.0	2.8	4.8	5.8	8.8	2.0	3.3	7.3	4.7	8.9	7.6	7.3	4.9	7.2	4.7	8.5	9.5	7.0	8.0	7.1	9.3	8.7	8.8	15.0	7.5	8.0	8.8	6.5	4.8	4.7	8.1	6.0	8.3	4.3	7.1	6.6	5.2	6.9	4.7	5.4	2.2	6.3	7.1	5.2	6.3	4.0											8.9	11.8	9.0	6.6	8.1	33.3	9.7	10.2	10.7	7.9	8.7	29.5	13.5	1.7	8.3	6.1	11.1	4.2	0.0	9.0	7.3	8.0	8.9	17.4	20.7	7.7	44.5	15.6	11.1	11.4	1.9	14.1	6.8	13.5	4.6	6.8	10.4	10.2	6.2	15.9	3.4	31.5	12.9	9.2	37.2	39.4	7.9	24.8	9.6	7.0	9.8
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.8	21.8	3.9	20.1	40.7	19.8	8.0	10.2	24.2	17.0	17.2	11.6	28.2	17.1	7.5	14.6	28.8	11.6	11.0	20.6	8.3	13.7	17.6	16.3	13.6	15.4	36.3	10.2	18.3	26.1	32.9	19.2	19.7	15.5	12.4	13.0	8.5	29.9	17.5	13.7	16.3	23.8	4.3	19.6	24.5	7.9	5.2	32.2	26.8	16.5	5.6	9.2	12.5	34.5	15.7	5.6	16.8	21.7	9.1	17.2	7.2	18.0	13.5	20.9	22.5	8.4	21.0	21.6	17.1	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5	32.8	15.0	27.5	46.0	30.9	30.1	22.8	53.5	25.4	28.4	94.2	55.0	125.5	53.0	63.6	30.2	49.7	69.9	0.0	67.2	73.8	45.6	36.2	16.1	51.7	92.2	39.7	31.6	28.3	36.7	48.4	47.2	49.0	62.4	55.9	51.0	59.8	56.9	65.4	46.0	101.0	46.9	25.8	20.0	310.0	58.8	30.9	63.8	52.4	81.7	32.5
GRM2	"GPRC1B, mGlu2, MGLUR2"	ENSG00000164082	"Glutamate metabotropic receptor 2"	Q14416	3	51707070-51718613	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 13.2"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 5.9;Rod photoreceptor cells: 1.6;Spermatocytes: 3.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027868, HPA065166"	Approved	Supported				NA	NA					"HPA027868: , HPA065166: AB_2685425"	"unprognostic (1.01e-1)"	"unprognostic (8.61e-4)"	"unprognostic (7.66e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.19e-2)"	0.8	0.6	4.6	0.8	6.3	1.6	0.7	3.8	13.2	0.6	0.6	0.4	0.0	0.6	0.8	0.4	0.5	0.5	0.4	0.9	3.0	3.1	0.5	0.5	0.6	0.7	1.2	7.0	0.5	0.4	0.4	0.4	0.6	8.3	0.7	0.5	0.6	0.8	0.6	1.8	1.3	0.5	0.6	0.5	1.1	0.5	1.3	0.2	0.0	0.5	0.0	0.5	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	6.3	3.8	13.2	3.0	3.1	1.2	7.0	8.3	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	1.6	0.0	0.0	3.7	0.9	0.3	0.0	0.0	0.0	0.0
IQCF6		ENSG00000214686	"IQ motif containing F6"	A8MYZ5	3	51778561-51779241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 19.2"	"Group enriched"	"Detected in some"	202	"Early spermatids: 334.6;Late spermatids: 125.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 2.7;U-937: 6.0"	"Not detected"	"Not detected"													NA	NA																		"unprognostic (4.98e-4)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	334.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	125.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0
IQCF3		ENSG00000229972	"IQ motif containing F3"	P0C7M6	3	51817604-51830856	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"testis: 71.2"	"Group enriched"	"Detected in some"	141	"Early spermatids: 1497.4;Late spermatids: 4174.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;U-2 OS: 2.2;U-698: 1.0;U-937: 4.6"															NA	NA																				"unprognostic (2.83e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.2	0.1	0.2	0.7	0.0	1.0	0.0	4.6	0.1	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1497.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4174.7	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	12.9	0.0	18.9	8.5	0.0	0.0	0.0	0.0	0.0
IQCF2		ENSG00000184345	"IQ motif containing F2"	Q8IXL9	3	51861629-51863424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	43	"testis: 22.3"	"Group enriched"	"Detected in some"	168	"Early spermatids: 1079.4;Late spermatids: 1957.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.5;U-2197: 1.1"					"Low region specificity"	"Detected in many"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1079.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1957.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	9.0	4.3	0.0	0.0	0.0	0.0	0.0
IQCF5		ENSG00000214681	"IQ motif containing F5"	A8MTL0	3	51873721-51875584	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	92	"testis: 41.2"	"Group enriched"	"Detected in some"	68	"Early spermatids: 751.7;Late spermatids: 1880.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.1;U-2 OS: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA																				"unprognostic (3.45e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	751.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1880.8	11.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	19.4	0.0	11.9	5.3	0.0	0.0	0.0	0.0	0.0
IQCF1	MGC39725	ENSG00000173389	"IQ motif containing F1"	Q8N6M8	3	51894876-51903335	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	228	"testis: 47.4"	"Group enriched"	"Detected in some"	151	"Early spermatids: 1159.2;Late spermatids: 2587.3"	"Cancer enriched"	"Detected in single"	30	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 1.4;PC-3: 3.1;U-2 OS: 1.0"					"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (1.47e-1)"						"unprognostic (1.67e-1)"			"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1159.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2587.3	9.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.0	0.0	0.0	0.0	11.2	5.1	0.0	0.0	0.0	0.0	0.0
RRP9	"RNU3IP2, U3-55K"	ENSG00000114767	"Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein"	O43818	3	51933430-51941941	"Predicted intracellular proteins"	"rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038798	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038798: AB_10672653"	"unprognostic (5.57e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.92e-2)"	18.6	19.4	17.5	17.3	22.9	14.1	15.9	11.0	16.3	15.0	12.7	9.3	11.2	14.4	16.4	8.9	16.5	16.7	15.9	12.7	13.6	9.1	12.0	18.6	13.4	18.7	14.2	18.6	17.4	34.7	12.6	10.6	12.1	12.8	13.8	10.5	8.7	13.2	13.1	30.9	15.7	11.0	14.1	9.5	15.6	12.1	15.3	14.0	11.1	12.7	17.7	13.6	13.9	21.6	12.8	13.1	1.5	9.3	12.9	13.7	7.0	10.6	15.3	7.3	17.5	10.8	6.1	18.7	11.8	6.5	20.1	12.8	26.0	12.2	31.0	5.0	8.3	27.3	9.9	25.4	18.2	8.1	14.1	11.0	21.0	9.1	23.1	21.8	22.8	17.6	12.5	13.5	25.1	23.9	4.9	7.7	11.1	19.8	7.9	8.8	17.0	19.2	22.8	28.9	16.5	39.4	11.9	8.4	23.8	9.7	15.9	9.1	10.7	10.7	12.0	11.4	6.6	6.2	14.9	7.3	14.1	18.8	34.8	48.5	13.6	21.9	29.0	12.5	28.6	22.1	1.5	6.6	0.4	12.8	9.3	13.7	12.8	11.0	11.2	12.4	10.5	8.7	10.4	0.5	12.9	4.5	13.1	8.9	7.0	17.5	22.9	11.0	16.3	13.6	9.1	14.2	18.6	12.8	14.0	0.0	10.9	20.3	16.9	59.3	13.0	3.1	10.2	9.4	9.1	5.2	3.9	23.6	13.3	18.6	5.8	7.5	4.2	0.0	11.8	33.0	17.5	9.1	15.0	7.2	20.5	15.9	8.1	4.9	2.1	3.6	8.1	6.9	20.3	14.4	7.2	10.0	15.4	8.6	8.5	14.9	7.8	6.5	18.9	7.6	26.6	44.2	14.0	10.9	15.3	13.2
PARP3	"ADPRT3, ADPRTL3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		Yes	No			"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"prognostic favorable (6.39e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.44e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (1.25e-8)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.65e-3)"	15.2	29.2	11.2	14.6	17.1	2.8	13.6	5.7	18.8	7.5	17.3	10.6	14.3	26.9	10.3	14.1	10.8	12.1	16.2	12.4	11.6	12.3	17.3	22.3	13.3	9.7	12.0	14.2	8.2	3.9	34.2	9.8	6.2	12.2	12.1	10.7	13.2	14.0	18.1	14.6	6.1	26.3	18.9	8.7	12.8	15.8	4.5	10.2	2.9	17.0	9.6	10.3	15.1	8.9	9.0	2.9	1.7	4.1	6.6	4.9	2.3	5.9	3.3	0.9	9.0	8.7	16.5	2.5	9.8	15.8	12.1	13.6	1.9	15.8	8.1	2.6	16.1	7.0	0.9	2.5	8.8	5.9	19.9	0.6	4.1	6.7	6.3	9.4	2.5	5.7	13.0	5.5	7.7	5.2	18.6	6.0	5.1	1.7	7.7	9.3	1.5	2.2	6.3	1.2	2.0	9.5	3.5	1.5	7.0	7.4	6.5	1.0	3.4	9.9	2.8	5.2	0.7	3.4	2.8	13.6	24.4	5.1	3.6	5.9	11.8	14.3	3.5	15.7	7.4	7.6	0.0	2.6	1.7	3.6	4.1	3.4	9.0	4.2	2.8	2.9	4.3	4.9	4.9	0.1	6.6	2.0	1.2	4.3	2.3	11.2	17.1	5.7	18.8	11.6	12.3	12.0	14.2	12.2	10.2	6.0	10.6	10.1	10.0	2.4	1.7	5.9	12.7	9.4	7.9	0.0	0.0	0.4	6.6	8.8	5.9	3.0	15.8	0.0	5.7	0.3	4.5	3.4	4.6	8.5	3.4	0.0	2.9	1.8	2.2	8.4	4.4	2.9	6.8	6.4	11.0	4.0	7.9	3.5	1.4	16.1	2.1	6.5	6.2	3.2	1.8	1.3	0.5	5.3	11.2	6.4
GPR62		ENSG00000180929	"G protein-coupled receptor 62"	Q9BZJ7	3	51955314-51957504	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	11	"brain: 24.2"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 1.7;Cone photoreceptor cells: 3.9;Distal tubular cells: 1.7;Horizontal cells: 4.8;Rod photoreceptor cells: 1.4"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.5"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (9.56e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-5)"	"unprognostic (3.64e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-2)"	1.0	1.3	5.6	0.6	12.5	0.6	0.8	1.4	16.2	0.8	0.7	24.2	0.0	0.7	1.1	1.4	0.8	1.1	1.0	1.3	9.7	5.3	1.2	1.0	0.7	0.7	17.8	5.4	2.1	0.8	1.3	0.4	0.7	10.6	0.9	0.7	0.0	1.1	1.0	1.3	0.8	0.7	0.8	18.6	0.8	1.0	0.8	14.5	0.0	0.9	0.0	0.7	0.8	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.2	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.2	0.2	0.0	0.0	0.1	6.5	1.3	1.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.1	0.6	0.2	0.0	0.4	0.9	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	12.5	1.4	8.5	9.7	5.3	17.8	5.4	10.6	14.5	0.0	0.0	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.0	0.0	3.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PCBP4	"LIP4, MCG10"	ENSG00000090097	"Poly(rC) binding protein 4"	P57723	3	51957454-51974016	"Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 389.4;Cone photoreceptor cells: 616.5;Rod photoreceptor cells: 516.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"B-cells: 4.6;granulocytes: 4.6;T-cells: 10.2"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 49.4;SK-MEL-30: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057754			Supported	Cytosol		NA	NA			Cytosol		"HPA057754: AB_2683517"	"unprognostic (7.17e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.94e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.72e-2)"	19.5	16.6	27.2	9.6	21.9	3.0	10.6	86.0	56.3	12.7	16.7	36.2	16.0	15.1	15.4	12.1	14.5	10.4	18.3	36.5	29.2	29.9	21.2	38.9	13.9	17.0	28.9	13.0	16.3	22.0	22.9	15.8	7.8	16.4	20.1	8.6	47.3	20.3	19.6	97.5	13.6	29.0	14.4	44.4	10.9	13.3	10.6	19.7	11.9	17.3	11.0	15.7	13.3	9.6	4.6	0.3	4.6	0.0	0.1	10.2	2.4	10.2	3.5	14.1	20.5	6.4	11.5	2.4	23.6	11.5	14.2	9.2	13.0	3.7	0.3	3.5	18.6	12.6	2.4	13.1	8.2	6.7	16.2	2.1	1.3	11.8	13.5	10.4	1.3	10.0	15.5	15.4	9.0	4.0	17.7	7.1	6.0	0.6	4.6	22.7	4.8	0.5	1.6	6.8	6.5	9.5	7.1	6.8	1.8	5.0	7.3	27.8	49.4	6.4	3.5	41.8	3.9	6.5	5.0	14.1	15.2	28.8	4.8	12.5	3.1	1.9	2.0	17.6	2.9	22.1	4.6	0.0	3.1	10.2	0.0	7.1	4.6	9.6	9.8	0.3	2.3	4.6	3.5	0.0	0.1	0.0	0.1	10.0	2.4	27.2	21.9	86.0	24.2	29.2	29.9	28.9	13.0	16.4	19.7	3.0	2.7	2.2	13.9	7.7	389.4	6.7	2.5	1.4	4.5	8.7	616.5	1.2	14.9	28.1	52.1	11.2	7.3	0.0	20.1	1.1	16.4	16.8	1.1	3.9	1.0	39.7	59.5	12.3	0.3	76.2	20.8	1.1	21.9	1.0	8.6	56.4	34.6	14.0	15.2	7.9	516.1	6.5	15.3	0.9	2.3	10.3	0.5	6.9	4.8	9.7
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		2600000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favorable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	40.0	34.2	6.2	19.8	7.5	11.4	25.2	10.7	7.0	21.9	33.6	8.6	32.1	30.3	19.6	21.7	27.7	22.0	32.9	12.2	6.2	5.8	42.6	78.4	21.5	35.1	7.8	7.3	29.5	45.0	14.2	15.2	11.4	6.7	30.9	20.2	29.1	39.4	35.0	11.7	16.0	58.7	22.6	8.9	23.3	18.7	11.2	6.2	26.0	35.3	15.2	32.5	24.6	16.9	24.9	15.5	12.5	9.4	9.9	27.2	14.0	10.3	8.8	0.7	10.4	28.8	25.7	2.7	4.1	4.8	7.6	8.9	6.5	20.5	11.6	3.3	14.3	3.5	5.2	6.4	5.9	5.8	15.8	6.9	18.3	7.7	25.5	15.5	10.2	18.9	33.2	20.4	7.7	10.5	11.7	9.2	17.7	10.6	18.6	14.7	10.1	4.5	7.8	1.0	11.3	22.6	11.6	1.4	52.4	13.8	4.2	4.4	4.7	10.4	19.4	33.0	1.6	27.9	7.0	8.7	4.0	19.1	9.1	2.4	23.7	11.1	4.8	8.8	32.8	7.0	12.5	9.4	4.2	18.3	7.6	27.2	24.9	23.0	22.4	15.5	18.7	23.4	21.3	0.8	9.9	4.8	11.3	16.3	14.0	6.2	7.5	10.7	7.0	6.2	5.8	7.8	7.3	6.7	6.2	6.0	25.8	75.9	43.7	26.9	12.4	3.2	56.0	24.1	9.1	66.3	13.7	13.4	124.3	28.2	1.4	33.6	100.6	0.0	40.7	15.9	35.2	36.3	50.7	104.1	49.3	7.9	72.9	30.7	50.2	0.5	60.1	36.2	52.3	32.5	83.5	7.7	25.4	66.2	43.9	216.2	37.1	38.8	41.0	0.5	3.4	26.6	9.8	59.8	107.0	52.8
ABHD14A	"DKFZP564O243, DORZ1"	ENSG00000248487	"Abhydrolase domain containing 14A"	Q9BUJ0	3	51971426-51981199	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038153, HPA056913"	Approved		Enhanced	Vesicles		NA	NA		260000	Vesicles		"HPA038153: AB_2675868, HPA056913: AB_2683275"	"unprognostic (4.15e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.30e-2)"	11.8	28.0	23.3	6.0	25.8	9.0	9.2	39.6	45.0	18.3	7.3	12.2	8.5	8.0	6.9	23.2	5.4	19.6	9.3	16.4	22.3	27.8	26.2	13.0	9.7	8.9	16.6	23.4	14.8	20.6	15.6	21.3	7.0	18.7	11.6	5.6	26.1	17.7	12.5	23.8	3.9	6.6	8.8	14.5	7.7	11.0	6.2	7.0	6.6	24.1	8.4	8.8	9.2	7.4	15.4	13.9	4.5	6.0	12.0	30.9	15.3	2.8	5.4	3.5	10.6	35.3	17.8	1.9	3.8	6.3	4.6	6.2	6.2	11.5	3.2	2.6	9.4	5.2	2.4	3.8	4.2	1.5	10.3	4.3	9.4	16.2	20.5	9.9	12.8	12.6	16.7	2.9	3.9	2.0	10.3	5.9	6.2	3.8	10.9	7.1	3.2	5.9	13.1	2.0	13.5	13.0	4.2	1.8	30.3	8.8	4.4	7.3	11.3	9.5	2.0	5.6	0.8	3.0	14.1	3.4	4.2	4.5	10.0	4.3	15.9	14.8	2.6	7.8	20.6	6.0	2.1	6.0	4.5	30.2	3.5	30.9	15.4	26.7	26.8	10.4	12.4	24.6	26.2	0.6	12.0	2.2	13.9	25.7	15.3	23.3	25.8	39.6	45.0	22.3	27.8	16.6	23.4	18.7	7.0	6.0	17.1	20.4	20.4	8.7	89.3	21.0	15.3	24.1	19.4	31.4	23.6	9.0	28.2	13.8	3.6	14.2	8.5	0.0	10.8	11.5	41.8	21.4	15.0	11.6	25.9	55.6	38.7	17.2	11.8	18.4	81.4	13.0	11.8	4.6	11.8	36.2	13.3	2.9	31.1	69.3	86.1	19.4	11.3	16.9	59.2	4.8	4.1	34.6	14.0	13.2
ABHD14A-ACY1		ENSG00000114786	"ABHD14A-ACY1 readthrough"		3	51974706-51989183	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 3.7;Club cells: 3.4;Collecting duct cells: 5.2;Distal tubular cells: 3.3;Proximal tubular cells: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 3.4;HUVEC TERT2: 4.2;SH-SY5Y: 3.4"									"HPA036174, HPA036175, HPA038153"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.90e-2)"	"unprognostic (7.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.11e-4)"	2.7	2.9	3.5	2.6	8.2	2.0	2.3	8.3	15.1	3.7	3.5	3.2	1.9	4.8	2.5	3.2	2.0	3.3	3.5	4.8	3.2	4.1	5.8	8.4	3.0	1.9	2.7	7.2	2.7	4.6	1.4	3.7	1.7	5.6	2.8	1.6	8.2	4.1	2.2	8.0	2.0	10.5	2.0	3.9	3.3	2.6	2.2	1.3	0.9	4.7	1.8	2.8	2.3	2.7	2.4	5.2	1.2	4.0	4.7	4.1	2.7	0.0	0.0	0.3	0.5	2.0	1.1	0.2	0.0	2.0	0.4	0.4	2.0	3.4	0.8	0.1	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.1	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.5	4.2	1.1	2.1	0.0	0.0	0.0	2.0	1.5	1.3	1.0	1.8	0.5	0.0	0.2	0.0	0.0	0.4	3.4	0.0	2.4	0.0	0.0	0.9	0.0	0.0	1.0	0.0	2.1	0.0	0.0	0.0	2.0	1.6	0.0	0.0	0.2	1.7	1.2	4.1	4.0	2.4	2.4	2.3	4.1	5.2	1.7	2.1	2.7	0.0	4.7	2.0	2.4	2.5	2.7	3.5	8.2	8.3	15.1	3.2	4.1	2.7	7.2	5.6	1.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	5.2	0.0	0.0	3.3	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	1.3	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983278-51989202	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 53.3;kidney: 91.6;liver: 77.8"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 70.2;Erythroid cells: 23.3;Proximal tubular cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		28000000			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	4.4	8.5	2.5	3.9	3.0	1.5	4.4	1.5	3.3	3.2	24.9	4.1	9.8	34.5	1.9	7.9	3.8	3.0	8.4	4.1	2.3	1.8	91.6	77.8	3.5	6.3	2.8	2.9	2.1	9.0	6.2	1.9	4.3	2.9	3.7	6.2	6.6	9.4	9.2	7.6	2.6	53.3	2.1	3.5	3.4	4.9	1.5	1.7	0.6	5.9	6.7	4.1	3.3	2.5	5.0	12.1	3.8	10.0	12.1	6.4	4.5	3.9	8.0	3.9	10.8	9.0	12.1	12.8	4.2	7.9	9.3	5.1	12.4	20.8	2.5	3.5	7.3	3.4	4.9	4.0	25.6	3.7	6.9	5.1	8.9	4.6	38.3	16.6	6.0	5.8	14.0	21.2	8.2	22.1	7.6	3.5	4.4	13.4	7.9	9.1	11.1	0.0	11.0	5.7	25.3	13.6	3.1	3.3	22.5	24.3	15.0	5.5	5.0	5.3	17.5	9.2	1.6	14.1	7.9	1.7	6.7	6.4	8.3	4.9	20.9	4.9	3.8	7.8	12.5	8.0	3.8	10.0	0.2	6.4	9.0	3.6	5.0	2.0	2.8	12.1	4.0	3.3	4.0	0.0	12.1	3.4	1.9	2.7	4.5	2.5	3.0	1.5	3.3	2.3	1.8	2.8	2.9	2.9	1.7	3.0	2.7	0.8	0.8	0.6	0.0	0.1	2.5	2.7	3.4	5.2	0.0	3.3	8.3	12.2	0.2	0.5	70.2	23.3	7.4	3.7	0.8	0.5	6.9	10.9	1.7	0.0	2.4	1.8	2.1	0.4	0.6	2.4	0.0	16.2	9.3	0.8	12.6	21.0	0.0	35.6	0.9	0.0	0.5	0.0	0.2	0.4	3.4	1.5	12.1	0.3
RPL29	"HIP, HUMRPL29, L29, RPL29P10"	ENSG00000162244	"Ribosomal protein L29"	P47914	3	51993600-51995942	"Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 434.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA069064	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA069064: AB_2686077"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	91.6	61.7	42.5	64.6	33.0	110.2	111.0	30.1	39.7	102.4	98.1	30.3	57.1	53.6	59.6	72.8	124.7	76.0	68.7	72.1	33.8	26.0	55.7	122.9	64.8	219.4	36.0	26.0	150.1	434.1	16.3	34.3	50.7	26.3	91.1	41.2	38.9	103.7	54.8	160.8	102.5	73.8	80.2	38.1	83.9	59.7	58.7	25.2	85.9	83.3	123.3	92.4	88.5	87.1	137.9	98.1	32.8	80.0	74.8	132.2	202.9	69.9	91.0	70.2	107.0	125.2	196.8	99.0	78.3	96.8	107.6	89.5	108.3	107.5	195.7	34.1	79.5	65.9	63.7	101.2	166.6	51.5	79.6	137.7	101.3	117.7	180.6	148.5	146.9	97.8	240.5	236.9	79.3	141.3	123.3	120.4	87.9	79.0	150.3	79.2	159.8	127.5	191.1	116.5	106.6	154.5	59.3	77.3	189.8	137.5	146.3	56.8	110.8	58.5	135.2	133.7	46.8	101.2	251.4	104.3	60.4	81.1	93.1	116.7	98.1	139.0	139.2	79.9	176.2	79.8	32.8	80.0	22.6	68.8	61.7	115.0	137.9	112.2	87.6	98.1	128.2	132.2	109.9	10.8	74.8	48.4	82.8	100.8	202.9	42.5	33.0	30.1	39.7	33.8	26.0	36.0	26.0	26.3	25.2	175.7	330.0	3392.7	4367.8	3531.6	218.0	72.2	1398.7	310.5	437.9	675.2	96.2	2332.5	1848.6	1477.5	867.6	2040.8	1839.8	957.8	3975.0	4390.8	2112.5	3132.4	683.0	1270.4	2074.0	101.7	1376.0	1509.4	2270.2	3389.8	3344.0	2646.2	2103.8	1980.2	2585.2	359.2	2990.7	2489.9	1488.6	2639.2	288.1	1125.4	2454.4	526.4	450.8	4436.8	2053.3	2519.7	3632.3	5133.1
DUSP7	"MKP-X, PYST2"	ENSG00000164086	"Dual specificity phosphatase 7"	Q16829	3	52048919-52056550	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 104.2;Suprabasal keratinocytes: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 41.4;hTERT-HME1: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073007	Approved					NA	NA					"HPA073007: "	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.38e-3)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (4.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.46e-2)"	5.5	5.9	7.8	4.3	8.5	1.6	3.7	6.5	19.2	8.6	2.9	15.3	3.4	2.4	5.6	2.4	22.0	4.4	5.3	8.3	7.3	4.8	3.6	2.5	7.0	5.6	9.9	10.0	4.7	4.3	3.9	3.8	8.9	4.9	4.0	2.3	4.6	5.2	5.3	11.4	24.1	3.5	4.2	4.8	10.7	3.7	5.4	9.2	3.2	3.4	15.0	8.6	5.8	14.7	1.0	7.5	1.7	10.7	2.3	8.2	1.7	7.6	1.6	1.9	4.4	6.3	5.5	2.3	7.7	14.8	7.7	5.6	2.1	3.9	2.1	2.1	11.4	3.9	9.0	7.4	28.0	5.3	1.8	3.0	10.0	3.9	3.7	5.1	8.9	6.1	5.7	41.4	9.9	35.3	5.3	7.3	6.2	5.7	6.1	6.1	2.1	6.6	12.7	4.8	2.1	14.0	5.6	1.7	5.6	3.2	3.3	2.4	7.2	3.4	3.2	5.4	1.6	1.1	21.6	9.5	14.9	9.6	15.6	23.5	2.9	2.7	3.4	8.2	15.1	4.7	0.9	3.9	1.7	6.0	10.7	8.2	1.0	7.2	4.3	5.0	0.6	5.3	4.8	1.4	2.3	10.0	7.5	4.6	1.7	7.8	8.5	6.5	19.2	7.3	4.8	9.9	10.0	4.9	9.2	8.9	0.6	1.5	23.5	104.2	4.7	15.3	0.0	1.4	5.7	0.0	0.0	0.4	1.7	3.3	1.1	11.3	0.7	0.0	2.3	3.4	9.0	3.2	0.0	0.4	6.7	0.0	2.4	28.3	10.7	0.0	8.1	8.3	20.3	0.0	2.9	0.9	7.4	0.0	4.6	0.9	1.0	25.8	15.1	3.2	4.3	118.3	1.0	4.5	2.9	24.4
POC1A	"DKFZP434C245, WDR51A"	ENSG00000164087	"POC1 centriolar protein A"	Q8NBT0	3	52075253-52154690	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Dwarfism, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.7;testis: 34.3"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 39.9;Extravillous trophoblasts: 27.7;Late spermatids: 45.8;Spermatocytes: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040600	Approved					NA	NA					"HPA040600: AB_10672837"	"unprognostic (2.68e-1)"	"unprognostic (7.17e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (5.08e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (9.43e-7)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.32e-2)"	2.2	4.6	1.3	5.5	1.6	9.2	1.8	1.0	2.2	1.3	5.5	1.5	1.5	4.4	1.0	2.8	5.0	1.4	2.8	1.7	1.8	1.4	1.8	5.2	2.2	4.6	1.5	0.6	1.1	0.9	0.5	0.7	5.9	1.3	1.4	5.9	0.9	1.5	1.5	1.5	2.2	3.5	2.5	1.4	3.1	2.7	34.3	1.1	19.7	1.1	5.5	6.9	1.8	1.8	2.2	3.9	1.1	4.5	2.8	5.5	2.2	13.4	11.5	11.7	15.6	2.4	3.1	15.9	13.8	13.3	29.7	23.2	10.1	14.4	14.2	4.1	10.9	22.9	8.5	17.6	15.6	21.7	11.6	7.4	9.6	12.3	10.8	0.6	10.9	6.1	1.7	3.4	23.4	12.3	4.1	13.5	21.4	8.3	15.4	17.5	10.7	20.2	19.9	8.9	15.3	19.1	8.8	9.3	13.5	6.6	9.6	5.4	7.9	11.0	11.0	8.4	12.8	13.6	20.7	4.4	13.5	13.3	21.7	22.2	13.1	21.4	11.9	9.1	19.2	13.5	0.0	3.4	0.0	2.8	4.5	0.3	2.2	2.0	0.9	3.9	1.1	1.6	1.1	1.1	2.8	3.2	3.9	5.5	2.2	1.3	1.6	1.0	2.2	1.8	1.4	1.5	0.6	1.3	1.1	0.0	2.2	7.8	1.0	1.4	0.7	0.6	0.0	2.7	0.0	1.8	0.0	9.2	0.0	1.8	39.9	1.1	1.7	0.0	2.7	27.7	1.0	0.8	0.0	3.9	11.1	1.6	1.7	1.3	1.6	45.8	1.1	2.9	1.7	4.6	2.1	0.8	1.5	0.0	0.4	2.2	0.0	0.0	1.4	27.7	18.5	1.6	6.3	1.3	4.1	1.1
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 167.6;liver: 136.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 55.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	9.2	167.6	7.8	6.7	10.6	39.1	8.9	17.0	15.4	6.0	11.0	12.0	15.3	11.4	6.3	11.8	10.5	4.7	8.7	24.8	8.8	7.0	14.1	136.4	13.5	10.0	7.6	9.9	5.8	6.1	8.5	5.8	13.4	12.2	7.3	11.1	8.3	15.7	16.9	24.6	6.8	17.4	6.5	7.3	6.3	12.2	9.7	5.0	7.5	7.4	11.4	9.6	12.1	7.6	6.8	8.4	55.0	12.2	8.8	11.3	6.3	10.3	16.1	11.4	10.5	17.8	13.3	31.0	15.2	14.1	20.4	19.8	21.4	19.6	9.7	3.8	10.6	41.4	6.1	16.3	12.5	16.7	18.8	6.4	12.4	12.7	16.2	25.2	20.1	25.0	16.5	11.7	32.4	10.8	7.5	18.6	17.0	7.3	8.0	18.5	8.4	9.5	30.7	9.8	11.9	27.9	5.7	7.1	15.3	17.9	62.7	6.0	4.0	24.6	12.1	13.7	9.6	6.9	28.7	13.3	11.4	11.3	23.5	21.9	11.9	20.5	14.6	12.7	21.9	18.1	55.0	9.2	27.8	6.9	12.2	11.3	6.8	7.2	7.7	8.4	6.0	6.5	7.0	14.2	8.8	10.2	4.8	9.7	6.3	7.8	10.6	17.0	15.4	8.8	7.0	7.6	9.9	12.2	5.0	32.8	47.6	4.5	16.4	15.3	15.1	88.4	35.7	38.8	27.3	22.7	3.9	67.2	48.0	28.5	9.7	25.9	35.4	0.0	27.6	21.7	19.9	18.1	89.4	210.5	62.6	11.1	33.3	25.2	14.6	3.1	12.4	23.3	5.0	73.9	18.6	9.1	33.4	18.7	15.6	25.9	6.8	12.9	27.3	23.7	19.0	14.2	258.6	17.3	16.1	24.3
TLR9	CD289	ENSG00000239732	"Toll like receptor 9"	Q9NR96	3	52221080-52226163	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"blood: 33.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	10	"plasmacytoid DC: 33.8"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 33.8"	"Group enriched"	"Detected in some"	12	"Daudi: 24.7;RPMI-8226: 15.7;U-698: 9.5"															NA	NA						"unprognostic (6.03e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.69e-7)"	"unprognostic (1.16e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.91e-3)"	0.5	0.2	0.0	2.8	0.5	2.5	0.4	4.9	0.4	0.8	1.2			0.7	0.9	0.0	0.2	1.0	0.9	0.3	0.2	0.3	0.3	0.1	0.6	6.5	0.1		2.5	0.0	0.0	0.3	0.1		0.9	0.1		1.4	0.4	1.8	0.1	2.2	0.1	0.4	3.9	0.5	0.3			0.7		3.9	1.2	1.2	3.3	33.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.0	0.7	9.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC097637.1		ENSG00000173366			3	52221081-52231190	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"blood: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 31.7"	"Group enriched"	"Detected in some"	5	"Daudi: 11.6;RPMI-8226: 21.8;U-698: 10.8"															NA	NA										"unprognostic (4.08e-2)"					"unprognostic (9.63e-2)"								0.3	0.0	0.4	2.9	0.7	0.3	0.1	1.1	0.5	0.3	0.4			0.1	0.2	0.0	0.1	0.1	0.6	0.3	0.4	0.4	0.2	0.1	0.1	6.5	0.3		0.8	0.0	0.0	0.0	0.2		0.2	0.0		0.5	0.1	1.4	0.3	4.0	0.0	0.3	6.2	0.5	0.0			0.1		5.3	1.0	0.2	7.0	31.7	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.7	0.0	0.0	0.2	0.8	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.8	0.4	10.8	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	1.2	7.0	0.5	0.5	0.1	3.7	0.0	0.2	0.1	0.0	0.0	31.7	1.1	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TWF2	"A6r, A6RP, PTK9L"	ENSG00000247596	"Twinfilin actin binding protein 2"	Q6IBS0	3	52228610-52239260	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.7"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 187.1;monocytes: 272.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053874	Uncertain		Uncertain	"Plasma membrane"		NA	NA		14000000	"Plasma membrane"		"HPA053874: AB_2682287"	"unprognostic (4.24e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.07e-2)"	25.0	13.0	10.4	21.0	10.9	17.0	22.3	17.5	21.1	13.8	15.2	7.7	10.4	12.1	14.3	13.1	17.2	11.4	18.7	38.8	13.2	9.4	13.9	11.7	16.5	39.4	9.2	13.2	14.4	10.9	5.4	7.5	11.0	9.1	13.4	7.1	10.4	18.2	13.5	81.7	11.9	13.5	13.5	8.4	23.3	13.4	7.9	7.3	34.5	9.4	15.4	19.5	18.7	14.3	32.3	46.8	72.5	50.1	26.9	40.9	38.7	6.6	17.1	6.0	10.4	19.6	24.0	10.7	15.7	25.4	18.8	16.9	8.9	18.3	23.9	10.4	18.4	17.2	11.8	7.5	22.0	4.2	15.1	9.9	24.6	12.8	21.5	16.9	14.8	41.3	22.2	10.6	22.3	7.6	12.8	28.6	15.2	5.7	12.5	14.0	5.8	20.4	34.0	9.3	8.7	48.6	7.9	6.2	25.0	14.8	10.8	4.7	17.9	5.6	23.7	31.1	3.8	5.4	16.1	29.4	18.5	20.1	14.3	13.5	11.2	9.9	11.6	36.4	42.0	22.2	26.8	50.1	39.6	33.7	48.9	30.6	32.3	35.9	35.8	46.8	25.4	28.9	35.6	72.5	26.9	49.5	42.3	40.9	38.7	10.4	10.9	17.5	21.1	13.2	9.4	9.2	13.2	9.1	7.3	6.0	8.5	43.9	25.9	15.2	12.0	25.8	30.6	5.3	4.5	12.2	0.0	35.9	31.5	70.3	2.8	31.5	60.1	0.0	89.7	67.2	36.1	19.7	40.3	8.9	187.1	6.4	21.2	23.4	112.2	2.4	32.5	86.2	32.1	272.3	18.1	14.9	81.2	38.6	31.8	14.6	4.5	51.8	24.5	0.9	23.6	13.4	18.9	73.4	21.1	23.7
PPM1M	"FLJ32332, PP2Ceta"	ENSG00000164088	"Protein phosphatase, Mg2+/Mn2+ dependent 1M"	Q96MI6	3	52245793-52250597	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 38.2;Kupffer cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 26.2"									"HPA036905, HPA062291"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA036905: AB_10602818, HPA062291: AB_2684740"	"unprognostic (4.26e-3)"	"prognostic favorable (7.73e-4)"	"unprognostic (2.55e-2)"	"unprognostic (4.85e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"prognostic favorable (6.69e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.37e-2)"	14.3	7.2	13.9	22.7	14.8	16.5	26.3	3.6	9.2	16.9	12.5	4.6	7.8	4.4	13.6	12.0	10.8	11.7	19.4	14.5	8.7	8.5	8.7	4.9	30.1	38.0	5.4	12.3	14.9	5.9	6.9	7.5	8.6	4.9	15.1	6.7	11.0	10.8	12.4	3.1	7.5	8.8	18.1	6.8	22.5	8.3	6.2	5.9	20.5	11.3	9.9	20.5	11.3	13.5	5.0	9.6	19.6	18.6	7.4	15.0	10.1	0.4	2.5	1.5	3.7	22.8	22.8	2.4	5.8	12.5	8.2	6.4	1.4	2.0	4.2	1.7	15.1	4.6	0.7	5.1	1.1	3.3	5.0	1.2	9.6	6.7	1.5	16.7	1.4	9.1	18.8	2.5	9.2	5.8	13.3	10.6	19.5	1.6	7.0	9.6	1.0	6.2	0.4	2.0	1.9	7.0	1.4	0.7	9.2	3.5	1.1	1.1	4.5	4.2	1.0	5.2	3.4	3.6	3.7	7.3	3.1	5.3	1.8	0.7	26.2	4.8	4.5	6.2	2.5	3.8	1.2	15.7	8.5	15.0	12.4	11.7	5.0	11.8	13.8	9.6	3.8	11.1	13.8	19.6	7.4	18.6	5.8	13.2	10.1	13.9	14.8	3.6	9.2	8.7	8.5	5.4	12.3	4.9	5.9	0.0	4.8	11.5	3.9	4.5	1.0	2.0	5.1	1.4	3.4	1.8	0.0	3.0	3.3	1.7	9.9	6.9	0.7	0.0	1.0	5.3	8.2	2.7	5.7	2.4	38.2	1.6	1.2	10.4	40.0	14.2	11.8	24.5	5.0	10.0	0.2	5.1	1.6	1.9	9.2	2.2	0.4	19.4	6.1	0.4	3.6	3.3	1.6	22.0	0.7	1.8
WDR82	"MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A"	ENSG00000164091	"WD repeat domain 82"	Q6UXN9	3	52254421-52288020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 144.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040427			Supported	"Nucleoli rim"		NA	NA			"Nucleoli rim"		"HPA040427: AB_2676979"	"unprognostic (7.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.26e-1)"	27.5	28.4	33.8	31.5	38.4	33.1	27.9	58.7	42.9	36.8	29.0	24.1	23.4	23.3	40.3	23.5	34.1	32.0	30.3	34.5	32.0	36.6	21.3	22.5	24.8	39.3	26.9	35.8	40.6	19.5	29.1	19.9	29.8	27.9	30.2	28.1	28.2	26.0	36.6	49.8	29.2	24.9	37.1	26.4	34.1	22.8	25.4	25.2	63.5	28.7	29.7	40.7	31.7	37.0	7.9	5.6	12.5	9.6	7.4	17.0	7.9	14.6	17.7	33.4	25.0	31.9	26.6	16.8	25.0	20.8	24.7	20.6	20.6	14.7	38.9	9.8	26.7	21.7	13.3	45.8	26.8	29.1	28.2	17.5	49.9	22.6	21.1	22.2	46.9	26.4	26.6	26.6	29.1	26.7	23.1	26.0	32.0	22.2	28.1	23.8	14.7	36.3	18.5	30.2	19.3	34.4	18.8	22.3	29.0	25.8	27.0	8.0	33.6	26.8	8.1	15.4	23.6	15.3	18.9	26.6	23.3	26.6	24.3	28.7	27.5	40.2	39.5	19.9	35.8	25.4	6.8	6.4	8.2	14.1	6.4	17.0	7.9	12.9	13.7	5.6	6.1	15.1	15.2	12.5	7.4	9.6	5.4	10.8	7.9	33.8	38.4	58.7	42.9	32.0	36.6	26.9	35.8	27.9	25.2	26.8	43.4	37.8	28.6	45.7	48.0	47.5	28.1	18.7	30.7	14.0	19.6	24.8	11.6	15.9	37.2	35.7	29.3	0.0	16.1	26.8	30.3	30.6	14.0	37.5	28.5	58.8	42.6	43.0	59.0	144.0	54.1	37.6	35.4	23.4	37.2	36.8	25.4	31.6	59.1	17.5	33.2	51.8	33.1	19.1	27.7	49.7	25.7	50.3	34.1	34.2
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52293476	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 108.4"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 46.7;Hepatocytes: 151.6;Proximal tubular cells: 59.6"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.0;Hep G2: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	6.4	4.9	1.9	8.4	5.0	5.2	4.8	2.7	6.2	2.3	7.9	7.1	4.2	23.8	4.3	4.8	2.8	2.5	7.2	2.7	1.9	2.2	10.7	108.4	3.1	6.5	2.5	4.9	2.3	3.6	1.9	2.5	3.1	3.9	2.8	3.5	4.7	3.2	3.0	7.0	1.9	17.8	1.9	1.8	5.5	6.0	2.7	1.8	3.3	3.1	2.4	5.9	2.7	2.2	8.3	9.1	10.9	9.5	5.7	11.8	6.3	2.3	5.6	3.0	1.1	16.1	2.2	1.8	2.5	2.6	4.8	3.5	19.0	1.9	5.9	1.6	2.2	3.6	1.5	1.7	6.2	0.9	1.6	2.0	8.3	6.7	25.2	1.6	2.7	5.0	2.2	3.1	7.0	2.7	1.6	9.0	4.8	2.3	4.3	3.6	1.7	4.6	2.2	1.6	12.2	4.6	1.6	2.7	8.9	4.8	3.2	2.2	2.2	2.4	1.3	2.5	0.9	3.2	1.3	3.9	3.7	4.4	2.4	4.8	4.6	3.1	3.9	2.6	4.5	2.8	3.0	9.5	10.9	11.8	5.1	6.1	8.3	9.0	10.3	9.1	5.7	6.8	10.1	7.8	5.7	6.1	5.6	11.7	6.3	1.9	5.0	2.7	6.2	1.9	2.2	2.5	4.9	3.9	1.8	6.0	2.7	9.3	2.6	0.3	1.4	1.2	15.3	1.4	2.3	8.7	0.0	6.7	16.6	4.3	0.1	4.4	29.7	46.7	5.4	4.3	2.1	2.5	1.1	151.6	11.4	0.0	22.4	12.9	16.5	0.0	1.1	7.2	3.3	6.4	9.1	1.0	3.5	34.5	0.0	59.6	1.5	0.0	0.2	0.2	7.7	1.1	9.3	10.2	11.5	3.1
DNAH1	"DNAHC1, HDHC7, HL-11, HL11, XLHSRF-1"	ENSG00000114841	"Dynein axonemal heavy chain 1"	Q9P2D7	3	52316319-52400491	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 22.7;Late spermatids: 15.6"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.3"	"Low region specificity"	"Detected in some"							"HPA036805, HPA036806"	Uncertain					NA	NA					"HPA036805: AB_10670924, HPA036806: AB_10670849"	"unprognostic (8.34e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.60e-4)"	"unprognostic (1.54e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.59e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.84e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.80e-5)"	2.3	1.5	1.3	2.3	2.3	7.8	1.7	3.7	2.8	1.0	1.5			1.3	1.8	1.5	1.3	5.8	1.8	0.8	2.0	2.3	1.7	2.6	2.8	3.8	1.1		2.4	1.7	2.7	2.0	0.9		1.7	1.4		1.5	0.6	0.9	1.9	3.4	2.0	1.7	3.5	1.8	5.3			1.7		2.9	1.0	1.1	0.7	0.6	0.9	0.4	0.1	1.4	0.0	0.3	1.3	2.1	2.0	2.5	9.3	1.1	0.9	2.0	0.4	0.5	0.1	1.1	0.6	1.2	1.5	0.3	0.2	0.1	0.3	0.8	1.5	2.7	3.8	0.2	0.4	1.2	2.9	2.6	4.0	0.7	1.6	2.0	4.1	1.6	1.6	0.4	3.3	1.5	0.4	0.7	2.8	1.0	0.3	1.8	1.3	0.1	1.1	0.7	1.6	0.2	1.0	1.9	0.3	1.6	0.7	0.4	4.5	2.0	0.5	0.5	1.8	0.4	3.5	3.2	0.9	0.7	2.3	0.5	0.0	0.1	0.0	1.2	0.0	1.4	0.5	0.2	0.3	0.6	0.7	0.0	0.5	0.9	0.1	0.4	0.0	0.0	0.0											6.0	3.0	3.0	0.2	0.5	1.5	3.6	0.0	22.7	2.3	0.0	3.9	0.4	0.0	0.2	8.4	1.5	3.3	0.0	0.5	0.2	0.6	0.8	3.5	3.2	1.1	4.8	5.2	2.5	2.4	15.6	1.1	2.0	1.7	2.8	1.7	0.8	0.2	2.3	0.4	0.9	5.0	0.0	0.4	7.7	1.6	0.3	0.7	6.4	1.6	0.5
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401013-52410350	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	13.8	17.6	35.6	14.7	33.3	37.3	13.5	21.8	50.4	12.5	17.0	16.3	11.5	12.4	14.7	14.6	21.2	12.1	15.7	16.4	41.5	15.5	16.6	19.0	14.9	15.2	19.4	27.6	16.9	16.3	30.0	11.1	14.8	19.6	14.4	14.9	15.6	17.9	14.6	24.8	40.5	13.9	14.5	10.0	16.1	13.3	37.3	14.7	18.6	15.3	12.9	16.0	14.1	11.7	5.5	8.4	11.3	5.0	3.0	8.5	3.9	14.8	16.9	20.6	17.4	19.9	12.8	23.2	14.7	19.1	24.0	18.6	20.5	13.9	21.4	7.4	20.5	27.1	12.1	21.6	23.8	15.3	21.1	20.5	26.4	35.8	21.2	18.5	24.8	23.5	19.1	31.9	26.5	14.2	13.2	19.1	41.2	22.6	18.9	18.0	12.9	29.4	34.0	23.2	11.8	20.6	12.7	16.7	21.1	14.8	24.1	7.8	25.3	18.1	5.3	21.5	12.1	14.8	34.3	20.4	21.7	20.0	26.0	27.3	28.7	37.7	30.6	23.7	26.2	25.6	3.4	5.0	7.4	8.5	3.9	4.0	5.0	6.8	6.9	3.3	5.5	4.9	6.4	11.3	3.0	3.1	8.4	6.0	3.9	35.6	33.3	21.8	50.4	41.5	15.5	19.4	27.6	19.6	14.7	0.0	13.6	15.0	8.8	28.0	15.3	19.3	10.2	5.3	9.1	24.4	0.0	12.2	10.0	12.0	81.1	12.4	17.6	0.0	14.3	13.1	11.8	9.7	20.7	25.8	11.0	9.5	10.4	15.4	19.3	32.6	9.5	10.2	11.8	11.8	12.9	9.9	12.6	15.3	11.0	14.6	11.3	19.4	13.2	30.9	12.4	20.6	10.1	11.3	16.4	8.5
PHF7	"HSPC226, NYD-SP6"	ENSG00000010318	"PHD finger protein 7"	Q9BWX1	3	52410657-52423641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"testis: 260.7"	"Group enriched"	"Detected in many"	45	"Early spermatids: 2196.1;Late spermatids: 5962.4;Spermatocytes: 1575.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 14.1;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA036283, HPA070305"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA036283: AB_10795026, HPA070305: AB_2686248"	"prognostic favorable (7.38e-5)"	"unprognostic (4.57e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (9.44e-5)"	"unprognostic (3.63e-1)"	"unprognostic (2.61e-3)"	"unprognostic (7.44e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (2.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.34e-2)"	"unprognostic (6.79e-2)"	0.9	0.6	0.3	0.6	1.5	0.8	0.9	1.0	1.4	0.5	1.0	1.2	0.4	0.7	0.5	2.0	0.6	0.6	0.4	1.9	0.6	0.4	0.6	0.9	0.6	0.5	1.1	0.7	0.4	0.9	0.6	0.5	0.5	0.7	0.7	1.0	1.2	1.0	0.7	1.5	1.0	1.0	0.5	0.9	0.7	0.6	260.7	0.4	1.7	0.5	0.6	0.6	0.9	0.5	6.7	2.6	3.9	2.5	2.2	4.9	1.7	2.0	0.6	1.5	6.4	1.1	1.6	2.7	2.0	2.1	1.6	2.0	1.0	0.8	3.4	0.2	1.5	1.0	1.1	1.1	3.2	2.8	4.1	1.5	3.8	0.4	2.3	1.1	4.2	7.2	0.9	3.6	1.5	3.4	0.5	2.3	7.8	2.3	14.1	1.2	0.9	4.9	1.6	0.7	0.6	4.3	2.2	1.4	4.1	1.7	0.9	1.1	1.2	1.8	0.1	1.6	2.0	0.9	2.1	1.7	2.7	1.9	2.9	4.1	16.7	8.0	2.0	1.1	9.7	1.6	0.7	2.2	3.9	2.1	2.5	2.5	6.7	2.5	3.7	1.1	3.8	1.7	3.5	0.5	2.2	1.4	2.6	4.9	1.7	0.3	1.5	1.0	1.4	0.6	0.4	1.1	0.7	0.7	0.4	3.0	2.9	5.6	4.6	4.0	10.6	7.0	2.5	6.7	0.0	7.0	7.9	3.0	11.6	2.4	2196.1	2.9	8.4	0.0	2.5	1.7	2.9	1.7	6.9	4.0	3.7	12.7	11.1	1.8	4.3	5962.4	71.4	2.6	8.5	2.8	3.3	6.5	3.1	0.0	59.4	5.5	15.7	51.8	3.9	1575.4	63.9	2.6	0.5	4.4	11.8	2.2
SEMA3G	"FLJ00014, sem2"	ENSG00000010319	"Semaphorin 3G"	Q9NS98	3	52433053-52445085	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.2;breast: 89.1"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 8.2;Endothelial cells: 9.0;Intestinal endocrine cells: 9.2;Syncytiotrophoblasts: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	18	"T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.9;Hep G2: 6.3;HUVEC TERT2: 6.7;THP-1: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001761	Uncertain				"Secreted to blood"	NA	NA		4400000			"HPA001761: AB_1079902"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.79e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.14e-1)"	"prognostic favorable (8.86e-5)"	"unprognostic (5.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.14e-1)"	46.2	1.6	3.1	2.4	5.0	0.2	89.1	11.5	5.3	3.5	5.4	2.8	1.5	2.1	3.3	3.0	3.5	3.2	4.5	8.0	3.8	3.3	8.8	0.7	30.4	1.2	5.5	2.5	2.0	2.2	1.1	1.1	19.3	3.1	2.9	2.8	6.8	13.6	2.1	8.0	5.2	6.7	3.2	3.6	7.2	2.7	2.0	1.1	0.4	3.5	4.7	1.4	3.7	5.3	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.1	0.2	23.9	0.2	2.7	0.0	0.0	0.0	0.0	0.7	0.4	3.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.5	0.2	6.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	6.7	2.4	0.0	0.3	0.0	0.2	0.2	4.1	1.2	0.6	0.1	0.0	0.0	3.8	0.0	0.2	0.6	0.6	0.0	0.3	0.5	0.1	2.0	5.9	2.5	0.0	2.5	0.0	0.0	0.5	1.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	5.0	11.5	5.3	3.8	3.3	5.5	2.5	3.1	1.1	3.0	2.2	0.0	0.0	0.3	0.5	8.2	0.0	0.0	0.0	3.5	0.0	1.4	0.0	0.0	2.1	9.0	0.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.2	0.0	9.2	1.3	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	6.3	0.0	0.1	0.0
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451102-52454070	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"heart muscle: 431.6;skeletal muscle: 765.7"	"Cell type enriched"	"Detected in many"	8	"Cardiomyocytes: 2506.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 88.3"	"Not detected"	"Not detected"			"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		260000	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	2.0	0.3	0.1	0.0	0.1	0.0	0.7	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	17.8	12.8	0.1	0.0	431.6	0.1	0.1	0.6	0.1	2.6	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.2	0.5	5.5	0.1	0.7	10.4	0.0	765.7	0.4	0.1	0.1	0.7	0.1	0.1	0.7	0.0	0.0	3.0	86.9	8.7	0.4	0.2	0.2	0.6	0.0	0.0	0.0	4.0	0.5	0.2	1.8	1.3	0.2	0.0	0.2	2.9	0.1	0.1	0.1	0.1	24.3	12.2	0.2	24.4	3.5	0.0	0.1	0.0	0.1	0.0	0.4	0.6	0.1	16.0	16.2	0.1	0.1	0.0	25.3	0.4	0.0	0.2	0.2	0.0	0.7	0.0	1.9	0.7	0.0	0.0	0.2	0.2	5.4	0.2	0.0	1.0	0.8	1.2	4.6	0.0	0.0	0.1	2.5	0.0	1.5	9.8	0.2	0.0	0.0	37.5	0.3	0.0	1.0	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	4.0	0.2	0.9	0.5	0.0	0.1	1.4	0.5	0.0	0.0	0.0	0.6	2.5	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.5	0.0	116.1	13.0	0.0	0.6	1.3	0.2	2506.5	0.0	0.0	7.9	3.5	2.0	44.2	23.2	6.6	0.6	0.0	0.7	0.0	11.8	4.0	14.0	0.6	0.0	0.6	4.1	0.0	318.5	0.6	0.0	3.6	20.8	1.0	5.0	0.0	0.3	1.5	4.4	0.0	166.9	0.5	0.0	0.0	15.5	1.2	0.4	0.6	26.0	0.8	1.5	4.1
NISCH	"I-1, IRAS, KIAA0975"	ENSG00000010322	Nischarin	Q9Y2I1	3	52455118-52493071	"FDA approved drug targets, Predicted intracellular proteins"	Apoptosis	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 162.6;Peritubular cells: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023189	Approved		Approved	"Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Vesicles, Microtubules, Cytokinetic bridge"	"HPA023189: AB_1854495"	"unprognostic (6.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.96e-2)"	"unprognostic (8.33e-3)"	"prognostic favorable (1.91e-4)"	"unprognostic (1.40e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.05e-3)"	16.5	24.9	29.7	14.3	36.1	18.1	16.7	84.5	47.5	24.1	16.4	21.4	22.1	12.9	24.4	19.5	14.1	20.9	16.4	14.1	24.7	18.8	14.9	11.8	17.1	15.9	13.2	35.6	30.7	21.8	23.3	55.3	21.0	20.8	29.8	11.4	27.0	26.5	30.2	12.2	42.5	14.8	20.9	13.3	16.8	14.8	27.3	13.9	16.3	17.1	7.8	12.6	21.9	19.5	5.8	6.6	6.5	8.3	6.1	8.1	6.4	7.4	7.9	24.6	20.0	18.4	20.4	20.2	16.2	10.7	13.0	13.3	11.8	11.3	10.5	4.5	22.4	10.7	10.1	13.0	17.6	7.7	10.6	14.0	18.9	27.5	11.4	16.8	11.1	17.0	32.0	14.2	14.0	12.0	27.5	20.9	21.1	10.0	11.7	12.1	10.7	19.8	24.6	15.0	9.6	13.5	11.8	6.7	12.2	14.8	15.0	10.4	18.2	17.5	4.6	11.2	22.4	14.5	18.7	22.8	18.3	17.6	18.5	11.5	19.5	11.1	13.3	12.6	18.1	11.1	6.3	8.3	6.5	6.4	7.6	6.3	4.7	5.4	8.1	4.5	5.8	6.5	6.5	2.9	6.1	1.1	6.6	5.8	6.4	29.7	36.1	84.5	47.5	24.7	18.8	13.2	35.6	20.8	13.9	23.8	28.8	12.0	14.1	24.5	39.6	18.2	7.6	10.7	18.2	14.0	7.9	26.9	8.3	11.4	7.2	20.2	15.8	0.0	8.2	11.6	19.3	13.0	24.3	12.4	25.4	27.0	162.6	52.2	62.2	16.8	81.7	22.2	18.6	5.4	16.3	10.6	9.2	13.9	231.3	11.0	23.3	25.8	23.1	31.1	15.6	19.4	20.3	13.8	15.0	10.8
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 90.8"	"Cell type enriched"	"Detected in many"	5	"Ito cells: 1114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	68	"classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8"	"Group enriched"	"Detected in many"	69	"dendritic cells: 2.8;monocytes: 10.8"	"Group enriched"	"Detected in some"	47	"HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		60000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	39.5	37.6	8.0	26.7	12.8	6.5	41.3	3.2	6.8	13.1	23.4	6.9	4.2	16.1	13.6	26.4	9.7	15.5	16.8	19.7	5.4	4.2	19.2	35.8	21.7	80.7	9.1	2.7	9.9	7.1	4.9	11.9	32.1	10.2	13.5	18.0	23.7	10.4	9.7	8.0	5.1	18.7	18.3	7.2	90.8	11.6	9.7	8.7	2.6	11.9	11.4	11.1	15.9	15.4	0.0	2.8	0.0	10.8	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	33.9	0.0	0.1	0.0	0.0	0.0	0.0	46.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	6.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	8.0	12.8	3.2	6.8	5.4	4.2	9.1	2.7	10.2	8.7	0.0	6.7	12.3	0.5	5.4	1.0	2.0	12.7	0.0	0.0	3.5	0.0	1.3	0.0	0.0	0.4	14.5	0.0	46.7	0.0	1.5	3.8	0.0	17.4	8.3	103.3	0.0	1.2	1114.7	238.9	1.9	4.0	46.3	11.8	0.0	0.0	0.5	0.0	0.0	19.1	0.3	0.0	19.4	1.5	0.7	1.1	4.3	1.8	4.3	0.0	0.2
NT5DC2	FLJ12442	ENSG00000168268	"5'-nucleotidase domain containing 2"	Q9H857	3	52524385-52535054	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Peritubular cells: 127.3;Sertoli cells: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.1;memory B-cell: 1.8;myeloid DC: 2.6;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	4	"B-cells: 1.8;dendritic cells: 3.8;monocytes: 1.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050683	Approved					NA	NA					"HPA050683: AB_2681215"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	9.8	35.1	6.8	7.8	8.9	5.8	24.0	19.7	8.2	16.0	7.1	7.2	7.0	6.1	12.4	13.5	23.1	11.1	8.5	39.2	7.5	8.4	10.9	2.6	14.0	18.2	6.8	5.7	22.3	13.7	12.4	17.2	15.3	18.8	25.5	6.0	16.2	20.1	20.1	4.2	18.9	5.4	21.1	7.9	5.8	5.3	18.4	8.0	5.9	9.9	19.7	17.9	16.7	24.0	1.8	3.8	0.0	1.1	0.4	0.5	0.5	23.9	13.5	43.9	23.4	35.5	48.7	34.5	24.9	22.3	18.0	14.7	38.9	12.2	30.9	2.7	32.4	14.2	8.6	36.2	33.1	16.8	12.4	23.7	18.1	23.1	58.9	52.9	0.0	16.4	63.9	7.6	30.6	9.3	32.6	37.6	22.9	34.0	10.4	20.9	25.6	12.6	31.2	57.7	22.8	43.9	18.4	18.1	29.8	9.9	6.3	20.6	59.2	9.7	18.4	12.6	34.3	17.5	17.2	17.1	23.2	28.9	22.6	52.4	4.8	7.8	22.3	68.9	0.1	27.4	0.0	1.1	0.0	0.2	0.1	0.5	1.8	0.2	0.0	2.6	0.3	0.0	0.4	0.0	0.4	0.1	3.8	0.0	0.5	6.8	8.9	19.7	8.2	7.5	8.4	6.8	5.7	18.8	8.0	8.9	8.6	0.8	19.7	6.9	20.4	15.8	7.6	1.4	9.1	12.2	0.0	1.7	14.9	7.8	5.2	4.9	0.4	0.0	1.9	22.9	15.5	14.5	18.4	0.9	9.6	1.6	12.1	11.1	12.8	16.7	46.1	6.4	15.1	1.0	3.4	27.3	6.1	0.0	127.3	6.1	3.9	109.9	49.5	2.9	38.3	12.0	1.9	0.0	5.9	7.5
SMIM4	C3orf78	ENSG00000168273	"Small integral membrane protein 4"	Q8WVI0	3	52534013-52579237	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 90.6"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 211.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047771	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA047771: AB_2680150"	"unprognostic (3.76e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.89e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (1.78e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.25e-2)"	"prognostic favorable (5.00e-4)"	"unprognostic (6.35e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (8.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-2)"	11.1	47.3	6.8	9.3	12.0	4.1	15.9	10.3	13.4	6.0	8.7	3.2	16.0	7.5	5.2	16.3	5.5	5.0	13.0	90.6	8.4	6.1	12.2	9.3	21.7	26.5	8.5	6.9	19.1	28.3	6.2	22.1	4.1	17.4	10.6	6.7	10.5	25.8	19.1	66.8	6.7	7.9	17.0	9.1	5.7	8.5	14.1	7.6	1.8	17.3	30.8	5.3	7.0	5.3	13.7	26.2	8.8	24.7	11.0	16.9	10.4	23.0	8.1	9.5	24.0	11.2	5.8	19.4	10.5	4.9	12.1	10.6	9.9	6.2	10.0	4.8	4.4	12.2	12.2	3.1	8.4	4.9	6.6	24.6	9.4	23.2	19.9	17.0	11.1	13.1	12.5	5.2	10.2	7.4	6.6	11.0	11.0	12.4	15.0	8.1	10.0	10.3	15.6	16.1	12.7	17.3	7.1	9.1	19.7	6.7	10.1	10.3	13.0	20.5	6.8	19.8	5.6	7.0	9.4	9.7	6.7	22.0	31.6	21.3	17.5	19.0	21.9	36.8	20.9	9.2	3.5	24.7	8.8	10.8	18.7	10.5	13.7	15.6	13.2	26.2	12.5	16.9	15.2	0.9	11.0	7.5	14.0	14.9	10.4	6.8	12.0	10.3	13.4	8.4	6.1	8.5	6.9	17.4	7.6	44.7	44.8	30.4	29.5	24.2	16.1	211.3	61.1	62.9	77.3	50.6	11.8	35.0	180.8	36.8	15.8	36.5	60.3	0.0	74.3	16.7	27.7	17.7	56.7	143.5	98.6	3.2	76.2	60.8	84.6	8.0	60.1	52.8	35.4	17.2	57.4	43.6	50.1	28.1	95.1	134.6	12.7	45.3	51.1	7.7	15.8	30.2	23.1	25.9	67.6	18.2
PBRM1	"BAF180, PB1"	ENSG00000163939	"Polybromo 1"	Q86U86	3	52545352-52685917	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015629, HPA059373"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015629: AB_1855012, HPA059373: AB_2683994"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.06e-1)"	24.3	14.8	13.8	20.6	15.9	17.2	24.4	19.1	13.8	18.9	18.5	14.0	22.9	12.2	25.9	13.9	19.9	18.9	13.7	15.9	11.1	10.0	11.7	14.5	14.9	16.5	16.5	8.2	25.1	15.4	14.4	30.6	28.0	14.7	16.1	15.3	12.7	17.5	16.2	21.8	17.2	14.3	21.1	15.6	19.1	14.8	13.1	13.7	51.0	22.0	10.5	17.1	22.4	23.0	6.6	10.7	11.1	8.7	4.6	7.4	1.9	12.5	8.1	29.0	14.2	14.3	14.6	20.3	17.3	11.9	20.0	17.6	9.1	8.5	30.4	2.4	20.3	16.6	8.6	25.1	13.1	24.4	32.5	13.5	28.8	15.3	7.0	20.5	24.0	21.9	13.6	15.2	22.4	14.5	15.8	19.3	24.1	16.4	16.7	20.1	4.2	39.5	7.2	17.6	8.5	13.3	20.7	18.2	15.5	8.3	24.5	19.7	21.8	20.8	5.0	16.5	18.4	9.4	13.9	22.2	18.8	14.3	16.2	21.1	12.1	19.0	28.9	11.6	19.5	18.7	10.1	5.0	11.1	4.8	3.2	4.9	3.6	4.8	5.3	4.8	6.6	7.4	4.7	2.7	4.6	8.7	10.7	4.5	1.9	13.8	15.9	19.1	13.8	11.1	10.0	16.5	8.2	14.7	13.7	38.7	54.1	19.5	31.0	35.9	42.0	48.4	28.1	53.5	38.7	22.7	45.2	31.3	16.6	31.4	28.7	40.3	25.3	23.3	40.4	28.9	31.5	35.3	27.8	37.0	45.9	28.6	33.8	35.0	63.3	14.7	31.7	46.6	45.5	50.5	30.6	28.5	42.9	28.1	54.8	13.9	43.3	25.8	45.3	41.9	32.8	45.0	42.6	34.1	34.5	33.3
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694492	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Nucleoli rim"	"Nuclear bodies, Mitotic chromosome"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (6.11e-4)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	27.7	28.0	14.8	21.8	17.5	13.0	40.5	17.2	25.4	25.0	27.0	10.0	22.8	21.6	22.2	17.5	41.8	17.4	16.1	20.5	21.6	15.9	19.3	50.4	19.5	26.6	18.4	15.7	27.2	45.1	14.1	43.3	24.7	23.4	28.3	27.0	8.8	30.3	27.3	52.2	24.1	21.2	19.5	19.6	32.0	22.7	15.0	16.9	18.3	18.1	34.3	35.8	44.3	24.9	16.2	21.6	1.8	8.9	13.6	19.4	10.0	21.6	16.2	23.7	25.4	22.6	23.1	36.4	26.7	21.2	28.6	21.5	24.4	15.9	50.6	8.9	20.5	22.0	15.7	39.1	25.5	38.4	31.6	27.8	38.7	27.6	37.4	47.2	55.0	28.7	20.5	45.5	30.9	48.3	19.1	22.4	20.5	42.5	27.1	19.4	15.4	33.0	30.7	40.9	31.2	31.8	19.6	19.3	62.6	22.5	30.3	16.9	21.7	16.7	38.4	37.4	22.2	15.1	31.2	17.3	19.2	20.4	27.9	55.8	29.9	48.3	76.7	20.4	40.1	30.2	0.6	8.0	1.8	11.3	8.9	19.4	16.2	15.3	13.4	13.9	13.5	17.7	16.6	1.0	13.6	6.4	21.6	9.7	10.0	14.8	17.5	17.2	25.4	21.6	15.9	18.4	15.7	23.4	16.9	20.8	41.6	75.9	90.4	145.4	17.9	47.2	20.4	58.9	134.2	12.2	9.8	64.5	34.9	72.1	42.3	45.7	17.0	23.3	90.4	94.6	60.7	74.6	59.2	40.2	36.4	20.6	45.8	21.5	21.0	20.0	48.1	42.7	74.2	74.9	51.9	16.5	84.9	24.6	32.2	31.0	12.2	6.5	94.8	32.6	58.9	134.4	75.5	45.9	64.1	112.5
GLT8D1	"AD-017, FLJ14611"	ENSG00000016864	"Glycosyltransferase 8 domain containing 1"	Q68CQ7	3	52694488-52706032	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010588	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA010588: AB_1078098"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.42e-3)"	"unprognostic (3.97e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.21e-2)"	18.6	23.7	16.1	14.5	20.9	4.7	21.0	15.3	19.9	29.3	17.3	18.3	22.1	14.6	23.5	26.8	14.1	31.9	19.9	19.3	16.6	17.0	23.2	39.4	16.8	16.0	17.9	14.4	32.4	23.6	24.3	40.8	34.7	18.1	21.1	18.9	19.7	22.0	25.2	11.5	13.0	15.2	18.7	17.4	14.8	16.0	43.3	21.6	17.5	37.8	11.6	14.7	21.8	16.8	8.6	15.7	20.5	8.4	20.1	16.3	6.6	8.1	9.7	19.7	15.5	43.7	55.6	11.0	20.6	31.9	18.2	20.9	4.5	15.5	6.9	5.9	35.7	22.0	9.3	12.4	21.1	24.1	12.4	9.0	6.5	17.8	20.6	21.0	9.7	20.5	31.9	18.8	15.6	20.2	42.3	27.0	12.0	8.3	16.0	23.8	8.3	6.5	14.9	10.0	14.4	18.2	5.0	11.2	23.3	21.2	8.9	8.1	13.9	17.1	8.4	13.9	19.2	14.1	12.8	19.7	13.2	10.3	19.1	11.4	18.1	20.5	7.7	23.1	15.5	16.6	20.5	8.4	14.1	13.3	5.7	13.2	8.6	16.0	14.3	8.1	6.4	16.3	11.5	4.8	20.1	6.0	15.7	10.6	6.6	16.1	20.9	15.3	19.9	16.6	17.0	17.9	14.4	18.1	21.6	0.0	8.1	11.5	17.3	10.8	37.5	11.3	7.6	33.5	15.9	17.4	11.8	47.2	19.9	28.5	40.0	19.6	13.1	0.0	23.8	55.2	49.3	12.9	5.7	29.3	23.5	20.6	17.9	35.0	14.5	13.6	49.8	10.6	23.6	34.3	18.6	33.9	21.1	19.2	45.6	19.8	17.9	25.8	15.9	90.1	50.7	6.9	21.9	21.5	17.5	6.7
SPCS1	"HSPC033, SPC1, SPC12, YJR010C-A"	ENSG00000114902	"Signal peptidase complex subunit 1"	Q9Y6A9	3	52704955-52711146	"Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046091, HPA055273"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA046091: AB_10959614, HPA055273: AB_2682768"	"unprognostic (5.47e-2)"	"unprognostic (4.04e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (5.93e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.09e-2)"	31.0	53.4	39.7	28.5	41.5	27.5	42.2	24.2	55.3	39.1	46.3	40.8	46.3	47.8	34.9	53.2	39.1	33.9	35.6	39.4	38.0	47.0	62.3	98.7	37.1	68.9	47.2	38.1	34.7	112.1	30.5	48.8	50.9	41.7	41.0	41.6	38.4	87.7	57.8	43.2	34.3	53.4	34.2	48.3	37.4	45.7	57.1	25.5	42.6	55.2	38.3	52.0	36.6	30.2	40.2	123.4	48.5	27.8	22.2	34.1	43.1	21.5	20.5	19.5	25.2	31.5	25.7	32.5	30.0	27.5	27.2	24.5	21.4	31.6	23.1	13.2	27.1	26.0	20.8	19.7	28.0	26.5	30.8	23.7	27.3	34.0	29.8	35.6	37.8	45.2	21.0	36.8	30.0	32.7	22.3	22.0	29.0	23.2	73.4	27.7	20.9	29.9	38.4	37.1	53.1	42.6	12.2	18.2	116.3	40.0	26.6	14.1	31.8	29.5	31.7	39.8	18.0	35.4	43.4	20.8	24.6	23.1	44.0	35.3	81.0	120.8	32.6	38.1	41.8	32.0	45.3	26.0	48.5	27.8	26.0	32.8	40.2	34.1	30.5	28.4	29.0	32.2	32.8	19.8	22.2	27.8	123.4	33.9	43.1	39.7	41.5	24.2	55.3	38.0	47.0	47.2	38.1	41.7	25.5	59.6	94.5	189.7	185.2	139.0	485.2	136.5	219.1	186.0	126.3	294.8	111.9	309.5	306.7	288.1	445.8	151.7	198.8	93.5	296.3	331.3	163.9	238.4	205.7	300.1	274.6	96.9	161.0	125.8	194.0	878.2	200.2	191.2	361.0	334.6	203.8	220.7	242.0	238.9	180.4	563.8	195.8	161.7	195.7	623.3	495.0	161.2	293.7	203.7	226.0	258.6
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708449-52770949	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.7"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 58.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA015750: AB_1854367, HPA058543: AB_2732623"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	7.2	10.7	15.5	9.1	15.7	7.3	11.0	20.2	16.1	10.6	8.4	10.6	9.6	7.6	10.3	10.7	8.1	15.8	7.5	7.4	12.5	14.2	11.6	12.4	7.7	8.8	12.7	8.6	15.8	10.2	13.4	17.6	8.7	11.9	9.4	9.7	9.1	8.5	11.3	10.8	5.3	6.6	9.5	10.7	7.9	11.0	47.7	12.4	11.1	15.5	5.0	10.4	9.3	10.7	5.1	6.4	12.4	11.8	4.6	5.2	5.5	12.9	10.1	13.9	10.9	12.7	9.2	15.1	9.2	12.5	17.3	17.5	8.8	9.7	13.3	4.3	9.0	19.1	6.1	16.9	10.9	23.2	13.3	7.1	10.4	12.3	11.2	7.9	25.4	10.5	5.6	10.1	22.1	14.8	9.2	6.4	11.7	12.9	10.9	10.9	11.1	13.7	9.3	12.0	13.7	10.0	12.0	12.1	9.8	9.8	18.7	10.3	6.1	19.4	11.9	9.1	11.2	11.1	15.3	5.9	11.6	11.8	18.5	17.0	12.2	17.7	13.1	13.3	12.0	12.5	12.4	11.8	5.8	4.6	7.3	5.2	3.6	4.0	4.8	6.4	5.1	4.9	4.2	1.8	4.6	4.8	3.2	3.1	5.5	15.5	15.7	20.2	16.1	12.5	14.2	12.7	8.6	11.9	12.4	11.9	5.1	9.5	4.6	3.7	12.7	3.5	0.0	21.4	15.9	5.2	11.8	6.1	8.3	6.4	16.2	5.3	5.1	0.0	8.4	6.8	4.6	6.5	7.0	13.4	7.2	6.4	4.6	4.9	14.9	16.1	13.6	7.0	1.7	5.4	9.6	16.2	7.8	0.0	11.7	14.6	17.4	6.5	5.9	58.3	31.9	3.6	5.6	5.3	8.2	4.1
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777592-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	95	"liver: 321.2"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 864.9"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.9;Hep G2: 3.3;HL-60: 2.5;RH-30: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	4490000	31000000000	Vesicles		"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	321.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	38.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	864.9	0.1	0.0	0.0	18.4	14.8	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.5	0.0	0.0
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	233	"liver: 326.9"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 931.8"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 19.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	NA	NA		4500000000			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	0.9	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0.0	0.5	0.5	0.3	0.3	0.5	0.2	0.1	0.0	0.2	326.9	0.4	0.3	0.2	0.1	0.6	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.2	0.2	0.4	0.3	0.1	0.1	0.1	0.1	1.4	0.1	0.4	0.1	0.1	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	35.0	0.0	0.1	0.5	0.4	91.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.5	0.0	23.3	0.0	0.0	0.1	0.0	0.0	931.8	0.0	0.0	0.0	69.3	71.7	90.2	1.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.0	0.0	6.7	0.2	0.1	0.1	0.2	0.5	0.0	0.0
ITIH4	"H4P, IHRP, ITIHL1"	ENSG00000055955	"Inter-alpha-trypsin inhibitor heavy chain family member 4"	Q14624	3	52812975-52831479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 461.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 104.1;Hepatocytes: 95.7;Late spermatids: 94.2"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 7.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.3;JURKAT: 4.5;U-266/70: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001835, HPA003948, CAB072872"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	3060000	53000000000	Vesicles		"CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433"	"unprognostic (6.08e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-14)"	"unprognostic (1.71e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.21e-5)"	0.5	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.1	1.3	0.2	0.1	0.1	0.6	0.1	0.0	0.2	461.4	0.2	0.1	0.1	0.2	0.2	22.8	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.2	4.1	0.1	0.1	0.2	0.1	0.5	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.3	0.3	0.6	0.6	2.6	0.8	0.0	0.0	0.4	1.0	2.1	1.1	0.0	0.4	0.1	0.0	0.0	0.2	0.3	0.2	1.3	0.0	0.5	0.2	1.1	0.0	0.0	0.5	5.3	0.2	2.2	0.0	2.8	0.9	2.4	0.2	0.3	0.3	0.0	0.1	0.0	0.0	4.5	0.6	1.8	0.0	0.2	0.5	0.7	1.0	0.2	0.0	1.8	1.0	0.0	0.8	0.7	0.1	1.0	0.7	0.0	0.4	1.1	1.1	0.7	0.2	0.0	0.9	1.0	0.0	6.5	3.0	0.5	0.1	0.7	1.2	0.0	0.6	0.0	0.1	0.1	0.1	0.3	0.7	0.0	0.0	0.2	0.0	0.8	0.6	2.6	0.1	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.6	1.9	0.2	0.7	10.2	0.4	5.1	0.0	1.2	0.0	11.8	0.0	0.0	0.3	104.1	0.6	0.0	23.3	2.3	0.0	0.4	0.3	0.0	95.7	0.4	4.8	0.0	3.1	2.6	94.2	1.1	1.6	0.0	1.0	0.0	1.7	3.5	0.0	1.8	0.0	5.6	6.5	2.1	0.9	1.4	0.3	0.2	1.3	0.0	0.1
MUSTN1	Mustang	ENSG00000272573	"Musculoskeletal, embryonic nuclear protein 1"	Q8IVN3	3	52833114-52835219	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"skeletal muscle: 252.5"	"Cell type enriched"	"Detected in single"	7	"Alveolar cells type 2: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 9.5;HSkMC: 6.0;RH-30: 8.5"															NA	NA						"unprognostic (2.79e-2)"	"unprognostic (3.73e-2)"			"unprognostic (4.11e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.88e-2)"	12.1	1.8	2.5	1.8	5.2	1.3	6.1	1.5	5.7	16.0	4.6	2.6	2.4	1.7	11.1	18.9	7.9	6.4	10.6	15.5	2.6	2.2	1.8	0.8	3.2	1.4	4.3	3.9	5.1	1.6	0.8	1.1	1.3	5.2	11.6	3.4	3.8	5.9	8.9	252.5	2.7	2.6	6.1	2.2	0.9	2.3	6.4	0.2	0.0	5.4	26.9	3.6	8.1	7.9	0.0	0.0	2.1	0.6	0.0	0.3	0.2	0.1	0.2	3.0	0.0	0.8	2.1	3.5	0.2	0.9	0.4	0.3	0.4	0.5	0.0	0.0	1.4	0.1	1.3	0.7	0.6	0.5	0.1	0.9	0.0	1.6	9.5	1.4	1.9	0.6	6.0	1.0	0.9	0.0	1.4	1.2	0.4	0.2	0.0	0.1	0.6	0.7	2.8	0.4	0.4	2.2	1.0	8.5	0.0	0.6	0.0	0.3	0.3	0.6	0.7	1.5	3.2	0.0	0.7	0.0	0.4	0.7	1.2	0.6	0.0	0.1	0.0	0.3	2.4	0.3	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.6	0.0	0.0	0.2	2.5	5.2	1.5	5.7	2.6	2.2	4.3	3.9	5.2	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM110-MUSTN1		ENSG00000248592	"TMEM110-MUSTN1 readthrough"		3	52833121-52897562	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.0"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 2: 1.4;Cholangiocytes: 2.5;Club cells: 1.2;Exocrine glandular cells: 1.6;Ito cells: 1.3;Kupffer cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.3;Karpas-707: 9.1"									HPA051855	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051855: AB_2681639"	"unprognostic (4.19e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.95e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.11e-4)"	"unprognostic (4.73e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.01e-6)"	"unprognostic (5.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.09e-5)"	13.3	6.7	3.8	5.4	7.6	5.2	5.8	5.2	9.6	4.9	5.5	8.6	3.7	4.1	8.6	3.4	6.4	4.2	3.8	5.8	4.1	3.7	8.0	23.6	5.0	8.6	6.6	3.4	5.2	9.2	2.0	3.8	3.9	6.0	4.1	2.6	6.0	5.5	3.1	58.0	4.2	7.9	7.8	4.8	5.7	5.0	3.9	4.1	8.6	4.4	2.7	6.1	5.8	5.7	0.9	1.6	1.6	1.7	0.0	2.3	0.4	1.5	0.8	1.6	6.2	0.5	0.0	0.0	3.2	1.0	0.2	0.4	0.0	1.0	1.1	0.5	0.0	2.2	1.4	1.6	1.6	0.0	8.3	3.3	2.1	0.0	0.0	0.2	1.4	3.2	0.0	0.6	0.6	1.3	0.0	0.3	4.2	0.9	9.1	0.1	1.0	1.9	1.1	1.1	0.6	4.2	0.3	0.0	2.0	0.3	0.0	0.6	0.4	0.8	0.9	1.9	0.4	0.7	3.1	0.9	1.1	2.9	1.2	1.8	4.2	3.8	1.2	1.4	4.0	1.7	0.0	0.2	1.6	0.4	1.7	2.3	0.9	0.7	0.9	0.8	0.3	0.0	0.0	0.4	0.0	0.0	1.6	0.6	0.4	3.8	7.6	5.2	7.6	4.1	3.7	6.6	3.4	6.0	4.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.2	0.0	0.0	0.3	0.0	1.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
STIMATE	"MGC52022, TMEM110"	ENSG00000213533	"STIM activating enhancer"	Q86TL2	3	52836219-52897596	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 17.4;Collecting duct cells: 7.0;Hofbauer cells: 8.1;Proximal tubular cells: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA051855	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051855: AB_2681639"	"unprognostic (1.45e-1)"	"unprognostic (7.93e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.55e-4)"	"unprognostic (3.34e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	12.0	13.0	8.9	12.0	13.9	26.4	12.8	11.6	16.1	12.5	10.7	17.8	8.8	7.8	14.4	7.9	9.2	17.7	9.6	8.3	9.5	6.7	9.9	34.7	15.2	18.1	9.9	8.1	12.2	19.2	7.7	8.9	7.8	13.0	10.2	6.7	13.0	12.8	11.5	17.9	10.5	10.1	16.5	10.2	14.9	11.2	8.4	9.5	18.0	11.8	6.8	13.2	12.5	12.5	1.7	4.0	1.7	5.8	0.7	4.6	1.4	6.8	6.0	9.2	15.9	20.9	13.3	18.5	10.1	11.3	13.7	12.6	7.3	7.2	6.7	2.0	11.5	13.1	6.5	10.8	9.8	9.6	14.9	8.3	10.9	7.6	11.4	14.0	16.4	8.4	10.5	13.6	15.3	6.9	8.6	11.1	10.9	3.8	6.7	11.4	5.6	8.9	9.2	8.3	5.6	12.3	4.9	7.1	4.5	6.4	8.9	2.0	6.8	10.2	7.0	9.5	5.4	5.9	14.3	11.2	10.9	6.4	14.3	12.0	13.1	8.4	6.3	9.5	16.5	8.3	0.0	3.3	1.7	2.2	5.8	1.8	1.7	3.5	2.4	4.0	1.5	1.9	1.4	0.3	0.7	5.5	2.3	4.6	1.4	8.9	13.9	11.6	16.1	9.5	6.7	9.9	8.1	13.0	9.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	17.4	1.2	7.0	0.0	1.5	1.7	2.1	0.0	0.0	0.0	0.0	2.5	5.3	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	2.7	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0
SFMBT1	"DKFZp434L243, RU1, SFMBT"	ENSG00000163935	"Scm like with four mbt domains 1"	Q9UHJ3	3	52903572-53046750	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 30.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036152, HPA064564"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036152: AB_2674972, HPA064564: AB_2685288"	"unprognostic (2.78e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.39e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.57e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.55e-2)"	3.1	2.4	5.1	7.0	3.7	5.5	6.8	10.5	5.8	3.2	4.9	3.1	2.7	3.1	2.8	5.2	4.9	3.7	3.8	4.8	4.1	2.4	4.5	6.3	7.3	6.3	2.6	4.3	2.4	11.8	15.1	12.0	3.1	3.1	4.6	5.4	2.9	4.6	2.1	17.7	4.8	4.4	4.1	4.1	5.9	4.2	30.2	2.4	3.9	5.1	2.7	5.6	3.2	12.9	8.2	0.9	10.9	2.1	3.6	5.3	2.4	15.3	4.2	6.9	12.4	1.5	1.1	14.0	3.4	3.2	10.3	12.8	8.6	13.3	7.9	4.0	2.1	11.3	1.3	6.8	4.3	12.5	14.3	4.3	6.6	8.9	3.8	2.4	10.4	6.9	1.0	6.3	7.0	4.8	1.1	1.8	9.1	2.2	11.9	3.4	4.8	6.5	4.2	3.6	5.9	4.5	5.9	6.3	4.4	1.4	16.6	8.1	5.1	14.5	6.0	7.3	0.8	3.9	9.7	1.1	4.6	10.4	7.9	10.4	5.7	19.9	16.9	4.2	4.3	7.7	2.0	2.1	10.9	3.4	1.1	4.5	8.2	5.2	3.1	0.9	6.9	4.8	5.3	3.8	3.6	1.1	0.9	2.5	2.4	5.1	3.7	10.5	5.8	4.1	2.4	2.6	4.3	3.1	2.4	8.9	6.5	14.7	7.5	10.3	13.3	13.7	12.7	13.4	6.8	1.8	43.2	8.8	6.6	6.0	33.8	4.5	6.2	23.3	11.7	8.3	4.2	7.6	9.2	12.4	5.6	7.9	5.8	3.7	5.3	43.6	2.0	5.4	0.0	4.6	8.5	6.0	8.6	8.6	7.1	6.9	21.2	6.5	5.9	123.8	23.2	7.5	4.5	12.5	10.6	4.2
RFT1	CDG1N	ENSG00000163933	"RFT1 homolog"	Q96AA3	3	53088483-53130462	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA060327, HPA069022"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA060327: AB_2684253, HPA069022: AB_2732126"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.54e-2)"	12.9	19.1	10.8	13.8	14.7	7.2	13.2	11.0	19.2	11.9	11.7	17.0	9.6	10.2	16.2	14.0	16.9	13.0	11.0	12.4	10.2	7.4	10.1	17.7	11.6	15.3	10.5	10.5	15.5	43.7	15.4	9.4	13.8	10.6	11.0	13.8	13.4	18.6	11.3	7.0	13.4	10.5	11.6	11.5	14.5	12.8	23.8	11.1	16.8	15.2	9.1	16.3	12.5	12.1	16.5	27.5	25.9	23.1	11.7	14.5	13.6	16.2	15.4	10.6	16.9	12.5	13.3	22.1	14.8	13.9	25.9	23.7	15.2	32.1	21.5	9.3	14.2	24.4	17.5	23.9	24.2	23.0	20.2	10.5	21.2	11.2	15.0	21.9	19.3	12.5	14.0	20.5	34.8	25.2	11.5	16.4	22.6	11.1	19.7	17.0	16.5	18.1	11.4	21.2	28.4	20.3	7.5	10.2	32.6	14.3	11.0	6.0	8.2	18.3	13.5	13.3	12.0	10.1	27.6	10.8	24.1	15.6	16.4	29.0	12.5	15.0	16.3	17.2	24.8	25.1	25.9	23.1	9.9	13.3	22.4	13.4	12.2	12.5	13.6	24.1	16.5	14.5	14.5	7.7	11.7	15.5	27.5	10.9	13.6	10.8	14.7	11.0	19.2	10.2	7.4	10.5	10.5	10.6	11.1	3.0	3.0	0.8	9.0	4.4	3.9	5.9	10.2	5.3	4.5	8.7	3.9	35.2	1.7	14.2	1.0	5.8	4.3	0.0	18.4	27.2	7.5	7.0	2.3	9.5	19.8	4.8	2.4	10.4	8.7	1.4	8.1	4.7	6.8	10.8	6.7	4.9	11.3	10.2	5.6	4.8	6.1	0.0	2.8	9.3	9.6	3.8	20.3	6.4	10.0	6.4
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in all"	7	"dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 64.7;THP-1: 46.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 124.2;thalamus: 366.1"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		300000	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.24e-4)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	27.8	33.4	9.4	29.7	11.5	30.3	17.6	5.7	10.7	10.3	27.8	10.1	43.7	21.4	5.5	21.3	18.3	16.1	33.7	11.9	8.3	3.7	16.5	4.5	29.2	24.5	10.2	5.6	8.1	13.4	6.1	5.1	7.5	7.1	17.9	16.1	10.3	14.1	40.7	3.9	17.1	42.9	17.4	10.2	32.1	24.8	9.6	8.0	10.5	26.9	13.4	26.3	22.9	12.7	3.1	17.6	20.7	22.9	2.4	1.5	6.4	7.9	3.0	1.2	2.1	9.2	5.3	11.4	4.8	6.1	5.9	5.8	7.4	7.8	20.4	2.1	10.4	10.3	3.6	8.1	11.8	4.9	17.8	6.1	11.3	4.2	7.9	5.9	14.9	25.7	4.1	8.6	6.1	5.6	5.3	5.1	2.2	2.2	2.9	8.5	19.5	1.6	25.5	3.2	11.9	5.6	1.7	3.1	4.9	6.4	17.0	2.0	1.4	3.6	64.7	9.9	6.3	5.4	46.1	7.4	2.9	3.6	3.8	4.5	4.5	6.9	10.5	6.8	25.8	5.5	17.7	22.9	17.0	1.5	22.2	1.0	3.1	1.1	1.2	17.6	2.9	0.8	0.7	20.7	2.4	15.3	8.5	1.1	6.4	9.4	11.5	5.7	10.7	8.3	3.7	10.2	5.6	7.1	8.0	3.0	19.7	17.6	21.2	26.0	0.0	4.5	12.7	16.0	17.0	14.0	0.0	2.5	3.3	7.6	26.7	1.8	56.8	0.0	9.6	13.5	8.7	14.8	5.7	1.7	38.4	1.6	25.5	3.7	43.0	59.4	8.3	35.2	10.1	21.6	29.0	1.8	10.3	49.1	6.3	10.9	0.0	6.5	9.4	5.2	1.9	24.3	7.3	7.5	20.6	28.8
TKT		ENSG00000163931	Transketolase	P29401	3	53224707-53256052	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 216.3"	"Cell type enhanced"	"Detected in all"	5	"Kupffer cells: 587.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		190000000	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	53.6	37.0	21.2	24.1	26.0	216.3	70.1	18.1	24.3	19.0	24.3	21.1	9.9	31.8	16.9	9.5	60.4	21.8	36.5	15.3	19.4	23.0	51.9	27.4	50.1	45.6	33.4	16.0	35.2	69.9	22.5	16.9	29.8	28.7	25.2	19.6	17.5	21.0	21.6	5.2	16.8	22.5	34.5	28.2	45.6	24.5	10.8	23.3	44.8	67.7	37.9	25.1	58.2	57.3	6.8	32.5	60.1	63.0	4.7	5.7	37.6	31.4	159.3	22.8	25.3	50.9	62.2	46.6	21.3	37.0	37.0	35.4	44.0	81.1	39.6	10.3	31.1	71.5	45.6	39.5	80.3	11.0	13.2	21.9	26.4	111.4	66.0	62.3	32.2	17.8	45.0	46.2	44.2	22.8	101.2	46.5	33.7	18.7	17.3	15.0	38.5	33.6	36.1	77.4	61.4	38.5	20.3	10.4	73.6	57.8	53.5	14.8	11.0	39.7	63.6	38.3	72.9	19.8	44.6	34.8	11.4	17.7	33.7	40.7	10.0	18.7	23.7	25.0	32.7	21.2	7.0	63.0	41.5	3.0	31.0	3.8	6.8	4.4	3.4	32.5	3.5	4.6	3.4	60.1	4.7	35.5	5.5	5.7	37.6	21.2	26.0	18.1	24.3	19.4	23.0	33.4	16.0	28.7	23.3	125.0	107.1	122.7	318.5	70.5	32.5	12.0	68.8	60.2	69.4	59.3	27.5	317.9	68.0	167.6	5.0	48.1	125.0	23.3	233.6	204.0	47.6	102.3	61.2	73.1	233.2	35.0	50.5	56.4	587.5	2.7	145.6	247.7	72.6	160.5	113.7	78.1	222.7	69.1	100.4	170.5	36.1	51.8	72.1	14.1	21.1	58.6	345.9	84.1	213.7	357.0
DCP1A	"HSA275986, SMAD4IP1, SMIF"	ENSG00000272886	"Decapping mRNA 1A"	Q9NPI6	3	53283428-53347610	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 30.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013202	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA013202: AB_1857287"	"unprognostic (2.10e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (9.01e-4)"	"unprognostic (9.79e-3)"	"unprognostic (7.68e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.33e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	8.0	5.7	4.8	5.4	6.9	18.5	6.1	11.1	8.8	7.2	4.7	6.8	2.1	3.9	8.4	5.8	5.5	6.5	5.5	5.4	4.3		4.6	4.9	5.1	6.3	5.1	3.7	11.2	6.9	8.5	10.0	9.9	5.8	5.8	5.8	7.0	3.8	5.0	5.0	4.9	6.4	7.6	5.8	6.5	4.1	4.9	6.0	11.4	6.1	4.0	10.0	8.2	5.8	26.7	17.4	23.6	25.8	29.4	30.3	19.0	5.8	6.1	14.4	11.6	9.9	10.4	19.3	6.9	9.2	15.4	14.5	17.9	10.7	13.6	2.8	8.7	9.0	5.0	18.7	7.1	13.4	12.1	8.3	13.3	8.4	9.2	8.7	15.7	18.2	8.1	6.9	13.8	11.3	9.4	11.1	9.6	11.1	14.8	7.4	3.6	21.6	7.9	9.1	6.1	8.9	10.0	9.7	9.4	6.4	13.3	7.6	12.3	12.0	7.9	10.3	11.2	5.1	12.2	11.9	7.4	10.6	7.5	10.3	9.3	8.0	15.7	9.0	9.1	13.1	23.6	13.6	22.4	24.3	14.4	30.1	21.7	24.8	28.1	15.0	26.7	30.3	28.1	13.9	29.4	25.8	17.4	16.9	19.0											26.8	30.7	38.9	43.4	51.1	29.0	23.8	15.3	8.1	19.4	7.0	45.2	35.0	3.3	24.3	8.2	29.2	20.6	0.0	30.3	45.7	31.6	39.2	36.8	11.0	17.6	27.0	49.6	26.4	22.2	19.1	23.0	23.0	10.1	34.3	24.7	17.5	34.8	14.0	24.4	13.1	28.3	12.9	30.9	12.2	16.6	36.0	53.5	27.4	26.1	50.6
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 45.9;Cone photoreceptor cells: 33.4;Intestinal endocrine cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 7.2"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 14.4;RPMI-8226: 33.6;SK-BR-3: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.6	13.4	10.0	0.8	12.6	1.4	3.6	12.2	16.5	11.2	2.8	3.7	0.1	3.3	6.8	13.2	1.2	14.9	6.2	1.8	5.3	3.5	4.2	3.0	9.0	0.5	2.5	9.6	1.2	5.3	3.0	13.6	1.4	8.7	5.7	3.1	10.1	1.1	3.5	0.6	1.5	4.2	1.7	2.2	4.4	1.8	3.0	1.6	0.0	5.2	0.0	0.6	2.3	0.6	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.0	0.0	0.1	33.6	0.3	2.2	3.1	1.3	0.2	6.3	0.7	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	7.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.0	12.6	12.2	16.5	5.3	3.5	2.5	9.6	8.7	1.6	3.0	45.9	0.0	0.6	0.8	23.0	1.2	12.7	14.7	14.8	1.8	33.4	0.6	0.0	5.5	3.6	0.5	3.3	0.0	2.0	0.1	1.0	2.6	11.6	2.4	0.2	7.9	57.1	0.0	1.0	4.9	4.0	0.3	5.0	0.0	2.7	2.5	2.6	3.5	25.5	1.6	13.0	0.0	2.8	1.1	2.5	0.9	0.2	1.3	4.5	0.6
CHDH		ENSG00000016391	"Choline dehydrogenase"	Q8NE62	3	53812335-53846390	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.6;liver: 24.0"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 53.5;Proximal tubular cells: 81.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 6.4;T-reg: 2.8"	"Group enriched"	"Detected in many"	15	"granulocytes: 6.4;T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.0;Hep G2: 24.6;OE19: 17.7;T-47d: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036633, HPA058130"	Enhanced					NA	NA					"HPA036633: AB_10670841, HPA058130: AB_2683615"	"unprognostic (3.40e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.26e-3)"	"unprognostic (7.17e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (1.88e-8)"	"unprognostic (3.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.29e-2)"	0.7	2.2	11.6	2.3	9.7	0.9	7.8	12.9	10.2	4.1	8.8	8.2	0.8	8.3	3.2	3.8	1.0	2.8	5.5	3.3	13.8	4.0	36.6	24.0	2.6	1.4	11.9	6.5	1.6	15.5	8.0	5.9	0.8	10.0	5.4	9.4	3.3	13.7	1.5	3.8	1.6	14.0	1.4	6.4	0.7	8.1	4.5	13.0	0.0	4.1	0.1	1.6	0.8	1.0	0.3	0.1	6.4	0.1	0.1	2.8	0.1	0.3	3.3	0.8	0.1	0.0	0.0	3.7	0.2	0.4	0.0	0.0	8.0	0.6	0.3	0.6	0.6	0.1	0.0	5.3	0.0	0.0	0.0	2.8	0.0	1.1	24.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.8	0.5	0.0	4.7	0.0	0.1	5.2	17.7	0.6	0.0	1.4	5.6	3.7	2.9	2.2	2.8	1.3	0.1	0.0	0.7	8.1	0.1	0.0	0.0	0.6	0.1	0.7	0.7	1.0	0.0	0.0	0.0	0.0	6.4	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.1	2.8	0.1	11.6	9.7	12.9	10.2	13.8	4.0	11.9	6.5	10.0	13.0	3.0	5.0	2.7	6.1	6.0	16.8	7.6	53.5	6.7	10.3	10.4	13.7	2.5	6.6	15.1	21.5	0.7	23.4	0.0	11.9	1.8	2.1	17.6	6.9	38.9	0.3	1.6	46.0	1.3	1.9	28.5	5.5	1.9	3.3	0.0	34.1	13.4	9.1	17.5	14.5	81.4	14.6	0.0	1.9	3.3	1.9	4.5	0.7	1.5	45.1	1.2
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846580-53865800	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 63.0;liver: 26.6"	"Group enriched"	"Detected in many"	4	"Intestinal endocrine cells: 28.0;Proximal tubular cells: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 11.1;Hep G2: 32.2;OE19: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002837, HPA005482"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitotic spindle,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"HPA002837: , HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	1.1	2.1	13.4	2.2	12.2	0.9	9.2	15.1	14.7	17.1	5.8	6.8	0.0	5.1	5.0	1.3	1.9	3.2	2.4	2.5	17.1	7.4	63.0	26.6	3.5	2.3	11.9	6.4	1.8	5.3	1.4	3.9	1.2	11.2	2.5	6.1	1.9	4.1	1.0	1.4	2.3	5.1	1.2	11.3	1.4	3.4	2.5	15.2	0.0	2.9	0.0	1.0	1.7	1.0	0.9	1.1	4.1	0.6	0.5	3.1	0.5	0.8	1.7	2.5	1.9	0.0	0.0	4.0	1.7	0.0	0.0	0.0	11.1	0.8	2.5	0.6	0.5	0.9	0.4	6.8	0.0	0.0	0.9	1.9	3.3	3.4	32.2	0.0	3.0	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.9	2.6	1.2	0.0	2.2	0.5	1.2	6.8	25.2	1.4	0.9	1.0	2.9	0.7	2.9	3.6	2.1	5.6	1.3	1.0	1.9	5.2	1.1	1.3	1.7	1.9	1.5	2.1	2.6	2.9	1.6	1.5	1.8	0.9	4.1	0.6	0.2	1.0	0.6	0.6	0.5	2.1	0.6	0.2	0.9	0.8	0.9	0.3	0.5	0.2	1.1	3.1	0.5	13.4	12.2	15.1	14.7	17.1	7.4	11.9	6.4	11.2	15.2	0.0	2.6	0.0	2.0	0.2	0.0	3.4	10.2	0.0	2.3	0.0	0.0	0.3	8.3	3.7	0.8	0.0	1.3	0.0	1.3	0.9	0.2	6.7	2.3	8.9	0.1	0.0	28.0	0.6	0.0	0.0	1.1	0.8	0.0	0.0	4.3	4.5	2.7	2.0	0.4	57.9	0.0	0.0	0.6	0.4	1.3	0.1	0.3	0.0	6.6	0.5
ACTR8	INO80N	ENSG00000113812	"ARP8 actin related protein 8 homolog"	Q9H981	3	53867066-53882202	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 28.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065236			Supported	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA065236: AB_2685442"	"unprognostic (9.05e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.97e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (2.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.68e-2)"	"prognostic favorable (7.88e-9)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	13.2	11.2	19.8	12.6	20.0	11.3	12.9	25.6	24.5	13.7	12.4	13.9	10.5	9.9	14.1	14.3	14.1	12.8	11.3	24.3	18.2	13.7	17.9	11.8	12.4	17.0	17.7	15.5	15.0	15.8	21.9	22.0	14.8	16.0	13.0	16.8	12.5	14.2	12.6	20.1	14.5	11.9	15.3	16.1	14.4	12.6	27.5	19.9	19.9	16.8	10.5	19.2	16.1	11.8	6.1	6.3	28.8	7.1	8.6	8.5	4.4	6.5	8.1	15.9	13.1	13.1	16.5	11.9	15.5	19.8	21.0	16.8	12.6	8.0	20.0	4.6	21.3	15.5	5.6	11.9	10.7	20.0	8.1	4.9	19.9	12.6	13.4	15.5	21.1	17.9	12.9	11.0	21.7	13.7	16.3	16.2	10.7	8.9	7.0	21.1	7.6	7.0	12.6	14.8	9.5	12.9	9.3	9.9	12.0	15.9	18.4	4.7	13.7	10.1	8.8	8.9	15.7	5.7	11.8	11.0	16.1	10.5	14.7	14.0	19.6	24.9	20.5	11.9	15.5	10.0	28.8	4.7	5.8	5.8	7.1	5.8	6.1	5.4	5.5	6.3	3.8	5.7	6.1	2.4	8.6	4.2	4.6	8.5	4.4	19.8	20.0	25.6	24.5	18.2	13.7	17.7	15.5	16.0	19.9	3.0	7.7	7.8	6.1	6.9	6.5	17.8	10.2	2.7	4.5	3.5	3.9	10.4	18.3	13.2	35.7	7.7	5.2	0.0	13.7	9.4	7.1	5.7	5.7	4.7	10.2	1.6	10.4	7.4	6.3	71.4	10.0	8.2	5.0	13.6	9.0	7.0	11.6	2.9	9.2	15.9	4.7	0.0	9.2	17.6	15.4	5.6	8.6	12.2	5.7	5.4
SELENOK	SELK	ENSG00000113811	"Selenoprotein K"	Q9Y6D0	3	53884410-53891988	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 244.0;Pancreatic endocrine cells: 237.2;Proximal tubular cells: 306.1;Syncytiotrophoblasts: 292.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 78.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 78.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008196	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008196: AB_1856665"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.85e-1)"	"prognostic favorable (7.18e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.56e-3)"	20.4	33.5	29.2	19.0	30.2	38.8	24.1	19.7	21.7	18.9	20.5	20.9	28.3	17.3	15.8	49.4	15.0	16.3	17.1	43.2	25.3	26.2	27.6	38.5	18.0	15.1	32.8	16.8	24.8	72.6	20.0	33.0	18.4	27.9	19.3	22.1	27.3	34.2	20.6	41.0	11.5	20.4	16.7	30.1	16.9	18.4	16.8	27.4	8.7	37.7	18.6	20.3	20.2	18.7	12.4	13.4	78.6	10.9	9.9	15.2	15.4	8.8	6.0	13.1	9.7	20.3	12.4	15.5	12.7	14.8	15.1	18.6	13.4	13.6	13.3	5.7	8.2	18.8	5.5	14.6	8.5	13.9	23.3	20.8	8.3	27.0	31.7	18.0	10.9	20.0	7.1	15.1	10.9	14.8	10.2	13.6	9.5	8.0	36.1	14.6	10.0	7.0	13.4	13.6	10.8	22.6	4.6	8.2	24.8	18.8	15.4	7.1	20.5	8.1	12.1	12.6	16.0	7.9	18.0	8.6	10.2	11.8	25.4	17.9	24.9	29.2	11.7	15.4	14.3	15.3	78.6	8.9	21.9	15.2	9.4	14.6	12.4	14.1	15.1	7.5	9.9	12.3	14.1	19.6	9.9	10.9	13.4	14.3	15.4	29.2	30.2	19.7	21.6	25.3	26.2	32.8	16.8	27.9	27.4	125.0	114.9	0.0	0.0	0.0	0.0	0.0	0.0	99.0	99.0	141.3	0.0	144.5	160.8	244.0	0.0	0.0	0.0	0.0	174.6	157.8	0.0	0.0	218.6	0.0	145.4	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	130.8	0.0	0.0	237.2	0.0	0.0	306.1	0.0	0.0	0.0	0.0	0.0	0.0	292.8	0.0	0.0	0.0
CACNA2D3	HSA272268	ENSG00000157445	"Calcium voltage-gated channel auxiliary subunit alpha2delta 3"	Q8IZS8	3	54122547-55074557	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;skeletal muscle: 19.5"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 28.9;Early spermatids: 77.9;Late spermatids: 41.2;Syncytiotrophoblasts: 56.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.2;HAP1: 2.8;HeLa: 14.0"					"Low region specificity"	"Detected in all"			HPA030849			Uncertain	Nucleoplasm		NA	NA		49000	Nucleoplasm		"HPA030849: "	"unprognostic (6.92e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-5)"	"unprognostic (5.53e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.84e-3)"	"unprognostic (7.22e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.95e-2)"	1.5	10.3	6.4	1.3	21.9	1.0	1.5	2.4	23.2	1.5	2.0	1.4	0.2	1.4	1.4	4.0	2.1	2.1	1.6	5.1	8.9	8.0	3.8	1.1	2.2	2.2	4.8	12.8	6.7	1.2	1.1	2.4	2.1	9.0	3.4	1.7	2.4	1.9	4.4	19.5	1.2	1.7	2.4	1.7	1.6	1.9	3.9	4.2	0.0	2.1	3.6	2.1	1.0	2.1	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	1.7	0.2	14.0	0.0	0.8	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	6.4	21.9	2.4	16.1	8.9	8.0	4.8	12.8	9.0	4.2	0.0	0.0	0.0	0.3	0.2	9.8	28.9	0.0	1.4	1.2	0.0	7.9	8.4	6.6	0.0	77.9	0.1	0.0	0.0	0.6	2.3	2.4	0.2	0.0	0.0	5.4	0.0	0.0	0.6	7.9	41.2	2.6	10.3	0.0	0.0	0.0	4.3	0.8	0.0	1.4	0.1	1.3	6.5	1.9	5.0	2.2	0.1	56.9	0.0	0.0	0.4
LRTM1	HT017	ENSG00000144771	"Leucine rich repeats and transmembrane domains 1"	Q9HBL6	3	54918237-54967088	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3"	"Cell type enriched"	"Detected in many"	14	"Bipolar cells: 403.4"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"								"unprognostic (9.56e-2)"	"unprognostic (2.16e-1)"		"unprognostic (1.87e-3)"	0.3	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.3	3.6	0.1	0.4	0.1	0.3	0.2	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.3	0.1	0.4	2.9	1.2	0.0	18.8	2.1	0.4	22.5	0.1	0.3	0.0	1.0	12.2	0.1	0.3	0.0	0.0	0.1	15.3	0.5	0.1	0.1	0.7	1.0	2.3	1.9	0.7	0.9	0.5	0.5	0.3	1.7	0.2	0.2	0.0	1.8	0.0	0.5	0.9	1.6	0.3	1.3	0.0	0.8	0.8	0.0	1.0	0.4	1.5	0.6	1.0	0.2	4.3	1.1	0.9	0.2	0.5	1.1	1.8	0.4	0.7	0.2	0.1	0.1	0.3	0.1	1.6	0.3	0.2	0.4	2.3	1.5	0.0	0.5	0.1	0.3	1.3	0.2	0.7	0.5	0.7	0.5	2.3	0.3	0.7	1.2	0.3	0.0	0.7	0.9	0.7	0.1	0.0	1.0	0.1	0.4	0.6	0.9	2.3	0.5	0.6	0.7	0.6	0.9	0.7	0.6	0.3	1.0	0.3	0.8	0.6	1.5	0.7	1.9	0.6	0.7	0.5	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.3	403.4	0.4	0.0	0.0	0.0	1.8	15.7	7.8	0.0	0.0	2.0	0.2	0.0	0.0	0.3	1.1	0.8	0.4	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	16.2	1.4	0.0	4.2	0.0	28.5	0.0	1.0	3.0	2.2	0.4	18.5	0.0	0.0	0.4
WNT5A	hWNT5A	ENSG00000114251	"Wnt family member 5A"	P41221	3	55465715-55490539	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 47.6;Club cells: 47.8;Peritubular cells: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 43.0;BJ hTERT+: 59.3;HeLa: 45.3;SiHa: 67.1;U-87 MG: 48.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.34e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.58e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.63e-2)"	2.1	0.8	3.4	3.8	2.0	0.0	3.4	2.5	3.8	6.1	2.3	1.6	6.8	2.2	19.6	2.8	15.8	4.8	5.0	2.3	2.6	2.0	2.7	1.6	3.6	4.6	2.3	1.3	8.2	5.3	0.1	1.9	25.6	2.0	5.0	2.1	1.0	26.8	18.2	1.1	2.3	2.5	4.2	4.8	2.5	2.2	1.6	2.5	1.9	2.7	13.1	6.8	21.0	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	3.0	7.3	0.0	43.0	59.3	8.8	15.5	0.2	0.0	1.2	0.1	24.4	3.7	0.0	1.8	0.0	9.2	0.0	1.2	1.2	45.3	0.0	6.8	0.0	0.0	4.8	1.1	26.6	1.4	4.3	0.0	0.0	0.0	21.0	21.3	0.0	0.0	0.0	2.1	0.1	2.6	0.0	2.7	0.1	1.1	1.4	0.0	0.2	67.1	8.2	0.0	3.6	0.0	0.0	0.0	14.9	2.6	13.5	3.4	5.0	0.0	0.4	48.3	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.0	2.5	3.8	2.6	2.0	2.3	1.3	2.0	2.5	47.6	18.0	0.0	1.7	1.3	6.9	3.2	0.0	1.4	47.8	12.2	0.0	2.4	0.0	0.2	16.8	1.7	0.3	0.0	0.2	0.4	8.6	0.8	2.3	2.5	1.2	0.0	0.0	1.8	2.2	3.6	18.1	1.1	0.0	7.2	0.0	1.5	0.4	0.0	28.3	0.8	1.3	0.0	0.3	0.0	0.9	1.4	1.3	0.0	0.9	6.7
ERC2	"CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110"	ENSG00000187672	"ELKS/RAB6-interacting/CAST family member 2"	O15083	3	55508308-56468363	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 30.5"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 11.9;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 12.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HUVEC TERT2: 3.7;Karpas-707: 12.3;SH-SY5Y: 3.0;U-266/70: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073739	Enhanced					NA	NA					"HPA073739: AB_2732240"	"unprognostic (2.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.09e-2)"	0.9	1.6	13.4	1.0	9.5	0.9	1.1	11.5	30.5	1.0	1.0	0.7	1.3	1.0	1.2	0.9	1.0	1.0	1.1	2.2	9.4	5.3	1.4	0.9	1.1	0.9	3.8	12.6	2.9	1.3	0.9	7.4	1.3	8.8	1.5	1.0	1.1	1.0	3.1	0.9	0.9	1.1	1.1	2.3	0.9	1.2	1.5	1.5	0.0	1.3	0.0	0.9	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	3.7	0.0	0.0	12.3	0.0	1.5	0.0	0.0	2.7	0.0	0.3	0.0	0.2	0.0	2.8	0.0	1.5	3.0	0.0	0.0	0.0	2.1	0.0	0.0	0.5	0.0	1.3	0.0	0.3	8.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.4	9.5	11.5	16.8	9.4	5.3	3.8	12.6	8.8	1.5	3.0	0.3	0.0	0.2	0.1	11.9	2.7	0.0	2.7	2.3	0.0	23.6	0.0	0.0	0.4	4.7	0.3	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.5	4.8	0.0	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.7	0.3	12.0	0.0	0.0	1.4	2.7	0.1	0.0	0.0	0.0	0.1
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621818	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	8.4	7.5	9.3	7.6	11.7	6.5	12.0	31.0	15.1	11.7	11.0	9.6	7.6	5.9	12.7	12.7	6.7	12.9	7.6	8.4	9.8	6.4	9.2	4.6	7.7	10.1	10.8	10.6	14.7	7.1	10.1	32.9	7.6	11.0	9.7	9.4	7.8	9.1	10.9	11.9	5.7	7.7	11.1	11.2	8.7	8.0	8.6	12.9	11.9	12.1	5.7	10.2	11.0	9.7	2.6	1.1	7.0	2.2	5.0	14.1	2.7	5.5	1.9	6.2	3.7	9.3	5.6	4.9	7.1	6.5	9.4	8.3	4.3	4.4	15.5	1.6	3.8	6.1	3.1	3.4	6.5	10.5	5.5	4.2	9.7	8.6	4.9	6.6	12.4	3.6	5.4	9.4	7.8	5.5	8.3	5.9	7.9	9.0	2.4	7.2	4.5	9.9	7.9	10.1	4.7	7.7	3.3	5.3	8.3	5.6	1.9	2.3	4.3	8.6	5.5	5.3	5.5	1.9	5.4	3.2	7.0	5.5	6.5	9.6	5.0	5.3	8.3	5.2	14.2	5.5	7.0	1.5	3.3	4.3	1.9	5.6	2.6	7.4	5.3	1.1	1.7	8.6	6.2	0.3	5.0	2.2	1.0	14.1	2.7	9.3	11.7	31.0	15.1	9.8	6.4	10.8	10.6	11.0	12.9	20.8	19.9	24.5	21.3	25.0	66.8	26.9	25.5	57.6	35.2	21.0	102.1	17.7	24.9	17.3	158.6	28.7	8.0	23.3	9.1	11.3	30.0	13.3	33.5	7.5	16.2	49.3	20.2	27.0	26.2	74.4	50.0	20.8	25.3	43.3	9.4	34.0	13.6	10.2	44.9	16.5	99.9	32.3	30.2	49.7	45.4	25.7	13.7	47.3	13.6	9.5
FAM208A	"C3orf63, KIAA1105, RAP140, se89-1, TASOR"	ENSG00000163946	"Family with sequence similarity 208 member A"	Q9UK61	3	56620133-56683237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006735, HPA017142"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006735: AB_1852384, HPA017142: AB_1852382"	"unprognostic (1.46e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-3)"	"unprognostic (9.31e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.74e-1)"	10.3	11.6	11.4	10.9	14.7	8.0	9.8	13.8	11.6	9.9	10.1	14.3	10.5	7.3	12.6	5.8	11.2	11.1	9.0	9.9	9.2	5.4	8.1	5.8	8.5	14.6	15.2	7.1	11.9	12.6	22.9	19.2	7.0	10.5	7.6	9.6	8.6	11.4	7.6	7.4	8.2	10.4	16.9	11.6	10.5	10.2	21.1	13.0	13.8	14.6	4.1	14.2	14.3	12.9	4.1	3.3	3.7	2.6	2.9	4.4	2.0	23.1	9.2	14.4	11.3	7.8	13.7	7.2	10.4	10.7	10.0	10.5	7.6	17.4	36.8	3.9	10.4	16.8	9.3	14.3	12.2	14.6	18.1	7.2	14.4	13.5	3.4	5.5	15.1	22.9	6.5	10.3	9.7	17.6	11.8	12.9	14.0	13.9	21.3	12.7	8.1	18.5	3.0	8.0	12.3	14.2	9.9	14.3	12.2	9.6	17.1	9.6	11.9	22.7	9.1	11.4	8.6	15.0	17.5	13.8	13.0	12.0	11.7	15.8	19.4	27.0	18.7	15.0	22.4	17.1	1.8	2.6	3.7	4.3	2.0	2.8	2.8	3.8	4.4	3.3	4.1	4.1	4.2	0.8	2.9	2.3	2.5	3.3	2.0	11.4	14.7	13.8	11.6	9.2	5.4	15.2	7.1	10.5	13.0	14.9	33.1	18.2	14.9	17.5	31.9	22.6	28.1	33.5	21.6	14.0	21.6	11.6	8.3	12.5	13.8	28.2	12.7	23.3	14.7	7.4	19.2	13.4	17.4	13.0	18.1	35.0	17.9	31.3	45.6	6.3	34.5	23.3	13.5	17.2	17.4	26.0	14.8	10.5	21.5	14.1	25.8	45.3	22.9	72.1	46.0	20.3	7.7	26.1	17.2	10.9
ARHGEF3	"DKFZP434F2429, GEF3, STA3, XPLN"	ENSG00000163947	"Rho guanine nucleotide exchange factor 3"	Q9NR81	3	56727418-57079329	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"T-cells: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 35.6;RPMI-8226: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034715, HPA064945"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA034715: AB_10600780, HPA064945: AB_2685389"	"unprognostic (1.84e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (8.25e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (9.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.99e-2)"	"prognostic favorable (1.96e-7)"	"unprognostic (8.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-2)"	14.5	33.0	8.3	14.2	22.8	6.4	13.5	24.0	31.1	12.8	12.9	8.8	8.2	4.8	29.6	14.4	16.2	17.8	16.6	9.3	19.0	12.0	19.5	3.9	18.1	19.5	9.3	18.4	20.6	36.9	29.8	30.4	15.5	18.3	11.6	10.5	19.9	18.6	12.3	7.7	10.8	9.1	26.1	9.7	14.9	11.3	10.2	5.8	33.4	10.9	10.2	20.4	13.9	11.2	8.4	4.4	4.9	9.3	11.9	32.7	20.8	9.6	3.4	0.5	3.2	1.1	0.9	6.9	1.0	0.9	1.1	1.4	1.6	9.2	5.0	1.0	1.9	10.7	5.0	3.0	12.7	1.2	7.3	1.4	4.1	2.2	35.6	2.8	0.0	4.6	4.2	8.4	0.9	1.4	10.0	10.5	5.4	1.1	11.3	2.4	1.4	13.7	0.5	0.9	7.8	5.3	0.0	3.8	37.0	8.3	5.3	0.6	1.6	6.2	4.6	2.7	3.7	1.2	4.3	4.8	0.5	2.6	2.2	1.6	14.5	5.6	18.4	9.1	5.0	4.4	4.9	7.1	1.1	32.7	8.0	24.5	8.4	25.2	28.5	4.4	5.6	20.7	25.2	2.7	11.9	9.3	1.9	20.7	20.8	8.3	22.8	24.0	31.1	19.0	12.0	9.3	18.4	18.3	5.8	14.9	21.9	10.7	8.2	9.8	9.6	8.7	0.0	8.1	6.8	22.7	3.9	9.4	10.0	8.6	15.7	23.0	1.1	0.0	8.7	6.3	12.2	14.3	12.8	0.0	7.2	0.0	9.2	12.3	28.4	10.9	16.4	15.8	10.1	5.4	0.7	8.9	7.8	0.0	22.6	6.9	1.1	0.0	4.2	1.7	2.7	13.0	10.0	44.8	2.6	10.7
SPATA12		ENSG00000186451	"Spermatogenesis associated 12"	Q7Z6I5	3	57060441-57075432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"testis: 26.6"	"Group enriched"	"Detected in some"	125	"Early spermatids: 496.6;Late spermatids: 837.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 5.4;HUVEC TERT2: 2.4;RH-30: 3.1"									"HPA043323, HPA075578"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA043323: AB_10796792, HPA075578: "	"unprognostic (2.31e-1)"	"unprognostic (2.18e-4)"	"unprognostic (3.47e-4)"	"unprognostic (2.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.71e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-3)"	0.2	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.8	0.1	0.3	2.4	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.4	26.6	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.5	0.5	0.0	5.4	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.6	0.0	0.0	1.1	0.2	0.5	0.0	0.0	1.1	2.4	0.0	0.0	0.6	0.2	0.1	0.0	0.0	1.5	1.2	1.5	0.0	3.1	0.1	2.0	1.2	0.0	0.0	0.2	0.0	1.3	0.6	0.0	0.0	0.8	0.0	2.0	0.4	0.3	0.0	0.2	1.0	0.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	496.6	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.3	837.5	4.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	5.3	0.0	0.0	0.0	0.0	4.6	2.3	0.0	0.0	0.0	0.0	0.3
IL17RD	"FLJ35755, IL-17RD, IL17RLM, SEF"	ENSG00000144730	"Interleukin 17 receptor D"	Q8NFM7	3	57089982-57170306	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 15.4;Late spermatids: 17.2;Leydig cells: 10.6;Peritubular cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 10.6;AN3-CA: 28.7;NTERA-2: 16.6;SH-SY5Y: 43.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039577, HPA043550"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA039577: AB_2676580, HPA043550: AB_2678546"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.92e-9)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.58e-3)"	2.7	1.3	5.2	1.8	6.5	0.4	8.9	2.8	6.1	14.7	7.7	7.6	7.4	0.9	18.5	13.7	3.4	8.4	6.1	3.0	4.8	3.6	7.1	0.5	1.1	0.7	4.0	2.4	12.6	1.4	20.8	14.0	0.7	5.7	8.1	2.5	10.2	7.2	10.8	1.0	2.6	1.8	14.7	7.2	3.1	2.2	11.2	3.1	0.0	1.0	2.2	1.4	8.9	5.2	0.6	0.6	1.5	0.5	0.6	0.4	0.0	1.6	0.3	10.6	28.7	0.0	0.2	1.7	0.2	0.1	0.1	0.3	0.2	0.7	0.0	0.0	0.6	2.3	0.1	2.0	0.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.2	7.1	0.4	0.2	0.0	0.0	0.5	0.2	0.0	0.0	16.6	0.9	0.8	0.0	3.8	0.0	2.2	0.4	0.2	43.7	0.4	0.6	1.2	3.6	0.3	0.0	0.3	0.5	0.7	0.5	1.7	0.0	0.0	0.0	0.3	0.0	0.7	1.4	0.5	0.3	0.3	0.3	0.2	0.4	0.3	0.3	0.1	0.6	0.4	0.4	1.5	0.6	0.3	0.6	0.3	0.0	5.2	6.5	2.8	4.0	4.8	3.6	4.0	2.4	5.7	3.1	0.0	2.9	0.0	1.6	0.8	0.0	1.1	2.5	2.7	2.3	0.0	0.0	0.3	0.0	2.6	15.4	2.2	0.0	0.0	0.2	0.1	3.7	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	10.6	0.7	0.0	0.0	0.3	0.5	0.6	0.0	24.4	5.1	0.0	0.0	0.4	8.8	7.6	0.6	0.1	0.0	0.0	0.5
HESX1	"ANF, RPX"	ENSG00000163666	"HESX homeobox 1"	Q9UBX0	3	57197843-57226521	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"ductus deferens: 14.7;lymphoid tissue: 15.2"	"Cell type enhanced"	"Detected in some"	11	"Spermatocytes: 10.7;Spermatogonia: 5.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.0;plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 40.4;U-266/84: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024187	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024187: AB_1850620"	"unprognostic (6.47e-2)"	"unprognostic (1.66e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.96e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.48e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.14e-1)"	1.5	2.6	2.1	1.4	2.0	4.2	3.5	1.4	2.3	1.4	1.4	1.4	14.7	1.0	1.4	5.7	1.4	1.2	2.1	1.4	2.2	2.3	2.7	4.8	1.5	15.2	3.3	2.4	2.1	2.5	3.4	2.6	3.4	1.4	1.9	0.8	2.3	1.5	7.0	1.4	5.7	1.4	1.4	5.1	4.6	2.1	8.7	2.0	3.0	3.3	1.4	1.8	1.4	1.4	1.5	4.6	0.3	4.0	1.1	0.3	0.5	0.7	0.6	1.4	2.7	0.2	1.0	0.4	0.0	0.2	0.4	0.8	0.2	2.4	1.9	0.4	0.0	0.6	0.1	0.7	0.7	0.5	1.1	1.5	2.7	0.7	0.1	1.8	1.0	0.2	2.5	0.7	0.2	1.5	1.3	0.4	4.3	0.4	2.5	0.1	0.1	1.2	5.1	40.4	0.5	0.5	0.4	0.9	1.0	1.9	0.2	0.6	2.0	0.6	0.8	1.5	0.8	0.6	4.1	0.3	1.8	0.7	0.6	0.8	7.4	12.5	6.0	0.7	1.7	1.0	0.0	2.1	0.3	0.3	4.0	0.0	1.5	0.1	0.0	1.1	1.1	0.2	0.0	0.3	1.1	0.3	4.6	0.0	0.5	2.1	2.0	1.4	2.3	2.2	2.3	3.3	2.4	1.4	2.0	0.0	0.3	0.0	0.8	0.3	0.2	0.5	2.5	0.0	0.0	1.8	0.0	1.4	0.0	0.2	0.3	1.6	0.8	0.0	0.2	1.0	0.6	0.7	0.0	0.9	1.7	1.6	0.0	0.6	1.8	0.0	0.9	1.3	0.0	1.0	0.0	2.0	0.6	0.0	0.4	1.0	2.4	0.0	0.3	10.7	5.8	1.0	0.5	0.5	0.4	0.0
APPL1	APPL	ENSG00000157500	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1"	Q9UKG1	3	57227737-57273468	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"naive B-cell: 20.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011138, HPA073477"	Approved		Uncertain	"Mitotic spindle,Centrosome"		Yes	No		28000	"Mitotic spindle, Centrosome"		"HPA011138: AB_1844959, HPA073477: AB_2797272"	"unprognostic (1.39e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.55e-2)"	"prognostic favorable (7.26e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.55e-1)"	18.3	14.0	20.9	15.3	17.9	13.7	22.5	25.2	23.7	18.5	15.7	12.8	16.8	12.6	19.2	14.5	21.0	16.0	13.2	23.7	15.8	15.4	17.0	14.3	15.3	24.3	15.4	18.8	24.0	38.2	28.4	20.4	14.1	18.8	15.7	14.4	11.0	18.0	22.2	40.5	19.9	14.5	20.5	16.7	15.0	16.3	10.5	15.7	20.9	20.0	15.2	18.9	17.7	20.8	20.7	12.0	2.5	3.9	4.7	3.5	1.7	14.9	6.5	6.4	23.2	11.0	15.5	13.5	7.9	4.9	8.0	9.2	7.6	9.0	24.3	3.3	12.2	12.6	3.0	17.1	13.7	13.8	18.3	7.6	13.7	10.4	8.0	11.9	30.4	10.1	11.4	12.5	10.2	11.1	16.1	12.7	15.3	4.6	15.3	9.0	5.1	23.9	7.5	10.0	10.6	11.2	0.8	26.0	13.0	14.1	8.4	6.5	13.8	10.9	16.4	10.4	9.0	8.0	19.8	12.0	13.3	9.4	19.3	15.3	14.1	20.6	17.1	14.4	14.7	8.6	1.6	3.9	2.5	2.6	3.0	3.5	11.3	2.8	2.4	7.2	20.7	2.6	1.9	1.0	4.7	2.5	12.0	1.1	1.7	20.9	17.9	25.2	23.7	15.8	15.4	15.4	18.8	18.8	15.7	47.6	39.2	44.5	41.0	47.1	39.5	88.3	45.9	20.1	55.7	40.1	29.5	40.0	49.7	52.3	22.7	58.0	26.9	0.0	52.6	38.3	45.7	34.4	22.0	37.6	46.6	49.3	43.8	35.6	50.8	15.5	67.6	54.0	18.6	85.6	35.9	55.2	46.8	11.5	71.5	43.7	52.2	51.8	38.7	40.0	39.4	60.9	23.5	30.5	44.7	23.4
ASB14	DKFZp313L0121	ENSG00000239388	"Ankyrin repeat and SOCS box containing 14"	A6NK59	3	57268347-57292682	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"skeletal muscle: 26.3;tongue: 33.6"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 1: 3.0;Cardiomyocytes: 6.7;Ciliated cells: 1.4;Club cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.14e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.14e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.81e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.69e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.71e-3)"	0.7	0.4	0.3	0.6	0.3	1.9	0.7	0.6	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.6	0.5	0.5	0.3	5.0	0.3	0.3	0.3	0.3	0.6	0.7	0.3	0.3	0.7	2.3	0.0	0.3	0.3	0.3	0.3	0.0	0.6	0.8	0.3	26.3	1.0	0.6	0.3	0.3	0.6	0.5	0.3	0.3	0.3	0.8	33.6	1.3	0.3	0.7	2.4	1.6	0.0	0.5	0.5	0.6	0.1	0.8	0.4	0.6	1.3	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.7	2.3	3.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.7	0.8	1.4	2.8	0.3	0.0	2.7	1.5	0.0	0.0	0.0	0.0	2.1	0.0	1.5	0.4	2.1	0.0	0.4	2.4	3.0	0.6	0.5	1.1	0.5	0.8	0.6	0.0	2.1	0.8	2.7	0.6	1.1	0.3	1.3	1.0	0.5	1.0	0.5	0.8	2.4	2.0	1.5	1.8	1.3	2.3	1.8	0.8	0.0	0.5	0.0	0.2	0.1	0.2	0.7	0.3	0.0	0.4	2.4	0.6	0.6	0.0	0.5	0.2	1.6	0.0	0.1	0.3	0.3	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.3	3.0	0.3	0.0	0.0	0.0	0.0	6.7	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAH12	"DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19"	ENSG00000174844	"Dynein axonemal heavy chain 12"	Q6ZR08	3	57293699-57544344	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 439.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enriched"	"Detected in many"	8	"pons and medulla: 23.0"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.1;GAMG: 1.9;LHCN-M2: 2.1"									"HPA037493, HPA058203, HPA061365"	Enhanced					NA	NA					"HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493"	"unprognostic (4.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.43e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.47e-2)"	0.2	0.3	0.6	0.1	3.0	0.1	0.4	0.2	0.5	1.3	0.2	5.3	0.0	0.1	1.4	11.6	0.2	16.7	0.5	0.1	2.9	0.8	0.2	0.3	17.5	0.2	0.4	0.0	7.6	3.1	0.1	8.9	0.1	23.0	0.2	0.2	0.0	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.2	0.2	17.6	1.0	0.0	0.3	0.0	0.1	0.2	0.2	0.5	0.5	0.0	0.0	1.2	0.9	0.1	0.3	0.7	0.0	0.0	0.9	0.3	0.1	0.0	0.2	0.3	0.0	3.1	0.3	0.1	0.0	0.4	1.9	0.4	0.0	0.3	0.2	0.7	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.1	0.4	0.4	0.2	0.6	0.2	0.1	2.1	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.9	0.1	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.5	0.2	0.0	0.0	1.2	0.0	0.5	0.0	0.1	0.6	3.0	0.2	0.3	2.9	0.8	0.4	0.0	23.0	1.0	3.0	1.4	0.0	0.2	0.0	0.2	0.8	0.0	439.0	70.5	0.0	0.0	0.1	0.0	0.1	38.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.1	0.0	0.1	0.0	1.7	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.4	0.4	0.0	0.0	0.0	24.4	2.6	0.0	0.0	0.0	0.0	0.0
PDE12	"2'-PDE, 3635, DKFZp667B1218"	ENSG00000174840	"Phosphodiesterase 12"	Q6L8Q7	3	57556276-57566844	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043171	Approved					NA	NA					"HPA043171: AB_10794654"	"unprognostic (2.79e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (2.85e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (3.63e-8)"	"unprognostic (6.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.62e-1)"	14.2	22.1	10.0	13.7	15.7	21.1	11.2	18.0	18.4	10.7	12.4	16.9	10.6	15.7	14.9	8.5	19.8	10.9	12.7	11.2	11.0	10.8	16.8	22.1	11.4	14.3	15.5	10.6	15.7	17.0	18.2	15.5	12.7	13.6	11.8	12.2	13.2	14.6	12.4	19.1	11.4	13.8	12.2	12.4	12.6	13.8	9.9	14.2	21.7	13.0	11.7	16.4	14.1	11.6	10.4	10.1	16.6	12.6	14.5	13.4	9.5	12.9	12.8	8.0	14.9	10.4	7.4	14.6	11.0	10.6	12.4	11.2	16.9	8.9	21.3	4.4	9.9	16.6	8.6	17.0	11.5	10.3	9.7	8.9	16.0	11.2	12.9	11.9	20.7	16.6	10.1	7.9	15.0	13.3	6.5	10.7	11.2	13.2	15.7	11.2	10.0	18.5	6.8	12.4	10.2	22.1	7.0	6.5	15.8	10.0	15.1	7.1	11.5	11.9	14.0	11.9	6.8	10.6	12.0	13.1	10.4	9.9	19.7	17.8	15.4	22.3	18.8	12.2	16.3	15.3	16.6	9.1	8.2	11.6	12.6	12.9	7.2	10.9	11.9	10.1	10.4	13.4	13.4	2.6	14.5	12.5	5.4	12.9	9.5	10.0	15.7	18.0	18.4	11.0	10.8	15.5	10.6	13.6	14.2	23.8	18.7	12.8	16.2	32.6	18.3	9.7	17.8	2.7	13.6	29.6	11.8	16.3	5.0	8.9	1.0	11.8	13.4	23.3	8.4	9.0	11.5	15.3	19.6	24.1	12.9	25.4	12.0	18.4	14.0	1.1	9.8	12.5	11.8	8.2	9.9	17.8	7.8	12.9	11.7	13.5	24.8	6.5	10.3	13.4	8.7	34.6	17.2	13.8	14.9	16.5
ARF4	ARF2	ENSG00000168374	"ADP ribosylation factor 4"	P18085	3	57571363-57598220	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		4000000				"unprognostic (1.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.29e-7)"	"unprognostic (4.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (4.98e-3)"	52.8	60.2	26.3	29.0	30.1	17.5	55.8	21.6	38.5	64.6	44.2	25.1	59.2	34.7	40.6	70.4	43.5	33.6	46.7	42.9	26.5	32.2	52.1	164.0	52.5	52.6	25.9	16.1	52.7	105.9	32.2	46.4	89.2	26.2	41.8	57.0	35.5	105.0	66.7	21.7	23.4	60.3	49.0	28.7	34.3	38.7	45.2	17.5	19.8	54.5	39.4	45.3	47.4	32.2	17.9	36.2	62.6	28.4	17.6	25.9	27.6	31.0	12.5	28.0	24.0	70.4	72.1	27.8	78.0	76.1	49.5	63.5	34.1	29.9	11.6	14.5	99.5	45.6	12.2	31.3	45.6	63.3	14.3	10.7	23.2	28.0	44.1	87.5	14.8	16.5	69.8	39.6	47.9	57.5	64.8	61.8	11.6	16.7	22.5	85.2	15.2	9.3	18.9	34.4	41.9	42.4	5.3	23.3	21.0	58.7	22.3	9.5	21.9	32.6	30.0	38.9	40.9	21.3	25.2	47.9	39.3	22.8	57.4	46.0	16.6	14.2	16.1	43.8	29.8	50.1	62.6	28.4	29.7	14.8	23.9	25.1	17.9	20.8	18.9	23.8	15.6	25.9	19.6	33.4	17.6	20.2	36.2	18.9	27.6	26.3	30.1	21.6	38.5	26.5	32.2	25.9	16.1	26.2	17.5	71.5	83.4	93.2	472.7	311.0	31.7	42.9	81.5	80.3	92.1	92.5	5.9	284.4	162.5	264.9	118.7	96.6	180.2	70.0	204.2	382.2	378.2	305.6	102.4	153.0	179.4	17.5	157.7	105.6	93.2	50.6	164.0	120.4	229.5	146.1	207.5	137.3	299.5	183.7	174.6	143.1	24.7	77.6	172.0	122.4	74.5	281.4	583.9	68.2	233.7	532.0
DENND6A	"AFI1A, FAM116A, FLJ34969"	ENSG00000174839	"DENN domain containing 6A"	Q8IWF6	3	57625457-57693089	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062618, HPA069725, HPA071711"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA062618: AB_2684809, HPA069725: AB_2686184, HPA071711: AB_2686435"	"unprognostic (6.20e-2)"	"unprognostic (3.86e-2)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.76e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (7.16e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.77e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.94e-1)"	18.6	12.0	8.6	16.7	12.4	15.0	18.1	18.6	12.8	19.8	16.9	15.3	15.3	9.7	23.7	16.8	16.1	16.3	13.7	11.4	9.3	9.7	14.6	10.5	15.1	20.9	10.7	10.6	29.8	10.5	16.1	17.2	16.0	12.1	15.3	13.0	21.4	14.8	17.2	22.0	14.2	16.9	22.3	12.2	21.8	13.8	11.3	9.6	23.0	19.6	11.3	19.8	18.2	17.4	1.7	1.5	13.5	1.6	2.4	4.4	1.0	12.1	9.9	13.4	8.2	7.2	8.1	7.7	6.3	8.1	7.9	6.2	6.4	13.6	14.4	2.7	6.5	7.0	6.4	10.6	13.4	6.7	3.6	9.6	11.3	10.8	4.9	6.9	8.6	6.7	8.7	9.7	5.4	14.2	8.0	11.2	15.6	7.6	15.8	5.6	5.3	18.5	10.7	7.6	7.7	6.9	7.8	8.0	10.5	9.7	20.5	4.7	16.6	12.5	10.4	9.0	6.1	6.8	10.6	12.2	9.7	5.2	10.2	16.4	11.8	15.1	15.0	11.2	14.5	14.0	13.5	1.2	1.6	3.2	1.3	3.6	1.1	2.9	3.0	1.5	1.7	4.4	3.2	2.0	2.4	1.6	1.2	1.5	1.0	8.6	12.4	18.6	12.8	9.3	9.7	10.7	10.6	12.1	9.6	17.9	10.9	6.5	10.0	11.4	16.2	21.9	20.4	4.0	9.1	5.2	7.9	5.3	3.3	6.8	21.3	11.3	4.1	0.0	9.3	3.8	10.2	5.5	2.3	7.8	9.4	9.5	2.9	21.5	26.7	10.5	10.9	10.0	3.3	10.0	4.5	9.4	14.2	2.9	13.4	7.9	14.6	6.5	11.8	11.6	4.1	9.4	1.9	16.0	4.7	11.6
SLMAP	"KIAA1601, SLAP"	ENSG00000163681	"Sarcolemma associated protein"	Q14BN4	3	57755450-57929168	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 133.6;urinary bladder: 114.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 272.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002357, HPA002358"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		12000	"Endoplasmic reticulum"		"HPA002357: AB_1080023, HPA002358: AB_1080021"	"unprognostic (3.70e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.82e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.58e-6)"	"unprognostic (8.18e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.08e-2)"	10.6	10.7	7.0	22.4	11.1	7.4	12.0	10.2	7.2	26.5	50.3	5.8	24.7	9.8	43.0	19.5	44.0	21.3	15.0	58.2	6.5	5.6	8.0	7.8	8.0	7.2	6.9	6.0	21.4	5.8	16.0	8.0	7.7	6.8	47.8	12.2	8.7	8.6	37.7	26.1	9.4	23.3	133.6	6.0	7.2	27.2	14.9	6.8	11.2	11.1	12.1	6.3	114.2	26.4	5.9	5.1	15.8	5.5	7.1	5.9	4.5	22.1	12.5	10.7	15.4	16.1	16.2	14.6	20.5	21.2	14.4	13.9	30.0	33.0	14.9	9.8	16.3	25.8	12.2	19.1	27.3	18.9	16.4	10.9	25.8	17.7	23.5	15.7	25.5	14.4	11.7	21.9	17.7	33.0	18.6	16.4	15.1	21.0	13.5	14.7	7.2	17.4	13.1	16.1	16.1	24.3	7.2	11.7	14.8	29.4	24.2	6.1	7.2	26.7	20.3	12.6	14.7	11.0	16.2	19.4	15.9	12.7	20.1	26.5	15.7	26.7	20.3	14.3	22.3	14.9	7.5	5.5	15.8	5.9	3.6	4.9	5.9	4.6	5.0	5.1	4.5	5.4	5.5	13.4	7.1	3.6	2.9	5.1	4.5	7.0	11.1	10.2	7.2	6.5	5.6	6.9	6.0	6.8	6.8	35.7	34.1	6.2	37.6	81.7	24.0	272.3	33.1	29.4	29.6	31.4	47.1	15.6	16.6	39.8	28.6	23.2	38.0	0.0	29.8	10.7	23.5	70.4	3.5	20.3	13.9	30.2	13.8	16.0	19.4	17.7	30.2	18.8	27.0	11.8	24.3	98.5	46.3	29.2	67.5	24.5	32.2	51.8	116.9	81.2	26.8	64.1	13.6	23.0	23.4	106.8
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 215.6;Extravillous trophoblasts: 184.6;Pancreatic endocrine cells: 247.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 71.8;TIME: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		37000000	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	24.7	17.8	7.8	25.3	10.6	2.2	30.0	12.6	7.4	21.3	33.5	17.2	49.6	19.4	36.1	47.4	18.6	17.3	16.0	7.7	10.6	8.5	20.6	29.2	14.1	9.4	16.1	5.3	22.9	22.4	25.6	7.8	36.0	13.2	35.8	28.5	20.1	25.5	44.0	7.7	28.9	50.2	39.7	24.3	12.1	21.2	11.7	13.5	49.3	28.2	12.0	13.0	32.8	34.7	3.8	15.9	7.4	1.2	5.9	4.9	1.2	20.2	34.7	3.5	5.1	2.4	4.1	61.2	7.5	6.1	16.9	17.3	34.7	34.8	3.3	2.8	26.6	27.5	33.4	6.5	48.2	16.5	18.3	3.2	2.8	29.5	16.8	17.5	2.4	10.0	6.5	20.9	23.4	71.8	20.0	57.0	14.8	4.6	1.0	10.5	4.4	7.3	5.8	5.4	22.4	30.1	3.2	0.9	2.8	22.5	34.6	3.9	3.6	38.3	21.0	4.2	26.8	17.3	6.7	80.8	4.4	13.8	52.7	26.9	0.7	0.2	2.6	16.4	4.4	4.6	7.4	0.3	4.2	0.5	0.8	2.6	3.8	1.6	0.7	1.2	1.6	4.9	3.5	0.1	5.9	1.2	15.9	1.7	1.2	7.8	10.6	12.6	7.4	10.6	8.5	16.1	5.3	13.2	13.5	47.6	33.3	5.1	35.9	45.0	2.7	10.5	58.6	54.9	44.3	45.4	37.3	23.5	0.0	81.2	15.8	61.2	215.6	0.0	57.7	184.6	26.7	99.5	24.3	46.4	13.6	1.6	47.3	130.8	11.4	17.1	15.0	10.9	5.0	17.2	70.6	10.0	247.2	108.7	26.2	6.8	10.9	0.0	12.0	1.9	5.1	45.2	41.6	7.5	60.6	62.1
DNASE1L3	"DNAS1L3, LSD"	ENSG00000163687	"Deoxyribonuclease 1 like 3"	Q13609	3	58192257-58214697	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Necrosis"	"Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 78.1;liver: 72.3;lymphoid tissue: 46.9"	"Cell type enriched"	"Detected in many"	11	"Ito cells: 2006.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"plasmacytoid DC: 78.1"	"Lineage enriched"	"Detected in many"	20	"dendritic cells: 78.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;Karpas-707: 3.2;RPMI-8226: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019955	Approved				"Secreted to blood"	NA	NA					"HPA019955: AB_1847805"	"unprognostic (7.49e-3)"	"unprognostic (3.08e-3)"	"unprognostic (9.75e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (1.01e-2)"	"prognostic favorable (1.20e-6)"	"unprognostic (4.74e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (6.95e-2)"	"prognostic favorable (1.06e-7)"	"unprognostic (7.57e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.64e-3)"	3.5	7.2	0.5	27.8	0.5	0.1	3.8	0.6	0.5	2.7	6.1	0.5	1.1	6.1	0.9	1.1	4.2	0.8	1.7	3.4	0.5	0.5	14.3	72.3	5.7	38.5	0.5	0.1	1.5	0.8	0.0	6.0	2.0	0.4	1.4	9.2	12.0	3.3	1.2	0.9	1.8	14.0	0.4	1.3	46.9	0.8	1.5	0.0	11.0	3.9	20.1	17.0	3.6	3.2	3.8	78.1	0.1	0.0	0.1	0.0	0.6	0.2	0.8	0.5	0.3	0.1	0.1	5.4	0.3	0.2	0.3	0.1	1.0	0.3	0.5	0.4	0.0	1.3	1.6	0.2	0.0	0.1	0.2	0.1	0.5	0.8	2.1	0.2	1.1	1.2	0.2	1.1	0.5	0.7	0.2	1.1	0.1	0.5	3.2	0.0	0.7	0.3	1.3	0.5	0.1	0.4	0.6	0.7	5.6	0.2	0.3	0.8	0.5	0.4	0.4	0.6	0.5	0.4	0.6	0.9	0.7	0.3	0.4	0.3	0.9	0.5	0.8	0.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	6.1	3.8	0.0	0.0	0.1	0.1	0.0	78.1	0.0	0.6	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.1	0.4	0.0	0.0	15.6	31.8	0.3	8.1	0.0	0.6	48.4	0.0	2.3	0.0	0.0	0.1	3.3	0.0	1.3	29.5	0.0	46.7	0.3	0.7	3.1	0.4	1.1	21.7	0.4	1.6	0.0	2006.5	176.2	3.1	3.7	12.8	3.3	55.1	0.0	0.0	0.0	0.0	24.1	1.8	0.1	0.0	1.3	0.1	0.0	14.3	0.2	13.8	0.0	0.9
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6"	Q9BV23	3	58237506-58295693	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	8.3	10.0	11.6	4.6	14.0	1.0	5.8	17.7	22.5	3.7	8.1	30.0	10.3	26.3	4.7	10.8	4.8	6.9	4.4	4.1	19.0	9.2	24.3	43.4	6.3	5.2	18.6	12.2	4.1	2.4	4.8	15.2	4.8	19.0	4.4	8.1	10.5	3.0	12.9	3.1	17.2	33.5	6.8	24.0	22.8	9.0	3.1	14.3	2.0	6.6	2.1	5.4	4.6	4.1	3.9	7.0	2.1	9.3	0.7	2.6	1.1	2.0	7.7	1.1	5.0	14.5	2.6	13.4	5.4	4.8	5.7	7.7	4.0	2.8	3.9	0.5	2.9	17.6	6.0	5.2	2.4	5.1	6.6	2.6	3.3	5.2	5.5	4.9	1.0	17.6	2.5	11.1	5.2	2.5	6.7	3.2	6.5	3.9	9.0	4.6	1.5	6.7	0.4	3.7	16.7	17.0	2.5	2.3	8.7	8.7	2.8	6.7	2.7	5.9	3.3	11.1	2.3	2.2	2.7	3.4	4.1	4.5	10.1	6.4	2.6	7.6	0.1	10.5	9.9	5.6	0.0	2.8	2.1	2.1	9.3	2.0	3.9	1.2	2.6	4.6	3.0	1.2	1.5	0.0	0.7	6.2	7.0	1.4	1.1	11.6	14.0	17.7	22.5	19.0	9.2	18.6	12.2	19.0	14.3	0.0	2.6	8.8	2.6	7.7	13.8	4.8	0.0	17.4	5.7	3.5	3.9	2.2	1.7	2.9	0.8	7.8	13.6	0.0	1.6	0.4	2.1	1.3	10.5	53.3	8.1	14.3	0.0	26.4	14.6	0.4	6.4	9.6	3.3	14.4	2.2	10.8	1.6	0.0	7.8	15.4	3.0	0.0	3.5	0.5	2.3	21.5	0.5	3.2	4.5	2.0
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306247-58324695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	7.1	8.5	8.3	5.7	12.9	5.3	7.1	15.8	10.7	6.6	8.6	5.9	6.6	10.2	8.2	7.8	8.5	7.4	6.2	11.8	7.2	6.8	11.2	15.0	5.6	7.6	6.5	9.9	8.4	11.9	10.8	9.4	6.0	7.2	7.4	8.2	9.0	8.5	7.0	53.5	7.4	9.1	11.7	5.5	7.7	7.7	9.1	5.9	6.3	8.1	18.5	8.5	7.2	7.0	4.6	6.6	4.7	9.8	9.8	6.4	3.5	10.1	8.1	9.4	7.5	7.9	8.5	10.4	8.6	9.3	12.4	14.0	12.3	6.7	12.2	2.0	11.5	10.8	6.2	14.1	12.8	12.1	8.5	7.4	11.6	9.7	6.7	7.7	19.9	9.7	9.3	12.4	14.7	14.1	6.2	9.7	15.0	9.9	8.7	12.0	5.5	13.5	7.0	12.3	8.4	15.4	5.5	7.4	11.8	9.0	14.6	5.9	10.5	8.1	9.7	11.6	6.8	9.3	9.6	8.8	9.4	10.5	9.9	16.3	13.0	22.3	17.6	10.7	14.0	6.6	3.0	5.7	4.7	4.2	4.9	5.6	4.1	5.5	5.8	6.6	4.6	6.4	6.2	2.6	9.8	9.8	6.2	3.0	3.5	8.3	12.9	15.8	10.7	7.2	6.8	6.5	9.9	7.2	5.9	8.9	11.0	7.0	7.1	27.7	24.7	26.6	5.1	8.1	5.7	3.5	23.6	7.2	10.0	5.3	0.7	7.2	11.7	0.0	5.3	5.2	8.4	6.9	3.5	17.9	5.4	17.5	9.2	12.3	11.4	0.9	11.5	9.5	21.9	8.2	12.5	12.9	6.2	3.5	9.2	10.1	28.1	0.0	20.5	8.6	13.5	37.6	8.6	7.0	13.4	6.2
HTD2		ENSG00000255154	"Hydroxyacyl-thioester dehydratase type 2"	P86397	3	58306262-58318574	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Club cells: 2.3;granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA066812, HPA077228"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA066812: AB_2685727, HPA077228: "	"unprognostic (1.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	7.9	8.9	9.0	6.6	13.9	6.9	9.4	17.0	11.5	7.4	9.2	6.4	7.1	11.3	8.6	8.5	9.4	7.8	7.1	15.9	7.9	9.3	12.1	16.2	6.9	8.2	8.5	10.7	11.0	12.9	8.8	14.2	6.7	7.8	9.6	10.1	9.7	9.2	9.4	35.2	7.2	9.7	12.6	6.0	9.7	8.6	9.8	6.4	6.8	10.7	19.8	9.2	7.8	8.1	23.9	21.6	23.7	20.4	21.3	26.5	13.5	8.2	6.3	9.6	6.8	8.2	9.2	12.3	11.7	8.9	14.6	12.9	13.7	6.2	16.3	3.5	8.4	11.7	7.2	16.0	10.6	15.0	9.1	11.2	9.8	13.9	11.5	8.9	12.8	9.3	11.3	10.9	15.5	9.4	7.8	12.7	12.1	9.6	15.5	9.1	4.8	8.3	6.5	12.4	8.4	14.2	5.8	6.1	11.7	9.8	12.1	6.0	9.0	7.2	6.8	13.3	10.6	9.1	11.4	7.4	12.4	8.8	11.2	14.3	11.9	21.3	12.7	10.0	9.5	7.5	13.5	17.3	23.7	18.7	20.4	20.1	23.9	18.7	23.5	17.5	23.8	26.5	20.2	18.4	21.3	16.7	21.6	13.4	13.5	9.0	13.9	17.0	11.5	7.9	9.3	8.5	10.7	7.8	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426126	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 81.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Approved		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favorable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	9.3	9.4	20.7	17.0	51.4	33.6	7.6	22.6	31.4	28.9	8.9	81.1	2.4	6.3	14.2	5.3	6.6	8.0	9.6	7.5	33.7	19.9	10.4	5.7	8.2	23.8	68.6	23.4	11.1	8.5	13.7	6.1	17.5	43.9	6.0	6.4	4.4	8.8	7.7	7.6	7.5	7.7	11.8	55.9	13.5	8.3	6.7	56.6	3.7	40.3	2.5	26.1	9.8	13.1	31.3	18.8	31.8	22.5	8.7	11.2	13.4	4.3	2.5	1.9	3.5	26.9	23.9	5.7	6.9	14.7	6.7	9.4	1.2	0.9	22.8	1.6	11.7	9.7	1.3	6.0	4.4	7.1	5.7	3.8	3.9	3.1	1.7	31.4	33.9	6.9	20.4	10.6	8.4	14.6	23.6	5.9	14.6	4.8	7.5	12.0	1.6	7.4	35.0	2.3	1.3	6.3	12.8	3.3	4.1	4.2	2.4	1.7	1.2	4.7	3.4	5.5	3.6	11.5	35.1	6.0	8.4	3.5	15.9	7.3	5.9	5.8	22.7	12.1	48.2	3.5	14.6	20.1	29.4	11.2	16.2	9.9	29.0	8.1	9.4	18.8	31.3	7.1	8.4	31.8	8.7	22.5	13.5	8.7	13.4	20.7	51.4	22.6	31.4	33.7	19.9	68.6	23.4	43.9	56.6	8.9	4.6	34.0	4.9	12.6	29.2	11.8	7.6	8.1	6.8	22.7	19.6	13.3	28.2	5.9	60.8	14.3	6.3	23.3	5.0	6.5	30.9	6.4	19.6	6.8	12.0	19.1	7.5	18.4	24.8	27.6	28.4	16.3	16.9	8.2	5.2	29.3	3.5	3.5	23.7	9.1	20.8	19.4	15.5	14.0	19.4	11.4	29.4	15.9	4.4	3.2
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 beta subunit"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		6500000	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	21.8	34.3	22.5	19.5	28.4	8.6	17.1	15.1	26.2	18.0	21.6	18.4	19.2	16.2	17.2	18.2	22.8	15.0	16.5	64.2	24.1	20.8	38.7	41.8	13.9	18.2	23.7	23.3	11.0	17.2	26.0	20.0	21.6	26.4	19.5	23.9	16.1	17.6	22.1	92.2	14.3	17.3	24.5	22.8	23.2	21.4	21.8	17.5	20.9	16.1	33.8	20.6	17.9	14.4	37.0	50.1	33.6	39.8	43.4	38.6	38.3	19.0	26.7	27.7	20.8	28.2	34.7	33.3	24.1	30.2	35.7	36.8	48.2	18.5	40.8	13.6	30.5	33.1	11.1	33.7	22.1	27.3	23.6	24.8	36.4	50.5	36.3	28.6	29.5	20.5	30.3	20.5	28.7	16.9	41.9	30.7	34.1	18.7	18.4	38.7	18.2	27.9	31.0	38.2	20.2	30.4	13.3	21.6	39.3	56.3	26.2	19.3	21.2	22.3	32.2	24.0	41.8	47.6	31.7	22.5	19.1	25.5	20.0	27.2	25.8	36.6	28.7	29.3	35.1	18.0	16.4	35.4	33.6	31.5	39.8	33.2	37.0	31.2	30.0	50.1	33.3	35.1	31.4	7.0	43.4	35.9	33.7	38.6	38.3	22.5	28.4	15.1	26.2	24.1	20.8	23.7	23.3	26.4	17.5	56.6	28.0	47.4	32.8	24.7	30.0	245.7	48.4	69.6	48.9	33.2	23.6	144.4	195.6	84.1	43.2	62.9	34.8	23.3	63.6	85.4	31.9	17.8	38.1	61.1	74.4	54.0	55.7	43.6	38.0	10.4	55.8	41.0	54.0	89.2	44.3	51.8	51.0	41.3	48.1	105.9	44.7	64.7	61.8	85.0	80.3	26.1	131.5	46.0	47.8	28.8
KCTD6	"KCASH3, MGC27385"	ENSG00000168301	"Potassium channel tetramerization domain containing 6"	Q8NC69	3	58492114-58502360	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036100, HPA036101"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA036100: AB_10673230, HPA036101: AB_2674941"	"unprognostic (8.63e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.00e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.67e-3)"	"unprognostic (9.36e-3)"	"unprognostic (7.48e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.44e-2)"	7.8	8.4	15.3	4.4	13.2	13.5	11.4	35.9	21.8	11.1	7.9	10.0	6.4	5.6	12.3	28.8	10.9	12.4	8.8	7.7	16.9	11.7	15.4	12.2	6.6	9.1	15.3	10.5	13.1	7.1	10.4	14.4	10.9	11.9	9.2	8.1	14.7	7.3	9.4	6.8	7.5	5.3	11.2	12.5	8.8	5.7	5.7	12.4	6.3	14.1	6.3	7.3	6.4	11.9	13.0	20.2	17.1	14.6	8.2	15.6	6.6	5.5	5.3	15.9	6.8	14.0	10.0	5.9	6.7	6.0	9.9	11.7	5.1	3.1	11.0	2.2	4.8	11.7	3.0	12.8	3.9	8.9	11.3	5.8	5.1	12.1	6.3	6.6	4.0	4.1	6.0	6.2	7.9	5.0	23.6	6.5	3.9	2.8	5.3	8.6	5.2	5.9	6.1	11.7	5.0	10.1	5.9	4.4	7.7	9.4	2.6	9.0	7.8	3.8	8.8	4.8	12.7	35.4	2.9	3.5	9.1	8.2	11.6	10.0	5.8	8.9	13.0	7.8	8.2	6.9	17.1	14.6	9.8	13.7	14.6	15.6	13.0	10.1	12.8	20.2	10.3	11.5	9.8	5.0	8.2	10.5	7.8	9.5	6.6	15.3	13.2	35.9	16.2	16.9	11.7	15.3	10.5	11.9	12.4	3.0	2.4	0.9	10.6	7.9	14.6	7.5	7.6	5.3	10.3	8.7	23.6	8.7	16.6	7.1	3.7	9.0	2.1	0.0	3.7	6.3	12.4	5.1	0.0	4.7	6.2	23.8	8.7	4.9	10.3	1.7	10.0	7.2	11.8	4.6	4.2	19.3	3.3	5.5	11.3	24.5	17.9	0.0	12.0	5.6	20.7	8.8	7.3	0.0	7.0	3.0
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537319	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 70.5"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 75.4;Proximal tubular cells: 33.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;ASC TERT1: 20.7;fHDF/TERT166: 6.7;Hep G2: 8.0;HSkMC: 13.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		190000	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	4.0	5.3	1.9	3.8	2.5	0.1	3.4	1.6	2.1	4.4	10.2	2.7	9.5	10.0	9.0	6.2	3.8	4.4	4.8	8.8	2.4	1.4	17.1	70.5	2.8	0.7	2.0	1.7	5.1	2.9	3.8	3.0	1.4	4.0	7.2	3.4	11.4	3.0	5.9	4.2	1.7	13.7	10.6	2.5	0.9	2.6	4.0	2.0	1.0	7.7	2.7	1.6	5.4	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.5	20.7	3.6	2.3	0.2	0.0	0.3	0.6	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	1.8	0.0	0.0	13.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	1.6	2.1	2.4	1.4	2.0	1.7	4.0	2.0	3.0	4.3	0.5	7.2	0.6	0.2	14.4	0.0	0.0	1.2	3.5	0.0	0.6	13.3	0.3	0.1	1.1	5.4	0.0	1.7	0.2	5.0	0.8	1.1	75.4	5.3	1.6	2.9	4.3	2.2	1.4	10.0	0.8	0.0	0.0	4.7	10.0	0.5	0.0	8.1	33.8	0.8	6.5	3.4	0.2	0.5	0.3	0.7	0.0	3.6	0.8
FAM107A	"DRR1, TU3A"	ENSG00000168309	"Family with sequence similarity 107 member A"	O95990	3	58564117-58627610	"Predicted intracellular proteins"	"Cell cycle, Growth regulation, Stress response"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 149.7"	"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 151.7;Ito cells: 84.7;Muller glia cells: 82.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 110.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"ASC diff: 11.7;HUVEC TERT2: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055888	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055888: AB_2682957"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.80e-3)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.95e-3)"	22.4	4.6	119.4	4.7	86.5	1.3	8.4	32.4	149.7	17.0	7.6	68.6	1.7	3.6	9.4	25.1	13.9	39.6	8.4	15.8	91.5	52.0	12.4	3.5	18.1	2.4	66.6	44.3	4.3	11.1	4.1	12.0	13.8	33.5	16.3	8.4	10.7	17.5	19.4	7.5	3.5	5.8	19.8	77.5	12.0	5.8	2.5	87.2	1.2	9.9	1.4	4.8	6.5	10.2	0.3	0.3	1.3	0.9	0.7	0.6	0.1	0.0	0.0	0.5	0.0	11.7	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	35.6	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	1.9	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	1.3	0.4	0.5	0.3	0.4	0.6	0.2	0.3	0.2	0.2	0.3	0.2	0.3	0.6	0.7	0.9	0.3	0.3	0.1	119.4	86.5	32.4	80.7	91.5	52.0	66.6	44.3	33.5	87.2	6.0	8.5	0.0	39.0	1.9	4.2	23.8	5.1	4.0	5.7	36.6	49.1	0.0	8.3	0.9	13.1	151.7	0.0	0.0	0.2	0.0	9.4	6.0	1.1	0.8	0.0	3.2	3.5	84.7	1.3	25.6	30.5	1.9	5.0	0.0	0.0	82.8	0.5	0.0	11.0	1.9	41.9	6.5	14.4	0.7	0.2	2.4	0.0	0.0	0.0	0.9
FAM3D	"EF7, OIT1"	ENSG00000198643	"Family with sequence similarity 3 member D"	Q96BQ1	3	58633946-58666848	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6"	"Group enriched"	"Detected in some"	6	"Enterocytes: 558.6;Mucus-secreting cells: 1112.4;Paneth cells: 854.0;Undifferentiated cells: 821.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.7"	"Cell line enriched"	"Detected in single"	72	"OE19: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013844	Approved				"Secreted to digestive system"	NA	NA		8200			"HPA013844: AB_2668897"	"prognostic favorable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.3	0.2	0.3	8.5	0.3	0.0	2.2	0.2	0.2	4.4	48.2	0.3	26.1	11.2	0.5	0.3	61.2	0.3	20.0	0.2	0.2	0.2	0.5	0.2	1.5	0.2	0.3	0.2	0.2	0.8	0.0	0.3	0.5	0.3	3.3	69.2	0.3	146.0	88.6	0.4	0.8	26.1	0.8	0.2	0.3	9.5	0.3	0.2	0.3	0.6	15.2	47.1	2.2	13.1	0.0	0.7	6.7	1.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	38.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.5	0.0	0.0	0.9	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.0	0.6	0.0	7.9	0.0	0.0	0.2	56.0	28.1	9.1	14.0	0.0	0.0	0.0	0.6	0.4	0.6	558.6	0.0	0.0	0.0	0.0	70.7	9.2	0.0	0.3	0.0	146.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1112.4	0.0	1.9	854.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.0	821.7	144.0
C3orf67	"FLJ42117, FLJ42930"	ENSG00000163689	"Chromosome 3 open reading frame 67"	Q6ZVT6	3	58717365-59050084	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.4;testis: 28.4"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 80.6;Late spermatids: 61.4;Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2;T-reg: 2.2"	"Group enriched"	"Detected in many"	13	"B-cells: 2.2;T-cells: 2.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069696			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA069696: AB_2686174"	"unprognostic (4.59e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-5)"	"unprognostic (1.91e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.68e-3)"	"unprognostic (8.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.81e-2)"	0.5	1.8	1.2	1.0	4.3	0.3	0.6	0.5	2.0	1.5	0.7	0.5	0.0	0.1	0.6	1.6	10.4	3.4	0.7	0.4	0.9	0.9	0.7	1.9	0.6	1.8	0.5	0.9	0.7	0.8	1.3	8.4	1.3	1.3	1.0	0.9	1.6	2.6	0.4	0.2	0.4	0.3	0.5	0.6	0.4	0.5	28.4	0.5	0.4	0.4	2.0	3.6	0.3	2.9	2.2	0.0	0.0	0.1	0.1	2.2	0.3	10.5	1.7	3.0	0.0	1.8	5.8	0.0	5.0	1.7	2.2	1.8	0.9	3.5	11.0	1.7	1.2	0.0	1.1	4.7	2.4	4.0	1.7	0.3	0.0	1.8	0.0	1.0	0.0	0.0	1.1	2.4	4.7	3.8	2.8	4.6	7.3	8.4	0.1	3.0	1.4	0.5	0.0	3.7	3.4	7.5	10.6	0.0	4.5	2.4	0.1	7.7	3.6	1.4	1.0	3.2	5.1	3.4	0.0	0.1	0.2	3.4	5.5	2.3	4.5	9.4	2.1	2.6	0.0	7.0	0.0	0.1	0.0	0.2	0.0	0.0	1.7	0.7	0.0	0.0	2.2	0.1	0.7	0.0	0.1	0.0	0.0	2.2	0.3	1.2	4.3	0.5	2.0	0.9	0.9	0.5	0.9	1.3	0.5	0.0	0.0	0.0	1.5	0.8	0.1	0.8	0.0	13.4	2.3	1.8	0.0	0.7	1.7	3.2	80.6	0.9	0.0	0.0	0.3	1.6	1.6	0.9	0.0	1.7	0.8	0.0	2.4	0.6	0.3	61.4	2.0	0.2	1.7	0.0	0.5	0.6	4.1	0.0	1.1	0.8	0.3	0.0	1.2	27.9	15.8	0.1	0.5	0.0	1.2	1.4
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad"	P49789	3	59749310-61251459	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 138.8;Proximal tubular cells: 112.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"naive CD4 T-cell: 38.3"	"Lineage enriched"	"Detected in all"	14	"T-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.1;U-266/70: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	6.4	24.0	13.7	8.0	17.5	9.0	12.1	4.7	13.3	7.9	8.0	21.0	12.4	8.2	6.2	9.5	5.1	9.2	13.0	14.9	15.3	13.8	30.9	10.7	5.2	9.3	19.5	9.3	8.9	11.8	16.3	15.2	4.1	14.4	5.8	7.8	14.0	11.4	9.9	11.6	7.0	7.6	9.1	17.1	6.0	8.1	10.5	18.2	3.7	15.6	5.7	6.9	7.3	6.1	1.6	2.4	1.8	1.8	2.6	38.3	4.7	0.0	0.0	1.0	0.0	0.6	0.0	1.7	0.1	0.1	0.0	0.0	1.8	3.1	2.6	0.5	0.1	1.9	0.0	10.1	2.1	0.0	1.4	3.5	2.2	1.3	4.2	2.7	5.7	0.1	6.9	4.2	0.1	5.1	0.2	0.0	2.8	1.7	8.4	0.1	2.5	10.2	4.6	0.8	8.7	0.6	7.6	0.0	12.1	11.3	1.4	2.1	2.9	1.0	7.0	6.6	4.1	0.4	0.1	0.0	1.2	0.4	0.1	1.6	24.7	7.5	0.0	2.7	0.0	1.5	1.8	1.8	0.2	0.9	1.2	0.5	1.6	6.9	0.7	2.2	1.4	38.3	6.7	0.3	2.6	0.4	2.4	7.4	4.7	13.7	17.5	4.7	13.3	15.3	13.8	19.5	9.3	14.4	18.2	6.0	8.8	14.1	16.1	6.8	12.4	9.2	33.1	2.7	3.4	26.2	55.0	33.8	66.3	17.3	41.1	6.2	12.3	0.0	4.1	6.5	4.3	10.2	5.7	20.8	17.6	28.6	7.5	11.6	6.7	138.8	17.8	9.6	11.8	6.4	11.4	17.8	11.6	14.0	9.2	112.3	19.5	0.0	3.1	18.1	6.4	9.8	27.3	7.5	17.2	19.0
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase, receptor type G"	P23470	3	61561569-62297613	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 91.5;Horizontal cells: 146.2;Ito cells: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 36.2;HSkMC: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"		NA	NA		520000000	"Plasma membrane"		"HPA000546: , HPA064237: AB_2685221"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	22.2	18.0	12.9	10.1	10.7	1.2	26.1	8.1	16.4	17.2	13.9	5.2	12.0	5.6	15.8	19.0	6.4	13.1	15.7	12.4	24.5	9.9	20.2	8.2	38.9	10.2	8.3	10.5	16.6	6.0	58.6	11.9	13.1	15.1	11.3	8.9	23.3	7.9	17.2	19.2	6.6	8.4	17.4	12.7	9.2	8.7	11.4	5.0	0.1	21.7	7.0	3.2	10.0	14.6	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	11.7	0.0	36.2	18.5	5.7	7.2	11.8	7.7	10.4	5.4	0.2	0.2	4.2	8.5	6.1	0.1	5.6	5.6	12.2	0.6	3.2	0.5	0.0	6.2	12.2	3.0	0.0	26.8	2.3	10.9	13.2	2.5	8.3	0.8	0.0	7.2	6.9	3.1	0.0	0.0	7.2	0.0	0.0	4.7	3.6	0.2	7.9	3.3	0.9	1.9	1.7	0.0	2.8	5.0	0.0	0.1	18.9	10.8	10.3	17.2	6.0	2.3	2.6	0.0	8.2	1.3	13.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	12.9	10.7	8.1	16.4	24.5	9.9	8.3	10.5	15.1	5.0	11.9	25.9	0.8	5.2	8.1	91.5	10.4	7.6	2.7	5.7	21.0	5.9	7.6	5.0	7.9	2.9	41.3	11.0	0.0	1.6	0.6	33.6	7.0	0.0	26.0	15.0	146.2	23.6	89.0	2.2	2.5	61.5	1.8	16.9	1.0	7.6	38.3	4.5	7.0	53.4	13.3	4.8	71.1	52.3	1.0	6.1	4.3	10.5	0.9	11.0	2.2
C3orf14	HT021	ENSG00000114405	"Chromosome 3 open reading frame 14"	Q9HBI5	3	62318973-62336213	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 111.9;Spermatocytes: 148.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 106.9"					"Low region specificity"	"Detected in all"			HPA048286	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA048286: AB_2680340"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.69e-3)"	"unprognostic (6.91e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.76e-5)"	"unprognostic (1.57e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.33e-5)"	"unprognostic (8.19e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	3.8	14.7	28.2	5.6	23.6	1.0	35.0	16.4	31.2	5.0	3.9	7.7	2.5	3.3	5.5	6.8	11.0	4.1	6.8	4.6	20.9	22.0	9.6	2.9	6.4	5.0	19.9	20.5	8.2	6.3	2.3	19.0	4.8	25.9	17.8	4.1	4.1	5.0	5.6	1.0	12.0	2.7	6.8	15.2	3.0	6.1	20.9	8.1	1.2	9.2	3.8	8.2	13.5	3.4	3.7	6.7	5.2	21.0	0.7	6.1	2.1	0.0	5.8	7.0	0.0	5.1	7.4	5.4	9.5	5.7	12.0	11.9	0.0	8.5	0.0	0.0	6.4	24.7	1.5	0.0	6.0	9.2	0.0	4.0	5.1	0.0	0.0	3.4	0.0	11.2	3.3	8.1	13.5	11.1	0.2	5.8	0.0	0.6	0.1	11.8	106.9	0.0	0.0	8.8	8.4	12.0	0.0	0.0	2.9	9.8	16.3	12.3	10.4	6.3	22.6	8.7	6.1	9.2	5.8	0.1	5.9	0.0	27.4	9.4	5.8	0.0	0.0	5.7	0.0	20.5	5.2	4.3	0.4	0.2	14.3	0.1	3.7	3.6	2.8	4.6	1.1	1.0	0.7	0.3	0.7	21.0	6.7	6.1	2.1	28.2	23.6	16.4	31.2	20.9	22.0	19.9	20.5	25.9	8.1	20.8	10.2	2.7	19.7	32.6	31.2	4.5	7.6	4.0	19.4	21.0	3.9	16.3	51.4	31.3	111.9	11.7	2.6	0.0	47.7	18.9	20.3	22.1	1.1	3.0	27.0	35.0	84.0	4.9	7.8	44.2	13.0	19.5	43.9	83.8	2.6	27.9	29.7	0.0	9.9	34.8	23.1	0.0	15.5	148.6	37.5	25.1	8.2	4.4	3.8	17.0
FEZF2	"FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312"	ENSG00000153266	"FEZ family zinc finger 2"	Q8TBJ5	3	62369681-62374324	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"brain: 22.0"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 1.7;Horizontal cells: 1.6;Intestinal endocrine cells: 1.7;Rod photoreceptor cells: 2.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in many"	7	"amygdala: 12.2;basal ganglia: 6.4;cerebral cortex: 11.3;hippocampal formation: 22.0;olfactory region: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 5.2;NTERA-2: 3.5;U-266/84: 2.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 15.6;cerebral cortex: 15.0;hippocampal formation: 26.2"							NA	NA										"unprognostic (2.37e-1)"					"unprognostic (1.74e-2)"				"unprognostic (1.70e-1)"				0.7	0.5	12.2	0.4	6.4	0.4	0.5	0.0	18.0	0.4	1.4	1.8	0.0	0.4	0.5	0.4	0.4	0.5	0.5	0.5	22.0	1.8	0.7	0.5	0.5	0.4	1.1	10.0	0.5	0.4	0.4	0.7	0.5	0.0	0.6	0.4	1.1	0.5	0.5	0.8	0.6	0.5	0.4	0.0	0.8	0.9	0.5	0.3	3.3	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	6.4	0.0	11.3	22.0	1.8	1.1	10.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CADPS	"CAPS, CAPS1, KIAA1121, UNC-31"	ENSG00000163618	"Calcium dependent secretion activator"	Q9ULU8	3	62398346-62875389	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 784.0;Cone photoreceptor cells: 591.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"OE19: 9.2;SCLC-21H: 16.5;SK-MEL-30: 7.3;U-698: 10.5;U-87 MG: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059328	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA059328: AB_2683982"	"unprognostic (3.46e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.91e-3)"	"unprognostic (5.35e-3)"	1.2	17.2	18.2	2.8	16.0	1.0	1.6	22.4	58.0	4.0	3.5	2.4	0.0	3.9	1.5	3.4	1.1	1.1	3.2	11.6	21.9	24.7	1.1	1.1	1.6	1.4	33.7	18.4	2.8	13.5	0.9	19.6	1.1	43.6	4.5	3.3	5.3	1.3	3.8	1.0	2.2	4.0	1.7	7.1	1.4	4.1	3.2	2.7	0.0	1.1	0.0	1.6	1.2	0.6	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	9.2	0.0	0.1	0.0	0.0	0.0	0.0	16.5	1.2	0.0	0.0	7.3	0.3	0.0	0.0	0.0	1.4	0.1	2.7	0.7	0.0	1.4	10.5	17.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.2	16.0	22.4	32.0	21.9	24.7	33.7	18.4	43.6	2.7	0.0	3.4	0.0	0.2	1.1	784.0	16.5	5.1	0.0	0.0	0.0	591.0	0.1	0.0	2.1	0.9	0.1	0.3	0.0	0.3	0.0	2.6	0.3	41.5	0.0	0.0	44.5	92.0	0.0	0.0	0.9	14.1	0.0	8.5	0.0	1.9	16.8	1.2	0.2	2.5	0.0	60.9	0.0	1.2	0.2	0.2	0.1	0.0	0.0	0.4	0.3
SYNPR	"MGC26651, SPO"	ENSG00000163630	Synaptoporin	Q8TBG9	3	63228315-63616921	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 99.9"	"Group enriched"	"Detected in some"	12	"Horizontal cells: 100.1;Muller glia cells: 40.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enhanced"	"Detected in all"		"basal ganglia: 99.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;SCLC-21H: 4.3;SH-SY5Y: 1.2;SuSa: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051368, HPA061671"	Enhanced					NA	NA					"HPA051368: AB_2681456, HPA061671: AB_2684582"			"unprognostic (1.69e-1)"		"unprognostic (3.77e-2)"			"unprognostic (3.14e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-1)"		"unprognostic (5.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.89e-1)"		1.1	1.5	13.3	1.3	99.9	1.1	1.1	26.9	58.4	1.2	1.2	1.5	0.0	1.4	1.1	1.2	1.1	1.2	1.2	6.1	20.4	7.6	1.2	1.1	1.1	1.1	4.6	14.4	1.1	1.3	1.1	0.1	1.1	4.3	1.1	1.2	11.9	1.8	1.2	1.1	1.1	1.2	1.2	2.2	1.1	1.8	1.1	4.6	0.0	1.2	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.2	0.0	0.0	0.7	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	99.9	26.9	31.2	20.4	7.6	4.6	14.4	4.3	4.6	0.0	0.0	0.0	0.0	0.0	4.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	100.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNTN	"FLJ44379, S100AL"	ENSG00000188817	"Sentan, cilia apical structure protein"	A6NMZ2	3	63652668-63679020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5"	"Cell type enriched"	"Detected in some"	13	"Ciliated cells: 823.1"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"OE19: 3.1;RH-30: 2.4;SH-SY5Y: 3.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA043322, HPA058399"	Enhanced					NA	NA					"HPA043322: AB_10793945, HPA058399: AB_2683705"	"unprognostic (9.70e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-3)"				"unprognostic (4.34e-3)"		"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.73e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"		"unprognostic (8.43e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.1	26.6	0.0	73.9	0.0	0.0	0.6	0.3	0.0	0.0	29.5	0.0	0.0	0.0	18.5	0.1	0.0	1.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	5.8	0.0	0.1	0.0	0.0	0.9	0.4	1.6	0.2	0.4	0.5	0.1	0.3	0.2	0.6	0.8	0.1	1.4	0.5	0.0	0.0	0.0	0.3	0.2	0.8	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.5	0.0	0.0	0.2	0.4	0.2	3.1	0.0	0.3	2.4	0.2	0.1	0.3	0.3	3.4	0.1	0.3	0.0	0.6	0.1	0.3	0.0	0.6	0.6	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.6	1.6	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.0	0.9	0.5	0.4	1.1	0.4	0.2	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0	3.0	3.4	0.0	0.0	0.0	0.0	0.2	0.0	823.1	64.8	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1
C3orf49		ENSG00000163632	"Chromosome 3 open reading frame 49"	Q96BT1	3	63819362-63848636	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Group enriched"	"Detected in some"	12	"Early spermatids: 19.9;Late spermatids: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 4.7"					"Not detected"	"Not detected"			HPA053582	Uncertain		Approved	Vesicles,Centrosome,Cytosol		NA	NA			Cytosol	"Vesicles, Centrosome"	"HPA053582: AB_2682199"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.07e-1)"	0.4	0.1	0.5	0.4	1.0	0.9	0.4	1.8	4.0	0.4	0.4	0.4	0.4	1.3	0.5	0.4	1.7	0.4	0.4	0.8	0.5	0.5	0.4	0.6	0.6	0.4	0.4	0.4	1.2	1.3	0.0	0.4	0.4	0.4	0.4	0.0	0.4	0.5	0.4	2.6	2.0	0.4	0.4	0.4	0.4	0.3	3.6	0.4	0.4	0.7	0.4	0.4	0.5	0.4	1.1	0.5	1.7	0.9	2.2	1.1	0.1	0.7	2.0	1.0	1.3	0.0	0.3	1.2	1.7	0.0	0.1	0.0	1.2	1.0	2.6	0.4	0.0	0.7	1.1	0.0	0.1	0.3	1.5	1.8	2.2	4.7	0.5	0.0	0.8	0.8	0.2	0.1	0.0	0.1	0.5	0.0	0.9	1.3	1.2	0.0	4.4	1.2	1.2	1.3	1.2	0.4	1.7	1.1	2.5	0.1	1.1	1.2	0.8	0.3	2.6	0.3	0.3	0.7	1.0	1.5	0.8	1.0	1.7	2.0	0.8	2.4	0.5	2.7	3.7	1.0	1.7	0.6	0.2	1.1	0.4	0.4	0.6	0.6	0.8	0.4	1.1	1.1	1.0	1.2	2.2	0.9	0.5	0.8	0.1	0.5	1.0	1.8	1.3	0.5	0.5	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.3	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.8	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3
THOC7	"FLJ23445, fSAP24, NIF3L1BP1"	ENSG00000163634	"THO complex 7"	Q6I9Y2	3	63833870-63863903	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 147.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044143	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"		"HPA044143: AB_10794892"	"unprognostic (4.33e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.31e-1)"	24.3	28.5	41.1	19.7	34.7	29.0	33.3	20.6	37.6	24.6	29.6	14.8	24.1	27.7	22.2	24.6	43.6	18.7	27.2	36.1	38.5	28.3	30.5	32.5	17.2	25.9	33.9	35.2	21.1	35.6	18.0	23.8	42.0	33.7	24.6	30.4	14.8	30.4	22.8	52.9	27.0	34.9	31.1	27.2	20.4	21.5	24.6	15.5	34.4	21.3	43.0	27.6	28.4	22.8	25.4	31.4	32.2	24.8	27.6	32.1	17.7	19.8	12.2	14.1	3.4	18.9	25.8	13.4	17.6	18.3	20.6	20.8	14.6	22.0	23.8	7.5	22.6	20.6	11.7	15.7	27.6	28.9	24.3	11.5	21.3	16.0	16.9	19.8	29.6	10.5	18.6	23.3	17.7	31.4	20.3	22.6	16.0	16.2	23.2	25.0	147.5	25.9	26.9	17.8	43.0	9.8	18.9	13.3	32.4	35.7	19.1	7.0	16.3	15.2	21.4	23.8	14.4	13.7	41.2	16.2	15.0	16.1	18.6	31.0	15.2	22.3	28.9	18.7	38.0	19.6	32.2	21.9	17.1	22.2	24.8	30.7	25.4	27.6	30.0	31.4	17.4	23.8	24.8	13.1	27.6	20.7	28.9	32.1	17.7	41.1	34.7	20.6	37.6	38.5	28.3	33.9	35.2	33.7	15.5	83.4	45.5	85.5	64.3	54.7	49.8	132.7	66.2	89.7	81.9	80.3	17.7	145.0	175.8	128.4	54.2	60.1	73.9	93.5	108.7	140.5	54.4	56.4	52.1	76.8	98.6	46.1	53.0	41.1	67.5	71.0	82.3	73.9	64.1	181.3	101.8	52.7	119.8	91.2	67.1	197.6	51.9	51.8	72.2	202.6	43.2	62.6	178.5	55.5	119.9	83.0
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000285258	"Ataxin 7"	O15265	3	63864557-64003462	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.9"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 72.4"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034989: AB_10602596"																		0.4	0.0		1.5		2.8	1.3		0.0	2.0	0.7			0.0	2.0	2.0	0.0	0.9	0.8	0.0			1.0	0.9	0.9	2.1			0.5	1.0	3.0		1.9		0.9	0.9		0.5	0.6	0.3	3.1	0.8	0.3		1.5	1.0	0.0			0.8		1.8	0.1		4.9	3.6	8.9	1.9	2.5	4.3	0.7	2.4	0.1	3.5	3.3	3.3	6.1	3.3	3.0	2.5	4.1	5.6	1.5	3.2	6.9	1.1	2.1	4.8	2.8	3.4	2.3	4.9	6.6	2.6	6.3	4.3	2.5	4.6	4.6	5.8	1.9	6.9	5.2	6.8	4.2	2.9	3.9	2.3	9.8	2.9	13.2	3.0	4.0	2.2	1.6	0.8	5.8	2.9	2.5	2.6	3.4	1.1	1.7	6.0	4.9	3.9	2.9	1.4	6.7	4.0	6.1	3.3	3.6	4.7	5.4	4.8	4.3	2.4	4.8	3.6	5.7	1.9	2.7	2.5	1.2	2.9	4.9	2.9	2.4	1.6	4.3	3.5	2.5	8.9	2.5	1.4	3.6	4.3	0.7											8.9	7.8	5.7	20.9	38.7	67.5	0.0	33.1	8.1	5.7	5.2	96.2	0.0	0.0	2.5	11.6	15.5	24.4	0.0	3.7	0.0	4.1	20.9	14.9	17.4	0.0	23.8	25.3	33.7	34.3	6.2	11.8	10.2	11.8	8.2	19.4	28.6	2.0	27.1	12.4	0.3	72.4	0.0	19.6	12.5	15.3	40.4	0.0	40.6	18.2	34.4
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000163635	"Ataxin 7"	O15265	3	63898399-64003453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.4"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA034989			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA034989: AB_10602596"	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	8.8	6.4	4.9	14.5	7.4	19.7	8.9	10.2	6.5	9.5	10.7	4.9	6.7	8.0	10.9	9.2	9.2	7.5	11.4	7.5	5.0	4.3	6.3	8.2	10.2	19.9	6.1	3.1	12.4	21.7	15.3	10.9	15.1	6.0	8.2	8.1	15.1	12.2	7.8	9.6	10.6	12.5	9.2	5.7	11.1	7.2	14.6	6.7	55.4	8.8	8.5	24.2	8.4	10.2	0.9	0.5	11.1	0.5	2.6	5.9	1.1	6.0	4.9	5.0	4.1	5.8	6.6	6.6	3.5	6.5	7.5	6.1	6.9	5.9	5.8	2.1	6.8	8.1	4.0	6.4	6.6	8.0	15.2	2.6	10.1	5.8	2.1	2.9	4.2	12.2	6.3	3.6	11.1	12.4	5.6	5.6	9.6	3.8	17.7	4.6	14.4	8.9	3.5	3.4	4.1	2.2	3.8	4.6	7.0	3.7	7.2	2.0	3.7	7.8	5.2	7.1	4.2	3.6	6.1	7.7	6.5	8.9	9.5	8.1	8.0	8.1	6.4	7.7	7.1	6.2	11.1	0.3	0.9	3.2	0.5	2.6	0.0	5.9	3.4	0.1	0.9	5.7	3.7	1.2	2.6	0.1	0.5	4.7	1.1	4.9	7.4	10.2	6.5	5.0	4.3	6.1	3.1	6.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.1	0.0	0.0	0.0
PSMD6	"KIAA0107, p44S10, Rpn7, S10"	ENSG00000163636	"Proteasome 26S subunit, non-ATPase 6"	Q15008	3	64010549-64024010	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 401.5;Late spermatids: 551.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"MCF7: 181.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036921, HPA036922"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA		8600	Vesicles	"Golgi apparatus"	"HPA036921: AB_2675383, HPA036922: AB_10670850"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (8.65e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.95e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.22e-3)"	17.1	27.4	16.1	16.3	19.3	33.8	18.4	15.8	24.2	14.5	16.0	13.2	21.4	12.1	17.9	23.1	23.5	14.5	18.7	31.4	16.2	16.8	24.5	29.1	14.2	20.0	18.4	17.7	13.6	100.6	21.9	16.3	22.2	21.1	15.8	16.2	12.3	20.3	20.1	55.9	20.3	12.9	18.0	16.2	17.0	17.4	41.7	16.2	23.5	14.9	32.4	21.8	15.9	15.1	54.1	53.5	62.3	58.1	47.2	59.6	65.6	12.5	13.0	19.3	13.5	13.7	12.2	16.4	17.4	17.5	30.5	22.6	24.3	10.8	17.1	7.6	17.6	21.2	8.6	22.4	19.4	28.8	17.5	13.3	22.9	10.6	16.1	20.1	25.9	15.0	13.1	13.9	25.2	11.1	14.8	19.1	15.7	23.0	11.6	21.4	181.1	17.9	16.3	24.2	20.8	9.2	14.9	13.2	17.0	24.1	18.1	7.0	11.3	12.9	11.5	17.2	17.7	10.1	16.5	15.9	13.6	14.5	19.3	28.3	14.0	20.9	26.2	19.9	24.7	15.5	41.0	51.7	60.2	48.8	58.0	51.0	54.1	55.8	53.1	53.5	49.4	56.2	54.3	62.3	47.2	58.1	37.3	59.6	65.6	16.1	19.3	15.8	24.2	16.2	16.8	18.4	17.7	21.1	16.2	29.8	36.3	40.9	57.5	55.2	35.4	98.4	28.1	53.5	46.6	41.8	21.6	173.1	72.9	84.8	401.5	53.2	21.7	46.7	117.0	81.1	52.4	42.3	43.9	45.0	81.1	31.8	24.8	27.6	38.6	551.8	48.1	48.7	45.5	71.3	23.8	72.2	82.5	27.5	48.1	77.2	37.1	58.2	62.2	226.2	118.2	61.1	243.0	41.5	33.0	57.1
PRICKLE2	DKFZp686D143	ENSG00000163637	"Prickle planar cell polarity protein 2"	Q7Z3G6	3	64092242-64445476	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 60.9;Ito cells: 33.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.1;NK-cell: 1.1"	"Group enriched"	"Detected in many"	6	"B-cells: 2.1;NK-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.3;ASC TERT1: 11.4;HSkMC: 16.8;U-87 MG: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035493			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA035493: AB_10696504"	"unprognostic (2.87e-1)"	"unprognostic (4.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.77e-1)"	26.5	4.9	15.2	6.9	14.2	1.3	19.8	2.6	23.0	24.4	20.4	5.2	13.8	3.9	24.8	13.7	11.2	14.3	12.6	7.8	15.7	8.4	6.0	4.9	13.2	1.8	7.0	13.2	12.7	5.5	13.3	8.7	8.1	8.9	11.0	7.1	8.7	6.1	19.9	2.6	5.3	7.4	22.8	6.2	2.7	11.4	2.9	5.5	0.0	9.9	3.6	2.2	14.9	18.2	2.1	0.0	0.2	0.0	1.1	0.1	0.1	0.0	3.4	0.9	0.0	18.3	11.4	0.0	2.5	3.3	2.1	3.1	6.0	0.1	0.0	0.3	2.4	5.6	0.1	0.0	2.3	2.1	2.3	0.1	0.0	0.3	0.0	5.1	0.0	0.0	16.8	3.0	6.1	2.6	6.3	1.3	0.0	0.0	1.3	2.9	3.2	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.1	3.3	8.4	0.9	0.1	0.0	0.6	0.1	6.0	1.2	0.1	0.1	9.0	4.2	2.1	4.9	2.7	0.0	0.5	11.6	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.1	15.2	14.2	2.6	21.6	15.7	8.4	7.0	13.2	8.9	5.5	0.0	10.4	0.0	4.0	5.6	22.7	4.9	2.5	5.3	10.3	3.5	60.9	1.1	0.0	2.2	10.4	5.2	0.0	0.0	0.4	0.3	12.4	0.6	0.0	1.5	3.2	15.9	0.0	33.7	1.5	2.3	9.2	0.9	5.0	0.0	0.4	7.1	0.7	0.0	21.5	5.1	3.6	12.9	10.4	0.4	0.9	2.6	4.1	0.0	1.3	3.0
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 51.4"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 62.4;Ductal cells: 67.2;Endothelial cells: 76.0;Glandular cells: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 9.4;RPTEC TERT1: 11.2;SH-SY5Y: 52.5;SuSa: 17.3;WM-115: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	No	NA			Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	51.4	4.7	5.6	12.0	11.5	0.5	15.2	3.9	8.0	10.4	10.4	2.8	7.2	1.6	13.9	5.6	6.8	7.7	8.2	29.6	5.7	2.7	9.0	3.1	11.5	7.7	6.8	0.3	17.4	9.9	17.2	2.4	30.5	12.4	7.4	3.2	0.7	3.5	4.3	10.8	2.6	3.2	12.2	12.6	4.4	4.6	3.1	5.9	0.0	6.4	3.7	1.6	19.6	29.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	3.6	1.0	0.0	0.0	0.2	0.0	9.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.0	0.4	0.0	0.0	1.0	0.0	11.2	0.1	0.0	52.5	0.0	0.0	0.0	17.3	0.0	0.2	2.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	11.5	3.9	8.0	5.7	2.7	6.8	0.3	12.4	5.9	3.0	4.5	0.0	62.4	15.5	0.0	5.9	5.1	0.0	4.5	36.6	2.0	0.6	0.0	67.2	0.8	76.0	0.0	0.0	2.9	0.5	35.3	51.3	0.0	0.0	5.8	0.0	1.2	23.4	0.3	0.0	2.3	3.0	25.3	0.0	1.4	0.0	27.6	0.0	2.1	6.3	0.0	0.0	38.9	0.3	0.2	11.8	1.4	0.0	0.4	26.6
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031852, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031852: AB_2674074, HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	18.0	6.0	10.1	6.4	9.8	1.0	16.5	38.6	16.8	6.9	11.2	10.1	25.7	10.7	11.6	7.6	9.4	12.6	19.7	11.1	9.4	11.8	14.3	17.6	13.3	2.9	8.8	10.4	4.3	16.7	18.7	13.1	11.1	9.6	9.2	9.5	7.7	17.4	37.9	7.7	13.0	11.6	7.9	8.3	13.9	19.8	10.7	7.7	0.6	23.2	5.8	4.4	6.9	13.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.8	1.5	8.8	0.9	1.8	1.3	3.9	4.9	4.2	1.9	2.9	10.5	2.5	0.0	0.7	5.8	1.5	0.9	2.4	1.7	3.0	0.0	1.4	24.8	3.0	7.0	1.1	0.0	0.8	1.9	1.5	6.4	1.3	4.9	4.2	3.3	10.5	0.0	1.9	2.1	0.0	0.0	11.8	8.4	1.5	0.0	2.5	0.6	2.3	9.4	2.8	7.7	1.9	2.3	0.0	6.0	4.5	0.0	1.1	6.0	4.4	1.5	2.0	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	9.8	38.6	15.5	9.4	11.8	8.8	10.4	9.6	7.7	71.5	24.3	2.2	16.9	19.8	93.8	31.3	91.7	37.5	30.7	22.7	70.7	11.8	3.3	33.9	112.5	42.5	30.4	0.0	28.1	2.1	7.3	19.7	1.1	50.5	3.7	219.3	35.1	72.4	7.8	11.8	6.1	1.9	5.0	1.0	37.8	13.0	33.5	25.1	8.1	12.4	23.8	32.3	13.0	16.9	9.7	16.4	4.2	1.0	22.1	10.8
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	11.8	12.9	20.2	8.5	14.8	13.3	16.5	7.9	27.2	10.3	12.6	15.8	9.2	9.7	11.1	12.9	14.3	13.1	10.1	19.5	16.9	12.8	15.7	22.7	10.0	15.2	17.6	11.8	20.0	21.2	16.2	11.6	11.9	14.6	10.8	13.4	12.6	16.1	12.6	29.8	16.5	11.0	16.8	14.3	11.4	12.7	18.3	12.6	12.0	19.0	14.2	12.9	13.4	10.8	12.0	12.2	3.6	7.1	10.5	14.4	9.1	6.3	6.2	3.8	7.7	8.5	8.8	8.0	5.3	10.2	7.2	6.8	8.1	8.5	6.5	3.2	9.7	8.8	4.7	4.4	9.9	7.4	6.8	10.3	9.9	4.9	11.7	10.2	13.8	8.4	12.0	19.7	5.7	13.8	6.9	5.3	13.2	4.4	8.7	8.6	7.9	5.8	15.9	11.1	14.4	3.6	6.0	6.9	11.0	5.9	4.7	2.9	8.9	7.7	6.7	12.6	7.0	5.6	10.9	6.0	7.6	7.2	9.5	9.3	12.9	16.8	8.4	10.5	13.2	8.2	1.3	6.8	3.6	10.9	7.1	9.9	12.0	12.1	11.1	12.2	10.2	14.4	12.3	0.4	10.5	4.1	11.6	11.1	9.1	20.2	14.8	7.9	27.2	16.9	12.8	17.6	11.8	14.6	12.6	29.8	20.3	23.3	31.4	31.8	17.7	96.8	20.4	13.4	12.5	17.4	11.8	29.9	29.9	25.2	20.6	19.7	19.1	0.0	38.7	36.6	33.9	31.6	18.5	34.2	26.5	11.1	17.9	9.2	19.0	19.2	15.0	17.8	35.4	20.8	25.5	22.4	26.4	14.0	20.5	46.3	21.5	19.4	29.5	21.4	30.2	32.1	27.3	46.5	33.0	33.6
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 64.0"	"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 48.2;Muller glia cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.7"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.8;hTEC/SVTERT24-B: 18.7;U-698: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		21000	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	12.6	1.7	22.3	8.1	21.1	2.4	13.4	9.6	31.8	15.5	24.6	20.3	0.7	8.2	12.7	2.6	6.9	13.3	13.8	16.8	24.6	7.1	2.5	15.8	8.6	4.1	19.8	12.4	8.8	64.0	4.2	6.7	2.8	18.9	12.2	7.6	4.8	9.4	4.3	16.6	6.6	7.5	14.5	10.9	2.4	21.2	6.4	19.8	0.2	8.1	5.0	5.0	5.1	5.4	0.3	0.0	0.7	0.0	0.0	2.7	0.4	0.4	0.4	9.5	0.1	2.6	1.7	0.8	1.5	8.9	1.5	4.8	7.4	0.0	23.8	4.1	0.7	2.1	0.0	1.8	3.2	3.4	0.0	4.9	0.0	1.4	0.6	0.6	0.2	5.4	2.1	1.8	18.7	3.1	6.5	8.2	0.1	0.0	0.0	0.3	1.1	0.0	0.0	7.1	0.7	0.0	4.3	2.8	1.2	1.8	0.0	1.2	0.3	1.4	1.4	0.0	1.7	8.5	2.1	2.5	4.7	2.0	9.2	3.9	1.9	0.9	18.2	8.3	0.0	1.6	0.0	0.0	0.7	0.4	0.0	1.4	0.3	1.1	1.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	2.7	0.4	22.3	21.1	9.6	20.2	24.6	7.1	19.8	12.4	18.9	19.8	35.7	42.0	2.7	7.5	10.1	1.7	28.8	7.6	48.2	30.7	0.0	7.9	0.2	1.7	5.5	1.5	9.8	7.1	0.0	14.9	0.1	9.4	18.3	1.1	17.4	1.5	7.9	25.4	4.3	1.0	1.3	10.6	3.1	10.1	1.8	24.4	47.3	6.2	7.0	16.3	1.0	6.5	0.0	9.2	1.5	18.1	10.0	0.1	9.6	19.5	3.7
KBTBD8	"KIAA1842, TA-KRP"	ENSG00000163376	"Kelch repeat and BTB domain containing 8"	Q8NFY9	3	66998307-67011210	"Predicted intracellular proteins"	"Translation regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.7"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 15.9;Cardiomyocytes: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 31.8;Karpas-707: 14.9;U-698: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041285, HPA069190"	Approved					NA	NA					"HPA041285: AB_10796341, HPA069190: AB_2686101"	"unprognostic (2.62e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-4)"	"unprognostic (1.99e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.54e-1)"	1.6	1.4	3.4	7.3	10.3	12.5	1.2	5.1	4.7	0.9	2.5	1.0	0.0	1.9	0.9	0.3	2.3	1.0	2.0	4.4	3.6	2.5	1.2	2.2	2.9	19.8	2.5	0.6	0.8	2.0	0.4	3.5	3.7	3.6	2.6	2.2	0.5	1.9	0.5	3.5	1.1	7.0	5.9	2.8	9.9	2.2	7.9	3.0	5.4	1.4	0.4	20.7	4.1	2.1	8.9	3.2	0.5	3.8	1.5	3.0	1.6	0.6	0.7	1.3	1.5	0.9	0.5	2.8	1.6	0.6	1.2	0.9	2.9	0.3	31.8	0.4	0.4	0.7	0.8	7.5	1.7	1.9	5.3	2.4	11.6	0.3	1.5	1.2	7.4	12.6	1.0	0.8	2.4	2.1	0.4	0.8	6.4	2.8	14.9	0.8	1.2	5.9	1.2	5.5	1.2	0.5	3.4	1.3	4.3	0.3	1.0	4.6	1.6	0.6	0.5	1.2	1.7	0.3	2.1	2.5	4.1	0.9	8.8	3.0	8.7	13.4	22.1	1.1	6.0	1.3	0.0	1.5	0.5	1.5	3.8	0.9	8.9	1.8	1.6	3.2	8.8	1.8	1.2	0.0	1.5	3.2	0.4	3.0	1.6	3.4	10.3	5.1	4.7	3.6	2.5	2.5	0.6	3.6	3.0	0.0	2.6	15.9	0.4	4.6	1.3	9.2	0.0	0.0	1.2	0.0	2.0	3.3	0.0	0.5	0.7	0.6	1.5	0.0	0.8	1.0	1.0	0.4	4.6	0.4	3.4	3.2	1.2	1.8	0.3	0.4	0.0	6.5	0.0	1.0	0.7	1.6	0.8	0.8	0.4	0.4	0.3	0.0	2.1	7.2	4.8	4.8	2.1	4.1	1.1	0.5
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming beta subunit"	Q96I99	3	67360460-67654614	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 90.9"	"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 290.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Approved	"Plasma membrane,Mitochondria"		NA	NA		290000	Mitochondria	"Plasma membrane"	"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favorable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	17.0	19.3	8.8	26.5	10.0	3.4	12.4	2.4	7.2	15.3	38.9	9.5	16.4	31.4	11.5	18.3	18.6	9.9	27.9	23.6	6.6	6.2	38.3	90.9	14.6	21.1	9.8	6.5	16.5	20.9	5.9	8.5	8.5	7.6	14.0	34.5	9.6	21.0	17.3	57.0	9.3	42.4	23.5	8.6	24.7	25.4	6.5	8.1	9.6	16.4	27.0	16.7	19.9	13.2	19.2	10.2	5.8	18.2	27.1	31.1	18.9	12.8	11.2	11.1	13.5	18.7	32.4	13.5	15.4	22.5	18.1	20.3	12.3	28.7	16.4	5.0	21.6	11.9	6.6	8.6	21.2	23.5	6.9	5.9	14.8	10.1	19.2	24.1	19.5	10.4	24.2	18.5	14.2	32.6	22.5	19.2	12.6	11.3	15.0	39.4	9.0	7.3	6.2	10.4	58.8	6.9	5.1	17.2	24.5	30.7	19.9	2.2	7.5	24.4	28.2	20.3	7.8	21.7	12.5	16.7	18.0	11.9	19.7	18.2	10.3	15.0	11.5	26.5	15.3	21.1	5.8	15.3	5.2	13.8	18.2	16.7	19.2	20.0	17.4	10.2	16.7	31.1	23.7	0.7	27.1	14.8	4.0	18.5	18.9	8.8	10.0	2.4	7.2	6.6	6.2	9.8	6.5	7.6	8.1	32.8	40.3	57.4	34.0	33.0	2.6	146.2	84.1	61.6	42.1	76.8	7.9	46.8	207.2	71.1	2.4	35.8	224.3	46.7	70.7	37.8	47.4	43.6	29.0	290.2	50.0	4.8	55.9	44.8	60.1	4.1	38.3	46.7	40.5	32.5	187.4	22.3	55.1	140.3	44.6	211.1	3.8	32.3	67.3	1.4	6.8	43.2	31.8	55.8	241.0	45.3
FAM19A1	"TAFA-1, TAFA1"	ENSG00000183662	"Family with sequence similarity 19 member A1, C-C motif chemokine like"	Q7Z5A9	3	68004216-68545625	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 13.9;brain: 28.0"	"Cell type enriched"	"Detected in some"	12	"Early spermatids: 14.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 13.9;MAIT T-cell: 10.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 7.5;naive CD4 T-cell: 8.2;naive CD8 T-cell: 11.5;T-reg: 5.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 13.9"	"Cell line enriched"	"Detected in single"	9	"REH: 6.1"	"Low region specificity"	"Detected in many"							HPA013407	Approved				"Secreted in brain"	NA	NA					"HPA013407: AB_1848386"	"unprognostic (5.19e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.95e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.41e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-4)"	"unprognostic (5.77e-2)"	0.7	2.0	10.6	0.8	9.0	0.4	0.5	0.4	28.0	0.5	0.7	0.1	0.3	2.3	0.8	2.0	0.5	0.5	1.4	0.5	18.4	4.8	0.8	0.8	0.5	1.2	4.4	10.4	0.4	0.4	0.4	0.6	0.4	25.2	2.6	0.6	0.0	0.6	6.2	0.6	0.4	0.5	0.9	1.3	0.9	0.5	0.7	0.2	0.0	0.6	0.0	0.7	0.7	0.3	0.0	0.0	0.2	0.1	2.1	13.9	2.6	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.9	0.0	10.7	0.0	11.5	7.5	0.0	0.0	8.2	11.5	0.2	2.1	0.0	0.0	5.0	2.6	10.6	9.0	0.4	24.4	18.4	4.8	4.4	10.4	25.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
FAM19A4	TAFA-4	ENSG00000163377	"Family with sequence similarity 19 member A4, C-C motif chemokine like"	Q96LR4	3	68731766-68953297	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.0;brain: 10.9"	"Cell type enriched"	"Detected in some"	7	"Cone photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;NTERA-2: 13.9;SuSa: 4.1"	"Region enriched"	"Detected in some"	5	"thalamus: 14.7"	"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA						"unprognostic (1.92e-1)"			"unprognostic (9.97e-3)"	"unprognostic (2.28e-1)"			"unprognostic (8.19e-3)"		"unprognostic (8.78e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.50e-1)"		0.5	26.0	2.3	0.9	7.3	0.5	0.6	0.4	7.5	0.5	0.7	10.8	0.0	0.6	0.5	0.5	1.1	0.6	2.7	0.5	2.9	4.2	0.7	0.5	0.6	0.6	10.9	1.8	1.0	0.5	0.5	1.8	1.8	8.7	2.2	0.6	5.0	0.7	1.1	0.5	0.5	0.5	1.0	10.4	0.6	8.3	2.1	8.2	0.0	0.6	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.3	0.4	7.5	2.9	4.2	10.9	1.8	8.7	8.2	0.0	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975214-69013961	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	14.9	5.8	3.4	10.1	4.4	3.0	11.9	2.5	4.8	16.8	12.1	4.4	10.2	4.8	23.3	10.4	15.1	11.4	18.1	18.2	3.9	3.6	6.6	5.5	15.8	9.6	4.2	5.0	12.7	7.8	3.9	5.5	15.2	5.1	18.9	5.8	8.7	14.0	24.0	28.0	6.1	7.7	29.4	4.9	10.2	10.1	7.4	2.4	8.3	5.4	14.2	7.3	27.0	9.8	1.7	3.4	5.5	2.2	3.3	9.2	1.8	8.2	2.8	5.4	6.6	7.7	15.2	4.0	11.2	13.7	7.1	9.4	3.7	4.7	0.4	1.7	12.1	6.1	2.7	3.7	14.6	9.0	26.7	2.6	8.6	6.3	5.3	8.6	4.8	3.6	12.6	12.4	9.2	11.7	8.7	39.1	0.3	2.3	5.1	23.8	2.1	0.7	1.5	6.3	2.7	1.3	0.3	5.7	3.5	6.1	19.0	0.5	3.0	12.9	1.0	10.1	6.0	2.8	6.6	20.7	20.1	6.1	2.3	10.8	2.6	8.4	4.0	8.0	7.5	11.2	5.5	2.2	0.0	3.0	1.9	3.5	1.7	4.8	6.4	3.4	1.2	4.1	4.1	0.3	3.3	0.7	0.6	9.2	1.8	3.4	4.4	2.5	4.8	3.9	3.6	4.2	5.0	5.1	2.4	11.9	10.1	1.5	10.1	6.4	2.2	13.7	7.6	8.1	14.8	1.8	15.7	0.8	0.0	4.0	13.9	15.0	2.5	0.0	7.0	3.8	7.5	7.5	0.0	3.8	5.9	0.0	5.8	21.5	5.1	12.0	2.8	7.7	8.5	9.0	3.4	1.3	9.0	2.9	38.2	1.5	4.8	0.0	23.8	1.1	2.4	4.0	0.7	4.4	2.5	5.8
TMF1	"ARA160, TMF"	ENSG00000144747	"TATA element modulatory factor 1"	P82094	3	69019827-69052339	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Ciliated cells: 269.0;Early spermatids: 404.2;Late spermatids: 399.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008729	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA008729: AB_1080310"	"unprognostic (2.71e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.02e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-1)"	17.4	14.2	12.8	15.2	14.2	26.2	20.8	20.8	15.6	18.8	21.1	9.5	26.6	14.8	18.3	24.2	14.9	17.7	16.8	16.7	11.9	12.1	17.5	17.2	19.0	16.8	13.5	11.1	20.2	23.0	22.3	36.1	28.9	17.2	19.0	16.9	9.5	24.3	28.9	21.3	13.3	22.9	13.8	13.6	16.3	15.9	20.9	16.0	20.3	24.7	11.1	16.4	23.2	18.6	6.6	4.6	10.0	5.9	5.0	6.4	3.1	12.7	5.6	5.4	5.4	14.5	18.7	12.1	16.5	16.1	11.1	13.5	7.9	9.5	4.9	2.7	16.7	7.8	7.0	6.9	7.3	18.3	9.3	5.2	9.5	7.4	9.3	13.1	10.6	13.5	11.0	11.7	14.7	13.4	11.8	11.8	4.1	5.7	8.0	14.4	7.3	6.1	9.2	4.6	8.2	2.9	5.1	6.8	7.0	14.4	10.3	3.7	5.7	13.6	9.7	10.2	7.5	7.3	12.8	15.4	10.9	4.6	19.1	9.8	9.1	8.7	4.8	16.7	11.1	8.7	7.6	4.5	9.1	6.4	3.7	4.3	5.2	5.7	5.4	4.0	6.6	5.9	5.4	10.0	5.0	5.9	4.6	5.8	3.1	12.8	14.2	20.8	15.6	11.9	12.1	13.5	11.1	17.2	16.0	59.6	65.7	33.6	29.6	33.3	42.8	29.1	30.6	269.0	109.2	40.1	35.3	34.3	13.3	43.9	404.2	35.8	38.6	46.7	49.2	49.4	43.7	52.7	71.7	16.6	25.1	33.4	53.4	27.6	28.1	399.8	47.2	46.8	33.7	57.7	56.2	41.0	42.1	35.7	58.4	22.6	49.1	32.3	42.5	94.3	23.7	34.5	67.4	49.7	33.0	76.5
UBA3	"hUba3, NAE2, UBE1C"	ENSG00000144744	"Ubiquitin like modifier activating enzyme 3"	Q8TBC4	3	69054730-69080408	"Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA034873, HPA034874, HPA065335"	Supported		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA		9600	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473"	"unprognostic (2.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.56e-3)"	"unprognostic (9.26e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.60e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.61e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.52e-1)"	19.1	25.3	29.7	22.2	31.0	53.7	26.8	30.9	31.4	20.3	19.7	31.3	15.9	16.1	22.8	25.4	25.4	19.5	18.4	38.2	23.8	22.7	24.7	17.6	19.3	28.7	37.5	21.2	20.4	15.1	17.9	28.0	27.8	40.8	22.6	22.6	21.8	28.0	20.4	25.0	27.6	21.9	24.0	30.2	27.8	17.3	13.5	31.9	28.4	18.2	17.2	31.0	22.9	20.4	18.9	22.3	35.6	27.8	20.2	22.2	26.0	26.8	11.4	28.1	17.1	26.3	34.9	21.7	24.1	27.3	26.3	26.5	14.1	19.0	20.5	7.0	25.9	26.5	15.5	21.6	27.6	30.0	37.3	13.7	27.7	21.5	14.2	20.3	27.1	23.3	27.4	18.5	24.8	20.8	32.4	33.8	16.9	11.4	17.6	34.6	9.6	17.8	18.3	24.9	34.1	9.8	13.9	20.8	18.8	41.9	34.4	12.1	16.9	25.4	18.5	20.6	31.6	12.6	26.7	25.6	20.0	17.6	25.9	33.4	20.2	32.3	24.4	20.5	30.2	25.4	34.7	25.4	35.6	14.3	27.8	16.1	18.9	18.9	17.6	22.3	16.0	17.9	18.0	24.4	20.2	27.7	11.4	22.2	26.0	29.7	31.0	30.9	31.4	23.8	22.7	37.5	21.2	40.8	31.9	32.8	28.9	17.1	23.8	30.0	21.0	57.2	20.4	37.5	23.9	33.2	37.3	64.4	16.6	30.4	10.9	27.1	14.3	0.0	20.5	47.2	31.1	21.5	40.5	16.2	30.1	31.8	17.9	20.3	43.2	7.9	37.4	39.1	28.7	53.3	15.3	27.7	25.3	8.6	35.7	26.4	44.9	25.8	29.3	32.3	33.0	37.4	47.5	33.8	16.6	28.2
ARL6IP5	"DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b"	ENSG00000144746	"ADP ribosylation factor like GTPase 6 interacting protein 5"	O75915	3	69084944-69106066	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015540, CAB019321"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		19000000	"Endoplasmic reticulum"		"CAB019321: , HPA015540: AB_1852061"	"unprognostic (8.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.31e-2)"	53.2	53.2	44.0	37.4	48.5	21.3	51.5	32.9	62.1	48.1	31.9	41.5	16.8	21.1	33.8	40.0	38.5	34.5	37.3	76.0	42.9	51.0	43.3	28.4	44.9	43.7	53.1	30.7	28.9	23.3	18.3	36.3	50.6	81.7	49.2	31.8	32.1	54.9	35.6	69.3	18.5	30.3	37.0	51.6	40.7	27.9	21.4	46.1	32.5	39.9	32.7	45.2	46.9	30.2	57.3	40.4	91.5	57.5	41.4	74.8	114.8	15.2	10.6	13.1	9.6	68.3	64.0	16.6	15.8	35.8	12.3	14.5	5.3	37.4	3.0	5.3	27.1	23.1	12.2	10.7	18.2	10.6	59.8	10.0	10.5	18.0	8.1	17.6	8.9	52.1	46.0	32.9	11.3	14.4	43.7	37.6	10.1	4.6	28.7	29.8	8.8	9.7	11.8	3.4	35.6	10.0	8.6	12.0	28.0	60.7	25.7	3.3	8.7	15.7	17.1	20.6	13.5	11.3	14.3	36.7	8.2	6.5	20.7	17.1	25.8	36.1	5.6	27.2	22.4	13.2	81.4	57.5	91.5	52.3	51.4	40.1	57.3	73.9	66.5	40.4	43.9	63.1	66.2	24.0	41.4	43.0	25.6	74.8	114.8	44.0	48.5	32.9	62.1	42.9	51.0	53.1	30.7	81.7	46.1	163.8	103.0	121.2	73.7	64.7	192.5	338.6	84.1	117.8	116.0	89.0	176.7	275.4	21.6	231.6	8.1	130.0	85.8	70.0	188.9	320.0	170.5	132.5	322.8	62.5	267.8	116.0	40.4	118.4	223.5	12.7	191.8	306.3	258.1	527.6	54.0	207.9	194.4	84.2	246.1	66.8	224.8	187.5	100.4	8.1	2.5	64.5	149.2	256.0	66.9	73.3
LMOD3		ENSG00000163380	"Leiomodin 3"	Q0VAK6	3	69106872-69123032	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 28.3;skeletal muscle: 121.1;tongue: 53.1"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 241.3"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"HSkMC: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036034	Uncertain					NA	NA					"HPA036034: AB_10673494"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (3.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.96e-1)"	0.8	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	4.8	1.9	0.1	0.0	28.3	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.9	0.0	0.0	4.4	0.1	121.1	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.0	1.4	53.1	0.7	0.6	0.1	0.9	0.3	4.1	1.1	0.4	1.0	0.2	0.3	0.1	0.9	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.7	0.6	0.0	0.2	0.7	8.2	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.6	1.8	0.1	0.0	0.3	0.1	0.0	0.2	0.1	0.6	0.1	0.0	0.8	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.3	0.1	0.4	0.5	0.2	0.3	0.2	0.3	4.1	0.6	0.8	0.5	0.4	0.6	0.6	0.9	0.7	0.1	0.9	0.6	0.7	0.8	0.4	1.1	0.3	1.0	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	3.7	1.4	2.1	4.5	241.3	10.2	0.0	0.0	0.0	37.3	0.7	0.0	0.8	0.7	0.7	2.4	0.0	0.0	1.6	2.2	1.9	18.4	1.0	0.7	6.4	0.0	1.3	1.0	0.2	0.3	1.7	11.8	1.8	1.5	1.6	1.0	0.0	1.1	0.3	14.1	0.0	1.9	0.4	0.1	1.3	0.3	7.5	0.6	1.8
FRMD4B	"GRSP1, KIAA1013"	ENSG00000114541	"FERM domain containing 4B"	Q9Y2L6	3	69169990-69542583	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 206.2;Urothelial cells: 174.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.8;hTCEpi: 16.9;hTERT-HME1: 22.5;HUVEC TERT2: 24.4;TIME: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009705	Uncertain	Supported				NA	NA		7400			"HPA009705: AB_1849147"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.59e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (5.01e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-3)"	10.0	3.7	10.0	7.8	32.0	9.3	11.1	2.3	16.6	17.4	8.4	47.9	3.3	5.9	7.8	9.7	25.9	9.2	13.3	11.6	14.9	8.1	11.6	23.7	16.7	9.3	27.1	11.1	7.7	5.8	1.5	4.8	16.9	21.2	12.0	8.9	11.5	23.8	6.8	2.8	22.1	8.2	7.0	21.3	20.0	10.0	2.8	30.2	9.4	27.4	10.2	8.4	7.9	15.0	1.4	11.0	8.3	18.9	2.4	9.9	4.5	3.1	0.8	5.0	0.1	0.1	0.7	5.5	0.2	0.7	0.4	0.4	18.8	5.4	0.3	1.7	0.2	0.4	12.3	1.9	14.4	0.6	1.0	1.5	8.0	0.6	1.0	0.3	2.1	4.2	0.7	16.9	0.5	22.5	0.7	24.4	2.2	0.7	2.8	1.5	3.4	0.2	0.4	2.7	4.2	3.6	13.0	1.3	0.5	7.3	2.2	5.5	7.2	0.8	5.9	15.5	4.8	2.2	3.2	19.1	0.2	2.0	0.2	0.8	0.2	0.1	0.4	0.2	6.2	6.3	8.3	18.9	1.5	1.4	9.2	5.0	1.1	4.6	1.9	10.8	1.4	1.4	1.3	4.9	2.4	1.5	11.0	9.9	4.5	10.0	32.0	2.3	16.6	14.9	8.1	27.1	11.1	21.2	30.2	38.7	65.7	4.2	29.3	53.9	14.1	27.8	35.7	38.8	60.3	14.0	206.2	43.3	28.2	26.3	12.6	60.2	37.2	0.0	15.3	15.1	16.7	39.3	32.5	41.9	75.9	0.0	23.5	76.1	110.7	2.7	6.1	57.5	27.0	1.8	27.1	13.0	19.0	42.1	17.3	43.9	106.6	6.5	6.1	0.0	2.4	44.9	48.7	19.1	16.6	174.0
MITF	"bHLHe32, MI, WS2, WS2A"	ENSG00000187098	"Melanogenesis associated transcription factor"	O75030	3	69739435-69968337	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Albinism, Cancer-related genes, Deafness, Disease mutation, Microphthalmia, Osteopetrosis, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Melanocytes: 555.0"	"Group enriched"	"Detected in all"	8	"melanoma: 39.2;renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 4.5;classical monocyte: 10.9;intermediate monocyte: 3.6;myeloid DC: 6.8;non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.8;granulocytes: 4.5;monocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 27.1;SK-MEL-30: 72.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002578, HPA003259"	Enhanced					NA	NA					"CAB002578: AB_564111, HPA003259: AB_1079381"	"unprognostic (3.29e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.94e-1)"	"prognostic favorable (8.35e-10)"	"unprognostic (6.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	12.8	3.8	2.6	2.6	3.9	0.8	17.8	1.7	3.0	30.6	10.1	5.9	6.4	1.5	37.9	6.2	8.3	6.4	9.9	23.4	3.1	2.4	12.8	1.8	7.1	1.7	4.2	1.1	11.1	2.4	9.7	6.2	1.8	4.0	9.0	2.5	40.1	4.0	8.2	39.1	5.8	4.1	26.2	5.0	1.8	5.1	4.7	5.1	0.1	4.4	8.1	1.0	12.1	10.3	0.0	6.8	4.5	10.9	1.4	0.1	3.4	4.9	3.4	0.4	1.5	5.7	0.1	0.6	5.0	2.9	2.3	1.4	1.8	0.2	0.0	1.2	0.0	6.4	2.7	1.0	2.7	2.6	0.0	0.6	10.9	7.3	0.1	1.4	0.2	27.1	4.7	1.1	0.6	2.6	8.7	0.7	0.0	3.6	1.5	1.6	0.2	0.2	0.3	0.2	0.2	2.4	0.0	0.5	2.3	13.7	2.5	0.2	0.6	2.6	0.9	72.8	0.6	0.2	0.6	0.0	1.1	4.1	1.6	1.0	0.1	0.3	0.0	2.3	0.8	2.9	4.5	10.9	0.0	0.0	3.6	0.0	0.0	0.0	0.1	6.8	0.0	0.0	0.0	0.7	1.4	5.7	0.5	0.0	3.4	2.6	3.9	1.7	3.0	3.1	2.4	4.2	1.1	4.0	5.1	26.8	5.0	0.0	3.1	38.0	0.2	101.2	5.1	12.0	9.1	14.0	0.0	1.2	43.1	11.4	1.1	6.8	0.0	0.0	7.7	1.0	21.0	4.4	100.8	2.4	40.1	6.4	1.2	4.3	23.9	0.6	41.1	24.0	555.0	10.8	0.0	0.8	7.4	0.0	47.4	18.3	0.2	12.9	20.3	3.3	7.3	16.6	0.9	2.5	0.6	4.7
MDFIC2		ENSG00000242120	"MyoD family inhibitor domain containing 2"	A0A1B0GVS7	3	70196894-70312726	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 3.5;salivary gland: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HeLa: 2.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA																							0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXP1	"12CC4, hFKH1B, HSPC215, QRF1"	ENSG00000114861	"Forkhead box P1"	Q9H334	3	70952817-71583993	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 40.2"									"HPA003876, CAB011501"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011501: AB_732428, HPA003876: AB_1078907"	"unprognostic (2.31e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	24.6	5.1	7.0	30.2	19.2	32.7	21.9	7.2	13.1	16.3	29.3	8.7	10.3	10.1	19.8	9.9	19.6	13.1	19.3	15.5	8.4	5.9	7.6	12.9	26.1	34.0	7.6	10.2	30.3	14.7	7.2	25.7	11.4	7.4	21.6	21.6	11.3	24.6	11.2	12.7	12.2	16.7	34.3	7.9	18.6	20.4	11.7	10.1	38.1	19.8	13.1	27.0	28.5	31.8	29.9	8.4	14.4	9.9	9.2	29.6	11.2	3.8	2.9	7.1	4.8	3.3	9.6	3.4	11.4	13.1	10.0	7.3	21.3	4.5	10.3	1.7	5.1	7.2	2.6	13.1	9.8	16.9	3.1	5.4	5.3	7.1	20.0	8.3	9.9	13.1	9.8	4.0	40.2	17.8	7.0	14.9	6.1	5.3	15.1	4.5	16.8	4.9	3.9	8.7	2.7	18.6	14.9	12.3	1.8	8.2	12.1	6.0	10.9	11.9	3.3	0.7	7.1	2.3	7.3	18.8	13.9	6.0	19.3	15.7	3.8	2.8	14.6	8.8	12.7	2.9	14.4	5.7	6.0	8.3	5.7	9.3	25.8	18.3	10.3	5.3	29.9	29.6	18.9	8.3	9.2	9.9	8.4	15.9	11.2	7.0	19.2	7.2	13.1	8.4	5.9	7.6	10.2	7.4	10.1	68.5	106.7	181.2	154.9	162.6	27.9	38.3	114.7	87.0	93.3	31.4	17.7	37.3	26.6	65.8	141.2	159.5	75.9	70.0	81.8	13.6	54.0	219.0	213.7	53.9	43.0	6.4	260.7	120.9	97.8	57.5	38.9	86.3	35.4	111.0	226.3	20.3	98.8	101.7	23.3	15.6	38.0	90.5	74.6	10.8	6.4	88.7	43.8	126.3	146.7	116.8
EIF4E3	MGC39820	ENSG00000163412	"Eukaryotic translation initiation factor 4E family member 3"	Q8N5X7	3	71675416-71754773	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.8;monocytes: 4.2;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 20.0;U-937: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058649, HPA076465"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA058649: AB_2683785, HPA076465: "	"unprognostic (3.16e-3)"	"unprognostic (7.60e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.31e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (3.10e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.16e-2)"	"unprognostic (4.58e-2)"	"prognostic favorable (6.99e-5)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.83e-2)"	18.8	9.4	17.2	11.8	22.6	17.7	25.6	13.9	19.4	9.6	16.3	11.5	3.7	10.4	11.0	8.5	16.0	12.2	11.9	30.3	18.6	14.6	10.5	8.8	13.7	11.7	15.2	12.4	17.9	19.4	26.7	14.6	4.7	12.8	14.8	13.0	10.8	12.9	14.5	40.4	7.2	17.6	25.6	19.4	15.3	9.9	5.9	6.7	7.8	19.7	14.5	7.8	17.6	21.8	0.2	0.9	14.8	4.2	1.0	5.4	1.6	0.3	1.3	1.3	4.3	1.3	3.4	1.7	1.1	1.2	1.1	0.6	0.7	0.6	0.0	2.9	1.1	7.4	1.6	4.7	6.5	0.9	14.9	1.4	0.0	0.1	0.1	4.6	2.3	2.6	3.0	4.2	0.3	3.6	0.6	3.6	2.7	0.5	20.0	0.2	5.0	2.0	0.5	10.5	0.5	2.3	1.1	5.2	0.6	14.3	7.2	2.7	7.2	7.8	1.7	0.2	4.3	7.5	0.1	0.9	0.6	3.4	9.2	1.0	14.1	13.1	0.0	0.5	27.1	2.6	1.2	4.2	5.9	2.2	1.8	3.4	0.2	3.1	3.6	0.9	0.1	2.3	2.7	14.8	1.0	2.3	0.0	5.4	1.6	17.2	22.6	13.9	19.4	18.6	14.6	15.2	12.4	12.8	6.7	26.8	12.6	0.0	8.5	9.0	10.3	35.1	7.6	2.7	10.3	10.4	0.0	3.3	3.3	4.9	0.9	9.3	27.6	0.0	4.9	2.3	8.4	10.8	6.9	4.9	4.0	1.6	8.7	14.7	15.7	1.1	11.8	5.8	3.3	1.0	11.1	13.5	8.0	14.4	8.9	11.4	0.5	0.0	17.5	0.2	0.4	11.8	1.3	13.8	6.4	7.6
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71754050-71756496	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;parathyroid gland: 29.6"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 11.0;Collecting duct cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.7;neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.0;HL-60: 12.5;MCF7: 10.8;NTERA-2: 21.5;RPTEC TERT1: 10.4;SH-SY5Y: 8.2;T-47d: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA029395: AB_10602907"	"prognostic favorable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.7	4.5	14.9	1.7	23.2	14.5	4.3	4.4	15.4	3.4	1.0	5.8	1.7	0.6	5.5	3.3	2.7	7.7	1.2	3.5	12.8	12.4	3.2	0.9	2.4	5.5	10.6	8.8	5.0	2.6	29.6	5.1	2.0	5.9	5.7	0.7	3.3	1.7	5.1	1.8	1.9	0.7	3.3	16.8	3.7	2.4	4.2	3.6	0.0	6.8	1.2	0.5	2.1	2.8	0.0	0.2	10.5	0.8	0.0	0.4	0.1	0.0	0.8	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	13.0	0.0	0.6	0.0	3.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	12.5	0.7	0.0	2.2	0.0	0.9	0.0	0.0	2.7	0.0	0.0	0.0	10.8	0.9	0.2	21.5	0.0	0.0	0.0	0.0	0.0	10.4	5.8	2.3	8.2	2.8	0.0	0.0	2.9	7.5	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.8	3.7	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	10.5	0.0	0.1	0.0	0.0	0.1	14.9	23.2	4.4	9.9	12.8	12.4	10.6	8.8	5.9	3.6	0.0	1.4	0.0	4.0	1.6	11.0	2.8	5.1	2.7	2.3	12.2	3.9	1.1	1.7	0.4	0.1	0.0	0.0	0.0	0.0	1.1	0.9	4.5	0.0	0.0	1.0	0.0	1.2	0.0	5.1	0.0	0.9	0.5	0.0	0.0	0.0	0.5	0.4	0.0	1.1	0.0	0.3	0.0	0.4	0.2	0.9	1.5	0.2	0.0	0.0	1.8
PROK2	"BV8, KAL4, MIT1, PK2"	ENSG00000163421	"Prokineticin 2"	Q9HC23	3	71771656-71785206	"Disease related genes, Predicted secreted proteins"	"Biological rhythms"	Neuropeptide	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 82.6;bone marrow: 42.8"	"Group enriched"	"Detected in some"	7	"Kupffer cells: 15.8;Spermatocytes: 25.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	49	"neutrophil: 82.6"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 82.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 9.0;NB-4: 7.8;NTERA-2: 5.5;U-266/70: 12.4;U-266/84: 20.1;U-937: 8.3"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.7;hypothalamus: 1.3;olfactory region: 4.3"	"Region enhanced"	"Detected in many"		"olfactory region: 11.4"	HPA041408	Approved				"Secreted to blood"	NA	NA					"HPA041408: AB_10964057"	"unprognostic (5.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.51e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.91e-3)"	"unprognostic (6.89e-2)"	"unprognostic (5.73e-1)"	"unprognostic (1.59e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	5.7	0.2	0.8	12.6	0.9	42.8	0.3	0.5	2.1	0.3	0.4	0.6	0.0	0.2	0.2	0.1	0.5	2.7	0.9	9.0	0.8	0.8	0.5	2.0	10.7	21.9	3.7	0.0	0.7	0.7	0.0	0.5	2.2	0.8	0.8	0.1	0.9	0.2	0.0	0.6	0.2	0.7	1.0	1.3	20.8	0.6	22.1	1.1	0.4	1.4	0.1	0.3	2.0	4.3	0.0	0.1	82.6	1.6	0.0	1.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.5	0.0	0.0	0.0	0.2	7.8	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.1	0.0	0.0	8.3	0.0	0.0	1.6	0.6	0.7	0.1	0.0	0.0	0.6	0.6	0.1	0.0	0.2	1.1	82.6	0.0	0.0	0.0	0.3	0.5	0.8	0.9	0.5	2.1	0.8	0.8	3.7	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.5	0.0	0.0	0.0	15.8	1.9	0.3	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.1	0.0	0.0	3.1	0.0	0.0
RYBP	"AAP1, DEDAF, YEAF1"	ENSG00000163602	"RING1 and YY1 binding protein"	Q8N488	3	72371825-72446621	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053357	Approved		Supported	Nucleoplasm		NA	No			Nucleoplasm		"HPA053357: AB_2682124"	"unprognostic (6.80e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (2.50e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.22e-1)"	7.7	6.3	9.5	10.5	12.1	8.2	8.6	6.1	13.3	9.7	7.6	23.1	7.7	5.8	13.3	6.8	7.0	7.1	8.2	5.8	10.9	8.6	7.4	10.2	11.3	6.3	20.4	4.2	10.4	6.3	6.4	11.5	15.8	15.8	10.9	7.6	9.0	5.8	8.0	3.4	6.7	9.4	8.8	12.6	9.0	6.0	9.3	26.1	3.8	6.0	5.2	7.1	7.9	6.8	1.6	4.2	8.5	3.0	1.9	1.8	0.8	5.7	3.5	7.4	6.2	8.4	11.9	5.5	5.8	8.6	7.4	8.7	5.3	6.6	4.6	5.0	6.5	10.7	2.5	7.7	5.9	9.6	33.3	4.0	17.9	4.2	5.4	9.0	4.4	6.0	13.2	12.2	9.6	16.3	12.7	4.3	5.9	5.8	15.2	7.8	7.4	5.5	5.2	18.7	10.3	4.9	5.8	5.6	3.5	7.2	8.3	6.5	17.5	10.6	10.0	10.4	14.2	4.5	6.4	4.6	11.2	9.3	7.5	4.9	15.4	13.6	5.2	4.4	9.7	12.1	3.3	1.4	4.7	1.4	2.8	1.4	1.3	1.6	1.2	1.5	1.6	1.8	1.3	8.5	1.9	3.0	4.2	1.8	0.8	9.5	12.1	6.1	13.3	10.9	8.6	20.4	4.2	15.8	26.1	53.6	25.9	40.2	53.6	95.2	67.6	35.5	35.7	32.1	30.7	40.1	15.7	21.9	28.2	17.6	17.9	54.0	40.7	23.3	20.9	26.6	75.6	56.6	67.0	28.7	14.8	36.5	77.9	52.8	44.8	10.5	23.9	39.3	33.7	13.6	41.9	21.1	24.4	32.3	41.1	15.0	40.9	32.3	33.0	37.0	33.1	84.8	156.3	27.7	25.8	52.2
SHQ1	"FLJ10539, Shq1p"	ENSG00000144736	"SHQ1, H/ACA ribonucleoprotein assembly factor"	Q6PI26	3	72749277-72861914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 49.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042792	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042792: AB_10959736"	"unprognostic (1.10e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.83e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.05e-1)"	"unprognostic (4.54e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.30e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	10.5	15.6	6.8	17.2	9.2	11.4	14.8	8.7	9.0	10.1	12.1	9.6	11.9	9.1	15.6	16.7	13.3	15.5	9.7	14.8	8.0	8.0	10.7	10.7	14.8	15.5	15.1	5.9	12.3	17.5	12.2	12.8	7.2	10.4	9.7	12.3	11.0	13.1	13.6	17.5	11.3	10.3	11.4	7.5	12.0	10.7	17.3	7.5	29.8	12.5	10.4	13.4	11.2	17.0	10.1	12.9	3.1	9.7	17.0	14.9	10.4	5.9	8.1	5.5	9.1	7.3	9.1	5.6	10.1	7.2	10.5	11.5	6.3	4.8	10.0	4.9	6.8	8.5	4.9	11.3	9.3	12.8	8.8	9.0	10.3	6.7	7.6	7.5	17.5	8.6	9.2	7.1	15.4	6.3	4.8	9.7	16.3	8.3	6.2	8.4	8.8	49.1	6.1	15.4	18.3	10.4	11.9	8.7	7.5	9.1	7.9	3.4	14.2	9.2	6.6	4.7	7.6	6.7	6.6	6.7	8.4	8.3	13.8	8.6	11.5	23.1	14.9	7.5	14.1	8.3	0.6	8.6	3.1	11.2	9.7	14.9	10.1	12.6	12.0	9.1	9.3	14.3	12.4	0.4	17.0	8.4	12.9	10.2	10.4	6.8	9.2	8.7	9.0	8.0	8.0	15.1	5.9	10.4	7.5	11.9	5.8	1.5	3.7	11.7	7.9	8.1	2.5	17.4	6.8	5.2	0.0	5.4	6.6	7.0	2.8	6.8	3.8	0.0	5.3	6.3	6.6	3.8	15.0	5.7	6.1	3.2	4.1	16.0	4.7	0.9	5.5	5.4	5.0	1.8	6.9	2.9	5.6	3.5	5.3	5.1	4.4	0.0	5.1	7.9	22.7	8.9	4.8	4.9	8.8	4.2
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888073-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 37.7;Fibroblasts: 14.2;Late spermatids: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 14.6;JURKAT: 14.1;MOLT-4: 22.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	8.7	7.2	3.1	6.2	4.0	2.1	5.2	1.1	4.0	10.2	4.5	8.1	3.4	0.9	8.4	9.3	4.2	6.7	12.4	20.6	3.4	2.4	2.2	1.0	5.2	2.4	5.6	4.7	24.8	11.9	2.8	3.8	4.9	4.2	11.3	2.7	10.7	8.0	5.2	2.2	2.6	2.5	12.0	5.4	1.0	2.6	8.4	4.7	14.9	12.1	3.7	2.3	12.2	6.9	0.4	3.0	1.7	0.1	0.8	1.4	0.1	0.1	1.1	0.0	7.2	6.6	13.0	1.1	1.1	2.7	2.6	6.4	0.3	0.8	0.0	2.0	3.0	14.6	0.1	0.7	1.4	2.5	0.0	0.8	0.0	4.8	7.7	8.4	3.0	0.0	12.5	0.7	6.3	1.0	3.9	0.0	14.1	3.5	0.1	1.5	1.6	22.3	0.1	4.3	0.1	1.4	0.1	6.1	0.0	0.8	1.1	0.7	3.3	6.2	0.3	0.8	1.4	2.4	0.9	0.0	2.8	9.0	8.7	4.1	0.6	0.1	0.1	7.3	1.4	4.9	0.4	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.2	1.7	0.8	0.1	3.0	1.4	0.1	3.1	4.0	1.1	4.0	3.4	2.4	5.6	4.7	4.2	4.7	3.0	1.6	0.0	1.5	1.6	0.6	9.8	2.5	1.4	1.2	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.9	0.0	1.0	0.2	14.2	1.3	0.0	0.0	0.3	0.0	3.4	1.3	0.0	17.8	7.5	0.3	0.0	0.0	2.3	2.5	1.2	0.0	6.7	0.4	0.4	0.0	1.0	2.9	3.2	0.4	0.7	0.0	1.5	0.4
PPP4R2		ENSG00000163605	"Protein phosphatase 4 regulatory subunit 2"	Q9NY27	3	72996785-73069199	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034695, HPA039837, HPA073758"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632"	"unprognostic (4.60e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.62e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.35e-1)"	16.7	19.6	18.3	17.2	25.9	57.7	17.7	18.0	23.4	19.7	17.5	15.7	10.7	16.1	18.0	13.2	15.9	18.7	15.6	24.5	18.6	14.2	15.8	34.0	17.6	15.8	30.8	14.8	24.0	15.1	21.0	20.2	28.5	20.5	14.3	16.2	13.4	16.1	12.0	27.2	12.1	18.1	15.9	20.8	17.1	14.0	17.0	25.8	28.4	17.1	9.8	16.5	14.4	18.8	7.1	14.3	17.7	4.7	8.5	13.6	3.2	12.6	14.8	31.7	19.3	17.0	15.0	19.2	25.3	17.9	23.1	24.2	21.6	15.2	23.7	14.8	15.2	22.0	9.0	24.6	14.1	30.0	36.1	9.2	26.9	16.7	25.5	18.6	39.0	28.1	16.1	21.0	27.8	22.8	16.1	16.4	24.5	23.7	27.4	19.0	18.3	32.4	17.4	29.1	18.8	12.3	30.5	17.9	22.0	19.4	33.8	7.6	18.9	29.5	19.5	23.4	24.1	17.8	22.2	17.9	20.8	25.0	23.8	21.5	17.1	35.0	46.9	14.6	30.2	23.2	5.4	4.7	10.7	10.6	2.6	11.7	5.5	10.9	10.9	4.0	7.1	9.6	8.7	17.7	8.5	4.1	14.3	13.6	3.2	18.3	25.9	18.0	23.4	18.6	14.2	30.8	14.8	20.5	25.8	53.6	23.0	41.6	103.2	104.1	49.6	47.9	48.4	57.6	52.4	26.2	13.7	62.2	16.6	53.0	36.6	47.4	48.4	46.7	46.6	59.6	54.0	103.0	29.0	63.5	37.8	47.7	51.6	33.2	36.2	6.8	49.5	45.3	54.0	37.9	52.8	50.0	57.3	56.9	45.6	38.3	34.0	38.8	45.8	101.1	66.9	95.4	115.7	31.6	45.2	114.6
EBLN2		ENSG00000255423	"Endogenous Bornavirus like nucleoprotein 2"	Q6P2I7	3	73061659-73063337	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA062510, HPA068795"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA062510: AB_2684787, HPA068795: AB_2686038"	"unprognostic (1.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.38e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.12e-1)"	2.2	1.2	0.0	2.1	0.0	15.3	2.6	0.5	0.3	2.4	1.5			1.0	2.6	2.5	1.8	3.1	1.1	2.1	0.1	0.0	0.8	1.8	3.1	1.7	0.1		5.1	2.6	1.2	1.2	1.9		1.6	2.4		3.1	0.5	1.3	2.2	2.1	1.4	1.0	2.1	1.8	0.9			2.4		1.5	2.4	2.9	2.6	2.2	6.3	1.5	1.1	3.8	0.2	1.3	0.9	5.3	4.7	1.4	3.0	4.0	2.1	0.4	1.3	1.0	2.6	4.3	3.3	0.8	2.8	1.3	1.8	2.0	2.2	2.7	1.3	1.2	2.2	5.0	2.3	0.8	4.2	4.9	2.9	1.6	2.7	2.6	2.6	1.8	2.9	1.6	5.1	1.5	2.8	2.0	5.9	3.3	1.1	1.4	5.3	1.3	2.0	1.4	5.5	1.2	2.6	1.3	2.3	0.7	3.9	3.5	1.6	3.4	1.5	2.9	4.0	3.2	5.1	2.4	2.6	1.5	4.6	2.6	0.3	1.5	6.3	3.6	0.5	3.0	1.5	3.2	3.1	0.5	2.6	2.7	3.8	3.3	1.1	0.6	2.2	3.7	0.2											0.0	2.1	5.0	11.6	5.0	4.7	0.8	15.3	2.7	2.3	3.5	7.9	7.1	0.0	3.1	1.5	4.5	4.5	23.3	1.4	5.4	6.2	7.7	1.1	4.4	2.5	3.2	4.1	7.4	3.3	0.2	7.8	3.9	1.7	1.8	3.3	2.8	3.5	3.5	3.5	0.1	5.0	6.5	3.1	3.7	4.8	5.5	12.2	7.5	3.3	11.2
PDZRN3	"KIAA1095, LNX3, SEMACAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382433-73624940	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 61.9;Fibroblasts: 24.4;Peritubular cells: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	52	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	52	"dendritic cells: 5.2"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;ASC diff: 28.1;ASC TERT1: 14.8;BJ hTERT+: 20.0;HSkMC: 20.5;U-87 MG: 14.8"	"Group enriched"	"Detected in many"	5	"amygdala: 12.4;basal ganglia: 7.4;cerebral cortex: 17.9;hippocampal formation: 14.5"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	13.0	17.4	11.5	4.8	12.9	0.0	10.3	1.7	26.8	18.7	32.6	4.5	4.6	4.3	29.0	12.4	13.6	11.6	13.1	19.8	9.1	2.5	5.3	0.9	6.3	1.9	3.6	11.2	35.1	2.9	0.3	2.2	8.1	6.8	15.4	6.9	9.7	9.7	14.9	38.3	7.5	10.2	26.3	3.8	1.0	19.3	3.4	2.9	0.2	1.6	5.1	1.1	21.3	18.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	28.1	14.8	0.0	8.0	20.0	2.4	1.5	7.5	0.0	0.0	0.0	10.7	0.3	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.0	4.7	0.0	0.0	20.5	0.0	6.7	0.0	2.9	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.1	2.2	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.8	5.1	0.0	3.7	5.8	4.7	2.2	0.0	0.0	10.1	0.7	11.3	1.0	0.3	0.0	0.1	14.8	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	11.5	12.9	1.7	26.8	9.1	2.5	3.6	11.2	6.8	2.9	0.0	0.0	0.0	9.3	2.2	9.5	61.9	0.0	0.0	0.0	5.2	5.9	0.6	1.7	0.0	0.4	1.3	0.0	0.0	0.4	0.2	24.4	12.7	0.0	0.0	0.7	0.0	20.3	0.0	0.0	0.4	21.6	0.9	15.1	0.0	7.0	20.0	0.4	0.0	26.5	6.3	1.5	0.0	15.5	0.2	4.1	1.6	0.7	0.0	2.3	4.3
CNTN3	"BIG-1, PANG"	ENSG00000113805	"Contactin 3"	Q9P232	3	74262568-74521140	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.9;fallopian tube: 8.7"	"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ: 7.5;fHDF/TERT166: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003341	Approved				"Intracellular and membrane"	NA	NA		54000000			"HPA003341: AB_1078556"	"unprognostic (1.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.94e-5)"	"unprognostic (4.25e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.30e-7)"	"unprognostic (4.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	2.2	3.3	5.3	0.0	3.0	0.0	1.2	1.2	8.9	2.6	3.3			0.1	0.7	1.7	0.1	8.7	2.1	1.7	4.4	3.9	4.1	3.2	0.6	0.0	1.4		0.9	1.6	0.0	3.7	0.0		6.9	3.0		0.3	5.1	0.0	0.3	0.2	0.1	0.5	1.7	1.0	0.4			1.5		0.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	7.5	0.0	1.2	0.4	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	2.6	0.0	1.5	0.0	0.2	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	1.7	0.0	1.0	0.6	4.9	3.0	7.6	6.7	6.8	8.7	0.0	0.0	1.7	1.1	2.2	0.3	0.9	0.0	0.5	0.0	1.1	4.2	0.0	5.6	0.1	20.6	1.2	1.3	0.0	1.1	0.0	0.0	0.0	0.0	6.0	0.1	0.6	3.5	0.0	6.5	0.4	0.0	1.4	0.1	0.2	0.3	0.0	0.0	5.7	1.0
FRG2C		ENSG00000172969	"FSHD region gene 2 family member C"	A6NGY1	3	75664330-75667220	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"kidney: 3.5;testis: 3.8"	"Group enriched"	"Detected in some"	150	"Distal tubular cells: 23.2;Early spermatids: 11.8;Late spermatids: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"HDLM-2: 16.8"									"HPA039264, HPA047769"	Uncertain					NA	NA					"HPA039264: AB_2676420, HPA047769: AB_2680149"	"unprognostic (3.47e-2)"				"unprognostic (8.28e-2)"			"unprognostic (9.57e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.33e-1)"		"unprognostic (2.29e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.2	0.1	0.1	0.1	0.0	0.1	0.4	1.4	0.0	0.1	0.1	0.1	0.0	3.5	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	3.8	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.3	0.2	0.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF717	"X17, ZNF838"	ENSG00000227124	"Zinc finger protein 717"		3	75709643-75785583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 38.5"									HPA044549	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"HPA044549: AB_10964630"	"unprognostic (2.49e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.60e-6)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	8.1	8.6	11.9	7.2	14.4	4.6	11.2	12.1	12.4	7.7	6.7	11.7	7.3	6.9	11.0	24.6	7.7	11.3	8.1	8.2	10.9	8.3	13.4	10.5	6.8	6.2	16.2	7.1	12.6	12.7	14.7	22.8	7.3	12.6	9.4	8.9	10.8	9.9	9.6	6.1	13.7	7.3	10.9	15.6	10.1	10.1	11.2	13.6	8.4	16.2	5.3	8.4	8.6	7.8	9.5	6.2	6.8	5.3	4.0	10.2	3.2	7.4	4.7	4.5	2.7	4.9	6.9	2.7	2.5	4.9	3.1	3.9	6.3	6.4	4.0	4.3	4.6	4.9	3.7	7.1	5.3	2.8	0.4	6.8	7.8	7.1	0.7	9.6	0.3	6.9	6.7	4.4	7.5	11.4	3.2	0.6	0.8	38.5	9.5	4.1	2.4	0.8	10.3	5.1	5.5	8.3	5.9	4.3	21.9	5.0	3.6	3.7	17.4	2.1	4.3	9.2	7.3	15.3	3.5	0.9	7.9	10.8	6.5	1.1	11.4	13.9	4.7	4.3	0.8	4.8	1.5	4.0	6.8	3.6	5.3	1.8	7.6	5.1	3.4	4.1	9.5	10.2	6.2	1.0	4.0	4.9	6.2	1.9	3.2	11.9	14.4	12.1	12.4	10.9	8.3	16.2	7.1	12.6	13.6	3.0	1.9	3.0	3.6	2.9	8.3	5.3	10.2	5.3	3.4	7.0	2.0	3.3	10.0	4.0	2.6	4.5	2.6	0.0	3.8	1.6	4.3	4.9	9.2	6.6	6.1	9.5	5.1	6.7	3.8	1.3	2.3	3.8	1.7	5.4	7.2	5.7	3.8	0.0	2.8	12.5	8.0	0.0	3.8	9.5	7.4	3.9	2.9	2.6	5.5	3.9
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 34.7;Horizontal cells: 49.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 15.2;HEL: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013371	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA		660000	"Nucleoplasm, Centriolar satellite"		"HPA013371: AB_1856391"	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	1.1	3.3	6.4	0.8	13.8	0.3	1.1	19.0	26.1	3.6	1.3	2.2	0.0	0.9	2.9	0.8	6.2	0.4	3.1	1.0	6.3	6.5	2.5	1.8	12.3	1.8	9.6	5.5	9.4	2.2	6.8	2.1	6.4	9.9	1.9	0.8	4.8	2.1	7.8	0.4	3.0	1.2	1.9	7.8	3.6	1.1	4.5	3.6	3.6	0.4	4.2	3.0	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.0	4.3	0.0	0.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.0	41.7	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	4.7	0.0	0.0	0.5	2.7	6.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	13.8	19.0	11.3	6.3	6.5	9.6	5.5	9.9	3.6	0.0	0.3	0.0	1.5	1.5	34.7	1.9	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.1	49.3	0.0	4.3	0.0	1.7	2.8	0.0	0.0	0.0	1.4	0.9	0.3	0.0	5.6	0.0	4.4	0.0	0.8	0.2	0.7	1.0	0.1	0.0	0.0	0.1
ROBO1	"DUTT1, FLJ21882, SAX3"	ENSG00000169855	"Roundabout guidance receptor 1"	Q9Y6N7	3	78597240-79767815	"Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 46.4;Urothelial cells: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013524, HPA052968, HPA074461"	Uncertain		Enhanced	"Plasma membrane"		NA	NA		6500000	"Plasma membrane"		"CAB013524: , HPA052968: AB_2682001, HPA074461: AB_2732256"	"unprognostic (2.89e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.16e-2)"	12.5	10.1	15.5	10.7	30.2	0.4	7.3	12.5	22.0	15.9	9.4	14.7	1.6	3.5	10.5	8.2	13.7	5.6	8.6	9.0	12.3	12.4	3.7	4.0	8.3	9.3	14.7	8.9	18.4	2.3	2.1	29.6	8.4	12.2	14.5	6.9	8.5	5.5	13.8	4.5	21.8	5.4	11.4	8.1	9.2	5.0	10.8	15.7	14.0	5.5	8.8	18.8	13.2	14.1	1.0	0.7	0.0	0.4	0.1	3.1	0.1	0.1	11.0	10.5	16.8	14.8	9.7	0.5	8.4	11.3	6.7	5.7	0.2	4.6	0.0	0.0	10.4	5.3	4.4	12.8	8.7	8.5	0.1	16.3	6.4	22.0	17.3	3.5	0.1	1.7	16.1	12.0	25.4	12.1	12.7	6.7	0.0	0.8	20.0	6.9	5.2	0.0	0.0	13.4	3.1	4.0	0.3	11.1	0.1	0.0	3.5	8.2	5.6	18.2	4.1	6.7	10.6	12.9	0.1	0.1	22.5	9.8	13.3	14.3	0.7	0.0	0.0	20.4	0.0	18.6	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.7	0.3	0.0	3.1	0.0	0.1	0.4	0.0	0.0	0.1	15.5	30.2	12.5	13.6	12.3	12.4	14.7	8.9	12.2	15.7	3.0	11.2	0.0	17.6	29.5	10.2	3.6	0.0	1.4	7.9	7.0	3.9	8.4	0.0	0.5	21.1	4.7	0.3	0.0	0.2	7.3	26.7	15.0	1.1	0.0	1.2	1.6	1.2	15.4	2.5	46.4	18.4	1.3	13.5	2.8	0.1	6.7	0.3	0.3	23.0	0.2	1.0	12.9	11.2	1.6	5.1	29.5	4.7	0.0	0.2	49.2
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489699-81762161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Cytosol		NA	NA		5900000	Cytosol		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	23.1	22.4	2.2	7.8	4.2	5.6	19.2	4.2	4.6	6.4	7.7	5.2	5.2	4.1	8.4	4.9	7.5	4.9	11.5	19.7	3.6	4.3	14.0	36.3	11.3	7.5	7.9	3.4	8.2	5.7	8.2	11.6	11.4	8.4	5.7	4.5	9.9	8.0	10.1	56.9	5.9	6.3	7.2	6.1	8.0	4.5	4.6	4.1	5.4	6.5	11.2	4.5	9.6	10.0	11.6	13.6	14.5	11.4	13.0	7.2	6.1	12.1	7.3	2.4	34.9	61.4	46.7	4.4	20.2	28.8	12.1	20.6	1.4	3.2	13.6	8.9	24.8	7.2	1.4	2.0	9.3	28.6	6.4	1.1	4.2	15.2	4.5	42.3	14.3	3.7	34.4	6.9	19.5	20.1	30.5	26.9	1.6	3.3	7.9	39.4	3.5	2.4	17.0	2.4	3.4	11.2	4.5	11.1	16.0	8.6	4.1	1.2	1.6	13.2	3.8	4.1	3.7	2.7	11.8	37.3	25.1	5.9	17.6	18.6	36.1	4.1	5.0	40.9	9.6	10.2	6.3	11.4	14.5	5.6	10.4	5.4	11.0	6.0	5.9	13.6	11.6	7.0	7.2	11.0	13.0	10.8	4.5	5.0	6.1	2.2	4.2	4.2	4.6	3.6	4.3	7.9	3.4	8.4	4.1	14.9	11.3	7.2	17.9	27.2	15.9	51.9	15.3	13.4	10.3	29.6	0.0	25.8	34.9	29.0	29.2	28.5	9.6	0.0	21.8	58.4	22.2	15.3	42.7	67.1	23.2	28.6	21.2	14.1	14.5	11.6	16.1	15.1	23.6	12.6	6.9	9.6	34.4	6.8	12.4	46.6	16.8	32.3	41.6	6.5	5.1	18.6	45.9	10.0	7.3	12.4
CADM2	"IGSF4D, Necl-3, NECL3, SynCAM2"	ENSG00000175161	"Cell adhesion molecule 2"	Q8N3J6	3	84958981-86074429	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 52.7"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 214.8;Cone photoreceptor cells: 488.9;Rod photoreceptor cells: 463.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 5.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"AF22: 6.4;AN3-CA: 18.4;U-266/70: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010024	Enhanced					NA	NA		350000			"HPA010024: AB_2068039"	"unprognostic (2.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-4)"	"unprognostic (8.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.07e-5)"	"unprognostic (9.82e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.16e-2)"	5.8	6.3	33.5	2.1	22.7	1.7	3.6	44.8	52.7	2.3	3.0	7.0	0.0	2.0	2.0	2.2	2.7	4.6	2.6	4.2	28.6	11.7	1.9	2.5	2.2	1.8	16.3	31.0	2.3	2.4	3.0	5.5	1.9	24.2	3.4	2.7	8.8	2.3	6.2	4.9	2.0	2.6	2.1	14.0	2.0	3.2	2.2	20.5	0.0	2.1	0.0	1.8	2.0	1.1	1.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	2.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	22.7	44.8	49.5	28.6	11.7	16.3	31.0	24.2	20.5	0.0	0.6	0.0	0.3	0.9	214.8	4.4	0.0	0.0	1.2	0.0	488.9	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.1	1.0	0.7	0.0	0.0	0.3	89.0	1.7	4.9	0.0	1.7	1.7	0.0	3.3	0.0	0.0	62.5	0.2	0.0	0.4	0.0	463.1	0.0	0.8	0.4	1.1	0.9	0.0	0.0	0.0	0.3
VGLL3	VGL-3	ENSG00000206538	"Vestigial like family member 3"	A8MV65	3	86876388-86991119	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 195.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 105.6;Extravillous trophoblasts: 167.0;Late spermatids: 52.5;Leydig cells: 122.6;Peritubular cells: 140.4;Syncytiotrophoblasts: 67.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"U-2197: 106.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054983	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA054983: AB_2682663"	"unprognostic (9.08e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.73e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.05e-1)"	22.5	1.0	0.5	3.4	0.5	0.2	8.6	0.2	0.3	6.3	6.2	0.4	3.3	0.6	8.2	7.8	6.1	5.2	6.8	4.3	1.0	0.7	1.8	0.6	16.1	3.6	0.6	0.3	10.6	2.7	0.7	0.4	195.7	0.8	8.0	1.6	2.8	1.9	3.1	7.5	4.0	2.1	11.9	0.8	2.4	2.9	8.0	0.3	0.1	3.4	1.9	1.0	12.2	9.2	1.1	0.6	2.3	0.5	0.8	0.7	0.1	1.5	2.6	14.2	0.0	19.0	23.8	0.2	9.8	6.9	8.4	10.5	3.0	0.6	0.0	0.0	15.3	0.9	1.3	0.9	0.9	11.6	5.5	0.0	0.7	0.9	0.0	8.7	0.1	0.0	18.1	1.5	12.3	5.5	4.5	1.2	0.0	0.0	0.0	10.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	18.9	0.1	0.0	1.6	0.0	0.0	4.2	0.1	0.0	0.5	0.0	0.0	0.5	18.7	2.7	106.2	0.3	0.0	0.0	0.0	3.4	0.0	0.7	2.3	0.5	0.7	0.4	0.3	0.4	0.5	0.5	0.3	0.2	1.1	0.6	0.7	2.0	0.8	0.4	0.6	0.5	0.1	0.5	0.5	0.2	0.3	1.0	0.7	0.6	0.3	0.8	0.3	3.0	2.1	0.0	7.4	7.1	0.0	0.7	0.0	5.3	4.5	10.4	0.0	20.7	0.0	10.3	105.6	1.5	0.0	0.0	2.1	167.0	26.2	18.3	0.0	0.0	6.7	0.0	0.0	4.3	0.0	52.5	122.6	2.4	3.3	0.0	0.0	15.8	8.4	0.0	140.4	0.0	0.3	12.9	17.8	1.4	1.0	4.5	67.5	0.0	0.0	3.7
CHMP2B	"CHMP2.5, DKFZP564O123, VPS2B"	ENSG00000083937	"Charged multivesicular body protein 2B"	Q9UQN3	3	87227271-87255548	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 108.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035069, HPA052754"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035069: AB_10602798, HPA052754: AB_2681936"	"unprognostic (7.83e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (5.76e-2)"	"prognostic favorable (1.74e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.21e-1)"	21.8	21.5	20.1	17.6	23.5	36.5	22.1	12.5	35.9	23.6	32.4	21.4	19.2	30.1	28.2	20.5	30.9	20.1	23.4	26.2	20.8	22.0	30.9	36.1	21.5	17.7	29.5	21.0	22.9	23.5	14.7	41.7	45.1	30.7	29.2	30.5	14.7	22.7	25.4	30.1	22.9	45.8	24.8	52.6	22.3	24.3	13.3	25.6	14.5	35.5	26.3	16.4	30.7	25.3	21.2	22.4	53.4	24.8	11.4	20.0	14.3	16.8	18.3	6.2	3.9	11.4	9.2	8.0	13.3	16.9	11.0	14.2	14.3	27.6	6.0	9.4	14.3	10.1	8.6	8.1	9.2	13.3	10.6	8.5	7.4	6.6	5.8	10.0	9.9	10.3	7.0	15.6	10.9	14.8	10.6	8.4	7.4	4.4	9.1	11.8	12.1	9.6	4.1	8.1	20.3	16.4	5.1	7.7	5.8	8.3	17.3	2.4	2.5	13.0	10.6	20.2	7.5	9.5	3.0	7.6	10.2	9.4	108.6	9.0	9.2	13.6	10.3	11.2	5.7	7.3	42.8	20.8	53.4	11.9	24.8	16.0	20.0	14.9	14.6	22.4	21.2	14.1	13.7	40.3	11.4	24.7	12.8	20.0	14.3	20.1	23.5	12.5	35.9	20.8	22.0	29.5	21.0	30.7	25.6	77.4	53.5	37.2	193.5	117.3	17.0	65.5	58.6	95.0	73.9	47.1	3.9	64.1	117.7	128.3	5.1	42.3	109.6	46.7	227.8	159.4	64.8	193.3	71.7	54.0	75.6	35.0	44.9	35.6	51.1	4.0	61.2	79.5	38.8	48.7	61.4	189.8	186.7	138.6	90.5	117.0	14.1	71.1	49.5	56.6	68.8	127.2	151.3	45.3	63.1	267.1
POU1F1	"GHF-1, PIT1, POU1F1a"	ENSG00000064835	"POU class 1 homeobox 1"	P28069	3	87259404-87276587	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"pituitary gland: 138.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.8;SiHa: 1.1;U-87 MG: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041646, HPA050624"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041646: AB_10794672, HPA050624: AB_2681192"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.05e-4)"	0.3	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	138.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.8	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.7	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HTR1F	"5-HT1F, HTR1EL"	ENSG00000179097	"5-hydroxytryptamine receptor 1F"	P30939	3	87990696-87993835	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 5.7"	"Group enriched"	"Detected in some"	10	"Muller glia cells: 19.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	16	"basophil: 3.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 3.2"	"Group enriched"	"Detected in some"	6	"A549: 1.2;K-562: 4.5;LHCN-M2: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005555	Uncertain					NA	NA					"HPA005555: AB_1856708"	"unprognostic (1.66e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.67e-6)"	"unprognostic (1.25e-4)"	"unprognostic (1.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.31e-2)"	2.8	0.5	0.7	0.0	0.6	1.5	1.6	0.0	1.8	1.4	0.0			0.0	1.2	0.3	0.1	0.4	0.1	0.3	0.6	0.4	0.6	0.0	0.9	0.1	0.8		0.4	0.7	0.3	1.4	5.7		0.4	0.0		0.1	1.0	0.6	0.4	0.0	1.3	0.3	1.7	0.0	0.3			1.5		0.5	0.6	0.7	0.1	0.2	3.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.7	0.0	0.0	19.5	0.1	0.0	0.0	0.0	1.0	19.4	11.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0
CGGBP1	"CGGBP, p20-CGGBP"	ENSG00000163320	"CGG triplet repeat binding protein 1"	Q9UFW8	3	88051944-88149885	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 111.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035568, HPA037017"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035568: AB_10670022, HPA037017: AB_2675433"	"unprognostic (2.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.79e-4)"	29.6	23.9	26.1	27.5	28.6	38.5	80.0	33.3	36.9	28.7	28.3	19.4	23.7	23.1	30.7	23.6	23.5	24.2	23.6	33.8	23.1	21.6	28.4	30.8	29.1	39.4	24.4	26.4	37.1	25.9	40.6	33.2	26.4	21.2	27.3	26.0	23.7	25.2	24.9	30.8	19.2	30.0	29.7	28.9	33.9	25.1	22.4	22.0	76.0	32.7	16.7	37.4	27.7	30.9	24.8	19.9	41.6	23.0	20.8	25.1	19.8	8.0	13.8	23.0	16.4	20.3	18.1	7.4	16.1	14.6	17.0	20.2	10.1	11.9	17.6	10.9	14.4	13.3	6.4	18.1	12.2	21.0	26.6	10.0	26.9	12.1	9.0	18.1	17.8	19.2	16.3	12.7	18.7	24.2	21.0	17.3	20.1	12.7	18.4	19.2	12.8	26.7	12.7	12.6	13.5	11.6	17.3	21.6	12.6	12.7	12.3	4.5	15.1	13.6	7.8	38.0	16.9	11.8	21.6	16.7	20.6	15.2	111.3	16.8	13.5	16.3	19.3	15.7	17.4	17.6	41.6	21.2	39.4	23.3	21.7	22.7	22.5	20.7	23.9	19.9	24.8	25.1	20.5	39.8	20.8	23.0	17.9	23.0	19.8	26.1	28.6	33.3	36.9	23.1	21.6	24.4	26.4	21.2	22.0	47.6	40.0	45.5	57.2	47.3	33.0	39.5	35.7	16.0	46.6	38.4	15.7	48.1	56.3	34.4	15.7	65.2	42.3	23.3	36.4	51.7	55.0	57.7	45.1	49.4	36.3	63.5	40.2	61.4	45.7	28.6	64.5	53.4	38.8	34.3	30.1	61.7	41.1	34.9	47.0	52.9	30.4	64.7	68.9	82.4	49.4	43.7	70.1	69.0	31.8	57.8
ZNF654	"FLJ10997, FLJ21142"	ENSG00000175105	"Zinc finger protein 654"	Q8IZM8	3	88059274-88144665	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036172, HPA036173, HPA049262, HPA077939"	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364"	"unprognostic (2.54e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.89e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.72e-3)"	"prognostic unfavorable (9.97e-6)"	"unprognostic (1.29e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-2)"	18.2	8.9	10.9	13.2	11.6	15.1	12.6	18.6	13.3	13.5	11.8	9.8	13.5	9.7	14.0	12.1	14.4	9.5	10.8	10.4	11.3	8.5	11.0	15.4	11.8	12.3	13.9	10.3	14.7	9.5	12.8	21.8	11.9	11.1	12.8	9.8	10.7	12.5	10.2	13.9	14.9	13.4	13.1	15.8	10.1	10.0	12.3	14.8	22.2	13.4	9.4	12.0	16.6	14.6	2.6	2.3	10.0	2.0	6.5	4.0	1.7	4.7	2.0	3.4	4.8	7.6	6.3	3.1	6.3	5.7	4.2	6.0	3.0	2.9	7.5	4.3	5.4	3.0	3.2	3.7	5.8	8.5	4.6	2.0	4.7	2.7	2.2	5.7	5.3	5.3	6.2	5.8	4.7	5.6	9.0	5.7	4.4	3.1	6.2	9.5	3.6	5.3	4.9	1.8	3.9	3.2	3.7	2.3	3.6	4.1	6.2	2.6	2.3	4.5	3.7	11.9	4.6	5.0	4.2	6.4	9.4	6.2	35.2	4.5	7.0	4.8	5.3	7.6	5.1	6.0	10.0	1.9	2.7	2.9	2.0	3.3	1.8	3.2	4.0	2.3	2.6	3.9	2.6	2.7	6.5	1.4	1.1	2.2	1.7	10.9	11.6	18.6	13.3	11.3	8.5	13.9	10.3	11.1	14.8	8.9	13.3	6.9	8.9	19.9	12.3	10.9	7.6	9.4	11.4	5.2	11.8	3.7	1.7	5.6	0.8	11.3	8.7	0.0	4.5	2.9	14.1	9.3	15.1	11.3	5.3	15.9	5.1	9.2	11.7	1.1	6.9	13.3	8.5	1.8	9.2	9.5	7.0	7.0	11.7	4.8	13.3	6.5	6.2	10.4	7.9	16.3	6.9	11.7	7.1	11.5
C3orf38	MGC26717	ENSG00000179021	"Chromosome 3 open reading frame 38"	Q5JPI3	3	88149743-88168729	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Early spermatids: 252.0;Late spermatids: 238.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034736, HPA034737"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034736: AB_2674307, HPA034737: AB_10671505"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (9.28e-3)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.88e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.67e-2)"	12.2	11.7	13.7	12.8	16.1	35.2	12.3	12.9	12.8	11.6	11.9	13.6	8.4	9.5	11.5	10.7	14.6	10.7	9.4	9.7	11.3	11.1	10.2	13.5	10.6	19.2	15.1	9.4	12.1	9.3	7.1	15.8	12.5	11.4	11.2	11.2	9.0	10.6	10.2	9.7	11.6	11.4	10.9	11.3	17.0	10.1	33.2	13.5	29.5	11.6	9.0	17.1	12.4	11.6	20.0	17.7	25.8	24.2	17.1	17.4	15.3	6.4	6.7	13.2	7.0	8.8	8.0	6.1	10.5	12.6	15.7	21.3	7.7	8.9	8.7	9.4	9.7	7.5	4.7	9.5	7.7	13.6	15.6	4.5	10.6	5.2	6.5	12.6	14.5	9.2	11.4	7.8	10.5	9.0	10.3	9.0	9.5	6.7	10.0	17.0	7.5	14.6	6.1	16.0	12.1	7.6	9.2	4.6	8.2	10.4	8.8	4.0	5.8	9.6	5.3	15.8	11.2	10.2	11.1	8.2	9.8	10.7	59.4	11.5	9.2	13.6	12.9	7.6	11.5	9.2	25.8	16.8	17.5	13.5	24.2	17.4	20.0	12.6	13.8	17.7	15.9	12.6	12.8	7.5	17.1	19.7	12.3	15.1	15.3	13.7	16.1	12.9	12.8	11.3	11.1	15.1	9.4	11.4	13.5	17.9	6.9	32.0	16.6	10.4	21.8	5.6	0.0	14.7	11.4	5.2	21.6	19.3	16.6	14.7	252.0	8.7	11.8	0.0	12.0	18.8	15.4	14.2	13.9	7.4	23.4	6.4	15.5	8.6	17.2	238.1	15.3	21.8	15.1	27.1	10.7	22.8	11.6	13.3	14.2	9.8	21.7	12.9	12.2	25.9	12.0	12.3	21.4	28.7	9.0	18.6
CSNKA2IP		ENSG00000283434	"Casein kinase 2 subunit alpha' interacting protein"		3	88338413-88467562	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in single"	24	"testis: 22.9"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 66.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.8	0.0	0.0	4.1	0.0	0.0	0.6	0.7	0.0	1.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.8	0.0	0.0	0.0	0.6	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0	0.0	0.0	0.0	0.3	0.5	1.5	2.1	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.1	12.2	0.1	0.0	0.0	0.1	19.1	0.0	0.6	0.0	1.3	2.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	7.8	0.0	16.9	6.5	20.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873033-93974066	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 114.6"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 266.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 24.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.8;ASC TERT1: 31.9;HSkMC: 28.9;hTERT-RPE1: 24.2;SK-MEL-30: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	NA	NA	22500000000	3400000000			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"	16.0	3.9	2.5	3.8	3.8	0.1	15.5	0.8	2.8	7.4	8.0	4.1	2.8	3.9	7.6	9.5	10.9	8.5	11.3	30.2	4.0	3.1	17.6	114.6	17.3	13.7	4.3	1.8	23.9	2.7	10.1	6.2	10.2	24.2	6.8	8.5	9.3	5.6	4.3	5.6	8.5	6.5	8.3	4.8	8.8	4.9	5.5	2.2	0.1	10.6	6.9	3.3	8.0	9.5	0.0	0.8	1.9	0.8	0.1	0.4	6.8	0.3	2.4	2.5	10.3	42.8	31.9	0.8	1.5	3.5	0.8	3.1	6.1	0.9	0.2	9.3	2.3	7.8	0.1	0.8	0.6	1.1	0.1	2.7	16.6	1.1	17.0	3.6	0.6	0.8	28.9	0.6	1.8	0.6	24.2	3.5	2.1	11.5	0.2	16.6	0.2	0.1	0.0	2.0	1.5	2.4	0.3	2.0	0.0	9.0	0.0	3.8	7.0	1.8	0.0	46.2	0.8	0.1	8.1	3.0	6.8	1.5	3.7	0.8	0.0	0.1	0.0	21.2	10.6	9.9	0.0	0.8	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	1.9	0.1	0.2	0.0	0.2	6.8	2.5	3.8	0.8	2.8	4.0	3.1	4.3	1.8	24.2	2.2	59.6	29.8	3.7	2.9	13.2	0.6	40.3	12.7	76.3	12.5	1.8	9.8	0.6	3.3	5.6	2.3	47.0	2.6	0.0	4.0	0.6	62.0	4.7	29.0	266.4	9.9	1.6	15.1	69.3	24.7	4.0	26.4	7.7	18.6	1.0	14.6	22.0	3.9	7.0	34.6	36.2	7.8	12.9	26.2	0.2	0.5	29.1	1.4	4.5	13.3	2.0
ARL13B	"ARL2L1, DKFZp761H079, JBTS8"	ENSG00000169379	"ADP ribosylation factor like GTPase 13B"	Q3SXY8	3	93980139-94055668	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 86.4;Ciliated cells: 107.1;Rod photoreceptor cells: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA048926	Approved					NA	NA					"HPA048926: AB_2680559"	"unprognostic (2.29e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.50e-2)"	10.0	6.3	6.6	6.0	9.0	2.4	8.4	6.2	9.0	10.7	6.6	6.5	3.8	3.8	12.5	10.2	6.8	11.8	10.6	7.6	8.9	6.3	10.9	8.2	10.7	5.1	9.0	5.9	10.4	6.0	11.6	17.1	7.8	10.3	6.8	4.4	10.2	5.9	7.3	3.1	6.5	6.7	9.4	9.3	8.3	6.2	10.7	9.4	7.3	14.2	7.8	4.3	8.7	7.4	5.8	7.7	5.6	7.4	5.3	6.5	2.8	5.6	8.5	5.2	3.7	7.0	2.6	2.7	6.1	3.3	9.2	11.8	5.0	2.8	3.9	8.1	5.2	8.6	3.2	5.1	3.8	11.7	8.8	5.9	8.3	4.4	4.0	5.1	9.5	4.5	3.8	2.5	10.4	13.1	3.2	3.5	6.5	8.2	4.3	5.3	3.4	8.4	0.4	2.6	2.2	7.3	6.5	19.5	1.6	5.1	0.9	14.3	4.2	12.4	0.5	7.0	1.9	1.8	3.0	3.6	9.0	9.7	3.9	5.0	1.6	1.5	7.7	6.6	6.4	5.1	5.6	6.5	4.8	6.5	6.8	6.1	5.8	5.9	5.4	5.2	4.5	5.8	5.0	3.2	5.3	7.4	7.7	4.3	2.8	6.6	9.0	6.2	9.0	8.9	6.3	9.0	5.9	10.3	9.4	86.4	27.5	5.6	24.8	41.6	19.5	6.4	17.8	107.1	31.8	1.8	39.3	1.5	13.3	14.4	6.6	23.7	1.2	0.0	10.5	5.1	41.4	18.4	43.9	6.6	10.3	14.3	21.2	17.2	7.3	5.4	22.2	11.2	15.1	4.6	2.5	25.5	8.8	2.9	24.1	15.5	100.3	6.5	41.2	38.4	13.4	51.3	0.7	10.2	2.5	8.4
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014369-94028610	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 24.1;Enterocytes: 18.8;Mucus-secreting cells: 26.4;Paneth cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;HaCaT: 2.2;hTCEpi: 7.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.4	0.2	0.3	7.0	0.4	0.0	4.0	1.8	3.5	3.9	11.7	0.1	1.5	5.7	0.5	13.6	12.8	0.8	2.3	0.3	0.5	0.3	1.0	0.4	7.1	0.1	0.3	0.7	0.5	7.7	7.1	0.5	0.7	0.1	4.3	10.6	0.1	9.8	3.2	0.2	6.9	20.9	0.1	0.4	1.0	6.0	0.4	0.1	0.4	0.4	5.0	1.5	0.7	4.1	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	10.6	0.1	0.1	0.0	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.1	7.3	0.0	0.8	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.5	1.2	0.7	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	1.8	3.5	0.5	0.3	0.3	0.7	0.1	0.1	14.9	12.8	0.0	2.2	1.4	3.5	0.0	0.0	24.1	7.9	0.0	11.8	0.1	1.7	3.2	1.1	0.0	18.8	0.0	7.3	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.4	6.7	34.8	0.7	0.0	16.1	0.0	0.3	0.2	0.0	1.6	0.2	0.0	13.9	1.0
DHFR2	"DHFRL1, DHFRP4, FLJ16119"	ENSG00000178700	"Dihydrofolate reductase 2"	Q86XF0	3	94047836-94063389	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 11.9;Ciliated cells: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	13	"hTERT-RPE1: 61.0"									HPA051465	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA051465: AB_2681494"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.30e-6)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-2)"	6.6	8.0	9.7	5.2	10.9	2.2	7.7	5.2	13.2	9.8	6.3	15.2	2.8	5.8	11.7	9.9	5.3	9.4	7.6	5.1	9.8	8.1	10.6	9.3	7.1	7.3	10.2	6.9	15.3	10.8	15.4	13.1	4.5	12.2	9.5	6.7	6.2	6.6	8.9	2.8	5.8	10.1	9.0	12.6	9.4	6.6	8.2	8.6	16.9	10.3	4.8	6.4	7.3	6.2	5.0	4.1	3.8	3.3	2.8	7.3	2.5	1.3	2.1	1.6	1.6	2.3	2.9	0.6	2.1	2.3	1.1	1.2	0.4	2.2	0.9	1.4	1.1	1.4	1.9	1.2	1.5	1.7	3.0	0.7	1.1	1.0	1.2	2.3	0.7	1.3	2.9	2.0	1.2	1.6	61.0	1.1	4.6	0.5	2.1	1.4	1.7	3.9	0.4	1.3	3.9	2.6	1.0	2.1	1.5	1.5	0.7	2.0	2.1	3.1	0.8	3.5	1.3	2.1	1.1	1.7	1.7	2.9	0.7	0.8	1.6	1.5	1.3	1.7	2.0	2.3	3.6	2.2	3.8	3.8	3.2	7.3	3.8	5.1	6.1	1.4	5.0	6.9	6.2	3.5	2.8	3.3	4.1	6.1	2.5	9.7	10.9	5.2	13.2	9.8	8.1	10.2	6.9	12.2	8.6	11.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	16.0	3.4	3.5	0.0	2.0	3.3	4.8	0.0	0.0	0.0	0.0	4.8	1.5	0.0	0.0	2.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.6	0.0	0.0	4.6	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
NSUN3	FLJ22609	ENSG00000178694	"NOP2/Sun RNA methyltransferase family member 3"	Q9H649	3	94062916-94128545	"Disease related genes, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036181	Uncertain					NA	NA					"HPA036181: AB_10602715"	"unprognostic (5.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-1)"	"unprognostic (7.35e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.63e-3)"	"unprognostic (6.94e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.33e-2)"	9.1	11.3	8.7	17.4	14.1	10.9	10.3	9.3	11.6	11.5	13.3	10.4	8.7	10.7	10.9	13.7	9.1	10.4	9.0	9.2	9.0	9.4	10.3	15.0	11.7	15.4	8.8	10.6	12.5	11.7	11.8	19.8	8.7	13.0	11.6	14.9	8.6	10.3	8.2	4.8	9.4	18.2	10.2	9.7	14.1	11.4	11.2	10.6	19.5	11.8	7.6	10.7	10.3	9.3	5.5	4.4	10.4	7.9	8.3	6.5	3.5	4.4	6.1	6.5	5.0	3.9	6.1	2.9	7.0	5.6	8.5	9.0	3.7	5.0	6.8	8.9	4.7	5.8	6.3	7.6	5.2	11.9	11.8	5.5	11.1	7.6	4.9	5.2	10.9	9.4	5.8	6.2	6.3	7.1	6.7	7.3	7.6	4.7	10.5	7.6	4.4	10.0	5.2	5.4	5.7	6.8	8.0	11.3	7.3	6.4	4.3	11.9	8.4	7.2	4.7	7.2	5.0	8.2	6.9	6.4	6.0	6.7	3.1	7.7	8.4	9.6	13.1	7.6	9.3	8.9	10.4	4.9	5.8	4.1	4.7	6.5	5.5	4.6	5.2	4.4	4.3	5.2	6.0	8.5	8.3	7.9	3.9	5.3	3.5	8.7	14.1	9.3	11.6	9.0	9.4	8.8	10.6	13.0	10.6	6.0	2.7	7.4	6.7	2.7	7.8	4.1	5.1	5.3	11.4	7.0	9.8	5.1	5.0	6.7	43.2	6.5	9.1	23.3	6.9	3.7	4.9	6.2	2.3	6.4	5.6	11.1	2.4	9.2	12.1	20.9	4.0	8.1	3.3	7.2	7.9	12.3	6.3	8.2	3.9	7.5	6.7	6.5	6.6	8.8	7.2	3.0	3.3	11.5	5.6	6.9
MTRNR2L12		ENSG00000269028	"MT-RNR2-like 12"	P0DMP1	3	96617188-96618236	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"blood: 603.3"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 31937.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 603.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 603.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 496.6"														"Secreted to blood"	NA	NA						"unprognostic (3.79e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.81e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-2)"	18.0	29.1	32.5	5.2	31.0	4.5	7.5	8.8	19.2	5.1	20.2	6.4	5.7	8.1	5.1	75.3	10.9	3.8	40.2	114.2	26.3	19.8	32.9	29.8	5.4	7.8	26.2	7.5	4.9	9.7	4.3	6.6	5.0	10.4	6.9	16.5	6.8	10.8	9.3	101.3	10.6	9.3	6.9	15.3	5.3	13.3	9.7	8.7	72.1	5.1	11.0	5.3	6.0	8.5	69.1	53.1	603.3	81.8	37.9	45.5	57.6	99.3	122.4	91.7	329.0	142.5	76.9	84.3	129.6	26.5	25.0	32.3	67.2	160.7	219.2	105.6	48.9	14.5	274.9	6.4	54.7	34.2	64.2	118.4	232.2	496.6	283.0	54.2	46.0	128.5	139.1	65.6	26.3	72.2	153.1	27.8	99.1	164.5	75.6	84.7	52.0	39.7	145.5	26.7	60.3	36.9	63.6	88.2	67.6	149.9	74.0	41.8	81.5	84.4	85.9	111.3	85.1	88.3	134.4	122.9	103.5	86.0	115.6	36.6	40.2	25.1	108.9	64.2	290.2	27.9	183.7	81.8	153.2	28.1	44.0	37.0	65.7	35.7	29.9	31.2	69.1	45.5	40.8	603.3	37.9	42.3	53.1	31.4	57.6	32.5	31.0	8.8	19.0	26.3	19.8	26.2	7.5	10.4	8.7	2513.2	2660.0	61.6	386.4	99.9	0.0	31937.7	112.1	2625.9	2640.0	80.3	0.0	6.1	53.0	0.7	11.2	82.6	5.6	163.5	1.6	7.5	167.2	335.7	1581.1	147.2	10.6	0.0	4.7	79.2	93.4	36.3	39.7	230.1	183.9	1.0	7.8	0.0	1.3	7.0	21.5	70.0	0.0	45.3	270.2	25.4	36.6	70.6	8.8	96.9	2.4	333.1
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;ovary: 13.2;testis: 15.5"	"Group enriched"	"Detected in some"	67	"Early spermatids: 305.1;Late spermatids: 156.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 8.2;U-266/70: 24.9"	"Low region specificity"	"Detected in many"							"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007397: AB_2667821, HPA058047: AB_2683588"	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.8	0.5	8.7	0.5	9.8	0.3	0.8	27.9	9.9	2.2	5.8	1.1	0.3	0.6	2.2	1.0	2.1	4.2	2.1	1.1	15.4	1.3	1.3	0.5	0.5	0.4	1.1	6.8	13.2	1.4	0.7	0.6	0.5	5.7	2.5	1.8	0.2	0.6	1.7	0.4	0.5	1.1	3.2	0.8	0.4	1.7	15.5	2.8	0.0	4.3	0.0	0.5	2.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	8.2	0.0	2.1	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.1	0.0	0.8	24.9	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	9.8	27.9	9.9	15.4	1.3	1.1	6.8	5.7	2.8	0.0	0.0	0.0	0.1	0.2	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	305.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	156.3	2.8	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.4	0.6	0.2	0.0	0.1	3.4	2.3	0.0	0.1	0.0	0.0	0.0
ARL6	"BBS3, RP55"	ENSG00000113966	"ADP ribosylation factor like GTPase 6"	Q9H0F7	3	97764521-97801242	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 22.7;Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 54.6;Spermatocytes: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019361	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA019361: AB_1845028"	"unprognostic (1.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.88e-2)"	"unprognostic (5.55e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (9.49e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.97e-1)"	5.5	9.2	8.8	3.6	18.6	1.6	6.0	10.0	17.7	6.5	4.9	5.0	7.3	2.7	7.9	7.3	5.3	11.9	6.2	5.9	17.1	11.0	13.2	4.4	8.4	3.9	8.9	14.1	6.4	5.6	22.6	22.3	5.0	12.9	7.1	4.6	7.3	9.1	6.5	2.9	5.2	3.2	7.2	8.0	4.7	5.0	10.9	9.0	4.2	9.1	2.0	3.8	5.6	5.1	2.7	1.0	0.5	1.0	4.1	4.8	1.6	7.7	4.4	4.0	3.3	10.1	7.1	1.0	5.1	4.8	4.5	5.8	1.6	3.1	4.2	4.9	2.4	7.4	3.8	5.1	5.8	9.2	5.2	3.1	1.2	3.3	1.7	4.9	5.3	2.8	3.6	4.2	6.0	1.5	4.0	4.4	5.5	1.4	0.8	7.2	2.8	3.0	2.6	5.0	4.1	5.0	1.5	4.2	2.5	5.1	2.2	22.0	11.7	4.4	3.0	9.2	2.8	3.6	2.1	3.3	4.5	3.9	3.9	6.8	3.5	4.2	4.9	8.3	2.9	5.4	0.5	0.5	0.2	2.4	0.7	4.8	1.9	2.1	2.5	0.9	2.7	3.6	3.0	0.0	4.1	1.0	1.0	3.6	1.6	8.8	18.6	10.0	17.7	17.1	11.0	8.9	14.1	12.9	9.0	3.0	2.2	0.5	2.8	2.9	11.0	1.8	0.0	22.7	5.7	8.7	25.5	1.1	3.3	3.4	15.0	2.9	0.0	0.0	2.2	1.7	2.3	1.7	0.0	2.6	1.6	4.8	2.4	4.9	1.3	3.7	3.7	0.8	1.7	0.0	1.3	6.5	2.0	2.0	3.9	8.2	54.6	6.5	3.3	30.4	5.3	1.8	0.6	1.5	1.2	1.4
CRYBG3	DKFZp667G2110	ENSG00000080200	"Crystallin beta-gamma domain containing 3"	Q68DQ2	3	97822040-97944963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 113.3;Early spermatids: 95.6;Late spermatids: 103.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 1.9;classical monocyte: 3.0;intermediate monocyte: 1.8;myeloid DC: 2.6;non-classical monocyte: 1.9;plasmacytoid DC: 7.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 7.1;granulocytes: 1.9;monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.3"					"Low region specificity"	"Detected in many"			HPA075635			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA075635: "	"unprognostic (1.88e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.10e-2)"	"unprognostic (3.41e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.86e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (1.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.38e-3)"	19.9	5.1	6.4	13.4	20.9	1.9	13.1	1.6	13.0	14.6	19.2	8.2	12.1	6.0	10.4	7.4	13.9	9.0	8.6	14.9	9.1	5.3	8.2	5.3	11.3	6.5	28.4	5.1	8.7	8.5	10.2	7.4	15.8	15.0	12.9	11.9	4.7	10.6	9.0	21.5	19.5	8.4	10.1	20.3	7.8	11.1	19.2	20.5	2.0	39.7	12.3	7.0	11.2	16.9	0.5	7.1	1.9	3.0	0.1	0.6	0.5	11.4	4.3	2.5	3.0	8.0	8.6	4.5	4.1	3.6	3.0	4.5	0.3	3.8	0.1	1.4	6.9	4.6	7.4	4.9	3.4	5.7	14.0	2.7	2.8	1.9	1.4	4.2	4.2	0.7	5.6	3.5	3.7	4.2	4.8	5.7	0.9	0.2	2.2	5.1	0.1	1.5	0.4	2.2	3.3	4.0	0.0	8.8	1.4	4.3	7.6	28.3	2.0	8.6	3.3	2.8	1.7	3.0	4.6	7.7	6.5	5.0	3.7	4.9	3.6	0.1	2.6	6.8	2.5	4.1	1.9	3.0	0.1	0.3	1.8	0.5	0.2	0.6	0.4	2.6	0.5	0.2	0.4	0.0	0.1	1.9	7.1	0.1	0.5	6.4	20.9	1.6	13.0	9.1	5.3	28.4	5.1	15.0	20.5	29.8	18.7	0.0	5.9	4.5	113.3	36.3	2.5	36.1	27.3	17.4	5.9	2.9	1.7	7.7	95.6	22.6	3.2	0.0	11.4	8.6	6.2	6.7	0.0	5.0	6.0	12.7	12.2	15.4	14.3	103.5	7.8	11.0	8.5	13.6	8.9	36.4	13.1	10.4	4.2	1.7	7.3	38.8	8.2	40.4	6.8	5.4	1.9	0.0	4.4	6.4
RIOX2	"FLJ14393, JMJD10, mdig, MINA, MINA53, NO52"	ENSG00000170854	"Ribosomal oxygenase 2"	Q8IUF8	3	97941818-97972457	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 25.4;Cytotrophoblasts: 30.5;Distal tubular cells: 41.4;Extravillous trophoblasts: 36.7;Syncytiotrophoblasts: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007603, HPA008080, CAB013458"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960"	"prognostic unfavorable (4.41e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.68e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.76e-1)"	13.9	9.6	12.7	13.6	16.7	2.2	14.1	8.1	11.1	9.8	11.0	12.2	14.5	8.1	10.7	11.3	20.4	11.3	12.1	8.2	10.9	12.6	13.1	14.2	9.1	13.1	13.9	11.9	14.2	22.5	13.8	15.0	27.1	14.1	11.2	13.9	10.2	20.3	11.3	27.1	14.9	8.3	11.2	14.7	12.1	10.5	6.6	11.2	6.3	48.4	12.8	15.6	14.7	12.5	13.1	21.8	1.6	11.1	8.2	13.6	9.1	20.3	12.3	4.4	9.5	10.3	15.9	11.6	10.0	7.6	11.8	9.7	8.3	10.8	27.3	11.5	11.3	16.0	11.9	13.9	14.2	18.5	51.7	6.4	8.6	5.4	9.9	16.8	17.6	4.1	12.1	19.2	9.0	22.1	5.8	11.9	12.3	11.9	12.2	11.9	6.0	13.9	5.7	9.5	22.4	16.4	0.0	14.8	27.3	11.9	12.0	23.5	8.5	10.7	14.8	16.6	5.1	13.1	7.3	9.6	11.8	13.0	6.4	20.6	18.0	9.3	27.5	13.9	17.6	12.7	1.6	10.9	0.6	8.7	9.4	13.3	13.1	13.6	10.6	13.4	10.3	13.2	10.8	0.7	8.2	11.1	21.8	12.0	9.1	12.7	16.7	8.1	11.1	10.9	12.6	13.9	11.9	14.1	11.2	8.9	10.2	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.4	7.0	0.0	30.5	41.4	14.2	0.0	0.0	0.0	0.0	11.5	36.7	0.0	0.0	2.3	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	12.6	0.0	0.0	10.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0
GABRR3		ENSG00000183185	"Gamma-aminobutyric acid type A receptor rho3 subunit (gene/pseudogene)"	A8MPY1	3	97986673-98035304	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	7	"retina: 18.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 10.5;Rod photoreceptor cells: 11.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	25	"plasmacytoid DC: 2.4"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;U-266/70: 2.0;U-698: 4.7"	"Not detected"	"Not detected"													NA	NA										"unprognostic (3.22e-2)"		"unprognostic (2.06e-3)"							"unprognostic (5.65e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.84e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	18.2	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0											0.0	0.0	0.0	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5AC2	HSA1	ENSG00000196578	"Olfactory receptor family 5 subfamily AC member 2"	Q9NZP5	3	98087173-98088102	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"testis: 2.3"	"Cell type enriched"	"Detected in single"	9	"Early spermatids: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5H1	"HSHTPCRX14, HTPCRX14"	ENSG00000231192	"Olfactory receptor family 5 subfamily H member 1"	A6NKK0	3	98130721-98138548	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.1;testis: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.1"	"Cell line enriched"	"Detected in single"	6	"BEWO: 5.2"															NA	NA																							0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.1			0.0	0.6	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.2		0.0	0.1	0.0	0.0	0.6		0.0	0.0		0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.5	0.1	1.5			0.2		0.0	0.6	0.1	0.2	1.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.8	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5H14		ENSG00000236032	"Olfactory receptor family 5 subfamily H member 14"	A6NHG9	3	98147479-98156614	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.1;placenta: 2.1"	"Group enriched"	"Detected in some"	17	"Collecting duct cells: 1.8;Early spermatids: 1.6"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Low cell line specificity"	"Detected in some"																	NA	NA																							0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.4	0.1			0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.2	0.1		0.2	0.1	0.0	0.1	2.1		0.1	0.0		0.3	0.0	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5			0.1		0.0	0.2	0.1	0.4	0.4	2.1	0.4	0.4	0.4	0.0	0.6	0.6	0.6	0.6	0.3	0.1	0.5	0.8	0.5	0.1	0.0	0.9	0.5	0.3	0.4	0.0	0.6	0.9	0.1	0.3	0.0	0.5	0.6	0.6	1.0	0.7	0.2	0.4	0.5	0.1	0.7	0.2	0.0	0.5	0.0	1.1	0.3	1.4	0.0	1.0	0.3	0.7	0.7	0.3	1.1	0.7	0.2	0.4	0.1	1.0	0.3	0.5	0.4	0.4	0.5	1.1	0.6	0.3	0.1	0.6	1.1	0.9	0.4	0.8	0.8	0.7	0.5	0.3	0.5	2.1	0.4	0.4	0.4	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	1.4	0.4	0.2	0.4	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5H15		ENSG00000233412	"Olfactory receptor family 5 subfamily H member 15"	A6NDH6	3	98166696-98169774	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5H6		ENSG00000230301	"Olfactory receptor family 5 subfamily H member 6 (gene/pseudogene)"	Q8NGV6	3	98263252-98265356	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Group enriched"	"Detected in some"	12	"Early spermatids: 1.2;Late spermatids: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;NTERA-2: 1.2"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.1		0.1	0.0		0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5			0.1		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5H2		ENSG00000197938	"Olfactory receptor family 5 subfamily H member 2"	Q8NGV7	3	98282888-98283832	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HL-60: 1.1"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.0	0.0		0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.1		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5K4		ENSG00000196098	"Olfactory receptor family 5 subfamily K member 4"	A6NMS3	3	98353854-98354819	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5K3		ENSG00000206536	"Olfactory receptor family 5 subfamily K member 3"	A6NET4	3	98390666-98391631	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5K1	"HSHTPCRX10, HTPCRX10"	ENSG00000232382	"Olfactory receptor family 5 subfamily K member 1"	Q8NHB7	3	98463201-98472924	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.1"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2			0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.1	0.1			0.0		0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR5K2		ENSG00000231861	"Olfactory receptor family 5 subfamily K member 2"	Q8NHB8	3	98497604-98498663	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;THP-1: 3.0;U-266/70: 1.5"															NA	NA						"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"			"unprognostic (8.45e-3)"	"unprognostic (1.69e-3)"		"unprognostic (6.47e-3)"			"unprognostic (7.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.93e-2)"	0.4	0.4	0.0	0.6	1.3	0.0	0.4	2.3	0.8	0.9	1.4			0.2	1.2	0.0	0.6	0.1	0.4	0.9	0.0	0.0	0.4	0.0	1.4	1.2	0.0		1.4	0.0	0.0	0.0	0.1		0.5	0.0		0.6	0.0	4.3	1.5	1.3	0.0	0.0	1.4	0.4	0.6			0.4		0.0	1.1	0.6	0.5	0.3	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.3	0.9	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 75.9;brain: 227.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	14.7	12.4	61.6	10.7	76.1	11.7	14.1	11.9	77.1	14.1	10.4	100.5	3.3	10.0	16.9	12.6	22.6	10.9	14.3	15.9	85.4	52.3	11.0	14.0	12.2	13.6	133.4	28.9	19.1	5.8	7.0	6.7	20.5	72.7	14.6	13.6	4.9	6.8	15.7	9.7	17.6	9.4	18.5	227.4	11.5	7.5	28.5	95.4	4.3	11.5	4.7	14.8	14.7	11.1	19.9	19.7	28.1	18.6	49.5	75.9	28.6	17.9	7.3	22.9	14.0	27.7	21.6	12.5	14.2	19.6	20.0	27.7	14.8	18.3	9.0	19.2	13.6	38.0	24.3	17.6	10.8	35.1	21.2	7.5	18.7	5.2	13.2	22.2	16.8	18.7	25.2	58.3	15.6	16.8	21.5	21.7	17.9	9.3	27.7	28.1	9.4	12.3	11.1	19.9	7.8	15.6	8.3	30.8	11.4	18.7	8.1	8.3	22.8	19.6	6.6	28.1	32.1	6.6	14.3	20.1	26.1	24.1	17.7	18.4	36.7	15.7	14.5	43.6	16.2	33.3	28.1	18.6	19.8	21.7	10.7	40.8	19.9	40.9	39.8	19.7	16.4	16.6	16.9	13.8	49.5	10.5	12.7	75.9	28.6	61.6	76.1	11.9	38.8	85.4	52.3	133.4	28.9	72.7	95.4	32.8	39.6	30.5	103.2	128.0	19.7	48.0	12.7	16.0	23.9	26.2	23.6	44.0	24.9	18.4	58.8	63.1	19.7	46.7	14.2	132.7	70.7	85.5	35.8	18.7	31.6	14.3	27.5	54.0	25.9	62.2	47.8	38.0	108.0	43.3	18.8	28.6	24.0	11.5	43.9	18.2	31.4	51.8	126.4	168.0	50.6	171.8	80.1	103.6	17.1	110.7
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98521132-98593723	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 140.2;Extravillous trophoblasts: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Enhanced	Mitochondria		No	No		140000	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	6.6	8.9	12.6	9.0	29.9	30.2	6.6	10.1	21.1	7.5	8.2	29.6	5.7	17.7	8.8	6.4	14.1	6.4	7.2	6.9	17.5	11.7	5.6	29.3	6.3	9.1	42.9	16.2	9.5	6.9	9.9	5.5	14.8	23.7	7.4	10.3	3.4	7.2	7.2	8.5	10.8	12.3	7.7	32.8	9.1	7.7	3.9	36.0	7.7	6.2	7.0	9.8	8.5	10.4	1.7	1.7	0.0	2.1	2.1	3.0	0.7	16.6	8.1	7.2	12.7	13.5	10.0	20.7	10.8	7.8	11.1	12.7	13.4	5.2	1.7	12.1	5.7	12.3	12.1	8.9	11.6	19.0	5.3	7.8	58.1	4.6	17.3	6.9	12.2	13.8	7.8	9.8	10.5	4.4	13.1	10.6	7.2	11.1	7.5	10.4	5.1	12.3	10.5	8.5	9.3	14.8	8.8	16.4	7.7	9.4	6.9	4.8	4.7	11.4	3.9	32.3	8.4	6.1	7.9	8.8	16.6	16.3	9.5	7.8	11.6	9.1	9.4	16.5	13.5	12.1	0.0	2.1	0.0	1.4	1.0	2.5	1.7	2.4	2.9	1.7	1.5	0.8	3.0	0.0	2.1	0.7	1.1	1.1	0.7	12.6	29.9	10.1	21.1	17.5	11.7	42.9	16.2	23.7	36.0	3.0	8.3	6.9	4.0	6.5	3.4	7.1	2.5	1.4	0.0	3.5	7.9	21.7	1.7	3.0	0.0	5.8	6.4	140.2	1.6	67.8	9.9	4.4	1.1	30.1	11.2	0.0	8.1	11.6	10.8	0.0	6.9	8.9	11.8	10.8	8.6	6.0	2.8	0.0	7.4	5.1	5.3	12.9	9.0	0.0	3.2	8.9	8.9	10.7	9.7	3.7
GPR15		ENSG00000154165	"G protein-coupled receptor 15"	P49685	3	98531899-98533150	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.9;intestine: 27.1;lymphoid tissue: 26.3;urinary bladder: 9.4"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 4.4;memory CD4 T-cell: 12.9;memory CD8 T-cell: 6.1;T-reg: 12.9"	"Group enriched"	"Detected in many"	30	"B-cells: 4.4;T-cells: 12.9"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.1;HDLM-2: 11.1;U-266/70: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013775	Approved					NA	NA					"HPA013775: AB_1849264"	"unprognostic (8.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.66e-2)"	"unprognostic (9.48e-3)"	"unprognostic (5.60e-5)"	"unprognostic (5.17e-1)"	"unprognostic (6.77e-3)"	"unprognostic (3.96e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	0.9	0.1	0.1	13.4	0.1	0.0	2.5	0.1	0.2	1.1	15.3	0.1	0.1	1.8	0.1	0.1	2.6	0.2	2.1	0.2	0.1	0.1	0.3	0.4	1.9	24.9	0.1	0.4	0.4	0.1	0.0	0.2	0.1	0.3	1.4	27.1	0.3	4.6	0.7	0.1	0.4	11.8	1.5	0.2	4.3	1.1	0.2	0.1	3.6	0.7	2.0	26.3	9.4	2.4	4.4	0.2	0.2	0.0	0.0	12.9	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	11.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.9	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.4	4.4	12.9	6.1	0.0	0.7	0.6	1.0	0.2	0.0	0.0	0.2	12.9	2.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST3GAL6	"SIAT10, ST3GALVI"	ENSG00000064225	"ST3 beta-galactoside alpha-2,3-sialyltransferase 6"	Q9Y274	3	98732236-98821201	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 46.7"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.5;Hepatocytes: 74.4;Melanocytes: 62.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 17.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 20.7;neutrophil: 25.8"	"Group enriched"	"Detected in many"	144	"dendritic cells: 10.6;granulocytes: 25.8;monocytes: 7.7"	"Group enriched"	"Detected in many"	4	"RPMI-8226: 36.4;SK-MEL-30: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018792	Approved					NA	NA		3000000			"HPA018792: AB_10964349"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.17e-2)"	"unprognostic (5.20e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (9.47e-3)"	"unprognostic (6.79e-4)"	11.5	7.5	5.9	3.6	8.3	2.4	6.0	14.4	8.2	4.9	3.6	6.7	1.9	2.2	2.4	11.3	2.4	6.0	2.4	21.8	7.1	5.9	12.2	46.7	7.1	3.5	9.5	4.3	1.7	4.7	1.1	4.6	20.1	10.1	3.5	3.0	6.3	15.9	2.3	6.5	14.4	2.2	2.3	17.4	3.0	4.6	1.8	7.4	14.3	3.1	2.2	2.8	1.6	1.9	0.0	10.6	25.8	7.7	0.0	0.1	1.8	0.1	0.5	0.8	1.1	1.3	0.4	5.0	0.1	0.6	0.5	0.9	3.3	0.2	2.4	1.3	0.0	1.8	0.8	1.5	0.8	0.4	0.0	1.0	0.1	0.2	5.9	5.8	5.0	9.5	0.6	0.0	1.4	2.7	9.1	5.7	1.0	0.0	2.5	0.5	0.0	0.8	8.6	1.4	0.0	1.4	0.4	0.6	36.4	1.3	0.0	1.5	7.8	2.0	0.2	43.1	1.5	0.1	9.0	4.2	1.1	0.9	0.3	0.4	9.7	0.7	0.0	1.9	7.2	4.0	7.4	7.7	20.7	0.0	4.1	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	25.8	0.0	2.0	2.4	0.0	1.8	5.9	8.3	14.4	8.2	7.1	5.9	9.5	4.3	10.1	7.4	11.9	35.7	2.2	2.8	10.2	1.0	33.9	5.1	32.1	1.2	3.5	7.9	36.5	11.6	4.9	0.2	13.4	0.0	0.0	1.8	61.5	2.2	4.8	36.0	74.4	33.3	0.0	15.4	33.2	23.8	0.2	2.6	39.4	62.4	44.1	0.0	0.6	4.2	0.0	6.3	9.0	2.6	6.5	2.0	0.0	0.4	11.2	22.5	0.0	0.0	0.9
DCBLD2	"CLCP1, ESDN"	ENSG00000057019	"Discoidin, CUB and LCCL domain containing 2"	Q96PD2	3	98795941-98901689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 66.0;Cone photoreceptor cells: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 59.8;hTERT-RPE1: 84.9;LHCN-M2: 99.6;RPTEC TERT1: 62.4;U-87 MG: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016909	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		1800000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA016909: AB_1847510"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-3)"	"unprognostic (9.29e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.32e-5)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.59e-3)"	13.1	14.6	4.5	6.4	7.2	1.1	19.3	9.7	9.6	12.0	13.1	5.1	8.1	2.7	16.8	9.2	8.8	13.9	11.7	24.2	4.5	6.2	11.3	9.2	13.1	3.2	6.7	3.5	19.0	6.4	17.6	12.7	9.9	6.5	11.2	6.8	19.3	11.1	14.7	6.6	7.7	5.2	16.7	7.1	2.1	8.6	33.8	7.3	8.1	18.7	6.3	3.6	15.1	6.8	0.6	1.2	1.7	0.5	0.1	1.1	0.2	6.8	50.2	6.7	5.3	9.0	21.4	2.9	15.5	7.4	10.6	12.0	4.2	21.9	0.0	48.8	26.6	32.5	6.4	3.0	25.2	24.4	0.1	1.0	2.4	1.6	6.4	5.5	1.1	1.1	8.4	3.9	30.4	59.8	84.9	6.9	0.9	0.4	0.6	99.6	1.8	0.9	0.6	4.7	0.0	17.4	1.0	12.7	0.6	62.4	1.8	1.8	3.1	4.2	0.8	18.1	4.8	3.4	0.9	11.4	27.3	21.9	6.9	54.2	0.8	1.1	0.9	76.2	0.4	11.8	1.2	0.5	1.7	0.0	0.1	0.0	0.6	0.1	0.1	0.5	0.2	1.1	0.1	0.9	0.1	0.3	1.2	0.0	0.2	4.5	7.2	9.7	9.6	4.5	6.2	6.7	3.5	6.5	7.3	29.8	44.4	4.5	12.4	20.3	11.2	66.0	12.7	18.7	20.5	17.4	72.6	9.6	0.0	20.3	2.5	7.1	0.9	0.0	7.0	8.2	18.1	10.1	36.9	18.7	3.5	12.7	3.5	4.9	1.6	3.6	20.4	2.6	8.5	1.8	7.3	44.0	17.8	3.5	47.4	6.9	49.1	0.0	19.1	15.8	23.3	13.7	3.3	0.0	10.7	5.9
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 56.0"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 229.3;Ito cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.3;fHDF/TERT166: 149.2;hTERT-RPE1: 63.4;LHCN-M2: 43.8;TIME: 64.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	20.5	4.7	1.0	6.1	3.0	0.1	7.5	2.4	0.9	5.8	16.9	1.8	11.8	0.6	5.9	16.8	15.3	6.4	6.8	26.7	1.2	1.4	9.4	1.9	36.5	0.5	1.8	2.1	7.7	0.9	32.3	9.4	5.5	2.9	13.1	4.8	38.7	5.2	8.8	5.0	2.3	2.7	18.8	3.0	0.9	4.2	6.4	0.6	0.0	56.0	6.4	0.8	21.3	12.1	0.4	0.1	0.9	0.2	0.3	0.4	0.1	0.0	0.0	0.4	0.0	22.0	36.3	0.0	8.9	5.8	9.0	18.1	0.0	0.0	0.0	0.8	149.2	0.2	0.0	0.0	11.6	23.4	0.0	0.0	0.0	1.2	0.0	4.0	0.0	0.0	20.7	0.4	7.0	11.8	63.4	17.4	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	64.9	4.2	3.3	0.2	4.7	0.0	0.0	0.0	8.2	0.0	32.0	0.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.4	0.4	0.7	0.3	0.1	0.1	0.1	0.1	1.0	3.0	2.4	0.9	1.2	1.4	1.8	2.1	2.9	0.6	229.3	23.2	0.0	0.4	0.7	0.4	4.2	0.0	1.4	6.8	8.7	0.0	0.1	0.0	0.2	0.7	1.5	0.0	0.0	0.0	0.2	2.4	0.1	4.7	0.8	0.1	0.0	0.0	85.3	1.9	0.4	2.0	0.9	1.7	0.0	0.0	0.5	0.1	0.0	8.9	0.8	0.5	0.0	8.3	0.3	0.2	0.5	0.3	1.0	0.0	0.2
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog (yeast)"	Q9BQ75	3	99817834-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"		NA	NA			Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	21.4	34.1	23.7	15.1	24.5	17.7	20.6	24.1	27.4	13.4	12.9	9.4	8.2	8.3	19.6	10.7	12.0	13.3	10.5	16.6	24.0	22.2	17.1	17.5	10.8	15.8	15.3	22.3	21.1	26.4	20.7	25.9	11.7	19.2	15.1	12.4	9.3	12.4	14.5	58.2	11.5	9.3	13.8	15.7	12.9	11.0	28.1	13.5	13.6	14.9	14.4	14.7	18.8	15.7	23.5	26.1	1.6	10.9	11.2	19.0	7.9	28.9	13.1	13.0	18.7	9.2	10.9	13.4	13.5	7.3	24.3	20.3	16.3	9.7	31.4	23.7	7.2	21.5	17.5	18.0	15.3	32.2	16.2	17.2	24.7	9.3	13.2	16.6	33.8	13.6	7.4	14.9	18.1	30.3	7.7	16.8	25.4	15.2	20.4	17.6	20.0	27.0	31.5	19.0	27.6	32.9	12.2	21.0	33.6	15.0	7.1	36.7	15.4	13.5	11.0	30.7	13.0	13.3	21.2	4.8	19.3	54.8	11.2	27.4	14.6	29.0	61.0	12.5	37.4	32.2	0.3	4.7	0.8	10.0	10.9	14.2	23.2	14.8	13.5	9.9	23.5	18.7	19.0	1.6	11.2	9.7	26.1	13.7	7.9	23.7	24.5	24.1	27.4	24.0	22.2	15.3	22.3	19.2	13.5	6.0	14.2	29.8	33.2	55.3	30.0	40.3	43.3	29.4	23.9	59.3	17.7	34.3	82.9	17.0	137.8	37.9	1.1	0.0	40.8	46.0	41.2	21.8	61.1	44.9	24.7	120.8	14.5	19.0	5.8	151.1	46.9	25.2	35.4	14.4	13.3	17.6	29.9	0.0	55.2	66.2	21.4	25.8	64.6	105.9	127.7	57.7	18.3	28.7	20.7	22.0
FILIP1L	"DOC-1, GIP130"	ENSG00000168386	"Filamin A interacting protein 1 like"	Q4L180	3	99830141-100114513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 302.8;Sertoli cells: 252.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.3;HDLM-2: 25.5;TIME: 47.6"	"Region enriched"	"Detected in some"	7	"olfactory region: 22.1"	"Low region specificity"	"Detected in all"			HPA043133	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA043133: AB_10793991"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (2.46e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.82e-3)"	29.0	7.5	11.7	22.1	2.4	0.0	15.2	1.3	7.4	36.2	28.3	0.9	27.2	6.9	52.5	50.0	25.3	17.8	24.3	23.8	4.0	2.1	12.5	6.7	15.9	10.9	2.9	6.5	65.6	10.3	7.7	3.1	14.6	9.4	36.7	7.7	5.5	6.1	36.8	44.8	9.5	19.2	86.3	2.2	27.1	25.1	19.9	1.3	2.5	11.7	53.4	5.8	49.8	16.2	1.5	4.4	0.5	5.9	1.0	0.4	0.5	18.7	0.0	7.4	0.0	12.2	10.4	0.6	9.6	19.3	16.8	19.1	5.7	0.0	0.0	1.7	27.3	4.4	2.3	0.0	4.7	20.0	25.5	0.2	1.5	0.0	7.5	6.1	0.4	0.0	8.2	1.7	1.9	0.0	10.8	7.5	0.0	1.2	0.1	2.5	0.1	1.6	0.3	0.4	1.0	0.0	0.0	8.7	0.2	11.3	0.3	0.6	1.2	0.1	0.1	0.0	4.1	0.0	3.4	47.6	2.9	0.0	0.6	5.0	1.4	0.0	0.1	2.2	0.1	0.0	0.3	1.0	0.2	0.3	2.2	0.1	1.4	0.4	0.3	4.4	1.5	0.2	0.2	0.5	1.0	5.9	0.8	0.3	0.5	11.7	2.4	1.3	7.4	4.0	2.1	2.9	6.5	9.4	1.3	14.9	17.2	0.0	37.5	24.6	4.0	115.5	33.1	2.7	2.3	5.2	7.9	0.6	1.7	158.4	302.8	69.7	2.9	0.0	97.5	0.6	90.1	2.5	33.5	0.5	3.0	100.1	2.9	44.2	29.2	157.4	76.8	76.0	16.9	28.9	3.0	1.0	44.0	0.0	97.9	0.3	5.9	252.2	159.4	7.1	1.9	19.8	2.6	0.5	0.3	3.7
TBC1D23	FLJ11046	ENSG00000036054	"TBC1 domain family member 23"	Q9NUY8	3	100261000-100325251	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038151, HPA038152"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA038151: AB_10672405, HPA038152: AB_10672620"	"unprognostic (9.23e-3)"	"unprognostic (6.01e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.87e-3)"	"unprognostic (6.16e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.32e-1)"	26.2	28.3	13.4	13.2	14.3	20.4	17.8	28.2	18.9	18.0	17.9	13.6	18.2	18.3	19.1	14.3	20.5	13.3	14.4	16.2	12.8	10.6	20.8	23.2	15.8	11.6	17.6	13.8	19.6	18.5	18.3	25.6	33.5	16.8	16.5	16.0	12.2	20.6	10.6	30.9	20.5	29.6	15.5	19.3	18.2	15.2	17.0	18.1	19.1	16.8	15.7	15.1	21.0	16.9	11.5	17.5	22.5	20.1	20.8	15.5	14.8	33.6	6.9	8.1	4.4	15.7	21.3	7.9	20.4	20.5	21.3	25.6	13.8	5.8	8.0	10.0	21.3	12.5	11.4	29.0	12.9	33.4	4.8	7.4	22.0	8.5	8.9	16.0	9.8	17.9	17.2	10.7	11.7	17.2	18.3	11.3	6.4	18.1	12.0	13.6	6.9	7.8	4.8	9.2	11.5	13.3	6.6	17.6	9.5	12.7	7.3	11.6	6.6	10.7	8.2	13.6	10.7	8.9	9.6	11.2	15.1	14.9	7.1	13.0	11.7	12.4	14.5	20.3	9.5	12.8	22.5	16.6	20.6	12.0	19.3	12.6	11.5	11.8	11.1	17.5	10.8	10.9	11.6	11.2	20.8	20.1	7.5	15.5	14.8	13.4	14.3	28.2	18.9	12.8	10.6	17.6	13.8	16.8	18.1	38.7	9.3	9.3	16.1	27.9	16.9	25.0	10.2	20.1	19.4	12.2	13.7	16.8	26.6	23.0	40.2	21.5	17.1	23.3	25.5	16.4	27.8	23.7	28.9	15.3	12.5	33.4	6.9	9.2	15.9	34.7	19.0	16.5	23.6	4.6	15.5	15.1	27.7	11.8	13.4	16.1	29.3	12.9	23.7	18.2	14.7	33.9	55.0	15.9	12.3	20.7
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		960000	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.2	8.9	12.1	6.2	4.1	6.1	9.7	9.3	8.4	11.2	10.0	6.2	5.9	4.2	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.9	4.7	4.9	7.6	16.8	5.2	8.5	5.1	6.2	5.7	3.3	8.1	11.8	9.5	3.1	4.3	4.4	12.5	15.1	3.5	4.2	9.8	16.0	6.3	6.9	3.2	5.6	9.6	6.1	3.3	7.1	4.5	4.5	6.1	2.5	2.9	3.5	5.0	5.5	8.5	9.6	8.0	7.7	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3	11.9	12.1	26.5	41.3	29.0	11.3	49.4	30.6	38.8	26.1	55.8	15.7	80.0	159.2	63.8	2.3	15.5	14.9	0.0	46.2	64.1	34.7	40.0	20.7	147.3	56.1	12.7	23.1	16.0	18.8	2.4	40.9	33.3	47.2	136.1	20.8	11.7	55.0	25.7	35.3	436.2	23.6	38.8	46.4	1.5	14.5	36.4	49.5	26.2	34.7	40.6
TOMM70	"KIAA0719, Tom70, TOMM70A"	ENSG00000154174	"Translocase of outer mitochondrial membrane 70"	O94826	3	100363431-100401398	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 22.5;Extravillous trophoblasts: 28.8;Proximal tubular cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014589, CAB017156, HPA048020"	Enhanced		Enhanced	Mitochondria		NA	NA		120000	Mitochondria		"CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234"	"unprognostic (2.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.01e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.98e-3)"	21.7	16.1	16.2	12.4	52.4	9.6	21.3	23.6	26.5	16.9	18.2	12.5	13.8	19.4	17.4	15.0	20.8	14.2	12.2	25.2	16.5	19.8	24.9	40.7	10.5	13.5	16.1	20.6	21.7	18.0	20.1	17.1	15.5	29.0	19.0	20.6	13.3	14.5	19.4	42.8	13.3	17.8	22.3	14.0	12.1	14.8	14.7	15.6	18.7	20.5	19.9	16.6	22.3	22.5	4.3	3.0	2.5	2.5	5.6	5.4	1.8	23.5	16.5	14.1	20.2	20.0	21.8	18.4	20.3	17.2	18.5	19.2	23.4	13.6	28.2	17.8	17.0	16.7	23.4	25.4	18.5	27.4	10.7	11.8	32.4	11.0	22.7	12.5	39.4	14.9	19.4	17.1	16.5	26.9	16.5	13.5	13.9	23.0	23.1	22.0	17.4	26.6	15.9	19.4	36.5	35.3	24.5	28.6	30.0	15.0	17.8	25.6	21.3	14.7	23.6	26.4	14.1	30.6	22.4	12.1	16.4	21.7	9.1	15.0	25.2	35.9	48.0	15.7	23.9	12.4	2.2	2.2	2.5	4.1	2.2	5.1	4.3	5.1	4.5	2.9	3.1	5.3	5.4	0.6	5.6	2.5	3.0	2.0	1.8	16.2	52.4	23.6	26.5	16.5	19.8	16.1	20.6	29.0	15.6	6.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	18.7	20.5	14.0	0.0	22.5	10.0	17.3	0.0	0.0	0.0	0.0	16.9	28.8	0.0	0.0	7.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	10.0	0.0	0.0	19.2	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
LNP1	NP3	ENSG00000206535	"Leukemia NUP98 fusion partner 1"	A1A4G5	3	100401193-100456319	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.9"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 107.8;Horizontal cells: 243.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4"	HPA047926			Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA			Vesicles	"Nuclear speckles, Cytosol"	"HPA047926: "	"unprognostic (1.78e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.40e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.08e-2)"	3.1	2.8	6.5	1.7	11.4	0.6	2.7	7.9	9.7	3.4	2.3	1.5	3.4	1.2	4.6	8.4	1.9	4.0	2.7	9.5	5.3	7.2	4.8	7.4	3.8	1.4	5.7	5.6	6.3	4.5	3.0	17.0	3.7	7.4	2.8	2.2	9.0	2.4	3.3	4.3	1.0	1.5	4.5	4.2	1.8	1.9	31.9	3.5	1.6	5.3	0.8	1.7	3.1	1.8	0.9	0.2	0.0	0.4	0.2	2.7	0.8	2.9	1.6	8.5	1.2	5.5	2.4	0.7	2.3	5.6	1.9	2.2	0.6	0.7	2.6	1.0	1.6	3.0	1.9	2.2	2.0	2.2	2.6	2.3	6.2	0.8	2.8	1.7	3.6	0.7	2.6	0.7	1.0	4.8	2.5	0.4	1.3	2.4	9.7	1.7	2.1	5.0	3.6	5.8	1.7	12.8	3.8	4.7	5.1	1.7	0.3	8.8	4.4	1.7	2.5	3.5	2.5	0.6	0.4	0.6	0.9	9.0	0.8	2.0	11.4	12.2	7.5	2.6	3.1	1.6	0.0	0.4	0.0	1.1	0.2	2.5	0.9	1.1	0.6	0.2	0.9	1.0	1.1	0.0	0.2	0.0	0.0	2.7	0.8	6.5	11.4	7.9	9.7	5.3	7.2	5.7	5.6	7.4	3.5	0.0	0.3	4.2	1.2	0.9	32.6	9.6	0.0	5.3	2.3	1.8	47.1	1.2	6.6	0.4	107.8	0.7	0.4	23.3	0.8	1.6	3.1	0.9	0.0	1.6	0.6	243.1	2.4	0.0	0.3	17.2	3.1	0.0	20.3	1.0	1.0	9.4	0.6	0.0	1.1	3.1	35.6	0.0	2.2	31.5	2.7	0.5	0.3	0.0	0.6	0.1
TMEM45A	"DERP7, FLJ10134"	ENSG00000181458	"Transmembrane protein 45A"	Q9NWC5	3	100492619-100577444	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 118.9"	"Cell type enhanced"	"Detected in many"	9	"Club cells: 118.3;Early spermatids: 138.9;Hepatocytes: 109.4;Suprabasal keratinocytes: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.3;myeloid DC: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 94.3;ASC TERT1: 27.6;HSkMC: 29.0"					"Low region specificity"	"Detected in all"			HPA062101	Uncertain		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA062101: AB_2684682"	"unprognostic (5.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.43e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.18e-11)"	"unprognostic (1.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-5)"	"unprognostic (2.68e-2)"	5.3	5.2	1.6	3.0	7.3	0.6	12.5	0.3	1.9	8.6	2.7	1.9	2.5	1.0	8.5	5.7	4.4	5.2	5.7	5.7	1.3	0.9	1.4	45.2	5.8	5.2	4.4	0.7	6.4	20.2	0.3	25.1	20.2	2.1	5.9	1.8	3.1	23.9	2.2	2.4	118.9	1.7	6.6	2.2	2.2	2.0	5.4	4.4	0.0	6.5	3.7	12.2	7.7	18.5	0.5	2.9	0.9	3.3	0.0	0.5	2.0	6.1	0.4	0.6	2.1	94.3	27.6	0.0	14.8	13.8	2.1	19.4	0.5	0.1	0.0	7.4	9.7	5.6	7.0	0.5	2.8	5.3	1.5	1.8	5.2	2.3	1.7	5.9	0.0	0.3	29.0	1.6	3.8	5.8	8.9	0.8	0.0	0.1	0.7	5.0	0.0	0.0	0.1	0.7	0.0	3.7	0.0	5.3	0.0	0.1	0.2	0.6	4.4	3.6	1.9	1.5	4.3	0.2	2.9	2.0	14.4	10.1	0.1	3.3	12.2	6.9	0.0	11.3	0.4	9.5	0.0	3.3	0.9	0.3	0.0	0.0	0.5	0.2	0.3	2.9	0.0	0.1	0.5	0.4	0.0	0.5	1.6	0.0	2.0	1.6	7.3	0.3	1.9	1.3	0.9	4.4	0.7	2.1	4.4	56.6	52.0	7.0	4.3	84.0	3.3	1.9	0.0	97.7	118.3	0.0	0.0	2.2	0.0	7.1	138.9	3.8	0.0	0.0	13.5	42.5	64.8	3.2	60.4	109.4	5.6	7.9	1.2	12.3	6.1	11.8	15.0	5.0	21.9	1.8	1.7	1.4	8.9	0.3	26.2	0.0	0.8	6.5	16.4	1.2	1.9	222.8	6.3	3.2	0.0	4.1
ADGRG7	"FLJ14454, GPR128"	ENSG00000144820	"Adhesion G protein-coupled receptor G7"	Q96K78	3	100609589-100695479	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"intestine: 58.4;liver: 26.9"	"Cell type enhanced"	"Detected in some"	25	"Collecting duct cells: 1.8;Enterocytes: 2.6;Hepatocytes: 10.4;Paneth cells: 4.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 2.9;CACO-2: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA056451			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA056451: "		"unprognostic (1.65e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.79e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"			"unprognostic (9.37e-3)"		"unprognostic (2.84e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"		"unprognostic (6.77e-2)"	0.1	0.2	0.1	0.5	0.1	1.2	0.1	0.1	0.1	0.9	17.1	0.1	0.1	25.7	0.3	0.1	0.2	0.9	0.3	0.2	0.1	0.1	0.1	26.9	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	1.7	0.1	0.1	0.1	0.1	0.2	58.4	0.8	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0
TFG	"FLJ36137, SPG57, TF6"	ENSG00000114354	"TRK-fused gene"	Q92734	3	100709331-100748966	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019473, HPA052206"	Approved		Supported	Vesicles,Cytosol		No	No			Vesicles	Cytosol	"HPA019473: AB_1857936, HPA052206: AB_2681760"	"unprognostic (1.14e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.31e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.45e-2)"	36.4	40.3	27.2	21.9	33.8	29.7	31.0	28.1	40.5	31.2	34.7	33.3	44.2	52.5	31.2	45.8	46.7	29.0	40.8	46.2	28.1	30.7	44.6	68.6	29.9	25.4	28.2	21.5	33.5	49.2	52.3	45.1	63.3	33.7	27.5	40.7	31.9	39.6	45.8	38.6	31.0	67.1	37.5	31.7	28.3	28.9	33.5	23.0	27.6	43.6	42.9	41.2	29.5	30.1	25.8	27.8	43.2	28.4	27.7	26.8	21.8	48.7	26.6	33.1	21.0	41.8	47.4	40.9	35.3	47.5	46.2	55.1	33.5	24.4	6.5	26.0	43.8	35.8	36.6	35.6	40.3	55.0	30.0	20.9	24.5	20.5	31.1	46.8	18.1	14.7	38.8	54.4	27.6	48.8	42.9	40.8	11.5	17.6	18.1	47.6	34.1	15.9	14.3	31.5	45.4	40.0	14.0	19.4	21.2	56.0	32.9	26.2	24.0	23.2	30.2	41.1	28.7	35.6	24.6	27.3	27.9	33.8	12.8	25.5	15.5	15.6	23.4	44.6	19.8	32.7	43.2	28.3	27.0	21.8	28.4	26.4	25.8	22.6	24.4	27.8	22.9	21.6	21.6	18.7	27.7	26.4	19.4	26.8	21.8	27.2	33.8	28.1	40.5	28.1	30.7	28.2	21.5	33.7	23.0	56.6	28.8	33.5	90.7	121.3	43.5	83.1	53.5	36.1	40.9	34.9	23.6	186.8	116.0	161.1	64.7	63.1	162.1	23.3	94.6	171.9	101.9	94.0	76.1	59.6	75.5	54.0	50.5	51.0	25.1	36.9	65.6	40.7	60.8	142.5	99.4	86.6	108.9	83.4	69.6	72.7	59.0	38.8	84.4	49.9	48.5	104.0	237.9	28.8	82.9	98.7
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 53.6;Club cells: 70.5;Leydig cells: 90.0;Muller glia cells: 112.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 48.4;hTEC/SVTERT24-B: 86.0;hTERT-HME1: 87.3;HUVEC TERT2: 35.5;TIME: 187.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.0;basal ganglia: 15.3;cerebellum: 5.8;cerebral cortex: 13.1;olfactory region: 13.7"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"	NA	NA		570000000			"HPA044127: AB_2678823"	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	35.3	5.2	2.7	24.7	9.0	0.0	16.1	1.2	3.3	45.0	15.8	9.7	6.9	1.7	29.4	23.6	23.4	16.9	44.1	28.1	4.2	2.9	6.6	2.2	34.5	8.2	4.4	3.6	33.5	3.8	0.5	4.3	45.8	4.7	23.0	19.4	80.6	10.5	4.2	8.7	9.8	10.2	39.2	8.0	3.8	22.3	12.3	5.3	0.2	23.2	23.7	25.3	38.5	19.1	0.7	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.5	48.4	0.0	9.9	9.7	18.2	8.6	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.1	28.9	0.0	0.0	0.2	0.1	0.0	2.5	0.0	0.0	2.8	0.1	86.0	87.3	0.3	35.5	0.0	0.0	0.1	15.8	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	187.0	3.9	0.0	32.9	1.9	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	9.0	1.2	2.4	4.2	2.9	4.4	3.6	4.7	5.3	53.6	5.6	0.0	1.5	14.2	1.0	10.3	2.5	5.3	70.5	17.4	2.0	0.5	0.0	0.0	7.2	9.0	0.0	0.0	0.3	0.6	43.8	1.1	3.5	0.0	0.8	0.0	1.2	11.1	1.2	7.8	90.0	2.9	18.6	0.0	0.5	112.5	1.1	4.5	26.2	6.5	3.5	0.0	18.6	0.1	0.2	17.3	0.6	0.0	0.6	2.5
IMPG2	"IPM200, RP56"	ENSG00000081148	"Interphotoreceptor matrix proteoglycan 2"	Q9BZV3	3	101222546-101320560	"Disease related genes, Predicted membrane proteins"		"Heparin-binding, Receptor"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 72.1"	"Group enriched"	"Detected in some"	29	"Cone photoreceptor cells: 486.9;Rod photoreceptor cells: 298.9"	"Cancer enriched"	"Detected in single"	12	"ovarian cancer: 2.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008779, HPA015907"	Enhanced					NA	NA					"HPA008779: AB_2668138, HPA015907: AB_2669323"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.80e-5)"	"unprognostic (6.66e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-9)"	"unprognostic (7.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.08e-2)"	0.2	0.3	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.1	0.1	0.3	0.3	0.1	16.5	0.2	0.3	0.3	0.6	0.3	0.1	0.1	0.4	0.5	0.1	0.4	0.2	0.1	0.4	0.1	0.4	0.2	0.2	72.1	0.2	0.1	0.2	0.2	0.4	0.3	0.2	0.6	0.5	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.6	0.1	1.0	0.1	1.1	0.3	0.0	0.1	0.0	1.1	1.3	0.4	1.0	0.1	0.1	0.2	0.3	0.5	0.0	0.1	0.1	1.0	0.1	0.4	0.0	0.3	0.1	1.1	0.4	0.3	0.6	0.4	0.1	0.1	0.3	2.0	1.3	0.7	0.2	0.0	0.6	1.8	0.2	0.0	1.2	0.9	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.7	0.3	1.6	0.2	0.0	0.0	0.1	0.8	0.2	0.4	1.4	1.2	0.6	0.4	0.7	0.6	1.1	0.2	0.0	0.0	1.2	0.6	0.1	0.3	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.3	1.0	1.1	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.2	0.3	0.6	0.5	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	13.2	0.6	0.0	0.0	0.0	0.0	486.9	0.0	1.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.7	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	0.0	13.7	0.1	0.0	0.7	0.0	298.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0
SENP7		ENSG00000138468	"SUMO1/sentrin specific peptidase 7"	Q9BQF6	3	101324205-101513241	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027259, HPA071998"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Centrosome, Cytosol"	"HPA027259: AB_1856679, HPA071998: "	"unprognostic (1.50e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.38e-3)"	"unprognostic (9.25e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.08e-3)"	"unprognostic (3.27e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.23e-2)"	17.0	9.0	11.0	19.1	14.5	19.5	16.5	35.5	19.5	21.7	13.1	11.8	8.2	6.4	24.3	15.2	11.9	18.6	12.8	10.0	13.2	9.1	10.5	7.7	11.5	19.0	12.9	10.8	27.9	15.9	22.4	24.4	17.0	18.7	15.1	10.0	9.2	10.2	11.1	11.1	18.6	13.8	16.0	17.3	14.1	13.6	7.9	16.8	32.1	16.0	9.4	15.4	17.2	14.0	6.8	3.2	24.5	4.1	6.2	7.6	3.8	7.0	4.8	23.6	13.0	4.5	6.9	4.3	4.1	3.0	6.8	8.5	3.1	6.6	5.4	6.4	3.9	6.3	7.1	7.3	3.7	13.8	10.1	2.2	9.8	3.7	4.2	3.7	5.7	9.7	5.3	6.8	3.4	7.8	6.2	9.8	10.7	8.1	14.0	6.4	4.6	10.4	6.6	4.8	3.7	5.1	11.6	6.3	4.9	8.2	4.1	9.1	7.0	3.8	3.9	5.1	12.7	6.3	7.6	8.0	9.5	5.9	3.2	4.0	9.9	5.9	12.8	3.3	7.6	7.7	24.5	4.1	3.8	4.2	3.6	5.2	4.2	5.6	4.2	3.2	6.8	7.6	5.1	12.6	6.2	3.8	2.8	4.5	3.8	11.0	14.5	35.5	19.5	13.2	9.1	12.9	10.8	18.7	16.8	14.9	26.4	9.5	7.3	8.0	47.4	19.3	5.1	38.8	25.0	15.7	19.6	5.0	5.0	6.0	2.1	22.9	5.6	0.0	4.5	2.2	13.9	6.7	34.8	9.6	6.7	49.3	12.6	42.4	22.1	2.5	17.0	11.6	10.1	1.8	6.3	20.1	6.1	2.9	18.4	6.7	33.6	45.3	9.9	20.4	17.1	8.7	2.1	22.4	4.9	3.9
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561862-101566446	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	18.0	21.2	13.1	13.6	14.1	14.4	19.7	16.4	19.1	16.1	15.3	5.5	12.9	11.6	14.6	13.1	20.9	15.0	10.7	20.4	13.0	13.4	26.6	34.6	10.0	19.3	12.5	16.7	18.8	12.1	9.9	19.9	18.2	18.5	16.2	14.2	5.5	14.5	13.0	35.2	15.2	16.5	15.3	14.3	19.6	15.6	14.7	10.6	23.0	16.6	30.5	18.5	15.6	11.3	21.6	15.4	27.4	14.8	12.2	23.1	11.8	21.0	10.3	13.7	13.8	12.6	10.8	12.8	12.6	12.3	16.4	18.4	15.6	14.3	43.8	16.4	7.8	13.3	21.3	26.4	19.2	22.7	15.6	13.0	29.4	8.2	11.3	9.7	25.8	12.5	12.6	20.0	14.3	13.4	8.8	15.9	16.8	24.9	9.8	17.6	14.4	20.6	18.9	25.5	27.4	22.4	15.4	11.2	19.5	21.0	17.9	34.2	19.5	9.8	20.9	27.6	12.6	27.6	28.4	10.5	9.0	17.0	5.9	13.2	11.4	20.8	42.0	15.2	18.6	13.4	27.4	11.2	7.3	13.6	14.4	18.8	21.6	16.8	15.8	13.5	20.4	23.1	21.1	4.9	12.2	14.8	15.4	15.0	11.8	13.1	14.1	16.4	19.1	13.0	13.4	12.5	16.7	18.5	10.6	20.8	20.0	45.2	114.9	83.8	27.3	45.1	15.3	44.2	47.8	27.9	13.7	57.1	44.7	44.7	22.0	33.0	12.7	0.0	29.3	34.7	35.1	33.3	46.1	46.1	28.0	20.6	34.3	28.8	19.4	6.3	34.5	28.4	13.5	36.9	26.7	27.5	31.9	14.0	35.3	55.3	29.1	32.3	41.5	61.4	51.3	91.8	54.8	41.7	40.3	115.3
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574095-101594437	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	27.9	30.4	40.0	25.8	48.5	30.7	34.0	48.6	40.2	33.8	32.2	25.0	25.0	24.1	34.1	34.4	30.5	28.3	25.5	35.6	35.1	36.9	32.0	29.7	29.0	32.2	41.1	35.7	45.9	25.2	34.6	32.9	30.7	39.8	36.9	28.6	26.8	25.4	32.8	37.2	24.1	22.8	48.6	32.3	24.3	24.8	17.8	38.0	25.1	38.7	22.4	34.6	40.1	44.3	19.8	15.8	31.0	22.1	23.6	22.9	25.6	39.0	21.5	30.6	24.4	28.8	41.5	34.4	27.0	36.0	27.6	31.3	25.7	21.5	41.5	20.0	28.8	27.4	21.2	41.0	34.3	58.1	30.0	23.3	44.6	26.7	30.7	21.5	40.9	21.7	24.4	33.7	23.3	31.2	39.3	38.1	18.4	41.6	24.4	33.9	16.5	35.1	34.6	49.6	31.9	34.6	20.6	28.8	31.5	36.5	23.1	41.2	32.5	25.1	24.7	36.0	36.3	22.6	31.1	24.4	25.4	35.3	13.2	28.5	18.5	28.6	50.9	25.4	43.7	31.3	31.0	15.1	24.7	15.6	17.7	20.3	19.8	20.5	18.9	15.8	16.0	21.1	19.4	13.7	23.6	22.1	12.5	22.9	25.6	40.0	48.5	48.6	40.2	35.1	36.9	41.1	35.7	39.8	38.0	56.6	85.6	123.1	198.8	206.6	88.0	104.4	40.8	76.3	75.1	61.1	37.3	103.3	225.5	110.5	19.7	119.3	36.9	93.5	83.2	165.8	133.0	159.9	99.4	48.4	81.1	92.2	78.6	69.3	77.9	9.6	121.1	124.6	237.8	140.7	62.5	68.0	98.5	63.1	126.6	113.9	66.7	129.4	228.9	90.0	72.4	208.4	197.3	140.2	67.4	167.6
ZBTB11	"ZNF-U69274, ZNF913"	ENSG00000066422	"Zinc finger and BTB domain containing 11"	O95625	3	101648889-101677495	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015328, HPA024138"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015328: AB_1858938, HPA024138: AB_1858939"	"unprognostic (3.25e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.86e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.09e-1)"	11.6	11.0	14.8	14.8	16.5	44.0	13.7	21.9	16.0	14.1	11.9	8.5	8.4	11.4	13.6	10.4	14.1	10.9	10.5	9.1	12.3	12.4	10.5	12.9	14.2	16.6	11.2	12.9	15.0	16.4	19.1	14.3	14.2	14.3	13.0	10.8	7.1	15.2	13.2	16.2	16.6	12.7	12.3	13.5	16.6	11.7	13.7	13.6	28.7	13.6	10.2	16.4	14.4	22.3	6.8	8.0	9.6	11.6	5.2	9.0	4.6	9.8	11.0	7.3	9.7	11.4	11.2	12.8	9.7	9.4	8.8	9.7	9.9	6.8	11.9	7.9	7.2	8.1	12.2	10.8	10.8	15.8	12.4	7.7	26.5	10.2	9.1	8.8	18.6	9.7	9.0	14.0	8.1	18.9	8.0	8.6	13.8	15.1	14.6	9.4	12.0	16.3	8.3	6.9	10.4	16.3	13.4	11.4	14.4	8.2	11.7	21.4	7.9	12.5	10.3	12.8	4.8	13.1	10.2	9.8	13.6	10.1	5.6	9.6	16.8	13.9	22.3	8.5	12.3	9.6	9.6	6.3	7.0	6.8	8.2	9.0	5.4	5.8	7.5	8.0	6.8	6.8	5.6	4.3	5.2	11.6	4.8	6.3	4.6	14.8	16.5	21.9	16.0	12.3	12.4	11.2	12.9	14.3	13.6	29.8	14.4	13.7	18.0	41.2	12.0	10.8	12.7	24.1	26.1	1.8	31.4	8.2	0.0	5.5	2.6	16.7	9.1	0.0	4.8	6.6	21.6	14.6	8.1	8.9	6.8	20.6	19.4	15.4	25.9	2.3	7.8	20.4	18.6	8.2	10.2	11.7	6.7	3.5	13.4	4.8	22.8	6.5	16.2	16.1	19.3	42.9	14.1	22.4	9.5	20.4
RPL24	L24	ENSG00000114391	"Ribosomal protein L24"	P83731	3	101681091-101686782	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA051653	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		19000	"Endoplasmic reticulum, Cytosol"		"HPA051653: AB_2681564"	"unprognostic (7.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.08e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (5.37e-2)"	61.3	58.9	60.6	99.3	68.8	87.9	135.5	73.0	90.1	94.7	64.0	15.8	84.3	49.6	74.2	98.0	75.5	65.4	82.9	110.0	45.6	43.8	58.3	70.3	122.0	256.0	50.7	46.3	174.7	211.4	25.9	65.5	68.2	53.4	69.0	54.7	30.4	133.9	109.9	175.9	66.2	46.2	98.7	80.7	51.4	60.5	30.2	44.1	61.3	84.7	134.3	71.7	105.1	175.4	128.2	107.7	29.6	65.6	85.5	173.8	214.1	165.3	55.0	84.4	93.1	92.6	165.8	127.7	95.3	106.6	129.0	94.5	109.4	73.3	182.5	118.4	72.9	51.6	88.1	97.7	118.2	129.2	97.8	98.0	108.2	47.8	81.8	91.0	121.6	57.3	160.9	151.6	81.1	145.0	127.7	109.1	88.3	99.0	91.1	118.6	110.6	129.7	186.4	151.8	150.8	119.5	114.4	83.3	174.3	131.6	73.9	180.7	84.0	49.7	89.3	211.5	75.5	109.1	223.9	79.7	56.3	104.4	30.7	115.9	80.1	102.2	319.2	75.4	128.8	94.2	29.6	65.6	16.3	86.1	57.1	125.2	128.2	136.4	104.2	90.5	127.0	173.8	132.3	10.9	85.5	56.9	107.7	121.1	214.1	60.6	68.8	73.0	90.1	45.6	43.8	50.7	46.3	53.4	44.1	881.4	1070.5	2163.1	2834.4	2028.6	247.2	305.0	1187.2	758.8	1325.1	579.3	80.5	1779.8	1921.5	1279.6	726.1	1676.7	912.8	607.3	2525.7	2622.3	1595.4	2203.5	1283.3	1194.7	1386.3	111.2	1311.9	1225.8	1564.2	477.7	2781.1	1768.0	1307.5	1765.6	1777.1	437.9	2399.6	1553.6	1411.5	2120.0	319.1	860.2	1451.3	472.4	280.9	2033.8	1958.3	1532.8	2167.1	2738.5
CEP97	"FLJ23047, LRRIQ2"	ENSG00000182504	"Centrosomal protein 97"	Q8IW35	3	101723925-101770562	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 46.8;Spermatocytes: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002980	Uncertain		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	Cytosol	"HPA002980: AB_1848820"	"unprognostic (7.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.05e-1)"	3.8	4.3	7.5	5.2	11.8	6.6	4.1	15.2	11.8	4.5	3.9	12.1	3.6	2.5	5.7	4.1	3.8	8.7	3.5	3.5	7.9	4.9	3.5	2.9	3.7	6.5	15.3	7.0	5.4	3.1	10.2	9.9	4.1	12.8	3.9	3.7	3.0	4.1	3.6	4.8	4.1	3.9	6.6	8.1	4.3	3.5	20.0	14.8	10.8	5.3	1.7	6.8	4.7	4.1	2.7	1.3	5.1	1.1	0.9	2.5	0.8	9.4	5.6	9.6	7.0	5.4	4.2	2.9	10.3	7.2	7.9	9.8	2.4	4.5	8.2	4.7	5.7	6.3	6.5	7.2	5.6	13.5	9.1	3.5	4.7	6.2	1.7	2.6	5.9	7.4	2.5	4.5	6.8	5.8	4.1	4.3	8.4	3.8	14.9	9.7	2.8	9.7	3.0	3.4	3.3	7.5	7.1	13.4	5.6	2.6	3.7	18.5	7.6	5.5	3.5	4.9	5.3	6.1	5.1	4.4	10.8	8.0	3.2	7.4	9.4	8.5	14.9	4.4	5.4	10.6	5.1	0.4	1.9	2.2	0.1	1.8	2.7	1.9	1.3	0.5	1.7	1.3	1.1	3.1	0.9	1.1	1.3	2.5	0.8	7.5	11.8	15.2	11.8	7.9	4.9	15.3	7.0	12.8	14.8	3.0	3.8	2.2	2.1	4.1	12.6	5.9	5.1	46.8	12.5	1.8	11.8	3.0	3.3	4.0	15.4	4.4	0.9	0.0	1.8	2.4	5.6	2.2	9.2	3.6	2.3	17.5	4.1	4.3	3.5	5.6	7.2	1.1	8.5	2.8	3.4	21.1	3.1	0.0	7.1	2.5	13.4	12.9	5.9	30.7	8.3	3.1	1.6	4.5	3.3	1.0
NXPE3	"FAM55C, MGC15606"	ENSG00000144815	"Neurexophilin and PC-esterase domain family member 3"	Q969Y0	3	101779202-101827392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.6"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 37.8;Horizontal cells: 46.1;Ito cells: 40.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036259	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA		7600	Vesicles	Nucleoplasm	"HPA036259: AB_10671838"	"unprognostic (3.30e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-5)"	"unprognostic (4.98e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (2.89e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.75e-3)"	6.1	4.7	7.2	7.6	16.6	7.8	5.3	6.1	16.2	6.3	5.2	29.5	6.0	2.4	7.9	2.6	4.5	8.2	4.8	12.6	9.8	5.9	3.0	2.5	6.9	10.7	24.0	8.6	5.5	2.6	15.8	6.9	4.7	22.0	6.2	3.4	3.4	4.2	7.5	44.6	2.5	4.9	7.6	9.4	8.7	4.6	5.1	17.2	6.6	5.3	4.1	9.8	7.3	5.0	8.9	11.6	15.9	13.6	6.7	19.5	11.1	7.8	12.0	10.4	3.7	11.2	11.7	2.3	8.7	11.1	10.5	15.3	2.8	0.8	11.5	25.8	9.8	12.7	1.7	11.5	9.4	13.0	14.3	3.6	8.9	7.6	7.4	14.8	7.5	8.3	6.7	1.6	8.7	3.2	13.7	11.3	11.2	1.8	37.8	17.3	4.1	10.0	1.8	5.9	0.4	7.4	4.6	12.6	4.9	7.7	2.0	8.2	9.8	3.7	0.9	6.5	6.5	1.7	10.8	9.8	11.7	13.9	1.3	9.0	18.0	17.8	13.6	10.0	33.3	2.2	6.3	13.6	15.9	12.7	10.4	8.8	8.9	14.2	13.2	11.6	5.8	19.5	15.5	6.9	6.7	9.9	7.4	16.3	11.1	7.2	16.6	6.1	16.2	9.8	5.9	24.0	8.6	22.0	17.2	23.8	6.1	9.7	1.9	3.3	23.7	37.8	5.1	2.7	3.4	0.0	7.9	0.7	0.0	2.6	1.0	11.7	0.0	0.0	2.2	1.2	7.8	0.8	12.7	1.6	6.3	46.1	6.9	40.5	18.4	1.3	8.6	9.5	6.8	10.8	0.5	22.7	2.0	0.0	7.1	0.5	15.7	19.4	7.6	9.3	15.2	2.6	0.6	10.9	0.4	1.0
NFKBIZ	"FLJ34463, INAP, MAIL"	ENSG00000144802	"NFKB inhibitor zeta"	Q9BYH8	3	101827991-101861022	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.9"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 368.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 20.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.8;monocytes: 20.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.5;RPTEC TERT1: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010547, HPA075363"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA010547: AB_1854442, HPA075363: AB_2686745"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (2.69e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.52e-3)"	26.4	4.4	2.2	35.5	3.4	116.9	46.9	2.4	2.0	17.4	23.7	3.6	5.5	16.8	21.3	13.0	22.1	39.5	31.5	17.3	2.8	1.9	13.8	26.8	29.6	21.3	4.4	0.3	18.2	15.7	2.4	7.2	18.8	5.0	16.3	10.4	10.9	37.4	8.1	9.8	21.0	18.5	17.9	5.2	21.5	16.8	7.1	3.3	3.3	26.5	30.8	23.8	18.7	20.0	3.2	3.8	15.8	20.0	0.5	4.1	1.1	2.8	2.2	1.5	1.9	4.4	7.7	2.4	11.4	31.5	5.1	4.8	2.7	3.4	5.2	14.6	3.1	15.7	9.0	1.1	4.9	13.1	15.3	1.0	5.0	3.9	1.4	6.9	0.3	0.3	5.3	7.7	13.5	6.2	12.5	3.7	0.2	0.8	10.9	7.2	3.5	0.1	2.9	2.6	0.9	6.7	0.6	6.9	0.7	31.5	18.4	0.7	0.9	1.9	2.3	12.2	3.4	2.8	2.1	4.7	8.2	8.2	3.0	3.7	9.2	3.2	3.6	14.9	1.0	1.1	4.9	3.6	1.0	1.0	8.3	1.1	1.9	1.4	1.0	2.4	3.2	4.1	2.7	15.8	0.5	20.0	3.8	0.7	1.1	2.2	3.4	2.4	2.0	2.8	1.9	4.4	0.3	5.0	3.3	80.4	236.3	41.4	30.7	250.1	8.8	17.3	45.9	72.3	110.3	62.8	2.0	14.6	0.0	152.4	3.7	112.8	123.3	0.0	113.5	33.8	98.5	56.9	368.8	58.2	52.3	9.5	70.7	47.9	91.7	1.1	18.7	186.1	67.4	68.5	64.5	19.2	152.1	109.7	0.7	1.9	7.4	19.4	108.2	0.0	0.6	220.1	21.4	55.3	73.5	38.8
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;gallbladder: 6.7;kidney: 2.6"	"Cell type enhanced"	"Detected in some"	18	"Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 3.0"	"Cell line enriched"	"Detected in some"	8	"RPTEC TERT1: 12.4"	"Region enriched"	"Detected in single"	7	"olfactory region: 3.4"	"Low region specificity"	"Detected in all"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA077519: AB_2732349"	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5			2.5	1.0	0.0	0.0	0.2	6.7	0.3	0.0	0.6	2.6	0.3	0.0	0.0	0.3		0.7	0.2	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.1	1.9			0.0		0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	1.3	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	12.4	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 122.5"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 684.9;Ciliated cells: 364.1;Club cells: 315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 20.7"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.7"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 64.5;U-138 MG: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced				"Intracellular and membrane"	NA	NA		1800000000			"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	16.6	14.1	23.6	5.2	31.1	4.2	34.2	4.2	25.3	12.9	8.2	25.0	13.9	7.2	7.0	15.4	4.0	20.6	9.9	4.7	23.2	24.3	9.6	19.4	29.6	4.2	45.1	19.7	24.6	15.3	122.5	11.9	5.3	31.5	14.0	6.6	3.0	17.9	17.5	0.9	5.9	7.3	10.8	35.3	3.0	14.2	2.3	43.8	2.2	25.6	2.7	6.2	9.9	5.5	3.5	20.7	3.7	3.2	0.4	1.6	2.0	38.3	14.8	10.6	5.4	16.2	7.1	0.1	31.4	18.4	20.3	28.5	0.1	8.0	2.7	13.1	44.2	11.2	29.8	1.7	25.0	60.1	2.5	2.6	0.3	11.3	0.7	18.2	15.6	0.1	12.6	18.6	25.9	64.5	56.7	22.2	2.8	0.0	4.6	26.6	2.6	2.2	5.7	2.2	12.4	16.8	1.4	0.9	0.1	30.8	4.3	7.7	21.5	3.2	3.1	2.0	4.4	6.0	10.3	46.1	77.7	26.5	3.3	37.2	0.0	0.0	0.2	17.7	3.3	33.2	0.0	3.2	2.4	0.4	1.5	1.4	3.5	1.1	0.7	20.7	2.2	0.2	0.2	3.7	0.4	0.8	7.4	1.6	2.0	23.6	31.1	4.2	24.6	23.2	24.3	45.1	19.7	31.5	43.8	684.9	108.8	7.2	17.0	10.8	3.0	5.6	61.1	364.1	315.1	15.7	2.0	0.6	1.7	16.4	49.7	10.5	7.5	0.0	36.7	0.6	27.3	97.5	10.5	40.4	60.4	1.6	16.1	3.7	38.7	47.9	3.4	105.6	23.6	140.7	15.0	1.3	39.9	5.8	6.0	23.3	0.5	0.0	19.6	2.1	3.4	17.7	0.7	3.2	9.8	69.3
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	38.4	9.0	3.7	19.5	4.9	15.5	16.3	24.4	3.8	13.7	18.7	5.9	7.7	9.3	13.8	12.2	8.3	12.5	13.4	27.5	3.8	4.8	7.4	6.7	16.3	19.1	4.4	1.9	17.7	6.8	3.4	13.5	25.4	7.9	12.9	8.0	11.6	9.1	6.3	10.3	8.5	13.8	25.6	5.7	16.4	12.4	9.2	5.2	11.6	13.5	7.0	18.0	24.9	24.1	5.1	3.1	2.8	2.1	10.3	9.9	1.6	1.6	2.3	7.7	3.8	8.9	9.0	5.0	5.8	2.9	1.7	2.7	2.9	2.0	3.6	4.0	3.0	2.7	2.9	1.0	1.0	2.1	2.8	2.9	2.0	12.0	1.9	13.1	1.4	1.5	8.6	3.1	4.5	12.3	6.4	5.6	3.7	2.1	11.7	3.6	2.1	2.0	0.9	2.7	2.0	3.3	4.2	2.3	0.6	4.1	7.4	6.0	6.5	6.8	0.8	8.9	5.6	1.7	2.9	3.1	23.9	2.0	3.2	1.4	6.6	0.6	5.7	6.4	1.2	1.5	0.7	1.5	2.8	9.9	0.9	8.8	2.2	5.1	5.6	1.3	5.1	4.4	8.0	1.0	10.3	2.1	3.1	5.6	1.6	3.7	4.9	24.4	3.8	3.8	4.8	4.4	1.9	7.9	5.2	14.9	6.7	21.6	6.8	9.6	44.8	39.9	0.0	10.7	6.8	12.2	25.5	8.9	5.0	6.0	27.4	22.6	8.7	0.0	6.9	53.5	21.6	9.6	8.1	6.7	12.2	3.2	12.1	39.3	11.3	9.0	6.9	10.4	15.1	5.4	16.2	7.4	11.7	7.0	10.3	3.1	27.4	6.5	19.9	9.8	15.8	6.0	38.0	52.3	10.7	3.0
CCDC54	"FLJ25362, NYD-SP17, SP17"	ENSG00000138483	"Coiled-coil domain containing 54"	Q8NEL0	3	107377194-107378637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"testis: 53.5"	"Group enriched"	"Detected in some"	156	"Early spermatids: 1268.4;Late spermatids: 2231.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	9	"B-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;SuSa: 1.2;U-138 MG: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.83e-1)"	"unprognostic (4.53e-1)"		"unprognostic (9.56e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.79e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.87e-3)"	"unprognostic (8.75e-4)"	"unprognostic (5.58e-2)"	"unprognostic (5.78e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.5	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.5	0.0	0.0	0.5	1.2	0.2	0.4	0.0	1.6	0.7	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1268.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2231.2	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	11.2	5.7	0.0	0.0	0.0	0.0	0.0
BBX	"HBP2, HSPC339, MDS001"	ENSG00000114439	"BBX, HMG-box containing"	Q8WY36	3	107522936-107811324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 761.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006049, HPA050646"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006049: AB_2667504, HPA050646: AB_2681200"	"unprognostic (7.57e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	10.6	22.6	13.1	11.0	20.6	11.2	10.8	12.8	15.1	14.3	13.2	15.4	27.8	6.7	15.1	28.3	10.2	13.2	12.7	11.5	14.8	11.6	14.9	7.3	10.8	10.4	24.5	9.0	21.0	9.0	35.7	39.6	17.8	17.5	17.4	7.3	9.1	11.8	25.1	8.5	7.5	9.4	14.0	26.7	14.1	9.6	43.9	25.5	13.5	19.3	8.0	10.1	15.9	15.6	33.7	16.3	25.2	17.5	25.2	26.1	11.4	18.6	17.3	14.9	22.3	13.3	19.4	12.2	17.7	18.3	16.1	17.9	1.9	15.2	9.7	22.2	11.2	18.4	13.0	16.7	21.5	24.4	12.5	7.8	14.5	14.0	4.1	15.8	19.9	9.0	16.2	15.8	16.2	32.6	22.7	13.5	11.7	6.7	14.6	13.6	6.2	11.2	2.0	7.3	0.2	14.7	15.9	14.1	11.0	10.2	14.1	10.7	10.9	31.3	3.1	15.4	16.0	12.4	4.5	17.7	19.8	14.7	7.3	12.6	6.2	4.1	11.0	17.9	10.3	11.5	25.2	9.1	21.6	22.6	9.2	26.1	32.8	20.3	22.8	12.7	33.7	25.7	21.1	14.9	25.2	17.5	16.3	13.4	11.4	13.1	20.6	12.8	15.1	14.8	11.6	24.5	9.0	17.5	25.5	59.6	69.7	91.3	125.6	75.7	90.3	93.6	76.5	44.2	45.5	90.7	60.9	172.5	41.4	69.4	761.4	73.0	16.6	46.7	65.1	74.7	80.3	95.3	31.2	27.6	41.9	162.1	63.8	57.1	54.0	372.5	144.7	68.9	64.1	36.1	33.3	141.5	56.6	43.5	193.7	88.0	61.1	142.3	128.8	73.5	118.0	66.0	165.9	68.7	36.0	108.0
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043094-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		2000000	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (3.54e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.05e-3)"	"unprognostic (8.77e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (7.37e-2)"	"unprognostic (3.78e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (1.83e-1)"	16.2	24.3	23.0	28.8	46.5	58.0	29.0	44.0	55.5	20.5	25.7	42.5	13.4	19.8	16.2	30.4	46.7	31.7	26.0	26.7	24.1	24.4	19.1	22.1	49.6	35.1	27.4	28.8	16.2	25.7	11.5	34.8	23.3	43.6	40.2	29.0	15.7	43.8	18.9	18.1	19.3	21.2	21.0	37.7	29.0	33.4	20.6	25.0	34.4	30.1	22.0	42.5	25.1	29.1	40.1	35.6	44.1	64.4	45.1	65.3	51.7	45.7	8.2	16.6	9.4	23.8	25.6	21.9	17.3	27.1	13.5	23.1	0.4	25.9	21.0	28.1	16.6	31.0	31.4	9.2	17.5	17.6	12.4	6.3	53.5	7.7	0.7	13.8	38.1	72.3	16.4	10.7	12.9	10.4	21.0	13.3	21.8	12.6	50.0	20.0	23.5	46.3	14.3	6.9	42.7	21.0	24.6	12.2	29.7	34.2	18.3	12.6	7.8	10.3	20.5	17.5	8.8	37.1	12.5	12.8	35.0	6.4	19.6	11.7	19.4	13.1	29.5	25.5	19.1	9.6	31.7	24.7	44.1	40.2	48.1	35.0	40.1	47.0	42.0	35.6	39.2	35.4	38.3	30.1	45.1	64.4	27.7	65.3	51.7	23.0	46.5	44.0	55.5	24.1	24.4	27.4	28.8	43.6	25.0	342.4	135.6	141.2	259.6	146.8	90.6	37.8	109.5	58.9	102.4	89.0	90.3	137.8	13.3	418.5	33.5	71.3	35.8	23.3	357.7	75.9	79.2	245.6	56.6	30.2	163.7	116.0	61.4	82.9	78.2	40.6	31.7	105.3	111.3	90.2	60.0	47.2	337.0	107.2	45.6	11.9	214.8	64.7	72.9	25.2	13.2	122.5	101.4	137.1	79.7	264.1
IFT57	"ESRRBL1, FLJ10147, HIPPI, MHS4R2"	ENSG00000114446	"Intraflagellar transport 57"	Q9NWB7	3	108160812-108222570	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	DNA-binding	Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	14	"Ciliated cells: 679.9;Early spermatids: 1393.1;Late spermatids: 2088.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035514, HPA035515"	Supported		Approved	"Nuclear speckles,Mitochondria,Cytosol"		NA	NA			"Nuclear speckles"	"Mitochondria, Cytosol"	"HPA035514: AB_10601757, HPA035515: AB_10696505"	"unprognostic (1.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (2.98e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.59e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (5.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.12e-2)"	8.5	13.1	9.4	12.1	11.0	8.8	10.4	5.5	16.4	13.3	10.9	6.3	15.7	5.0	11.8	36.3	11.6	24.8	11.6	12.1	9.2	11.2	19.7	3.7	34.3	12.2	9.1	9.9	21.6	13.4	16.4	30.6	6.2	13.5	21.9	11.6	9.4	8.2	16.0	5.7	7.1	9.4	13.1	6.2	14.3	10.0	38.6	5.6	8.3	31.3	7.4	12.2	14.1	9.1	22.4	5.8	1.8	6.7	3.6	4.7	2.9	18.6	9.7	7.0	12.5	14.7	15.3	3.9	5.7	14.0	8.5	7.6	6.6	3.3	21.1	7.4	9.5	12.2	7.5	6.2	9.6	14.5	3.3	6.7	7.2	4.3	1.7	11.0	14.9	16.7	9.2	8.9	10.9	19.1	13.5	9.5	3.7	3.3	3.8	9.7	10.4	5.0	13.7	7.5	1.4	11.6	3.2	6.3	3.6	17.4	6.8	11.7	8.1	8.6	2.8	5.2	4.1	6.1	4.6	4.0	10.9	5.6	5.7	6.7	4.5	3.2	11.1	15.8	1.5	4.0	0.1	2.1	1.8	2.2	3.6	3.6	22.4	4.7	2.8	5.8	18.6	4.1	2.3	1.1	3.6	6.7	1.2	2.9	2.9	9.4	11.0	5.5	16.4	9.2	11.2	9.1	9.9	13.5	5.6	437.7	206.1	73.5	89.1	36.5	19.9	27.8	48.4	679.9	320.8	48.8	64.8	19.7	99.5	136.8	1393.1	36.5	31.6	23.3	116.3	16.0	63.9	111.6	42.8	4.9	12.7	27.0	54.9	30.7	7.3	2088.2	60.4	26.4	43.9	5.4	28.2	42.9	82.4	31.7	60.5	97.1	66.9	51.8	57.7	146.9	42.2	32.5	12.5	26.6	47.6	75.8
HHLA2	"B7-H5, B7H7, B7y"	ENSG00000114455	"HERV-H LTR-associating 2"	Q9UM44	3	108296490-108378285	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 125.2"	"Cell type enriched"	"Detected in many"	5	"Enterocytes: 168.4"	"Group enriched"	"Detected in many"	12	"colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.1;Karpas-707: 5.9"					"Low region specificity"	"Detected in all"			HPA055478	Enhanced					NA	NA					"HPA055478: AB_2682830"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.14e-5)"	"unprognostic (1.76e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-2)"	0.2	0.2	0.3	4.3	0.3	0.0	0.2	0.2	0.3	0.3	39.6	0.2	0.2	25.5	0.2	0.5	0.2	0.9	8.5	0.2	0.3	0.3	7.8	0.4	2.2	0.2	0.3	0.2	0.6	1.2	0.0	0.3	0.2	0.2	0.2	25.2	0.2	0.2	0.2	0.2	0.1	125.2	0.3	0.5	0.3	2.5	1.9	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.3	5.1	1.2	1.5	0.3	0.5	0.7	0.4	0.6	0.4	0.5	0.0	0.0	1.6	0.1	0.0	0.0	0.5	3.5	0.5	0.3	0.4	0.1	0.2	0.4	1.2	0.0	0.0	8.1	0.3	0.2	2.7	0.5	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.7	5.9	0.0	0.5	0.8	3.0	1.2	0.4	0.6	0.7	0.3	1.7	0.1	0.4	1.5	1.4	1.4	0.1	0.4	1.1	0.3	0.4	0.3	0.3	1.5	0.5	0.4	3.1	1.4	0.8	0.1	1.0	0.2	1.2	0.3	1.1	0.1	0.4	0.1	0.3	0.2	0.5	5.1	0.3	0.2	0.1	0.5	0.3	1.5	0.1	0.0	0.7	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.1	20.4	24.1	2.3	0.0	0.0	0.0	0.0	5.2	2.6	0.0	168.4	0.0	32.0	0.1	0.0	0.1	2.3	0.0	0.1	0.0	1.7	0.0	0.0	3.1	0.3	0.2	0.0	1.8	9.4	0.0	36.5	9.5	0.0	19.5	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.0	13.6	0.0
MYH15	KIAA1000	ENSG00000144821	"Myosin heavy chain 15"	Q9Y2K3	3	108380369-108529322	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.6"	"Cell type enhanced"	"Detected in some"	13	"Muller glia cells: 7.0;Rod photoreceptor cells: 5.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.4;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	13	"B-cells: 1.4;dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"GAMG: 7.9;Karpas-707: 4.1;PC-3: 8.9;SH-SY5Y: 3.2;U-87 MG: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034871, HPA057915"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA034871: AB_10669996, HPA057915: "	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.57e-2)"	0.1	0.9	2.9	0.3	2.4	0.1	0.1	1.1	4.6	0.3	1.4			1.5	0.0	1.1	0.0	0.5	0.8	1.3	2.8	2.3	0.0	0.0	1.1	0.2	3.3		0.0	0.1	0.0	1.5	0.0		0.7	1.0		0.0	0.0	0.7	1.2	2.3	0.0	3.3	0.6	0.5	1.4			0.3		0.1	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.8	1.7	0.2	0.4	0.1	0.7	0.0	0.2	0.0	7.9	0.1	0.2	0.0	1.4	0.0	0.1	0.2	0.0	0.0	0.3	2.3	0.0	0.1	0.0	0.5	0.3	0.4	0.5	0.3	0.0	4.1	2.1	0.0	0.0	0.0	0.1	0.0	8.9	0.2	0.1	0.0	0.0	0.0	0.5	3.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.8	0.9	0.0	0.9	2.2	0.3	0.0	3.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0											0.0	0.3	0.0	0.1	0.0	1.3	1.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.0	7.0	0.3	0.0	0.0	0.0	5.3	0.0	0.0	1.2	0.2	0.1	0.0	0.0	1.0	0.0
CIP2A	KIAA1524	ENSG00000163507	"Cell proliferation regulating inhibitor of protein phosphatase 2A"	Q8TCG1	3	108549869-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.5"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 8.9;Exocrine glandular cells: 6.4;Extravillous trophoblasts: 10.7;Hofbauer cells: 6.7;monocytes: 5.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes			Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	2.1	2.3	2.5	8.5	6.3	10.4	3.6	6.3	6.2	3.2	3.1	2.6	0.8	2.0	3.2	1.8	4.0	1.8	2.0	2.7	2.9	2.1	2.2	1.6	2.2	10.2	2.0	3.2	3.8	1.8	1.8	3.0	3.3	2.4	3.0	4.4	2.2	2.3	1.4	2.0	1.9	2.7	2.5	2.4	5.5	2.0	8.5	1.5	21.5	1.9	1.5	8.0	4.0	2.7	1.9	0.3	0.7	1.1	0.0	1.6	0.6	18.9	5.6	15.9	10.2	0.7	1.5	6.5	14.4	6.8	17.1	20.1	6.8	8.5	12.8	5.0	5.2	13.0	9.7	5.4	5.1	31.2	4.0	5.3	15.3	7.8	5.1	0.2	9.8	11.0	0.6	1.0	13.3	5.5	2.8	7.6	5.9	9.4	20.7	16.7	3.9	11.8	8.8	16.4	7.1	9.8	13.6	14.8	7.0	5.2	5.3	7.7	10.2	10.6	4.2	5.9	9.7	7.1	7.0	5.5	17.6	19.9	5.3	17.3	4.8	5.3	21.2	7.8	10.7	17.9	0.6	0.3	0.7	0.0	0.5	1.3	1.2	0.7	0.3	0.0	1.9	0.7	1.6	0.0	0.0	1.1	0.3	0.8	0.6	2.5	6.3	6.3	6.2	2.9	2.1	2.0	3.2	2.4	1.5	8.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.5	3.5	0.0	2.5	1.7	2.4	0.0	0.0	0.0	0.0	6.4	10.7	0.0	0.0	3.5	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0
DZIP3	"hRUL138, PPP1R66"	ENSG00000198919	"DAZ interacting zinc finger protein 3"	Q86Y13	3	108589682-108694846	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 57.4"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 183.4;Cone photoreceptor cells: 308.3;Spermatocytes: 314.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035066, HPA049232"	Approved		Approved	Vesicles		No	No			Vesicles		"HPA035066: AB_10601549, HPA049232: AB_2680684"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.38e-2)"	"prognostic favorable (3.65e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.51e-3)"	"unprognostic (3.81e-2)"	4.6	9.3	14.1	4.5	25.7	3.1	5.0	14.5	23.7	5.2	4.4	5.8	2.1	2.8	7.4	9.7	3.8	17.4	5.4	10.8	13.2	18.5	10.5	3.9	6.0	8.4	10.3	16.0	10.3	4.9	10.3	57.4	4.5	20.3	9.2	4.5	4.0	3.3	7.0	10.1	3.4	3.6	7.9	9.2	7.0	6.0	29.9	8.0	10.4	12.0	2.8	7.0	5.0	3.5	6.8	1.8	5.2	1.6	11.7	6.5	1.8	6.5	6.0	17.0	10.2	7.6	7.9	5.8	4.1	8.2	6.9	9.4	8.3	4.5	11.8	8.9	4.4	14.9	2.4	9.7	3.5	14.7	4.3	4.1	5.4	2.2	5.7	4.5	2.1	3.1	8.2	1.9	6.4	8.0	7.1	4.3	7.6	5.1	5.8	13.1	5.9	5.3	2.3	10.4	3.4	4.3	6.8	14.0	1.1	5.8	3.2	11.5	11.0	6.9	0.7	7.4	16.0	10.2	1.8	4.9	6.2	9.5	1.2	3.6	6.7	3.8	23.0	4.7	1.7	7.5	5.2	0.7	1.4	5.0	1.0	6.0	6.8	5.1	6.1	0.6	6.0	4.5	6.0	0.1	11.7	1.6	1.8	6.5	1.8	14.1	25.7	14.5	23.7	13.2	18.5	10.3	16.0	20.3	8.0	11.9	13.8	8.3	8.5	6.6	67.2	33.6	2.5	183.4	29.6	31.4	308.3	19.8	11.6	8.1	23.6	8.2	3.9	0.0	8.1	7.3	13.9	8.8	8.1	3.6	7.8	73.1	50.7	6.7	7.3	46.6	16.1	6.2	6.8	14.4	6.1	33.9	8.4	3.5	16.6	15.3	32.1	19.4	9.2	314.4	93.7	6.5	12.4	18.5	6.3	4.3
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 71.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 1.9;Intestinal endocrine cells: 1.7;Late spermatids: 3.5;Mucus-secreting cells: 4.5"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 6.6"					"Not detected"	"Not detected"			HPA049152	Enhanced				"Secreted to blood"	NA	NA	123000				"HPA049152: AB_2680655"			"prognostic favorable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.1	7.0	0.1	0.0	0.1	0.1	0.1	0.1	20.6	0.1	0.1	4.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	71.9	0.1	0.1	0.1	0.1	0.0	24.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822698-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"blood: 57.9;lymphoid tissue: 128.9"	"Cell type enriched"	"Detected in some"	10	"T-cells: 74.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 57.9"	"Group enriched"	"Detected in many"	160	"granulocytes: 53.1;T-cells: 57.9"	"Group enriched"	"Detected in some"	23	"JURKAT: 16.4;MOLT-4: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		NA	NA			"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	2.6	0.3	0.2	8.2	0.2	1.8	1.3	0.2	0.3	0.8	1.0	0.1	0.1	0.9	0.7	0.3	0.9	0.8	1.9	0.7	0.2	0.2	1.1	1.0	4.0	17.8	0.2	0.2	0.5	0.5	0.0	0.4	0.3	0.3	1.1	1.0	0.1	1.9	0.3	0.4	1.0	5.5	0.2	0.3	9.0	1.6	0.5	0.1	128.9	1.1	1.0	9.8	2.8	1.1	0.1	0.1	53.1	0.1	0.3	57.9	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	1.1	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.1	0.1	0.0	10.5	0.0	21.2	0.1	42.1	21.6	0.0	0.0	57.9	14.2	0.6	0.3	0.1	0.1	17.9	22.9	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.1	0.0	5.6	0.9	0.1	7.4	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	2.3	0.6	0.2	0.0	0.0	1.8	0.0	1.4	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	6.9	0.1	74.0	0.0	0.0
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953895	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"heart muscle: 10.2;pancreas: 31.0;retina: 15.7"	"Cell type enriched"	"Detected in some"	6	"Cone photoreceptor cells: 117.8"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	84	"RPTEC TERT1: 18.0"									HPA041597	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.7	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.7	31.0	0.0	0.2	0.0	0.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.0	0.0	2.8	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.7	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	7.4	5.5	0.0	0.0	0.0	0.0	117.8	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	8.2	0.5	0.0	0.0	0.0	19.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
MORC1	"CT33, MORC, ZCW6"	ENSG00000114487	"MORC family CW-type zinc finger 1"	Q86VD1	3	108958239-109118142	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 21.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 45.5;Late spermatids: 21.8;Spermatocytes: 37.7;Spermatogonia: 41.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"	"Group enriched"	"Detected in some"	10	"Karpas-707: 4.4;RPMI-8226: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036413	Enhanced					NA	NA					"HPA036413: AB_10669989"					"unprognostic (1.66e-1)"				"unprognostic (4.30e-2)"	"unprognostic (2.17e-2)"		"unprognostic (2.63e-1)"	"unprognostic (7.45e-6)"	"unprognostic (4.80e-2)"	"unprognostic (2.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	2.2	21.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	37.7	41.6	0.0	0.0	0.0	0.0	0.1
C3orf85	FLJ22763	ENSG00000241224	"Chromosome 3 open reading frame 85"		3	109118252-109150514	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	5	"intestine: 50.1"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 108.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;CACO-2: 5.0;RPMI-8226: 1.5;SH-SY5Y: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA								"unprognostic (9.10e-2)"				"unprognostic (9.48e-3)"						"unprognostic (3.80e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.70e-2)"			0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	36.2	0.0	0.6	0.0	0.0	0.0	0.4	0.0		6.8	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DPPA2	"CT100, PESCRG1"	ENSG00000163530	"Developmental pluripotency associated 2"	Q7Z7J5	3	109293788-109316517	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 4.9;testis: 9.0"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 2.7;Extravillous trophoblasts: 9.2"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 35.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Group enriched"	"Detected in some"	5	"BEWO: 7.6;EFO-21: 14.5;SuSa: 8.7"									HPA036134	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036134: AB_10601547"				"unprognostic (2.23e-1)"						"unprognostic (2.79e-1)"				"unprognostic (1.81e-2)"	"unprognostic (3.50e-2)"			0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.5	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	8.7	0.5	0.1	0.1	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.3;lymphoid tissue: 35.8"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 18.3;Extravillous trophoblasts: 16.9;Syncytiotrophoblasts: 5.1"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 10.3"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 10.3"	"Group enriched"	"Detected in some"	4	"HAP1: 22.5;NTERA-2: 83.0;SuSa: 32.3"									"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.1	0.1	0.2	0.3	1.0	8.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.1	0.2	1.3	0.6	0.8	0.3	0.0	0.0	0.0	0.0	2.2	4.2	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	8.1	0.0	35.8	0.1	0.0	1.0	0.4	0.1	0.9	10.3	0.0	0.0	0.7	0.2	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.7	0.0	10.3	0.0	0.1	0.2	1.0	0.1	0.3	0.6	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.4	1.2	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.3	0.2	1.1	1.0	1.4	0.0	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	2.1	0.0	5.1	0.7	0.0	0.3
NECTIN3	"CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3"	ENSG00000177707	"Nectin cell adhesion molecule 3"	Q9NQS3	3	111070071-111275563	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 94.2"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"AF22: 33.5;TIME: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009869, HPA011038"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		20000000	Cytosol	"Cell Junctions"	"CAB009869: AB_2284699, HPA011038: AB_1079719"	"unprognostic (3.76e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.77e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.04e-2)"	"prognostic favorable (9.82e-7)"	"unprognostic (2.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.05e-1)"	5.6	4.0	5.4	4.4	6.0	0.0	4.5	1.3	8.9	4.6	12.6	6.5	2.8	17.8	5.0	2.2	3.5	5.4	4.4	4.8	6.3	5.0	6.9	16.4	5.6	1.9	6.0	4.1	9.2	4.7	1.9	1.9	94.2	5.5	6.9	12.6	10.7	3.4	4.8	2.3	1.8	18.9	7.2	8.9	1.8	13.2	27.6	4.5	0.4	24.1	2.0	1.4	5.4	7.7	0.1	0.0	0.3	0.0	0.2	1.7	0.7	0.0	10.1	33.5	2.2	13.6	25.2	2.0	22.0	23.3	13.7	11.7	9.3	4.7	0.0	7.3	31.3	7.6	0.1	9.3	3.2	25.2	0.2	2.5	0.0	3.6	0.7	23.0	1.6	0.3	12.7	1.4	9.0	8.7	12.3	11.5	0.4	0.0	8.8	29.5	0.0	2.2	0.0	9.4	3.1	3.6	0.0	16.6	0.0	8.5	5.3	0.8	6.1	0.4	0.0	4.6	11.7	0.3	0.1	47.5	17.4	7.2	3.1	13.1	4.9	0.0	0.0	11.0	0.0	16.0	0.0	0.0	0.3	0.1	0.0	1.2	0.0	1.7	1.0	0.0	0.1	0.3	0.4	0.0	0.2	0.0	0.0	0.1	0.7	5.4	6.0	1.3	8.9	6.3	5.0	6.0	4.1	5.5	4.5	23.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.7	12.2	0.0	3.3	0.0	3.9	0.0	0.0	0.0	0.0	16.4	7.6	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	13.3	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	98.1	0.0	0.0	0.0
CD96	TACTILE	ENSG00000153283	"CD96 molecule"	P40200	3	111292719-111665750	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 32.0;lymphoid tissue: 82.4"	"Cell type enriched"	"Detected in many"	6	"T-cells: 148.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 20.0;T-cells: 32.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.8;JURKAT: 7.7;MOLT-4: 29.8;RT4: 27.6;U-937: 24.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066754	Enhanced					NA	NA		37000			"HPA066754: AB_2685714"	"unprognostic (1.06e-3)"	"unprognostic (3.95e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.91e-5)"	"unprognostic (4.72e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.06e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (5.23e-5)"	5.7	0.9	0.4	18.6	0.5	8.6	3.1	0.6	0.4	2.2	7.1	0.6	0.5	3.6	1.7	1.8	3.4	2.1	3.5	1.3	0.4	0.5	2.3	2.7	9.7	21.9	1.5	0.2	1.4	0.8	0.0	1.1	1.1	1.0	2.6	3.7	2.5	4.0	1.6	0.6	1.3	13.4	1.4	2.0	14.2	3.5	1.0	0.4	82.4	4.8	2.3	23.9	9.9	3.2	5.5	0.1	3.8	0.2	20.0	32.0	11.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	6.8	0.1	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.6	0.0	7.7	0.1	0.9	0.0	0.0	29.8	0.1	0.3	0.0	0.0	0.0	0.9	0.2	0.2	27.6	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	2.7	0.8	0.0	0.1	24.7	5.3	0.5	0.1	3.8	20.2	0.0	32.0	2.8	18.6	23.5	0.1	5.5	19.4	23.6	0.8	20.0	0.2	0.1	11.8	11.2	0.4	0.5	0.6	0.4	0.4	0.5	1.5	0.2	1.0	0.4	17.9	24.2	7.5	0.6	2.9	1.6	0.8	0.0	2.7	17.0	1.8	0.0	0.5	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.1	2.8	0.3	15.1	0.8	0.2	0.0	0.0	0.6	5.1	0.0	0.3	2.5	3.3	0.0	0.0	0.2	0.0	0.2	0.0	0.5	2.2	0.0	0.9	0.5	0.4	2.8	1.6	148.1	0.0	0.4
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595443	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 21.0;thyroid gland: 74.5"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 41.7"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.4"	"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.0;T-cells: 2.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.1	0.9	1.4	0.0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0.0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0.0	0.4	4.0	0.1	0.1	0.0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21.0	74.5	7.5	7.4	0.2	6.2	4.0	0.0	0.1	0.0	0.5	2.5	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.1	14.0	0.0	0.0	19.4	0.0	43.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	3.6	0.6	0.3	0.0	4.0	1.9	2.5	0.1	0.5	0.0	0.0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	41.7	1.4	0.0	0.2	3.9	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.7	0.0	0.1
PLCXD2	FLJ31579	ENSG00000240891	"Phosphatidylinositol specific phospholipase C X domain containing 2"	Q0VAA5	3	111674676-111846447	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 16.0"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 57.6;Distal tubular cells: 135.9;Hepatocytes: 132.8;Proximal tubular cells: 94.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055947	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055947: AB_2682981"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.23e-7)"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (2.99e-4)"	1.5	1.0	1.9	3.4	5.8	9.6	1.2	5.8	10.9	1.6	2.8	0.4	0.0	6.1	1.0	0.6	1.8	1.2	1.9	1.5	3.6	2.5	2.5	4.1	2.0	5.9	2.9	6.8	1.1	2.3	0.4	4.1	16.0	10.3	1.5	3.6	4.1	2.0	0.7	1.2	1.5	5.9	0.9	2.9	3.5	2.1	4.2	1.1	3.1	3.2	0.5	4.8	1.9	1.6	0.9	7.2	0.6	0.0	2.1	3.6	0.6	3.0	2.7	2.6	1.2	0.1	0.1	0.8	5.3	2.5	5.0	4.4	1.9	1.5	2.2	2.7	0.2	1.6	7.5	1.1	5.1	9.7	0.6	1.3	0.5	5.0	1.7	0.4	0.7	2.6	0.0	1.0	1.6	3.0	4.7	2.8	2.9	0.1	5.4	0.6	0.3	1.5	0.5	0.9	2.0	6.8	1.4	3.8	2.0	2.4	3.1	0.6	4.6	1.1	0.7	1.1	3.1	0.4	0.2	2.6	1.1	6.8	0.5	1.0	6.5	0.9	0.4	0.5	0.4	0.3	0.6	0.0	0.0	3.6	0.0	3.5	0.5	1.9	3.5	0.3	0.9	0.9	2.0	0.2	2.1	0.0	7.2	1.7	0.6	1.9	5.8	5.8	10.9	3.6	2.5	2.9	6.8	10.3	1.1	17.9	2.1	0.5	6.9	0.1	0.7	1.9	28.1	0.0	1.2	57.6	3.9	0.0	135.9	36.1	11.5	0.0	1.3	0.0	43.6	0.0	0.1	3.8	0.0	132.8	0.0	6.4	24.1	0.0	1.6	8.9	0.3	0.0	0.0	0.0	4.9	0.0	45.8	0.0	0.4	94.0	3.7	0.0	0.0	0.5	0.4	0.1	0.0	2.2	1.1	12.2
PHLDB2	"FLJ21791, LL5b, LL5beta"	ENSG00000144824	"Pleckstrin homology like domain family B member 2"	Q86SQ0	3	111732497-111976517	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 104.0"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 138.6;Basal keratinocytes: 222.0;Smooth muscle cells: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 32.4;HaCaT: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035146, HPA035147"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035146: AB_10600927, HPA035147: AB_2674492"	"unprognostic (2.83e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.53e-1)"	"prognostic favorable (7.03e-8)"	"unprognostic (3.24e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.83e-1)"	15.5	3.8	1.3	13.2	1.9	0.4	9.9	1.6	2.9	13.9	22.8	1.4	8.4	2.8	17.4	10.1	10.7	10.7	9.1	21.7	1.3	1.2	36.6	24.6	14.4	2.2	2.1	1.9	8.5	6.4	0.9	5.3	104.0	7.1	16.7	4.4	6.9	7.0	14.3	6.0	5.8	6.5	49.3	2.4	7.9	11.4	4.3	0.4	1.7	5.9	6.8	2.3	33.8	17.8	1.0	1.0	0.4	0.1	1.7	5.6	1.3	32.4	3.6	20.4	0.0	6.6	10.9	8.4	18.8	9.2	12.5	14.8	10.2	2.4	0.0	19.8	7.2	12.6	33.8	0.3	12.1	22.8	0.5	0.4	0.0	8.7	3.3	7.2	0.0	0.1	12.8	7.2	8.6	16.0	14.1	20.0	0.3	0.0	0.1	3.7	0.0	1.3	0.0	8.2	0.3	6.3	2.8	26.3	0.0	7.4	7.8	0.5	1.5	18.5	0.3	1.9	11.7	0.6	0.1	17.4	3.4	28.6	9.0	4.5	1.7	0.0	0.0	3.4	0.0	6.4	0.2	0.0	0.0	5.2	0.0	3.7	0.4	3.6	5.6	0.1	1.0	0.0	2.3	0.4	1.7	0.1	1.0	0.8	1.3	1.3	1.9	1.6	2.9	1.3	1.2	2.1	1.9	7.1	0.4	74.5	9.8	2.4	138.6	222.0	0.1	94.0	25.5	5.3	12.5	31.4	2.0	21.1	19.9	56.7	10.2	32.4	0.0	0.0	17.6	42.7	33.9	48.7	6.9	28.4	3.0	0.0	10.4	43.6	3.2	3.9	13.3	3.2	21.9	1.8	3.4	0.0	37.0	0.0	21.2	28.0	0.3	12.9	129.6	0.3	2.1	100.2	55.8	7.0	1.4	85.9
ABHD10	FLJ11342	ENSG00000144827	"Abhydrolase domain containing 10"	Q9NUJ1	3	111979010-111993363	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036991, HPA036992, HPA066081"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No		85000	Mitochondria		"HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610"	"unprognostic (1.65e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.76e-2)"	8.5	18.3	17.5	8.1	27.5	7.6	12.4	23.2	23.2	9.9	11.3	13.7	8.6	9.4	9.4	42.4	7.0	12.5	8.4	19.8	18.6	19.6	39.1	26.6	9.7	14.0	17.0	21.6	16.8	12.1	8.8	26.1	8.8	19.1	17.1	12.3	12.6	19.8	12.0	10.4	8.2	8.6	8.9	14.8	12.4	11.6	12.6	15.1	16.6	25.3	6.7	12.6	8.7	7.9	18.3	19.7	17.7	14.8	7.8	12.7	10.8	18.7	16.3	18.0	5.9	10.4	14.0	9.7	19.9	10.5	16.4	15.8	16.8	10.9	17.0	11.2	8.3	11.2	10.4	7.9	11.0	22.5	5.7	10.0	14.0	8.0	14.5	8.3	28.0	15.1	8.5	8.3	8.4	21.2	11.3	17.5	20.4	6.4	7.3	17.9	6.3	26.4	13.1	11.7	20.9	25.9	23.9	11.5	7.8	17.0	8.2	12.1	8.9	15.9	11.6	18.5	7.4	13.0	10.3	9.8	9.8	12.6	7.0	10.3	11.7	4.1	29.0	9.9	15.4	10.4	17.7	11.8	17.5	7.4	14.8	12.7	18.3	9.3	8.4	19.7	15.9	12.0	10.5	1.8	7.8	11.6	12.5	8.8	10.8	17.5	27.5	23.2	23.2	18.6	19.6	17.0	21.6	19.1	15.1	0.0	4.5	17.1	8.5	6.3	20.8	20.0	7.6	18.7	9.1	10.4	7.9	15.2	29.9	4.3	0.7	7.5	5.3	0.0	6.9	12.2	9.4	5.4	9.2	22.5	12.6	39.7	11.6	11.6	20.8	1.9	9.8	11.2	10.1	2.8	10.9	18.9	4.7	2.9	7.1	27.8	12.6	0.0	10.7	29.6	34.3	7.2	4.6	10.9	10.5	4.2
TAGLN3	"NP22, NP25"	ENSG00000144834	"Transgelin 3"	Q9UI15	3	111998664-112013887	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 139.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 84.8;Horizontal cells: 281.3"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 39.4;RPTEC TERT1: 16.1;SCLC-21H: 21.5;SH-SY5Y: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062620	Enhanced					NA	NA					"HPA062620: AB_2684810"	"unprognostic (1.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.28e-1)"	"unprognostic (4.07e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.67e-3)"	1.7	21.9	47.3	2.4	40.6	1.5	1.6	40.2	139.0	1.5	2.7	4.6	0.0	1.9	1.6	1.5	1.6	1.6	1.7	1.7	32.9	37.9	4.2	1.5	1.8	1.6	30.5	33.2	1.6	4.6	1.6	13.5	1.5	29.8	1.7	2.9	2.3	1.5	1.7	1.5	1.6	2.2	2.2	8.3	1.5	3.7	1.6	2.7	0.0	1.8	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.0	0.2	0.0	2.8	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.5	0.0	3.5	5.4	1.0	0.0	16.1	0.0	21.5	36.3	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	40.6	40.2	65.7	32.9	37.9	30.5	33.2	29.8	2.7	0.0	0.0	0.0	0.8	0.7	84.8	0.3	0.0	10.7	2.3	5.2	7.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.1	281.3	5.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	14.5	3.6	0.0	0.0	4.7	33.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9
TMPRSS7		ENSG00000176040	"Transmembrane serine protease 7"	Q7RTY8	3	112034843-112081269	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.2;testis: 5.2"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 3.4;Ciliated cells: 10.7;Early spermatids: 3.3;Urothelial cells: 2.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.4;hTCEpi: 2.8;RT4: 1.3;U-266/70: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040630	Uncertain					NA	NA					"HPA040630: AB_10796124"	"unprognostic (4.02e-2)"	"unprognostic (9.87e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.64e-3)"		"unprognostic (6.63e-2)"		"unprognostic (2.16e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.06e-2)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.2	0.0	0.1			0.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0		0.0	0.7	0.0	0.8	0.0		0.0	0.2		0.1	0.1	0.0	0.5	0.8	0.0	0.0	0.0	1.0	5.2			0.3		0.0	0.2	0.0	0.8	0.5	2.2	0.3	0.5	0.7	0.1	0.3	0.0	0.7	0.2	0.4	0.1	0.9	0.6	0.7	0.2	0.5	0.6	0.2	0.0	0.0	0.0	0.8	1.4	0.0	0.9	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.9	0.4	0.0	0.8	0.0	0.5	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	2.2	0.3	0.7	0.2	0.2	0.1	0.6	0.3	0.2	0.0	0.8	0.7	0.2	1.7	0.5	0.2	0.5	0.2	0.1											0.0	0.0	0.0	3.4	0.5	0.0	0.3	0.0	10.7	2.3	0.0	0.0	0.3	0.0	0.2	3.3	0.0	1.4	0.0	0.2	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.7	0.0	0.1	2.6
C3orf52	"FLJ23186, TTMP"	ENSG00000114529	"Chromosome 3 open reading frame 52"	Q5BVD1	3	112086335-112131004	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 41.2"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 112.5;Glandular cells: 75.6;Syncytiotrophoblasts: 62.7;Urothelial cells: 119.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;U-698: 20.8"									"HPA007678, HPA008119, HPA011968"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826"	"unprognostic (8.86e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.49e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-6)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.59e-2)"	1.1	1.0	0.3	5.3	0.7	0.4	1.9	0.3	0.4	1.0	9.1	0.0	6.9	2.8	1.7	1.5	2.7	1.0	12.4	3.0	0.4	0.4	7.1	0.5	6.3	0.8	0.3	0.0	0.6	41.2	0.0	8.7	6.1	0.5	5.4	9.0	0.6	3.9	9.6	1.5	22.3	12.7	4.2	0.3	0.8	10.6	1.0	0.0	20.8	10.7	4.3	3.6	6.1	6.1	0.8	0.8	0.0	0.0	0.0	2.7	1.0	8.7	1.4	2.4	0.0	0.3	0.0	3.2	6.9	2.9	4.0	4.6	14.9	4.7	0.3	1.3	2.0	4.6	6.2	2.8	1.7	7.6	0.0	2.3	6.0	2.0	0.7	1.8	0.0	0.0	0.5	3.5	3.6	6.1	2.8	0.9	0.0	1.5	1.5	3.0	0.6	0.2	0.0	5.2	5.6	1.9	0.2	7.9	0.0	7.1	7.7	0.3	0.6	2.6	2.7	2.5	2.9	4.0	0.0	2.2	1.4	2.4	0.0	0.0	5.5	0.0	20.8	1.2	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.4	0.8	2.7	1.3	0.5	0.3	1.5	0.6	0.0	0.0	0.0	0.8	0.0	1.0	0.3	0.7	0.3	0.4	0.4	0.4	0.3	0.0	0.5	0.0	14.9	7.7	0.5	112.5	28.8	0.0	1.4	5.1	13.4	22.7	17.4	0.0	15.2	0.0	29.6	24.4	0.3	14.6	0.0	31.2	16.0	1.7	75.6	0.0	0.0	1.6	0.0	11.3	0.6	0.3	18.2	0.3	0.3	1.7	4.6	32.5	0.0	53.5	5.9	0.4	1.7	0.0	0.0	3.3	1.8	5.5	29.4	62.7	0.8	5.4	119.7
GCSAM	"GCET2, HGAL, MGC40441"	ENSG00000174500	"Germinal center associated signaling and motility"	Q8N6F7	3	112120841-112133305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.7;skin 1: 15.4"	"Cell type enhanced"	"Detected in some"	31	"B-cells: 9.3;monocytes: 39.7;T-cells: 10.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Daudi: 50.7;U-698: 29.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002473	Approved					NA	NA					"HPA002473: AB_1078960"	"unprognostic (8.23e-4)"	"unprognostic (1.64e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.17e-3)"	"unprognostic (9.20e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.38e-2)"	0.8	0.2	0.1	29.0	0.3	1.2	0.6	0.1	0.3	0.6	1.6	0.3	0.7	1.3	0.3	0.5	3.2	0.5	1.0	0.8	0.1	0.0	1.0	1.1	2.4	16.4	0.3	0.1	0.5	4.4	0.0	0.8	0.1	0.3	1.0	0.6	0.4	3.0	0.4	0.6	15.4	4.0	0.5	0.2	11.1	2.7	0.4	0.2	59.7	3.4	1.3	24.6	1.8	1.0	10.8	5.7	5.9	0.1	0.5	10.1	3.1	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.4	0.0	50.7	0.0	0.0	0.3	1.1	0.0	0.9	0.0	1.0	0.3	0.3	0.1	0.1	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.4	0.0	2.9	0.0	0.0	4.7	0.0	0.4	0.2	0.2	5.5	0.4	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.1	0.3	0.5	0.0	0.3	0.4	0.2	0.0	0.0	0.2	0.0	29.0	0.0	0.0	0.1	5.9	0.0	0.0	2.0	0.1	0.4	9.0	10.1	5.2	5.7	10.8	9.5	5.1	0.3	0.5	0.0	3.1	1.5	3.1	0.1	0.3	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.2	0.0	0.3	9.3	0.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	1.0	0.0	0.0	0.5	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	10.9	0.0	0.6
SLC9C1	"NHE, SLC9A10"	ENSG00000172139	"Solute carrier family 9 member C1"	Q4G0N8	3	112140887-112294258	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 25.5"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.0;HaCaT: 1.5;Karpas-707: 1.0;REH: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.21e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.25e-1)"	0.3	0.1	0.1	1.4	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.4	0.0	0.2	0.1	0.1	0.3	1.7	0.5	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.3	1.2	0.0	0.8	0.7	0.4	0.1	0.1	0.3	0.2	1.1	0.1	4.0	1.0	0.2	0.3	0.4	0.3	25.5	0.0	1.0	0.5	0.5	0.4	0.3	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.4	0.0	0.3	0.0	0.0	0.0
CD200	"MOX1, MOX2, MRC, OX-2"	ENSG00000091972	"CD200 molecule"	P41217	3	112332347-112362812	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 63.5"	"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 82.9;Intestinal endocrine cells: 36.9;Syncytiotrophoblasts: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"memory B-cell: 9.9;naive B-cell: 36.4"	"Lineage enriched"	"Detected in many"	25	"B-cells: 36.4"	"Cell line enhanced"	"Detected in some"		"AF22: 31.9;HHSteC: 11.7;NTERA-2: 19.9;REH: 17.0;SH-SY5Y: 9.8;SK-MEL-30: 11.7;WM-115: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031149	Approved					NA	NA					"HPA031149: AB_10600694"	"unprognostic (1.84e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-3)"	"unprognostic (4.97e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.22e-2)"	12.8	9.5	18.1	10.9	34.3	1.8	7.1	20.9	38.3	16.0	4.5	11.0	1.5	2.6	21.4	5.7	7.0	20.3	10.1	5.8	17.3	42.4	4.9	1.0	7.2	17.7	12.7	19.3	9.3	3.8	10.9	27.9	63.5	19.6	9.7	6.5	7.5	5.4	13.0	1.4	2.8	4.3	13.9	8.4	4.4	3.4	2.3	6.7	12.7	12.4	1.6	17.6	13.9	3.9	36.4	1.1	1.2	0.1	0.6	1.4	1.3	0.0	0.0	31.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.4	0.0	3.4	0.1	0.1	0.1	0.3	0.0	0.1	0.2	11.7	0.0	0.0	0.2	0.1	0.6	0.0	0.1	4.5	0.0	0.0	0.3	0.0	0.0	0.4	0.1	19.9	0.0	0.0	17.0	0.0	0.2	0.2	0.0	8.4	9.8	0.0	0.1	11.7	6.2	0.0	0.1	0.0	0.1	1.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	34.7	1.2	0.1	0.1	0.1	0.0	1.4	9.9	0.8	0.2	0.5	36.4	0.9	0.5	0.7	0.6	0.1	1.1	0.4	1.3	18.1	34.3	20.9	38.3	17.3	42.4	12.7	19.3	19.6	6.7	3.0	14.5	33.0	11.5	3.8	24.4	0.4	0.0	4.0	2.3	1.8	0.0	2.3	0.0	0.3	20.1	82.9	0.7	0.0	0.0	7.3	5.6	4.6	2.3	0.0	0.8	3.2	36.9	1.8	0.0	21.1	0.3	1.9	8.5	24.4	5.5	5.6	0.3	2.9	0.0	0.0	2.5	0.0	4.1	0.5	0.2	2.9	63.5	0.7	5.8	17.2
BTLA	"BTLA1, CD272"	ENSG00000186265	"B and T lymphocyte associated"	Q7Z6A9	3	112463968-112499561	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 37.2;lymphoid tissue: 30.9"	"Cell type enhanced"	"Detected in some"	26	"B-cells: 26.7;Melanocytes: 6.8;T-cells: 5.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.6;naive B-cell: 37.2"	"Lineage enriched"	"Detected in many"	4	"B-cells: 37.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.5;Daudi: 2.0;JURKAT: 1.3;U-698: 6.3"	"Not detected"	"Not detected"							"HPA047211, HPA062029"	Enhanced					NA	NA					"HPA047211: AB_2679983, HPA062029: AB_2684665"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (5.79e-4)"	"unprognostic (1.01e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.74e-6)"	"unprognostic (6.20e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.53e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-2)"	0.6	0.3	0.3	20.3	0.4	1.2	1.1	0.4	0.3	0.5	1.2	0.1	0.0	0.9	0.4	0.1	2.3	0.5	1.0	0.4	0.3	0.3	1.0	0.5	1.2	30.9	0.3	0.0	0.4	0.3	0.0	0.4	0.3	0.1	0.5	0.9	0.2	5.7	0.4	0.3	0.5	6.0	0.2	0.4	18.6	1.7	0.6	0.0	14.6	0.9	1.1	19.4	2.8	0.5	37.2	8.6	0.1	0.0	0.1	5.1	2.4	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.1	22.6	5.1	2.4	1.5	37.2	4.8	4.7	0.1	0.1	0.0	8.6	1.1	2.4	0.3	0.4	0.4	0.3	0.3	0.3	0.3	0.0	0.1	0.0	0.0	0.3	26.7	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.6	1.3	3.0	0.0	1.1	6.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	5.3	0.0	0.0
ATG3	"APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96"	ENSG00000144848	"Autophagy related 3"	Q9NT62	3	112532509-112562046	"Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 501.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037260, HPA040471"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000	"Plasma membrane, Cytosol"		"CAB037260: AB_1078236, HPA040471: AB_2677000"	"unprognostic (2.77e-2)"	"prognostic favorable (6.82e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.35e-6)"	"unprognostic (6.79e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.52e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	24.2	27.7	30.8	30.3	34.2	51.6	23.1	19.5	26.8	20.0	24.3	29.9	16.6	24.5	18.0	17.0	23.6	15.7	17.4	20.9	31.4	27.1	32.2	36.2	23.2	31.0	38.9	17.9	21.1	29.0	24.5	27.7	24.5	33.3	18.5	26.9	13.1	20.3	22.3	18.7	19.6	27.9	19.6	53.3	40.1	23.5	51.7	34.8	33.8	28.2	23.4	28.6	21.6	19.7	12.3	34.5	35.6	61.9	9.7	15.0	24.0	31.2	17.1	16.1	16.4	21.2	17.6	18.1	27.7	20.2	27.4	25.1	23.9	18.7	39.4	21.1	23.8	33.6	22.8	26.3	24.0	38.5	6.7	12.7	24.8	17.0	15.3	33.1	43.3	21.1	16.2	18.4	26.8	41.4	18.0	25.4	25.1	21.2	33.9	28.9	27.4	25.5	20.4	17.6	41.1	34.1	22.4	14.4	33.2	22.7	17.1	27.8	10.9	23.0	22.0	32.3	15.9	24.8	32.5	20.5	29.3	23.9	12.3	24.2	22.1	21.1	61.0	26.8	40.4	21.5	10.8	34.3	23.9	8.6	51.6	10.7	12.3	10.6	10.6	34.5	11.5	10.4	10.2	35.6	9.7	61.9	7.4	15.0	24.0	30.8	34.2	19.5	26.8	31.4	27.1	38.9	17.9	33.3	34.8	44.7	36.6	54.6	35.3	65.8	20.1	77.1	38.2	29.4	29.6	24.4	11.8	64.1	99.5	58.2	501.6	54.0	48.5	93.5	75.2	69.9	44.7	31.1	38.2	35.8	111.6	17.5	30.0	36.2	92.5	97.9	39.4	118.7	65.8	143.3	50.3	40.1	56.9	45.6	40.7	62.4	18.1	58.2	69.0	227.9	110.0	61.7	102.3	47.9	67.3	39.9
SLC35A5	FLJ20730	ENSG00000138459	"Solute carrier family 35 member A5"	Q9BS91	3	112561709-112585577	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035519, HPA057964"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035519: AB_10601487, HPA057964: AB_2683566"	"unprognostic (7.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.60e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.42e-1)"	13.4	17.7	19.4	11.2	22.1	4.4	13.0	14.2	24.1	15.0	13.6	32.7	9.7	14.9	15.2	15.0	13.0	13.3	13.8	9.6	22.9	22.0	18.2	18.0	12.8	12.4	37.8	19.5	16.9	12.6	17.9	17.6	17.2	27.5	14.8	14.8	14.4	11.7	13.4	5.5	8.0	15.5	14.1	42.9	12.7	12.5	15.4	26.6	11.6	23.8	6.4	13.1	13.2	10.4	12.0	15.2	15.7	20.1	5.2	11.5	7.8	11.3	10.3	17.6	10.7	23.1	22.0	10.2	18.5	13.5	16.0	18.3	7.6	13.0	10.3	15.9	16.2	18.1	14.3	12.8	8.9	20.1	7.7	6.3	12.9	9.9	6.7	19.1	11.5	12.4	19.1	17.8	14.1	8.7	20.1	14.2	7.9	7.4	12.7	21.9	4.0	8.7	7.3	11.9	13.0	11.0	7.7	6.6	10.6	19.7	8.5	10.3	14.0	12.0	5.9	21.0	12.7	7.9	8.1	15.9	23.3	12.8	5.0	8.5	8.9	12.8	17.9	17.3	9.6	17.0	8.4	12.6	15.7	8.9	19.8	8.3	12.0	8.5	7.0	15.2	11.5	11.5	9.4	11.2	5.2	20.1	7.2	8.4	7.8	19.4	22.1	14.2	24.1	22.9	22.0	37.8	19.5	27.5	26.6	3.0	8.5	10.0	7.0	5.7	12.3	4.7	10.2	5.3	6.8	14.0	0.0	30.6	8.3	6.8	94.9	12.4	12.4	0.0	6.7	20.1	15.1	7.4	13.9	10.2	15.8	35.0	7.5	12.9	19.1	17.6	15.8	9.1	25.3	11.8	10.7	18.5	6.5	12.9	16.3	12.3	14.0	25.8	9.9	15.4	10.0	5.8	24.9	10.9	8.5	2.7
CCDC80	"DRO1, SSG1, URB"	ENSG00000091986	"Coiled-coil domain containing 80"	Q76M96	3	112596794-112649530	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 130.0;endometrium 1: 143.8"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 452.4;Fibroblasts: 524.3;Late spermatids: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.6;fHDF/TERT166: 113.6;hTERT-RPE1: 221.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002266	Approved				"Secreted to extracellular matrix"	NA	NA		57000			"HPA002266: AB_1078423"	"unprognostic (1.26e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.99e-3)"	"unprognostic (8.40e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (5.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.26e-4)"	49.5	3.3	1.4	16.4	3.1	0.0	39.4	3.1	3.3	130.0	14.9	3.4	54.7	1.1	143.8	94.7	34.2	17.4	39.7	87.6	2.3	2.8	10.7	2.1	17.0	10.1	3.0	1.0	53.3	6.6	2.5	2.7	6.0	7.2	28.6	12.7	8.7	8.7	21.7	4.1	19.2	8.6	81.3	14.0	19.8	12.0	14.0	3.3	4.1	20.4	29.6	10.8	57.3	33.8	2.9	3.0	2.9	1.3	1.3	2.1	0.2	2.2	0.9	11.6	0.5	48.6	38.7	0.6	32.1	9.7	10.8	15.8	0.2	0.1	0.1	1.2	113.6	1.0	3.0	0.4	0.4	11.4	2.1	0.1	0.0	2.6	0.0	10.2	0.0	0.0	38.2	1.3	15.9	1.0	221.6	2.5	0.0	0.0	0.1	31.8	0.0	0.0	0.0	2.8	0.0	0.3	0.0	1.2	0.0	0.3	0.0	0.0	0.2	4.7	0.2	0.1	2.2	0.1	0.0	12.6	31.8	5.2	6.0	13.9	0.1	0.0	0.1	9.4	0.0	5.1	2.9	1.3	0.9	1.6	0.8	1.6	1.7	1.6	1.3	0.5	2.9	2.1	1.9	1.7	1.3	0.8	3.0	1.1	0.2	1.4	3.1	3.1	1.7	2.3	2.8	3.0	1.0	7.2	3.3	6.0	12.8	0.0	3.8	54.1	0.6	19.6	0.0	33.5	9.1	5.2	0.0	40.0	1.7	22.1	452.4	12.8	0.0	0.0	1.1	85.3	524.3	1.2	1.1	0.5	8.3	0.0	0.0	56.4	2.7	232.6	71.4	5.8	136.7	3.6	0.4	119.7	10.8	0.0	32.5	0.0	1.7	19.4	127.8	6.0	3.2	45.2	23.3	0.0	0.0	1.7
CD200R1L	"CD200R2, CD200RLa"	ENSG00000206531	"CD200 receptor 1 like"	Q6Q8B3	3	112815709-112846856	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	85	"blood: 31.3;testis: 7.8"	"Group enriched"	"Detected in some"	28	"Early spermatids: 13.7;Late spermatids: 33.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	304	"basophil: 31.3"	"Lineage enriched"	"Detected in single"	313	"granulocytes: 31.3"	"Cell line enhanced"	"Detected in some"		"A-431: 4.0;CACO-2: 3.6;CAPAN-2: 1.3;RPMI-8226: 1.9"															NA	NA							"unprognostic (3.80e-1)"				"unprognostic (1.88e-1)"		"unprognostic (2.37e-2)"		"unprognostic (1.55e-1)"				"unprognostic (1.16e-2)"	"unprognostic (1.78e-1)"		"unprognostic (1.40e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.8			0.0		0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.9	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	33.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CD200R1	"CD200R, HCRTR2, MOX2R, OX2R"	ENSG00000163606	"CD200 receptor 1"	Q8TD46	3	112921209-112975122	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 46.7;lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in some"	11	"Erythroid cells: 23.3;granulocytes: 14.0;Hofbauer cells: 24.1;Ito cells: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 46.7;eosinophil: 12.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 46.7"	"Cell line enriched"	"Detected in some"	8	"HEL: 25.6"									HPA068512			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1500000	"Plasma membrane"		"HPA068512: AB_2732784"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-3)"	3.6	1.6	1.0	9.5	1.4	1.8	3.8	0.8	1.4	5.0	3.5	0.3	1.5	2.0	3.9	5.4	7.5	1.3	2.7	5.8	1.0	1.2	1.4	3.4	4.3	9.0	1.0	0.0	1.0	1.1	0.5	1.0	7.8	0.4	4.2	3.5	2.4	2.5	1.6	0.9	3.4	3.3	1.7	0.9	21.2	1.7	2.5	0.5	15.8	2.0	3.9	17.0	3.8	2.0	2.3	5.8	46.7	0.8	0.6	3.7	1.3	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	25.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	46.7	0.8	12.7	1.0	0.4	1.8	2.3	3.7	2.1	5.8	1.2	3.6	1.7	0.2	0.6	0.1	0.1	1.0	1.3	1.0	1.4	0.8	1.4	1.0	1.2	1.0	0.0	0.4	0.5	0.0	1.4	2.9	0.1	1.6	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	23.3	0.0	0.1	1.3	0.0	14.0	0.0	24.1	0.0	0.0	19.6	4.7	0.0	0.0	3.6	5.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.6	0.6	7.5	0.0	0.1
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990918-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA034831: AB_10671506, HPA058631: AB_2683783"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	7.5	9.3	7.4	7.3	7.8	9.5	7.3	8.5	10.1	7.1	11.9	9.2	8.3	8.0	8.3	5.2	12.2	6.4	7.4	20.0	7.6	7.6	12.2	8.2	6.2	13.2	7.6	8.3	10.4	12.1	13.0	12.1	9.3	9.5	8.2	9.3	6.6	9.6	5.2	25.3	6.5	11.8	7.4	11.7	9.3	9.1	22.7	8.9	25.4	13.4	14.3	10.2	9.6	8.0	6.7	12.2	6.7	7.0	11.9	15.8	7.8	19.6	9.0	11.9	13.4	7.3	12.6	9.5	13.6	11.8	14.0	17.5	15.8	8.5	12.9	8.0	7.5	11.3	13.5	15.8	13.1	16.1	5.7	11.1	35.3	9.0	8.2	6.9	22.5	8.7	10.0	9.4	7.7	5.5	14.5	12.8	15.2	12.4	15.3	13.4	7.7	14.3	11.0	24.5	9.9	17.1	12.2	11.0	8.2	9.8	12.4	13.8	14.0	11.0	8.7	18.1	10.7	9.8	15.3	7.7	10.2	15.1	3.7	12.7	10.0	13.1	18.0	10.2	18.7	11.2	6.7	7.0	4.5	10.4	4.6	9.1	6.7	11.9	10.0	12.2	5.9	15.8	10.3	1.0	11.9	3.9	5.8	8.2	7.8	7.4	7.8	8.5	10.1	7.6	7.6	7.6	8.3	9.5	8.9	14.9	9.6	16.3	11.9	11.9	9.3	24.2	7.6	13.4	7.9	5.2	5.9	23.6	19.9	14.6	58.0	10.3	10.5	23.3	15.9	20.5	12.6	10.8	19.6	7.2	20.3	9.5	9.8	10.4	14.5	21.7	10.9	14.2	10.1	12.6	9.7	8.9	13.4	10.2	5.3	23.1	12.2	0.0	17.5	35.6	28.1	10.7	12.7	16.7	11.9	16.1
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002440-113019861	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Club cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	15.1	12.3	12.6	12.9	19.8	15.9	15.5	22.8	21.3	14.4	12.8	15.3	11.6	12.3	15.4	19.0	12.7	12.8	13.0	14.0	13.2	12.5	12.4	10.3	11.3	19.3	14.2	13.7	14.8	16.5	13.4	18.2	12.4	15.6	12.4	9.8	11.5	13.5	15.1	28.1	18.2	13.6	16.0	17.5	17.5	14.2	19.1	12.8	21.9	20.0	16.4	15.5	17.5	10.9	3.8	3.4	2.9	3.0	7.9	6.4	2.7	10.0	8.4	13.4	10.0	4.4	8.0	7.2	9.7	6.1	5.4	3.6	7.6	6.6	13.3	5.3	3.1	7.6	10.6	9.8	4.3	7.5	2.6	6.2	20.4	7.4	5.6	8.0	12.9	7.5	12.6	7.8	4.4	11.2	14.7	4.7	13.2	6.9	10.7	3.9	6.4	11.1	7.6	13.9	8.9	10.8	9.1	10.6	6.9	6.1	8.9	9.3	13.6	5.5	7.0	15.9	10.4	8.0	11.1	9.4	7.5	7.5	2.7	6.8	10.6	8.2	15.7	12.0	10.3	5.3	2.9	2.3	2.7	4.4	3.0	4.5	3.8	5.1	3.7	3.4	3.1	6.4	6.3	1.5	7.9	1.2	2.4	2.2	2.7	12.6	19.8	22.8	21.3	13.2	12.5	14.2	13.7	15.6	12.8	8.9	10.9	0.0	0.0	0.0	0.0	0.0	0.0	16.0	19.4	17.4	0.0	15.4	14.9	12.5	0.0	0.0	0.0	0.0	11.1	12.4	0.0	0.0	16.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	16.2	0.0	0.0	12.4	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Basal keratinocytes: 18.8;Leydig cells: 78.6;Peritubular cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 31.2;ASC diff: 46.2;BJ hTERT+: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025806	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	No		4500000	"Nuclear bodies, Plasma membrane"	Nucleoplasm	"CAB025806: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.18e-5)"	19.4	4.8	5.3	10.4	8.1	0.4	21.6	4.2	6.0	26.6	23.8	5.4	10.6	3.9	25.8	25.3	19.6	33.2	14.5	20.3	13.3	2.9	4.7	1.0	3.6	3.6	5.5	2.2	26.1	12.0	1.9	12.5	1.9	26.2	21.2	3.9	45.6	17.9	17.4	4.6	25.7	9.6	35.2	36.7	3.5	11.8	9.2	7.6	1.2	13.4	12.9	4.9	28.4	25.0	1.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	2.9	11.0	31.2	46.2	2.4	0.3	5.0	16.5	1.2	1.1	0.0	0.0	0.0	3.1	8.4	0.7	0.0	2.2	1.0	0.4	0.0	1.3	0.0	1.0	0.0	0.2	0.1	0.1	8.0	0.7	0.7	0.1	10.3	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.5	2.8	0.0	2.7	0.0	4.9	0.0	0.3	0.0	3.3	4.7	0.0	0.2	0.1	3.4	1.3	0.1	0.0	1.8	2.9	0.0	1.6	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	5.3	8.1	4.2	6.0	13.3	2.9	5.5	2.2	26.2	7.6	0.0	0.3	0.0	2.3	18.8	0.4	0.8	0.0	0.0	1.2	5.2	0.0	4.4	0.0	0.0	1.3	3.3	0.0	0.0	0.0	4.0	12.4	2.8	0.0	0.0	0.7	0.0	1.7	2.5	0.0	1.1	78.6	0.9	10.1	0.0	0.0	14.1	0.5	0.0	44.9	0.0	0.5	0.0	8.3	1.1	3.0	9.7	1.6	0.0	0.0	0.3
CFAP44	"FLJ11142, WDR52"	ENSG00000206530	"Cilia and flagella associated protein 44"	Q96MT7	3	113286947-113441610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;epididymis: 20.2;testis: 20.3"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 192.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA067258	Uncertain					NA	NA					"HPA067258: AB_2685814"	"unprognostic (2.83e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-6)"	"unprognostic (8.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-2)"	"prognostic favorable (7.09e-6)"	1.5	1.2	2.8	1.5	10.1	1.4	3.6	3.9	2.3	2.8	2.3	15.4	0.7	1.1	3.2	20.2	1.6	11.1	1.6	1.7	6.1	1.3	2.6	1.9	7.0	2.1	1.2	1.0	8.8	4.0	6.0	5.8	1.1	38.2	3.9	3.9	0.8	5.7	1.9	1.3	3.7	2.9	1.2	2.0	1.8	3.5	20.3	5.9	0.9	3.4	0.7	1.9	2.6	2.6	1.3	0.3	0.8	0.2	0.1	0.7	0.0	3.9	2.6	4.2	4.5	2.8	4.0	5.6	1.8	0.9	1.2	2.3	1.3	2.3	4.4	0.6	1.1	1.5	4.8	2.8	1.4	2.4	1.9	3.0	3.0	7.9	1.5	0.1	4.9	3.0	0.9	3.3	1.0	1.1	4.5	0.9	4.3	1.2	2.8	1.5	2.5	2.7	4.9	2.7	5.3	6.1	3.3	1.1	0.7	2.1	6.3	4.3	4.7	2.7	0.6	2.6	2.5	3.3	3.5	2.8	3.4	3.7	1.3	1.7	3.9	2.2	0.4	2.1	3.0	2.7	0.0	0.2	0.8	0.4	0.1	0.4	0.4	0.5	0.0	0.0	1.3	0.7	0.4	0.6	0.1	0.0	0.3	0.2	0.0	2.8	10.1	3.9	2.3	6.1	1.3	1.2	1.0	38.2	5.9	8.9	10.7	0.0	1.8	0.0	7.0	5.3	0.0	192.7	34.2	3.5	19.6	0.8	0.0	1.9	46.7	2.2	1.0	0.0	2.6	0.8	0.7	3.3	10.5	3.0	0.5	7.9	0.0	0.6	1.2	38.2	5.8	0.0	0.0	0.0	5.2	5.3	2.0	0.0	6.3	1.1	20.3	0.0	0.9	25.0	4.8	0.0	0.7	0.0	3.7	1.7
SPICE1	"CCDC52, SPICE"	ENSG00000163611	"Spindle and centriole associated protein 1"	Q8N0Z3	3	113442718-113515187	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064843	Approved		Supported	Centrosome		NA	NA			Centrosome		"HPA064843: AB_2685367"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.89e-2)"	"unprognostic (4.75e-3)"	"unprognostic (6.53e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.95e-2)"	8.1	6.3	9.3	13.4	8.6	6.1	11.7	17.8	8.4	14.0	9.6	8.1	20.6	6.4	16.3	9.8	10.2	13.5	11.1	8.3	8.9	4.9	7.8	7.7	11.5	6.6	7.1	7.6	15.3	11.2	12.5	40.4	7.7	8.6	11.6	10.9	7.8	15.0	19.6	5.1	10.2	8.9	11.3	9.9	6.8	10.5	10.5	8.9	17.1	12.9	4.7	10.7	13.2	14.4	8.5	12.0	4.5	5.4	3.2	9.3	2.5	15.8	10.4	13.0	11.1	8.0	9.8	9.2	8.3	5.7	10.1	12.7	8.7	9.4	10.0	10.6	6.8	10.1	15.4	6.7	7.7	14.1	6.2	3.6	9.3	10.6	6.1	4.0	16.9	7.0	6.8	7.7	10.5	4.7	10.3	7.4	17.5	5.6	8.5	4.3	16.5	14.4	8.0	12.7	13.6	12.5	11.1	9.7	7.9	4.4	11.2	7.1	12.0	8.9	9.1	5.4	13.2	10.3	8.0	7.2	7.3	9.7	4.9	7.0	8.5	5.5	14.2	11.1	10.1	8.2	4.5	5.4	1.9	4.5	3.7	6.9	7.3	6.7	5.2	3.7	8.5	9.3	6.9	2.8	3.2	3.4	12.0	3.2	2.5	9.3	8.6	17.8	8.4	8.9	4.9	7.1	7.6	8.6	8.9	0.0	3.4	9.0	6.6	6.1	6.8	2.0	2.5	12.0	3.4	5.2	7.9	3.8	0.0	3.8	4.7	3.5	4.9	0.0	3.8	4.0	5.1	5.5	1.1	3.9	3.8	3.2	3.5	2.5	2.2	2.1	9.2	4.8	0.0	0.0	8.1	10.1	4.4	3.5	3.2	2.8	27.6	6.5	4.8	17.6	11.8	6.8	2.9	4.3	6.8	7.1
SIDT1	"FLJ20174, SID-1"	ENSG00000072858	"SID1 transmembrane family member 1"	Q9NXL6	3	113532296-113629578	"Predicted membrane proteins, Transporters"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.6"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 13.7;Mucus-secreting cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 11.6;OE19: 12.3;PC-3: 16.4;RT4: 11.4;T-47d: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035862	Approved					NA	NA					"HPA035862: AB_10671110"	"unprognostic (4.23e-1)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.43e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.64e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.50e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.32e-2)"	"prognostic favorable (4.09e-5)"	1.8	4.1	7.5	13.6	5.9	4.1	7.8	17.3	11.7	4.7	8.4	5.5	3.7	2.8	1.2	0.7	2.7	2.8	5.1	1.1	7.9	9.2	1.6	1.1	2.7	17.6	4.7	8.5	0.9	1.7	1.5	12.8	1.6	4.7	7.2	14.0	0.4	13.2	9.7	0.8	1.3	8.4	1.3	4.5	11.6	4.9	1.8	1.2	13.2	1.3	0.7	13.3	6.8	1.9	4.9	21.6	0.2	0.4	5.9	4.9	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.4	0.0	11.6	3.1	0.1	0.0	12.3	16.4	4.7	0.0	0.4	0.0	11.4	0.1	0.1	0.0	3.3	0.1	0.0	10.8	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	4.9	0.1	4.9	4.9	3.2	3.9	0.9	4.3	4.2	3.5	0.1	5.9	0.0	21.6	2.5	2.1	7.5	5.9	17.3	11.7	7.9	9.2	4.7	8.5	4.7	1.2	6.0	3.5	13.7	1.6	0.3	0.0	0.8	2.5	9.4	3.4	1.8	0.0	0.0	0.0	0.3	2.8	0.7	4.3	0.0	1.0	0.1	0.3	6.3	3.5	0.0	8.7	0.0	9.8	0.6	3.5	1.3	0.0	2.5	5.0	2.8	20.6	0.0	0.7	2.9	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	0.1	8.9	6.3	1.4
USF3	KIAA2018	ENSG00000176542	"Upstream transcription factor family member 3"	Q68DE3	3	113648385-113696646	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029243, HPA029245"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Nucleoplasm, Nucleoli"	Centrosome	"HPA029243: AB_10611114, HPA029245: AB_10600443"	"unprognostic (2.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.55e-2)"	9.0	5.1	8.8	11.0	7.3	13.8	11.4	13.9	7.5	7.2	12.2	5.3	5.4	4.8	5.8	13.3	7.0	6.3	5.3	8.1	7.6	5.5	12.7	24.0	6.1	9.2	6.3	5.6	6.9	10.8	14.4	8.9	4.9	6.5	6.2	6.7	6.4	8.3	5.4	28.7	11.4	14.7	8.3	11.2	12.0	7.3	4.8	6.9	13.3	7.1	11.5	8.9	6.1	6.0	5.9	5.1	6.9	3.7	2.6	3.1	1.4	5.2	4.0	5.0	4.7	12.1	4.7	3.4	2.1	3.4	2.1	2.0	3.7	2.2	9.3	3.9	5.4	3.4	3.3	5.3	4.2	4.0	2.8	2.2	6.6	2.5	6.1	3.6	12.1	7.4	6.7	7.7	3.9	4.4	3.2	5.0	7.1	3.1	5.0	4.4	7.4	6.7	6.7	3.6	7.1	4.1	2.9	3.9	3.7	7.5	7.4	2.4	3.6	5.1	2.9	6.1	3.6	3.9	9.0	6.8	3.3	7.2	1.8	3.0	5.8	3.2	11.1	3.8	5.1	2.4	4.1	2.4	3.5	3.1	2.8	2.3	2.2	2.2	2.3	1.7	5.9	2.7	2.8	6.9	2.6	3.7	5.1	1.1	1.4	8.8	7.3	13.9	7.5	7.6	5.5	6.3	5.6	6.5	6.9	20.8	10.8	4.8	9.6	0.0	20.4	0.0	10.2	22.7	11.4	24.4	13.7	6.7	21.6	7.4	4.6	10.8	9.7	0.0	10.3	3.1	5.4	14.9	4.7	36.5	6.7	12.7	5.8	20.3	16.4	9.1	12.0	10.4	0.0	3.6	13.2	11.3	10.2	16.5	13.1	18.7	17.2	6.5	0.0	9.5	3.9	0.0	12.1	13.4	13.3	17.8
NAA50	"FLJ13194, MAK3, NAT13, NAT5, San"	ENSG00000121579	"N(alpha)-acetyltransferase 50, NatE catalytic subunit"	Q9GZZ1	3	113716460-113746300	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074489	Approved					NA	NA					"HPA074489: "	"unprognostic (9.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (1.62e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.97e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.43e-1)"	23.4	23.6	15.9	18.0	19.8	19.7	25.6	17.1	16.5	14.7	16.2	9.3	12.9	12.7	18.4	13.3	32.6	14.7	13.6	17.0	14.1	10.8	17.6	31.8	17.3	20.7	13.8	13.7	17.8	20.7	18.4	14.1	14.9	15.6	14.5	14.7	10.7	21.6	13.8	86.5	17.7	14.0	16.1	15.7	17.7	16.9	19.0	12.9	22.5	18.3	37.0	23.2	19.9	19.8	32.3	24.7	28.7	22.6	17.4	27.3	26.2	90.0	39.4	21.7	25.2	29.5	24.0	45.3	48.5	27.3	30.0	34.6	56.5	32.5	62.4	30.1	25.7	23.7	37.3	37.7	33.2	55.1	13.0	19.3	67.2	29.7	34.0	27.1	70.0	21.9	20.4	26.3	33.5	48.5	19.8	26.7	26.4	42.2	25.2	30.9	42.7	46.2	15.2	48.5	35.3	58.0	47.6	33.3	49.3	22.8	68.8	33.4	19.3	35.2	26.2	35.3	19.6	36.3	23.3	24.6	41.5	41.2	17.5	36.5	28.0	46.4	115.8	32.5	39.5	25.4	8.5	22.5	11.9	27.3	22.6	24.3	32.3	20.6	25.5	24.7	20.5	18.2	24.0	28.7	17.4	19.8	14.4	21.9	26.2	15.9	19.8	17.1	16.5	14.1	10.8	13.8	13.7	15.6	12.9	44.7	29.9	65.7	72.5	149.5	21.5	41.9	22.9	25.4	42.1	34.9	7.9	37.5	66.3	50.5	52.7	36.5	37.5	0.0	47.8	76.9	38.8	84.6	46.2	63.8	57.0	38.1	19.1	26.4	50.8	39.9	28.4	52.5	59.1	42.3	31.3	30.1	51.1	34.9	29.4	56.1	16.9	19.4	85.8	52.4	57.5	155.5	52.3	62.5	39.8	140.8
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747019-113812056	"Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 467.9;Late spermatids: 569.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.6"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		2700000	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	12.8	19.8	24.1	10.4	33.2	7.4	12.7	34.8	52.8	14.0	11.1	10.3	5.6	9.3	7.5	8.2	13.2	10.0	10.8	4.7	26.2	38.2	47.9	18.2	12.3	11.4	25.4	25.0	6.2	10.5	39.3	13.5	12.3	52.0	11.2	11.8	14.7	18.0	8.4	4.5	12.6	7.9	8.2	13.6	13.7	10.9	8.9	8.3	9.6	21.0	5.7	13.6	10.2	8.2	3.8	16.4	33.6	15.4	3.8	3.4	6.0	25.4	11.6	14.6	12.7	30.9	13.8	15.6	13.8	21.1	14.5	20.1	21.8	20.5	20.9	32.9	20.1	16.1	16.6	33.0	18.2	19.1	9.5	9.1	18.5	18.0	16.8	25.5	13.6	21.7	18.6	12.6	18.8	13.2	22.6	23.6	10.6	21.1	15.8	21.5	16.7	9.9	6.1	18.3	17.8	14.6	8.6	10.6	23.7	39.8	24.3	28.3	10.4	24.2	16.5	18.1	21.0	25.0	11.0	21.7	13.6	10.1	9.3	8.2	16.6	17.8	19.3	26.6	17.2	15.0	9.2	15.4	5.2	2.8	11.7	2.6	3.8	2.6	2.7	16.4	2.9	2.5	2.9	33.6	3.8	9.5	4.6	3.4	6.0	24.1	33.2	34.8	52.8	26.2	38.2	25.4	25.0	52.0	8.3	26.8	28.3	28.9	13.2	27.0	92.7	7.9	33.1	14.7	19.4	94.2	39.3	18.1	69.6	25.2	467.9	26.0	24.0	0.0	23.9	18.8	17.8	28.2	10.4	64.4	67.8	95.3	53.6	36.2	95.4	569.6	16.7	67.0	43.9	49.5	25.8	42.1	22.3	24.6	21.5	62.8	37.3	6.5	14.6	25.3	14.3	41.9	36.7	17.1	21.3	21.1
GRAMD1C	DKFZp434C0328	ENSG00000178075	"GRAM domain containing 1C"	Q8IYS0	3	113828182-113947174	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 74.3;Late spermatids: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 5.1;naive B-cell: 4.1;neutrophil: 4.0"	"Group enriched"	"Detected in many"	11	"B-cells: 5.1;granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.4;HUVEC TERT2: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012316	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA012316: AB_1849949"	"unprognostic (2.73e-3)"	"unprognostic (6.16e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.49e-2)"	"prognostic favorable (4.22e-15)"	"unprognostic (8.48e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.09e-2)"	1.7	2.6	12.6	2.5	13.0	0.5	9.1	5.0	13.4	3.4	8.0	2.6	0.5	7.6	5.2	5.1	6.0	10.3	2.9	1.5	13.6	7.6	23.3	26.5	5.0	2.0	9.4	8.1	1.1	12.5	11.8	24.1	6.2	9.2	2.9	4.2	4.5	10.8	2.8	1.1	12.0	24.5	1.0	8.2	1.7	8.6	14.5	9.3	0.0	6.9	1.6	3.7	3.8	3.8	5.1	0.1	4.0	0.0	0.3	0.4	0.1	1.5	0.0	4.1	3.2	0.8	2.1	5.9	3.7	3.3	0.7	2.2	0.0	14.4	0.4	1.1	1.9	1.3	1.6	0.7	1.6	1.7	1.9	0.6	0.3	0.1	0.0	1.6	0.2	0.1	3.3	1.1	0.6	0.1	7.5	11.2	4.5	0.0	0.2	1.1	0.4	1.6	0.2	0.3	1.5	0.5	0.0	0.8	2.5	4.5	2.0	0.8	1.0	1.0	5.9	3.0	1.6	4.1	0.0	2.3	1.5	2.9	0.0	0.3	2.2	1.3	1.8	2.4	0.1	1.7	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.3	0.4	0.1	4.1	0.3	0.4	4.0	0.3	0.0	0.1	0.0	0.1	12.6	13.0	5.0	13.4	13.6	7.6	9.4	8.1	9.2	9.3	11.9	10.9	0.0	5.9	0.9	0.0	0.8	20.4	18.7	7.9	14.0	35.3	14.6	26.6	2.1	74.3	2.9	12.0	0.0	2.4	3.7	1.0	2.9	0.0	14.8	1.3	11.1	4.7	3.7	0.0	57.8	2.6	0.0	1.7	0.0	4.7	14.5	2.1	5.9	1.4	11.2	18.3	0.0	0.9	25.7	5.1	4.1	35.5	0.0	3.9	5.7
ZDHHC23	MGC42530	ENSG00000184307	"Zinc finger DHHC-type containing 23"	Q8IYP9	3	113947901-113965401	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.8"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 20.4;Late spermatids: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7;naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016808	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016808: AB_1859002"	"unprognostic (2.10e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.48e-7)"	"unprognostic (2.58e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (5.90e-4)"	"unprognostic (3.29e-3)"	1.0	0.8	6.3	2.1	5.9	0.4	1.9	2.7	10.4	1.4	7.7	0.9	2.2	6.0	1.5	1.6	1.7	2.1	1.8	1.3	8.9	1.9	4.7	3.2	2.4	2.7	0.9	4.7	1.1	4.4	8.2	3.5	0.4	1.4	1.8	9.9	1.2	4.9	1.4	1.2	2.9	5.4	0.7	0.9	1.9	5.0	25.8	0.6	0.8	5.5	0.9	2.8	1.7	1.5	2.7	1.1	0.5	0.0	0.0	0.5	0.1	13.1	3.3	0.4	7.8	1.2	0.2	11.5	5.2	1.6	1.0	1.6	5.4	8.9	6.1	4.6	3.0	8.6	8.7	10.0	1.4	1.7	3.6	4.6	5.6	4.8	3.3	0.4	6.2	5.2	0.2	1.7	0.2	0.6	1.2	0.8	6.5	0.0	3.6	0.1	7.6	5.1	0.4	2.4	13.6	3.7	0.9	4.5	5.0	5.6	6.5	13.7	3.5	4.0	13.5	2.6	3.2	8.1	2.1	0.2	3.8	7.6	0.8	2.3	4.0	5.2	9.8	3.2	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.1	0.0	1.7	0.1	0.0	0.5	0.0	0.0	1.1	0.1	0.1	6.3	5.9	2.7	10.4	8.9	1.9	0.9	4.7	1.4	0.6	0.0	1.0	5.9	1.6	2.7	1.8	1.2	10.2	5.3	2.3	15.7	7.9	0.6	0.0	2.1	20.4	1.4	15.7	0.0	1.6	1.2	0.6	3.5	0.0	5.4	0.4	0.0	13.3	1.8	0.3	26.8	1.1	1.2	3.3	1.0	12.2	3.8	0.7	9.5	0.0	3.4	0.7	0.0	0.3	11.6	1.9	2.4	0.2	0.0	11.4	1.7
CCDC191	KIAA1407	ENSG00000163617	"Coiled-coil domain containing 191"	Q8NCU4	3	113964137-114056613	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 191.4;Spermatocytes: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047833	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA047833: AB_10961639"	"unprognostic (2.59e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.90e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.45e-4)"	3.8	4.5	6.3	4.5	13.3	4.2	7.6	3.0	9.7	7.6	4.0	11.7	11.5	2.9	8.2	12.4	3.4	18.5	5.7	2.4	8.2	7.8	7.7	2.4	7.2	6.1	6.2	9.8	7.7	6.6	16.7	31.1	3.4	12.5	6.5	5.2	7.1	5.0	7.9	1.6	11.4	5.1	7.0	8.9	7.5	4.8	12.7	7.9	3.6	11.3	2.4	6.1	5.2	4.5	10.0	4.4	5.3	0.9	0.8	2.2	1.0	4.9	2.8	4.4	3.6	1.2	6.6	1.4	1.2	2.2	1.7	2.7	0.6	5.8	1.3	2.0	2.3	1.3	6.2	1.3	2.4	4.0	0.9	1.1	0.9	0.9	0.5	1.8	1.6	0.7	2.8	6.3	2.2	3.3	3.0	3.3	3.8	0.4	3.1	1.0	2.4	3.0	0.6	0.8	3.4	2.1	2.0	0.9	2.9	6.1	2.5	2.5	4.3	2.0	0.5	2.1	2.3	10.6	0.6	3.4	2.7	0.8	1.4	0.8	4.5	3.6	5.0	3.8	0.8	1.4	0.1	0.9	1.8	1.1	0.9	1.2	10.0	2.2	1.8	1.0	9.4	1.1	1.8	5.3	0.8	0.6	4.4	1.6	1.0	6.3	13.3	3.0	9.7	8.2	7.8	6.2	9.8	12.5	7.9	11.9	11.8	7.3	3.8	0.0	8.7	0.0	0.0	191.4	29.6	12.2	35.3	1.4	11.6	3.7	21.9	1.4	1.1	0.0	3.1	0.4	1.5	2.6	1.1	0.8	2.7	19.1	4.7	5.5	1.8	10.9	3.7	0.7	0.0	1.0	3.0	20.1	2.4	0.0	4.9	3.6	39.1	0.0	0.0	76.7	12.3	0.0	0.2	0.0	3.2	1.7
QTRT2	"FLJ12960, QTRTD1"	ENSG00000151576	"Queuine tRNA-ribosyltransferase accessory subunit 2"	Q9H974	3	114005833-114088422	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.9;Club cells: 19.4;granulocytes: 14.0;monocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036827, HPA036828"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA036827: AB_2675336, HPA036828: AB_10696788"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.41e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-3)"	17.1	13.9	8.7	12.4	10.4	13.3	14.1	6.4	10.3	11.0	11.2	14.9	7.9	10.4	16.1	9.2	13.7	13.1	13.6	7.5	6.7	6.7	15.8	15.7	12.2	14.9	11.0	7.6	12.6	15.3	10.7	16.9	11.6	9.4	11.2	12.5	17.7	11.8	9.8	7.5	12.4	12.9	10.8	11.3	19.9	10.7	14.1	10.0	17.3	13.2	10.9	21.6	11.6	10.9	13.9	15.8	5.3	12.9	6.4	6.6	5.0	13.4	14.0	11.7	12.9	5.2	6.4	11.1	7.1	4.5	12.1	11.2	13.3	9.8	25.1	10.4	6.5	14.5	13.5	22.7	10.7	16.0	4.7	10.2	11.3	8.4	9.4	7.4	20.4	10.6	5.0	9.7	11.0	15.7	4.9	12.5	11.7	11.8	9.0	6.8	10.7	17.1	8.0	22.4	19.2	15.4	15.5	8.2	13.5	9.5	9.3	16.0	7.6	10.3	10.2	13.0	10.2	11.3	10.4	8.2	10.6	11.6	4.1	13.7	6.4	9.2	35.1	9.3	15.2	21.3	0.3	12.4	2.9	5.6	12.9	5.3	13.9	4.8	5.5	15.8	9.5	6.6	5.3	5.3	6.4	9.1	6.6	5.9	5.0	8.7	10.4	6.4	10.3	6.7	6.7	11.0	7.6	9.4	10.0	17.9	16.9	0.0	0.0	0.0	0.0	0.0	0.0	8.1	19.4	3.5	0.0	9.4	1.7	13.8	0.0	0.0	0.0	0.0	10.8	8.6	0.0	0.0	14.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	14.4	0.0	0.0	12.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
DRD3		ENSG00000151577	"Dopamine receptor D3"	P35462	3	114128652-114199407	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.0;brain: 8.3;testis: 4.2"	"Group enriched"	"Detected in some"	39	"Early spermatids: 5.5;Late spermatids: 12.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.0;T-reg: 1.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Region enriched"	"Detected in some"	5	"basal ganglia: 7.5"	"Region enriched"	"Detected in many"	12	"basal ganglia: 25.2"							NA	NA										"unprognostic (2.32e-1)"													0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2			0.0		0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	2.0	0.6	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	1.4	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
ZNF80	pT17	ENSG00000174255	"Zinc finger protein 80"	P51504	3	114234631-114237578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.4;breast: 17.4"	"Cell type enhanced"	"Detected in some"	23	"granulocytes: 1.1;Ito cells: 1.3;T-cells: 3.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 2.8;T-cells: 4.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;SK-BR-3: 3.6"									HPA065484	Uncertain					NA	NA					"HPA065484: AB_2685496"	"unprognostic (6.27e-3)"	"unprognostic (3.00e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-5)"	"unprognostic (5.36e-1)"	"unprognostic (6.52e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.69e-12)"	"unprognostic (1.85e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-2)"	0.4	0.0	0.0	1.1	0.0	0.2	17.4	0.0	0.0	0.4	0.7			0.0	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.3	0.3	1.0	2.1	0.0		0.1	0.2	0.0	0.2	0.0		0.3	1.1		0.2	0.0	0.0	0.1	2.3	0.0	0.2	3.6	0.2	1.2			0.6		0.2	0.6	0.4	0.8	0.1	2.8	0.2	0.5	4.4	0.8	0.3	0.4	0.7	0.7	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.6	0.9	1.0	0.1	0.1	0.7	0.3	0.0	0.0	0.0	2.7	0.3	0.2	1.2	0.8	0.0	0.0	0.5	0.4	1.1	0.1	0.0	0.1	0.0	1.1	0.6	1.5	0.7	6.5	0.2	0.4	2.3	0.8	0.1	0.2	1.3	0.2	0.1	0.8	0.7	0.3	0.4	3.6	0.5	0.4	2.1	0.8	0.7	0.3	2.8	0.3	0.3	1.8	0.5	1.5	1.5	0.4	0.3	2.8	0.2	1.3	2.1	0.1	0.6	0.7	1.7	4.2	0.0	0.8	0.9	0.9	0.4	0.5	0.0	0.1	4.4	0.8											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.4	0.0	3.3	0.0	0.0
TIGIT	"DKFZp667A205, FLJ39873, VSIG9, VSTM3"	ENSG00000181847	"T cell immunoreceptor with Ig and ITIM domains"	Q495A1	3	114276913-114310288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 49.8;lymphoid tissue: 25.9"	"Cell type enriched"	"Detected in some"	22	"T-cells: 83.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 49.8"	"Lineage enriched"	"Detected in many"	11	"T-cells: 49.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.9;Karpas-707: 1.7;NTERA-2: 1.9;U-266/84: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.24e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.22e-6)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.50e-4)"	"unprognostic (3.51e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.18e-3)"	1.4	0.3	0.4	20.2	0.7	0.9	1.1	0.2	0.3	0.5	1.2	0.2	1.2	0.8	1.4	1.1	1.1	0.9	3.8	0.8	0.4	0.7	1.3	1.6	5.0	25.9	0.6	0.3	0.4	0.3	0.0	0.6	0.5	0.4	1.0	1.4	1.1	4.4	1.9	0.6	0.6	8.0	0.3	1.5	13.4	2.0	0.6	0.1	4.3	1.6	1.7	20.2	4.1	1.0	0.4	0.2	0.2	0.0	4.4	49.8	5.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.5	0.3	0.0	0.3	0.0	0.1	0.0	0.5	4.9	0.0	0.1	0.9	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	1.9	0.9	0.0	0.1	1.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.0	0.4	0.5	0.1	0.1	1.4	1.9	0.0	0.9	0.3	0.0	0.0	0.0	0.0	8.5	0.0	0.9	0.4	13.6	25.0	0.0	0.2	1.5	11.4	0.2	4.4	0.0	0.2	49.8	5.4	0.4	0.7	0.2	0.3	0.4	0.7	0.6	0.3	0.4	0.1	0.0	3.5	1.9	0.0	2.7	0.4	0.3	0.0	0.0	2.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	3.7	2.4	0.0	0.0	0.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.6	2.9	0.0	83.0	0.0	0.0
ZBTB20	"DKFZp566F123, DPZF, ODA-8S, ZNF288"	ENSG00000181722	"Zinc finger and BTB domain containing 20"	Q9HC78	3	114314501-115147271	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 279.2;Early spermatids: 317.2"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015551, HPA016815"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA015551: AB_2669217, HPA016815: AB_1858947"	"unprognostic (1.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.81e-1)"	10.7	7.3	6.3	2.9	12.3	4.0	6.2	17.3	9.3	7.2	4.2	10.8	5.3	1.7	6.6	17.4	3.5	4.9	4.3	6.1	9.7	5.2	9.8	9.8	4.4	3.3	14.9	3.7	12.7	5.9	5.3	26.1	2.2	11.5	10.0	2.7	7.9	5.4	9.2	12.1	4.4	4.0	7.5	19.2	4.4	3.9	44.6	14.2	2.1	9.1	8.1	3.3	5.2	5.0	18.2	4.3	7.8	3.6	4.1	7.7	2.7	2.3	4.4	1.7	4.2	6.3	2.8	0.0	1.8	3.9	1.1	0.9	2.5	0.8	0.6	6.1	4.6	1.5	0.1	6.1	1.0	1.1	0.5	0.1	0.6	2.1	1.9	1.5	0.3	0.0	2.7	0.3	2.5	0.8	3.9	1.3	0.5	0.1	1.0	6.4	0.0	0.3	0.2	0.4	0.0	0.2	0.2	5.1	0.0	4.3	0.0	0.4	1.0	0.8	0.0	1.3	0.2	0.0	0.5	7.2	1.6	5.5	0.3	2.7	1.6	0.0	0.3	2.6	0.4	2.0	7.8	1.4	5.1	6.1	2.0	4.2	18.2	6.0	5.6	1.6	10.7	7.7	6.6	3.1	4.1	3.6	4.3	2.8	2.7	6.3	12.3	17.3	9.3	9.7	5.2	14.9	3.7	11.5	14.2	148.9	92.8	51.6	33.4	22.9	70.0	42.8	101.9	45.5	35.2	279.2	56.9	0.2	41.4	165.4	317.2	68.7	13.9	0.0	71.6	0.5	90.0	35.5	79.6	95.2	3.8	76.3	30.5	49.7	16.5	71.3	97.8	22.0	30.4	34.3	15.3	183.7	101.7	11.4	113.5	147.9	113.2	84.1	55.2	6.6	4.3	16.2	0.5	36.3	16.6	21.7
GAP43	"B-50, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623324-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 132.7"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 2.4;Cone photoreceptor cells: 2.0;Fibroblasts: 1.7;Melanocytes: 1.7;Rod photoreceptor cells: 3.1;Smooth muscle cells: 1.9"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"naive CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.7;NTERA-2: 35.6;SCLC-21H: 22.9;SH-SY5Y: 17.2;U-87 MG: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	1.8	5.0	48.8	5.2	38.3	1.4	1.9	31.2	132.7	1.6	4.1	4.3	0.0	2.7	1.5	1.5	1.9	1.5	3.8	3.6	29.0	56.6	1.4	1.4	1.5	1.5	30.6	42.2	1.4	1.8	1.4	1.5	2.2	25.7	1.7	4.0	0.8	2.2	1.5	1.4	1.4	4.3	3.6	6.1	1.4	1.5	1.6	5.7	0.0	1.5	0.0	1.6	1.7	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	17.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	48.8	38.3	31.2	75.7	29.0	56.6	30.6	42.2	25.7	5.7	0.0	0.0	0.0	0.0	0.2	2.4	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.0	0.8	1.2	0.0	0.0	0.0	3.1	0.0	1.9	0.7	1.5	0.1	0.0	0.0	0.0	0.0
LSAMP	"IGLON3, LAMP"	ENSG00000185565	"Limbic system-associated membrane protein"	Q13449	3	115802363-117139389	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell type enhanced"	"Detected in many"	13	"Horizontal cells: 208.2;Leydig cells: 116.8;Muller glia cells: 166.8;Peritubular cells: 86.3"	"Cancer enhanced"	"Detected in many"		"glioma: 13.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;SH-SY5Y: 14.2;WM-115: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054051, HPA076122"			Enhanced	Cytosol		NA	NA		200000000	Cytosol		"HPA054051: AB_2682358, HPA076122: AB_2686779"	"unprognostic (4.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.97e-3)"	"unprognostic (6.03e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.31e-2)"	2.3	12.7	21.9	4.3	23.7	1.1	1.6	43.4	48.4	17.8	5.5	16.6	0.0	1.9	4.4	2.8	3.4	2.9	11.3	2.1	23.7	18.8	2.5	1.0	8.5	4.0	17.6	21.5	4.8	11.1	0.6	3.1	1.2	18.3	21.1	3.5	1.2	1.7	6.2	0.7	4.6	1.9	3.3	13.1	1.7	3.2	3.9	21.3	0.0	4.2	0.0	5.2	7.3	3.4	1.6	0.4	3.0	0.8	0.3	1.0	0.3	0.2	2.2	7.0	0.2	0.7	2.2	0.7	0.6	0.3	0.2	0.7	0.2	0.4	0.5	0.2	3.6	0.2	0.1	0.1	0.1	0.3	0.5	0.1	0.2	0.8	0.3	0.1	0.5	0.4	1.7	0.0	0.8	0.1	0.2	0.0	0.9	0.3	2.3	0.0	0.2	0.8	0.6	2.7	0.3	0.8	0.2	0.1	0.1	1.7	1.6	1.6	14.2	0.0	0.1	2.2	3.2	0.2	0.8	0.1	1.5	1.3	1.7	0.4	1.5	1.9	0.2	0.5	0.2	34.6	3.0	0.8	1.4	0.9	0.5	1.0	0.7	0.6	0.5	0.2	1.6	1.0	0.7	2.8	0.3	0.6	0.4	0.5	0.3	21.9	23.7	43.4	23.7	23.7	18.8	17.6	21.5	18.3	21.3	0.0	0.6	0.5	0.2	6.8	47.9	18.9	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.0	15.9	2.5	0.0	0.0	3.0	0.0	16.0	17.5	0.0	0.0	0.3	208.2	0.0	1.8	0.0	18.1	116.8	1.8	54.0	0.0	0.0	166.8	0.6	0.0	86.3	0.0	9.7	0.0	1.3	0.9	0.2	4.4	0.0	0.0	0.0	0.5
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;ovary: 21.1;testis: 39.9"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	1.1	10.5	12.5	1.4	14.6	0.9	1.2	3.4	23.9	1.3	2.6	27.8	0.0	1.1	1.6	2.3	2.0	1.6	1.9	2.2	12.3	6.0	10.6	0.9	1.0	1.0	25.2	8.9	21.1	5.1	3.8	1.4	1.1	15.3	1.3	1.8	7.0	1.4	2.0	2.9	2.6	1.6	1.5	20.5	1.0	1.4	39.9	20.7	0.0	5.0	0.0	1.1	1.1	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	6.0	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	2.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	26.2	1.7	0.5	0.1	0.0	0.0	1.0	0.0	0.0	9.1	10.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.5	14.6	3.4	13.6	12.3	6.0	25.2	8.9	15.3	20.7	0.0	0.0	0.0	0.1	0.3	5.1	1.1	0.0	0.0	0.0	0.0	70.7	0.1	0.0	0.3	226.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	237.3	3.4	0.2	3.3	0.0	0.0	24.3	0.2	0.0	1.8	5.1	24.8	0.0	0.0	11.7	5.9	0.0	0.1	0.0	0.0	0.2
C3orf30	"FLJ32859, TSCPA"	ENSG00000163424	"Chromosome 3 open reading frame 30"	Q96M34	3	119146150-119160042	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	156	"testis: 46.4"	"Group enriched"	"Detected in some"	128	"Early spermatids: 547.1;Late spermatids: 266.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.9;HEL: 1.3"									HPA062468	Enhanced					NA	NA					"HPA062468: AB_2684772"				"unprognostic (4.06e-3)"				"unprognostic (3.67e-2)"									"unprognostic (2.66e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	547.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	266.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.0
AC083800.1		ENSG00000251012			3	119147375-119187807	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	8	"adipose tissue: 1.3;testis: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"HEL: 3.9"															NA	NA																							1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPK1B	"TSPAN20, UPK1"	ENSG00000114638	"Uroplakin 1B"	O75841	3	119173517-119205153	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.4;urinary bladder: 41.9"	"Cell type enhanced"	"Detected in some"	16	"Cholangiocytes: 35.7;Club cells: 9.1;Ductal cells: 10.8;Proximal tubular cells: 11.2;Urothelial cells: 19.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 147.3"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CACO-2: 15.4;RPTEC TERT1: 14.4;RT4: 55.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA031799, HPA031800"	Enhanced					NA	NA					"HPA031799: AB_10671579, HPA031800: AB_10671580"	"unprognostic (1.20e-2)"	"unprognostic (7.18e-2)"		"prognostic favorable (3.87e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"		"unprognostic (8.77e-3)"	"unprognostic (3.67e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.68e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	6.1	0.2	0.2	0.2	1.2	0.0	0.2	0.2	0.3	3.6	0.7	0.0	0.0	0.0	1.5	0.3	2.4	5.1	12.9	1.8	0.2	0.2	6.6	0.6	1.4	0.0	0.2	0.1	0.8	11.6	0.0	0.4	56.4	1.1	15.4	0.0	0.0	0.4	0.0	0.2	0.6	0.2	4.3	1.8	0.2	22.9	0.7	0.0	1.4	0.2	1.4	12.9	41.9	1.1	0.7	1.1	2.5	0.5	0.6	1.9	0.5	0.0	6.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	15.4	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.4	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.5	0.3	0.3	0.2	0.4	0.2	0.3	0.5	0.7	1.9	0.3	1.8	0.6	0.4	1.1	0.2	0.5	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.1	1.1	0.0	0.0	1.0	0.0	0.3	0.2	0.4	0.1	35.7	0.0	9.1	0.0	0.0	1.0	0.0	10.8	3.0	0.1	0.0	0.0	0.6	7.7	0.2	0.8	2.3	0.0	0.5	1.6	0.0	0.0	0.0	1.0	0.0	1.4	1.7	1.8	0.0	0.2	0.6	0.0	0.0	11.2	0.6	0.0	0.2	0.2	0.2	0.0	1.3	0.0	0.0	19.0
B4GALT4	beta4Gal-T4	ENSG00000121578	"Beta-1,4-galactosyltransferase 4"	O60513	3	119211732-119241103	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 38.8"	"Low region specificity"	"Detected in all"							"HPA046819, HPA063546"	Approved		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA046819: AB_2679824, HPA063546: AB_2685036"	"unprognostic (4.07e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (6.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	9.6	7.7	7.0	8.6	8.5	11.6	8.8	5.3	6.6	10.1	20.8	8.2	12.6	14.6	15.1	43.4	13.2	12.6	21.3	11.1	6.0	6.2	15.0	11.8	8.9	8.0	7.7	7.3	13.5	20.8	8.5	16.2	23.7	9.1	9.4	17.9	10.2	10.1	16.1	4.8	10.9	40.4	11.3	9.3	8.2	16.8	5.8	6.5	8.5	10.8	6.5	11.4	13.0	8.7	3.7	4.7	11.2	4.6	11.7	12.2	4.8	17.6	34.3	4.0	2.8	12.5	10.4	20.4	38.8	17.2	18.1	18.2	20.2	5.7	3.8	8.1	20.3	10.9	24.3	6.8	5.2	18.3	7.5	2.3	5.2	5.8	10.7	8.6	3.1	4.7	7.5	7.3	7.7	6.2	6.9	1.7	2.8	3.6	4.0	7.4	6.7	1.4	2.7	5.2	10.2	9.3	1.4	3.7	1.5	9.9	19.4	3.5	8.2	9.3	4.1	8.4	9.0	8.9	1.4	1.2	8.6	7.9	4.3	4.3	8.9	7.0	5.0	7.2	2.9	7.1	11.2	3.7	6.8	12.2	4.6	6.9	3.7	6.0	6.4	4.7	2.9	11.3	6.8	2.2	11.7	4.0	3.1	2.3	4.8	7.0	8.5	5.3	6.6	6.0	6.2	7.7	7.3	9.1	6.5	0.0	6.5	17.8	18.3	9.5	10.5	7.7	40.8	30.8	18.2	7.0	3.9	30.1	1.7	26.8	0.9	8.3	39.8	0.0	29.7	111.2	24.4	21.4	12.7	9.0	12.7	17.5	13.3	4.3	7.5	1.7	13.8	10.8	13.5	13.6	76.6	21.5	28.0	42.1	26.5	21.6	9.4	19.4	12.7	1.6	10.5	9.3	43.7	14.6	21.7	68.6
ARHGAP31	CDGAP	ENSG00000031081	"Rho GTPase activating protein 31"	Q2M1Z3	3	119294373-119420714	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 35.0;Ito cells: 27.0;Macrophages: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 21.2;TIME: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036380	Approved					NA	NA					"HPA036380: AB_10673129"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.18e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (8.45e-4)"	"unprognostic (3.57e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-3)"	24.5	3.7	9.0	9.3	8.0	1.3	15.1	6.3	12.2	10.1	8.3	7.6	5.0	4.1	14.2	6.0	7.9	8.5	11.1	25.6	9.5	6.4	6.8	5.0	24.4	8.5	8.5	5.5	8.9	3.9	7.7	4.2	15.2	7.4	6.4	7.2	11.0	5.4	5.7	5.5	9.2	7.6	15.3	6.8	8.7	5.7	3.4	7.6	11.0	16.7	7.8	8.5	8.4	14.3	2.4	8.2	0.0	4.0	1.5	1.2	1.3	0.2	1.5	3.8	7.4	2.2	1.8	1.1	4.5	5.2	3.6	2.6	0.0	0.3	0.0	5.4	11.6	6.2	0.1	3.6	1.1	4.1	6.4	0.4	1.0	0.5	0.0	3.6	0.2	4.3	4.8	0.1	9.2	1.0	2.8	21.2	0.7	0.0	1.8	7.9	0.1	0.0	0.2	1.3	0.0	4.6	0.0	1.7	0.0	1.0	0.0	0.0	14.0	2.3	0.0	9.7	2.1	0.4	0.4	23.3	9.9	4.0	1.2	3.4	3.1	3.2	3.7	6.7	3.3	9.9	0.0	3.5	0.0	0.6	4.0	1.2	2.4	0.5	0.7	8.2	0.7	0.4	0.3	0.0	1.5	1.5	7.5	1.2	1.3	9.0	8.0	6.3	8.1	9.5	6.4	8.5	5.5	7.4	7.6	17.9	18.2	1.9	0.5	4.6	0.0	15.4	0.0	1.4	4.5	0.0	0.0	0.9	0.0	1.7	0.2	35.0	0.0	0.0	1.8	8.8	3.8	0.6	9.2	0.0	9.2	0.0	0.0	27.0	12.1	0.2	2.6	20.8	10.1	14.4	2.6	3.6	1.4	0.0	2.5	1.8	0.3	0.0	5.2	0.3	0.1	4.4	0.8	1.0	0.4	0.4
TMEM39A	FLJ10902	ENSG00000176142	"Transmembrane protein 39A"	Q9NV64	3	119429500-119468830	"Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039140	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA039140: AB_10673303"	"unprognostic (2.16e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (9.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (4.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.41e-2)"	13.7	12.7	5.6	13.0	8.8	9.3	13.2	10.5	6.4	18.3	8.7	10.4	27.0	9.6	20.8	18.3	10.9	13.5	13.4	14.4	5.1	3.8	9.7	16.7	15.2	11.0	8.9	2.4	17.6	37.5	8.3	47.9	19.5	7.6	13.9	9.5	12.1	30.2	30.0	8.7	10.7	10.6	9.6	8.4	11.8	11.5	15.4	8.0	11.3	17.4	9.5	19.2	11.9	13.0	8.6	18.1	11.5	11.2	11.9	13.8	9.2	15.9	8.0	14.3	10.1	28.5	26.7	15.1	15.8	27.1	17.1	23.8	14.0	12.2	6.7	15.0	14.5	21.2	16.6	14.7	6.2	18.9	6.6	5.7	8.2	6.1	14.2	19.2	15.2	12.3	16.1	10.4	12.4	30.3	19.5	11.3	10.4	8.0	19.3	9.5	7.3	8.0	5.5	13.7	15.9	16.0	8.7	7.4	14.3	5.0	6.2	6.2	8.7	14.9	8.6	21.3	10.5	8.1	14.3	9.7	10.6	10.1	7.4	9.9	22.2	6.2	15.9	15.9	11.0	15.1	11.5	11.2	8.0	13.5	6.2	13.8	8.5	8.4	11.3	13.2	8.6	7.0	7.1	4.7	11.9	4.8	18.1	9.8	9.2	5.6	8.8	10.5	6.4	5.1	3.8	8.9	2.4	7.6	8.0	8.9	12.0	7.5	13.8	20.3	4.5	9.8	2.5	12.0	7.9	7.0	5.9	22.9	5.0	10.2	19.6	8.0	5.6	0.0	12.5	45.9	30.1	16.5	1.1	9.8	12.1	1.6	10.4	7.4	21.0	4.2	15.8	13.2	10.1	45.9	14.6	4.8	9.1	3.5	12.4	3.4	6.3	6.5	13.9	23.2	14.7	19.1	50.0	15.8	10.8	17.5
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468938-119494708	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	13	"monocytes: 247.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (2.23e-4)"	11.9	12.1	7.6	10.7	12.0	3.9	10.9	13.9	10.6	10.1	9.5	9.8	27.4	5.9	13.7	11.7	9.3	10.1	6.9	8.3	7.3	8.9	8.3	10.3	9.1	14.3	15.0	5.6	10.5	29.2	12.1	14.5	11.5	10.9	9.4	10.9	8.7	7.8	25.7	5.1	14.0	12.1	15.2	14.0	14.9	8.2	4.7	8.9	11.7	8.6	4.1	15.6	10.6	10.2	9.9	14.3	9.4	11.5	19.8	16.0	10.3	7.5	5.1	8.8	9.8	22.3	12.8	6.3	12.1	12.4	9.9	13.5	8.3	4.9	11.7	16.4	15.2	7.9	9.0	11.8	12.0	15.7	10.1	7.7	13.7	8.0	8.9	14.6	15.0	16.2	13.2	7.9	9.7	13.7	11.5	11.2	7.9	7.5	14.3	10.0	7.6	8.6	14.6	9.1	13.3	9.3	8.5	9.0	17.2	8.6	9.8	9.7	14.8	5.8	3.6	9.4	9.0	9.7	12.6	14.1	9.7	6.0	2.8	6.2	19.7	17.1	15.9	8.4	15.3	13.6	1.9	11.5	9.4	12.0	10.8	13.8	9.9	13.6	12.5	14.3	7.0	16.0	15.2	0.9	19.8	7.0	8.0	14.7	10.3	7.6	12.0	13.9	10.6	7.3	8.9	15.0	5.6	10.9	8.9	0.0	3.8	8.8	5.8	14.9	14.7	3.4	15.3	6.7	7.9	19.2	5.9	9.2	0.0	6.3	0.5	13.9	6.5	0.0	4.5	12.3	10.1	5.0	17.3	9.8	7.5	4.8	9.1	11.1	13.0	0.0	8.1	16.5	11.8	247.1	11.4	12.1	5.1	7.0	15.9	5.5	12.5	12.9	9.9	1.4	0.9	13.0	5.5	14.6	12.1	5.8
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498532-119525090	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053214: AB_2682081, HPA055846: AB_2682941"	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	13.6	17.2	18.1	10.4	16.7	5.9	13.8	8.6	16.2	16.4	12.2	20.4	21.5	9.2	13.3	19.4	18.5	13.6	14.9	43.9	15.9	15.4	22.8	20.5	13.0	15.9	20.9	11.9	11.8	12.5	20.4	17.4	21.4	16.4	15.2	14.5	14.0	14.3	21.6	37.2	16.0	15.3	12.7	21.9	14.3	12.3	13.3	15.6	9.9	19.9	20.3	14.5	16.7	11.1	12.4	13.8	16.3	15.5	8.5	15.8	15.5	14.3	13.5	6.7	5.8	26.2	17.7	15.2	4.2	14.1	12.2	14.0	9.1	8.8	10.5	7.3	14.8	8.4	6.8	16.9	13.7	20.0	8.8	6.1	7.7	6.3	10.2	13.8	6.0	5.1	15.5	21.1	9.8	12.8	7.8	17.2	9.9	10.5	10.1	22.4	17.8	6.3	12.7	9.0	12.1	16.8	5.3	4.7	13.8	18.3	7.2	8.9	16.6	4.3	6.6	16.1	9.5	10.8	16.5	8.6	6.9	5.2	6.3	7.3	6.5	6.1	14.3	11.7	15.3	10.8	6.8	13.8	16.3	8.4	13.0	10.1	12.2	8.3	10.3	13.8	12.4	10.4	9.0	3.4	8.5	15.5	11.9	15.8	15.5	18.1	16.7	8.6	16.2	15.9	15.4	20.9	11.9	16.4	15.6	23.8	35.3	16.0	40.6	33.3	24.2	144.4	40.8	61.6	37.5	38.4	13.7	129.0	127.6	61.0	5.3	55.2	40.2	23.3	54.8	92.7	41.0	35.4	40.4	45.5	75.0	20.6	27.6	31.3	30.4	5.2	43.7	39.7	42.2	83.0	41.1	57.9	47.3	40.1	51.2	112.8	25.9	71.1	52.6	99.3	50.0	36.8	148.4	31.6	44.9	43.4
CD80	"B7-1, B7.1, CD28LG, CD28LG1"	ENSG00000121594	"CD80 molecule"	P33681	3	119524293-119559602	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 17.5"	"Cell type enriched"	"Detected in some"	22	"monocytes: 113.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 4.3;non-classical monocyte: 1.1;T-reg: 3.3"	"Group enriched"	"Detected in many"	24	"B-cells: 4.3;monocytes: 1.1;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.2;HDLM-2: 29.0;Karpas-707: 12.1;U-266/70: 5.2"					"Low region specificity"	"Detected in all"			"CAB025368, HPA050092"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB025368: , HPA050092: AB_2681012"	"unprognostic (2.36e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.03e-8)"	"unprognostic (3.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.94e-2)"	0.7	0.6	0.4	11.7	0.3	1.5	1.2	0.3	0.3	0.6	0.7	0.3	0.7	1.3	0.4	0.6	0.7	0.3	1.0	0.5	0.9	0.3	0.7	2.0	6.2	7.4	0.4	0.0	0.3	0.9	0.0	1.1	0.7	0.6	0.6	1.7	0.8	3.9	0.2	0.5	0.4	2.4	0.2	0.8	17.5	0.6	0.4	0.0	5.6	1.6	0.8	17.2	1.8	0.4	4.3	0.1	0.0	1.1	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.2	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	4.3	0.5	0.3	0.1	0.6	0.0	0.0	0.0	0.0	1.1	0.0	3.3	0.2	0.4	0.3	0.3	0.3	0.9	0.3	0.4	0.0	0.6	0.0	0.0	1.0	0.5	0.0	0.6	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.9	0.0	0.0	5.2	0.0	113.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0
ADPRH	ARH1	ENSG00000144843	"ADP-ribosylarginine hydrolase"	P54922	3	119579268-119589945	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.0;HEL: 11.5;HMC-1: 13.0;Karpas-707: 17.6;U-266/70: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001701, HPA036961"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB001701: , HPA036961: AB_2675405"	"prognostic favorable (2.42e-4)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.35e-2)"	14.3	8.5	2.3	10.9	4.6	2.5	14.8	1.2	2.4	7.1	6.2	4.7	14.6	1.9	7.9	6.2	5.0	5.4	6.6	8.4	2.3	2.4	5.1	5.5	17.4	18.9	3.7	2.7	3.6	11.9	8.1	2.8	23.0	4.0	6.3	3.9	6.8	6.5	14.5	19.7	3.1	6.4	8.8	4.7	13.6	5.1	4.1	3.6	5.3	7.4	5.8	12.0	7.1	6.9	8.2	8.0	13.3	13.0	3.4	9.6	4.9	1.6	2.0	0.5	0.0	1.7	1.9	0.0	1.4	0.3	1.2	1.6	0.6	1.3	0.4	0.6	2.1	0.0	0.1	1.4	0.0	1.2	16.0	0.1	11.5	0.2	0.0	2.8	0.0	13.0	2.8	0.0	0.6	0.0	0.5	5.0	0.0	1.0	17.6	7.6	0.5	0.0	2.7	4.8	0.1	4.0	0.0	5.7	0.7	0.7	0.6	0.3	0.0	0.0	0.1	4.3	0.7	3.1	7.2	4.1	0.0	0.8	3.2	0.3	17.2	3.8	0.0	2.1	0.0	3.1	7.8	13.0	13.3	0.6	12.0	0.6	8.2	1.4	1.3	8.0	4.9	0.2	0.6	0.4	3.4	9.2	7.0	9.6	4.9	2.3	4.6	1.2	2.4	2.3	2.4	3.7	2.7	4.0	3.6	8.9	7.5	4.5	0.7	0.7	0.6	4.1	2.5	2.7	4.5	3.5	3.9	4.8	1.7	2.2	0.8	8.4	0.0	0.0	2.9	3.2	1.1	0.9	10.4	1.3	8.4	0.0	0.0	5.5	9.4	0.4	0.3	10.6	1.7	7.2	0.1	0.8	2.4	0.0	2.8	0.8	4.6	0.0	2.9	0.5	0.2	0.6	9.8	1.3	0.0	0.1
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597842-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 14.0;Hepatocytes: 21.7;Peritubular cells: 13.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.9"	"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"	NA	NA			"Nuclear speckles, Cytoplasmic bodies"	Nucleoplasm	"HPA059740: AB_2684118"	"unprognostic (1.35e-1)"	"prognostic favorable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	2.5	0.4	3.8	1.5	4.7	0.2	1.8	1.4	2.5	2.5	1.3	1.7	47.8	0.6	3.2	63.1	0.8	2.7	1.3	5.0	3.6	4.3	9.3	17.2	13.7	6.1	6.0	1.0	0.5	1.8	11.4	1.0	4.4	7.0	6.0	1.2	10.7	1.5	123.8	10.3	0.3	1.9	4.2	7.4	0.5	2.2	2.0	2.5	0.4	5.0	0.4	3.7	2.1	1.3	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	0.3	0.5	0.1	0.0	0.2	0.0	0.0	23.9	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	3.8	4.7	1.4	2.5	3.6	4.3	6.0	1.0	7.0	2.5	0.0	1.7	0.0	0.3	0.6	0.0	1.2	2.5	2.7	1.2	14.0	0.0	0.1	1.7	2.7	5.2	8.7	0.0	0.0	1.9	0.0	0.6	0.3	1.1	21.7	1.6	0.0	1.7	4.9	0.3	2.2	0.3	5.3	1.7	7.2	0.0	0.0	2.2	0.0	13.4	4.9	0.0	0.0	0.3	0.0	0.2	0.5	1.6	0.0	0.0	0.3
POPDC2	POP2	ENSG00000121577	"Popeye domain containing 2"	Q9HBU9	3	119636457-119665324	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 90.5"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 250.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	10	"SH-SY5Y: 26.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024255	Enhanced					NA	NA					"HPA024255: AB_1855545"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-2)"	1.3	0.3	0.2	1.0	0.2	0.0	0.6	0.3	0.2	1.8	16.0	0.2	7.6	0.6	2.0	1.3	3.3	1.8	6.1	90.5	0.2	0.0	0.5	0.3	0.3	1.4	0.2	0.3	0.8	0.7	0.1	0.2	0.3	0.3	5.0	1.5	0.3	0.6	13.4	12.1	0.4	2.2	12.6	0.2	0.5	2.4	0.5	0.2	0.3	0.5	3.8	0.8	10.2	1.1	0.9	0.7	2.1	3.0	0.3	2.2	0.4	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	26.1	0.0	0.0	0.4	2.5	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.7	0.0	0.1	0.1	0.2	0.5	2.1	0.1	1.3	0.9	0.1	1.1	0.3	1.1	1.0	0.1	0.9	2.2	0.7	0.1	0.3	3.0	0.7	1.6	0.4	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	0.3	0.2	0.0	0.3	0.0	0.2	0.3	2.4	250.7	0.0	2.7	1.2	0.0	0.0	0.4	0.0	0.4	0.2	3.6	0.3	0.0	0.2	0.1	1.4	0.7	1.1	0.0	1.3	1.6	2.9	1.3	1.2	0.4	1.1	2.2	0.0	2.8	0.6	1.2	0.7	0.0	1.8	0.3	2.8	58.2	8.5	0.5	0.4	0.5	1.0	1.0	0.4	0.2
COX17		ENSG00000138495	"COX17, cytochrome c oxidase copper chaperone"	Q14061	3	119654513-119677454	"Cancer-related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042226, HPA048158"	Supported		Supported	Mitochondria		NA	NA		1000000	Mitochondria		"HPA042226: AB_2677911, HPA048158: AB_2680292"	"unprognostic (1.98e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.11e-3)"	"unprognostic (2.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.64e-2)"	16.6	42.9	20.0	18.2	19.4	21.2	30.4	21.1	20.4	10.2	16.8	9.2	43.5	22.0	11.9	22.9	11.7	11.0	13.6	53.5	17.2	23.0	27.6	37.0	17.8	20.3	23.2	15.2	7.9	39.9	21.1	45.7	18.2	33.7	17.2	16.2	19.4	25.6	33.3	80.4	8.7	21.0	15.4	20.8	15.3	22.3	13.4	16.7	11.1	16.6	37.1	17.2	13.7	20.1	35.6	53.5	52.8	46.9	19.8	33.9	22.0	27.7	28.9	15.8	3.9	6.1	5.7	5.7	15.5	9.3	14.3	14.9	25.5	20.1	20.1	18.8	7.4	22.1	10.5	15.7	15.8	8.6	25.2	18.8	17.4	22.9	20.1	7.0	25.3	32.5	6.5	15.2	8.9	12.3	9.8	9.2	25.2	14.1	48.2	16.6	45.1	25.4	36.5	17.8	25.2	48.4	11.2	10.7	33.1	22.2	16.3	26.4	11.6	19.1	18.4	23.2	10.4	23.1	40.3	7.3	12.3	19.3	7.7	21.3	34.4	34.3	42.5	17.5	19.4	21.2	50.1	22.4	52.8	21.8	33.2	23.0	35.6	27.2	24.7	22.9	27.2	21.7	22.6	17.7	19.8	46.9	53.5	33.9	22.0	20.0	19.4	21.1	20.4	17.2	23.0	23.2	15.2	33.7	16.7	145.9	163.6	145.9	99.6	83.6	101.3	592.3	244.5	194.1	118.3	472.8	41.2	125.7	606.8	206.9	59.6	165.4	386.9	210.2	359.2	147.4	95.8	189.0	295.2	628.7	191.0	71.5	205.8	109.2	171.8	19.7	84.3	254.2	263.2	453.6	223.0	88.7	397.0	333.1	128.7	464.7	118.6	181.1	142.8	266.2	132.2	109.7	176.4	137.1	121.4	191.1
MAATS1	"AAT1, AAT1alpha, C3orf15, CaM-IP2, SPATA26"	ENSG00000183833	"MYCBP associated and testis expressed 1"	Q7Z4T9	3	119703022-119767102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 31.6"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 158.0;Early spermatids: 481.0;Late spermatids: 243.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.3;hTERT-RPE1: 2.8;RPTEC TERT1: 4.7;SCLC-21H: 7.0;SH-SY5Y: 5.0;T-47d: 3.6;U-87 MG: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074084	Enhanced					NA	NA					"HPA074084: "	"unprognostic (6.70e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.46e-2)"	1.1	3.4	2.6	0.8	7.7	0.5	3.5	1.8	3.8	5.8	2.1	4.4	10.5	0.7	6.7	12.0	1.1	23.1	3.5	0.8	3.0	4.7	4.8	1.2	3.8	0.6	1.5	3.2	6.7	7.8	7.6	31.6	0.8	17.1	4.4	1.5	7.2	2.6	12.8	0.6	0.7	1.1	3.4	1.5	4.0	2.9	19.5	2.2	0.0	7.9	0.4	0.9	2.2	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	3.3	0.0	0.4	0.0	0.0	0.0	0.4	0.5	2.5	0.0	2.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	4.7	0.0	7.0	5.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	3.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	7.7	1.8	3.8	3.0	4.7	1.5	3.2	17.1	2.2	3.0	2.7	0.0	1.8	0.8	3.2	1.4	7.6	158.0	20.5	7.0	41.2	0.0	0.0	2.6	481.0	1.5	0.0	0.0	2.4	0.0	0.9	1.5	1.1	0.5	0.1	11.1	3.5	0.6	0.3	243.3	6.6	1.5	3.3	1.0	0.0	4.1	0.9	0.0	8.5	2.1	26.5	0.0	1.4	33.8	4.2	0.6	0.1	0.0	0.0	0.5
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818485	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 7.1;intestine: 15.4;liver: 22.2"	"Group enriched"	"Detected in some"	4	"Enterocytes: 29.0;Hepatocytes: 28.7"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"					"Cell type enriched"	"Detected in single"	18	"NK-cell: 7.1"	"Lineage enriched"	"Detected in single"	18	"NK-cells: 7.1"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.6			15.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	22.2	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	5.5		0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.1	0.7	0.0			0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.1											0.0	0.0	0.5	0.0	0.0	0.0	0.8	2.5	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.0	0.0	29.0	0.0	0.2	0.0	0.0	0.0	0.0	28.7	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0
GSK3B		ENSG00000082701	"Glycogen synthase kinase 3 beta"	P49841	3	119821323-120094417	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase"	"Alzheimer disease, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 135.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016263, HPA028017"	Approved		Supported	Nucleoplasm		No	No		81000	Nucleoplasm		"CAB016263: AB_2279451, HPA028017: AB_10600708"	"unprognostic (1.09e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (3.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.79e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.16e-1)"	17.6	17.6	17.4	13.8	21.3	25.0	13.7	32.7	28.3	15.8	16.0	15.6	7.1	15.5	14.5	12.6	20.3	12.4	14.4	20.8	17.1	22.4	15.7	21.7	17.1	17.5	17.0	22.6	14.0	14.9	25.0	19.2	24.1	18.1	13.9	17.9	14.9	18.5	11.7	23.9	21.6	18.2	17.1	13.4	26.3	13.3	30.8	14.4	46.5	17.4	8.4	14.1	14.2	15.7	1.7	2.0	10.6	3.1	1.4	3.0	1.0	28.7	13.9	23.3	13.5	15.5	15.8	22.6	16.2	31.2	15.6	14.3	15.0	11.8	11.7	10.0	23.1	18.1	19.7	11.0	31.5	24.3	7.9	3.1	17.0	10.4	11.2	17.7	17.5	22.9	15.9	21.2	16.6	34.0	12.7	17.1	15.5	7.2	22.8	20.4	15.6	18.5	4.9	12.7	11.0	14.4	7.4	19.9	11.2	11.3	20.6	17.6	10.9	19.1	13.9	18.7	23.8	17.2	11.8	21.9	22.4	25.3	7.0	9.6	15.1	13.9	22.6	13.9	11.7	17.8	4.3	2.9	7.5	2.4	2.6	2.1	1.1	2.0	3.0	2.0	1.7	2.0	1.5	10.6	1.4	3.1	1.6	1.3	1.0	17.4	21.3	32.7	28.3	17.1	22.4	17.0	22.6	18.1	14.4	29.8	26.1	16.6	27.4	45.2	58.2	34.8	17.8	13.4	17.0	17.4	56.9	22.4	10.0	21.7	114.4	21.8	32.1	0.0	28.0	43.2	22.6	25.0	17.3	20.3	19.0	135.1	25.8	23.9	27.9	40.1	12.0	22.7	33.7	24.4	23.3	27.6	35.4	22.6	18.7	11.5	40.3	12.9	20.0	34.2	22.5	35.9	35.9	24.1	20.4	35.8
GPR156	"GABABL, PGR28"	ENSG00000175697	"G protein-coupled receptor 156"	Q8NFN8	3	120164645-120285094	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 7.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 6.5;Late spermatids: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 3.1;PC-3: 3.0;SiHa: 8.1;U-2 OS: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028642, HPA028644"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA028642: AB_10599711, HPA028644: AB_10600441"	"unprognostic (2.85e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.62e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.03e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.71e-2)"	0.9	0.5	0.8	1.6	2.2	0.0	1.0	0.1	1.0	1.4	0.7	0.0	0.0	0.0	1.2	0.0	1.9	3.4	1.3	0.2	0.4	0.3	0.3	0.0	0.2	0.0	0.3	0.0	1.4	0.0	0.0	1.4	1.2	0.7	1.9	0.2	0.4	2.4	1.5	0.1	0.3	0.2	1.6	1.5	0.1	0.3	7.7	1.2	0.0	0.1	0.0	0.4	2.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.8	0.1	0.9	1.3	0.1	0.6	0.0	0.9	3.1	0.7	0.1	0.1	0.1	0.5	0.0	0.0	0.0	2.0	0.0	0.8	0.2	0.0	2.0	0.2	0.5	0.0	0.2	0.0	0.1	0.0	0.3	1.0	0.0	0.0	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.0	1.6	8.1	0.0	1.0	0.4	1.1	0.1	0.2	0.2	4.5	0.0	0.3	1.0	0.4	0.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.1	1.0	0.4	0.3	0.3	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.0
LRRC58		ENSG00000163428	"Leucine rich repeat containing 58"	Q96CX6	3	120324509-120349339	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057574	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA057574: AB_2683474"	"unprognostic (7.87e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.06e-1)"	15.8	30.1	12.7	10.7	14.3	10.0	15.4	13.9	14.8	15.4	13.3	16.3	11.3	9.6	14.5	11.3	14.6	11.0	9.7	9.6	12.9	9.6	19.2	14.1	10.9	12.7	15.9	10.5	19.7	13.1	21.0	9.8	12.1	14.4	15.1	9.9	13.2	11.6	12.1	9.2	13.8	12.2	15.5	22.9	14.6	10.0	7.9	15.5	27.9	18.3	9.0	11.0	17.2	16.1	5.7	6.4	3.5	5.8	3.7	8.4	3.4	24.8	8.8	6.0	7.7	14.0	13.4	9.6	8.9	7.8	9.6	12.0	8.2	7.7	16.3	11.2	9.6	13.6	10.9	11.1	8.8	18.3	6.3	6.9	17.4	12.0	9.5	9.4	28.1	9.0	9.8	11.3	11.6	15.0	6.2	5.6	10.5	9.8	21.0	10.3	11.3	22.0	9.0	6.1	11.0	16.1	4.9	16.2	10.5	7.3	9.2	7.7	10.3	15.7	10.8	22.3	4.4	11.8	12.8	8.3	16.1	17.9	10.7	11.3	18.1	20.8	34.6	16.2	21.3	13.4	2.4	5.8	2.3	4.4	5.1	6.4	5.4	5.5	5.6	5.5	5.7	8.4	6.2	3.5	3.7	3.9	6.4	5.4	3.4	12.7	14.3	13.9	13.5	12.9	9.6	15.9	10.5	14.4	15.5	68.5	57.6	28.8	17.3	45.2	28.0	15.5	28.1	37.5	38.7	17.4	53.0	14.2	10.0	19.4	6.7	20.4	18.0	23.3	26.5	21.7	39.0	27.8	33.6	31.0	24.2	23.8	16.1	25.2	43.8	4.0	51.8	30.3	32.1	8.2	22.2	43.2	26.4	14.4	68.6	33.1	20.4	25.8	33.5	17.4	24.0	49.8	11.3	27.7	29.0	14.4
FSTL1	"FRP, FSL1, OCC-1, OCC1, tsc36"	ENSG00000163430	"Follistatin like 1"	Q12841	3	120392293-120451253	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 309.5;Fibroblasts: 318.9;Leydig cells: 303.2;Peritubular cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 10.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 129.7;BJ: 150.5;fHDF/TERT166: 185.7;HBF TERT88: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035251, HPA040815"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		32000000	"Vesicles, Cytosol"		"HPA035251: AB_10601906, HPA040815: AB_2732489"	"unprognostic (2.60e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.84e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.47e-3)"	72.3	28.6	4.8	23.1	5.8	0.0	104.0	2.5	6.7	52.1	39.1	7.3	28.7	5.8	41.6	58.1	39.2	42.6	45.6	69.4	5.9	3.2	15.1	5.5	33.6	44.4	4.3	4.3	26.9	8.7	5.5	7.9	110.0	13.2	36.3	15.4	26.2	17.5	32.5	23.6	18.4	18.6	90.2	9.4	16.7	22.1	19.8	4.9	4.7	23.8	29.1	11.1	67.1	65.8	0.1	1.2	10.2	0.1	0.0	0.0	3.6	5.4	1.4	15.7	6.5	94.2	129.7	0.0	150.5	84.5	97.5	86.5	0.0	12.5	0.0	12.8	185.7	7.9	1.4	4.8	18.7	124.2	0.0	2.2	0.0	11.9	0.0	20.7	0.0	0.0	98.5	0.6	62.9	13.7	43.5	56.4	0.7	0.0	0.0	15.8	0.0	1.5	0.1	12.9	0.0	12.6	0.0	6.5	0.0	10.4	0.1	2.8	6.6	53.4	0.9	5.4	34.2	1.6	0.4	68.9	36.7	35.2	19.1	22.3	0.0	0.0	0.1	12.8	0.0	4.7	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	3.6	4.8	5.8	2.5	6.7	5.9	3.2	4.3	4.3	13.2	4.9	59.6	13.1	0.0	32.3	56.9	1.8	102.1	7.6	37.5	35.2	22.7	0.0	90.3	0.0	52.7	1.9	103.4	0.0	0.0	5.1	309.5	318.9	79.3	1.1	12.2	18.0	1.6	2.9	169.4	14.3	3.6	303.2	5.6	104.6	17.2	0.0	128.4	76.1	0.0	254.5	2.4	2.8	58.2	135.9	0.9	1.3	42.0	45.8	0.5	0.6	31.6
NDUFB4	B15	ENSG00000065518	"NADH:ubiquinone oxidoreductase subunit B4"	O95168	3	120596309-120602500	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.7"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 1416.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051739, HPA064441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria"		No	No			Mitochondria	"Nucleoplasm, Nuclear membrane"	"HPA051739: AB_2681585, HPA064441: "	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.95e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.79e-4)"	25.5	68.2	37.6	20.1	37.7	22.4	59.4	40.7	51.6	25.6	37.2	19.1	25.6	33.6	23.2	32.2	30.2	24.3	27.8	130.2	32.5	30.8	53.3	46.9	25.4	42.0	37.3	29.4	25.8	36.5	34.1	32.8	18.5	36.7	26.8	34.8	24.6	33.9	29.5	195.7	27.3	30.6	37.6	32.4	22.6	28.7	26.6	25.6	31.1	25.9	64.8	25.4	32.3	29.1	64.5	73.4	52.1	60.5	39.1	79.7	49.0	51.3	37.5	44.9	44.9	28.3	33.8	36.5	28.9	38.4	37.6	41.6	36.4	39.5	26.1	58.7	32.3	47.2	49.8	34.6	36.8	28.4	40.0	39.8	40.3	39.4	36.6	17.2	35.4	47.8	30.5	49.1	18.3	24.1	45.6	46.9	49.7	23.8	40.2	40.3	40.3	70.0	51.3	35.7	84.6	102.8	40.6	25.6	57.4	60.9	32.1	50.6	51.8	33.9	38.0	61.5	31.3	64.0	56.5	36.0	33.3	43.9	14.1	40.2	49.6	44.7	78.9	52.6	49.9	45.1	46.2	46.2	52.1	45.5	60.5	47.4	64.5	63.5	51.3	58.4	47.2	54.8	53.4	28.1	39.1	60.5	73.4	79.7	49.0	37.6	37.7	40.7	51.6	32.5	30.8	37.3	29.4	36.7	25.6	151.8	116.9	147.4	227.4	197.5	114.3	1416.5	333.7	208.8	175.1	303.6	55.0	310.4	1039.5	474.7	797.6	248.2	436.8	93.5	541.7	349.0	180.0	247.2	169.9	411.5	288.6	79.4	286.7	153.4	221.7	73.1	254.9	235.4	411.7	399.5	378.0	175.1	503.3	436.8	260.6	758.9	123.5	252.2	270.2	329.1	90.3	219.8	294.7	162.0	391.3	307.0
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628173-120682571	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 176.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 460.4;Proximal tubular cells: 326.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 119.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.1;Hep G2: 38.7;OE19: 68.2;RPTEC TERT1: 50.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		210000	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.2	0.2	0.2	0.6	0.6	0.0	1.8	0.2	0.5	3.7	7.2	0.3	1.4	4.7	0.6	4.0	0.2	0.4	11.5	0.3	0.2	0.1	33.3	176.7	0.7	0.3	0.2	0.2	0.3	6.9	0.0	0.4	0.3	0.3	6.7	2.7	5.9	3.3	1.0	0.4	0.3	15.0	0.3	0.4	0.3	3.9	0.3	0.2	0.2	8.1	0.3	0.3	0.2	0.2	0.0	0.3	2.8	0.4	0.0	0.0	5.1	0.0	2.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.3	2.6	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	38.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	68.2	0.0	0.0	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	5.1	0.2	0.6	0.2	0.5	0.2	0.1	0.2	0.2	0.3	0.2	0.0	1.3	26.4	0.5	0.0	0.2	0.3	73.9	0.0	0.0	26.2	2.0	0.0	87.9	3.5	0.0	0.0	22.2	23.3	15.6	0.0	0.0	6.7	1.1	460.4	0.2	0.0	42.1	18.4	11.1	0.0	0.0	0.0	0.0	1.8	14.1	2.7	17.1	25.9	0.0	326.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.4	7.0	0.2
RABL3	MGC23920	ENSG00000144840	"RAB, member of RAS oncogene family like 3"	Q5HYI8	3	120686681-120742993	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Cone photoreceptor cells: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035150, HPA035151"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035150: AB_2674493, HPA035151: AB_10601154"	"unprognostic (1.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.78e-1)"	"prognostic favorable (2.79e-5)"	"unprognostic (2.33e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.65e-1)"	21.5	26.7	16.5	9.3	19.5	8.8	14.8	15.7	19.9	12.2	14.1	16.6	13.6	10.6	11.8	12.2	16.6	11.0	9.9	11.9	14.6	16.6	19.7	20.5	10.3	10.3	19.2	16.2	18.7	13.9	23.3	14.7	13.4	20.9	14.4	15.1	12.8	11.2	14.9	19.6	10.3	13.0	11.6	22.5	11.3	11.4	8.2	14.0	11.2	22.9	12.6	11.8	13.8	11.9	7.8	11.4	5.7	11.8	13.1	10.9	5.6	16.6	12.9	11.6	3.7	12.6	17.1	9.7	15.0	11.3	8.7	8.1	8.8	6.9	13.5	7.8	13.2	13.7	6.8	11.7	8.2	16.5	11.3	5.5	13.7	9.2	11.3	8.1	24.0	8.7	8.9	15.8	7.4	8.9	11.6	13.0	8.8	11.1	9.1	11.4	14.4	18.4	6.3	7.1	18.9	7.7	8.6	14.2	7.5	11.4	7.5	5.5	7.4	7.1	6.4	8.3	4.7	11.8	15.7	17.7	6.7	6.0	4.9	15.7	6.7	6.3	11.4	19.0	23.8	8.2	5.6	5.8	4.2	10.9	11.8	9.0	7.8	9.7	10.3	10.7	6.8	9.3	10.8	5.7	13.1	6.6	11.4	10.3	5.6	16.5	19.5	15.7	19.9	14.6	16.6	19.2	16.2	20.9	14.0	8.9	9.4	9.3	14.5	5.7	16.9	11.6	20.4	17.4	14.8	8.7	110.0	11.8	6.6	14.2	16.2	11.9	9.8	0.0	13.9	15.5	8.2	11.6	8.1	14.7	12.8	7.9	5.2	4.3	8.3	6.9	5.5	9.5	10.1	10.8	12.2	15.7	13.4	13.6	5.6	20.3	18.0	0.0	5.9	9.7	7.5	9.7	18.4	6.9	10.2	13.1
GTF2E1	"FE, TFIIE-A"	ENSG00000153767	"General transcription factor IIE subunit 1"	P29083	3	120742637-120783069	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009884, HPA056359, HPA066881"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.29e-3)"	"unprognostic (4.94e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.97e-1)"	11.1	18.0	8.6	10.7	9.9	6.6	10.0	9.1	9.9	9.2	8.5	11.6	7.3	7.8	13.3	8.1	9.4	7.6	6.4	8.5	8.8	8.3	12.9	12.7	8.4	14.0	9.3	7.6	10.5	14.5	8.4	12.9	11.9	9.1	8.2	10.4	7.9	18.7	10.2	12.8	7.8	9.8	10.0	11.9	14.0	7.8	16.3	8.9	25.6	9.6	10.0	14.9	9.2	9.5	10.9	10.5	16.8	12.9	11.9	12.0	8.7	9.2	13.0	16.3	9.9	12.3	5.7	14.2	6.2	5.7	9.8	10.6	15.5	6.7	15.2	11.0	4.6	7.6	11.2	15.0	8.2	13.8	10.5	3.5	19.6	9.5	12.9	9.6	17.6	11.9	7.5	8.9	7.3	10.4	6.7	15.0	13.1	13.6	8.0	10.3	10.6	14.5	8.9	15.5	9.0	12.1	12.0	19.2	11.3	9.7	6.0	3.5	10.8	9.4	8.2	8.4	15.4	10.4	13.6	13.1	9.2	10.1	2.9	7.0	7.1	7.7	21.8	9.7	17.9	8.8	16.8	8.5	13.0	8.5	12.9	11.1	10.9	10.1	12.0	10.5	9.1	11.1	10.7	6.2	11.9	11.7	4.9	11.4	8.7	8.6	9.9	9.1	9.9	8.8	8.3	9.3	7.6	9.1	8.9	3.0	4.1	11.0	2.7	1.6	4.5	4.5	10.2	2.7	6.8	7.0	0.0	7.7	5.0	4.5	5.6	3.6	2.6	0.0	3.9	7.0	3.1	2.6	12.7	3.8	8.1	15.9	1.2	6.2	6.5	2.0	2.0	6.3	3.3	12.6	3.2	5.2	4.3	0.0	4.6	4.8	4.1	0.0	1.9	12.6	21.5	2.3	7.3	5.0	3.5	2.8
STXBP5L	"KIAA1006, LLGL4"	ENSG00000145087	"Syntaxin binding protein 5 like"	Q9Y2K9	3	120908072-121424761	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.2;ovary: 19.7"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 29.3;Cone photoreceptor cells: 70.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.2;HeLa: 6.0;MOLT-4: 7.9;NTERA-2: 4.1;RH-30: 4.1;SCLC-21H: 11.3;SH-SY5Y: 4.9;U-937: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.42e-1)"	"unprognostic (9.47e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.89e-2)"		"unprognostic (7.01e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.61e-3)"	0.9	4.3	9.1	0.9	15.4	0.8	0.8	55.2	22.6	1.8	1.6	1.3	1.3	1.3	2.6	0.8	1.4	1.1	0.9	0.8	13.9	3.4	0.8	0.8	0.9	0.8	3.1	17.1	19.7	1.2	0.8	12.6	0.9	22.4	5.2	1.2	0.0	0.9	7.4	0.8	0.8	1.4	2.5	2.1	0.8	1.7	4.3	2.5	0.0	16.1	0.0	0.8	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	7.9	0.0	4.1	0.0	0.9	0.0	4.1	0.0	0.0	0.8	11.3	4.9	0.0	0.0	0.1	0.0	1.1	3.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.0	2.2	4.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	15.4	55.2	22.6	13.9	3.4	3.1	17.1	22.4	2.5	0.0	0.0	0.0	1.0	0.1	29.3	0.5	0.0	0.0	0.0	0.0	70.7	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	9.5	11.6	0.0	0.0	10.0	2.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.4	0.0	1.4	0.0	0.4	3.6	2.5	0.0	0.0	0.0	0.0	0.1
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.5;lymphoid tissue: 21.4"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.2"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.5	0.8	0.2	8.2	0.7	9.5	0.6	0.6	0.4	0.9	3.5	0.2	0.8	2.0	0.9	0.6	6.0	0.3	0.4	0.8	0.3	0.2	0.4	0.6	0.9	4.7	0.3	0.0	0.4	0.4	0.0	0.2	2.8	0.3	0.4	3.7	0.1	1.1	0.8	1.2	2.4	3.9	0.5	0.4	2.6	1.1	5.8	0.6	21.4	0.3	5.6	7.5	0.6	1.7	0.5	1.1	1.6	0.4	0.0	0.4	0.0	13.5	9.2	7.9	5.6	0.7	0.9	7.2	6.4	2.5	7.6	10.2	7.3	5.0	16.1	2.9	3.5	9.2	10.7	9.3	4.1	12.9	4.7	5.1	10.3	5.7	4.5	0.0	11.1	9.5	0.1	0.3	6.9	4.3	1.3	3.7	6.0	6.8	12.3	7.9	5.2	10.0	6.5	7.5	4.1	4.5	8.5	9.5	5.7	2.4	7.8	4.3	3.9	7.4	4.0	2.6	7.2	3.7	11.1	2.9	6.7	8.8	2.6	8.3	6.2	5.0	16.7	3.2	8.3	4.9	1.6	0.2	0.0	0.3	0.2	0.0	0.3	0.4	0.3	0.4	0.5	0.0	0.2	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.7	0.6	0.4	0.3	0.2	0.3	0.0	0.3	0.6	0.0	0.3	0.0	0.4	0.8	0.3	1.4	0.0	1.4	3.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.4	0.0	0.0	2.8	0.7	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.2	0.3	1.5	0.0	1.0	0.4	0.5	0.3	0.3	0.0	0.1	0.1	0.0	0.5	7.0	3.3	0.1	0.2	0.9	0.9	0.9
ARGFX		ENSG00000186103	"Arginine-fifty homeobox"	A6NJG6	3	121570704-121586634	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.6;testis: 2.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	119	"testis cancer: 6.4"					"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"K-562: 1.7;Karpas-707: 1.5;U-698: 1.9"									HPA043049	Uncertain					NA	NA					"HPA043049: AB_2678288"															"unprognostic (6.00e-2)"			0.3	0.1	0.2	0.5	0.2	0.9	0.2	0.1	0.2	0.1	0.1			0.0	0.2	0.1	0.0	0.1	0.3	0.3	0.2	0.2	0.0	0.4	0.1	0.1	0.1		0.1	0.5	0.0	0.1	0.0		0.1	0.0		0.2	0.1	1.1	0.8	0.4	0.0	0.1	0.5	0.1	2.2			0.1		0.0	0.2	0.1	0.4	0.2	3.6	0.8	0.7	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.2	1.0	0.5	0.7	0.0	0.4	0.0	1.1	0.0	0.3	0.4	0.0	0.2	0.0	0.2	1.7	1.5	0.4	0.0	0.0	0.1	0.4	0.8	1.0	0.3	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.6	0.0	1.4	0.4	0.5	0.0	0.2	0.5	0.0	0.5	1.2	0.5	1.9	0.0	0.2	0.2	0.8	0.3	0.4	0.2	0.4	0.2	0.4	0.1	0.1	0.2	0.4	0.2	0.3	3.6	0.7	0.8	0.2	0.1	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FBXO40	"Fbx40, KIAA1195"	ENSG00000163833	"F-box protein 40"	Q9UH90	3	121593119-121630295	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 48.3;skeletal muscle: 58.2;tongue: 38.0"	"Cell type enriched"	"Detected in single"	2762	"Cardiomyocytes: 346.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.5;U-266/70: 3.0;U-266/84: 1.9"	"Region enhanced"	"Detected in some"		"pons and medulla: 1.8"	"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (1.67e-2)"	"unprognostic (1.23e-4)"			"unprognostic (9.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-1)"		"unprognostic (4.30e-2)"	1.0	0.1	0.2	0.0	0.1	0.3	0.1	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	1.1	0.1	0.1	48.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	1.3	2.3	0.0	58.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.9	38.0	3.9	0.1	0.1	0.5	0.6	2.8	0.8	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.5	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.3	0.5	0.4	0.0	0.0	0.0	3.0	1.9	0.8	0.2	0.1	0.0	0.2	0.8	0.8	0.9	0.6	0.3	0.2	0.8	0.2	0.2	0.5	0.4	0.6	2.8	0.2	0.4	0.6	0.9	0.1	0.2	0.1	0.1	1.0	0.1	0.1	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 149.7;lymphoid tissue: 110.1"	"Cell type enhanced"	"Detected in many"	15	"Kupffer cells: 535.9;Macrophages: 194.3;monocytes: 183.1;T-cells: 152.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.1;HMC-1: 61.2;Karpas-707: 39.8;RPMI-8226: 40.9;THP-1: 42.7;U-266/70: 60.6;U-698: 60.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		200000	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	24.7	10.7	7.8	44.9	14.7	35.5	9.1	1.3	7.4	6.3	10.4	8.5	2.2	5.5	5.6	8.2	4.8	9.1	10.1	7.5	6.7	5.0	10.5	10.1	18.7	59.4	12.9	3.2	4.6	5.1	1.4	6.1	15.4	10.9	6.1	8.6	4.9	7.4	3.1	7.0	4.6	23.0	8.9	15.1	110.1	7.1	3.6	11.6	41.0	6.1	4.4	61.5	12.5	5.6	33.4	59.6	149.7	84.9	24.3	44.1	103.5	0.1	0.0	0.0	0.0	3.6	2.0	0.9	0.6	0.6	0.1	0.2	0.0	0.0	43.1	21.0	0.0	0.0	0.0	1.1	1.6	0.1	19.2	0.0	27.9	0.0	0.0	2.0	30.6	61.2	0.3	0.0	0.0	0.3	0.0	25.4	17.6	5.5	39.8	0.0	0.0	21.7	25.9	0.0	0.0	0.7	22.0	0.0	40.9	0.0	11.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	42.7	33.1	0.0	0.3	0.0	0.1	60.6	18.4	60.6	0.3	29.5	0.0	26.6	64.1	104.2	40.2	80.6	32.9	33.4	33.3	36.8	59.6	29.4	28.5	33.0	149.7	24.3	84.9	18.5	44.1	103.5	7.8	14.7	1.3	7.4	6.7	5.0	12.9	3.2	10.9	11.6	8.9	51.2	119.0	0.8	2.9	0.4	1.7	7.6	18.7	12.5	0.0	0.0	96.0	0.0	0.3	0.8	14.6	0.1	23.3	0.2	50.7	6.0	0.3	70.6	2.1	117.6	0.0	0.0	33.2	535.9	0.9	3.1	194.3	18.6	183.1	0.3	0.6	0.3	0.0	1.1	0.6	0.7	12.9	6.6	0.3	0.6	3.9	121.6	152.2	0.2	1.8
GOLGB1	"GCP, GCP372, giantin, GOLIM1"	ENSG00000173230	"Golgin B1"	Q14789	3	121663199-121749767	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011008, HPA011555"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		35000	"Golgi apparatus"		"HPA011008: AB_1079011, HPA011555: AB_1079010"	"unprognostic (2.56e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.90e-3)"	"unprognostic (9.05e-2)"	16.7	22.3	17.6	12.5	24.0	12.8	25.7	22.3	28.0	24.6	16.8	8.2	27.1	12.7	16.5	35.0	15.9	14.0	14.0	16.6	16.8	10.3	19.7	17.2	13.4	8.5	26.1	14.5	20.9	23.4	26.2	39.4	24.4	17.7	28.0	18.4	12.5	21.5	29.3	11.7	20.5	20.6	21.3	30.6	14.8	16.6	12.1	20.7	9.0	19.3	12.9	10.1	17.2	13.6	3.6	5.8	16.4	4.4	3.9	5.0	1.5	12.4	10.1	10.0	6.5	19.4	21.0	6.3	8.1	17.9	7.9	8.9	8.8	4.6	2.7	6.9	15.1	7.9	5.8	5.9	8.8	9.3	3.9	11.4	7.7	12.1	12.1	11.6	8.5	10.6	17.1	21.0	4.9	12.4	17.1	9.9	4.7	3.5	6.3	8.3	9.0	2.5	6.2	6.5	12.1	10.6	3.4	7.9	6.4	11.7	12.9	7.1	7.9	10.0	7.1	10.5	11.9	8.9	9.6	13.8	7.6	4.6	3.3	5.8	11.7	6.9	4.6	10.2	4.2	2.8	1.7	4.4	4.3	5.0	2.2	4.0	3.6	4.0	3.6	2.7	3.2	3.7	4.0	16.4	3.9	1.7	5.8	3.8	1.5	17.6	24.0	22.3	28.0	16.8	10.3	26.1	14.5	17.7	20.7	271.0	217.5	57.3	76.1	45.8	96.8	233.9	61.1	235.5	260.5	50.6	115.8	64.0	10.0	92.8	49.3	75.2	103.8	0.0	97.4	43.0	46.5	79.1	109.0	56.8	29.9	65.2	88.1	67.5	38.4	14.5	183.8	42.9	32.1	73.9	106.8	82.0	80.8	76.4	187.0	23.3	194.7	84.1	52.3	117.3	42.8	40.0	126.1	28.8	70.0	79.9
IQCB1	"KIAA0036, NPHP5, SLSN5"	ENSG00000173226	"IQ motif containing B1"	Q15051	3	121769763-121835079	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Calmodulin-binding	"Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 111.8;Spermatogonia: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042028	Approved	Approved	Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA042028: AB_2677806"	"unprognostic (3.82e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (3.08e-5)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-3)"	11.5	10.8	9.9	25.1	12.6	16.6	21.9	14.7	16.8	14.4	11.8	8.8	16.9	11.0	14.7	19.4	13.1	15.9	11.5	10.4	10.1	10.1	10.6	9.0	15.0	20.6	12.5	14.5	19.8	22.7	13.9	20.7	12.1	12.4	16.2	15.6	10.9	14.4	30.2	11.4	14.2	14.0	14.6	11.4	19.3	11.2	40.1	12.5	16.2	11.4	9.5	23.0	16.7	14.1	18.9	7.6	8.9	10.4	8.6	10.0	4.9	14.0	3.8	18.8	21.1	3.0	4.6	22.1	6.7	4.1	7.6	9.2	12.9	6.8	28.4	9.4	3.8	11.7	10.8	11.5	5.4	11.4	5.5	9.3	18.8	7.5	10.6	7.8	23.3	5.7	2.9	10.4	5.2	11.7	3.9	5.7	12.2	11.2	10.6	8.4	7.1	15.2	16.5	15.8	8.4	6.9	15.1	8.9	9.0	4.4	6.3	10.0	8.1	6.5	4.6	11.6	6.4	4.1	18.3	4.8	7.2	8.7	3.5	8.7	25.7	16.3	48.3	6.9	10.7	6.5	2.5	5.2	8.9	6.3	9.9	9.0	18.9	8.3	7.6	7.6	17.5	10.0	6.3	2.1	8.6	10.4	7.2	8.7	4.9	9.9	12.6	14.7	16.8	10.1	10.1	12.5	14.5	12.4	12.5	6.0	15.9	17.1	15.3	16.8	14.7	7.7	15.3	62.9	27.3	10.4	25.5	23.4	3.3	8.8	2.8	9.0	5.9	0.0	11.3	6.9	13.9	12.8	8.1	5.6	9.1	12.7	6.9	6.2	10.0	5.3	14.4	10.5	13.5	17.2	8.9	11.8	10.6	9.1	12.7	5.8	27.3	12.9	11.7	111.8	63.7	18.1	11.8	13.3	12.6	14.8
EAF2	"BM040, TRAITS, U19"	ENSG00000145088	"ELL associated factor 2"	Q96CJ1	3	121835183-121886526	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 40.1"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 44.6;Proximal tubular cells: 115.5;Spermatocytes: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.1;naive B-cell: 30.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.7;HL-60: 39.5;THP-1: 21.0;U-698: 32.6;U-937: 22.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA008411	Enhanced					NA	NA					"HPA008411: AB_1847950"	"unprognostic (3.43e-1)"	"prognostic favorable (2.25e-9)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.34e-2)"	3.4	3.7	7.2	21.3	6.1	40.1	6.5	9.3	5.7	3.8	6.4	1.7	20.7	5.5	2.0	3.4	4.1	3.3	3.3	3.0	8.2	3.9	18.4	4.1	4.5	30.7	4.5	4.7	1.9	6.9	2.8	19.8	2.0	4.6	13.6	7.6	1.9	8.3	29.7	1.9	1.8	8.2	2.4	7.8	26.0	5.0	5.7	6.5	6.1	2.6	1.0	25.5	7.9	3.6	32.1	9.8	13.1	16.1	0.5	1.0	4.3	1.2	1.0	0.7	0.9	0.2	0.6	2.2	0.4	0.2	0.8	1.6	2.1	0.7	25.7	0.5	0.1	2.7	1.9	1.8	0.9	2.2	12.5	1.0	14.8	1.1	3.9	0.3	39.5	16.4	0.3	2.5	1.0	0.9	0.0	0.8	3.5	1.6	5.1	0.4	0.3	5.6	5.2	1.0	4.7	0.9	5.9	2.3	3.8	0.9	1.5	0.8	0.2	0.7	0.7	2.0	2.1	0.6	21.0	0.2	0.5	0.9	0.5	1.2	9.3	4.1	32.6	1.0	22.6	1.7	3.2	6.2	13.1	0.4	12.8	0.9	32.1	0.7	0.5	6.9	30.8	1.0	0.5	1.1	0.5	16.1	9.8	0.8	4.3	7.2	6.1	9.3	5.7	8.2	3.9	4.5	4.7	4.6	6.5	3.0	3.4	44.6	7.2	2.2	1.0	4.1	0.0	8.1	5.7	1.8	3.9	12.6	14.9	3.8	14.3	2.8	2.1	0.0	15.6	1.6	2.5	12.3	9.3	1.1	15.0	0.0	1.2	1.8	23.2	1.1	4.6	27.6	15.1	32.5	3.4	7.2	4.3	3.5	2.8	115.5	4.6	0.0	4.4	40.5	4.5	2.0	6.4	5.9	2.5	5.0
SLC15A2	PEPT2	ENSG00000163406	"Solute carrier family 15 member 2"	Q16348	3	121894089-121944102	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.2;ductus deferens: 35.8"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 92.3;Club cells: 31.8;Muller glia cells: 64.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 8.4;U-937: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.72e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.74e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.60e-2)"	1.0	1.2	13.8	1.9	15.0	3.3	3.2	4.0	15.3	35.2	1.8	7.6	35.8	1.5	1.5	26.2	3.6	7.4	4.2	2.0	14.6	5.3	7.4	1.1	12.9	3.6	5.3	12.9	1.0	3.6	2.4	3.6	1.6	6.8	26.5	2.1	15.1	14.6	25.1	0.8	0.7	2.2	0.9	4.0	6.1	1.1	3.9	6.7	0.0	4.6	0.5	3.8	3.6	2.6	4.2	1.6	2.4	2.5	0.3	0.3	0.3	1.9	0.9	1.1	0.4	1.3	0.7	1.4	0.2	0.1	0.5	0.6	1.8	3.2	3.5	0.2	0.1	0.6	2.1	0.8	1.9	0.6	2.8	0.6	5.0	1.3	0.8	0.2	5.3	5.0	1.1	5.5	0.6	0.4	0.6	0.3	1.0	0.8	1.5	0.6	1.4	1.0	8.4	5.8	2.1	0.5	1.2	0.5	1.0	1.3	1.2	0.4	0.4	0.5	0.3	0.1	1.7	0.3	4.7	0.1	0.4	0.3	0.4	0.4	1.9	0.5	5.0	0.6	7.1	0.5	2.4	1.1	0.4	0.3	0.4	0.3	3.3	0.3	0.2	0.3	4.2	0.3	0.3	0.6	0.3	2.5	1.6	0.2	0.3	13.8	15.0	4.0	11.0	14.6	5.3	5.3	12.9	6.8	6.7	92.3	21.4	4.4	2.1	0.5	1.0	1.9	7.6	12.0	31.8	10.4	0.0	2.1	3.3	0.3	0.3	0.8	0.2	0.0	7.5	0.6	0.6	22.7	3.5	0.0	2.1	0.0	0.0	1.3	10.0	0.6	6.1	3.8	0.0	1.0	1.0	64.9	2.6	0.0	4.9	1.1	2.4	0.0	0.1	0.5	0.1	0.5	1.1	0.0	0.6	8.2
ILDR1	"DFNB42, MGC50831"	ENSG00000145103	"Immunoglobulin like domain containing receptor 1"	Q86SU0	3	121987323-122022258	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.9;seminal vesicle: 27.8"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 11.9;Ciliated cells: 13.4;Club cells: 11.4;Collecting duct cells: 19.2;Cytotrophoblasts: 12.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.7;HDLM-2: 9.8;MCF7: 6.1;RT4: 9.1;T-47d: 6.5;U-266/70: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018207	Approved				"Intracellular and membrane"	NA	NA					"HPA018207: AB_1851742"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.46e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.37e-1)"	"prognostic favorable (5.79e-9)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.21e-2)"	0.3	1.5	0.3	0.7	0.4	0.0	1.8	0.3	0.3	8.6	5.6	0.3	28.9	2.0	1.6	17.2	5.9	3.4	4.7	0.3	0.3	0.2	8.0	0.4	2.9	0.3	0.3	0.3	0.9	16.5	14.8	4.1	2.6	0.4	4.9	5.0	1.3	10.6	27.8	0.3	1.7	2.4	0.3	0.3	1.1	0.3	1.5	0.3	0.9	5.1	1.9	3.7	5.6	1.6	5.1	0.5	1.5	0.7	0.1	1.0	0.4	3.4	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	7.7	1.4	0.1	0.0	0.1	1.2	0.0	0.0	0.0	9.8	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	6.1	0.0	0.1	0.1	1.4	0.0	0.0	0.1	2.8	3.5	9.1	0.4	0.1	0.0	0.9	0.1	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.1	7.5	1.6	1.4	0.0	0.2	0.1	0.6	0.7	0.1	0.2	0.4	0.2	5.1	0.2	0.3	0.5	3.4	0.4	0.3	1.5	0.1	0.2	0.4	1.0	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3	11.9	6.1	0.0	0.5	0.0	0.0	0.4	2.5	13.4	11.4	19.2	0.0	12.1	1.7	6.0	0.2	0.0	3.9	0.0	3.3	0.4	0.0	3.0	0.0	0.0	1.1	0.0	3.4	0.0	0.6	0.0	0.0	0.0	1.7	0.0	7.6	0.0	3.1	7.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	4.2	0.0	6.9	2.8
CD86	"B7-2, B7.2, CD28LG2"	ENSG00000114013	"CD86 molecule"	P42081	3	122055366-122121139	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.0;brain: 26.1"	"Cell type enriched"	"Detected in many"	5	"monocytes: 760.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 25.6;intermediate monocyte: 26.4;memory B-cell: 13.6;myeloid DC: 25.9;naive B-cell: 8.0;non-classical monocyte: 27.0"	"Group enriched"	"Detected in many"	17	"B-cells: 13.6;dendritic cells: 25.9;monocytes: 27.0"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 80.7"					"Low region specificity"	"Detected in all"			"CAB004319, HPA026802"	Approved		Supported	"Plasma membrane"		NA	NA		220000	"Plasma membrane"		"CAB004319: AB_627200, HPA026802: "	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (9.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.67e-2)"	10.5	4.7	7.1	23.6	9.5	6.0	3.6	1.5	6.3	2.9	4.3	9.8	0.6	2.5	2.6	5.2	2.8	3.3	10.4	3.5	7.3	6.0	4.0	7.8	13.0	17.8	11.7	3.0	2.5	2.3	2.1	2.6	10.3	8.1	3.1	5.6	3.0	3.6	1.8	1.3	2.4	6.9	5.1	26.1	22.5	3.4	2.4	10.3	7.7	2.3	2.1	15.0	9.2	2.2	13.6	25.9	0.3	27.0	1.2	0.4	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	4.3	0.1	9.6	0.0	0.2	0.0	0.0	25.6	0.2	0.0	26.4	0.0	13.6	0.1	0.1	25.9	8.0	0.0	0.0	0.3	1.2	27.0	2.6	0.4	9.3	7.1	9.5	1.5	6.3	7.3	6.0	11.7	3.0	8.1	10.3	0.0	10.6	25.1	0.0	3.2	0.0	0.2	0.0	0.0	4.5	1.8	0.0	1.6	0.0	0.2	3.0	0.2	0.0	0.0	2.9	0.5	1.7	0.3	2.3	0.8	106.9	0.0	0.0	1.8	111.1	1.3	0.0	155.5	6.8	760.2	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	3.4	1.6	0.0	0.0	0.3
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183683-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 155.3"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 13.2;Cholangiocytes: 33.1;Ciliated cells: 28.1;Club cells: 10.3;Distal tubular cells: 11.6;Intestinal endocrine cells: 11.1"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039686, HPA050335"	Enhanced					NA	NA					"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	21.0	0.0	0.1	0.2	18.1	0.5	0.0	0.0	0.1	0.0	0.6	12.1	155.3	0.6	0.0	0.2	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.6	0.3	0.2	0.2	0.5	0.3	0.0	0.1	1.6	0.0	0.1	0.7	0.0	1.4	0.5	1.1	0.3	0.8	1.1	0.2	0.6	1.3	0.7	1.1	0.3	0.3	0.7	0.7	0.0	0.0	0.1	0.6	0.9	1.1	0.9	0.4	0.8	0.5	0.2	0.2	0.3	0.8	0.1	1.4	1.1	1.1	0.0	0.7	0.8	0.4	0.4	0.5	0.2	0.5	0.2	1.1	0.6	2.0	0.3	0.7	0.5	0.9	1.4	0.8	0.7	0.6	0.5	0.6	4.0	1.5	0.6	0.8	0.9	0.5	0.3	1.7	1.0	0.3	1.3	1.0	1.9	1.0	0.3	1.7	1.1	0.5	0.7	0.6	1.0	1.0	0.3	0.1	0.9	0.2	0.9	0.7	0.9	0.9	0.1	1.4	0.7	0.6	1.1	0.8	0.2	0.5	1.1	0.2	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.0	0.2	0.0	23.8	13.2	0.0	0.0	0.0	0.0	0.8	33.1	28.1	10.3	3.5	0.0	0.0	11.6	3.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	11.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325244-122341972	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 312.4;tongue: 421.9"	"Cell type enhanced"	"Detected in many"	16	"Kupffer cells: 712.6;monocytes: 1063.2;Syncytiotrophoblasts: 279.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 405.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	20	"classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6"	"Group enriched"	"Detected in many"	193	"dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 33.8;hTCEpi: 149.9;THP-1: 93.6;U-698: 59.6;U-937: 29.8"									"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		39000000	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favorable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	2.0	0.2	0.3	4.4	0.8	19.8	4.5	0.2	0.5	55.4	0.4	0.2	1.1	0.0	4.7	1.7	312.4	0.2	0.7	1.0	0.3	0.0	0.4	3.4	6.8	4.8	1.1	0.2	1.8	0.2	0.0	0.3	1.3	0.5	1.3	0.1	0.3	57.4	0.7	0.7	28.2	0.3	0.4	0.7	2.0	2.2	0.3	0.6	2.2	0.3	421.9	99.0	1.5	93.5	0.1	54.6	36.0	74.6	0.2	0.2	32.0	1.7	0.1	0.0	0.4	3.9	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.7	0.0	10.5	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.8	0.8	13.6	0.2	3.8	149.9	0.3	14.7	0.0	0.0	0.1	0.1	3.6	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.8	0.0	0.0	1.6	0.9	1.2	0.0	0.1	93.6	0.0	0.2	2.4	0.0	0.1	0.0	0.2	59.6	3.2	29.8	0.0	0.7	74.6	2.2	0.0	37.5	0.2	0.1	0.1	0.1	54.6	0.0	0.0	0.1	36.0	0.2	21.6	1.0	0.1	32.0	0.3	0.8	0.2	0.5	0.3	0.0	1.1	0.2	0.5	0.6	6.0	27.0	9.0	93.6	74.1	0.0	0.0	2.5	30.8	34.2	0.0	0.0	203.1	0.0	2.0	0.2	3.5	1.3	0.0	19.8	10.9	5.6	14.2	12.8	90.0	136.3	0.0	0.0	8.0	712.6	0.6	9.5	248.7	8.5	1063.2	0.5	0.0	27.6	1.1	3.5	0.5	0.0	32.3	4.2	0.1	0.1	179.2	279.5	4.3	0.8	83.6
CCDC58	FLJ33273	ENSG00000160124	"Coiled-coil domain containing 58"	Q4VC31	3	122359591-122383231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047777, HPA051965"	Approved		Approved	Nucleoli,Mitochondria		No	No			Mitochondria	Nucleoli	"HPA047777: AB_2680152, HPA051965: AB_2681676"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (5.64e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.84e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (7.29e-4)"	9.5	13.3	8.7	6.8	8.1	7.1	9.2	6.9	12.6	8.2	13.3	7.1	12.4	10.6	7.3	12.4	14.0	5.8	7.7	12.4	7.2	7.0	21.9	23.3	5.4	10.0	8.6	5.3	8.8	9.3	3.1	7.7	6.7	8.5	8.2	14.4	6.5	7.2	6.9	35.2	6.9	10.2	6.3	7.2	8.6	9.1	8.7	9.3	5.5	8.8	24.5	9.6	8.7	7.1	13.9	18.3	1.7	10.2	11.4	16.1	4.6	34.9	11.1	21.2	13.5	7.9	11.1	27.3	13.4	14.6	32.6	32.1	31.3	17.7	25.7	23.2	10.2	25.4	24.5	34.4	23.0	39.1	8.8	12.2	30.2	7.9	37.8	13.2	44.9	10.8	9.1	11.9	20.0	21.9	13.9	15.0	22.9	34.2	11.2	17.1	17.4	28.6	32.2	40.7	38.6	21.0	19.0	25.2	31.6	22.4	18.6	21.5	10.5	15.6	16.6	37.3	18.7	16.5	29.6	8.6	18.3	23.4	7.7	26.7	8.9	11.9	55.4	20.8	21.8	16.1	0.4	5.0	1.7	10.2	10.2	12.0	13.9	13.6	13.4	10.3	13.5	16.1	14.9	0.9	11.4	8.5	18.3	10.5	4.6	8.7	8.1	6.9	12.6	7.2	7.0	8.6	5.3	8.5	9.3	3.0	17.1	19.3	16.0	13.6	9.4	23.0	25.5	32.1	20.5	12.2	9.8	19.1	46.4	27.4	0.3	11.3	13.4	0.0	25.7	38.8	10.2	10.9	19.8	46.1	15.7	0.0	5.2	11.6	7.6	0.7	11.8	12.4	8.5	26.2	14.7	6.6	31.7	14.0	7.8	78.7	8.8	12.9	8.0	13.5	23.4	16.2	12.7	7.1	22.4	21.2
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA058113"	Approved		Enhanced	Mitochondria,Cytosol		NA	NA		29000	"Mitochondria, Cytosol"		"HPA035856: AB_10611965, HPA058113: AB_2683609"	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favorable (3.93e-4)"	13.6	32.8	24.9	18.6	49.9	14.1	18.7	10.7	44.8	21.8	57.8	11.5	19.6	22.7	17.0	25.5	58.7	13.8	25.4	54.2	40.2	21.7	35.9	78.1	12.2	16.5	23.6	27.7	30.2	71.5	24.6	16.1	7.3	31.0	27.3	61.3	16.2	17.7	23.1	56.6	29.2	21.2	27.2	24.4	10.9	25.7	16.9	18.8	8.6	17.9	48.6	16.7	34.6	36.0	26.8	29.4	25.3	24.4	16.4	33.1	12.9	28.8	6.2	9.2	17.1	16.9	15.7	4.7	11.8	10.6	11.3	28.8	15.4	13.3	31.4	20.6	4.0	9.3	20.2	16.6	28.8	30.2	16.2	12.4	25.4	10.7	27.5	11.1	24.8	9.1	18.1	15.1	10.7	22.7	38.0	14.9	31.0	17.1	12.6	16.1	11.3	25.2	30.2	13.6	65.2	32.8	15.2	13.2	40.9	32.7	70.4	13.8	11.0	8.8	21.0	24.1	14.4	13.1	12.2	10.5	11.2	8.0	6.5	12.2	25.0	8.5	31.8	33.2	24.3	5.1	2.6	9.3	25.3	21.7	23.0	32.1	26.8	29.8	27.1	29.4	23.9	32.6	33.1	3.0	16.4	24.4	24.6	27.1	12.9	24.9	49.9	10.7	44.8	40.2	21.7	23.6	27.7	31.0	18.8	26.8	42.4	71.1	131.6	113.8	30.4	312.0	96.8	46.8	43.3	123.9	45.2	42.9	457.6	109.5	73.0	47.4	279.5	23.3	152.7	35.4	52.8	85.5	85.3	207.9	83.9	36.5	102.7	38.1	49.4	23.4	124.5	76.0	99.5	146.9	326.4	45.5	161.9	325.6	139.7	345.2	28.5	103.5	89.6	141.1	55.3	116.1	39.5	54.9	245.2	156.6
WDR5B	FLJ11287	ENSG00000196981	"WD repeat domain 5B"	Q86VZ2	3	122412332-122416051	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042994	Approved					NA	NA					"HPA042994: AB_10960397"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.45e-3)"	10.8	8.4	6.2	5.8	9.0	2.8	11.0	7.1	6.3	7.6	4.2	7.6	13.7	5.8	6.2	17.5	5.4	12.5	3.8	4.9	6.9	4.6	7.4	10.4	5.6	8.7	11.3	5.0	8.6	12.5	7.9	19.5	7.4	10.7	8.2	4.8	5.7	7.8	15.5	3.9	5.8	7.5	4.4	9.2	10.9	7.7	7.3	11.1	12.3	14.7	3.4	8.9	5.7	4.7	4.6	2.3	5.1	8.1	2.4	6.7	2.6	6.6	4.2	6.3	7.3	11.9	9.9	4.0	5.1	7.7	7.1	6.2	3.7	6.0	4.0	7.1	4.9	5.9	9.5	5.0	3.8	9.4	2.5	4.1	5.9	4.7	3.7	7.7	3.2	6.6	6.5	10.6	5.4	12.4	8.0	5.5	7.2	2.6	3.6	5.9	7.9	5.1	5.9	3.1	10.1	7.0	5.0	6.2	3.5	6.7	2.9	7.2	7.7	5.2	3.4	9.8	7.5	9.9	7.1	4.3	5.6	6.9	2.6	3.3	3.0	1.3	8.0	7.3	3.2	6.9	5.1	4.3	2.8	2.9	4.7	3.6	2.7	4.3	2.5	2.3	4.6	6.7	4.8	1.6	2.4	8.1	1.4	4.8	2.6	6.2	9.0	7.1	6.3	6.9	4.6	11.3	5.0	10.7	11.1	3.0	3.7	0.0	2.9	0.5	3.6	2.1	7.6	10.7	1.2	12.2	5.9	4.6	6.6	3.5	6.3	3.6	1.2	0.0	3.5	1.7	2.1	3.3	0.0	4.0	2.1	6.4	0.0	5.5	3.3	0.0	4.4	1.3	0.0	1.0	2.7	6.0	1.9	2.0	2.8	5.3	7.1	0.0	2.3	6.3	4.6	1.8	2.4	1.8	2.3	1.4
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421949-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.4"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	15.4	16.9	15.1	14.4	15.5	7.6	17.8	14.6	19.3	11.8	13.6	12.0	9.0	9.9	14.4	12.3	17.2	10.8	9.6	18.7	13.9	11.6	13.1	24.6	12.5	11.2	14.4	16.8	10.8	14.5	19.6	13.8	13.6	16.5	12.3	12.3	8.6	13.2	15.1	89.4	13.1	11.3	17.7	15.8	10.9	12.3	15.2	13.5	12.4	14.1	10.9	15.3	14.5	13.6	11.4	17.3	29.3	18.2	13.5	13.9	10.9	29.9	17.8	30.7	15.5	20.0	22.1	9.7	23.2	19.7	25.5	23.1	21.4	14.7	21.9	21.4	25.5	20.2	15.8	24.0	19.8	37.7	5.9	9.1	26.9	16.0	11.9	11.7	23.8	12.4	15.3	25.8	18.3	25.8	12.5	27.8	11.9	18.8	12.7	23.1	14.0	17.2	5.7	13.3	21.2	19.2	17.7	25.5	14.0	11.1	21.1	21.2	12.8	24.9	13.6	20.2	25.1	18.0	14.1	23.7	16.0	17.6	7.8	17.9	12.2	12.3	40.7	22.4	16.7	16.2	15.7	13.1	12.5	12.6	13.4	13.5	11.4	11.2	13.9	17.3	8.8	11.6	11.8	29.3	13.5	18.2	5.5	11.8	10.9	15.1	15.5	14.6	16.7	13.9	11.6	14.4	16.8	16.5	13.5	14.9	28.5	15.2	21.0	36.9	27.4	26.5	25.5	46.8	42.1	14.0	29.5	18.8	11.6	21.1	89.9	29.2	15.5	46.7	28.8	20.9	21.6	27.0	38.1	43.9	20.5	19.1	15.6	26.4	29.7	145.2	20.8	25.2	16.9	25.2	17.0	23.9	27.4	17.5	23.3	16.7	47.9	12.9	33.5	30.1	16.6	39.6	20.8	27.3	10.7	24.2
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: AB_2685707"	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.3	13.0	0.9	2.7	14.7	35.1	41.9	4.2	8.9	1.8	6.0	5.4	22.1	8.9	2.3	4.8	7.3	14.0	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.6	4.7	5.0	1.2	7.0	7.5	5.6	0.8	7.5	1.4	3.5	8.9	3.5	0.4	1.6	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.2	1.2	32.4	0.5	3.8	3.1	4.5	1.5	4.4	0.3	1.6	4.7	2.4	3.3	5.2	3.1	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3	38.7	36.9	16.7	9.4	6.4	0.8	5.2	10.2	61.6	44.3	19.2	0.0	4.3	1.7	24.9	1.3	19.0	15.3	0.0	34.9	16.2	11.4	10.4	9.3	43.1	36.1	0.0	10.3	21.5	31.3	2.6	17.0	29.4	6.8	32.5	9.7	14.7	28.4	7.2	22.6	18.9	0.8	19.4	9.6	1.0	0.9	5.8	1.4	12.7	6.6	15.5
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564238-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.2;BJ hTERT+ SV40 Large T+ RasG12V: 42.4;GAMG: 32.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	32.3	13.0	5.9	22.7	8.4	8.1	11.2	2.0	6.8	14.2	18.5	5.9	6.0	14.8	14.0	12.8	17.9	12.0	15.1	21.5	5.0	5.1	17.3	39.2	21.3	18.3	6.4	3.3	21.7	18.5	10.3	13.9	22.2	6.5	20.9	12.1	7.6	13.9	9.8	14.6	6.2	31.8	10.8	9.7	35.2	12.4	4.9	6.9	24.8	23.9	8.0	18.3	17.0	22.1	6.4	6.5	21.9	13.6	7.8	10.2	6.7	11.1	3.4	1.0	2.9	4.6	10.6	3.8	2.9	10.7	34.2	42.4	3.3	11.4	1.2	5.7	4.7	32.9	11.2	3.4	4.6	7.5	9.4	1.3	9.7	2.6	3.5	9.0	4.9	7.6	9.1	5.5	5.1	2.9	6.5	6.4	6.2	1.2	6.9	2.5	3.4	12.0	3.5	0.6	3.4	6.3	13.4	7.8	2.1	8.7	7.2	1.4	1.5	6.0	2.7	21.6	0.7	3.1	6.3	7.9	3.9	5.5	0.3	3.7	2.5	1.4	5.9	6.8	6.5	4.0	12.5	8.5	8.7	9.3	13.6	10.2	5.9	7.8	10.0	6.5	6.4	7.1	7.6	21.9	7.8	13.5	0.7	7.4	6.7	5.9	8.4	2.0	6.8	5.0	5.1	6.4	3.3	6.5	6.9	29.8	25.5	10.7	7.5	7.9	0.2	4.4	20.4	16.0	15.9	7.0	0.0	3.1	0.0	21.6	1.5	16.6	25.5	0.0	27.9	13.8	9.6	16.0	15.1	50.5	24.2	0.0	17.7	24.5	34.9	0.6	7.8	19.5	5.0	20.8	21.5	5.0	28.4	11.5	8.5	11.1	0.2	32.3	6.6	0.9	0.7	5.3	1.5	13.4	16.9	18.6
PARP15	"FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577602-122639047	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.9;lymphoid tissue: 40.4"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 12.8;B-cells: 22.9;Ciliated cells: 18.7;granulocytes: 18.5;Hofbauer cells: 6.6;monocytes: 6.4;T-cells: 12.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5"	"Group enriched"	"Detected in many"	6	"B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3"	"Cell line enhanced"	"Detected in some"		"HEL: 10.6;JURKAT: 6.6;REH: 4.9;THP-1: 5.1;TIME: 12.6"					"Not detected"	"Not detected"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	2.4	0.9	0.5	24.5	0.4	9.8	1.3	0.3	0.8	1.2	2.8	1.2	0.5	1.0	1.5	2.3	1.9	1.4	2.8	1.5	0.6	0.5	1.5	1.9	5.6	20.3	0.6	0.6	1.1	2.7	0.0	1.0	1.0	0.6	1.3	2.1	1.8	5.5	0.2	2.6	0.7	22.9	0.9	0.9	40.4	1.7	1.7	0.4	9.4	1.9	1.7	34.8	3.6	1.2	11.9	1.2	1.3	0.6	5.2	9.3	2.7	0.6	0.2	0.5	0.5	0.2	0.3	0.6	0.3	0.2	0.1	0.1	0.3	1.0	0.8	0.6	0.2	0.3	0.6	0.1	0.0	0.0	1.9	0.2	10.6	0.8	0.5	0.2	0.7	0.5	2.2	0.1	0.4	0.2	0.4	2.4	6.6	0.3	2.1	0.0	0.5	3.2	0.7	0.7	0.2	0.3	4.9	0.4	0.6	0.0	1.0	0.8	0.5	0.3	0.2	0.3	0.6	0.8	5.1	12.6	0.4	1.1	0.5	0.4	1.0	0.7	2.4	0.7	0.3	0.2	1.3	0.2	0.1	9.3	0.5	6.5	11.2	5.0	6.4	0.9	11.9	4.3	5.9	0.7	5.2	0.6	1.2	4.5	2.7	0.5	0.4	0.3	0.8	0.6	0.5	0.6	0.6	0.6	0.4	17.9	12.8	22.9	0.0	0.5	0.0	0.4	0.0	18.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	18.5	0.5	6.6	0.0	0.0	2.5	3.5	0.0	0.0	3.2	1.7	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	12.9	0.0	0.0
PARP14	"KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680618-122730840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 229.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 29.6;BJ hTERT+ SV40 Large T+ RasG12V: 45.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	21.6	10.3	5.6	15.8	7.2	11.7	9.3	2.3	6.0	11.6	13.3	5.9	6.4	11.4	10.6	12.7	11.7	7.2	10.0	6.5	5.2	4.8	13.7	21.5	26.0	16.7	7.3	5.2	10.0	6.7	7.2	6.8	17.5	6.3	12.3	6.7	7.5	8.5	5.5	5.2	5.7	22.3	11.9	6.8	29.7	7.6	4.6	4.9	18.7	20.4	6.4	18.9	12.8	12.4	15.9	4.2	20.8	10.5	7.4	7.0	2.8	5.9	5.0	3.2	3.4	4.5	10.7	0.0	2.3	15.6	29.6	45.6	2.6	11.9	0.0	9.8	5.2	16.6	4.6	4.6	4.8	6.0	9.1	0.5	5.5	2.3	4.0	10.9	2.4	2.7	6.4	2.4	5.1	2.0	7.2	12.8	4.9	2.6	8.9	1.0	3.1	9.1	1.6	0.4	0.9	4.3	12.8	3.2	1.6	7.2	6.2	0.2	0.0	6.0	1.3	6.7	0.4	2.2	4.3	8.6	1.6	3.9	0.9	2.1	3.5	0.6	1.0	4.8	5.7	2.8	8.3	8.2	4.0	6.9	10.5	6.0	10.2	3.8	4.5	4.2	15.9	3.2	3.4	20.8	7.4	9.3	0.6	7.0	2.8	5.6	7.2	2.3	6.0	5.2	4.8	7.3	5.2	6.3	4.9	229.3	87.3	41.0	15.2	14.9	1.1	10.1	30.6	52.2	84.2	24.4	3.9	12.0	3.3	28.1	0.3	61.9	21.0	0.0	35.6	24.3	19.7	23.9	30.2	29.6	32.4	0.0	10.3	67.5	50.6	0.2	25.9	50.6	15.1	94.6	14.3	18.7	33.8	17.5	16.3	7.0	0.8	12.9	18.4	1.6	1.1	9.3	4.0	27.4	11.0	21.3
HSPBAP1	"FLJ22623, PASS1"	ENSG00000169087	"HSPB1 associated protein 1"	Q96EW2	3	122740003-122793824	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 56.9;Syncytiotrophoblasts: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044930	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044930: AB_10961122"	"unprognostic (3.40e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.70e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.24e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.12e-3)"	7.2	9.3	6.7	9.2	6.9	4.5	13.1	3.1	6.7	6.8	6.0	7.0	9.1	4.1	7.9	5.3	5.2	5.3	6.0	6.1	6.0	5.3	7.1	5.8	10.4	9.1	7.8	4.5	5.8	6.3	5.3	9.0	17.0	8.7	5.8	5.9	10.2	6.0	6.4	25.4	7.0	5.9	8.1	10.8	11.4	5.4	16.5	8.3	9.1	10.6	8.9	8.8	7.9	5.6	8.3	9.2	22.0	15.5	4.5	7.2	5.8	4.5	3.5	5.1	4.5	6.1	4.6	9.9	2.3	5.8	5.4	7.6	4.7	3.6	5.8	3.7	1.6	13.6	5.5	7.8	4.3	6.3	3.6	2.1	3.8	4.1	2.7	13.8	3.5	5.4	6.8	15.8	4.4	14.4	5.1	5.0	5.9	2.5	5.0	4.8	2.9	5.0	4.4	5.8	3.5	7.1	5.2	6.8	5.6	5.5	1.7	5.6	5.7	5.3	2.1	19.1	5.0	2.5	7.4	5.0	6.3	3.7	2.0	3.1	5.0	5.0	6.9	3.9	5.2	6.1	13.3	12.1	8.3	4.7	8.6	5.8	8.3	6.1	4.6	9.2	5.6	6.8	6.5	22.0	4.5	15.5	3.1	7.2	5.8	6.7	6.9	3.1	6.7	6.0	5.3	7.8	4.5	8.7	8.3	6.0	7.7	8.7	3.7	9.5	5.3	4.1	2.5	5.3	2.3	5.2	56.9	13.9	3.3	4.6	17.2	4.7	3.9	0.0	5.2	9.6	4.2	2.6	5.8	2.5	11.6	7.9	0.0	12.9	18.1	3.6	8.9	21.8	5.0	17.2	2.6	3.4	3.9	2.6	4.6	3.6	10.8	6.5	3.8	22.6	7.1	6.6	40.6	10.2	3.3	1.7
DIRC2	"FLJ14784, RCC4"	ENSG00000138463	"Disrupted in renal carcinoma 2"	Q96SL1	3	122794795-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Syncytiotrophoblasts: 189.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles		NA	NA			Vesicles		"HPA072579: AB_2686536"	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favorable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	7.6	7.8	6.5	4.0	7.7	7.9	6.8	5.2	8.8	5.0	6.2	10.0	4.4	3.0	4.2	6.1	8.8	5.0	5.9	9.9	6.4	6.3	7.5	9.2	8.0	6.9	7.5	4.5	4.9	12.9	18.4	7.6	34.8	6.7	7.8	6.9	11.9	7.7	6.0	27.0	9.7	6.1	6.7	7.8	5.8	5.9	4.2	3.8	3.1	8.0	11.2	7.4	7.4	5.4	0.6	0.3	4.2	0.8	0.0	0.5	0.1	5.6	4.7	4.7	2.6	6.1	5.0	15.7	2.4	5.3	3.9	4.0	11.1	6.4	0.8	3.1	2.7	8.8	8.3	3.4	4.4	3.8	1.2	2.5	0.9	2.6	4.7	4.5	0.5	0.6	4.1	12.0	2.8	4.8	6.1	4.4	1.6	0.5	1.0	5.0	2.5	0.7	0.6	4.2	1.9	7.8	1.5	10.6	1.2	5.6	6.6	4.9	3.8	7.1	3.3	6.3	3.1	3.8	1.2	6.2	6.1	2.3	3.7	2.0	1.1	0.9	0.3	3.1	1.0	3.3	0.0	0.7	0.1	0.5	0.8	0.0	0.1	0.0	0.0	0.3	0.6	0.5	0.3	4.2	0.0	0.7	0.0	0.1	0.1	6.5	7.7	5.2	8.8	6.4	6.3	7.5	4.5	6.7	3.8	11.9	5.9	2.7	17.9	9.4	4.8	11.8	7.6	6.7	7.9	14.0	3.9	38.7	1.7	19.4	2.9	3.9	4.4	0.0	22.2	50.7	5.1	13.3	2.3	3.9	11.3	1.6	14.3	4.3	12.7	1.0	3.1	12.2	8.5	21.6	5.6	20.3	18.6	6.8	4.2	5.7	5.4	6.5	3.8	4.7	4.1	10.2	189.5	1.8	4.7	14.5
SEMA5B	"FLJ10372, KIAA1445, SEMAG, SemG"	ENSG00000082684	"Semaphorin 5B"	Q9P283	3	122909193-123028605	"Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;heart muscle: 11.7"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 2.5;Cardiomyocytes: 3.2;Cholangiocytes: 2.5;Ito cells: 3.1;Muller glia cells: 10.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 42.4;NTERA-2: 8.2;SH-SY5Y: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066548	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA066548: AB_2685689"	"unprognostic (7.34e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.92e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (1.31e-3)"	"unprognostic (5.96e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.12e-1)"	1.5	1.2	12.0	0.7	12.3	0.3	1.1	0.8	13.6	2.1	1.5	4.3	0.4	1.9	2.8	5.5	1.5	3.0	4.7	11.7	13.0	3.3	6.1	1.4	2.2	1.1	2.5	3.3	1.3	3.1	1.1	2.5	5.0	2.0	1.8	1.8	6.0	0.9	3.1	1.6	1.2	1.3	3.8	1.7	0.5	0.7	1.1	5.7	0.1	2.2	2.5	1.3	3.3	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	42.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	11.3	0.0	0.1	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.0	12.3	0.8	13.2	13.0	3.3	2.5	3.3	2.0	5.7	0.0	0.6	0.0	0.0	0.0	2.5	3.2	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	1.0	0.0	10.6	0.0	0.0	0.0	0.0	0.9	0.0	2.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067062-123225227	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.0"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA		2900000	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	11.6	17.1	2.6	11.2	3.1	6.3	9.3	1.0	4.0	10.0	11.0	2.4	10.9	5.6	12.2	17.1	6.7	9.1	22.2	7.2	2.5	1.2	11.0	66.0	14.4	7.1	2.2	1.8	11.4	18.3	5.2	12.1	29.1	1.9	14.3	10.8	12.7	10.8	7.6	8.1	6.1	8.2	9.5	2.3	8.6	17.6	18.0	2.5	3.2	18.2	5.5	7.9	7.8	6.9	3.2	12.8	0.3	9.0	0.5	2.4	2.3	8.2	5.1	6.4	7.7	29.4	26.7	34.1	15.8	26.5	8.8	24.4	16.3	7.6	0.0	20.6	24.4	5.7	4.4	2.8	9.6	9.4	0.2	3.1	3.6	1.5	19.4	12.2	9.1	0.6	22.8	14.5	6.0	12.6	9.5	29.8	3.5	4.6	21.6	6.0	10.1	2.4	10.6	4.7	18.9	5.3	2.3	4.6	22.8	7.4	4.8	6.9	4.2	7.7	8.6	13.5	10.9	7.5	11.1	16.6	2.3	7.3	10.6	4.2	6.4	1.7	3.7	7.3	7.2	7.7	0.0	9.0	0.3	1.4	2.2	2.4	3.2	1.0	0.9	5.4	0.8	0.6	0.6	0.2	0.5	0.4	12.8	0.0	2.3	2.6	3.1	1.0	4.0	2.5	1.2	2.2	1.8	1.9	2.5	17.9	27.8	1.5	3.6	4.4	9.3	2.0	25.5	8.1	13.6	5.2	37.3	39.8	0.0	28.0	1.1	21.8	3.3	0.0	25.3	119.9	23.6	13.9	3.5	42.3	10.8	0.0	8.1	37.4	8.4	1.5	22.5	4.5	8.5	1.8	26.1	2.0	13.8	3.5	20.8	4.9	29.6	12.9	7.3	1.2	1.5	3.6	42.0	2.2	16.3	4.3
SEC22A	SEC22L2	ENSG00000121542	"SEC22 homolog A, vesicle trafficking protein"	Q96IW7	3	123201927-123274130	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.25e-1)"	14.5	15.8	12.0	12.3	12.2	5.3	15.9	15.7	14.8	14.8	12.2	11.0	13.2	9.0	27.6	15.7	18.0	13.7	13.3	12.2	14.1	9.0	14.8	19.1	16.4	13.0	10.6	10.7	16.0	25.8	13.7	31.1	13.6	12.6	12.6	14.6	13.4	13.7	14.5	8.8	18.9	11.9	17.7	10.6	14.3	12.1	26.3	11.6	17.5	14.9	11.9	17.2	12.6	13.9	14.2	14.2	11.4	14.7	20.4	22.9	12.6	27.9	9.2	13.2	10.9	19.6	19.3	13.6	23.0	16.6	17.6	23.2	8.4	13.7	16.4	17.6	14.6	16.7	18.7	11.8	14.8	27.4	6.7	9.3	11.0	8.4	6.6	20.1	13.8	8.2	13.9	19.2	13.8	14.4	13.5	20.7	12.1	7.1	12.0	16.6	12.2	10.6	8.9	5.0	19.9	18.3	7.8	17.5	14.1	13.8	8.5	10.6	7.8	15.3	10.1	15.2	10.7	21.7	14.5	11.3	12.1	13.3	21.5	14.1	7.3	7.1	23.6	18.1	14.4	19.0	9.8	14.7	11.4	18.6	13.7	22.9	14.2	19.3	20.2	14.2	11.9	21.1	17.2	2.2	20.4	13.0	13.8	19.4	12.6	12.0	12.2	15.7	14.8	14.1	9.0	10.6	10.7	12.6	11.6	3.0	8.9	5.1	15.3	7.4	6.6	5.1	12.7	5.3	11.4	7.0	3.9	23.6	8.3	15.7	23.7	8.3	4.7	0.0	8.9	16.8	10.8	8.9	6.9	7.5	12.1	1.6	7.5	16.0	3.7	13.7	11.2	6.3	5.0	11.8	6.5	6.1	8.9	3.5	6.3	7.1	7.2	19.4	9.2	41.6	9.6	8.3	36.8	10.2	6.6	10.5
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449758	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.9"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 56.0;Paneth cells: 59.6;Peritubular cells: 69.3;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 18.0;RPMI-8226: 3.1;RPTEC TERT1: 6.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 347.3"	"Region enriched"	"Detected in all"	6	"basal ganglia: 205.1"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	13.3	3.0	12.5	3.7	32.0	0.6	9.3	2.6	14.4	4.5	11.7	10.4	3.1	4.2	6.2	4.4	13.8	5.3	7.3	69.9	10.4	8.3	5.3	2.4	2.6	2.0	15.0	8.6	10.1	5.7	1.1	7.7	4.8	9.7	13.8	4.6	4.6	3.1	16.3	2.2	1.1	4.8	13.5	8.8	4.7	9.6	5.9	16.0	0.0	1.0	0.2	2.6	9.5	8.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.7	1.6	0.1	0.1	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.4	0.2	2.7	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	18.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	3.1	6.5	0.6	2.2	2.0	0.0	0.6	0.1	2.2	0.0	0.1	0.0	0.1	1.5	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	12.5	32.0	2.6	14.4	10.4	8.3	15.0	8.6	9.7	16.0	0.0	0.0	0.0	0.1	0.2	16.5	56.0	2.5	0.0	0.0	7.0	0.0	1.1	0.0	11.5	0.7	0.4	0.5	0.0	6.3	3.1	2.3	0.1	0.0	0.0	0.2	0.0	0.0	2.5	0.0	1.1	19.0	0.0	0.0	1.8	0.3	0.8	0.6	59.6	69.3	0.7	1.5	64.7	12.2	0.7	5.6	0.6	10.4	0.0	1.2	0.0
HACD2	PTPLB	ENSG00000206527	"3-hydroxyacyl-CoA dehydratase 2"	Q6Y1H2	3	123490820-123585185	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019282	Approved					NA	NA					"CAB019282: "	"unprognostic (3.04e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.36e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.59e-5)"	"unprognostic (6.90e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.59e-2)"	43.2	9.7	18.0	11.2	30.0	5.7	16.6	20.5	18.7	14.1	20.4	28.6	7.4	21.2	12.4	13.5	18.8	9.9	12.2	9.9	20.7	13.4	20.7	34.3	13.8	14.1	29.4	12.0	13.8	13.4	15.6	12.5	11.1	18.5	22.1	20.4	7.3	15.5	10.2	5.6	23.2	30.8	12.3	24.9	9.6	15.3	13.3	25.7	9.1	16.0	10.5	19.7	10.9	16.6	4.9	6.4	2.4	3.5	2.9	5.3	2.4	19.6	11.2	7.7	5.6	24.2	5.4	28.7	14.1	5.9	14.7	10.7	22.8	17.5	11.4	10.2	13.5	17.1	43.2	13.8	17.7	15.6	7.2	4.6	7.9	10.5	17.7	7.9	10.5	7.9	7.5	45.7	7.1	20.0	23.1	7.6	7.9	1.6	11.4	8.8	15.3	4.9	3.1	9.9	24.0	9.9	7.6	8.5	12.1	17.8	12.7	13.6	4.2	65.7	14.1	9.0	11.7	14.6	5.4	5.9	15.4	11.6	15.4	13.7	6.8	8.6	9.4	6.9	7.4	8.2	1.5	3.5	2.4	3.6	2.8	5.3	3.4	4.8	4.6	6.4	4.9	4.4	4.3	1.1	2.9	2.2	3.7	5.3	2.4	18.0	30.0	20.5	18.7	20.7	13.4	29.4	12.0	18.5	25.7	6.0	35.5	13.7	26.4	0.0	8.3	12.6	15.3	5.3	28.4	43.6	5.9	20.9	6.6	13.4	12.7	13.7	18.6	0.0	16.5	13.3	10.4	36.8	3.5	42.9	20.1	1.6	15.2	14.7	20.2	7.3	10.6	17.1	0.0	16.2	21.7	13.5	16.4	21.0	16.6	13.9	12.9	6.5	8.8	8.1	20.5	0.0	5.6	11.7	24.7	26.3
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell type enhanced"	"Detected in many"	16	"Peritubular cells: 649.2;Sertoli cells: 271.7;Smooth muscle cells: 829.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ: 36.4;BJ hTERT+: 55.1;fHDF/TERT166: 45.0;HBF TERT88: 29.0;hTERT-RPE1: 38.5;RPTEC TERT1: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		3000000	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.0	1.3	2.1	0.4	0.9	36.4	55.1	23.6	16.9	1.6	1.4	0.1	8.2	45.0	11.2	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	10.9	0.1	1.9	6.8	0.7	4.6	6.9	38.5	1.8	0.2	0.2	0.1	17.4	0.3	0.0	0.5	2.2	0.1	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	5.0	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0	14.9	34.7	2.9	24.1	18.2	2.5	16.5	33.1	5.3	6.8	26.2	117.8	0.6	3.3	4.5	38.5	34.3	13.8	0.0	3.6	0.6	23.4	4.9	2.3	169.4	4.0	3.2	10.9	66.9	9.2	26.0	97.0	8.0	18.6	0.0	3.0	4.8	2.7	24.0	649.2	9.6	18.7	271.7	829.4	3.0	3.3	17.7	2.1	0.5	3.7	1.6
CCDC14	"DKFZp434L1050, FLJ12892"	ENSG00000175455	"Coiled-coil domain containing 14"	Q49A88	3	123897305-123961408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035278, HPA035279"	Uncertain		Enhanced	Centrosome		NA	NA			Centrosome		"HPA035278: AB_2674548, HPA035279: AB_10601253"	"unprognostic (7.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.45e-2)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (6.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (4.76e-4)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (2.14e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.37e-2)"	"prognostic favorable (2.72e-5)"	11.3	9.7	13.6	22.4	15.2	30.0	19.1	8.0	16.2	14.5	18.8	10.8	7.7	12.0	20.4	31.9	10.2	15.8	14.9	9.1	13.6	8.7	13.3	13.7	14.1	14.3	14.3	13.0	20.6	15.4	7.8	24.4	9.7	14.5	17.2	31.8	9.6	14.3	9.8	5.9	20.2	15.9	13.6	17.4	13.7	12.8	22.5	16.0	36.5	14.0	11.2	13.3	12.7	13.0	2.1	4.5	3.0	2.2	6.0	5.6	1.9	16.7	9.8	30.3	12.0	4.2	6.2	14.2	33.7	11.1	16.3	18.9	7.6	11.9	5.0	8.6	7.0	12.7	19.0	11.0	5.5	22.1	4.1	7.7	19.9	18.0	7.1	4.0	13.0	12.8	6.2	3.5	8.5	9.1	20.7	7.7	19.8	10.2	9.2	11.2	8.3	11.3	6.2	9.1	7.3	11.5	19.5	12.6	5.7	9.4	13.7	10.6	12.6	19.7	4.9	12.8	19.1	11.8	9.6	10.1	39.5	20.5	12.1	10.9	8.7	6.0	14.9	13.3	10.0	13.7	2.8	1.6	3.0	3.9	2.2	2.6	2.1	3.4	3.3	1.0	2.0	3.8	3.2	0.3	6.0	0.6	4.5	5.6	1.9	13.6	15.2	8.0	16.2	13.6	8.7	14.3	13.0	14.5	16.0	20.8	56.7	6.7	33.3	19.5	35.1	11.0	28.1	18.7	30.7	34.9	56.9	19.0	0.0	20.0	29.2	21.5	42.4	46.7	12.1	20.0	27.5	16.9	24.4	17.3	17.6	27.0	86.3	27.0	18.7	14.7	30.2	21.2	23.6	13.6	87.0	23.6	17.3	49.1	29.4	7.8	79.1	19.4	25.5	98.1	43.0	14.1	9.7	24.9	75.9	16.3
ROPN1	"CT91, ODF6, ROPN1A, ropporin"	ENSG00000065371	"Rhophilin associated tail protein 1"	Q9HAT0	3	123968521-123992178	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 50.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 1101.7;Late spermatids: 384.4"	"Group enriched"	"Detected in some"	33	"breast cancer: 0.8;melanoma: 3.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 24.9"									HPA052530	Supported					NA	NA					"HPA052530: AB_2681861"	"unprognostic (1.75e-5)"			"unprognostic (2.24e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.66e-2)"			"unprognostic (1.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.13e-1)"			"unprognostic (2.08e-2)"	"unprognostic (8.35e-4)"			0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.1			0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	50.7			0.0		0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.9	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.2	0.4	0.0	0.1	0.0	0.1	0.3	0.2											0.0	0.0	0.0	0.0	0.7	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1101.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	384.4	8.1	0.0	11.8	0.0	0.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	88.5	4.1	0.0	0.0	0.0	0.0	0.0
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;retina: 31.2"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 71.2;Early spermatids: 45.5;Ito cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.4;HEL: 19.8;OE19: 11.2;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in many"							"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		110000	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	5.5	4.3	12.7	2.4	14.1	0.6	4.2	1.8	35.2	4.0	3.8	3.7	0.5	2.7	5.6	2.3	9.6	4.2	3.1	12.1	17.6	3.9	2.6	7.3	2.9	1.1	4.1	15.8	2.3	11.9	2.5	14.4	6.8	9.4	3.1	2.1	31.2	2.2	5.4	23.5	1.5	7.2	6.4	3.6	8.0	11.5	2.2	2.4	0.0	5.3	6.7	3.1	2.9	4.1	0.1	0.0	0.9	0.0	0.1	4.3	1.2	0.3	0.6	3.6	0.7	0.5	0.1	4.7	1.4	0.9	1.4	0.6	32.4	2.5	0.1	0.4	3.6	2.2	0.2	0.8	0.0	1.1	0.0	0.3	19.8	0.3	4.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.5	1.6	0.0	4.5	0.1	0.4	2.4	0.0	0.0	2.0	11.2	3.2	1.0	1.6	0.0	0.1	0.3	1.2	9.3	0.4	0.3	0.3	3.6	0.7	0.1	8.2	4.1	1.6	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.0	2.4	0.7	0.9	0.1	0.0	0.0	4.3	1.2	12.7	14.1	1.8	35.2	17.6	3.9	4.1	15.8	9.4	2.4	3.0	3.8	0.0	1.4	1.4	71.2	33.4	17.8	8.1	0.0	15.7	5.9	7.3	1.7	4.7	45.5	26.9	30.6	0.0	7.2	0.7	4.8	2.8	3.5	17.4	0.8	0.0	9.2	50.3	2.6	34.6	3.4	0.7	3.3	0.0	12.2	5.4	3.9	20.4	31.1	2.4	2.7	19.4	14.6	1.9	1.7	1.0	11.9	0.7	10.0	1.4
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730366-124749273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 91.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	8.4	12.2	4.9	6.8	6.8	4.8	8.0	9.3	7.6	5.9	9.1	8.5	5.2	8.4	6.8	6.7	13.2	8.2	6.6	3.6	4.0	3.9	9.6	20.7	5.2	10.1	7.3	3.6	8.9	19.0	9.5	9.3	11.6	4.7	6.4	7.1	6.4	8.9	4.0	10.9	9.5	8.5	5.5	5.9	9.8	8.3	6.8	6.2	10.6	7.4	12.0	9.3	7.8	6.4	16.6	13.1	4.6	9.8	10.2	13.0	7.9	1.4	4.4	5.0	2.1	3.0	3.5	5.3	7.5	2.3	3.2	2.7	3.8	2.0	3.8	8.3	2.9	6.6	8.4	7.1	2.5	5.0	4.4	4.1	7.8	2.8	2.6	2.6	8.2	5.9	3.9	2.3	2.0	3.9	1.9	1.4	7.7	3.5	1.8	2.3	3.4	10.0	1.6	11.1	3.9	2.8	6.6	6.0	3.2	2.5	2.5	4.0	2.6	11.3	4.0	4.2	3.8	4.0	3.0	14.4	2.5	5.0	6.9	3.0	7.5	10.2	10.5	2.8	3.4	2.5	4.5	9.0	4.6	12.5	9.8	12.1	13.7	8.9	11.3	13.1	16.6	13.0	10.4	0.6	10.2	8.0	9.7	10.3	7.9	4.9	6.8	9.3	5.7	4.0	3.9	7.3	3.6	4.7	6.2	6.0	7.8	5.2	15.9	14.1	8.0	5.7	12.7	22.7	10.3	8.7	3.9	56.7	24.9	23.5	3.1	13.4	10.4	0.0	26.6	27.5	9.3	9.3	11.5	28.8	19.3	4.8	9.2	8.0	5.4	3.9	12.7	9.6	3.3	21.6	9.4	10.1	19.5	7.0	13.1	19.5	7.7	12.9	9.9	19.7	30.7	16.7	91.3	12.8	15.8	15.5
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"		NA	NA		95000	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	72.5	13.8	9.7	9.7	10.0	0.8	50.1	5.7	8.2	34.2	18.8	14.8	28.0	12.9	31.7	17.2	25.6	13.9	29.1	32.9	9.4	5.1	19.6	22.1	20.4	3.5	12.0	6.2	17.4	12.1	8.9	8.4	36.4	13.0	23.0	10.1	27.1	18.6	23.1	15.9	33.3	16.1	25.1	9.0	18.7	12.4	17.0	8.7	2.8	18.8	16.2	10.9	24.4	27.1	0.1	1.1	0.4	0.6	0.9	2.1	5.8	28.5	71.2	5.1	12.9	48.3	14.1	26.4	30.6	19.0	5.7	9.2	14.2	37.3	0.1	14.9	51.9	28.1	22.9	4.6	15.9	5.0	0.3	3.1	10.1	11.0	14.9	8.4	0.0	18.5	8.4	3.7	14.3	7.5	81.6	19.1	0.0	9.0	15.3	19.5	29.0	0.1	0.1	22.9	16.0	7.9	0.0	8.2	10.7	16.1	6.3	0.1	10.7	22.7	33.8	25.8	9.4	19.1	0.6	49.1	21.5	32.5	18.6	15.8	2.6	2.7	0.1	22.5	0.1	74.2	0.4	0.6	0.2	2.1	0.2	0.0	0.0	0.2	0.0	1.1	0.1	0.3	0.4	0.4	0.9	0.4	0.1	0.0	5.8	9.7	10.0	5.7	8.2	9.4	5.1	12.0	6.2	13.0	8.7	6.0	7.9	2.2	18.8	15.2	6.2	26.4	43.3	5.3	10.3	27.9	3.9	56.6	10.0	34.5	7.5	22.6	19.6	0.0	16.3	4.7	30.7	22.0	0.0	32.1	60.3	33.4	3.4	41.1	27.6	2.3	18.7	16.7	10.1	0.0	13.3	47.4	43.9	27.4	15.6	10.2	15.2	38.8	35.3	1.4	6.4	19.4	46.1	0.0	15.0	12.0
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 334.4"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 474.6;Intestinal endocrine cells: 147.6;Mucus-secreting cells: 321.7;Paneth cells: 299.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"OE19: 70.4"									HPA045163	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045163: AB_10960396"	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.5	0.6	0.5	16.4	0.5	0.0	0.5	0.5	0.5	0.5	83.1	0.0	0.0	79.9	0.5	0.3	0.5	0.5	16.7	0.5	0.5	0.5	3.3	8.7	0.5	0.0	0.5	0.0	0.5	1.8	0.0	0.5	0.1	0.1	0.5	40.6	0.1	0.5	0.0	0.5	0.5	334.4	1.0	0.5	0.5	4.1	0.5	0.0	0.1	0.5	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	2.0	4.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.0	70.4	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.1	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.3	15.3	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.6	0.1	474.6	0.0	28.4	0.0	0.0	2.1	9.2	0.0	0.0	0.0	147.6	0.0	0.3	2.7	0.0	0.0	0.0	0.0	321.7	0.0	14.3	299.5	0.7	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	111.9	0.1
HEG1	"HEG, KIAA1237"	ENSG00000173706	"Heart development protein with EGF like domains 1"	Q9ULI3	3	124965710-125055958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 80.4;Cardiomyocytes: 80.5;Cone photoreceptor cells: 249.4;Ito cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 42.0;HHSteC: 51.1;hTERT-RPE1: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010952, HPA011559"	Approved		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		360000000	Vesicles	"Plasma membrane"	"HPA010952: AB_2668389, HPA011559: AB_1850580"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.11e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.16e-4)"	23.6	8.2	5.8	12.1	8.4	0.7	16.4	2.6	8.9	12.2	9.6	14.7	8.0	3.9	12.0	7.3	9.0	11.4	29.6	36.3	6.9	5.5	8.9	5.5	42.4	7.7	9.7	4.7	8.1	16.6	14.2	4.0	17.4	11.6	7.2	6.5	26.2	7.1	7.4	6.2	4.3	7.9	14.4	11.9	11.5	7.5	11.3	6.5	3.0	29.1	10.8	8.7	13.0	15.6	1.0	0.9	1.2	3.9	7.3	4.0	1.1	1.8	1.9	13.4	1.1	16.6	14.7	5.0	15.7	20.6	17.5	19.3	13.7	0.2	0.5	10.7	42.0	12.8	3.3	2.0	7.7	21.1	1.4	1.0	0.3	10.2	1.6	51.1	0.3	20.4	18.0	2.2	22.8	5.4	77.1	17.0	1.2	0.0	0.2	5.3	0.2	0.8	0.0	2.3	0.0	1.2	1.2	10.2	0.0	3.0	0.3	0.2	1.2	34.9	2.4	1.3	12.4	5.7	0.8	26.4	9.9	11.0	35.4	6.7	1.4	4.3	0.0	18.6	1.5	19.2	1.2	0.3	0.0	4.0	3.6	2.7	0.9	1.6	3.6	0.7	1.0	2.4	1.5	0.0	7.3	3.9	0.9	0.5	1.1	5.8	8.4	2.6	8.9	6.9	5.5	9.7	4.7	11.6	6.5	80.4	7.2	4.9	7.1	4.4	3.0	80.5	5.1	0.0	4.5	26.2	249.4	0.8	0.0	31.8	5.1	76.0	0.0	0.0	5.8	53.1	23.5	2.8	26.5	2.5	5.7	1.6	0.0	95.2	15.8	7.6	4.6	4.8	6.8	2.8	0.6	4.1	6.9	0.0	13.1	1.2	62.4	0.0	21.2	0.2	0.2	3.9	2.7	14.6	0.1	0.9
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;thyroid gland: 20.5"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 22.7;granulocytes: 18.4;Mucus-secreting cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.2;OE19: 17.3;U-2197: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031123	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.1	1.1	11.1	0.7	19.4	0.0	2.0	0.8	7.0	1.2	3.0	1.7	0.4	4.9	0.4	2.9	3.5	1.7	8.1	0.5	3.8	1.2	2.1	5.7	1.9	0.4	1.0	3.6	0.5	9.0	8.2	1.9	2.2	8.6	2.5	4.1	6.2	10.0	0.4	1.8	1.0	3.4	0.4	1.3	0.4	3.8	4.6	2.0	0.4	20.5	0.4	0.7	1.9	1.7	0.2	0.2	1.8	0.5	0.0	0.2	0.0	8.2	0.0	1.4	0.0	1.7	2.4	4.1	0.4	1.0	0.4	0.9	10.7	3.9	0.0	1.0	3.7	1.4	5.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	18.2	0.0	0.6	4.7	5.0	1.4	0.5	9.7	0.0	0.0	0.0	0.3	0.6	2.2	0.0	0.0	5.7	17.3	0.4	0.0	0.1	0.0	4.2	0.6	2.4	0.0	4.8	5.1	0.1	0.6	9.1	0.2	0.1	0.1	0.7	35.3	0.0	0.1	1.0	2.7	1.7	0.0	0.7	1.8	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	19.4	0.8	7.0	3.8	1.2	1.0	3.6	8.6	2.0	0.0	0.3	0.0	1.1	0.9	0.0	1.0	0.0	0.0	1.2	22.7	0.0	0.3	0.0	3.9	0.2	0.0	2.0	0.0	2.9	6.2	1.3	5.0	18.4	6.4	0.8	0.0	5.2	0.0	0.0	0.0	0.0	0.6	0.0	3.6	28.6	0.0	4.3	2.9	0.0	1.1	0.0	0.0	0.3	0.7	0.4	0.3	2.5	0.0	5.0	0.9
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225561-125375354	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	10.5	9.2	12.5	13.4	17.4	5.3	9.4	18.4	17.7	10.7	8.9	4.1	3.3	5.7	11.2	8.3	8.9	10.2	8.6	11.7	11.2	7.2	10.6	9.0	8.8	8.8	11.9	11.8	14.5	7.7	15.7	18.2	7.6	10.5	9.1	9.2	6.7	10.3	12.2	12.2	7.6	8.0	11.0	7.6	8.6	7.4	9.5	10.9	25.4	24.4	3.2	10.8	10.7	9.8	13.9	7.3	29.7	12.1	18.8	17.3	10.2	18.4	12.2	13.3	11.8	11.9	12.9	10.1	16.8	19.7	18.9	18.1	11.5	10.3	14.9	11.8	24.8	15.3	15.1	14.5	12.7	27.0	6.6	5.5	18.3	14.7	5.9	8.8	12.5	18.5	10.4	13.3	17.7	18.8	12.5	12.9	10.9	8.9	12.7	13.9	14.4	15.5	4.6	8.5	12.5	10.5	11.2	14.6	8.3	10.8	20.6	11.5	9.7	22.4	11.4	18.7	7.7	14.2	12.6	16.6	14.4	15.5	18.0	10.7	11.1	12.6	22.6	10.8	8.0	13.2	2.5	8.7	17.4	13.4	8.4	13.8	13.8	11.8	12.5	7.3	13.9	17.3	13.5	29.7	18.8	12.1	6.5	10.8	10.2	12.5	17.4	18.4	17.7	11.2	7.2	11.9	11.8	10.5	10.9	86.4	32.9	27.3	25.1	31.6	67.0	66.1	28.1	24.1	43.3	31.4	37.3	23.6	21.6	32.2	73.6	43.1	22.7	46.7	32.7	20.8	30.5	30.4	48.6	37.5	26.6	71.5	46.0	36.8	37.3	83.4	44.5	32.2	16.9	28.9	37.1	41.2	29.0	17.5	55.5	36.0	37.8	32.3	38.1	18.2	18.1	33.5	26.4	45.9	33.3	32.5
SNX4	ATG24B	ENSG00000114520	"Sorting nexin 4"	O95219	3	125446644-125520197	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005709	Uncertain					NA	NA					"HPA005709: AB_1080049"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	18.8	22.1	19.9	18.3	17.3	11.5	21.1	20.3	20.2	17.8	24.6	16.7	10.8	28.8	17.6	13.6	15.1	12.5	16.5	17.1	20.8	20.4	43.1	45.2	15.7	14.2	20.1	17.6	15.6	18.5	13.3	19.3	26.1	18.7	19.5	23.2	11.7	17.8	14.7	32.4	10.2	38.7	17.3	27.7	15.0	17.4	14.4	13.3	20.5	37.3	10.8	13.6	14.0	13.5	12.3	15.6	21.0	15.7	14.4	15.1	10.7	17.0	5.4	17.8	11.1	11.0	9.3	20.2	9.3	8.9	18.5	16.7	11.8	7.8	10.9	11.1	11.2	8.0	9.1	16.5	7.9	22.3	10.1	12.1	17.6	7.6	17.8	12.9	18.4	11.4	11.9	8.8	9.4	7.6	10.4	17.3	16.1	18.7	5.5	14.1	12.8	20.2	12.5	10.3	18.6	6.6	18.8	21.6	19.8	17.1	15.3	18.7	26.3	15.0	19.6	22.9	17.3	19.2	30.4	11.2	9.4	11.9	12.0	10.9	11.4	9.7	30.0	11.4	11.8	14.1	9.3	12.4	21.0	9.0	15.7	11.8	12.3	11.6	10.2	15.6	9.5	15.1	12.9	2.2	14.4	15.1	13.8	12.7	10.7	19.9	17.3	20.3	20.2	20.8	20.4	20.1	17.6	18.7	13.3	26.8	32.5	17.9	16.5	10.8	12.8	14.5	38.2	38.8	34.2	21.0	0.0	75.6	51.4	39.6	16.4	19.6	35.3	0.0	31.9	48.0	28.6	16.9	30.1	69.5	43.8	17.5	28.8	20.3	29.7	25.0	20.4	30.5	28.7	50.5	35.2	19.3	37.1	43.5	17.0	107.8	11.3	12.9	24.7	29.3	30.0	10.3	34.4	22.3	28.0	13.4
OSBPL11	"FLJ13012, FLJ13164, ORP-11, ORP11"	ENSG00000144909	"Oxysterol binding protein like 11"	Q9BXB4	3	125528858-125595090	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 48.9"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039144			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA039144: AB_10794086"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.73e-3)"	"unprognostic (6.38e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.13e-1)"	8.1	5.1	12.6	8.1	16.9	4.7	13.2	5.7	9.7	5.4	7.2	14.1	4.9	5.1	6.1	6.1	6.8	5.0	5.2	5.3	11.0	7.7	6.8	22.4	10.9	11.1	11.2	8.3	4.5	3.8	8.5	5.1	9.0	8.7	4.6	6.6	4.6	5.1	9.7	48.9	6.3	6.0	7.0	10.3	11.4	5.2	7.8	10.9	8.3	5.9	6.0	9.4	6.3	5.3	3.5	11.8	12.8	9.5	1.9	2.2	3.2	13.1	7.1	13.6	7.7	15.5	8.3	17.8	9.9	8.0	12.6	14.5	13.7	4.7	21.7	12.4	8.2	10.4	9.9	15.1	8.7	16.9	5.8	6.5	9.9	8.6	9.1	8.7	7.4	13.6	6.7	10.7	10.5	9.2	5.1	9.1	10.5	10.2	9.9	11.4	7.8	14.7	3.6	18.7	9.7	6.4	13.0	7.9	25.3	10.5	8.2	3.0	8.1	12.2	7.0	10.5	9.8	7.3	3.9	9.4	10.1	9.1	14.6	7.7	6.3	6.6	26.6	7.1	2.6	9.7	10.8	9.3	2.4	1.8	9.5	1.5	3.5	1.0	1.8	11.8	2.7	1.2	1.4	12.8	1.9	7.8	4.5	2.2	3.2	12.6	16.9	5.7	8.4	11.0	7.7	11.2	8.3	8.7	10.9	8.9	11.8	18.6	7.4	8.9	18.9	7.9	5.1	9.4	12.5	8.7	11.8	10.0	5.0	8.2	0.8	9.2	12.6	0.0	6.1	9.0	7.4	5.3	3.5	31.6	22.8	7.9	4.1	11.6	56.9	2.5	6.1	35.7	11.8	13.6	5.2	11.2	8.5	11.9	6.7	8.0	32.0	6.5	8.1	9.1	20.4	13.8	19.3	8.4	6.2	9.6
ALG1L	ALG1L1	ENSG00000189366	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like"	Q6GMV1	3	125929275-125937039	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.4;urinary bladder: 12.5"	"Cell type enriched"	"Detected in many"	5	"Ciliated cells: 30.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 11.0;CAPAN-2: 10.0;HaCaT: 10.7;MCF7: 20.7;OE19: 13.1;T-47d: 13.9"									HPA036108	Uncertain					NA	NA					"HPA036108: AB_10673344"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.57e-2)"	"prognostic favorable (6.24e-4)"	0.0	0.5	2.3	0.8	1.6	0.0	1.1	0.3	1.8	0.8	0.9			0.0	0.9	11.4	1.3	2.0	0.4	0.1	1.6	2.0	1.0	1.0	0.7	0.0	2.2		1.7	0.7	0.0	1.2	1.2		1.2	0.6		1.6	0.6	5.9	5.5	0.1	0.2	1.0	0.0	1.1	0.5			1.0		2.3	12.5	0.9	3.1	2.4	4.8	0.2	5.3	5.0	2.1	0.7	0.6	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.3	11.0	10.0	3.0	4.9	0.0	0.2	10.7	0.3	0.0	0.6	0.4	2.5	0.5	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	2.9	0.8	1.0	0.0	20.7	0.6	0.2	4.5	13.1	2.6	0.1	0.0	5.0	0.0	0.6	1.7	0.7	0.4	0.1	0.5	2.4	13.9	0.2	0.2	0.1	1.7	0.1	0.0	7.8	1.1	4.0	0.1	0.0	0.7	4.8	0.1	0.2	3.9	0.2	2.1	3.1	2.1	4.2	0.0	1.9	2.3	1.6	0.8	5.3	0.0	2.4	5.0	2.1											0.0	0.3	0.8	1.6	3.0	0.2	0.0	0.0	30.8	3.4	1.8	0.0	2.8	1.7	0.3	1.5	0.0	0.0	0.0	0.3	1.8	1.5	0.6	1.1	0.0	0.2	0.0	1.7	0.0	0.0	1.5	1.7	0.0	1.7	0.0	0.0	0.6	0.4	0.8	2.8	0.7	0.0	0.0	1.2	1.7	1.6	4.4	1.1	0.0	0.2	6.4
ROPN1B		ENSG00000114547	"Rhophilin associated tail protein 1B"	Q9BZX4	3	125969144-125983454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 64.4"	"Group enriched"	"Detected in some"	11	"Early spermatids: 1602.2;Late spermatids: 1647.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 4.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.0;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"SK-MEL-30: 33.3;WM-115: 12.0"									HPA052530	Supported					NA	NA					"HPA052530: AB_2681861"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.89e-3)"	"unprognostic (3.78e-2)"	0.2	0.0	0.4	0.2	0.8	0.0	12.1	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.5	7.7	0.2	0.0	0.2	0.6	0.2	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.8	0.4	0.3	0.2	0.0	0.2	4.7	0.2	0.2	1.8	0.2	0.2	0.2	0.2	0.0	64.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	1.2	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	1.9	0.0	0.2	0.1	0.1	0.1	1.6	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.0	0.1	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.2	0.1	0.0	33.3	0.0	0.4	0.4	0.0	0.0	0.3	0.1	0.1	3.5	0.7	0.2	0.0	0.0	12.0	0.0	0.0	0.0	0.2	0.0	0.2	0.7	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.3	0.1	0.4	0.8	0.2	0.5	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.1	3.3	0.0	14.9	0.0	16.0	4.5	0.0	0.0	0.2	0.0	0.2	1602.2	0.7	0.0	0.0	0.2	1.2	0.2	0.7	0.0	0.2	0.1	3.2	0.0	0.0	0.0	1647.5	17.5	0.0	141.7	0.0	0.0	0.0	0.1	0.0	9.2	0.0	0.2	19.4	0.3	130.6	7.5	0.5	0.1	0.0	0.0	1.1
SLC41A3	FLJ20473	ENSG00000114544	"Solute carrier family 41 member 3"	Q96GZ6	3	126006355-126101561	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045847	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045847: AB_2679472"	"unprognostic (1.77e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.36e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (6.04e-7)"	"unprognostic (1.26e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.54e-2)"	11.2	20.2	21.3	10.7	20.7	5.3	22.2	29.8	43.4	18.6	10.6	12.6	12.1	10.1	21.1	32.9	10.8	24.0	16.3	17.1	17.9	20.6	14.0	8.5	9.5	14.3	17.1	16.5	31.2	17.6	19.7	16.9	10.9	21.4	12.5	10.9	18.6	16.7	14.5	25.5	10.7	8.9	17.1	11.7	8.8	10.7	30.5	6.0	27.7	18.0	11.5	10.4	12.3	11.9	9.0	8.6	9.3	8.2	13.0	18.8	5.6	17.7	7.3	12.1	10.2	34.5	20.3	18.3	10.2	17.7	14.2	16.8	9.7	16.2	13.0	19.3	20.1	15.4	14.0	4.4	17.7	12.4	12.6	13.9	7.1	13.8	14.0	28.6	12.8	7.9	19.7	21.7	8.5	17.6	20.9	19.5	16.1	5.9	10.9	18.6	9.5	14.1	10.5	9.2	23.6	11.5	7.5	12.5	17.6	16.9	13.2	9.4	10.2	15.7	5.1	43.1	11.9	5.1	17.3	13.4	13.2	10.2	20.1	11.4	8.3	6.7	6.3	12.0	5.7	12.1	9.3	5.7	3.9	11.2	8.2	9.1	9.0	10.6	11.5	8.6	8.4	9.2	8.7	1.2	13.0	5.1	8.4	18.8	5.6	21.3	20.7	29.8	43.4	17.9	20.6	17.1	16.5	21.4	6.0	14.9	10.4	8.0	20.1	12.2	12.9	12.9	25.5	6.7	14.8	21.0	3.9	30.6	3.3	30.8	27.0	24.2	6.8	0.0	21.8	27.8	22.2	13.0	5.7	5.8	14.0	27.0	20.3	27.0	8.9	12.0	34.8	9.4	13.5	14.4	12.7	23.0	21.6	3.5	51.6	10.9	10.8	25.8	19.6	12.6	38.4	13.4	21.2	17.5	16.6	16.8
ALDH1L1	"10-fTHF, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 48.1;liver: 148.7"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 554.3;Proximal tubular cells: 175.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.9;Hep G2: 23.9;Karpas-707: 24.7;RPMI-8226: 12.9;RT4: 66.0;U-266/70: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		640000	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	28.9	12.1	13.7	1.8	17.1	1.2	6.0	8.6	10.9	7.8	4.9	5.7	2.3	1.1	1.9	2.2	3.6	3.4	1.9	8.1	8.9	5.3	48.1	148.7	1.3	1.2	9.2	10.1	11.3	10.2	1.4	0.9	1.1	10.8	3.3	3.3	5.1	34.1	4.1	30.7	1.5	1.3	2.4	7.7	1.1	1.9	4.9	6.2	0.0	1.7	6.2	2.8	11.0	3.1	0.1	0.8	0.8	0.2	0.2	0.4	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.9	0.7	3.2	0.0	0.6	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	23.9	3.2	3.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	24.7	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	12.9	0.3	66.0	0.1	0.1	0.3	3.2	0.0	0.2	0.0	0.0	0.1	0.4	1.9	0.0	0.0	13.6	4.2	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	13.7	17.1	8.6	10.9	8.9	5.3	9.2	10.1	10.8	6.2	0.0	5.9	4.5	44.7	0.1	0.2	14.9	22.9	10.7	64.8	12.2	0.0	0.0	61.3	2.2	18.0	2.7	2.3	0.0	4.8	0.1	0.8	8.1	25.6	554.3	0.1	0.0	1.2	12.3	15.3	25.4	24.5	2.6	3.3	0.0	9.1	35.7	1.9	0.0	21.2	175.8	1.0	6.5	1.0	1.1	1.2	0.0	0.1	7.0	2.2	48.0
KLF15	KKLF	ENSG00000163884	"Kruppel like factor 15"	Q9UIH9	3	126342635-126357442	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 25.6;Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 54.2;Peritubular cells: 18.7;Proximal tubular cells: 19.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.4;HHSteC: 20.3;RPMI-8226: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003286, HPA028866"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA003286: , HPA028866: AB_10600819"	"unprognostic (3.77e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (3.27e-7)"	"unprognostic (6.75e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.58e-3)"	35.0	7.7	11.8	2.3	19.8	1.5	13.8	10.0	14.2	6.1	6.2	11.6	4.4	2.8	7.4	6.0	7.3	10.4	5.1	16.9	15.7	6.0	20.1	32.5	7.1	2.9	24.8	7.0	40.6	46.3	3.2	6.1	3.2	14.6	9.3	2.4	7.0	23.1	7.5	41.0	3.7	3.6	5.8	10.5	4.0	11.1	4.7	22.3	0.0	8.6	4.5	2.3	11.9	22.0	12.2	9.4	18.6	10.4	13.9	12.0	9.1	0.4	0.0	1.2	5.2	33.4	0.6	5.7	0.3	0.8	0.4	0.7	0.6	0.0	1.8	0.5	0.0	1.0	0.0	3.0	0.1	0.1	0.1	1.2	0.1	0.4	4.2	20.3	0.0	0.1	3.1	0.2	0.0	0.7	0.0	0.3	2.5	2.3	4.1	0.1	0.4	0.0	0.7	3.7	0.7	0.1	2.6	0.1	10.9	0.1	0.4	0.4	4.4	0.1	0.2	5.4	1.9	0.3	2.5	0.1	0.1	0.2	0.2	0.1	2.7	0.3	0.4	0.1	0.8	0.7	18.6	7.4	10.2	7.7	10.4	9.3	12.2	8.2	8.1	8.4	11.8	10.7	12.0	17.9	13.9	9.1	9.4	10.7	9.1	11.8	19.8	10.0	14.2	15.7	6.0	24.8	7.0	14.6	22.3	6.0	2.9	1.9	2.3	0.0	1.6	25.6	10.2	1.4	1.2	0.0	0.0	0.1	24.9	0.0	0.1	1.1	0.0	23.3	0.0	0.2	0.9	3.9	0.0	54.2	0.1	0.0	0.0	5.5	2.2	0.6	11.2	0.0	1.7	0.0	0.0	11.0	0.6	0.0	18.7	19.2	3.2	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	1.4
CFAP100	"CCDC37, FLJ40083, MIA1"	ENSG00000163885	"Cilia and flagella associated protein 100"	Q494V2	3	126394939-126436556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 38.7;fallopian tube: 29.2;testis: 21.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 282.0;Late spermatids: 505.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 14.7;pons and medulla: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BEWO: 1.4;HaCaT: 1.2;Hep G2: 1.1;NTERA-2: 1.2"	"Low region specificity"	"Detected in all"							HPA046354	Enhanced					NA	NA					"HPA046354: AB_2679634"	"unprognostic (1.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (7.17e-5)"	"unprognostic (1.61e-3)"	"unprognostic (6.75e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-5)"	"unprognostic (3.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.58e-4)"	0.3	0.3	1.6	0.3	14.7	0.3	0.3	0.0	0.8	3.2	0.3	10.9	0.0	0.3	1.5	12.0	0.3	29.2	0.3	0.3	4.5	3.0	0.4	0.3	8.2	0.4	0.1	1.1	3.4	0.3	0.3	1.9	0.3	38.7	0.3	0.3	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	21.9	4.5	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	14.7	0.0	0.8	4.5	3.0	0.1	1.1	38.7	4.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	88.3	21.6	0.0	0.0	0.0	0.0	0.0	282.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	505.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	6.5	0.0	4.1	1.2	0.0	0.0	0.0	0.0	0.0
ZXDC	"FLJ13861, MGC11349"	ENSG00000070476	"ZXD family zinc finger C"	Q2QGD7	3	126437601-126475919	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049593			Approved	Nucleoli		Yes	No			Nucleoli		"HPA049593: AB_2680828"	"unprognostic (3.06e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.06e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.12e-3)"	13.4	9.7	11.5	8.5	13.1	44.5	12.6	15.9	11.7	12.1	10.6	16.0	12.3	6.9	14.4	12.0	11.9	12.3	10.3	8.5	10.5	5.7	10.2	14.9	10.6	9.9	17.4	7.9	15.7	19.3	19.2	11.9	9.9	10.9	12.4	7.6	13.4	13.2	9.7	28.9	18.0	10.2	10.0	10.5	11.0	9.8	9.0	13.2	14.1	11.6	8.5	9.1	14.5	12.3	1.0	2.2	2.5	7.6	0.8	1.1	0.4	14.1	7.3	9.2	8.6	10.0	7.9	16.3	6.5	7.2	9.5	8.5	10.9	6.2	10.6	11.0	5.8	8.8	11.7	12.2	7.5	7.5	5.6	10.3	8.2	8.4	7.1	10.7	12.6	13.5	6.2	14.7	5.8	10.5	9.4	9.6	12.6	8.8	14.2	7.9	8.3	12.1	7.0	13.0	9.3	7.4	13.1	6.2	13.3	6.7	10.3	16.7	9.3	12.4	9.2	17.1	6.3	12.4	11.2	9.7	8.8	11.4	13.1	7.8	11.8	5.5	14.0	9.6	9.9	9.6	2.4	0.8	1.6	1.1	0.4	0.4	0.3	0.8	0.8	1.4	1.0	1.1	1.0	2.5	0.8	7.6	2.2	0.5	0.4	11.5	13.1	15.9	11.7	10.5	5.7	17.4	7.9	10.9	13.2	23.8	14.1	2.7	7.3	5.6	28.6	3.4	15.3	6.7	9.1	5.2	43.2	6.2	6.6	4.4	1.5	6.8	7.7	0.0	5.2	2.0	3.8	5.0	2.3	11.3	5.1	12.7	3.5	7.4	4.3	0.2	6.9	6.2	1.7	1.8	5.9	24.0	4.0	4.9	7.1	6.9	27.2	0.0	4.7	3.2	7.7	3.8	5.3	5.0	6.3	5.3
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481281-126517773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 50.7"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 31.8"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	8	"NB-4: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					NA	NA		510000			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	31.8	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524283-126543291	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 46.8;liver: 42.5"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 56.2;Hepatocytes: 33.7;Spermatocytes: 29.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 46.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 46.8"	"Group enriched"	"Detected in some"	8	"CACO-2: 12.5;Hep G2: 22.4;NB-4: 14.9;THP-1: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA067960			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA067960: "	"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.5	0.2	0.2	0.5	0.3	0.9	0.0	0.2	0.6	0.1	0.9	0.1	0.0	0.8	0.0	1.1	0.1	0.1	0.2	1.1	0.2	0.1	2.6	42.5	0.6	0.6	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.6	0.5	0.1	0.3	0.0	1.8	0.0	0.3	2.9	0.6	9.7	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	7.0	46.8	10.6	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	10.6	46.8	0.0	6.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	9.8	0.0	5.2	0.0	0.0	3.6	0.2	0.3	0.2	0.6	0.2	0.1	0.3	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	12.3	0.0	1.2	1.3	7.6	3.8	1.4	3.2	0.0	0.0	0.9	0.0	0.0	2.9	1.1	7.9	0.0	0.0	0.0	29.3	2.7	0.0	0.2	0.0	1.6	0.0
C3orf22	MGC34728	ENSG00000180697	"Chromosome 3 open reading frame 22"	Q8N5N4	3	126526999-126558965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"testis: 28.3"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 1235.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"MCF7: 1.5;SCLC-21H: 1.0"					"Not detected"	"Not detected"			HPA059199	Enhanced					NA	NA					"HPA059199: AB_2683946"	"unprognostic (2.10e-1)"			"unprognostic (5.14e-5)"	"unprognostic (2.55e-1)"		"unprognostic (9.21e-2)"			"unprognostic (2.01e-1)"		"unprognostic (2.75e-1)"	"unprognostic (1.08e-3)"		"unprognostic (1.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1235.7	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	8.6	3.8	0.0	0.0	0.0	0.0	0.0
TXNRD3NB	"TR2IT1, TXNRD3IT1, TXNRD3NT1"	ENSG00000283374	"Thioredoxin reductase 3 neighbor"	Q6F5E7	3	126571779-126608555	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"parathyroid gland: 1.1"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.8;PC-3: 1.4"									HPA058257	Uncertain					NA	NA					"HPA058257: AB_2683655"																		0.1	0.0		0.1		0.0	0.0		0.0	0.0	0.0			0.0	0.2	0.0	0.0	0.5	0.0	0.0			0.2	0.0	0.2	0.0			0.7	0.0	1.1		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.1	0.0		0.0	0.0	0.7			0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.7	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TXNRD3NB	"TR2IT1, TXNRD3IT1, TXNRD3NT1"	ENSG00000206483	"Thioredoxin reductase 3 neighbor"	Q6F5E7	3	126571789-126572636	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"ovary: 1.4;testis: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;HL-60: 2.2;NTERA-2: 1.5;PC-3: 1.0;U-937: 1.1"									HPA058257	Uncertain					NA	NA					"HPA058257: AB_2683655"																		0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.6	0.1	0.4	0.0			0.0	0.3	0.7	0.8	0.8	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0		1.4	0.0	0.0	0.1	0.0		0.1	0.0		0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2			0.3		0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.8	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	1.0	0.2	0.0	0.8	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	14.0	3.6	4.6	7.2	8.5	13.0	2.3	6.2	5.6	5.1	7.2	6.4	7.9	0.0	7.9	8.5	3.1	5.6	5.7	6.4	6.5	0.0	4.2	1.6	3.3	4.9	7.4	5.7	0.5	11.9	5.6	1.7	11.8	7.0	3.7	4.6	3.4	0.0	8.2	10.1	1.2	3.1	6.5	3.8	2.7	0.4	4.0	2.3	5.4	7.0	8.0	4.9	17.8	5.2	9.0	3.7	7.2	2.2	6.1	6.3	1.5	8.5	2.9	3.7	1.6	0.0	3.4	2.0	5.3	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8	3.0	7.4	0.0	4.8	0.9	1.9	3.6	5.1	2.7	3.4	3.5	2.0	7.5	3.3	4.3	15.1	1.5	0.0	0.0	3.4	4.6	3.7	2.1	5.7	7.3	2.6	0.0	4.1	1.3	0.3	2.9	4.4	0.3	0.0	0.0	2.3	2.3	3.9	0.0	8.1	2.8	0.5	0.0	2.7	54.7	15.3	0.5	6.1	0.0	1.5	2.5
CHCHD6	"CHCM1, MGC13016, Mic25, PPP1R23"	ENSG00000159685	"Coiled-coil-helix-coiled-coil-helix domain containing 6"	Q9BRQ6	3	126704220-126960406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 136.0;Melanocytes: 163.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047673, HPA051975"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA047673: AB_10961761, HPA051975: AB_2681679"	"unprognostic (3.94e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.83e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (6.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.11e-3)"	5.5	13.8	23.2	5.8	20.8	3.8	8.7	8.9	27.0	7.4	5.3	8.7	4.9	4.1	6.7	5.6	7.2	14.6	5.6	11.6	31.1	17.0	7.5	6.1	8.3	3.7	15.3	18.8	14.5	15.1	6.7	7.7	4.4	11.4	7.0	3.4	7.6	14.2	8.9	4.0	8.1	4.6	5.8	9.9	4.8	7.4	34.0	7.6	3.3	12.3	5.9	4.3	5.0	7.4	10.5	6.3	1.8	3.5	6.3	11.1	4.3	18.9	11.1	9.8	23.8	3.5	5.4	5.6	7.3	5.0	8.6	8.4	15.2	8.3	8.3	17.1	4.3	9.4	11.1	7.3	20.1	4.2	2.3	20.0	6.8	8.1	14.8	10.4	14.9	4.6	5.4	12.3	4.1	8.8	7.0	5.6	15.0	6.2	5.0	7.5	14.2	21.7	14.9	11.8	10.8	12.6	11.7	15.0	20.0	7.5	8.3	18.1	11.2	7.5	12.9	23.4	5.0	7.5	5.6	5.0	9.7	12.1	13.0	7.5	6.4	3.0	10.3	10.9	4.9	9.0	0.0	2.3	1.8	6.9	3.5	8.7	7.8	9.8	8.1	6.3	10.5	9.5	11.1	0.0	6.3	3.3	4.4	8.9	4.3	23.2	20.8	8.9	25.6	31.1	17.0	15.3	18.8	11.4	7.6	17.9	8.4	6.5	16.7	26.3	12.6	12.6	5.1	37.5	21.6	14.0	17.7	27.5	49.7	22.8	69.0	6.8	2.6	0.0	21.3	9.3	13.9	13.7	13.9	5.9	136.0	19.1	7.5	6.2	6.6	82.1	14.7	9.4	163.6	3.6	9.1	14.0	15.3	7.0	20.8	22.3	13.5	0.0	18.8	64.1	46.7	26.3	12.9	5.3	12.0	17.3
PLXNA1	"NOV, PLXN1"	ENSG00000114554	"Plexin A1"	Q9UIW2	3	126988594-127037392	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007499, CAB012483"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		2600000	Nucleoplasm	Cytosol	"CAB012483: , HPA007499: AB_1079637"	"unprognostic (1.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.79e-2)"	"unprognostic (9.06e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.77e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.64e-5)"	"unprognostic (4.50e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	4.6	2.1	4.4	3.8	2.5	0.0	3.1	5.2	9.3	3.6	2.5	2.5	2.5	1.6	3.8	5.2	3.7	3.3	2.7	10.2	6.2	5.3	2.5	5.3	6.3	3.1	2.9	5.0	5.0	4.9	18.7	2.5	4.9	3.9	3.7	0.7	2.5	7.9	4.1	5.6	8.8	2.5	2.9	2.5	5.6	2.3	5.2	2.5	2.5	3.2	2.5	2.5	3.5	12.6	0.6	0.0	0.0	0.9	0.0	1.1	0.5	18.0	8.6	9.5	7.5	12.6	14.1	15.2	10.8	9.2	6.2	6.2	28.5	8.5	2.0	16.3	11.6	8.4	28.0	4.9	21.2	2.6	2.9	7.7	0.2	5.0	7.3	8.3	2.1	1.5	14.1	14.9	11.5	9.0	6.3	3.1	6.1	10.4	3.8	6.6	10.6	4.2	4.0	9.2	5.7	7.7	5.6	24.4	5.6	5.4	36.5	8.5	9.3	7.8	7.5	10.3	6.5	12.0	13.7	11.4	10.0	12.9	18.2	11.3	2.3	1.5	3.9	14.3	4.1	10.5	0.0	0.0	0.0	0.7	0.1	1.1	0.5	0.6	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.9	0.0	0.8	0.5	4.4	2.5	5.2	9.3	6.2	5.3	2.9	5.0	3.9	2.5	44.7	2.6	1.5	4.5	14.1	3.8	10.9	2.5	5.3	18.2	12.2	3.9	16.8	0.0	7.4	1.2	4.3	5.1	0.0	6.0	2.1	11.4	4.7	0.0	1.0	11.3	19.1	9.2	2.5	5.6	0.8	7.2	2.8	8.5	1.8	4.5	2.4	12.9	2.9	6.0	1.1	2.9	6.5	9.5	6.3	9.2	14.1	6.1	0.0	3.9	5.0
C3orf56	FLJ40141	ENSG00000214324	"Chromosome 3 open reading frame 56"	Q8N813	3	127193131-127198185	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	12	"testis: 3.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"testis cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;U-937: 1.0"															NA	NA																				"unprognostic (1.12e-1)"			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0
TPRA1	"FLJ32197, GPR175, TMEM227, TPRA40"	ENSG00000163870	"Transmembrane protein adipocyte associated 1"	Q86W33	3	127573069-127598251	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019784	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA019784: AB_2670266"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.91e-3)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.28e-2)"	17.6	21.0	14.6	11.4	13.5	22.4	22.1	20.3	16.7	22.6	25.8	15.9	26.9	17.1	21.5	16.7	19.5	21.9	18.2	15.4	14.9	12.4	18.1	23.5	20.4	13.1	16.3	11.6	21.9	30.4	24.0	15.9	35.7	14.0	19.5	11.1	21.0	24.3	19.5	31.3	28.7	18.2	16.9	10.7	17.7	16.8	18.3	12.5	13.9	30.2	15.8	14.5	19.5	19.8	9.5	19.2	13.7	16.3	6.5	14.1	7.3	21.5	15.5	6.2	12.3	24.0	13.3	23.3	13.5	15.2	11.2	10.2	10.0	14.1	18.9	24.6	16.6	36.9	22.8	10.2	15.5	5.9	11.9	9.1	12.4	21.1	9.6	26.3	7.8	24.3	13.2	13.1	7.7	19.1	23.4	8.4	13.0	7.5	17.6	13.7	17.9	8.7	21.2	10.5	11.3	12.0	16.3	9.4	16.8	13.1	8.8	12.5	4.8	21.0	25.8	17.1	5.1	13.0	18.3	15.4	13.7	8.3	29.4	7.4	15.1	11.2	18.2	15.2	18.8	10.4	3.6	16.3	13.7	10.2	11.0	12.9	9.5	12.4	14.1	19.2	8.2	9.9	10.0	10.3	6.5	9.6	13.4	8.7	7.3	14.6	13.5	20.3	16.7	14.9	12.4	16.3	11.6	14.0	12.5	20.8	6.5	13.8	19.1	44.4	7.0	11.1	10.2	4.0	9.1	24.4	3.9	48.5	5.0	23.8	2.4	25.4	18.2	0.0	17.0	37.2	30.5	18.2	18.4	17.9	30.0	4.8	16.7	19.6	16.2	1.1	31.1	22.0	28.7	81.2	16.1	11.2	24.3	15.9	18.4	12.3	8.6	12.9	24.4	7.7	18.1	47.6	57.0	12.1	19.6	17.8
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598223-127622436	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 69.9"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		8600	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	2.9	3.7	2.1	24.3	4.0	32.5	3.5	6.7	3.2	4.7	7.1	3.3	2.2	4.7	4.7	5.9	11.2	4.8	5.4	3.6	2.0	2.3	3.9	3.4	3.4	14.6	2.2	3.5	5.1	3.0	2.4	2.4	26.4	3.0	3.2	6.0	2.5	4.7	1.9	7.0	6.0	7.1	2.9	2.9	13.3	3.8	20.3	3.9	69.9	4.1	16.6	20.7	3.4	5.1	10.4	3.6	0.9	1.4	5.8	10.6	3.4	25.1	21.4	23.5	20.5	1.4	3.0	23.0	13.2	8.5	26.6	29.0	35.5	16.7	27.1	12.9	6.5	22.8	20.3	41.9	15.2	16.6	22.4	26.2	44.9	28.7	25.8	0.9	41.9	19.6	1.6	1.7	18.0	2.7	3.2	8.3	29.6	22.3	24.9	9.8	33.3	38.8	30.7	34.4	21.6	18.9	43.6	33.7	38.8	5.5	19.5	29.3	22.2	33.9	10.1	3.5	9.9	21.7	32.9	4.2	20.7	17.7	25.5	17.8	25.8	29.2	67.4	14.3	31.7	7.9	0.0	0.6	0.2	4.7	1.4	5.9	10.4	4.1	5.5	2.8	9.2	3.9	5.0	0.9	5.8	0.3	3.6	10.6	3.4	2.1	4.0	6.7	3.2	2.0	2.3	2.2	3.5	3.0	3.9	3.0	1.3	6.7	1.7	4.0	2.2	7.6	0.0	10.7	5.7	0.0	0.0	45.7	0.0	4.1	0.7	1.7	1.0	0.0	1.6	22.4	3.3	0.7	1.1	1.7	15.2	0.0	3.5	1.3	1.6	0.7	1.7	1.6	1.7	15.4	5.1	1.5	1.7	0.0	1.4	0.5	1.7	0.0	2.8	6.2	27.1	2.6	28.0	3.2	12.0	0.6
PODXL2	"endoglycan, PODLX2"	ENSG00000114631	"Podocalyxin like 2"	Q9NZ53	3	127629181-127672809	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 84.6;Horizontal cells: 77.9;Intestinal endocrine cells: 61.0;Late spermatids: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 32.6;SCLC-21H: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024934, HPA042265"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"CAB024934: , HPA042265: AB_2677920"	"unprognostic (2.07e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-3)"	3.0	16.1	19.1	2.6	19.7	1.8	8.1	31.4	42.8	3.0	8.3	9.0	1.6	6.6	4.5	2.5	2.8	4.3	4.4	2.5	22.2	37.3	4.5	1.6	2.1	2.2	21.3	17.5	10.8	12.0	1.2	20.9	1.3	31.5	12.0	7.6	8.7	21.4	2.4	2.8	4.6	6.1	2.0	17.0	2.1	12.2	16.4	7.7	0.6	4.1	1.6	2.7	2.1	0.9	1.6	2.6	0.1	0.8	0.2	2.7	0.7	0.1	3.9	10.8	25.6	0.0	0.0	16.0	1.2	0.0	2.3	0.4	8.0	0.4	9.5	9.7	0.1	3.5	0.0	8.8	0.0	0.2	0.0	18.1	0.2	9.0	8.1	0.3	21.5	22.0	0.4	1.9	0.0	0.0	6.1	0.6	0.0	12.4	0.0	0.8	4.8	0.1	0.0	16.2	2.2	19.1	0.0	0.3	32.6	3.2	1.1	48.6	27.3	11.6	24.8	21.1	1.1	6.3	10.9	0.1	0.0	5.0	0.4	7.5	0.0	0.0	7.4	0.2	14.0	7.1	0.0	0.2	0.0	0.8	0.8	1.1	1.6	2.7	0.7	0.0	1.3	1.3	0.6	0.1	0.2	0.0	2.6	1.7	0.7	19.1	19.7	31.4	33.8	22.2	37.3	21.3	17.5	31.5	7.7	0.0	0.6	0.0	3.7	4.8	84.6	0.4	0.0	1.4	0.0	8.7	29.5	1.9	1.7	5.5	45.3	0.6	8.0	0.0	17.9	3.1	4.6	10.6	1.1	0.5	1.1	77.9	61.0	0.6	0.6	110.3	8.1	0.7	20.3	12.6	18.4	17.7	13.0	18.2	5.3	3.3	35.4	6.5	5.3	18.6	51.7	4.8	1.3	0.0	19.5	2.2
ABTB1	"BPOZ, Btb3, BTBD21, EF1ABP"	ENSG00000114626	"Ankyrin repeat and BTB domain containing 1"	Q969K4	3	127672935-127680920	"Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 107.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 107.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035022, HPA035023"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA035022: AB_10669998, HPA035023: AB_10602104"	"unprognostic (6.76e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.55e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.92e-3)"	20.4	13.7	11.7	17.7	20.1	42.3	14.2	43.4	27.2	15.4	14.3	13.8	12.9	12.3	15.6	10.9	9.6	13.1	17.6	20.4	10.9	8.2	11.4	8.3	15.5	22.1	9.7	15.8	15.8	11.2	7.8	15.3	12.0	11.4	13.5	4.9	12.4	15.2	14.5	25.1	11.6	13.0	13.3	7.5	41.4	11.7	5.9	12.5	17.8	10.2	9.1	10.4	14.6	17.4	2.9	3.8	107.3	8.6	3.2	5.8	5.1	3.1	7.6	0.7	1.5	7.2	6.9	5.8	5.0	8.7	3.5	4.8	0.2	6.7	1.4	9.0	3.8	4.3	1.4	0.0	3.8	0.8	14.7	2.1	2.3	13.5	1.8	5.8	0.3	7.1	8.6	4.1	3.5	0.9	11.3	3.6	5.9	0.1	10.3	3.7	5.0	3.5	9.9	0.6	3.6	8.4	2.2	4.2	9.8	5.2	2.0	7.0	4.7	3.6	4.4	18.2	1.9	1.1	2.6	6.6	3.6	3.1	6.5	1.6	8.4	2.7	0.4	8.5	2.9	5.7	4.5	8.6	20.5	2.4	6.2	2.3	2.5	2.6	2.3	3.8	2.9	2.2	1.9	107.3	3.2	5.4	2.4	5.8	5.1	11.7	20.1	43.4	27.2	10.9	8.2	9.7	15.8	11.4	12.5	17.9	18.3	15.2	14.1	10.4	9.9	6.2	10.2	4.0	2.3	7.0	17.7	6.5	13.3	12.2	0.4	13.5	12.4	0.0	15.1	20.9	14.5	11.3	14.9	8.5	19.9	3.2	23.0	23.4	52.6	1.9	31.4	20.7	10.1	45.9	16.6	16.2	19.1	23.0	21.2	17.0	30.1	64.7	31.9	0.7	6.8	8.2	13.3	46.5	11.2	8.4
MGLL	"HU-K5, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-127823250	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 404.8;Pancreatic endocrine cells: 322.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		4300000	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	72.2	6.7	29.4	22.6	29.7	7.5	39.0	32.8	36.9	13.3	36.3	8.3	8.4	16.5	8.7	10.8	63.8	16.3	24.1	35.5	23.6	10.2	22.6	32.1	32.4	6.0	15.4	17.8	3.9	3.6	1.7	5.0	18.9	10.2	10.6	27.6	10.0	31.4	13.6	40.9	11.9	22.3	13.6	12.2	19.2	17.5	3.2	15.5	2.4	6.4	33.4	19.7	14.4	14.5	1.8	30.4	11.6	28.5	0.6	0.9	6.0	11.2	10.1	0.0	0.0	17.8	21.0	1.3	46.5	53.6	10.3	16.6	0.3	4.6	2.9	12.9	15.7	3.1	0.4	0.0	6.1	5.7	5.0	0.1	0.3	7.2	0.0	6.4	0.0	0.3	7.8	3.6	19.3	21.1	5.8	21.8	0.1	0.0	0.5	42.8	1.1	0.0	0.1	0.0	7.3	16.0	0.0	5.5	23.8	38.6	1.2	6.0	0.4	8.0	15.8	2.7	0.4	0.7	0.4	27.9	11.3	3.3	27.2	6.3	0.0	0.0	9.5	23.4	0.6	35.0	4.2	2.8	11.6	0.2	28.5	0.9	1.8	0.2	0.3	3.1	0.2	0.0	0.0	0.5	0.6	18.3	30.4	0.0	6.0	29.4	29.7	32.8	36.9	23.6	10.2	15.4	17.8	10.2	15.5	181.7	90.0	5.2	8.0	20.3	16.7	42.0	119.8	56.2	34.2	40.1	0.0	68.4	142.6	90.3	3.6	101.2	167.0	23.3	144.8	129.8	47.2	9.2	8.1	126.2	122.7	0.0	85.0	14.7	24.4	4.0	30.2	33.6	20.3	404.8	177.1	46.3	322.3	129.8	65.4	60.0	6.1	84.1	176.1	0.2	1.1	19.4	60.8	10.2	49.8	4.2
KBTBD12	"FLJ46299, KLHDC6"	ENSG00000187715	"Kelch repeat and BTB domain containing 12"	Q3ZCT8	3	127915232-127987671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"heart muscle: 13.1;skeletal muscle: 44.5;tongue: 16.6"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 8.5;Early spermatids: 25.7;Exocrine glandular cells: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 3.1;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.8;RT4: 2.4"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 14.9"							NA	NA						"unprognostic (3.60e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.49e-2)"	0.6	0.5	2.1	1.2	2.7	0.6	0.5	2.6	2.6	0.4	1.5	0.8	1.0	1.1	0.7	1.3	1.4	1.2	1.1	13.1	2.2	0.7	1.1	0.4	0.5	0.5	0.7	2.2	0.5	3.7	0.4	0.5	0.5	1.6	0.8	1.5	1.4	1.7	0.8	44.5	0.7	1.0	1.0	0.5	0.4	1.9	0.9	1.2	0.0	0.4	16.6	0.7	1.0	0.4	0.3	0.4	3.1	0.3	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.4	0.4	0.3	0.1	0.6	0.2	0.1	0.2	0.0	0.1	0.1	1.8	2.4	0.5	0.2	0.2	0.1	0.0	0.2	0.3	0.1	0.6	0.3	0.2	0.5	0.1	0.4	0.4	0.0	0.2	0.1	0.3	3.1	0.3	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.2	1.5	0.2	0.1	0.4	0.0	0.0	2.1	2.7	2.6	2.6	2.2	0.7	0.7	2.2	1.6	1.2	3.0	3.0	0.0	0.0	0.1	1.7	8.5	0.0	1.4	2.3	1.8	5.9	0.0	1.7	0.2	25.7	0.0	1.1	0.0	8.0	0.0	0.2	0.0	0.0	0.0	0.1	1.6	2.4	0.0	0.0	1.3	0.0	0.7	0.0	0.0	5.3	1.0	3.6	5.8	0.0	0.0	0.6	0.0	0.3	5.4	7.2	0.3	0.0	0.0	2.3	0.0
SEC61A1		ENSG00000058262	"Sec61 translocon alpha 1 subunit"	P61619	3	128051641-128071683	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	28.6	38.2	15.2	23.2	16.2	18.5	38.4	12.8	16.2	45.0	24.2	15.9	77.9	22.1	32.6	52.8	31.1	28.3	34.4	27.6	14.3	13.5	37.6	132.2	33.2	44.9	17.4	10.3	28.5	178.4	31.5	36.5	51.6	15.2	26.2	26.0	19.0	87.1	81.7	22.7	22.7	32.5	31.3	15.4	28.8	33.8	21.2	15.4	22.9	35.5	28.8	36.6	24.2	26.4	13.8	35.6	40.0	25.1	18.7	39.3	29.0	40.1	21.1	21.2	37.7	60.3	52.1	39.1	64.8	75.2	56.5	61.0	40.0	29.3	26.8	39.1	83.6	42.3	35.7	33.2	45.8	54.8	24.2	18.2	30.5	23.6	42.1	88.9	38.7	34.8	57.1	55.4	53.2	68.8	42.8	49.6	18.7	20.0	65.7	65.5	36.6	19.9	12.8	28.6	35.6	29.6	21.0	19.0	52.5	29.4	35.2	24.2	23.7	32.0	30.5	40.8	25.6	28.4	33.1	48.7	44.6	25.3	51.7	30.2	60.1	28.6	38.6	72.9	25.2	57.5	40.0	25.1	19.1	28.3	23.0	39.3	13.8	20.5	24.8	24.7	8.5	13.0	15.0	6.6	18.7	22.4	35.6	13.1	29.0	15.2	16.2	12.8	16.2	14.3	13.5	17.4	10.3	15.2	15.4	29.8	34.5	23.1	22.5	32.7	16.8	12.9	35.7	10.7	20.5	47.1	33.4	56.4	3.3	77.1	35.8	35.6	73.5	23.3	133.3	103.4	63.4	59.6	25.4	101.3	67.9	25.4	70.7	53.4	26.8	17.6	38.0	27.4	32.1	25.2	85.2	24.5	95.2	53.4	41.1	22.6	14.1	32.3	34.0	9.3	15.8	25.7	107.0	25.4	63.1	30.3
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		47000	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	17.6	15.1	10.7	15.8	14.2	11.9	13.9	7.9	14.0	12.5	11.6	12.9	14.3	8.4	19.2	11.4	19.2	37.3	11.3	18.6	11.4	13.6	20.9	13.7	12.9	18.7	10.0	9.8	15.4	13.6	26.5	14.2	19.9	13.0	12.0	14.1	11.5	10.2	12.0	12.9	11.8	10.2	16.1	8.8	21.9	10.9	44.7	10.3	33.4	15.2	18.1	23.9	12.6	15.0	10.6	8.7	1.5	7.9	10.9	20.2	7.2	26.9	24.5	15.1	24.5	11.8	11.5	19.7	13.2	11.4	25.5	17.6	25.6	16.1	38.3	13.2	12.6	19.7	21.5	40.1	28.1	29.8	15.6	19.7	31.8	14.2	17.1	12.2	29.7	10.2	11.7	14.8	21.4	27.6	9.7	17.1	14.6	26.0	9.0	14.5	38.4	31.8	22.5	37.9	30.5	21.0	26.2	18.3	26.6	15.3	10.2	25.3	22.7	14.6	12.1	20.2	14.6	22.0	22.0	11.0	11.6	14.2	17.4	20.0	9.2	14.6	37.6	14.3	18.3	14.5	0.8	4.8	1.5	11.3	7.9	14.6	10.6	13.6	14.0	7.7	10.2	11.5	12.8	0.2	10.9	7.4	8.7	20.2	7.2	10.7	14.2	7.9	14.0	11.4	13.6	10.0	9.8	13.0	10.3	20.8	11.7	25.1	16.5	17.7	16.3	18.7	22.9	208.8	31.8	21.0	2.0	45.7	39.7	29.2	14.5	21.2	2.9	0.0	26.3	53.6	20.6	11.7	25.4	13.2	26.2	22.3	16.3	11.1	5.6	19.6	14.1	10.5	10.1	12.6	12.4	26.0	22.8	14.0	17.3	41.5	16.2	12.9	13.3	96.8	64.3	14.8	20.1	24.9	23.0	11.9
EEFSEC	"eEFSec, EFSEC, SELB"	ENSG00000132394	"Eukaryotic elongation factor, selenocysteine-tRNA specific"	P57772	3	128153454-128408646	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;GAMG: 10.3;SH-SY5Y: 8.8;SK-BR-3: 14.7;SK-MEL-30: 12.7;T-47d: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035795	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA035795: AB_10696512"	"unprognostic (1.01e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-3)"	"unprognostic (6.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	8.2	6.8	5.6	7.9	7.9	3.1	7.9	8.4	9.8	11.6	8.6	9.3	7.3	2.5	10.8	5.4	8.0	9.4	7.1	18.7	7.6	6.4	9.4	18.1	7.1	15.5	5.4	4.2	11.5	8.4	23.9	9.2	9.7	6.9	9.0	4.9	7.2	10.7	11.2	20.3	15.9	15.7	10.0	5.0	9.2	6.9	11.5	6.2	17.2	8.4	6.7	10.5	7.7	7.9	7.1	10.9	7.3	7.8	9.7	7.0	3.8	0.4	0.1	3.4	1.4	0.1	0.2	0.4	0.0	0.2	0.2	0.2	0.3	5.7	12.4	0.1	3.1	10.3	0.9	0.3	0.1	0.1	0.3	0.2	0.0	0.1	0.1	4.9	0.2	0.3	0.1	0.1	3.4	0.1	0.1	0.2	0.0	0.0	0.2	2.9	0.1	6.2	0.3	0.4	0.0	0.1	0.2	0.2	0.8	0.0	0.0	0.3	8.8	0.0	14.7	12.7	0.3	7.9	0.5	0.0	0.1	0.0	0.1	0.2	0.4	0.6	0.3	0.1	0.4	0.2	0.5	7.5	7.3	6.7	7.8	5.6	7.1	5.9	5.8	10.9	5.8	5.6	6.5	0.0	9.7	6.2	4.6	7.0	3.8	5.6	7.9	8.4	9.8	7.6	6.4	5.4	4.2	6.9	6.2	0.0	5.9	11.8	7.7	5.7	8.7	9.4	0.0	2.7	1.2	15.7	2.0	19.4	13.3	5.9	21.8	7.1	5.5	0.0	6.2	14.9	10.0	7.4	27.7	11.9	13.0	12.7	10.9	6.2	6.0	63.4	12.0	8.6	11.8	3.6	8.7	8.3	5.4	0.0	8.1	21.4	6.6	25.8	7.5	26.5	16.0	8.7	24.8	10.2	8.7	5.6
DNAJB8	"CT156, MGC33884"	ENSG00000179407	"DnaJ heat shock protein family (Hsp40) member B8"	Q8NHS0	3	128462439-128467248	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	286	"testis: 28.6"	"Group enriched"	"Detected in some"	114	"Early spermatids: 999.2;Late spermatids: 3374.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SH-SY5Y: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	999.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3374.7	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	6.5	0.0	19.3	7.5	0.0	0.0	0.0	0.0	0.0
GATA2	NFE1B	ENSG00000179348	"GATA binding protein 2"	P23769	3	128479427-128493185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Phagocytosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.2;ductus deferens: 85.8;seminal vesicle: 209.1"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 226.1;granulocytes: 616.3;Syncytiotrophoblasts: 268.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 36.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	339	"basophil: 81.2"	"Lineage enriched"	"Detected in single"	813	"granulocytes: 81.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 57.0;HEL: 70.3;HMC-1: 38.1;SH-SY5Y: 66.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA005633, CAB024847"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB024847: , HPA005633: AB_1078954"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.61e-2)"	"unprognostic (8.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.96e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.50e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (5.22e-5)"	7.0	6.2	2.1	1.5	2.4	2.5	7.9	1.2	1.9	22.4	2.8	1.4	85.8	2.5	20.6	5.4	3.2	23.0	9.7	4.8	1.5	1.0	7.6	0.6	16.1	2.2	1.8	1.1	4.6	5.8	3.4	4.5	51.8	2.4	27.8	1.8	6.1	1.9	209.1	3.5	4.1	3.4	8.4	1.4	5.1	2.9	2.7	1.5	0.4	3.3	2.7	1.5	22.4	12.4	0.0	0.0	81.2	0.0	0.0	0.0	0.4	4.7	1.1	0.2	3.1	0.4	0.1	57.0	10.6	9.1	3.6	1.3	1.9	2.1	0.1	3.0	6.3	0.3	5.0	2.9	0.0	1.5	0.0	1.6	70.3	7.8	3.1	0.8	7.1	38.1	0.0	0.0	0.1	0.0	0.5	5.7	0.0	18.4	0.1	0.0	1.7	0.0	14.4	0.2	0.0	0.3	0.0	1.4	0.0	0.1	4.2	4.4	66.4	2.7	14.1	0.4	3.0	2.7	2.9	10.2	0.2	0.1	2.5	1.4	0.0	0.0	0.0	0.1	0.4	0.7	81.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	2.4	1.2	1.9	1.5	1.0	1.8	1.1	2.4	1.5	6.0	48.7	0.5	16.6	4.2	0.2	6.1	0.0	1.4	3.4	71.5	0.0	50.4	1.7	0.3	5.8	56.9	0.0	0.0	12.6	226.1	5.8	36.8	616.3	0.0	9.5	0.0	2.9	34.4	0.8	4.0	0.6	2.9	8.5	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.2	0.0	7.6	0.5	2.8	2.0	268.8	0.0	0.1	10.0
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619970-128681075	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		8200000	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	52.3	37.5	22.2	26.6	23.8	24.4	48.2	20.9	31.4	45.8	40.8	31.9	58.8	28.5	38.3	110.2	32.2	38.3	38.8	47.1	23.0	28.0	55.4	174.0	47.4	50.6	26.4	18.3	37.8	62.9	43.5	36.9	58.3	24.3	31.4	41.1	28.6	54.1	55.5	34.4	24.0	37.0	33.5	31.8	48.0	33.7	26.9	23.3	34.3	69.1	27.3	36.5	32.7	39.7	26.7	53.1	64.4	43.5	23.4	45.1	53.3	60.5	33.0	27.6	50.7	74.7	50.1	62.5	52.2	68.7	69.4	80.9	68.4	57.1	37.9	49.3	75.3	64.7	61.0	44.5	46.5	68.0	27.2	28.6	66.8	24.6	56.2	82.4	54.2	35.2	41.5	54.4	45.6	67.5	46.5	54.2	28.7	27.5	50.9	45.5	55.4	30.0	59.6	35.0	81.1	30.3	32.9	37.1	91.2	48.1	36.4	42.5	24.5	42.9	44.5	52.8	36.9	47.6	56.1	35.2	35.9	28.1	52.5	38.7	54.9	43.2	40.5	58.9	40.4	51.8	38.8	43.5	35.7	37.3	40.0	45.1	26.7	30.7	33.8	43.5	18.3	19.1	29.2	64.4	23.4	40.2	53.1	30.5	53.3	22.2	23.8	20.9	31.4	23.0	28.0	26.4	18.3	24.3	23.3	56.6	71.5	37.3	71.3	44.0	11.5	35.3	61.1	66.9	47.8	106.4	7.9	108.3	13.3	99.9	13.7	58.2	107.9	46.7	81.2	161.1	79.3	88.0	42.7	155.3	122.7	19.1	41.6	107.4	134.1	20.7	87.2	73.4	55.6	36.9	102.4	27.5	98.9	83.4	60.5	80.2	11.7	45.3	39.6	49.9	59.8	46.7	131.0	50.0	106.2	66.4
RAB7A	RAB7	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128726122-128814796	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"		"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes		NA	NA		9000000	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	61.5	57.0	64.6	43.8	59.9	41.7	49.5	44.8	67.1	43.5	55.4	69.5	29.4	45.1	49.8	60.7	63.2	44.2	43.1	73.5	62.9	60.2	58.4	69.6	51.7	42.7	66.9	53.6	51.3	34.1	44.0	52.7	64.2	66.2	39.2	50.8	60.9	47.0	41.6	146.3	54.2	45.9	48.9	69.0	52.3	40.7	26.3	61.9	37.7	52.0	51.0	50.7	42.8	47.7	27.7	60.7	102.8	58.7	31.7	33.8	52.9	73.3	24.9	32.4	18.7	73.5	41.5	35.0	70.9	51.6	39.8	42.0	43.8	42.3	33.8	46.5	46.6	64.5	38.6	35.9	48.4	45.1	43.6	25.4	74.1	24.3	43.0	60.7	73.2	46.7	48.9	51.8	37.0	43.5	43.5	35.4	25.1	33.8	32.9	52.0	54.1	45.5	55.3	31.4	55.5	34.2	33.6	37.0	35.9	44.4	71.1	24.4	33.9	45.3	41.4	74.5	37.7	42.4	49.7	62.7	44.5	27.5	83.5	32.7	46.9	51.4	57.1	66.7	49.6	56.2	38.2	54.1	59.1	27.5	58.7	26.1	27.7	28.5	27.3	60.7	25.1	27.2	26.5	102.8	31.7	54.6	23.6	33.8	52.9	64.6	59.9	44.8	60.8	62.9	60.2	66.9	53.6	66.2	61.9	83.4	69.7	117.9	285.8	263.5	65.1	109.4	73.9	99.0	59.1	125.6	17.7	198.6	203.9	226.9	9.1	153.7	157.4	46.7	173.6	224.2	194.3	231.2	141.1	117.7	351.9	69.9	93.0	134.4	189.9	11.4	123.7	256.5	322.2	245.3	103.4	146.4	226.3	108.4	147.8	239.3	30.0	135.8	163.7	86.8	95.4	269.2	416.4	112.2	85.4	273.2
ACAD9	"MGC14452, NPD002"	ENSG00000177646	"Acyl-CoA dehydrogenase family member 9"	Q9H845	3	128879596-128916067	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037716, HPA046720"	Supported		Enhanced	Mitochondria		No	No			Mitochondria		"HPA037716: AB_10673638, HPA046720: AB_2679773"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.67e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-3)"	"prognostic favorable (4.32e-8)"	"unprognostic (1.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.96e-2)"	18.1	20.6	14.0	13.1	15.4	8.0	15.4	14.7	17.9	13.6	13.4	15.9	21.1	11.3	16.9	13.1	21.6	15.6	16.4	21.6	10.7	13.2	15.8	24.0	11.6	10.4	13.6	17.8	13.1	21.1	30.6	14.2	13.8	13.6	13.0	12.4	16.0	19.0	16.0	30.8	45.0	10.1	13.8	10.2	12.1	14.6	19.5	10.8	13.9	14.8	18.2	14.9	12.6	14.0	7.2	14.0	4.1	18.1	5.0	7.5	8.9	25.1	13.2	10.6	7.9	16.4	11.6	11.3	12.5	13.8	24.1	20.7	18.5	15.3	18.7	11.7	15.7	16.3	21.1	18.5	24.5	16.0	12.3	12.6	17.0	26.7	13.1	12.0	13.3	7.9	12.6	9.6	14.0	15.8	13.9	19.4	14.9	8.0	9.1	16.0	25.4	19.6	11.1	6.4	26.0	18.9	15.2	10.0	19.0	16.9	16.1	12.3	7.9	19.5	18.3	12.1	10.0	24.2	28.8	11.5	10.1	8.8	10.2	11.9	9.1	4.4	16.3	16.1	12.4	12.7	3.1	12.0	4.1	7.5	14.7	7.2	7.2	6.8	6.4	14.0	4.9	5.7	7.3	1.0	5.0	18.1	7.9	6.5	8.9	14.0	15.4	14.7	17.9	10.7	13.2	13.6	17.8	13.6	10.8	14.9	23.7	9.7	10.0	5.6	14.5	26.4	7.6	10.7	11.4	14.0	9.8	22.7	18.3	18.4	14.9	9.8	8.1	0.0	15.5	15.2	10.1	7.5	16.1	23.3	26.7	9.5	5.2	17.8	9.5	12.6	9.5	8.4	15.1	16.2	6.3	15.8	13.0	7.6	13.8	18.0	10.9	12.9	13.3	15.6	10.0	12.4	25.6	7.5	14.1	6.0
KIAA1257		ENSG00000114656	KIAA1257	Q9ULG3	3	128909866-129002690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.3;testis: 38.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 154.5;Late spermatids: 157.4;Spermatocytes: 41.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	14	"neutrophil: 23.3"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 23.3"	"Cell line enhanced"	"Detected in many"		"AF22: 8.5;BEWO: 13.2;HL-60: 14.3;THP-1: 8.8"									"HPA042811, HPA048445"	Uncertain					NA	NA					"HPA042811: AB_2678180, HPA048445: AB_2680397"	"unprognostic (4.17e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.41e-3)"	"unprognostic (2.45e-1)"	"unprognostic (6.74e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.50e-2)"	0.6	0.5	1.7	0.9	7.7	1.9	0.8	0.8	3.2	0.5	0.5	2.4	0.2	0.8	0.5	1.7	1.0	4.1	1.6	0.5	2.5	1.6	0.6	0.4	1.8	0.9	0.6	1.7	1.3	0.6	1.1	3.6	3.7	2.1	0.9	0.7	0.1	0.7	0.7	0.4	5.3	0.6	0.3	0.5	1.0	0.9	38.5	0.9	0.8	0.7	0.0	0.1	0.7	0.5	0.3	0.2	23.3	0.4	0.1	0.4	0.1	1.2	1.8	8.5	1.8	0.0	0.1	13.2	0.1	0.3	0.0	0.0	2.4	1.2	2.1	0.4	0.0	1.1	1.3	2.8	0.1	0.0	0.8	1.5	4.3	1.1	1.1	0.1	14.3	0.8	0.0	1.4	0.0	0.0	0.3	0.0	4.1	1.0	2.4	0.0	1.6	1.8	3.1	1.7	2.4	1.9	1.3	0.8	1.3	0.0	1.9	1.6	0.7	0.5	0.4	0.8	1.9	2.3	8.8	0.3	0.8	1.4	0.7	0.6	2.8	2.7	3.7	0.7	5.4	0.8	0.4	0.4	1.7	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.3	0.3	0.4	23.3	0.1	0.2	0.2	0.1	0.1	1.7	7.7	0.8	3.2	2.5	1.6	0.6	1.7	2.1	0.9	3.0	1.4	0.0	0.7	0.6	0.4	0.8	0.0	21.4	1.2	0.0	3.9	0.1	0.0	0.3	154.5	1.1	0.0	0.0	0.3	0.1	0.9	0.9	0.0	0.0	0.2	1.6	8.2	2.5	0.6	157.4	2.8	0.9	0.0	0.0	1.3	1.5	0.3	0.0	0.4	0.0	1.1	0.0	0.8	41.4	10.4	0.3	0.0	0.0	0.4	0.7
EFCC1	"C3orf73, CCDC48, FLJ12057"	ENSG00000114654	"EF-hand and coiled-coil domain containing 1"	Q9HA90	3	129001629-129040742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 34.1"	"Cell type enhanced"	"Detected in some"	9	"Endothelial cells: 4.6;Intestinal endocrine cells: 9.1;Leydig cells: 4.4;Peritubular cells: 7.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 3.3;HL-60: 8.7;U-266/84: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042798, HPA050888"	Uncertain					NA	NA					"HPA042798: AB_2678173, HPA050888: AB_2681263"	"unprognostic (1.74e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.70e-4)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.20e-1)"	3.7	0.5	0.9	4.7	0.5	0.3	1.9	1.7	1.0	2.3	4.6	0.5	2.2	4.8	5.1	2.3	1.6	0.8	34.1	1.9	1.5	0.8	1.8	0.7	12.9	0.4	0.4	0.2	6.1	0.5	0.3	1.5	1.0	2.3	2.7	1.2	1.4	1.8	1.6	2.3	1.1	3.8	5.0	0.4	6.2	4.5	0.6	0.0	0.3	2.6	3.6	0.7	2.0	2.5	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.6	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.5	1.7	1.0	1.5	0.8	0.4	0.2	2.3	0.0	0.0	1.4	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	4.6	0.0	0.0	0.5	0.0	1.6	0.1	0.0	0.0	0.1	0.0	9.1	3.1	0.3	3.9	4.4	0.0	1.7	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.0	6.5	1.7	0.2	0.5	0.4	0.1	0.0	0.0	0.1
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060767-129062406	"CD markers, Disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5"	"Group enriched"	"Detected in some"	11	"Early spermatids: 14.0;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 8.8;neutrophil: 7.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.8"	"Cell line enriched"	"Detected in some"	14	"HEL: 43.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		68000000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.2	0.1	0.1	0.1	0.1	10.0	0.1	0.0	0.6	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.1	5.0	0.8	0.1	0.1	0.4	4.8	0.0	0.8	0.2	0.5	0.1	0.0	0.3	1.5	0.4	0.1	0.4	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	24.5	0.3	2.2	0.0	0.0	0.6	0.6	0.0	0.6	3.0	0.1	1.5	8.8	0.6	0.0	0.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.6	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	7.5	0.0	0.0	1.5	0.0	27.1	0.1	0.1	0.0	0.6	0.8	0.1	0.8	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	13.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RAB43	"ISY1, RAB11B, RAB41"	ENSG00000172780	"RAB43, member RAS oncogene family"	Q86YS6	3	129087569-129122801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 73.9"	"Cell type enhanced"	"Detected in single"	13	"Club cells: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.3;T-cells: 3.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046840, HPA060085"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA046840: , HPA060085: AB_2684199"	"unprognostic (3.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	5.4	6.2	3.9	8.0	3.3	14.6	5.3	6.0	3.6	6.4	7.0	3.2	7.2	5.8	5.4	6.8	4.1	5.3	12.0	3.8	2.8	2.0	9.1	73.9	11.4	12.1	2.7	1.6	7.8	7.4	2.5	8.0	4.7	3.7	7.3	1.7	7.7	7.4	4.7	1.9	3.0	5.9	4.9	2.7	9.9	5.7	5.2	2.1	17.3	17.1	2.6	13.6	6.6	6.0	1.3	1.1	13.3	1.6	1.5	3.5	1.3	15.6	4.3	1.0	4.1	2.0	0.9	6.2	5.4	3.6	3.1	2.6	6.7	6.7	0.4	12.6	4.0	4.2	6.6	0.4	6.2	0.7	7.9	4.2	1.0	0.7	8.7	19.4	3.6	9.3	5.3	3.8	1.6	0.4	1.3	6.2	9.4	1.7	7.9	4.3	6.6	3.5	6.9	5.0	3.6	7.0	7.5	2.3	4.5	10.1	13.3	0.3	1.9	2.4	5.0	10.0	1.7	2.1	3.8	8.9	6.9	4.9	5.6	2.0	12.4	6.5	2.4	6.2	0.7	7.4	0.5	1.5	2.6	1.9	1.6	0.9	0.6	1.8	1.5	0.7	1.3	3.5	3.0	13.3	1.5	0.7	1.1	2.7	1.3	3.9	3.3	6.0	3.6	2.8	2.0	2.7	1.6	3.7	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0
ISY1-RAB43		ENSG00000261796	"ISY1-RAB43 readthrough"		3	129087575-129161036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 1.4;Club cells: 1.2;granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA006312, HPA016995"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (1.09e-1)"	"unprognostic (5.42e-2)"			"unprognostic (1.52e-1)"	"unprognostic (9.05e-3)"		"unprognostic (2.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"		"unprognostic (5.67e-2)"	"unprognostic (1.87e-1)"	14.4	15.8	11.8	17.9	13.1	11.9	16.2	15.9	14.2	15.0	14.7	9.9	11.5	7.9	17.8	14.6	11.7	12.9	12.8	11.5	11.6	7.7	15.9	22.5	19.1	17.0	10.6	11.5	19.1	17.6	17.7	13.3	13.0	9.0	15.3	14.4	10.3	13.7	17.2	18.2	10.6	13.3	16.1	9.2	20.4	13.1	11.1	12.0	18.6	17.1	14.8	16.8	12.6	23.0	0.6	0.7	2.3	1.8	2.1	3.3	1.9	15.5	3.5	8.0	7.4	10.2	6.0	3.6	7.5	17.6	12.1	15.0	1.8	8.1	0.5	11.0	13.5	13.9	6.0	3.1	12.6	7.6	5.9	1.1	1.4	1.5	6.2	17.6	6.4	8.0	13.9	6.8	7.6	4.9	12.2	15.7	14.7	2.5	6.1	10.5	6.5	9.6	4.7	5.5	16.8	4.2	8.2	3.5	5.4	13.2	6.0	0.6	3.6	3.5	8.1	11.2	7.0	4.0	6.1	12.7	6.0	5.0	8.4	3.4	8.9	4.1	2.7	6.8	0.7	8.2	0.4	1.8	0.5	2.4	0.9	2.6	0.2	2.2	3.0	0.7	0.6	3.3	2.5	2.3	2.1	1.6	0.6	1.8	1.9	11.8	13.1	15.9	14.2	11.6	7.7	10.6	11.5	9.0	12.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ISY1	"fSAP33, KIAA1160"	ENSG00000240682	"ISY1 splicing factor homolog"	Q9ULR0	3	129127415-129161293	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006312, HPA016995"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (2.20e-2)"	"prognostic favorable (2.46e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (4.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	20.7	17.1	16.4	21.8	18.1	43.4	22.2	21.8	19.5	18.8	22.5	13.9	15.9	15.2	25.0	20.0	25.2	16.9	17.7	20.9	16.0	13.2	15.6	13.6	16.8	28.3	14.8	15.9	22.5	24.1	12.3	15.3	21.6	12.6	15.6	17.4	14.4	17.4	18.1	31.6	22.8	17.6	22.1	13.7	21.8	17.5	15.4	16.7	25.5	17.0	20.4	28.2	20.7	31.3	28.7	32.3	46.9	30.0	41.6	36.1	26.7	18.9	7.3	10.9	15.2	13.3	13.9	12.7	14.2	12.9	17.2	16.6	14.5	14.3	23.9	15.4	11.7	14.9	16.3	20.5	11.5	24.3	22.9	9.4	27.7	12.5	11.6	12.3	42.4	19.8	8.7	8.1	15.0	23.3	10.7	13.6	15.7	19.8	12.3	9.2	19.1	25.7	23.7	11.9	20.0	11.4	22.8	24.8	16.8	6.4	12.1	17.4	13.1	26.2	5.8	14.9	6.2	11.1	35.3	16.3	12.5	12.5	18.4	14.8	15.0	8.9	47.3	11.5	24.6	14.2	35.7	30.0	46.8	30.3	28.5	33.7	28.7	30.9	32.0	32.3	26.8	34.3	30.8	46.9	41.6	24.3	28.1	36.1	26.7	16.4	18.1	21.8	19.5	16.0	13.2	14.8	15.9	12.6	16.7	23.8	16.0	20.8	15.0	24.4	17.9	16.6	15.3	14.7	22.7	8.7	21.6	38.3	19.9	22.1	1.5	22.6	14.7	0.0	24.6	33.6	22.0	14.5	43.9	11.1	30.7	19.1	8.6	22.7	21.5	1.1	15.0	25.9	10.1	56.9	15.9	19.9	19.9	14.0	15.2	18.3	17.0	19.4	16.8	24.6	30.6	31.2	38.3	35.2	18.4	14.9
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129169484-129183922	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Approved	Nucleoplasm,Cytosol		NA	NA		43000	Nucleoplasm	Cytosol	"HPA063097: AB_2684939"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	54.2	52.8	36.4	33.6	33.7	35.9	46.6	43.5	35.6	58.1	47.1	34.5	40.5	32.4	54.5	49.4	55.6	40.9	48.5	78.2	33.0	32.0	38.0	71.6	47.5	40.6	39.7	30.3	67.4	65.4	39.3	33.5	41.5	33.3	62.3	37.1	41.3	48.9	50.9	182.1	46.7	40.6	71.9	38.0	43.2	43.1	32.1	33.1	39.0	67.3	81.1	41.2	76.1	63.5	74.3	60.3	120.1	84.1	61.7	83.4	172.9	61.7	36.6	53.4	42.3	53.4	45.8	42.2	48.6	77.1	53.0	60.9	53.6	43.5	82.2	41.7	45.2	38.9	46.5	69.8	56.3	71.9	55.1	50.8	79.4	37.8	57.7	53.2	85.1	45.7	44.3	66.2	37.1	134.1	36.1	46.7	46.4	59.4	56.6	55.5	73.9	78.8	62.6	65.1	55.1	61.9	69.3	49.6	97.9	54.9	59.5	72.8	58.3	38.3	37.9	103.0	32.6	43.6	58.6	49.2	39.3	38.7	53.9	49.1	53.2	48.4	129.3	40.5	58.4	51.8	93.4	84.1	96.8	64.1	63.8	80.6	74.3	77.4	68.9	60.3	62.7	83.4	72.0	120.1	61.7	48.9	35.1	73.9	172.9	36.4	33.7	43.5	35.6	33.0	32.0	39.7	30.3	33.3	33.1	241.2	236.8	168.8	346.4	466.2	151.2	559.4	112.1	211.5	257.0	75.0	31.4	228.5	316.7	172.7	25.7	265.4	148.7	46.7	254.5	331.1	308.6	248.1	302.0	134.8	219.0	87.4	164.4	125.8	185.1	30.7	292.6	305.9	301.9	415.6	158.2	306.6	196.4	147.3	300.5	191.8	122.5	258.7	447.2	255.1	271.9	512.9	243.9	251.4	182.3	305.2
COPG1	COPG	ENSG00000181789	"Coatomer protein complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		110000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428"	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	25.2	39.4	21.1	22.2	28.0	20.1	37.3	23.6	50.3	43.3	42.1	24.3	50.6	34.2	27.6	66.5	29.5	24.4	34.5	33.4	24.2	26.7	32.4	72.1	36.5	39.4	23.0	21.6	28.6	75.6	47.6	49.7	49.3	34.9	45.1	45.1	22.4	59.9	45.5	24.1	24.3	32.4	29.1	20.7	29.0	36.3	23.6	16.2	26.9	33.0	22.0	27.7	19.9	24.1	15.7	31.9	34.9	33.0	31.1	31.8	26.0	32.7	16.7	24.4	21.1	57.2	46.4	26.0	53.5	51.1	36.9	46.7	30.6	20.4	18.0	31.2	75.9	30.0	19.8	20.1	31.5	40.2	21.9	8.3	29.9	22.1	49.4	52.1	22.6	32.2	48.4	27.8	29.5	48.7	40.6	33.2	13.9	10.4	43.6	44.4	49.8	13.2	23.1	14.5	48.1	20.5	14.4	22.9	34.8	46.0	27.3	15.2	17.8	41.1	30.7	49.0	28.0	34.0	33.1	44.8	20.1	19.1	42.4	20.6	34.1	16.2	31.6	49.1	17.3	38.5	34.9	26.8	20.2	26.2	33.0	31.8	15.0	23.7	25.7	31.9	15.7	18.5	21.6	21.3	31.1	29.7	29.4	23.6	26.0	21.1	28.0	23.6	50.3	24.2	26.7	23.0	21.6	34.9	16.2	14.9	29.8	27.4	13.9	7.8	8.7	19.3	17.8	16.0	18.2	26.2	3.9	52.4	36.5	39.6	7.8	19.4	69.2	46.7	40.7	53.3	25.8	24.8	14.0	53.3	34.3	4.8	37.1	35.6	31.0	3.1	38.0	19.0	21.9	44.1	67.9	14.2	35.7	37.4	29.4	28.8	7.5	19.4	17.3	21.1	16.4	8.9	60.4	20.1	38.2	17.5
HMCES	"C3orf37, DC12, SRAPD1"	ENSG00000183624	"5-hydroxymethylcytosine binding, ES cell specific"	Q96FZ2	3	129278828-129306186	"Predicted intracellular proteins"	"DNA damage"	"DNA-binding, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044968	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044968: AB_2679160"	"unprognostic (9.18e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.16e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.08e-3)"	16.4	10.8	15.9	29.8	23.1	15.1	15.2	19.2	22.8	13.2	16.3	9.3	18.1	13.3	13.4	11.8	19.6	12.8	13.9	27.9	13.6	16.7	13.1	24.6	12.5	42.6	14.9	18.6	14.4	7.3	62.2	11.2	10.5	14.4	12.7	14.8	12.2	13.0	13.0	24.9	16.2	13.2	15.5	10.4	14.4	11.9	17.8	9.7	36.5	14.3	14.3	57.5	12.8	15.1	33.3	14.9	32.9	19.7	13.3	24.4	15.5	33.6	15.2	17.5	20.2	21.8	9.0	15.8	11.9	9.6	17.3	13.5	23.8	15.9	65.4	12.9	10.6	13.5	24.7	22.1	25.5	20.1	13.1	11.8	13.5	12.3	16.9	9.4	11.7	10.0	8.6	13.3	14.4	14.2	8.4	10.4	14.6	13.6	57.8	9.5	44.5	16.7	10.1	11.3	24.6	9.9	15.0	15.0	11.4	18.2	20.2	17.5	10.8	26.5	16.7	16.1	11.3	28.5	11.9	8.4	8.7	15.3	20.7	15.2	32.2	19.0	65.8	10.4	9.5	9.6	14.8	13.8	32.9	17.1	14.2	17.7	19.1	20.9	20.1	13.8	33.3	20.8	22.7	27.7	13.3	19.7	14.9	24.4	15.5	15.9	23.1	19.2	22.8	13.6	16.7	14.9	18.6	14.4	9.7	29.8	24.6	19.3	61.1	51.7	17.8	29.9	35.7	14.7	10.3	21.0	9.8	34.4	31.5	32.8	6.8	25.4	21.3	23.3	41.3	29.6	19.4	28.9	21.9	24.3	17.4	25.4	20.2	17.2	6.9	7.8	22.7	20.3	55.6	19.8	13.3	37.7	25.1	17.5	29.4	15.1	10.3	12.9	33.2	68.2	65.8	38.3	29.3	37.3	28.7	50.3
H1FX	"H1X, MGC15959, MGC8350"	ENSG00000184897	"H1 histone family member X"	Q92522	3	129314771-129316277	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"bone marrow: 381.6;lymphoid tissue: 238.6"	"Cell type enhanced"	"Detected in all"	6	"Basal glandular cells: 485.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 139.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012235, HPA040099, HPA068431"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB012235: , HPA040099: AB_2676846, HPA068431: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	23.1	13.1	11.9	19.0	14.5	381.6	33.7	29.0	22.9	30.9	21.0	9.6	13.4	21.1	26.0	19.6	34.5	25.1	24.0	27.5	11.3	11.2	12.9	24.9	30.9	44.2	6.7	16.3	39.0	22.4	18.4	20.5	15.0	6.9	26.2	7.8	18.4	32.3	16.3	30.8	40.5	26.0	19.1	9.6	29.9	29.0	14.2	6.3	238.6	21.9	18.1	20.5	35.6	25.0	5.7	10.8	15.9	5.3	4.8	8.3	2.2	19.9	10.6	20.1	8.7	2.0	2.4	19.1	8.8	6.4	10.5	11.1	6.3	11.0	2.5	9.7	3.1	7.0	20.1	8.4	5.6	1.6	18.3	16.3	7.6	8.2	8.6	8.7	8.8	2.0	4.9	7.7	4.2	9.7	4.7	6.0	35.4	11.7	45.5	1.4	20.9	40.7	17.5	18.8	3.6	12.0	29.4	8.6	23.7	3.2	4.2	32.1	37.2	9.3	4.6	26.6	4.0	18.2	17.8	5.9	8.1	42.6	7.9	7.3	139.5	53.3	21.5	6.6	8.4	8.9	0.4	5.3	15.9	4.3	3.7	4.0	4.4	6.7	5.1	7.4	5.7	8.3	4.3	1.2	4.8	3.3	10.8	5.1	2.2	11.9	14.5	29.0	22.9	11.3	11.2	6.7	16.3	6.9	6.3	14.9	12.8	95.3	485.3	89.5	119.1	25.5	63.7	2.7	3.4	89.0	29.5	60.0	94.5	42.6	7.4	89.9	34.4	70.0	71.0	93.0	97.3	173.5	5.7	38.5	77.7	138.2	153.1	85.3	93.5	8.0	92.0	75.7	118.1	25.2	86.3	209.9	59.2	48.9	48.8	25.1	84.3	122.9	82.1	13.2	36.5	96.0	57.2	72.6	52.5	312.3
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 24.4;fallopian tube: 29.9;testis: 24.8"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 58.9;Early spermatids: 23.2;Late spermatids: 14.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"basal ganglia: 14.9;pons and medulla: 24.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.7;RPTEC TERT1: 3.8;SCLC-21H: 2.9"					"Region enhanced"	"Detected in many"		"midbrain: 14.2"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		NA	NA			Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.7	0.6	2.2	0.7	14.9	1.5	0.9	1.7	3.0	2.0	0.6	7.8	0.0	0.5	1.8	10.1	0.6	29.9	1.5	0.7	4.2	4.3	1.2	2.1	3.6	0.8	0.5	3.5	6.1	1.0	3.1	15.2	0.7	24.4	4.1	0.6	1.5	0.6	0.9	0.5	0.5	0.5	0.6	1.0	0.7	1.0	24.8	1.6	0.0	2.4	0.0	0.9	0.5	0.1	1.4	0.0	1.3	0.4	0.3	0.6	0.0	0.4	2.2	0.7	2.2	0.4	0.1	0.4	0.0	0.2	0.3	0.1	0.8	1.2	0.5	0.4	0.0	0.0	0.3	0.0	0.4	0.3	0.6	0.5	0.6	0.6	4.7	0.3	0.3	0.9	0.5	0.0	0.5	0.0	0.4	0.0	1.3	1.4	0.9	0.0	0.3	0.1	1.7	0.3	0.2	0.1	0.8	0.0	0.5	3.8	0.0	2.9	0.1	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.0	0.5	1.1	0.2	1.4	1.8	2.2	0.5	0.8	0.2	0.0	0.4	0.8	0.1	0.0	0.3	0.3	0.0	0.6	0.0	1.4	0.3	0.2	1.3	0.3	0.0	0.0	0.2	0.0	2.2	14.9	1.7	3.0	4.2	4.3	0.5	3.5	24.4	1.6	3.0	1.7	0.0	0.1	0.5	0.2	1.1	2.5	58.9	2.3	0.0	2.0	0.0	0.0	0.1	23.2	0.3	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.8	0.1	4.8	0.0	0.0	0.0	14.5	0.3	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	5.2	0.0	0.0	8.2	2.5	0.3	0.0	0.0	0.0	0.1
MBD4	MED1	ENSG00000129071	"Methyl-CpG binding domain 4, DNA glycosylase"	O95243	3	129430944-129440179	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002031	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA002031: AB_1079319"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (9.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.35e-2)"	18.1	14.5	14.9	41.9	19.0	26.2	22.8	22.1	16.3	24.0	17.2	14.2	11.2	16.0	16.6	17.8	14.1	15.3	17.4	22.0	15.3	12.8	24.1	30.1	19.0	41.6	17.6	13.7	26.5	18.9	14.8	23.8	17.4	13.6	14.7	16.2	8.4	16.2	16.2	18.2	16.0	21.9	14.7	15.9	34.2	18.7	11.3	15.4	30.4	16.0	14.7	47.8	18.3	18.0	40.3	8.7	19.6	9.5	9.3	15.1	8.7	19.8	12.0	14.7	16.4	16.9	15.2	17.0	17.2	16.3	16.5	19.7	14.7	13.4	28.0	14.1	10.7	15.3	18.0	11.2	10.6	20.2	15.8	7.4	16.7	13.8	10.6	27.0	30.5	22.3	18.0	15.3	14.1	12.5	16.6	15.6	16.4	18.6	21.2	12.2	18.4	17.6	21.5	12.9	16.8	10.4	16.6	8.6	19.2	18.4	9.9	16.5	9.2	21.7	11.4	18.1	13.3	14.4	27.1	10.3	15.7	12.1	16.8	11.3	14.5	8.7	49.1	13.4	17.4	12.9	19.6	8.7	11.6	11.5	7.8	8.7	40.3	12.3	11.3	7.3	36.0	15.1	12.6	15.4	9.3	9.5	8.7	10.5	8.7	14.9	19.0	22.1	16.3	15.3	12.8	17.6	13.7	13.6	15.4	17.9	51.1	69.0	27.1	15.3	31.5	31.3	12.7	30.8	33.0	41.8	17.7	40.7	38.1	28.3	15.4	28.5	22.2	0.0	61.2	41.7	32.4	24.5	56.7	29.7	66.1	20.6	32.3	25.8	40.5	5.3	30.5	34.9	20.3	36.9	23.5	18.6	35.8	24.3	34.3	52.3	41.2	38.8	29.2	38.6	68.7	17.1	31.0	39.9	24.4	28.8
IFT122	"SPG, WDR10, WDR10p, WDR140"	ENSG00000163913	"Intraflagellar transport 122"	Q9HBG6	3	129440036-129520507	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 84.7"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 61.8;Late spermatids: 52.6;Spermatocytes: 117.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041815	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA041815: AB_10804118"	"unprognostic (7.16e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.67e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.33e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.20e-3)"	7.4	5.7	11.1	4.9	14.0	6.4	9.1	13.3	13.1	10.2	5.6	7.6	6.4	3.5	10.2	9.6	5.4	18.5	5.0	10.0	7.8	6.4	8.8	6.7	6.7	4.5	4.4	9.2	19.0	9.6	13.1	18.9	7.7	7.2	5.7	5.2	10.5	6.3	6.7	3.7	9.9	4.1	7.6	4.2	3.7	6.7	84.7	5.7	7.6	9.6	2.0	4.2	5.3	6.9	4.7	6.0	8.3	5.7	2.8	5.5	3.8	11.0	16.7	14.5	9.5	21.1	15.0	7.7	5.9	8.9	10.3	10.0	8.0	7.3	7.1	7.0	7.6	10.2	7.1	5.6	5.2	9.4	3.8	6.0	5.4	13.6	6.8	5.8	14.9	5.0	17.5	3.9	7.9	6.2	9.0	13.9	15.2	5.5	15.3	8.3	12.2	12.2	7.7	9.7	8.3	4.8	10.9	5.5	5.1	11.1	2.0	18.4	7.5	16.9	5.7	5.1	5.7	15.5	12.0	6.1	7.3	6.2	9.4	7.0	10.5	7.3	6.2	6.6	7.6	5.5	8.3	5.7	6.6	1.9	3.9	3.3	3.8	3.3	4.5	6.0	4.7	3.7	4.5	2.7	2.8	1.7	1.4	5.5	3.8	11.1	14.0	13.3	13.1	7.8	6.4	4.4	9.2	7.2	5.7	8.9	8.0	2.4	4.9	2.4	9.5	5.6	7.6	13.4	4.5	24.4	35.3	5.6	6.6	4.5	61.8	6.0	5.8	0.0	7.8	5.0	8.8	2.8	4.7	3.9	8.4	4.8	2.9	17.8	6.5	52.6	17.3	2.5	3.3	1.8	9.2	10.8	3.4	3.5	13.1	6.0	19.6	0.0	7.1	117.0	35.3	2.5	2.2	3.2	7.0	2.2
RHO	"CSNBAD1, OPN2, RP4"	ENSG00000163914	Rhodopsin	P08100	3	129528640-129535169	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Congenital stationary night blindness, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	151	"retina: 415.0"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 2822.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.6;cerebral cortex: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013440, CAB022486, CAB034887, CAB034888"	Enhanced					NA	NA					"CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844"	"unprognostic (4.32e-2)"			"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.87e-1)"		"unprognostic (1.94e-1)"			"unprognostic (9.19e-11)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.91e-1)"		0.2	0.0	0.0	0.0	0.3	0.0	0.1	1.6	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	415.0	0.3	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	2.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	290.1	0.6	0.0	0.0	0.0	0.0	428.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	206.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	393.2	0.0	0.0	0.0	0.0	2822.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H1FOO		ENSG00000178804	"H1 histone family member O oocyte specific"	Q8IZA3	3	129543214-129551467	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	80	"testis: 10.8"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 20.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.1;SCLC-21H: 1.5"					"Low region specificity"	"Detected in many"			HPA037992	Enhanced					NA	NA					"HPA037992: AB_10671517"															"unprognostic (5.43e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
PLXND1	KIAA0620	ENSG00000004399	"Plexin D1"	Q9Y4D7	3	129555175-129606818	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 69.9;Ito cells: 161.4;Kupffer cells: 82.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 11.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.9;HSkMC: 52.3;HUVEC TERT2: 61.2;TIME: 71.7"	"Group enriched"	"Detected in many"	6	"amygdala: 37.7;basal ganglia: 29.6;cerebral cortex: 27.0;hippocampal formation: 28.7"	"Low region specificity"	"Detected in many"			CAB020819	Approved					NA	NA		58000000			"CAB020819: "	"unprognostic (8.97e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.93e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.00e-2)"	35.3	13.5	10.8	17.4	19.5	11.0	47.9	2.7	14.3	31.7	9.7	18.5	7.2	3.0	21.1	16.2	10.9	20.0	19.6	25.8	9.3	8.2	16.2	14.5	33.0	37.0	25.9	7.2	10.5	8.4	11.9	7.2	54.6	14.4	11.2	8.7	31.9	8.2	14.2	10.4	9.5	11.6	26.1	19.1	22.1	9.4	7.0	17.4	28.6	18.0	14.4	11.2	19.1	16.8	0.0	3.9	0.1	11.7	2.8	7.6	1.5	1.6	10.1	8.4	2.8	71.9	31.0	17.4	7.4	21.8	4.6	5.3	2.3	1.4	0.3	32.1	26.6	2.3	0.1	4.5	0.1	1.3	0.3	0.5	6.9	5.1	10.5	8.2	2.2	1.9	52.3	0.3	4.7	0.5	6.6	61.2	0.3	2.4	0.2	6.1	5.3	0.4	7.5	2.0	0.4	1.4	8.1	5.7	8.6	1.8	0.4	4.9	0.2	1.8	0.6	2.8	20.2	2.7	10.3	71.7	3.8	5.2	0.1	5.5	0.3	0.3	3.3	1.3	5.0	3.3	0.0	11.7	0.0	1.9	5.3	7.6	0.0	1.4	1.5	3.0	0.0	0.0	0.2	0.1	2.8	4.9	3.9	0.0	1.5	10.8	19.5	2.7	14.3	9.3	8.2	25.9	7.2	14.4	17.4	3.0	25.6	9.3	0.2	7.1	0.0	5.3	10.2	1.4	2.3	0.0	0.0	6.1	0.0	1.6	1.0	55.4	0.0	0.0	3.1	13.2	18.4	0.4	21.9	2.5	69.9	0.0	12.6	161.4	82.1	0.7	35.9	27.3	8.5	23.4	2.2	6.0	2.6	0.0	13.1	0.2	0.0	32.3	22.6	0.4	3.8	3.9	4.5	10.2	0.4	0.4
TMCC1	KIAA0779	ENSG00000172765	"Transmembrane and coiled-coil domain family 1"	O94876	3	129647792-129893576	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 12.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053894	Uncertain					NA	NA					"HPA053894: AB_2682295"	"unprognostic (4.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (7.75e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (6.82e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.32e-1)"	7.8	8.1	10.0	7.1	10.9	3.5	8.4	28.9	11.5	11.6	6.7	14.1	2.6	4.7	8.9	7.9	8.6	8.0	9.7	8.8	9.8	8.8	6.7	37.2	7.5	5.2	16.1	9.2	9.4	7.2	8.7	19.8	10.7	11.3	8.8	6.0	6.2	6.0	7.5	28.2	7.7	4.8	7.9	13.5	7.2	4.7	14.0	13.1	10.3	7.8	5.6	5.9	8.3	7.3	1.3	1.8	12.2	2.4	1.0	2.2	0.9	8.6	9.6	7.5	6.1	11.3	8.0	7.6	3.4	4.5	3.0	3.2	6.0	4.8	5.3	9.8	6.6	3.6	8.0	4.2	6.8	2.3	7.0	1.4	3.5	2.8	22.0	3.8	2.6	2.2	4.6	12.9	2.4	5.7	6.7	9.3	3.2	1.7	3.9	7.0	9.3	4.6	1.6	5.7	6.3	3.0	4.2	6.3	4.4	7.1	10.7	6.9	4.9	11.7	4.0	3.4	7.6	7.8	2.9	8.0	4.9	8.0	4.4	7.0	5.9	3.9	4.1	3.6	3.1	2.5	0.8	1.2	2.6	1.6	1.1	1.7	0.9	1.3	1.3	0.6	1.3	1.6	2.0	12.2	1.0	2.4	1.8	2.2	0.9	10.0	10.9	28.9	11.3	9.8	8.8	16.1	9.2	11.3	13.1	50.6	6.1	7.5	11.5	6.0	33.3	19.3	7.6	21.4	15.9	21.0	29.5	8.1	6.6	15.6	8.8	9.4	4.9	0.0	7.2	17.9	7.6	20.7	3.5	28.0	8.7	33.4	12.1	9.8	18.3	8.8	12.0	7.4	1.7	2.8	10.4	28.6	19.7	14.8	8.1	11.8	24.9	6.5	10.3	31.0	15.1	6.0	20.0	4.5	6.8	18.6
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974305-129977938	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5"	"Cell type enriched"	"Detected in some"	31	"Muller glia cells: 222.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 13.3;endometrial cancer: 10.2"	"Group enriched"	"Detected in many"	14	"hypothalamus: 33.9;pons and medulla: 33.8"	"Group enriched"	"Detected in some"	11	"intermediate monocyte: 1.1;non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"REH: 2.6;SuSa: 4.0;T-47d: 2.4"	"Group enriched"	"Detected in many"	5	"hypothalamus: 204.6;olfactory region: 182.2"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"	NA	NA					"HPA035596: AB_2674695"	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.3	0.1	0.4	0.2	2.4	2.8	0.9	0.3	1.7	23.6	0.1	0.1	0.6	0.2	17.5	0.1	0.1	2.3	0.1	0.5	2.0	33.9	0.1	0.1	0.6	0.1	0.4	0.8	3.2	0.1	0.1	0.1	0.3	33.8	0.1	0.1	6.3	1.0	0.2	0.2	0.5	0.1	0.4	3.6	0.1	0.1	0.8	0.0	0.8	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	4.0	2.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	2.4	0.3	1.7	2.0	33.9	0.4	0.8	33.8	0.0	0.0	0.0	0.0	0.5	0.7	6.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	222.3	0.0	0.0	0.0	0.0	7.1	0.0	0.4	0.4	0.4	0.1	0.1	0.0	0.0	0.5
ALG1L2		ENSG00000251287	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2"	C9J202	3	130081831-130113227	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 4.0;lymphoid tissue: 3.5"	"Cell type enhanced"	"Detected in some"	5	"Basal glandular cells: 4.9;Cone photoreceptor cells: 3.9;Horizontal cells: 4.8;Muller glia cells: 4.8"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 4.0"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 4.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.6;HDLM-2: 1.9;HEL: 1.8;Karpas-707: 1.4;REH: 2.9"									HPA060392	Uncertain		Uncertain	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: AB_2684273"	"unprognostic (1.05e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.44e-3)"	"unprognostic (8.15e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.38e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.28e-3)"	0.0	0.0		0.8		1.2	0.0		0.0	0.0	0.0			0.8	0.0	0.0	0.3	0.3	0.0	0.0			0.0	0.0	0.0	0.0			0.2	0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0	0.9	0.0	0.0		3.5	0.3	0.0			0.0		0.0	0.1		0.7	4.0	0.0	0.3	0.0	0.9	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	1.4	0.0	0.0	0.0	0.5	0.1	0.9	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.6	0.3	0.3	0.4	0.1	0.0	0.0	0.0	4.0	0.9	0.1											0.0	1.6	0.8	4.9	0.0	1.9	0.2	0.0	1.4	1.2	1.8	3.9	0.2	1.7	0.0	0.4	0.0	0.9	0.0	0.0	0.2	0.6	1.8	0.0	0.2	0.2	4.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	4.8	0.0	0.0	2.5	0.3	3.0	0.0	0.1	0.5	0.1	0.0	0.0	0.5	0.6	1.4
COL6A5	"COL29A1, FLJ35880, VWA4"	ENSG00000172752	"Collagen type VI alpha 5 chain"		3	130345516-130484844	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"lung: 9.6;skin 1: 11.1"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 3.1;Club cells: 1.2;Early spermatids: 4.1;Late spermatids: 2.4;Suprabasal keratinocytes: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	63	"HDLM-2: 18.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			HPA043138	Uncertain				"Secreted in other tissues"	NA	NA					"HPA043138: AB_10796687"	"unprognostic (3.45e-2)"	"unprognostic (4.08e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-6)"		"unprognostic (8.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.71e-1)"		"unprognostic (7.58e-8)"	"unprognostic (3.85e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-2)"	0.2	0.0	0.2	0.2	0.5	0.1	1.0	0.2	0.2	0.2	0.4	0.2	0.2	1.5	0.2	0.2	2.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	9.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	11.1	1.8	0.2	0.2	0.2	1.5	1.1	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.0	0.0	0.0	0.0	0.0
COL6A6		ENSG00000206384	"Collagen type VI alpha 6 chain"	A6NMZ7	3	130560334-130678155	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 5.6;lung: 11.1;pituitary gland: 5.7"	"Cell type enriched"	"Detected in some"	4	"Fibroblasts: 7.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"SuSa: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045239	Uncertain				"Secreted to extracellular matrix"	NA	NA		490000			"HPA045239: AB_2679268"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.08e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-5)"	"unprognostic (3.74e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.96e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.07e-1)"	2.3	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0			0.0	0.7	0.3	1.2	0.3	0.0	5.6	0.0	0.0	0.0	0.9	11.1	0.0	0.0		0.2	0.0	0.0	5.7	0.8		0.0	0.0		2.2	0.0	0.0	0.4	0.0	0.5	0.0	1.5	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	5.5	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0											0.0	1.4	0.0	0.0	0.8	1.2	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.4	0.6	0.1	0.0	0.0	0.0
PIK3R4	"p150, VPS15"	ENSG00000196455	"Phosphoinositide-3-kinase regulatory subunit 4"	Q99570	3	130678935-130746829	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036032, HPA036033"	Approved		Approved	Vesicles,Microtubules		NA	NA			Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: AB_2674911"	"unprognostic (7.50e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (8.25e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	15.5	16.2	11.6	11.6	15.9	10.6	14.9	14.7	17.2	16.5	13.1	14.9	9.5	10.3	18.8	12.0	12.9	15.6	12.0	12.2	9.7	10.0	14.9	28.2	13.7	12.4	12.0	11.4	17.8	12.0	40.7	20.6	14.4	17.3	14.1	11.6	14.1	14.0	15.4	14.8	16.0	13.4	14.6	12.1	18.5	13.3	14.9	11.8	29.7	18.1	10.2	13.6	16.5	13.9	8.4	9.6	12.0	8.5	11.5	13.7	7.0	14.3	9.1	13.4	9.7	19.9	15.9	9.3	10.7	12.9	14.8	17.2	11.8	12.2	16.9	13.5	10.8	11.8	20.6	22.0	16.6	23.3	10.2	8.2	13.8	10.5	8.2	9.1	20.9	6.9	10.9	12.0	15.8	10.0	9.3	13.7	9.9	16.0	8.6	13.0	12.6	17.1	6.4	16.9	13.0	9.0	12.0	15.6	15.2	9.7	11.8	12.4	9.1	15.4	9.7	10.8	16.5	13.4	9.2	10.8	11.4	9.9	12.8	8.5	10.1	9.1	22.3	12.5	8.0	10.5	12.0	7.2	9.2	9.4	8.4	13.7	8.4	8.6	6.9	9.6	5.7	10.1	9.0	6.0	11.5	8.5	3.4	9.3	7.0	11.6	15.9	14.7	17.2	9.7	10.0	12.0	11.4	17.3	11.8	6.0	5.4	0.0	3.4	3.4	8.2	7.5	15.3	14.7	11.4	10.4	13.7	4.6	1.7	4.1	3.4	6.7	5.3	0.0	5.1	3.1	3.5	3.7	9.2	15.6	5.1	4.8	2.9	8.0	6.7	2.7	8.9	3.8	5.0	5.4	6.2	8.0	5.3	5.8	11.0	4.9	12.0	6.5	3.2	10.8	12.7	3.9	3.5	4.6	5.8	2.5
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"		NA	NA		28000	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	18.6	22.9	29.6	14.5	29.4	20.4	36.8	24.5	34.6	22.2	21.6	23.0	14.3	14.4	19.3	18.0	16.9	23.4	16.8	19.2	31.6	32.3	28.0	17.1	30.7	16.0	31.8	25.4	18.5	14.6	47.6	31.0	19.6	26.7	54.0	22.4	18.1	20.3	16.6	16.1	21.3	16.0	19.2	44.6	11.1	18.7	16.0	25.6	20.5	21.7	15.5	15.4	19.3	29.6	4.7	7.6	21.6	7.0	8.7	7.2	4.9	36.6	14.4	14.5	13.9	40.6	32.9	15.6	40.1	53.5	20.2	25.5	23.4	30.3	13.3	27.9	37.9	28.1	43.7	27.2	22.1	29.6	28.7	9.8	35.4	15.3	10.8	25.9	14.1	43.2	25.8	22.3	21.2	24.1	36.9	21.3	16.9	10.2	24.3	24.8	16.3	13.8	11.3	16.4	20.0	15.7	10.0	14.4	20.9	37.2	24.7	22.4	13.4	34.5	10.8	20.2	21.6	16.0	11.6	29.1	21.5	12.0	27.6	18.4	15.7	19.0	19.7	22.2	10.6	17.9	21.6	7.0	12.1	6.3	6.0	5.9	4.7	6.2	5.6	7.6	2.9	4.3	4.3	3.5	8.7	7.0	6.6	7.2	4.9	29.6	29.4	24.5	34.6	31.6	32.3	31.8	25.4	26.7	25.6	35.7	45.2	11.3	32.9	34.9	26.4	27.0	40.8	24.1	23.9	43.6	19.6	13.5	5.0	32.7	12.6	25.1	15.9	0.0	33.1	24.1	29.4	68.4	27.7	24.6	26.6	77.9	34.2	22.7	18.3	14.0	15.0	28.6	20.3	19.8	31.3	22.6	44.4	25.9	13.8	18.6	33.2	6.5	24.2	15.2	14.9	46.2	14.8	13.8	29.3	33.5
ASTE1	HT001	ENSG00000034533	"Asteroid homolog 1"	Q2TB18	3	131013875-131027649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037010, HPA037011"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA037010: AB_10673629, HPA037011: AB_10696929"	"unprognostic (7.42e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (2.27e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-2)"	10.1	9.2	6.8	11.7	9.5	10.2	10.3	9.3	9.4	11.9	14.3	13.1	7.1	10.4	12.4	11.4	7.7	9.3	9.4	6.1	8.5	7.1	7.2	10.9	7.4	11.9	11.3	9.7	11.1	12.9	10.7	14.0	8.0	8.8	7.9	10.8	8.2	7.2	8.2	4.9	7.4	16.6	8.9	9.7	12.0	8.7	12.1	8.0	17.7	12.9	6.9	13.8	8.3	7.8	9.8	9.1	25.1	12.1	17.6	19.9	7.0	10.2	7.4	4.9	5.0	8.8	9.3	2.2	5.8	5.1	7.1	7.3	12.2	4.3	11.3	8.9	5.6	6.0	11.4	9.7	4.8	10.7	6.1	5.8	6.7	4.0	5.6	8.9	10.4	4.0	6.1	6.6	5.7	5.4	6.1	5.9	9.5	5.8	5.8	7.3	7.0	9.0	5.3	4.5	12.2	7.5	9.8	6.9	9.9	5.8	6.4	8.4	7.7	10.9	2.6	7.9	5.0	6.7	7.2	4.1	8.0	5.4	13.3	4.6	7.4	6.5	15.2	6.2	9.0	4.0	25.1	8.4	16.9	13.8	9.5	14.5	9.6	15.2	12.0	9.1	9.8	19.9	14.5	6.1	17.6	12.1	6.6	16.7	7.0	6.8	9.5	9.3	9.4	8.5	7.1	11.3	9.7	8.8	8.0	11.9	4.3	4.2	3.5	2.9	9.1	1.7	2.5	1.4	7.9	3.5	13.7	5.1	5.0	4.4	25.5	5.8	9.3	0.0	5.1	4.2	3.7	2.4	8.1	4.4	4.2	3.2	6.4	5.5	2.2	9.3	6.6	5.9	1.7	2.8	4.7	6.9	2.8	5.8	4.6	3.7	12.7	0.0	5.1	1.8	5.1	1.3	3.3	11.5	6.6	2.5
NEK11	FLJ23495	ENSG00000114670	"NIMA related kinase 11"	Q8NG66	3	131026850-131350465	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.9"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 148.5;Early spermatids: 122.2;Late spermatids: 80.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016908	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016908: AB_1854364"	"unprognostic (9.15e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.92e-6)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.58e-1)"	3.9	5.8	9.3	2.7	11.1	0.5	8.7	2.7	7.6	7.3	2.8	11.2	8.4	2.0	6.5	16.0	3.2	26.9	6.0	2.9	9.1	10.0	8.2	1.1	5.5	1.7	7.8	5.4	8.7	2.8	5.0	9.3	4.6	17.3	4.0	3.3	3.0	3.8	6.7	1.7	2.8	2.6	4.3	7.3	1.8	2.3	17.8	5.5	0.2	12.3	2.5	1.7	4.2	3.0	0.9	1.0	1.1	1.3	0.3	2.9	0.3	5.9	2.4	1.8	5.2	7.0	10.5	1.0	2.9	5.5	4.5	3.4	2.2	8.3	0.3	2.1	5.2	4.3	3.3	0.5	5.1	6.3	0.6	0.7	0.8	0.4	1.0	2.3	0.6	1.5	4.4	8.5	4.8	2.2	4.8	0.9	2.6	0.2	0.9	7.5	4.2	0.1	0.5	0.5	0.9	2.3	0.0	0.2	0.1	10.3	2.3	2.2	2.5	1.4	0.1	2.0	0.8	4.9	0.1	0.9	4.7	2.3	3.6	1.4	1.4	2.3	0.1	3.2	0.2	0.8	0.0	0.3	1.1	0.6	1.3	1.2	0.9	2.9	2.6	0.5	0.6	1.0	0.8	0.9	0.3	0.9	1.0	1.5	0.3	9.3	11.1	2.7	7.6	9.1	10.0	7.8	5.4	17.3	5.5	14.9	2.7	0.0	3.4	3.8	2.7	1.1	2.5	148.5	29.6	1.8	5.9	0.5	5.0	4.7	122.2	2.4	1.7	0.0	2.2	1.0	5.4	1.4	0.0	0.0	1.8	0.0	2.4	2.5	0.0	80.8	6.4	1.4	0.0	1.0	2.7	5.7	2.9	3.7	5.6	8.4	6.9	6.5	2.2	30.5	4.9	1.8	1.4	0.0	1.7	1.8
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	25.9	13.4	22.1	13.1	22.0	8.7	13.1	13.5	20.5	11.1	32.8	23.9	13.9	20.2	11.7	11.6	8.7	14.0	13.6	22.2	21.1	19.6	25.9	23.1	16.2	31.1	27.7	16.9	23.0	18.3	32.9	9.7	7.6	20.1	13.4	18.4	13.6	11.7	13.6	20.3	6.8	37.5	18.5	30.4	22.2	13.8	9.5	21.6	2.2	17.1	11.5	9.1	12.4	8.4	4.3	13.6	18.8	24.5	3.7	4.3	6.7	12.6	6.8	11.2	5.8	22.5	20.5	5.2	10.4	9.6	7.0	7.3	10.4	5.7	2.1	9.1	9.6	13.9	9.3	9.9	6.5	11.2	6.3	7.2	5.4	8.7	10.0	14.4	9.0	9.9	18.2	5.8	4.6	12.7	6.3	10.9	0.0	6.1	11.0	6.8	13.2	0.0	2.4	8.7	12.7	10.1	7.1	8.1	16.0	7.0	10.3	5.5	9.6	6.2	6.3	9.5	9.9	13.8	7.2	10.7	11.5	5.0	21.0	8.0	11.0	10.8	0.3	7.4	7.0	6.3	2.2	18.2	18.8	2.6	21.9	2.7	4.3	2.7	2.4	13.6	4.2	2.4	2.4	14.6	3.7	24.5	1.8	4.3	6.7	22.1	22.0	13.5	20.5	21.1	19.6	27.7	16.9	20.1	21.6	14.9	31.3	19.1	10.7	7.4	22.7	83.1	40.8	16.0	18.2	19.2	7.9	18.7	58.0	20.4	59.4	30.8	62.9	23.3	32.8	21.8	21.4	14.7	18.5	95.7	54.0	41.3	24.3	84.1	138.2	27.2	24.5	46.3	16.9	14.4	61.2	10.0	23.8	50.3	37.1	92.4	18.3	25.8	23.7	17.6	5.1	4.6	6.1	20.8	42.4	14.7
MRPL3	"MRL3, RPML3"	ENSG00000114686	"Mitochondrial ribosomal protein L3"	P09001	3	131462212-131502983	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043665, HPA060132"	Approved					NA	NA					"HPA043665: AB_2678606, HPA060132: AB_2684209"	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.61e-3)"	"unprognostic (7.83e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.33e-7)"	"unprognostic (1.54e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (1.36e-4)"	"prognostic unfavorable (3.51e-6)"	"unprognostic (2.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-1)"	30.8	32.6	23.3	23.4	25.9	13.8	34.7	20.4	29.6	27.1	31.1	17.8	32.8	25.1	26.8	39.7	36.0	31.7	22.9	46.3	23.6	26.3	48.9	53.5	20.2	36.5	23.0	20.1	38.7	44.8	33.7	31.7	23.5	27.0	32.1	35.7	19.9	29.4	27.2	51.6	21.5	30.7	26.6	21.4	28.7	26.9	34.9	17.2	42.3	47.5	37.5	30.3	35.5	23.8	23.8	46.1	5.8	32.3	28.3	30.3	33.7	54.7	23.2	26.1	29.3	24.7	32.1	47.4	30.0	26.4	38.8	34.7	51.2	32.0	44.7	40.7	29.9	30.5	36.1	44.3	43.0	59.7	29.0	34.6	41.4	25.7	42.9	29.0	82.8	26.7	25.2	35.8	29.8	53.3	21.2	25.0	34.4	37.8	24.5	32.0	41.8	41.4	41.6	55.5	58.7	41.9	16.6	33.6	68.5	38.2	38.7	42.6	28.7	26.8	30.7	42.0	22.9	35.9	44.6	22.6	28.1	29.2	39.6	41.3	23.5	23.6	80.1	30.0	40.0	38.5	3.4	24.7	5.8	19.5	32.3	30.3	23.8	24.2	23.2	46.1	22.0	28.1	25.0	1.4	28.3	23.3	16.1	23.4	33.7	23.3	25.9	20.4	29.6	23.6	26.3	23.0	20.1	27.0	17.2	23.8	21.1	52.2	74.7	40.8	27.8	31.9	38.2	34.8	38.7	29.6	7.9	83.1	129.3	84.1	64.2	20.3	35.7	0.0	88.7	110.1	51.3	58.9	28.8	45.2	60.4	28.6	28.9	35.6	49.5	14.8	51.5	54.1	40.5	45.9	68.9	30.1	77.5	21.0	48.4	133.1	17.3	32.3	35.4	148.5	76.8	41.5	53.4	32.4	73.7	68.6
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;prostate: 35.7"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 17.1;Glandular cells: 18.5;Intestinal endocrine cells: 4.7"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A549: 9.9;AF22: 9.3;Karpas-707: 2.8;RT4: 3.1"	"Low region specificity"	"Detected in many"							"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA032036: AB_10600898, HPA078300: AB_2732377"	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	1.4	1.4	7.0	0.8	11.6	0.8	0.7	0.4	27.2	1.0	1.1	2.5	0.7	1.6	0.9	1.6	1.1	1.2	0.7	1.9	17.5	5.3	2.1	0.8	1.2	0.7	1.3	11.8	0.7	0.8	3.8	9.5	0.7	3.1	35.7	1.0	0.1	1.1	6.0	0.6	1.0	1.4	1.2	4.6	1.8	1.4	2.3	3.6	0.0	1.1	0.0	0.7	0.7	1.1	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	9.9	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	2.8	1.3	0.6	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.6	3.1	1.4	0.6	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.2	2.3	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	7.0	11.6	0.4	27.2	17.5	5.3	1.3	11.8	3.1	3.6	0.0	0.0	0.0	0.4	0.2	0.8	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.5	18.5	0.0	0.0	0.1	1.6	4.7	0.0	0.0	3.6	0.3	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	1.2	0.5	0.0	0.8	1.2	1.1	0.1	0.0	0.0	0.0	0.8
ACPP	"ACP-3, ACP3, PAP"	ENSG00000014257	"Acid phosphatase, prostate"	P15309	3	132317367-132368298	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"prostate: 345.2"	"Cell type enriched"	"Detected in many"	135	"Glandular cells: 2098.0"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 43.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.2;OE19: 12.7;RPMI-8226: 32.4;U-698: 9.4;U-87 MG: 9.0"	"Low region specificity"	"Detected in some"							"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	NA	NA	460000	9200			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	0.4	0.6	0.4	0.7	1.6	1.4	0.8	0.3	0.7	3.9	0.4	0.2	0.0	0.4	0.3	2.5	14.7	0.6	0.2	0.9	0.3	0.3	6.2	0.3	2.0	2.7	0.6	0.8	0.4	0.8	0.5	0.3	5.3	0.7	345.2	0.7	0.8	9.1	0.2	0.3	2.5	0.4	0.4	2.2	1.0	0.5	1.0	0.6	0.2	1.3	6.6	6.8	0.5	1.5	0.2	11.2	43.1	9.7	0.9	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.6	7.0	0.1	10.2	0.0	0.0	0.2	0.2	5.7	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	1.2	0.2	0.1	0.1	4.1	0.1	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.1	0.1	0.0	7.8	0.4	12.7	1.2	0.0	0.0	32.4	3.1	3.8	0.0	2.5	0.0	1.2	0.3	1.1	0.2	3.7	0.0	0.0	0.1	1.5	0.0	0.4	0.2	9.4	9.0	7.3	0.1	0.0	9.7	43.1	0.0	8.6	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	8.5	0.9	7.7	0.8	0.0	2.9	0.4	1.6	0.3	0.7	0.3	0.3	0.6	0.8	0.7	0.6	0.0	10.7	0.0	13.0	0.8	0.0	0.5	0.0	0.0	4.5	7.0	0.0	9.6	0.0	1.1	0.0	0.0	1.0	0.0	1.6	1.0	0.8	2098.0	0.0	0.0	4.1	0.0	15.5	0.0	9.2	0.0	0.0	2.8	0.0	0.0	2.4	0.3	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	7.4	0.0	1.0	11.5
DNAJC13	"KIAA0678, RME8"	ENSG00000138246	"DnaJ heat shock protein family (Hsp40) member C13"	O75165	3	132417526-132539032	"Predicted membrane proteins"	"Protein transport, Transport"	Chaperone	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036923, HPA036924"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA036923: AB_10672480, HPA036924: AB_2675386"	"unprognostic (3.35e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (3.68e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (8.36e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.81e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	23.3	17.8	20.4	15.1	14.4	20.5	16.2	18.0	19.9	20.8	23.1	8.1	23.3	14.5	25.0	18.7	22.3	16.8	13.1	20.5	19.9	11.0	23.6	12.1	17.7	14.9	11.5	17.8	20.1	12.2	21.1	12.3	22.9	17.3	17.8	18.8	10.2	16.1	24.6	20.0	13.7	20.1	26.3	12.5	19.4	16.0	10.3	16.4	13.0	20.6	13.8	13.6	24.5	32.4	2.2	5.7	3.4	7.0	1.7	2.1	1.6	14.8	8.5	11.7	5.9	27.2	24.2	7.1	16.2	30.3	15.7	17.4	9.5	9.5	7.8	10.3	21.9	21.1	12.2	10.8	11.7	22.0	8.9	3.0	9.6	8.6	6.3	14.4	9.6	9.5	17.6	8.6	14.2	17.7	12.0	22.0	12.8	5.4	13.0	22.2	11.4	7.9	4.6	6.8	12.9	7.7	7.7	8.3	6.2	14.2	15.7	4.2	6.9	15.4	8.1	17.5	10.4	12.7	9.1	20.4	17.8	9.2	17.3	6.9	7.4	7.2	10.6	18.6	6.8	13.0	3.4	5.2	0.7	1.9	4.3	1.8	2.2	2.0	1.7	5.7	1.4	1.5	2.1	1.2	1.7	7.0	2.7	1.1	1.6	20.4	14.4	18.0	19.9	19.9	11.0	11.5	17.8	17.3	16.4	11.9	18.7	7.5	6.2	6.0	10.4	41.1	10.2	14.7	11.4	12.2	31.4	6.7	1.7	7.9	1.3	15.5	16.5	0.0	7.9	6.5	10.3	11.3	11.5	7.8	17.4	63.5	13.8	16.5	39.6	1.9	14.1	18.3	27.0	9.0	13.3	13.4	10.9	11.5	20.1	15.8	11.0	6.5	10.3	3.4	12.3	6.6	4.2	6.1	12.1	10.5
ACAD11	FLJ12592	ENSG00000240303	"Acyl-CoA dehydrogenase family member 11"	Q709F0	3	132558138-132660723	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 35.0;liver: 42.7"	"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 6.0;Intestinal endocrine cells: 4.6;Syncytiotrophoblasts: 8.1"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048317	Enhanced					NA	NA					"HPA048317: AB_2680354"	"unprognostic (5.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.93e-1)"	10.0	7.6	4.9	2.6	9.6	6.3	5.2	5.4	8.0	7.4	9.8	7.2	6.8	11.1	7.2	8.3	3.2	6.4	4.2	8.8	6.6	3.9	35.0	42.7	4.9	3.2	12.9	3.8	7.6	5.9	3.8	13.9	5.9	8.7	4.7	2.7	5.5	4.7	7.4	3.7	6.9	18.8	4.9	12.6	4.5	4.0	5.3	10.2	4.0	5.5	2.3	3.3	5.4	4.7	1.9	2.3	0.2	0.8	2.4	3.7	0.9	4.0	4.0	5.8	8.1	6.2	6.5	7.6	8.7	12.6	4.5	5.8	11.6	1.3	2.8	5.3	3.4	6.6	3.4	3.2	5.7	4.9	4.9	4.1	3.3	3.3	8.5	8.8	2.3	2.3	4.9	3.9	5.9	11.5	9.4	4.2	3.1	1.8	5.4	4.8	5.3	2.3	2.6	3.7	1.9	4.4	2.5	4.7	4.0	7.8	2.2	3.4	5.5	7.5	3.0	18.1	4.4	8.2	2.6	4.0	3.4	1.9	2.5	3.4	5.7	1.8	3.0	4.6	0.9	2.7	0.0	0.7	0.2	1.6	0.8	1.6	1.3	1.4	0.7	0.5	1.9	3.7	1.7	0.0	2.4	0.8	2.3	0.7	0.9	4.9	9.6	5.4	8.0	6.6	3.9	12.9	3.8	8.7	10.2	6.0	2.7	0.0	0.1	0.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	3.3	0.0	0.7	0.6	0.5	0.9	0.0	1.0	0.6	0.7	0.2	1.1	3.0	0.6	0.0	4.6	0.0	1.5	0.0	0.6	0.3	0.0	3.6	0.0	1.0	0.3	0.0	0.7	1.1	1.9	0.0	0.4	0.0	0.2	0.3	8.1	0.0	0.8	0.1
NPHP3-ACAD11		ENSG00000274810	"NPHP3-ACAD11 readthrough (NMD candidate)"		3	132558142-132722459	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 6.0"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 3.0;granulocytes: 1.1;Rod photoreceptor cells: 1.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.4"															NA	NA						"unprognostic (1.50e-1)"	"unprognostic (1.82e-1)"			"unprognostic (1.04e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.63e-5)"	"unprognostic (4.17e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.59e-2)"	2.1	0.4		0.0		0.6	1.7		1.2	0.5	1.2			0.0	2.5	0.0	0.2	0.8	0.3	0.0			0.0	0.2	1.7	0.4			6.0	0.0	0.0		0.0		0.0	0.1		1.1	0.0	3.5	0.0	0.0	0.0		0.6	0.1	0.8			0.0		0.3	0.0		0.6	0.7	1.0	1.1	0.1	2.0	0.0	1.5	0.0	2.6	0.4	1.8	10.4	1.6	2.9	2.6	0.5	1.2	0.0	0.9	0.5	1.3	2.8	3.6	0.4	0.3	0.8	1.5	0.0	0.6	0.0	0.0	1.8	1.0	0.0	3.5	4.8	1.7	0.6	1.5	5.9	0.0	0.8	0.4	0.9	0.7	0.0	0.0	1.1	0.5	1.9	0.0	0.0	2.0	0.5	0.2	0.0	0.3	2.4	2.0	0.3	3.0	2.3	0.5	1.6	5.4	3.2	2.4	1.4	0.0	1.6	0.0	0.5	3.3	0.0	2.0	0.3	0.0	1.0	0.1	1.1	0.1	0.6	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.1	0.0	0.7	2.0	0.0											3.0	0.6	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	1.1	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.5
ACKR4	"CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1"	ENSG00000129048	"Atypical chemokine receptor 4"	Q9NPB9	3	132597237-132618967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 35.6;salivary gland: 29.0"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 35.7;monocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"	"Cell line enriched"	"Detected in some"	6	"BJ hTERT+: 88.7"	"Group enriched"	"Detected in some"	7	"cerebellum: 5.3;pons and medulla: 1.6"	"Low region specificity"	"Detected in all"			HPA054926			Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA054926: "	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	13.9	1.9	0.3	2.9	0.4	0.5	10.9	0.4	0.4	3.7	8.7	0.2	4.5	16.2	5.6	7.1	5.7	2.6	9.8	7.1	0.6	0.6	6.6	2.0	10.0	2.7	0.6	0.2	2.1	3.0	0.0	8.2	0.7	0.6	5.2	1.2	1.3	29.0	2.0	3.1	10.7	35.6	5.0	0.4	1.5	10.5	3.4	0.1	0.8	1.8	12.8	1.5	8.2	4.5	0.2	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.4	3.4	0.0	14.5	88.7	0.9	2.5	0.0	0.1	1.0	0.0	9.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.6	0.6	0.6	0.2	0.6	0.1	35.7	1.4	0.0	0.4	5.8	1.8	0.7	0.0	1.4	2.3	5.2	5.9	0.2	0.0	0.2	2.1	5.1	1.3	0.0	10.8	0.0	4.1	0.4	0.0	0.0	0.4	1.6	0.0	9.8	0.8	0.0	2.0	0.0	1.7	11.8	0.0	1.1	6.6	0.0	2.5	2.4	3.1	0.0	1.9	0.1	0.0	5.6	0.2	0.0	0.6	1.0
UBA5	"FLJ23251, UBE1DC1"	ENSG00000081307	"Ubiquitin like modifier activating enzyme 5"	Q9GZZ9	3	132654446-132678097	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 126.0;Late spermatids: 301.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017235	Uncertain		Enhanced	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA017235: AB_1858507"	"unprognostic (4.34e-3)"	"unprognostic (6.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	14.8	30.3	17.8	12.3	19.8	13.2	17.4	17.9	26.2	14.5	15.0	10.5	27.8	16.2	13.4	24.2	15.1	13.3	12.7	21.2	15.3	16.3	22.7	29.8	13.7	14.8	16.0	25.0	15.1	41.4	29.3	32.7	18.1	21.2	18.8	16.7	11.7	37.8	33.5	32.5	15.7	17.9	14.6	13.6	18.9	18.5	15.3	12.7	17.9	23.5	17.5	17.4	15.1	12.5	11.1	14.1	5.0	6.6	18.9	15.0	7.9	27.3	10.2	18.0	14.8	12.7	14.6	18.9	23.7	24.4	14.9	17.3	18.5	10.2	21.8	17.4	17.1	9.8	16.7	17.8	18.7	22.2	20.7	7.6	26.5	16.5	20.7	12.7	32.5	15.6	12.7	11.0	14.1	21.3	13.9	16.7	11.9	16.5	32.4	16.6	24.3	17.9	12.2	16.4	23.5	9.8	15.7	15.7	41.3	13.7	21.2	17.4	15.7	13.9	14.0	20.0	17.2	16.8	16.5	14.9	15.8	15.5	7.6	12.4	30.6	20.5	40.4	18.0	11.9	14.0	4.1	5.1	5.0	9.6	5.8	11.6	11.1	10.8	15.0	11.8	6.9	12.9	12.8	1.1	18.9	6.6	14.1	10.7	7.9	17.8	19.8	17.9	26.2	15.3	16.3	16.0	25.0	21.2	12.7	32.8	23.4	11.1	16.1	15.2	19.2	32.5	15.3	17.4	19.4	7.0	13.7	52.9	58.0	21.3	126.0	17.0	14.5	0.0	39.4	38.1	22.6	19.5	23.1	20.2	20.4	20.6	20.7	15.4	6.4	301.4	15.5	11.7	16.9	27.9	20.1	24.6	21.2	15.9	25.5	29.4	19.8	32.3	25.0	27.9	14.9	16.2	83.4	17.5	15.6	14.8
NPHP3	"CFAP31, FLJ30691, FLJ36696, KIAA2000, MKS7, NPH3, SLSN3"	ENSG00000113971	"Nephrocystin 3"	Q7Z494	3	132680609-132722442	"Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Ciliopathy, Disease mutation, Meckel syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA009150	Uncertain					NA	NA					"HPA009150: AB_1078086"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.36e-5)"	"unprognostic (8.02e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (8.28e-9)"	"unprognostic (2.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	9.7	6.8	4.7	9.0	10.3	3.1	9.0	6.5	7.2	15.0	10.1	8.6	8.8	3.5	19.3	8.8	5.4	12.8	8.5	7.0	5.6	3.6	6.0	3.9	8.5	4.5	11.6	4.8	19.2	5.1	3.9	6.7	9.3	8.6	8.2	4.3	8.1	5.7	10.3	6.3	7.5	7.1	9.9	8.3	6.4	6.5	4.0	11.0	2.0	8.6	3.9	6.4	9.6	15.7	1.9	1.2	2.5	2.6	0.1	1.6	0.0	3.4	2.8	10.2	7.0	5.9	12.9	4.0	11.1	8.7	5.2	6.3	3.0	1.5	0.4	4.9	11.1	4.0	3.0	4.3	5.1	5.6	2.0	3.0	2.7	2.3	2.8	7.1	0.4	2.8	9.6	2.3	5.8	9.4	9.1	7.2	2.1	1.2	2.4	14.0	3.3	0.3	1.7	4.4	1.7	3.0	1.2	9.6	3.3	4.9	2.6	0.2	6.9	7.4	1.6	5.9	7.4	2.7	1.0	10.2	7.2	4.9	8.6	4.1	2.1	0.7	0.8	8.5	0.7	7.0	0.0	0.8	0.7	0.7	0.6	0.5	1.4	1.5	1.0	0.5	1.9	1.6	0.7	2.5	0.1	2.6	1.2	1.4	0.0	4.7	10.3	6.5	7.2	5.6	3.6	11.6	4.8	8.6	11.0	26.8	18.1	17.2	14.0	16.9	18.3	7.5	7.6	12.0	9.1	15.7	53.0	12.6	0.0	6.2	1.7	22.6	9.7	0.0	4.3	9.1	20.2	15.1	7.0	13.0	8.2	25.4	12.2	43.0	18.0	1.6	55.5	8.9	13.5	3.6	9.1	17.3	7.2	2.9	37.8	3.1	33.4	32.3	22.1	5.7	2.4	16.4	7.7	16.2	11.4	7.3
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: AB_2684993"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.8	4.0	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.6	0.3	0.0	0.1	1.8	0.0	0.0	0.0	2.3	0.0	0.5	0.0	10.3	45.3	0.0	0.0	0.1	2.8	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.9	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3	3.0	2.9	0.0	0.5	2.2	11.4	1.2	0.0	0.0	9.1	0.0	96.2	1.8	0.0	0.0	57.1	1.4	0.0	0.0	0.3	7.2	1.1	0.2	1.1	0.0	0.2	1.6	0.0	0.0	0.0	29.1	0.9	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.7	0.0	56.3	0.0	1.4	19.1	8.0	1.4	0.9	0.0	0.0	0.3
BFSP2	"CP47, CP49, LIFL-L, phakinin"	ENSG00000170819	"Beaded filament structural protein 2"	Q13515	3	133399995-133475222	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"blood: 12.7"	"Group enriched"	"Detected in some"	4	"B-cells: 10.7;Melanocytes: 5.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"T-reg: 12.7"	"Lineage enriched"	"Detected in single"	48	"T-cells: 12.7"	"Group enriched"	"Detected in some"	7	"Daudi: 5.7;U-698: 6.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA038464, HPA062959"	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038464: AB_10672746, HPA062959: AB_2684912"	"unprognostic (1.58e-3)"	"unprognostic (7.47e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.04e-5)"	"unprognostic (8.13e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.21e-2)"	0.0	0.0	0.1	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.9	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573730-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 485.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 153.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Enhanced	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		220000	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	46.4	26.5	20.7	45.7	22.4	44.9	38.1	13.2	22.3	25.6	29.5	20.2	16.2	18.5	27.0	26.1	34.1	22.0	25.4	50.5	19.0	18.3	26.2	40.2	34.3	47.6	22.5	20.6	32.8	34.4	25.6	22.5	34.8	24.4	24.6	23.9	18.7	24.6	16.7	106.6	23.1	27.7	33.1	25.4	56.6	31.4	38.2	21.5	61.1	33.9	32.5	52.1	43.8	37.2	10.6	14.2	14.7	11.1	5.3	20.8	4.5	50.8	11.8	20.9	13.8	24.2	29.9	24.8	28.1	36.6	28.2	28.0	29.3	20.5	65.0	42.7	31.4	32.6	22.0	29.9	28.1	52.8	41.5	11.3	38.4	13.0	17.9	37.7	42.7	24.7	28.3	29.5	25.1	67.9	20.0	35.5	19.3	27.6	43.7	40.7	14.6	34.9	24.7	21.1	22.1	15.2	21.3	27.8	52.1	29.6	20.7	16.6	12.5	26.7	19.9	33.4	31.3	64.3	26.2	43.9	30.1	28.4	23.8	27.8	63.8	47.8	153.1	16.8	25.9	17.4	11.5	9.6	14.7	12.2	10.7	12.8	10.6	11.7	12.4	8.5	6.5	9.4	14.4	8.7	5.3	11.1	14.2	20.8	4.5	20.7	22.4	13.2	22.3	19.0	18.3	22.5	20.6	24.4	21.5	53.6	71.1	101.7	142.6	129.7	20.9	78.7	53.5	28.1	42.1	80.3	9.8	43.1	31.5	38.9	281.1	76.6	64.9	0.0	75.3	62.7	68.5	184.4	43.9	86.4	99.8	22.3	45.3	81.0	95.3	485.8	31.7	84.0	52.3	32.5	44.7	88.5	74.6	39.3	33.6	39.1	27.1	25.8	54.6	20.4	24.7	112.0	29.4	62.3	47.8	220.3
TOPBP1	"KIAA0259, TOP2BP1"	ENSG00000163781	"DNA topoisomerase II binding protein 1"	Q92547	3	133598175-133662380	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 79.9;Spermatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022451, HPA036738, HPA036739"	Approved		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281"	"unprognostic (7.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.05e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (8.03e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (2.74e-3)"	"unprognostic (8.65e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.60e-1)"	13.0	8.2	9.7	16.1	11.7	32.9	17.2	14.4	13.8	9.6	10.8	5.4	8.2	9.7	11.5	10.3	15.0	9.7	8.8	12.1	9.2	7.8	7.4	8.6	10.2	21.3	8.8	9.2	11.0	12.6	10.0	9.8	14.0	10.7	9.5	14.0	5.1	12.0	7.2	10.8	13.6	13.0	11.0	13.1	18.9	10.9	24.6	8.8	38.0	10.3	11.5	20.9	11.0	11.1	2.8	3.1	6.1	2.7	3.0	4.4	1.2	16.0	10.0	16.3	13.2	3.1	4.1	12.2	12.5	10.0	15.5	20.1	13.9	10.2	29.1	11.1	9.1	18.8	18.7	23.4	8.3	24.0	17.6	10.4	27.3	14.5	8.5	3.0	29.1	21.6	4.8	5.2	15.2	9.1	5.8	10.6	17.3	16.9	20.9	12.2	11.0	28.5	15.5	13.4	18.4	8.5	19.3	20.3	21.2	5.5	11.1	15.5	17.2	15.4	8.5	12.9	16.6	14.2	27.2	7.3	16.4	14.9	16.6	13.7	12.6	18.9	56.1	9.7	15.6	14.4	4.6	2.0	6.1	2.2	2.7	3.3	2.8	2.3	2.2	2.0	1.9	2.2	2.3	2.4	3.0	1.5	3.1	4.4	1.2	9.7	11.7	14.4	13.8	9.2	7.8	8.8	9.2	10.7	8.8	20.8	24.5	14.2	6.9	11.0	14.7	7.9	15.3	12.0	30.7	10.4	2.0	15.8	8.3	9.3	56.8	13.2	6.5	23.3	11.5	18.3	8.0	7.5	7.0	8.6	9.8	3.2	6.9	7.4	11.9	79.9	9.5	14.0	8.5	20.8	10.1	10.4	11.7	10.5	9.2	5.0	8.5	12.9	5.2	68.9	51.3	10.0	11.7	13.8	12.4	8.8
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133745956-133796640	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Ion transport, Iron transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 711.5"	"Group enriched"	"Detected in many"	34	"Hepatocytes: 5940.2;Muller glia cells: 11013.4"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	48	"Hep G2: 132.2"					"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	NA	NA	19800000000000	120000000000			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favorable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	7.8	1.3	6.7	1.2	26.7	1.3	1.9	3.7	20.4	1.4	1.3	57.2	0.0	1.2	1.3	1.3	1.8	1.3	1.3	2.4	11.3	7.4	1.5	711.5	1.3	1.3	50.8	12.3	1.4	1.6	1.4	0.8	1.3	40.2	1.5	1.3	14.0	4.0	1.3	1.3	1.3	1.2	1.3	46.9	1.3	1.3	2.4	39.9	0.0	1.4	0.0	1.4	1.3	0.6	1.1	1.0	2.6	1.1	0.9	0.8	0.4	0.3	0.2	0.3	0.2	0.9	0.6	0.1	0.3	0.3	0.1	0.1	0.5	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.1	2.7	0.4	132.2	0.2	0.7	0.4	0.4	0.6	0.1	0.3	0.3	0.3	0.1	1.0	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.5	0.2	0.2	0.5	0.3	0.2	0.4	0.4	1.0	0.2	0.3	0.2	0.4	0.4	0.2	0.2	0.1	0.3	0.4	0.2	0.3	0.2	0.2	2.6	1.1	0.7	0.6	0.7	0.6	0.6	0.6	0.6	0.6	1.1	0.8	0.8	2.4	0.9	0.7	1.0	0.4	0.4	6.7	26.7	3.7	19.6	11.3	7.4	50.8	12.3	40.2	39.9	14.9	26.7	55.9	6.2	0.9	74.3	2.5	132.5	40.2	35.2	0.0	86.4	0.1	1.7	0.7	5.3	0.5	0.0	46.7	1.0	0.1	0.2	14.8	16.3	5940.2	0.1	44.5	0.0	93.9	109.2	2.5	0.3	0.9	0.0	1.0	0.0	11013.4	0.9	0.0	0.4	0.2	250.7	0.0	0.4	0.4	0.1	0.0	0.2	6.9	0.0	2.0
SRPRB	"APMCF1, SR-beta"	ENSG00000144867	"SRP receptor beta subunit"	Q9Y5M8	3	133784033-133825772	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 104.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011173	Approved		Approved	"Plasma membrane"		NA	NA		54000	"Plasma membrane"		"HPA011173: AB_1857484"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (1.99e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.07e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.79e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.26e-2)"	10.4	15.7	8.7	10.2	9.3	5.8	12.5	5.2	10.2	14.4	11.3	5.1	33.2	8.9	8.0	25.6	16.8	9.1	11.0	10.9	9.0	10.7	17.2	56.3	9.2	17.3	10.4	7.7	8.9	104.0	11.7	15.6	7.7	8.8	9.5	13.4	7.6	53.3	29.9	10.6	8.6	7.4	10.3	7.4	9.5	12.5	14.7	5.4	6.3	16.5	10.2	13.7	8.7	10.4	15.4	20.0	3.8	15.2	14.3	29.0	18.0	12.1	9.9	6.3	20.0	26.3	18.3	11.8	25.8	13.5	14.4	12.5	18.0	9.5	23.1	38.2	19.7	14.5	17.8	19.6	13.9	13.7	15.6	15.7	20.7	9.8	17.0	32.0	32.3	16.8	16.5	23.5	13.1	38.8	8.0	12.2	11.8	17.5	26.9	15.4	17.7	11.1	15.4	11.9	32.4	17.1	13.5	11.7	49.3	17.3	8.4	20.8	8.6	19.8	18.4	7.2	5.0	20.9	15.0	12.1	14.2	8.4	22.3	13.8	34.7	34.5	34.9	12.7	21.5	15.8	3.8	11.6	1.4	21.4	15.2	29.0	15.4	18.3	19.0	13.2	13.4	18.0	21.2	0.8	14.3	9.9	20.0	10.6	18.0	8.7	9.3	5.2	10.2	9.0	10.7	10.4	7.7	8.8	5.4	14.9	22.3	15.6	21.0	33.5	6.2	22.2	43.3	20.1	19.4	34.9	11.8	58.0	10.0	42.5	49.3	24.9	15.5	0.0	58.0	60.5	38.5	38.7	32.3	77.2	46.0	6.4	30.9	17.8	19.9	31.5	29.7	19.3	33.7	10.0	36.2	15.6	40.9	21.0	26.2	24.9	8.8	12.9	23.7	52.8	41.9	27.6	43.3	20.8	32.9	21.4
RAB6B		ENSG00000154917	"RAB6B, member RAS oncogene family"	Q9NRW1	3	133824239-133895836	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 86.5;parathyroid gland: 33.1"	"Cell type enhanced"	"Detected in many"	17	"Cardiomyocytes: 26.9;Erythroid cells: 93.5;Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 10.5"	"Lineage enriched"	"Detected in single"	54	"T-cells: 10.5"	"Cell line enriched"	"Detected in many"	4	"HEL: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017713, HPA059131"	Uncertain		Approved	"Golgi apparatus"		NA	NA		11000000	"Golgi apparatus"		"CAB017713: , HPA059131: AB_2683916"	"unprognostic (2.87e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (3.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.80e-2)"	"prognostic favorable (3.97e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.05e-3)"	5.3	8.4	38.2	2.6	26.1	7.0	2.3	18.4	86.5	2.8	3.1	4.1	2.7	2.5	2.6	2.3	3.6	11.5	2.9	14.4	29.2	29.1	3.6	1.1	2.1	2.8	25.6	43.6	2.2	3.8	33.1	4.4	2.0	26.9	2.7	2.3	3.4	6.8	5.0	2.4	1.5	1.9	6.1	12.1	4.6	4.3	3.5	7.0	0.0	4.3	0.0	2.2	1.6	1.0	0.1	0.1	0.0	0.0	0.1	10.5	1.1	0.0	0.9	1.8	4.7	3.3	3.4	0.1	1.0	1.9	2.3	0.2	0.5	0.4	0.0	2.1	0.7	6.7	0.1	4.3	0.1	1.1	0.0	3.3	70.8	1.0	0.1	0.4	0.4	2.8	1.0	0.9	0.3	0.0	0.0	0.9	2.6	16.5	0.2	0.3	1.6	0.2	6.5	5.8	3.3	0.8	0.0	0.1	0.7	1.2	0.4	15.3	3.3	1.4	1.3	8.3	7.5	5.2	3.0	1.1	2.1	5.1	1.0	1.7	1.8	0.4	0.1	0.2	0.1	1.7	0.0	0.0	0.0	1.0	0.0	10.5	0.1	0.2	2.5	0.1	0.1	0.2	0.6	0.0	0.1	0.0	0.1	0.1	1.1	38.2	26.1	18.4	54.0	29.2	29.1	25.6	43.6	26.9	7.0	0.0	0.0	0.0	1.7	1.1	6.9	26.9	2.5	10.7	3.4	1.8	2.0	0.2	3.3	2.4	0.1	2.4	0.0	93.5	1.2	0.5	4.0	2.1	0.0	0.0	0.2	63.5	0.0	3.1	0.3	0.0	1.7	0.0	1.7	0.0	0.0	6.6	3.6	0.0	6.3	0.8	17.4	0.0	9.2	0.5	3.8	1.3	0.2	1.0	0.0	0.6
C3orf36	FLJ22173	ENSG00000221972	"Chromosome 3 open reading frame 36"	Q3SXR2	3	133928145-133929812	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"lung: 8.2;seminal vesicle: 14.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 6.6;HeLa: 1.7;TIME: 5.2"									HPA046432			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA046432: AB_2679664"	"unprognostic (3.56e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-3)"	"unprognostic (4.64e-4)"	"unprognostic (5.05e-3)"	"unprognostic (8.18e-5)"	"unprognostic (1.22e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	1.1	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.2	0.7			0.2	1.3	0.0	0.6	1.1	0.8	0.7	0.0	0.0	1.9	0.0	8.2	0.1	0.0		0.0	0.7	1.6	0.2	0.1		2.3	0.3		0.4	14.7	0.0	0.1	1.4	1.0	0.0	1.5	0.8	0.0			2.7		0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932696-134052184	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 112.9;seminal vesicle: 147.1"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 38.0;Ito cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 45.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA013742	Enhanced					NA	NA					"HPA013742: AB_2668877"	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favorable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	9.3	14.7	1.0	6.0	1.0	0.0	6.2	0.4	1.6	13.9	8.1	1.5	112.9	3.7	18.4	4.5	7.8	11.5	15.3	10.1	0.7	0.5	32.9	4.2	56.8	10.6	0.7	1.2	7.2	9.2	16.1	6.5	40.3	1.8	13.7	7.2	15.1	8.2	147.1	1.5	4.5	10.1	13.6	3.0	17.7	8.3	3.0	0.6	4.6	33.6	8.6	9.0	10.5	7.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	2.0	0.2	0.0	0.0	0.0	0.0	45.0	0.4	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	2.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	2.1	0.7	0.0	1.9	0.0	0.0	10.5	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	1.0	0.4	1.6	0.7	0.5	0.7	1.2	1.8	0.6	0.0	4.5	3.2	8.7	4.5	0.0	2.2	2.5	1.4	2.3	3.5	0.0	0.2	0.0	0.9	0.6	38.0	7.4	0.0	2.9	2.0	1.0	1.5	1.1	0.2	0.2	0.0	1.2	74.3	1.0	0.8	0.3	0.2	0.0	0.0	1.5	0.0	10.3	3.6	0.0	1.7	0.0	0.0	1.0	0.5	0.2	1.5	0.7	0.0	0.4	2.0
RYK	"D3S3195, JTK5, JTK5A, RYK1"	ENSG00000163785	"Receptor-like tyrosine kinase"		3	134065303-134250744	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034117, HPA045503, HPA075430"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293"	"unprognostic (7.84e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.85e-2)"	23.8	13.2	8.5	12.1	9.3	6.3	27.5	10.6	9.5	26.5	19.3	12.7	18.2	8.8	25.8	19.1	21.1	16.7	15.8	17.1	8.1	6.7	12.9	12.7	12.4	9.1	10.8	7.3	39.7	17.7	14.1	17.9	18.8	8.6	26.9	12.1	16.4	15.2	21.5	15.3	15.5	13.3	28.6	8.4	13.8	14.3	20.3	10.0	13.6	23.2	11.4	15.2	27.5	31.9	2.8	0.7	6.7	1.6	3.1	4.3	1.1	26.0	6.9	21.9	16.7	28.2	30.1	16.9	17.3	40.2	23.1	26.0	21.9	20.0	5.1	28.8	21.2	22.2	24.4	15.5	21.8	33.1	8.5	7.0	13.5	7.5	14.0	22.1	6.5	11.9	19.9	25.7	14.3	28.8	25.3	19.3	9.0	4.7	2.5	22.6	12.4	9.1	8.5	18.4	21.7	8.3	4.5	16.8	10.7	18.9	19.3	10.7	15.9	21.0	15.3	26.2	14.7	19.1	11.9	14.2	19.2	17.4	20.0	13.9	1.1	1.3	2.8	12.2	11.0	13.5	6.7	1.6	3.1	2.5	1.6	2.9	1.5	4.2	3.0	0.7	2.8	4.3	3.4	0.6	3.1	1.6	0.0	1.0	1.1	8.5	9.3	10.6	9.5	8.1	6.7	10.8	7.3	8.6	10.0	11.9	24.7	11.9	30.3	36.7	18.8	28.1	22.9	5.3	22.7	41.8	27.5	16.4	0.0	14.3	7.9	26.0	12.7	0.0	18.1	11.9	35.7	30.8	17.3	17.4	9.7	12.7	13.4	39.9	17.7	4.0	30.8	14.0	13.5	10.0	21.0	26.7	18.6	17.3	30.8	8.1	37.2	45.3	26.4	27.0	33.8	33.2	9.0	12.5	20.0	36.3
AMOTL2	LCCP	ENSG00000114019	"Angiomotin like 2"	Q9Y2J4	3	134355874-134375479	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Suprabasal keratinocytes: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063027			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA063027: AB_2684924"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.01e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.17e-2)"	49.4	9.5	9.2	8.8	22.6	0.6	29.0	6.1	19.3	25.7	13.5	47.7	7.9	6.9	24.2	10.2	19.4	19.1	18.2	14.0	13.1	7.6	21.4	10.4	20.4	8.5	25.5	15.1	12.6	21.3	11.1	3.4	27.6	16.6	21.0	4.9	20.3	13.8	14.8	11.5	19.8	8.2	27.8	17.7	15.9	12.6	7.6	28.1	0.1	18.6	15.9	8.6	15.1	31.8	0.0	0.0	0.2	0.0	0.0	0.2	0.0	25.4	10.9	7.8	8.3	8.0	10.5	68.8	25.8	15.1	25.0	12.3	34.3	7.7	0.0	33.8	17.6	13.2	19.5	5.0	6.9	10.2	0.0	0.5	0.0	6.0	3.5	16.2	0.0	0.0	14.7	21.8	9.3	10.1	9.0	11.6	0.2	0.2	0.0	15.4	8.0	0.0	0.0	10.0	5.3	4.4	0.0	10.4	0.1	14.9	5.9	1.2	3.2	20.9	24.6	17.3	17.5	23.4	0.2	19.6	16.4	14.5	10.9	15.9	0.0	0.0	0.0	5.9	0.0	17.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.2	22.6	6.1	19.3	13.1	7.6	25.5	15.1	16.6	28.1	56.6	15.9	0.0	14.9	64.8	9.5	13.0	58.6	10.7	5.7	17.4	17.7	17.7	14.9	22.7	3.6	24.3	7.3	0.0	11.3	28.9	30.5	20.3	1.1	21.5	2.6	1.6	12.0	54.6	1.6	8.0	33.1	3.3	13.5	0.0	3.9	10.0	35.7	3.5	18.7	15.1	4.1	12.9	23.6	0.3	0.4	113.8	20.7	0.0	3.7	21.4
ANAPC13	"APC13, DKFZP566D193, SWM1"	ENSG00000129055	"Anaphase promoting complex subunit 13"	Q9BS18	3	134477706-134486716	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 393.0;Proximal tubular cells: 267.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046114	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"		"HPA046114: AB_10961429"	"unprognostic (2.84e-2)"	"prognostic favorable (1.66e-4)"	"unprognostic (2.98e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (3.57e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.44e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (2.66e-7)"	"unprognostic (3.10e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.16e-1)"	35.5	29.5	29.0	10.8	24.0	9.7	26.2	14.6	26.7	21.3	20.0	14.8	19.6	13.2	18.7	46.5	24.5	19.2	19.3	37.5	25.3	36.3	47.1	54.4	22.1	17.3	33.3	13.3	30.1	36.0	29.6	34.3	34.8	29.2	29.1	18.3	23.4	30.5	22.6	36.8	14.4	25.4	20.7	23.2	19.2	20.1	20.4	12.4	14.1	44.3	22.2	13.4	27.3	16.9	25.5	26.9	69.4	30.5	18.7	30.0	22.8	21.1	13.3	21.0	17.9	35.8	47.6	16.2	27.6	25.5	20.2	19.1	16.6	12.6	14.4	60.0	40.4	24.4	12.5	19.6	19.7	29.2	7.2	9.1	14.7	10.8	27.7	25.8	24.0	10.5	31.6	21.6	20.3	38.1	22.7	31.3	14.1	19.5	12.3	63.7	27.2	12.2	23.6	14.3	36.7	13.0	9.8	16.5	26.2	39.4	13.2	8.6	14.1	24.5	9.0	24.0	23.5	22.5	23.6	21.8	28.2	11.4	39.5	12.1	13.6	14.7	29.8	17.3	13.3	24.0	28.9	28.3	24.2	16.4	30.5	21.3	25.5	24.6	21.4	26.9	18.6	30.0	25.2	69.4	18.7	29.6	20.5	20.5	22.8	29.0	24.0	14.6	26.7	25.3	36.3	33.3	13.3	29.2	12.4	32.8	43.1	47.7	44.5	37.4	40.5	107.7	56.0	49.5	20.5	80.3	11.8	81.7	393.0	47.8	34.9	60.7	30.8	0.0	47.0	87.8	59.7	60.7	17.4	58.7	70.2	19.1	39.2	50.3	63.1	66.9	46.9	40.0	92.8	13.6	36.6	50.4	36.3	39.1	41.4	267.1	26.5	19.4	61.3	39.2	65.8	44.3	58.8	34.5	32.7	45.2
CEP63	FLJ13386	ENSG00000182923	"Centrosomal protein 63"	Q96MT8	3	134485743-134575017	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Mitosis"		"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 54.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058154, HPA058313"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058154: AB_2683624, HPA058313: "	"unprognostic (1.80e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	21.6	15.4	17.7	17.1	18.1	25.3	16.5	19.7	22.6	13.8	15.4	14.5	18.8	9.1	13.7	17.6	15.1	12.2	12.3	25.6	17.2	15.0	15.2	20.5	12.4	15.7	20.4	15.7	16.7	17.8	21.8	23.1	13.5	20.0	16.7	14.5	11.1	15.5	17.4	38.1	15.0	11.3	20.2	20.2	15.3	13.9	37.2	21.5	21.7	18.3	14.9	16.3	17.3	19.9	6.1	7.2	54.1	8.2	5.9	5.6	3.5	17.2	7.7	14.6	9.5	21.3	18.1	13.7	18.7	15.4	15.0	12.7	6.1	7.4	19.6	12.0	13.5	14.5	10.3	7.5	10.4	18.2	21.9	4.0	25.3	8.3	8.6	14.7	16.0	11.8	15.7	13.8	8.0	26.7	16.9	14.8	27.4	7.5	17.1	17.6	11.6	19.1	19.1	10.4	11.1	9.1	12.4	21.6	28.0	12.8	10.8	8.6	8.2	16.8	6.6	25.2	18.3	13.5	21.8	16.8	17.0	10.1	16.1	13.8	15.8	10.9	25.2	18.2	17.1	21.5	18.1	6.0	9.9	4.0	6.2	5.4	4.8	3.9	5.1	7.2	6.1	5.6	4.2	54.1	5.9	8.2	4.8	4.8	3.5	17.7	18.1	19.7	22.6	17.2	15.0	20.4	15.7	20.0	21.5	17.9	25.9	21.5	13.0	9.5	30.0	76.9	20.4	45.5	27.3	7.0	19.6	22.1	26.6	22.3	64.2	20.4	10.5	0.0	17.7	22.5	17.3	16.0	50.8	13.9	24.8	30.2	12.6	15.4	22.3	37.5	22.2	24.5	16.9	20.8	15.3	24.6	18.7	17.5	24.4	22.3	42.3	19.4	18.4	95.2	46.4	8.5	14.5	12.7	15.0	12.3
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 74.7"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 74.7"	"Group enriched"	"Detected in some"	33	"neutrophil: 15.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 15.4;granulocytes: 15.9"	"Group enriched"	"Detected in some"	4	"HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	2.0	1.5	9.0	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2.0	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1.0	3.3	2.8	7.0	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6.0	1.7	1.7	6.0	3.4	1.3	16.7	6.0	0.0	11.6	2.9	3.3	4.5	2.6	0.0	15.4	15.9	0.0	0.0	0.4	0.1	0.0	0.0	4.8	0.0	0.1	0.0	0.1	3.6	0.0	0.2	0.0	0.0	0.0	0.6	1.0	1.9	0.3	0.0	3.2	0.0	0.7	34.7	0.4	2.6	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	2.6	0.1	0.1	0.1	1.4	0.6	0.0	0.0	0.5	0.1	9.4	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.1	0.4	0.2	0.6	2.0	0.3	4.3	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	15.4	0.0	0.1	9.0	16.6	74.7	19.0	9.4	5.3	2.8	7.0	7.1	6.0	0.0	0.0	0.9	0.0	3.3	1.2	1.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.8	30.2	0.6	0.0	0.0	0.3	0.0	0.2	0.1	0.0	5.8	0.4	0.0	0.0	0.0	0.0	26.8	0.6	0.0	1.7	0.0	0.0	16.2	0.6	0.0	0.0	0.0	0.9	0.0	0.8	0.4	0.9	5.1	0.0	0.0	0.0	0.1
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134603138-134651636	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease"	"Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 19.5;tongue: 36.2"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 3.0;Late spermatids: 5.2;Muller glia cells: 2.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 7.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.4;U-2197: 4.6;U-87 MG: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036492: AB_10672222, HPA036668: AB_2675239"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.3	5.7	3.5	0.4	2.3	0.5	1.4	2.5	4.6	2.2	1.7	2.1	1.7	0.9	3.9	2.3	3.1	3.7	0.9	4.8	4.9	2.1	0.7	0.2	0.3	0.2	1.7	6.9	1.7	0.2	8.5	6.8	0.2	3.2	3.6	0.6	3.3	1.7	2.8	19.5	12.6	0.5	7.4	2.0	0.3	1.7	0.7	3.6	0.5	5.2	36.2	1.1	1.3	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	13.9	0.7	0.0	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.5	2.3	2.5	4.6	4.9	2.1	1.7	6.9	3.2	3.6	0.0	0.0	0.0	0.0	0.6	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PPP2R3A	"PPP2R3, PR130, PR72"	ENSG00000073711	"Protein phosphatase 2 regulatory subunit B''alpha"	Q06190	3	135965673-136147891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 85.6"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 102.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 19.2;BJ hTERT+: 18.8;RPTEC TERT1: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035829, HPA035830, HPA065338"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475"	"unprognostic (3.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.91e-4)"	6.3	3.3	3.4	1.9	6.4	0.7	4.3	1.5	4.9	5.5	6.7	5.2	5.8	1.7	6.8	5.1	5.0	3.0	3.3	27.4	3.9	2.8	31.7	1.2	2.6	0.9	7.0	4.4	3.7	3.8	7.5	3.7	9.0	5.3	3.8	3.5	1.6	7.7	7.8	85.6	10.4	2.5	11.4	6.1	1.2	5.2	4.2	6.5	0.0	2.3	31.6	1.2	6.5	3.9	1.5	1.8	1.7	1.4	1.8	1.5	0.6	19.2	1.1	5.5	2.6	4.5	5.7	6.4	15.1	18.8	7.1	8.9	1.2	1.2	0.0	5.8	15.4	5.1	2.5	2.3	5.3	15.5	0.0	0.7	0.8	0.6	0.0	3.2	0.0	0.8	5.1	4.6	9.1	4.3	7.2	6.8	0.5	0.5	0.0	10.2	3.2	0.1	0.1	3.8	0.2	3.7	0.0	8.1	0.0	25.0	0.7	0.4	3.1	2.4	3.0	5.8	5.2	4.8	0.2	4.4	7.5	4.1	10.1	6.6	0.2	0.5	0.0	5.5	0.4	2.6	1.1	1.2	1.5	0.9	1.4	0.5	0.7	1.0	0.8	1.1	1.5	1.5	1.2	1.7	1.8	1.2	1.8	0.7	0.6	3.4	6.4	1.5	4.9	3.9	2.8	7.0	4.4	5.3	6.5	26.8	22.2	2.7	15.3	23.5	4.1	102.3	0.0	9.4	11.4	52.4	0.0	7.6	18.3	18.1	6.1	8.7	15.8	0.0	8.5	13.2	12.8	12.5	3.5	2.4	2.2	3.2	12.5	5.5	2.1	9.5	22.7	4.6	27.0	14.4	7.9	9.5	12.6	9.9	17.3	37.2	2.2	6.5	11.9	6.6	19.6	29.1	8.7	3.8	7.3	15.3
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148922-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003413	Uncertain		Approved	Nucleoplasm,Cytosol		NA	No			"Nucleoplasm, Cytosol"		"HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	13.1	10.1	13.3	16.2	15.6	40.2	13.5	31.0	15.8	13.7	11.3	14.8	9.9	11.1	15.5	8.2	12.2	14.1	10.0	9.8	12.4	9.0	10.0	14.1	13.4	23.7	12.6	11.2	18.3	12.7	19.9	19.8	15.9	12.0	13.0	10.1	10.6	13.2	9.8	14.9	14.1	18.2	9.6	14.2	24.2	12.3	13.6	15.6	59.3	13.8	7.4	23.9	13.4	12.9	7.6	3.8	8.7	3.9	6.6	13.3	5.4	12.6	4.2	8.7	9.9	6.0	6.8	15.9	7.7	6.5	6.1	6.2	8.4	6.7	23.7	10.6	5.7	7.5	9.1	10.0	6.6	9.7	12.5	7.7	25.8	8.4	4.7	6.2	21.2	13.5	5.3	7.3	5.0	14.2	6.0	6.1	20.8	9.2	20.6	5.1	7.7	38.3	12.4	11.6	6.0	7.4	17.9	14.8	15.1	3.1	9.0	11.3	8.1	17.5	7.2	11.6	7.0	6.4	13.9	9.6	8.3	7.3	7.7	7.1	24.5	12.7	35.5	7.1	9.0	5.5	5.2	3.7	5.0	7.0	3.9	8.8	4.5	6.6	8.2	3.8	7.6	13.3	8.9	8.7	6.6	2.8	2.5	5.0	5.4	13.3	15.6	31.0	15.8	12.4	9.0	12.6	11.2	12.0	15.6	17.9	9.1	20.4	14.9	24.8	12.8	13.4	10.2	4.0	6.8	12.2	3.9	7.2	3.3	4.6	2.3	10.7	6.9	0.0	4.7	5.4	8.2	10.7	6.9	17.8	7.6	15.9	17.2	19.0	22.8	1.6	8.6	10.5	20.3	9.0	14.4	7.2	5.5	3.5	8.1	5.6	10.1	6.5	12.3	12.6	10.5	23.3	4.0	25.4	10.9	11.2
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase beta subunit"	P05166	3	136250306-136337896	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 317.0;Late spermatids: 128.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"	NA	NA		79000			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	13.0	46.0	14.3	7.7	16.3	12.7	11.8	7.8	19.2	8.1	17.5	21.0	11.6	15.3	7.1	6.4	11.8	8.1	12.5	36.7	14.1	12.6	36.0	80.2	7.7	8.7	18.9	16.4	6.8	20.8	16.2	9.6	10.0	22.3	10.2	17.6	10.0	10.9	10.6	30.5	8.0	11.1	14.1	18.6	7.9	11.5	17.6	15.5	6.3	15.7	12.4	8.1	9.6	6.6	12.4	24.6	3.9	16.6	12.8	14.9	11.5	19.8	14.2	13.7	20.5	10.4	11.5	24.2	10.5	11.4	16.0	22.6	21.1	14.1	24.8	29.3	14.8	14.3	11.1	16.0	14.1	24.3	14.8	13.6	43.5	16.8	31.8	22.2	33.4	19.4	13.6	13.5	10.1	23.1	10.3	17.9	41.8	31.6	13.3	12.2	37.9	33.0	19.6	11.5	30.5	12.9	9.2	11.3	35.5	29.3	21.8	27.3	20.3	26.5	15.8	24.1	12.9	31.3	19.9	13.4	8.0	8.6	22.4	9.2	25.4	21.0	20.7	11.4	13.0	9.3	2.8	16.2	3.9	13.2	16.6	14.9	12.4	8.8	13.6	24.6	10.2	9.0	11.1	1.4	12.8	14.6	21.2	7.9	11.5	14.3	16.3	7.8	19.2	14.1	12.6	18.9	16.4	22.3	15.5	8.9	9.4	10.0	7.3	3.7	15.1	45.4	12.7	18.7	11.4	19.2	9.8	51.9	33.2	19.9	317.0	6.0	14.4	23.3	12.5	19.8	10.3	9.0	28.8	63.8	31.1	11.1	8.7	8.6	13.1	128.9	12.7	15.4	18.6	24.4	12.7	10.3	14.9	14.8	10.3	71.0	13.1	12.9	8.3	10.9	28.8	2.9	42.6	9.6	21.7	8.9
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336233-136752403	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"HPA035015: AB_10603117, HPA058653: AB_2683787"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	26.0	10.9	13.3	12.9	15.6	12.9	17.9	46.5	14.3	24.8	14.9	11.2	12.0	9.1	21.3	10.8	12.8	16.8	10.5	12.3	12.9	7.4	12.0	10.2	13.3	12.9	14.0	7.2	22.6	13.8	17.3	20.4	20.5	14.3	16.3	14.3	13.0	14.5	14.0	20.8	17.2	12.7	16.8	9.5	14.5	12.2	9.5	18.9	29.7	15.6	11.7	18.6	17.0	29.0	8.9	6.7	13.2	4.8	8.0	7.4	2.9	17.6	9.2	15.5	13.3	11.7	20.4	8.3	19.9	25.5	18.7	17.8	15.6	7.8	13.8	12.6	20.6	15.1	12.3	16.7	9.0	25.6	16.9	7.8	14.7	13.4	8.6	8.9	25.6	14.9	12.8	10.3	13.7	15.4	10.9	14.5	15.1	9.4	28.0	11.8	15.1	16.8	8.3	10.1	12.2	7.3	15.1	16.9	18.4	10.2	12.7	7.6	12.2	21.3	8.5	8.9	8.4	12.1	10.9	12.1	21.6	15.8	19.2	17.5	20.9	14.3	31.4	13.3	8.8	13.8	4.8	4.4	6.5	7.0	4.6	7.4	8.9	5.9	6.3	4.1	7.3	6.7	5.2	13.2	8.0	4.8	6.7	6.9	2.9	13.3	15.6	46.5	14.3	12.9	7.4	14.0	7.2	14.3	18.9	23.8	21.6	31.2	28.0	35.5	41.8	8.9	12.7	16.0	29.6	15.7	37.3	24.5	10.0	17.5	1.9	25.1	29.0	23.3	19.2	22.1	23.6	19.6	21.9	17.8	15.8	27.0	18.0	32.5	14.6	2.3	45.8	19.5	15.1	24.4	23.3	29.1	21.6	17.3	30.4	8.4	65.9	25.8	27.2	32.7	43.2	32.0	26.5	27.7	21.2	21.7
SLC35G2	"DKFZp564K2464, MGC3295, TMEM22"	ENSG00000168917	"Solute carrier family 35 member G2"	Q8TBE7	3	136818647-136855892	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 36.2;Endothelial cells: 26.0;Ito cells: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 1.6;memory CD8 T-cell: 3.5;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052054, HPA064728"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA052054: AB_2681709, HPA064728: AB_2685336"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.91e-4)"	"unprognostic (2.56e-4)"	"unprognostic (5.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.30e-2)"	20.2	24.6	10.6	3.7	12.0	1.3	18.3	16.6	17.4	8.1	3.6	6.4	6.6	2.2	6.7	8.1	4.1	5.0	8.7	7.6	11.6	15.2	4.3	7.1	6.0	3.3	10.9	10.5	5.3	13.3	6.7	15.9	11.7	11.3	4.8	3.8	3.2	2.7	4.8	2.8	3.0	2.4	8.5	12.4	3.1	3.1	17.2	4.9	0.9	8.8	2.1	2.5	8.2	9.3	0.2	0.0	0.0	0.1	0.0	3.5	0.3	1.7	4.9	5.0	2.2	10.1	8.2	0.0	7.8	34.1	11.7	17.7	4.6	2.6	0.0	6.0	8.0	18.7	0.6	5.9	0.3	10.9	0.0	1.6	1.4	6.0	2.8	12.9	0.0	0.0	11.6	0.9	10.2	2.8	8.6	8.7	3.1	0.8	0.0	14.9	0.0	2.1	1.5	1.1	0.0	3.7	1.8	3.3	0.0	10.0	0.4	8.3	5.5	6.3	0.0	10.7	1.8	0.0	0.8	5.9	8.7	2.2	3.8	8.4	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.5	0.0	0.1	3.5	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.3	10.6	12.0	16.6	17.0	11.6	15.2	10.9	10.5	11.3	4.9	11.9	6.5	2.7	3.7	3.0	5.4	2.0	0.0	1.4	10.3	1.8	11.8	1.0	1.7	2.7	36.2	26.0	0.5	0.0	9.3	1.1	11.0	3.3	2.3	1.8	0.6	6.4	4.1	26.4	1.0	19.8	9.2	3.5	3.3	3.6	0.6	6.8	9.1	0.0	2.8	0.4	4.7	6.5	7.2	22.7	9.4	2.6	1.8	4.8	0.6	1.8
NCK1	"NCK, NCKalpha"	ENSG00000158092	"NCK adaptor protein 1"	P16333	3	136862208-136949823	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005063, HPA030766"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB005063: AB_562169, HPA030766: AB_2673602"	"unprognostic (7.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.77e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.14e-5)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.17e-2)"	44.5	15.7	11.5	24.5	13.4	19.3	38.9	22.6	11.6	23.7	18.3	8.4	16.5	10.2	20.8	19.2	35.9	14.6	13.9	16.8	11.8	11.1	14.0	20.9	22.4	33.0	13.9	12.1	19.6	14.3	17.9	17.7	22.7	13.5	26.3	19.5	10.8	24.0	15.8	29.0	27.3	14.3	24.0	13.5	18.7	12.8	14.7	12.7	41.1	23.8	23.5	29.0	27.3	43.3	8.5	13.3	26.8	27.1	11.2	20.2	11.9	20.0	8.9	11.8	9.7	27.4	26.6	13.2	14.9	26.8	17.3	18.1	12.9	20.0	19.7	30.9	17.4	22.4	15.5	16.6	15.1	23.1	14.2	6.8	17.1	12.6	10.1	44.6	12.3	11.8	24.1	19.9	16.8	33.5	17.7	26.5	18.7	10.2	17.6	18.1	10.9	27.9	10.0	11.2	18.1	11.3	15.3	11.0	18.9	16.1	13.8	8.4	8.1	26.8	12.0	23.9	15.0	17.3	13.6	13.1	11.3	7.3	16.0	8.4	17.7	13.8	24.4	11.9	11.1	12.0	26.8	12.4	13.2	19.7	27.1	20.2	8.1	15.6	19.8	13.3	8.5	12.6	15.0	7.2	11.2	13.4	5.2	15.0	11.9	11.5	13.4	22.6	11.6	11.8	11.1	13.9	12.1	13.5	12.7	8.9	15.7	26.5	64.7	66.4	18.9	9.4	15.3	10.7	23.9	8.7	5.9	42.1	13.3	38.5	9.2	68.0	17.2	0.0	24.2	41.6	41.4	45.8	9.2	33.7	45.3	23.8	13.3	25.2	28.8	7.3	40.9	45.6	40.5	48.7	17.1	19.3	29.4	23.0	25.1	18.7	12.7	12.9	33.0	44.9	32.9	72.8	51.0	68.2	15.6	120.8
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 64.5;skin 1: 61.2"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 32.6;Early spermatids: 38.8;Late spermatids: 24.0;Suprabasal keratinocytes: 33.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 106.6"	"Region enriched"	"Detected in single"	9	"cerebellum: 0.6"	"Not detected"	"Not detected"			HPA063914			Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	1.6	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	13.2	0.2	0.0	0.0	0.0	1.3	0.3	64.5	0.1	0.1	0.3	0.0	0.0	0.1	2.1	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.2	2.8	0.0	1.6	0.3	0.4	4.1	0.2	0.4	61.2	0.1	0.1	0.3	0.0	0.1	0.9	0.0	0.5	0.2	22.6	17.1	0.9	19.2	0.1	0.4	0.0	0.3	0.0	0.6	0.0	4.9	0.0	0.0	0.0	3.0	12.9	0.5	0.1	0.3	0.0	0.2	0.4	0.6	0.0	2.8	1.8	0.1	16.0	0.0	26.4	0.1	0.0	0.0	0.0	3.3	0.0	17.8	0.0	0.0	2.2	106.6	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.5	0.8	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	32.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	38.8	1.0	0.6	0.0	0.2	1.1	0.8	1.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	24.0	0.3	0.8	3.3	2.8	0.7	0.0	0.8	0.0	0.7	0.1	0.0	0.0	2.3	0.6	1.5	33.2	1.4	0.0	0.5	4.8
SOX14	SOX28	ENSG00000168875	"SRY-box 14"	O95416	3	137764284-137766338	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.4;placenta: 15.1;prostate: 3.1"	"Cell type enriched"	"Detected in some"	4	"Cytotrophoblasts: 12.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.8"	"Group enriched"	"Detected in many"	15	"hypothalamus: 5.4;midbrain: 1.6;pons and medulla: 4.4;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.1;midbrain: 5.9"	"Group enriched"	"Detected in many"	7	"midbrain: 10.3;pons and medulla: 5.6;thalamus: 16.5"							NA	NA								"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"								"unprognostic (1.88e-2)"		"unprognostic (2.49e-3)"	"unprognostic (5.08e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	15.1	4.4	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	5.4	1.6	0.0	4.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"gallbladder: 37.4;lung: 91.9;stomach 1: 126.9"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 1488.8"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.7;stomach cancer: 186.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"OE19: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	0.1	0.1	0.3	0.1	37.4	2.0	0.1	0.0	0.1	0.1	91.9	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	126.9	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.9	0.3	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.6	18.9	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	1488.8	318.5	0.0	0.0	0.0	0.8	18.9	0.0	1.4	20.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	9.9	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	257.5	0.0	0.0	0.0	1.4	0.0	0.0	6.6	3.8	0.0	0.0	0.0	0.0	0.0
DZIP1L	"DZIP2, FLJ32844"	ENSG00000158163	"DAZ interacting zinc finger protein 1 like"	Q8IYY4	3	138061990-138115818	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Ciliated cells: 93.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"classical monocyte: 1.8;eosinophil: 1.7;intermediate monocyte: 1.3;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	17	"dendritic cells: 1.5;granulocytes: 1.7;monocytes: 1.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030404	Approved		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			Microtubules	"Nucleoplasm, Cytokinetic bridge"	"HPA030404: AB_10601548"	"unprognostic (3.65e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.47e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.72e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.77e-2)"	5.3	2.0	2.2	6.1	2.5	10.9	5.5	12.1	3.3	17.4	5.1	5.3	3.1	2.9	14.8	6.5	4.3	15.2	7.9	3.8	2.4	2.1	5.1	1.2	6.4	2.0	2.6	1.6	12.4	8.3	6.2	5.6	2.7	6.1	9.3	2.1	10.9	2.5	5.0	1.7	10.4	2.3	11.3	3.4	3.1	10.0	4.2	3.4	0.1	4.2	4.2	2.5	8.0	17.8	0.0	1.5	1.7	1.8	0.0	0.0	0.4	5.2	3.1	6.2	5.2	4.0	5.3	1.4	8.6	5.2	5.1	6.5	2.1	0.4	0.0	4.4	7.9	7.1	1.7	4.5	2.0	2.5	1.1	4.4	2.3	6.4	0.3	3.2	1.7	4.0	5.6	2.1	5.6	2.7	5.2	2.8	1.4	1.7	0.0	6.9	0.3	0.0	0.7	7.5	0.0	1.1	0.0	7.2	0.0	2.3	8.4	2.2	4.9	8.8	0.0	4.4	3.6	2.3	3.6	2.1	12.7	5.8	6.1	4.4	0.0	0.0	0.1	5.0	2.5	4.9	0.0	1.8	1.7	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	2.2	2.5	12.1	3.3	2.4	2.1	2.6	1.6	6.1	3.4	3.0	1.3	0.0	0.6	3.2	6.5	2.7	2.5	93.7	11.4	1.8	7.9	0.0	5.0	3.1	15.6	1.8	0.0	0.0	1.1	0.1	3.5	0.5	0.0	0.0	1.4	3.2	0.0	0.0	1.0	1.0	5.8	2.7	0.0	1.0	0.0	2.3	3.7	0.0	3.9	0.5	17.8	0.0	4.7	0.4	1.5	3.8	0.0	0.0	0.0	0.1
A4GNT	alpha4GnT	ENSG00000118017	Alpha-1,4-N-acetylglucosaminyltransferase	Q9UNA3	3	138123718-138132387	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"gallbladder: 25.9;pancreas: 7.0;stomach 1: 25.0"	"Cell type enriched"	"Detected in single"	9	"Cholangiocytes: 2.5"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 2.5;stomach cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;BJ: 3.7;hTERT-RPE1: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008017	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008017: AB_1078073"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"			"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.48e-3)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	25.9	0.1	0.1	0.1	1.5	0.4	0.3	0.1	0.1	0.1	0.2	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	25.0	0.1	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DBR1		ENSG00000138231	"Debranching RNA lariats 1"	Q9UK59	3	138161012-138174949	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035365	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035365: AB_10611956"	"unprognostic (1.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.33e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.79e-2)"	11.8	13.5	9.3	10.0	10.5	20.7	12.2	12.5	10.5	13.3	10.1	14.4	12.8	8.3	15.8	13.6	12.3	11.8	12.4	9.3	9.3	8.9	13.4	12.2	15.3	12.6	11.0	10.5	13.7	15.5	13.1	16.1	9.1	10.0	12.3	10.1	12.7	12.8	10.7	10.8	11.9	12.4	11.6	10.9	17.0	18.3	5.8	12.0	22.3	13.2	7.7	13.6	11.0	12.7	8.3	9.8	14.3	11.2	9.2	13.3	7.0	14.9	6.2	11.3	12.5	6.3	5.9	11.7	8.9	6.5	9.6	11.8	10.4	6.7	13.7	17.0	8.0	14.6	11.1	13.0	4.4	12.7	11.7	10.7	14.8	8.1	8.6	7.7	19.1	13.1	8.1	7.4	8.9	8.4	5.7	7.9	12.0	9.6	3.0	9.7	11.5	18.7	11.3	13.0	11.6	7.3	11.8	12.8	12.5	8.3	14.6	10.9	14.1	23.7	8.3	12.7	9.6	15.6	15.7	7.4	8.2	5.7	15.0	10.2	4.5	6.2	28.7	5.3	13.8	10.5	4.8	8.1	14.3	10.4	11.2	13.3	8.3	11.8	9.9	9.8	8.0	12.1	13.1	3.5	9.2	9.0	6.0	9.5	7.0	9.3	10.5	12.5	10.5	9.3	8.9	11.0	10.5	10.0	12.0	6.0	11.7	7.5	3.0	4.6	5.4	4.3	10.2	5.3	5.7	8.7	0.0	9.2	8.3	9.5	0.0	5.3	3.8	0.0	7.7	8.3	6.9	3.6	5.7	6.4	9.2	6.4	5.8	6.7	16.1	0.0	8.1	5.6	3.3	8.2	5.6	8.9	6.1	5.5	7.8	5.1	4.8	0.0	4.2	4.4	2.1	3.6	3.8	10.1	6.6	2.6
ARMC8	"DKFZP434A043, GID5, HSPC056, VID28"	ENSG00000114098	"Armadillo repeat containing 8"	Q8IUR7	3	138187248-138298389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036996, HPA044869"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA036996: AB_10672786, HPA044869: AB_2679123"	"unprognostic (2.04e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (3.51e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.18e-1)"	19.4	13.5	16.9	14.3	21.9	43.5	14.5	52.6	26.4	17.1	14.4	16.8	9.4	9.9	15.2	10.8	18.0	13.7	13.0	14.4	16.9	20.9	16.6	13.8	13.9	16.3	17.6	16.1	14.3	11.9	20.5	26.1	16.3	26.3	14.5	15.9	12.5	11.9	15.8	34.6	11.8	13.1	20.6	18.7	16.7	14.2	14.7	19.1	21.3	18.2	12.1	18.4	16.9	12.9	25.6	25.4	40.1	23.8	25.3	26.5	19.3	20.4	10.0	13.2	10.7	16.7	14.8	17.8	15.9	15.4	21.8	21.4	15.7	10.9	19.4	16.4	13.6	25.6	10.8	17.0	15.5	27.0	13.0	12.0	34.5	6.6	10.6	21.2	26.7	38.7	22.0	9.9	14.0	20.2	11.9	17.0	17.0	12.8	11.0	27.0	18.0	18.7	12.6	18.3	15.5	8.8	14.7	21.3	15.4	14.3	19.1	15.4	11.2	22.8	7.9	13.2	18.0	15.7	14.1	18.4	11.7	9.5	15.4	11.6	21.2	16.2	29.7	10.5	12.8	11.5	32.3	22.1	40.1	22.8	23.8	26.0	25.6	21.0	24.0	25.4	22.0	24.6	24.4	15.6	25.3	23.5	11.2	26.5	19.3	16.9	21.9	52.6	26.4	16.9	20.9	17.6	16.1	26.3	19.1	26.8	13.1	26.2	26.3	27.5	36.5	20.9	20.4	10.7	29.6	12.2	31.4	25.9	10.0	17.4	5.7	22.2	15.9	70.0	12.8	23.2	20.3	19.7	33.6	21.2	20.1	41.3	22.5	23.4	25.0	5.8	28.1	27.7	18.6	15.4	15.1	24.5	11.5	20.4	20.8	23.7	42.0	12.9	28.9	44.1	30.6	24.8	28.5	26.1	16.1	24.0
NME9	"NM23-H9, TXL-2, TXNDC6"	ENSG00000181322	"NME/NM23 family member 9"	Q86XW9	3	138261437-138329886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 30.4"	"Cell type enriched"	"Detected in some"	12	"Ciliated cells: 64.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020943, HPA040000, HPA043881"	Enhanced		Approved	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712"	"unprognostic (2.71e-5)"	"unprognostic (1.68e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.17e-3)"	1.0	1.7	5.3	1.3	11.3	4.4	1.0	6.2	8.3	1.5	0.8	4.1	3.5	1.1	1.6	3.6	0.8	30.4	1.3	0.9	5.6	8.2	1.7	0.8	4.0	1.1	3.6	3.1	2.5	3.3	1.8	7.5	1.1	10.3	1.7	0.8	0.9	3.4	1.9	4.3	1.8	1.1	1.0	3.6	1.2	1.5	6.0	3.9	0.9	2.3	0.0	1.0	0.8	0.5	0.6	0.6	0.3	0.9	0.3	4.2	0.5	1.1	1.6	1.1	0.5	0.0	0.0	1.7	0.7	0.0	0.2	0.1	0.9	1.9	2.5	1.2	0.0	1.3	1.3	0.2	0.0	0.0	0.5	1.8	2.1	1.6	0.6	0.0	2.7	4.9	0.9	0.0	0.1	0.0	2.9	0.1	3.2	0.6	1.4	0.2	0.4	0.6	2.5	0.7	0.5	1.2	1.0	0.0	0.7	1.7	2.6	3.7	1.0	1.6	0.6	0.4	0.9	0.9	0.1	3.0	0.5	0.8	0.8	0.6	0.9	1.2	1.1	1.0	1.1	0.5	0.1	0.9	0.0	0.5	0.0	4.2	0.2	1.7	0.4	0.3	0.6	2.8	1.2	0.3	0.3	0.2	0.6	0.7	0.5	5.3	11.3	6.2	8.3	5.6	8.2	3.6	3.1	10.3	3.9	0.0	0.3	0.0	0.2	0.0	1.3	1.1	2.5	64.3	3.4	1.8	0.0	0.1	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	2.3	0.0	0.0	5.5	0.5	0.0	0.2	0.0	0.0	0.0
MRAS	"M-RAs, R-RAS3, RRAS3"	ENSG00000158186	"Muscle RAS oncogene homolog"	O14807	3	138347648-138405534	"Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 69.1"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 103.5;Distal tubular cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 18.9"	"Lineage enriched"	"Detected in many"	9	"monocytes: 18.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;BJ: 31.3;EFO-21: 39.0;fHDF/TERT166: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042728	Approved		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA042728: AB_10796582"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.69e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.23e-2)"	49.3	32.6	32.0	6.4	37.6	1.3	17.7	12.3	37.3	6.4	5.4	9.4	1.7	2.3	11.9	5.2	5.1	6.8	8.6	69.1	29.0	23.9	8.9	3.7	8.9	3.3	31.3	18.0	17.2	3.4	7.6	4.7	6.9	25.2	7.6	3.4	8.2	8.0	12.0	22.5	2.7	2.7	16.9	21.5	7.3	3.4	5.9	19.3	0.0	12.1	2.4	2.8	10.0	6.4	0.0	2.1	0.3	18.9	0.6	0.0	0.5	0.2	2.5	6.7	8.8	29.2	13.4	13.9	31.3	7.9	3.2	3.9	1.1	1.0	0.1	39.0	30.6	8.3	0.0	3.3	0.7	2.5	2.7	1.0	0.1	1.6	6.4	7.4	0.0	0.6	19.2	3.0	0.2	0.5	5.9	0.5	0.0	3.5	0.2	14.4	1.1	0.0	7.6	7.3	0.0	0.9	0.3	12.2	0.0	14.1	0.6	7.0	15.5	20.5	0.2	16.4	5.0	6.0	15.2	0.1	8.2	9.3	8.9	0.8	0.0	0.3	0.3	8.3	0.0	4.5	0.1	1.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.6	18.9	0.1	0.0	0.5	32.0	37.6	12.3	28.9	29.0	23.9	31.3	18.0	25.2	19.3	8.9	1.0	0.5	2.6	1.9	4.1	103.5	5.1	1.4	4.5	8.7	9.8	16.8	49.7	8.5	9.6	16.3	0.0	0.0	2.7	2.0	11.9	1.9	5.8	1.5	26.7	27.0	1.7	8.6	13.8	26.2	21.6	13.8	27.0	15.4	0.0	15.8	4.3	0.0	32.2	23.1	10.4	6.5	19.8	4.6	11.9	0.9	12.0	0.0	0.0	0.5
ESYT3	"CHR3SYT, FAM62C"	ENSG00000158220	"Extended synaptotagmin 3"	A0FGR9	3	138434586-138481686	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;skin 1: 13.7"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 35.7;Alveolar cells type 2: 30.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.3;NTERA-2: 7.5;SCLC-21H: 8.1;SiHa: 3.3;SK-MEL-30: 4.0;SuSa: 3.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.5"	"Low region specificity"	"Detected in all"			HPA039200	Approved					NA	NA					"HPA039200: AB_10805356"	"unprognostic (4.48e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.55e-3)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.38e-1)"	"unprognostic (5.57e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.16e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.43e-2)"	0.6	0.8	5.7	0.6	5.8	0.5	2.6	28.5	5.9	1.3	4.9	0.6	0.2	0.7	5.3	0.8	0.9	1.0	2.8	1.1	5.3	3.0	1.8	0.5	12.4	0.5	1.9	4.0	0.9	2.0	3.5	3.0	1.5	4.2	1.0	1.1	0.7	0.8	0.7	0.8	13.7	0.7	4.8	1.2	0.5	2.7	1.4	1.2	0.0	11.5	1.8	1.6	2.5	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.2	0.4	0.0	2.0	1.8	0.2	0.6	3.0	0.2	0.0	0.5	0.1	0.2	1.0	1.1	0.3	0.1	0.3	0.1	1.3	0.1	0.1	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.2	0.7	7.5	0.0	0.5	0.0	0.1	0.0	0.8	0.2	8.1	0.0	3.3	0.4	4.0	3.7	0.8	0.3	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	5.8	28.5	5.9	5.3	3.0	1.9	4.0	4.2	1.2	35.7	30.7	0.0	0.7	0.7	1.8	2.0	2.5	1.4	7.9	1.8	3.9	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.8	0.4	1.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.5	0.0	0.0	0.2	2.3	0.0	0.5	2.1	0.5	1.4	0.6	0.0	0.1	0.0
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 163.4;Late spermatids: 214.6;Spermatocytes: 140.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0"	"Group enriched"	"Detected in many"	8	"B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favorable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	5.5	8.3	11.0	5.7	15.8	3.5	9.0	14.7	15.6	20.8	12.2	7.1	22.8	35.7	14.0	14.8	10.2	20.3	8.9	11.3	10.9	15.9	17.0	18.8	11.5	4.2	12.6	10.2	14.4	17.4	16.6	27.8	2.7	14.4	14.3	12.1	12.6	6.1	28.7	10.6	4.6	11.5	14.0	19.1	3.9	8.6	41.5	15.3	24.2	26.2	6.7	4.5	13.3	9.1	2.9	0.2	0.5	0.1	3.6	6.4	2.0	21.6	4.5	10.7	13.0	6.7	7.5	10.0	4.3	8.1	6.0	8.9	6.3	11.8	5.1	10.3	8.0	22.8	9.6	9.7	8.6	13.5	9.0	6.4	14.6	10.5	8.2	10.5	0.7	5.4	40.3	5.0	4.5	11.2	16.0	8.6	16.8	10.6	17.1	9.8	8.2	15.3	0.8	6.3	5.7	10.2	16.9	13.9	13.1	11.4	9.7	13.0	8.5	22.5	5.4	25.5	12.8	27.1	7.1	5.0	4.4	8.4	9.0	5.2	15.9	8.7	17.4	9.8	1.4	15.0	0.4	0.1	0.2	4.2	0.1	5.0	2.9	3.4	3.7	0.1	2.0	5.9	6.4	0.5	3.6	0.0	0.2	2.0	2.0	11.0	15.8	14.7	15.6	10.9	15.9	12.6	10.2	14.4	15.3	29.8	54.7	0.8	31.2	8.7	15.6	23.2	17.8	48.2	38.7	19.2	33.4	5.9	61.3	18.3	163.4	7.1	4.6	0.0	15.5	3.6	6.2	27.5	19.7	12.4	2.2	20.6	15.0	4.9	0.8	214.6	9.2	3.3	10.1	1.0	9.5	19.7	13.7	7.0	12.0	17.0	29.1	6.5	11.8	140.5	9.1	7.0	8.0	4.9	22.3	24.8
FAIM	"FAIM1, FLJ10582"	ENSG00000158234	"Fas apoptotic inhibitory molecule"	Q9NVQ4	3	138608606-138633376	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 61.9"	"Cell type enhanced"	"Detected in many"	8	"Rod photoreceptor cells: 189.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 45.4"					"Low region specificity"	"Detected in all"			"HPA042440, HPA052209"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042440: AB_2677999, HPA052209: AB_2681761"	"unprognostic (6.45e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (3.96e-5)"	"unprognostic (4.84e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.63e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.98e-2)"	13.7	6.6	12.3	6.7	11.6	2.6	19.0	7.8	9.9	24.5	6.8	10.2	38.5	4.7	9.6	15.1	8.8	28.5	9.0	4.7	12.2	12.5	15.4	6.0	7.6	7.2	13.9	7.1	8.4	27.5	7.2	15.4	6.1	10.7	11.4	6.0	9.1	7.2	61.9	6.1	6.2	4.2	7.2	19.6	3.7	6.7	5.4	9.1	13.2	15.2	9.3	9.6	10.3	13.2	13.9	5.0	11.1	2.6	13.9	9.1	3.4	26.9	5.3	0.5	4.8	5.2	9.8	19.4	8.3	5.0	8.8	7.6	9.1	7.9	0.0	7.4	10.9	10.2	7.1	23.1	4.7	10.0	22.1	24.1	5.1	14.6	13.1	5.8	0.0	1.6	13.7	9.3	3.3	5.1	5.4	9.5	1.9	3.3	6.9	5.4	10.2	0.1	22.8	10.5	0.8	5.3	27.2	6.3	0.7	14.0	13.4	9.1	7.7	14.8	8.2	20.8	6.0	13.9	6.7	5.8	1.8	4.2	9.0	4.0	0.0	0.1	45.4	7.3	0.0	7.2	11.1	2.4	1.7	9.1	2.6	8.5	13.9	5.0	7.2	5.0	7.9	3.4	8.5	0.3	13.9	1.7	3.5	5.4	3.4	12.3	11.6	7.8	8.2	12.2	12.5	13.9	7.1	10.7	9.1	17.9	15.6	9.3	23.8	9.6	27.4	4.5	63.7	87.0	36.4	24.4	62.8	37.0	26.6	49.3	9.6	10.8	2.0	0.0	43.5	25.4	17.6	19.1	40.4	10.2	24.6	14.3	20.3	8.6	3.5	11.1	16.1	5.5	15.1	23.4	8.3	34.0	31.2	0.0	18.7	19.0	189.9	0.0	19.6	16.8	2.2	11.4	12.2	9.6	11.5	23.3
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 42.0;HMC-1: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	23.0	10.0	4.3	3.6	3.9	5.3	29.3	5.4	5.2	5.5	5.9	10.7	8.8	9.3	14.8	5.3	10.6	9.9	5.6	8.6	9.9	11.8	6.3	42.0	6.8	6.4	4.0	10.2	66.6	4.5	6.6	3.8	7.8	9.8	8.3	4.5	16.0	6.9	6.9	10.6	5.9	7.2	6.2	17.0	9.4	4.3	4.5	6.6	8.5	12.8	3.7	2.7	15.0	6.5	19.3	13.2	16.3	24.4	8.7	3.5	4.5	7.7	7.6	11.7	7.6	8.5	8.6	9.9	4.9	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7	8.9	14.7	4.7	12.9	16.9	15.4	30.2	12.7	14.7	21.6	17.4	23.6	29.1	5.0	9.4	0.9	8.5	21.3	0.0	16.5	46.3	6.5	23.0	13.9	15.8	13.4	20.6	15.6	11.6	28.8	1.1	3.4	19.7	6.8	14.4	14.9	8.2	15.2	21.8	6.3	18.9	17.9	6.5	6.1	10.7	14.9	20.5	40.0	6.1	12.7	15.3
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947140	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.6;fHDF/TERT166: 6.5;HEL: 9.2;hTCEpi: 8.5;K-562: 9.4;SiHa: 6.5;THP-1: 6.7"	"Not detected"	"Not detected"							HPA069613	Enhanced		Supported	"Nucleoplasm,Midbody ring"		NA	NA			Nucleoplasm	"Midbody ring"	"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	1.5	0.3	0.0	1.2	0.0	0.0	0.3	1.0	13.9	0.0	0.6	0.0	0.0	10.0	0.4	0.1	6.4	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.4	55.5	0.6	15.3	13.1	1.4	0.8	0.2	0.0	1.7	0.0	0.4	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	2.2	0.3	4.0	0.1	0.0	1.7	0.2	0.0	0.4	0.1	0.0	0.4	0.0	2.7	6.5	0.2	1.3	0.0	0.0	0.1	0.0	0.0	9.2	1.1	0.0	0.0	0.1	0.0	0.0	8.5	0.0	0.0	1.4	0.0	0.0	9.4	0.0	3.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	6.5	0.0	0.0	0.3	0.0	6.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.3	1.0	0.4	0.2	0.3	0.4	0.8	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0
FOXL2NB	"C3orf72, FLJ43329"	ENSG00000206262	"FOXL2 neighbor"	Q6ZUU3	3	138947234-138953451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 51.6;parathyroid gland: 25.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;fHDF/TERT166: 10.7;HEL: 10.6;hTCEpi: 5.0;SiHa: 8.3"									"HPA061017, HPA071790"			Enhanced	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA061017: AB_2684415, HPA071790: AB_2686447"	"unprognostic (3.32e-1)"	"unprognostic (1.13e-1)"		"unprognostic (3.86e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.40e-5)"		"unprognostic (3.30e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-10)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-2)"	0.1	1.0	0.6	0.1	1.4	0.2	0.1	0.2	0.9	15.3	0.1	0.5	0.1	0.0	12.6	0.9	0.2	7.3	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.5	0.4	51.6	0.4	25.0	9.4	3.2	1.0	0.1	0.0	1.3	0.1	0.5	0.1	0.3	0.1	2.5	0.3	0.1	0.0	0.4	0.3	0.1	0.4	0.3	0.1	0.4	2.3	0.6	0.5	2.8	0.4	0.7	0.4	0.0	2.1	1.4	0.7	5.5	0.3	0.1	2.3	0.1	0.0	0.2	0.0	0.3	0.4	0.2	1.1	10.7	0.1	0.5	0.2	0.1	0.2	0.1	0.3	10.6	3.3	0.1	0.0	0.1	0.4	0.2	5.0	0.2	0.1	0.6	0.0	0.3	4.0	0.3	2.6	0.3	0.1	0.3	0.3	0.2	0.2	0.1	0.0	0.0	0.5	1.5	0.2	0.2	8.3	0.2	0.0	1.0	0.2	3.1	0.2	0.4	0.3	0.3	0.1	0.4	0.2	0.1	0.3	0.3	0.1	1.3	0.4	0.3	0.4	0.3	0.2	0.4	0.3	0.3	0.2	0.6	0.4	0.3	2.8	0.7	0.2	0.5	0.4	0.0	0.6	1.4	0.2	0.9	0.3	0.2	0.5	0.4	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR23A		ENSG00000206260	"Proline rich 23A"	A6NEV1	3	139005468-139006268	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	8	"testis: 6.1"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 1.1"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 2.8"									HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.48e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.7	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0
MRPS22	"C3orf5, GIBT, GK002, MRP-S22"	ENSG00000175110	"Mitochondrial ribosomal protein S22"	P82650	3	139005806-139357223	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006083, HPA007830"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA006083: AB_1854122, HPA007830: AB_1854123"	"unprognostic (8.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (5.22e-3)"	"unprognostic (5.45e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.49e-3)"	"prognostic unfavorable (1.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.22e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.40e-1)"	17.6	45.3	16.9	14.5	24.9	22.1	18.3	15.5	26.7	16.3	22.7	14.6	12.2	24.0	17.0	14.7	26.7	14.5	13.8	39.2	23.4	15.0	24.9	43.3	12.9	20.2	18.2	19.7	15.7	22.4	13.6	15.2	16.9	22.6	11.6	22.0	8.8	15.3	15.8	50.8	17.2	21.1	16.8	18.1	14.0	19.0	21.9	19.9	15.3	15.1	31.0	16.0	16.5	16.9	24.9	27.9	21.7	31.6	21.1	27.8	20.9	30.7	13.3	11.3	13.7	17.0	14.4	26.1	18.1	23.4	32.5	26.7	42.3	22.2	21.2	34.1	22.0	32.1	35.0	20.4	24.7	31.3	12.0	19.0	33.9	11.5	29.3	19.0	31.7	18.5	15.4	19.4	19.5	20.4	14.5	19.8	24.5	46.8	13.4	19.6	22.7	15.8	24.9	20.2	30.3	23.4	20.1	19.3	29.7	23.5	18.3	13.5	12.1	29.3	43.2	45.9	11.7	30.2	28.7	14.1	13.0	13.8	25.8	17.0	20.8	11.4	38.0	16.1	22.6	12.6	21.7	24.0	21.2	22.9	31.6	27.6	24.9	24.7	25.7	27.9	21.6	27.3	25.3	5.4	21.1	30.3	17.8	27.8	20.9	16.9	24.9	15.5	26.7	23.4	15.0	18.2	19.7	22.6	19.9	17.9	11.2	18.2	23.5	20.3	19.9	43.4	25.5	37.5	14.8	17.4	13.7	54.0	58.0	36.5	37.3	20.4	26.9	0.0	52.8	37.9	24.4	15.6	26.5	34.2	42.5	19.1	15.0	18.4	17.7	5.6	21.6	21.0	15.1	38.7	25.1	18.5	38.5	20.1	22.3	37.0	25.3	38.8	24.2	73.7	46.5	17.9	63.0	22.4	39.6	26.5
PRR23B	FLJ46116	ENSG00000184814	"Proline rich 23B"	Q6ZRT6	3	139019031-139020926	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	36	"testis: 4.7"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 6.6;Spermatogonia: 4.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (7.57e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	4.1	0.0	0.0	0.0	0.0	0.1
PRR23C	FLJ46210	ENSG00000233701	"Proline rich 23C"	Q6ZRP0	3	139042102-139044892	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 3.4;testis: 4.3"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 3.0;Late spermatids: 1.5;Spermatocytes: 1.4;Spermatogonia: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"									HPA047473	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (1.00e-1)"			0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.1	4.3			0.0		0.0	0.0	0.0	1.0	0.4	3.4	0.4	0.8	0.4	0.2	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.9	1.2	0.0	0.3	0.6	0.3	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.3	0.2	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	3.4	0.4	0.6	0.2	0.2	0.2	0.3	0.3	0.1	0.0	1.0	0.3	0.4	2.2	0.8	0.1	0.4	0.3	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.5	0.1	0.0	0.0	0.0	0.0
COPB2	"beta'-COP, betaprime-COP"	ENSG00000184432	"Coatomer protein complex subunit beta 2"	P35606	3	139355600-139389732	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036867, HPA058180"	Approved		Approved	Cytosol		NA	NA		1000000	Cytosol		"HPA036867: AB_10672271, HPA058180: AB_2683630"	"unprognostic (3.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.95e-2)"	28.7	40.8	21.9	22.3	26.2	12.1	28.7	31.7	29.0	39.5	32.4	22.6	40.3	26.1	33.0	44.7	35.9	28.9	26.2	31.4	21.6	18.9	42.1	67.5	29.1	20.1	26.0	16.6	36.0	65.5	41.2	72.2	51.7	28.7	35.5	33.8	20.5	46.5	28.6	20.6	23.5	37.1	30.0	21.1	31.3	29.9	21.1	25.7	33.1	40.4	27.4	31.2	30.0	26.5	22.6	36.4	35.9	34.4	27.4	23.5	22.6	53.5	21.5	31.6	28.5	63.6	58.6	27.7	64.2	61.0	41.5	51.3	40.2	20.4	21.7	59.4	68.0	37.6	28.5	35.9	34.3	52.1	37.4	24.6	32.6	34.1	38.4	38.1	29.0	37.4	41.0	31.2	32.6	33.8	48.2	40.0	19.6	21.3	26.3	49.1	32.4	14.5	17.8	28.7	53.3	23.7	19.6	25.6	37.3	38.1	38.8	22.4	20.6	63.1	57.2	35.4	44.7	45.6	31.3	46.6	23.3	18.8	34.4	22.5	41.1	24.5	38.3	39.0	16.5	36.0	35.9	28.4	30.1	22.9	34.4	23.2	22.6	20.4	23.5	36.4	16.3	15.9	20.0	26.9	27.4	32.3	17.0	21.9	22.6	21.9	26.2	31.7	29.0	21.6	18.9	26.0	16.6	28.7	25.7	53.6	34.0	32.0	34.0	17.4	34.8	47.2	33.1	93.7	52.4	19.2	29.5	71.4	34.9	71.2	24.9	41.9	41.4	0.0	72.1	64.7	71.0	57.8	43.9	43.3	46.9	39.7	61.3	37.4	38.0	5.8	50.6	31.5	20.3	57.7	71.8	55.4	68.4	28.8	47.0	37.2	44.9	19.4	46.7	47.7	43.0	13.0	111.3	34.9	36.6	37.8
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	198	"intestine: 333.2"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 8.9;Collecting duct cells: 12.2;Cone photoreceptor cells: 7.9;Enterocytes: 17.1;Pancreatic endocrine cells: 9.4;Paneth cells: 14.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 41.9"	"Region enriched"	"Detected in single"	4	"basal ganglia: 4.6"	"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		96000	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	130.1	0.0	0.0	221.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	1.6	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	333.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	41.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.2	5.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	8.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	12.2	7.9	0.0	0.0	0.5	0.0	0.0	17.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	9.4	14.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 161.0;pancreas: 107.4;retina: 85.3"	"Group enriched"	"Detected in many"	7	"Ductal cells: 920.8;Exocrine glandular cells: 932.2;Ito cells: 319.8;Pancreatic endocrine cells: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 136.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 56.8"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	1.9	43.1	6.5	3.3	11.3	0.1	7.5	5.1	7.8	7.8	3.2	11.5	8.4	4.5	26.8	11.3	3.3	58.4	42.7	7.5	7.7	8.1	3.7	20.1	4.9	6.5	10.4	4.9	161.0	107.4	4.3	26.2	20.6	31.5	9.8	2.1	85.3	4.7	6.4	1.8	2.9	4.8	17.5	8.7	4.7	2.8	12.9	4.3	0.9	3.3	2.6	2.0	7.7	7.2	0.5	0.5	2.1	0.9	0.7	0.4	0.2	1.2	0.3	1.1	26.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.0	8.7	0.0	0.4	0.0	6.1	0.1	0.0	0.0	0.7	0.0	0.4	11.2	25.8	0.0	0.0	0.4	0.0	0.0	0.0	26.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	5.2	0.0	0.0	0.0	3.2	136.6	5.6	0.0	0.0	2.3	0.5	0.1	0.0	0.0	20.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.9	0.8	0.4	0.8	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	2.1	0.7	0.5	0.5	0.1	0.2	6.5	11.3	5.1	7.8	7.7	8.1	10.4	4.9	31.5	4.3	29.8	5.1	10.5	43.6	15.7	12.3	15.5	63.7	5.3	12.5	22.7	2.0	2.6	11.6	920.8	3.9	54.2	0.0	0.0	932.2	6.9	95.1	21.2	0.0	6.6	16.2	3.2	41.3	319.8	11.5	8.3	25.0	2.8	8.5	23.4	0.5	79.7	450.0	0.0	4.2	2.7	7.0	25.8	22.5	2.3	4.1	30.6	3.2	2.5	0.8	27.7
NMNAT3	PNAT3	ENSG00000163864	"Nicotinamide nucleotide adenylyltransferase 3"	Q96T66	3	139560180-139678017	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 527.0;Alveolar cells type 2: 437.0;Ciliated cells: 459.0;Club cells: 396.9;granulocytes: 256.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039077, HPA057402"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039077: AB_2676336, HPA057402: AB_2683427"	"unprognostic (9.45e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (4.57e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.13e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.07e-1)"	6.2	6.3	9.9	7.0	9.8	14.1	10.8	7.7	9.8	7.4	7.4	6.8	2.7	7.8	7.9	7.3	6.5	11.6	7.9	12.6	11.9	8.1	7.9	6.2	4.7	3.6	7.7	14.0	17.9	10.0	6.2	6.6	1.8	6.7	7.6	6.4	12.7	7.5	4.8	21.9	14.9	6.5	7.3	7.0	4.2	4.8	16.8	8.4	2.4	8.3	9.0	4.8	6.3	6.8	7.2	4.2	11.9	5.0	6.1	5.1	2.1	6.8	3.0	3.3	3.7	0.8	0.7	4.4	2.9	0.4	0.5	0.4	3.9	5.2	4.8	8.8	0.6	3.3	3.5	2.3	1.0	0.7	4.4	3.9	22.3	6.3	5.0	1.8	4.2	4.3	1.2	5.8	0.9	1.4	7.0	0.5	2.9	3.9	10.6	0.5	4.7	4.0	3.7	7.5	12.0	2.9	3.5	3.7	3.2	1.0	5.2	7.2	4.4	6.9	3.8	2.5	6.5	9.5	11.2	3.9	4.7	10.4	5.6	4.3	17.6	8.3	3.4	3.2	6.7	4.3	11.9	5.0	3.0	4.1	4.5	3.0	3.6	3.6	3.4	3.6	7.2	5.1	5.1	10.8	6.1	4.4	4.2	2.2	2.1	9.9	9.8	7.7	9.8	11.9	8.1	7.7	14.0	6.7	8.4	527.0	437.0	3.0	5.2	3.7	2.5	7.5	2.5	459.0	396.9	8.7	3.9	0.3	10.0	2.6	101.2	2.3	2.0	0.0	2.7	0.3	4.7	3.7	256.9	2.1	1.9	1.6	6.4	3.1	2.6	164.7	7.2	4.0	6.8	0.0	5.5	7.8	0.7	3.5	6.0	12.0	18.2	6.5	1.2	39.2	2.6	8.4	0.1	0.0	11.4	3.8
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;ovary: 59.4"	"Cell type enhanced"	"Detected in some"	13	"Early spermatids: 17.1;Late spermatids: 10.8;Leydig cells: 25.9"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 21.0;SCLC-21H: 9.3;SuSa: 28.6;THP-1: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		Yes	No		9100	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	14.2	5.0	4.9	1.0	9.8	0.8	8.5	1.5	19.7	4.1	1.8	2.4	0.3	1.2	5.2	1.8	1.6	3.6	2.6	5.9	15.4	4.0	4.5	1.5	1.7	2.8	4.1	14.3	59.4	2.0	1.5	1.3	1.5	23.7	5.4	1.4	3.0	1.6	1.8	1.9	2.1	1.5	6.6	1.4	0.8	1.4	1.9	0.5	0.0	2.9	0.5	1.0	1.9	4.7	0.3	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	3.3	0.0	1.4	0.4	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	1.3	0.0	0.0	0.0	28.6	1.4	5.8	0.0	0.7	0.3	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	4.9	9.8	1.5	19.7	15.4	4.0	4.1	14.3	23.7	0.5	0.0	0.0	0.0	0.2	0.5	0.7	5.3	0.0	5.3	1.2	3.5	0.0	0.2	1.7	0.0	17.1	0.7	0.0	0.0	0.2	0.0	1.6	5.3	0.0	0.0	0.1	0.0	0.0	3.1	0.8	10.8	25.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	7.9	3.7	0.0	6.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1
TRIM42	"FLJ40097, PPP1R40, T4A1"	ENSG00000155890	"Tripartite motif containing 42"	Q8IWZ5	3	140678039-140701150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 43.2"	"Group enriched"	"Detected in some"	113	"Early spermatids: 249.5;Late spermatids: 89.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003581, HPA022481"			Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA003581: AB_1080383, HPA022481: AB_1858301"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	249.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0
SLC25A36	"FLJ10618, PNC2"	ENSG00000114120	"Solute carrier family 25 member 36"	Q96CQ1	3	140941830-140979933	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027036	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoplasm	"HPA027036: AB_1857048"	"unprognostic (4.12e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (1.55e-4)"	20.2	16.9	14.9	13.4	20.5	36.5	25.2	18.7	31.3	23.5	19.4	18.3	17.3	22.3	25.6	37.3	12.2	25.1	13.7	29.5	15.9	19.0	29.0	3.1	22.4	18.6	15.6	16.7	32.6	33.9	29.7	26.3	19.1	21.6	20.6	14.8	21.1	17.5	17.7	60.6	16.2	17.2	20.4	18.5	14.1	23.6	24.4	12.2	15.4	23.7	15.1	12.7	20.7	18.5	17.0	14.9	15.7	13.1	18.1	16.6	10.9	23.8	5.4	17.5	14.3	16.1	20.6	22.1	9.0	11.5	10.1	14.3	14.9	11.4	19.9	22.4	7.6	14.5	16.0	21.2	8.8	20.7	15.2	17.2	16.4	13.0	9.4	24.2	23.4	10.2	23.2	29.6	7.4	22.7	22.7	10.6	14.7	8.7	12.9	14.7	10.3	13.9	16.1	17.4	5.9	10.1	15.1	15.6	28.2	11.9	8.2	11.3	18.5	12.2	22.2	39.1	16.0	15.4	13.3	10.7	14.1	7.9	24.9	8.6	26.2	17.0	23.2	18.2	9.8	6.9	10.5	10.4	15.7	11.4	13.1	13.3	17.0	11.7	12.5	14.9	16.0	16.6	15.7	1.8	18.1	13.1	10.9	10.2	10.9	14.9	20.5	18.7	31.3	15.9	19.0	15.6	16.7	21.6	12.2	92.3	107.7	22.2	58.2	60.7	96.5	82.2	38.2	133.8	62.6	68.0	125.7	48.2	54.7	22.9	5.0	40.0	22.6	0.0	33.6	33.4	49.8	72.0	63.6	0.4	22.8	87.4	57.0	29.4	35.2	11.5	55.3	36.5	54.0	29.7	27.0	70.1	26.8	17.5	55.9	52.8	122.5	58.2	54.2	29.3	61.1	47.6	41.3	41.1	40.3	64.7
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051402-141148611	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 22.0"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 18.4;Kupffer cells: 4.1;Late spermatids: 6.3;Spermatocytes: 7.6"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.2;NTERA-2: 4.6;RH-30: 5.5;SH-SY5Y: 4.6;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.8	0.9	1.0	0.2	1.5	0.2	0.2	0.2	2.0	0.1	0.3	0.7	0.0	0.2	0.1	0.3	0.2	0.1	0.2	2.2	1.1	1.1	0.4	0.3	1.3	3.2	1.5	0.6	0.1	22.0	0.1	4.6	0.2	1.2	0.2	0.1	0.0	0.1	0.1	1.7	0.2	0.2	0.2	1.9	2.5	0.1	3.6	0.2	0.1	0.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.2	0.3	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	1.1	0.0	4.6	0.0	0.0	0.0	5.5	0.8	0.0	0.0	1.4	4.6	0.0	0.0	0.0	2.7	0.3	0.4	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.5	0.2	1.2	1.1	1.1	1.5	0.6	1.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	7.6	0.7	0.0	0.1	0.0	0.0	0.0
PXYLP1	"ACPL2, FLJ23751"	ENSG00000155893	"2-phosphoxylose phosphatase 1"	Q8TE99	3	141228726-141367753	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 89.2"	"Cell type enhanced"	"Detected in many"	16	"Collecting duct cells: 43.6;Early spermatids: 163.2;Late spermatids: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017243	Uncertain				"Intracellular and membrane"	NA	NA					"HPA017243: AB_1844509"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.05e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.07e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.17e-3)"	4.1	4.4	9.1	3.8	11.8	3.2	5.5	3.8	13.2	6.5	3.7	5.9	23.7	3.8	8.6	89.2	2.2	5.8	5.4	8.9	6.6	6.6	5.1	3.5	4.9	9.0	4.5	7.4	6.5	8.6	8.6	6.5	10.8	5.2	6.7	4.0	5.2	5.1	20.7	3.3	4.2	4.7	4.8	5.4	3.8	5.5	13.7	4.6	28.0	4.3	1.9	6.1	6.0	4.5	0.5	3.8	7.2	4.1	13.0	16.8	6.3	3.4	3.6	15.6	12.3	6.2	5.4	3.7	2.3	5.9	6.1	8.5	6.0	1.2	0.2	3.3	5.4	1.3	0.8	16.4	1.5	5.9	11.1	10.8	1.2	4.9	4.7	13.2	3.0	0.6	5.0	7.0	1.8	0.6	7.7	0.4	11.8	0.5	1.4	2.8	2.9	16.3	3.9	6.5	8.5	2.0	2.3	9.1	2.1	4.3	14.9	6.8	12.1	6.1	1.9	5.0	3.0	6.5	1.8	0.7	7.9	4.7	5.3	2.2	3.3	0.2	0.5	7.3	4.2	6.9	7.2	4.1	6.2	9.9	2.8	6.4	0.5	5.7	6.6	3.8	0.4	16.8	13.5	2.8	13.0	1.3	1.3	3.0	6.3	9.1	11.8	3.8	13.2	6.6	6.6	4.5	7.4	5.2	4.6	8.9	8.3	0.8	3.8	0.0	2.2	6.7	2.5	5.3	3.4	43.6	5.9	1.6	0.0	3.0	163.2	1.5	2.6	0.0	3.3	5.9	3.1	6.0	2.3	3.0	0.6	6.4	4.1	0.6	1.9	68.3	18.7	1.4	0.0	2.8	2.2	6.0	3.3	8.6	14.2	9.5	5.4	12.9	1.7	31.9	9.4	0.0	0.9	2.5	3.7	5.5
ZBTB38	"CIBZ, FLJ35036, PPP1R171, ZNF921"	ENSG00000177311	"Zinc finger and BTB domain containing 38"	Q8NAP3	3	141324213-141449792	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 52.0;RPMI-8226: 75.3;U-266/70: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014865, HPA059378"			Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA014865: AB_2732412, HPA059378: AB_2683998"	"unprognostic (1.78e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.04e-1)"	18.4	27.6	19.6	16.3	26.5	5.4	20.2	50.9	30.1	28.0	23.2	11.6	15.5	14.9	36.1	11.1	14.4	20.1	25.4	21.7	16.3	12.5	18.8	13.2	20.1	16.7	17.6	21.0	21.3	17.3	43.5	21.8	19.9	18.3	19.7	21.9	13.4	22.8	21.3	56.7	11.1	20.4	30.1	18.7	11.8	17.1	17.4	20.1	2.6	20.3	9.4	19.5	25.7	24.5	11.4	5.1	13.6	5.3	14.8	17.8	6.7	10.7	16.0	1.9	3.8	17.2	16.3	2.5	17.4	21.0	16.9	24.7	8.3	6.3	0.3	7.2	15.1	13.2	3.1	2.1	14.7	38.7	10.4	3.0	3.0	15.3	4.8	19.3	0.2	4.5	12.2	8.7	17.9	36.4	27.7	12.9	0.3	3.2	52.0	19.1	1.1	0.2	0.6	1.9	3.0	2.0	0.2	5.5	75.3	10.9	6.7	0.7	2.7	25.5	2.5	9.2	3.4	5.2	2.7	31.0	13.8	3.5	26.8	8.1	51.9	30.2	3.8	23.7	0.3	7.6	13.6	3.4	9.4	17.8	5.3	13.3	11.4	11.7	17.7	5.1	5.1	9.1	14.7	4.0	14.8	4.2	2.5	15.3	6.7	19.6	26.5	50.9	30.1	16.3	12.5	17.6	21.0	18.3	20.1	71.5	54.7	23.8	31.7	18.1	86.6	104.9	66.2	48.2	69.4	55.8	70.7	27.6	24.9	35.6	201.9	74.9	41.3	0.0	27.8	12.6	45.6	45.5	64.9	27.0	27.6	133.5	34.5	48.5	19.7	97.7	65.3	39.9	37.1	95.6	43.1	55.0	48.7	28.8	96.9	39.2	66.4	116.4	91.0	7.2	10.0	16.3	104.5	67.8	69.1	34.1
RASA2	GAP1M	ENSG00000155903	"RAS p21 protein activator 2"	Q15283	3	141487047-141615342	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035374, HPA035375"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA035374: AB_10602122, HPA035375: AB_2674596"	"unprognostic (1.85e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.36e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.23e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavorable (7.62e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.34e-5)"	12.0	7.4	11.1	25.2	10.6	26.8	14.4	20.8	12.2	13.4	12.7	7.9	7.7	7.7	19.1	11.2	11.6	11.3	9.9	7.4	8.7	9.9	9.3	7.5	14.4	27.1	8.2	7.8	16.2	8.7	9.2	15.0	12.2	8.7	10.5	10.8	11.4	13.2	9.4	6.1	15.7	12.9	12.3	11.2	21.4	8.2	6.7	7.8	25.4	10.1	7.3	23.6	11.8	14.0	10.5	3.4	14.4	5.9	11.5	17.7	5.8	16.0	3.0	6.5	4.9	7.2	8.9	9.3	11.7	23.1	7.6	9.4	6.9	5.3	10.3	8.1	10.1	7.3	6.7	4.6	5.0	13.9	5.5	4.5	5.5	2.4	2.5	3.8	10.4	14.5	5.2	4.6	6.9	8.2	9.2	9.6	8.9	4.9	13.4	7.5	2.3	13.6	8.6	7.5	5.4	2.2	5.1	11.0	12.7	7.5	5.8	2.3	4.7	9.3	8.3	8.5	7.1	4.1	7.9	8.0	9.0	4.1	12.4	5.2	21.9	6.4	13.9	7.8	7.2	4.4	7.7	3.7	3.8	11.9	3.7	11.7	7.0	10.6	11.9	3.4	10.5	17.7	13.5	14.4	11.5	5.9	2.6	9.7	5.8	11.1	10.6	20.8	12.2	8.7	9.9	8.2	7.8	8.7	7.8	41.7	23.4	14.6	30.7	19.2	15.7	6.1	10.2	12.0	21.6	12.2	35.3	15.3	1.7	15.2	84.9	16.3	12.7	23.3	14.3	6.1	14.4	45.5	30.1	8.7	10.8	28.6	15.1	15.4	26.9	4.6	12.7	26.0	11.8	7.2	16.3	17.5	21.7	16.1	13.4	7.0	56.0	6.5	21.5	14.2	13.9	24.0	11.0	50.3	15.9	49.5
RNF7	"CKBBP1, ROC2, SAG"	ENSG00000114125	"Ring finger protein 7"	Q9UBF6	3	141738204-141747560	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 615.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036995	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036995: AB_10673627"	"unprognostic (5.68e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.17e-3)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (1.54e-9)"	"unprognostic (4.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.36e-2)"	26.0	44.0	31.4	21.7	37.0	30.7	38.3	19.4	28.6	26.1	37.0	17.5	36.3	38.6	30.4	42.0	37.1	22.9	41.8	47.6	27.4	27.6	33.2	35.3	27.2	32.1	26.7	21.6	30.5	57.6	16.2	33.9	40.6	20.5	37.3	34.5	29.2	36.2	28.9	69.9	35.7	42.7	36.2	23.9	23.7	26.8	44.4	18.7	27.0	35.1	50.6	27.4	37.5	35.2	32.7	44.9	36.3	52.2	22.5	41.7	42.9	46.6	18.9	28.2	22.7	26.9	37.2	18.6	26.2	24.8	22.5	23.9	22.0	23.3	15.7	61.5	29.0	55.4	22.9	17.4	24.6	28.6	15.0	32.6	15.5	17.9	31.8	35.9	24.3	15.2	34.7	27.8	17.9	30.7	30.2	31.8	27.0	16.3	22.0	33.3	35.9	15.3	27.4	29.9	47.4	31.5	16.8	18.0	33.9	48.0	20.6	15.6	19.5	30.0	31.1	43.6	38.3	29.1	32.0	24.1	22.6	21.6	39.9	22.0	21.0	17.5	32.3	35.2	27.0	25.5	36.3	52.2	33.7	33.0	44.5	33.1	32.7	35.6	35.0	44.9	29.3	34.7	35.9	18.5	22.5	46.6	41.4	41.7	42.9	31.4	37.0	19.4	28.6	27.4	27.6	26.7	21.6	20.5	18.7	56.6	51.0	67.8	126.0	117.7	34.2	80.9	84.1	76.3	55.7	96.0	25.5	151.5	215.5	196.2	256.9	96.6	240.4	0.0	216.5	209.1	117.2	147.3	71.5	105.8	191.8	27.0	120.6	99.4	110.4	615.6	109.0	126.7	136.7	155.1	160.5	58.0	201.5	213.1	114.5	270.8	43.1	84.1	120.7	194.2	117.2	126.5	108.6	109.0	157.3	138.1
GRK7	GPRK7	ENSG00000114124	"G protein-coupled receptor kinase 7"	Q8WTQ7	3	141778148-141818490	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.4"	"Cell type enriched"	"Detected in some"	168	"Cone photoreceptor cells: 310.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HeLa: 1.5;U-937: 1.8"					"Not detected"	"Not detected"			"HPA075093, HPA078232"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA075093: , HPA078232: "	"unprognostic (1.11e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.91e-1)"	0.2	0.5	0.3	0.5	0.4	1.5	0.2	0.9	0.3	0.2	0.1			0.4	0.3	0.0	0.3	0.3	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2		0.6	0.3	0.7	0.2	0.2		0.3	0.0		0.4	0.2	1.6	1.5	0.4	0.0	0.2	0.4	0.1	1.0			0.1		0.3	0.1	0.3	0.7	0.2	2.4	0.4	0.5	0.6	0.1	0.0	0.1	0.1	0.6	0.4	0.0	4.1	0.1	0.0	0.0	0.1	0.2	0.6	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.5	0.5	0.2	1.5	0.2	0.0	0.4	0.3	0.1	1.1	0.0	0.1	0.0	0.0	0.3	0.2	0.2	0.0	0.2	0.2	0.7	0.4	0.2	0.2	0.2	0.1	0.2	0.0	0.5	0.3	0.4	0.2	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	1.8	0.2	0.2	0.4	0.3	0.4	0.2	0.6	0.6	0.5	0.3	0.1	0.7	0.5	0.5	2.4	0.5	0.3	0.2	0.2	0.1											0.0	0.0	0.0	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.0	310.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926514	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 712.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"		NA	NA		100000	"Plasma membrane"		"CAB020697: , HPA048963: AB_2680574"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (5.19e-5)"	"unprognostic (2.60e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (8.11e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.15e-2)"	50.5	79.9	12.7	26.3	23.3	17.5	105.9	25.7	35.1	17.7	48.2	9.1	16.8	37.3	17.9	14.6	36.9	20.0	47.8	44.0	16.0	18.9	24.9	7.7	44.9	43.4	21.3	12.8	34.7	11.5	6.3	33.8	32.6	43.3	20.5	58.1	23.9	18.4	24.8	7.4	85.4	57.3	24.3	28.4	16.5	13.5	21.1	13.6	14.5	15.6	41.4	18.4	21.9	31.5	10.4	26.8	13.6	60.9	7.8	20.0	22.5	46.4	28.9	27.2	25.5	73.0	21.3	62.3	54.5	49.6	39.7	45.0	44.9	23.4	37.9	49.3	41.4	57.5	102.0	26.9	26.0	45.2	20.6	34.2	33.1	32.5	29.1	28.9	27.2	26.0	22.5	62.3	31.1	30.1	28.4	42.3	26.6	22.7	33.7	40.6	21.1	27.6	45.6	37.8	64.7	13.9	38.0	20.4	38.6	33.3	35.9	22.4	15.3	71.2	33.1	73.1	49.4	25.2	33.2	29.4	34.9	13.4	52.1	31.7	25.1	32.3	61.1	45.5	29.6	28.6	13.6	27.1	8.9	19.2	44.5	14.1	10.4	15.6	20.0	26.8	7.5	9.2	16.7	1.9	7.8	60.9	16.4	16.9	22.5	12.7	23.3	25.7	35.1	16.0	18.9	21.3	12.8	43.3	13.6	53.6	46.5	109.5	333.7	437.8	35.4	16.7	20.4	10.7	43.3	209.3	23.6	255.9	34.9	71.5	391.5	178.3	384.3	140.2	52.8	199.5	109.5	121.1	129.2	6.0	276.1	23.8	53.9	79.8	137.2	712.2	78.6	209.3	210.9	518.4	67.0	42.5	54.6	123.0	64.3	29.8	25.4	122.9	189.2	42.4	191.3	362.3	327.4	66.0	109.6	362.4
TFDP2	Dp-2	ENSG00000114126	"Transcription factor Dp-2"	Q14188	3	141944428-142149544	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 140.3"	"Cell type enhanced"	"Detected in all"	12	"Early spermatids: 731.6;Late spermatids: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 42.8;MOLT-4: 80.4;REH: 42.9;U-698: 70.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018396, HPA070399"	Supported		Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	No			Nucleoplasm	"Vesicles, Mitotic spindle"	"CAB018396: AB_2287284, HPA070399: "	"unprognostic (1.35e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (8.08e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.60e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.84e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.08e-1)"	8.4	8.4	6.1	6.3	8.7	20.7	9.3	9.9	8.6	8.9	11.1	6.5	6.5	10.4	9.9	8.6	8.3	7.2	11.6	12.0	7.5	4.9	14.3	9.5	6.8	5.3	6.0	5.0	11.6	8.8	10.4	19.4	13.5	8.0	9.9	6.6	8.8	7.9	6.9	14.5	8.0	14.6	11.8	8.5	5.3	8.6	51.9	5.4	140.3	10.6	4.8	6.4	9.7	8.0	9.3	16.5	24.6	4.5	18.0	14.7	5.7	6.3	2.9	12.3	9.8	4.1	4.5	27.1	3.2	3.7	5.1	8.3	3.7	6.3	22.5	15.0	3.6	9.0	3.8	3.1	6.1	7.2	9.0	5.6	27.1	4.4	4.9	4.0	8.2	9.6	4.2	4.3	5.6	5.4	4.8	3.5	42.8	10.1	1.2	8.8	4.8	80.4	3.1	9.9	3.3	4.0	42.9	8.5	5.2	5.9	3.3	5.4	5.0	10.8	4.0	5.5	9.6	9.3	4.2	2.3	4.9	4.5	3.9	4.0	4.2	3.8	70.6	3.9	2.2	2.3	24.6	2.1	22.3	14.7	3.4	5.7	6.6	6.7	7.6	4.8	9.3	10.1	11.8	2.4	18.0	4.5	16.5	6.1	5.7	6.1	8.7	9.9	8.6	7.5	4.9	6.0	5.0	8.0	5.4	29.8	20.4	15.7	43.3	22.2	30.3	70.0	38.2	54.9	33.0	45.4	31.4	191.4	79.6	29.5	731.6	22.4	31.6	116.8	23.1	95.8	33.4	41.8	31.3	35.9	24.4	35.0	37.2	20.9	9.2	294.5	71.4	15.0	5.0	17.2	32.3	24.6	24.5	32.3	70.7	74.6	34.6	25.8	21.4	52.6	55.1	17.6	83.0	35.5	42.3	22.7
GK5	MGC40579	ENSG00000175066	"Glycerol kinase 5 (putative)"	Q6ZS86	3	142157527-142225607	"Enzymes, Predicted intracellular proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042606, HPA057998"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042606: AB_10795509, HPA057998: AB_2683573"	"unprognostic (7.79e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.59e-3)"	6.1	12.2	5.6	5.7	7.2	10.8	10.9	9.0	9.4	11.5	10.9	8.4	11.5	14.4	10.9	14.8	7.9	7.2	8.3	5.4	5.5	4.1	5.7	3.1	6.2	3.5	9.3	6.0	11.5	4.8	5.4	20.3	3.7	12.6	13.5	11.8	6.7	14.8	14.7	5.0	8.8	14.0	9.4	11.6	3.5	8.1	6.2	5.3	4.6	7.4	4.2	6.1	8.5	6.7	1.3	1.1	3.6	5.3	3.8	3.8	0.5	11.0	2.8	4.0	2.7	8.3	15.9	6.9	3.7	2.6	4.1	2.6	4.2	6.1	8.0	3.3	3.5	4.5	4.7	4.6	3.5	5.4	2.8	4.4	5.2	6.6	3.1	4.5	5.9	6.9	6.5	3.1	2.7	3.6	2.6	2.3	9.2	4.5	4.9	7.3	7.1	5.2	4.9	2.6	7.4	3.2	4.9	4.3	2.9	4.2	6.9	3.9	2.9	10.2	10.8	3.3	2.5	15.0	3.9	2.5	3.2	2.7	7.1	4.0	5.1	4.9	8.1	5.8	3.7	5.4	3.6	1.1	0.7	3.8	0.9	1.9	0.5	1.3	1.4	0.8	1.3	1.0	1.7	3.2	3.8	5.3	1.1	0.6	0.5	5.6	7.2	9.0	9.4	5.5	4.1	9.3	6.0	12.6	5.3	35.7	27.8	0.0	11.1	3.5	30.1	9.3	15.3	21.4	27.3	26.2	27.5	11.1	6.6	12.3	2.0	5.9	31.1	0.0	17.9	6.4	7.8	21.5	8.1	11.1	5.0	14.3	26.9	2.5	10.0	3.6	31.4	8.2	3.3	1.0	51.9	13.2	13.9	39.1	43.9	5.1	35.7	25.8	4.9	4.2	4.7	3.4	5.7	17.5	38.6	11.6
XRN1	SEP1	ENSG00000114127	"5'-3' exoribonuclease 1"	Q8IZH2	3	142306607-142448062	"Predicted intracellular proteins"		"DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 58.4"	"Low region specificity"	"Detected in all"							"HPA035005, HPA035006"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035005: AB_10670695, HPA035006: AB_10672750"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.32e-2)"	16.5	12.4	9.9	16.2	15.5	24.4	15.9	23.8	15.7	15.7	17.5	7.5	12.4	14.7	15.2	14.2	13.4	11.5	11.0	10.1	8.4	6.8	9.6	21.7	15.9	16.1	11.7	9.0	17.4	13.2	17.4	26.5	23.6	10.7	12.5	13.0	8.2	14.4	13.3	21.2	17.2	25.0	14.4	15.2	16.2	11.7	11.8	10.9	30.8	12.9	10.8	15.3	15.0	15.2	7.4	6.1	18.3	4.7	4.3	8.4	2.5	10.0	1.9	4.6	3.9	5.2	8.6	2.8	4.7	6.3	6.1	7.6	1.7	3.0	4.0	4.9	6.2	4.9	3.9	4.1	2.4	9.4	10.2	3.1	5.9	3.3	1.6	4.5	5.9	6.0	6.7	2.7	4.4	5.8	5.7	5.5	4.5	3.9	9.6	5.5	1.9	5.1	3.1	1.4	1.4	2.1	4.2	58.4	5.0	2.9	5.1	2.7	3.4	8.4	4.6	3.6	2.9	5.6	4.6	7.4	4.3	2.4	4.9	4.0	13.8	7.0	6.4	4.0	3.1	3.7	18.3	4.7	12.2	8.3	4.2	5.8	7.4	6.4	7.4	2.3	6.0	8.4	5.8	17.2	4.3	4.0	6.1	4.6	2.5	9.9	15.5	23.8	15.7	8.4	6.8	11.7	9.0	10.7	10.9	50.6	26.6	34.1	28.0	22.8	31.5	23.0	17.8	26.8	33.0	43.6	47.1	17.6	10.0	12.9	37.7	26.6	30.0	23.3	11.0	6.0	21.8	33.7	19.8	42.4	14.1	25.4	27.1	36.8	30.0	15.1	23.0	23.1	13.5	26.2	18.5	23.2	15.6	24.6	27.3	12.0	57.0	6.5	17.9	55.7	14.9	24.7	44.7	35.5	13.6	42.3
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449235-142578826	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3;Spermatocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	10.5	24.3	7.7	11.4	15.9	10.1	14.8	11.3	14.6	10.1	8.5	10.0	10.4	6.0	14.7	16.8	9.4	12.1	9.3	8.8	9.8	7.1	9.6	12.0	10.3	16.0	10.0	8.1	12.3	13.6	18.0	22.5	8.8	12.5	11.0	11.2	9.5	12.5	10.8	7.7	11.2	10.9	9.8	8.8	14.2	9.0	15.3	9.7	19.0	13.8	7.7	15.1	10.9	10.6	5.8	2.8	2.2	4.0	6.7	6.0	0.8	22.7	11.2	7.5	8.5	10.7	11.8	8.9	12.6	7.1	9.4	9.7	5.2	7.3	18.6	13.0	8.9	12.3	14.8	11.0	11.6	14.2	5.9	7.2	10.2	8.5	5.1	4.7	17.1	5.7	9.2	6.4	8.9	10.6	6.4	9.7	9.7	7.1	8.4	9.6	10.0	12.9	7.1	7.2	14.9	8.0	10.7	10.9	13.5	9.5	10.6	5.3	5.4	23.2	8.4	8.2	7.1	12.2	6.9	12.5	9.6	4.8	12.4	13.5	11.0	6.5	17.3	12.5	6.7	7.6	0.7	2.7	2.2	4.4	4.0	6.0	3.1	3.2	4.2	2.8	5.8	4.1	4.0	1.7	6.7	2.5	2.5	2.4	0.8	7.7	15.9	11.3	14.6	9.8	7.1	10.0	8.1	12.5	9.7	6.0	8.8	13.4	6.5	3.5	14.7	7.1	7.6	18.7	6.8	3.5	35.3	6.6	0.0	5.3	12.0	7.1	2.1	0.0	4.3	3.3	4.8	6.7	1.1	6.0	5.7	7.9	7.5	8.6	9.1	6.9	6.1	6.9	10.1	4.6	5.4	4.8	6.2	0.0	6.7	4.1	23.4	0.0	6.4	42.3	15.8	4.0	4.2	5.1	7.0	5.2
PLS1	"I-plastin, Plastin-1"	ENSG00000120756	"Plastin 1"	Q14651	3	142596387-142713664	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 193.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 327.0;Mucus-secreting cells: 111.2;Paneth cells: 126.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.9;NK-cells: 5.9;T-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.7;OE19: 48.1;RPTEC TERT1: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA055744, HPA061936"	Enhanced					NA	NA		50000000			"HPA055744: AB_2682903, HPA061936: "	"unprognostic (1.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (3.14e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (1.99e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.82e-2)"	0.5	2.3	1.0	8.2	1.0	1.0	1.7	1.5	2.0	2.0	42.3	0.6	0.2	40.0	0.5	1.1	5.7	1.3	6.3	0.9	1.2	1.1	12.5	10.6	4.4	0.3	0.9	1.0	0.6	5.0	3.8	13.6	0.8	4.5	1.8	30.0	2.9	5.3	0.9	0.5	1.2	193.0	0.6	1.2	0.5	9.6	2.6	0.5	2.5	3.7	1.3	1.6	5.1	2.3	0.7	0.9	4.9	0.4	5.9	5.0	1.8	25.7	20.3	1.4	3.1	0.2	0.0	33.7	0.5	0.7	2.8	6.1	9.2	20.3	4.4	10.8	0.1	9.6	5.5	5.5	8.4	6.0	1.5	8.0	7.8	3.2	3.3	0.2	3.7	0.5	0.0	1.4	5.3	3.4	4.5	1.3	4.8	3.3	0.5	0.3	6.0	6.0	2.0	5.6	48.1	7.6	2.5	6.1	3.6	43.1	23.9	7.2	2.9	2.9	2.1	2.3	4.1	16.6	0.6	0.3	0.3	3.4	1.0	6.2	3.8	3.5	5.1	0.9	3.7	1.0	3.4	0.4	4.9	2.9	0.3	3.8	0.7	3.5	3.8	0.7	0.6	4.3	5.0	3.3	5.9	0.4	0.9	2.1	1.8	1.0	1.0	1.5	2.0	1.2	1.1	0.9	1.0	4.5	0.5	50.6	29.4	4.7	3.1	2.6	2.4	2.4	43.3	40.2	51.2	41.8	15.7	4.9	18.3	15.2	52.6	0.4	327.0	0.0	29.7	1.6	0.5	7.8	9.2	28.7	0.6	4.8	51.8	1.3	0.6	12.6	1.1	1.3	1.7	1.0	111.2	2.8	50.2	126.2	0.0	34.0	12.5	0.0	0.8	5.1	3.6	2.9	1.1	0.0	65.5	9.7
TRPC1	HTRP-1	ENSG00000144935	"Transient receptor potential cation channel subfamily C member 1"	P48995	3	142724074-142807888	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 18.1;Cone photoreceptor cells: 15.7;Horizontal cells: 12.7;Rod photoreceptor cells: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009387, HPA021130"	Supported		Approved	Vesicles		NA	NA			Vesicles		"CAB009387: AB_2240941, HPA021130: AB_1858361"	"unprognostic (1.66e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (1.44e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.49e-2)"	6.8	8.3	8.5	3.5	13.4	1.2	6.8	23.0	15.9	17.7	8.3	11.4	4.3	2.6	20.4	9.2	6.5	10.1	9.1	15.9	10.0	11.4	6.0	2.0	5.4	3.3	9.4	12.2	24.5	3.0	12.2	14.4	6.1	14.7	12.3	4.9	13.0	3.7	13.6	2.4	6.2	4.7	17.6	11.4	5.0	4.4	8.0	7.9	0.4	8.9	3.9	2.3	9.3	8.9	0.6	0.0	0.0	0.0	0.3	1.3	0.3	3.2	4.6	8.4	1.0	7.6	18.7	3.8	5.1	8.1	6.5	9.6	1.4	0.9	0.0	1.7	5.3	11.4	0.3	2.3	2.4	9.4	0.8	3.4	5.1	1.9	2.2	3.1	0.2	0.0	9.0	2.4	6.0	7.3	11.0	3.7	0.0	0.2	0.0	9.1	2.0	0.3	0.4	4.7	0.0	2.4	0.0	4.0	0.0	4.5	0.1	5.4	4.0	6.3	0.0	1.1	8.0	2.6	0.0	3.4	8.2	1.3	11.0	6.9	3.4	1.4	1.6	6.2	0.1	2.4	0.0	0.0	0.0	0.2	0.0	1.2	0.6	1.3	0.6	0.0	0.3	1.2	1.3	0.0	0.3	0.0	0.0	0.0	0.3	8.5	13.4	23.0	15.9	10.0	11.4	9.4	12.2	14.7	7.9	3.0	0.3	0.0	2.2	2.6	18.1	10.1	0.0	2.7	0.0	5.2	15.7	0.1	0.0	0.2	2.1	2.9	0.0	0.0	0.2	0.2	7.2	0.8	0.0	0.0	0.1	12.7	1.7	4.3	0.0	1.7	7.8	0.0	1.7	0.0	0.0	6.8	0.1	0.0	10.3	0.3	15.0	0.0	9.0	10.3	2.1	1.0	0.2	0.0	0.0	0.2
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889203	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 55.6"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 99.1;Extravillous trophoblasts: 55.3;Fibroblasts: 87.7;Syncytiotrophoblasts: 202.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;RPMI-8226: 13.5;U-2197: 29.0;U-266/70: 28.7;U-266/84: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	35.2	1.2	1.0	2.0	0.5	5.5	29.0	0.3	0.7	12.4	3.6	0.5	9.1	0.0	3.9	6.0	16.8	2.1	3.8	55.6	1.4	1.2	7.3	7.9	6.9	1.6	0.6	0.7	2.5	0.6	0.1	13.8	20.1	0.4	14.2	2.1	2.5	2.7	3.9	6.3	2.7	1.5	41.6	0.8	1.2	2.0	1.9	0.3	0.0	3.5	6.2	0.9	28.2	30.6	0.0	0.0	1.4	0.2	0.0	0.0	0.3	0.5	4.3	1.4	0.0	25.9	7.2	0.0	0.3	0.1	1.2	1.5	0.2	0.5	0.0	1.2	1.9	6.4	0.0	5.1	0.0	1.4	0.0	8.5	0.9	2.8	0.0	0.0	0.5	0.0	2.9	0.0	2.6	0.7	5.9	0.0	0.7	0.2	0.0	0.5	0.7	1.5	0.4	2.1	0.1	9.0	0.0	3.2	13.5	1.3	0.0	2.7	1.7	6.7	0.0	2.5	1.9	0.0	1.8	0.0	2.3	5.2	29.0	2.1	28.7	13.2	0.0	6.4	0.7	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.5	0.3	0.7	1.4	1.2	0.6	0.7	0.4	0.3	0.0	2.7	0.0	0.5	6.5	13.2	33.1	0.0	0.0	1.2	12.2	23.6	99.1	0.0	0.0	0.5	2.7	0.0	0.0	0.0	55.3	87.7	0.6	1.1	12.1	13.7	6.4	0.0	0.6	0.6	0.6	0.6	2.6	3.3	0.0	0.0	13.7	0.5	0.0	0.0	0.0	11.1	0.0	6.3	8.7	49.4	6.5	202.1	0.0	0.0	0.1
PAQR9	FLJ41938	ENSG00000188582	"Progestin and adipoQ receptor family member 9"	Q6ZVX9	3	142949164-142963682	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.1;heart muscle: 12.1;liver: 18.6;testis: 20.8"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 33.7;Erythroid cells: 23.3;Hepatocytes: 17.3;Late spermatids: 72.6;Syncytiotrophoblasts: 30.6"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.4;AF22: 3.4;HEL: 3.7;NTERA-2: 4.1;U-266/70: 10.2;U-266/84: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052798	Uncertain					NA	NA					"HPA052798: AB_2681955"		"unprognostic (4.13e-2)"		"unprognostic (2.54e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.12e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.91e-2)"	0.4	0.6	2.5	0.3	7.0	7.0	0.3	0.5	10.1	0.3	0.3	0.6	0.0	0.3	0.3	0.3	0.3	0.3	0.4	12.1	3.3	1.7	0.3	18.6	0.3	0.3	0.7	3.1	0.3	0.5	0.3	1.4	0.8	6.0	0.4	0.3	2.7	0.3	0.3	5.9	0.3	0.3	0.3	1.0	0.3	0.3	20.8	0.3	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	1.0	0.0	0.1	0.0	0.3	3.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	4.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.0	0.7	0.4	10.2	5.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.0	0.5	10.1	3.3	1.7	0.7	3.1	6.0	0.3	0.0	0.0	0.0	0.0	0.2	4.5	5.3	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	33.7	0.0	0.0	23.3	0.0	0.1	0.0	0.0	0.0	17.3	0.1	0.0	0.0	0.0	0.0	72.6	1.1	0.0	0.0	0.0	0.0	1.9	0.1	0.0	1.8	0.0	6.4	0.0	0.0	1.1	4.9	0.1	30.6	0.0	0.0	0.0
U2SURP	"fSAPa, SR140"	ENSG00000163714	"U2 snRNP associated SURP domain containing"	O15042	3	142964497-143060546	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037545, HPA037546, HPA061407"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506"	"unprognostic (2.01e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (8.86e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.12e-1)"	"prognostic favorable (6.78e-4)"	21.2	17.7	21.3	17.6	30.8	48.2	24.0	29.7	27.9	26.3	20.3	18.8	18.0	12.9	24.3	22.2	22.3	19.2	12.7	16.6	18.4	16.4	17.8	22.1	17.9	26.8	24.5	24.8	28.4	22.8	22.3	39.6	21.7	25.8	21.2	20.7	19.2	18.6	15.8	26.4	21.9	22.1	26.0	26.6	23.5	18.3	19.2	27.3	32.3	21.2	16.5	24.5	23.2	19.0	33.8	31.2	19.9	25.7	18.4	26.6	11.3	38.0	12.8	14.3	9.6	7.6	7.1	24.9	17.2	11.1	19.9	14.9	17.0	11.7	44.0	18.5	11.1	38.2	13.8	29.4	15.3	22.8	11.9	20.6	47.7	11.8	13.5	7.9	46.2	18.0	8.6	7.7	15.4	19.7	8.9	10.7	28.2	29.3	14.1	9.2	10.7	22.9	20.2	23.1	12.2	12.0	23.4	28.1	18.4	10.0	24.1	18.5	10.8	34.6	11.4	20.2	15.5	20.3	20.0	11.7	10.8	12.7	8.4	27.6	16.9	21.6	75.4	8.6	16.8	14.8	18.9	19.7	18.3	25.2	18.6	22.0	31.7	23.1	22.3	15.4	33.8	26.6	22.8	19.9	18.4	25.7	31.2	22.1	11.3	21.3	30.8	29.7	27.9	18.4	16.4	24.5	24.8	25.8	27.3	110.2	113.9	58.8	76.8	54.0	118.7	107.4	50.9	109.7	113.7	59.3	62.8	66.9	44.7	59.1	24.0	69.2	40.4	23.3	69.1	74.2	66.7	59.6	93.8	51.4	53.1	87.4	53.0	59.5	57.8	14.6	100.7	82.2	49.0	103.6	66.5	100.5	72.4	56.1	75.0	46.0	116.0	77.6	76.2	174.5	202.9	56.7	66.1	72.6	70.6	61.5
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119331-143124014	"Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.9"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 106.5;Sertoli cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	4	"monocytes: 11.4;NK-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 20.5;ASC TERT1: 21.0;HEL: 16.2;HHSteC: 42.2;HMC-1: 19.4;HSkMC: 22.1;U-266/70: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: AB_2668861"	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	6.5	2.6	8.2	11.6	16.6	20.0	4.1	9.8	15.1	4.6	3.1	6.5	2.6	3.6	6.4	2.7	2.0	1.6	3.1	2.6	7.3	10.4	4.8	1.6	5.1	10.2	10.6	5.8	3.6	2.0	1.5	5.5	15.3	14.0	7.6	2.3	5.9	4.0	15.9	2.7	3.0	4.9	6.0	32.9	17.0	5.4	2.3	4.8	24.7	5.4	0.1	8.1	7.4	5.4	1.4	1.8	0.8	11.4	4.8	0.8	0.9	0.0	0.1	1.0	0.9	20.5	21.0	0.0	1.1	3.2	0.8	0.7	0.0	0.0	0.2	0.7	0.7	1.1	0.0	0.7	2.7	0.4	0.2	0.5	16.2	0.0	0.0	42.2	0.4	19.4	22.1	3.4	1.0	3.5	1.2	1.2	2.5	1.8	1.0	5.3	0.0	3.0	4.1	5.8	0.0	2.7	0.1	0.3	0.0	0.6	0.7	1.3	0.0	0.2	0.0	1.8	1.0	0.0	0.6	4.2	2.5	1.4	3.3	4.7	18.6	0.2	1.1	4.8	3.1	12.8	0.7	0.6	0.8	0.4	4.5	0.0	1.4	0.1	0.2	1.8	1.0	0.8	0.6	0.3	4.8	11.4	0.1	0.5	0.9	8.2	16.6	9.8	15.1	7.3	10.4	10.6	5.8	14.0	4.8	0.0	0.0	14.2	7.0	2.2	20.1	1.2	0.0	0.0	2.3	3.5	2.0	0.4	0.0	0.3	0.1	6.4	0.0	23.3	0.2	0.3	7.1	9.4	11.5	0.0	2.8	1.6	0.0	4.3	6.4	0.4	11.8	13.0	16.9	9.0	0.0	106.5	3.5	0.0	2.1	0.0	19.2	90.5	5.5	0.0	1.9	0.5	0.8	8.7	0.0	15.6
SLC9A9	"FLJ35613, NHE9"	ENSG00000181804	"Solute carrier family 9 member A9"	Q8IVB4	3	143265222-143848531	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 23.3;Hofbauer cells: 42.3;Ito cells: 25.2;Kupffer cells: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.6;ASC TERT1: 13.8;HSkMC: 9.6;Karpas-707: 33.4;RPMI-8226: 15.5;U-266/70: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058234	Approved					NA	NA		41000			"HPA058234: AB_2683648"	"unprognostic (8.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.35e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (5.57e-7)"	"unprognostic (5.01e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-2)"	17.4	8.4	16.8	11.4	25.9	2.7	7.7	4.5	17.2	10.6	9.6	17.2	2.0	4.5	6.2	5.7	18.0	9.2	13.4	8.2	14.7	11.7	3.7	9.9	8.3	17.5	23.0	7.4	11.8	2.2	1.9	6.5	21.3	18.3	12.9	8.6	4.6	7.1	12.8	3.5	10.3	9.3	12.1	27.5	16.9	7.3	2.9	24.1	10.7	5.7	7.1	17.8	17.3	10.8	4.4	8.7	0.7	10.8	3.9	9.3	4.7	0.3	0.3	0.4	0.5	10.6	13.8	0.1	0.5	3.5	0.2	1.7	0.0	0.1	1.6	0.1	1.6	0.9	0.4	0.5	1.0	0.4	6.8	0.1	0.9	0.2	0.0	1.2	0.4	0.7	9.6	2.8	0.3	0.5	0.6	0.1	1.2	0.0	33.4	2.2	0.0	0.8	0.0	0.1	0.0	0.2	1.3	0.1	15.5	0.0	0.2	0.2	0.0	0.8	0.0	0.0	0.2	0.1	0.3	0.0	1.3	0.3	1.5	0.7	15.6	0.0	0.0	2.3	0.2	0.6	0.1	6.6	0.7	5.2	10.8	4.5	3.7	5.5	8.1	8.7	4.4	3.1	4.6	0.5	3.9	9.2	0.6	9.3	4.7	16.8	25.9	4.5	17.2	14.7	11.7	23.0	7.4	18.3	24.1	0.0	1.4	3.7	9.4	3.3	0.1	1.1	0.0	1.4	2.3	3.5	2.0	0.4	0.0	0.8	3.9	2.8	0.0	23.3	0.2	0.3	9.4	12.5	0.0	0.0	42.3	0.0	0.0	25.2	24.1	2.7	8.6	9.6	6.8	19.8	0.0	3.7	1.0	0.0	6.7	0.4	0.0	0.0	3.1	0.2	0.2	4.4	0.9	10.2	0.0	4.8
C3orf58	"DIA1, HASF, MGC33365"	ENSG00000181744	"Chromosome 3 open reading frame 58"	Q8NDZ4	3	143971798-144048719	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 86.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048992	Approved				"Secreted in other tissues"	NA	NA					"HPA048992: AB_2680591"	"unprognostic (5.96e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavorable (2.92e-7)"	"unprognostic (4.82e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.50e-2)"	9.1	6.0	12.4	7.8	15.5	21.5	13.4	27.5	15.3	11.7	9.3	21.9	5.0	5.2	11.5	4.9	12.1	10.4	11.4	9.0	13.2	10.9	5.6	15.0	10.1	9.1	16.5	10.9	16.8	7.3	11.3	5.0	29.3	10.6	9.6	7.2	5.4	7.6	10.7	4.2	19.0	6.7	12.2	14.5	7.9	8.2	6.0	18.4	10.9	10.2	4.7	8.3	11.6	12.5	6.8	11.9	16.0	9.4	7.4	5.2	4.1	9.4	3.8	9.9	58.5	9.2	8.4	5.4	6.9	6.7	6.6	7.1	2.6	3.8	5.9	5.4	2.6	4.7	5.4	14.6	5.6	10.4	2.8	5.3	8.8	3.9	3.8	4.0	8.0	4.1	6.9	3.0	4.0	6.2	6.7	10.2	2.7	1.5	17.4	8.3	2.5	2.9	3.9	6.2	3.9	2.4	4.3	5.1	6.6	4.0	11.3	6.6	0.0	4.9	2.3	2.2	2.8	6.1	4.4	4.8	5.9	2.8	9.1	7.9	7.0	2.4	8.7	9.5	3.8	7.5	16.0	9.4	15.5	3.0	6.1	5.2	6.6	3.6	3.2	11.9	6.8	3.2	3.0	2.8	7.4	7.8	7.4	3.1	4.1	12.4	15.5	27.5	15.3	13.2	10.9	16.5	10.9	10.6	18.4	86.4	8.1	22.3	12.5	31.7	3.6	13.2	28.1	14.7	15.9	5.2	23.6	1.1	0.0	5.8	2.9	24.3	8.9	23.3	4.8	1.5	32.1	15.1	18.4	16.6	18.6	9.5	32.1	16.0	26.2	3.2	16.4	18.5	21.9	3.6	8.4	30.9	3.4	13.5	18.0	2.8	6.3	19.4	23.9	2.7	17.3	26.6	2.9	10.1	9.4	6.3
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavorable (7.64e-10)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.99e-11)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	16.4	11.8	3.7	1.2	13.5	14.5	9.4	58.5	17.9	31.9	60.2	0.9	1.7	0.0	11.4	9.9	14.6	3.5	4.3	50.3	82.6	0.0	6.8	4.1	11.5	8.2	34.7	0.0	0.0	25.4	7.2	27.6	13.5	93.9	44.0	0.0	5.4	0.2	56.3	6.0	0.0	0.0	2.3	0.0	5.1	0.0	2.4	0.0	13.4	0.8	1.8	0.0	46.6	5.0	4.9	18.1	13.6	0.5	55.2	39.5	12.0	12.5	34.9	17.9	2.5	0.0	73.6	0.0	7.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9	14.9	10.7	0.5	5.9	6.3	14.5	10.6	61.1	12.0	13.6	26.2	33.4	6.8	8.3	62.8	0.4	21.2	46.1	0.0	45.9	109.4	34.5	8.1	0.0	50.8	4.7	0.0	19.0	18.4	1.5	1.3	12.0	2.7	13.5	1.0	18.3	65.1	83.0	31.5	4.6	6.9	22.4	19.4	38.1	8.0	16.3	4.8	15.7	0.7	21.3	5.4
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192339-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 48.7;Fibroblasts: 48.9;Ito cells: 88.4;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.5;ASC TERT1: 19.3;hTERT-RPE1: 24.1;HUVEC TERT2: 19.8;TIME: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	40.5	29.6	19.4	5.9	20.4	1.7	53.3	19.1	23.4	25.1	17.7	14.8	10.8	4.6	21.9	13.9	15.8	28.0	29.4	20.3	23.1	13.8	16.9	43.4	24.2	16.7	13.7	14.6	25.2	13.0	3.8	11.7	35.9	21.8	17.9	16.9	15.9	14.8	18.2	8.7	11.1	9.3	25.0	28.7	18.4	11.0	16.8	16.6	0.9	25.1	8.9	4.5	23.3	28.7	0.0	0.2	0.0	0.2	1.3	0.0	0.5	0.0	3.6	0.6	0.0	24.5	19.3	0.1	4.3	5.9	1.9	4.3	0.4	4.8	0.0	4.8	8.1	1.9	0.5	0.9	0.4	1.1	0.0	0.0	1.9	2.9	0.4	11.2	0.0	0.5	11.7	0.6	4.0	1.2	24.1	19.8	0.0	0.0	0.3	2.9	0.1	0.0	0.0	0.8	1.9	1.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	7.4	0.0	1.4	1.0	0.3	0.2	40.8	4.1	1.0	9.1	0.8	0.1	0.0	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.5	19.4	20.4	19.1	23.4	23.1	13.8	13.7	14.6	21.8	16.6	3.0	10.1	0.0	4.4	9.6	0.3	3.2	17.8	6.7	10.3	3.5	0.0	0.7	0.0	5.0	0.9	48.7	9.1	23.3	10.2	0.2	48.9	3.1	1.1	39.0	0.7	0.0	9.9	88.4	8.6	1.3	39.7	2.5	3.3	0.0	13.5	48.4	5.7	8.6	30.4	16.5	1.3	0.0	25.0	0.7	0.4	7.5	0.7	1.0	6.6	2.2
PLSCR2		ENSG00000163746	"Phospholipid scramblase 2"	Q9NRY7	3	146391421-146495991	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 8.1;testis: 16.8"	"Group enriched"	"Detected in some"	25	"Early spermatids: 161.5;Late spermatids: 194.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.9;EFO-21: 2.3;GAMG: 3.7;Karpas-707: 2.5;U-266/70: 2.1"									HPA051352			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA051352: "	"unprognostic (1.11e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.94e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.23e-2)"	0.3	0.3	0.3	1.7	0.3	1.3	0.4	1.0	0.4	0.4	1.5	0.0	1.3	0.2	0.3	8.1	0.6	0.9	1.4	0.3	1.1	0.3	1.4	0.3	1.0	1.8	0.3	0.4	1.0	1.2	0.3	3.2	0.5	1.6	0.4	0.5	0.6	1.4	3.0	0.3	0.3	0.4	0.2	0.8	0.3	0.5	16.8	0.0	0.1	2.5	0.7	0.1	0.3	2.2	0.6	0.5	1.7	1.1	1.3	1.6	0.6	0.0	0.3	0.0	0.0	0.0	1.4	0.2	0.0	0.4	0.6	0.8	0.2	1.9	0.0	2.3	0.0	3.7	0.2	0.3	0.0	0.4	0.1	0.4	0.6	0.8	0.2	0.8	0.0	0.7	0.5	0.5	0.2	0.9	0.6	0.0	0.2	0.3	2.5	0.1	0.0	0.0	0.0	0.5	0.0	1.5	0.2	0.0	0.0	1.5	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.6	0.6	1.3	0.6	0.9	1.4	0.5	0.3	1.4	1.6	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.3	1.0	0.4	1.1	0.3	0.3	0.4	1.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.5	1.4	0.0	7.0	0.0	0.1	1.7	0.8	161.5	0.0	0.0	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.1	0.0	1.7	0.6	0.0	194.1	1.7	0.3	0.0	0.0	0.0	1.0	0.7	0.0	1.4	1.1	0.3	0.0	0.1	4.8	2.3	0.1	0.0	0.0	0.6	0.1
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544864	"Predicted intracellular proteins, Transporters"	"Antiviral defense"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 55.1;BJ hTERT+ SV40 Large T+ RasG12V: 73.3;HHSteC: 50.5;SK-MEL-30: 91.2"									"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Nucleoplasm, Golgi apparatus, Plasma membrane"		"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.9	14.9	11.9	39.7	21.4	27.0	31.1	5.7	19.0	20.9	29.6	7.2	22.1	18.4	19.6	25.7	25.4	19.5	30.8	22.7	16.1	12.7	32.0	36.5	33.8	38.6	17.6	4.9	40.0	26.1	10.3	18.4	25.7	22.1	25.0	28.0	12.6	32.3	34.2	16.4	9.9	24.6	19.4	29.8	46.0	20.5	15.4	14.8	16.4	27.5	14.9	19.5	27.5	48.0	6.5	27.5	26.2	41.2	14.3	8.1	17.6	17.2	6.9	4.4	2.0	6.6	11.2	6.8	5.4	14.8	55.1	73.3	5.5	14.4	1.3	12.9	3.4	43.1	14.2	3.5	5.1	9.3	5.3	3.5	11.1	2.2	4.1	50.5	6.3	5.8	17.8	8.7	6.1	31.1	8.8	8.0	3.2	7.1	17.2	11.2	6.7	4.9	2.4	4.2	11.7	6.2	4.4	4.9	0.4	15.5	4.7	2.7	0.0	6.9	3.4	91.2	6.3	3.4	7.7	4.8	4.4	3.8	9.9	9.0	13.2	2.4	0.0	4.5	4.6	3.8	8.2	41.2	11.0	5.6	40.4	8.1	6.5	3.7	5.0	27.5	4.9	2.6	3.8	26.2	14.3	22.7	7.3	2.1	17.6	11.9	21.4	5.7	19.0	16.1	12.7	17.6	4.9	22.1	14.8	32.8	47.9	22.6	70.0	32.7	0.4	4.0	86.6	81.7	60.3	90.7	0.0	46.8	63.0	225.1	1.5	110.1	67.7	0.0	192.6	100.1	54.5	74.2	26.7	25.9	121.5	0.0	31.9	91.4	84.8	2.2	106.4	157.8	45.5	24.4	60.9	52.6	150.7	102.1	43.2	33.8	1.3	38.8	58.7	0.3	2.2	25.0	37.2	21.3	51.4	160.1
PLSCR5		ENSG00000231213	"Phospholipid scramblase family member 5"	A0PG75	3	146576555-146606216	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.8;intestine: 1.8;parathyroid gland: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"SuSa: 5.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047249	Uncertain					NA	NA					"HPA047249: AB_2679997"																		0.1	0.0	0.5	0.1	1.8	0.0	0.1	0.1	0.3	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.4	0.1	0.1	0.1	5.6	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.8	0.1	0.1	0.1	0.0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.1	0.3	0.1	0.5	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406860	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 52.2"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Early spermatids: 2.8;Late spermatids: 6.7;Muller glia cells: 4.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	18	"cerebellum: 52.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.7;ASC diff: 5.3;BEWO: 4.0;MCF7: 5.3;SH-SY5Y: 5.6;U-2197: 4.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 118.4"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030194: AB_2673367"	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.2	0.0	0.2	0.0	0.4	0.0	0.0	52.2	7.9	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.0	0.0	0.0	3.7	3.5	0.5	0.0	1.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.7	0.0	5.3	2.2	4.0	1.9	0.4	0.2	0.5	0.0	0.0	0.0	2.4	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.4	0.0	4.4	2.0	0.0	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	52.2	0.4	0.3	0.8	0.3	0.4	2.9	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ZIC1	"ZIC, ZNF201"	ENSG00000152977	"Zic family member 1"	Q15915	3	147393422-147510293	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 124.7"	"Cell type enhanced"	"Detected in some"	14	"Hepatocytes: 4.4;Leydig cells: 1.4;Muller glia cells: 4.2;Peritubular cells: 1.4;Rod photoreceptor cells: 1.5"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 124.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"AF22: 62.2"	"Region enhanced"	"Detected in many"		"cerebellum: 232.6"	"Region enriched"	"Detected in many"	9	"cerebellum: 491.0"	HPA004098	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004098: AB_1859065"	"unprognostic (1.33e-2)"			"unprognostic (1.82e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.19e-1)"		"unprognostic (5.01e-1)"	"unprognostic (2.61e-7)"	"unprognostic (2.95e-3)"	"unprognostic (1.67e-2)"		"unprognostic (3.01e-1)"	0.7	0.6	1.5	0.5	8.6	0.5	0.8	124.7	25.5	0.5	0.7	12.3	0.0	0.9	0.6	3.8	1.0	0.5	0.8	0.5	6.2	5.2	0.5	7.3	0.7	0.7	5.2	8.0	0.9	0.5	0.6	0.6	0.5	15.3	0.5	0.7	3.0	0.5	0.6	7.4	4.1	1.9	0.5	10.0	0.5	0.5	1.0	4.5	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.2	0.0	6.5	7.2	3.5	4.0	4.8	4.3	3.6	0.0	0.0	0.0	3.2	0.3	3.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.0	0.2	0.0	0.0	1.0	0.0	3.8	15.0	0.0	0.0	0.1	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	6.5	0.0	10.1	3.8	0.0	0.0	0.0	4.8	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	8.6	124.7	5.2	6.2	5.2	5.2	8.0	15.3	4.5	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.4	0.0	1.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 29.6;placenta: 44.9"	"Group enriched"	"Detected in many"	5	"Leydig cells: 134.3;Sertoli cells: 142.3"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 64.4;ASC TERT1: 9.0;BJ hTERT+ SV40 Large T+: 12.3;HBF TERT88: 19.4;HSkMC: 11.7"					"Low region specificity"	"Detected in many"			HPA003596	Enhanced		Uncertain	Vesicles		NA	NA			Vesicles		"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	18.8	11.6	0.0	0.1	0.0	0.0	10.8	0.0	0.0	0.8	5.5			0.0	0.6	0.5	0.5	2.2	1.6	3.1	0.0	0.1	5.7	29.6	2.6	0.0	0.9		0.8	0.6	0.6	0.8	44.9		1.3	1.0		1.0	1.0	2.9	4.4	0.7	1.1	0.0	2.3	1.7	0.2			4.1		0.0	4.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	64.4	9.0	0.0	0.0	1.3	12.3	7.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	1.1	0.6	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.1	0.0	0.2	3.1	0.0	5.7	5.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	6.6	0.2	13.7	1.2	0.0	26.8	0.6	0.0	22.7	29.4	0.8	0.2	134.3	0.0	1.7	0.0	0.0	4.5	0.8	0.0	7.1	0.0	0.0	142.3	15.5	0.0	0.4	1.5	0.2	0.0	0.0	0.0
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	590	"pancreas: 3628.4"	"Cell type enriched"	"Detected in some"	7	"Exocrine glandular cells: 6332.0"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.8;EFO-21: 2.9;HDLM-2: 3.1;U-2 OS: 5.2;U-251 MG: 1.5;U-266/84: 2.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	NA	NA		6600000			"CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628"	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	0.2	1.7	0.1	0.1	0.2	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	3628.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.8	1.1	6.1	1.0	3.1	3.5	0.9	0.0	0.0	0.0	0.0	2.8	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.2	0.0	1.5	0.0	2.4	0.6	0.0	0.0	0.0	6.1	0.7	1.1	3.0	0.9	2.2	0.9	1.3	2.6	0.3	1.8	0.9	3.5	4.5	3.1	1.0	1.1	0.6	0.9	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	9.9	0.1	0.0	0.0	6332.0	0.0	1.4	6.8	0.0	0.0	0.8	0.0	158.6	0.0	0.0	1.9	0.6	0.0	0.0	31.5	0.0	0.0	954.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.1
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell type enriched"	"Detected in some"	15	"granulocytes: 4120.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 81.5"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	81.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4	29.8	269.3	0.0	0.2	1.4	0.0	0.2	0.0	16.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.1	4120.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.3
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991341-149027668	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.0"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 202.8;Early spermatids: 172.2;Late spermatids: 292.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030497, HPA073229"	Supported		Approved	Vesicles		NA	NA			Vesicles		"HPA030497: AB_10602326, HPA073229: "	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	10.8	7.9	7.0	8.5	8.5	55.7	10.0	9.2	7.5	10.6	31.0	6.0	11.9	4.8	15.6	15.4	18.1	11.1	12.0	32.0	8.0	9.0	8.5	6.3	9.1	14.7	11.6	7.1	13.3	14.3	6.5	7.8	6.5	10.0	16.3	7.6	7.7	11.3	19.4	113.0	4.7	8.4	32.5	8.1	13.6	12.8	47.3	7.4	4.2	9.4	39.6	8.5	28.7	14.6	7.0	26.7	16.8	26.7	17.7	32.5	17.5	18.8	12.2	9.1	10.2	25.3	26.5	12.4	27.8	23.2	40.6	38.1	15.9	19.3	0.0	13.8	32.2	21.7	5.8	23.9	12.3	41.1	6.3	10.3	14.4	5.8	18.0	22.9	14.6	21.8	14.5	20.1	13.4	17.0	21.2	23.3	9.5	8.8	34.3	23.3	33.2	2.8	11.7	10.9	14.6	10.0	8.0	13.8	27.0	11.2	17.7	7.5	3.5	14.7	20.3	15.8	9.0	20.1	15.6	19.3	20.8	6.2	14.9	20.3	31.2	17.3	13.4	17.6	22.6	6.7	7.2	23.4	16.8	17.4	24.5	32.5	7.0	11.6	18.1	26.7	5.1	6.3	10.7	11.6	17.7	26.7	10.7	15.9	17.5	7.0	8.5	9.2	7.5	8.0	9.0	11.6	7.1	10.0	7.4	11.9	12.0	15.2	20.5	10.8	7.4	202.8	10.2	16.0	11.4	31.4	17.7	31.4	23.2	37.5	172.2	32.3	12.4	0.0	67.2	38.6	32.6	36.2	17.4	13.9	84.7	6.4	13.8	43.0	102.9	292.0	49.2	51.1	38.8	27.9	13.4	81.1	32.6	13.3	72.2	12.2	4.9	64.7	60.5	46.6	19.8	13.0	24.5	62.3	12.1	16.9
HLTF	"HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3"	ENSG00000071794	"Helicase like transcription factor"	Q14527	3	149030127-149086554	"Enzymes, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 88.3;Spermatocytes: 110.2;Spermatogonia: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015284, HPA049001"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015284: AB_1857263, HPA049001: AB_2680594"	"unprognostic (3.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.07e-2)"	10.2	22.1	12.6	8.4	17.6	9.0	12.4	29.3	23.8	11.1	11.0	12.4	6.2	4.8	12.4	9.6	7.1	10.8	8.6	16.5	15.8	16.6	15.6	16.3	7.1	9.8	15.7	19.0	17.6	12.0	16.5	25.1	7.3	29.9	14.7	7.0	11.3	9.3	11.1	9.7	5.1	6.6	12.7	19.0	7.5	8.7	37.7	14.0	17.1	19.0	4.8	9.6	10.0	7.8	8.4	9.2	8.8	2.3	5.4	10.4	3.5	24.6	12.0	17.2	13.4	11.5	14.9	1.7	16.7	10.0	12.4	14.5	9.7	17.2	15.9	20.5	7.7	24.3	0.7	23.0	6.6	20.8	8.8	11.2	38.2	9.4	3.9	7.2	10.0	15.9	9.4	3.6	9.2	5.4	19.0	7.1	26.0	13.3	10.4	16.9	12.4	20.5	15.4	12.9	12.5	15.1	23.8	19.3	2.5	10.2	8.0	17.0	10.0	25.4	11.8	23.0	9.5	35.2	9.8	5.0	14.6	8.8	20.5	18.2	15.4	8.6	20.8	14.3	13.7	5.6	8.8	1.3	4.0	5.6	2.1	10.4	8.4	4.9	7.2	3.9	5.4	7.2	7.4	0.2	5.4	2.3	9.2	4.4	3.5	12.6	17.6	29.3	23.8	15.8	16.6	15.7	19.0	29.9	14.0	23.8	14.8	13.8	7.6	4.9	88.3	34.8	17.8	30.8	21.6	29.6	39.3	6.6	29.9	7.9	9.5	10.8	1.3	0.0	7.3	8.2	10.6	11.9	53.2	14.9	7.6	44.5	4.7	15.4	4.0	5.8	31.4	7.5	5.0	3.6	6.2	35.2	6.8	2.8	30.4	15.6	75.2	12.9	14.1	110.2	89.0	3.8	1.4	13.8	6.6	4.3
HPS3	"BLOC2S1, SUTAL"	ENSG00000163755	"HPS3, biogenesis of lysosomal organelles complex 2 subunit 1"	Q969F9	3	149129584-149173732	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Albinism, Disease mutation, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046281, HPA052778"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"		"HPA046281: AB_10961641, HPA052778: AB_2681943"	"unprognostic (1.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.06e-2)"	14.4	17.6	10.5	16.1	11.5	6.3	18.8	8.1	11.8	13.0	11.7	12.8	6.2	13.7	17.1	10.3	10.2	12.4	11.5	8.9	9.9	8.7	15.3	10.1	12.1	25.1	11.5	10.4	18.7	13.8	10.1	11.8	13.3	11.9	13.4	11.8	13.9	13.4	11.5	5.9	8.9	16.3	13.4	17.1	19.8	12.5	8.5	12.6	23.8	13.7	4.5	19.9	16.3	17.9	16.3	19.9	16.1	15.4	9.3	16.0	10.7	19.8	11.0	6.6	6.8	9.3	12.0	5.0	8.2	16.1	10.8	14.0	3.7	13.2	5.1	10.5	9.8	49.5	6.8	7.3	5.6	14.0	12.4	5.8	2.3	5.3	4.1	8.3	6.3	3.9	7.8	5.7	10.4	4.3	22.2	11.0	8.4	2.6	12.4	13.7	12.3	4.5	8.9	15.9	10.8	8.9	5.4	4.3	13.6	5.9	10.0	2.0	5.3	7.0	7.5	15.2	15.0	8.1	8.4	5.5	10.8	1.9	10.9	11.8	10.2	4.0	12.6	16.1	12.4	2.6	16.1	12.8	11.9	13.4	15.4	16.0	16.3	12.2	13.8	19.9	13.3	9.5	12.5	5.8	9.3	10.1	11.3	10.5	10.7	10.5	11.5	8.1	11.8	9.9	8.7	11.5	10.4	11.9	12.6	11.9	15.0	15.9	4.2	3.3	6.4	2.0	5.1	24.1	30.7	7.0	2.0	20.2	5.0	9.2	2.4	7.7	8.4	0.0	15.5	11.9	8.0	7.2	15.0	6.7	18.3	3.2	8.6	20.3	25.2	2.6	10.6	17.8	13.5	3.6	8.6	26.3	10.6	3.5	28.3	18.9	5.0	0.0	5.1	2.6	9.3	4.5	11.8	20.0	6.0	4.4
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149222055	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 311.1"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 505.9;Club cells: 754.1;Hepatocytes: 1101.0;Muller glia cells: 606.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"EFO-21: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	830000000000			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	1.8	0.7	2.6	0.6	5.7	0.4	3.5	2.6	3.5	10.5	2.0	2.5	0.0	1.7	2.3	0.3	1.1	1.5	0.5	6.6	3.6	1.7	1.6	311.1	2.1	2.4	4.2	0.9	0.4	1.2	1.4	5.3	1.9	9.4	2.1	2.7	15.5	6.9	0.4	1.2	2.0	2.6	0.7	4.8	3.5	0.7	0.5	4.4	0.0	2.8	0.4	3.0	3.2	2.9	1.3	0.8	0.6	1.0	0.3	1.3	0.4	0.0	4.9	4.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.2	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.1	1.8	4.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.5	0.8	0.6	0.8	0.9	0.4	0.5	0.6	1.3	0.4	1.3	0.4	0.3	0.4	0.8	0.4	0.4	2.6	5.7	2.6	3.5	3.6	1.7	4.2	0.9	9.4	4.4	17.9	59.9	35.0	6.7	3.0	6.0	0.4	86.6	505.9	754.1	8.7	5.9	0.0	0.0	26.9	0.5	5.3	0.0	93.5	17.8	0.2	12.7	23.8	2.3	1101.0	0.6	4.8	0.0	42.4	37.9	0.4	0.3	3.4	0.0	2.8	0.0	606.4	111.7	0.0	0.4	0.1	13.8	0.0	2.6	0.0	0.0	2.3	0.2	4.3	0.0	44.8
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endothelial cells: 155.8;Ito cells: 174.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 29.6;EFO-21: 62.5;GAMG: 12.4;HUVEC TERT2: 20.7;NTERA-2: 14.9"					"Low region specificity"	"Detected in all"			"HPA053639, HPA069378"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA053639: , HPA069378: AB_2686133"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	17.9	4.8	7.1	4.0	8.8	0.1	14.4	3.7	7.3	7.9	3.5	1.7	4.7	3.1	7.6	7.2	5.4	5.6	9.0	10.8	8.4	6.2	26.6	9.7	7.4	8.0	9.3	1.5	5.4	8.0	4.2	7.4	14.1	12.3	9.1	2.9	11.9	3.5	5.6	9.3	2.7	3.9	12.3	7.4	34.6	3.5	2.6	8.2	0.6	12.0	5.7	4.0	6.0	5.8	0.9	0.6	1.2	0.4	2.8	0.5	0.0	0.0	29.6	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	62.5	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.9	20.7	0.0	0.0	0.0	1.9	0.2	0.0	0.0	14.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	2.6	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.7	1.2	0.4	0.4	0.3	0.2	0.1	0.5	0.4	0.2	0.0	0.9	0.4	0.5	0.5	2.8	0.3	0.6	0.1	0.0	7.1	8.8	3.7	7.3	8.4	6.2	9.3	1.5	12.3	8.2	0.0	4.1	2.2	0.0	2.9	0.1	1.1	7.6	1.4	0.0	1.8	0.0	0.0	8.3	21.2	0.3	155.8	0.0	0.0	0.2	0.0	0.9	1.0	1.1	0.6	0.1	0.0	0.0	174.3	13.0	1.0	2.0	0.2	1.7	1.0	0.0	0.6	1.2	0.0	6.3	25.4	0.0	0.0	2.1	0.0	0.2	2.5	0.0	1.3	0.0	0.4
TM4SF1	"L6, M3S1"	ENSG00000169908	"Transmembrane 4 L six family member 1"	P30408	3	149369022-149377865	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 4692.6;Glandular cells: 2223.6;Pancreatic endocrine cells: 1835.5;Urothelial cells: 5293.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 71.8;hTERT-RPE1: 98.5;HUVEC TERT2: 64.8;LHCN-M2: 69.8;OE19: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002760, HPA002823"	Uncertain					NA	NA					"CAB002760: , HPA002823: AB_1079221"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.09e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (4.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.43e-6)"	72.7	16.9	10.2	11.8	15.5	0.3	44.3	6.4	11.6	33.6	16.3	8.2	4.0	8.6	32.0	35.5	89.2	18.2	54.2	37.5	10.2	10.0	26.9	22.8	111.0	10.9	13.2	2.9	26.0	54.3	3.9	5.2	50.8	17.6	26.0	14.0	20.4	45.4	7.8	29.6	14.8	15.9	21.5	13.1	35.8	25.9	14.4	11.8	1.7	17.0	76.0	48.4	32.4	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	36.5	39.0	0.0	0.1	12.1	46.4	0.0	11.6	46.6	2.5	0.9	15.6	71.8	0.0	37.4	2.3	57.6	44.2	0.2	8.2	2.4	0.1	0.0	0.6	42.4	51.7	4.4	0.0	0.0	4.5	2.1	17.8	8.8	98.5	64.8	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.1	70.9	17.7	0.0	0.0	0.0	46.3	5.5	0.0	0.0	4.9	2.6	0.4	0.6	0.0	0.1	40.9	24.2	4.2	0.4	24.5	0.0	0.0	0.0	35.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.2	15.5	6.4	11.6	10.2	10.0	13.2	2.9	17.6	11.8	536.0	334.5	11.8	4692.6	246.9	0.0	21.3	221.7	149.9	565.3	54.1	0.0	0.4	0.0	1034.2	4.3	1040.2	30.7	23.3	1399.4	0.7	167.3	2223.6	29.1	22.1	1.6	0.0	37.5	904.2	35.1	4.7	236.8	42.2	285.1	45.9	2.1	0.0	1835.5	0.9	165.5	0.2	0.0	316.9	211.2	1.4	1.2	221.8	1.1	4.8	7.1	5293.1
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149473974-149503281	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 196.0;intestine: 126.4;liver: 81.8"	"Cell type enriched"	"Detected in many"	5	"Cholangiocytes: 2236.9"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.3"	"Group enriched"	"Detected in some"	6	"A549: 15.4;OE19: 14.2;RPTEC TERT1: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	68.2	0.0	0.0	70.3	0.2	0.1	0.3	0.3	196.0	0.2	0.2	0.2	0.4	81.8	0.3	0.0	0.2	0.0	0.2	24.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.2	126.4	0.0	0.2	0.3	2.3	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.3	0.2	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.6	0.1	14.2	0.0	0.0	0.3	0.9	24.0	0.0	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.1	0.0	3.4	2236.9	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.8	0.0	2.6	23.3	1.7	0.1	0.0	0.0	0.0	475.7	0.1	0.0	2.9	8.0	11.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	7.6	0.0	0.0	2.1	0.0	0.0	1.1	3.6	0.1	0.0	0.1	0.0	0.1	0.1
WWTR1	"DKFZp586I1419, TAZ"	ENSG00000018408	"WW domain containing transcription regulator 1"	Q9GZV5	3	149517235-149736714	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 158.0;Endothelial cells: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6;memory CD8 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 60.9;SK-MEL-30: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007415, CAB017483, CAB068248"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602"	"unprognostic (1.85e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.01e-3)"	25.1	9.9	9.3	16.0	18.6	0.2	20.4	7.7	10.5	27.2	38.5	18.4	15.0	5.6	27.2	17.6	41.2	16.4	25.8	20.6	14.7	9.0	31.0	13.1	29.8	6.2	15.2	5.6	30.9	21.7	10.4	8.5	29.0	20.7	34.6	9.1	29.4	15.8	22.4	12.1	13.4	11.7	81.5	25.8	13.8	20.8	12.0	16.4	0.7	18.2	13.2	7.1	68.4	31.0	0.2	0.1	0.6	0.1	0.1	2.8	0.4	16.8	20.0	10.6	14.2	12.7	22.7	11.2	9.8	14.4	4.4	4.7	11.2	14.3	0.0	60.9	11.0	13.6	10.0	6.9	7.1	4.4	4.7	5.3	0.0	5.2	9.3	7.2	0.0	0.0	12.0	1.8	15.4	6.8	17.0	34.5	0.0	0.0	0.0	15.3	2.2	0.0	0.0	2.4	0.0	25.3	0.0	14.3	0.1	37.8	2.5	0.0	0.1	6.5	4.6	42.0	8.3	7.8	0.3	28.0	8.7	4.2	7.0	19.1	0.2	0.1	0.2	18.7	0.0	22.2	0.4	0.1	0.1	2.6	0.0	0.0	0.0	0.3	2.8	0.0	0.2	0.1	1.3	0.6	0.1	0.0	0.1	1.9	0.4	9.3	18.6	7.7	10.5	14.7	9.0	15.2	5.6	20.7	16.4	59.6	79.0	0.0	158.0	45.9	2.0	42.0	147.7	60.2	128.5	47.1	3.9	10.5	6.6	55.4	14.8	172.1	0.7	0.0	23.5	70.1	58.9	72.2	7.0	20.3	3.7	0.0	0.0	92.7	6.4	3.6	53.5	8.0	28.7	3.6	0.0	10.4	31.6	0.0	118.8	48.8	2.0	58.2	48.4	1.7	0.7	31.0	12.4	5.3	0.0	80.1
COMMD2	HSPC042	ENSG00000114744	"COMM domain containing 2"	Q86X83	3	149738470-149752499	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044190	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA044190: AB_10966289"	"unprognostic (2.17e-1)"	"unprognostic (8.34e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (3.69e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.86e-2)"	14.1	11.2	13.3	9.6	16.1	10.3	20.9	22.0	18.3	17.2	10.9	21.1	4.8	10.6	18.8	10.5	14.6	13.2	10.6	11.2	13.4	12.3	21.9	17.2	17.0	13.2	16.0	12.5	18.1	11.3	14.4	14.2	22.3	18.7	14.0	11.7	14.1	14.6	12.2	9.4	13.3	15.8	17.0	19.6	15.2	10.4	9.6	14.4	20.5	19.3	9.6	14.6	12.4	12.8	8.7	10.0	16.4	14.2	11.7	11.4	9.4	17.0	5.0	16.3	9.4	14.3	16.5	10.8	10.7	11.2	16.6	16.8	8.7	10.6	13.7	12.3	10.4	10.5	10.9	15.5	13.0	19.4	10.1	14.8	12.3	6.9	5.8	15.3	17.6	5.6	12.4	14.4	8.2	14.7	11.2	11.6	8.7	6.0	7.8	11.8	5.3	12.2	8.7	18.0	10.4	6.7	11.3	16.5	18.3	15.7	4.5	7.5	11.5	12.4	10.1	22.9	13.5	18.6	11.7	10.1	9.8	3.9	9.7	12.6	14.1	5.5	22.6	9.5	15.9	4.0	16.4	8.2	13.9	8.0	12.0	11.4	8.7	9.8	9.5	10.0	8.0	10.4	10.9	6.4	11.7	14.2	6.2	7.8	9.4	13.3	16.1	22.0	18.3	13.4	12.3	16.0	12.5	18.7	14.4	59.6	21.7	26.8	30.7	18.5	54.4	14.9	30.6	28.1	51.2	21.0	176.7	44.6	36.5	47.3	2.3	33.1	18.8	23.3	34.6	49.7	36.6	22.9	45.1	14.4	39.4	27.0	23.6	31.9	20.9	3.2	33.6	37.2	32.1	121.8	16.3	33.3	44.0	20.1	33.9	23.3	98.2	51.8	29.9	48.9	49.0	18.9	26.7	32.4	20.0	20.5
ANKUB1	C3orf16	ENSG00000206199	"Ankyrin repeat and ubiquitin domain containing 1"	A6NFN9	3	149761100-149968385	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.2;lung: 11.9;ovary: 10.4"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 100.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.2"	"Cell type enriched"	"Detected in single"	8	"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.8"	"Cell line enhanced"	"Detected in some"		"OE19: 4.6"					"Low region specificity"	"Detected in all"			HPA053749	Uncertain					NA	NA					"HPA053749: AB_2682248"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-9)"	"unprognostic (3.06e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.07e-4)"	0.0	0.0	0.8	0.2	1.2	0.6	0.0	0.0	0.3	2.1	0.0	1.8	0.0	0.2	0.9	0.1	0.0	12.2	0.1	0.0	1.5	1.7	0.0	0.0	11.9	0.1	0.0	0.0	10.4	0.1	0.0	1.1	0.1	5.2	0.1	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.3	0.2	0.3	2.2	0.8	0.0	0.0	0.6	0.1	0.1	0.0	0.4	0.3	4.8	0.4	0.2	0.3	0.0	0.4	0.6	0.6	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.9	0.9	0.8	0.2	0.0	0.2	1.4	0.4	0.4	0.2	0.5	0.3	0.8	1.9	0.4	0.0	0.4	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.4	0.8	0.0	0.3	0.5	0.8	0.4	4.6	0.5	0.9	0.6	0.5	0.0	0.8	0.5	0.1	0.4	0.4	0.0	0.3	0.7	0.2	0.0	0.6	0.5	0.2	0.3	0.5	0.4	0.8	0.4	0.7	0.2	0.5	0.4	0.5	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.4	0.1	0.3	4.8	0.2	0.1	0.3	0.1	0.0	0.8	1.2	0.0	0.3	1.5	1.7	0.0	0.0	5.2	0.8	0.0	1.7	0.0	0.6	0.5	0.0	0.3	0.0	100.4	20.5	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	3.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812708-149962139	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	24.0	21.3	30.6	19.0	39.4	9.8	28.5	19.9	30.4	19.0	17.7	39.9	16.2	14.3	16.8	33.7	16.8	15.9	20.4	16.4	40.5	29.7	35.8	39.2	31.7	19.6	60.9	26.8	18.1	19.6	23.5	14.9	32.4	40.7	25.5	20.3	19.5	36.1	20.9	18.0	18.4	16.3	20.4	102.2	25.5	17.0	12.5	51.2	13.3	32.1	18.8	15.9	21.4	16.5	8.8	15.7	72.4	31.5	7.8	8.5	14.6	19.7	12.3	8.3	9.5	32.8	20.1	13.9	10.9	28.2	10.6	15.8	10.8	28.4	8.2	16.0	13.4	19.5	18.8	11.1	14.0	14.9	10.0	8.1	9.9	5.7	10.5	21.8	10.6	14.1	21.2	26.6	8.9	24.2	12.8	11.7	7.9	3.1	16.7	9.4	11.1	7.6	7.0	5.5	19.1	9.6	5.5	8.9	34.8	20.5	9.2	4.4	12.7	9.0	13.6	35.2	6.8	25.9	11.2	12.2	14.4	5.8	15.2	7.0	28.4	18.7	16.9	12.1	9.9	7.7	12.9	20.3	16.6	6.8	25.2	8.5	8.8	7.6	7.6	15.7	8.3	7.3	7.5	72.4	7.8	31.5	11.2	8.3	14.6	30.6	39.4	19.9	29.2	40.5	29.7	60.9	26.8	40.7	51.2	101.3	59.5	39.3	61.2	65.4	43.7	25.6	38.2	34.8	61.4	45.4	27.5	86.4	36.5	54.3	2.2	62.6	27.6	0.0	62.0	65.2	68.3	63.5	58.9	46.6	172.6	20.6	19.4	77.3	168.9	4.7	70.5	155.4	97.8	42.3	26.4	85.9	48.5	29.6	82.7	59.8	32.2	90.5	50.9	19.7	29.6	63.2	43.8	51.0	24.3	45.5
PFN2		ENSG00000070087	"Profilin 2"	P35080	3	149964904-150050788	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 89.7"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 391.3;Muller glia cells: 211.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035611, CAB037073"	Enhanced					NA	NA					"CAB037073: AB_1079600, HPA035611: AB_10672870"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.42e-4)"	"prognostic unfavorable (2.19e-7)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.99e-1)"	9.2	13.9	59.1	6.7	49.6	1.3	12.8	35.1	89.7	14.5	10.3	22.8	11.6	8.8	21.4	54.1	9.0	33.8	12.5	15.4	64.8	39.9	39.8	8.7	6.6	2.6	36.1	44.6	21.8	11.7	15.7	12.9	7.4	33.6	23.4	10.0	11.7	15.8	23.9	75.0	2.9	11.7	20.5	30.5	5.5	8.5	9.4	15.9	2.3	34.4	9.1	3.7	15.2	6.8	2.7	0.3	1.5	0.3	1.6	9.7	3.1	76.1	26.6	64.0	26.2	14.3	48.9	17.1	24.5	37.2	38.7	45.1	9.9	61.6	0.0	51.8	53.5	67.1	0.8	26.5	34.8	56.3	2.4	15.7	0.8	14.5	28.3	19.1	4.2	1.2	30.7	29.5	38.0	49.6	41.4	22.5	12.4	0.2	3.1	40.1	28.2	3.6	0.2	27.9	0.5	35.2	4.2	47.6	0.3	28.5	38.9	34.8	35.9	12.1	5.8	32.9	46.4	9.3	0.6	16.2	18.5	26.0	30.7	31.5	4.1	0.3	2.0	40.0	0.2	22.5	1.2	0.3	0.5	2.9	0.1	6.0	2.7	6.3	5.3	0.1	1.5	9.7	5.7	1.5	1.6	0.1	0.3	1.6	3.1	59.1	49.6	35.1	87.5	64.8	39.9	36.1	44.6	33.6	15.9	6.0	5.8	3.7	35.9	8.8	49.5	43.7	17.8	87.0	28.4	129.1	17.7	12.7	391.3	40.2	41.5	12.8	18.6	0.0	24.2	9.3	48.3	55.3	8.1	10.6	2.8	25.4	116.4	20.9	1.5	20.9	68.4	4.9	33.7	8.2	29.0	211.2	14.6	22.1	90.9	120.7	30.8	12.9	44.3	20.5	17.4	6.6	8.6	2.2	31.2	22.7
TSC22D2	"KIAA0669, TILZ4a, TILZ4b, TILZ4c"	ENSG00000196428	"TSC22 domain family member 2"	O75157	3	150408335-150466431	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 132.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004926	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA004926: AB_1080401"	"unprognostic (4.65e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.28e-3)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (1.10e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.49e-1)"	22.4	13.5	15.3	18.6	15.2	33.3	13.7	20.5	28.2	15.5	14.3	12.3	10.0	6.7	25.3	16.5	23.0	13.4	25.0	23.7	14.2	13.2	17.3	31.7	15.5	10.6	15.9	14.6	16.4	12.2	11.7	12.8	17.8	14.5	14.0	13.9	12.6	11.3	18.5	17.3	10.9	13.8	28.2	13.7	14.0	15.7	23.9	15.7	19.4	15.3	11.6	10.9	16.7	23.8	4.1	2.9	5.6	6.9	5.0	4.8	2.7	20.4	2.8	9.1	8.7	12.0	5.9	26.4	20.4	7.8	15.1	18.7	11.3	10.3	6.7	11.8	15.3	31.0	8.7	9.1	7.5	30.2	5.3	5.1	7.1	5.2	5.7	13.7	4.3	5.0	10.8	5.8	9.8	14.8	9.1	9.4	3.3	12.2	11.1	10.4	7.2	4.6	5.4	11.7	6.1	5.7	4.9	16.7	7.9	9.6	12.1	5.3	4.7	9.4	5.0	19.9	11.5	4.8	5.8	15.0	10.0	10.4	11.8	18.8	15.0	2.9	9.3	6.8	13.3	5.8	1.2	3.5	4.4	3.0	4.2	4.8	3.0	3.8	3.2	2.8	4.1	2.9	2.9	5.6	5.0	6.9	2.9	1.5	2.7	15.3	15.2	20.5	28.2	14.2	13.2	15.9	14.6	14.5	15.7	59.6	31.5	11.2	64.3	132.2	16.9	39.2	20.4	6.7	18.2	12.2	27.5	21.8	14.9	13.1	15.0	26.3	47.3	0.0	12.1	24.7	49.4	47.1	65.6	35.1	16.5	15.9	30.3	25.8	19.9	21.3	17.3	22.5	40.5	19.8	28.2	31.8	19.0	38.6	14.2	8.1	19.8	12.9	46.4	36.3	24.4	94.6	45.9	15.2	23.5	72.6
SERP1	"FLJ43424, RAMP4"	ENSG00000120742	"Stress associated endoplasmic reticulum protein 1"	Q9Y6X1	3	150541994-150603228	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 122.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (8.81e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.78e-1)"	24.5	34.2	23.1	22.4	22.6	25.4	38.0	12.5	18.4	38.6	26.7	15.6	59.9	21.4	20.2	56.7	29.6	28.1	25.1	15.1	17.4	16.5	27.7	93.6	38.1	47.8	17.5	15.6	31.5	137.6	21.1	33.0	33.2	14.7	32.9	23.8	15.6	103.1	58.9	9.7	18.1	33.5	15.6	18.9	42.9	38.4	17.8	16.0	38.4	51.3	17.3	33.6	31.2	29.8	49.6	67.9	76.4	89.1	36.8	68.2	90.5	33.1	7.1	10.9	8.2	16.0	18.8	25.0	23.7	15.3	13.0	15.3	18.5	14.6	26.8	45.8	17.1	10.8	16.2	17.6	12.2	17.3	16.5	15.2	28.4	6.2	18.7	31.3	25.6	19.1	11.2	22.0	7.5	37.7	14.2	15.1	18.3	13.8	37.9	11.0	14.3	21.6	22.3	20.4	21.0	18.5	28.2	8.3	83.3	15.7	10.7	18.8	16.0	9.1	20.1	35.9	13.7	17.7	25.1	14.6	6.2	11.4	13.3	18.2	122.2	34.9	36.0	11.3	25.2	5.7	62.2	88.3	76.4	52.9	81.8	68.2	49.6	56.9	53.3	67.5	47.9	56.7	52.1	64.4	36.8	89.1	67.9	54.3	90.5	23.1	22.6	12.5	18.4	17.4	16.5	17.5	15.6	14.7	16.0	62.5	139.6	390.1	556.3	477.8	73.3	37.8	160.5	156.6	144.5	164.0	55.0	242.2	310.0	207.9	287.5	159.5	300.1	0.0	263.4	394.7	208.5	631.9	219.9	431.3	345.7	39.7	243.7	217.3	540.1	505.4	203.4	389.3	330.7	232.6	361.6	114.7	332.1	414.1	178.9	241.5	64.5	109.9	173.1	132.7	83.4	518.0	790.1	279.9	304.6	899.5
EIF2A	EIF-2A	ENSG00000144895	"Eukaryotic translation initiation factor 2A"	Q9BY44	3	150546678-150584242	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036256	Approved		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA036256: AB_10611961"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.05e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (6.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-1)"	33.5	23.7	12.6	21.4	22.8	27.2	34.3	38.3	23.8	35.1	29.4	12.6	17.3	23.1	31.5	19.9	37.2	20.6	19.0	24.9	11.3	11.9	27.0	44.5	24.7	32.8	16.5	11.7	35.6	39.4	22.6	36.4	26.2	22.7	32.9	23.8	15.4	29.8	23.9	53.3	26.8	33.1	25.0	16.9	28.9	26.5	16.3	17.9	38.5	41.8	33.8	25.8	44.0	26.1	17.0	27.7	7.9	24.6	20.5	26.9	19.0	38.5	14.0	19.7	20.7	25.3	50.4	27.2	23.8	33.0	30.5	33.0	38.8	42.6	50.9	36.5	28.3	39.0	31.3	32.6	33.0	43.5	19.2	21.9	29.8	16.9	30.0	24.3	37.2	28.5	33.6	37.6	22.4	50.1	44.5	37.8	26.3	24.5	30.3	24.6	27.1	27.0	19.7	27.9	38.8	22.2	23.8	25.8	59.0	31.9	24.0	25.0	26.8	14.3	22.9	37.2	23.2	33.6	34.6	22.1	19.3	18.4	27.3	45.7	52.6	27.6	46.8	24.5	32.6	9.6	7.9	22.6	4.7	14.9	23.5	23.3	17.0	21.2	18.2	27.7	14.9	26.9	21.0	1.8	20.5	24.6	13.1	17.3	19.0	12.6	22.8	38.3	23.8	11.3	11.9	16.5	11.7	22.7	17.9	32.8	55.5	71.7	137.7	124.4	27.0	97.7	48.4	41.5	48.9	33.2	25.5	72.1	116.0	60.9	13.8	61.2	56.4	0.0	94.1	85.0	60.9	65.4	74.9	27.6	57.0	22.3	54.5	46.1	95.5	5.0	57.0	72.0	65.8	64.9	76.1	26.1	62.8	40.3	53.0	90.1	30.8	77.6	69.4	29.9	39.0	107.4	100.6	76.1	82.2	109.1
SELENOT	SELT	ENSG00000198843	"Selenoprotein T"	P62341	3	150602875-150630445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 180.2;Extravillous trophoblasts: 191.0;Hofbauer cells: 214.0;monocytes: 215.6;Syncytiotrophoblasts: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039780	Approved					NA	NA					"HPA039780: AB_10805594"	"unprognostic (1.13e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.91e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	29.7	52.6	39.9	32.1	44.1	54.5	31.0	33.9	48.2	29.9	29.7	37.7	26.7	29.7	29.2	41.8	30.3	31.2	23.5	32.7	41.6	47.4	47.0	52.5	31.1	44.5	41.3	28.2	27.7	34.2	30.6	46.6	50.8	48.0	31.8	36.7	30.2	31.5	33.0	30.5	20.0	38.5	33.4	50.0	49.8	28.5	23.6	31.9	32.3	45.7	23.0	43.2	34.3	23.1	32.1	34.0	54.5	43.2	26.5	42.3	71.0	48.7	20.3	13.1	11.7	20.2	19.9	24.8	38.9	28.8	27.0	18.5	32.1	28.8	27.7	39.8	28.8	23.9	16.9	20.4	24.4	41.6	23.1	17.0	28.8	12.4	15.0	22.2	16.9	21.9	17.1	19.6	24.1	21.0	20.1	29.1	12.5	6.6	81.8	39.3	30.0	22.4	9.8	14.0	29.4	21.8	16.1	16.5	46.1	23.3	29.3	14.0	8.6	23.3	14.7	15.4	17.1	28.0	20.3	27.3	14.7	9.2	26.4	35.7	57.3	29.4	38.3	20.0	30.8	12.5	41.9	43.2	36.4	38.5	35.0	42.3	32.1	32.0	35.2	34.0	26.7	25.3	32.0	54.5	26.5	37.7	24.1	33.5	71.0	39.9	44.1	33.9	48.2	41.6	47.4	41.3	28.2	48.0	31.9	56.6	58.2	0.0	0.0	0.0	0.0	0.0	0.0	60.2	53.4	102.9	0.0	180.2	82.9	154.9	0.0	0.0	0.0	0.0	118.0	191.0	0.0	0.0	41.8	0.0	214.0	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	215.6	0.0	0.0	158.1	0.0	0.0	154.8	0.0	0.0	0.0	0.0	0.0	0.0	409.2	0.0	0.0	0.0
ERICH6	"C3orf44, ERICH6A, FAM194A, MGC39662"	ENSG00000163645	"Glutamate rich 6"	Q7L0X2	3	150659885-150703971	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 35.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 72.0;Late spermatids: 42.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 3.7;SH-SY5Y: 3.9;U-266/70: 4.1;U-266/84: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA048373	Enhanced					NA	NA					"HPA048373: AB_2680375"	"unprognostic (7.38e-2)"	"unprognostic (3.89e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-2)"	0.4	0.4	0.4	0.2	1.8	0.3	0.3	0.4	1.5	0.3	0.3	0.4	0.1	0.6	0.5	1.9	0.3	0.4	0.8	0.4	0.7	0.4	0.8	0.3	0.3	0.6	0.3	0.6	0.5	0.5	0.0	3.9	0.4	0.5	0.5	0.1	0.3	0.3	0.5	0.2	0.3	0.4	0.4	0.3	0.4	0.4	35.4	0.6	0.0	1.3	0.0	0.2	0.4	0.3	2.6	3.5	0.1	0.1	5.9	8.0	2.0	0.2	3.7	0.2	1.5	0.0	0.0	0.0	0.3	0.0	0.3	0.6	1.7	1.5	0.0	2.2	0.0	1.4	0.2	0.0	0.0	0.2	1.6	1.2	1.0	0.6	0.1	0.0	0.0	0.1	0.2	0.0	1.0	0.0	0.0	0.0	1.2	0.0	2.5	0.0	0.6	0.9	0.0	0.9	0.0	0.0	1.0	0.9	0.0	0.1	0.8	1.8	3.9	0.0	0.3	0.0	0.0	0.9	1.3	0.1	0.6	1.4	1.5	0.2	4.1	6.3	0.8	0.7	0.1	0.0	0.0	0.1	0.1	4.1	0.0	8.0	2.6	2.6	3.1	0.1	2.3	3.5	3.6	0.1	5.9	0.1	3.5	2.5	2.0	0.4	1.8	0.4	1.5	0.7	0.4	0.3	0.6	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	42.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	9.1	1.0	0.0	0.0	0.0	0.0	0.0
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741127-150763477	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 325.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	9.6	48.0	7.6	11.8	10.3	22.7	23.5	10.9	17.2	30.0	10.5	8.4	20.3	7.9	23.5	13.9	28.8	14.9	11.0	10.7	7.2	7.3	8.4	35.5	11.8	19.1	9.9	7.5	19.0	14.6	6.4	8.1	31.4	7.9	18.8	9.2	8.3	11.2	21.7	8.3	19.3	9.5	17.4	9.4	16.9	12.0	8.7	8.6	23.6	11.4	10.6	25.1	22.7	25.6	3.0	3.1	10.0	2.7	1.6	3.6	1.1	16.9	4.2	3.3	6.6	11.3	8.5	13.3	7.1	8.2	8.6	10.4	8.6	7.6	9.4	10.4	7.3	7.2	10.5	8.8	6.3	8.1	7.9	6.3	18.5	5.1	28.4	16.2	10.2	5.5	7.7	14.7	5.1	11.7	6.8	6.6	18.6	4.6	37.4	5.3	20.3	18.6	5.2	10.7	15.8	8.4	13.7	7.1	33.9	5.4	5.9	12.7	6.0	5.3	5.0	12.5	7.8	33.4	15.4	4.6	5.9	5.3	12.8	9.5	44.5	16.9	13.2	5.6	14.7	3.0	9.5	2.7	10.0	2.1	1.5	3.2	2.5	3.6	3.2	2.4	3.0	1.9	1.9	5.9	1.6	1.5	3.1	2.0	1.1	7.6	10.3	10.9	17.2	7.2	7.3	9.9	7.5	7.9	8.6	6.0	3.7	47.8	71.4	130.4	40.0	14.9	15.3	17.4	7.9	21.0	35.3	144.9	11.6	5.6	2.0	9.2	26.2	46.7	5.7	18.3	47.9	44.4	10.3	47.4	28.4	33.4	36.8	16.5	64.5	1.5	40.9	27.9	42.2	16.2	31.8	33.5	8.9	10.5	29.0	13.0	2.2	12.9	39.1	0.5	6.6	124.5	325.6	52.4	29.9	65.9
MINDY4B	"C3orf76, FAM188B2"	ENSG00000214237	"MINDY family member 4B"		3	150871045-150905439	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 7.5;endometrium 1: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;T-47d: 3.8"	"Low region specificity"	"Detected in single"													NA	NA						"unprognostic (1.91e-4)"	"unprognostic (6.32e-3)"	"unprognostic (6.09e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.07e-3)"		"unprognostic (3.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.16e-1)"	0.0	0.9	0.0	0.0	7.5	0.2	0.0	0.0	0.6	0.0	0.0			0.2	2.8	0.0	0.4	0.7	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.1		0.4	0.0	0.0	0.0	0.4		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9			0.0		0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLRN1	"RP61, USH3, USH3A"	ENSG00000163646	"Clarin 1"	P58418	3	150926163-150972999	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 11.2;retina: 16.2"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 150.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	32	"NTERA-2: 8.9"															NA	NA						"unprognostic (1.00e-3)"				"unprognostic (1.26e-1)"					"unprognostic (5.54e-1)"					"unprognostic (9.68e-2)"			0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.1	0.0	1.6	0.0	2.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.8	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	150.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MED12L	"KIAA1635, TNRC11L, TRALP, TRALPUSH"	ENSG00000144893	"Mediator complex subunit 12 like"	Q86YW9	3	151085697-151437072	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 14.2;Horizontal cells: 31.8;Muller glia cells: 35.7;Syncytiotrophoblasts: 22.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 15.8;HEL: 17.1;JURKAT: 10.9;MOLT-4: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036807	Enhanced		Approved	Nucleoli		NA	NA			Nucleoli		"HPA036807: AB_10670242"	"unprognostic (1.01e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.12e-2)"	"unprognostic (8.14e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	2.8	5.2	6.4	1.2	11.1	5.5	0.5	4.9	23.1	1.6	0.6	4.4	0.0	2.2	0.9	3.0	0.9	0.6	1.8	1.7	5.5	5.1	0.4	0.4	0.7	4.4	5.8	2.6	1.0	1.7	0.5	5.4	2.0	3.9	1.2	0.3	1.9	1.7	0.7	0.5	0.4	1.6	0.6	6.1	2.1	0.8	6.1	5.7	0.6	1.0	0.0	1.5	1.3	0.8	1.0	5.1	3.1	2.8	0.1	0.4	0.8	0.7	0.3	2.5	0.2	0.1	0.0	15.8	0.0	0.2	0.6	0.7	0.8	0.3	0.0	0.2	0.1	1.8	0.1	3.2	0.2	0.7	0.0	1.5	17.1	0.1	0.1	0.0	0.5	6.1	0.0	0.1	0.1	0.1	0.1	0.0	10.9	0.0	2.6	0.0	2.5	7.9	0.0	2.9	0.1	0.5	0.1	0.9	0.4	0.2	2.5	4.2	0.6	0.4	0.2	0.0	4.6	0.8	0.1	0.0	0.0	1.9	0.0	1.3	5.0	0.0	6.1	0.2	1.5	0.9	3.1	0.3	0.0	0.1	2.8	0.4	0.1	0.1	0.2	1.6	1.0	0.0	0.0	0.3	0.1	0.8	5.1	0.0	0.8	6.4	11.1	4.9	6.9	5.5	5.1	5.8	2.6	3.9	5.7	0.0	0.0	0.0	1.2	1.0	9.0	1.2	0.0	1.4	2.3	1.8	3.9	14.2	0.0	0.1	9.9	0.1	0.0	0.0	0.5	0.6	0.6	1.0	0.0	0.0	1.6	31.8	0.0	0.6	1.0	4.5	0.9	0.9	0.0	1.8	0.0	35.7	0.2	0.0	0.4	0.1	1.8	0.0	0.1	7.5	1.5	0.1	22.5	0.0	0.0	0.1
GPR171	H963	ENSG00000174946	"G protein-coupled receptor 171"	O14626	3	151197832-151203201	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.2;intestine: 19.5;lymphoid tissue: 33.0"	"Cell type enhanced"	"Detected in many"	26	"Horizontal cells: 20.6;monocytes: 22.6;T-cells: 87.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 45.2"	"Lineage enriched"	"Detected in many"	18	"T-cells: 45.2"	"Cell line enriched"	"Detected in single"	26	"U-266/70: 25.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067323	Supported					NA	NA					"HPA067323: "	"unprognostic (6.82e-6)"	"unprognostic (4.90e-3)"	"unprognostic (7.10e-2)"	"unprognostic (6.85e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.04e-3)"	"unprognostic (4.19e-4)"	"unprognostic (6.09e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	4.1	0.9	0.4	15.1	0.4	0.4	1.6	0.3	0.3	4.0	6.8	0.3	0.6	3.5	1.4	1.6	2.7	3.9	4.6	1.3	0.4	0.4	4.3	2.7	10.7	33.0	0.7	0.5	1.9	1.0	0.0	0.7	0.8	1.5	2.2	3.8	1.7	2.4	1.2	1.0	1.1	19.5	1.1	2.7	20.7	4.0	1.0	0.5	19.9	2.2	1.8	8.5	7.0	2.4	0.1	0.8	1.0	0.1	2.5	45.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	11.6	0.0	45.2	0.0	16.2	21.5	0.8	0.1	9.9	8.4	0.3	2.5	0.1	0.7	8.0	3.4	0.4	0.4	0.3	0.3	0.4	0.4	0.7	0.5	1.5	0.5	0.0	2.1	2.4	0.3	1.0	3.6	0.3	0.0	0.0	2.3	0.0	2.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	2.3	1.1	0.1	20.6	0.0	3.1	3.1	0.0	0.0	6.9	0.0	22.6	0.0	5.6	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.9	0.1	0.5	0.6	87.7	0.0	0.3
P2RY14	"GPR105, KIAA0001"	ENSG00000174944	"Purinergic receptor P2Y14"	Q15391	3	151212117-151278467	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 54.9"	"Group enriched"	"Detected in some"	4	"granulocytes: 45.0;Macrophages: 18.5;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"eosinophil: 54.9;plasmacytoid DC: 24.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 24.4;granulocytes: 54.9"	"Cell line enriched"	"Detected in single"	73	"HMC-1: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022646	Uncertain					NA	NA					"CAB022646: "	"unprognostic (9.78e-2)"	"unprognostic (7.47e-4)"	"unprognostic (3.89e-2)"	"unprognostic (4.52e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.57e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (3.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.58e-2)"	14.3	0.9	3.9	9.0	6.9	0.5	6.1	1.9	3.8	5.2	17.6	1.3	1.3	5.7	7.2	9.4	17.6	1.2	4.4	4.4	4.3	3.0	2.1	0.7	8.5	7.1	5.0	2.8	1.8	0.9	2.2	4.7	25.9	3.7	10.4	8.3	11.2	2.1	1.1	4.2	2.8	16.3	15.8	2.3	4.4	17.2	2.1	4.2	4.7	3.6	8.9	5.3	21.4	1.7	4.9	24.4	54.9	0.1	2.8	5.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.1	54.9	0.2	0.0	5.0	0.8	0.1	0.5	3.3	4.9	0.0	0.0	2.2	2.8	0.0	24.4	0.2	0.5	3.9	6.9	1.9	3.8	4.3	3.0	5.0	2.8	3.7	4.2	3.0	0.3	6.7	0.0	2.1	1.7	1.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.3	2.8	0.0	45.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	18.5	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	25.8	2.7	0.0	0.1	1.5	0.2	2.9	0.0	0.1
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No			"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.2	0.0	0.0	11.5	0.0	0.0	0.0	0.1	25.2	0.0	33.5	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	44.8	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	1.1	13.2	0.0	0.0	5.6	0.1	0.0	0.9	0.1	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	127.1	52.7	0.0	0.0	0.0	4.0	20.5	3.5	0.0	46.3	0.0	1.3	0.1	0.2	0.0	0.0	0.6	10.3	2.1	36.4	1.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	59.6	171.4	0.0	0.0	178.7
P2RY13	"FKSG77, GPR86, GPR94, P2Y13"	ENSG00000181631	"Purinergic receptor P2Y13"	Q9BPV8	3	151326312-151329548	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 88.4;lymphoid tissue: 44.1"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 83.1;Macrophages: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 88.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 88.4;monocytes: 26.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;U-937: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049047	Enhanced					NA	NA					"HPA049047: AB_2680611"	"unprognostic (1.09e-3)"	"unprognostic (7.51e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (7.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.46e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.78e-1)"	4.0	2.6	5.1	13.4	6.1	15.1	2.7	1.7	8.2	1.7	2.8	13.8	0.1	3.0	1.5	2.2	2.1	2.1	2.5	1.7	4.9	4.7	1.8	5.1	5.0	35.1	7.1	3.4	1.3	2.1	1.0	1.7	3.2	8.1	2.1	4.2	2.0	1.9	2.1	1.3	1.6	7.4	3.5	8.2	44.1	1.8	1.2	5.1	2.0	1.5	1.1	5.5	3.8	1.5	0.2	10.1	88.4	26.1	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.2	0.2	0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	23.6	20.3	0.0	23.5	0.0	0.2	0.0	0.0	10.1	0.0	0.0	0.0	88.4	0.0	26.1	0.1	0.0	10.2	5.1	6.1	1.7	8.2	4.9	4.7	7.1	3.4	8.1	5.1	0.0	9.6	3.2	0.1	0.0	0.8	0.4	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	6.6	1.6	0.0	0.6	83.1	0.0	0.0	40.1	0.0	6.4	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
P2RY12	"HORK3, P2Y12, SP1999"	ENSG00000169313	"Purinergic receptor P2Y12"	Q9H244	3	151337380-151384812	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.0"	"Cell type enhanced"	"Detected in some"	27	"granulocytes: 1.1;Kupffer cells: 2.9"	"Cancer enriched"	"Detected in many"	14	"glioma: 17.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 12.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 5.0;monocytes: 12.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.7;JURKAT: 1.1;Karpas-707: 1.1;REH: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013796, HPA014518"	Enhanced					NA	NA					"HPA013796: AB_1854884, HPA014518: AB_2669027"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.64e-4)"	"unprognostic (4.84e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.04e-1)"	7.4	4.3	15.3	2.2	14.2	0.8	4.3	2.3	46.0	2.0	2.0	13.4	0.0	1.6	1.1	1.1	1.7	3.2	2.7	1.8	14.3	11.6	1.1	2.7	2.9	9.2	21.1	10.0	2.2	0.9	2.0	0.9	2.7	16.8	1.4	1.8	0.2	3.1	2.9	0.6	0.8	3.1	2.1	24.9	5.3	1.5	0.6	18.8	0.0	0.9	0.0	8.6	1.9	0.9	0.6	5.0	0.3	12.4	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.3	0.3	0.0	2.9	0.0	0.0	12.4	0.0	0.6	0.0	0.0	5.0	0.6	0.0	0.0	0.3	0.0	3.3	0.5	0.0	2.0	15.3	14.2	2.3	14.6	14.3	11.6	21.1	10.0	16.8	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGSF10	"CMF608, FLJ25972"	ENSG00000152580	"Immunoglobulin superfamily member 10"	Q6WRI0	3	151425384-151458709	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 17.8"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 118.2;Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 1.5"	"Group enriched"	"Detected in some"	5	"HeLa: 25.6;HL-60: 12.4;REH: 9.2;RPMI-8226: 29.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA012655, HPA012921"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		280000	Vesicles		"HPA012655: , HPA012921: AB_1851526"	"unprognostic (1.78e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.47e-7)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.84e-4)"	"unprognostic (9.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.52e-4)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.57e-4)"	2.5	2.9	0.6	0.1	0.4	0.0	4.5	0.0	0.2	0.3	0.5			0.0	0.7	0.8	2.0	3.4	7.3	4.1	0.7	0.8	0.0	0.0	6.7	0.5	0.3		17.8	0.1	0.7	1.5	0.0		0.0	0.6		3.7	0.0	0.0	1.2	0.7	0.7	0.3	0.2	0.4	0.3			1.3		1.6	1.5	0.1	0.2	1.5	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.2	4.0	25.6	0.0	0.9	12.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	29.6	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	3.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0											0.0	0.3	0.5	1.2	2.2	14.0	1.1	2.5	13.4	10.3	1.8	3.9	18.9	0.0	0.2	118.2	0.7	0.0	0.0	1.2	2.6	5.4	0.9	0.0	0.0	1.2	57.2	5.8	0.0	0.3	22.0	6.4	1.6	3.3	1.0	0.4	23.5	0.3	0.0	1.1	0.3	2.2	0.0	0.9	6.7	2.4	2.0	25.9	0.0	0.0	0.0
AADACL2	MGC72001	ENSG00000197953	"Arylacetamide deacetylase like 2"	Q6P093	3	151733916-151761339	"Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"placenta: 8.6;skin 1: 26.1;tongue: 22.2"	"Cell type enriched"	"Detected in some"	8	"Suprabasal keratinocytes: 26.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"hTCEpi: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA							"unprognostic (2.20e-2)"				"unprognostic (3.10e-3)"		"unprognostic (2.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"				"unprognostic (3.00e-1)"			"unprognostic (2.91e-4)"	1.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.8	0.0	0.7	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.4	0.0	0.0	0.4	0.0	0.2	26.1	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	22.2	1.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.1	0.0	0.0	0.0
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 610.4"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7"	"Not detected"	"Not detected"							HPA002911	Approved					NA	NA					"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.5	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.4	0.0	0.1	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0.0	2.3	0.2	1.9	0.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	2.4	1.4	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	11.0	0.0	0.0	0.2	0.0	1.1	58.6	4.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.2	0.0	0.0	610.4	0.2	0.0	0.0	3.7	10.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.0	0.1
SUCNR1	GPR91	ENSG00000198829	"Succinate receptor 1"	Q9BXA5	3	151873643-151884619	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 63.1;lymphoid tissue: 23.3"	"Group enriched"	"Detected in some"	5	"Distal tubular cells: 16.6;Hofbauer cells: 18.9;Kupffer cells: 22.2;Macrophages: 11.8;Proximal tubular cells: 31.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.0;intermediate monocyte: 1.0;non-classical monocyte: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.2;granulocytes: 2.0;monocytes: 1.7"	"Group enriched"	"Detected in some"	5	"HEL: 28.0;NB-4: 16.2;U-937: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022745	Uncertain					NA	NA					"CAB022745: "	"unprognostic (1.54e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.58e-1)"	13.7	1.6	0.6	0.7	0.9	4.7	1.6	0.2	1.2	0.3	0.5	0.7	0.0	0.7	0.4	0.6	0.5	0.3	0.2	2.8	0.4	0.4	63.1	3.6	2.2	3.3	0.6	0.1	0.7	0.4	4.2	0.3	0.2	0.8	0.5	0.5	0.1	1.3	0.0	0.3	0.7	0.5	0.3	0.5	23.3	6.7	0.4	0.0	1.3	14.6	0.8	0.3	0.7	0.3	0.0	2.2	2.0	1.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	4.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.1	2.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.7	2.2	0.0	0.2	0.6	0.9	0.2	1.2	0.4	0.4	0.6	0.1	0.8	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.4	0.0	2.7	0.0	3.5	0.0	0.0	16.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.2	18.9	0.0	0.0	0.0	22.2	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: AB_2674461"	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	55.9	17.5	14.5	50.8	17.0	28.5	43.8	11.8	14.5	46.4	44.0	10.8	18.0	15.2	41.1	23.6	33.3	22.3	27.5	29.9	14.3	12.9	18.6	16.5	39.6	45.6	18.0	9.1	30.5	12.5	12.5	16.0	10.4	12.6	30.5	26.0	12.7	18.3	25.1	87.6	22.8	29.5	59.8	22.1	39.6	23.1	14.6	17.4	71.9	18.5	34.5	46.0	64.4	29.3	25.0	30.7	38.2	27.4	33.6	39.9	40.2	27.8	23.0	3.7	8.4	29.6	30.6	2.8	35.0	28.4	23.1	19.4	10.1	16.4	28.7	17.9	49.0	7.2	12.8	6.9	20.2	34.3	22.3	9.4	31.3	11.7	4.7	16.5	37.4	22.9	14.2	11.0	26.6	20.8	17.8	47.4	11.6	15.9	39.2	22.4	9.6	34.8	13.7	1.5	8.2	18.4	35.7	11.6	35.9	11.7	14.1	3.0	3.4	15.2	8.3	14.8	1.4	11.5	57.1	39.8	31.7	12.2	21.0	30.1	41.0	23.4	33.0	18.5	46.8	17.0	32.6	22.7	38.2	37.2	27.4	39.9	25.0	30.5	30.9	30.7	24.1	38.9	33.3	35.4	33.6	22.8	11.1	27.0	40.2	14.5	17.0	11.8	14.5	14.3	12.9	18.0	9.1	12.6	17.4	140.0	156.6	98.0	41.0	189.8	25.7	160.6	45.9	78.9	139.9	36.6	60.9	20.0	18.3	32.5	2.1	146.2	138.0	70.0	54.4	8.3	91.5	50.3	155.2	83.5	55.2	30.2	45.4	75.5	193.7	5.9	82.8	171.1	97.8	129.0	61.7	16.0	47.0	71.9	67.1	29.9	84.3	97.0	113.3	4.9	10.9	213.0	12.4	228.4	54.7	46.0
P2RY1	"P2Y1, SARCC"	ENSG00000169860	"Purinergic receptor P2Y1"	P47900	3	152834693-152841439	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;placenta: 24.7"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 22.9;Kupffer cells: 17.8;Muller glia cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 29.1"	"Group enriched"	"Detected in some"	5	"basophil: 7.0;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.0;monocytes: 4.1"	"Cell line enriched"	"Detected in some"	5	"HEL: 30.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015577	Enhanced					NA	NA					"HPA015577: AB_1854882"	"unprognostic (3.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (1.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	2.9	1.7	4.7	5.9	29.1	4.8	2.0	3.1	6.3	6.7	8.7	4.9	0.6	3.3	8.5	0.8	19.4	2.3	2.2	2.9	8.4	2.3	1.1	1.6	10.4	2.1	1.8	6.1	9.6	3.6	0.5	2.3	24.7	2.4	8.0	6.9	2.6	5.6	2.6	7.1	8.8	6.1	4.8	3.8	2.4	1.7	1.3	3.3	3.0	1.5	9.9	3.5	3.0	9.5	0.0	0.9	7.0	4.1	0.0	0.0	0.2	0.0	0.5	4.8	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.4	6.0	0.0	0.0	0.5	0.0	0.7	1.0	2.6	0.8	0.2	0.0	2.3	30.3	0.0	0.0	0.0	3.5	2.8	0.4	6.0	0.0	0.3	2.4	0.0	1.0	0.9	0.0	0.0	0.0	0.5	0.1	4.4	0.0	3.7	0.0	0.1	0.8	0.0	2.0	0.8	0.0	0.0	0.0	0.6	1.1	0.0	1.6	0.0	0.5	1.2	0.0	2.5	0.0	0.0	0.0	3.1	0.0	3.5	7.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.1	0.9	0.0	0.2	4.7	29.1	3.1	6.3	8.4	2.3	1.8	6.1	2.4	3.3	0.0	0.3	0.8	6.8	1.6	8.2	6.3	22.9	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.6	10.5	0.0	0.0	0.2	2.7	6.6	9.3	0.2	6.2	0.0	0.0	12.9	17.8	0.0	13.8	6.3	0.0	0.0	8.4	16.6	1.1	10.5	5.6	0.0	1.0	0.0	0.5	0.5	0.4	1.8	0.1	0.0	6.6	4.2
RAP2B		ENSG00000181467	"RAP2B, member of RAS oncogene family"	P61225	3	153162270-153170620	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 171.5;Suprabasal keratinocytes: 170.6;Urothelial cells: 286.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA		2400000				"unprognostic (2.44e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	13.4	5.3	8.2	9.9	8.1	21.9	10.2	2.1	10.4	12.0	8.8	5.4	2.5	4.8	7.3	8.6	26.5	5.8	11.2	6.6	9.5	6.0	5.8	7.7	13.1	22.8	4.6	5.9	8.9	7.8	3.1	3.1	14.5	3.8	8.1	6.7	11.1	9.7	4.7	4.2	8.6	6.7	6.5	6.8	16.6	14.6	4.2	3.7	16.2	4.6	9.9	14.8	10.1	12.4	4.9	9.2	15.5	19.8	9.7	14.7	7.7	18.6	6.9	3.4	4.9	7.4	6.7	9.3	4.8	7.2	3.3	3.7	3.6	11.0	1.3	5.4	4.4	5.4	18.8	2.6	8.7	3.9	7.5	5.0	7.6	3.6	6.6	3.8	7.0	12.0	7.2	7.5	4.9	9.3	5.8	7.9	3.6	4.3	16.0	6.2	7.4	6.5	10.1	7.0	3.9	10.7	5.7	9.2	16.9	5.1	18.2	0.0	1.8	5.0	4.6	14.7	6.3	3.4	3.7	15.8	5.1	8.0	5.5	12.0	10.4	1.7	3.4	6.8	7.9	5.2	15.5	13.1	5.0	14.7	19.8	11.2	4.9	12.8	12.8	9.2	3.1	7.4	11.4	5.1	9.7	18.3	6.6	9.0	7.7	8.2	8.1	2.1	10.4	9.5	6.0	4.6	5.9	3.8	3.7	11.9	16.8	24.9	111.7	171.5	3.9	3.9	20.4	9.4	17.0	15.7	2.0	13.9	3.3	22.9	0.4	14.3	61.1	0.0	18.9	45.9	40.4	85.7	26.5	11.9	112.5	3.2	46.5	20.9	130.9	1.3	17.8	75.3	33.7	102.8	31.8	6.8	46.0	17.5	13.8	8.6	6.2	0.0	16.2	1.8	5.5	170.6	12.7	40.2	11.0	286.3
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 315.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 10.0;U-251 MG: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: AB_2680671"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	11.2	4.0	9.1	5.8	8.7	1.0	9.8	5.6	17.8	9.2	20.0	6.5	3.3	10.3	5.9	3.1	12.0	8.3	17.6	4.1	8.7	4.6	3.1	22.0	18.6	1.0	5.4	6.3	5.3	27.1	13.9	2.9	4.7	12.2	5.3	3.7	4.4	4.1	5.5	1.5	7.0	11.5	12.7	9.7	1.6	12.3	7.4	5.5	0.0	4.1	2.5	2.0	7.4	11.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	5.3	3.1	6.1	4.2	2.7	0.4	0.1	0.3	0.0	1.6	1.8	2.5	0.4	2.5	0.4	0.1	2.8	6.3	3.1	1.5	2.8	0.0	8.1	0.0	2.3	0.8	2.5	0.8	0.1	0.9	0.1	1.9	0.3	0.9	0.1	2.6	0.0	0.0	1.0	6.2	1.1	0.1	3.9	1.2	2.7	0.0	10.0	0.0	0.5	3.5	2.3	0.7	0.7	8.8	1.3	3.3	5.4	0.4	0.0	0.9	4.0	0.0	18.1	2.6	0.4	0.0	1.6	0.0	6.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.1	8.7	5.6	10.1	8.7	4.6	5.4	6.3	12.2	5.5	315.6	29.8	0.9	7.9	17.3	9.4	1.2	20.4	21.4	17.0	3.5	3.9	1.4	0.0	1.9	9.1	3.0	2.6	0.0	2.2	1.0	8.1	6.7	4.7	44.5	0.6	4.8	0.0	8.6	2.8	1.7	9.8	0.9	3.3	1.8	4.5	70.3	1.7	2.9	17.7	0.0	50.2	0.0	4.2	2.9	32.4	20.7	5.1	5.7	1.7	5.3
DHX36	"DDX36, KIAA1488, MLEL1"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324497	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 381.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035399	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	16.3	14.0	11.5	14.1	27.5	12.6	15.7	19.0	21.3	17.9	14.7	10.3	12.4	10.7	20.4	10.6	14.5	14.3	13.7	23.9	13.4	12.7	16.7	17.1	14.6	17.0	12.2	15.0	20.0	13.7	34.0	36.2	16.4	20.1	15.7	12.2	9.3	15.5	20.5	53.4	14.7	14.3	15.1	13.7	18.9	13.4	28.3	11.3	24.3	20.4	13.4	17.1	20.7	15.6	6.3	5.9	3.1	5.7	4.8	6.9	1.1	27.0	18.5	25.1	14.4	11.9	16.7	12.5	17.7	17.8	20.2	24.1	18.8	21.8	26.2	28.7	15.5	18.6	17.5	23.6	15.0	31.8	25.1	15.6	19.0	15.9	10.7	20.2	26.4	16.7	18.8	12.7	21.6	26.6	11.0	17.3	16.3	17.8	15.1	18.6	13.2	21.8	5.8	33.4	14.4	17.8	22.7	21.2	37.8	14.5	19.2	23.6	25.1	18.4	19.6	25.7	17.9	20.1	13.5	19.5	21.2	13.4	19.8	35.3	28.4	18.3	37.9	17.1	13.9	22.4	1.9	2.7	3.1	6.9	2.8	4.4	4.7	6.1	4.7	2.3	6.3	5.8	6.0	1.1	4.8	5.7	5.9	5.4	1.1	11.5	27.5	19.0	21.3	13.4	12.7	12.2	15.0	20.1	11.3	53.6	78.8	70.6	103.5	82.5	148.4	52.9	61.1	50.9	96.7	57.6	121.7	106.5	33.2	60.5	381.7	74.4	34.4	23.3	54.3	56.1	68.1	82.0	99.5	71.8	54.2	146.2	88.2	62.6	59.6	255.9	102.4	80.8	50.6	65.9	47.0	93.9	58.1	42.4	114.2	44.2	123.0	77.6	80.4	174.2	142.0	72.6	309.5	99.1	47.7	105.0
GPR149	"IEDA, PGR10, R35"	ENSG00000174948	"G protein-coupled receptor 149"	Q86SP6	3	154337672-154429715	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7"	"Cell type enhanced"	"Detected in single"	37	"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basal ganglia: 23.5;pons and medulla: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 15.0"	"Low region specificity"	"Detected in all"			HPA018020	Uncertain					NA	NA					"HPA018020: AB_1849334"																		0.2	0.3	0.2	0.2	23.5	0.2	0.2	0.0	0.8	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.9	0.2	0.2	0.2	0.2	0.8	0.0	0.2	0.2	0.2	6.5	0.2	6.5	0.3	0.3	0.4	0.2	8.7	0.2	0.3	0.3	0.2	0.6	0.2	0.5	1.1	2.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.5	0.0	0.8	0.2	1.9	0.8	0.0	6.5	2.1	0.0	0.0	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183729	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.1;intestine: 136.0;kidney: 64.9"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 62.4;Cytotrophoblasts: 71.6;Proximal tubular cells: 101.6;Syncytiotrophoblasts: 105.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	129	"neutrophil: 61.1"	"Lineage enriched"	"Detected in single"	129	"granulocytes: 61.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 97.1;BJ hTERT+: 146.1;HSkMC: 94.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 26.8"	"CAB000013, HPA052583, HPA056072"	Enhanced					NA	NA		99000			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	26.5	0.4	0.4	3.4	7.4	1.9	14.7	0.4	0.7	4.8	65.6	0.1	18.4	74.0	2.8	8.1	0.7	0.9	8.5	1.8	0.3	0.4	64.9	11.5	13.7	3.0	2.1	0.2	0.9	0.6	0.0	0.6	35.0	8.6	18.3	0.4	1.3	3.7	11.3	11.7	1.4	136.0	0.6	0.9	2.7	0.7	1.0	1.2	13.2	1.0	5.3	2.3	3.4	4.9	0.1	0.4	61.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	39.4	97.1	0.2	21.7	146.1	11.1	28.7	0.0	0.0	23.9	0.0	19.2	15.1	0.0	0.7	0.8	26.7	0.0	0.1	0.0	0.0	0.0	31.6	0.0	0.0	94.2	0.1	5.9	42.5	12.3	8.4	0.0	0.0	0.0	17.7	0.1	0.0	0.1	0.9	0.0	0.1	39.7	18.7	0.1	0.6	0.2	0.0	0.2	0.0	0.0	4.2	8.9	0.0	0.0	23.8	47.7	0.1	16.3	3.7	0.0	0.0	31.5	5.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	61.1	0.0	0.0	0.4	0.0	0.0	0.4	7.4	0.4	0.7	0.3	0.4	2.1	0.2	8.6	1.2	8.9	18.3	0.9	62.4	0.7	0.0	1.1	17.8	2.7	19.4	21.0	0.0	71.6	8.3	0.1	0.3	0.6	0.0	0.0	0.0	48.9	19.2	29.2	2.3	48.9	8.1	0.0	0.0	3.1	1.8	0.2	3.7	2.7	0.0	0.0	0.2	0.0	0.3	0.0	1.1	101.6	0.0	0.0	3.1	0.2	0.4	0.3	105.4	0.0	0.0	29.2
DWORF		ENSG00000240045	"DWARF open reading frame"		3	155290229-155293775	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 173.0"	"Cell type enriched"	"Detected in some"	4	"Proximal tubular cells: 7.9"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Low cell line specificity"	"Detected in some"			"Region enriched"	"Detected in some"	8	"basal ganglia: 19.5"											NA	NA									"unprognostic (6.77e-4)"		"unprognostic (1.60e-2)"					"unprognostic (6.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.33e-2)"				0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.2	2.9	0.0	0.0	0.6	0.0		0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	173.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	23.7	0.9	0.0	0.0	0.5	0.4	2.9	0.2	0.4	0.2	0.0	0.2	0.0	0.6	0.0	0.0	2.3	0.7	0.3	0.0	0.0	0.6	0.0	1.3	0.0	0.4	0.0	0.4	0.5	0.3	0.5	0.0	0.3	0.6	0.4	0.5	0.5	0.0	1.8	0.4	2.1	0.0	0.0	0.5	0.4	0.8	0.0	0.6	1.3	1.2	0.4	0.2	1.7	1.2	0.7	0.6	0.3	0.2	0.3	0.0	0.0	1.0	0.9	0.0	0.7	0.1	1.0	0.9	1.1	1.9	1.8	1.3	0.8	0.2	0.2	0.3	0.8	0.8	0.3	0.0	2.9	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.5	0.2	0.2	0.8	0.4	0.1	0.4	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLCH1	"DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3"	ENSG00000114805	"Phospholipase C eta 1"	Q4KWH8	3	155375580-155745067	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7;testis: 15.8"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 148.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 8.4;AF22: 27.2;NTERA-2: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036176, HPA057978"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA036176: AB_10671837, HPA057978: AB_2683569"	"unprognostic (1.08e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.94e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (3.03e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-2)"	0.3	0.3	3.9	0.7	14.1	0.5	3.9	7.4	14.7	2.1	3.9	5.7	4.1	3.9	1.4	12.9	0.5	12.4	2.4	2.5	4.5	3.6	2.1	0.4	6.1	0.3	3.4	7.3	0.5	2.5	0.8	3.2	0.8	6.5	0.8	3.9	5.6	2.3	3.4	0.6	0.5	3.9	0.5	1.9	0.3	5.8	15.8	2.9	0.0	8.9	0.0	0.4	1.3	0.4	0.1	0.3	0.7	0.0	0.0	1.2	0.9	0.0	8.4	27.2	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.6	6.7	0.0	0.6	0.0	0.1	0.0	4.8	0.0	0.0	0.0	2.5	6.8	0.0	0.9	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	0.0	0.0	2.9	1.6	6.2	14.5	0.9	1.1	0.6	0.0	0.0	1.7	0.1	2.5	0.6	0.0	6.5	0.0	4.2	2.9	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.9	3.9	14.1	7.4	14.7	4.5	3.6	3.4	7.3	6.5	2.9	3.0	12.8	0.0	0.3	0.0	10.0	0.5	7.6	25.4	3.4	1.8	3.9	0.0	0.0	1.9	148.2	0.1	2.4	0.0	2.0	0.2	0.0	0.1	0.0	0.0	0.2	23.8	2.9	0.0	0.3	10.0	1.1	0.0	0.0	0.0	4.3	19.3	1.5	2.9	0.4	1.9	3.0	0.0	0.0	2.1	1.1	0.1	0.0	0.0	4.7	0.1
C3orf33	"AC3-33, FLJ31139"	ENSG00000174928	"Chromosome 3 open reading frame 33"	Q6P1S2	3	155762617-155806351	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037663	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			Nucleoplasm	Cytosol	"HPA037663: AB_10672610"	"unprognostic (1.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.31e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (6.48e-7)"	"unprognostic (3.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.56e-1)"	4.3	16.9	6.7	3.1	7.9	2.3	6.8	9.2	9.5	5.0	3.6	6.5	5.0	4.1	6.1	9.7	2.5	5.4	3.5	9.3	7.6	7.9	9.4	4.1	5.2	2.8	5.6	11.0	6.9	19.4	11.7	8.6	2.1	7.9	7.2	3.4	5.5	4.5	6.6	5.6	1.6	2.8	11.1	5.0	2.8	4.3	6.2	6.9	1.7	13.4	2.4	1.7	4.0	6.3	2.3	3.0	3.0	1.8	6.1	7.7	3.4	6.0	8.5	4.0	5.6	0.3	5.1	1.8	2.5	4.0	2.5	6.1	2.9	7.7	1.1	6.2	2.6	3.8	0.9	4.1	0.1	4.6	2.9	6.0	3.7	1.4	7.8	7.1	5.0	1.2	4.0	4.5	2.7	5.3	3.3	4.3	6.3	5.8	2.9	4.3	4.4	5.3	4.5	5.4	5.5	1.9	5.4	2.2	5.9	14.1	2.8	3.1	4.1	5.8	7.8	5.2	2.2	10.7	6.6	2.7	2.9	2.1	6.1	6.5	4.9	4.6	0.0	2.1	4.7	2.9	3.0	1.8	0.2	6.2	1.6	7.7	2.3	4.9	5.5	3.0	2.2	6.2	6.4	0.1	6.1	1.1	2.4	3.2	3.4	6.7	7.9	9.2	9.5	7.6	7.9	5.6	11.0	7.9	6.9	3.0	7.9	0.0	5.1	1.1	7.9	9.8	2.5	5.3	7.9	0.0	5.9	3.0	5.0	3.2	5.2	2.2	1.3	0.0	2.9	2.5	4.6	4.0	6.9	3.0	2.2	6.4	3.5	1.3	0.3	4.2	5.8	1.6	1.7	0.0	3.1	15.6	1.6	3.4	7.4	5.3	7.0	0.0	3.1	11.3	17.2	1.3	3.1	2.5	4.1	2.0
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042430, HPA060345"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042430: AB_10806238, HPA060345: AB_2732647"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	11.3	17.3	6.5	9.9	8.6	3.1	12.1	9.4	9.4	18.8	13.1	10.5	29.9	11.3	14.0	22.9	11.8	12.3	11.5	12.9	7.8	6.7	19.4	38.3	12.8	13.6	9.4	5.6	13.6	42.4	18.8	24.6	13.9	8.9	15.0	10.5	9.2	26.6	33.9	7.0	9.4	15.2	10.4	8.2	11.9	12.4	8.9	8.8	14.9	26.1	5.8	10.7	10.2	11.6	6.0	16.7	12.1	8.3	6.9	10.8	6.0	14.9	10.4	5.4	6.7	20.0	17.3	10.2	11.2	15.0	13.6	13.4	5.9	16.0	7.7	18.1	9.1	14.2	12.7	9.3	11.0	15.4	10.9	9.6	8.0	5.0	11.6	29.0	8.8	7.1	13.8	22.1	7.2	28.1	15.2	14.9	7.3	6.4	18.6	12.2	9.5	3.5	5.2	5.2	12.6	10.0	4.0	6.0	23.1	13.9	9.5	6.3	5.2	9.4	21.9	19.9	8.0	6.9	11.2	15.4	8.0	4.0	14.7	11.7	21.9	7.7	8.1	11.5	7.2	11.4	12.1	8.3	6.0	9.4	6.5	10.8	6.0	6.8	7.4	10.7	4.1	6.5	6.3	1.8	6.9	6.3	16.7	6.1	6.0	6.5	8.6	9.4	9.4	7.8	6.7	9.4	5.6	8.9	8.8	20.8	20.6	11.9	10.4	7.9	16.4	21.8	22.9	21.4	18.2	10.4	25.5	15.7	5.0	13.3	10.1	11.3	14.8	0.0	13.5	23.4	14.7	16.8	11.5	43.1	17.3	17.5	12.0	18.4	16.2	9.1	17.3	15.9	11.8	14.4	14.7	17.2	15.0	3.5	20.1	15.5	19.9	12.9	17.2	17.2	7.2	8.3	31.5	15.8	12.1	9.1
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870536-155944026	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 191.9;Late spermatids: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol		No	No			Cytosol		"HPA046630: AB_2679727"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	15.9	18.3	10.4	19.7	14.0	24.6	22.4	22.1	24.9	16.1	13.9	9.8	15.3	10.3	17.5	15.4	19.5	14.0	10.8	15.3	9.2	7.7	11.0	14.7	15.8	19.5	9.3	12.1	15.7	23.5	19.1	14.1	13.5	14.8	13.0	15.3	9.0	21.6	18.6	16.6	21.0	12.6	16.1	8.9	14.6	15.4	60.9	10.5	28.3	13.6	12.5	18.4	15.9	18.5	11.1	17.2	10.9	18.1	19.0	20.7	10.8	56.8	22.5	30.6	25.0	12.5	19.8	29.5	24.3	22.5	32.1	32.5	41.0	38.4	41.1	29.0	18.7	24.6	28.0	26.0	25.5	44.2	23.8	20.0	43.8	16.5	22.2	14.3	44.5	17.1	14.6	15.7	24.8	38.0	17.1	19.6	22.4	30.8	15.8	23.8	38.2	36.1	23.6	29.3	31.3	16.7	35.5	36.3	49.6	16.5	25.1	18.3	17.0	27.0	38.7	24.2	22.0	40.5	29.4	13.8	21.3	17.3	30.0	48.9	22.1	13.6	70.3	21.4	33.2	18.9	10.9	10.4	7.2	17.3	13.1	20.7	11.1	16.8	15.7	17.2	8.8	16.8	15.8	1.4	19.0	18.1	9.5	17.6	10.8	10.4	14.0	22.1	24.9	9.2	7.7	9.3	12.1	14.8	10.5	17.9	19.8	20.4	39.9	35.4	21.9	14.1	15.3	13.4	22.7	7.0	2.0	33.4	21.6	24.9	191.9	28.5	8.4	23.3	25.9	43.0	27.2	23.6	28.8	11.1	26.5	20.6	6.9	14.7	18.3	149.6	21.3	24.7	21.9	29.7	17.8	17.3	20.4	10.5	23.3	22.3	7.7	19.4	31.6	80.1	54.5	33.4	25.7	24.9	24.7	34.5
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.1;thyroid gland: 25.7"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 54.8;Cone photoreceptor cells: 29.5;Sertoli cells: 77.6;Smooth muscle cells: 66.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 5.9;hTEC/SVTERT24-B: 9.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 300.5"	"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	12.6	5.9	7.5	1.1	41.1	1.4	3.5	10.7	16.4	5.7	2.9	4.6	2.5	1.6	3.4	11.9	2.1	2.7	2.7	4.8	12.3	4.3	1.8	2.3	3.1	0.9	3.7	10.3	2.8	3.7	1.8	1.2	1.3	3.0	21.1	1.8	7.2	3.4	17.9	1.7	1.3	1.9	2.6	2.6	4.3	1.3	2.7	12.3	0.0	25.7	1.0	0.5	2.0	3.0	1.0	4.3	2.4	1.2	0.9	2.7	0.4	0.9	0.8	1.3	0.3	0.1	0.0	2.5	2.2	0.0	0.0	0.2	1.7	0.2	0.6	1.2	0.0	0.5	0.6	0.0	0.0	0.0	0.7	1.7	5.9	1.1	2.7	0.0	1.7	0.5	0.0	0.0	9.2	0.0	2.1	3.7	0.9	0.2	0.5	0.4	0.2	0.5	1.0	1.9	2.6	0.5	0.9	1.3	4.7	0.0	0.4	1.4	1.4	0.5	1.1	1.2	0.9	1.5	0.9	3.8	1.5	0.9	2.5	2.0	3.2	0.7	0.7	4.5	1.9	1.7	2.4	0.6	0.2	1.5	0.7	2.7	0.9	1.4	1.3	0.9	1.0	1.2	1.3	0.1	0.9	1.2	4.3	1.7	0.4	7.5	41.1	10.7	16.4	12.3	4.3	3.7	10.3	3.0	12.3	0.0	0.0	0.5	0.1	0.7	54.8	4.1	0.0	0.0	1.2	0.0	29.5	0.1	0.0	0.4	11.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	3.6	0.0	0.0	1.3	9.3	4.7	0.0	1.1	1.7	0.0	0.0	1.6	0.0	0.0	2.5	0.0	6.1	77.6	66.2	0.1	0.9	0.6	0.1	0.0	0.0	0.1
SSR3	TRAPG	ENSG00000114850	"Signal sequence receptor subunit 3"	Q9UNL2	3	156540140-156555184	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014906	Approved					NA	NA					"HPA014906: AB_2195736"	"unprognostic (4.11e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (3.43e-4)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.68e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.23e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.29e-2)"	30.8	33.0	17.7	21.8	19.4	14.2	31.7	13.6	20.6	46.9	25.3	22.4	77.9	18.9	36.4	59.8	24.1	33.4	21.2	42.2	17.0	17.6	44.6	89.1	27.2	30.6	21.2	12.9	33.8	153.1	14.8	37.4	26.6	23.0	23.6	28.9	23.7	90.0	82.3	19.9	14.3	22.7	34.9	26.2	28.7	25.8	26.0	18.9	17.7	38.3	23.4	25.7	24.6	23.4	25.6	51.4	29.1	40.3	20.1	32.3	21.5	47.5	9.9	12.5	15.7	42.4	39.9	13.3	70.6	39.0	35.7	49.9	19.7	23.3	16.0	31.4	45.6	32.7	22.4	20.5	82.4	85.5	19.0	9.9	28.5	6.8	20.0	45.1	29.7	13.7	35.6	30.3	59.7	121.2	34.4	43.2	13.6	15.7	58.9	100.3	14.0	10.1	6.8	15.5	27.4	20.3	14.5	20.9	103.9	32.3	11.3	10.2	8.5	18.3	27.1	37.9	20.6	28.3	15.4	56.0	48.5	23.1	37.4	77.9	54.3	21.2	27.3	28.8	25.1	27.8	29.1	27.8	21.8	20.5	32.3	32.3	25.6	22.1	25.4	37.2	14.7	14.9	17.8	9.6	20.1	40.3	51.4	25.0	21.5	17.7	19.4	13.6	20.6	17.0	17.6	21.2	12.9	23.0	18.9	101.3	135.9	87.1	116.1	74.4	30.6	141.9	122.3	61.6	117.2	69.8	29.5	103.0	92.9	200.0	71.4	90.5	72.2	210.2	199.1	383.2	142.4	205.1	93.5	200.3	348.4	23.8	68.2	133.2	196.5	22.2	199.0	201.2	138.3	223.6	140.9	89.4	235.6	60.4	209.7	184.1	31.2	71.1	74.1	120.7	68.6	68.8	158.0	102.6	121.2	105.2
TIPARP	"DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1"	ENSG00000163659	"TCDD inducible poly(ADP-ribose) polymerase"	Q7Z3E1	3	156673235-156706770	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 174.1;Early spermatids: 204.3;Urothelial cells: 186.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 24.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036796			Approved	Microtubules		NA	NA			Microtubules		"HPA036796: AB_10672268"	"prognostic favorable (2.00e-5)"	"unprognostic (3.50e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.16e-3)"	"unprognostic (4.90e-3)"	31.6	29.8	10.9	11.1	24.7	31.8	19.9	7.1	16.3	16.2	12.7	14.2	18.8	6.8	18.3	20.7	27.2	27.8	18.8	26.5	16.0	9.4	14.2	21.3	20.2	15.2	16.2	6.2	37.0	14.5	73.8	11.4	6.1	30.9	13.6	7.5	10.0	8.2	36.0	17.4	26.2	22.1	21.6	37.4	8.4	11.3	23.1	12.5	8.4	10.8	19.1	13.8	18.7	16.7	3.7	3.3	24.1	5.4	7.0	6.0	2.2	12.5	8.8	3.0	2.5	11.1	8.2	2.4	21.0	17.0	10.7	14.9	5.0	26.2	3.7	6.8	23.8	14.3	13.1	7.6	50.4	15.9	7.9	5.6	6.3	9.2	3.4	4.7	2.1	11.7	6.6	31.6	10.9	26.3	29.0	9.7	2.8	4.9	15.1	37.1	2.4	1.8	2.8	3.4	15.8	7.4	3.1	6.8	12.9	11.3	6.0	9.2	2.3	16.5	5.1	3.5	7.2	7.9	3.7	21.0	4.6	1.5	8.7	7.5	16.9	3.0	3.3	7.9	3.3	15.5	24.1	3.5	4.7	4.2	2.2	6.0	1.9	4.2	5.6	2.3	3.7	2.6	3.5	10.7	7.0	5.4	3.3	4.7	2.2	10.9	24.7	7.1	16.3	16.0	9.4	16.2	6.2	30.9	12.5	80.4	77.0	6.1	84.9	174.1	4.4	21.3	30.6	46.8	81.9	7.0	37.3	3.3	18.3	29.3	204.3	26.0	33.2	0.0	20.7	6.8	35.1	72.6	116.2	17.0	17.1	20.6	52.3	13.5	16.1	11.0	18.1	36.2	35.4	20.8	21.8	7.8	28.1	28.1	18.0	8.2	9.4	12.9	57.7	61.8	20.2	106.1	6.3	34.5	12.3	186.7
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"	Q6ZMV7	3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 29.8"	"Group enriched"	"Detected in many"	10	"Ciliated cells: 34.8;Early spermatids: 63.2;Late spermatids: 32.2;Spermatocytes: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 6.6;U-266/70: 6.2"	"Low region specificity"	"Detected in all"							"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	1.4	1.7	1.4	2.5	4.6	0.6	2.7	1.4	2.2	1.5	1.0	1.6	3.5	1.7	1.3	8.2	0.9	6.3	1.7	1.4	1.5	2.0	2.8	1.3	3.0	1.6	1.1	1.4	2.9	2.7	4.8	4.5	0.5	2.2	1.7	1.1	2.5	1.6	4.9	0.7	0.9	1.6	0.8	1.9	1.8	1.5	29.8	0.7	4.4	4.0	0.7	1.4	1.2	1.8	3.2	1.9	2.5	0.3	2.5	2.0	0.4	6.6	2.7	0.1	1.6	1.2	0.6	0.4	0.4	1.0	1.4	1.1	0.3	3.8	0.1	2.0	1.1	2.6	2.5	0.0	0.5	2.7	1.2	0.6	2.5	0.5	0.0	0.0	2.1	0.6	3.1	1.6	0.5	1.9	0.8	0.6	0.1	1.5	1.6	2.4	2.4	0.0	1.9	2.2	1.9	1.5	0.0	1.8	1.5	2.1	0.6	4.2	1.7	2.2	1.5	0.1	0.5	4.6	3.6	0.0	0.4	0.7	0.5	1.0	6.2	1.0	0.0	1.2	1.5	2.3	2.5	0.3	0.3	0.7	0.1	1.4	3.1	1.6	0.6	1.2	3.2	1.8	0.9	0.3	2.5	0.2	1.9	2.0	0.4	1.4	4.6	1.4	2.2	1.5	2.0	1.1	1.4	2.2	0.7	0.0	1.4	0.0	1.1	1.1	1.3	0.8	2.5	34.8	3.4	3.5	2.0	0.2	3.3	0.6	63.2	0.4	1.3	0.0	1.4	0.1	0.5	0.7	1.1	1.6	0.2	3.2	0.0	0.0	1.8	32.2	1.4	1.1	1.7	1.8	0.6	1.4	0.7	0.0	1.8	3.3	4.5	0.0	0.3	49.4	3.2	0.6	0.1	1.3	0.8	0.8
CCNL1	ania-6a	ENSG00000163660	"Cyclin L1"	Q9UK58	3	157146508-157160760	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Cyclin	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057911			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA057911: AB_2683553"	"unprognostic (1.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-3)"	"unprognostic (7.50e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (3.71e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.62e-2)"	"prognostic favorable (6.96e-7)"	32.0	23.2	12.4	36.1	18.7	60.9	26.5	17.1	15.0	16.8	24.3	13.6	17.0	19.8	15.2	20.0	16.7	21.5	25.8	15.6	11.7	8.7	20.4	29.5	23.2	20.6	20.9	9.8	23.3	24.2	13.5	25.3	17.5	18.7	18.0	10.4	15.9	14.9	26.5	16.1	18.5	28.0	19.2	24.6	27.7	19.8	8.6	18.0	25.9	18.5	17.7	20.8	20.2	22.4	12.3	11.3	24.0	8.5	13.1	15.0	6.7	13.3	8.7	11.8	8.6	12.2	8.0	12.3	8.6	10.0	10.2	9.4	15.2	10.5	15.2	7.7	6.3	7.0	11.4	9.0	10.1	9.3	13.3	11.0	10.1	9.4	12.6	10.0	6.6	5.7	9.6	18.7	9.7	12.9	10.0	8.0	8.0	6.4	8.9	7.3	11.1	12.2	12.1	10.6	10.3	10.5	11.5	10.5	21.8	6.4	8.2	6.9	13.0	7.1	6.2	17.0	9.3	6.2	18.1	6.6	9.4	5.5	10.3	10.9	18.6	15.3	19.3	9.5	9.3	8.9	4.3	8.5	12.5	11.6	7.1	12.2	11.2	10.8	11.9	10.6	12.3	15.0	12.1	24.0	13.1	8.2	11.3	11.9	6.7	12.4	18.7	17.1	15.0	11.7	8.7	20.9	9.8	18.7	18.0	202.5	402.1	106.8	367.8	238.1	68.5	43.3	109.5	174.0	241.1	64.6	125.7	121.6	19.9	124.2	27.5	202.1	397.6	46.7	112.4	131.0	201.5	320.1	214.0	72.5	144.7	38.1	237.5	142.4	220.1	14.0	118.5	210.1	133.3	125.4	150.2	55.6	123.2	199.9	70.7	16.6	185.9	129.4	199.9	42.5	20.4	242.1	174.8	208.8	128.5	426.8
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 38.1;pituitary gland: 70.3"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 2.2;pons and medulla: 5.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.5	16.0	0.3	0.2	0.3	1.1	1.4	2.2	3.5	1.9	0.4	0.7	2.0	0.2	0.4	12.1	0.2	3.4	1.1	0.4	0.8	0.5	20.7	0.6	38.1	0.1	0.7	0.1	1.1	8.6	0.7	70.3	1.6	5.5	1.2	0.3	17.7	6.9	4.9	0.2	0.7	0.2	0.1	0.3	2.3	0.6	1.7	0.2	0.1	1.1	0.5	0.6	0.5	0.8	0.0	0.0	1.5	0.7	0.0	0.0	5.1	1.8	0.2	4.3	0.0	2.5	9.4	0.0	11.0	24.5	3.3	4.8	0.3	1.7	0.0	4.3	11.8	0.5	0.0	0.1	0.2	18.3	0.0	0.0	1.8	0.2	0.0	0.8	0.0	0.0	2.7	0.1	14.0	2.8	26.3	65.1	0.0	0.6	0.0	8.9	0.2	0.0	0.0	1.7	0.5	1.6	0.0	0.3	0.0	1.6	0.9	0.1	0.0	0.3	0.5	4.3	0.0	18.9	0.0	38.7	13.1	0.4	4.5	15.1	0.0	0.0	0.0	10.5	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.1	0.3	0.3	2.2	0.4	0.8	0.5	0.7	0.1	5.5	0.2	247.1	124.4	0.0	0.2	1.5	0.0	0.3	12.7	14.7	26.1	29.6	2.0	1.6	39.7	5.5	67.1	0.0	0.0	0.0	8.7	0.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	63.8	1.4	0.4	27.0	1.0	0.2	0.8	2.0	2.8	0.4	24.1	0.3	0.0	0.0	0.3	0.6	0.4	0.0	0.0	0.6	0.1
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell type enhanced"	"Detected in some"	10	"Ductal cells: 6.0;Fibroblasts: 10.1;Macrophages: 5.9;Melanocytes: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.4;ASC TERT1: 125.2;BJ hTERT+: 82.2;HHSteC: 160.8;HSkMC: 167.5;hTEC/SVTERT24-B: 88.5;TIME: 119.2;U-2197: 111.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1090000	310000	"Plasma membrane"		"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	52.1	0.0	86.4	125.2	0.0	9.0	82.2	3.9	4.2	0.0	0.5	0.0	32.1	10.6	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	160.8	0.1	0.0	167.5	0.0	88.5	30.1	7.7	18.2	0.0	0.0	0.0	26.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	119.2	17.7	0.8	111.1	1.5	0.0	0.0	0.0	3.7	0.4	5.0	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2	0.0	1.7	0.0	1.1	1.4	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	6.0	1.9	2.0	0.0	0.0	0.0	0.0	10.1	0.4	0.0	0.0	2.6	0.0	0.0	3.1	4.6	0.8	0.3	5.9	13.5	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	0.0	4.2	0.0	0.4	0.9	0.2	0.0	0.0	0.1
PQLC2L	C3orf55	ENSG00000174899	"PQ loop repeat containing 2 like"	A1A4F0	3	157543246-157677749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.8;breast: 36.0"	"Cell type enhanced"	"Detected in some"	20	"Collecting duct cells: 21.0;Ductal cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.9;ASC TERT1: 18.8;EFO-21: 12.8;HSkMC: 12.1;hTERT-RPE1: 13.4;LHCN-M2: 17.0"									HPA054395	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	NA			"Nucleoplasm, Nuclear bodies"		"HPA054395: AB_2682473"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.83e-5)"	"unprognostic (2.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.47e-7)"	"unprognostic (1.17e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.56e-3)"	29.8	1.6	0.2	1.8	1.3	0.1	36.0	0.0	0.8	5.3	4.1	0.0	0.0	0.1	1.3	2.0	3.1	1.8	4.3	5.6	0.3	1.2	4.5	0.1	8.4	1.6	0.5	0.1	0.4	1.4	0.1	5.9	2.6	1.3	3.9	1.4	4.6	4.5	1.0	4.8	2.2	1.6	3.4	0.3	0.1	3.8	2.7	0.0	0.0	11.8	3.0	0.5	4.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	0.0	33.9	18.8	0.0	1.7	3.5	0.7	1.0	0.0	2.4	0.0	12.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	2.7	0.0	0.0	12.1	0.6	5.2	0.3	13.4	5.3	0.0	0.3	0.0	17.0	0.1	0.0	0.0	0.1	0.6	3.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.1	0.0	0.0	4.8	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.8	0.3	1.2	0.5	0.1	1.3	0.0	0.0	0.3	0.0	0.6	0.0	0.3	0.3	2.5	1.4	1.2	21.0	0.0	0.0	0.0	5.8	4.2	0.0	0.0	0.0	1.8	0.6	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	4.2	0.3	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.7	0.8	1.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6
SHOX2	"OG12, OG12X, SHOT"	ENSG00000168779	"Short stature homeobox 2"	O60902	3	158095954-158106503	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"Early spermatids: 89.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"pons and medulla: 10.1;thalamus: 2.9"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;SH-SY5Y: 15.0;THP-1: 24.8"	"Group enriched"	"Detected in some"	5	"midbrain: 43.1;thalamus: 60.0"	"Group enriched"	"Detected in some"	36	"midbrain: 13.2;pons and medulla: 15.8;thalamus: 28.2"							NA	NA						"unprognostic (2.62e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.28e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.75e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	10.0	0.3	0.1	0.1	0.1	0.4	6.6	0.1	0.2	10.0	0.5	3.0	2.8	0.0	1.1	1.4	2.5	0.2	0.6	9.9	0.1	1.5	0.1	0.2	0.4	4.1	0.4	0.1	1.0	1.5	0.0	0.4	1.3	10.1	1.5	0.1	0.3	2.8	1.1	3.6	2.5	0.3	1.3	0.3	0.1	0.3	4.4	2.9	0.0	0.7	2.4	1.1	1.7	4.6	0.3	0.0	2.9	0.7	0.0	0.1	0.0	3.2	0.3	0.1	5.3	15.5	9.7	0.9	5.9	2.1	2.9	5.5	1.1	0.4	0.7	0.1	7.6	6.3	0.1	6.2	0.0	1.2	3.6	1.9	8.9	1.3	0.0	0.0	0.7	7.3	4.4	0.1	2.9	0.3	9.5	0.0	0.4	2.4	0.5	1.4	0.2	0.0	0.4	0.0	0.0	0.2	3.7	4.9	0.8	0.0	0.0	1.8	15.0	0.7	0.1	3.2	0.1	0.1	24.8	0.3	9.7	2.1	10.7	9.4	0.7	1.6	0.5	9.3	4.9	9.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	1.5	0.4	0.1	10.1	2.9	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.3	0.1	0.0	0.0	0.2	0.6	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	7.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	4.7	5.5	1.4	0.4	0.2	0.0	0.0	0.0
RSRC1	"BM-011, MGC12197, SFRS21, SRrp53"	ENSG00000174891	"Arginine and serine rich coiled-coil 1"	Q96IZ7	3	158105855-158545730	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044792	Supported		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA044792: AB_10794502"	"unprognostic (1.06e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (7.40e-5)"	"unprognostic (5.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.84e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.48e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.15e-1)"	26.2	24.4	23.8	16.6	25.6	18.7	23.0	43.0	32.3	22.6	17.3	17.7	12.2	12.3	19.4	19.2	18.2	14.6	14.7	20.1	23.8	27.0	22.1	23.1	13.2	17.9	26.5	22.5	18.8	21.5	22.8	28.2	16.5	31.9	19.3	20.7	12.5	16.7	21.5	22.8	15.4	14.3	20.7	33.7	19.5	16.4	14.8	23.2	24.0	24.1	13.3	19.9	19.6	16.2	24.5	33.8	17.6	21.6	9.4	15.7	6.6	31.6	15.2	12.0	15.4	28.5	20.0	15.7	15.9	13.9	18.2	20.2	21.1	24.3	30.4	29.7	19.4	20.2	14.2	22.3	14.3	27.1	46.1	19.0	31.4	13.4	17.2	4.5	26.6	20.3	14.4	13.8	14.2	12.7	19.5	8.5	18.0	18.3	22.9	13.8	25.9	20.7	17.9	10.0	21.5	14.7	24.4	20.5	37.0	13.4	10.5	20.8	23.6	17.6	12.1	19.6	13.5	27.6	23.1	9.4	22.7	13.7	29.4	31.3	19.3	20.6	32.6	23.2	36.3	27.9	17.6	19.8	10.3	14.8	21.6	15.6	24.5	15.7	14.8	11.9	24.1	14.9	15.7	13.7	9.4	19.9	33.8	12.5	6.6	23.8	25.6	43.0	32.3	23.8	27.0	26.5	22.5	31.9	23.2	29.8	20.2	41.2	28.8	33.2	75.7	40.1	53.5	38.8	22.7	78.5	31.4	31.3	63.0	45.2	33.4	29.6	17.7	46.7	52.3	44.9	43.5	26.6	73.0	63.5	34.6	60.4	31.7	32.5	42.4	6.6	42.8	58.5	42.2	45.1	40.3	59.2	39.6	28.1	33.6	44.6	92.1	19.4	39.1	31.6	37.3	24.0	24.7	37.0	28.1	24.0
MLF1		ENSG00000178053	"Myeloid leukemia factor 1"	P58340	3	158571163-158607252	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1"	"Group enriched"	"Detected in many"	15	"Early spermatids: 4250.8;Late spermatids: 9284.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in single"	12	"T-cells: 10.4"	"Cell line enhanced"	"Detected in many"		"A-431: 33.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA069479, HPA079339"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA069479: AB_2686140, HPA079339: "	"unprognostic (6.49e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.72e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (9.34e-3)"	"unprognostic (2.47e-3)"	"unprognostic (3.36e-2)"	3.5	2.6	6.0	1.8	11.9	0.9	5.3	3.4	7.1	3.1	2.7	6.5	0.5	0.8	4.9	5.6	3.5	18.3	4.9	41.4	6.3	6.3	5.7	1.2	5.2	1.0	4.9	6.3	6.2	3.1	5.2	10.4	1.0	20.1	2.0	1.7	2.8	2.2	1.6	53.6	1.8	1.3	4.5	4.7	1.2	1.9	101.1	5.7	0.0	5.3	18.9	1.4	4.2	1.5	0.6	0.3	0.4	0.3	0.8	10.4	2.3	33.7	4.4	11.4	0.0	6.0	7.1	3.4	3.5	3.3	12.8	11.7	0.0	19.2	0.0	13.4	6.0	18.7	6.6	0.1	5.9	17.1	0.0	7.4	2.0	3.3	0.3	4.1	0.0	2.5	4.4	8.7	6.1	3.4	13.4	3.0	0.0	2.5	0.0	8.4	4.9	0.0	0.1	2.7	18.0	9.9	0.0	6.4	0.4	9.8	2.4	14.7	8.7	15.9	5.6	16.7	11.7	16.2	3.4	1.1	12.0	12.2	14.1	13.6	6.1	3.8	0.0	8.7	0.0	8.6	0.0	0.0	0.0	3.6	0.0	1.6	0.6	8.3	8.7	0.3	0.3	2.1	4.4	0.4	0.8	0.3	0.2	10.4	2.3	6.0	11.9	3.4	7.1	6.3	6.3	4.9	6.3	20.1	5.7	23.8	26.2	2.2	109.9	39.8	12.6	168.2	0.0	238.3	60.3	19.2	31.4	0.6	61.3	22.4	4250.8	23.3	4.2	0.0	6.9	3.5	36.8	26.1	43.8	0.0	6.4	9.5	32.5	8.0	2.7	9284.2	64.7	13.2	21.9	1.8	14.3	25.9	7.6	14.4	47.4	27.5	58.5	19.4	36.9	440.7	150.0	29.9	1.4	8.9	10.3	65.9
GFM1	"EFGM, EGF1, GFM"	ENSG00000168827	"G elongation factor mitochondrial 1"	Q96RP9	3	158644278-158692575	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034764, HPA034765, HPA061405"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.62e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.78e-2)"	20.1	23.3	17.6	14.1	18.6	14.7	19.8	32.8	23.4	11.4	20.7	17.8	19.1	18.8	15.4	17.9	16.2	14.3	12.6	27.9	18.0	17.9	34.1	42.2	13.5	13.2	18.9	19.5	13.2	17.0	30.9	16.4	17.4	22.6	15.3	23.3	13.8	16.3	15.4	46.5	15.4	16.0	16.0	18.5	14.2	17.1	19.8	17.8	14.5	21.4	17.6	13.6	15.0	13.2	13.2	16.5	10.8	19.8	16.0	21.1	11.5	30.1	17.3	8.4	10.2	13.5	8.8	11.3	15.6	13.6	21.8	17.1	23.1	18.6	25.9	19.8	11.6	10.4	18.4	18.8	14.5	24.4	14.3	12.7	21.5	11.9	12.8	15.4	27.6	11.7	12.2	17.2	14.1	13.1	6.2	14.6	14.4	22.3	15.9	19.8	16.7	16.2	11.0	19.1	32.4	11.7	15.7	10.1	41.7	17.4	12.7	15.3	14.8	24.6	33.4	26.5	7.0	41.1	22.5	10.7	14.6	7.2	22.8	24.6	30.6	19.3	47.1	13.8	23.2	16.3	10.8	13.2	9.1	16.1	19.8	21.1	13.2	15.0	16.9	16.5	11.9	17.6	18.5	1.9	16.0	14.0	8.6	11.9	11.5	17.6	18.6	32.8	23.4	18.0	17.9	18.9	19.5	22.6	17.8	17.9	14.7	27.9	22.5	19.2	53.1	51.8	17.8	28.1	12.5	12.2	29.5	26.9	10.0	16.6	12.5	28.9	18.2	23.3	21.6	15.7	18.2	17.8	18.5	53.5	25.1	14.3	18.6	25.8	22.5	5.7	21.0	23.4	16.9	31.5	21.4	25.3	16.3	5.8	15.9	31.0	49.5	12.9	21.9	25.1	32.1	18.3	25.7	20.0	24.7	18.2
LXN		ENSG00000079257	Latexin	Q9BS40	3	158645822-158672693	"Predicted intracellular proteins"	"Inflammatory response"	"Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 129.8;granulocytes: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"hTERT-RPE1: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014179, CAB025128"	Approved		Approved	Nucleoplasm,Cytosol		No	NA		4200000	"Nucleoplasm, Cytosol"		"CAB025128: , HPA014179: AB_1853404"	"unprognostic (4.46e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (8.45e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.84e-2)"	32.3	31.5	2.8	13.6	3.3	9.4	35.8	11.7	3.5	11.8	20.9	1.2	12.7	12.4	9.8	17.7	14.0	15.2	17.2	24.4	5.7	3.6	13.6	4.0	16.9	17.8	3.0	2.1	37.1	15.0	7.9	20.6	15.5	4.4	34.0	18.6	11.1	29.3	11.3	7.8	4.8	24.1	22.8	2.6	10.0	7.0	8.5	1.3	12.4	15.8	6.6	7.3	29.3	31.5	5.9	4.5	22.2	3.6	5.2	17.0	4.2	0.0	5.3	0.4	0.0	2.3	8.0	0.4	4.1	10.5	1.0	2.0	0.0	12.0	0.0	3.8	1.1	0.0	1.8	1.0	1.6	1.5	0.0	5.2	2.5	4.6	0.0	2.6	0.6	0.0	17.9	0.3	1.9	0.3	161.2	38.9	0.0	0.0	0.1	0.0	21.2	0.2	0.0	0.4	0.9	1.3	0.7	0.0	5.0	3.6	14.7	0.6	0.0	0.0	5.6	1.3	1.3	0.0	0.0	5.5	0.0	0.0	5.6	0.0	0.1	0.0	0.0	2.0	0.2	0.0	13.8	3.6	5.0	3.7	3.4	3.6	5.9	7.6	5.9	4.3	4.1	8.5	4.7	22.2	5.2	2.1	4.5	17.0	4.2	2.8	3.3	11.7	3.5	5.7	3.6	3.0	2.1	4.4	1.3	14.9	8.6	7.5	61.6	4.9	0.2	3.4	2.5	129.8	31.8	15.7	3.9	11.7	13.3	14.9	2.9	28.6	33.3	23.3	23.6	13.4	20.3	29.5	113.9	0.4	21.7	0.0	33.7	49.1	4.0	7.2	7.8	14.2	18.6	27.9	63.3	8.3	13.1	69.1	2.5	11.5	1.4	12.9	3.7	0.4	8.8	7.2	3.3	7.7	25.5	71.1
RARRES1	"LXNL, TIG1"	ENSG00000118849	"Retinoic acid receptor responder 1"	P49788	3	158696892-158732696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 105.0;vagina: 111.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 153.1;Glandular cells: 151.9;Paneth cells: 100.4;Urothelial cells: 237.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"CAPAN-2: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003892	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA003892: AB_1856079"	"unprognostic (5.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.09e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.88e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	49.4	6.1	0.4	26.5	0.5	0.0	54.5	0.3	0.4	18.5	29.9	0.6	10.0	2.1	6.8	24.2	11.5	40.6	8.3	105.0	0.6	0.3	26.8	2.7	13.4	13.3	0.5	0.5	75.5	3.9	0.0	19.7	1.6	2.0	46.2	15.7	19.4	49.0	17.9	10.5	3.3	9.3	20.7	2.4	3.2	6.6	19.0	0.2	1.0	31.5	1.7	5.9	39.6	111.3	1.0	1.2	0.0	0.9	0.2	0.7	0.1	2.5	0.8	0.0	0.1	0.5	1.6	0.0	0.2	0.7	0.1	0.2	0.1	162.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	17.8	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.2	2.2	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.4	1.0	0.7	0.3	0.0	0.2	0.9	1.2	0.3	0.1	0.4	0.5	0.3	0.4	0.6	0.3	0.5	0.5	2.0	0.2	0.0	1.1	0.0	153.1	0.5	0.4	0.8	7.6	28.1	30.7	14.0	0.0	2.4	0.0	8.0	19.5	1.6	68.0	0.0	4.2	0.6	13.4	151.9	29.9	3.8	10.7	0.0	35.9	16.5	1.5	25.5	10.0	2.9	5.0	0.0	75.6	3.4	1.6	100.4	1.1	18.7	0.4	0.0	1.0	2.3	0.5	0.4	9.5	0.0	69.1	237.5
MFSD1	"FLJ14153, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Hofbauer cells: 192.2;Kupffer cells: 259.8;Macrophages: 135.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065858	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		14000	"Plasma membrane"	Cytosol	"HPA065858: AB_2685569"	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	26.2	29.5	11.4	22.0	11.8	17.2	24.2	9.1	14.0	18.7	15.7	13.4	18.9	13.2	18.3	20.6	37.0	18.4	17.5	17.7	10.8	10.3	20.7	24.8	24.9	39.8	15.7	11.7	15.3	16.8	16.5	16.8	18.3	13.6	14.7	11.5	14.5	34.5	17.9	9.2	18.6	16.8	15.0	14.5	29.1	19.9	15.0	14.3	11.3	18.7	16.3	16.7	23.8	24.1	10.5	45.3	42.6	49.6	5.4	7.3	35.3	14.9	6.4	1.6	5.0	8.7	8.2	10.3	23.4	10.5	8.3	8.2	2.6	14.8	4.2	17.2	14.9	5.0	7.8	4.0	5.1	7.8	16.6	10.9	11.2	4.9	1.1	9.4	41.3	28.1	12.2	6.7	7.5	2.1	3.3	6.5	2.8	8.7	8.6	14.7	3.4	2.5	12.2	1.6	6.3	16.4	5.6	2.4	36.6	3.0	3.9	4.8	7.2	17.2	13.3	4.1	2.0	10.5	16.2	21.3	11.9	4.6	17.6	11.5	27.4	19.2	2.3	15.0	30.0	8.3	14.0	49.6	42.6	7.3	38.5	6.6	10.5	5.8	6.5	45.3	8.5	6.4	7.0	17.6	5.4	31.6	14.7	6.8	35.3	11.4	11.8	9.1	14.0	10.8	10.3	15.7	11.7	13.6	14.3	17.9	31.3	39.5	33.3	19.1	11.9	17.1	12.7	40.2	29.6	21.0	5.9	23.7	16.6	28.2	3.5	25.1	25.5	23.3	24.8	27.2	23.6	39.9	47.4	30.1	192.2	17.5	21.9	39.3	259.8	5.3	11.2	135.3	30.4	15.4	26.6	23.4	26.7	20.1	10.6	25.9	10.0	12.9	15.5	8.8	7.0	22.7	46.8	15.4	24.0	47.5
IQCJ-SCHIP1		ENSG00000283154	"IQCJ-SCHIP1 readthrough"	B3KU38	3	158962235-159897366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 6.0;Basal glandular cells: 6.9;Bipolar cells: 12.0;Cone photoreceptor cells: 5.9"									"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA003243, HPA003445"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA003243: AB_1079877, HPA003445: AB_1079875"																		5.3	2.1	11.1	4.1	12.4	0.5	2.4	1.5	30.0	1.9	3.8	17.8	0.3	1.7	5.6	2.8	7.3	1.4	5.8	16.4	7.7		7.6	6.3	6.8	0.6	18.8	10.6	0.8	0.9	0.2	1.3	10.9	13.1	6.3	3.0	0.4	0.6	10.0	1.8	0.8	1.7	11.8	7.3	1.2	1.0	1.7	15.1	0.0	0.6	0.1	0.4	5.9	0.9	0.0	1.0	0.1	0.0	0.9	0.2	0.2	28.8	5.0	9.9	11.8	2.3	2.2	8.7	24.9	5.9	20.6	14.1	18.6	7.1	1.4	16.1	8.2	7.8	11.7	3.8	8.4	17.0	24.0	9.4	0.0	11.0	0.9	2.7	1.3	0.1	2.3	7.2	9.1	10.9	17.1	15.2	1.6	0.0	0.1	9.4	1.2	0.1	0.0	8.3	2.3	10.9	3.4	20.1	0.0	19.8	1.6	2.0	9.4	13.4	5.7	7.1	11.9	3.3	0.2	12.6	11.9	16.5	7.9	33.7	0.1	0.1	0.1	6.6	4.1	31.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.9	0.0	1.0	0.0	0.2											6.0	0.0	0.0	6.9	1.3	12.0	0.4	0.0	4.0	2.3	1.8	5.9	0.0	0.0	0.6	1.2	0.2	0.0	0.0	0.5	0.0	0.5	0.4	2.3	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.3	0.8	0.0	1.0	0.1	0.4	0.8	0.0	1.1	2.7	0.5	0.0	3.4	0.0	0.4	0.6	0.0	0.0	0.2	1.4
IQCJ		ENSG00000214216	"IQ motif containing J"	Q1A5X6	3	158962928-159266307	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 19.5"	"Group enriched"	"Detected in some"	105	"Early spermatids: 26.3;Late spermatids: 33.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Daudi: 10.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052835	Uncertain					NA	NA					"HPA052835: AB_2681970"	"unprognostic (1.99e-2)"																	0.5	0.5	19.5	0.5	10.0	0.5	1.6	0.4	14.5	0.5	0.5	0.1	0.0	0.5	0.5	0.5	0.8	0.5	0.7	1.0	9.4	0.6	0.6	0.5	0.5	0.9	0.9	7.4	0.6	0.5	0.5	3.6	0.5	6.8	0.5	0.5	0.0	0.5	0.9	0.5	0.5	0.5	0.5	0.5	0.5	0.5	4.8	1.5	0.0	0.5	0.0	0.6	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	10.0	0.4	14.5	9.4	0.6	0.9	7.4	6.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 11.3;Horizontal cells: 14.3"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	58	"dendritic cells: 9.7;granulocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;AN3-CA: 17.3;HUVEC TERT2: 20.5;NTERA-2: 10.5;SH-SY5Y: 59.6"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	3.9	30.1	1.5	22.0	2.0	1.9	23.9	55.0	3.7	3.6	21.1	0.0	2.2	4.7	2.0	4.2	3.4	3.0	65.9	29.6	17.9	3.5	1.9	3.1	1.7	22.8	24.1	1.8	1.6	1.4	6.0	10.3	15.6	6.2	2.3	0.7	2.9	2.6	54.5	1.4	1.9	5.9	28.9	5.1	2.0	2.7	24.3	0.0	2.0	7.6	1.6	1.9	0.6	0.0	9.7	3.1	0.0	0.1	0.0	0.1	0.0	0.0	9.5	17.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.4	0.1	4.0	0.1	20.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	59.6	0.0	0.0	0.0	2.6	0.0	1.0	3.7	0.2	0.5	0.1	0.8	0.7	0.0	0.0	0.2	0.7	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.1	30.1	22.0	23.9	28.9	29.6	17.9	22.8	24.1	15.6	24.3	6.0	1.7	0.0	4.6	0.3	4.2	11.3	0.0	4.0	3.4	3.5	2.0	1.0	0.0	0.2	0.0	4.6	0.0	0.0	0.2	0.4	0.6	0.5	0.0	0.5	0.2	14.3	0.0	1.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	4.9	0.9	0.0	0.0	0.7	0.5	0.0	1.8	0.0	0.4	0.5	0.7	0.0	0.0	1.4
IL12A	"CLMF, IL-12A, NFSK, NKSF1, p35"	ENSG00000168811	"Interleukin 12A"	P29459	3	159988750-159996019	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 10.1"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 8.1;Sertoli cells: 6.5;Spermatogonia: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.1"	"Group enriched"	"Detected in many"	7	"B-cells: 5.1;granulocytes: 1.3;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 7.5;HDLM-2: 11.4;SK-BR-3: 17.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.7"	"Low region specificity"	"Detected in some"			HPA001886	Uncertain				"Secreted to blood"	NA	NA					"HPA001886: AB_1079132"	"unprognostic (6.23e-2)"	"unprognostic (7.82e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.18e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.57e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.61e-2)"	0.7	1.4	3.4	1.6	6.2	3.3	2.0	2.6	5.6	0.5	1.6	1.0	0.0	1.5	1.2	0.8	10.1	5.7	0.6	1.4	3.1	2.2	1.2	0.6	5.2	2.9	3.2	1.7	1.6	1.1	0.1	1.0	0.4	5.4	0.9	1.3	0.2	2.1	1.1	0.4	0.2	1.5	0.8	2.7	2.8	1.2	0.9	4.1	0.0	0.5	0.5	2.1	0.9	1.1	5.1	0.1	1.3	0.3	0.0	1.6	0.3	2.8	0.3	0.4	2.4	0.0	0.1	0.2	3.1	1.9	3.6	7.5	1.2	0.1	0.0	0.2	0.5	4.2	0.3	0.8	0.5	3.4	11.4	3.9	0.1	0.1	0.8	2.6	0.6	5.3	0.6	0.9	6.4	2.5	2.5	1.2	0.3	0.0	2.0	2.2	0.0	0.1	0.0	0.4	0.1	1.7	2.2	0.0	0.4	0.4	0.2	0.1	1.2	0.0	17.1	0.4	0.6	0.8	1.2	0.8	0.9	0.8	2.1	5.8	1.2	0.0	0.0	1.4	5.2	0.7	0.0	0.1	1.3	0.9	0.3	1.4	1.3	0.4	1.6	0.1	5.1	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.3	3.4	6.2	2.6	5.6	3.1	2.2	3.2	1.7	5.4	4.1	0.0	1.1	1.9	1.1	0.1	0.0	0.2	0.0	8.1	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.5	0.1	0.0	0.0	0.5	1.6
C3orf80		ENSG00000180044	"Chromosome 3 open reading frame 80"	F5H4A9	3	160225496-160228213	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.0;intestine: 8.6"	"Cell type enhanced"	"Detected in some"	13	"Early spermatids: 4.5;Horizontal cells: 6.4;Intestinal endocrine cells: 4.1;Spermatocytes: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 57.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047439	Uncertain					NA	NA					"HPA047439: AB_10965171"	"unprognostic (5.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.92e-3)"	"unprognostic (6.70e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.09e-10)"	"unprognostic (1.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.11e-3)"	"unprognostic (5.00e-2)"	1.3	0.4	5.2	1.6	9.3	1.4	0.7	5.4	25.0	0.5	8.6	0.1	0.0	1.8	1.2	0.5	5.7	0.3	1.4	0.6	4.3	2.0	0.6	0.8	2.0	0.3	1.7	9.3	0.3	0.4	1.4	0.7	0.3	1.2	1.8	3.3	0.0	0.6	0.8	0.2	0.2	1.3	1.8	0.5	2.7	2.5	1.3	0.0	0.0	0.5	0.0	0.4	2.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.1	0.7	4.8	1.3	0.0	0.0	0.9	57.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.0	0.1	11.7	0.0	0.0	0.2	0.0	1.4	0.1	0.0	0.0	0.4	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.2	9.3	5.4	25.0	4.3	2.0	1.7	9.3	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.5	0.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	6.4	4.1	1.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	2.1	0.5	0.0	0.0	0.0	0.0	0.0
IFT80	"KIAA1374, WDR56"	ENSG00000068885	"Intraflagellar transport 80"	Q9P2H3	3	160256986-160399880	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 52.0"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035868	Uncertain					NA	NA					"HPA035868: AB_10959463"	"unprognostic (2.71e-2)"	"unprognostic (4.47e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.70e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.60e-3)"	6.2	8.9	14.9	7.1	15.9	4.6	10.1	16.2	22.2	12.4	6.4	9.0	11.1	5.6	13.4	15.3	7.4	15.8	10.2	8.3	19.3	13.4	14.0	5.8	12.7	9.6	17.1	17.1	15.2	8.3	26.2	52.0	6.3	14.2	9.5	9.0	10.4	6.1	9.8	3.5	10.6	6.5	9.9	16.5	7.8	9.3	20.2	9.3	21.0	15.9	4.9	9.9	8.7	7.3	3.4	5.0	3.1	2.0	3.5	4.2	2.2	11.6	7.9	18.7	8.5	17.5	31.0	4.6	9.9	14.7	8.1	9.9	6.5	16.9	7.6	13.3	9.6	11.9	10.2	6.5	9.4	17.5	11.6	7.5	10.2	10.7	4.8	17.5	4.7	8.8	17.1	6.6	8.9	9.4	34.3	8.5	9.9	4.3	14.8	12.1	5.6	9.0	5.6	6.3	7.5	4.9	8.0	9.9	12.6	16.1	3.4	11.4	12.5	10.8	10.4	12.4	12.7	18.1	4.6	7.8	8.0	5.5	11.0	9.7	21.4	13.8	13.9	13.4	8.6	7.8	3.1	2.0	1.7	2.7	0.9	2.4	3.4	3.2	2.9	2.7	3.2	4.2	2.9	2.3	3.5	1.7	5.0	3.9	2.2	14.9	15.9	16.2	22.2	19.3	13.4	17.1	17.1	14.2	9.3	38.7	27.0	4.7	4.8	3.0	16.4	7.3	17.8	80.3	18.2	22.7	15.7	2.6	6.6	4.2	17.6	4.5	2.1	0.0	1.6	2.3	6.6	2.9	2.3	2.9	2.5	1.6	10.9	6.7	4.6	5.6	15.3	2.7	1.7	1.0	5.3	7.1	2.6	2.9	20.5	5.9	16.8	6.5	5.6	36.1	8.7	3.3	0.6	6.5	4.7	3.3
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434962	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.2"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 332.4;Spermatogonia: 238.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (4.20e-5)"	"prognostic unfavorable (9.00e-4)"	"prognostic unfavorable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	4.8	5.5	3.0	25.4	4.4	15.1	4.0	3.1	3.2	5.3	10.1	1.7	5.3	6.5	5.2	4.9	19.3	4.6	7.0	5.7	2.4	1.7	4.4	6.3	7.9	16.5	3.1	1.3	4.7	4.2	1.7	10.8	7.4	2.6	4.4	6.9	2.7	5.7	6.9	5.9	4.6	7.0	6.2	3.1	13.1	5.7	20.7	3.2	70.2	5.1	7.6	14.3	7.8	6.3	8.8	6.1	30.5	7.6	7.8	15.8	4.8	63.3	11.7	26.7	12.3	5.1	5.2	12.3	31.6	14.9	36.6	31.7	14.8	36.5	40.1	18.5	13.0	24.3	36.6	30.3	15.3	58.8	53.1	21.1	38.8	20.1	4.7	2.8	25.7	31.8	2.6	2.2	19.3	15.8	13.3	15.5	17.1	22.3	46.7	21.8	11.4	31.5	6.4	15.7	15.7	27.6	32.0	41.9	29.1	6.8	7.9	16.1	16.7	24.1	22.3	11.0	13.1	26.8	19.2	14.6	23.4	19.6	21.3	57.6	31.2	31.8	73.2	16.8	26.4	25.9	30.5	3.2	12.1	6.7	4.7	6.5	8.8	10.5	8.0	3.5	7.2	6.7	6.0	5.7	7.8	7.6	6.1	15.8	4.8	3.0	4.4	3.1	3.2	2.4	1.7	3.1	1.3	2.6	3.2	98.3	146.6	24.2	16.6	36.2	14.2	31.9	22.9	32.1	44.3	33.2	7.9	29.7	3.3	18.2	26.7	45.6	21.1	116.8	12.6	126.9	41.4	11.7	76.3	15.6	51.1	0.0	28.9	39.3	26.0	21.5	23.3	45.4	16.9	37.9	24.6	9.8	11.3	20.1	45.3	6.2	24.1	129.4	30.3	332.4	238.9	31.1	28.5	48.4	46.6	17.6
TRIM59	"Mrf1, RNF104, TRIM57, TSBF1"	ENSG00000213186	"Tripartite motif containing 59"	Q8IWR1	3	160432445-160485773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.6;lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017750	Uncertain		Approved	"Rods & Rings"		NA	Yes			"Rods & Rings"		"HPA017750: AB_1858312"	"unprognostic (3.74e-1)"	"prognostic favorable (4.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.00e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.02e-3)"	"unprognostic (2.44e-11)"	"unprognostic (7.92e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.91e-3)"	1.3	1.4	8.0	6.0	19.3	18.6	2.7	2.1	14.5	1.8	3.5	30.6	0.3	3.6	4.1	1.3	6.6	2.8	3.6	1.2	13.4	6.4	2.0	1.6	2.6	13.8	28.3	6.3	2.1	2.4	2.7	2.5	2.6	14.3	2.9	3.5	0.1	2.6	1.6	1.6	6.8	4.0	3.8	14.5	6.3	3.3	10.4	28.4	24.6	2.8	0.3	14.5	6.1	3.1	7.8	4.7	16.1	2.2	8.8	15.2	2.6	8.9	7.1	9.1	0.6	3.6	5.0	12.0	14.2	12.3	17.8	17.1	0.7	15.6	23.9	10.6	10.6	5.6	15.3	0.0	5.8	23.5	21.7	8.6	0.8	2.1	1.0	5.1	10.5	1.4	4.2	1.7	8.6	6.1	10.8	12.4	3.6	11.2	10.2	16.6	9.4	6.4	0.7	23.9	5.8	11.9	9.0	7.9	10.7	6.2	2.9	5.9	1.3	4.0	11.9	0.3	12.8	14.1	9.8	9.4	1.3	4.2	2.1	1.3	17.0	6.1	6.0	1.5	13.8	1.4	16.1	2.2	3.7	8.3	2.2	9.4	7.8	13.6	11.2	3.2	6.9	9.4	11.1	2.7	8.8	1.0	4.7	15.2	2.6	8.0	19.3	2.1	11.8	13.4	6.4	28.3	6.3	14.3	28.4	0.0	6.2	12.3	4.2	4.2	0.4	0.7	2.5	1.4	1.2	1.8	5.9	4.1	0.0	1.7	23.4	1.8	1.1	0.0	1.7	9.8	1.8	1.8	1.1	0.0	2.5	0.0	10.4	2.5	3.0	10.7	0.3	2.1	3.3	1.0	2.2	0.5	1.4	3.5	0.7	1.4	1.3	0.0	0.5	12.5	13.9	3.9	2.1	12.8	4.4	2.7
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160494995-160565588	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		250000	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	18.0	9.4	12.6	12.9	12.7	15.2	25.1	13.1	14.1	14.8	14.4	8.6	11.1	7.3	13.1	10.8	22.1	8.9	13.9	45.0	12.0	12.1	11.0	12.6	11.4	12.4	11.6	10.8	15.0	10.7	12.5	6.9	17.5	11.1	11.0	9.7	7.1	10.9	13.1	66.1	10.6	9.5	20.4	10.4	12.1	10.8	13.5	6.3	13.8	11.4	22.2	10.2	21.8	25.2	2.9	2.9	6.8	11.5	8.3	5.6	3.2	33.8	12.0	12.4	16.7	14.3	13.2	16.3	21.1	15.1	15.5	13.2	15.3	17.8	18.0	25.3	21.6	23.2	15.8	13.9	13.6	23.4	22.3	7.8	15.2	10.7	9.1	18.6	21.2	13.7	13.5	14.4	15.0	30.6	12.5	20.4	8.9	11.4	14.6	22.0	9.5	19.1	8.8	25.2	15.3	11.2	12.8	18.5	18.2	12.5	13.0	10.1	9.8	20.4	20.5	29.3	14.4	17.8	11.6	22.7	17.8	15.3	17.7	33.9	26.8	17.7	41.3	16.2	22.2	15.7	6.8	3.6	6.0	3.1	6.7	5.6	2.9	4.5	4.5	2.7	2.5	3.6	4.7	5.4	8.3	11.5	2.9	4.2	3.2	12.6	12.7	13.1	13.3	12.0	12.1	11.6	10.8	11.1	6.3	35.7	24.3	27.5	63.0	109.9	56.4	153.2	20.4	40.2	43.3	10.4	74.6	22.7	29.9	33.3	19.9	45.0	51.2	0.0	32.4	20.6	50.3	69.0	30.1	26.1	35.0	50.9	27.5	29.4	41.9	14.3	31.4	45.8	42.2	26.2	29.9	52.1	57.1	33.4	32.5	31.4	60.8	32.3	42.2	40.3	21.8	110.2	34.0	29.9	30.5	94.6
ARL14	"ARF7, FLJ22595"	ENSG00000179674	"ADP ribosylation factor like GTPase 14"	Q8N4G2	3	160677159-160678452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 44.5;intestine: 49.1;stomach 1: 24.5"	"Cell type enhanced"	"Detected in some"	21	"Enterocytes: 271.2;Intestinal endocrine cells: 85.5;Mucus-secreting cells: 83.6;Paneth cells: 63.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 6.6;pancreatic cancer: 26.0;stomach cancer: 14.3;urothelial cancer: 8.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"memory B-cell: 5.1"	"Lineage enriched"	"Detected in single"	52	"B-cells: 5.1"	"Group enriched"	"Detected in some"	4	"A-431: 6.5;CAPAN-2: 25.0;HaCaT: 6.2;OE19: 17.1;RT4: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.65e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.70e-3)"		"unprognostic (6.36e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-2)"	0.2	0.2	0.2	6.9	0.2	0.0	0.2	0.2	0.2	0.5	26.3	0.3	0.2	16.4	0.2	0.2	0.8	0.2	44.5	0.2	0.2	0.1	0.3	1.5	0.2	0.2	0.2	0.2	0.2	6.7	0.0	0.2	0.2	0.2	1.7	11.8	0.2	0.2	0.2	0.2	0.2	49.1	0.7	0.2	0.2	24.5	0.4	0.2	0.5	0.2	0.6	1.1	6.5	1.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	25.0	0.0	0.5	0.0	3.0	6.2	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	17.1	1.4	0.0	0.0	0.2	2.0	12.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	1.4	0.0	3.1	1.6	0.0	0.0	20.4	1.4	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	271.2	0.0	35.2	0.1	0.0	0.9	9.2	0.0	0.0	0.0	85.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.6	0.0	30.7	63.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	28.8	23.0
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078907	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 59.9;Cardiomyocytes: 33.6;Cone photoreceptor cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 35.6;U-266/70: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	7.7	8.5	7.4	3.5	11.5	3.3	6.3	15.8	23.2	11.3	7.0	5.5	1.1	3.0	6.2	3.7	8.7	6.1	12.6	9.9	6.3	7.8	8.4	6.0	4.6	1.9	8.0	10.1	3.7	5.4	33.6	26.3	11.5	13.8	9.6	5.9	5.6	18.9	3.7	25.7	7.6	3.6	16.4	4.6	3.4	8.4	2.8	3.7	5.6	14.4	9.6	3.5	16.6	10.8	0.7	1.3	4.9	7.6	1.1	2.6	2.0	1.2	0.8	4.1	2.1	2.4	0.0	2.5	0.2	0.1	0.4	0.1	0.2	0.2	0.2	0.4	0.1	0.9	3.7	3.4	0.2	0.1	35.6	3.6	3.5	3.3	0.4	0.1	2.1	4.1	0.4	1.6	0.1	0.2	0.3	0.2	1.7	0.1	5.6	0.0	1.9	0.8	0.2	2.3	6.5	0.8	4.2	0.7	0.8	0.1	3.8	4.9	4.2	2.0	2.4	0.1	1.4	2.7	2.1	0.2	0.4	0.4	0.3	1.3	35.6	0.1	2.0	0.6	1.8	0.8	0.7	2.3	4.9	2.6	5.5	0.2	0.2	0.6	1.7	1.3	0.7	1.0	1.8	0.2	1.1	7.6	0.8	0.0	2.0	7.4	11.5	15.8	17.9	6.3	7.8	8.0	10.1	13.8	3.7	6.0	2.4	0.0	5.2	7.7	59.9	33.6	10.2	13.4	5.7	1.8	33.4	2.4	0.0	1.5	1.1	2.4	3.8	0.0	3.7	1.6	7.0	6.0	0.0	14.9	5.9	6.4	13.3	0.6	12.4	0.4	4.6	7.2	3.3	2.8	7.6	9.3	1.7	7.0	4.9	3.3	10.1	0.0	11.2	1.5	3.1	7.5	2.2	2.9	4.9	18.0
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105384	"Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 36.8"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 52.9;Cardiomyocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;NK-cell: 16.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.9;NK-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.2;RT4: 52.6"	"Low region specificity"	"Detected in all"							HPA041204			Approved	Vesicles		NA	NA		290000	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	3.8	5.4	14.0	3.0	24.5	3.1	7.4	17.2	24.7	15.5	2.3	5.5	2.6	1.5	8.3	6.9	5.4	10.4	7.1	36.8	15.4	21.6	14.3	1.0	10.8	3.5	11.3	16.2	13.8	7.8	6.5	8.5	10.0	17.7	8.9	2.0	7.5	14.8	6.7	1.1	2.2	1.9	7.2	7.6	4.2	7.5	6.2	5.0	1.1	19.5	2.3	3.9	10.5	4.7	1.4	1.4	4.9	0.2	16.7	0.7	0.5	6.7	0.2	3.1	0.1	0.3	1.0	0.1	3.7	3.3	8.2	2.8	4.4	5.1	0.0	15.1	3.1	4.9	1.5	0.0	6.6	2.7	0.1	0.0	3.7	2.8	0.0	4.8	0.1	0.1	10.1	2.0	2.2	0.5	6.4	12.1	0.0	0.0	0.0	3.3	10.9	0.0	0.0	7.5	0.1	17.2	0.1	0.0	0.1	3.9	52.6	6.3	0.0	9.5	3.5	2.7	1.4	14.5	5.5	0.0	0.1	6.6	0.2	0.1	1.5	0.0	0.0	5.8	0.0	0.0	4.9	0.2	0.0	0.4	0.1	0.4	1.4	0.2	0.4	1.4	0.3	0.5	0.7	0.4	16.7	0.0	1.0	0.0	0.5	14.0	24.5	17.2	24.7	15.4	21.6	11.3	16.2	17.7	5.0	17.9	2.1	3.4	4.2	4.4	52.9	51.9	0.0	2.7	10.3	14.0	11.8	18.5	10.0	3.0	0.6	6.8	0.0	0.0	7.4	10.2	16.9	4.9	10.3	0.0	8.4	6.4	1.7	6.7	1.3	1.7	6.6	4.6	10.1	7.2	0.0	10.8	7.2	0.0	4.9	13.6	7.2	0.0	13.3	3.7	16.8	2.3	4.2	1.8	0.4	4.1
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.8	15.7	16.2	10.7	16.5	34.7	20.3	26.6	21.8	23.1	14.4	13.2	10.9	10.8	23.4	17.7	22.9	14.3	14.2	24.1	15.5	13.6	25.7	46.7	19.4	12.5	16.7	18.2	27.9	29.0	13.4	27.5	20.1	21.6	21.7	13.5	14.1	19.7	13.3	31.8	15.5	16.3	22.1	16.3	17.1	25.3	12.1	13.1	19.6	21.7	21.3	15.0	32.1	16.0	12.1	13.2	15.9	11.8	22.8	18.7	13.6	21.9	12.8	12.7	12.9	15.9	21.9	17.5	25.2	19.1	18.8	22.0	21.7	18.2	28.0	32.2	17.6	13.2	14.5	20.2	18.5	29.5	29.0	12.4	28.8	11.3	13.5	17.5	34.6	17.5	18.3	13.8	13.3	44.0	20.2	20.4	9.8	21.1	15.5	22.2	50.2	15.6	13.2	15.9	26.6	20.5	19.3	18.3	28.3	17.9	49.9	20.2	12.6	14.3	35.2	20.8	14.4	26.2	15.9	17.8	15.1	10.8	17.2	30.3	25.6	17.2	28.7	18.8	22.6	20.5	15.9	10.8	5.7	11.8	11.8	18.3	12.1	13.9	14.5	13.2	10.4	18.7	14.5	2.5	22.8	7.3	7.4	17.1	13.6	16.2	16.5	26.6	21.8	15.5	13.6	16.7	18.2	21.6	13.1	17.9	13.4	25.1	43.8	57.7	23.4	39.6	20.4	16.0	17.0	10.4	13.7	29.3	29.9	22.3	12.2	23.2	13.4	0.0	33.9	37.0	34.9	39.0	25.3	38.5	21.3	28.6	13.2	20.9	32.4	4.7	23.6	22.5	23.6	25.2	17.7	12.3	30.1	10.5	25.8	26.9	18.0	25.8	91.0	30.3	26.0	65.0	47.4	25.9	18.8	62.7
SPTSSB	"ADMP, C3orf57, ssSPTb"	ENSG00000196542	"Serine palmitoyltransferase small subunit B"	Q8NFR3	3	161344792-161372880	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 68.6;skin 1: 27.5;stomach 1: 42.0"	"Cell type enhanced"	"Detected in some"	13	"Exocrine glandular cells: 42.0;Glandular cells: 74.2;Melanocytes: 43.9;Suprabasal keratinocytes: 31.9;Urothelial cells: 53.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 24.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	12	"NK-cell: 68.6"	"Lineage enriched"	"Detected in many"	12	"NK-cells: 68.6"	"Group enriched"	"Detected in some"	10	"MCF7: 159.0;RT4: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047712			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA047712: AB_2680127"	"unprognostic (2.09e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.37e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.08e-2)"	"unprognostic (5.37e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.51e-3)"	1.4	0.4	2.0	0.7	3.4	0.5	6.4	8.9	18.5	4.0	0.9	1.6	0.0	0.5	1.0	0.4	5.1	0.6	1.5	0.4	2.2	2.2	0.7	0.6	0.3	1.0	2.0	6.2	0.4	1.5	0.3	0.3	0.3	12.0	12.4	0.8	0.2	8.0	0.4	0.4	27.5	0.5	1.4	1.1	1.1	42.0	0.3	0.4	0.1	0.4	2.1	1.7	23.5	5.4	0.0	0.0	0.2	0.0	68.6	5.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.0	0.0	0.0	0.6	9.7	1.8	0.0	0.0	0.0	0.0	42.2	0.2	1.7	0.0	5.7	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.6	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.2	68.6	0.0	0.0	0.0	0.5	2.0	3.4	8.9	18.5	2.2	2.2	2.0	6.2	12.0	0.4	0.0	0.0	0.0	17.2	3.4	1.5	0.3	2.5	0.0	0.0	3.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	42.0	0.0	0.4	74.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	1.6	0.0	16.3	0.0	0.0	0.0	1.3	0.0	2.7	0.0	0.0	31.9	0.1	0.9	0.0	53.8
OTOL1	"C1QTNF15, C1QTNF16"	ENSG00000182447	"Otolin 1"	A6NHN0	3	161496808-161503942	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	8	"brain: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041030	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041030: AB_10795000"																		0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.1		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078495	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	123	"intestine: 181.4"	"Group enriched"	"Detected in some"	7	"Enterocytes: 48.7;Mucus-secreting cells: 79.9;Paneth cells: 46.3;Undifferentiated cells: 29.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 4.1;HeLa: 3.2;NB-4: 3.4;RPMI-8226: 4.9;SH-SY5Y: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011897	Enhanced					NA	NA					"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.1	0.1	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	93.3	0.0	0.0	94.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.4	0.0	0.1	0.0	0.1	0.1	181.4	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.8	0.0	0.0	0.0	0.0	79.9	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	29.8	0.0
SLITRK3	KIAA0848	ENSG00000121871	"SLIT and NTRK like family member 3"	O94933	3	165186720-165197109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;liver: 12.8"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 4.5;Hepatocytes: 2.4"	"Cancer enriched"	"Detected in single"	22	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.6;HAP1: 5.5;Karpas-707: 1.6;SCLC-21H: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017636, HPA048042"	Enhanced		Approved	Mitochondria		No	NA		1400000	Mitochondria		"HPA017636: AB_1857232, HPA048042: AB_2732542"	"unprognostic (8.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.08e-2)"		"unprognostic (1.96e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-1)"		"unprognostic (6.74e-3)"	"unprognostic (5.03e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.03e-4)"	0.6	0.6	7.4	2.0	12.0	0.4	0.5	10.6	17.4	9.9	3.0	1.5	0.3	1.1	12.1	2.0	7.6	12.6	0.8	1.0	13.2	5.5	0.6	12.8	0.9	0.5	3.7	6.5	2.5	0.4	0.4	0.3	0.4	4.2	3.3	3.1	0.3	0.8	9.6	0.9	0.5	1.5	6.2	2.3	0.4	0.8	1.0	2.4	0.0	0.6	0.0	0.5	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	12.0	10.6	15.7	13.2	5.5	3.7	6.5	4.2	2.4	0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837472	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 145.4"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 360.7"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Karpas-707: 131.7"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	NA	NA		13000000000			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	14.0	3.9	6.7	6.2	4.3	0.4	1.9	3.6	9.1	24.4	15.5	4.7	8.3	1.8	20.2	13.4	20.0	18.0	2.2	7.8	6.1	4.4	2.8	145.4	3.7	0.7	5.5	2.7	10.3	1.1	0.4	1.2	0.5	4.7	4.7	5.3	0.7	1.0	10.5	1.1	2.8	6.4	13.9	3.4	3.7	1.9	1.8	6.1	1.0	0.8	0.4	0.5	9.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.9	0.0	1.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	4.2	0.2	0.0	1.4	4.4	0.6	5.2	0.0	131.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.8	10.9	0.1	0.0	0.0	0.1	0.0	0.0	7.5	0.0	5.8	0.0	0.0	3.2	0.0	0.0	1.3	0.5	0.0	0.2	1.3	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.3	3.6	4.3	6.1	4.4	5.5	2.7	4.7	6.1	0.0	0.0	0.0	0.3	4.8	0.9	4.3	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	1.5	0.0	0.0	0.0	0.0	2.2	0.2	0.0	360.7	0.1	1.6	0.0	6.2	5.3	5.5	2.0	0.0	18.6	0.0	0.0	34.4	0.0	0.0	0.0	2.9	1.0	0.0	4.6	0.3	0.1	3.0	0.0	0.0	0.0	0.1
ZBBX	FLJ23049	ENSG00000169064	"Zinc finger B-box domain containing"	A8MT70	3	167240287-167381346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;epididymis: 14.2;fallopian tube: 23.4;testis: 33.3"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 290.4;Early spermatids: 339.8;Late spermatids: 178.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.4;CAPAN-2: 1.7;SCLC-21H: 1.5;SuSa: 5.2;U-87 MG: 1.8"					"Low region specificity"	"Detected in many"			"HPA036327, HPA036328"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036327: AB_10672240, HPA036328: AB_2675063"	"unprognostic (2.68e-3)"	"unprognostic (4.49e-2)"		"unprognostic (6.94e-2)"	"unprognostic (3.99e-1)"			"unprognostic (4.08e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"		0.3	0.6	2.5	0.3	12.9	0.3	0.3	0.0	3.3	1.3	0.4	4.5	0.0	0.3	1.1	14.2	0.3	23.4	0.3	0.3	4.7	3.9	0.5	0.3	7.2	0.4	0.4	2.6	6.9	0.3	0.8	5.3	0.4	22.0	0.4	0.3	0.0	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.3	0.4	33.3	3.4	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.2	0.4	0.0	0.0	1.1	0.6	0.0	0.1	0.6	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	12.9	0.0	3.3	4.7	3.9	0.4	2.6	22.0	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	290.4	40.9	1.8	0.0	0.0	0.0	0.0	339.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	178.7	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	21.8	10.0	0.0	0.0	0.0	0.0	0.0
SERPINI2	"MEPI, PANCPIN, PI14, TSA2004"	ENSG00000114204	"Serpin family I member 2"	O75830	3	167441789-167479004	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	73	"pancreas: 184.7"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 29.4;Exocrine glandular cells: 82.5"	"Cancer enriched"	"Detected in some"	6	"pancreatic cancer: 7.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.5"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.5"	"Cell line enriched"	"Detected in some"	6	"THP-1: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to digestive system"	NA	NA						"unprognostic (1.88e-2)"	"unprognostic (2.23e-3)"		"unprognostic (1.14e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.17e-2)"		"unprognostic (1.29e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.76e-5)"	"unprognostic (5.35e-2)"	"unprognostic (4.16e-2)"			0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	184.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	14.1	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.1	2.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.4	0.0	29.4	10.3	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	82.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 21.6;fallopian tube: 20.7"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 50.9;Club cells: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2"	"Group enriched"	"Detected in many"	24	"dendritic cells: 5.2;monocytes: 5.6"	"Cell line enhanced"	"Detected in some"		"AF22: 3.4;NTERA-2: 3.8;THP-1: 17.1;U-937: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA036225: AB_10696652, HPA036226: AB_2675007"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.5	0.7	6.5	1.1	6.8	3.6	0.6	12.6	5.0	1.2	0.9	8.5	0.0	3.9	1.2	4.4	2.1	20.7	0.7	4.7	12.3	5.4	1.0	0.4	4.0	0.9	7.6	2.8	3.2	0.9	0.4	1.7	0.4	21.6	0.7	0.6	0.0	0.7	0.4	0.4	0.5	8.0	0.7	17.6	1.1	0.8	1.5	14.2	0.0	0.5	0.0	1.0	0.8	0.6	0.2	5.2	0.0	5.6	0.0	0.0	0.7	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	5.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	6.5	6.8	12.6	3.7	12.3	5.4	7.6	2.8	21.6	14.2	0.0	1.1	0.0	0.8	0.0	0.0	1.0	0.0	50.9	18.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5
PDCD10	"CCM3, TFAR15"	ENSG00000114209	"Programmed cell death 10"	Q9BUL8	3	167683298-167734939	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027095	Approved					NA	NA		680000			"HPA027095: AB_1855101"	"unprognostic (3.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.98e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.95e-3)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (3.08e-2)"	"prognostic favorable (5.88e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.58e-2)"	29.1	24.9	22.4	24.8	29.6	35.5	28.5	23.6	33.1	24.1	33.4	17.7	12.7	32.3	22.6	20.6	42.3	19.1	20.2	23.3	23.5	24.0	45.3	27.4	24.6	32.1	31.3	19.6	24.3	20.7	18.1	34.9	44.8	34.0	22.1	33.5	14.6	27.0	18.4	16.9	20.7	45.0	20.5	35.3	35.8	26.6	27.9	25.8	38.4	30.1	27.3	33.7	31.1	25.8	40.2	24.0	57.6	38.9	30.7	53.1	38.3	36.1	13.7	17.5	11.2	16.5	18.3	19.3	21.9	23.3	25.7	26.0	25.5	43.0	29.6	43.2	20.3	44.9	24.1	20.5	25.4	31.2	46.9	14.9	45.1	18.2	16.7	23.5	29.7	26.6	13.9	26.5	16.2	26.7	18.5	20.6	24.9	34.8	29.8	23.2	31.9	23.7	18.4	22.5	32.8	19.1	14.0	13.3	43.0	32.1	14.8	16.8	15.0	21.0	22.9	40.3	23.0	42.2	25.5	19.6	18.3	11.8	19.6	31.1	32.4	45.4	51.0	21.7	31.5	14.9	53.9	25.7	57.6	27.0	31.9	32.2	40.2	36.8	32.3	24.0	38.7	30.9	31.8	53.7	30.7	38.9	22.1	53.1	38.3	22.4	29.6	23.6	33.1	23.5	24.0	31.3	19.6	34.0	25.8	41.7	32.3	53.3	71.3	96.0	20.2	66.6	33.1	69.6	67.1	31.4	5.9	95.8	89.5	94.1	39.6	59.9	63.0	23.3	107.3	94.2	49.1	73.3	61.2	36.4	81.7	19.1	33.3	40.5	50.3	20.3	46.1	74.1	47.2	107.4	66.6	42.2	96.2	77.2	37.1	84.8	23.0	32.3	59.0	110.0	100.9	112.8	86.2	65.4	43.1	105.0
SERPINI1	"neuroserpin, PI12"	ENSG00000163536	"Serpin family I member 1"	Q99574	3	167735243-167825568	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 96.0"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 71.8;Muller glia cells: 71.6;Smooth muscle cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 15.9;HeLa: 16.5;Karpas-707: 18.5;U-266/84: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001565, HPA056092"	Enhanced		Uncertain	Cytosol	"Secreted in brain"	NA	NA		200000	Cytosol		"HPA001565: AB_1079924, HPA056092: AB_2683036"	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.11e-1)"	5.9	8.2	31.9	2.4	27.9	1.3	6.1	3.6	96.0	4.2	2.8	7.1	0.4	1.5	4.3	4.3	3.2	3.9	3.4	6.4	35.9	35.3	14.5	2.5	3.4	2.3	36.9	35.7	4.0	16.3	3.7	10.3	3.5	22.9	5.8	2.5	2.4	9.9	3.6	1.7	2.1	2.5	3.1	51.6	4.1	3.6	7.0	15.9	0.0	5.2	0.3	3.8	3.1	1.6	15.4	4.4	1.0	0.4	6.0	16.0	3.4	0.4	2.0	3.2	0.2	6.0	1.6	0.2	1.2	1.8	0.8	1.3	0.7	3.9	15.9	6.1	0.8	2.7	0.9	2.1	2.2	0.9	5.0	4.5	5.4	16.5	6.7	0.4	0.8	0.6	2.3	0.8	0.4	0.8	1.8	0.2	6.1	10.1	18.5	0.7	1.5	0.4	1.1	2.0	2.5	2.5	1.8	0.1	2.0	6.9	0.5	1.3	8.4	2.3	4.3	5.1	7.8	6.6	2.4	0.5	3.5	0.3	0.3	5.7	13.9	17.1	11.6	2.9	4.1	2.0	1.0	0.2	0.5	6.2	0.4	4.5	12.7	6.5	6.6	0.3	15.4	4.7	5.7	0.6	6.0	0.3	4.4	16.0	3.4	31.9	27.9	3.6	78.9	35.9	35.3	36.9	35.7	22.9	15.9	6.0	1.0	8.0	12.2	3.3	71.8	7.3	0.0	13.4	7.9	5.2	13.7	5.0	6.6	1.5	0.3	9.2	0.0	0.0	15.6	4.7	5.2	9.8	2.3	0.6	2.3	4.8	4.6	3.1	0.8	1.8	3.7	1.9	6.8	1.8	0.1	71.6	4.6	0.0	2.5	31.2	31.4	25.8	68.9	1.8	13.2	1.5	4.2	5.3	0.0	1.6
GOLIM4	"GIMPC, GOLPH4, GPP130, P138"	ENSG00000173905	"Golgi integral membrane protein 4"	O00461	3	168008677-168095975	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Muller glia cells: 383.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001677, HPA002315"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		730000	"Golgi apparatus"		"HPA001677: AB_1079017, HPA002315: AB_1079018"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-3)"	13.0	7.1	25.5	10.8	25.6	4.2	9.3	12.4	24.2	11.3	28.0	18.6	7.4	34.8	15.6	7.1	9.3	9.7	16.2	28.5	31.3	13.8	17.1	31.7	15.6	5.5	24.6	23.2	11.6	8.8	13.3	10.3	12.0	26.8	10.2	28.0	13.3	8.9	7.9	15.5	6.1	44.2	14.6	36.2	11.7	13.0	4.9	30.9	1.8	11.0	12.0	5.0	10.7	12.2	2.0	4.5	11.7	3.3	6.0	0.8	0.7	6.6	9.9	14.1	8.9	24.1	17.9	4.2	39.4	21.2	10.8	9.9	11.0	8.2	14.7	47.4	23.7	17.3	12.3	12.9	11.6	16.4	22.9	16.6	23.8	29.8	13.6	9.7	22.6	13.6	18.6	6.1	9.9	9.8	9.6	12.3	0.0	12.1	42.9	12.1	11.1	0.0	6.1	13.8	12.6	10.7	0.0	14.2	20.4	6.0	2.4	12.7	16.5	24.2	7.3	7.9	9.8	9.0	10.3	22.8	34.4	13.2	23.9	31.4	16.7	11.9	31.7	17.0	13.6	15.3	3.0	3.0	11.7	0.8	3.3	0.2	1.5	0.2	0.6	3.7	2.0	0.0	0.3	0.1	6.0	2.5	4.5	0.0	0.7	25.5	25.6	12.4	24.2	31.3	13.8	24.6	23.2	26.8	30.9	44.7	105.2	7.5	21.5	36.9	14.2	142.4	53.5	13.4	34.2	34.9	35.3	9.2	14.9	18.7	1.3	65.5	167.7	23.3	25.9	12.0	109.4	20.4	56.6	158.4	37.0	15.9	60.8	43.0	34.5	1.5	36.8	47.8	35.4	18.0	109.7	383.7	19.8	168.4	48.1	30.0	58.3	45.3	104.0	5.0	38.5	31.5	4.6	20.1	119.7	6.8
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663618	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 169.5;Club cells: 93.3;Collecting duct cells: 118.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.6;HUVEC TERT2: 22.0;RPTEC TERT1: 28.2;RT4: 44.4;TIME: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046537	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA046537: AB_2679689"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	25.9	0.7	3.3	5.7	5.6	0.3	9.1	3.4	5.3	13.5	13.9	1.6	22.1	11.2	15.4	5.7	10.4	14.3	8.1	8.2	3.3	2.9	32.2	2.6	30.0	1.5	4.6	1.4	6.2	27.8	1.1	5.3	10.0	4.7	9.3	17.5	4.2	5.9	25.3	16.0	2.3	5.9	5.6	5.8	6.4	39.4	2.7	3.5	0.2	4.7	3.3	3.5	18.1	18.5	0.3	0.0	0.6	1.5	1.8	1.0	0.0	9.8	0.1	0.2	0.0	1.3	1.0	0.1	1.3	1.6	0.5	0.9	3.9	10.1	0.0	15.6	0.2	2.2	5.2	4.1	6.1	1.1	0.5	6.4	6.2	1.7	0.1	0.1	0.0	1.9	2.1	0.8	0.3	4.6	4.8	22.0	0.5	4.7	0.7	3.9	1.0	0.0	0.0	0.2	5.1	2.5	3.7	5.1	0.2	28.2	44.4	0.3	1.2	0.4	2.6	0.1	0.3	3.0	0.0	20.9	3.9	2.5	1.0	6.5	0.5	0.1	0.3	1.9	0.0	0.6	0.3	0.0	0.6	0.4	0.2	1.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	1.8	1.5	0.0	0.1	0.0	3.3	5.6	3.4	5.3	3.3	2.9	4.6	1.4	4.7	3.5	56.6	169.5	0.0	27.4	1.9	0.0	6.7	5.1	64.3	93.3	118.7	0.0	0.9	44.7	0.8	4.6	40.2	10.5	0.0	65.4	0.1	1.5	9.9	9.2	0.0	0.0	0.0	19.1	34.4	0.6	1.7	0.3	1.0	1.7	1.8	23.3	0.0	42.3	3.5	0.0	0.3	0.0	0.0	0.7	2.1	0.4	1.3	0.3	0.5	49.4	38.8
ACTRT3	ARPM1	ENSG00000184378	"Actin related protein T3"	Q9BYD9	3	169766921-169769895	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"testis: 57.4"	"Cell type enriched"	"Detected in many"	9	"Early spermatids: 728.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.0;HSkMC: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA035817, HPA035818"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035817: AB_10671938, HPA035818: AB_2674801"	"unprognostic (2.35e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.22e-1)"	1.0	0.7	0.9	0.4	1.1	0.5	1.5	2.4	1.3	1.0	0.5	0.5	1.3	0.7	0.7	1.4	0.6	1.4	0.5	0.7	0.7	0.9	1.8	1.7	0.7	0.6	1.0	0.4	1.1	0.3	0.8	1.0	0.7	1.1	1.0	0.4	0.6	0.5	1.3	0.7	0.3	0.5	1.0	0.6	0.1	0.8	57.4	0.7	0.2	1.0	0.1	0.5	1.5	3.1	1.2	0.5	0.0	0.0	0.0	3.4	0.4	3.6	2.2	0.2	1.1	16.0	5.2	0.0	4.4	2.6	2.7	2.3	0.0	4.6	0.0	6.1	4.9	1.8	2.3	1.2	2.1	2.8	2.7	1.6	8.4	1.9	0.4	2.6	0.9	0.7	10.3	0.5	3.3	0.6	1.8	4.9	1.0	0.0	0.0	4.8	1.8	0.3	0.1	3.9	3.1	4.6	0.7	0.0	0.1	2.9	0.9	2.9	2.0	5.2	1.3	0.1	0.5	2.2	3.6	2.2	0.0	0.0	2.2	0.0	0.5	0.2	0.2	1.1	0.0	0.5	0.0	0.0	0.0	0.7	0.0	3.4	1.2	0.0	1.1	0.5	1.1	0.4	0.4	0.0	0.0	0.0	0.5	0.0	0.4	0.9	1.1	2.4	1.3	0.7	0.9	1.0	0.4	1.1	0.7	0.0	1.0	0.0	0.7	0.3	1.0	0.6	0.0	2.7	2.3	0.0	2.0	1.4	1.7	2.0	728.6	0.7	0.0	0.0	1.8	1.1	1.4	0.4	1.1	1.7	1.4	3.2	0.0	1.8	0.6	82.5	8.9	0.6	1.7	0.0	0.1	1.4	1.3	0.0	5.3	2.5	1.1	12.9	1.9	5.5	4.0	0.0	0.7	0.0	0.4	0.3
MYNN	"SBBIZ1, ZBTB31, ZNF902"	ENSG00000085274	Myoneurin	Q9NPC7	3	169772831-169789716	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045149	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045149: AB_10960839"	"unprognostic (7.13e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.36e-3)"	20.3	10.3	10.3	10.6	13.3	22.4	16.4	29.7	15.3	18.4	12.3	8.9	17.7	8.8	17.7	10.9	15.4	15.1	10.5	12.1	13.0	9.0	13.5	13.7	11.4	13.6	12.9	13.7	22.4	15.8	16.2	18.4	17.5	16.0	16.7	12.0	7.7	12.5	11.6	17.9	13.0	16.4	14.3	12.4	16.3	14.3	16.1	15.8	17.5	15.4	13.1	15.9	15.3	12.9	8.2	5.2	19.0	5.0	10.0	10.6	7.6	9.5	4.3	5.3	10.3	10.8	9.3	6.7	6.8	9.2	9.8	10.9	5.4	9.9	14.7	11.8	6.9	8.0	7.7	9.3	8.0	13.0	13.2	7.3	13.9	6.4	5.2	9.3	12.4	10.0	8.2	10.4	6.0	17.5	8.0	8.6	6.4	5.7	14.8	9.6	8.0	7.3	6.4	7.9	11.7	5.0	8.0	7.3	15.2	6.4	16.4	7.4	8.9	7.9	17.7	10.7	7.1	21.7	9.0	6.6	9.0	4.4	8.5	12.3	17.5	12.1	20.0	7.3	7.8	8.9	19.0	5.0	11.9	7.6	5.0	10.2	8.2	8.7	7.2	5.1	8.1	10.6	8.4	13.5	10.0	4.1	5.2	8.4	7.6	10.3	13.3	29.7	15.3	13.0	9.0	12.9	13.7	16.0	15.8	26.8	16.3	8.3	27.3	36.7	10.7	10.9	17.8	20.1	19.4	10.4	21.6	13.1	11.6	8.7	32.8	15.7	8.8	0.0	8.2	14.2	14.2	14.5	7.0	6.4	7.1	9.5	13.7	11.1	9.1	8.9	15.8	9.1	15.1	10.8	7.6	12.0	9.1	9.3	17.7	10.4	30.3	6.5	15.7	28.4	16.8	33.5	17.4	15.4	8.3	23.0
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793428-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 13.7;testis: 23.8"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 144.6;Cone photoreceptor cells: 35.3;Early spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	7	"B-cells: 2.2;dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.4;HEL: 9.3;HL-60: 9.8;JURKAT: 8.1;NTERA-2: 9.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Cell Junctions, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	2.8	1.1	4.8	1.2	9.6	2.7	2.3	1.1	4.0	2.3	0.9	4.2	1.4	1.0	1.9	3.9	1.0	13.7	1.1	2.0	4.1	3.8	2.1	0.9	3.4	1.9	3.5	5.6	2.2	0.5	1.0	7.9	0.9	11.8	2.0	0.7	2.6	1.3	2.4	0.9	1.0	1.1	2.0	3.6	1.8	1.1	23.8	4.8	1.7	2.7	0.5	1.2	1.0	0.9	2.2	4.6	0.1	0.3	0.0	0.5	0.4	2.7	0.4	0.8	0.0	1.1	4.1	0.0	1.2	2.4	2.8	2.7	0.1	0.0	1.6	0.0	0.7	3.8	0.0	2.5	0.0	1.0	0.4	7.4	9.3	0.1	0.0	0.7	9.8	2.4	1.4	0.4	1.1	0.0	0.1	1.7	8.1	0.2	0.0	1.0	0.0	0.9	1.9	9.9	0.0	3.1	4.9	0.0	0.5	2.3	0.2	4.9	3.8	0.8	0.1	0.0	0.3	0.0	4.7	0.4	0.6	0.0	0.3	0.0	0.0	0.0	2.3	4.5	0.1	2.6	0.0	0.2	0.0	0.0	0.3	0.2	2.2	0.0	0.0	1.4	1.5	0.0	0.0	0.1	0.0	0.0	4.6	0.5	0.4	4.8	9.6	1.1	4.0	4.1	3.8	3.5	5.6	11.8	4.8	3.0	1.6	0.0	0.9	0.3	5.3	2.8	0.0	144.6	15.9	5.2	35.3	0.2	1.7	0.5	74.2	1.5	0.0	0.0	0.2	0.2	3.2	0.7	1.1	0.0	2.2	11.1	4.1	11.1	0.3	23.5	9.8	1.7	0.0	6.4	0.5	6.0	0.2	0.0	9.9	3.2	18.6	0.0	1.7	29.6	8.6	0.3	0.5	0.7	0.1	0.3
LRRIQ4	LRRC64	ENSG00000188306	"Leucine rich repeats and IQ motif containing 4"	A6NIV6	3	169821922-169837775	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 7.1"	"Group enriched"	"Detected in some"	51	"Early spermatids: 39.4;Late spermatids: 18.7"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HEL: 2.6;JURKAT: 2.3;RT4: 4.8;T-47d: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036271, HPA036706"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036271: , HPA036706: AB_2675264"	"unprognostic (5.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-4)"	"unprognostic (5.26e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (4.56e-3)"	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	1.0			0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1		0.3	0.0	0.0	0.2	0.0		0.1	0.1		0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.6	7.1			0.0		0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.3	0.0	0.3	0.2	0.0	0.4	0.0	0.0	1.7	0.3	0.2	1.6	0.0	0.7	0.0	0.4	2.0	0.1	2.6	0.0	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.2	0.0	0.1	0.5	0.4	1.1	0.7	1.0	0.0	0.0	0.1	4.8	1.9	0.6	0.1	0.4	0.0	0.0	4.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
LRRC31	FLJ23259	ENSG00000114248	"Leucine rich repeat containing 31"	Q6UY01	3	169839179-169869930	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.3;salivary gland: 7.0;stomach 1: 7.6"	"Cell type enhanced"	"Detected in some"	22	"Intestinal endocrine cells: 9.9;Mucus-secreting cells: 20.2;Paneth cells: 6.6;Undifferentiated cells: 4.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"		"unprognostic (9.90e-2)"	"unprognostic (4.40e-2)"		"unprognostic (7.90e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.20e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.96e-3)"	0.3	0.0	0.3	1.2	0.3	0.0	0.3	0.3	0.3	0.9	14.2	0.3	0.3	6.4	0.3	0.3	0.3	0.0	1.0	0.3	0.3	0.0	0.3	3.9	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.5	17.3	0.3	7.0	0.3	0.3	0.0	10.5	0.3	0.3	0.3	7.6	0.3	0.3	0.3	0.3	0.3	1.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.3	0.0	6.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.1
SAMD7	DKFZp686E1583	ENSG00000187033	"Sterile alpha motif domain containing 7"	Q7Z3H4	3	169911572-169939175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"retina: 34.7"	"Group enriched"	"Detected in some"	13	"Cone photoreceptor cells: 45.2;Rod photoreceptor cells: 125.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Daudi: 2.4;U-698: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (1.27e-3)"									"unprognostic (5.46e-2)"				0.0	0.3	0.1	0.0	0.2	0.6	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	34.7	0.1	0.0	0.1	0.2	0.3	0.0	0.0	0.5	0.1	1.2	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.5	0.0	0.8	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	4.2	0.0	0.1	0.0	0.4	0.1	0.4	0.2	0.0	0.2	0.4	0.1	0.2	0.0	0.5	0.2	0.1	0.8	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.7	0.1	0.0	0.0	0.0	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	125.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1
SEC62	"Dtrp1, HTP1, TLOC1"	ENSG00000008952	"SEC62 homolog, preprotein translocation factor"	Q99442	3	169966635-169998373	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014059, HPA061450"	Approved		Approved	"Endoplasmic reticulum,Intermediate filaments"		NA	NA			"Endoplasmic reticulum"	"Intermediate filaments"	"HPA014059: AB_1858029, HPA061450: AB_2684524"	"unprognostic (8.15e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-1)"	33.2	30.8	43.1	18.8	46.0	27.3	22.5	30.3	51.7	28.7	26.6	19.7	33.1	19.6	26.1	47.7	25.5	18.7	20.2	21.0	41.7	40.7	41.7	65.7	25.7	19.5	53.2	25.9	31.9	39.5	37.3	34.7	37.8	53.9	34.0	19.9	10.5	39.7	30.8	22.1	11.2	24.4	32.5	55.1	35.3	30.1	16.3	40.2	17.6	42.3	12.2	21.8	43.7	28.3	38.5	14.9	25.0	15.5	12.7	23.6	11.0	34.3	24.2	19.1	16.8	57.2	30.3	12.0	44.1	32.5	20.6	21.5	25.8	36.3	38.7	49.3	31.5	34.4	32.9	23.4	21.3	32.4	30.2	22.7	26.8	15.1	25.9	41.6	27.1	17.6	30.2	20.5	22.6	22.1	28.3	20.3	12.0	16.4	37.5	24.4	28.7	14.2	14.4	19.5	27.6	15.9	19.1	27.6	52.1	29.5	22.1	19.6	18.5	36.1	39.7	30.1	19.2	59.4	25.0	27.0	29.3	13.3	24.4	35.5	43.5	32.6	60.5	30.7	21.2	27.3	6.4	14.1	25.0	19.4	15.5	22.2	33.2	18.4	19.4	13.0	38.5	23.6	20.9	22.2	12.7	11.6	14.9	16.0	11.0	43.1	46.0	30.3	51.7	41.7	40.7	53.2	25.9	53.9	40.2	220.3	262.7	342.9	200.0	226.0	367.3	496.5	300.7	294.5	280.9	645.6	261.1	203.3	165.8	224.9	14.0	313.8	139.0	771.0	299.5	183.3	350.0	241.8	280.2	977.5	192.3	427.5	250.7	386.1	211.1	22.8	518.6	248.1	264.9	296.6	208.7	387.4	260.2	190.0	409.4	320.7	346.7	291.1	249.2	173.4	114.7	150.7	363.1	201.5	162.6	151.0
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037929-170085403	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.0"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 186.9;Rod photoreceptor cells: 156.5;Undifferentiated cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 31.0;SK-BR-3: 24.8;THP-1: 48.9;U-266/70: 54.0;U-266/84: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA006970	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.61e-4)"	7.0	1.4	3.1	21.7	2.5	23.6	8.2	0.9	1.8	2.6	31.2	1.5	7.9	18.0	1.9	21.5	2.6	1.8	16.2	3.0	1.9	1.7	27.4	2.1	23.2	25.6	2.7	0.4	1.6	14.7	71.0	3.5	2.9	1.8	10.7	18.1	11.8	14.2	4.7	2.0	1.8	43.2	0.9	4.7	17.9	18.0	2.9	2.4	6.6	3.8	1.0	10.7	9.1	6.9	11.2	2.9	10.1	1.1	0.3	3.0	1.2	15.9	0.3	0.0	0.1	0.1	0.1	4.0	0.1	0.1	0.1	0.5	2.9	2.0	7.4	3.4	0.1	1.0	0.1	2.2	0.1	0.2	11.3	4.4	4.8	0.2	6.0	0.0	9.4	6.5	0.0	0.2	0.5	0.6	0.7	0.3	3.5	1.5	19.2	0.1	10.2	0.7	2.0	2.6	9.8	0.6	1.3	0.3	31.0	8.4	22.1	1.6	0.4	0.2	24.8	1.1	2.2	14.5	48.9	0.5	0.0	0.1	1.8	1.2	54.0	31.0	12.9	0.2	10.2	0.7	1.5	1.1	8.1	0.5	0.4	0.9	6.8	0.9	0.4	2.2	11.2	3.0	1.1	10.1	0.3	0.1	2.9	0.3	1.2	3.1	2.5	0.9	1.8	1.9	1.7	2.7	0.4	1.8	2.4	8.9	39.0	27.8	3.1	0.3	7.9	1.0	25.5	18.7	18.2	59.3	37.3	2.6	46.4	10.6	24.4	4.5	103.3	0.0	63.8	15.0	0.4	47.4	1.1	0.5	7.0	14.3	186.9	16.0	9.2	32.2	0.6	10.0	27.0	97.4	129.6	7.7	48.2	137.8	0.4	121.7	156.5	0.0	0.3	6.4	11.9	0.6	22.8	2.5	149.6	25.7
PHC3	"EDR3, FLJ12729, FLJ12967, HPH3"	ENSG00000173889	"Polyhomeotic homolog 3"	Q8NDX5	3	170086732-170181749	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039162, HPA062031"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039162: AB_10671038, HPA062031: AB_2684666"	"unprognostic (4.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.76e-2)"	17.9	11.7	12.0	13.1	19.2	50.9	17.4	28.2	16.7	14.9	16.1	18.8	13.8	12.8	19.1	10.1	14.6	14.4	15.0	14.2	14.8	7.6	12.0	11.2	18.7	19.2	15.4	11.7	19.0	13.5	23.3	26.3	11.5	14.7	15.4	13.3	19.1	18.4	16.0	17.3	15.9	17.0	20.4	16.5	15.0	16.0	14.6	17.7	16.4	19.2	8.6	17.1	20.9	15.4	15.7	19.7	18.6	8.7	8.9	14.5	5.3	16.9	16.0	3.5	5.8	9.9	10.2	6.5	7.2	8.1	7.5	9.4	10.6	8.5	8.1	17.8	10.1	10.0	8.5	7.6	6.9	13.5	18.6	7.1	13.7	14.4	4.8	5.9	17.0	7.5	7.3	4.1	11.2	15.9	5.4	5.6	6.3	3.3	22.6	6.9	15.6	7.8	3.6	3.6	5.4	6.0	5.8	15.0	11.6	3.8	19.1	3.8	2.3	24.0	15.1	5.0	2.3	17.4	13.2	11.1	10.4	6.3	8.6	12.4	21.8	17.6	23.8	6.6	6.5	6.3	6.6	5.5	18.6	12.7	8.7	10.7	13.1	12.3	11.1	5.9	15.7	12.7	11.2	7.5	8.9	5.4	19.7	14.5	5.3	12.0	19.2	28.2	16.7	14.8	7.6	15.4	11.7	14.7	17.7	20.8	26.4	22.3	15.2	12.6	33.3	19.6	20.4	21.4	19.4	26.2	56.9	12.6	0.0	6.9	4.8	19.6	11.4	23.3	6.4	8.0	18.8	19.0	12.7	13.4	9.8	50.9	7.5	17.8	14.8	2.7	27.3	20.3	18.6	11.8	13.9	21.0	9.1	19.0	26.2	8.2	131.7	6.5	19.8	19.1	19.0	13.9	15.3	30.6	12.9	14.3
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222365-170305981	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	10.3	7.5	11.4	5.9	15.5	2.1	9.5	14.8	16.6	12.5	11.1	7.0	6.0	10.4	13.1	8.4	20.6	15.1	10.5	10.1	9.5	7.7	13.0	6.7	14.8	3.9	5.6	9.4	15.2	7.7	12.4	14.7	9.8	11.0	16.3	12.2	7.3	25.8	12.6	12.7	11.0	11.6	12.5	6.8	6.1	30.2	15.0	5.3	12.6	23.1	8.4	9.9	16.3	13.0	1.9	1.8	1.0	1.3	5.8	4.8	1.4	34.3	8.7	8.8	9.4	7.8	10.9	14.2	8.8	13.0	11.7	12.7	12.7	16.8	10.5	29.1	12.3	16.1	16.1	16.5	17.3	20.1	7.6	10.2	9.7	11.0	7.0	12.4	8.7	4.4	9.8	12.1	10.0	15.7	19.0	9.1	5.8	10.7	8.7	11.7	11.8	12.6	3.4	18.4	36.7	9.7	9.2	13.5	17.3	18.4	10.5	14.0	11.4	19.0	25.0	8.6	13.6	27.5	6.0	9.6	12.2	9.4	11.4	14.5	15.0	14.4	15.0	8.8	6.9	4.7	0.1	1.3	1.0	2.6	1.2	4.0	1.8	3.6	4.8	1.8	1.9	3.9	2.2	0.7	5.8	1.1	1.8	2.3	1.4	11.4	15.5	14.8	16.6	9.5	7.7	5.6	9.4	11.0	5.3	68.5	56.0	2.2	46.0	50.7	15.9	14.9	25.5	22.7	46.6	47.1	13.7	23.8	21.6	13.9	5.5	18.0	21.2	0.0	19.5	22.1	25.6	78.7	8.1	17.8	8.9	14.3	28.2	16.5	20.8	3.6	21.6	10.0	16.9	6.4	28.1	8.1	36.5	17.5	26.9	15.1	9.3	19.4	11.4	12.9	15.1	55.7	17.3	5.7	27.7	69.1
SKIL	"SNO, SnoA, SnoN"	ENSG00000136603	"SKI like proto-oncogene"	P12757	3	170357678-170396835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"granulocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008472, HPA014233"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA008472: AB_1856933, HPA014233: "	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (2.94e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.34e-1)"	16.2	15.0	10.5	21.1	14.7	22.8	12.4	5.0	18.2	14.0	11.8	12.2	13.4	15.9	17.1	12.7	14.4	12.0	26.8	21.7	11.2	11.4	15.0	18.0	23.8	15.2	11.6	10.6	17.8	11.4	9.6	21.1	26.6	16.0	15.8	11.7	14.8	14.2	17.0	19.5	10.3	28.0	13.5	17.3	12.6	17.9	14.4	8.3	14.0	18.9	13.5	21.1	15.3	16.3	5.7	2.9	5.4	11.3	3.2	2.6	2.3	8.3	10.3	6.9	4.4	8.9	3.9	12.7	8.4	5.8	5.8	4.6	2.1	18.1	10.4	27.0	7.6	9.9	19.2	4.2	3.9	9.3	17.9	4.1	13.8	10.0	4.5	7.7	5.8	7.6	6.7	3.8	8.5	6.6	19.4	14.7	1.0	6.1	11.7	12.2	8.9	2.4	1.8	26.9	9.3	3.6	5.7	23.2	2.1	8.8	13.2	5.1	6.3	20.9	21.3	4.4	14.6	14.2	6.3	28.1	16.9	15.8	14.3	15.6	15.7	7.3	19.9	6.4	3.0	7.8	3.4	4.3	2.0	1.6	9.8	2.3	4.6	1.4	2.1	2.9	5.7	2.5	2.6	5.4	3.2	11.3	2.0	0.5	2.3	10.5	14.7	5.0	18.2	11.2	11.4	11.6	10.6	16.0	8.3	68.5	62.7	31.1	75.8	64.6	24.9	9.5	10.2	92.3	77.3	33.2	51.1	7.8	13.3	46.2	69.5	57.1	35.2	0.0	98.8	47.2	82.2	47.0	200.8	27.0	26.1	50.9	22.8	70.6	59.0	24.0	35.1	68.2	33.7	39.7	42.7	11.8	128.3	18.2	64.0	35.6	30.1	25.8	66.2	51.9	26.9	83.9	34.4	25.5	13.8	127.8
CLDN11	"OSP, OTM"	ENSG00000013297	"Claudin 11"	O75508	3	170418865-170454733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;ovary: 47.7;testis: 86.1"	"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 37.5;Ito cells: 49.1;Leydig cells: 97.5;Peritubular cells: 63.6"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 57.6;ASC TERT1: 72.7;EFO-21: 43.2;HSkMC: 26.6;HUVEC TERT2: 62.3;TIME: 98.4"									"CAB009789, HPA013166, HPA013657"	Enhanced		Supported	"Lipid droplets,Cell Junctions"		NA	NA			"Cell Junctions"	"Lipid droplets"	"CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: "	"prognostic favorable (6.31e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (5.28e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.70e-11)"	"unprognostic (2.50e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.29e-1)"	8.2	1.9	14.1	2.0	40.6	1.7	6.3	3.5	50.3	1.9	3.4	85.9	0.5	2.2	2.7	4.6	4.6	4.2	18.9	4.0	28.7	13.0	3.2	2.8	2.8	2.1	59.5	17.1	47.7	2.1	1.8	5.5	4.2	37.3	5.1	2.5	0.6	4.7	4.2	1.7	3.6	2.6	2.8	80.6	2.6	2.5	86.1	47.9	0.0	2.0	0.9	2.0	6.3	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	57.6	72.7	0.0	0.7	3.7	4.7	7.9	0.0	9.7	0.0	43.2	5.8	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	3.3	17.8	0.0	0.0	26.6	0.0	25.9	0.0	0.2	62.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.1	40.6	3.5	25.0	28.7	13.0	59.5	17.1	37.3	47.9	0.0	1.1	0.0	12.0	12.8	0.4	1.4	0.0	0.0	0.0	1.8	0.0	1.0	0.0	0.0	6.5	21.9	0.0	0.0	0.0	1.7	37.5	1.3	0.0	0.8	0.8	0.0	0.0	49.1	0.0	16.0	97.5	1.7	13.5	0.0	0.0	0.3	0.5	0.0	63.6	0.0	0.0	0.0	5.9	7.2	2.6	8.9	0.7	0.0	0.0	1.0
AC026316.5		ENSG00000285218			3	170418868-170860380	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	5	"brain: 64.6;testis: 27.4"	"Cell type enriched"	"Detected in single"	18	"Collecting duct cells: 1.8"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																	NA	NA																							2.4	3.9	6.2	3.5	30.3	9.0	3.1	2.1	18.4	1.2	1.4	64.6	0.0	2.7	3.4	4.2	2.8	1.9	4.9	2.4	9.0		2.4	1.8	2.1	3.0	44.6	12.4	7.2	1.7	2.6	0.0	2.2	27.8	4.4	1.2	0.0	3.8	2.2	3.1	6.2	2.7	2.1	27.1	2.1	1.9	27.4	35.8	0.0	2.5	0.2	1.6	1.8	1.6	1.0	0.6	2.4	0.9	0.4	1.3	0.3	1.5	2.4	2.9	2.4	0.7	0.6	2.4	1.6	1.0	0.5	0.1	0.5	2.2	2.4	3.6	1.2	1.0	3.0	0.1	0.0	0.5	2.4	2.0	3.2	3.6	2.1	0.0	2.0	3.3	0.7	0.6	0.7	0.3	0.9	0.6	2.1	1.5	2.7	0.7	0.7	0.8	3.4	4.0	2.5	3.1	1.5	0.8	1.0	1.4	2.0	5.6	1.7	1.9	1.6	0.8	2.5	1.8	0.5	2.0	1.5	2.2	5.8	0.6	1.6	2.0	1.0	1.0	2.4	1.2	0.6	0.6	0.5	0.8	0.9	1.3	0.8	1.1	1.1	0.6	1.0	1.3	1.2	2.4	0.4	0.9	0.5	0.9	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 31.5;Horizontal cells: 27.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.3	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	1.8	0.0	0.1	1.3	0.8	0.2	0.1	0.0	0.2	7.2	0.0	0.0	0.2	1.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	7.2	2.1	0.0	0.1	0.0	0.3	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3	3.0	2.1	0.0	0.3	0.3	31.5	0.8	0.0	5.3	4.5	0.0	2.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.5	0.2	2.3	1.0	0.0	27.0	1.7	0.0	0.0	0.4	2.0	0.9	3.3	0.0	0.0	1.8	0.1	0.0	2.5	0.0	3.9	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1
RPL22L1		ENSG00000163584	"Ribosomal protein L22 like 1"	Q6P5R6	3	170864875-170870483	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 101.9"	"Low region specificity"	"Detected in all"							"HPA048060, HPA056207, HPA068294"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (5.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.96e-2)"	17.2	14.6	8.9	28.1	9.5	36.0	21.5	6.0	9.3	14.3	15.7	5.3	6.6	8.4	12.2	12.3	33.6	15.3	11.8	11.3	7.4	8.5	11.4	64.3	18.8	31.4	10.1	5.7	18.6	71.6	1.9	12.1	10.5	10.7	14.7	15.7	6.4	15.7	14.0	17.7	19.4	13.7	12.2	11.5	37.5	17.4	9.7	8.9	17.9	15.2	32.5	27.8	18.9	15.9	24.1	24.2	1.9	7.6	13.1	13.8	3.5	15.8	17.9	5.8	67.6	17.3	101.9	17.8	16.1	37.2	13.1	8.5	7.6	3.7	49.0	3.7	15.0	41.1	4.1	14.4	41.1	7.3	2.9	2.6	4.4	2.2	17.1	70.0	9.0	6.5	74.0	84.0	4.1	44.6	20.5	44.5	27.2	3.1	3.1	71.8	20.1	65.7	5.1	90.9	6.1	3.2	88.2	2.1	7.5	32.5	35.3	0.9	4.9	1.6	8.1	7.0	3.3	11.3	8.0	20.6	2.5	19.3	5.0	22.4	5.0	3.5	7.8	45.9	5.5	52.1	1.0	4.8	1.9	6.8	5.7	13.8	24.1	10.0	9.0	5.1	17.9	6.7	7.4	1.0	13.1	7.6	24.2	6.3	3.5	8.9	9.5	6.0	8.1	7.4	8.5	10.1	5.7	10.7	8.9	8.9	36.6	274.9	201.6	175.5	13.0	14.5	53.5	57.6	92.1	19.2	3.9	84.0	56.3	132.5	30.8	89.5	76.2	23.3	199.7	252.2	105.2	161.6	105.0	90.9	170.2	7.9	138.8	87.8	140.5	29.1	129.2	89.6	74.2	57.7	130.6	34.1	350.4	115.2	83.8	69.0	18.4	45.3	94.8	47.6	26.2	216.6	82.3	126.9	150.6	274.6
EIF5A2		ENSG00000163577	"Eukaryotic translation initiation factor 5A2"	Q9GZV4	3	170888415-170908693	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 309.4;Late spermatids: 705.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029090	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA029090: AB_10671359"	"unprognostic (2.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.05e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (1.11e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.29e-3)"	5.6	3.9	3.6	4.1	8.4	4.9	4.2	1.9	14.4	4.4	4.6	4.3	2.0	2.5	6.2	2.0	4.1	3.6	4.9	5.4	4.3	5.8	6.8	3.4	3.2	3.6	6.7	6.2	6.4	4.5	2.2	5.2	2.5	21.6	4.8	3.8	3.4	2.7	4.2	1.9	3.0	2.6	9.6	5.1	3.0	11.0	31.2	2.5	6.1	3.1	2.6	4.2	6.3	6.2	2.6	0.9	10.2	1.3	6.9	11.2	4.3	11.6	6.1	2.2	3.1	12.0	7.9	5.3	8.8	11.5	9.4	13.2	12.4	7.7	7.4	16.6	12.3	21.1	3.9	7.1	3.2	12.0	8.1	3.1	3.4	2.5	3.9	8.1	9.1	10.7	8.6	4.7	14.1	11.7	13.1	4.6	1.9	2.8	0.0	15.3	3.7	4.1	4.1	4.2	9.1	3.9	0.0	6.5	0.0	3.9	2.1	1.8	3.4	9.4	2.4	7.4	3.7	5.4	6.2	6.4	11.6	8.2	23.8	20.2	11.6	0.1	16.8	3.9	3.2	8.2	10.2	1.2	1.2	11.2	1.3	7.7	2.0	7.7	10.6	0.9	2.6	4.6	7.6	0.6	6.9	1.2	0.8	9.2	4.3	3.6	8.4	1.9	14.4	4.3	5.8	6.7	6.2	21.6	2.5	0.0	0.3	3.2	5.2	15.1	2.8	8.1	0.0	4.0	1.2	1.8	0.0	0.8	1.7	6.4	309.4	7.1	1.0	0.0	6.6	1.7	11.3	4.4	2.3	2.4	7.4	0.0	4.7	2.5	4.1	705.4	11.8	4.9	10.1	11.8	1.1	7.5	12.5	4.2	10.6	18.0	2.6	45.3	14.5	25.1	9.3	18.9	0.6	16.6	1.6	5.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996348-171026750	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 77.4;liver: 172.8"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 433.3"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	68	"CACO-2: 7.3;Hep G2: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	27.9	0.0	0.0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	77.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	1.7	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	433.3	0.0	0.0	0.0	6.7	8.9	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	49.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171061339-171460408	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 79.9;Muller glia cells: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3"	"Group enriched"	"Detected in many"	29	"granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;HEL: 27.0;HMC-1: 30.8;WM-115: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		9100	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	2.2	5.4	29.0	7.4	30.9	4.9	3.6	21.1	26.1	1.9	10.9	12.2	4.1	25.8	4.3	2.1	5.6	4.3	7.1	11.2	30.9	14.8	5.6	4.6	11.3	7.9	11.4	18.3	2.6	5.2	0.7	9.0	3.1	13.6	5.6	9.5	3.5	2.9	7.3	23.2	1.6	25.6	6.0	14.5	5.8	9.2	10.7	21.1	3.7	7.1	2.2	6.9	6.4	2.6	0.2	0.0	10.5	0.1	2.7	6.7	1.1	0.3	0.5	19.9	2.1	0.3	0.0	4.7	4.1	1.2	3.3	2.2	17.8	7.4	0.0	1.5	3.8	3.0	6.1	2.8	1.1	3.6	0.1	4.4	27.0	1.5	0.0	9.5	5.3	30.8	2.9	3.0	1.9	0.4	7.7	19.8	4.5	9.7	0.0	0.5	0.4	1.7	6.8	8.2	14.2	7.7	0.0	5.1	7.1	6.4	0.0	0.9	1.0	2.5	0.2	4.4	2.2	9.0	1.3	0.2	0.0	3.5	9.0	3.0	0.0	0.0	0.0	0.9	6.0	23.0	4.4	0.1	10.5	4.2	0.0	5.2	0.0	5.0	3.7	0.0	0.2	6.7	3.8	0.1	2.7	0.1	0.0	5.3	1.1	29.0	30.9	21.1	22.2	30.9	14.8	11.4	18.3	13.6	21.1	6.0	37.9	0.5	1.4	2.3	9.3	25.7	25.5	2.7	12.5	8.7	13.7	4.7	5.0	9.2	29.5	1.6	26.2	0.0	6.8	1.8	4.4	0.6	79.9	6.8	2.5	0.0	12.7	1.3	5.6	33.0	2.3	3.3	1.7	0.0	9.4	79.4	4.8	16.5	6.0	14.9	27.7	0.0	7.6	2.8	1.0	1.4	2.1	31.2	15.3	2.4
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600405-171810950	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 52.1"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 50.9;Proximal tubular cells: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 30.3;SK-MEL-30: 16.9;TIME: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004527, HPA042396"	Enhanced					NA	NA					"CAB004527: AB_677324, HPA042396: AB_2677977"	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.0	26.6	5.3	6.1	20.4	4.5	6.3	1.4	10.8	8.6	19.7	31.4	1.8	27.7	6.9	4.9	25.0	4.9	52.1	14.7	7.7	4.7	7.5	20.2	4.4	5.2	25.3	7.2	17.1	13.9	0.9	2.7	6.6	18.8	3.5	9.4	8.5	13.2	4.2	2.0	17.6	29.5	3.4	16.8	9.9	5.3	3.5	21.8	0.9	4.1	10.7	8.5	4.3	11.5	0.1	0.9	10.2	2.6	3.0	4.1	0.8	2.3	3.7	1.9	0.7	6.0	6.8	4.1	1.2	5.3	1.9	2.3	0.5	3.4	0.0	9.5	0.5	13.1	7.9	0.3	1.0	3.0	1.9	1.6	2.2	5.9	13.2	2.7	3.8	10.5	2.6	5.8	2.2	1.1	5.4	30.3	0.6	1.4	0.0	0.4	0.6	0.0	3.2	0.4	6.0	2.7	0.1	0.8	0.0	4.7	0.9	0.0	0.0	4.1	2.5	16.9	2.8	4.7	5.0	26.3	0.8	3.2	2.1	1.3	5.1	4.1	0.0	3.7	4.6	1.0	10.2	2.6	3.2	0.5	1.6	4.1	0.0	0.4	1.0	0.9	0.1	0.0	0.1	1.5	3.0	0.5	0.0	1.2	0.8	5.3	20.4	1.4	10.8	7.7	4.7	25.3	7.2	18.8	21.8	0.0	6.6	1.3	2.8	6.4	0.2	30.1	50.9	5.3	7.9	1.8	0.0	2.4	3.3	5.9	7.9	5.4	31.5	0.0	3.0	3.0	6.6	0.7	27.6	13.1	16.2	0.0	4.1	3.7	11.7	6.1	9.8	3.8	11.8	1.8	21.0	0.0	2.0	14.4	4.2	44.6	0.0	19.4	2.0	5.4	3.6	30.6	1.9	4.5	12.7	4.3
TMEM212	FLJ23172	ENSG00000186329	"Transmembrane protein 212"	A6NML5	3	171843349-171938715	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.2;lung: 10.0;ovary: 12.8"	"Cell type enhanced"	"Detected in some"	30	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 22.8;Ciliated cells: 167.3;Club cells: 46.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045736			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA045736: AB_2679436"	"unprognostic (3.39e-2)"			"unprognostic (1.78e-2)"	"unprognostic (3.05e-1)"			"unprognostic (5.54e-2)"		"unprognostic (3.06e-1)"				"unprognostic (2.87e-1)"				0.4	0.4	0.5	0.6	0.8	2.2	0.4	0.4	0.5	1.6	0.8	0.9	0.4	0.2	1.3	2.5	0.8	19.2	0.4	0.4	0.6	0.7	0.4	3.3	10.0	0.6	0.4	0.4	12.8	0.4	0.0	0.4	0.4	0.7	0.4	0.8	0.4	0.4	2.1	1.1	1.5	0.5	0.4	0.4	0.4	0.4	1.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	4.1	3.2	6.3	2.1	3.8	2.7	0.5	4.1	2.5	2.8	3.1	0.8	0.4	5.5	3.0	0.9	1.2	1.2	2.0	3.3	5.4	3.6	1.4	3.1	2.9	1.7	1.3	2.6	7.1	2.8	6.4	6.5	2.7	0.5	3.7	5.4	1.1	1.5	1.4	1.2	1.8	1.3	3.4	4.4	8.6	0.9	2.7	3.2	4.1	4.9	2.1	2.7	2.7	4.4	4.5	1.1	3.2	3.4	3.3	4.1	3.1	2.3	3.3	3.6	3.3	6.6	4.6	5.0	7.2	3.2	5.1	4.0	3.6	2.3	3.4	2.4	6.3	2.1	1.8	2.7	1.8	2.1	1.9	2.0	1.8	1.1	4.1	2.3	2.5	5.0	3.8	2.0	3.2	1.3	0.5	0.5	0.8	0.4	0.4	0.6	0.7	0.4	0.4	0.7	0.4	32.8	22.8	0.0	0.0	0.0	0.0	0.0	0.0	167.3	46.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0
FNDC3B	"DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421"	ENSG00000075420	"Fibronectin type III domain containing 3B"	Q53EP0	3	172039628-172401665	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007859	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007859: AB_1078900"	"unprognostic (7.18e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (2.17e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (5.65e-7)"	"unprognostic (4.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-2)"	39.6	22.1	4.0	16.5	5.7	18.2	27.3	2.9	5.1	20.8	18.4	4.2	20.9	7.5	28.9	21.7	13.2	12.3	18.3	18.9	4.9	4.2	17.6	35.6	23.1	10.9	6.7	2.3	26.4	30.7	12.3	21.4	64.1	5.9	15.1	11.5	13.4	27.7	19.8	22.0	8.1	13.1	17.8	6.6	17.5	15.0	10.5	5.0	4.8	21.2	10.5	12.8	25.4	25.8	0.6	2.7	22.7	5.0	2.4	2.6	1.8	12.2	14.2	9.9	12.0	31.0	21.4	24.0	17.6	19.9	11.9	16.3	7.8	27.1	1.2	47.2	26.5	23.7	7.3	3.4	14.3	21.0	7.0	2.5	1.7	9.1	21.4	31.2	15.7	27.6	21.6	7.3	22.2	21.2	28.6	31.7	2.2	2.8	8.9	12.5	3.8	0.6	6.9	5.7	4.7	5.8	1.4	10.2	5.9	13.1	10.9	0.6	3.0	16.8	8.7	14.6	14.3	8.2	8.1	45.8	16.8	7.8	21.2	13.8	18.7	20.7	2.4	17.7	9.1	16.5	7.8	5.0	11.4	2.6	3.0	1.1	0.6	0.8	1.4	2.7	0.0	0.9	1.6	22.7	2.4	1.5	0.4	0.7	1.8	4.0	5.7	2.9	5.1	4.9	4.2	6.7	2.3	5.9	5.0	80.4	43.5	12.0	47.6	56.7	7.5	43.1	50.9	13.4	35.2	43.6	11.8	35.6	13.3	62.0	7.7	56.2	22.4	0.0	39.5	90.0	84.5	54.9	15.0	60.6	44.9	0.0	16.1	62.0	65.2	5.3	53.2	61.1	65.8	50.5	28.4	16.6	73.1	40.8	51.2	30.5	12.2	51.8	50.5	2.4	2.7	29.4	29.1	19.2	20.0	74.5
GHSR		ENSG00000121853	"Growth hormone secretagogue receptor"	Q92847	3	172445133-172448456	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.4;blood: 2.4;pituitary gland: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	25	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 2.4"	"Cell line enriched"	"Detected in single"	4	"HMC-1: 1.8"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.8"	"Low region specificity"	"Detected in all"									NA	NA																"unprognostic (1.27e-1)"			"unprognostic (3.31e-2)"				0.0	2.4	0.0	0.8	0.5	0.7	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.8	0.0	0.0	0.6	0.0	0.0		0.0	0.1	0.0	7.4	0.0		0.0	0.1		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFSF10	"Apo-2L, CD253, TL2, TRAIL"	ENSG00000121858	"TNF superfamily member 10"	P50591	3	172505508-172523507	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 115.1"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 542.5;Exocrine glandular cells: 368.6;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 42.4;classical monocyte: 25.6;intermediate monocyte: 39.5;neutrophil: 50.3;non-classical monocyte: 38.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 50.3;monocytes: 39.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 21.0;CAPAN-2: 14.9;HaCaT: 14.7;HMC-1: 69.1;RPTEC TERT1: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054938	Uncertain				"Secreted to blood"	NA	NA	67400				"HPA054938: AB_2682643"	"unprognostic (9.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.27e-2)"	30.9	22.1	3.4	14.6	4.7	2.0	23.3	3.0	5.4	31.4	25.8	4.4	17.1	20.6	13.0	10.3	33.3	9.6	10.7	9.9	3.8	3.2	115.1	44.4	91.5	23.5	5.5	3.4	13.5	11.6	10.9	6.7	100.8	6.7	37.6	19.5	12.0	50.6	12.9	13.9	13.0	54.0	7.9	5.6	35.8	9.5	6.0	4.6	8.3	28.2	17.7	16.1	22.4	24.0	3.4	9.5	50.3	39.5	9.3	7.0	11.9	3.4	0.1	0.0	0.0	2.4	1.8	21.0	0.0	0.1	1.0	1.6	0.0	14.9	2.1	10.1	0.0	0.9	14.7	0.0	1.8	0.2	5.3	0.0	0.0	0.4	0.3	0.1	3.9	69.1	2.4	2.4	0.4	0.0	0.0	7.6	0.4	0.0	2.5	0.0	0.0	0.5	5.2	0.0	0.1	0.1	0.8	0.0	0.9	34.8	1.3	0.1	0.1	7.7	0.3	0.1	0.1	4.2	2.2	0.3	0.0	0.0	0.0	0.2	2.6	0.3	2.6	0.2	2.2	0.0	42.4	25.6	2.7	2.3	39.5	3.1	3.2	6.4	3.5	9.5	3.4	4.7	1.8	50.3	9.3	38.3	0.6	7.0	11.9	3.4	4.7	3.0	5.4	3.8	3.2	5.5	3.4	6.7	4.6	65.5	119.9	15.2	153.0	19.6	0.1	4.5	63.7	99.0	113.7	62.8	0.0	1.1	38.1	542.5	3.9	163.8	223.5	23.3	368.6	166.3	27.9	96.6	248.5	58.7	22.3	1.6	46.3	140.0	77.7	2.8	17.0	51.4	6.8	16.2	96.5	21.7	249.5	190.0	4.6	449.0	0.8	0.0	10.3	0.0	0.2	22.3	9.2	43.6	68.5	109.1
NCEH1	"AADACL1, KIAA1363, NCEH"	ENSG00000144959	"Neutral cholesterol ester hydrolase 1"	Q6PIU2	3	172630249-172711218	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 30.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.8;LHCN-M2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026888, HPA043873"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA026888: AB_10601557, HPA043873: "	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.88e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (5.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.28e-1)"	17.0	14.8	6.5	7.1	23.8	6.0	5.1	14.3	30.1	4.1	9.8	2.3	1.4	3.5	3.9	2.9	4.4	3.5	6.0	14.6	13.2	9.6	18.8	4.2	17.0	11.2	6.6	11.4	2.5	4.0	6.3	4.2	5.7	17.7	6.0	10.7	4.3	8.2	4.2	6.6	2.7	4.1	2.9	5.0	9.1	10.9	2.0	4.0	1.9	3.9	3.1	9.3	5.1	3.4	3.0	10.6	4.8	15.1	2.8	2.3	4.8	23.3	13.6	0.4	0.7	0.8	0.9	1.9	17.6	11.7	11.7	6.8	3.4	70.8	1.9	26.5	10.6	11.2	4.7	0.5	8.6	27.2	6.5	1.1	1.3	2.2	2.6	1.0	3.5	4.9	0.4	0.8	8.0	12.0	11.0	7.8	1.0	0.3	1.7	33.1	1.9	0.5	1.2	0.6	6.6	11.2	0.5	1.3	2.4	20.9	3.1	0.4	0.2	10.6	11.2	2.3	0.8	3.8	1.6	21.1	18.0	2.7	8.4	31.8	2.0	3.8	1.6	13.4	3.4	13.6	4.8	15.1	0.5	2.3	9.6	1.5	3.0	1.5	1.6	10.6	1.9	1.5	1.8	0.5	2.8	6.2	0.6	1.3	4.8	6.5	23.8	14.3	30.1	13.2	9.6	6.6	11.4	17.7	4.0	44.7	19.9	6.4	16.9	6.1	12.9	27.7	25.5	30.8	28.4	15.7	21.6	6.2	3.3	54.9	4.5	8.7	13.1	46.7	26.6	3.8	6.1	23.2	4.7	1.6	48.4	4.8	7.5	5.5	34.7	2.6	0.9	14.5	5.0	1.8	9.7	4.9	50.0	10.5	2.5	25.4	19.2	6.5	5.8	0.0	0.9	3.0	8.8	3.8	6.0	22.8
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.8"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.82e-6)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	6.4	6.0	5.4	9.9	7.2	16.3	7.4	11.1	7.6	9.0	11.0	2.6	2.1	9.1	4.6	2.8	14.9	3.2	6.6	4.2	5.4	5.0	10.1	4.3	8.9	9.6	6.7	5.8	3.2	4.1	4.0	6.1	11.1	10.2	4.1	16.1	2.4	9.0	2.7	2.9	7.0	7.6	7.2	8.4	8.7	9.2	14.7	6.8	50.8	5.7	9.3	10.8	8.0	6.5	2.8	2.6	10.4	3.2	1.3	3.6	1.0	46.2	33.0	26.1	13.5	2.7	5.6	13.0	20.5	16.8	30.8	30.0	18.3	49.1	11.5	31.2	12.0	29.5	20.4	21.0	13.1	42.1	16.4	11.6	7.2	18.1	9.3	1.2	11.1	8.3	1.8	2.2	18.3	18.7	8.7	13.2	17.1	7.4	16.9	24.3	16.3	11.3	8.3	21.2	38.3	18.0	8.1	25.6	14.8	23.4	10.8	17.4	11.2	25.9	29.5	10.4	13.7	49.1	8.3	11.4	15.0	14.4	20.1	42.6	8.3	11.1	21.7	13.2	9.7	19.5	6.8	3.2	1.3	1.8	2.8	1.9	2.2	2.4	1.6	2.4	2.8	1.2	1.8	10.4	1.3	1.2	2.6	3.6	1.0	5.4	7.2	11.1	7.6	5.4	5.0	6.7	5.8	10.2	6.8	6.0	2.7	9.0	4.3	17.3	3.4	3.1	7.6	10.7	4.5	3.5	60.9	4.9	0.0	9.0	2.7	6.4	3.2	70.0	7.9	13.0	7.0	8.8	0.0	1.5	6.1	0.0	4.6	5.5	3.1	2.3	0.9	5.1	6.8	1.8	10.8	2.9	14.3	3.5	1.4	1.9	13.4	0.0	3.3	33.1	37.4	11.2	3.2	1.5	6.2	7.8
SPATA16	NYD-SP12	ENSG00000144962	"Spermatogenesis associated 16"	Q9BXB7	3	172889358-173141268	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"testis: 49.2"	"Group enriched"	"Detected in some"	20	"Early spermatids: 184.3;Late spermatids: 101.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"GAMG: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037884	Enhanced					NA	NA					"HPA037884: AB_2675717"															"unprognostic (3.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	184.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.0	7.0	1.5	0.0	0.0	0.0	0.0	0.0
NLGN1	KIAA1070	ENSG00000169760	"Neuroligin 1"	Q8N2Q7	3	173396284-174286644	"Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 50.9;Leydig cells: 23.9;Muller glia cells: 30.8"	"Group enriched"	"Detected in some"	9	"glioma: 3.8;melanoma: 2.2;renal cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.2;HUVEC TERT2: 15.8;RH-30: 16.9;WM-115: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006572, HPA006680, CAB033261"	Enhanced		Uncertain	"Nuclear bodies,Plasma membrane"		NA	NA		40000	"Plasma membrane"	"Nuclear bodies"	"CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400"	"unprognostic (2.81e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.08e-5)"	"unprognostic (7.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.07e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.41e-3)"	"unprognostic (5.37e-2)"	3.9	2.4	13.4	1.4	9.4	0.6	1.6	20.2	26.9	6.3	3.2	5.6	0.0	1.0	4.3	5.0	4.8	5.9	3.3	5.7	8.8	9.1	5.6	0.6	1.2	1.0	6.3	7.8	2.8	2.0	0.6	6.9	1.4	6.8	4.4	2.2	4.3	0.9	5.9	0.7	1.0	1.6	8.2	4.6	0.7	2.0	11.1	8.9	0.0	2.2	0.4	0.8	5.1	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	7.7	8.3	0.0	3.2	8.1	0.4	0.5	0.0	0.3	0.0	0.1	16.2	3.0	0.0	2.3	0.0	0.8	0.0	3.8	1.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	6.5	15.8	0.0	0.0	1.0	0.1	0.0	0.0	0.0	4.6	0.0	1.1	0.0	16.9	3.9	3.0	0.0	1.6	1.1	0.0	0.0	7.9	0.7	0.4	0.0	1.9	8.8	0.9	6.3	7.2	7.6	0.0	0.0	3.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	9.4	20.2	10.9	8.8	9.1	6.3	7.8	6.8	8.9	0.0	0.3	0.0	0.6	0.7	11.4	2.0	0.0	0.0	0.0	3.5	3.9	0.2	0.0	0.3	50.9	0.3	0.0	0.0	0.0	0.1	2.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	23.9	0.0	13.5	0.0	0.0	30.8	0.1	0.0	13.4	7.1	9.7	6.5	1.0	0.4	0.7	0.6	0.1	0.0	0.0	0.1
NAALADL2		ENSG00000177694	"N-acetylated alpha-linked acidic dipeptidase like 2"	Q58DX5	3	174438573-175810552	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 29.3"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 60.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.7;BJ hTERT+: 4.2;fHDF/TERT166: 4.9;WM-115: 4.5"	"Low region specificity"	"Detected in many"							"HPA012413, HPA017425, CAB025586"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275"	"unprognostic (7.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.29e-4)"	"unprognostic (3.44e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (3.66e-6)"	"unprognostic (7.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	4.9	2.3	2.2	4.6	3.7	0.8	7.0	1.9	2.7	8.3	8.3	5.4	23.8	2.4	9.7	10.5	2.3	5.0	8.9	5.4	2.5	1.8	7.0	3.7	3.3	1.3	2.3	2.0	5.4	3.9	20.6	3.0	6.4	4.0	9.6	3.3	4.4	17.0	29.3	1.8	3.2	6.6	6.0	3.6	2.6	4.5	1.9	2.9	4.9	3.5	2.6	1.7	8.7	5.0	0.1	1.7	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.2	0.0	3.5	11.7	0.1	2.3	4.2	0.6	0.7	0.2	1.3	0.0	0.5	4.9	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	3.2	0.6	0.1	0.0	3.0	0.4	0.0	0.0	0.1	2.3	0.4	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.1	1.7	0.2	0.0	0.0	0.2	0.2	0.9	0.3	3.1	0.1	0.5	2.3	0.1	0.1	0.5	0.0	0.0	0.0	1.5	0.0	4.5	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	1.7	0.0	0.0	2.2	3.7	1.9	2.7	2.5	1.8	2.3	2.0	4.0	2.9	0.0	11.5	0.0	7.2	2.1	7.6	2.8	10.2	18.7	6.8	12.2	11.8	16.3	6.6	6.8	60.1	2.1	11.1	0.0	2.3	1.5	7.8	18.3	4.6	2.4	1.6	0.0	8.6	3.1	0.3	28.0	14.1	0.7	3.3	0.0	1.1	7.7	2.5	3.5	11.3	1.7	6.6	0.0	2.3	3.2	1.9	1.6	10.3	0.0	14.9	13.7
TBL1XR1	"C21, DC42, FLJ12894, IRA1, TBLR1"	ENSG00000177565	"Transducin beta like 1 X-linked receptor 1"	Q9BZK7	3	177019340-177228000	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 71.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019182	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019182: AB_1857800"	"unprognostic (4.11e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-3)"	"prognostic favorable (5.16e-5)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (3.75e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	20.7	26.0	27.4	24.3	26.8	27.3	20.3	27.5	28.1	28.9	29.9	22.6	15.4	24.0	23.9	20.5	23.8	21.9	22.7	30.3	26.2	20.7	19.9	21.8	30.8	27.8	21.4	25.9	26.5	19.9	30.6	11.3	24.0	19.7	24.4	23.2	24.7	21.3	17.7	21.1	17.8	24.3	21.9	19.6	24.7	21.3	17.4	22.3	28.4	45.6	14.9	32.1	29.1	25.5	7.4	13.3	12.9	4.6	6.8	8.3	4.1	23.9	12.3	16.0	9.0	13.6	14.8	9.6	7.6	11.8	6.6	9.1	14.1	19.9	24.6	35.9	10.9	17.5	14.8	11.9	15.8	13.3	25.8	3.7	13.8	21.0	8.4	11.7	21.9	8.2	21.8	8.2	9.7	24.1	13.0	10.3	17.3	10.3	43.6	8.5	8.6	20.4	3.0	10.1	15.4	8.3	11.7	20.4	26.2	5.9	34.0	5.8	9.2	10.2	8.0	9.5	10.5	29.3	16.8	15.7	10.8	9.1	6.0	16.4	23.8	30.5	71.1	7.3	16.4	12.3	11.4	3.0	3.8	5.8	4.6	5.1	7.3	5.7	6.6	4.0	7.4	5.0	6.4	12.9	6.8	3.9	13.3	8.3	4.1	27.4	26.8	27.5	28.1	26.2	20.7	21.4	25.9	19.7	22.3	68.5	47.1	43.4	46.9	81.4	116.0	84.2	48.4	61.6	62.6	99.5	117.8	22.3	24.9	43.8	5.7	62.9	42.8	23.3	37.3	28.5	65.8	123.0	24.3	58.7	32.8	109.7	81.9	55.9	85.4	5.2	59.2	54.6	62.4	31.5	74.5	41.8	53.4	23.0	68.6	46.2	81.2	45.3	41.5	8.4	53.9	97.7	23.0	49.8	75.7	61.8
KCNMB2		ENSG00000197584	"Potassium calcium-activated channel subfamily M regulatory beta subunit 2"	Q9Y691	3	178272932-178844429	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 36.8"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 14.7;Intestinal endocrine cells: 13.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.5;fHDF/TERT166: 2.6;RPMI-8226: 1.8;SCLC-21H: 8.5"									CAB022649	Uncertain					NA	NA					"CAB022649: "	"unprognostic (9.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.85e-2)"	0.7	6.3	7.8	0.5	6.2	0.4	1.3	1.8	11.2	2.5	1.9	2.2	4.4	1.0	7.2	36.8	0.9	14.3	0.9	7.4	13.2	4.5	4.1	0.6	1.6	0.4	4.7	4.9	16.3	4.5	0.4	10.2	0.5	6.2	1.1	0.9	0.5	0.6	1.9	0.6	0.7	0.9	3.0	3.2	1.9	3.6	0.6	3.2	0.0	1.1	0.0	0.4	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.4	0.0	0.0	1.4	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.8	0.0	1.0	8.5	0.0	0.0	0.5	0.0	0.6	1.4	0.0	0.3	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	6.2	1.8	11.2	13.2	4.5	4.7	4.9	6.2	3.2	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	14.7	1.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	13.3	2.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC117457.1		ENSG00000275163			3	178419123-178843300	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"brain: 11.1;epididymis: 11.8;fallopian tube: 12.2;kidney: 5.2;pituitary gland: 19.9"	"Cell type enhanced"	"Detected in some"	23	"Ciliated cells: 1.4;Distal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"HSkMC: 5.7"															NA	NA																							0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.0	11.8	0.0	12.2	0.3	0.2	0.3		5.2	0.2	1.5	0.0	0.0	0.0	2.6	2.9	0.0	19.9	0.0	11.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZMAT3	"FLJ12296, MGC10613, PAG608, WIG-1, WIG1"	ENSG00000172667	"Zinc finger matrin-type 3"	Q9HA38	3	179017223-179072279	"Predicted intracellular proteins"	"Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 150.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 28.8;LHCN-M2: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027569, HPA028671, HPA054356"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027569: AB_2732438, HPA028671: AB_2672725, HPA054356: AB_2682460"	"unprognostic (3.53e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.37e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.46e-2)"	7.1	11.9	18.8	7.1	19.7	4.4	8.3	7.5	27.3	9.1	8.4	9.6	4.4	4.9	8.5	8.6	10.0	8.2	12.6	8.6	15.8	17.1	9.1	16.2	8.2	9.2	16.9	13.3	7.0	7.3	15.7	10.1	7.8	17.4	8.6	12.6	7.1	7.6	11.5	5.5	8.4	5.4	15.5	14.4	9.2	7.2	4.6	9.4	15.7	10.6	3.2	8.6	9.4	6.7	3.6	1.8	3.9	3.3	4.0	5.8	1.3	2.0	1.4	4.5	2.6	21.7	24.8	10.4	8.0	12.4	1.2	1.5	1.8	1.2	8.5	4.1	13.1	1.8	1.9	1.5	8.8	2.7	6.1	2.4	3.5	2.8	5.7	17.3	3.9	5.6	28.8	16.6	2.9	5.8	19.1	17.1	2.4	1.9	1.0	31.8	2.0	3.3	0.7	2.0	2.8	1.1	3.6	4.1	1.8	6.9	4.0	0.9	4.7	2.5	2.3	2.7	8.8	2.8	1.7	19.1	18.4	6.8	3.1	3.7	1.0	0.9	3.5	11.0	0.5	12.5	3.4	1.8	3.9	4.8	1.3	2.7	2.3	3.5	3.9	1.7	3.6	5.8	4.2	2.3	4.0	3.3	1.8	2.5	1.3	18.8	19.7	7.5	22.3	15.8	17.1	16.9	13.3	17.4	9.4	50.6	150.5	11.0	9.5	35.1	19.2	17.1	33.1	33.5	54.6	33.2	23.6	6.8	6.6	13.0	0.7	12.3	11.6	0.0	18.0	2.5	17.4	17.4	37.1	30.0	15.3	58.8	20.1	19.0	40.6	1.5	18.7	15.1	49.0	47.7	10.0	11.8	21.3	12.9	27.3	14.6	10.8	38.8	27.2	7.1	12.8	32.0	3.7	20.8	8.3	9.2
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Supported	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB017804: , HPA009985: AB_1079610"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-2)"	20.1	12.3	13.7	11.5	13.4	25.7	22.4	17.1	24.5	12.9	14.0	5.2	5.7	6.5	15.3	7.9	11.6	11.1	13.2	14.2	18.4	9.7	11.7	10.8	13.2	13.8	9.8	15.7	15.4	9.2	24.7	11.6	16.5	16.3	10.7	8.9	7.2	10.9	10.9	15.2	12.0	10.5	12.8	14.4	16.2	10.6	9.3	9.8	29.6	11.0	7.3	13.9	15.1	15.7	6.2	2.6	7.8	3.8	2.4	5.0	1.1	14.6	5.0	8.0	7.4	19.0	22.2	5.9	9.4	12.7	9.3	14.7	4.3	10.9	13.4	16.1	11.2	13.2	6.0	6.6	8.1	13.5	22.4	5.8	18.4	5.5	3.8	9.1	10.3	10.5	14.0	8.6	10.2	11.7	10.4	13.3	9.7	9.1	15.0	13.3	5.8	7.9	9.3	6.4	7.3	6.8	12.0	8.1	16.1	7.3	9.0	4.5	7.7	10.2	9.1	12.2	7.3	15.2	8.9	14.0	8.7	5.7	13.7	9.3	7.3	10.3	24.1	7.9	7.8	5.1	2.1	3.8	1.6	5.0	2.9	3.9	5.8	4.2	2.8	2.2	6.2	4.6	3.8	7.8	2.4	3.0	2.6	4.1	1.1	13.7	13.4	17.1	24.5	18.4	9.7	9.8	15.7	16.3	9.8	29.8	23.2	13.7	15.2	13.1	26.3	15.4	7.6	18.7	17.0	7.0	29.5	8.1	1.7	9.8	1.7	21.4	4.9	0.0	11.9	5.0	18.3	27.3	30.1	17.4	9.5	36.5	2.4	29.4	21.2	1.6	30.2	16.4	13.5	16.2	9.6	15.6	13.1	12.7	37.1	11.2	26.2	25.8	22.1	9.6	7.6	13.0	7.3	14.0	9.2	27.6
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 13.7;Late spermatids: 10.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 11.2;NB-4: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	3.0	2.0	0.7	2.9	0.7	1.2	3.3	0.2	0.6	1.8	2.0			1.9	2.0	2.3	0.7	1.0	2.4	1.8	1.0	0.9	2.2	4.0	1.2	2.9	1.1		1.6	5.3	3.7	2.1	6.6		2.9	2.2		2.7	1.4	0.5	0.6	2.2	1.9	1.5	5.9	2.6	4.5			2.4		2.6	1.9	1.5	3.5	0.3	2.3	0.4	3.6	1.0	0.0	3.0	0.7	1.2	0.0	1.4	1.1	1.9	0.8	0.5	1.3	0.6	6.5	2.6	0.1	3.0	0.6	2.7	1.1	0.0	0.2	1.5	3.8	0.4	11.2	2.9	2.5	1.2	0.2	3.7	1.9	0.6	0.9	0.0	1.0	1.1	0.1	0.4	0.1	1.5	1.8	0.1	7.6	0.0	1.2	2.3	3.3	0.0	0.1	1.0	2.1	1.5	0.4	1.0	1.2	0.7	1.1	3.1	6.1	0.7	0.6	1.1	0.3	0.9	1.0	0.4	3.6	0.6	4.3	0.8	2.3	0.4	0.5	1.0	0.3	0.6	3.5	0.6	0.8	0.1	2.1	0.4	0.7	1.9	3.6	0.1	0.3	0.9	0.0											0.0	2.2	0.8	1.8	0.2	2.3	0.6	2.5	1.4	2.3	0.0	13.7	1.0	0.0	4.3	8.0	2.7	1.5	0.0	3.1	1.0	1.2	1.6	2.3	1.5	1.0	0.0	4.7	1.8	1.6	10.9	2.6	0.8	0.0	1.0	1.3	1.9	2.7	0.0	2.8	0.0	5.3	6.5	1.4	1.6	1.4	0.1	1.0	0.0	1.1	0.7
ZNF639	"ANC-2H01, ZASC1"	ENSG00000121864	"Zinc finger protein 639"	Q9UID6	3	179322991-179338583	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049023, HPA052163"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049023: AB_2680603, HPA052163: AB_2681747"	"unprognostic (5.64e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (7.74e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.56e-1)"	19.4	17.2	18.4	12.4	18.0	36.7	28.5	25.4	25.8	24.0	23.7	18.3	15.9	12.7	24.6	20.0	18.8	21.7	14.8	22.1	17.7	15.8	18.8	19.2	17.3	27.5	17.0	17.0	25.6	21.4	31.1	25.2	16.3	19.4	23.6	16.9	19.5	19.6	21.5	23.5	12.3	16.7	23.4	17.2	23.1	17.4	13.3	19.1	25.9	36.4	15.3	17.5	25.1	22.8	4.0	1.7	4.6	2.3	4.5	5.7	1.6	25.6	6.1	11.9	14.6	10.8	13.3	11.7	12.3	18.7	20.5	18.6	10.1	10.4	30.0	18.7	15.2	25.0	9.8	18.3	16.5	25.9	27.4	13.9	30.5	8.9	10.1	18.9	24.1	11.5	10.6	17.5	10.5	24.7	15.4	13.9	20.2	18.5	16.3	16.1	13.1	24.9	10.7	19.8	18.4	14.1	24.0	12.3	36.0	12.7	10.6	21.9	13.2	12.3	13.7	15.9	10.5	34.9	19.1	11.3	14.0	14.7	11.0	31.3	6.5	5.8	56.1	10.3	18.7	9.6	4.6	2.3	2.2	3.5	1.5	3.2	4.0	5.7	5.6	1.7	3.6	4.9	4.7	1.6	4.5	0.9	0.8	4.6	1.6	18.4	18.0	25.4	25.8	17.7	15.8	17.0	17.0	19.4	19.1	17.9	13.2	12.1	24.6	18.5	20.3	16.8	7.6	6.7	10.3	14.0	51.1	12.4	28.2	10.4	16.8	19.4	7.4	0.0	8.5	9.5	17.9	24.8	9.3	14.1	8.6	15.9	18.0	20.9	14.2	6.6	22.7	13.0	13.5	12.6	16.3	17.5	8.8	7.0	22.6	17.0	41.5	25.8	17.5	24.5	20.2	15.3	2.9	10.9	11.3	20.3
MFN1	FLJ20693	ENSG00000171109	"Mitofusin 1"		3	179347692-179394931	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033437, HPA059230"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB033437: AB_2250540, HPA059230: AB_2683952"	"unprognostic (2.94e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (6.70e-4)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.91e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.79e-2)"	13.7	16.5	12.2	12.1	17.2	9.9	15.4	24.3	22.4	18.4	16.5	15.9	19.4	12.0	19.6	21.3	19.6	18.5	13.4	31.1	12.0	11.4	17.9	14.9	12.3	16.0	16.9	14.5	16.6	29.9	18.2	22.3	12.4	21.5	17.7	14.6	12.8	17.4	17.4	21.7	19.6	16.6	15.7	16.0	18.2	17.8	11.8	17.0	16.9	14.5	20.1	19.6	17.6	15.1	10.5	4.1	8.9	4.5	4.1	7.3	2.1	16.7	5.0	9.7	15.8	14.0	13.0	12.9	10.5	10.8	11.1	13.2	12.5	7.0	5.7	11.0	15.4	22.4	9.9	13.6	10.3	19.5	9.0	10.5	9.3	11.6	6.8	11.5	4.9	9.0	9.0	9.1	11.9	8.5	9.2	14.0	9.6	6.8	7.6	15.4	8.9	7.2	3.7	11.5	16.9	9.3	5.1	15.3	21.1	10.6	17.8	9.2	13.1	9.8	26.3	14.2	10.4	36.0	3.6	11.7	9.7	10.8	15.0	15.3	10.2	11.0	9.5	10.8	8.3	10.5	5.5	3.8	8.5	4.3	4.5	7.3	7.8	4.9	4.4	3.4	10.5	4.6	5.1	8.9	4.1	3.6	4.1	4.4	2.1	12.2	17.2	24.3	22.4	12.0	11.4	16.9	14.5	21.5	17.0	23.8	33.7	14.5	9.5	14.8	16.0	28.0	10.2	33.5	27.3	17.4	37.3	9.7	8.3	11.0	2.3	9.4	11.7	23.3	15.0	8.4	13.8	17.9	8.1	16.6	7.2	11.1	9.8	17.2	10.7	2.5	12.4	11.3	11.8	6.4	16.0	11.5	14.1	8.6	16.6	10.3	16.6	6.5	13.9	25.4	11.5	23.6	11.0	7.4	13.3	20.1
GNB4		ENSG00000114450	"G protein subunit beta 4"	Q9HAV0	3	179396089-179451590	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 75.0;Ito cells: 52.2;Kupffer cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018383, CAB018737, HPA040736"	Supported		Supported	"Plasma membrane"		NA	NA		18000000	"Plasma membrane"		"CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: AB_2677106"	"unprognostic (2.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (1.90e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.80e-3)"	16.6	5.3	11.9	16.7	9.9	20.7	12.4	3.2	16.6	10.4	11.1	13.9	2.2	4.4	11.3	10.7	16.1	10.2	11.9	11.0	9.8	6.2	5.0	6.3	14.3	12.6	10.1	8.0	6.3	3.7	2.1	4.3	16.6	9.9	5.1	7.2	6.6	8.8	3.6	4.3	27.0	7.7	16.9	19.4	14.9	10.6	3.7	9.4	5.6	8.8	9.6	8.6	9.5	11.9	8.2	13.6	7.0	15.3	1.8	0.3	4.2	10.4	4.6	12.6	0.2	8.4	14.4	14.6	14.8	10.1	16.5	19.6	0.1	1.1	19.4	3.4	16.2	16.1	0.2	11.1	13.4	17.6	41.4	8.3	21.9	17.6	0.1	8.2	19.2	5.1	11.8	2.1	13.0	6.6	4.1	18.1	4.3	5.7	0.2	14.7	0.4	9.4	7.8	6.4	0.0	5.5	18.9	16.2	8.1	12.2	0.5	2.0	6.7	11.9	11.3	19.7	8.0	22.3	8.7	14.7	16.2	9.0	4.1	19.7	0.0	0.2	0.2	8.8	17.1	11.2	2.2	11.5	5.4	0.1	15.3	0.1	3.6	0.2	0.1	13.6	8.2	0.2	0.1	7.0	1.8	12.6	6.9	0.3	4.2	11.9	9.9	3.2	14.7	9.8	6.2	10.1	8.0	9.9	9.4	23.8	13.8	11.5	1.7	16.7	1.3	17.0	0.0	13.4	21.6	3.5	5.9	11.9	3.3	1.0	1.1	32.9	0.0	0.0	1.4	16.3	18.6	1.7	10.4	0.9	75.0	1.6	0.0	52.2	78.1	0.9	9.5	47.8	13.5	29.7	0.0	1.4	2.0	0.0	14.9	0.0	3.9	25.8	22.8	2.1	17.5	22.2	3.4	1.3	0.0	1.1
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562880-179588408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 197.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	18.8	17.9	9.9	23.4	16.8	8.7	21.3	8.7	9.6	16.8	21.3	15.3	15.6	14.5	24.8	16.4	23.2	16.3	14.9	24.2	8.7	7.4	19.6	18.6	14.6	17.4	16.7	5.4	24.8	20.9	13.7	23.4	20.1	13.7	17.7	23.5	10.4	19.0	17.4	12.8	19.4	19.8	16.1	14.8	19.3	16.7	47.5	17.0	46.1	21.9	20.4	23.8	18.7	22.7	17.5	19.8	8.0	16.1	14.5	22.4	13.8	46.2	14.0	34.9	18.4	13.4	14.7	27.4	18.7	14.6	34.9	29.6	31.6	22.8	36.2	33.6	17.5	40.6	21.4	30.5	23.0	43.5	35.8	25.4	29.6	15.5	23.9	15.3	36.7	18.6	10.2	23.6	22.5	19.0	11.0	19.8	21.9	23.0	20.7	25.1	31.6	32.1	22.7	31.0	42.0	31.4	30.2	29.2	66.9	27.6	18.7	28.7	20.5	28.8	28.8	28.8	18.2	56.2	30.3	14.9	24.9	21.5	25.5	56.3	13.5	20.1	55.5	13.8	39.1	27.4	3.3	11.3	8.0	15.1	14.3	20.0	17.5	17.5	17.4	19.8	13.7	19.2	19.4	1.5	14.5	16.1	11.2	22.4	13.8	9.9	16.8	8.7	9.6	8.7	7.4	16.7	5.4	13.7	17.0	20.8	23.9	24.3	37.3	41.9	4.8	6.0	28.1	30.8	23.9	26.2	7.9	42.0	29.9	42.1	15.5	20.7	13.0	0.0	39.2	57.0	28.9	28.3	13.9	14.0	30.6	0.0	29.2	12.3	18.6	11.4	30.0	16.7	28.7	33.3	24.6	16.3	32.2	17.5	28.3	17.9	12.3	25.8	23.6	197.2	97.8	40.1	25.6	19.2	36.2	35.1
MRPL47	"CGI-204, NCM1"	ENSG00000136522	"Mitochondrial ribosomal protein L47"	Q9HD33	3	179588285-179604654	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 290.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037553, HPA047779"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037553: AB_10671375, HPA047779: AB_2680154"	"unprognostic (6.37e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.84e-2)"	17.4	23.5	22.3	16.4	21.7	29.6	20.2	23.9	25.0	14.2	22.5	12.8	13.0	16.7	16.8	17.3	21.3	13.3	13.4	35.5	21.1	21.8	34.0	31.8	14.8	19.3	25.6	19.4	15.2	12.1	18.1	23.8	17.8	28.5	15.9	23.6	11.2	14.5	14.7	31.7	13.5	20.3	17.8	20.1	20.2	17.4	32.8	22.0	25.3	20.1	27.8	20.7	16.3	13.9	21.0	28.2	24.6	29.0	22.7	28.1	18.9	32.1	12.5	21.9	20.1	13.9	14.6	25.0	18.9	16.9	29.8	24.9	50.8	13.5	26.4	37.5	16.1	36.4	24.4	26.8	19.8	32.1	30.3	23.5	25.3	12.6	28.4	27.1	45.4	14.4	13.4	17.3	22.0	22.6	14.2	20.0	24.8	14.8	21.3	23.0	25.0	24.3	42.5	37.9	29.3	30.0	26.0	21.4	44.3	31.3	20.4	19.0	22.1	20.8	33.7	37.2	17.2	52.0	34.9	15.9	16.2	23.2	20.3	51.5	27.0	44.1	57.8	18.9	37.4	19.6	15.9	19.3	24.6	20.0	24.8	19.9	21.0	22.2	21.5	28.2	17.4	19.9	20.2	5.1	22.7	29.0	24.4	28.1	18.9	22.3	21.7	23.9	25.0	21.1	21.8	25.6	19.4	28.5	22.0	20.8	17.1	55.1	67.4	66.5	17.4	73.3	66.2	62.9	26.1	54.1	9.8	90.1	218.8	97.2	290.3	43.8	39.9	46.7	100.3	89.9	50.5	55.2	55.4	55.9	88.0	9.5	52.6	46.1	44.3	51.4	39.7	53.0	45.5	92.0	41.1	32.9	97.8	52.6	46.3	153.7	21.7	58.2	63.4	159.6	42.8	61.6	87.1	52.9	59.0	80.8
NDUFB5	"CI-SGDH, MGC12314, SGDH"	ENSG00000136521	"NADH:ubiquinone oxidoreductase subunit B5"	O43674	3	179604690-179627647	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005640	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA005640: AB_1079461"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.46e-2)"	"unprognostic (5.96e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (3.32e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	32.2	39.6	41.3	16.0	44.6	12.1	27.2	20.0	45.7	23.7	32.3	22.0	21.2	43.7	16.2	15.4	26.4	20.0	20.5	86.9	34.1	31.7	48.1	42.3	17.8	21.7	39.4	33.6	22.1	23.2	31.1	18.7	21.3	37.6	19.6	29.9	24.8	35.8	21.3	96.3	17.5	38.5	21.3	30.9	20.4	24.9	21.8	18.4	22.7	27.7	47.3	18.5	26.5	17.3	27.7	41.4	19.5	44.9	14.6	25.0	26.7	23.4	6.6	16.4	19.9	21.7	29.2	22.2	14.9	18.8	21.3	21.6	19.7	17.1	20.5	45.2	12.6	36.6	26.0	17.7	19.7	21.5	42.4	14.8	22.0	12.0	16.4	19.9	26.3	17.5	26.9	25.5	12.0	20.0	22.1	24.4	20.0	18.6	29.9	22.8	16.7	15.1	20.4	23.7	45.5	26.7	16.8	19.0	63.6	38.6	18.1	11.7	19.6	9.0	50.9	35.1	15.4	77.6	42.9	15.7	14.1	13.4	19.2	35.4	39.8	41.2	30.3	22.8	28.2	20.0	19.5	29.9	14.4	13.9	37.6	22.1	27.7	20.0	17.0	41.4	19.5	20.8	21.0	6.7	14.6	44.9	24.0	25.0	26.7	41.3	44.6	20.0	45.7	34.1	31.7	39.4	33.6	37.6	18.4	44.7	44.0	87.9	92.8	75.7	45.3	340.1	112.1	52.2	53.4	83.7	31.4	192.8	431.0	110.3	85.8	85.1	125.2	0.0	92.5	115.9	83.1	75.7	92.3	108.0	222.8	38.1	112.9	97.6	229.9	13.7	75.1	156.2	128.2	124.4	173.7	74.4	86.7	189.4	65.7	379.0	54.1	71.1	81.4	233.1	125.2	77.5	192.3	81.2	242.9	137.2
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179652755-179789401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.8;skeletal muscle: 90.3"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 182.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"MAIT T-cell: 15.4"	"Lineage enriched"	"Detected in many"	8	"T-cells: 15.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.4	7.5	2.0	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2.0	2.3	2.3	3.4	6.0	2.5	2.1	2.1	7.2	3.0	3.3	9.8	1.9	3.0	3.0	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2.0	1.9	0.0	0.4	0.0	15.4	0.7	12.5	5.4	10.2	7.8	4.6	6.4	4.9	7.4	8.5	10.9	9.2	7.9	4.4	15.5	8.3	8.9	12.3	0.9	11.4	4.5	13.0	36.6	4.9	4.1	8.1	7.4	3.3	11.4	0.0	6.9	1.6	8.5	10.8	5.3	8.7	6.1	2.0	20.0	9.0	8.2	6.9	2.1	7.9	1.1	4.9	11.9	10.1	12.7	7.4	3.5	5.8	7.5	7.1	9.5	4.3	3.0	16.4	8.2	9.4	13.2	10.5	11.3	28.4	9.7	8.1	31.7	6.1	7.7	12.2	0.0	0.2	0.0	1.3	0.4	15.4	2.0	1.3	2.9	1.5	0.6	1.0	1.0	0.0	0.0	0.4	1.9	0.6	0.7	2.0	2.8	2.9	4.1	2.0	2.3	2.1	2.1	3.0	1.3	8.9	31.0	4.3	1.7	2.3	12.7	182.3	5.1	2.7	9.1	1.8	5.9	8.7	13.3	1.0	2.1	9.7	0.3	0.0	3.7	1.6	7.1	3.4	2.3	6.8	3.7	15.9	9.2	27.6	3.1	2.0	8.6	4.7	13.5	0.0	1.6	6.3	1.6	5.8	8.9	2.7	9.7	12.9	5.3	5.1	2.1	1.4	4.2	3.2	3.8	1.6
PEX5L	"PEX5R, PXR2, TRIP8b"	ENSG00000114757	"Peroxisomal biogenesis factor 5 like"	Q8IYB4	3	179794958-180037053	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 41.9;parathyroid gland: 60.1"	"Cell type enriched"	"Detected in some"	10	"Cone photoreceptor cells: 237.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 5.8;MOLT-4: 20.2;RPMI-8226: 16.1;SCLC-21H: 9.9;U-266/70: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058026	Enhanced					NA	NA					"HPA058026: AB_2683582"	"unprognostic (5.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.67e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.66e-10)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.03e-3)"	1.3	1.4	17.0	1.3	26.6	1.2	1.2	1.8	41.9	1.3	1.2	24.5	0.0	1.3	1.2	1.5	1.3	1.4	1.2	1.3	16.9	8.1	1.3	1.2	1.3	1.2	38.4	18.9	2.9	10.6	60.1	5.3	1.1	24.1	1.4	1.2	0.0	1.3	1.2	1.4	1.2	1.3	1.1	32.3	1.2	1.3	5.4	36.5	0.0	1.3	0.0	1.2	1.2	0.4	0.8	0.4	0.8	0.1	0.4	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	5.8	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.1	0.0	0.0	1.0	0.5	0.0	0.5	0.0	2.9	0.0	0.0	20.2	0.0	1.2	0.0	0.2	0.1	0.0	16.1	0.0	0.0	9.9	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.1	0.1	0.0	0.5	13.0	0.4	0.0	0.3	0.1	0.5	0.6	0.1	0.2	0.6	0.1	0.5	0.0	0.1	0.0	0.0	0.8	0.2	0.3	0.8	0.4	0.1	0.4	0.0	0.0	17.0	26.6	1.8	26.0	16.9	8.1	38.4	18.9	24.1	36.5	0.0	0.0	0.0	0.2	0.0	6.9	2.8	0.0	0.0	0.0	0.0	237.6	0.0	0.0	0.0	23.1	0.4	0.0	0.0	0.5	0.0	0.2	0.3	0.0	0.0	0.1	9.5	0.0	0.0	0.0	15.4	0.3	0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.7	0.9	0.3	0.0	0.0	0.0	0.0
TTC14	"FLJ00166, KIAA1980"	ENSG00000163728	"Tetratricopeptide repeat domain 14"	Q96N46	3	180602130-180617828	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009295	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009295: AB_1858425"	"unprognostic (2.72e-1)"	"unprognostic (4.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.33e-3)"	17.2	20.3	30.0	30.4	32.0	23.1	20.5	18.2	32.4	22.8	20.8	15.8	25.6	19.3	29.0	37.9	12.7	25.2	16.9	16.8	25.6	15.4	22.3	14.1	18.6	30.7	22.8	28.7	41.9	24.3	33.7	49.0	18.0	22.1	26.4	19.0	15.9	15.5	28.7	11.9	17.8	20.7	17.5	23.8	25.7	19.8	16.6	24.3	41.1	35.2	11.1	23.0	20.3	23.4	14.2	18.2	17.1	13.7	14.3	15.0	5.9	8.7	7.0	11.0	6.4	15.0	12.9	10.5	12.7	10.3	9.3	15.3	9.6	11.8	13.3	13.7	9.1	21.0	12.7	10.3	6.7	12.5	24.4	10.4	12.4	16.2	22.3	11.1	13.2	11.5	16.6	13.1	9.2	4.6	15.3	7.3	17.0	5.2	2.6	10.4	2.5	10.0	1.0	7.8	11.2	14.2	11.8	6.9	14.1	5.3	6.7	9.4	9.3	12.2	6.2	12.0	11.9	22.7	12.9	11.5	18.9	9.7	8.5	23.4	19.9	30.2	29.7	9.0	16.8	8.2	17.1	9.8	10.4	11.6	10.7	14.1	14.2	12.2	11.4	7.4	12.5	15.0	11.9	7.8	14.3	13.7	18.2	10.4	5.9	30.0	32.0	18.2	32.4	25.6	15.4	22.8	28.7	22.1	24.3	8.9	32.3	41.3	27.4	15.8	104.5	11.7	48.4	33.5	31.8	62.8	110.0	27.3	3.3	22.4	5.0	35.9	27.6	0.0	28.2	16.2	30.9	22.4	58.8	23.5	20.7	76.3	37.5	39.9	24.9	4.0	85.7	28.0	28.7	28.9	19.8	67.7	26.1	30.8	76.4	5.6	125.3	84.1	27.8	33.0	28.7	13.4	20.6	50.7	18.3	18.0
CCDC39		ENSG00000284862	"Coiled-coil domain containing 39"	Q9UFE4	3	180602858-180679500	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3"	"Cell type enhanced"	"Detected in many"	19	"Ciliated cells: 200.8;Cone photoreceptor cells: 60.9;Early spermatids: 78.4;Late spermatids: 44.6;Rod photoreceptor cells: 44.0"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA035363, HPA035364"	Enhanced					NA	NA					"HPA035363: AB_2674588, HPA035364: AB_10601095"																		0.0	1.7	1.1	3.6	7.5	1.8	0.0	0.3	2.9	0.6	0.1	3.3	0.0	3.1	2.0	10.4	1.2	5.8	3.4	1.4	1.7		0.1	0.0	5.7	10.3	0.0	1.3	4.6	0.3	0.0	6.4	0.0	23.3	0.7	0.0	1.4	1.6	0.0	0.2	10.7	2.7	0.0	0.2	4.2	1.6	12.4	1.1	0.0	3.5	0.0	0.0	1.9	0.0	1.2	0.6	0.0	0.2	0.7	1.5	0.3	3.9	2.6	8.3	2.2	0.0	0.0	2.7	1.9	0.0	0.0	0.0	3.1	3.7	10.5	3.5	0.0	1.8	3.5	0.1	0.0	0.0	5.8	5.0	5.0	6.8	6.7	0.0	8.0	4.9	0.0	0.0	0.0	0.0	8.9	0.0	10.2	3.4	0.7	0.3	1.0	4.0	0.1	5.1	1.8	5.2	5.5	2.7	13.2	0.0	5.6	3.9	4.4	2.3	2.3	1.5	4.0	5.7	5.2	6.3	6.9	3.0	2.2	6.5	6.6	4.5	10.9	4.4	7.6	1.4	0.0	0.2	0.0	0.8	0.1	1.5	1.2	0.4	0.0	0.2	0.3	1.1	0.3	0.0	0.7	0.2	0.6	1.1	0.3											0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	200.8	13.6	0.0	60.9	0.0	0.0	0.0	78.4	0.0	0.0	0.0	0.2	0.0	1.7	0.2	0.0	0.0	0.0	1.6	0.0	16.0	1.9	44.6	12.4	0.0	1.7	0.0	0.0	2.4	0.0	0.0	9.2	0.0	44.0	6.5	0.0	32.4	6.1	0.5	0.0	0.0	0.0	0.0
CCDC39	"CILD14, DKFZp434A128, FAP59"	ENSG00000145075	"Coiled-coil domain containing 39"		3	180614008-180870933	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.4"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 1.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;ASC TERT1: 2.7;HSkMC: 3.8;HUVEC TERT2: 1.2"															NA	NA						"unprognostic (3.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.35e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.88e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.88e-4)"	"unprognostic (7.40e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.16e-4)"	7.9	0.5	0.4	1.0	0.4	1.5	2.6	0.4	0.4	10.7	2.2	0.0	0.7	0.1	5.2	4.8	1.1	1.0	2.2	2.3	0.4	0.4	0.4	0.8	1.1	0.3	0.4	0.0	7.5	0.5	0.0	1.1	0.3	0.2	2.0	0.3	4.7	1.6	0.1	12.4	0.8	0.6	6.0	0.4	4.5	0.6	8.3	0.0	0.0	0.6	1.8	0.0	2.4	0.9	0.5	0.1	1.1	0.8	0.1	0.7	0.0	0.0	0.0	0.0	0.2	1.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.4	3.8	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.8	0.4	0.7	0.1	0.6	0.4	0.6	0.2	0.0	0.5	0.4	0.5	1.1	0.1	0.1	0.1	0.1	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 215.4"	"Group enriched"	"Detected in all"	4	"Early spermatids: 827.9;Late spermatids: 1326.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA018246: AB_1849204, HPA055475: AB_2682828"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	12.4	13.8	13.0	7.6	16.1	13.7	11.7	14.8	15.0	11.5	14.3	10.5	11.4	7.5	14.7	10.1	13.4	11.7	8.9	36.1	13.7	14.3	10.1	11.3	8.5	9.4	19.4	9.6	16.9	11.4	11.4	17.3	12.7	18.1	13.1	7.4	6.5	10.2	11.8	215.4	7.7	7.9	12.3	23.4	9.1	10.5	39.1	19.4	17.2	16.2	22.7	10.0	15.6	28.8	13.8	14.9	11.4	14.0	11.0	21.8	9.4	36.1	16.8	36.4	28.2	28.0	32.0	16.5	28.8	29.5	32.4	32.1	24.7	18.3	18.5	47.6	19.8	51.2	17.5	29.3	17.6	45.4	24.4	19.7	18.8	22.2	28.2	29.9	11.6	15.5	33.7	20.2	16.3	39.1	48.6	32.6	18.2	15.0	22.5	40.7	13.0	22.1	19.6	41.0	22.4	18.5	15.4	46.5	19.7	24.9	11.3	15.4	19.7	24.9	29.0	37.2	53.4	40.3	22.4	25.9	24.4	27.3	15.2	56.5	21.0	26.3	22.0	25.5	16.8	31.1	8.9	12.9	10.0	12.9	14.0	13.6	13.8	13.8	11.7	14.9	9.5	17.6	14.4	11.4	11.0	10.2	10.5	21.8	9.4	13.0	16.1	14.8	15.0	13.7	14.3	19.4	9.6	18.1	19.4	59.6	64.8	54.7	82.6	69.6	69.6	196.5	38.2	131.2	89.9	33.2	53.0	80.5	49.7	73.6	827.9	71.9	29.3	93.5	65.6	84.4	66.3	54.2	121.5	58.7	58.6	82.6	51.6	52.2	63.0	1326.2	77.9	61.8	47.2	139.7	33.0	89.6	70.5	35.1	71.5	67.7	82.8	32.3	61.4	245.3	103.5	61.7	51.1	57.5	38.5	60.3
DNAJC19	"Pam18, Tim14, TIMM14"	ENSG00000205981	"DnaJ heat shock protein family (Hsp40) member C19"	Q96DA6	3	180983709-180989774	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone	Cardiomyopathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 399.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA037782	Approved					NA	NA					"HPA037782: AB_10672611"	"unprognostic (4.52e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (8.53e-5)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-3)"	14.6	32.0	24.5	11.0	23.1	8.5	23.8	12.0	25.8	17.1	17.0	14.0	15.6	18.9	13.9	30.9	15.8	17.2	15.7	53.2	21.4	23.3	44.1	38.1	11.8	13.4	22.3	17.9	24.6	22.0	22.2	24.7	12.8	19.9	19.4	16.4	15.1	23.3	17.7	45.5	11.5	16.9	19.2	17.9	14.0	17.2	9.8	14.5	13.3	22.9	30.9	13.5	18.4	12.6	20.6	19.6	16.8	14.1	13.6	24.9	16.4	21.0	5.5	15.9	12.1	19.1	11.6	14.3	12.1	7.4	12.1	10.6	19.6	10.6	8.9	25.6	10.3	29.4	10.7	15.3	14.7	15.1	14.2	19.6	10.6	9.5	19.2	20.5	25.4	11.3	10.8	12.3	10.0	18.0	15.9	13.9	22.0	16.3	14.6	9.4	17.4	18.8	21.2	21.0	30.0	17.8	11.9	10.9	26.8	17.7	9.9	15.9	8.4	12.5	30.9	30.5	19.1	34.3	17.5	6.6	7.6	11.3	10.5	21.4	19.3	23.0	30.9	7.7	19.6	9.1	13.2	11.5	16.8	20.0	11.4	23.6	20.6	23.3	20.7	15.8	17.2	24.9	24.8	2.4	13.6	14.1	19.6	18.6	16.4	24.5	23.1	12.0	25.8	21.4	23.3	22.3	17.9	19.9	14.5	35.7	48.6	66.8	59.9	50.4	31.2	138.0	79.0	53.5	51.2	73.3	13.7	99.1	399.6	71.6	5.8	54.0	53.5	0.0	94.7	95.3	70.0	81.0	105.4	133.3	59.2	46.1	43.5	49.7	30.2	7.9	78.9	50.7	70.9	62.3	81.2	47.0	73.4	66.6	68.2	169.2	52.1	84.1	69.7	70.5	59.6	52.6	57.4	61.8	84.7	48.6
SOX2		ENSG00000181449	"SRY-box 2"	P48431	3	181711924-181714436	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 80.1"	"Cell type enriched"	"Detected in some"	9	"Muller glia cells: 455.6"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 68.9;HAP1: 29.3;NTERA-2: 56.2;U-251 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"	1.8	2.5	30.3	2.0	25.8	1.5	1.6	13.9	80.1	1.8	2.3	24.3	0.0	2.0	1.5	1.8	15.9	5.0	1.8	1.7	36.0	19.2	1.5	1.5	3.4	1.5	19.4	18.5	1.7	1.6	1.5	5.8	1.5	18.6	3.9	2.0	1.0	6.3	1.9	1.6	1.8	2.3	1.7	18.4	1.6	9.7	3.0	22.4	0.0	1.5	2.1	6.9	2.3	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	68.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	29.3	0.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	56.2	2.9	0.1	0.0	0.1	0.0	7.6	0.1	0.1	0.3	0.0	0.0	0.0	11.9	0.4	0.0	0.0	0.0	1.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	25.8	13.9	20.0	36.0	19.2	19.4	18.5	18.6	22.4	0.0	5.9	0.0	41.2	0.2	3.5	0.4	0.0	52.2	38.7	3.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	4.9	1.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.6	0.2	3.3	0.0	0.0	455.6	0.0	0.0	0.0	0.0	8.2	0.0	0.1	1.5	0.2	0.4	0.2	0.0	0.0	7.0
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793500-182921635	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	16.8	7.9	7.7	19.7	9.8	35.4	17.0	18.4	9.4	20.5	21.6	8.9	14.3	13.6	15.0	11.7	37.3	11.8	12.7	21.1	6.9	5.9	13.7	14.3	19.4	20.3	10.3	5.7	15.2	14.6	21.0	26.0	8.0	8.3	16.8	16.9	9.8	19.7	13.8	13.1	21.8	22.8	16.5	11.3	23.4	27.6	22.8	8.9	49.0	10.8	20.4	21.9	22.7	25.5	3.6	4.2	7.5	1.8	3.0	3.4	1.3	22.7	3.3	7.2	10.0	15.3	16.8	6.6	10.5	14.5	8.2	9.6	8.1	11.8	10.6	18.0	15.1	17.1	13.8	8.5	10.8	14.3	23.4	6.8	25.4	4.4	1.7	8.9	20.0	16.3	11.3	12.3	9.2	13.3	12.1	12.8	16.9	9.0	32.9	13.2	7.7	16.6	6.4	5.1	12.9	6.4	6.9	21.0	12.7	9.9	19.1	4.3	7.7	29.3	3.7	12.8	6.8	4.1	14.9	12.6	12.5	13.5	10.7	18.2	45.0	40.2	19.8	8.6	8.6	7.3	7.5	1.7	7.2	3.1	1.8	3.0	3.6	2.7	3.1	1.9	2.4	2.3	3.4	6.8	3.0	1.7	4.2	2.0	1.3	7.7	9.8	18.4	9.4	6.9	5.9	10.3	5.7	8.3	8.9	14.9	10.4	9.7	20.0	30.5	11.4	15.9	17.8	6.7	11.4	19.2	13.7	9.6	0.0	10.9	27.7	14.5	26.1	46.7	14.4	3.2	14.9	34.3	10.5	13.6	9.2	36.5	6.4	14.1	17.8	19.9	17.8	17.7	13.5	5.4	27.5	8.1	20.8	27.1	19.8	6.2	28.3	19.4	16.5	15.4	10.7	39.0	8.0	24.9	20.4	44.2
DCUN1D1	"DCUN1L1, RP42, SCCRO, SCRO, Tes3"	ENSG00000043093	"Defective in cullin neddylation 1 domain containing 1"	Q96GG9	3	182938074-182985953	"Predicted intracellular proteins"	"Ubl conjugation pathway"		Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 95.0"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 9862.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		70000	Nucleoplasm	Cytosol	"HPA035911: AB_10673489"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.98e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.52e-1)"	5.0	5.2	7.9	5.0	7.1	6.9	4.8	9.3	8.3	4.5	4.9	4.1	2.7	4.9	5.4	4.9	6.7	4.3	4.6	5.5	7.4	5.0	7.2	11.2	4.3	5.0	9.3	6.8	4.7	3.6	4.6	14.6	4.5	8.0	6.1	4.8	2.8	4.9	5.4	14.7	5.2	6.5	8.1	9.2	5.2	4.2	95.0	7.6	7.2	6.7	5.2	6.0	8.4	4.9	7.4	10.7	17.3	9.8	11.2	8.0	5.7	23.3	10.4	13.9	6.0	14.7	14.5	11.8	15.0	16.9	16.9	16.6	15.3	17.4	27.4	33.0	14.0	25.5	13.1	11.6	12.0	22.5	22.4	6.3	26.4	8.1	6.4	9.3	15.5	19.9	10.3	14.7	9.4	8.9	12.5	11.6	16.8	8.8	14.4	12.3	12.5	15.2	8.3	11.3	17.6	9.5	12.0	14.7	18.1	12.2	16.5	10.1	10.1	26.3	18.9	14.1	15.3	38.7	12.6	11.2	10.5	10.1	14.3	17.6	11.9	22.0	27.8	13.2	14.7	15.1	9.4	9.1	17.3	7.8	9.8	7.5	7.4	6.4	7.7	10.7	4.7	7.5	7.9	15.0	11.2	6.3	8.2	8.0	5.7	7.9	7.1	9.3	8.3	7.4	5.0	9.3	6.8	8.0	7.6	20.8	25.6	17.1	21.7	38.5	14.2	28.2	17.8	20.1	27.3	45.4	9.8	16.2	31.5	26.1	2225.5	18.8	26.6	46.7	26.5	15.7	27.7	32.3	28.9	42.3	24.9	17.5	25.8	17.8	32.1	9862.3	80.3	36.4	11.8	45.1	19.9	16.6	27.2	23.4	60.5	33.6	20.5	77.6	25.5	86.4	52.0	37.1	16.7	25.3	19.6	34.8
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	25.1	26.0	14.1	10.4	16.4	9.0	24.6	23.1	20.6	9.0	12.6	15.1	10.1	12.6	11.0	11.4	15.8	9.5	11.6	24.4	12.2	10.1	42.4	41.1	13.8	8.0	17.0	14.4	12.8	32.3	10.2	15.8	5.5	13.4	11.4	13.7	9.9	14.2	15.6	19.4	11.5	10.1	11.3	10.5	8.3	17.7	8.9	16.4	8.9	14.0	8.5	13.2	23.2	9.5	13.1	19.4	17.1	11.3	18.9	11.6	7.6	14.2	5.4	3.4	3.6	15.1	6.9	7.0	6.6	9.2	7.2	8.2	7.5	5.7	15.8	10.7	5.8	12.6	7.4	5.2	4.3	9.3	5.3	5.8	13.4	6.2	7.9	10.0	8.9	7.7	7.8	5.0	3.4	7.8	4.9	9.7	13.9	7.4	8.3	8.1	11.7	8.7	4.5	3.9	22.4	6.0	7.2	7.8	20.2	10.6	22.7	7.7	5.6	25.2	34.7	7.1	3.7	53.1	12.7	4.7	5.6	4.5	4.4	9.7	8.5	15.5	16.0	6.1	12.9	5.2	8.5	9.7	17.1	8.3	11.3	9.4	13.1	10.8	9.0	19.4	11.1	11.6	10.4	1.6	18.9	11.2	12.7	6.8	7.6	14.1	16.4	23.1	20.6	12.2	10.1	17.0	14.4	13.4	16.4	8.9	42.2	11.0	15.2	6.3	10.8	27.0	33.1	25.4	13.6	26.2	9.8	24.8	28.2	16.0	4.4	5.2	9.2	0.0	14.9	3.5	6.7	11.8	7.0	30.1	14.2	7.9	5.8	5.5	9.7	4.1	8.1	11.7	6.8	10.0	11.7	12.1	18.1	19.5	9.9	36.0	11.4	6.5	8.1	6.4	3.2	5.1	23.7	10.1	22.9	19.4
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122213-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 123.9"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 2: 374.8;monocytes: 592.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 7.6;T-cells: 6.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 57.7;HDLM-2: 14.6;HHSteC: 21.4;hTCEpi: 19.5;JURKAT: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles		NA	NA		47000	Vesicles		"CAB025133: , HPA051467: AB_2681495"	"unprognostic (1.43e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (1.89e-7)"	"unprognostic (3.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	0.5	0.7	0.4	14.1	0.4	0.0	0.5	0.3	0.4	1.0	0.6	0.1	0.6	0.4	0.4	1.0	2.5	0.5	0.8	0.4	0.4	0.4	0.8	0.6	123.9	11.2	0.4	0.1	0.4	8.3	0.0	0.6	1.0	0.6	1.0	1.7	0.2	6.8	1.9	0.4	1.9	1.4	0.8	0.5	2.0	0.8	8.4	0.0	21.3	8.3	3.1	11.3	3.3	0.9	0.4	0.0	7.6	0.1	0.8	6.6	1.1	3.5	0.1	0.0	0.5	0.0	0.0	2.8	0.0	0.9	0.6	0.1	0.8	1.8	0.0	57.7	0.3	6.5	0.5	1.2	2.2	0.1	14.6	1.7	0.0	0.1	0.1	21.4	0.0	0.5	0.3	19.5	0.0	2.6	0.0	2.6	17.7	0.1	3.4	0.1	0.0	0.8	0.1	0.1	0.3	0.8	0.0	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.1	1.5	0.7	1.1	0.1	2.7	0.0	1.0	0.1	0.0	1.2	4.3	0.1	0.0	0.0	0.0	0.4	0.1	7.6	0.4	0.0	3.2	0.1	2.7	1.7	0.0	0.4	3.5	2.0	1.9	0.8	0.1	0.0	6.6	1.1	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.1	0.6	0.0	59.6	374.8	0.5	3.2	5.4	0.0	1.2	2.5	9.4	15.9	1.8	0.0	1.9	0.0	0.6	26.0	0.5	0.0	0.0	5.3	0.2	0.2	1.2	17.4	0.0	1.3	0.0	0.0	0.0	0.0	69.6	0.6	3.1	1.7	592.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	5.0	1.0	0.5	0.3	2.0
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.4;brain: 23.7"	"Group enriched"	"Detected in many"	11	"Bipolar cells: 64.6;Cone photoreceptor cells: 208.1;Early spermatids: 86.7;Rod photoreceptor cells: 135.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"T-reg: 4.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.4;Karpas-707: 8.2;REH: 5.4"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655"	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.9	16.4	12.8	1.4	14.9	1.1	1.1	11.3	23.7	1.3	1.4	3.6	0.0	0.9	1.3	1.3	1.3	1.0	1.5	1.1	12.2	7.6	1.4	0.8	1.2	1.7	5.6	13.0	1.2	1.2	10.5	8.9	0.8	7.3	2.1	1.4	7.5	0.8	1.6	1.4	1.0	1.2	1.4	4.5	5.3	1.2	5.5	4.3	0.0	0.9	0.0	2.1	1.6	0.4	0.1	0.0	0.6	0.0	0.1	4.6	0.2	0.1	0.6	0.2	1.8	0.1	0.2	0.4	0.0	0.1	0.3	0.0	1.2	0.2	1.5	0.2	0.1	1.9	0.0	0.3	0.2	0.1	9.4	1.4	4.0	0.3	0.0	0.3	1.2	0.8	0.3	0.0	0.0	0.7	0.0	0.7	2.5	1.2	8.2	0.5	1.2	1.2	0.9	1.3	0.0	1.6	5.4	0.0	1.5	0.4	0.2	2.6	0.9	1.0	0.0	2.1	0.6	0.5	0.9	0.6	0.0	0.9	0.1	0.1	3.3	3.5	1.7	0.8	1.4	0.1	0.1	0.0	0.1	0.4	0.0	1.0	0.0	1.0	0.6	0.0	0.1	0.0	0.9	0.6	0.1	0.0	0.0	4.6	0.2	12.8	14.9	11.3	23.7	12.2	7.6	5.6	13.0	7.3	4.3	0.0	2.1	0.0	0.4	0.3	64.6	1.2	0.0	4.0	0.0	5.2	208.1	0.2	0.0	0.1	86.7	0.7	0.3	0.0	0.2	0.1	0.7	0.2	1.1	0.0	0.4	7.9	0.0	3.1	0.6	11.7	0.9	1.0	1.7	2.8	0.0	3.0	0.2	0.0	0.4	0.0	135.4	0.0	0.4	0.7	3.4	0.4	1.1	2.1	0.0	0.6
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.1	1.5	8.7	5.3	7.3	21.6	7.9	0.2	0.4	1.7	1.4	3.2	8.5	0.0	1.0	0.0	30.4	7.4	8.9	25.2	1.4	0.0	5.5	0.8	0.7	0.0	9.3	8.1	4.0	10.1	30.7	1.3	23.0	2.3	15.7	0.0	9.2	0.0	13.8	0.0	0.0	2.6	3.6	9.5	14.0	2.5	4.4	0.0	5.3	4.5	0.4	8.3	4.5	0.0	1.9	4.1	0.0	9.9	23.1	0.4	3.4	0.5	3.9	0.0	0.0	0.0	3.3	19.2	8.6	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3	6.0	17.4	0.0	55.5	57.9	7.1	2.0	12.7	101.7	27.3	5.2	21.6	24.4	1.7	15.7	9.9	10.0	77.7	0.0	10.5	9.4	7.4	42.6	13.9	0.4	25.3	3.2	36.7	3.1	9.7	19.2	1.4	50.1	11.8	11.8	73.1	3.2	25.3	42.1	0.4	4.3	12.7	0.0	3.4	0.9	0.4	74.2	132.0	0.7	26.9	125.2
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487531-183555689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.2"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 16.2;Ciliated cells: 18.7;granulocytes: 47.6;Hofbauer cells: 22.0;Kupffer cells: 16.7;Macrophages: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.4;HEL: 9.8;HMC-1: 10.3;U-266/70: 31.6;U-266/84: 16.4;U-698: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"		Yes	NA			"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	4.4	1.2	1.4	43.2	3.3	2.9	2.2	0.5	1.8	1.7	4.1	2.4	0.5	2.3	1.1	0.3	1.7	4.2	2.3	1.9	1.8	1.3	1.4	1.4	8.0	23.8	4.4	0.0	0.7	0.8	0.2	1.0	1.8	2.8	1.4	2.2	0.8	4.6	0.6	0.7	0.8	9.9	0.7	8.8	15.1	3.5	0.7	2.3	21.4	1.6	0.5	34.5	2.8	2.7	4.4	5.2	13.3	3.3	2.8	4.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	9.8	0.0	0.0	0.0	2.6	10.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.1	7.0	0.0	0.0	3.2	1.5	0.0	0.0	0.0	5.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.0	0.0	31.6	16.4	46.4	0.0	2.9	0.0	7.1	3.3	13.3	0.8	2.7	0.9	4.4	3.0	1.3	2.3	3.3	3.6	2.2	3.1	2.8	3.0	5.2	4.8	2.7	1.4	3.3	0.5	1.8	1.8	1.3	4.4	0.0	2.8	2.3	6.0	9.2	16.2	1.5	1.0	0.6	3.2	0.0	18.7	9.1	0.0	2.0	0.2	0.0	0.0	1.5	2.9	0.0	0.0	0.0	0.2	1.1	1.1	47.6	0.0	22.0	0.0	0.0	1.8	16.7	0.0	0.3	17.0	8.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.5	0.5	10.8	0.0	1.0
KLHL24	"DRE1, FLJ20059"	ENSG00000114796	"Kelch like family member 24"	Q6TFL4	3	183635568-183684477	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056337	Uncertain					NA	NA					"HPA056337: AB_2683103"	"unprognostic (3.68e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.02e-2)"	23.4	12.9	12.0	10.7	18.1	29.1	16.8	17.2	16.6	14.7	17.0	20.9	11.8	14.8	17.4	9.7	11.2	10.2	12.7	44.1	12.9	11.2	17.9	19.5	21.4	13.1	23.3	12.3	20.5	13.9	40.6	18.6	12.7	17.3	16.3	13.2	11.9	20.9	11.6	51.5	12.8	14.2	19.6	17.5	13.8	13.7	7.7	21.1	22.3	25.4	10.8	13.3	21.0	21.5	17.0	9.0	25.4	14.8	9.4	14.1	9.6	2.3	2.1	5.4	5.6	13.1	7.4	10.7	1.1	9.0	1.4	3.1	1.5	4.2	4.6	16.6	3.5	13.8	3.2	3.1	1.4	2.5	4.7	4.1	2.4	3.8	1.4	10.6	2.3	3.7	14.6	7.5	1.6	5.6	9.4	7.9	7.3	1.9	14.9	2.0	1.1	4.0	2.9	3.3	3.5	3.2	5.2	4.0	13.6	4.1	7.0	9.3	13.0	5.3	17.6	12.7	8.5	6.1	5.3	7.1	1.8	2.3	2.8	1.5	29.8	19.0	18.9	3.1	3.7	1.2	23.7	13.1	15.3	11.6	14.8	10.0	14.6	9.8	10.3	9.0	17.0	14.1	9.8	25.4	9.4	13.3	6.9	12.7	9.6	12.0	18.1	17.2	16.6	12.9	11.2	23.3	12.3	17.3	21.1	104.2	49.1	45.8	26.9	38.7	35.5	127.8	28.1	29.4	28.4	29.6	66.8	7.7	11.6	20.5	10.0	28.7	27.1	46.7	16.5	16.5	34.2	41.0	25.4	39.4	23.3	57.2	40.5	30.1	47.9	4.8	28.4	23.4	33.7	12.6	33.8	28.4	17.5	24.6	23.0	25.8	43.6	32.3	28.8	15.4	7.2	38.3	36.6	34.8	26.0	26.0
YEATS2	"FLJ10201, FLJ12841, FLJ13308, KIAA1197"	ENSG00000163872	"YEATS domain containing 2"	Q9ULM3	3	183697818-183812625	"Predicted intracellular proteins"			Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045891	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045891: AB_10961271"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.33e-3)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (6.90e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.08e-2)"	11.1	8.5	17.9	18.9	21.0	20.4	13.1	27.2	22.7	13.7	12.8	17.9	4.9	9.0	16.0	8.5	13.1	17.5	10.9	10.7	15.5	14.9	10.5	5.9	16.1	19.1	14.1	17.8	25.8	8.9	18.1	20.2	17.9	14.9	14.2	11.6	12.8	12.5	12.9	8.4	13.6	10.7	19.6	16.2	13.6	9.8	13.0	15.0	21.7	16.2	5.1	18.5	15.0	14.3	2.6	2.8	10.5	8.0	1.5	2.7	2.3	18.9	5.7	16.9	7.5	8.3	12.3	18.8	11.3	8.8	16.9	19.9	14.0	6.9	17.4	21.0	9.9	26.2	12.2	16.4	10.9	17.3	14.2	9.7	17.6	6.2	6.8	12.8	13.0	10.2	8.4	8.5	12.1	14.7	16.9	17.1	18.1	6.9	14.7	12.6	5.1	18.8	10.1	15.2	6.9	11.4	26.8	15.9	20.9	6.8	8.4	16.4	11.7	8.4	28.8	14.9	14.9	14.2	9.0	14.4	15.6	11.4	7.8	12.6	14.1	11.0	29.6	12.1	13.1	11.0	0.1	6.0	1.6	2.7	2.5	1.9	2.6	2.3	1.9	2.0	1.8	1.9	2.1	10.5	1.5	8.0	2.8	0.9	2.3	17.9	21.0	27.2	22.7	15.5	14.9	14.1	17.8	14.9	15.0	32.8	2.9	7.6	2.7	1.8	18.1	8.7	2.5	9.4	5.7	5.2	9.8	3.9	0.0	5.5	1.9	9.5	4.0	0.0	3.5	7.5	4.3	4.8	6.9	2.1	6.0	12.7	8.2	8.0	8.4	2.1	9.2	5.8	1.7	2.8	5.8	6.1	6.9	0.0	8.9	0.8	16.5	0.0	4.1	1.9	14.3	3.0	1.7	3.2	4.3	2.1
AC131160.1		ENSG00000283765			3	183815568-183884889	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 12.1"									HPA019545	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019545: AB_1855796"																		3.8	3.8	2.9	2.2	3.8	3.2	2.3	2.8	12.7	2.4	2.9	3.3	2.3	1.2	2.2	3.1	4.5	1.7	2.6	4.2	3.0		2.5	3.3	2.8	3.7	2.3	2.5	2.3	7.9	3.2	2.5	2.0	2.3	2.3	3.1	3.6	5.4	5.1	9.7	3.2	3.8	6.0	1.7	2.2	2.2	7.1	2.2	2.8	2.6	3.5	3.3	3.0	0.5	1.0	1.0	3.1	1.2	0.2	1.0	0.6	1.4	0.0	1.6	0.5	0.4	0.4	0.0	1.1	0.7	0.7	0.5	3.7	0.2	1.6	0.2	0.5	1.8	0.0	4.5	0.4	1.9	1.8	1.6	2.4	1.2	1.2	0.0	1.3	0.4	1.0	0.9	1.0	0.0	0.1	0.0	2.6	0.5	1.8	2.4	2.4	2.8	0.1	2.7	0.0	0.3	2.9	1.0	3.2	0.5	2.2	1.8	1.7	0.5	1.7	1.5	0.0	12.1	0.0	0.0	0.0	2.0	0.2	1.4	2.8	3.6	2.3	0.8	3.0	0.9	0.0	1.0	3.1	1.0	0.5	0.9	1.0	0.4	0.5	0.1	0.4	0.8	0.6	1.1	0.2	1.2	1.0	0.3	0.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAP6D1	"FLJ12748, SL21"	ENSG00000180834	"MAP6 domain containing 1"	Q9H9H5	3	183815876-183825594	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 48.1;skeletal muscle: 33.5"	"Cell type enhanced"	"Detected in some"	5	"Early spermatids: 2.4;Glandular cells: 2.6;Intestinal endocrine cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.7"	"Cell line enriched"	"Detected in many"	5	"T-47d: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037991	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"HPA037991: AB_10672503"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (8.81e-12)"	"unprognostic (1.08e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.72e-2)"	1.1	1.2	11.8	1.5	16.0	1.1	2.0	30.9	32.1	1.5	1.4	48.1	0.0	1.9	1.4	2.0	1.1	1.5	1.3	1.9	18.8	9.2	1.2	1.3	1.4	1.7	24.7	8.7	1.7	6.0	1.8	0.5	1.3	18.4	2.7	1.4	0.0	1.6	2.0	33.5	4.6	1.5	1.4	37.7	1.5	1.2	1.3	20.4	2.2	1.1	0.0	1.4	1.1	0.2	0.5	0.3	0.2	0.2	0.0	2.7	0.3	1.9	1.4	2.2	0.4	0.5	0.7	1.7	2.4	0.4	4.6	3.1	1.8	0.1	0.2	3.1	3.6	2.3	1.4	4.5	1.2	3.1	1.3	6.8	0.2	0.0	0.0	1.3	2.4	0.8	0.3	0.3	1.1	0.4	0.6	0.9	3.6	0.3	0.0	0.6	8.4	5.9	3.4	2.0	1.1	3.9	2.9	3.4	0.0	0.2	0.0	7.2	1.3	1.8	1.3	2.5	1.6	39.9	2.4	0.4	1.1	1.6	1.6	3.5	1.5	0.9	1.1	0.3	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.5	2.7	0.3	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.3	11.8	16.0	30.9	19.9	18.8	9.2	24.7	8.7	18.4	20.4	0.0	0.0	0.0	0.5	1.0	2.2	1.3	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.4	0.5	2.6	0.0	0.0	0.8	1.6	2.4	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.4	1.7	1.3	0.6	0.0	0.3	0.6
PARL	"PRO2207, PSARL, PSARL1, RHBDS1"	ENSG00000175193	"Presenilin associated rhomboid like"	Q9H300	3	183829271-183884933	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019545	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019545: AB_1855796"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.11e-5)"	24.2	20.6	26.2	19.2	30.1	21.2	30.4	22.1	29.6	22.7	29.0	24.4	19.4	21.5	20.2	43.8	21.4	19.6	21.2	30.9	23.1	23.4	27.0	26.7	20.3	26.5	28.4	20.3	20.3	47.5	22.0	20.6	18.5	19.5	22.1	31.3	25.9	35.1	33.4	41.2	22.3	27.0	38.1	19.4	22.3	24.5	22.2	18.9	22.1	20.7	25.4	24.3	23.2	18.2	21.5	45.4	44.3	50.0	21.5	25.9	35.4	32.6	15.5	11.5	9.8	11.2	12.9	23.9	12.3	16.7	23.7	18.6	47.7	17.1	14.6	27.4	15.6	21.3	14.6	18.3	18.9	26.7	20.7	22.5	22.0	10.4	26.1	16.8	21.8	18.6	17.5	24.3	16.6	20.3	11.2	16.8	23.2	12.5	13.6	19.4	35.4	41.6	53.4	30.9	27.4	15.9	18.4	22.5	26.5	22.1	27.3	11.6	16.5	14.6	47.2	30.0	14.7	48.5	41.4	9.8	8.8	19.2	18.2	31.2	27.4	18.5	33.6	16.9	22.2	10.5	27.6	50.0	44.3	19.0	35.4	21.7	21.5	21.6	22.1	45.4	19.9	25.9	21.1	14.5	21.5	26.2	27.0	24.4	35.4	26.2	30.1	22.1	29.6	23.1	23.4	28.4	20.3	19.5	18.9	20.8	26.1	28.3	47.3	27.0	33.9	33.9	20.4	18.7	15.9	29.6	29.5	49.5	99.5	41.8	15.3	30.4	28.2	0.0	73.6	40.6	37.9	39.4	69.2	28.2	68.8	31.8	32.4	30.1	52.8	7.4	26.7	58.0	40.5	60.5	36.5	35.7	49.3	35.1	25.5	71.7	38.7	6.5	49.1	43.3	46.0	26.2	35.2	38.5	49.1	46.1
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184018015	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	7.9	11.2	24.7	9.6	26.2	12.0	6.7	42.8	28.6	7.7	11.4	12.0	13.4	6.8	14.1	7.0	17.1	6.1	11.6	16.0	19.1	13.7	12.8	3.6	9.4	7.3	20.5	18.5	11.8	4.9	22.4	20.5	10.8	21.7	10.6	14.4	31.1	7.4	9.3	41.0	14.5	8.5	10.5	12.9	16.3	48.5	9.4	20.9	9.3	5.5	7.3	7.4	18.1	12.7	4.2	3.5	15.8	4.5	5.0	7.0	4.5	7.3	4.1	9.4	11.2	9.4	10.7	14.6	6.0	4.7	5.4	5.9	6.3	5.7	8.0	14.1	5.7	8.2	29.9	11.6	6.6	7.1	8.7	11.2	16.9	10.3	5.7	3.9	5.1	13.2	17.0	6.7	5.8	3.8	11.1	6.3	23.7	15.7	11.1	9.2	19.5	14.1	5.9	9.7	13.4	7.9	9.8	3.1	4.7	19.6	48.0	17.2	10.2	6.1	33.9	10.1	12.7	20.5	1.6	7.2	6.3	6.2	8.0	8.2	4.3	8.3	7.4	4.6	10.3	6.4	10.7	4.5	7.7	7.0	2.1	4.5	3.2	4.0	3.1	3.5	4.2	4.6	6.3	15.8	5.0	3.5	1.3	5.0	4.5	24.7	26.2	42.8	28.6	19.1	13.7	20.5	18.5	21.7	20.9	8.9	4.0	1.9	12.9	7.9	34.3	31.9	2.5	56.2	46.6	41.8	184.6	2.7	6.6	5.0	4.8	6.7	9.5	0.0	4.0	3.9	8.0	10.9	4.7	2.4	39.9	31.8	56.9	5.5	27.9	2.2	7.5	11.2	11.8	6.4	6.3	9.4	6.1	9.3	7.4	2.7	122.3	0.0	8.6	3.1	14.7	10.7	3.8	5.0	7.2	50.3
HTR3D		ENSG00000186090	"5-hydroxytryptamine receptor 3D"	Q70Z44	3	184031544-184039369	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.8"					"Low region specificity"	"Detected in many"									NA	NA															"unprognostic (3.08e-1)"								0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1		0.0	0.0	0.0	0.2	0.0		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8			0.3		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR3C		ENSG00000178084	"5-hydroxytryptamine receptor 3C"	Q8WXA8	3	184053047-184060671	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"lung: 6.8"	"Cell type enriched"	"Detected in single"	7	"Intestinal endocrine cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"GAMG: 3.8"					"Not detected"	"Not detected"									NA	NA									"unprognostic (4.56e-2)"		"unprognostic (2.01e-1)"		"unprognostic (1.39e-1)"		"unprognostic (1.61e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.72e-2)"	"unprognostic (1.75e-1)"		"unprognostic (3.88e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3			1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.2		0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.3	0.0	0.1	0.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1
HTR3E		ENSG00000186038	"5-hydroxytryptamine receptor 3E"	A5X5Y0	3	184097064-184106995	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"intestine: 7.0"	"Cell type enriched"	"Detected in single"	24	"Intestinal endocrine cells: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RH-30: 5.5"									HPA049764	Enhanced					NA	NA					"HPA049764: AB_2680869"		"unprognostic (4.12e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.15e-1)"		"unprognostic (4.57e-4)"		"unprognostic (3.61e-3)"		"unprognostic (1.15e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.47e-1)"		"unprognostic (3.32e-1)"	"unprognostic (2.67e-1)"		"unprognostic (4.16e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
EIF2B5	"EIF-2B, EIF2Bepsilon"	ENSG00000145191	"Eukaryotic translation initiation factor 2B subunit epsilon"	Q13144	3	184135038-184145311	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015412, HPA064370, HPA069303"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (3.38e-8)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	15.2	20.1	15.3	15.4	20.2	10.6	21.5	24.5	25.8	15.1	18.8	17.8	24.3	17.3	16.3	14.9	24.3	15.4	14.0	21.5	13.0	16.1	17.5	27.5	15.6	20.1	20.8	15.1	16.0	19.1	27.0	21.2	20.6	17.7	20.4	23.7	15.3	23.2	21.0	47.2	22.8	18.2	17.5	14.7	21.1	19.6	11.9	17.3	20.9	17.4	16.9	26.9	19.1	18.3	12.7	10.3	10.9	8.4	11.2	17.2	6.5	24.4	11.2	13.8	15.0	13.9	11.4	14.9	14.6	15.6	21.4	18.2	18.4	12.3	22.2	16.9	14.3	28.0	18.9	24.7	17.0	21.9	19.9	20.3	36.3	11.4	16.1	10.8	27.4	19.3	9.5	15.4	12.9	13.4	11.0	15.3	22.3	19.6	19.4	15.1	20.5	20.0	19.1	18.6	29.8	20.8	21.7	16.6	25.0	19.5	21.6	14.9	16.5	12.5	39.7	16.2	11.5	36.7	27.2	14.2	13.0	15.2	12.3	28.0	16.7	23.1	28.3	15.5	29.4	16.2	7.2	8.4	10.9	7.6	7.4	10.5	12.0	11.9	12.7	10.3	12.7	17.2	10.7	1.6	11.2	7.7	5.0	9.5	6.5	15.3	20.2	24.5	25.8	13.0	16.1	20.8	15.1	17.7	17.3	23.8	20.7	22.3	31.6	27.4	19.3	21.5	10.2	18.7	30.7	34.9	7.9	33.4	44.7	20.0	2.6	22.5	23.8	23.3	31.3	23.2	16.4	34.3	16.1	23.6	22.0	33.4	44.0	16.0	16.5	2.1	17.0	20.5	18.6	34.3	24.5	13.3	21.9	14.4	13.8	25.8	15.0	12.9	21.7	13.4	13.0	25.3	32.3	23.6	26.5	37.1
DVL3	KIAA0208	ENSG00000161202	"Dishevelled segment polarity protein 3"	Q92997	3	184155388-184173610	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046486, HPA058265"	Approved		Approved	"Intermediate filaments,Midbody ring,Centrosome"		Yes	No			"Midbody ring, Centrosome"	"Intermediate filaments"	"CAB046486: AB_10610845, HPA058265: AB_2683658"	"unprognostic (2.20e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (8.61e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.77e-5)"	"prognostic unfavorable (1.53e-8)"	"unprognostic (1.87e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.95e-1)"	22.8	18.5	18.0	16.8	19.4	15.3	25.1	18.3	23.2	22.6	27.6	24.7	23.9	16.2	32.1	16.4	20.0	22.2	22.2	27.9	19.9	12.3	16.8	13.1	20.6	12.1	21.4	16.0	30.0	22.7	17.2	17.8	56.0	17.4	19.7	15.8	31.1	18.7	26.2	26.3	27.6	19.1	30.3	16.4	17.8	19.4	15.6	20.1	7.3	20.9	13.3	14.6	24.5	26.3	2.5	2.7	4.1	4.0	1.5	3.1	1.2	20.1	6.6	16.0	18.1	16.6	16.7	41.3	11.9	12.3	14.5	12.1	19.3	8.1	14.1	32.1	15.6	15.7	17.2	13.1	9.5	10.1	22.2	13.7	15.8	9.9	11.7	24.9	8.8	12.3	16.8	17.1	10.5	12.1	24.4	10.6	9.5	15.7	19.6	15.2	19.2	12.9	10.4	14.1	14.8	9.5	20.6	18.6	12.3	13.5	16.6	17.4	22.0	15.0	17.3	29.2	16.3	43.1	11.2	10.4	13.2	12.8	13.8	18.6	21.0	15.5	15.8	13.1	9.4	10.1	0.2	2.4	4.1	2.3	4.0	3.1	2.5	1.5	2.4	2.3	2.0	2.0	1.3	3.6	1.5	2.8	2.7	1.1	1.2	18.0	19.4	18.3	23.2	19.9	12.3	21.4	16.0	17.4	20.1	23.8	16.0	9.3	11.7	16.7	18.7	25.7	5.1	8.1	17.0	21.0	25.5	27.9	19.9	11.6	10.5	12.8	27.8	0.0	14.3	16.8	18.6	17.6	16.2	17.8	17.3	58.8	33.0	22.1	17.5	35.6	31.1	13.3	11.8	4.6	20.2	18.5	17.1	17.3	35.0	14.9	17.2	19.4	22.1	8.8	10.2	19.1	43.6	9.6	19.0	22.2
AP2M1	"AP50, CLAPM1, mu2"	ENSG00000161203	"Adaptor related protein complex 2 mu 1 subunit"	Q96CW1	3	184174689-184184091	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036849, HPA069870"	Uncertain		Supported	"Plasma membrane"		NA	NA		340000	"Plasma membrane"		"HPA036849: AB_10672101, HPA069870: AB_2686217"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (9.12e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (2.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.28e-1)"	37.6	78.2	58.6	38.3	78.2	47.7	32.5	64.2	111.9	52.4	42.7	33.5	35.4	40.7	46.7	27.0	54.9	39.1	41.2	86.8	62.5	64.6	39.7	36.8	35.8	35.2	57.5	83.0	49.8	26.0	53.6	48.2	59.0	79.8	40.0	35.6	44.4	40.2	61.3	33.9	38.1	36.1	60.3	41.5	34.1	32.9	27.8	32.1	30.5	35.3	34.5	37.1	49.5	38.8	26.4	59.3	51.4	62.6	34.9	39.5	77.6	48.6	37.4	32.2	36.2	51.8	54.5	33.3	82.0	47.8	92.7	65.3	40.2	35.7	22.3	100.3	122.6	60.8	55.3	43.5	55.4	76.9	45.8	54.3	57.6	43.0	35.6	61.2	28.3	36.7	69.2	31.5	58.7	37.7	84.0	68.9	29.8	27.6	43.9	86.8	111.4	36.4	16.8	78.5	43.8	56.2	33.9	41.2	44.2	57.5	44.4	34.3	25.0	64.4	81.1	38.1	52.6	108.6	34.6	73.8	58.9	47.8	57.5	108.0	39.6	34.6	49.9	111.0	41.8	38.3	37.5	62.6	51.4	32.5	52.7	32.0	26.4	30.3	31.1	59.3	25.5	26.1	26.7	28.5	34.9	42.2	29.7	39.5	77.6	58.6	78.2	64.2	111.9	62.5	64.6	57.5	83.0	79.8	32.1	50.6	49.0	96.0	145.4	110.9	179.9	166.5	81.5	20.1	39.8	108.2	66.8	350.0	318.3	216.7	238.9	157.2	189.4	116.8	141.3	275.4	160.1	132.3	147.6	66.5	475.3	262.2	135.2	174.3	117.8	263.1	152.5	165.2	189.0	547.4	101.7	147.8	177.5	138.2	201.9	236.1	93.7	194.1	212.7	73.4	100.5	110.7	429.5	123.6	136.9	178.1
ABCF3	EST201864	ENSG00000161204	"ATP binding cassette subfamily F member 3"	Q9NUQ8	3	184186023-184194012	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036332	Approved		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA036332: AB_10603571"	"unprognostic (1.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.53e-2)"	13.0	47.0	18.9	10.6	19.7	12.4	12.7	23.0	27.2	15.3	12.1	15.4	33.8	13.1	13.5	11.1	16.1	15.0	10.8	22.9	15.4	16.8	16.5	22.3	12.1	12.7	15.4	15.1	17.8	19.7	41.6	17.9	16.0	19.8	13.3	11.8	15.5	21.4	30.1	33.8	15.2	12.8	10.8	12.3	14.9	13.3	12.6	18.6	8.8	15.4	14.4	14.2	12.5	13.8	16.1	16.4	13.9	19.4	14.5	25.4	21.5	21.9	13.6	7.8	15.0	22.8	12.8	15.4	16.0	17.9	21.7	17.1	23.2	8.8	13.3	32.4	17.1	25.5	21.1	12.1	16.8	11.3	16.9	11.6	11.4	11.9	13.6	19.2	12.8	11.7	18.8	15.5	15.3	15.3	12.8	15.5	11.7	10.5	16.1	15.3	26.5	12.5	8.2	11.8	22.8	18.9	12.6	13.0	22.3	11.9	13.3	13.5	7.8	16.5	31.8	14.7	8.9	43.0	11.3	15.1	11.7	12.7	18.2	23.6	18.2	17.5	17.1	18.1	12.8	14.3	5.3	18.6	13.9	22.7	19.4	23.5	16.0	20.1	18.7	16.4	16.1	25.4	20.5	9.3	14.5	19.1	10.1	17.2	21.5	18.9	19.7	23.0	27.2	15.4	16.8	15.4	15.1	19.8	18.6	8.9	1.3	14.9	9.2	12.9	15.7	10.5	12.7	4.0	4.5	14.0	13.7	32.3	24.9	18.7	6.1	9.2	19.0	0.0	19.5	21.8	10.8	7.8	9.2	18.1	18.8	19.1	10.9	14.1	10.3	7.6	11.5	8.1	15.1	28.9	12.7	13.7	17.3	10.2	11.0	23.7	20.6	6.5	7.3	10.7	14.7	8.9	36.6	15.4	13.1	11.5
VWA5B2	"DKFZp761K032, LOC90113"	ENSG00000145198	"Von Willebrand factor A domain containing 5B2"	Q8N398	3	184230429-184242329	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 35.9;brain: 10.1;pancreas: 11.0"	"Cell type enriched"	"Detected in some"	34	"Intestinal endocrine cells: 107.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036823, HPA036824, HPA061412"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507"	"unprognostic (3.92e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-1)"	0.4	35.9	9.2	0.4	4.8	0.2	0.4	9.8	10.1	0.5	2.5	0.4	0.4	1.7	0.4	0.4	0.4	1.2	0.4	0.4	9.5	3.3	0.4	0.4	2.4	0.4	1.9	0.4	3.7	11.0	1.6	3.4	0.4	0.4	0.9	0.4	0.4	0.5	2.4	0.4	0.1	2.4	0.4	0.4	0.4	2.8	1.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	1.5	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.0	0.0	27.1	1.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.7	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	4.8	9.8	10.1	9.5	3.3	1.9	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	3.2	107.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0
ALG3	"CDGS4, D16Ertd36e, Not56, NOT56L"	ENSG00000214160	"ALG3, alpha-1,3- mannosyltransferase"	Q92685	3	184242301-184249548	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.4"	"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 169.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045103	Enhanced					NA	NA					"HPA045103: AB_10960547"	"unprognostic (3.63e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.63e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (1.58e-5)"	"prognostic unfavorable (8.67e-5)"	"unprognostic (6.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.02e-2)"	14.2	24.1	7.7	12.2	10.3	11.6	15.4	7.2	12.9	11.5	15.5	13.7	15.2	14.3	12.8	11.2	20.5	11.5	15.4	13.0	7.3	6.5	19.7	74.4	12.9	16.8	11.5	7.3	12.7	37.7	18.4	11.7	26.6	10.2	14.0	16.0	12.4	20.9	13.7	18.9	18.4	16.3	14.0	7.9	14.9	15.0	20.8	10.1	13.9	15.9	14.9	18.8	17.4	15.8	14.2	30.1	6.0	25.4	18.7	18.0	15.5	20.1	17.6	4.8	16.1	19.4	11.1	16.4	10.9	12.4	14.9	12.8	26.9	13.6	17.8	29.7	13.4	30.2	24.3	17.3	23.6	9.3	12.8	20.1	15.9	13.4	21.6	17.8	25.8	14.4	13.1	19.8	17.6	24.9	7.8	8.1	12.2	15.7	36.0	9.6	24.8	12.5	20.9	15.1	40.2	23.0	13.0	7.5	70.6	16.8	6.7	12.1	10.2	10.1	40.0	17.3	6.1	37.9	14.7	6.5	15.8	10.0	13.8	23.1	19.7	34.6	18.8	14.1	33.9	14.1	0.2	25.4	6.0	16.0	25.0	18.0	14.2	17.3	16.2	30.1	12.3	15.6	15.1	0.9	18.7	19.7	27.4	18.0	15.5	7.7	10.3	7.2	12.9	7.3	6.5	11.5	7.3	10.2	10.1	6.0	14.9	23.1	21.9	22.1	9.4	8.4	22.9	10.7	19.4	19.2	9.8	63.5	6.6	48.3	89.2	15.7	30.3	46.7	54.5	79.0	18.5	26.2	12.7	43.7	62.9	7.9	13.9	14.7	21.8	169.9	11.5	18.6	20.3	15.4	27.2	14.3	42.1	21.0	14.2	23.8	9.9	19.4	19.1	28.7	33.6	23.6	55.0	19.3	41.5	24.2
EEF1AKMT4		ENSG00000284753	"EEF1A lysine methyltransferase 4"	O60344	3	184249650-184259585	"Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 29.5"	"Group enriched"	"Detected in some"	4	"Club cells: 5.7;Collecting duct cells: 7.0;Distal tubular cells: 13.3;Ductal cells: 14.2;Exocrine glandular cells: 13.1;Pancreatic endocrine cells: 10.0;Proximal tubular cells: 17.7"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		2.1	1.7	0.2	3.3	0.8	1.8	1.9	0.3	0.5	1.3	4.2	0.0	2.5	2.5	0.6	0.5	4.1	0.4	1.4	2.4	0.4		4.2	29.5	2.3	2.5	0.2	0.0	1.7	8.3	1.0	3.1	8.4	0.8	1.6	2.3	0.8	5.7	2.7	5.4	2.4	4.3	1.1	0.1	3.7	1.6	13.0	0.6	4.8	6.9	4.5	3.7	1.3	1.6	4.9	10.1	1.2	12.0	3.4	7.6	5.6	13.1	6.9	1.6	4.4	2.4	1.6	10.1	1.5	2.9	2.3	2.2	12.9	2.0	15.6	10.3	1.7	12.2	4.9	7.4	7.5	1.3	6.1	8.7	4.1	4.4	8.2	2.9	10.8	3.5	2.0	9.1	2.6	4.5	1.0	1.9	5.2	7.4	14.5	1.1	20.6	4.4	13.1	3.3	17.2	13.1	9.2	2.2	12.6	2.7	3.2	8.0	2.7	3.0	23.7	5.8	2.4	19.9	5.0	1.4	2.6	3.5	6.1	7.6	8.7	17.5	15.4	2.1	17.9	2.7	0.0	12.0	1.2	4.3	9.7	4.8	4.9	4.6	4.2	10.1	3.2	3.3	5.2	0.2	3.4	6.2	9.0	7.6	5.6											0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	5.7	7.0	0.0	0.0	13.3	14.2	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.8	0.0	0.0	10.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EEF1AKMT4-ECE2		ENSG00000284917	"EEF1AKMT4-ECE2 readthrough"	O60344	3	184249695-184293031	"Predicted membrane proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"liver: 22.6"	"Not detected"	"Not detected"											"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"REH: 5.1"									HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		1.2	6.6	0.0	2.1	0.1	0.3	0.3	0.0	1.5	0.6	2.9	0.0	1.5	0.9	0.3	0.3	2.8	0.5	0.6	2.1	0.0		2.8	22.6	1.3	1.5	0.0	0.0	0.9	6.0	1.5	2.0	6.1	0.2	1.4	0.6	0.2	4.0	1.6	3.8	0.3	2.9	0.4	0.0	2.4	0.3	9.7	0.0	3.3	4.9	3.1	2.5	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell type enriched"	"Detected in some"	11	"Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA			"Nucleoplasm, Centrosome"		"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.3	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.2	2.7	2.8	0.4	0.5	0.4	2.8	0.2	5.5	1.5	0.7	0.5	1.5	9.3	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.7	0.4	1.9	0.6	0.0	0.3	0.0	3.3	0.4	6.0	0.1	0.1	8.1	0.2	3.7	19.0	5.5	1.6	0.6	2.2	20.0	4.3	1.8	0.5	0.1	0.1	6.1	0.1	0.0	20.8	9.1	1.9	3.3	2.2	3.3	2.7	4.8	1.2	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5	0.0	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	58.8	3.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	4.8	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0
ECE2	"KIAA0604, MGC2408"	ENSG00000145194	"Endothelin converting enzyme 2"	O60344	3	184276011-184293031	"Predicted membrane proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	12	"adrenal gland: 14.4;brain: 25.1;pancreas: 29.0;pituitary gland: 7.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 60.4;Late spermatids: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"REH: 14.3"															NA	NA						"unprognostic (2.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (8.41e-5)"	"unprognostic (1.37e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.63e-9)"	"unprognostic (3.66e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.25e-2)"	0.7	14.4	9.1	0.9	17.1	0.7	0.7	17.6	10.5	0.7	1.1	2.2	0.0	0.8	0.7	1.6	0.8	0.9	0.7	1.5	4.6	25.1	0.7	0.7	0.7	0.7	10.3	3.0	0.7	29.0	0.7	7.6	0.7	7.5	1.6	0.9	1.4	1.1	1.1	0.7	0.7	0.8	0.9	2.9	0.7	1.0	0.8	3.3	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	17.1	17.6	5.2	4.6	25.1	10.3	3.0	7.5	3.3	0.0	0.0	2.2	6.7	34.0	1.3	1.7	7.6	0.0	0.0	0.0	2.0	18.6	0.0	0.0	60.4	2.8	7.7	0.0	0.0	41.9	6.7	11.2	0.0	31.4	15.8	25.4	11.7	4.3	4.8	84.4	2.8	0.8	8.5	0.0	11.8	2.3	0.0	3.5	2.1	0.0	0.7	6.5	3.1	38.6	9.8	34.3	18.0	0.0	13.4	15.3
PSMD2	"MGC14274, P97, Rpn1, S2, TRAP2"	ENSG00000175166	"Proteasome 26S subunit, non-ATPase 2"	Q13200	3	184298709-184309054	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045192, HPA062363"	Enhanced					NA	NA		380000			"HPA045192: AB_10961324, HPA062363: "	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (9.98e-4)"	"prognostic unfavorable (6.63e-7)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.69e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.74e-3)"	21.6	33.7	31.7	20.8	28.7	23.2	16.3	22.2	31.5	19.4	20.4	17.9	20.6	16.5	22.6	16.8	25.3	18.8	15.7	39.2	27.1	21.2	22.9	28.5	18.3	18.6	23.8	29.7	16.5	16.4	28.2	18.9	25.2	25.0	18.8	22.2	15.7	19.0	22.2	107.0	22.9	16.4	26.2	15.1	19.0	19.2	34.1	17.7	20.1	19.2	28.4	25.2	18.1	24.8	28.3	53.2	37.0	40.4	34.7	35.3	42.7	111.8	29.5	23.7	40.3	28.8	16.3	29.0	63.6	43.5	70.3	40.8	41.0	19.9	29.5	94.0	46.8	58.2	32.2	35.3	62.0	89.4	51.4	27.1	31.8	28.0	25.5	16.0	21.6	28.4	18.6	19.4	67.2	42.3	27.7	42.3	23.0	22.4	27.5	57.9	36.9	22.6	13.2	37.0	35.1	49.1	26.5	33.6	31.1	30.2	29.8	20.4	17.6	45.3	39.1	22.7	27.3	55.7	19.3	52.8	43.9	55.3	35.0	133.0	30.9	67.4	55.2	56.5	27.3	31.2	20.3	40.4	37.0	31.1	36.1	30.7	28.3	30.6	35.3	53.2	23.4	30.5	30.3	12.3	34.7	37.2	22.7	29.8	42.7	31.7	28.7	22.2	31.5	27.1	21.2	23.8	29.7	25.0	17.7	62.5	63.9	41.2	59.2	63.2	62.9	103.0	30.6	49.5	51.2	54.1	19.6	136.0	76.3	201.7	125.6	43.6	54.6	93.5	113.2	103.2	54.6	49.2	39.3	59.2	74.8	68.3	76.4	35.0	43.2	62.8	45.1	52.9	50.6	121.8	34.9	107.1	229.6	31.7	61.9	72.1	48.3	32.3	72.3	181.8	143.7	58.6	186.4	41.5	44.8	52.5
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol		NA	NA		17000	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705"	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	30.2	33.1	18.3	26.4	18.9	26.3	30.3	18.0	23.2	24.1	25.2	19.6	33.6	21.9	24.5	30.5	45.2	20.9	31.1	33.0	16.9	16.9	40.6	108.0	26.0	21.0	19.4	15.9	29.3	46.4	47.5	21.9	34.6	18.3	24.0	21.8	19.9	31.4	34.1	103.7	39.0	31.6	26.8	15.7	33.1	27.1	30.8	18.0	25.8	30.0	46.2	34.3	28.6	27.6	8.8	15.9	5.5	17.0	8.1	11.4	9.1	90.3	37.9	31.9	36.2	35.6	35.1	55.1	49.9	35.3	55.5	42.3	80.4	29.5	57.8	66.5	61.8	66.5	48.9	54.9	61.2	43.2	61.1	57.8	52.2	38.8	35.6	30.9	52.3	36.6	35.4	35.6	50.5	48.2	28.9	48.4	22.1	37.9	45.8	36.6	67.1	35.4	18.8	62.7	44.3	30.7	36.5	31.4	46.4	29.4	55.1	33.4	29.7	42.5	70.5	33.9	28.5	75.1	37.4	60.4	39.4	39.9	51.6	93.4	35.7	43.1	107.0	44.3	45.9	43.0	4.8	13.6	5.5	11.4	13.9	11.0	7.6	7.7	9.2	12.2	8.8	7.1	7.0	5.1	8.1	17.0	15.9	5.4	9.1	18.3	18.9	18.0	23.2	16.9	16.9	19.4	15.9	18.3	18.0	71.5	58.2	39.7	51.5	52.5	25.1	95.4	50.9	40.2	67.1	59.3	13.7	53.1	11.6	92.9	153.5	57.6	100.2	23.3	116.3	63.6	52.3	82.5	45.2	130.2	58.2	20.6	53.5	43.6	38.3	140.5	67.6	40.6	32.1	49.5	68.5	21.9	122.3	58.5	52.6	40.9	22.0	77.6	66.8	27.0	39.1	80.3	66.6	33.8	68.7	78.7
FAM131A	"C3orf40, MGC21688"	ENSG00000175182	"Family with sequence similarity 131 member A"	Q6UXB0	3	184335926-184348421	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5"	HPA042800	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"	"Secreted - unknown location"	Yes	No			"Nucleoli rim"	"Mitotic chromosome"	"HPA042800: AB_10797023"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.28e-2)"	8.1	14.9	18.8	4.6	26.4	2.5	5.0	21.9	54.7	5.4	6.4	8.0	4.8	6.3	7.5	4.9	7.5	7.7	8.4	11.9	28.1	13.0	4.1	3.0	6.0	3.4	9.1	25.9	8.8	11.3	9.2	16.4	5.0	7.8	6.7	3.5	3.3	7.1	11.7	9.3	10.5	5.8	8.7	5.9	5.3	5.5	7.0	7.0	0.8	3.5	3.9	2.7	5.5	4.1	2.1	5.5	11.1	6.5	1.6	2.2	2.5	8.2	3.4	5.5	9.7	7.5	6.2	5.2	3.7	8.4	5.9	4.6	2.6	2.9	1.2	15.5	3.6	12.6	7.8	0.0	6.7	3.8	8.8	9.3	0.0	5.2	5.6	7.6	0.1	6.5	4.6	1.1	5.0	11.6	5.5	11.8	5.7	1.8	1.3	2.2	6.4	3.2	0.2	9.4	5.1	6.9	5.8	2.2	7.9	5.9	0.2	16.9	17.6	2.3	6.5	8.6	3.7	19.1	2.1	11.9	7.2	5.6	5.8	11.6	14.0	8.4	0.8	23.2	1.2	5.1	2.0	4.8	6.0	1.5	6.5	1.6	2.0	1.2	1.6	5.5	2.1	1.2	1.5	11.1	1.6	3.4	2.3	2.2	2.5	18.8	26.4	21.9	54.7	28.1	13.0	9.1	25.9	7.8	7.0	6.0	5.3	6.7	16.9	9.8	21.2	5.1	10.2	16.0	1.2	14.0	13.7	8.2	1.7	5.6	3.9	8.8	13.1	23.3	2.9	2.7	5.4	12.7	6.9	1.5	6.8	22.3	9.2	15.4	5.4	0.7	17.3	8.3	1.7	9.0	6.4	14.1	7.4	8.6	19.4	3.0	16.3	6.5	10.3	11.6	6.8	12.8	27.8	4.4	8.1	13.1
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361651	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 21.0;intestine: 20.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 10.2;Enterocytes: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.6	5.4	4.9	2.6	8.3	1.3	1.6	8.8	6.3	2.8	20.2	16.9	5.1	11.6	4.5	5.0	1.7	2.8	21.0	1.5	6.3	3.1	3.7	1.8	1.3	1.0	15.3	4.1	6.1	5.9	4.4	4.0	1.5	8.9	2.6	14.0	15.6	3.7	9.0	1.2	2.2	11.8	2.4	10.8	1.6	2.7	11.9	9.8	0.1	3.2	1.3	1.3	2.2	2.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	8.0	2.8	2.3	6.2	2.1	1.8	5.4	2.9	1.6	2.9	1.8	15.1	2.7	2.8	8.0	1.4	7.5	14.0	3.3	3.1	0.9	2.5	4.0	2.5	5.8	6.4	1.3	1.0	2.5	3.4	2.5	2.5	2.9	1.3	2.7	3.0	1.0	1.4	1.0	4.4	0.8	1.3	3.5	6.7	4.4	5.0	2.2	9.6	3.5	6.1	3.9	2.3	3.0	10.5	4.7	1.6	8.5	1.1	1.3	1.5	4.4	7.1	7.0	3.8	4.8	1.7	2.6	4.8	6.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	8.3	8.8	6.3	6.3	3.1	15.3	4.1	8.9	9.8	3.0	2.6	0.0	0.7	0.9	2.2	1.1	10.2	4.0	1.2	0.0	0.0	0.9	0.0	3.5	2.4	0.5	30.8	0.0	1.8	0.4	1.0	0.6	1.1	0.4	0.5	1.6	2.9	1.8	0.0	1.3	4.9	0.4	0.0	1.0	3.6	1.8	1.8	7.8	4.6	2.2	2.6	0.0	0.8	3.3	1.6	0.4	1.3	0.0	6.5	0.3
POLR2H	RPB8	ENSG00000163882	"RNA polymerase II subunit H"	P52434	3	184361718-184368596	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037745, HPA055813"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037745: AB_10672914, HPA055813: AB_2797254"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.61e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (8.82e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.02e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.34e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-3)"	18.1	32.6	19.6	19.2	17.5	14.8	24.5	24.2	24.6	28.8	29.9	13.8	19.8	32.0	19.9	23.5	26.7	23.1	26.7	16.3	17.8	16.3	34.1	41.0	17.8	21.7	16.4	17.0	21.8	46.4	15.8	20.7	27.2	17.0	19.2	33.6	19.7	26.0	17.0	19.9	20.7	38.8	20.0	13.2	21.5	25.6	20.6	12.5	28.1	29.7	23.1	26.3	18.5	16.2	17.4	18.2	7.7	15.3	14.6	26.6	11.5	49.5	17.4	18.8	27.8	21.0	14.9	23.4	18.7	19.7	25.7	33.1	44.5	23.8	28.1	47.0	14.6	39.1	20.1	33.6	33.6	22.9	27.4	44.4	26.9	20.5	27.8	19.0	28.3	15.7	19.2	19.2	16.7	30.3	23.1	26.5	28.2	20.7	18.6	20.3	58.8	27.9	37.9	20.4	62.1	36.4	16.4	17.3	38.0	30.5	22.5	28.5	20.3	15.8	49.1	27.2	19.0	61.4	22.8	13.8	12.2	19.4	16.3	49.8	37.5	38.8	52.5	19.4	30.3	16.3	3.4	9.6	7.7	15.2	15.3	18.4	17.4	18.0	16.2	18.0	16.4	26.6	19.7	0.7	14.6	9.6	18.2	18.7	11.5	19.6	17.5	24.2	24.6	17.8	16.3	16.4	17.0	17.0	12.5	35.7	40.3	38.7	63.2	100.7	21.3	13.7	53.5	36.1	31.8	41.8	15.7	88.4	119.3	59.7	14.9	50.9	83.1	0.0	78.5	122.8	54.6	65.8	31.1	57.8	53.4	23.8	53.5	32.5	21.4	9.6	42.6	31.5	49.0	30.7	62.9	23.6	80.3	69.9	26.2	102.6	23.4	38.8	60.4	72.4	110.1	64.7	102.3	28.8	72.3	83.9
THPO	"MGDF, MPLLG, TPO"	ENSG00000090534	Thrombopoietin	P40225	3	184371935-184381968	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Cytokine, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"liver: 55.5"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 11.1;Proximal tubular cells: 6.5"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.9;Hep G2: 17.7;K-562: 3.1;RPMI-8226: 4.6;SuSa: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	1070000					"unprognostic (5.57e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (1.40e-3)"	"unprognostic (4.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.25e-2)"	1.7	1.3	2.3	0.5	0.7	0.0	1.4	4.3	3.3	1.5	0.7	0.4	0.4	0.1	2.6	1.7	0.4	0.9	0.4	1.7	1.5	0.0	8.6	55.5	0.4	0.4	0.4	0.4	1.5	2.7	0.0	1.3	0.6	0.4	0.7	0.3	0.5	0.9	0.7	6.0	0.1	0.4	2.1	0.7	0.9	0.2	2.4	0.4	0.4	0.7	0.7	0.5	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.0	0.1	0.0	6.9	0.0	0.0	0.4	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	17.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.8	4.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	4.3	3.3	1.5	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	11.1	0.4	0.0	0.0	0.0	1.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CHRD		ENSG00000090539	Chordin	Q9H2X0	3	184380073-184390736	"Plasma proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.8;liver: 48.3"	"Cell type enhanced"	"Detected in many"	18	"Fibroblasts: 9.7;Hepatocytes: 33.8;Smooth muscle cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.6;Hep G2: 15.1;SuSa: 5.6;U-2 OS: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035827	Approved				"Secreted in other tissues"	NA	NA		120000			"HPA035827: AB_10669657"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (5.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-3)"	8.9	6.2	8.9	3.1	6.4	0.4	4.2	32.8	15.9	13.0	2.9	2.4	1.8	2.7	14.9	6.4	3.2	5.7	3.9	4.6	6.5	1.1	10.1	48.3	3.0	2.2	1.8	7.0	7.9	13.9	0.8	2.5	3.8	4.7	4.2	1.6	2.6	2.0	8.3	4.9	3.2	3.0	7.0	2.9	4.6	3.4	1.2	1.8	0.0	3.2	2.3	0.9	3.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.1	0.1	1.9	0.5	0.0	0.3	0.2	3.6	0.0	0.0	1.4	0.4	1.4	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.1	15.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.5	0.0	0.0	0.9	0.0	0.1	0.1	0.1	5.6	1.9	0.0	0.0	0.0	5.2	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.4	32.8	15.9	6.5	1.1	1.8	7.0	4.7	1.8	0.0	0.0	0.0	0.0	2.4	0.5	3.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	2.6	0.0	9.7	0.1	0.0	33.8	0.5	0.0	0.0	4.9	2.9	0.0	3.4	0.0	1.7	0.0	0.0	0.0	1.8	0.0	2.1	3.3	0.5	6.5	10.3	0.2	0.2	1.0	0.1	0.0	0.0	0.1
EPHB3	"ETK2, Hek2, Tyro6"	ENSG00000182580	"EPH receptor B3"	P54753	3	184561784-184582409	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Angiogenesis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 49.3"	"Cell type enhanced"	"Detected in many"	10	"Intestinal endocrine cells: 68.8;Mucus-secreting cells: 39.5;Suprabasal keratinocytes: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.1;myeloid DC: 3.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;HaCaT: 23.4;OE19: 16.1;SK-BR-3: 18.1;T-47d: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007698, HPA008184, CAB034350"	Enhanced					NA	NA		20000			"CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.10e-3)"	1.4	0.9	4.5	5.0	2.6	0.5	9.0	9.7	5.7	22.7	8.8	2.3	1.7	5.7	10.0	1.9	19.9	3.0	9.7	1.6	4.7	1.8	1.7	1.0	4.7	1.0	3.3	3.7	9.0	49.3	1.1	1.7	6.3	7.2	7.7	9.7	3.8	27.7	3.5	0.7	32.3	5.6	3.5	1.3	1.2	16.0	1.1	4.0	0.2	1.0	15.7	8.4	4.0	13.6	0.0	3.1	0.3	1.1	0.0	0.4	0.4	3.7	1.3	8.8	0.9	2.7	0.2	17.0	0.6	1.1	1.3	0.7	1.2	0.1	0.0	1.7	3.6	0.6	23.4	3.1	1.1	0.3	0.1	0.7	0.0	0.2	0.0	0.2	0.0	0.2	0.7	7.7	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.6	9.9	0.0	3.8	0.9	16.1	1.4	0.8	5.3	0.0	0.0	3.4	1.1	1.3	0.7	18.1	0.8	4.8	12.0	0.1	0.0	2.1	3.1	1.1	1.4	0.0	0.0	0.1	0.2	0.0	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.4	4.5	2.6	9.7	5.7	4.7	1.8	3.3	3.7	7.2	4.0	3.0	2.4	0.0	6.9	21.4	0.0	1.4	2.5	1.4	2.3	0.0	0.0	8.1	1.7	0.3	0.4	0.6	3.5	0.0	1.4	14.8	8.4	5.5	4.6	0.0	17.9	14.3	68.8	3.1	0.3	0.0	2.6	1.0	0.0	1.0	39.5	0.1	2.4	7.0	5.6	0.1	0.8	0.0	2.1	0.5	0.6	31.2	13.6	0.0	27.1	19.5
MAGEF1		ENSG00000177383	"MAGE family member F1"	Q9HAY2	3	184710367-184712002	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046899, HPA054190"	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA046899: AB_2679859, HPA054190: AB_2682411"	"unprognostic (7.36e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.46e-3)"	"unprognostic (2.34e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.51e-3)"	"prognostic favorable (7.59e-4)"	"unprognostic (7.65e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.19e-1)"	10.6	20.4	26.0	16.9	27.3	2.3	21.9	30.4	35.7	27.5	17.6	16.3	15.4	15.3	21.8	33.6	13.1	21.2	22.5	20.2	23.3	31.6	23.5	16.5	16.7	17.1	22.4	22.9	25.8	18.1	26.1	40.9	20.4	27.5	28.0	15.8	21.7	22.4	25.9	25.4	13.9	12.3	17.5	19.0	13.3	23.8	8.7	16.3	14.3	27.0	14.1	15.2	18.4	14.0	5.5	7.8	3.2	1.9	1.6	8.6	1.1	27.2	7.2	29.8	18.4	10.9	4.4	20.5	10.4	11.5	17.8	17.9	17.7	10.2	18.9	21.9	9.4	29.4	19.5	15.2	9.0	16.5	30.5	21.3	5.5	10.2	24.6	10.7	8.6	9.1	10.1	11.5	11.3	3.6	8.5	4.2	6.3	9.5	13.2	10.4	34.5	3.2	19.3	18.8	17.5	12.6	9.5	24.1	5.8	13.0	18.3	33.0	31.6	16.1	27.4	23.5	17.4	43.6	3.2	2.9	11.7	20.7	13.6	20.1	27.6	20.3	25.2	9.3	3.1	15.1	0.1	1.9	3.2	2.3	0.5	1.1	3.8	3.2	2.6	7.8	5.5	8.6	4.4	0.3	1.6	0.3	0.5	2.9	1.1	26.0	27.3	30.4	35.7	23.3	31.6	22.4	22.9	27.5	16.3	29.8	19.6	13.8	47.1	16.7	60.4	16.9	28.1	18.7	10.3	40.1	9.8	85.4	124.3	47.5	1.0	9.8	8.5	0.0	36.4	48.2	33.6	36.6	5.7	25.4	53.7	60.4	47.4	18.4	4.6	1.6	51.2	10.1	23.6	42.3	40.7	58.4	28.8	28.1	53.7	49.6	42.7	32.3	27.8	11.3	4.3	12.0	50.6	7.5	29.6	57.8
VPS8	"FLJ32099, KIAA0804"	ENSG00000156931	"VPS8, CORVET complex subunit"	Q8N3P4	3	184812143-185052614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036871	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA036871: AB_10672103"	"unprognostic (4.36e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.97e-2)"	12.6	11.1	14.9	11.1	20.9	22.6	12.0	21.6	24.8	15.5	12.5	18.2	8.0	9.1	16.4	19.0	11.5	10.1	12.5	20.3	17.1	19.3	12.5	9.2	13.8	14.8	21.5	13.6	16.7	10.1	21.8	23.6	13.3	28.4	12.8	16.7	12.1	9.5	12.0	28.4	14.2	9.9	14.5	21.9	14.9	14.1	17.8	15.9	13.2	17.5	9.0	11.5	12.5	11.6	3.9	6.0	17.7	4.9	3.9	6.4	3.1	10.2	6.3	9.6	9.6	20.0	17.9	6.4	10.1	11.2	7.4	10.4	7.9	5.4	11.1	17.8	15.8	30.6	12.2	10.3	12.4	14.4	20.0	9.2	12.1	7.8	4.7	12.4	8.2	16.3	12.7	11.9	10.5	10.7	13.7	18.7	10.4	6.2	8.0	13.5	7.3	6.5	4.9	6.3	10.6	6.0	8.1	18.4	8.6	7.4	18.0	9.8	6.4	11.8	12.5	9.2	14.9	19.8	4.3	16.4	11.5	6.5	11.6	8.9	9.9	12.0	15.2	13.1	10.3	8.9	11.7	4.9	16.2	4.0	3.7	3.8	3.5	4.3	4.0	6.0	3.9	6.4	4.3	17.7	3.9	4.6	1.7	3.5	3.1	14.9	20.9	21.6	24.8	17.1	19.3	21.5	13.6	28.4	15.9	11.9	8.6	13.7	7.9	9.3	20.3	23.2	12.7	16.0	7.9	8.7	17.7	10.2	6.6	7.7	11.6	12.0	9.3	0.0	4.0	4.9	9.5	7.7	2.3	6.7	17.6	11.1	17.3	12.3	16.2	13.6	9.8	20.2	10.1	31.5	14.3	12.1	6.3	11.9	12.0	7.0	16.6	6.5	8.1	45.6	24.9	14.1	6.4	14.4	10.7	12.9
C3orf70		ENSG00000187068	"Chromosome 3 open reading frame 70"	A6NLC5	3	185078050-185153014	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 26.6"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 17.4;Melanocytes: 37.1;Peritubular cells: 46.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"RH-30: 4.7;SCLC-21H: 19.5;SK-BR-3: 8.4;WM-115: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041861	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA041861: AB_10804119"	"unprognostic (1.45e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.62e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.06e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	4.6	2.3	14.4	4.7	13.8	0.9	2.0	7.9	18.2	7.2	12.1	11.1	7.9	5.3	12.1	6.1	10.1	6.8	6.1	3.3	11.1	10.2	1.6	1.3	2.4	1.3	11.4	7.1	5.9	1.1	4.0	1.4	2.9	10.5	10.2	8.2	5.2	5.5	16.4	1.5	2.9	6.5	26.6	11.1	4.2	4.4	7.5	7.0	0.0	2.4	1.0	1.7	13.2	3.3	1.2	1.2	3.4	1.6	1.7	1.1	0.5	0.0	0.1	2.3	0.0	0.0	0.1	0.1	3.0	0.1	0.5	0.0	1.4	0.0	0.0	0.0	0.3	0.1	0.1	1.0	0.0	0.2	0.0	0.8	2.5	0.1	0.7	0.0	0.4	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	1.0	2.2	0.2	0.1	4.7	0.1	0.0	0.5	19.5	0.2	0.9	8.4	0.5	0.1	0.6	2.2	0.8	0.0	2.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	10.5	3.4	1.2	1.7	0.8	1.0	1.0	1.0	0.8	0.8	0.6	1.2	1.0	1.1	3.3	1.7	1.6	1.2	0.7	0.5	14.4	13.8	7.9	9.6	11.1	10.2	11.4	7.1	10.5	7.0	0.0	0.0	1.5	0.2	3.7	17.4	1.2	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.1	1.0	2.3	4.0	0.0	0.2	0.6	2.3	0.3	0.0	0.0	3.1	3.2	1.2	4.9	0.6	1.2	3.1	0.0	37.1	1.0	8.1	1.3	0.2	0.0	46.7	0.0	6.2	6.5	15.8	7.9	12.5	1.6	0.7	0.0	5.3	0.3
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 227.5;Proximal tubular cells: 124.0"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA					"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.3	3.5	1.0	0.0	5.3	4.5	1.1	4.0	1.2	2.6	3.0	15.2	5.3	0.0	15.9	4.0	1.0	4.1	0.0	3.3	5.5	11.1	3.7	5.9	0.9	15.4	3.5	0.7	0.1	6.4	4.3	2.7	2.4	3.6	3.8	0.0	3.8	4.3	5.0	4.3	0.1	3.5	2.1	3.0	4.4	0.0	7.1	0.3	11.0	4.7	3.2	4.6	7.8	4.6	7.3	9.1	16.8	6.9	1.8	1.7	2.6	1.3	0.3	1.2	3.8	0.3	0.6	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9	14.9	7.5	13.7	1.5	1.3	0.2	17.9	25.5	4.0	4.5	19.2	3.9	7.2	16.6	2.0	0.1	2.8	13.8	0.0	5.9	2.1	1.5	1.8	0.0	227.5	3.7	0.0	7.5	12.3	12.4	0.0	0.6	1.3	3.3	15.4	11.6	1.7	3.3	8.6	0.4	124.0	0.9	0.0	2.0	3.9	4.1	0.4	1.1	3.2	10.6	1.6
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489097	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 456.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (1.11e-4)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	9.8	24.8	21.7	8.7	22.2	9.5	15.1	16.4	26.1	12.9	16.9	18.4	10.5	16.8	12.9	42.1	15.2	14.6	13.1	8.1	19.2	18.6	21.9	20.7	15.2	7.4	23.2	17.1	16.5	24.9	20.9	24.5	9.1	21.8	14.5	18.9	18.6	26.2	11.4	3.3	9.8	23.4	12.1	26.4	8.7	16.4	12.9	15.8	4.4	18.6	8.3	10.3	12.5	11.5	23.7	21.5	21.1	13.2	11.5	17.4	7.8	29.1	5.8	11.3	0.3	10.3	12.7	6.7	6.7	4.6	10.9	13.2	11.2	11.0	0.2	23.0	12.2	18.2	16.7	0.3	15.5	19.4	32.5	15.0	0.1	7.9	9.2	11.2	15.3	8.4	11.5	13.6	9.3	11.7	11.3	12.1	0.3	0.3	23.7	9.7	9.1	1.8	7.2	13.0	22.5	13.7	0.2	13.5	16.0	19.2	7.6	18.6	12.4	11.3	17.1	23.2	12.9	25.8	8.6	8.0	9.0	11.7	16.2	14.5	12.1	15.6	9.6	13.2	7.8	14.7	6.4	13.2	5.1	10.3	12.2	15.8	23.7	12.4	12.8	21.5	19.0	17.4	16.8	21.1	11.5	8.6	9.4	4.8	7.8	21.7	22.2	16.4	26.1	19.2	18.6	23.2	17.1	21.8	15.8	50.6	76.2	44.7	172.9	125.7	111.5	22.1	104.4	64.3	84.2	75.0	86.4	120.9	243.7	92.5	109.7	52.6	82.0	0.0	111.2	29.4	48.3	249.1	28.9	83.1	55.4	42.9	102.2	83.4	50.4	168.4	40.0	59.4	81.0	456.3	109.9	93.7	112.0	96.2	50.9	224.8	81.3	45.3	74.0	119.3	28.8	127.2	170.1	31.2	98.7	249.0
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 54.4"	"Cell type enhanced"	"Detected in many"	4	"monocytes: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059101: AB_2683905, HPA059790: AB_2684125"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	8.1	23.9	7.8	4.8	10.2	9.3	10.1	4.9	11.5	10.6	26.8	11.7	6.3	24.5	9.1	11.1	20.6	9.0	8.6	8.3	7.5	8.4	15.8	26.1	11.3	9.0	8.1	5.4	14.2	10.7	6.7	5.7	9.0	8.6	10.1	8.6	11.9	11.2	9.4	8.3	16.6	54.4	8.0	8.7	12.4	8.7	11.2	7.4	11.3	9.0	18.1	16.7	8.8	12.5	12.8	16.4	7.8	8.4	8.5	16.7	6.5	20.9	7.6	5.1	6.2	8.1	8.7	15.0	8.1	7.1	10.2	7.5	19.8	8.3	6.5	15.5	7.5	14.5	14.6	14.0	8.6	10.4	10.9	12.9	11.3	4.6	19.9	9.0	12.1	6.4	8.1	12.9	9.2	10.6	6.5	7.8	8.3	20.0	16.3	6.5	8.1	7.4	7.0	8.4	16.6	12.1	7.5	7.8	11.9	8.8	15.4	5.1	6.6	7.0	18.0	12.3	7.6	21.5	9.5	5.6	6.1	7.6	12.6	16.8	24.0	36.6	13.1	9.3	7.3	7.3	7.8	6.3	5.1	13.2	6.6	16.7	12.8	13.6	14.3	7.0	12.4	15.0	16.1	2.4	8.5	8.4	16.4	11.1	6.5	7.8	10.2	4.9	11.5	7.5	8.4	8.1	5.4	8.6	7.4	8.9	26.2	17.6	29.0	47.2	17.7	11.3	22.9	4.0	14.8	19.2	17.7	23.4	6.6	28.6	0.4	17.9	38.7	0.0	48.5	20.2	16.7	43.7	8.1	34.2	16.5	15.9	17.9	14.1	11.1	1.8	13.3	14.3	8.5	100.0	26.4	14.6	45.8	15.9	12.7	22.4	29.5	19.4	17.2	23.7	14.2	74.0	38.4	15.2	30.8	81.8
LIPH	"LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B"	ENSG00000163898	"Lipase H"	Q8WWY8	3	185506262-185552613	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.8;lung: 28.5;stomach 1: 27.0"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 134.0;Enterocytes: 247.9;Mucus-secreting cells: 115.8;Urothelial cells: 130.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 37.9;OE19: 8.6;RPTEC TERT1: 19.2;T-47d: 9.1;U-266/84: 9.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA049079	Approved				"Secreted to blood"	NA	NA					"HPA049079: AB_2680623"	"unprognostic (4.50e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (7.88e-2)"	"prognostic favorable (9.20e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (4.21e-4)"	"unprognostic (1.15e-1)"	0.3	0.5	0.5	5.1	1.2	0.0	2.1	0.3	1.4	2.5	20.4	0.6	3.1	6.2	0.2	5.1	12.9	0.5	16.5	0.6	0.4	0.7	8.5	0.5	28.5	0.0	0.3	0.0	0.7	13.6	0.0	2.1	0.9	1.8	10.7	21.9	2.1	15.7	3.0	0.3	6.1	28.8	1.6	0.3	0.5	27.0	6.2	0.0	0.2	0.4	4.1	14.9	8.8	5.0	0.9	0.4	2.4	0.9	0.6	0.7	1.7	5.1	6.8	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.1	0.1	0.6	37.9	0.0	3.9	0.1	1.5	1.8	2.8	0.0	0.2	0.0	0.8	0.9	0.9	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.6	0.2	0.0	0.3	8.6	0.5	0.0	0.0	0.5	19.2	4.6	0.0	0.0	0.5	6.3	0.1	0.3	9.1	0.1	0.0	0.0	0.5	0.0	0.1	0.6	9.0	0.0	0.0	0.0	0.0	2.2	0.9	0.4	0.5	0.2	0.3	0.4	0.5	0.4	0.2	0.9	0.7	0.6	2.4	0.6	0.4	0.4	0.3	1.7	0.5	1.2	0.3	1.4	0.4	0.7	0.3	0.0	1.8	0.0	134.0	29.7	0.0	12.6	0.7	0.4	0.4	68.8	45.5	54.6	64.6	0.0	0.2	1.7	42.3	0.0	0.2	247.9	0.0	22.4	0.1	0.4	71.5	6.9	0.0	0.0	0.0	21.4	1.3	0.0	0.0	0.0	0.1	15.1	1.0	115.8	0.3	39.8	89.6	0.0	1.6	0.7	0.0	0.2	0.5	0.0	1.8	0.2	0.0	61.8	130.6
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO1/sentrin/SMT3 specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 190.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	10.3	10.1	16.0	7.6	19.8	13.8	11.6	18.8	20.2	8.7	8.8	13.8	7.8	9.2	9.5	15.4	9.3	9.7	7.0	10.9	15.2	15.1	11.3	14.2	9.5	8.6	14.6	12.0	16.0	9.1	15.6	16.7	13.4	13.9	9.7	9.6	9.1	11.0	10.3	24.6	13.9	8.5	9.2	12.9	9.2	9.4	34.9	17.1	11.0	11.2	7.3	8.9	8.5	9.3	4.2	4.4	7.8	3.2	5.1	3.8	1.9	15.3	3.1	7.6	8.7	13.7	9.3	9.9	7.2	8.1	9.0	9.6	11.6	4.9	8.3	13.6	6.4	15.6	8.2	15.9	5.8	13.4	6.1	7.5	5.6	6.4	6.9	7.3	8.2	3.7	5.8	8.8	5.1	6.3	6.6	6.2	8.0	6.6	11.8	7.7	7.6	6.9	9.2	28.1	7.8	5.3	8.2	10.4	13.8	5.0	5.1	7.9	8.9	6.0	13.3	11.1	16.1	18.2	11.1	3.9	6.0	6.5	10.9	11.2	13.7	16.3	15.2	9.8	8.8	8.1	7.2	3.0	5.4	3.7	2.8	3.8	3.0	3.1	3.0	2.2	4.2	3.7	3.6	7.8	5.1	3.2	4.4	2.7	1.9	16.0	19.8	18.8	20.2	15.2	15.1	14.6	12.0	13.9	17.1	26.8	21.4	9.0	19.8	9.6	23.0	20.5	10.2	32.1	35.2	8.7	29.5	21.4	5.0	11.3	190.6	11.3	16.0	0.0	13.3	16.4	13.4	15.3	10.4	15.8	11.1	11.1	5.2	16.5	9.1	24.4	21.0	9.5	16.9	8.2	13.7	15.6	13.8	3.5	16.6	14.7	34.4	19.4	13.4	83.9	30.9	10.9	33.2	16.7	14.4	18.2
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643739-185825056	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 43.0"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 118.2;Rod photoreceptor cells: 160.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"CAB017126: , HPA035145: AB_2674491"	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	7.9	8.9	1.0	6.4	1.9	7.6	4.9	8.6	1.6	6.5	16.4	1.6	1.5	11.3	7.6	4.8	3.7	8.3	8.1	9.9	1.7	1.4	8.0	2.6	14.0	4.0	2.8	0.7	6.7	11.3	7.6	2.9	43.0	4.5	4.9	11.6	16.9	9.0	1.6	3.2	4.3	21.4	3.3	3.7	5.8	9.9	5.1	1.5	2.4	8.6	3.2	3.3	6.2	12.5	0.0	5.5	0.9	3.3	1.3	0.0	1.2	28.3	2.4	27.8	5.2	15.2	24.0	17.0	15.0	21.2	23.3	28.0	20.4	8.0	0.0	22.3	12.6	29.9	12.9	13.0	21.8	37.9	0.0	13.4	8.1	0.1	14.1	32.5	0.2	0.0	17.5	11.6	15.5	60.3	12.2	21.4	2.1	7.9	0.0	17.0	0.2	0.0	6.8	20.3	4.8	10.3	2.9	11.0	8.5	15.1	0.1	1.7	0.2	1.1	0.0	26.7	28.8	2.2	18.9	32.4	8.1	17.7	10.1	17.2	0.1	0.0	0.0	8.0	0.0	11.3	0.9	3.0	0.5	0.0	2.8	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.2	1.3	3.3	1.0	0.0	1.2	1.0	1.9	8.6	1.6	1.7	1.4	2.8	0.7	4.5	1.5	11.9	12.3	0.0	21.8	17.5	3.2	13.6	28.1	48.2	35.2	24.4	15.7	1.7	3.3	33.9	118.2	12.2	59.3	23.3	22.6	14.2	28.3	47.6	2.3	0.0	13.3	1.6	34.2	44.2	10.5	64.7	4.9	7.4	13.5	4.6	42.1	30.6	38.8	84.6	0.4	7.6	160.2	0.0	8.6	2.8	7.0	12.8	5.3	0.0	34.5	53.7
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185915906-185938136	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		40000	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	36.2	38.0	34.9	52.5	32.4	34.5	34.1	29.8	29.1	30.5	39.5	20.3	31.7	22.4	37.8	32.3	36.5	27.1	31.0	26.4	29.9	30.1	33.0	37.1	27.1	36.9	29.8	21.9	28.9	31.0	28.6	31.3	38.0	20.9	31.6	27.5	26.1	26.6	32.3	50.8	22.7	24.9	35.7	27.1	31.9	28.7	38.4	25.1	57.2	29.6	47.3	42.8	34.0	50.3	34.5	37.0	30.7	21.0	20.6	25.0	10.7	31.8	13.1	33.0	16.8	9.6	7.6	18.2	25.8	16.7	28.5	22.6	21.1	16.8	30.8	31.1	13.2	19.7	20.8	36.1	25.1	33.6	25.9	22.9	28.8	11.9	28.0	12.8	30.5	23.3	7.3	12.5	16.8	16.3	9.2	21.8	15.4	27.5	19.7	21.8	16.7	75.5	44.3	49.2	31.1	20.5	45.9	26.6	35.9	27.7	13.9	24.5	24.4	17.0	24.0	30.4	17.7	24.2	33.9	12.4	19.3	25.3	16.1	38.8	36.3	88.4	57.5	19.9	35.5	30.4	30.7	21.0	16.1	20.2	17.1	18.1	31.7	19.8	18.7	18.3	34.5	25.0	22.7	22.1	20.6	18.6	37.0	18.5	10.7	34.9	32.4	29.8	29.1	29.9	30.1	29.8	21.9	20.9	25.1	59.6	114.4	168.3	155.0	229.4	101.5	57.6	104.4	62.9	102.4	66.3	184.6	157.7	61.3	105.4	125.7	154.8	106.8	233.6	94.8	196.4	163.4	151.8	191.8	78.1	151.9	68.3	218.4	179.9	244.9	31.1	118.2	213.7	128.2	216.4	142.0	89.2	85.0	121.0	110.3	42.8	196.4	103.5	173.1	132.6	147.0	227.8	179.8	202.0	165.8	133.4
ETV5	ERM	ENSG00000244405	"ETS variant 5"	P41161	3	186046308-186110318	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 55.3"	"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 62.8;Syncytiotrophoblasts: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009590, HPA063065, HPA073889"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: "	"unprognostic (3.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (7.85e-9)"	"unprognostic (3.52e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.84e-3)"	5.8	30.3	13.2	5.5	21.7	1.6	11.3	12.1	35.2	4.7	3.0	15.7	1.3	5.1	6.8	6.2	3.8	4.6	4.8	8.8	13.6	9.4	7.1	6.2	21.9	8.9	9.9	11.0	2.5	25.4	55.3	28.1	24.3	11.5	6.3	3.1	7.4	5.5	5.1	9.8	5.3	2.8	6.1	9.6	10.0	11.9	7.2	6.1	2.0	16.6	1.7	3.6	3.6	3.6	0.6	1.8	0.9	3.1	0.1	0.3	0.5	13.0	9.0	11.6	25.3	7.2	7.4	0.8	11.2	12.6	8.9	9.6	9.9	8.0	0.3	15.1	10.8	13.4	2.2	0.2	8.5	13.2	2.8	0.3	3.8	0.3	11.1	11.9	9.5	7.1	6.5	1.4	14.2	17.4	10.6	13.0	1.3	3.5	4.7	15.1	6.0	1.2	14.5	17.3	3.7	10.2	26.7	11.6	8.7	7.3	3.1	0.5	14.9	2.7	0.1	56.7	4.8	0.0	5.3	12.6	4.9	8.0	12.3	21.9	3.6	14.7	0.1	14.9	7.6	29.1	0.0	0.3	0.1	0.3	3.1	0.0	0.6	0.0	0.0	1.8	0.1	0.0	0.0	0.9	0.1	1.5	1.6	0.0	0.5	13.2	21.7	12.1	31.7	13.6	9.4	9.9	11.0	11.5	6.1	3.0	55.6	4.2	10.8	14.0	15.6	4.7	20.4	1.4	2.3	0.0	11.8	53.9	3.3	8.2	19.2	8.3	1.0	0.0	8.0	16.2	11.4	2.6	8.1	8.5	45.7	4.8	10.3	14.7	47.8	37.8	8.3	13.5	15.1	2.8	0.3	62.8	9.4	0.0	14.5	11.8	15.8	0.0	15.7	17.4	9.3	4.5	74.3	0.9	0.4	1.6
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362237	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.4"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 16.2;Ito cells: 27.6;Muller glia cells: 7.5;Sertoli cells: 12.9;Smooth muscle cells: 16.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.2;HL-60: 6.4;U-266/84: 7.7;U-87 MG: 12.8;U-937: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	3.1	6.9	13.4	3.1	7.1	14.5	1.9	53.4	23.1	2.7	3.5	6.2	1.1	3.0	1.9	14.6	8.5	7.7	2.2	15.0	15.3	7.4	3.1	2.1	4.3	2.1	7.4	11.3	2.0	1.6	4.7	7.5	13.5	25.2	3.1	2.1	7.8	1.9	4.0	2.4	1.4	2.7	5.3	5.6	2.0	3.3	1.2	7.1	0.0	2.5	0.0	2.1	4.8	2.4	0.6	2.9	5.3	4.2	0.0	0.0	1.3	2.7	4.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.4	0.0	2.9	0.2	0.0	0.0	0.0	20.2	0.0	2.7	0.0	2.9	0.0	6.4	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.1	0.1	2.2	0.4	0.0	1.2	1.4	0.0	2.3	0.0	0.0	0.5	0.0	0.8	0.0	1.7	0.0	0.1	4.2	0.0	0.0	0.7	2.1	2.4	0.0	7.7	0.0	12.8	6.0	2.3	0.0	4.2	2.4	0.0	2.4	0.0	0.6	0.0	0.0	2.9	0.3	0.0	0.0	5.3	0.0	2.8	0.5	0.0	1.3	13.4	7.1	53.4	14.7	15.3	7.4	7.4	11.3	25.2	7.1	0.0	1.7	1.5	0.1	0.3	0.0	16.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.2	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	0.0	1.9	1.6	0.0	27.6	2.7	2.0	1.7	2.3	0.0	1.0	0.0	7.5	0.7	0.0	0.4	0.8	0.0	12.9	16.7	0.0	0.0	0.4	0.1	0.0	0.0	0.4
CRYGS	CRYG8	ENSG00000213139	"Crystallin gamma S"	P22914	3	186538441-186546702	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 15.1;cervix, uterine: 21.8"	"Cell type enhanced"	"Detected in some"	5	"Rod photoreceptor cells: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035103, HPA063539"	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"HPA035103: AB_10696367, HPA063539: "	"unprognostic (5.52e-4)"	"unprognostic (1.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.72e-9)"	"unprognostic (1.10e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.67e-1)"	"prognostic favorable (2.73e-4)"	1.6	1.9	3.6	1.8	2.7	4.0	3.4	15.1	3.3	21.8	1.8	3.5	1.6	1.7	2.7	3.8	1.6	1.3	1.6	1.6	4.1	4.1	2.2	1.8	2.6	4.2	4.2	1.6	2.2	1.8	1.9	1.6	1.6	3.0	1.6	3.7	5.8	1.8	2.9	1.6	3.0	1.8	2.3	3.2	3.6	2.4	1.8	1.6	6.0	1.6	3.2	3.3	1.6	1.6	0.3	0.6	0.2	0.2	0.0	2.1	0.1	1.0	2.0	3.7	3.1	3.6	5.6	0.5	0.5	1.2	1.3	2.5	0.4	1.5	3.8	4.1	2.7	1.6	3.2	1.7	2.8	5.5	3.2	4.9	5.0	1.4	1.9	1.4	2.9	3.4	5.9	3.8	1.2	2.1	5.4	4.2	4.2	1.0	2.2	3.0	1.2	2.6	1.5	0.2	1.7	1.6	4.3	0.8	1.8	1.5	2.3	1.7	1.6	2.6	2.5	1.0	3.0	2.0	1.7	4.5	1.4	1.1	1.6	2.7	4.6	2.3	5.3	1.9	1.9	2.7	0.0	0.2	0.0	1.4	0.0	2.1	0.3	1.9	0.8	0.4	0.1	0.2	0.4	0.2	0.0	0.0	0.6	0.2	0.1	3.6	2.7	15.1	3.3	4.1	4.1	4.2	1.6	3.0	1.6	0.0	1.7	0.5	0.2	0.2	1.0	2.2	2.5	0.0	1.2	0.0	2.0	0.1	0.0	0.4	0.1	0.7	0.4	0.0	0.2	0.1	0.5	0.2	1.1	1.1	0.3	1.6	0.0	1.8	0.0	1.0	0.3	1.6	0.0	0.0	0.9	0.5	0.3	0.0	0.7	0.0	3.0	0.0	0.6	1.4	0.7	0.1	0.2	1.3	1.0	0.1
TBCCD1	FLJ10560	ENSG00000113838	"TBCC domain containing 1"	Q9NVR7	3	186546073-186570543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.15e-1)"	"unprognostic (7.41e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.79e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.27e-1)"	9.9	9.2	6.9	8.8	9.9	8.3	14.3	14.4	11.6	9.2	9.1	10.5	13.5	8.5	11.9	10.6	10.4	9.1	8.6	8.6	8.6	6.7	8.7	12.6	8.4	11.9	11.5	8.5	10.8	11.7	13.2	13.2	10.3	12.0	8.2	9.9	14.2	10.6	7.7	8.9	10.2	10.0	8.8	7.9	9.3	8.5	27.2	10.5	15.1	11.8	5.8	13.4	9.0	9.9	12.8	13.5	15.7	10.8	14.9	18.2	9.8	8.2	6.3	9.5	9.5	8.9	9.9	6.9	6.4	4.6	8.4	9.4	10.9	7.2	9.3	17.0	5.1	7.0	9.3	13.5	6.4	10.8	15.3	7.6	12.8	5.2	6.7	5.2	12.1	9.1	5.8	7.2	7.2	9.3	5.5	12.9	12.8	9.9	10.0	8.2	10.2	11.4	7.2	5.6	18.6	10.7	13.0	10.2	11.8	6.0	5.6	10.9	6.9	11.7	13.9	6.7	8.3	18.5	8.0	8.1	6.2	7.6	7.1	10.2	13.9	22.4	24.6	6.6	11.5	11.7	15.7	10.4	12.0	13.4	10.2	17.3	12.8	14.5	15.0	13.5	11.6	12.1	14.7	4.6	14.9	10.8	7.9	18.2	9.8	6.9	9.9	14.4	11.6	8.6	6.7	11.5	8.5	12.0	10.5	14.9	5.9	4.9	2.2	5.7	6.0	2.7	2.5	10.7	1.2	1.8	2.0	3.2	10.0	5.4	1.3	4.5	3.6	0.0	5.7	4.7	4.1	1.8	11.5	4.0	4.2	0.0	3.5	6.7	4.6	2.4	5.5	5.4	5.0	5.4	5.9	4.8	4.1	3.7	3.5	2.8	6.3	6.5	3.8	40.3	18.3	3.6	3.4	5.7	5.2	1.8
DNAJB11	"EDJ, ERdj3, HEDJ"	ENSG00000090520	"DnaJ heat shock protein family (Hsp40) member B11"	Q9UBS4	3	186567403-186585800	"Predicted intracellular proteins"		Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA010814, HPA017051"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		18000	"Endoplasmic reticulum"		"HPA010814: AB_1078691, HPA017051: AB_1847792"	"unprognostic (4.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.86e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.44e-9)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-1)"	18.8	16.4	14.0	27.7	21.2	26.4	22.3	12.4	14.4	18.7	21.6	15.9	21.5	19.7	20.0	28.1	19.9	18.1	18.2	27.3	14.7	14.9	29.5	83.5	21.7	31.5	17.4	10.2	13.9	67.4	20.6	18.0	26.2	19.6	14.4	22.7	13.3	37.2	18.4	13.2	13.9	25.4	17.3	17.4	25.6	21.3	16.1	19.6	17.9	47.6	15.7	20.3	19.0	26.0	19.3	42.2	19.0	21.6	22.6	23.7	16.8	33.2	13.1	19.3	33.4	15.9	12.3	33.2	37.7	21.6	31.2	33.0	40.4	22.2	24.3	76.4	24.7	45.3	31.0	22.0	19.5	32.9	27.2	19.4	21.5	13.0	29.8	37.0	25.2	34.0	10.9	19.9	17.5	30.8	17.2	26.0	13.4	11.9	58.6	20.6	25.3	16.9	20.7	18.9	45.7	17.7	17.0	21.9	40.8	23.3	14.4	16.7	23.3	24.2	40.5	26.1	24.8	46.6	38.5	19.6	17.4	22.5	22.5	53.4	46.8	34.4	38.4	23.0	30.8	37.3	16.6	18.3	19.0	23.7	21.6	19.9	19.3	12.2	19.2	22.9	11.5	11.8	16.0	8.4	22.6	15.8	42.2	16.7	16.8	14.0	21.2	12.4	14.4	14.7	14.9	17.4	10.2	19.6	19.6	17.9	18.1	40.2	176.4	129.0	21.7	133.1	73.9	14.7	21.6	14.0	17.7	80.7	3.3	86.5	28.0	75.2	81.9	46.7	74.8	136.3	69.6	91.0	55.2	85.7	131.5	22.3	136.1	66.3	76.0	7.2	29.1	64.3	97.8	20.8	37.6	45.1	80.8	43.8	24.4	17.2	21.3	64.7	67.3	102.4	77.5	98.1	163.2	65.0	43.1	144.4
AC068631.2		ENSG00000283149			3	186581995-186597103	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 17.4"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA010814	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010814: AB_1078691"																		1.9	1.3		3.1		6.3	2.7		1.2	0.0	4.7			2.9	1.3	8.3	0.7	0.1	1.9	0.4			1.3	5.3	0.5	1.5			0.2	2.8	0.0		1.6		0.0	2.3		0.6	0.5	0.0	0.0	1.5	0.3		2.1	1.7	0.2			2.9		1.2	0.0		9.0	17.4	9.7	8.7	10.7	11.9	6.6	12.7	10.1	12.9	16.1	10.9	5.1	4.2	24.0	6.7	9.9	6.8	35.5	6.2	8.0	29.8	16.1	15.7	9.5	13.0	9.1	13.0	6.5	0.2	8.0	18.2	37.2	13.0	15.6	5.5	5.7	5.5	11.6	20.7	8.0	6.3	3.9	4.5	31.8	4.4	28.0	8.0	5.3	4.0	32.0	0.0	5.3	12.9	11.3	10.3	23.0	1.0	1.9	10.7	22.9	7.3	15.2	15.6	20.2	3.4	6.7	8.0	5.9	22.5	13.5	27.2	22.8	10.1	12.5	13.9	7.6	6.7	9.7	11.9	8.7	8.5	9.0	7.5	10.1	10.5	5.5	4.9	9.5	1.8	10.7	7.2	17.4	8.8	6.6											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186612923-186621318	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	269	"liver: 402.0"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 986.2"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.4"	"Cell line enriched"	"Detected in some"	77	"Hep G2: 215.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	140000000000	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	402.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	215.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	10.2	0.0	0.0	0.0	0.0	0.1	3.3	0.1	4.6	0.0	0.0	46.7	0.5	0.6	0.0	0.0	0.0	986.2	1.2	0.0	0.0	29.4	29.9	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.1
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 76.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 37.1"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.5;Hep G2: 4.5;HSkMC: 1.0;NTERA-2: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035132, HPA035133"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	47500000000	4500000000	Vesicles		"HPA035132: AB_10601650, HPA035133: "		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	2.6	11.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.5	0.0	1.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.7	0.4	0.2	0.0	0.4	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	1.3	2.4	4.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678240	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease mutation, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"liver: 425.4"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 394.5"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.8;HL-60: 5.9;RH-30: 6.9;RPTEC TERT1: 1.7;SiHa: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	NA	NA	120000000000	30000000000			"HPA050269: AB_2681068, HPA054598: AB_2682539"		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favorable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	425.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	6.9	0.0	1.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.8	0.0	1.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	394.5	0.0	0.0	0.0	13.5	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717276-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis, Inflammatory response"	"Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 323.8"	"Group enriched"	"Detected in some"	22	"Distal tubular cells: 555.4;Hepatocytes: 1509.4"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;Hep G2: 4.5;HL-60: 2.4;RH-30: 4.0;SiHa: 2.7"					"Low region specificity"	"Detected in some"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	NA	NA	90000000000	64000000000			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	41.9	323.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.4	2.3	0.2	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	1.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.5	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.7	0.1	0.0	0.1	4.0	0.0	0.2	0.0	0.5	0.1	2.7	0.4	0.0	1.5	0.1	0.0	0.9	0.0	0.2	0.0	0.0	1.0	0.0	1.9	0.0	2.0	0.0	2.3	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	1.6	0.7	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	23.2	0.0	0.0	0.0	0.4	38.2	0.0	0.0	31.4	0.0	0.0	555.4	0.0	0.3	0.0	0.5	46.7	0.0	0.0	0.0	0.0	0.0	1509.4	0.1	0.0	0.0	25.2	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789900	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB011690, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		1000000	Cytosol		"CAB011690: AB_732123, HPA068286: AB_2685968"	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	34.6	66.1	61.2	27.7	79.9	1.9	53.5	121.1	111.5	65.1	52.1	26.5	30.1	30.3	73.1	45.5	44.5	73.9	45.1	83.7	58.4	71.9	63.9	43.5	33.7	36.1	48.9	61.7	142.0	59.0	30.9	84.1	47.3	69.6	57.9	40.1	31.8	43.7	62.8	126.7	19.8	35.6	57.1	41.9	32.5	39.0	32.9	39.5	23.9	67.8	36.4	35.4	61.1	51.7	55.1	19.3	39.4	24.8	33.0	63.4	51.3	10.1	5.1	21.4	3.5	82.7	78.0	6.6	18.3	16.5	19.4	25.6	18.9	3.7	22.7	102.5	26.2	35.9	17.1	31.5	7.7	34.3	21.2	16.6	36.6	6.8	25.3	32.4	7.7	25.7	52.2	37.0	5.6	46.7	98.7	34.4	19.2	12.3	38.3	63.1	1.7	12.2	3.8	21.3	41.0	24.6	15.7	15.2	13.8	38.5	12.4	42.2	8.5	29.7	20.5	38.9	56.7	32.0	28.2	25.1	15.4	7.7	14.8	11.2	30.5	43.2	10.4	10.6	8.1	7.2	39.4	16.0	18.5	28.5	18.2	45.3	55.1	41.9	34.8	19.3	46.1	63.4	50.2	11.0	33.0	24.8	17.4	38.6	51.3	61.2	79.9	121.1	111.5	58.4	71.9	48.9	61.7	69.6	39.5	110.2	187.7	337.3	695.6	613.2	269.9	244.1	206.4	220.8	192.2	247.7	60.9	410.2	560.3	199.1	25.8	233.7	293.3	23.3	81.4	227.6	351.3	637.4	309.0	119.2	199.9	368.7	391.5	183.0	192.6	37.8	357.2	230.1	327.3	376.9	296.7	294.3	160.6	364.6	444.5	452.5	161.0	232.8	455.3	100.9	174.0	540.1	514.8	331.3	287.0	611.0
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 48.3;Spermatocytes: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favorable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.1	6.9	11.5	14.1	16.0	26.8	10.5	28.0	13.9	8.8	11.6	5.3	5.8	8.2	11.8	7.3	13.0	10.2	7.6	8.0	8.6	6.2	8.2	9.3	6.6	22.1	14.5	9.8	12.7	11.9	6.5	9.0	11.0	12.5	7.3	16.1	5.9	8.1	5.8	8.1	8.7	11.8	13.6	8.4	15.6	9.8	20.3	12.8	28.6	6.4	11.0	25.2	8.3	8.5	11.2	7.7	7.4	10.3	7.0	16.5	6.2	34.8	12.0	28.5	18.2	4.1	4.5	22.5	16.9	10.7	27.0	29.9	17.9	16.7	25.2	39.3	8.1	25.9	18.4	25.1	16.5	33.3	38.0	22.1	25.9	18.4	18.2	3.2	27.3	17.4	3.8	6.0	18.5	14.5	6.0	9.0	39.5	20.1	35.9	18.4	16.6	34.3	25.6	25.2	31.2	16.4	27.2	24.5	34.6	9.7	13.0	27.9	13.9	21.1	23.3	19.1	22.4	39.6	26.2	4.1	16.4	20.7	27.4	50.4	20.1	44.4	83.9	14.4	30.1	21.5	0.0	2.2	7.4	9.8	3.3	9.4	10.6	9.7	10.1	3.9	11.2	9.8	8.9	0.4	7.0	10.3	7.7	16.5	6.2	11.5	16.0	28.0	13.9	8.6	6.2	14.5	9.8	12.5	12.8	0.0	2.1	20.1	13.1	5.4	17.0	6.9	10.2	9.4	7.9	10.4	0.0	26.7	5.0	9.4	18.6	4.5	2.0	23.3	14.4	48.3	5.1	4.1	8.1	2.9	20.0	7.9	1.2	6.7	2.1	7.9	9.8	5.2	1.7	15.4	4.2	12.4	7.9	3.5	7.4	6.7	14.0	6.5	10.3	67.9	38.7	2.6	9.4	8.6	11.5	3.1
ADIPOQ	"ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842690-186858463	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 176.7;breast: 79.4"	"Cell type enriched"	"Detected in single"	12	"Distal tubular cells: 1.7"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	670	"ASC diff: 86.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	NA	NA	8360000000	1000000000			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			176.7	1.9	0.0	16.7	0.0	0.1	79.4	0.0	0.1	0.1	23.2	0.0	0.4	0.1	0.1	1.3	0.3	0.1	13.2	5.8	0.0	0.0	0.5	0.1	0.1	6.1	0.0	0.0	0.2	1.3	0.1	0.0	0.1	0.0	0.4	1.4	0.0	14.7	0.6	2.0	1.5	2.1	0.4	0.0	0.1	0.6	0.1	0.0	0.0	0.7	9.5	0.3	1.0	0.9	0.8	0.6	2.4	0.4	0.7	0.5	0.1	0.0	0.0	0.0	0.0	86.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.6	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.3	0.5	1.9	0.7	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST6GAL1	SIAT1	ENSG00000073849	"ST6 beta-galactoside alpha-2,6-sialyltransferase 1"	P15907	3	186930485-187078553	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.4"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 225.1;Hepatocytes: 512.9;Ito cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.6;U-266/70: 104.1;U-266/84: 133.1;U-698: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015018, CAB016122"	Supported				"Secreted to blood"	NA	NA	15000000	580000			"CAB015018: AB_629203, CAB016122: AB_627178"	"unprognostic (5.85e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-2)"	10.6	6.5	11.8	16.7	15.4	4.0	10.5	2.8	11.8	19.1	11.4	22.7	4.2	4.3	8.6	4.3	4.4	8.6	5.7	10.6	10.7	7.6	19.1	161.4	10.9	27.6	18.2	7.6	4.5	4.1	20.5	5.7	5.5	13.7	19.5	14.2	5.4	17.7	4.6	5.7	4.5	12.6	5.8	22.3	27.0	8.5	2.4	15.1	19.4	19.4	4.0	41.6	13.2	14.3	33.6	4.6	6.9	8.9	8.5	29.3	16.9	0.7	0.7	3.1	2.3	0.2	0.0	4.8	0.2	0.4	0.1	0.3	0.2	0.2	32.6	2.7	0.0	1.2	1.4	19.2	2.0	0.2	1.6	0.8	1.3	0.1	15.9	0.1	3.0	10.3	0.2	4.1	0.0	1.8	2.8	11.3	3.3	6.6	3.1	1.0	1.4	2.2	2.1	6.9	1.6	1.0	5.3	0.0	1.0	1.4	0.0	5.0	0.5	0.2	3.7	8.5	4.7	5.4	2.2	4.3	0.0	0.4	0.0	0.3	104.1	133.1	48.5	0.1	6.1	11.3	6.9	2.7	1.1	16.5	5.2	15.0	32.7	18.2	13.8	4.6	33.6	29.3	20.2	1.3	8.5	8.9	4.2	14.2	16.9	11.8	15.4	2.8	11.8	10.7	7.6	18.2	7.6	13.7	15.1	41.7	20.6	118.9	14.7	3.5	0.0	22.2	86.6	24.1	44.3	225.1	0.0	0.3	0.0	14.5	0.3	29.9	4.1	23.3	0.8	3.1	1.9	58.6	10.4	512.9	16.4	0.0	90.6	264.6	52.6	0.7	0.3	13.4	6.8	5.4	3.3	0.0	6.7	5.8	0.7	0.5	1.1	0.0	5.1	0.0	0.2	1.4	0.6	20.0	28.1	28.2
RPL39L	RPL39L1	ENSG00000163923	"Ribosomal protein L39 like"	Q96EH5	3	187120948-187180908	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 23.7;testis: 90.1"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 387.1;Late spermatids: 163.8;Spermatocytes: 729.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA047105	Approved					NA	NA					"HPA047105: AB_2679933"	"unprognostic (1.01e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.05e-4)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (6.94e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.66e-3)"	"unprognostic (8.02e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.27e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.60e-1)"	2.5	1.0	4.1	4.6	4.7	3.4	5.8	2.3	5.0	4.6	3.6	2.2	0.9	1.2	3.8	2.3	2.9	3.4	2.2	5.2	3.3	3.2	1.9	1.5	1.9	5.2	2.9	2.7	1.7	1.7	2.4	2.3	2.5	2.8	3.3	1.7	1.8	2.6	3.4	0.6	3.5	1.8	4.0	2.9	2.6	2.5	90.1	2.0	9.2	1.2	2.6	6.1	3.0	3.4	18.2	6.5	2.3	5.7	8.0	23.7	13.5	44.3	15.6	5.5	8.7	2.6	3.9	5.1	13.9	10.1	12.7	13.8	1.0	7.8	18.8	38.8	7.9	24.8	15.3	11.3	2.6	19.5	32.5	2.1	0.2	12.7	0.1	4.9	3.9	5.0	3.1	2.0	10.5	9.0	9.7	12.9	23.5	9.9	22.5	4.7	15.0	0.2	15.7	34.8	15.6	25.9	16.5	7.7	14.0	4.1	1.0	13.5	14.2	10.9	29.9	32.0	13.2	29.4	13.3	5.8	0.1	14.5	11.9	13.9	29.7	31.6	35.8	7.7	16.6	29.0	2.3	5.7	1.3	13.7	5.3	7.0	18.2	14.3	12.2	5.7	12.9	10.2	14.5	0.8	8.0	3.7	6.5	23.7	13.5	4.1	4.7	2.3	5.0	3.3	3.2	2.9	2.7	2.8	2.0	3.0	10.3	39.5	29.2	22.1	3.0	43.1	20.4	4.0	3.4	3.5	0.0	14.1	6.6	11.3	387.1	9.3	0.9	0.0	2.2	80.7	21.7	27.0	6.9	7.3	32.1	6.4	0.0	33.2	26.4	163.8	20.1	13.8	21.9	0.0	3.3	10.4	7.3	0.0	11.0	1.8	1.8	6.5	26.2	729.2	137.8	18.4	12.5	13.8	6.0	19.0
RTP1	"MGC35450, Z3CXXC1"	ENSG00000175077	"Receptor transporter protein 1"	P59025	3	187197486-187201465	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;testis: 1.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 1.9;Late spermatids: 1.1;Spermatocytes: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"SuSa: 9.2;T-47d: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA									"unprognostic (2.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.29e-1)"		"unprognostic (1.91e-1)"				"unprognostic (2.63e-1)"			"unprognostic (2.89e-1)"			0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	5.5	0.0	0.0			0.0	0.0	0.0	0.6	0.0	0.0	0.2	1.3	4.4	0.0	0.0	0.0	0.0	0.4		0.0	0.0	0.0	0.0	0.0		1.0	0.0		0.0	0.4	0.0	0.0	0.1	0.1	0.8	0.0	0.0	1.9			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 32.5;Cholangiocytes: 28.1;Hepatocytes: 57.1;Ito cells: 30.7"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 27.1;BJ hTERT+: 103.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1800000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	27.1	103.4	0.4	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7	0.0	2.6	0.0	0.1	2.6	0.0	32.5	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.2	11.0	0.0	0.0	57.1	0.4	0.0	0.0	30.7	2.4	3.8	2.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	5.9	0.0	0.0	1.5	0.1	0.5	0.0	0.1
RTP4	"IFRG28, Z3CXXC4"	ENSG00000136514	"Receptor transporter protein 4"	Q96DX8	3	187368332-187372076	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 27.5;Urothelial cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.9;GAMG: 11.9;HDLM-2: 9.8;Karpas-707: 8.1;REH: 7.9;SK-MEL-30: 15.2"									"HPA064887, HPA071189"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064887: AB_2685383, HPA071189: AB_2686357"	"unprognostic (1.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (4.35e-4)"	"prognostic favorable (1.45e-4)"	7.7	4.6	3.2	6.9	3.6	0.7	5.9	1.0	3.1	8.1	13.3	6.0	3.8	9.2	6.7	7.1	6.2	11.3	7.6	2.9	3.1	3.0	8.6	8.8	8.0	12.0	3.8	3.0	6.4	9.7	0.3	3.0	5.9	3.3	10.1	6.1	7.7	10.8	5.6	0.9	2.2	23.2	5.2	5.4	13.5	8.0	1.9	1.5	16.8	10.5	4.3	8.6	10.5	4.7	5.1	6.0	4.7	10.5	12.4	16.2	5.6	2.4	0.0	0.0	0.0	1.2	4.2	0.1	0.0	1.0	1.7	1.5	0.0	8.9	1.1	0.0	1.0	11.9	3.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.1	1.6	0.0	2.2	1.0	0.0	0.3	0.0	0.3	0.3	0.2	0.0	8.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	7.9	0.0	6.4	2.1	6.4	0.0	0.0	0.0	0.2	15.2	0.1	0.0	3.9	0.1	0.1	0.2	0.0	0.1	6.5	2.1	0.0	0.0	2.2	4.9	4.7	6.9	4.7	10.4	8.5	10.2	5.1	8.3	9.4	6.0	4.8	6.4	7.4	2.1	12.4	10.5	0.1	16.2	5.6	3.2	3.6	1.0	3.1	3.1	3.0	3.8	3.0	3.3	1.5	6.0	5.0	2.7	24.0	1.4	0.0	0.4	12.7	17.4	7.9	5.2	0.0	0.0	13.3	27.5	0.0	7.3	8.0	0.0	8.6	0.1	2.3	9.7	1.1	2.9	5.4	0.0	8.7	9.8	5.9	0.0	2.0	4.0	1.7	3.6	11.3	4.1	12.4	10.5	4.6	2.2	0.0	0.0	1.1	0.0	0.0	1.1	0.2	7.2	7.2	41.4
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668906-187670399	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4"	"Cell type enriched"	"Detected in some"	213	"Intestinal endocrine cells: 1353.8"	"Group enriched"	"Detected in many"	7	"ovarian cancer: 249.9;pancreatic cancer: 1039.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 15.6;U-2 OS: 29.0;U-251 MG: 4.8;U-698: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"	NA	NA					"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	2.0	13.0	28.6	1.9	53.8	1.7	0.7	0.1	47.9	0.7	45.1	1.8	21.9	105.2	0.9	0.7	1.1	0.7	1.0	0.9	17.5	102.8	2.5	0.7	0.7	1.0	6.2	15.4	0.8	105.6	0.7	1.5	0.7	16.1	1.5	7.4	0.4	0.7	7.5	0.7	3.1	36.1	1.4	18.4	0.7	90.4	0.7	8.6	0.0	0.9	0.0	0.7	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	29.0	0.3	4.8	0.0	1.7	6.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	53.8	0.1	47.9	17.5	102.8	6.2	15.4	16.1	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1353.8	0.0	0.0	0.0	0.0	0.0	0.0	6.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0
RTP2	"MGC78665, Z3CXXC2"	ENSG00000198471	"Receptor transporter protein 2"	Q5QGT7	3	187698259-187702557	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	42	"skeletal muscle: 5.7;testis: 3.1"	"Cell type enhanced"	"Detected in some"	34	"Distal tubular cells: 1.7;Early spermatids: 8.7;Late spermatids: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SK-BR-3: 6.4"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	27	"olfactory region: 0.3"							NA	NA																"unprognostic (5.86e-2)"		"unprognostic (1.12e-2)"					0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
BCL6	"BCL5, BCL6A, LAZ3, ZBTB27, ZNF51"	ENSG00000113916	"B cell CLL/lymphoma 6"	P41182	3	187721377-187745727	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Immunity, Inflammatory response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 114.3"	"Cell type enhanced"	"Detected in many"	5	"Smooth muscle cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 63.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 63.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 27.3;Daudi: 42.9;HSkMC: 31.1;U-698: 59.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000307, HPA004899, HPA050645"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199"	"unprognostic (5.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.62e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.27e-9)"	"unprognostic (5.22e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.58e-2)"	47.1	14.3	21.8	23.2	25.9	50.6	48.0	58.7	23.7	21.2	21.2	19.2	11.5	4.1	17.7	8.8	20.9	28.3	22.3	18.6	21.5	8.0	10.1	20.1	26.3	24.5	31.6	9.3	20.2	15.6	9.1	23.3	7.5	28.5	17.3	5.8	15.9	19.1	11.8	114.3	36.4	8.1	24.4	50.1	27.2	16.1	10.2	26.6	18.9	14.8	10.4	22.4	24.9	20.0	3.9	5.6	63.4	15.4	0.9	1.3	5.2	1.2	3.6	3.6	0.8	27.3	21.8	3.9	4.3	10.5	5.0	5.3	2.6	2.0	42.9	3.1	5.4	3.1	2.1	1.2	2.8	4.3	9.0	1.4	0.0	1.8	6.1	14.2	0.5	0.2	31.1	18.2	6.1	9.4	16.3	2.8	1.1	0.4	7.4	4.8	1.4	1.4	0.3	0.3	0.7	2.7	11.9	1.8	0.2	3.5	6.3	0.8	0.0	5.0	2.1	2.8	8.3	9.4	1.5	5.6	12.1	1.9	4.4	2.0	5.5	1.8	59.6	6.6	1.6	8.5	1.6	6.9	4.1	1.3	8.7	1.3	1.4	0.8	1.2	5.6	3.9	0.5	0.6	63.4	0.9	15.4	0.9	0.6	5.2	21.8	25.9	58.7	23.7	21.5	8.0	31.6	9.3	28.5	26.6	17.9	76.9	6.5	13.3	42.0	11.0	60.5	17.8	25.4	22.7	15.7	19.6	1.1	0.0	9.2	12.3	27.7	1.6	0.0	10.6	2.0	36.2	28.7	10.5	44.4	11.2	0.0	4.6	9.8	56.3	6.2	26.7	26.7	33.7	3.6	1.1	40.1	8.7	0.0	17.7	1.1	9.6	32.3	96.4	0.4	0.7	53.8	3.4	10.7	1.9	21.9
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 127.8;urinary bladder: 105.1"	"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 514.4;Late spermatids: 1329.9;Smooth muscle cells: 529.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.5;EFO-21: 36.6;U-698: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Enhanced	"Focal adhesion sites,Cytosol"		NA	NA		520000	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	19.6	4.2	2.7	29.5	2.8	3.1	12.5	3.0	2.7	42.2	29.9	2.1	19.6	5.0	68.6	14.9	59.7	10.0	37.9	9.3	2.6	2.8	10.9	5.3	11.4	6.0	2.8	1.6	26.1	4.4	4.7	3.2	5.2	3.0	37.7	12.8	8.5	7.0	28.4	11.6	5.9	17.2	127.8	3.2	9.5	12.1	30.7	1.5	5.1	5.4	4.2	7.8	105.1	38.3	5.9	4.9	18.0	4.5	4.3	5.0	1.4	7.7	7.1	5.2	3.5	11.3	11.7	5.6	5.1	6.5	3.7	2.5	12.9	3.7	29.5	36.6	11.4	4.6	3.3	1.5	3.4	9.4	3.2	1.7	1.4	5.5	3.4	4.8	0.6	1.7	8.3	4.8	8.3	7.2	5.4	6.2	1.6	0.0	0.6	6.5	2.4	1.5	0.6	2.1	4.9	2.3	1.9	3.9	0.1	4.1	8.2	0.3	0.0	10.9	3.6	6.1	9.0	2.8	2.4	13.4	8.6	6.6	6.1	12.5	0.0	1.1	61.0	4.3	1.3	7.7	0.8	4.5	1.9	5.0	4.2	3.2	2.9	4.3	3.6	2.4	5.9	2.3	2.9	18.0	4.3	4.0	4.9	1.6	1.4	2.7	2.8	3.0	2.7	2.6	2.8	2.8	1.6	3.0	1.5	83.4	55.0	41.3	72.1	69.3	7.7	101.6	99.3	40.2	83.0	66.3	13.7	35.7	24.9	114.3	514.4	83.0	142.7	23.3	78.6	20.6	102.9	124.2	17.4	84.7	36.8	4.8	74.4	114.2	61.5	1329.9	208.5	76.2	75.9	36.1	86.3	27.1	104.6	158.4	448.3	61.0	7.4	329.8	529.6	8.1	6.6	59.6	15.6	39.5	123.5	109.3
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.3;lymphoid tissue: 32.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 35.7;Early spermatids: 102.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 7.0"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.8;Karpas-707: 4.5;OE19: 21.7;U-266/70: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favorable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	16.1	1.0	0.3	0.9	0.8	0.0	14.4	1.7	0.8	19.7	1.2	0.1	1.0	0.0	5.0	1.6	43.3	5.2	1.6	2.4	0.2	0.2	0.6	5.1	2.7	0.3	0.3	0.5	1.9	0.3	0.0	0.8	1.0	0.5	2.5	0.0	0.8	3.7	0.7	5.0	14.5	0.5	1.9	0.3	0.7	0.4	2.6	0.3	7.9	0.8	25.5	32.9	2.3	17.8	0.2	0.7	1.3	2.3	0.0	6.3	1.3	0.8	0.2	0.3	0.0	2.0	1.7	0.0	0.0	0.0	0.0	0.1	1.0	2.1	1.2	3.3	0.1	0.5	0.2	0.0	0.0	0.0	8.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.2	0.3	0.0	0.0	0.6	21.7	0.3	0.0	0.0	1.5	0.0	1.7	0.0	0.0	0.2	0.5	0.0	0.7	3.9	0.6	0.0	0.1	0.3	0.0	0.3	4.2	3.3	0.3	0.1	0.0	0.1	0.0	2.3	0.0	6.0	1.8	0.9	0.2	4.9	6.3	0.7	0.0	1.0	2.5	1.3	0.0	1.6	0.1	5.4	1.3	0.3	0.8	1.7	0.8	0.2	0.2	0.3	0.5	0.5	0.3	35.7	1.7	5.7	16.1	4.9	0.2	0.7	0.0	1.4	10.3	0.0	0.0	0.3	0.0	0.3	102.2	0.7	0.0	0.0	0.5	0.2	1.4	1.5	1.1	6.6	5.0	0.0	0.0	0.0	1.9	7.8	6.6	2.2	0.0	0.0	0.0	0.0	4.6	0.0	2.8	0.0	0.0	0.0	0.7	1.2	1.1	5.1	0.2	13.4	0.2	5.1
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631416-189897279	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 83.2;skin 1: 54.2"	"Group enriched"	"Detected in many"	12	"Basal keratinocytes: 244.6;Suprabasal keratinocytes: 247.4"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HaCaT: 23.8;HBEC3-KT: 45.6;hTCEpi: 34.6;hTERT-HME1: 33.1;RT4: 50.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	2.9	0.1	0.2	0.7	0.1	0.0	7.2	0.1	0.2	9.5	0.1	0.1	5.7	0.0	0.3	8.0	33.7	0.3	0.0	0.2	0.1	0.1	0.4	0.1	1.2	0.2	0.1	0.2	0.1	0.1	0.0	0.3	7.8	0.8	9.6	0.0	0.3	9.0	7.8	83.2	54.2	0.1	2.7	0.6	0.1	0.1	1.2	0.0	9.0	0.4	36.7	26.1	9.6	19.2	3.7	1.3	3.0	0.9	1.2	1.2	0.2	0.6	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	23.8	0.0	45.6	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.0	34.6	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.3	0.1	0.0	0.2	2.0	0.4	1.1	0.9	0.5	0.7	3.7	1.2	1.0	0.4	1.7	0.8	0.7	3.0	1.2	0.9	1.3	0.8	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.8	0.0	0.0	4.0	0.0	20.4	244.6	0.0	0.6	0.0	1.4	5.7	0.0	0.0	18.7	0.0	0.2	0.7	0.3	0.0	0.0	0.2	1.8	1.0	2.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.5	1.0	0.0	0.0	1.2	0.0	1.1	0.0	0.0	0.0	0.5	0.3	2.6	247.4	7.4	0.0	0.0	10.1
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.5"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7;Alveolar cells type 2: 62.9;Collecting duct cells: 41.8;Ito cells: 44.8;Muller glia cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 20.3"	"Lineage enriched"	"Detected in single"	104	"dendritic cells: 20.3"	"Cell line enhanced"	"Detected in many"		"GAMG: 38.1;HaCaT: 34.0;RPTEC TERT1: 34.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles, Cytosol"	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	2.4	22.6	2.9	4.0	3.9	0.2	3.1	0.7	2.2	14.3	11.8	6.2	11.5	1.2	15.0	13.5	8.9	4.6	8.4	3.8	2.8	2.1	74.5	3.5	22.5	3.6	8.1	1.0	11.2	3.9	1.4	6.1	11.0	5.6	19.9	5.3	10.3	2.7	14.3	0.6	8.6	3.6	16.3	7.6	33.7	12.0	2.8	5.3	2.0	1.7	6.3	2.7	5.7	9.8	0.0	20.3	0.1	0.1	0.0	0.0	0.1	14.0	5.6	11.0	0.0	0.2	0.4	13.3	15.0	5.9	2.4	4.0	4.5	5.5	0.0	8.5	2.6	38.1	34.0	0.0	20.1	5.1	0.1	1.9	0.0	3.8	0.0	11.4	0.0	0.1	5.4	6.8	4.8	1.7	23.3	0.4	0.0	0.0	0.1	3.8	0.3	0.0	0.1	3.4	9.4	1.1	0.0	2.2	0.8	34.7	23.7	0.8	0.1	20.4	1.1	8.9	16.9	0.0	0.2	7.5	14.6	5.5	0.1	2.7	1.0	0.0	0.1	3.3	0.0	18.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.1	2.9	3.9	0.7	2.2	2.8	2.1	8.1	1.0	5.6	5.3	44.7	62.9	1.9	7.4	0.0	2.2	1.0	5.1	0.0	5.7	41.8	3.9	30.9	5.0	3.8	14.3	4.5	0.0	0.0	0.7	11.7	2.0	13.7	1.1	0.6	9.1	9.5	0.0	44.8	4.6	11.4	4.4	4.7	0.0	1.0	0.2	49.8	18.0	0.0	0.0	24.5	0.8	0.0	2.7	0.5	0.4	0.0	32.3	0.0	0.0	2.8
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305701-190322475	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 134.3;skin 1: 73.9"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 390.9;Suprabasal keratinocytes: 730.8;Urothelial cells: 538.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"EFO-21: 107.5;HaCaT: 37.6;hTCEpi: 46.9;RPTEC TERT1: 67.3;RT4: 42.1"	"Low region specificity"	"Detected in many"							"CAB002602, HPA048319"	Enhanced					NA	NA					"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	11.4	14.7	1.0	4.9	0.5	0.0	5.8	0.2	0.7	10.1	7.2	1.2	11.4	0.1	46.5	18.8	13.8	18.8	9.2	3.2	0.7	0.6	7.2	134.3	5.5	0.0	1.0	0.4	13.3	18.0	0.0	1.3	30.5	2.0	13.0	0.3	0.5	10.6	18.2	0.6	73.9	0.4	31.1	1.3	1.2	0.4	7.1	0.1	6.7	8.5	12.2	19.8	9.7	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	4.7	0.0	0.0	0.0	0.0	0.0	0.4	8.4	0.1	0.3	2.7	11.0	0.0	107.5	0.0	9.5	37.6	0.2	12.3	1.0	0.1	0.2	0.0	1.6	6.4	8.2	0.0	0.0	0.0	46.9	0.9	14.2	0.4	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.3	0.8	0.0	0.1	0.0	67.3	42.1	0.0	0.0	4.9	0.9	2.8	0.6	8.6	0.0	2.0	0.1	1.6	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.2	0.7	0.7	0.6	1.0	0.4	2.0	0.1	11.9	29.6	0.0	214.2	390.9	0.0	0.4	173.3	195.4	155.8	29.6	0.0	1.3	0.0	178.6	0.0	0.8	0.0	0.0	49.1	0.2	10.7	75.9	1.1	165.2	1.0	0.0	1.7	1.8	2.7	0.9	14.4	13.7	30.4	10.0	0.2	0.0	113.1	0.0	33.2	1.9	0.0	0.0	9.2	0.2	0.3	730.8	28.3	0.5	0.0	538.7
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412143	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"kidney: 55.9"	"Cell type enriched"	"Detected in many"	7	"Distal tubular cells: 159.2"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	131	"EFO-21: 101.3;RPTEC TERT1: 35.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA					"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.2	0.8	0.4	0.2	0.3	0.0	0.2	0.2	0.5	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.6	0.2	0.2	0.3	0.4	55.9	1.2	0.2	0.7	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.6	0.5	0.2	1.8	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	3.4	0.2	0.4	0.3	0.2	0.5	0.4	1.4	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	1.4	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	1.2	0.3	0.2	0.4	0.1	0.0	0.4	0.3	0.2	0.5	0.3	0.4	0.3	0.2	0.2	0.2	0.0	0.0	0.0	4.8	6.3	0.2	0.3	5.1	22.7	1.2	8.7	0.0	0.2	159.2	2.2	0.6	0.0	0.0	0.0	0.3	0.1	0.3	1.2	1.1	1.5	0.1	3.2	0.0	0.0	0.3	0.0	0.0	1.0	5.0	0.0	0.0	0.0	0.4	0.0	0.4	0.6	0.1	0.0	0.0	0.1	0.1	11.0	5.1	0.0	0.0	3.1
TMEM207		ENSG00000198398	"Transmembrane protein 207"	Q6UWW9	3	190428655-190449876	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	75	"kidney: 21.1"	"Cell type enriched"	"Detected in some"	17	"Distal tubular cells: 58.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-266/70: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014332	Uncertain					NA	NA					"HPA014332: AB_2204907"															"unprognostic (4.81e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	58.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.5;liver: 91.8;placenta: 35.9"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 100.2;Hepatocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 36.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 36.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 72.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		260000000	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	3.4	1.7	3.7	5.2	4.5	7.8	2.8	0.8	6.0	2.9	1.8	3.4	0.7	1.1	2.6	1.7	9.1	3.2	5.7	3.3	7.4	2.9	1.9	91.8	6.3	12.6	3.5	2.5	2.2	2.0	1.0	1.4	35.9	5.5	2.1	1.4	1.6	4.7	2.0	1.2	5.8	1.5	3.1	6.3	7.1	2.3	1.0	2.9	2.3	2.2	3.8	3.4	3.3	4.4	0.9	1.4	36.5	2.2	0.1	1.3	0.5	3.9	1.0	1.6	0.2	2.9	2.4	3.1	1.7	3.5	4.1	4.0	1.7	8.8	0.7	18.3	4.8	9.5	10.2	0.9	17.1	5.7	0.7	1.0	0.8	1.7	4.2	6.1	5.8	2.8	3.2	7.0	5.9	18.9	8.6	1.8	1.8	0.1	0.0	1.9	1.8	0.5	2.6	2.6	1.7	1.8	2.8	2.5	1.4	1.5	4.2	0.3	0.0	8.0	4.4	72.7	1.6	2.9	4.2	2.4	3.2	3.2	9.7	7.9	1.5	0.0	0.1	5.4	5.3	18.6	3.5	1.5	8.5	0.7	1.7	1.3	0.9	0.8	0.9	1.4	0.9	0.8	0.5	36.5	0.1	2.2	0.2	0.8	0.5	3.7	4.5	0.8	6.0	7.4	2.9	3.5	2.5	5.5	2.9	0.0	14.3	1.4	14.3	39.8	5.4	4.0	43.3	2.7	20.5	3.5	7.9	3.1	0.0	6.5	2.3	7.1	1.3	0.0	6.4	100.2	7.0	5.6	7.0	172.7	6.9	0.0	5.2	8.0	33.0	0.0	4.0	18.3	8.5	1.0	1.3	0.9	14.8	0.0	2.5	0.8	0.6	0.0	3.1	0.0	0.6	32.5	20.3	2.5	1.2	12.8
GMNC	GEMC1	ENSG00000205835	"Geminin coiled-coil domain containing"	A6NCL1	3	190852877-190892429	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.7;kidney: 26.9;liver: 8.5"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 8.1;Early spermatids: 8.8;Hepatocytes: 5.7;Proximal tubular cells: 6.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 4.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043663	Uncertain					NA	NA					"HPA043663: AB_10959313"				"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.73e-2)"		"unprognostic (2.55e-3)"		0.1	0.1	3.5	0.1	2.9	0.1	0.1	0.2	0.7	0.8	0.1	5.0	0.0	0.1	2.0	4.4	0.1	12.7	0.1	0.9	4.6	1.4	26.9	8.5	0.1	0.1	0.6	0.9	0.5	1.1	0.1	0.2	0.3	4.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.4	2.0	0.1	0.1	2.3	3.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.9	0.2	0.7	4.6	1.4	0.6	0.9	4.2	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.1	0.0	0.0	2.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
OSTN		ENSG00000188729	Osteocrin	P61366	3	191199241-191265615	"Predicted secreted proteins"	Differentiation	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 7.8;brain: 7.9;prostate: 8.0"	"Cell type enhanced"	"Detected in single"	31	"Early spermatids: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"memory B-cell: 7.8"	"Lineage enriched"	"Detected in single"	10	"B-cells: 7.8"	"Cell line enriched"	"Detected in some"	24	"U-2197: 30.2"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.2"	"Low region specificity"	"Detected in all"			"CAB024997, CAB025649, HPA030878"	Uncertain				"Secreted in other tissues"	NA	NA					"CAB024997: , CAB025649: , HPA030878: AB_2673642"					"unprognostic (2.35e-2)"		"unprognostic (9.12e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-1)"			0.9	0.4	1.9	1.6	2.1	0.0	0.6	0.2	7.9	7.1	0.4	0.0	0.0	0.0	0.2	4.4	0.1	1.9	1.9	1.5	1.8	1.9	0.5	1.6	1.0	1.3	1.5	2.4	0.5	0.1	0.0	0.3	1.1	0.4	8.0	0.1	0.0	0.4	0.2	2.3	3.4	0.3	2.3	1.1	0.5	0.6	1.1	0.0	0.0	0.6	0.7	0.0	3.7	1.0	7.8	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	1.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.9	2.1	0.2	7.9	1.8	1.9	1.5	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 19.0"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Early spermatids: 5.1;Late spermatids: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"amygdala: 19.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.2;naive B-cell: 3.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 7.2"									HPA026992	Uncertain				"Secreted - unknown location"	NA	NA					"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"	1.1	1.5	19.0	0.7	0.8	0.2	1.6	0.5	2.5	0.6	0.6	0.8	0.5	7.7	1.5	0.5	0.6	1.0	3.0	0.9	1.5	1.2	0.5	4.8	0.6	0.9	0.8	0.5	1.7	4.1	0.0	0.5	0.5	1.0	0.5	0.1	0.5	0.5	0.5	0.5	1.3	4.2	0.5	1.1	1.1	1.9	2.9	0.5	0.5	0.5	0.5	0.8	0.9	0.7	6.2	1.2	0.1	0.1	0.0	0.1	0.1	0.9	2.1	2.9	1.4	0.8	3.7	0.9	2.1	1.2	0.8	0.4	1.5	1.1	1.4	1.1	1.0	5.8	1.1	0.9	0.0	3.5	1.4	1.0	1.3	2.8	6.1	0.7	1.6	0.8	1.5	0.4	0.5	0.6	1.9	0.8	1.2	0.9	1.4	1.1	1.2	0.4	1.2	1.6	2.7	7.2	1.8	3.4	0.5	0.4	3.6	1.6	1.0	1.3	1.5	0.8	1.3	1.2	1.0	3.0	1.6	0.9	2.8	0.8	2.3	1.3	1.4	1.9	1.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	3.0	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	19.0	0.8	0.5	2.5	1.5	1.2	0.8	0.5	1.0	0.5	3.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.7	0.9	0.3	0.2	0.0	0.0	0.0
CCDC50	"C3orf6, DFNA44, Ymer"	ENSG00000152492	"Coiled-coil domain containing 50"	Q8IVM0	3	191329077-191398670	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 95.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 95.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001336	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA001336: AB_1078421"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.73e-2)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.03e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.19e-1)"	35.2	17.5	15.8	23.7	15.5	5.1	41.4	11.7	14.2	19.3	21.7	17.2	21.7	14.0	23.4	21.6	20.4	21.7	29.6	22.7	14.9	11.0	25.1	38.5	22.3	22.7	15.9	9.3	28.9	31.1	17.1	14.7	20.3	14.6	20.5	15.4	16.2	21.4	20.8	19.2	14.3	22.3	37.5	14.5	32.5	21.2	18.7	14.4	11.7	25.5	14.4	23.4	30.4	23.8	20.1	95.0	0.3	3.4	3.5	3.2	2.4	18.1	6.1	23.7	6.2	21.4	18.9	8.2	33.7	33.9	24.4	24.5	12.9	7.2	3.5	41.7	19.0	18.1	20.9	18.9	15.1	36.6	26.5	9.2	2.4	8.1	14.7	31.5	8.8	9.6	15.1	20.2	19.2	43.7	21.1	37.3	0.0	8.1	19.6	21.5	6.3	0.0	5.6	8.4	1.8	25.9	13.7	13.2	17.7	26.4	7.9	5.5	8.4	11.9	13.0	23.3	18.0	9.0	8.0	38.0	24.0	20.1	17.3	43.2	30.3	13.1	0.2	12.9	0.0	19.3	0.0	3.4	0.3	0.9	3.1	0.4	20.1	1.0	0.6	6.6	10.0	0.2	0.2	0.3	3.5	1.6	95.0	3.2	2.4	15.8	15.5	11.7	14.2	14.9	11.0	15.9	9.3	14.6	14.4	23.8	43.3	93.1	45.7	41.7	25.2	41.5	25.5	26.8	37.5	48.8	25.5	23.8	26.6	123.8	150.0	131.0	36.2	23.3	67.7	32.2	50.3	53.5	2.3	68.0	68.1	23.8	21.9	146.7	48.0	71.8	64.2	56.9	50.6	136.1	27.9	30.7	134.9	31.6	71.1	48.2	14.5	58.2	61.2	66.3	24.9	28.4	28.0	20.3	30.2	52.0
PYDC2	POP2	ENSG00000253548	"Pyrin domain containing 2"	Q56P42	3	191461163-191461456	"Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"fallopian tube: 1.0;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	51	"A549: 5.0"									HPA055895	Uncertain					NA	NA					"HPA055895: AB_2682962"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF12	"FGF12B, FHF1"	ENSG00000114279	"Fibroblast growth factor 12"	P61328	3	192139395-192767764	"Disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 381.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 11.8;NTERA-2: 8.1;SCLC-21H: 18.9;U-251 MG: 11.3;WM-115: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071557			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA071557: AB_2686417"	"unprognostic (1.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.75e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.87e-7)"	"unprognostic (2.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.99e-2)"	1.2	21.5	8.8	0.7	15.8	0.6	1.0	17.7	31.9	0.9	0.9	1.9	0.0	1.0	1.2	0.7	1.5	1.5	0.9	75.7	6.8	4.1	2.0	0.9	1.2	0.7	5.1	15.8	1.1	4.9	0.7	2.9	0.8	22.3	1.3	0.8	1.1	3.6	4.2	1.1	0.7	0.7	1.0	2.7	6.8	0.9	1.7	2.8	0.0	1.4	0.0	0.7	0.8	0.8	1.1	0.3	1.2	0.4	0.5	0.4	0.1	0.0	0.8	11.8	0.0	0.0	0.0	0.1	0.0	0.1	1.1	1.4	0.0	0.1	0.6	5.7	0.2	0.2	0.1	0.0	0.0	1.3	0.1	0.1	2.4	5.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.0	3.3	0.0	0.0	8.1	5.4	0.2	0.0	0.1	0.0	3.7	1.4	18.9	0.0	0.0	0.4	0.0	1.4	0.9	0.2	0.3	4.9	2.5	0.0	11.3	0.1	1.8	0.0	1.0	0.0	13.7	1.2	0.2	0.5	0.2	0.3	0.4	1.1	0.2	0.2	0.1	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.3	0.1	8.8	15.8	17.7	31.9	6.8	4.1	5.1	15.8	22.3	2.8	0.0	0.0	0.0	4.3	0.6	77.1	381.1	0.0	1.4	3.4	5.2	3.9	0.1	6.6	0.7	15.9	4.9	0.0	0.0	11.4	0.2	0.8	1.0	0.0	0.0	0.1	31.8	0.0	8.6	0.3	21.4	6.4	0.0	1.7	0.0	0.0	2.9	4.0	0.2	1.1	0.2	13.0	0.0	0.5	2.1	6.1	0.1	0.0	0.0	0.0	1.4
MB21D2	C3orf59	ENSG00000180611	"Mab-21 domain containing 2"	Q8IYB1	3	192796815-192918161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 34.9"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 55.7;Syncytiotrophoblasts: 92.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 6.6;T-reg: 5.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044026	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA044026: AB_10962840"	"unprognostic (3.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (2.76e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.28e-2)"	5.7	6.0	4.4	4.4	6.9	1.6	5.1	11.1	10.9	5.8	6.9	5.6	2.7	12.0	7.3	2.9	3.2	5.3	10.1	7.6	3.9	5.0	5.8	2.3	5.9	3.1	4.4	3.5	6.5	2.8	5.6	8.6	34.9	4.6	4.9	4.3	4.0	3.1	3.9	4.9	8.6	15.7	7.8	3.5	3.0	5.1	11.4	3.3	1.2	3.3	2.5	2.5	8.7	5.0	0.3	0.6	0.0	0.6	0.0	6.6	1.8	9.9	1.4	2.4	7.3	1.5	2.3	4.4	7.2	6.7	13.0	7.8	6.4	1.6	0.0	4.3	17.6	5.4	4.4	5.6	1.8	14.2	43.0	3.1	1.2	0.7	0.7	2.9	0.1	0.6	3.0	2.8	3.6	2.2	1.0	2.5	1.2	0.0	0.6	2.2	7.3	0.1	0.0	5.1	5.4	17.8	0.2	4.0	2.0	3.0	5.7	3.8	1.9	1.5	4.9	0.7	5.2	7.7	0.1	0.8	2.4	7.3	4.3	13.7	19.1	15.1	0.0	1.7	1.5	3.3	0.0	0.3	0.0	0.3	0.6	2.9	0.3	6.6	1.7	0.6	0.0	4.2	1.2	0.0	0.0	0.0	0.0	5.5	1.8	4.4	6.9	11.1	10.9	3.9	5.0	4.4	3.5	4.6	3.3	6.0	0.3	0.9	0.8	8.1	10.6	1.0	0.0	1.4	1.2	0.0	2.0	55.7	0.0	5.2	0.1	4.8	2.9	0.0	0.2	7.2	7.6	0.7	0.0	0.0	5.0	7.9	9.8	9.8	4.3	1.3	2.8	10.7	13.5	22.6	2.4	1.0	1.6	5.8	5.6	8.4	0.7	12.9	4.7	2.1	19.4	7.5	92.3	1.3	2.5	0.9
HRASLS	"H-REV107, HRASLS1"	ENSG00000127252	"HRAS like suppressor"		3	193241125-193277738	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"skeletal muscle: 40.9;testis: 42.1"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 449.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;NTERA-2: 7.6;PC-3: 16.8;RH-30: 7.4;SCLC-21H: 15.3;U-2 OS: 9.3;U-251 MG: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"		No	No			"Focal adhesion sites"	Cytosol	"HPA051179: AB_2681375"	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.6	1.1	1.8	0.2	3.1	0.1	1.0	0.6	3.3	0.5	0.6	1.7	0.0	0.1	0.6	3.1	2.4	0.5	0.2	4.3	2.0	1.1	0.6	0.6	0.5	0.1	1.5	2.1	0.6	0.8	0.5	0.7	0.1	2.4	0.5	0.1	3.1	6.1	0.5	40.9	1.7	0.6	0.7	0.6	0.6	0.6	42.1	1.7	0.2	3.7	6.2	0.2	0.5	0.6	0.0	0.2	1.7	0.1	0.0	0.0	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.3	0.0	0.1	0.0	0.1	0.0	3.7	0.0	8.7	0.2	0.4	0.0	3.9	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.6	0.2	16.8	0.0	7.4	0.0	2.5	0.0	15.3	2.9	1.0	2.2	0.0	1.4	4.4	0.0	0.1	0.0	9.3	0.0	11.7	0.0	0.0	0.0	4.8	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.2	1.8	3.1	0.6	3.3	2.0	1.1	1.5	2.1	2.4	1.7	0.0	0.0	0.0	0.1	0.9	10.8	10.6	2.5	0.0	1.2	0.0	31.4	0.7	0.0	0.7	449.3	0.6	0.0	0.0	0.2	0.8	0.4	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.3	85.3	6.9	0.8	1.7	0.0	0.0	1.6	0.5	0.0	4.6	0.1	5.6	0.0	0.4	112.1	25.2	5.4	0.3	0.0	0.0	0.0
ATP13A5	FLJ16025	ENSG00000187527	"ATPase 13A5"	Q4VNC0	3	193274790-193378843	"Predicted membrane proteins"		Translocase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"brain: 15.2;breast: 17.5;salivary gland: 28.9"	"Cell type enhanced"	"Detected in some"	25	"Club cells: 2.3;Early spermatids: 1.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Region enriched"	"Detected in many"	10	"pons and medulla: 15.2"	"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.7;SK-BR-3: 5.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA031771, HPA031774"	Uncertain					NA	NA					"HPA031771: AB_2674038, HPA031774: AB_2674039"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-4)"		"unprognostic (2.06e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.93e-1)"		"unprognostic (1.67e-4)"	"unprognostic (3.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.14e-2)"		"unprognostic (1.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.10e-2)"		0.1	0.0	1.4	0.1	1.5	0.1	17.5	0.3	0.9	0.1	0.1	2.8	0.1	0.0	0.3	0.9	0.9	0.0	0.1	0.1	1.0	0.7	0.1	0.1	0.4	0.1	0.9	0.1	0.2	0.1	0.1	0.2	0.1	15.2	0.3	0.0	0.4	28.9	0.1	1.3	5.1	0.1	0.1	0.3	0.1	1.4	0.3	0.1	0.4	1.4	1.3	0.7	0.1	0.1	0.4	0.4	4.1	0.3	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.7	1.0	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.0	0.0	0.2	0.7	0.0	1.7	0.3	1.0	0.0	0.0	0.4	0.7	0.0	0.0	5.8	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.3	1.0	0.0	0.3	0.4	0.3	0.4	0.3	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.2	4.1	0.3	0.0	0.4	0.1	0.1	1.4	1.5	0.3	0.9	1.0	0.7	0.9	0.1	15.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193402077-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2"	"Cell type enhanced"	"Detected in many"	19	"Alveolar cells type 1: 59.6;Alveolar cells type 2: 19.6;Cholangiocytes: 12.7;Ciliated cells: 13.4;Club cells: 22.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051932			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.6	0.7	11.2	0.6	11.1	0.6	17.8	2.6	10.1	1.8	2.2	8.4	9.0	0.9	0.6	46.4	11.8	2.7	4.3	0.6	11.1	5.1	0.8	0.7	22.0	0.8	7.5	7.7	0.8	3.9	52.5	3.5	0.6	9.0	0.6	3.2	0.5	4.5	16.7	0.6	11.2	0.6	0.7	6.1	0.7	7.6	0.8	7.5	0.0	51.2	7.8	9.5	0.6	3.7	0.4	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	9.4	0.2	0.1	1.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	1.9	1.0	1.5	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	11.2	11.1	2.6	10.1	11.1	5.1	7.5	7.7	9.0	7.5	59.6	19.6	0.0	0.0	0.1	1.9	0.4	12.7	13.4	22.7	0.0	0.0	0.8	0.0	2.1	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	1.1	0.0	0.2	1.6	0.0	1.8	0.8	0.8	0.0	0.6	1.7	0.0	1.5	0.6	1.2	1.7	0.4	0.2	0.9	0.0	0.0	0.7	1.2	1.4	0.6	0.8	1.7	0.0
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	26.0	8.4	8.5	9.3	7.5	11.9	9.0	12.7	11.7	13.9	13.6	20.3	8.8	17.3	27.4	11.9	12.7	17.0	14.8	14.3	24.7	20.8	12.0	29.9	7.5	10.2	11.7	24.6	13.8	13.3	12.8	13.4	19.1	8.6	11.7	7.3	12.7	17.0	13.8	20.6	9.5	13.7	11.9	15.0	28.0	12.5	18.7	18.5	10.4	16.3	18.5	11.3	18.9	21.2	13.4	6.8	27.8	19.5	11.7	12.9	9.8	13.8	26.6	15.4	17.8	33.9	14.3	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8	14.9	20.0	20.6	13.8	14.2	17.0	130.0	15.3	16.0	20.5	17.4	29.5	16.2	14.9	14.8	7.2	13.5	20.6	70.0	20.7	12.2	15.9	15.5	18.5	30.2	15.9	20.6	22.4	16.0	23.5	10.2	14.7	21.2	20.3	11.8	20.6	15.7	22.7	7.0	13.8	26.9	21.6	6.5	17.5	11.3	15.0	19.6	15.0	12.8	25.8	19.6
HES1	"bHLHb39, FLJ20408, HES-1, Hes1, HRY"	ENSG00000114315	"Hes family bHLH transcription factor 1"	Q14469	3	194136145-194138732	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 883.9;Paneth cells: 936.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 19.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 19.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 26.2;hTCEpi: 32.9;OE19: 32.2;SK-BR-3: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066929			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA066929: AB_2732753"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.04e-5)"	31.0	10.9	8.4	7.9	9.3	0.6	30.1	5.5	8.1	28.4	18.9	14.1	36.1	17.2	21.2	15.9	47.8	9.9	11.5	21.2	9.5	6.0	22.1	27.4	37.9	3.7	6.3	8.8	15.7	21.2	19.7	15.1	23.5	8.8	35.1	20.5	58.7	31.0	89.6	32.8	56.0	12.6	9.7	8.4	10.7	23.9	11.7	8.0	2.3	36.3	29.7	40.3	26.3	39.8	0.5	0.1	19.5	4.8	0.0	0.0	0.1	3.0	0.9	7.2	9.3	2.2	0.0	1.8	1.4	4.2	0.3	0.1	12.3	8.9	0.4	26.2	0.5	4.4	17.6	1.3	8.3	0.1	2.5	15.1	11.1	1.1	3.1	0.0	0.0	10.5	0.8	32.9	0.2	3.8	5.0	9.9	0.6	5.3	0.4	0.0	14.6	15.6	15.2	6.7	32.2	6.1	0.0	0.5	0.3	9.7	24.2	0.4	0.5	7.1	27.4	12.3	8.6	7.7	0.8	7.6	0.8	7.8	0.1	10.5	0.0	0.0	0.0	0.5	0.0	15.0	0.0	0.1	19.5	0.0	3.1	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.1	8.4	9.3	5.5	8.1	9.5	6.0	6.3	8.8	8.8	8.0	23.8	99.8	66.4	291.3	109.2	14.2	64.5	387.3	165.9	238.8	186.7	15.7	27.9	160.8	197.9	1.4	288.1	452.8	0.0	176.3	4.8	322.5	246.0	301.9	136.4	23.9	9.5	153.8	713.3	61.6	4.3	54.4	73.1	75.9	37.9	274.4	883.9	162.1	936.3	17.7	69.0	39.9	161.7	297.1	1.1	1.5	259.2	174.9	9.6	593.0	248.6
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339765-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 225.5"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 157.2"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	25	"Hep G2: 37.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004732	Uncertain				"Secreted to blood"	NA	NA		42000000000			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.2	1.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	8.5	225.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	2.5	0.3	0.2	0.6	0.0	0.1	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.5	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.3	37.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.4	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.9	1.1	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.5	0.5	0.2	0.4	0.2	0.5	0.4	0.0	0.6	0.3	0.6	2.5	0.2	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	157.2	0.2	0.0	0.0	3.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355247-194369743	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 48.1"	"Cell type enhanced"	"Detected in some"	17	"Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 48.9;U-138 MG: 9.5;U-87 MG: 26.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		1800000	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	3.3	0.5	0.5	3.1	0.6	0.0	5.3	0.5	0.5	4.6	2.1	0.2	0.0	0.4	3.5	0.3	1.0	1.3	2.0	1.8	0.5	0.5	0.5	0.5	2.5	0.8	0.5	0.0	3.1	0.8	0.0	0.5	48.1	0.3	0.6	4.2	0.7	1.6	0.0	1.0	9.1	0.8	0.7	0.5	1.3	1.9	0.9	0.0	1.1	1.8	7.7	7.7	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.4	48.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.5	1.6	1.2	0.0	0.0	0.0	0.0	26.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;T-cells: 2.2"	"Cell line enriched"	"Detected in some"	9	"HEL: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA072646			Approved	Cytosol		NA	NA		400000000	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.3	0.0	0.4	2.1	0.5	1.6	0.3	0.3	0.3	0.6	0.3	0.3	0.3	0.0	0.3	0.3	0.3	2.5	0.3	0.3	0.4	0.6	0.3	0.6	0.9	3.7	0.3	0.3	0.8	0.3	0.0	0.4	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.3	1.7	0.2	0.3	0.3	0.3	1.0	0.3	1.9	0.3	0.5	0.1	1.1	0.2	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.4	0.1	0.1	2.0	2.2	0.1	0.0	0.0	1.1	0.0	0.4	0.4	0.5	0.3	0.3	0.4	0.6	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	27.1	14.4	9.0	20.8	12.7	17.5	22.8	15.3	13.8	12.1	13.4	10.8	17.2	11.4	16.2	13.2	12.4	11.3	17.1	37.8	9.6	8.1	29.7	56.9	22.1	11.6	10.1	8.3	13.2	11.4	37.6	10.6	28.9	10.6	11.8	12.6	12.9	16.7	15.9	11.8	7.7	15.0	12.1	9.0	17.1	16.3	8.8	8.4	18.9	37.1	12.0	12.7	17.8	16.1	1.9	2.4	2.3	2.3	2.2	4.7	1.0	49.1	5.6	10.0	9.5	11.4	17.8	24.4	16.9	18.4	18.4	33.5	30.8	12.0	19.4	50.3	24.3	61.0	16.7	9.6	16.8	42.8	64.7	8.3	10.7	7.4	6.5	19.8	34.8	28.1	8.1	7.5	38.2	24.9	30.2	9.5	12.0	12.3	39.3	22.3	8.4	14.0	6.9	9.5	16.1	9.7	12.8	21.6	11.6	15.6	15.7	15.4	8.1	17.9	18.6	12.5	8.8	35.7	24.4	12.4	22.5	18.7	44.6	31.5	25.9	46.7	34.5	44.6	20.7	15.5	1.8	1.7	2.3	1.8	2.3	2.2	1.9	1.7	2.8	2.4	1.1	2.5	2.5	0.3	2.2	0.9	1.6	4.7	1.0	9.0	12.7	15.3	13.8	9.6	8.1	10.1	8.3	10.6	8.4	47.6	35.1	27.9	35.7	73.3	24.1	34.6	96.8	24.1	37.5	47.1	19.6	25.7	3.3	56.7	1.9	46.6	20.8	0.0	60.7	16.3	46.0	62.6	8.1	112.9	37.1	14.3	29.4	49.1	35.1	1.1	9.5	48.5	59.1	8.2	21.5	10.3	76.7	20.4	12.4	39.8	13.3	12.9	36.0	14.0	7.0	62.2	54.0	20.1	19.9	58.3
TMEM44	DKFZp686O18124	ENSG00000145014	"Transmembrane protein 44"	Q2T9K0	3	194587673-194633689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 50.3;Mucus-secreting cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 3.2;NK-cell: 11.5"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.2;NK-cells: 11.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043718	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA043718: AB_10794662"	"unprognostic (8.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.31e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.78e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (6.55e-13)"	"unprognostic (1.23e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.66e-2)"	13.2	2.8	4.8	6.2	11.8	10.6	21.2	1.9	7.3	6.6	11.8	2.4	9.2	4.6	6.8	22.9	5.1	4.9	7.9	5.9	6.1	6.3	5.6	3.6	15.1	6.3	5.2	7.8	5.1	3.3	1.3	2.3	12.0	6.7	4.8	11.9	3.3	7.0	5.8	6.7	3.4	6.0	5.6	3.7	9.0	6.7	4.1	3.3	4.1	5.3	5.5	3.7	5.0	6.7	0.3	0.6	3.2	0.4	11.5	0.8	0.0	6.3	5.1	7.8	8.3	2.9	9.8	6.9	4.9	9.2	4.1	6.5	2.8	12.6	1.1	23.3	5.7	11.8	7.4	2.6	3.7	2.7	10.4	3.7	7.1	5.3	2.1	5.3	2.2	11.3	6.3	4.1	9.2	4.1	19.4	16.6	7.0	2.0	0.3	13.2	5.9	3.3	5.6	4.1	6.2	8.4	6.3	4.9	0.2	4.2	3.6	2.2	4.7	3.5	1.1	7.2	3.4	5.3	4.7	19.6	12.3	4.6	3.8	6.3	0.9	0.7	2.2	18.4	8.6	6.1	3.2	0.3	0.3	0.5	0.2	0.1	0.2	0.2	0.8	0.0	0.3	0.1	0.3	0.8	11.5	0.4	0.6	0.0	0.0	4.8	11.8	1.9	7.3	6.1	6.3	5.2	7.8	6.7	3.3	0.0	2.9	3.7	3.0	0.5	0.8	1.1	0.0	2.7	3.4	5.2	2.0	6.6	0.0	5.1	0.6	15.2	13.4	0.0	4.3	2.8	4.8	5.1	17.3	0.8	3.0	0.0	5.8	50.3	2.2	0.0	2.8	0.8	1.7	0.0	20.6	0.6	9.6	17.5	1.8	0.1	0.3	6.5	1.2	0.5	5.9	0.5	7.3	1.5	16.2	5.1
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640788-194672477	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	20.4	17.8	14.2	17.9	20.7	28.8	21.8	14.5	18.9	17.7	18.5	19.2	16.6	20.4	21.6	24.8	22.5	18.3	15.3	17.8	13.3	15.1	20.4	30.6	18.2	20.2	19.9	13.3	21.9	25.6	20.6	24.4	24.2	23.8	21.0	22.3	15.9	19.8	22.2	30.1	26.0	20.0	18.0	16.3	22.2	18.5	18.6	15.9	25.0	23.5	15.8	28.1	18.7	20.3	13.2	14.0	10.7	10.6	17.0	14.9	8.2	20.3	13.5	8.2	13.8	12.9	7.0	16.7	12.2	11.8	16.8	14.9	17.8	9.4	16.1	36.8	11.2	29.4	14.9	25.9	13.9	20.5	20.8	12.5	17.2	14.0	10.1	9.2	18.9	16.7	6.8	12.1	17.4	16.2	6.2	18.2	11.4	14.3	17.9	13.8	28.3	17.0	11.3	22.4	27.5	24.9	20.7	13.5	18.2	9.0	17.7	15.6	10.8	15.9	14.6	14.9	16.2	34.3	12.4	13.9	12.8	14.6	18.0	25.0	19.7	25.9	38.2	10.3	24.4	19.8	2.8	8.1	10.7	13.5	10.6	14.9	13.2	11.0	11.9	14.0	11.0	12.9	11.5	1.1	17.0	7.1	7.4	12.2	8.2	14.2	20.7	14.5	18.9	13.3	15.1	19.9	13.3	23.8	15.9	17.9	26.4	14.6	12.3	14.3	17.0	13.4	25.5	49.5	39.8	8.7	11.8	20.5	5.0	16.5	8.6	13.5	11.5	23.3	19.4	16.2	10.6	9.4	51.0	12.4	11.2	14.3	7.5	9.8	4.5	6.5	14.4	13.1	11.8	10.8	11.2	18.2	16.1	9.9	13.8	10.2	17.4	19.4	9.8	18.1	33.3	14.1	23.8	13.8	14.5	7.1
FAM43A	FLJ90022	ENSG00000185112	"Family with sequence similarity 43 member A"	Q8N2R8	3	194686544-194689037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 61.8;Extravillous trophoblasts: 69.8;Ito cells: 78.5;Syncytiotrophoblasts: 135.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 47.9;NB-4: 28.5;PC-3: 22.6;TIME: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048345	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA048345: AB_2680367"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.71e-3)"	"unprognostic (5.13e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.91e-3)"	"prognostic unfavorable (9.96e-4)"	10.7	1.8	1.6	3.5	1.6	2.4	10.4	2.7	4.2	5.2	4.2	2.1	1.6	0.8	4.8	2.7	5.3	6.0	4.2	7.0	2.7	1.6	4.6	23.5	5.6	8.0	2.5	3.6	3.5	7.0	0.5	2.7	9.3	4.1	7.9	1.7	3.3	6.7	2.1	5.5	8.6	3.8	2.9	1.6	20.6	2.7	6.1	2.3	2.6	2.6	5.8	5.2	5.7	8.9	5.0	8.7	3.6	1.3	2.8	1.4	0.4	0.1	0.7	0.6	0.4	9.7	4.7	3.9	1.2	3.3	0.0	0.0	0.2	0.1	0.5	13.7	4.5	3.1	1.4	0.8	0.3	0.0	0.3	2.5	1.7	3.8	0.5	0.8	0.4	5.0	1.2	2.0	0.2	0.0	0.2	47.9	0.0	1.0	0.9	0.1	0.7	0.0	28.5	2.2	4.8	22.6	2.1	0.1	0.2	0.0	0.0	13.3	1.1	0.9	0.9	2.8	1.0	0.5	5.9	24.0	0.5	0.7	0.6	0.3	0.0	0.5	1.2	0.2	13.0	9.0	3.6	1.3	1.5	1.0	1.1	1.4	2.3	0.6	0.9	1.3	5.0	0.1	0.3	1.6	2.8	0.7	8.7	0.4	0.4	1.6	1.6	2.7	4.2	2.7	1.6	2.5	3.6	4.1	2.3	0.0	4.5	27.4	20.1	3.5	14.8	31.3	0.0	0.0	0.0	1.8	7.9	18.7	6.6	4.5	0.1	61.8	15.4	0.0	1.5	69.8	14.0	21.7	15.0	0.5	5.1	0.0	6.3	78.5	9.7	0.8	15.3	3.1	11.8	0.0	2.5	2.1	4.4	17.5	9.2	0.5	1.7	25.8	17.6	0.5	5.9	3.4	135.8	15.2	7.3	11.2
XXYLT1	"C3orf21, FLJ35155"	ENSG00000173950	"Xyloside xylosyltransferase 1"	Q8NBI6	3	195068279-195271167	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		34000				"unprognostic (1.39e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.32e-3)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.29e-3)"	"unprognostic (5.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.13e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.07e-2)"	10.1	7.0	7.4	10.3	8.8	8.1	10.2	8.1	13.6	11.1	8.5	11.0	3.6	7.0	14.5	8.0	16.7	9.6	9.5	8.3	6.7	9.5	7.0	5.2	10.3	10.7	8.5	8.7	11.3	4.6	9.9	8.7	16.3	10.7	7.9	7.8	9.8	7.8	9.5	3.4	13.4	6.7	13.8	7.5	9.1	6.8	6.6	6.1	8.1	7.0	10.0	10.8	9.7	11.7	2.3	12.7	2.1	4.8	2.1	1.9	1.4	7.6	6.6	19.9	32.4	11.4	9.9	7.1	12.3	8.5	12.2	10.6	6.9	5.4	9.1	13.2	9.6	9.4	9.2	8.3	7.2	6.4	5.1	13.2	9.1	5.4	7.4	5.3	11.4	14.8	7.1	9.6	4.3	4.8	6.7	25.5	6.1	11.1	2.7	4.1	19.2	7.6	14.6	15.3	7.3	11.7	13.0	8.1	9.9	8.9	2.6	18.4	17.0	7.6	6.0	7.6	11.1	18.2	6.4	16.8	7.1	1.8	6.8	12.4	2.3	6.9	22.4	4.6	14.7	7.5	1.1	4.8	2.1	1.9	3.4	1.6	1.7	1.7	1.9	3.3	2.3	1.7	1.7	1.4	2.1	2.9	12.7	0.9	1.4	7.4	8.8	8.1	13.6	6.7	9.5	8.5	8.7	10.7	6.1	3.0	4.1	4.5	4.0	3.8	7.1	2.8	5.1	5.3	5.7	7.0	3.9	9.0	3.3	9.1	0.2	6.8	1.3	0.0	4.6	12.7	11.5	3.9	2.3	0.8	7.2	0.0	8.1	13.5	8.9	1.6	6.1	4.0	0.0	4.6	2.0	5.1	6.6	0.0	9.9	3.1	2.6	6.5	5.1	0.4	6.1	6.1	4.0	2.2	4.3	4.4
ACAP2	"CENTB2, CNT-B2, KIAA0041"	ENSG00000114331	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 2"	Q15057	3	195274736-195443078	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 59.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034807, HPA034808"	Supported		Approved	Endosomes		NA	NA		9300	Endosomes		"HPA034807: AB_10669896, HPA034808: AB_10673103"	"unprognostic (9.13e-2)"	"unprognostic (1.75e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.54e-2)"	25.8	11.7	16.3	26.8	14.4	35.7	19.1	27.0	15.1	22.2	19.4	13.1	12.1	14.3	18.2	13.6	28.3	14.8	14.8	11.5	14.1	11.8	14.2	14.3	18.2	25.8	13.9	11.4	20.9	11.8	16.6	24.2	15.7	16.1	14.5	17.6	15.3	16.7	16.9	10.6	21.1	18.6	15.2	15.3	32.9	13.9	14.9	13.5	30.6	22.2	16.1	27.0	17.4	20.6	12.5	9.2	59.4	15.7	4.5	7.7	5.9	14.9	5.7	9.5	9.4	15.7	19.6	14.2	12.3	16.8	9.3	9.6	8.2	8.8	16.5	30.3	11.4	8.9	9.5	7.1	6.1	13.6	18.7	4.4	16.7	6.3	3.4	15.7	22.9	12.2	15.2	10.3	9.2	20.8	8.0	10.1	9.5	8.1	16.9	13.3	8.7	14.3	8.3	5.8	8.6	8.3	17.0	11.5	12.1	6.5	13.9	10.5	5.1	13.4	12.3	14.6	8.6	23.1	13.5	17.7	11.7	6.7	15.4	14.3	9.9	21.1	37.5	8.8	24.3	12.4	13.1	15.7	14.3	7.7	13.3	6.1	10.1	7.5	6.0	8.7	12.5	6.3	6.4	59.4	4.5	15.1	9.2	6.6	5.9	16.3	14.4	27.0	14.2	14.1	11.8	13.9	11.4	16.1	13.5	41.7	36.3	35.9	27.4	39.5	54.6	18.1	22.9	44.2	40.9	29.6	72.6	17.7	16.6	20.7	6.0	56.3	42.5	23.3	21.2	18.4	43.5	31.3	38.2	28.3	56.4	114.4	49.5	46.1	105.9	5.8	43.1	68.8	33.7	26.2	38.1	32.3	24.5	49.5	35.3	23.6	93.9	58.2	37.6	38.1	25.6	45.2	24.3	48.5	30.5	34.8
PPP1R2	"IPP2, PPP1R2A"	ENSG00000184203	"Protein phosphatase 1 regulatory inhibitor subunit 2"	P41236	3	195514425-195543386	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 363.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 67.5"									"HPA043729, HPA059420"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043729: AB_2678639, HPA059420: AB_2684009"	"unprognostic (1.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.13e-1)"	16.4	12.7	19.9	17.7	26.0	45.2	18.3	16.2	22.9	16.1	21.2	11.4	17.4	19.5	18.9	20.7	25.6	15.3	15.8	23.3	18.6	21.7	16.7	13.0	21.7	30.4	16.5	15.4	17.1	12.0	9.5	17.6	16.1	21.2	17.0	16.0	13.7	15.0	19.0	57.1	14.1	22.6	17.7	15.4	24.2	13.9	21.8	7.0	38.1	19.1	25.2	23.5	26.5	15.5	26.0	26.6	63.2	16.9	22.8	50.2	30.1	11.6	2.5	4.3	4.9	7.3	7.8	7.9	7.3	10.6	7.8	6.7	39.5	5.3	4.6	29.2	8.9	8.4	5.2	4.5	7.4	9.6	9.1	8.5	5.3	4.2	13.2	11.3	5.5	5.5	9.5	5.7	5.8	11.8	6.2	6.7	4.9	4.0	9.9	6.8	8.1	9.8	6.2	4.5	14.0	11.8	4.6	7.5	13.7	9.3	8.9	10.2	5.6	8.8	9.7	13.1	8.3	15.3	5.6	7.4	5.0	5.8	8.2	9.9	67.5	29.3	22.1	7.0	10.1	9.7	26.3	16.7	63.2	19.6	16.9	26.9	26.0	41.2	27.0	17.6	23.6	50.2	34.0	39.4	22.8	16.4	26.6	41.7	30.1	19.9	26.0	16.2	22.9	18.6	21.7	16.5	15.4	21.2	7.0	20.8	39.2	125.0	121.2	83.7	47.5	46.2	25.5	66.9	38.7	21.0	55.0	57.7	106.1	61.4	363.0	65.1	53.1	46.7	57.9	34.5	51.3	104.3	109.6	24.6	55.6	49.3	55.0	39.3	59.0	190.1	47.8	82.0	92.8	141.5	44.1	50.2	58.5	55.2	59.8	82.6	79.3	25.8	64.1	239.4	84.1	67.9	86.3	140.6	44.9	143.1
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568702-195584205	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"breast: 840.7"	"Group enriched"	"Detected in many"	5	"Leydig cells: 1923.5;Melanocytes: 975.2;Peritubular cells: 934.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 6.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 6.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 239.5;ASC TERT1: 129.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	98900000000	220000000000	"Plasma membrane"		"HPA040520: AB_2677020"	"prognostic favorable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.71e-3)"	134.4	15.2	39.7	5.7	39.9	3.4	840.7	14.7	66.1	75.0	16.4	79.7	10.9	12.9	36.6	30.0	46.1	42.9	36.4	124.7	45.5	29.2	8.5	3.5	11.8	6.5	96.9	28.2	19.4	28.3	9.0	14.3	59.6	50.9	39.7	13.1	99.1	152.5	35.1	110.4	66.0	7.2	30.4	81.6	3.6	28.7	32.0	56.5	0.0	87.7	42.2	6.6	62.1	95.7	6.7	0.1	0.4	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	239.5	129.1	0.3	2.0	0.5	0.0	0.0	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.5	1.4	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	2.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	25.9	0.4	0.1	0.0	0.1	0.1	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	39.7	39.9	14.7	39.5	45.5	29.2	96.9	28.2	50.9	56.5	0.0	8.3	0.0	14.6	128.8	0.0	31.1	0.0	40.2	104.6	5.2	0.0	4.1	0.0	0.2	9.1	55.0	0.0	0.0	0.0	5.0	271.0	22.1	0.0	0.0	12.4	0.0	44.5	30.1	0.3	22.5	1923.5	6.2	975.2	1.8	0.9	0.0	1.9	0.0	934.8	0.1	0.0	19.4	80.9	3.8	3.8	89.6	4.9	0.0	0.6	37.7
MUC20	"FLJ14408, KIAA1359"	ENSG00000176945	"Mucin 20, cell surface associated"	Q8N307	3	195720882-195741123	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 50.6"	"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 60.2;Urothelial cells: 102.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	7	"SK-BR-3: 25.3"									HPA042249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		11000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042249: "	"unprognostic (1.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.99e-4)"	"unprognostic (7.66e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.17e-1)"	1.7	1.2	1.1	3.4	2.1	1.2	1.8	2.5	1.2	6.3	15.2	1.1	4.7	3.2	1.5	5.2	15.9	5.7	8.7	1.1	1.1	0.7	50.6	4.8	6.4	1.1	1.1	1.1	4.6	7.6	1.0	4.6	13.3	1.1	4.9	7.6	1.2	10.6	1.8	2.5	2.1	4.1	2.0	1.1	1.6	2.3	1.8	1.1	3.0	3.9	1.9	14.9	10.6	26.6	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	3.0	0.1	0.5	0.0	0.2	1.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.5	3.4	0.1	0.8	0.1	0.8	0.0	1.9	1.0	0.3	0.0	25.3	0.2	0.4	0.1	0.0	0.0	0.2	0.7	0.9	0.1	1.1	1.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	2.5	1.2	1.1	0.7	1.1	1.1	1.1	1.1	32.8	14.7	0.0	8.8	1.5	20.2	0.5	10.2	60.2	37.5	21.0	33.4	0.0	1.7	32.3	0.0	1.3	15.6	0.0	8.7	0.1	1.5	12.8	1.1	6.4	0.4	11.1	13.3	1.8	0.6	0.0	4.9	0.9	3.3	0.0	7.2	5.6	13.7	18.6	6.0	1.4	22.0	0.0	1.6	1.1	0.7	1.6	0.0	0.5	13.5	102.7
MUC4		ENSG00000145113	"Mucin 4, cell surface associated"	Q99102	3	195746765-195812277	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.5;lymphoid tissue: 57.2"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 85.6;Club cells: 86.4;Mucus-secreting cells: 154.7;Undifferentiated cells: 114.6;Urothelial cells: 276.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.6"									"HPA005895, CAB013536"	Approved				"Secreted in other tissues"	NA	NA					"CAB013536: , HPA005895: AB_1079427"	"unprognostic (4.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.22e-3)"	"unprognostic (6.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.19e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.97e-3)"	0.4	0.4	0.0	28.7	0.0	0.4	0.4	0.0	0.4	13.4	21.5	0.0	0.0	0.4	1.4	0.4	13.0	1.7	0.4	0.4	0.0	0.0	0.4	0.4	10.3	0.4	0.0	0.0	0.5	0.4	0.4	0.0	6.2	0.2	10.0	1.9	0.0	5.5	0.4	0.4	0.4	1.7	0.4	0.0	0.4	2.4	0.5	0.0	0.5	0.4	6.1	57.2	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.0	14.1	0.0	11.3	0.0	0.0	2.0	0.0	85.6	86.4	0.0	0.0	0.1	0.0	0.2	2.4	0.0	53.1	0.0	4.7	4.0	0.0	10.6	2.3	0.0	0.1	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.7	0.0	22.6	40.3	0.4	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.0	114.6	276.8
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	"Tyrosine kinase non receptor 2"	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 47.1;Horizontal cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041954	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA041954: AB_10794164"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-3)"	"prognostic unfavorable (8.96e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (6.82e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.00e-4)"	9.2	7.6	36.3	16.2	27.6	38.9	8.5	20.7	43.7	6.0	6.3	17.6	3.8	6.6	8.0	6.6	13.0	10.7	6.5	10.6	28.4	21.8	4.1	7.2	9.3	18.1	21.6	31.8	8.6	7.8	5.1	19.3	8.4	20.0	10.8	3.9	5.3	16.8	8.2	30.5	37.1	6.9	7.6	10.3	17.0	12.1	7.7	21.8	3.4	4.6	9.8	12.8	7.7	12.3	6.1	3.1	6.3	3.2	0.9	1.9	1.2	31.9	3.1	5.2	5.5	7.2	4.6	31.1	6.2	5.9	3.7	3.4	4.9	24.7	9.3	21.6	8.4	6.3	11.4	4.5	7.6	1.1	21.9	5.7	8.4	10.4	3.5	3.2	4.3	4.2	3.4	12.2	5.1	6.1	10.6	4.7	3.5	3.4	12.9	3.4	23.5	1.8	15.7	4.9	8.5	11.5	5.4	6.2	9.4	3.3	15.5	6.3	6.4	4.0	16.2	7.9	5.2	26.5	5.4	7.6	8.6	5.0	4.4	17.1	28.2	3.0	5.8	7.7	14.0	6.3	2.0	2.4	0.9	1.9	3.2	1.1	2.7	1.8	1.0	1.1	6.1	1.4	1.3	6.3	0.9	2.8	3.1	0.2	1.2	36.3	27.6	20.7	33.3	28.4	21.8	21.6	31.8	20.0	21.8	6.0	4.8	11.8	6.8	6.2	26.5	12.8	5.1	5.3	11.4	0.0	47.1	10.6	1.7	3.5	0.8	7.5	6.9	0.0	4.5	2.6	5.3	7.2	1.1	13.5	7.2	93.8	5.8	9.8	20.5	0.8	6.1	11.4	5.0	9.0	1.4	6.6	19.1	3.5	6.0	1.4	20.9	0.0	5.5	3.9	10.0	9.3	3.5	8.9	3.3	16.3
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	22.2	20.2	9.3	18.9	20.6	12.0	58.3	31.8	24.2	22.4	37.2	49.3	20.5	22.8	60.4	11.8	49.0	34.3	31.9	10.5	27.5	109.0	10.8	86.4	17.3	22.9	16.3	70.8	17.5	13.5	10.4	19.3	17.4	6.4	7.4	12.6	36.0	21.9	17.5	20.6	23.2	15.0	28.4	29.3	41.5	12.3	13.8	27.3	20.1	56.3	21.3	8.8	30.7	80.8	7.2	16.1	78.4	14.8	9.5	26.7	21.7	23.3	47.6	6.2	48.1	35.6	31.2	19.2	16.1	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1	41.7	27.2	29.6	33.6	53.5	48.1	81.5	45.9	28.1	26.1	19.2	139.4	104.0	0.0	43.1	2.6	17.8	72.1	560.6	36.6	18.5	33.8	15.8	22.0	94.1	70.3	12.7	53.9	6.7	33.3	3.9	10.6	89.7	16.9	72.1	50.0	17.3	38.9	52.6	8.1	9.1	42.4	25.8	34.8	22.3	19.3	31.2	420.4	21.8	70.2	22.9
ZDHHC19	MGC33345	ENSG00000163958	"Zinc finger DHHC-type containing 19"	Q8WVZ1	3	196197449-196211437	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 53.4"	"Group enriched"	"Detected in some"	15	"Early spermatids: 298.7;Late spermatids: 632.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"eosinophil: 2.4;memory B-cell: 3.9;naive B-cell: 5.2;neutrophil: 3.4"	"Group enriched"	"Detected in many"	24	"B-cells: 5.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;K-562: 1.2;NTERA-2: 1.1;SH-SY5Y: 1.9;THP-1: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (2.87e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-3)"	"unprognostic (4.63e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.46e-7)"	"unprognostic (8.05e-4)"	"unprognostic (4.71e-1)"	"unprognostic (7.08e-3)"	"unprognostic (4.28e-2)"	0.0	0.6	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	5.2	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	298.7	0.7	0.0	0.0	0.0	0.4	0.3	0.1	0.0	3.4	1.3	0.0	0.0	0.0	1.5	632.3	15.3	1.4	0.0	0.0	0.0	0.2	0.0	0.0	30.1	0.4	0.0	0.0	0.0	4.9	3.0	0.0	2.1	0.0	0.0	0.0
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 alpha subunit"	Q86UW1	3	196211487-196243178	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 53.9;liver: 59.5"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 130.2;Leydig cells: 57.0;Peritubular cells: 95.5;Sertoli cells: 142.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"REH: 8.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045488	Enhanced					NA	NA					"HPA045488: "	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	0.5	2.3	0.3	3.8	0.3	2.4	0.4	0.3	0.4	0.5	12.3	0.4	0.7	13.6	0.4	2.8	0.5	0.5	0.5	0.5	0.3	0.1	2.2	59.5	0.8	0.3	0.3	0.3	0.6	0.3	1.4	0.5	0.3	0.3	0.5	0.1	0.3	0.6	0.3	0.5	1.0	53.9	0.3	0.3	0.8	0.2	1.8	0.3	0.6	0.8	0.3	0.5	0.3	0.7	0.2	0.0	1.7	0.6	0.4	0.6	0.1	1.1	1.7	1.4	1.7	0.0	1.1	0.1	0.8	0.0	0.1	0.0	0.7	0.5	0.1	2.0	1.1	0.1	0.9	0.2	0.0	0.0	0.7	2.9	1.0	0.8	1.8	0.2	1.4	1.4	0.3	0.0	0.2	1.3	1.5	0.2	0.3	0.2	3.3	0.0	0.6	0.1	1.2	0.1	0.4	2.0	8.1	0.1	0.5	0.0	0.9	0.3	0.5	0.5	3.3	0.3	0.4	2.4	0.5	0.6	1.7	0.7	1.3	0.9	3.3	4.0	0.6	1.1	0.7	0.6	0.0	0.2	1.7	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.6	1.6	0.4	0.5	0.0	0.1	0.1	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.3	0.0	1.9	3.0	0.5	3.3	2.5	10.7	4.5	0.0	3.9	0.5	3.3	0.3	16.2	1.8	130.2	23.3	0.2	0.3	3.1	1.4	0.0	38.6	0.5	1.6	0.0	4.3	3.8	10.3	57.0	3.3	3.3	0.0	0.4	0.3	0.1	8.6	95.5	4.9	0.9	142.3	2.0	2.1	1.1	2.3	0.8	2.6	0.5	2.6
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 73.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	24.8	22.2	15.3	19.9	18.7	25.8	18.0	14.2	17.8	13.6	25.3	23.0	21.1	41.1	18.2	18.7	25.2	15.0	19.8	36.0	14.8	13.8	20.2	17.8	18.7	15.6	16.6	14.1	15.6	13.9	16.0	12.1	14.2	20.5	13.3	16.5	14.4	17.1	19.2	45.8	32.8	37.2	19.5	18.3	23.4	18.1	19.4	18.6	13.2	14.8	28.0	19.0	17.6	16.7	7.8	8.7	20.5	9.8	7.9	13.5	4.6	28.7	11.6	8.1	11.9	16.7	18.6	12.3	22.0	15.7	18.9	16.7	28.3	10.5	7.4	73.8	25.2	19.9	22.5	12.9	16.9	16.2	13.4	9.0	21.2	12.2	12.0	15.0	10.2	18.2	15.7	13.0	18.3	13.1	12.2	20.2	6.9	11.8	16.5	18.8	24.3	6.4	5.4	7.0	18.1	17.3	10.6	10.4	11.9	11.6	16.2	8.0	5.9	14.9	25.7	14.3	11.8	37.7	12.8	30.2	15.1	8.4	20.5	29.7	15.3	29.1	13.6	23.1	14.3	18.9	7.5	8.7	9.2	9.6	9.2	8.0	7.8	7.2	10.2	8.7	5.7	4.6	6.8	20.5	7.9	9.8	5.6	13.5	4.6	15.3	18.7	14.2	17.8	14.8	13.8	16.6	14.1	20.5	18.6	14.9	18.8	17.9	8.2	12.9	14.3	58.5	17.8	33.5	15.9	14.0	23.6	10.4	11.6	21.4	63.4	19.5	43.0	0.0	19.9	14.2	13.7	9.7	19.7	31.7	32.6	7.9	21.2	25.2	28.9	52.1	18.4	30.0	18.6	33.3	20.4	11.8	20.8	14.8	26.5	19.4	12.4	25.8	13.7	30.0	10.6	18.7	15.6	22.7	20.5	11.0
TCTEX1D2	MGC33212	ENSG00000213123	"Tctex1 domain containing 2"	Q8WW35	3	196291219-196318299	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 37.4"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 301.2;Distal tubular cells: 102.8;Early spermatids: 174.6;Spermatocytes: 192.1;Spermatogonia: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 16.6;dendritic cells: 10.9;T-cells: 18.3"	"Cell line enhanced"	"Detected in many"		"T-47d: 38.9"									HPA049555			Approved	Cytosol		NA	NA			Cytosol		"HPA049555: AB_2680816"	"unprognostic (1.16e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (5.34e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.61e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.32e-1)"	4.3	7.4	20.5	5.1	21.6	5.3	7.0	15.0	18.3	5.2	5.3	7.0	7.2	4.7	8.4	10.4	10.7	37.4	6.3	6.3	15.4	18.6	11.8	2.3	9.1	9.1	12.1	15.8	8.7	6.6	6.8	18.8	4.1	10.6	6.4	4.9	6.8	7.6	6.2	3.1	9.2	3.0	5.3	8.7	4.1	5.2	24.2	8.1	6.8	11.2	5.1	6.5	4.9	5.9	16.6	10.9	1.4	2.3	2.9	18.3	5.6	13.6	10.2	15.7	10.2	4.1	8.1	2.2	5.6	3.2	6.0	6.7	3.5	16.7	8.8	10.3	4.0	2.3	14.4	6.4	5.1	5.6	7.7	5.7	3.4	10.1	1.4	4.5	2.2	0.3	4.0	13.5	4.9	6.2	10.9	3.5	17.2	4.9	4.4	11.5	33.5	11.5	11.3	11.1	12.7	19.4	14.5	3.1	3.6	12.8	5.6	19.8	16.7	12.7	6.4	11.2	6.5	38.9	6.5	7.9	5.8	2.5	2.3	6.5	7.5	14.3	18.9	17.4	4.3	9.9	0.0	2.3	1.2	9.2	0.8	5.6	16.6	11.6	7.3	6.0	9.5	7.4	7.3	1.4	2.9	0.6	10.9	18.3	5.6	20.5	21.6	15.0	18.3	15.4	18.6	12.1	15.8	10.6	8.1	8.9	6.9	10.0	18.9	14.7	17.4	5.0	30.6	301.2	39.8	34.9	9.8	24.1	102.8	23.6	174.6	10.5	4.0	0.0	9.4	7.0	11.6	10.3	8.1	3.4	13.5	28.6	24.6	14.7	3.2	30.9	16.1	6.3	18.6	19.8	9.5	29.8	9.2	3.5	29.4	35.2	18.4	12.9	7.3	192.1	110.5	15.9	5.1	11.5	11.9	14.4
TM4SF19		ENSG00000145107	"Transmembrane 4 L six family member 19"	Q96DZ7	3	196319342-196338503	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"adipose tissue: 69.9"	"Cell type enriched"	"Detected in some"	9	"Hofbauer cells: 78.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdT-cell: 14.8;memory CD8 T-cell: 3.8;naive CD8 T-cell: 5.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 14.8"	"Cell line enriched"	"Detected in some"	12	"GAMG: 100.5"															NA	NA						"unprognostic (9.90e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.90e-5)"	"unprognostic (8.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-3)"	69.9	0.4	0.4	0.7	0.4	0.9	4.5	0.4	0.5	2.1	0.4	0.4	0.4	0.0	0.4	0.6	5.0	0.3	0.8	0.4	0.4	0.1	0.4	0.8	4.9	0.6	0.4	0.4	1.2	0.4	0.0	0.4	1.1	0.4	0.6	0.1	0.4	2.2	0.4	2.1	3.2	0.4	0.4	0.4	0.8	0.6	8.2	0.4	0.5	1.0	2.0	1.3	0.9	2.1	0.3	0.5	0.6	0.4	0.8	14.8	1.4	3.4	1.6	0.1	0.1	0.2	1.1	0.1	0.0	1.0	0.3	0.7	0.0	1.9	0.0	0.6	0.0	100.5	0.5	0.0	0.3	0.2	0.1	0.0	0.1	0.4	0.0	0.2	0.2	0.1	0.1	0.3	4.4	7.4	0.0	0.0	0.2	2.1	0.2	1.1	0.2	0.0	0.1	0.0	0.0	8.4	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.3	4.4	3.6	0.6	2.0	0.1	1.2	0.0	4.7	0.1	0.1	0.6	0.3	0.4	14.8	0.4	0.1	0.1	1.4	3.8	0.1	0.3	0.8	5.4	0.6	0.8	0.1	0.5	0.3	1.4	0.4	0.4	0.4	0.5	0.4	0.1	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	78.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	3.8	0.0	0.3	0.0	0.0	0.0
UBXN7	"KIAA0794, UBXD7"	ENSG00000163960	"UBX domain protein 7"	O94888	3	196347662-196432474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048441, HPA049442"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048441: AB_2680394, HPA049442: AB_2680769"	"unprognostic (8.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	13.8	12.7	14.0	11.2	17.6	29.9	13.3	30.4	16.3	14.5	13.1	19.2	13.5	9.0	17.3	14.3	13.4	14.4	9.9	9.6	15.6	12.1	11.4	10.4	13.3	13.3	16.3	12.9	21.4	12.9	23.1	23.4	14.9	16.2	12.4	11.5	11.4	12.8	13.3	10.3	17.5	12.9	13.4	14.0	13.5	10.8	17.9	19.0	24.7	13.2	6.7	13.6	13.9	17.2	9.6	6.3	10.4	6.5	7.6	9.5	2.8	15.1	4.4	18.9	10.0	9.9	17.5	7.9	12.7	8.4	7.3	6.7	12.4	6.6	14.1	26.1	8.5	9.7	12.3	14.1	7.6	13.6	5.8	8.7	22.7	10.3	6.7	7.6	11.2	7.3	10.4	8.6	10.2	12.8	13.1	11.7	10.4	10.7	9.9	8.5	6.6	11.7	6.1	11.0	6.3	6.1	13.6	14.2	9.6	6.0	6.4	12.9	9.7	19.7	5.7	10.1	15.8	15.3	9.6	14.7	8.5	7.5	7.5	13.5	13.5	18.5	20.7	7.7	13.3	6.1	10.2	5.9	8.9	6.1	4.9	5.8	9.6	5.4	4.0	6.3	7.5	9.5	8.3	10.4	7.6	6.5	2.9	8.7	2.8	14.0	17.6	30.4	16.3	15.6	12.1	16.3	12.9	16.2	19.0	41.7	16.8	11.7	12.6	42.0	34.6	16.1	15.3	25.4	23.9	19.2	66.8	14.0	5.0	9.9	30.5	22.2	11.2	0.0	8.7	8.8	21.7	21.2	8.1	10.5	11.1	30.2	44.6	21.5	20.6	19.6	27.6	19.9	21.9	15.4	16.7	21.5	10.8	8.6	26.5	9.4	45.6	32.3	20.8	29.8	21.3	47.8	15.8	27.3	15.5	14.1
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 199.9;Late spermatids: 360.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046109: AB_2679540"	"unprognostic (6.15e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	20.8	9.3	8.9	10.7	11.1	31.6	18.7	21.1	13.0	13.6	11.2	10.7	12.3	11.1	13.9	8.5	14.3	10.1	10.9	12.0	10.2	10.2	7.5	18.8	14.3	12.0	13.8	11.0	14.6	9.2	12.0	8.1	9.9	15.3	10.1	10.8	9.1	11.0	13.6	20.8	20.1	10.1	12.9	10.5	11.7	10.7	18.4	13.4	17.6	9.6	13.9	15.2	14.7	17.1	6.2	5.8	21.8	10.0	7.7	11.6	5.7	12.5	5.0	9.0	11.8	8.4	6.1	12.9	7.7	4.9	5.2	8.2	9.8	6.2	13.3	17.8	6.4	7.3	12.8	12.6	9.2	8.0	6.3	6.2	25.2	12.7	12.1	4.4	7.7	6.3	6.1	3.5	8.1	7.2	3.7	7.5	11.0	7.5	14.0	5.2	21.2	25.5	4.6	10.7	6.8	6.5	11.5	10.5	10.8	4.4	17.4	7.5	7.6	8.7	10.7	6.6	7.0	16.2	6.9	7.4	9.0	7.1	9.5	10.1	12.0	11.2	20.2	8.8	9.4	7.1	21.8	6.6	7.5	11.6	7.1	10.4	5.7	9.8	8.3	5.8	6.2	8.7	9.1	7.3	7.7	10.0	5.5	6.2	5.7	8.9	11.1	21.1	13.0	10.2	10.2	13.8	11.0	15.3	13.4	14.9	29.1	17.1	44.2	89.0	35.1	19.7	12.7	18.7	19.4	14.0	56.9	11.4	14.9	11.9	199.9	29.2	13.6	0.0	7.9	20.7	33.6	23.5	49.6	25.8	15.9	14.3	13.8	17.2	29.0	360.7	18.7	39.0	25.3	37.9	16.0	13.4	8.6	14.4	19.4	8.4	39.6	12.9	35.0	11.1	67.5	110.7	8.9	46.0	18.6	50.5
SMCO1	"C3orf43, DKFZp313B0440, FLJ41923"	ENSG00000214097	"Single-pass membrane protein with coiled-coil domains 1"	Q147U7	3	196506877-196515366	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	22	"heart muscle: 48.6;skeletal muscle: 57.8;tongue: 66.9"	"Cell type enriched"	"Detected in single"	76	"Cardiomyocytes: 71.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.5;NTERA-2: 1.4;U-251 MG: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.86e-2)"	"unprognostic (1.62e-1)"		"unprognostic (1.51e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.72e-2)"		"unprognostic (1.73e-1)"		"unprognostic (3.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-2)"		"unprognostic (2.95e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	48.6	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	2.1	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	66.9	2.5	0.0	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.4	0.6	0.9	0.3	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.2	0.2	0.0	0.7	0.2	0.4	0.2	0.8	0.2	1.5	0.7	0.1	1.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.3	0.4	0.0	0.4	0.1	0.0	0.0	0.5	0.0	0.0	1.3	0.5	0.5	0.4	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	71.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0
WDR53	"MGC12928, MGC64882"	ENSG00000185798	"WD repeat domain 53"	Q7Z5U6	3	196554177-196568674	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.0"	"Group enriched"	"Detected in many"	6	"Early spermatids: 232.6;Late spermatids: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016420	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA016420: AB_1858812"	"unprognostic (3.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (9.89e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.48e-3)"	"unprognostic (8.01e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	4.3	4.3	5.9	6.8	6.9	7.2	5.2	6.4	5.9	4.0	4.2	4.5	7.1	2.1	4.9	6.6	5.1	3.9	3.5	4.0	4.8	3.8	4.0	5.4	3.8	5.5	5.9	4.3	4.3	3.3	7.5	11.9	4.4	6.1	4.1	4.1	4.8	4.0	4.5	6.8	6.7	4.5	4.1	5.0	6.2	4.0	48.0	4.6	7.4	4.2	3.2	6.5	3.9	4.2	7.5	5.9	13.9	6.7	6.5	14.9	4.9	19.1	4.1	7.4	6.6	7.6	6.6	11.9	10.1	7.9	11.5	10.9	11.2	10.2	9.1	34.1	6.1	10.6	11.2	9.3	8.7	14.4	14.3	8.1	9.2	10.1	7.3	9.5	12.9	7.6	5.4	12.8	10.2	11.2	5.7	8.9	11.6	8.9	17.6	8.7	17.8	10.9	13.2	10.1	12.2	12.0	13.1	12.7	19.4	6.3	6.7	7.3	8.0	7.0	10.5	14.8	10.4	27.0	12.1	8.3	9.8	9.2	10.9	19.7	15.0	30.0	27.2	6.5	16.6	9.8	9.6	5.1	13.9	8.6	4.4	14.0	7.5	12.3	8.7	4.1	7.1	10.3	6.2	4.4	6.5	6.7	5.9	14.9	4.9	5.9	6.9	6.4	5.9	4.8	3.8	5.9	4.3	6.1	4.6	0.0	3.2	0.8	2.8	3.8	3.1	2.7	2.5	1.4	4.5	3.5	0.0	4.7	5.0	4.2	232.6	5.2	1.0	0.0	3.7	5.5	2.8	2.3	9.2	2.4	3.9	3.2	0.0	3.1	4.5	86.7	4.6	5.0	5.0	8.2	1.5	3.6	2.6	1.9	3.2	3.5	2.3	19.4	6.2	27.9	13.1	4.1	3.9	5.7	2.3	2.3
FBXO45	Fbx45	ENSG00000174013	"F-box protein 45"	P0C2W1	3	196568611-196589059	"Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040730	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA040730: AB_10959311"	"unprognostic (7.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.61e-5)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.16e-5)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (5.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.65e-1)"	6.3	5.6	15.6	7.2	15.0	14.6	9.4	19.0	19.4	6.2	8.4	12.5	4.0	6.6	6.2	4.0	11.5	4.8	5.7	4.5	15.5	12.0	4.9	8.4	5.6	7.7	13.5	11.1	6.7	6.7	13.7	7.8	6.7	11.8	6.6	9.1	3.5	5.9	5.8	15.3	15.8	6.2	6.3	14.9	6.0	6.8	14.4	13.3	6.7	4.7	7.7	12.0	7.3	11.4	2.0	4.4	3.8	3.3	1.6	4.8	1.2	19.9	3.8	8.1	10.2	5.4	5.4	9.6	8.9	4.1	7.0	7.3	10.6	6.8	8.4	15.4	5.7	10.5	8.6	15.4	10.1	13.1	12.2	6.9	15.4	7.0	6.6	5.2	20.5	7.9	2.7	11.5	8.0	14.8	3.7	7.7	13.8	18.4	18.0	7.8	20.0	11.9	9.6	12.6	17.9	14.8	10.2	10.6	20.4	5.9	8.2	16.5	11.3	9.6	16.8	10.2	7.4	28.9	13.8	7.6	8.2	8.9	11.8	23.9	17.7	29.5	23.7	7.1	26.6	7.8	3.8	3.1	3.1	2.8	2.9	4.6	1.8	2.8	1.6	3.7	2.0	2.6	3.0	1.2	1.6	3.3	4.4	4.8	1.2	15.6	15.0	19.0	19.4	15.5	12.0	13.5	11.1	11.8	13.3	11.9	2.6	9.3	5.6	8.8	18.5	9.0	2.5	6.7	2.3	3.5	13.7	2.2	0.0	4.2	11.6	5.2	4.6	0.0	6.4	3.8	3.8	11.6	1.1	7.9	5.0	12.7	16.7	6.2	11.1	12.9	5.2	6.5	5.0	2.8	7.9	7.7	6.2	3.5	6.0	2.7	9.8	0.0	5.6	26.8	24.3	11.8	1.6	4.5	7.4	15.6
NRROS	"ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030"	ENSG00000174004	"Negative regulator of reactive oxygen species"	Q86YC3	3	196639686-196662004	"Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.4"	"Cell type enhanced"	"Detected in some"	14	"Hofbauer cells: 61.8;Ito cells: 18.4;Kupffer cells: 33.8;Macrophages: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 7.4;classical monocyte: 1.9;eosinophil: 3.3;intermediate monocyte: 2.0;myeloid DC: 2.5;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.5;granulocytes: 7.4;monocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"HEL: 16.4;HMC-1: 34.6;Karpas-707: 21.4;MOLT-4: 18.2;NB-4: 42.6;RPMI-8226: 21.2;THP-1: 18.8;U-937: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031586	Uncertain					NA	NA					"HPA031586: AB_10601543"	"unprognostic (5.28e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	17.0	3.6	3.8	9.3	4.4	30.4	12.4	1.6	3.1	4.7	3.3	4.0	1.0	3.0	7.6	7.1	2.7	4.2	5.8	8.5	3.1	2.7	4.3	3.4	13.4	23.0	4.3	1.3	2.6	2.6	1.2	2.3	12.4	3.4	4.5	2.2	5.7	3.8	2.2	3.1	3.1	6.9	4.9	5.2	22.5	3.4	2.8	4.8	15.6	3.5	2.4	8.8	6.3	3.5	0.6	2.5	7.4	2.0	0.6	0.7	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.3	0.0	0.0	1.2	0.0	16.4	0.0	0.0	0.1	13.4	34.6	0.1	0.0	0.5	0.2	0.6	1.3	15.5	1.6	21.4	0.4	0.0	18.2	42.6	1.4	0.0	0.0	4.9	0.0	21.2	0.0	0.1	0.1	0.0	0.0	0.0	8.6	0.3	0.0	18.8	0.1	0.1	0.0	0.6	0.0	8.6	12.9	3.8	1.1	23.7	0.2	7.4	1.9	3.3	0.7	2.0	0.2	0.6	0.5	0.4	2.5	0.5	0.2	0.4	0.0	0.6	1.9	0.3	0.5	1.2	3.8	4.4	1.6	3.1	3.1	2.7	4.3	1.3	3.4	4.8	0.0	0.3	15.9	0.0	1.3	0.0	0.1	0.0	0.0	1.2	0.0	3.9	0.3	0.0	0.0	0.9	3.8	0.0	0.0	0.0	0.5	0.8	0.0	13.9	0.0	61.8	0.0	0.0	18.4	33.8	0.0	0.6	36.2	8.5	3.6	0.0	0.0	0.0	0.0	0.7	0.0	0.4	6.5	0.5	0.5	0.2	0.6	0.5	13.1	0.0	0.0
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 34.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029409, HPA073301"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029409: AB_10610280, HPA073301: "	"unprognostic (8.83e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	19.1	13.7	25.1	12.7	25.5	9.3	19.2	16.9	25.8	13.1	15.5	13.1	7.8	12.3	15.2	18.5	16.6	12.6	12.7	13.9	23.2	25.4	18.1	12.5	15.6	27.0	24.8	13.4	10.9	16.0	28.1	18.2	17.7	14.5	18.6	17.1	16.3	12.9	18.5	18.6	12.3	11.8	17.1	21.7	18.4	10.6	9.0	14.2	24.6	15.5	10.6	14.7	13.6	10.7	1.7	3.2	34.5	4.4	3.6	2.1	1.5	22.3	10.2	13.4	9.4	14.2	10.8	7.6	10.1	12.2	12.4	12.9	9.8	14.6	11.0	33.9	10.1	15.4	12.3	11.4	9.6	15.4	10.0	10.6	9.1	7.1	6.6	13.1	10.2	17.0	8.1	15.0	10.0	9.5	9.9	6.7	18.0	6.2	22.1	11.3	20.3	26.3	13.3	6.0	17.8	11.6	14.3	15.8	15.9	12.8	7.5	13.0	14.4	17.0	11.7	13.9	10.5	40.5	9.5	3.5	11.9	5.2	13.0	15.5	27.9	32.1	20.8	10.8	12.6	12.3	15.5	3.0	34.5	1.5	4.4	1.3	1.7	1.4	2.1	3.2	1.7	1.6	1.4	8.6	3.6	4.4	1.4	1.7	1.5	25.1	25.5	16.9	25.8	23.2	25.4	24.8	13.4	14.5	14.2	17.9	21.8	19.9	24.6	15.1	31.0	10.7	20.4	9.4	11.4	27.9	45.2	17.1	29.9	6.9	19.9	15.7	18.7	0.0	4.9	17.4	22.4	27.9	11.5	14.4	17.0	31.8	15.1	17.8	18.3	17.2	25.9	19.4	20.3	10.8	17.7	33.8	5.4	14.4	32.9	29.9	34.6	25.8	19.4	21.4	33.5	13.9	9.7	17.8	26.3	16.3
CEP19	"C3orf34, MGC14126"	ENSG00000174007	"Centrosomal protein 19"	Q96LK0	3	196706277-196712293	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.3"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 26.8;Early spermatids: 19.5;Spermatocytes: 38.6;Spermatogonia: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 12.9;eosinophil: 17.5;neutrophil: 45.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 45.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047614, HPA071138"	Enhanced		Supported	Centrosome		NA	NA			Centrosome		"HPA047614: AB_2680103, HPA071138: AB_2686348"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (5.51e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.33e-2)"	3.2	5.2	10.2	5.7	11.7	2.4	2.4	7.3	10.8	3.6	2.3	3.0	2.6	2.0	3.3	6.2	3.2	8.0	3.8	2.4	8.4	9.0	5.2	2.3	3.2	5.0	6.5	6.0	3.8	1.4	6.1	9.2	3.9	8.3	3.5	2.2	2.5	2.3	4.4	1.3	3.3	2.0	3.0	4.4	6.1	1.7	17.5	4.4	8.3	5.1	0.4	6.3	4.0	2.6	1.4	3.4	45.3	1.3	2.3	3.5	1.2	5.2	3.7	5.1	3.1	11.7	9.0	1.5	4.3	8.1	4.6	6.0	1.8	3.5	3.9	12.2	2.1	10.1	2.3	3.4	1.1	5.5	5.4	3.4	5.9	1.9	0.5	4.7	2.7	7.6	4.1	5.1	6.0	1.6	8.5	1.9	4.8	3.2	4.8	4.7	2.7	6.7	4.8	2.6	2.3	6.1	7.9	3.1	2.7	4.9	0.5	5.1	3.6	5.8	0.8	6.5	4.6	4.6	5.2	1.5	5.4	1.2	8.3	2.8	14.8	14.1	8.0	7.7	6.9	5.2	12.9	1.3	17.5	1.8	0.9	2.0	1.1	2.6	2.3	0.8	1.4	3.5	2.2	45.3	2.3	1.0	3.4	1.4	1.2	10.2	11.7	7.3	10.8	8.4	9.0	6.5	6.0	8.3	4.4	0.0	1.3	2.7	1.0	1.8	4.5	2.0	0.0	26.8	2.3	1.8	0.0	1.4	5.0	1.6	19.5	4.5	0.0	0.0	0.7	1.2	3.7	1.0	1.1	0.2	2.7	4.8	0.0	5.5	3.8	3.1	6.1	2.5	0.0	14.4	0.2	7.6	1.0	0.0	4.9	3.5	7.4	0.0	1.9	38.6	38.7	0.6	0.3	3.2	0.4	0.1
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		590000	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	28.7	18.9	22.4	27.6	23.5	21.4	56.5	17.4	20.7	19.5	23.0	27.8	17.4	19.0	22.6	19.2	23.4	17.9	20.7	29.0	22.6	22.0	19.5	34.3	35.7	50.2	26.8	13.5	19.9	16.6	30.5	13.0	27.6	22.8	17.7	23.0	12.9	19.6	21.2	34.2	16.3	25.2	23.0	32.1	34.6	18.4	15.9	24.8	44.9	16.9	19.1	31.9	24.1	32.7	6.6	13.7	25.9	12.6	6.6	10.8	7.0	36.0	12.9	18.1	13.3	12.9	17.1	27.0	18.3	15.1	19.9	18.1	30.6	18.5	23.1	52.3	18.4	20.3	18.5	19.2	17.4	30.8	10.4	9.3	34.2	14.9	24.0	26.2	33.2	32.9	13.6	14.3	17.8	37.9	21.1	19.6	25.7	16.4	28.8	19.3	38.0	31.6	17.2	10.8	19.4	19.5	28.9	10.3	20.9	17.4	25.3	10.6	12.1	24.5	17.3	13.8	14.6	60.5	24.1	20.2	16.5	9.2	17.3	26.9	19.6	34.6	56.9	13.7	33.3	15.7	16.5	10.3	24.5	6.3	12.6	8.5	6.4	7.3	7.1	13.7	6.6	5.4	6.3	25.9	6.6	10.8	5.1	10.8	7.0	22.4	23.5	17.4	20.7	22.6	22.0	26.8	13.5	22.8	24.8	74.5	44.7	76.2	49.3	86.5	39.1	56.5	63.7	88.3	47.8	78.5	49.1	41.1	28.2	62.3	49.4	78.8	52.5	0.0	51.3	82.8	47.0	116.6	143.4	125.4	90.3	52.4	43.1	63.3	144.6	51.0	56.4	118.7	32.1	120.0	42.8	58.0	77.2	48.4	42.8	60.3	40.6	38.8	52.3	24.2	41.4	75.4	29.2	71.3	38.3	112.3
SENP5	MGC27076	ENSG00000119231	"SUMO1/sentrin specific peptidase 5"	Q96HI0	3	196867856-196934714	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006575			Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	"Centrosome, Cytosol"	"HPA006575: "	"unprognostic (4.07e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.63e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (2.14e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.71e-2)"	13.8	13.5	20.0	15.3	20.0	25.7	16.1	28.3	23.8	15.0	15.1	16.1	14.5	11.3	14.6	16.2	16.3	12.9	14.4	15.9	18.9	21.7	13.6	19.5	15.2	15.9	19.4	18.4	17.5	15.7	19.8	21.5	17.8	23.5	15.1	14.0	12.0	13.2	15.9	17.8	16.4	13.0	16.8	18.2	17.1	14.0	36.6	16.4	19.3	14.1	9.2	21.1	14.9	20.1	8.9	7.8	15.8	8.7	7.6	8.9	4.2	13.3	6.1	9.8	8.8	8.3	9.9	7.8	8.5	9.1	9.3	15.0	10.6	5.3	12.5	23.8	9.3	15.9	9.2	10.1	4.5	15.1	6.7	6.6	16.9	9.1	7.4	9.6	14.0	8.0	8.5	12.3	9.5	10.1	6.7	9.0	11.2	11.2	19.4	10.8	11.5	13.1	8.2	7.6	7.3	12.0	8.5	7.9	8.5	4.5	7.6	6.1	8.1	9.5	10.8	10.5	10.3	18.1	10.7	10.1	9.1	9.3	12.4	17.4	20.8	36.3	27.0	12.2	11.3	10.3	15.8	7.6	7.1	8.9	8.1	8.1	8.9	8.6	8.8	5.0	8.5	8.0	8.6	14.9	7.6	8.7	7.8	6.9	4.2	20.0	20.0	28.3	23.8	18.9	21.7	19.4	18.4	23.5	16.4	20.8	13.0	17.1	20.7	54.0	26.0	12.5	10.2	9.4	14.8	8.7	15.7	15.8	10.0	14.8	27.7	20.4	12.4	0.0	12.2	12.8	21.0	19.3	25.5	16.6	12.0	27.0	20.7	13.5	16.1	36.8	15.0	18.8	13.5	14.4	13.2	15.4	20.6	17.5	15.6	14.7	27.7	25.8	24.0	36.7	40.5	54.3	19.1	26.7	10.1	28.1
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942597	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	27.6	34.5	39.4	26.8	42.1	11.4	35.6	33.4	37.8	28.0	25.4	17.9	25.2	21.8	26.6	32.1	23.1	24.9	22.5	22.6	37.5	33.3	31.9	21.6	20.3	37.6	33.5	28.9	30.8	27.8	28.3	30.4	25.4	31.4	28.3	26.1	18.7	19.8	27.8	41.8	20.1	19.9	33.7	39.0	24.3	21.3	20.4	31.3	24.9	29.8	19.3	30.5	27.5	23.7	26.1	19.1	9.7	20.8	19.6	28.9	17.6	35.7	11.6	26.9	34.0	30.8	27.0	19.3	27.0	20.1	17.1	17.8	25.4	13.0	23.9	60.4	18.8	22.1	21.8	34.5	29.3	26.7	12.6	22.7	31.2	13.5	21.1	27.3	36.4	21.8	21.6	25.3	12.4	35.0	25.6	26.2	26.3	17.6	25.5	28.6	41.6	27.0	22.4	34.3	33.9	37.6	21.3	20.6	22.6	24.8	25.0	15.2	40.3	16.9	32.5	47.1	22.4	72.1	29.0	24.8	17.7	18.8	21.8	48.5	39.3	36.3	41.1	24.1	41.2	26.9	3.8	18.1	9.7	19.2	20.8	28.9	26.1	23.5	22.5	19.1	20.5	27.3	24.4	2.3	19.6	20.1	15.5	20.8	17.6	39.4	42.1	33.4	35.7	37.5	33.3	33.5	28.9	31.4	31.3	23.8	35.0	86.4	59.4	46.6	55.7	35.2	20.4	37.5	50.0	40.1	55.0	50.6	82.9	57.9	91.7	48.0	33.3	0.0	43.2	65.3	43.0	45.0	51.9	29.2	58.3	42.9	43.3	31.9	50.5	46.4	34.8	49.6	30.4	71.3	40.2	72.8	56.6	43.0	48.4	59.3	55.3	25.8	53.0	32.3	58.0	39.1	44.5	49.8	42.2	83.5
NCBP2-AS2		ENSG00000270170	"NCBP2 antisense RNA 2 (head to head)"	Q69YL0	3	196942623-196943540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.48e-1)"	"unprognostic (4.33e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.77e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (8.92e-4)"	"unprognostic (4.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.66e-3)"	5.0	5.1	6.2	3.5	9.8	14.5	6.2	4.4	12.4	4.2	9.6	4.5	3.8	6.7	3.8	5.8	3.8	4.4	5.8	7.1	5.1		6.5	5.1	4.1	5.0	5.1	5.8	3.9	11.9	5.1	2.5	3.7	7.1	5.6	7.3	5.4	6.8	5.9	16.2	4.4	6.0	4.3	2.8	4.9	6.1	2.4	5.5	3.9	5.3	8.6	4.7	2.5	5.3	41.4	46.6	40.4	45.5	41.4	56.0	37.7	17.7	5.2	9.2	10.9	7.4	6.7	17.6	8.4	5.8	11.7	7.8	10.1	6.5	16.7	31.3	6.2	9.2	14.2	14.9	7.4	9.2	5.9	22.3	13.2	6.3	16.4	8.3	12.2	8.3	11.1	13.8	6.8	8.5	5.4	7.6	15.9	13.2	13.4	5.0	31.5	15.3	22.1	20.1	20.0	25.7	13.8	8.0	20.5	9.7	10.1	21.2	24.1	9.0	13.9	19.9	9.9	28.4	14.1	5.7	5.5	16.1	8.6	17.7	20.3	23.2	40.0	6.4	21.2	7.2	25.0	45.5	40.4	36.1	34.1	37.8	35.2	45.3	41.0	39.9	41.4	56.0	45.7	17.6	41.4	29.9	46.6	40.9	37.7											14.9	8.8	33.7	40.9	44.0	22.6	36.4	33.1	6.7	18.2	45.4	11.8	43.8	101.2	32.4	4.9	40.9	47.7	70.0	48.5	33.2	35.1	44.2	13.9	38.1	37.7	17.5	48.6	35.0	33.2	5.8	30.8	29.6	45.5	27.1	55.7	34.4	47.8	37.4	26.5	64.0	23.4	25.8	40.6	12.6	25.3	57.6	28.7	40.2	57.9	59.3
PIGZ	"FLJ12768, MGC52163, SMP3"	ENSG00000119227	"Phosphatidylinositol glycan anchor biosynthesis class Z"	Q86VD9	3	196946343-196969060	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.5"	"Group enriched"	"Detected in many"	4	"Enterocytes: 66.9;Mucus-secreting cells: 56.2;Paneth cells: 75.0;Undifferentiated cells: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058599, HPA059920"	Approved					NA	NA					"HPA058599: AB_2683771, HPA059920: AB_2684162"	"unprognostic (1.46e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.25e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.02e-3)"	6.6	3.1	5.7	5.3	8.6	1.9	3.4	18.5	16.3	3.3	26.5	3.2	2.0	2.9	2.3	1.7	3.2	2.8	4.5	6.4	5.3	7.5	1.6	1.6	3.1	2.0	4.4	6.4	0.8	5.9	2.7	2.9	2.1	10.8	4.6	24.5	4.3	4.7	4.6	10.0	4.5	7.4	5.3	2.8	1.8	3.1	1.4	3.0	3.2	1.7	2.8	2.1	9.9	2.9	0.1	1.6	1.4	3.3	0.0	0.2	0.3	2.0	1.4	0.8	3.3	9.3	4.5	0.9	3.0	8.6	2.3	1.9	1.9	1.7	0.3	6.1	6.8	1.6	3.5	0.2	0.4	0.6	0.6	0.4	0.9	0.7	7.4	4.4	0.0	3.4	4.5	6.6	0.3	1.1	2.6	2.9	5.5	0.2	2.6	2.3	3.6	0.3	1.7	0.1	2.5	1.1	0.5	0.1	0.6	3.6	3.8	1.3	1.5	4.3	0.4	1.6	0.4	8.5	3.0	7.0	1.9	0.5	5.5	1.0	1.2	0.2	0.1	0.4	1.2	0.7	0.0	1.1	0.8	0.2	3.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	1.4	0.0	1.4	0.3	0.0	0.3	5.7	8.6	18.5	16.3	5.3	7.5	4.4	6.4	10.8	3.0	0.0	0.6	3.7	8.0	6.9	6.1	6.5	2.5	1.4	1.2	8.7	2.0	0.0	5.0	1.9	1.7	4.4	66.9	0.0	3.2	0.0	2.3	9.3	5.7	7.3	1.7	14.3	13.3	12.3	4.9	3.1	3.7	1.1	8.5	2.8	56.2	1.5	2.8	75.0	6.0	2.1	6.9	0.0	8.5	0.5	0.1	4.4	0.1	1.9	35.8	10.1
MELTF	"CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1"	ENSG00000163975	Melanotransferrin	P08582	3	196988621-197029816	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 65.7"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 14.0;Ductal cells: 23.5;Hofbauer cells: 16.2;Pancreatic endocrine cells: 42.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 32.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 3.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;monocytes: 2.1;T-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"A-431: 47.1;SK-MEL-30: 58.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004880	Approved				"Intracellular and membrane"	NA	NA		230000000			"HPA004880: AB_1853844"	"unprognostic (8.68e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.68e-3)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (6.99e-11)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.09e-2)"	6.0	1.6	1.9	3.5	2.0	1.8	7.5	2.7	2.8	4.4	5.1	3.3	3.5	2.1	4.9	4.8	2.4	6.4	2.5	3.3	1.8	1.1	5.1	1.4	1.6	1.7	1.0	1.0	1.3	4.3	15.9	1.8	4.4	2.9	3.7	1.9	2.9	65.7	4.7	1.4	10.5	8.7	3.1	1.1	1.0	1.1	2.6	0.9	3.6	2.0	1.3	2.4	2.0	5.4	0.2	1.9	0.2	2.1	0.5	3.3	0.6	47.1	10.3	0.1	0.3	1.5	1.9	1.2	0.8	0.4	1.6	1.9	2.9	7.1	1.3	10.2	1.6	1.4	14.8	0.5	0.0	0.7	2.1	3.3	1.6	2.2	1.2	9.6	0.2	9.4	10.3	1.3	1.3	0.1	0.0	0.2	2.7	1.2	9.3	0.9	2.8	2.7	0.0	1.1	2.0	6.8	3.9	1.6	0.5	0.2	0.4	0.9	3.5	9.8	0.8	58.2	1.2	2.9	1.4	0.3	0.3	8.3	1.7	5.8	1.6	13.1	1.3	1.2	2.8	0.0	0.1	0.3	0.0	1.2	1.0	3.3	0.2	1.0	1.0	1.9	0.2	0.3	0.1	0.2	0.5	2.1	0.0	0.1	0.6	1.9	2.0	2.7	2.8	1.8	1.1	1.0	1.0	2.9	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.4	14.0	0.0	0.2	0.0	23.5	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	42.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
DLG1	"dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97"	ENSG00000075711	"Discs large MAGUK scaffold protein 1"	Q12959	3	197042560-197299300	"Predicted intracellular proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016307, HPA069593"	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"CAB016307: AB_2092015, HPA069593: "	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.56e-3)"	"unprognostic (3.54e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-1)"	12.3	12.6	30.0	10.2	34.5	9.6	14.2	42.1	37.7	19.9	17.8	32.3	17.0	16.1	15.4	8.8	30.2	12.7	12.9	13.8	26.9	19.2	21.0	18.6	12.9	10.6	32.9	27.3	18.7	11.9	28.2	19.8	15.1	29.1	12.1	20.2	10.4	16.5	14.7	18.7	13.7	18.4	15.3	32.2	8.8	16.7	11.1	39.4	14.7	34.6	13.9	14.8	13.8	15.7	3.7	2.9	2.9	1.0	1.4	3.9	1.5	45.1	7.1	14.2	25.8	11.7	11.0	14.5	16.1	14.8	16.2	19.1	20.9	19.5	13.1	46.3	16.0	32.9	29.7	13.0	25.1	31.3	3.5	8.6	11.5	11.0	15.2	11.7	11.4	11.5	9.9	13.7	14.9	32.7	54.8	20.3	10.9	9.3	16.1	39.0	17.5	17.0	4.4	11.1	25.5	13.8	9.1	17.2	9.5	16.9	19.1	7.0	11.8	25.3	16.8	18.4	16.5	38.4	8.8	19.3	44.0	11.6	12.1	27.2	25.4	18.3	17.1	16.2	17.5	13.8	0.0	0.9	2.9	1.5	1.0	3.9	3.7	2.9	2.7	2.2	2.0	3.0	3.1	1.1	1.4	0.4	2.9	2.9	1.5	30.0	34.5	42.1	37.7	26.9	19.2	32.9	27.3	29.1	39.4	23.8	18.8	19.3	47.6	47.4	27.5	25.2	22.9	28.1	18.2	47.1	90.3	41.8	5.0	19.0	10.7	25.6	44.1	0.0	17.6	17.3	28.1	48.9	11.5	47.8	12.9	35.0	27.7	28.3	20.6	14.9	26.4	15.8	35.4	9.0	32.3	90.6	23.3	43.2	24.1	15.4	91.0	12.9	20.8	28.6	35.1	61.9	20.9	24.5	33.3	110.2
BDH1	"BDH, SDR9C1"	ENSG00000161267	"3-hydroxybutyrate dehydrogenase 1"	Q02338	3	197509783-197573323	"Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 156.0"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 20.3;U-937: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030947, HPA058709"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA030947: AB_10669548, HPA058709: AB_2683797"	"unprognostic (2.72e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.86e-7)"	"unprognostic (2.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (7.12e-8)"	"unprognostic (5.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.02e-1)"	3.5	2.8	6.6	5.2	11.2	4.7	4.6	18.1	13.8	4.0	13.9	4.6	6.3	9.6	2.1	3.6	12.9	5.5	6.1	19.6	6.3	5.8	6.0	156.0	2.0	4.2	5.9	9.1	3.0	2.8	5.8	3.6	1.4	7.7	4.5	11.1	6.2	8.6	4.4	7.3	8.0	13.7	2.4	3.5	2.3	4.7	1.8	3.6	5.4	5.2	11.3	7.4	3.6	3.6	6.1	4.6	2.9	1.6	4.7	9.9	4.0	10.4	1.4	0.6	5.4	0.9	0.0	0.0	1.2	1.0	5.4	3.1	9.4	3.5	0.0	15.6	0.3	0.4	4.9	4.7	2.5	2.1	0.1	0.0	5.5	3.6	3.2	4.0	12.3	5.8	1.6	2.9	2.1	4.6	0.5	1.3	6.3	0.0	4.2	0.1	18.6	9.5	8.3	4.1	20.3	1.9	9.0	2.0	14.3	5.8	4.8	9.9	4.3	3.8	0.5	2.0	0.2	12.5	10.3	0.1	0.3	1.8	0.0	9.8	4.8	9.1	0.1	0.3	35.0	0.6	2.9	1.6	0.6	5.9	0.2	8.2	6.1	6.5	5.3	4.2	5.5	9.9	5.9	0.0	4.7	0.3	4.6	4.2	4.0	6.6	11.2	18.1	13.8	6.3	5.8	5.9	9.1	7.7	3.6	3.0	6.5	8.0	8.1	8.2	20.4	35.0	17.8	49.5	10.3	12.2	19.6	1.6	44.7	4.7	7.8	1.5	56.7	0.0	4.9	3.6	5.1	6.8	1.1	92.8	7.2	17.5	26.2	4.9	3.3	10.3	5.2	5.5	15.1	0.0	38.7	16.2	2.2	31.6	3.9	12.1	32.8	0.0	5.4	14.1	4.7	9.5	1.6	9.6	56.2	11.9
RUBCN	"KIAA0226, rubicon, rundataxin"	ENSG00000145016	"RUN and cysteine rich domain containing beclin 1 interacting protein"	Q92622	3	197671393-197749727	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Endocytosis, Immunity, Phagocytosis"		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050908, HPA054497"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA050908: , HPA054497: AB_2682507"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.91e-5)"	"unprognostic (1.99e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.23e-1)"	10.7	8.4	19.3	15.5	24.0	10.7	6.8	30.0	24.6	7.9	9.8	12.4	6.4	10.7	9.1	6.5	14.5	7.7	10.4	10.3	18.1	18.8	7.8	5.7	12.4	19.8	14.6	19.4	14.0	11.0	13.3	16.6	8.5	18.3	7.4	8.8	8.3	7.1	11.2	9.7	11.7	12.0	11.4	15.1	22.3	11.3	22.0	15.8	7.9	7.4	7.0	22.3	9.6	8.0	7.8	14.7	12.8	4.1	1.5	4.4	1.2	15.1	3.5	4.3	8.6	7.5	4.3	4.4	7.0	4.6	8.4	7.2	6.3	4.2	17.4	13.8	7.6	8.3	8.3	7.9	3.8	6.9	4.4	7.0	10.6	6.1	2.3	4.3	6.0	8.9	3.5	5.0	7.4	8.8	3.9	5.1	7.4	5.8	43.4	5.6	12.2	7.2	3.8	3.6	4.5	11.7	7.2	4.3	10.8	4.9	6.6	17.3	4.1	5.1	10.0	5.6	2.9	14.8	3.9	6.9	5.1	4.9	13.9	9.3	20.6	16.5	13.2	6.7	11.1	4.4	0.6	2.4	12.8	3.6	3.5	2.3	6.6	3.0	4.4	1.4	7.8	2.2	3.0	2.7	1.5	4.1	14.7	3.6	1.2	19.3	24.0	30.0	24.6	18.1	18.8	14.6	19.4	18.3	15.8	6.0	12.8	22.8	4.6	0.0	17.7	0.0	2.5	1.4	7.9	12.2	17.7	1.5	1.7	5.8	13.1	4.7	3.8	23.3	5.5	3.0	2.7	6.2	2.3	3.9	7.7	20.6	0.0	11.1	12.6	11.4	4.6	8.5	0.0	105.6	3.6	15.3	6.3	0.0	6.0	2.2	13.7	6.5	0.0	21.4	15.6	0.0	5.4	6.9	3.1	10.0
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054474, HPA074880"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA054474: , HPA074880: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	12.0	10.2	12.8	13.6	13.1	14.5	24.5	20.5	13.9	11.3	11.9	6.9	13.3	6.6	13.2	10.2	19.0	13.2	10.3	19.4	11.0	12.5	11.1	12.0	11.8	13.5	11.1	10.9	13.3	17.0	13.8	13.2	13.9	13.4	11.0	9.2	6.0	10.0	13.9	82.6	11.6	10.1	21.8	17.1	11.4	10.3	16.7	10.7	10.5	12.6	15.8	15.3	15.7	21.8	11.2	15.9	23.7	16.6	32.5	22.7	21.5	30.1	6.7	13.2	12.6	15.6	17.3	4.1	14.8	15.2	23.0	18.9	10.4	10.4	19.4	54.5	17.5	12.2	10.9	16.6	15.2	24.5	4.2	7.6	29.1	10.2	4.7	15.2	21.6	14.2	12.4	19.7	12.4	17.9	15.9	18.1	11.0	13.1	41.9	20.3	25.3	23.4	5.1	2.9	13.2	12.3	21.8	16.2	13.6	16.7	19.9	25.2	10.9	22.8	18.1	16.8	10.1	42.5	11.5	15.9	11.8	11.8	14.9	15.6	25.4	38.6	23.3	12.5	31.3	12.1	23.7	14.2	13.6	18.3	16.6	22.7	11.2	17.6	20.1	15.9	9.9	19.4	18.7	4.6	32.5	15.2	8.9	15.5	21.5	12.8	13.1	20.5	13.9	11.0	12.5	11.1	10.9	13.4	10.7	32.8	25.6	37.5	37.5	73.2	33.7	111.7	22.9	56.2	30.7	45.4	29.5	21.1	76.3	32.4	14.6	54.0	13.7	0.0	31.3	24.4	46.8	54.4	65.7	45.5	33.4	42.9	54.2	37.4	46.8	12.1	29.7	54.4	49.0	141.5	21.6	36.9	28.5	18.4	35.0	39.2	39.7	38.8	66.5	84.2	83.9	79.5	41.9	50.3	18.0	59.3
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA012380: AB_1853260, HPA017299: AB_2669576"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	16.4	14.0	19.3	23.4	19.1	11.0	18.0	37.5	19.1	21.9	19.0	28.2	15.6	11.0	24.7	14.8	15.6	18.3	16.7	18.2	15.9	14.5	12.6	14.2	14.8	23.4	19.7	13.1	27.5	12.9	23.7	26.0	15.2	15.4	20.4	16.7	23.6	15.6	22.4	23.0	15.7	15.9	28.3	15.9	18.7	15.0	20.2	20.4	27.0	13.5	9.5	26.0	20.3	18.0	6.9	2.8	22.6	4.8	4.9	6.0	3.3	18.1	6.5	17.5	10.8	21.2	24.1	6.8	13.2	16.0	16.1	18.9	15.3	9.6	9.9	20.7	16.2	22.9	11.9	14.6	12.8	21.7	7.9	9.1	16.5	9.7	13.0	14.5	12.6	13.0	16.5	7.8	15.3	19.6	15.6	19.0	8.8	10.4	16.5	15.2	15.4	9.5	5.5	12.0	9.3	13.6	10.0	10.9	7.1	8.5	10.7	8.7	9.4	16.0	12.1	12.7	16.8	21.2	11.1	18.5	13.4	7.7	16.2	13.2	15.3	13.7	9.0	12.7	18.0	12.6	22.6	3.4	7.0	5.9	4.8	4.5	6.9	4.6	5.0	2.8	5.7	4.3	6.0	2.3	4.9	4.6	2.6	4.4	3.3	19.3	19.1	37.5	19.1	15.9	14.5	19.7	13.1	15.4	20.4	29.8	24.8	15.9	14.0	9.4	55.4	14.2	17.8	16.0	19.4	8.7	53.0	7.0	1.7	10.1	9.5	20.2	6.8	0.0	8.4	5.5	19.9	12.7	10.5	13.0	7.6	36.5	5.8	41.7	13.0	7.1	23.3	15.3	16.9	28.9	8.2	26.6	11.3	7.0	26.9	4.2	44.4	19.4	17.0	16.3	16.6	9.3	5.0	14.0	9.2	13.1
IQCG	"CFAP122, DKFZp434B227, DRC9"	ENSG00000114473	"IQ motif containing G"	Q9H095	3	197889075-197960142	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 44.9;testis: 34.2"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 433.6;Early spermatids: 224.8;Late spermatids: 337.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042787, HPA051981"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA042787: AB_10797021, HPA051981: AB_2732572"	"unprognostic (1.50e-2)"	"unprognostic (6.20e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.75e-2)"	6.2	5.0	10.9	3.0	14.6	3.0	5.4	3.6	7.6	5.7	3.0	12.3	4.1	2.5	4.5	11.6	3.9	44.9	4.4	4.2	12.6	12.9	5.9	3.6	8.0	3.9	9.0	5.7	5.0	2.1	4.5	12.0	3.4	20.8	3.9	3.7	5.3	2.5	4.6	2.0	2.8	2.6	4.1	9.2	3.1	3.4	34.2	11.2	1.4	7.4	1.0	3.9	4.5	2.2	8.9	7.3	8.9	8.4	6.6	9.1	5.0	3.9	4.3	5.6	5.4	12.1	12.4	2.2	4.8	5.3	5.7	5.9	0.8	3.8	1.3	5.4	3.9	7.4	3.7	4.0	3.7	9.3	3.0	2.8	2.4	2.3	2.0	2.8	3.1	3.8	6.4	4.7	6.2	2.0	4.7	2.7	6.6	2.5	5.4	4.3	9.0	1.7	1.5	3.4	5.7	5.8	5.0	3.7	1.9	5.5	1.6	4.9	5.9	8.0	3.2	3.3	5.2	24.4	2.1	2.7	3.7	2.5	11.0	4.4	4.7	13.2	2.3	13.6	4.5	5.9	4.6	8.4	8.9	8.2	6.4	5.3	8.9	6.9	5.4	7.3	4.2	6.2	9.1	5.8	6.6	5.7	6.5	6.8	5.0	10.9	14.6	3.6	7.6	12.6	12.9	9.0	5.7	20.8	11.2	6.0	7.7	5.1	2.8	8.2	12.5	9.7	0.0	433.6	42.1	5.2	70.7	5.1	13.3	5.5	224.8	6.9	1.7	0.0	3.7	4.6	6.8	2.4	8.1	3.9	5.8	9.5	4.1	6.7	5.7	337.4	21.0	10.2	13.5	1.0	2.6	13.5	8.6	1.9	22.3	7.8	44.0	6.5	4.6	84.6	32.3	7.9	4.3	11.3	2.3	2.0
RPL35A	L35A	ENSG00000182899	"Ribosomal protein L35a"	P18077	3	197949980-197956610	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, tRNA-binding"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (9.48e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.89e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (1.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.72e-2)"	67.4	61.5	50.0	69.8	62.5	97.2	142.7	55.7	73.5	79.5	58.7	24.0	62.6	48.6	144.5	79.4	70.5	74.4	60.6	108.6	66.7	33.7	52.4	49.8	89.4	255.9	41.6	53.5	172.0	304.9	21.5	49.1	36.4	90.1	61.0	54.8	35.0	180.2	48.5	108.0	81.3	51.8	97.8	38.8	63.0	65.1	73.9	28.5	64.4	76.9	109.8	84.2	62.7	108.4	160.0	100.9	38.8	82.2	83.4	213.5	234.3	169.4	47.9	80.9	68.3	82.7	170.7	100.2	85.4	91.9	105.7	80.5	155.8	64.2	174.3	300.9	69.2	59.2	82.3	86.7	102.7	112.1	34.9	163.5	96.2	80.1	103.3	131.6	153.3	64.7	154.1	119.9	58.7	180.2	139.1	109.6	74.9	84.6	153.5	104.5	221.7	86.8	172.9	121.6	144.8	162.9	81.7	56.3	226.3	115.4	98.6	78.4	82.0	57.4	156.6	217.2	57.2	272.1	239.4	79.8	45.4	63.3	72.3	150.2	127.3	180.0	222.1	66.9	277.0	70.2	38.8	82.2	25.9	88.3	60.9	139.0	160.0	160.9	121.4	97.2	150.9	213.5	163.2	12.8	83.4	52.5	100.9	105.9	234.3	50.0	62.5	55.7	73.5	66.7	33.7	41.6	53.5	90.1	28.5	985.6	1438.1	4533.0	3885.1	4741.1	298.3	448.9	1949.0	1452.1	2174.7	893.3	94.2	2354.2	2941.1	1752.5	1481.3	2286.5	1323.4	1168.1	3956.2	3881.0	3187.2	2899.3	1931.2	1482.5	2119.8	147.8	1576.2	2366.9	3134.8	1160.7	4192.2	3135.6	2815.7	2745.8	2752.9	433.9	3137.0	2556.6	2176.3	2591.2	311.2	1584.5	2269.1	617.6	658.1	5264.8	2251.4	2946.2	3554.4	3382.6
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 32.1;Early spermatids: 29.2;Spermatocytes: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	3.9	4.9	5.2	2.5	11.0	2.3	4.5	6.1	9.1	6.2	3.5	5.8	14.3	2.2	4.8	20.3	3.5	9.3	5.1	5.9	5.7	7.4	6.6	3.7	8.1	3.5	5.6	8.9	6.5	6.1	8.8	15.0	3.9	11.6	4.6	4.1	5.4	4.2	11.7	3.7	6.5	2.3	4.0	5.5	3.0	3.9	27.0	4.4	1.2	7.6	3.0	2.6	3.5	3.7	1.9	1.9	0.8	2.4	1.8	2.4	1.2	6.5	2.5	2.9	3.5	5.8	8.2	2.5	3.4	3.1	6.1	5.1	2.4	2.4	2.1	15.8	2.4	13.3	2.5	2.7	2.7	9.0	0.3	2.0	1.2	2.1	1.8	3.6	3.6	1.8	3.9	6.1	7.6	5.0	3.6	2.6	5.3	6.3	4.0	5.9	4.8	2.2	3.2	3.3	4.7	5.9	2.5	0.7	2.2	6.3	1.7	4.8	1.4	4.7	4.2	3.4	3.5	11.0	2.8	5.7	7.6	1.1	9.1	5.7	7.1	13.7	0.6	10.8	6.4	6.8	0.2	0.6	0.5	1.2	2.4	1.7	1.9	0.8	1.6	1.9	1.1	2.2	2.4	0.8	1.8	0.9	0.5	0.0	1.2	5.2	11.0	6.1	9.1	5.7	7.4	5.6	8.9	11.6	4.4	14.9	11.3	1.9	1.5	1.8	7.7	9.2	2.5	32.1	13.6	8.7	15.7	2.5	0.0	2.5	29.2	2.5	1.0	0.0	2.3	2.1	3.3	1.9	2.3	2.4	4.2	7.9	4.6	4.3	2.8	18.6	4.4	2.0	3.3	0.0	3.1	7.7	1.8	0.0	5.3	3.7	16.3	0.0	3.2	29.2	24.7	1.5	2.4	1.3	2.3	1.3
